PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cioce, M; Ganci, F; Canu, V; Sacconi, A; Mori, F; Canino, C; Korita, E; Casini, B; Alessandrini, G; Cambria, A; Carosi, MA; Blandino, R; Panebianco, V; Facciolo, F; Visca, P; Volinia, S; Muti, P; Strano, S; Croce, CM; Pass, HI; Blandino, G				Cioce, M.; Ganci, F.; Canu, V.; Sacconi, A.; Mori, F.; Canino, C.; Korita, E.; Casini, B.; Alessandrini, G.; Cambria, A.; Carosi, M. A.; Blandino, R.; Panebianco, V.; Facciolo, F.; Visca, P.; Volinia, S.; Muti, P.; Strano, S.; Croce, C. M.; Pass, H. I.; Blandino, G.			Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma	ONCOGENE			English	Article						mesothelioma; OCT4; mir-145; mesothelial cysts; chemoresistance; senescence	EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; HETEROCHROMATIN FORMATION; INHIBITS PROLIFERATION; ADENOCARCINOMA CELLS; PLURIPOTENCY FACTORS; LUNG ADENOCARCINOMA; CELLULAR SENESCENCE; GLIOMA-CELLS; OCT4	We identified a discrete number of microRNAs differentially expressed in benign or malignant mesothelial tissues. We focused on mir-145 whose levels were significantly downregulated in malignant mesothelial tissues and malignant pleural mesothelioma (MPM) cell lines as compared to benign tissues (pleura, peritoneum or cysts). We show that promoter hyper-methylation caused very low levels in MPM cell lines and specimens. Treatment of MPM cell lines with mir-145 agonists negatively modulated some protumorigenic properties of MPM cells, such as clonogenicity, cell migration and resistance to pemetrexed treatment. The main effector mechanism of the clonogenic death induced by mir-145 was that of accelerated senescence. We found that mir-145 targeted OCT4 via specific binding to its 30-UTR. Increased intracellular levels of mir-145 decreased the levels of OCT4 and its target gene ZEB1, thereby counteracting the increase of OCT4 induced by pemetrexed treatment which is known to favor the development of chemoresistant cells. In line with this, reintroduction of OCT4 into mimic-145 treated cells counteracted the effects on clonogenicity and replicative senescence. This further supports the relevance of the mir-145-OCT4 interaction for the survival of MPM cells. The potential use of mir-145 expression levels to classify benign vs malignant mesothelial tissues and the differences between pemetrexed-induced senescence and that induced by the re-expression of mir-145 are discussed.	[Cioce, M.; Canino, C.; Pass, H. I.] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA; [Ganci, F.; Canu, V.; Sacconi, A.; Korita, E.; Blandino, G.] Italian Natl Canc Inst Regina Elena, Translat Oncogen Unit, Rome, Italy; [Mori, F.; Strano, S.] Italian Natl Canc Inst Regina Elena, Mol Chemoprevent Grp, Rome, Italy; [Casini, B.; Carosi, M. A.; Visca, P.] Italian Natl Canc Inst, Dept Pathol, Rome, Italy; [Alessandrini, G.; Facciolo, F.] Regina Elena Inst Canc Res, Unit Thorac Surg, Rome, Italy; [Cambria, A.; Blandino, R.; Panebianco, V.] San Vincenzo Hosp, Dept Surg Oncol, Taormina, Italy; [Volinia, S.; Croce, C. M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Volinia, S.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Muti, P.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	New York University; NYU Langone Medical Center; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; McMaster University	Blandino, G (corresponding author), Regina Elena Inst Canc Res, Translat Oncogen Unit, Via Elio Chianesi 53, I-00144 Rome, Italy.	blandino@ifo.it	Volinia, Stefano/A-3029-2010; Strano, Sabrina/K-9654-2016; Cioce, Mario/R-9734-2017; Canu, Valeria/K-9333-2016; Volinia, Stefano/AAA-9264-2019; Young, Richard A/F-6495-2012; sacconi, andrea/J-3669-2018; Visca, Paolo/J-9547-2018; Ganci, Federica/K-9857-2016; Muti, Paola/AAD-9108-2020	Volinia, Stefano/0000-0003-0910-3893; Cioce, Mario/0000-0001-8129-6664; Canu, Valeria/0000-0001-9085-7320; Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; sacconi, andrea/0000-0002-8276-0438; Visca, Paolo/0000-0001-8484-6991; Ganci, Federica/0000-0002-8010-2183; Alessandrini, Gabriele/0000-0002-4380-7627; Facciolo, Francesco/0000-0002-7137-8946; CASINI, BEATRICE/0000-0002-9038-0179; strano, sabrina/0000-0002-6341-4230; Pass, Harvey/0000-0003-3222-3471	INAIL (Italian Workers' Compensation Authority); NATIONAL CANCER INSTITUTE [U01CA152758, P30CA016087] Funding Source: NIH RePORTER	INAIL (Italian Workers' Compensation Authority); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge INAIL (Italian Workers' Compensation Authority) for grant support (to GB).	Adammek M, 2013, FERTIL STERIL, V99, P1346, DOI 10.1016/j.fertnstert.2012.11.055; Basu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052188; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183; Calin GA, 2006, LEUKEMIA RES, V30, P653, DOI 10.1016/j.leukres.2005.10.017; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Casarsa C, 2011, CANCER LETT, V302, P136, DOI 10.1016/j.canlet.2011.01.009; Ceppi P, 2014, ONCOGENE, V33, P269, DOI 10.1038/onc.2013.55; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Dai XZ, 2013, ONCOL REP, V29, P155, DOI 10.3892/or.2012.2086; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Granville L, 2005, ARCH PATHOL LAB MED, V129, P1428; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hazarika M, 2005, CLIN CANCER RES, V11, P982; Jean D, 2012, ARCH PATHOL LAB MED, V136, P277, DOI 10.5858/arpa.2011-0215-RA; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kai K, 2010, LUNG CANCER, V70, P146, DOI 10.1016/j.lungcan.2010.04.020; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kaufman AJ, 2008, EXPERT REV ANTICANC, V8, P293, DOI 10.1586/14737140.8.2.293; Klinge CM, 2011, MOL CANCER THER, V10, P2062, DOI 10.1158/1535-7163.MCT-11-0381; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652; Linn Douglas E, 2010, Genes Cancer, V1, P908, DOI 10.1177/1947601910388271; Lu Y, 2013, ONCOL REP, V29, P67, DOI 10.3892/or.2012.2084; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Nakanishi H, 2014, ONCOGENE, V33, P702, DOI 10.1038/onc.2013.13; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Rodier Francis, 2013, Methods Mol Biol, V965, P165, DOI 10.1007/978-1-62703-239-1_10; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Rudd RM, 2010, BRIT MED BULL, V93, P105, DOI 10.1093/bmb/ldp047; Samardzija C, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-37; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schramm A, 2010, EUR J CARDIO-THORAC, V37, P566, DOI 10.1016/j.ejcts.2009.08.027; Speranza MC, 2012, ONCOTARGET, V3, P724; Tang GL, 2008, BBA-GENE REGUL MECH, V1779, P655, DOI 10.1016/j.bbagrm.2008.06.006; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wajapeyee Narendra, 2013, Methods Mol Biol, V965, P373, DOI 10.1007/978-1-62703-239-1_25; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Wu YJ, 2011, CANCER-AM CANCER SOC, V117, P3989, DOI 10.1002/cncr.25944; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211	57	50	55	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5319	5331		10.1038/onc.2013.476	http://dx.doi.org/10.1038/onc.2013.476			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24240684	Green Accepted, Green Submitted			2022-12-25	WOS:000345120600002
J	Smith, ES; Martinez-Velazquez, L; Ringstad, N				Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels			A Chemoreceptor That Detects Molecular Carbon Dioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Carbon Dioxide; Cyclic GMP (cGMP); Neurons; Receptors; Chemotransduction	GUANYLYL CYCLASE-D; C-ELEGANS; CAENORHABDITIS-ELEGANS; AVOIDANCE-BEHAVIOR; PRIMARY CULTURE; NEURONS; CO2; PH; OXYGEN; INTEGRATION	Animals from diverse phyla possess neurons that are activated by the product of aerobic respiration, CO2. It has long been thought that such neurons primarily detect the CO2 metabolites protons and bicarbonate. We have determined the chemical tuning of isolated CO2 chemosensory BAG neurons of the nematode Caenorhabditis elegans. We show that BAG neurons are principally tuned to detect molecular CO2, although they can be activated by acid stimuli. One component of the BAG transduction pathway, the receptor-type guanylate cyclase GCY-9, suffices to confer cellular sensitivity to both molecular CO2 and acid, indicating that it is a bifunctional chemoreceptor. We speculate that in other animals, receptors similarly capable of detecting molecular CO2 might mediate effects of CO2 on neural circuits and behavior.	[Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels] NYU, Med Ctr, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; [Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Smith, Ewan St. John] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	New York University; New York University; University of Cambridge	Smith, ES (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	es336@cam.ac.uk; Niels.Ringstad@med.nyu.edu	St. John Smith, Ewan/G-1776-2011	St. John Smith, Ewan/0000-0002-2699-1979	National Institutes of Health [R01-GM098320]; Max Kade Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS086750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Kade Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM098320 ( to N. R.). This work was also supported by XXXXXX.; Supported by a Max Kade Foundation Fellowship.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bianchi L., 2006, CULTURE EMBRYONIC C, DOI 10.1895/wormbook.1.122.1; Brandt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034014; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Carrillo MA, 2013, J NEUROSCI, V33, P9675, DOI 10.1523/JNEUROSCI.4541-12.2013; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Dean JB, 2010, RESP PHYSIOL NEUROBI, V173, P274, DOI 10.1016/j.resp.2010.07.002; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Filosa JA, 2002, J PHYSIOL-LONDON, V541, P493, DOI 10.1113/jphysiol.2001.014142; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3921, DOI 10.1113/jphysiol.2010.192096; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Huynh KT, 2011, J COMP PHYSIOL B, V181, P883, DOI 10.1007/s00360-011-0583-1; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Ma Dengke K, 2012, Front Biol (Beijing), V7, P246; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Scott K, 2011, NEURON, V69, P194, DOI 10.1016/j.neuron.2010.12.018; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Supuran CT, 2010, CURR PHARM DESIGN, V16, P3233; Wang WG, 2002, J PHYSIOL-LONDON, V540, P951, DOI 10.1113/jphysiol.2001.013443; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	43	34	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37071	37081		10.1074/jbc.M113.517367	http://dx.doi.org/10.1074/jbc.M113.517367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240097	Green Published, hybrid			2022-12-25	WOS:000329189700027
J	Birse, KM; Burgener, A; Westmacott, GR; McCorrister, S; Novak, RM; Ball, TB				Birse, Kenzie M.; Burgener, Adam; Westmacott, Garrett R.; McCorrister, Stuart; Novak, Richard M.; Ball, T. Blake			Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; ANTI-HIV-1 ACTIVITY; HIV-1 INFECTION; MICROBICIDE; IDENTIFICATION; INFLAMMATION; PROTECTION; INHIBITOR; S100A8/A9; CYTOKINE	Female genital tract secretions are commonly sampled by lavage of the ectocervix and vaginal vault or via a sponge inserted into the endocervix for evaluating inflammation status and immune factors critical for HIV microbicide and vaccine studies. This study uses a proteomics approach to comprehensively compare the efficacy of these methods, which sample from different compartments of the female genital tract, for the collection of immune factors. Matching sponge and lavage samples were collected from 10 healthy women and were analyzed by tandem mass spectrometry. Data was analyzed by a combination of differential protein expression analysis, hierarchical clustering and pathway analysis. Of the 385 proteins identified, endocervical sponge samples collected nearly twice as many unique proteins as cervicovaginal lavage (111 vs. 61) with 55% of proteins common to both (213). Each method/site identified 73 unique proteins that have roles in host immunity according to their gene ontology. Sponge samples enriched for specific inflammation pathways including acute phase response proteins (p = 3.37x10(-24)) and LXR/RXR immune activation pathways (p = 8.82x10(-22)) while the role IL-17A in psoriasis pathway (p = 5.98x10(-24)) and the complement system pathway (p = 3.91x10(-3)) were enriched in lavage samples. Many host defense factors were differentially enriched (p<0.05) between sites including known/potential antimicrobial factors (n = 21), S100 proteins (n = 9), and immune regulatory factors such as serpins (n = 7). Immunoglobulins (n = 6) were collected at comparable levels in abundance in each site although 25% of those identified were unique to sponge samples. This study demonstrates significant differences in types and quantities of immune factors and inflammation pathways collected by each sampling technique. Therefore, clinical studies that measure mucosal immune activation or factors assessing HIV transmission should utilize both collection methods to obtain the greatest representation of immune factors secreted into the female genital tract.	[Birse, Kenzie M.; Burgener, Adam; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Birse, Kenzie M.; Burgener, Adam; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Prote Grp, Winnipeg, MB, Canada; [Westmacott, Garrett R.; McCorrister, Stuart] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mass Spectrometry Core Facil, Winnipeg, MB, Canada; [Novak, Richard M.] Univ Illinois, Infect Dis Sect, Chicago, IL USA; [Ball, T. Blake] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Burgener, Adam; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada	University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi; Public Health Agency of Canada	Ball, TB (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	tball@cc.umanitoba.ca			National Institutes of Health; HIV Vaccine Trials Network; Public Health Agency of Canada	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Vaccine Trials Network; Public Health Agency of Canada	This work was funded through the National Institutes of Health (http://www.nih.gov/), HIV Vaccine Trials Network (http://www.hvtn.org/), and the Public Health Agency of Canada (http://www.phac-aspc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Broliden K, 2010, J INFECT DIS, V202, pS351, DOI 10.1086/655964; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Burgener A, 2012, AIDS; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Habte HH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-269; Hirbod T, 2008, CURR HIV RES, V6, P28, DOI 10.2174/157016208783571964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikemoto M, 2007, CLIN CHIM ACTA, V376, P197, DOI 10.1016/j.cca.2006.08.018; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Keller MJ, 2009, SEX TRANSM DIS, V36, pS92, DOI 10.1097/OLQ.0b013e318199417d; Klasse PJ, 2006, PLOS MED, V3, P1501, DOI 10.1371/journal.pmed.0030351; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031996; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Otsuka K, 2009, EUR J HEART FAIL, V11, P229, DOI 10.1093/eurjhf/hfn049; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rodriguez RM, 2012, ADV EXP MED BIOL, V739, P237, DOI 10.1007/978-1-4614-1704-0_15; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Sokal DC, 2013, ANTIVIR THER, V18, P301, DOI 10.3851/IMP2311; Sroussi HY, 2006, J DENT RES, V85, P829, DOI 10.1177/154405910608500910; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; UNAIDS, 2011, WORLD REF DAY 2019 H; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560	44	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79505	10.1371/journal.pone.0079505	http://dx.doi.org/10.1371/journal.pone.0079505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244515	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800086
J	Campling, BG; Kuryatov, A; Lindstrom, J				Campling, Barbara G.; Kuryatov, Alexander; Lindstrom, Jon			Acute Activation, Desensitization and Smoldering Activation of Human Acetylcholine Receptors	PLOS ONE			English	Article							ALPHA-4-BETA-2 NICOTINIC RECEPTORS; PARTIAL AGONISTS VARENICLINE; SAZETIDINE-A; SUBUNITS CONTRIBUTE; RB-86(+) EFFLUX; LOW-SENSITIVITY; ALPHA 4; PHARMACOLOGY; EXPRESSION; CHEMISTRY	The behavioral effects of nicotine and other nicotinic agonists are mediated by AChRs in the brain. The relative contribution of acute activation versus chronic desensitization of AChRs is unknown. Sustained "smoldering activation'' occurs over a range of agonist concentrations at which activated and desensitized AChRs are present in equilibrium. We used a fluorescent dye sensitive to changes in membrane potential to examine the effects of acute activation and chronic desensitization by nicotinic AChR agonists on cell lines expressing human alpha 4 beta 2, alpha 3 beta 4 and alpha 7 AChRs. We examined the effects of acute and prolonged application of nicotine and the partial agonists varenicline, cytisine and sazetidine-A on these AChRs. The range of concentrations over which nicotine causes smoldering activation of alpha 4 beta 2 AChRs was centered at 0.13 mu M, a level found in smokers. However, nicotine produced smoldering activation of alpha 3 beta 4 and alpha 7 AChRs at concentrations well above levels found in smokers. The alpha 4 beta 2 expressing cell line contains a mixture of two stoichiometries, namely (alpha 4 beta 2)(2)beta 2 and (alpha 4 beta 2)(2)alpha(4). The (alpha 4 beta 2)(2)beta 2 stoichiometry is more sensitive to activation by nicotine. Sazetidine-A activates and desensitizes only this stoichiometry. Varenicline, cytisine and sazetidine-A were partial agonists on this mixture of alpha 4 beta 2 AChRs, but full agonists on alpha 3 beta 4 and alpha 7 AChRs. It has been reported that cytisine and varenicline are most efficacious on the (alpha 4 beta 2)(2)alpha 4 stoichiometry. In this study, we distinguish the dual effects of activation and desensitization of AChRs by these nicotinic agonists and define the range of concentrations over which smoldering activation can be sustained.	[Campling, Barbara G.; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Campling, Barbara G.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	jslkk@mail.med.upenn.edu			National Institutes of Health [NS11232]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support provided by grant NS11232 from the National Institutes of Health (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSharari SD, 2012, J PHARMACOL EXP THER, V342, P742, DOI 10.1124/jpet.112.194506; Astroug Henri, 2010, Interdiscip Toxicol, V3, P15, DOI 10.2478/v10102-010-0003-5; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Cahill Kate, 2016, Cochrane Database Syst Rev, pCD006103, DOI 10.1002/14651858.CD006103.pub7; Caldarone BJ, 2011, PSYCHOPHARMACOLOGY, V217, P199, DOI 10.1007/s00213-011-2271-y; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Conroy WG, 2003, MOL PHARMACOL, V63, P419, DOI 10.1124/mol.63.2.419; Cucchiaro G, 2008, ANESTHESIOLOGY, V109, P512, DOI 10.1097/ALN.0b013e3181834490; Dunlop J, 2007, BIOCHEM PHARMACOL, V74, P1172, DOI 10.1016/j.bcp.2007.07.006; Etter JF, 2006, ARCH INTERN MED, V166, P1553, DOI 10.1001/archinte.166.15.1553; Faessel HM, 2010, CLIN PHARMACOKINET, V49, P799, DOI 10.2165/11537850-000000000-00000; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P441, DOI 10.1124/jpet.112.198085; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P434, DOI 10.1124/jpet.112.198069; Jia L, 2003, J NEUROCHEM, V84, P753, DOI 10.1046/j.1471-4159.2003.01578.x; Kozikowski AP, 2009, CHEMMEDCHEM, V4, P1279, DOI 10.1002/cmdc.200900079; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062246; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Levin ED, 2010, J PHARMACOL EXP THER, V332, P933, DOI 10.1124/jpet.109.162073; Lindstrom JM, 2002, CURRENT CLIN NEUROLO, P15; Liu Y, 2013, J MED CHEM, V56, P3000, DOI 10.1021/jm4000374; LUETJE CW, 1991, J NEUROSCI, V11, P837; Lummis SCR, 2011, J PHARMACOL EXP THER, V339, P125, DOI 10.1124/jpet.111.185306; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, J PHARMACOL EXP THER, V337, P367, DOI 10.1124/jpet.110.177485; Papke RL, 2010, J MOL NEUROSCI, V40, P77, DOI 10.1007/s12031-009-9261-0; PENG X, 1994, MOL PHARMACOL, V45, P546; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Rezvani AH, 2010, PSYCHOPHARMACOLOGY, V211, P161, DOI 10.1007/s00213-010-1878-8; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Turner JR, 2010, J PHARMACOL EXP THER, V334, P665, DOI 10.1124/jpet.110.166280; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	57	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79653	10.1371/journal.pone.0079653	http://dx.doi.org/10.1371/journal.pone.0079653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244538	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800096
J	Mao, QH; Ruan, JP; Cai, XT; Lu, WG; Ye, J; Yang, J; Yang, Y; Sun, XY; Cao, JL; Cao, P				Mao, Qinghong; Ruan, Jiaping; Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Junli; Cao, Peng			Antinociceptive Effects of Analgesic-Antitumor Peptide (AGAP), a Neurotoxin from the Scorpion Buthus martensii Karsch, on Formalin-Induced Inflammatory Pain through a Mitogen-Activated Protein Kinases-Dependent Mechanism in Mice	PLOS ONE			English	Article							TERMINAL PARTIAL SEQUENCE; ESCHERICHIA-COLI; NEUROPATHIC PAIN; SPINAL NEURONS; VENOM; PURIFICATION; CONTRIBUTES; EXPRESSION; HYPERSENSITIVITY; BMK	In the present study, we investigated the anti-nociceptive effect and the underlying mechanism of the analgesic-antitumor peptide (AGAP), a neurotoxin from the scorpion Buthus martensii Karsch. AGAP in doses of 0.2, 1 and 5 mu g was injected intraplantarly (i.pl.) before formalin injection 10 min at the same site. The suppression by intraplantar injection of AGAP on formalin-induced spontaneous nociceptive behaviors was investigated. The results show that AGAP could dose-dependently inhibit formalin-induced two-phase spontaneous flinching response. To investigate the mechanism of action of treatment with AGAP in inflammatory pain, the expressions of peripheral and spinal phosphorylated mitogen-activated protein kinases (phospho-MAPKs) including p-p38, p-ERK and p-JNK were examined. We found that formalin increased the expressions of peripheral and spinal MAPKs, which were prevented by pre-intraplantar injection of AGAP in inflammation pain model in mice. AGAP could also decrease the expression of spinal Fos induced by formalin. Furthermore, combinations the lower doses of the inhibitors of MAPKs (U0126, SP600125, or SB203580 0.1 mg) with the lower dose of AGAP (0.2 mu g), the results suggested that AGAP could potentiate the effects of the inhibitors of MAPKs on the inflammatory pain. The present results indicate that pre-intraplantar injection of AGAP prevents the inflammatory pain induced by formalin through a MAPKs-mediated mechanism in mice.	[Mao, Qinghong; Ruan, Jiaping; Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Peng] China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China; [Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Peng] Jiangsu Prov Inst Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Cao, Junli] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Jiangsu Key Lab Anesthesiol, Xuzhou, Peoples R China	China Academy of Chinese Medical Sciences; Xuzhou Medical University	Ruan, JP (corresponding author), China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China.	jpruan@163.com; pcao79@yahoo.com	Sheng, Lei/HDO-1972-2022	Cao, Jun-Li/0000-0002-8932-4743; , Peng/0000-0002-2044-3074	National Natural Science Foundation of China [81102834, 81302694]; Natural Science Foundation of Jiangsu Province [SBK201241903, SBK201342382, SBK201342799]; Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	This work was supported by the National Natural Science Foundation of China (81102834, 81302694), Natural Science Foundation of Jiangsu Province (SBK201241903, SBK201342382, SBK201342799), and Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao P, 2010, BIOTECHNOL PROGR, V26, P1240, DOI 10.1002/btpr.433; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Liu T, 2008, J ETHNOPHARMACOL, V117, P332, DOI 10.1016/j.jep.2008.02.003; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Liu YF, 2002, PREP BIOCHEM BIOTECH, V32, P317, DOI 10.1081/PB-120015456; Ma R, 2010, BIOCHEM BIOPH RES CO, V394, P330, DOI 10.1016/j.bbrc.2010.02.179; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Wang ZY, 2006, NEUROPHARMACOLOGY, V51, P764, DOI 10.1016/j.neuropharm.2006.05.024; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zhao YL, 2011, J CELL BIOCHEM, V112, P2424, DOI 10.1002/jcb.23166; ZHOU XH, 1989, BIOCHEM J, V257, P509, DOI 10.1042/bj2570509	21	24	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78239	10.1371/journal.pone.0078239	http://dx.doi.org/10.1371/journal.pone.0078239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244296	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800007
J	Qi, L; Zhu, ZF; Li, F; Wang, RF				Qi, Liang; Zhu, Zheng-Feng; Li, Feng; Wang, Ren-Fa			MR Imaging of Patients with Lateral Epicondylitis of the Elbow: Is the Common Extensor Tendon an Isolated Lesion?	PLOS ONE			English	Article							POSTEROLATERAL ROTATORY INSTABILITY; TENNIS ELBOW; MEDIAL EPICONDYLITIS	Objective: To investigate whether an injury of the common extensor tendon (CET) is associated with other abnormalities in the elbow joint and find the potential relationships between these imaging features by using a high-resolution magnetic resonance imaging (MRI). Methods: Twenty-three patients were examined with 3.0 T MR. Two reviewers were recruited for MR images evaluation. Image features were recorded in terms of (1) the injury degree of CET; (2) associated injuries in the elbow joint. Spearman's rank correlation analysis was performed to analyze the relationships between the injury degree of CET and associated abnormalities of the elbow joint, correlations were considered significant at p<0.05. Results: Total 24 elbows in 23 patients were included. Various degrees of injuries were found in total 24 CETs (10 mild, 7 moderate and 7 severe). Associated abnormalities were detected in accompaniments of the elbow joints including ligaments, tendons, saccussynovialis and muscles. A significantly positive correlation (r = 0.877, p<0.01) was found in injuries of CET and lateral ulnar collateral ligament (LUCL). Conclusion: Injury of the CET is not an isolated lesion for lateral picondylitis, which is mostly accompanied with other abnormalities, of which the LUCL injury is the most commonly seen in lateral epicondylitis, and there is a positive correlation between the injury degree in CET and LUCL.	[Qi, Liang] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Zheng-Feng] Huazhong Univ Sci & Technol, Union Hosp, Inst Cardiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Feng; Wang, Ren-Fa] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430074, Peoples R China	Nanjing Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, RF (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430074, Peoples R China.	wangrenfa52@126.com			Priority Academic Program Development of Jiangsu Highter Education Institution [JX10231801]	Priority Academic Program Development of Jiangsu Highter Education Institution	This study was supported by The Priority Academic Program Development of Jiangsu Highter Education Institution (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisset L, 2011, CLIN EVID; BOYD HB, 1973, J BONE JOINT SURG AM, VA 55, P1183, DOI 10.2106/00004623-197355060-00005; Bredella MA, 1999, AM J ROENTGENOL, V173, P1379, DOI 10.2214/ajr.173.5.10541124; Bunata RE, 2007, J BONE JOINT SURG AM, V89A, P1955, DOI 10.2106/JBJS.F.00727; Ciccotti MC, 2004, CLIN SPORT MED, V23, P693, DOI 10.1016/j.csm.2004.04.011; Ciccotti MC, 2004, CLIN SPORTS MED, V23, pxi; COEL M, 1993, AM J ROENTGENOL, V161, P1019, DOI 10.2214/ajr.161.5.8273602; Cohen MS, 2008, J SHOULDER ELB SURG, V17, P954, DOI 10.1016/j.jse.2008.02.021; COONRAD RW, 1973, J BONE JOINT SURG AM, VA 55, P1177, DOI 10.2106/00004623-197355060-00004; Degreef Ilse, 2005, Acta Orthop Belg, V71, P154; Gleason T F, 1983, J Bone Joint Surg Am, V65, P1031; Jacobson JA, 2005, SEMIN MUSCULOSKEL R, V9, P346, DOI 10.1055/s-2005-923379; Kijowski R, 2005, SKELETAL RADIOL, V34, P196, DOI 10.1007/s00256-005-0896-9; Kumar S, 2011, ANN ROY COLL SURG, V93, P432, DOI 10.1308/rcsann.2011.93.6.432; Lattermann C, 2010, J SHOULDER ELB SURG, V19, P651, DOI 10.1016/j.jse.2010.02.008; Lee BPH, 2003, J SHOULDER ELB SURG, V12, P476, DOI 10.1016/S1058-2746(03)00091-0; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; Olivieri I, 2004, CLIN RHEUMATOL, V23, P275, DOI 10.1007/s10067-004-0870-2; POTTER HG, 1995, RADIOLOGY, V196, P43, DOI 10.1148/radiology.196.1.7784585; Thornton Raymond, 2003, Top Magn Reson Imaging, V14, P69, DOI 10.1097/00002142-200302000-00006; Walz DM, 2010, RADIOGRAPHICS, V30, P167, DOI 10.1148/rg.301095078; Wixom SM, 2012, J HAND THER, V25, P421; Wixom Steven M, 2012, J Hand Ther, V25, P418, DOI 10.1016/j.jht.2012.06.007	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79498	10.1371/journal.pone.0079498	http://dx.doi.org/10.1371/journal.pone.0079498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244512	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800083
J	Sekihara, K; Harashima, N; Tongu, M; Tamaki, Y; Uchida, N; Inomata, T; Harada, M				Sekihara, Kazumasa; Harashima, Nanae; Tongu, Miki; Tamaki, Yukihisa; Uchida, Nobue; Inomata, Taisuke; Harada, Mamoru			Pifithrin-mu, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SMALL-MOLECULE INHIBITOR; RANDOMIZED-TRIAL; HSP70; APOPTOSIS; SURVIVAL; FAMILY; RADIOTHERAPY; QUERCETIN; STRESS	Hyperthermia (HT) improves the efficacy of anti-cancer radiotherapy and chemotherapy. However, HT also inevitably evokes stress responses and increases the expression of heat-shock proteins (HSPs) in cancer cells. Among the HSPs, HSP70 is known as a pro-survival protein. In this study, we investigated the sensitizing effect of pifithrin (PFT)-mu, a small molecule inhibitor of HSP70, when three human prostate cancer cell lines (LNCaP, PC-3, and DU-145) were treated with HT (43 degrees C for 2 h). All cell lines constitutively expressed HSP70, and HT further increased its expression in LNCaP and DU-145. Knockdown of HSP70 with RNA interference decreased the viability and colony-forming ability of cancer cells. PFT-mu decreased the viabilities of all cell lines at one-tenth the dose of Quercetin, a well-known HSP inhibitor. The combination therapy with suboptimal doses of PFT-mu and HT decreased the viability of cancer cells most effectively when PFT-mu was added immediately before HT, and this combination effect was abolished by pre-knockdown of HSP70, suggesting that the effect was mediated via HSP70 inhibition. The combination therapy induced cell death, partially caspase-dependent, and decreased proliferating cancer cells, with decreased expression of c-Myc and cyclin D1 and increased expression of p21(WAF1/Cip), indicating arrest of cell growth. Additionally, the combination therapy significantly decreased the colony-forming ability of cancer cells compared to therapy with either alone. Furthermore, in a xenograft mouse model, the combination therapy significantly inhibited PC-3 tumor growth. These findings suggest that PFT-mu can effectively enhance HT-induced antitumor effects via HSP70 inhibition by inducing cell death and arrest of cell growth, and that PFT-mu is a promising agent for use in combination with HT to treat prostate cancer.	[Sekihara, Kazumasa; Harashima, Nanae; Harada, Mamoru] Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan; [Sekihara, Kazumasa; Tamaki, Yukihisa; Inomata, Taisuke] Shimane Univ, Fac Med, Dept Radiat Oncol, Matsue, Shimane, Japan; [Tongu, Miki] Shimane Univ, Dept Expt Anim, Izumo, Shimane, Japan; [Uchida, Nobue] Tottori Prefectural Cent Hosp, Dept Radiat Oncol, Tottori, Japan	Shimane University; Shimane University; Shimane University	Harada, M (corresponding author), Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan.	haramamo@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [18591449, 23701074]; Shimane University "S-TAKUMI Medical Nanotechnology" Project	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shimane University "S-TAKUMI Medical Nanotechnology" Project	This study was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 18591449 to M. Harada and no. 23701074 to N. Harashima), and from Shimane University "S-TAKUMI Medical Nanotechnology" Project (to M. Harada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Asea A, 2001, INT J HYPERTHER, V17, P347, DOI 10.1080/02656730110053146; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Colombo R, 2003, J CLIN ONCOL, V21, P4270, DOI 10.1200/JCO.2003.01.089; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davenport EL, 2010, LEUKEMIA, V24, P1804, DOI 10.1038/leu.2010.168; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Galluzzi L, 2009, MOL CELL, V36, P176, DOI 10.1016/j.molcel.2009.10.003; Gleave ME, 1999, CAN MED ASSOC J, V160, P225; GRESS TM, 1994, CANCER RES, V54, P547; Haveman J, 2005, ONCOL REP, V14, P561; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kalapurakal JA, 2003, INT J RADIAT ONCOL, V57, P654, DOI 10.1016/S0360-3016(03)00625-4; Kampinga HH, 2001, INT J RADIAT BIOL, V77, P399, DOI 10.1080/09553000010024687; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kouloulias V, 2005, AM J CLIN ONCOL-CANC, V28, P91, DOI 10.1097/01.coc.0000139939.60056.42; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michalakis J, 2007, ANN SURG ONCOL, V14, P1220, DOI 10.1245/s10434-006-9305-4; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Morishima Y, 2000, J BIOL CHEM, V66, P535; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Nylandsted J, 2002, CANCER RES, V62, P7139; OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roigas J, 1998, PROSTATE, V34, P195; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tso CL, 2000, CANCER J, V6, P220; van der Zee J, 2000, LANCET, V355, P1119, DOI 10.1016/S0140-6736(00)02059-6	42	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78772	10.1371/journal.pone.0078772	http://dx.doi.org/10.1371/journal.pone.0078772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244355	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800014
J	Weng, TP; Huang, SC; Chuang, YF; Wang, JS				Weng, Tzu-Pin; Huang, Shu-Chun; Chuang, Yu-Fen; Wang, Jong-Shyan			Effects of Interval and Continuous Exercise Training on CD4 Lymphocyte Apoptotic and Autophagic Responses to Hypoxic Stress in Sedentary Men	PLOS ONE			English	Article							T-CELL-ACTIVATION; OXIDATIVE STRESS; HEART-FAILURE; IMMUNE FUNCTION; PROTECTS; HEMODYNAMICS; AGGREGATION; INTENSITY; PLATELET; CAPACITY	Exercise is linked with the type/intensity-dependent adaptive immune responses, whereas hypoxic stress facilitates the programmed death of CD4 lymphocytes. This study investigated how high intensity-interval (HIT) and moderate intensity-continuous (MCT) exercise training influence hypoxia-induced apoptosis and autophagy of CD4 lymphocytes in sedentary men. Thirty healthy sedentary males were randomized to engage either HIT (3-minute intervals at 40% and 80% VO2max, n=10) or MCT (sustained 60% VO2max, n=10) for 30 minutes/day, 5 days/week for 5 weeks, or to a control group that did not received exercise intervention (CTL, n=10). CD4 lymphocyte apoptotic and autophagic responses to hypoxic exercise (HE, 100W under 12%O-2 for 30 minutes) were determined before and after various regimens. The results demonstrated that HIT exhibited higher enhancements of pulmonary ventilation, cardiac output, and VO2 at ventilatory threshold and peak performance than MCT did. Before the intervention, HE significantly down-regulated autophagy by decreased beclin-1, Atg-1, LC3-II, Atg-12, and LAMP-2 expressions and acridine orange staining, and simultaneously enhanced apoptosis by increased phospho-Bcl-2 and active caspase-9/-3 levels and phosphotidylserine exposure in CD4 lymphocytes. However, five weeks of HIT and MCT, but not CTL, reduced the extents of declined autophagy and potentiated apoptosis in CD4 lymphocytes caused by HE. Furthermore, both HIT and MCT regimens manifestly lowered plasma myeloperoxidase and interleukin-4 levels and elevated the ratio of interleukin-4 to interferon-gamma at rest and following HE. Therefore, we conclude that HIT is superior to MCT for enhancing aerobic fitness. Moreover, either HIT or MCT effectively depresses apoptosis and promotes autophagy in CD4 lymphocytes and is accompanied by increased interleukin-4/interferon-gamma ratio and decreased peroxide production during HE.	[Weng, Tzu-Pin; Chuang, Yu-Fen; Wang, Jong-Shyan] Chang Gung Univ, Grad Inst Rehabil Sci, Healthy Aging Res Ctr, Tao Yuan, Taiwan; [Huang, Shu-Chun] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taiwan; [Weng, Tzu-Pin] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil Sci, Miaoli, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Wang, JS (corresponding author), Chang Gung Univ, Grad Inst Rehabil Sci, Healthy Aging Res Ctr, Tao Yuan, Taiwan.	s5492@mail.cgu.edu.tw		chuang, yufen/0000-0002-4797-625X	National Science Council of Taiwan (NSC) [100-2314-B-182-004-MY3]; Chang Gung Medical Research Program (CMRPG) [280241]; Healthy Aging Research Center, Chang Gung University [EMRPD1A0841]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Program (CMRPG); Healthy Aging Research Center, Chang Gung University	This work was supported by the National Science Council of Taiwan (grant number NSC 100-2314-B-182-004-MY3), Chang Gung Medical Research Program (grant number CMRPG 280241) and the Healthy Aging Research Center, Chang Gung University (grant number EMRPD1A0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/00041433-200308000-00003; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Feng CG, 2009, AUTOPHAGY, V5, P232, DOI 10.4161/auto.5.2.7445; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; Glanemann M, 2003, J HEPATOL, V38, P59, DOI 10.1016/S0168-8278(02)00327-6; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Higgins GC, 2011, CELL MOL LIFE SCI, V68, P3725, DOI 10.1007/s00018-011-0667-9; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Kontogianni K, 2007, ENVIRON MOL MUTAGEN, V48, P722, DOI 10.1002/em.20351; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Mazzeo RS, 2005, EXERC IMMUNOL REV, V11, P6; Paraskevaidis IA, 2005, INT J CARDIOL, V98, P221, DOI 10.1016/j.ijcard.2003.10.040; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Thompson W.R., 2010, ACSMS GUID EX TEST P, P152; van Baarle D, 2005, IMMUNOL LETT, V97, P19, DOI 10.1016/j.imlet.2004.10.003; Wang JS, 2007, J APPL PHYSIOL, V103, P305, DOI 10.1152/japplphysiol.00226.2007; Wang JS, 2013, INT J CARDIOL, V168, P1243, DOI 10.1016/j.ijcard.2012.11.053; Wang JS, 2011, BRAIN BEHAV IMMUN, V25, P270, DOI 10.1016/j.bbi.2010.09.018; Wang JS, 2010, EUR J APPL PHYSIOL, V108, P371, DOI 10.1007/s00421-009-1231-2; Wang JS, 2009, STROKE, V40, P656, DOI 10.1161/STROKEAHA.108.517995; Wang JS, 2006, THROMB HAEMOSTASIS, V95, P490, DOI 10.1160/TH05-09-0646; Wang JS, 2005, EUR J APPL PHYSIOL, V95, P290, DOI 10.1007/s00421-005-0005-8; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Woods JA, 1999, MED SCI SPORT EXER, V31, P57, DOI 10.1097/00005768-199901000-00011; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18	32	38	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80248	10.1371/journal.pone.0080248	http://dx.doi.org/10.1371/journal.pone.0080248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236174	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700175
J	Aiken, AM; Wanyoro, AK; Mwangi, J; Juma, F; Mugoya, IK; Scott, JAG				Aiken, Alexander M.; Wanyoro, Anthony K.; Mwangi, Jonah; Juma, Francis; Mugoya, Isaac K.; Scott, J. Anthony G.			Changing Use of Surgical Antibiotic Prophylaxis in Thika Hospital, Kenya: A Quality Improvement Intervention with an Interrupted Time Series Design	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTION; ANTIMICROBIAL PROPHYLAXIS; SITE INFECTIONS; AFRICA; SURVEILLANCE; COUNTRIES; RESISTANT; SURGERY; BENEFIT	Introduction: In low-income countries, Surgical Site Infection (SSI) is a common form of hospital-acquired infection. Antibiotic prophylaxis is an effective method of preventing these infections, if given immediately before the start of surgery. Although several studies in Africa have compared pre-operative versus post-operative prophylaxis, there are no studies describing the implementation of policies to improve prescribing of surgical antibiotic prophylaxis in African hospitals. Methods: We conducted SSI surveillance at a typical Government hospital in Kenya over a 16 month period between August 2010 and December 2011, using standard definitions of SSI and the extent of contamination of surgical wounds. As an intervention, we developed a hospital policy that advised pre-operative antibiotic prophylaxis and discouraged extended post-operative antibiotics use. We measured process, outcome and balancing effects of this intervention in using an interrupted time series design. Results: From a starting point of near-exclusive post-operative antibiotic use, after policy introduction in February 2011 there was rapid adoption of the use of pre-operative antibiotic prophylaxis (60% of operations at 1 week; 98% at 6 weeks) and a substantial decrease in the use of post-operative antibiotics (40% of operations at 1 week; 10% at 6 weeks) in Clean and Clean-Contaminated surgery. There was no immediate step-change in risk of SSI, but overall, there appeared to be a moderate reduction in the risk of superficial SSI across all levels of wound contamination. There were marked reductions in the costs associated with antibiotic use, the number of intravenous injections performed and nursing time spent administering these. Conclusion: Implementation of a locally developed policy regarding surgical antibiotic prophylaxis is an achievable quality improvement target for hospitals in low-income countries, and can lead to substantial benefits for individual patients and the institution.	[Aiken, Alexander M.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, London WC1, England; [Aiken, Alexander M.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Wanyoro, Anthony K.; Mwangi, Jonah; Juma, Francis] Thika Level 5 Hosp, Thika, Kenya; [Wanyoro, Anthony K.] Kenyatta Univ, Nairobi, Kenya; [Mugoya, Isaac K.] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX1 2JD, England	University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Kenyatta University; University of Oxford	Scott, JAG (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	alexander.aiken@lshtm.ac.uk	Aiken, Alexander/AAP-7661-2021	Aiken, Alexander/0000-0003-3372-9036	KEMRI-Wellcome Trust; Wellcome Trust of Great Britain [085042, 081835]; National Institute for Health Research [CL-2012-18-002] Funding Source: researchfish	KEMRI-Wellcome Trust(Wellcome Trust); Wellcome Trust of Great Britain(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	Surveillance at Thika Hospital was funded by the KEMRI-Wellcome Trust Research Programme as part of the Training Fellowship for AA. AA and JAGS are supported by research fellowships from the Wellcome Trust of Great Britain (grant numbers 085042 and 081835 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2013, J HOSP INFECT, V83, P140, DOI 10.1016/j.jhin.2012.11.003; Aiken AM, 2012, INT J SURG, V10, P242, DOI 10.1016/j.ijsu.2012.04.004; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; Davey P, 2009, COCHRANE DB SYST REV; Goff DA, 2012, CLIN INFECT DIS; Hedrick TL, 2012, LANCET INFECT DIS, V12, P357, DOI 10.1016/S1473-3099(12)70019-1; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kayihura V, 2003, ACTA OBSTET GYN SCAN, V82, P636, DOI 10.1034/j.1600-0412.2003.00205.x; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Owens SM, 2009, OBSTET GYNECOL, V114, P573, DOI 10.1097/AOG.0b013e3181b490f1; Reggiori A, 1996, BRIT J SURG, V83, P356, DOI 10.1002/bjs.1800830319; Saxer F, 2009, ANN SURG, V249, P322, DOI 10.1097/SLA.0b013e31819782fd; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	21	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78942	10.1371/journal.pone.0078942	http://dx.doi.org/10.1371/journal.pone.0078942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244390	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000327221600084
J	Hammouda, O; Chtourou, H; Aloui, A; Chahed, H; Kallel, C; Miled, A; Chamari, K; Chaouachi, A; Souissi, N				Hammouda, Omar; Chtourou, Hamdi; Aloui, Asma; Chahed, Henda; Kallel, Choumous; Miled, Abdelhedi; Chamari, Karim; Chaouachi, Anis; Souissi, Nizar			Concomitant Effects of Ramadan Fasting and Time-Of-Day on Apolipoprotein AI, B, Lp-a and Homocysteine Responses during Aerobic Exercise in Tunisian Soccer Players	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; C-REACTIVE PROTEIN; PHYSICAL PERFORMANCE; ANTIOXIDANT STATUS; DIURNAL-VARIATIONS; BODY-COMPOSITION; MUSCLE INJURY; LIPID-LEVELS; PLASMA; WEIGHT	Objective: To examine the time-of-day and Ramadan fasting (RF) effects on serum apolipoprotein-AI (Apo-AI) and B (Apo-B), lipoprotein particles-a (Lp-a), high-sensitive C-reactive-protein (hs-CRP), and homocysteine (Hcy) during the Yo-Yo intermittent recovery test (YYIRT). Design: Performance and biochemical measures were completed at two times-of-day (07: 00 and 17: 00 h), 1-week before RF (BR), the second week of RF (SWR), and the fourth week of RF (ER). Setting: For each session, subjects performed the YYIRT, and blood samples were taken before and 3-min after the test for biochemical measures. Participants: Fifteen soccer players. Main Outcome Measures: Total distance during the YYIRT, core temperature, body composition, dietary intakes, lipid (HDL-C, LDL-C, Apo-AI, B and Lp-a) and inflammatory (hs-CRP and Hcy) profiles. Results: Performances during the YYIRT were higher in the evening than the morning BR (P < 0.05), but this fluctuation was not observed during RF. Moreover, LDL-C, ApoB, and Lp-a were stable throughout the daytime BR. However, during RF, they decreased at 17: 00 h (P < 0.05). Likewise, HDL-C and Apo-AI increased after the exercise and were higher at 17: 00 h BR (P < 0.001). Moreover, these parameters increased during RF (P < 0.01). Furthermore, Hcy and hs-CRP increased during the exercise (P < 0.01) with higher evening levels BR. During ER, the diurnal pattern of Hcy was inversed (P < 0.001). Conclusions: This study concluded that caloric restriction induced by RF seems to ameliorate lipid and inflammatory markers of cardiovascular health during intermittent exercise performed in the evening.	[Hammouda, Omar; Chtourou, Hamdi; Aloui, Asma; Chaouachi, Anis; Souissi, Nizar] CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Chahed, Henda; Miled, Abdelhedi] CHU Farhat Hached, Biochem Res Lab, Sousse, Tunisia; [Kallel, Choumous] CHU Habib Bourguiba, Res Lab Hematol, Sfax, Tunisia; [Souissi, Nizar] Manouba Univ, High Inst Sport & Phys Educ Ksar Said, Manouba, Tunisia; [Hammouda, Omar; Chtourou, Hamdi] Sfax Univ, High Inst Sport & Phys Educ Sfax, Sfax, Tunisia; [Chamari, Karim] Qatar Orthoped & Sports Med Hosp, Aspetar, Res & Educ Ctr, Doha, Qatar	Centre National de la Medecine Sciences des Sports; Universite de Sousse; Hopital Farhat Hached; Universite de Sfax; Hopital Habib Bourguiba; Universite de la Manouba; Universite de Sfax; Aspetar Orthopaedic & Sports Medicine Hospital	Hammouda, O (corresponding author), CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia.	omarham007@yahoo.fr	HAMMOUDA, Omar/AGE-5171-2022; Aloui, Asma/J-1300-2019; CHAMARI, Karim/AAJ-7938-2021; Chtourou, Hamdi/GVU-1967-2022; Nizar, Souissi/AAF-4490-2019	HAMMOUDA, Omar/0000-0002-5002-687X; Aloui, Asma/0000-0001-5054-1540; CHAMARI, Karim/0000-0001-9178-7678; Chtourou, Hamdi/0000-0002-5482-9151; Nizar, Souissi/0000-0003-1227-8221	Ministry of Higher Education and Scientific Research, Tunisia	Ministry of Higher Education and Scientific Research, Tunisia	This study was conducted with financial support from the Ministry of Higher Education and Scientific Research, Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlouni A, 1997, ANN NUTR METAB, V41, P242, DOI 10.1159/000177999; Adlouni A, 1998, CLIN CHIM ACTA, V271, P179, DOI 10.1016/S0009-8981(97)00245-3; Afrasiabi A, 2003, SAUDI MED J, V24, P184; Aksungar FB, 2007, ANN NUTR METAB, V51, P88, DOI 10.1159/000100954; Bogdan A, 2001, LIFE SCI, V68, P1607, DOI 10.1016/S0024-3205(01)00966-3; Bouhlel E, 2006, DIABETES METAB, V32, P617, DOI 10.1016/S1262-3636(07)70317-8; Bouhlel E, 2008, INT J SPORT NUTR EXE, V18, P617, DOI 10.1123/ijsnem.18.6.617; Bremner WF, 2000, AM J CARDIOL, V86, P1153, DOI 10.1016/S0002-9149(00)01181-4; Castagna C, 2009, J STRENGTH COND RES, V23, P1954, DOI 10.1519/JSC.0b013e3181b7f743; Chaouachi A, 2008, INT J SPORTS MED, V29, P282, DOI 10.1055/s-2007-965338; Chaouachi A, 2009, APPL PHYSIOL NUTR ME, V34, P907, DOI 10.1139/H09-095; Chennaoui M, 2009, APPL PHYSIOL NUTR ME, V34, P587, DOI 10.1139/H09-014; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dominguez-Rodriguez A, 2006, REV ESP CARDIOL, V59, P1204; ELATI J, 1995, AM J CLIN NUTR, V62, P302, DOI 10.1093/ajcn/62.2.302; Finch GM, 1998, APPETITE, V31, P159, DOI 10.1006/appe.1998.0164; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GENEST JJ, 1991, ATHEROSCLEROSIS, V90, P149, DOI 10.1016/0021-9150(91)90109-G; HALLAK MH, 1988, AM J CLIN NUTR, V48, P1197, DOI 10.1093/ajcn/48.5.1197; Hammouda O, 2013, J SPORT SCI, V31, P963, DOI 10.1080/02640414.2012.757345; Hammouda Omar, 2012, Asian J Sports Med, V3, P239, DOI 10.5812/asjsm.34544; Hammouda O, 2012, BIOL RHYTHM RES, V43, P431, DOI 10.1080/09291016.2011.599638; Hammouda O, 2011, CHRONOBIOL INT, V28, P958, DOI 10.3109/07420528.2011.613683; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Haouari-Oukerro F, 1994, BIOCH CLIN, V18, P363; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hourani HM Al, 2009, JORDAN J BIOL SCI, V2, P103; KUUSI T, 1984, METABOLISM, V33, P527, DOI 10.1016/0026-0495(84)90007-6; LAMONFAVA S, 1989, J CLIN ENDOCR METAB, V68, P17, DOI 10.1210/jcem-68-1-17; Lamri-Senhadji MY, 2009, SINGAP MED J, V50, P288; MIETTINEN TA, 1980, ANN CLIN RES, V12, P295; POSTIGLIONE A, 1994, NUTR METAB CARDIOVAS, V4, P233; Reilly T, 2007, CHRONOBIOL INT, V24, P507, DOI 10.1080/07420520701420709; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Romon M, 1997, AM J CLIN NUTR, V65, P934, DOI 10.1093/ajcn/65.4.934; Stannard SR, 2008, J SCI MED SPORT, V11, P510, DOI 10.1016/j.jsams.2007.03.003; Stannard SR, 2010, J SCI MED SPORT, V13, P465, DOI 10.1016/j.jsams.2010.03.002; Trabelsi K, 2012, INT J SPORT NUTR EXE, V22, P11, DOI 10.1123/ijsnem.22.1.11; Tsai AC, 2003, J NUTR BIOCHEM, V14, P541, DOI 10.1016/S0955-2863(03)00105-0; Van Proeyen K, 2011, EUR J APPL PHYSIOL, V111, P1297, DOI 10.1007/s00421-010-1753-7; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Waterhouse J, 2007, CHRONOBIOL INT, V24, P63, DOI 10.1080/07420520601142551; Zare A, 2011, SINGAP MED J, V52, P491; Ziaee V., 2006, SMJ Singapore Medical Journal, V47, P409	44	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79873	10.1371/journal.pone.0079873	http://dx.doi.org/10.1371/journal.pone.0079873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244572	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600156
J	Zeng, GQ; Liu, R; Liao, HX; Zhang, XF; Qian, YX; Liu, BH; Wu, QH; Zhao, J; Gu, WW; Li, HT				Zeng, Guang-qiao; Liu, Rong; Liao, Hai-xing; Zhang, Xin-feng; Qian, Yuan-xin; Liu, Bao-hua; Wu, Qing-hong; Zhao, Jin; Gu, Wei-wang; Li, Hong-tao			Single Intraperitoneal Injection of Monocrotaline as a Novel Large Animal Model of Chronic Pulmonary Hypertension in Tibet Minipigs	PLOS ONE			English	Article							RIGHT HEART CATHETERIZATION; ARTERIAL-HYPERTENSION; CARDIOPULMONARY BYPASS; VASCULAR-RESISTANCE; DOPPLER-ECHOCARDIOGRAPHY; NONINVASIVE ASSESSMENT; SURVIVAL RATE; RABBIT MODEL; DIAGNOSIS; PIG	Objective: The purpose of this study was to establish an animal model of chronic pulmonary hypertension with a single-dose intraperitoneal injection of monocrotaline (MCT) in young Tibet minipigs, so as to enable both invasive and noninvasive measurements and hence facilitate future studies. Methods: Twenty-four minipigs (8-week-old) were randomized to receive single-dose injection of 12.0 mg/kg MCT (MCT group, n = 12) or placebo (control group, n = 12 each). On day 42, all animals were evaluated for pulmonary hypertension with conventional transthoracic echocardiography, right heart catheterization (RHC), and pathological changes. Findings of these studies were compared between the two groups. Results: At echocardiography, the MCT group showed significantly higher pulmonary arterial mean pressure (PAMP) compared with the controls (P<0.001). The pulmonary valve curve showed v-shaped signals with reduction of a-waves in minipigs treated with MCT. In addition, the MCT group had longer pulmonary artery pre-ejection phases, and shorter acceleration time and ejection time. RHC revealed higher mean pulmonary arterial pressure (mPAP) in the MCT group than in the control group (P<0.01). A significant and positive correlation between the mPAP values and the PAMP values (R = 0.974, P<0.0001), and a negative correlation between the mPAP and ejection time (R = 0.680, P<0.0001) was noted. Pathology demonstrated evidence of pulmonary vascular remodeling and higer index of right ventricular hypertrophy in MCT-treated minipigs. Conclusion: A chronic pulmonary hypertension model can be successfully established in young minipigs at six weeks after MCT injection. These minipig models exhibited features of pulmonary arterial hypertension that can be evaluated by both invasive (RHC) and noninvasive (echocardiography) measurements, and may be used as an easy and stable tool for future studies on pulmonary hypertension.	[Zeng, Guang-qiao; Liu, Rong; Liao, Hai-xing; Zhang, Xin-feng; Qian, Yuan-xin; Liu, Bao-hua; Zhao, Jin; Li, Hong-tao] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zeng, Guang-qiao; Liu, Rong; Zhao, Jin; Li, Hong-tao] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wu, Qing-hong; Gu, Wei-wang] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Southern Medical University - China	Li, HT (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	gyhongtao@126.com			Guangdong Department of Science and Technology Program Funds [2009B060300028, 2012B060300032]; Guangzhou Medical University [2008C33]	Guangdong Department of Science and Technology Program Funds; Guangzhou Medical University	This work was supported by Guangdong Department of Science and Technology Program Funds (RMB:150000; Program No.: 2009B060300028 and RMB:100000; Program No.: 2012B060300032) and Guangzhou Medical University Scientific Grant (RMB: 30000; Program No.: 2008C33), http://pro.gdstc.gov.cn/stms/main.jsp, http://www.gzhmc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2003, AM J CARDIOL, V92, P1373, DOI 10.1016/j.amjcard.2003.08.037; Akhavein F, 2007, J APPL PHYSIOL, V103, P287, DOI 10.1152/japplphysiol.01509.2005; ALLEN JR, 1972, EXP MOL PATHOL, V17, P220, DOI 10.1016/0014-4800(72)90071-8; BERG R, 1987, ANAT HISTOL EMBRYOL, V16, P265; Bonnell MR, 2004, ANN THORAC SURG, V77, P238, DOI 10.1016/S0003-4975(03)01489-9; Bossone E, 2005, CHEST, V127, P1836, DOI 10.1378/chest.127.5.1836; Carteaux JP, 1999, EUR J CARDIO-THORAC, V15, P346, DOI 10.1016/S1010-7940(99)00017-2; Celermajer DS, 2008, INT J CARDIOL, V125, P294, DOI 10.1016/j.ijcard.2007.04.184; Chen HM, 2008, CHINESE J ULTRASOUND, V24, P486; Chen HM, 2008, ULTRASOUND MED BIOL, V34, P221, DOI 10.1016/j.ultrasmedbio.2007.06.011; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; CLEMENT DL, 1994, J HYPERTENS, V12, pS49; Fitzgerald KP, 2011, CARDIOL CLIN, V29, P223, DOI 10.1016/j.ccl.2011.01.006; Fitzgerald Robert K, 2004, Pediatr Crit Care Med, V5, P571, DOI 10.1097/01.PCC.0000137357.52609.F0; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Geiger R, 2006, PEDIATR RES, V59, P147, DOI 10.1203/01.pdr.0000191813.60977.bf; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gust R, 2001, EXP LUNG RES, V27, P1, DOI 10.1080/019021401459734; Habib G, 2010, EUR RESPIR REV, V19, P288, DOI 10.1183/09059180.00008110; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Jormalainen M, 2007, ACTA ANAESTH SCAND, V51, P178, DOI 10.1111/j.1399-6576.2006.01185.x; Litwin SE, 2010, CIRC-CARDIOVASC IMAG, V3, P132, DOI 10.1161/CIRCIMAGING.110.945121; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Mutschler D, 2006, J INTERF CYTOK RES, V26, P661, DOI 10.1089/jir.2006.26.661; OKADA M, 1995, TRANSPLANTATION, V60, P9, DOI 10.1097/00007890-199507150-00002; OWALL A, 1991, ACTA ANAESTH SCAND, V35, P350; Pancholy SB, 2011, CATHETER CARDIO INTE, V78, P809, DOI 10.1002/ccd.23037; Petrossian E, 1999, J THORAC CARDIOV SUR, V117, P314, DOI 10.1016/S0022-5223(99)70429-0; Raoul W, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-8; Roldan CA, 2004, ULTIMATE ECHO GUIDE; ROSENKRANTZ JG, 1973, J SURG RES, V15, P67, DOI 10.1016/0022-4804(73)90165-0; Sandra L, 2002, HLTH SCI ASIAN ELSEV, V9, P582; Sawamura F, 2009, J PHARMACOL SCI, V111, P235, DOI 10.1254/jphs.09110FP; Scapellato F, 2001, J AM COLL CARDIOL, V37, P1813, DOI 10.1016/S0735-1097(01)01271-2; Selimovic N, 2007, J HEART LUNG TRANSPL, V26, P927, DOI 10.1016/j.healun.2007.06.008; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Thibault HB, 2010, CIRC-CARDIOVASC IMAG, V3, P157, DOI 10.1161/CIRCIMAGING.109.887109; Wang J, 2013, J THORAC DIS, V5, P169, DOI 10.3978/j.issn.2072-1439.2013.02.04; Wang L, 2004, EXP LUNG RES, V30, P31, DOI 10.1080/01902140490252821; Wang W, 2010, J THORAC CARDIOV SUR, V140, P395, DOI 10.1016/j.jtcvs.2009.04.071; Wang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-26; Willens HJ, 2008, INT J CARDIOVAS IMAG, V24, P703, DOI 10.1007/s10554-008-9306-4; Zhao Jin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P867	45	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78965	10.1371/journal.pone.0078965	http://dx.doi.org/10.1371/journal.pone.0078965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244396	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600089
J	Cheng, YY; Li, BB; Li, DB; Chen, JJ; Li, WW; Tong, ZH; Wu, C; Yu, HQ				Cheng, Yuan-Yuan; Li, Bing-Bing; Li, Dao-Bo; Chen, Jie-Jie; Li, Wen-Wei; Tong, Zhong-Hua; Wu, Chao; Yu, Han-Qing			Promotion of Iron Oxide Reduction and Extracellular Electron Transfer in Shewanella oneidensis by DMSO	PLOS ONE			English	Article							OUTER-MEMBRANE CYTOCHROMES; RESPIRATORY FLEXIBILITY; MICROBIAL REDUCTION; EXCHANGE; CYMA; IRON(III); REACTIVITY; GEOBACTER; MOLECULES; MECHANISM	The dissimilatory metal reducing bacterium Shewanella oneidensis MR-1, known for its capacity of reducing iron and manganese oxides, has great environmental impacts. The iron oxides reducing process is affected by the coexistence of alternative electron acceptors in the environment, while investigation into it is limited so far. In this work, the impact of dimethyl sulphoxide (DMSO), a ubiquitous chemical in marine environment, on the reduction of hydrous ferric oxide (HFO) by S. oneidensis MR-1 was investigated. Results show that DMSO promoted HFO reduction by both wild type and Delta dmsE, but had no effect on the HFO reduction by Delta dmsB, indicating that such a promotion was dependent on the DMSO respiration. With the DMSO dosing, the levels of extracellular flavins and omcA expression were significantly increased in WT and further increased in Delta dmsE. Bioelectrochemical analysis show that DMSO also promoted the extracellular electron transfer of WT and Delta dmsE. These results demonstrate that DMSO could stimulate the HFO reduction through metabolic and genetic regulation in S. oneidensis MR-1, rather than compete for electrons with HFO. This may provide a potential respiratory pathway to enhance the microbial electron flows for environmental and engineering applications.	[Cheng, Yuan-Yuan; Li, Dao-Bo; Chen, Jie-Jie; Li, Wen-Wei; Tong, Zhong-Hua; Wu, Chao; Yu, Han-Qing] Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China; [Li, Bing-Bing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, C (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China.	benny928@mail.ustc.edu.cn; hqyu@ustc.edu.cn	Li, Wen-Wei/B-6332-2015; Tong, Zhong-Hua/F-6873-2010; Cheng, Yuanyuan/C-4836-2014; Chen, Jie-Jie/D-9181-2014; Yu, Han-Qing/F-7925-2010	Li, Wen-Wei/0000-0001-9280-0045; Cheng, Yuanyuan/0000-0003-3437-5495; 	Natural Science Foundation of China [21107105, 21007064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors wish to thank the Natural Science Foundation of China (21107105 and 21007064) for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; Belchik SM, 2011, APPL ENVIRON MICROB, V77, P4035, DOI 10.1128/AEM.02463-10; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bewley KD, 2012, BIOCHEM SOC T, V40, P1268, DOI 10.1042/BST20120106; Biffinger JC, 2009, BIOTECHNOL BIOENG, V103, P524, DOI 10.1002/bit.22266; Bishop ME, 2011, GEOCHIM COSMOCHIM AC, V75, P5229, DOI 10.1016/j.gca.2011.06.034; Braibant M, 2002, ANTIMICROB AGENTS CH, V46, P3050, DOI 10.1128/AAC.46.9.3050-3053.2002; Bretschger O, 2008, APPL ENVIRON MICROB, V74, P553, DOI 10.1128/AEM.02560-07; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; Campbell KM, 2006, ENVIRON SCI TECHNOL, V40, P5950, DOI 10.1021/es0600476; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; Cooper DC, 2006, ENVIRON SCI TECHNOL, V40, P1884, DOI 10.1021/es051778t; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Dewan A, 2008, ENVIRON SCI TECHNOL, V42, P7643, DOI 10.1021/es800775d; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Kopf SH, 2013, ENVIRON SCI TECHNOL, V47, P2602, DOI 10.1021/es3049459; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Li SL, 2010, BIOSENS BIOELECTRON, V25, P2651, DOI 10.1016/j.bios.2010.04.038; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Marritt SJ, 2012, BIOCHEM SOC T, V40, P1217, DOI 10.1042/BST20120150; Marritt SJ, 2012, BIOCHEM J, V444, P465, DOI 10.1042/BJ20120197; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; MEYER FK, 1982, INORG CHEM, V21, P774, DOI 10.1021/ic00132a060; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1992, APPL ENVIRON MICROB, V58, P439, DOI 10.1128/AEM.58.2.439-443.1992; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Shi L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00050; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; SWADDLE TW, 1981, INORG CHEM, V20, P4212, DOI 10.1021/ic50226a036; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wu C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01945; Zhao JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009109	46	11	11	4	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78466	10.1371/journal.pone.0078466	http://dx.doi.org/10.1371/journal.pone.0078466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244312	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900017
J	Williams, G; Zentar, MP; Gajendra, S; Sonego, M; Doherty, P; Lalli, G				Williams, Gareth; Zentar, Marc P.; Gajendra, Sangeetha; Sonego, Martina; Doherty, Patrick; Lalli, Giovanna			Transcriptional Basis for the Inhibition of Neural Stem Cell Proliferation and Migration by the TGF beta-Family Member GDF11	PLOS ONE			English	Article							ZONE-DERIVED NEUROBLASTS; SUBVENTRICULAR ZONE; NS CELLS; ADULT NEUROGENESIS; POSTNATAL BRAIN; MUSCLE GROWTH; SELF-RENEWAL; MYOSTATIN; EGF; MICE	Signalling through EGF, FGF and endocannabinoid (eCB) receptors promotes adult neurogenesis, and this can be modelled in culture using the Cor-1 neural stem cell line. In the present study we show that Cor-1 cells express a TGF beta receptor complex composed of the ActRIIB/ALK5 subunits and that a natural ligand for this receptor complex, GDF11, activates the canonical Smad2/3 signalling cascade and significantly alters the expression of similar to 4700 gene transcripts within a few hours of treatment. Many of the transcripts regulated by GDF11 are also regulated by the EGF, FGF and eCB receptors and by the MAPK pathway -however, in general in the opposite direction. This can be explained to some extent by the observation that GDF11 inhibits expression of, and signalling through, the EGF receptor. GDF11 regulates expression of numerous cell-cycle genes and suppresses Cor-1 cell proliferation; interestingly we found down-regulation of Cyclin D2 rather than p27kip1 to be a good molecular correlate of this. GDF11 also inhibited the expression of numerous genes linked to cytoskeletal regulation including Fascin and LIM and SH3 domain protein 1 (LASP1) and this was associated with an inhibition of Cor-1 cell migration in a scratch wound assay. These data demonstrate GDF11 to be a master regulator of neural stem cell transcription that can suppress cell proliferation and migration by regulating the expression of numerous genes involved in both these processes, and by suppressing transcriptional responses to factors that normally promote proliferation and/or migration.	[Williams, Gareth; Zentar, Marc P.; Gajendra, Sangeetha; Sonego, Martina; Doherty, Patrick; Lalli, Giovanna] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	University of London; King's College London	Lalli, G (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London, England.	giovanna.lalli@kcl.ac.uk		Williams, Gareth/0000-0001-9205-4943; Doherty, Patrick/0000-0002-0407-5689	Wolfson CARD	Wolfson CARD	The work was supported by the Wolfson CARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frinchi M, 2008, NEUROSCI LETT, V447, P20, DOI 10.1016/j.neulet.2008.09.059; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Khodosevich K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.007.2009; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nomura T, 2008, BIOCHEM BIOPH RES CO, V365, P863, DOI 10.1016/j.bbrc.2007.11.087; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Santos R, 2012, ADV EXP MED BIOL, V723, P671, DOI 10.1007/978-1-4614-0631-0_85; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sonego M, 2013, J NEUROSCI, V33, P12171, DOI 10.1523/JNEUROSCI.0653-13.2013; Sutterlin P, 2013, MOL CELL NEUROSCI, V52, P20, DOI 10.1016/j.mcn.2012.10.006; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thies RS, 2001, GROWTH FACTORS, V18, P251; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	39	19	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78478	10.1371/journal.pone.0078478	http://dx.doi.org/10.1371/journal.pone.0078478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244313	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900018
J	Bird, CW; Gardiner, AS; Bolognani, F; Tanner, DC; Chen, CY; Lin, WJ; Yoo, S; Twiss, JL; Perrone-Bizzozero, N				Bird, Clark W.; Gardiner, Amy S.; Bolognani, Federico; Tanner, Daniel C.; Chen, Ching-Yi; Lin, Wei-Jye; Yoo, Soonmoon; Twiss, Jeffery L.; Perrone-Bizzozero, Nora			KSRP Modulation of GAP-43 mRNA Stability Restricts Axonal Outgrowth in Embryonic Hippocampal Neurons	PLOS ONE			English	Article							BINDING PROTEIN HUD; SPLICING REGULATORY PROTEIN; SPINAL MUSCULAR-ATROPHY; DENTATE GRANULE CELLS; 3 UNTRANSLATED REGION; POSTTRANSCRIPTIONAL REGULATION; BETA-ACTIN; NERVE REGENERATION; NEURITE OUTGROWTH; GENE-EXPRESSION	The KH-type splicing regulatory protein (KSRP) promotes the decay of AU-rich element (ARE)-containing mRNAs. Although KSRP is expressed in the nervous system, very little is known about its role in neurons. In this study, we examined whether KSRP regulates the stability of the ARE-containing GAP-43 mRNA. We found that KSRP destabilizes this mRNA by binding to its ARE, a process that requires the presence of its fourth KH domain (KH4). Furthermore, KSRP competed with the stabilizing factor HuD for binding to these sequences. We also examined the functional consequences of KSRP overexpression and knockdown on the differentiation of primary hippocampal neurons in culture. Overexpression of full length KSRP or KSRP without its nuclear localization signal hindered axonal outgrowth in these cultures, while overexpression of a mutant protein without the KH4 domain that has less affinity for binding to GAP-43's ARE had no effect. In contrast, depletion of KSRP led to a rise in GAP-43 mRNA levels and a dramatic increase in axonal length, both in KSRP shRNA transfected cells and neurons cultured from Ksrp(+/-) and Ksrp(-/-) embryos. Finally we found that overexpression of GAP-43 rescued the axonal outgrowth deficits seen with KSRP overexpression, but only when cells were transfected with GAP-43 constructs containing 3' UTR sequences targeting the transport of this mRNA to axons. Together, our results suggest that KSRP is an important regulator of mRNA stability and axonal length that works in direct opposition to HuD to regulate the levels of GAP-43 and other ARE-containing neuronal mRNAs.	[Bird, Clark W.; Gardiner, Amy S.; Bolognani, Federico; Tanner, Daniel C.; Perrone-Bizzozero, Nora] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Chen, Ching-Yi; Lin, Wei-Jye] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Yoo, Soonmoon] Alfred I duPont Hosp Children, Wilmington, DE USA; [Twiss, Jeffery L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of New Mexico; University of Alabama System; University of Alabama Birmingham; Nemours Alfred I. duPont Hospital for Children; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Perrone-Bizzozero, N (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	nbizzozero@salud.unm.edu	Lin, Wei-Jye/AGW-1054-2022	Lin, Wei-Jye/0000-0002-6057-7325; Bird, Clark/0000-0001-7712-6531; Chen, Ching-Yi/0000-0002-1978-6424; Gardiner, Amy S./0000-0002-8179-4919; Yoo, Soonmoon/0000-0002-1645-6809	NIH [5R01NS030255, R01NS041596, P20GM103464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596, R01NS030255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (5R01NS030255 to NPB and R01NS041596 to JLT and P20GM103464 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Bolognani F, 2006, J NEUROCHEM, V96, P790, DOI 10.1111/j.1471-4159.2005.03607.x; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Giovarelli M, 2013, BBA-GENE REGUL MECH, V1829, P469, DOI 10.1016/j.bbagrm.2013.02.008; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Kohn DT, 1996, MOL BRAIN RES, V36, P240, DOI 10.1016/0169-328X(95)00239-O; Li XL, 2012, GLIA, V60, P1773, DOI 10.1002/glia.22396; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero NI, 2011, ASN NEURO, V3, DOI 10.1042/AN20110015; Rehbein M, 2002, J NEUROCHEM, V82, P1039, DOI 10.1046/j.1471-4159.2002.01058.x; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsai KC, 1997, J NEUROSCI, V17, P1950; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Yoo S, 2013, J NEUROCHEM, V15, DOI [10.1111/jnc.12266, DOI 10.1111/JNC.12266.[]; Yoo S, 2010, EXP NEUROL, V223, P19, DOI 10.1016/j.expneurol.2009.08.011	50	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79255	10.1371/journal.pone.0079255	http://dx.doi.org/10.1371/journal.pone.0079255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244461	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800049
J	Tsegai, ZJ; Kivell, TL; Gross, T; Nguyen, NH; Pahr, DH; Smaers, JB; Skinner, MM				Tsegai, Zewdi J.; Kivell, Tracy L.; Gross, Thomas; Nguyen, N. Huynh; Pahr, Dieter H.; Smaers, Jeroen B.; Skinner, Matthew M.			Trabecular Bone Structure Correlates with Hand Posture and Use in Hominoids	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; FINITE-ELEMENT MODELS; FEMORAL-HEAD; POSITIONAL BEHAVIOR; LOCOMOTOR BEHAVIOR; KNUCKLE-WALKING; PAN-TROGLODYTES; CANCELLOUS BONE; MU-CT; ARCHITECTURE	Bone is capable of adapting during life in response to stress. Therefore, variation in locomotor and manipulative behaviours across extant hominoids may be reflected in differences in trabecular bone structure. The hand is a promising region for trabecular analysis, as it is the direct contact between the individual and the environment and joint positions at peak loading vary amongst extant hominoids. Building upon traditional volume of interest-based analyses, we apply a whole-epiphysis analytical approach using high-resolution microtomographic scans of the hominoid third metacarpal to investigate whether trabecular structure reflects differences in hand posture and loading in knuckle-walking (Gorilla, Pan), suspensory (Pongo, Hylobates and Symphalangus) and manipulative (Homo) taxa. Additionally, a comparative phylogenetic method was used to analyse rates of evolutionary changes in trabecular parameters. Results demonstrate that trabecular bone volume distribution and regions of greatest stiffness (i.e., Young's modulus) correspond with predicted loading of the hand in each behavioural category. In suspensory and manipulative taxa, regions of high bone volume and greatest stiffness are concentrated on the palmar or distopalmar regions of the metacarpal head, whereas knuckle-walking taxa show greater bone volume and stiffness throughout the head, and particularly in the dorsal region; patterns that correspond with the highest predicted joint reaction forces. Trabecular structure in knuckle-walking taxa is characterised by high bone volume fraction and a high degree of anisotropy in contrast to the suspensory brachiators. Humans, in which the hand is used primarily for manipulation, have a low bone volume fraction and a variable degree of anisotropy. Finally, when trabecular parameters are mapped onto a molecular-based phylogeny, we show that the rates of change in trabecular structure vary across the hominoid clade. Our results support a link between inferred behaviour and trabecular structure in extant hominoids that can be informative for reconstructing behaviour in fossil primates.	[Tsegai, Zewdi J.; Smaers, Jeroen B.; Skinner, Matthew M.] UCL, Dept Anthropol, London, England; [Kivell, Tracy L.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Tsegai, Zewdi J.; Kivell, Tracy L.; Nguyen, N. Huynh; Skinner, Matthew M.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Gross, Thomas; Pahr, Dieter H.] Vienna Univ Technol, Inst Lightweight Design & Struct Biomech, A-1040 Vienna, Austria; [Smaers, Jeroen B.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University of London; University College London; University of Kent; Max Planck Society; Technische Universitat Wien; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Skinner, MM (corresponding author), UCL, Dept Anthropol, London, England.	m.skinner@ucl.ac.uk	Tsegai, Zewdi/AAB-9996-2019; Kivell, Tracy/D-1225-2010; Skinner, Matthew/D-1104-2010	Tsegai, Zewdi/0000-0001-9041-4829; Skinner, Matthew/0000-0001-8321-3543; Smaers, Jeroen/0000-0003-1741-9839; Pahr, Dieter/0000-0002-5822-2082; Nguyen, Nhu Huynh/0000-0001-5493-3752	Max Planck Society	Max Planck Society(Max Planck Society)	This research was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badrian A, 1977, Oryx, V13, P463; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Coleman MN, 2008, AM J PHYS ANTHROPOL, V135, P404, DOI 10.1002/ajpa.20761; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Currey J.D., 2002, BONES STRUCTURE MECH; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Fajardo RJ, 2007, ANAT REC, V290, P422, DOI 10.1002/ar.20493; FLEAGLE J, 1974, NATURE, V248, P259, DOI 10.1038/248259a0; FLEAGLE JG, 1976, FOLIA PRIMATOL, V26, P245, DOI 10.1159/000155756; Griffin NL, 2010, J HUM EVOL, V59, P202, DOI 10.1016/j.jhevol.2010.06.006; Gross T, PAL ELEC UNPUB; Hollihn U., 1984, P85; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Inouye S. E., 2004, J ANTHROPOL SCI, P67; INOUYE SE, 1990, AM J PHYS ANTHROPOL, V81, P243; Isaksson H, 2011, OSTEOPOROSIS INT, V22, P167, DOI 10.1007/s00198-010-1219-0; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jenkins F.A. Jr., 1975, P213; Jones L.A., 2006, HUMAN HAND FUNCTION; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kivell TL, 2011, J ANAT, V218, P209, DOI 10.1111/j.1469-7580.2010.01314.x; Kothari M, 1998, BONE, V22, P437, DOI 10.1016/S8756-3282(98)00031-3; Lazenby RA, 2008, J HUM EVOL, V54, P875, DOI 10.1016/j.jhevol.2007.12.001; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P196, DOI 10.1002/ajpa.21385; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P215, DOI 10.1002/ajpa.21390; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.0.CO;2-Z; Loken B, 2013, AM J PRIMATOL UNPUB; Macho GA, 2010, FOLIA PRIMATOL, V81, P292, DOI 10.1159/000322631; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Maga M, 2006, AM J PHYS ANTHROPOL, V129, P410, DOI 10.1002/ajpa.20276; Martin RB, 2010, SKELETAL TISSUE MECH; Marzke MW, 1996, INT J PRIMATOL, V17, P117, DOI 10.1007/BF02696162; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Pahr DH, 2008, BIOMECH MODEL MECHAN, V7, P463, DOI 10.1007/s10237-007-0109-7; Pahr DH, 2009, J BIOMECH, V42, P455, DOI 10.1016/j.jbiomech.2008.11.028; Pahr DH, 2009, COMPUT METHOD BIOMEC, V12, P45, DOI [10.1080/10255840802144105, 10.1080/10255840903065399]; PAOLI G, 1993, AM J PHYS ANTHROPOL, V92, P263, DOI 10.1002/ajpa.1330920304; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; RAUX P, 1975, J BIOMECH, V8, P1, DOI 10.1016/0021-9290(75)90037-8; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P1090, DOI 10.1111/j.1558-5646.2009.00616.x; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Rose M.D., 1988, P299; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF CB, 1992, ANNU REV ANTHROPOL, V21, P407; Ryan TM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0172; Ryan TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041037; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2005, J MORPHOL, V265, P249, DOI 10.1002/jmor.10315; Ryan TM, 2005, AM J PHYS ANTHROPOL, V126, P82, DOI 10.1002/ajpa.10414; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Ryan TM, 2002, J HUM EVOL, V43, P241, DOI 10.1006/jhev.2002.0575; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schilling A-M, 2012, THESIS U STUDI PISA; Schilling A-M, 2013, J MORPH IN PRESS; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Skedros JG, 2007, J THEOR BIOL, V244, P15, DOI 10.1016/j.jtbi.2006.06.029; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Smaers JB, 2009, EVOL ECOL RES, V11, P991; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sode M, 2008, BONE, V42, P728, DOI 10.1016/j.bone.2007.12.004; Stephens NB, 2012, THESIS U LONDON UK; SUSMAN RL, 1980, AM J PHYS ANTHROPOL, V53, P69, DOI 10.1002/ajpa.1330530111; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P215, DOI 10.1002/ajpa.1330500211; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Treece G M, 1999, Med Image Anal, V3, P141, DOI 10.1016/S1361-8415(99)80004-8; Treece GM, 1999, COMPUT GRAPH-UK, V23, P583, DOI 10.1016/S0097-8493(99)00076-X; Treece GM, 2000, IEEE T MED IMAGING, V19, P1106, DOI 10.1109/42.896787; Tuttle R.H., 1985, P261; TUTTLE RH, 1969, SCIENCE, V166, P953, DOI 10.1126/science.166.3908.953; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Wolff J, 1892, GESETZ TRANSFORMATIO; Wunderlich RE, 2009, AM J PHYS ANTHROPOL, V139, P394, DOI 10.1002/ajpa.20994; Zeininger A, 2011, J HUM EVOL, V60, P703, DOI 10.1016/j.jhevol.2011.01.002; Zylstra M, 2000, AM J PHYS ANTHROPOL, P331; ZYSSET PK, 1995, MECH MATER, V21, P243, DOI 10.1016/0167-6636(95)00018-6; Zysset PK, 2003, J BIOMECH, V36, P1469, DOI 10.1016/S0021-9290(03)00128-3	90	79	79	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78781	10.1371/journal.pone.0078781	http://dx.doi.org/10.1371/journal.pone.0078781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244359	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000327143800017
J	Attar, A; Liu, TY; Chan, WTC; Hayes, J; Nejad, M; Lei, KC; Bitan, G				Attar, Aida; Liu, Tingyu; Chan, Wai-Ting Coco; Hayes, Jane; Nejad, Mona; Lei, KaiChyuan; Bitan, Gal			A Shortened Barnes Maze Protocol Reveals Memory Deficits at 4-Months of Age in the Triple-Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							REDUCES A-BETA; WATER-MAZE; COGNITIVE IMPAIRMENT; AMYLOID-BETA; 3XTG-AD MICE; ALPHA-SYNUCLEIN; SPATIAL MEMORY; PATHOLOGY; TAU; DEPOSITION	Alzheimer's disease is a progressive neurodegenerative disease that manifests as memory loss, cognitive dysfunction, and dementia. Animal models of Alzheimer's disease have been instrumental in understanding the underlying pathological mechanism and in evaluation of potential therapies. The triple transgenic (3xTg) mouse model of AD is unique because it recapitulates both pathologic hallmarks of Alzheimer's disease - amyloid plaques and neurofibrillary tangles. The earliest cognitive deficits in this model have been shown at 6-m of age by most groups, necessitating aging of the mice to this age before initiating evaluation of the cognitive effects of therapies. To assess cognitive deficits in the 3xTg mice, originally we employed a typical Barnes maze protocol of 15 training trials, but found no significant deficits in aged mice. Therefore, we shortened the protocol to include only 5 training trials to increase difficulty. We found cognitive deficits using this protocol using mainly measures from the probe day, rather than the training trials. This also decreased the effort involved with data analysis. We compared 3xTg and wild-type mice at 4-m- and 15-m of age using both the original, long training, and the short training paradigms. We found that differences in learning between 3xTg and wild-type mice disappeared after the 4th training trial. Measures of learning and memory on the probe day showed significant differences between 3xTg and wild-type mice following the short, 5-training trial protocol but not the long, 15-training trial protocol. Importantly, we detected cognitive dysfunction already at 4-m of age in 3xTg mice using the short Barnes-maze protocol. The ability to test learning and memory in 4-m old 3xTg mice using a shortened Barnes maze protocol offers considerable time and cost savings and provides support for the utilization of this model at pre-pathology stages for therapeutic studies.	[Attar, Aida; Liu, Tingyu; Chan, Wai-Ting Coco; Hayes, Jane; Nejad, Mona; Lei, KaiChyuan; Bitan, Gal] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bitan, G (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	gbitan@mednet.ucla.edu	liu, ting/GZM-3326-2022; Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754	University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation [20095024]; Cure Alzheimer's Fund grant; Individual Pre-doctoral National Research Service Award [1F31AG037283]; NATIONAL INSTITUTE ON AGING [F31AG037283] Funding Source: NIH RePORTER	University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation; Cure Alzheimer's Fund grant; Individual Pre-doctoral National Research Service Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development (G. B.); RJG Foundation grant 20095024 (G. B.); a Cure Alzheimer's Fund grant (G. B.); and an Individual Pre-doctoral National Research Service Award 1F31AG037283 (A. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambree O, 2009, NEUROBIOL AGING, V30, P1192, DOI 10.1016/j.neurobiolaging.2007.11.010; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chen YX, 2013, MOL NEUROBIOL, V47, P711, DOI 10.1007/s12035-012-8375-5; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Das P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-39; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Golde TE, 2013, J CLIN INVEST, V123, P1847, DOI 10.1172/JCI66029; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Guzman-Ramos K, 2012, LEARN MEMORY, V19, P453, DOI 10.1101/lm.026070.112; Hebda-Bauer EK, 2013, J ALZHEIMERS DIS, V33, P407, DOI 10.3233/JAD-2012-121438; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; INGRAM DK, 1994, LIFE SCI, V55, P2037, DOI 10.1016/0024-3205(94)00384-X; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Sun MK, 2004, NEUROSCIENCE, V129, P129, DOI 10.1016/j.neuroscience.2004.07.041; Sunyer B., 2007, NAT PROTOC, P390; Torres-Lista V, 2013, BEHAV BRAIN RES, V247, P153, DOI 10.1016/j.bbr.2013.03.021; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049	43	74	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80355	10.1371/journal.pone.0080355	http://dx.doi.org/10.1371/journal.pone.0080355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236177	Green Published, gold			2022-12-25	WOS:000327254700178
J	Gabriel, FC; Szucs, D; Content, A				Gabriel, Florence C.; Szucs, Denes; Content, Alain			The Development of the Mental Representations of the Magnitude of Fractions	PLOS ONE			English	Article							WHOLE NUMBER; JUDGMENTS; ORIGINS; REAL	We investigated the development of the mental representation of the magnitude of fractions during the initial stages of fraction learning in grade 5, 6 and 7 children as well as in adults. We examined the activation of global fraction magnitude in a numerical comparison task and a matching task. There were global distance effects in the comparison task, but not in the matching task. This suggests that the activation of the global magnitude representation of fractions is not automatic in all tasks involving magnitude judgments. The slope of the global distance effect increased during early fraction learning and declined by adulthood, demonstrating that the development of the fraction global distance effect differs from that of the integer distance effect.	[Gabriel, Florence C.; Szucs, Denes] Univ Cambridge, Dept Expt Psychol, Ctr Neuroscience Educ, Cambridge CB2 3EB, England; [Gabriel, Florence C.; Content, Alain] Univ Libre Bruxelles, Fac Sci Psychol & Educ, Lab Cognit Langage & Dev, Brussels, Belgium	University of Cambridge; Universite Libre de Bruxelles	Gabriel, FC (corresponding author), Univ Cambridge, Dept Expt Psychol, Ctr Neuroscience Educ, Downing St, Cambridge CB2 3EB, England.	fcg25@cam.ac.uk; ds377@cam.ac.uk	Gabriel, Florence/AAE-7977-2020	Gabriel, Florence/0000-0001-9721-5312; Content, Alain/0000-0003-4170-463X; Szucs, Denes/0000-0002-9477-0801	Wiener-Anspach Foundation; Belgian National Fund; Medical Research Council [G90951]; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	Wiener-Anspach Foundation; Belgian National Fund(Fonds de la Recherche Scientifique - FNRS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants to F. G. from the Wiener-Anspach Foundation (http://fwa.ulb.ac.be/) and from the Belgian National Fund for Scientific Research (http://www.frs-fnrs.be/) and grant G90951 from the Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball D.L., 1993, RATIONAL NUMBERS INT, P157; Behr M.J., 1986, ESTIMATION MENTAL CO, P103; Bonato M, 2007, J EXP PSYCHOL HUMAN, V33, P1410, DOI 10.1037/0096-1523.33.6.1410; BRIGHT GW, 1988, J RES MATH EDUC, V19, P215, DOI 10.2307/749066; Charalambous C.Y., 2007, EDUC STUD MATH, V64, P293; Christ SE, 2001, DEV NEUROPSYCHOL, V20, P653, DOI 10.1207/875656401753549852; Cohen DJ, 2009, PSYCHON B REV, V16, P332, DOI 10.3758/PBR.16.2.332; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; Gabriel F, 2012, MIND BRAIN EDUC, V6, P137, DOI 10.1111/j.1751-228X.2012.01149.x; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Holloway ID, 2008, DEVELOPMENTAL SCI, V11, P644, DOI 10.1111/j.1467-7687.2008.00712.x; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Ischebeck A, 2009, NEUROIMAGE, V47, P403, DOI 10.1016/j.neuroimage.2009.03.041; Iuculano T, 2011, Q J EXP PSYCHOL, V64, P2088, DOI 10.1080/17470218.2011.604785; Jacob SN, 2009, J NEUROSCI, V29, P4652, DOI 10.1523/JNEUROSCI.0651-09.2009; Kallai AY, 2009, J EXP PSYCHOL HUMAN, V35, P1845, DOI 10.1037/a0016892; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Mamede E, 2005, P 29 C INT GROUP PSY, V3, P281; Mazzocco MMM, 2008, DEVELOPMENTAL SCI, V11, P681, DOI 10.1111/j.1467-7687.2008.00717.x; McCrink K, 2007, PSYCHOL SCI, V18, P740, DOI 10.1111/j.1467-9280.2007.01969.x; Meert G, 2010, ACTA PSYCHOL, V135, P284, DOI 10.1016/j.actpsy.2010.07.014; Meert G, 2010, J EXP CHILD PSYCHOL, V107, P244, DOI 10.1016/j.jecp.2010.04.008; Meert G, 2009, Q J EXP PSYCHOL, V62, P1598, DOI 10.1080/17470210802511162; Mix KS, 1999, DEV PSYCHOL, V35, P164, DOI 10.1037/0012-1649.35.1.164; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Ni YJ, 2005, EDUC PSYCHOL-US, V40, P27, DOI 10.1207/s15326985ep4001_3; Nunes T., 1996, CHILDREN DOING MATH; Pitkethly A, 1996, EDUC STUD MATH, V30, P5, DOI [10.1007/BF00163751, DOI 10.1007/BF00163751]; Rubinsten O, 2002, J EXP CHILD PSYCHOL, V81, P74, DOI 10.1006/jecp.2001.2645; Sasanguie D, 2011, ACTA PSYCHOL, V136, P73, DOI 10.1016/j.actpsy.2010.10.004; Schneider M, 2010, J EXP PSYCHOL HUMAN, V36, P1227, DOI 10.1037/a0018170; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Siegler RS, 2013, TRENDS COGN SCI, V17, P13, DOI 10.1016/j.tics.2012.11.004; Siegler RS, 2011, COGNITIVE PSYCHOL, V62, P273, DOI 10.1016/j.cogpsych.2011.03.001; Szucs D, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-23; Vallentin D, 2008, CURR BIOL, V18, P1420, DOI 10.1016/j.cub.2008.08.042; van Opstal F, 2011, J COGN PSYCHOL, V23, P112, DOI 10.1080/20445911.2011.466796; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; White SLJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00392	40	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80016	10.1371/journal.pone.0080016	http://dx.doi.org/10.1371/journal.pone.0080016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236169	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700170
J	Kreidenweiss, A; Hopkins, AV; Mordmuller, B				Kreidenweiss, Andrea; Hopkins, Annika V.; Mordmueller, Benjamin			2A and the Auxin-Based Degron System Facilitate Control of Protein Levels in Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITES; EXPRESSION	Analysis of gene function in Plasmodium falciparum, the most important human malaria parasite, is restricted by the lack of robust and simple reverse genetic tools. Approaches to manipulate protein levels post-translationally are powerful tools to study protein-off effects especially in the haploid malaria parasite where genetic knockouts of essential genes are lethal. We investigated if the auxin-inducible degron system is functional in P. falciparum and found that degron-tagged yellow fluorescent protein levels were efficiently reduced upon addition of auxin which otherwise had no effect on parasite viability. The genetic components required in this conditional approach were co-expressed in P. falciparum by applying the small peptide 2A. 2A is a self-processing peptide from Foot-And-Mouth Disease virus that allows the whole conditional system to be accommodated on a single plasmid vector and ensures stoichiometric expression levels.	[Kreidenweiss, Andrea; Hopkins, Annika V.; Mordmueller, Benjamin] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Kreidenweiss, A (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	andrea.kreidenweiss@uni-tuebingen.de	Mordmüller, Benjamin/A-5749-2010	Mordmüller, Benjamin/0000-0001-9101-2768; Kreidenweiss, Andrea/0000-0002-5025-7221	Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany; Deutsche Forschungsgemeinschaft; Tubingen University	Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	This work was supported by the scientific budget of the Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; DUSSURGET O, 1994, APPL ENVIRON MICROB, V60, P953, DOI 10.1128/AEM.60.3.953-959.1994; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noedl H, 2004, ANTIMICROB AGENTS CH, V48, P4485, DOI 10.1128/AAC.48.11.4485-4487.2004; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	16	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78661	10.1371/journal.pone.0078661	http://dx.doi.org/10.1371/journal.pone.0078661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236031	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700028
J	Li, ZT; Zou, XF; Xie, LX; Dong, HM; Chen, YP; Liu, Q; Wu, X; Zhou, D; Tan, DF; Zhang, H				Li, Zongtai; Zou, Xiaofang; Xie, Liangxi; Dong, Hongmei; Chen, Yuping; Liu, Qing; Wu, Xiao; Zhou, David; Tan, Dongfeng; Zhang, Hao			Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma	PLOS ONE			English	Article							GASTRIC-CANCER CELLS; ESOPHAGOGASTRIC JUNCTION; P21-ACTIVATED KINASES; DOWN-REGULATION; EXPRESSION; ESOPHAGEAL; GROWTH; RESISTANCE; PHOSPHORYLATION; ACTIVATION	Gastroesophageal junction (GEJ) adenocarcinoma is a lethal cancer with rising incidence, yet the molecular biomarkers that have strong prognostic impact and also hold great therapeutic promise remain elusive. We used a data mining approach and identified the p21 protein-activated kinase 1 (PAK1), an oncogene and drugable protein kinase, to be among the most promising targets for GEJ adenocarcinoma. Immunoblot analysis and data mining demonstrated that PAK1 protein and mRNA were upregulated in cancer tissues compared to the noncancerous tissues. Immunohistochemistry revealed PAK1 overexpression in 72.6% of primary GEJ adenocarcinomas (n = 113). A step-wise increase in PAK1 levels was noted from paired normal epithelium, to atypical hyperplasia and adenocarcinoma. PAK1 overexpression in tumor was associated with lymph node (LN) metastasis (P < 0.001), advanced tumor stage (P < 0.001), large tumor size (P = 0.006), residual surgical margin (P = 0.033), and unfavorable overall survival (P < 0.001). Multivariate analysis showed PAK1 overexpression is an independent high-risk prognostic predictor (P < 0.001). Collectively, PAK1 is overexpressed during tumorigenic progression and its upregulation correlates with malignant properties mainly relevant to invasion and metastasis. PAK1 expression could serve as a prognostic predictor that holds therapeutic promise for GEJ adenocarcinoma.	[Li, Zongtai; Zou, Xiaofang; Liu, Qing; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China; [Li, Zongtai; Zou, Xiaofang; Dong, Hongmei; Liu, Qing; Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China; [Xie, Liangxi] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Radiat Oncol, Shantou, Peoples R China; [Chen, Yuping] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Thorac Surg, Shantou, Peoples R China; [Wu, Xiao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Pathol, Shantou, Peoples R China; [Wu, Xiao; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Tumor Tissue Bank, Shantou, Peoples R China; [Zhou, David] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; University of Rochester; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China.	haozhang@stu.edu.cn			National Natural Science Foundation of China [81071736, 30973508, 81171994]; Cancer Center Support Grant from National Institutes of Health [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Center Support Grant from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China grants 81071736 and 30973508 (H. Zhang), and 81171994 (L. Xie). The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant (CA016672) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Almhanna K, 2012, ADV PHARMACOL, V65, P437, DOI 10.1016/B978-0-12-397927-8.00014-2; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Badgwell B, 2008, ANN SURG ONCOL, V15, P2684, DOI 10.1245/s10434-008-0055-3; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Bain GH, 2010, ONCOLOGIST, V15, P270, DOI 10.1634/theoncologist.2009-0293; Bang YJ, 2010, LANCET, V376, P1302; Bostner J, 2010, CLIN CANCER RES, V16, P1624, DOI 10.1158/1078-0432.CCR-09-1733; Cai XZ, 2009, CANCER BIOL THER, V8, P1360, DOI 10.4161/cbt.8.14.8720; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Faber AC, 2010, CELL CYCLE, V9, P851, DOI 10.4161/cc.9.5.11096; Fan YJ, 2008, WORLD J SURG, V32, P1980, DOI 10.1007/s00268-008-9674-x; Feith M, 2006, SURG ONCOL CLIN N AM, V15, P751, DOI 10.1016/j.soc.2006.07.015; Field Jeffrey, 2012, Cell Logist, V2, P54; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Hasegawa S, 2013, ANN SURG ONCOL, V20, P773, DOI 10.1245/s10434-012-2780-x; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; He H, 2013, BBA-MOL CELL RES, V1833, P33, DOI 10.1016/j.bbamcr.2012.10.015; Hicks DG, 2011, APPL IMMUNOHISTO M M, V19, P1506, DOI 10.1097/PAI.0b013e31822c3a0f; Huang B, 2011, HUM PATHOL, V42, P808, DOI 10.1016/j.humpath.2010.04.022; Huang Q, 2011, MODERN PATHOL, V24, P138, DOI 10.1038/modpathol.2010.183; Isinger-Ekstrand A, 2010, CANCER GENET CYTOGEN, V200, P120, DOI 10.1016/j.cancergencyto.2010.03.013; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li LH, 2012, ONCOL REP, V27, P1435, DOI 10.3892/or.2012.1664; Li LH, 2010, INT J ONCOL, V37, P951, DOI 10.3892/ijo_00000746; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Moehler M, 2008, WORLD J GASTROENTERO, V14, P3773, DOI 10.3748/wjg.14.3773; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Mukherjee K, 2010, DIGEST DIS SCI, V55, P3304, DOI 10.1007/s10620-010-1187-4; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Ohshiro K, 2012, INT J BIOL MARKER, V27, pE305, DOI 10.5301/JBM.2012.10437; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Oshima T, 2012, SURG TODAY, V42, P313, DOI 10.1007/s00595-011-0065-9; Pohl H, 2005, ROLE OVERDIAGNOSIS R; Rexer BN, 2009, CELL CYCLE, V8, P18, DOI 10.4161/cc.8.1.7324; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rizk NP, 2009, J THORAC ONCOL, V4, P875, DOI 10.1097/JTO.0b013e3181a8cebf; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Singhal R, 2012, ONCOTARGET, V3, P700, DOI 10.18632/oncotarget.587; Stein HJ, 2000, SURG ONCOL, V9, P35, DOI 10.1016/S0960-7404(00)00021-9; Su AI, 2001, CANCER RES, V61, P7388; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Tada M, 2010, CANCER SCI, V101, P1261, DOI 10.1111/j.1349-7006.2010.01500.x; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Ye Diana Zi, 2012, Cell Logist, V2, P105; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yokoyama H, 2006, BRIT J CANCER, V95, P1504, DOI 10.1038/sj.bjc.6603459; Zhang GH, 2008, CANCER INVEST, V26, P296, DOI 10.1080/07357900701683901; Zhao X., 2012, ONCOGENE	65	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80665	10.1371/journal.pone.0080665	http://dx.doi.org/10.1371/journal.pone.0080665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236193	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700196
J	Lin, N; Ho, A; Charoenvimolphan, N; Frerichs, KU; Day, AL; Du, R				Lin, Ning; Ho, Allen; Charoenvimolphan, Nareerat; Frerichs, Kai U.; Day, Arthur L.; Du, Rose			Analysis of Morphological Parameters to Differentiate Rupture Status in Anterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; RISK; RATIO; PREVALENCE	In contrast to size, the association of morphological characteristics of intracranial aneurysms with rupture has not been established in a systematic manner. We present an analysis of the morphological variables that are associated with rupture in anterior communicating artery aneurysms to determine site-specific risk variables. One hundred and twenty-four anterior communicating artery aneurysms were treated in a single institution from 2005 to 2010, and CT angiograms (CTAs) or rotational angiography from 79 patients (42 ruptured, 37 unruptured) were analyzed. Vascular imaging was evaluated with 3D Slicer (c) to generate models of the aneurysms and surrounding vasculature. Morphological parameters were examined using univariate and multivariate analysis and included aneurysm volume, aspect ratio, size ratio, distance to bifurcation, aneurysm angle, vessel angle, flow angle, and parent-daughter angle. Multivariate logistic regression revealed that size ratio, flow angle, and parent-daughter angle were associated with aneurysm rupture after adjustment for age, sex, smoking history, and other clinical risk factors. Simple morphological parameters such as size ratio, flow angle, and parent-daughter angle may thus aid in the evaluation of rupture risk of anterior communicating artery aneurysms.	[Lin, Ning; Charoenvimolphan, Nareerat; Frerichs, Kai U.; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Lin, Ning; Ho, Allen; Frerichs, Kai U.; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA; [Day, Arthur L.] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lin, Ning/AAP-7745-2020; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Lin, Ning/0000-0002-3638-4814; Du, Rose/0000-0003-2641-6496	Daniel E. Ponton Fund	Daniel E. Ponton Fund	This work was supported by the Daniel E. Ponton Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Baharoglu MI, 2012, J NEUROSURGERY; Castro M A, 2009, AJNR Am J Neuroradiol, V30, P297, DOI 10.3174/ajnr.A1323; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Chien AC, 2011, NEUROSURGERY, V69, P349, DOI 10.1227/NEU.0b013e31821661c3; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Ecker Robert D, 2004, Neurosurg Focus, V17, pE4; Elsharkawy A, 2013, NEUROSURGERY; Fukazawa K, 2013, WORLD NEUROSURGERY; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Macdonald RL, 2012, J NEUROSURGERY; Matsukawa H, 2012, J NEUROSURGERY; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Mocco J, 2004, Neurosurg Focus, V17, pE3; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; PERLMUTTER D, 1976, J NEUROSURG, V45, P259, DOI 10.3171/jns.1976.45.3.0259; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rinkel GJE, 2008, REV NEUROL-FRANCE, V164, P781, DOI 10.1016/j.neurol.2008.07.012; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Weir B, 2002, J NEUROSURG, V96, P3, DOI 10.3171/jns.2002.96.1.0003; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Yasuda R, 2011, NEUROSURGERY, V68, P310, DOI 10.1227/NEU.0b013e3182010ed0	29	45	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79635	10.1371/journal.pone.0079635	http://dx.doi.org/10.1371/journal.pone.0079635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236149	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700148
J	Mackin, KE; Carter, GP; Howarth, P; Rood, JI; Lyras, D				Mackin, Kate E.; Carter, Glen P.; Howarth, Pauline; Rood, Julian I.; Lyras, Dena			Spo0A Differentially Regulates Toxin Production in Evolutionarily Diverse Strains of Clostridium difficile	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; HYPERVIRULENT STRAIN; EMERGING STRAIN; ALPHA-TOXIN; SPORULATION; GENE; PERFRINGENS; TRANSCRIPTION; HUMANS; IDENTIFICATION	Clostridium difficile is an important pathogen of humans and animals, representing a significant global healthcare problem. The last decade has seen the emergence of epidemic BI/NAP1/027 and ribotype 078 isolates, associated with the onset of more severe disease and higher rates of morbidity and mortality. However, little is known about these isolates at the molecular level, partly due to difficulties in the genetic manipulation of these strains. Here we report the development of an optimised Tn916-mediated plasmid transfer system, and the use of this system to construct and complement spo0A mutants in a number of different C. difficile strain backgrounds. Spo0A is a global regulator known to control sporulation, but may also be involved in the regulation of potential virulence factors and other phenotypes. Recent studies have failed to elucidate the role of Spo0A in toxin A and toxin B production by C. difficile, with conflicting data published to date. In this study, we aimed to clarify the role of Spo0A in production of the major toxins by C. difficile. Through the construction and complementation of spo0A mutants in two ribotype 027 isolates, we demonstrate that Spo0A acts as a negative regulator of toxin A and toxin B production in this strain background. In addition, spo0A was disrupted and subsequently complemented in strain 630 Delta erm and, for the first time, in a ribotype 078 isolate, JGS6133. In contrast to the ribotype 027 strains, Spo0A does not appear to regulate toxin production in strain 630Derm. In strain JGS6133, Spo0A appears to negatively regulate toxin production during early stationary phase, but has little effect on toxin expression during late stationary phase. These data suggest that Spo0A may differentially regulate toxin production in phylogenetically distinct C. difficile strain types. In addition, Spo0A may be involved in regulating some aspects of C. difficile motility.	[Mackin, Kate E.; Carter, Glen P.; Howarth, Pauline; Rood, Julian I.; Lyras, Dena] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University	Lyras, D (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	dena.lyras@monash.edu	Rood, Julian I/A-4858-2008	Rood, Julian I/0000-0003-2126-7209; Carter, Glen/0000-0002-7306-9362; Lyras, Dena/0000-0003-2345-9271	Australian National Health and Medical Research Council; Australian Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by funding from the Australian National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Awad MM, 1997, MICROB PATHOGENESIS, V22, P275, DOI 10.1006/mpat.1996.0115; BALLARD J, 1992, INFECT IMMUN, V60, P784, DOI 10.1128/IAI.60.3.784-790.1992; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Carter GP, 2011, INFECT IMMUN, V79, P1025, DOI 10.1128/IAI.00968-10; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Goorhuis A, 2008, J CLIN MICROBIOL, V46, P1157, DOI 10.1128/JCM.01536-07; Hall IC, 1931, J BACTERIOL, V22, P375, DOI 10.1128/JB.22.6.375-385.1931; Hammitt MC, 2008, VET MICROBIOL, V127, P343, DOI 10.1016/j.vetmic.2007.09.002; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Huang IH, 2004, FEMS MICROBIOL LETT, V233, P233, DOI [10.1016/j.femsle.2004.02.014, 10.1111/j.1574-6968.2004.tb09487.x]; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Keel MK, 2006, VET PATHOL, V43, P225, DOI 10.1354/vp.43-3-225; Keessen EC, 2011, VET MICROBIOL, V153, P205, DOI 10.1016/j.vetmic.2011.03.020; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; LYERLY DM, 1992, INFECT IMMUN, V60, P4633, DOI 10.1128/IAI.60.11.4633-4639.1992; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Paredes-Sabja D, 2011, MICROB PATHOGENESIS, V51, P384, DOI 10.1016/j.micpath.2011.05.006; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Poncet S, 1997, MICROBIOL-UK, V143, P2743, DOI 10.1099/00221287-143-8-2743; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Roberts AP, 2003, J MICROBIOL METH, V55, P617, DOI 10.1016/S0167-7012(03)00200-8; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Rosenbusch KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048608; Sambrook J, 2001, MOL CLONING LAB MANU; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Scaria J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015147; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	59	53	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79666	10.1371/journal.pone.0079666	http://dx.doi.org/10.1371/journal.pone.0079666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236153	Green Published, gold			2022-12-25	WOS:000327254700152
J	Ruiz-Ranwez, V; Posadas, DM; Estein, SM; Abdian, PL; Martin, FA; Zorreguieta, A				Ruiz-Ranwez, Veronica; Posadas, Diana M.; Estein, Silvia M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles			The BtaF Trimeric Autotransporter of Brucella suis Is Involved in Attachment to Various Surfaces, Resistance to Serum and Virulence	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; PROTEIN SECRETION; MORAXELLA-CATARRHALIS; BACTERIAL ADHESION; ABORTUS; CLONING; PATHWAY; COMPLEMENT; ACTIVATION; PREDICTION	The adhesion of bacterial pathogens to host cells is an event that determines infection, and ultimately invasion and intracellular multiplication. Several evidences have recently shown that this rule is also truth for the intracellular pathogen Brucella. Brucella suis displays the unipolar BmaC and BtaE adhesins, which belong to the monomeric and trimeric autotransporter (TA) families, respectively. It was previously shown that these adhesins are involved in bacterial adhesion to host cells and components of the extracellular matrix (ECM). In this work we describe the role of a new member of the TA family of B. suis (named BtaF) in the adhesive properties of the bacterial surface. BtaF conferred the bacteria that carried it a promiscuous adhesiveness to various ECM components and the ability to attach to an abiotic surface. Furthermore, BtaF was found to participate in bacterial adhesion to epithelial cells and was required for full virulence in mice. Similar to BmaC and BtaE, the BtaF adhesin was expressed in a small subpopulation of bacteria, and in all cases, it was detected at the new pole generated after cell division. Interestingly, BtaF was also implicated in the resistance of B. suis to porcine serum. Our findings emphasize the impact of TAs in the Brucella lifecycle.	[Ruiz-Ranwez, Veronica; Posadas, Diana M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Ruiz-Ranwez, Veronica; Posadas, Diana M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles] Consejo Nacl Invest Cient & Tecn, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Posadas, Diana M.; Martin, Fernando A.; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Estein, Silvia M.] Univ Nacl Cent Provincia Buenos Aires, Ctr Invest Vet Tandil CIVETAN, Fac Ciencias Vet, Lab Inmunol, Tandil, Buenos Aires, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Zorreguieta, A (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar	Abdian, Patricia/AAW-2420-2020; Martin, Fernando Ariel/AAA-6941-2021; martin, Fernando Ariel/GYV-1866-2022	Abdian, Patricia/0000-0002-8366-8115; ESTEIN, SILVIA/0000-0002-9533-0680	University of Buenos Aires [UBACyT, X-245, X-997]; CONICET [PIP 545]	University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from University of Buenos Aires (UBACyT, X-245 and X-997) and from CONICET (PIP 545) to AZ. VRR, DMP, and FAM were supported by fellowships from CONICET, Argentina. AZ and PLA are research fellows of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 1980, ZOONOSES COMMUNICABL, Vxv; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Castaneda-Roldan EI, 2004, CELL MICROBIOL, V6, P435, DOI 10.1111/j.1462-5822.2004.00372.x; Castaneda-Roldan EI, 2006, CELL MICROBIOL, V8, P1877, DOI 10.1111/j.1462-5822.2006.00754.x; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Czibener C, 2012, MICROBES INFECT, V14, P79, DOI 10.1016/j.micinf.2011.08.012; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Dotreppe D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-257; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Fernandez-Prada CM, 2001, INFECT IMMUN, V69, P4407, DOI 10.1128/IAI.69.7.4407-4416.2001; FINE DP, 1974, J IMMUNOL, V112, P763; Godefroid M, 2010, FEMS IMMUNOL MED MIC, V59, P364, DOI 10.1111/j.1574-695X.2010.00689.x; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Hallstrom T, 2011, J IMMUNOL, V186, P3120, DOI 10.4049/jimmunol.1002621; HEESEMANN J, 1983, J INFECT DIS, V147, P107, DOI 10.1093/infdis/147.1.107; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hernandez-Castro R, 2008, MICROB PATHOGENESIS, V44, P28, DOI 10.1016/j.micpath.2007.08.008; HOFFMANN EM, 1983, VET IMMUNOL IMMUNOP, V5, P65, DOI 10.1016/0165-2427(83)90032-6; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Kaiser PO, 2012, CELL MICROBIOL, V14, P198, DOI 10.1111/j.1462-5822.2011.01711.x; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Newman CL, 2004, CRIT REV MICROBIOL, V30, P275, DOI 10.1080/10408410490499872; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Pizarro-Cerda J, 1999, BRUCELLA ABORTUS INV; Posadas DM, 2012, CELL MICROBIOL, V14, P965, DOI 10.1111/j.1462-5822.2012.01771.x; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Thorne E. Tom, 2001, P372, DOI 10.1002/9780470344880.ch22; Tomlinson AD, 2009, CURR OPIN MICROBIOL, V12, P708, DOI 10.1016/j.mib.2009.09.014; Van der Henst C, 2012, J BACTERIOL, V194, P5305, DOI 10.1128/JB.00699-12; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292	64	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79770	10.1371/journal.pone.0079770	http://dx.doi.org/10.1371/journal.pone.0079770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236157	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700157
J	Harmel-Laws, E; Mann, EA; Cohen, MB; Steinbrecher, KA				Harmel-Laws, Eleana; Mann, Elizabeth A.; Cohen, Mitchell B.; Steinbrecher, Kris A.			Guanylate Cyclase C Deficiency Causes Severe Inflammation in a Murine Model of Spontaneous Colitis	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; SODIUM-INDUCED COLITIS; INTESTINAL INFLAMMATION; EPITHELIAL-CELLS; COLONIC INJURY; MECONIUM ILEUS; GOBLET CELLS; MICE; SUSCEPTIBILITY; RECEPTOR	Background: Guanylate Cyclase C (GC-C; Gucy2c) is a transmembrane receptor expressed in intestinal epithelial cells. Activation of GC-C by its secreted ligand guanylin stimulates intestinal fluid secretion. Familial mutations in GC-C cause chronic diarrheal disease or constipation and are associated with intestinal inflammation and infection. Here, we investigated the impact of GC-C activity on mucosal immune responses. Methods: We utilized intraperitoneal injection of lipopolysaccharide to elicit a systemic cytokine challenge and then measured pro-inflammatory gene expression in colonic mucosa. GC-C+/+ and GC-C-/- mice were bred with interleukin (IL)-10 deficient animals and colonic inflammation were assessed. Immune cell influx and cytokine/chemokine expression was measured in the colon of wildtype, IL-10(-/-), GC-C+/+ IL-10(-/-) and GC-C-/- IL-10(-/-) mice. GC-C and guanylin production were examined in the colon of these animals and in a cytokine-treated colon epithelial cell line. Results: Relative to GC-C+/+ animals, intraperitoneal lipopolysaccharide injection into GC-C-/- mice increased proinflammatory gene expression in both whole colon tissue and in partially purified colonocyte isolations. Spontaneous colitis in GC-C-/- IL-10(-/-) animals was significantly more severe relative to GC-C+/+ IL-10(-/-) mice. Unlike GC-C+/+ IL-10(-/-) controls, colon pathology in GC-C-/- IL-10(-/-) animals was apparent at an early age and was characterized by severely altered mucosal architecture, crypt abscesses, and hyperplastic subepithelial lesions. F4/80 and myeloperoxidase positive cells as well as proinflammatory gene expression were elevated in GC-C-/- IL-10(-/-) mucosa relative to control animals. Guanylin was diminished early in colitis in vivo and tumor necrosis factor alpha suppressed guanylin mRNA and protein in intestinal goblet cell-like HT29-18-N2 cells. Conclusions: The GC-C signaling pathway blunts colonic mucosal inflammation that is initiated by systemic cytokine burst or loss of mucosal immune cell immunosuppression. These data as well as the apparent intestinal inflammation in human GC-C mutant kindred underscore the importance of GC-C in regulating the response to injury and inflammation within the gut.	[Cohen, Mitchell B.; Steinbrecher, Kris A.] Univ Cincinnati, Dept Pediat, Coll Med Cincinnati, Cincinnati, OH 45221 USA; [Harmel-Laws, Eleana; Mann, Elizabeth A.; Cohen, Mitchell B.; Steinbrecher, Kris A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Steinbrecher, KA (corresponding author), Univ Cincinnati, Dept Pediat, Coll Med Cincinnati, Cincinnati, OH 45221 USA.	kris.steinbrecher@cchmc.org		Cohen, Mitchell/0000-0002-4412-350X	Crohn's and Colitis Foundation of America; NIH [DK047318]; PHS [DK P30DK078392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047318, R01DK047318, P30DK078392] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Crohn's and Colitis Foundation of America (KAS), NIH DK047318 (MBC/KAS), and, in part, by PHS Grant DK P30DK078392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berglund M, 2009, CELL IMMUNOL, V259, P27, DOI 10.1016/j.cellimm.2009.05.009; Brierley SM, 2012, CURR OPIN PHARMACOL, V12, P632, DOI 10.1016/j.coph.2012.10.005; COHEN MB, 1995, BIOCHEM BIOPH RES CO, V209, P803, DOI 10.1006/bbrc.1995.1571; COHEN MB, 1988, GASTROENTEROLOGY, V94, P367, DOI 10.1016/0016-5085(88)90423-4; Cohen MB, 2002, INFECT GASTROINTESTI, P579; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; GUARINO A, 1987, PEDIATR RES, V21, P551, DOI 10.1203/00006450-198706000-00009; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Houdeau E, 2007, GASTROENTEROLOGY, V132, P982, DOI 10.1053/j.gastro.2006.12.028; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Itoh H, 1999, BIOCHEM J, V341, P461, DOI 10.1042/0264-6021:3410461; LI ZP, 1995, GASTROENTEROLOGY, V109, P1863, DOI 10.1016/0016-5085(95)90753-X; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Mann EA, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-135; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Steinbrecher KA, 2002, AM J PHYSIOL-CELL PH, V283, pC1729, DOI 10.1152/ajpcell.00010.2002; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Steinbrecher KA, 2011, CURR OPIN GASTROEN, V27, P139, DOI 10.1097/MOG.0b013e328341ead5; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; TAL A, 1985, CLIN PEDIATR, V24, P460, DOI 10.1177/000992288502400809; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Verhaeghe C, 2007, BIOCHEM BIOPH RES CO, V356, P745, DOI 10.1016/j.bbrc.2007.02.166; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011	45	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79180	10.1371/journal.pone.0079180	http://dx.doi.org/10.1371/journal.pone.0079180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244444	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600115
J	Zheng, S; Li, Y; Han, J; Zhang, HB; Zeng, W; Xu, CL; Jia, YX; Wang, JG; Guo, KQ; Jiao, YQ; Meng, X				Zheng, Shuai; Li, Yan; Han, Jie; Zhang, Haibo; Zeng, Wen; Xu, Chunlei; Jia, Yixin; Wang, Jiangang; Guo, Kequan; Jiao, Yuqing; Meng, Xu			Long-Term Results of a Minimally Invasive Surgical Pulmonary Vein Isolation and Ganglionic Plexi Ablation for Atrial Fibrillation	PLOS ONE			English	Article							TRANSVENOUS CATHETER ABLATION; FOLLOW-UP; AUTONOMIC DENERVATION; METAANALYSIS; MANAGEMENT; STRATEGY; EFFICACY; RHYTHM; TRIAL	Background: Ganglionated plexi (GP) ablation has been become an adjunct to pulmonary vein isolation (PVI). This study describes the long-term results of minimally invasive surgical PVI, ablation of GPs, and exclusion of the left atrial appendage for atrial fibrillation (AF). Methods: Long-term follow-up of 55 months was performed in 139 consecutive patients (age 58.3 +/- 20.8 years) with symptomatic, drug-refractory lone AF who underwent minimally invasive surgical PVI, GPs ablation, and exclusion of the left atrial appendage. Success was defined as freedom from AF, atrial flutter, or atrial tachycardia off antiarrhythmic drugs. Results: AF was paroxysmal in 77.7%, persistent in 12.2% and long-standing persistent in 10.1%. Single-procedure success rate was 71.7%, 59.4% and 46.6% at 12, 24 and 60 months respectively. Single-procedure success rate was 72.9%, 62.6% and 51.8% for paroxysmal AF, 64.7%, 35.3%, and 28.2% for persistent AF, 71.4%, 64.3% and 28.6% for long-standing persistent AF at 12, 24 and 60 months respectively. Duration of AF>24 months (hazard ratio [HR]: 3.09, 95% confidence interval [CI]: 1.51 to 6.32; p = 0.002), left atrial diameter >= 40 mm (HR: 4.03, 95% CI: 1.88 to 8.65; p<0.001), early recurrence of AF (HR: 4.66, 95% CI: 2.25 to 9.63; p<0.001) independently predicted long-term recurrence of AF. There was no procedure-related death. One patient converted to median sternotomy because of uncontrolled bleeding. Two patients underwent perioperative cerebrovascular events. Conclusions: At nearly 5-year of clinical follow-up, single-procedure success rate of minimally invasive surgical PVI with GP ablation was 51.8% for paroxysmal AF, 28.2% for persistent AF, 28.6% for long-standing persistent AF after initial procedure. Patients with AF duration <= 24 months, left atrial diameter <40 mm and no early recurrence of AF, had favorable outcomes.	[Zheng, Shuai; Li, Yan; Han, Jie; Zhang, Haibo; Zeng, Wen; Xu, Chunlei; Jia, Yixin; Wang, Jiangang; Guo, Kequan; Jiao, Yuqing; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Atrial Fibrillat Ctr, Beijing, Peoples R China	Capital Medical University	Meng, X (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Atrial Fibrillat Ctr, Beijing, Peoples R China.	mxu@263.net	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [81270215]; Chinese Postdoctoral Science Foundation [2013M530664]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was partly supported by National Natural Science Foundation of China (Grant No. 81270215) and Chinese Postdoctoral Science Foundation (Grant No. 2013M530664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagge L, 2009, J THORAC CARDIOV SUR, V137, P1265, DOI 10.1016/j.jtcvs.2008.12.017; Beukema WP, 2008, EUR J CARDIO-THORAC, V34, P771, DOI 10.1016/j.ejcts.2008.07.026; Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047; Calkins H, 2012, J AM COLL CARDIOL, V60, P62, DOI 10.1016/j.jacc.2012.01.068; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Cui YQ, 2010, J THORAC CARDIOV SUR, V139, P326, DOI 10.1016/j.jtcvs.2009.04.029; Edgerton JR, 2007, J INTERV CARD ELECTR, V20, P89, DOI 10.1007/s10840-007-9177-y; Edgerton JR, 2010, J THORAC CARDIOV SUR, V140, P823, DOI 10.1016/j.jtcvs.2009.11.065; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Gaynor SL, 2005, J THORAC CARDIOV SUR, V129, P104, DOI 10.1016/j.jtcvs.2004.08.042; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Han FT, 2009, CIRC-ARRHYTHMIA ELEC, V2, P370, DOI 10.1161/CIRCEP.109.854828; Klotsche J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-63; Krul SPJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P262, DOI 10.1161/CIRCEP.111.961862; Mehall JR, 2007, ANN THORAC SURG, V83, P538, DOI 10.1016/j.athoracsur.2006.09.022; Nanthakumar K, 2004, CIRCULATION, V109, P1226, DOI 10.1161/01.CIR.0000121423.78120.49; Oral H, 2002, J AM COLL CARDIOL, V40, P100, DOI 10.1016/S0735-1097(02)01939-3; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Pison L, 2012, J AM COLL CARDIOL, V60, P54, DOI 10.1016/j.jacc.2011.12.055; Pokushalov E, 2009, HEART RHYTHM, V6, P1257, DOI 10.1016/j.hrthm.2009.05.018; Sakamoto S, 2010, J THORAC CARDIOV SUR, V139, P444, DOI 10.1016/j.jtcvs.2009.04.056; Scherlag BJ, 2005, J AM COLL CARDIOL, V45, P1878, DOI 10.1016/j.jacc.2005.01.057; Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060; Wang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022122; Wolf RK, 2005, J THORAC CARDIOV SUR, V130, P797, DOI 10.1016/j.jtcvs.2005.03.041; Yilmaz A, 2010, EUR J CARDIO-THORAC, V38, P356, DOI 10.1016/j.ejcts.2010.01.058; Zhang YJ, 2012, J CARDIOVASC ELECTR, V23, P592, DOI 10.1111/j.1540-8167.2011.02270.x; Zhou J, 2007, J CARDIOVASC ELECTR, V18, P83, DOI 10.1111/j.1540-8167.2006.00679.x; Zhou QN, 2011, PACE, V34, P1687, DOI 10.1111/j.1540-8159.2011.03220.x	31	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79755	10.1371/journal.pone.0079755	http://dx.doi.org/10.1371/journal.pone.0079755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244556	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600150
J	Harvey, A; Yen, TY; Aizman, I; Tate, C; Case, C				Harvey, Adam; Yen, Ten-Yang; Aizman, Irina; Tate, Ciara; Case, Casey			Proteomic Analysis of the Extracellular Matrix Produced by Mesenchymal Stromal Cells: Implications for Cell Therapy Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LATENT TGF-BETA; TANDEM MASS-SPECTROMETRY; STEM-CELLS; PROTEIN IDENTIFICATION; PLASMA FIBRONECTIN; STATISTICAL-MODEL; BRAIN-INJURY; SB623 CELLS; IN-VITRO	Mesenchymal stromal cells (MSCs) transiently transfected with notch1 intracellular domain (NICD) are beneficial for neurological disorders as observed in several preclinical studies. Extracellular matrix (ECM) derived from NICD-transfected MSCs has been previously shown to support in vitro neural cell growth and survival better than that of un-transfected MSCs. To understand the underlying mechanism(s) by which NICD-transfected MSC-derived ECM supports neural cell growth and survival, we investigated the differences in NICD-transfected MSC-and MSC-derived ECM protein quantity and composition. To compare the ECM derived from MSCs and NICD-transfected MSCs, the proteins were sequentially solubilized using sodium dodecyl sulfate (SDS) and urea, quantified, and compared across four human donors. We then analyzed ECM proteins using either in-gel digests or in-solution surfactant-assisted trypsin digests (SAISD) coupled with reverse phase nano-liquid chromatography and tandem mass spectrometry (nLC-MS/MS). Analyses using nLC-MS/MS identified key components of ECM from NICD-transfected MSCs and un-transfected MSCs and revealed significant differences in their respective compositions. This work provides a reproducible method for identifying and comparing in vitro cell-derived ECM proteins, which is crucial for exploring the mechanisms underlying cellular therapy.	[Harvey, Adam; Aizman, Irina; Tate, Ciara; Case, Casey] SanBio Inc, Mountain View, CA USA; [Harvey, Adam] Univ Calif San Francisco, Dept Biol, San Francisco, CA 94143 USA; [Yen, Ten-Yang] Univ Calif San Francisco, Dept Chem & Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Case, C (corresponding author), SanBio Inc, Mountain View, CA USA.	Casey.Case@san-bio.com			SanBio Inc.; National Science Foundation Science Master's Program Award [DGE-1011717]; National Science Foundation grant [CHE-0619163]; Direct For Mathematical & Physical Scien [1228656] Funding Source: National Science Foundation; Division Of Graduate Education [1011717] Funding Source: National Science Foundation	SanBio Inc.; National Science Foundation Science Master's Program Award; National Science Foundation grant(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	Funding for this research project was provided by SanBio Inc. (AH, IA, CT, CC), the National Science Foundation Science Master's Program Award DGE-1011717 (AH) and the National Science Foundation grant CHE-0619163 (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Allen Matthew, 1994, Clinical Materials, V16, P189; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arcinas A, 2009, J PROTEOME RES, V8, P3958, DOI 10.1021/pr900278c; Bruno V, 1998, J NEUROSCI, V18, P9594; Byron A, 2013, INT J EXP PATHOL; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GIESE A, 1994, CANCER RES, V54, P3897; Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; Heng BC, 2009, BIOL PROCED ONLINE, V11, P161, DOI 10.1007/s12575-009-9001-4; Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kwon SH, 2013, TISSUE ENG PT A, V19, P49, DOI [10.1089/ten.tea.2012.0245, 10.1089/ten.TEA.2012.0245]; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; McDonald CA, 2009, MOL CELL PROTEOMICS, V8, P287, DOI 10.1074/mcp.M800272-MCP200; Mimura T, 2005, J NEUROPATH EXP NEUR, V64, P1108, DOI 10.1097/01.jnen.0000190068.03009.b5; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Newman AC, 2013, ARTERIOSCL THROM VAS, V33, P513, DOI 10.1161/ATVBAHA.112.300782; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OHNO M, 1979, J SUPRAMOL STR CELL, V12, P457, DOI 10.1002/jss.400120405; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Rigato F, 2002, J NEUROSCI, V22, P6596; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; Song HJ, 2012, MOL BIOL REP, V39, P4017, DOI 10.1007/s11033-011-1182-7; Spahr CS, 2001, PROTEOMICS, V1, P93, DOI 10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; Strelau J, 2000, J NEUROSCI, V20, P8597; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Tate CC, 2010, CELL TRANSPLANT, V19, P973, DOI 10.3727/096368910X494885; TRIPATHI BJ, 1991, INVEST OPHTH VIS SCI, V32, P181; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wong JWH, 2010, METHODS MOL BIOL, V604, P273, DOI 10.1007/978-1-60761-444-9_18; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	54	37	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79283	10.1371/journal.pone.0079283	http://dx.doi.org/10.1371/journal.pone.0079283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244468	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800054
J	Shaw, LM; Turner, AS; Herry, L; Griffiths, S; Laurie, DA				Shaw, Lindsay M.; Turner, Adrian S.; Herry, Laurence; Griffiths, Simon; Laurie, David A.			Mutant Alleles of Photoperiod-1 in Wheat (Triticum aestivum L.) That Confer a Late Flowering Phenotype in Long Days	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; EUROPEAN WINTER WHEATS; FLORAL INDUCTION; GENES; BARLEY; CONSTANS; TIME; FT; PPD-A1A; ADAPTABILITY	Flowering time in wheat and barley is known to be modified by mutations in the Photoperiod-1 (Ppd-1) gene. Semidominant Ppd-1a mutations conferring an early flowering phenotype are well documented in wheat but gene sequencing has also identified candidate loss of function mutations for Ppd-A1 and Ppd-D1. By analogy to the recessive ppd-H1 mutation in barley, loss of function mutations in wheat are predicted to delay flowering under long day conditions. To test this experimentally, introgression lines were developed in the spring wheat variety 'Paragon'. Plants lacking a Ppd-B1 gene were identified from a gamma irradiated 'Paragon' population. These were crossed with the other introgression lines to generate plants with candidate loss of function mutations on one, two or three genomes. Lines lacking Ppd-B1 flowered 10 to 15 days later than controls under long days. Candidate loss of function Ppd-A1 alleles delayed flowering by 1 to 5 days while candidate loss of function Ppd-D1 alleles did not affect flowering time. Loss of Ppd-A1 gave an enhanced effect, and loss of Ppd-D1 became detectable in lines where Ppd-B1 was absent, indicating effects may be buffered by functional Ppd-1 alleles on other genomes. Expression analysis revealed that delayed flowering was associated with reduced expression of the TaFT1 gene and increased expression of TaCO1. A survey of the GEDIFLUX wheat collection grown in the UK and North Western Europe between the 1940s and 1980s and the A. E. Watkins global collection of landraces from the 1920s and 1930s showed that the identified candidate loss of function mutations for Ppd-D1 were common and widespread, while the identified candidate Ppd-A1 loss of function mutation was rare in countries around the Mediterranean and in the Far East but was common in North Western Europe. This may reflect a possible benefit of the latter in northern locations.	[Shaw, Lindsay M.; Turner, Adrian S.; Herry, Laurence; Griffiths, Simon; Laurie, David A.] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Shaw, LM (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	lindsay.shaw@csiro.au	Shaw, Lindsay/I-3365-2012	Shaw, Lindsay/0000-0001-8078-2409	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E007295/1, BB/F014031/1]; BBSRC [BBS/E/J/000CA393, BB/F014031/1, BB/E007295/1, BBS/E/J/000CA471, BB/H012370/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012370/1, BB/F014031/1, BBS/E/J/000CA393, BB/E007295/1, BBS/E/J/000CA471] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financially supported by research grants BB/E007295/1 and BB/F014031/1 from the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk) and by grant-in-aid to the John Innes Centre from the same source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bentley AR, 2011, PLANT BREEDING, V130, P10, DOI 10.1111/j.1439-0523.2010.01802.x; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Iqbal M, 2007, GENOME, V50, P511, DOI 10.1139/G07-028; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kitagawa S, 2012, GENES GENET SYST, V87, P161, DOI 10.1266/ggs.87.161; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; MCINTOSH RA, 2003, CATALOGUE GENE SYMBO; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Thomas B., 1997, PHOTOPERIODISM PLANT; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Welsh J. R., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P879; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; WORLAND AJ, 1994, EUPHYTICA, V80, P219, DOI 10.1007/BF00039653; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Worland AJ, 1999, J GENETICS BREEDING, V53, P165173; Worland AJ, 2001, WORLD WHEAT BOOK HIS; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y	37	58	59	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79459	10.1371/journal.pone.0079459	http://dx.doi.org/10.1371/journal.pone.0079459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244507	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800078
J	Yang, J; Wilksch, JJ; Tan, JWH; Hocking, DM; Webb, CT; Lithgow, T; Robins-Browne, RM; Strugnell, RA				Yang, Ji; Wilksch, Jonathan J.; Tan, Jason W. H.; Hocking, Dianna M.; Webb, Chaille T.; Lithgow, Trevor; Robins-Browne, Roy M.; Strugnell, Richard A.			Transcriptional Activation of the mrkA Promoter of the Klebsiella pneumoniae Type 3 Fimbrial Operon by the c-di-GMP-Dependent MrkH Protein	PLOS ONE			English	Article							COLI RNA-POLYMERASE; SECONDARY STRUCTURE PREDICTION; INTENSIVE-CARE-UNIT; ESCHERICHIA-COLI; BIOFILM FORMATION; ALPHA-SUBUNIT; CELLULOSE SYNTHESIS; CONTACT SITE; PILZ DOMAIN; EXPRESSION	The Gram-negative bacterial pathogen Klebsiella pneumoniae forms biofilms to facilitate colonization of biotic and abiotic surfaces. The formation of biofilms by K. pneumoniae requires the expression of type 3 fimbriae: elongate proteinaceous filaments extruded by a chaperone-usher system in the bacterial outer membrane. The expression of the mrkABCDF cluster that encodes this fimbrial system is strongly positively regulated by MrkH, a transcriptional activator that responds to the second messenger, c-di-GMP. In this study, we analyzed the mechanism by which the MrkH protein activates transcriptional initiation from the mrkA promoter. A mutational analysis supported by electrophoretic mobility shift assays demonstrated that a 12-bp palindromic sequence (the MrkH box) centered at -78.5 is the binding site of MrkH. Deletion of half a turn, but not a full turn, of DNA located between the MrkH box and the mrkA promoter destroyed the ability of MrkH to activate mrkA transcription. In addition, a 10-bp AT-rich sequence (the UP element) centered at -63.5 contributed significantly to MrkH-dependent mrkA transcription. In vivo analysis of rpoA mutants showed that the R265 and E273 determinants in the C-terminal domain of RNA polymerase a subunit are needed for MrkH-mediated activation of mrkA transcription. Furthermore, results from mutagenesis of the mrkH gene suggest that the N-terminal region of the protein is involved in transcriptional activation. Taken together, our results suggest that MrkH activates mrkA expression by interacting directly with RNA polymerase, to overcome the inefficient transcriptional initiation caused by the presence of defective core promoter elements.	[Yang, Ji; Wilksch, Jonathan J.; Tan, Jason W. H.; Hocking, Dianna M.; Robins-Browne, Roy M.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Webb, Chaille T.; Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	University of Melbourne; Monash University	Wilksch, JJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	wilkschj@unimelb.edu.au	Lithgow, Trevor J/H-5925-2017; Robinsbrowne, Roy/ABF-8434-2020	Lithgow, Trevor J/0000-0002-0102-7884; Robinsbrowne, Roy/0000-0001-9179-7884; Webb, Chaille/0000-0003-0918-0282; Strugnell, Richard/0000-0003-0614-5641	Australian National Health and Medical Research Council [606788]; Australian Research Council [DP130100957]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Work in the authors' laboratories was supported by research grants from the Australian National Health and Medical Research Council (Program Grant 606788) and the Australian Research Council (Project Grant DP130100957). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carter HD, 2004, J BACTERIOL, V186, P2829, DOI 10.1128/JB.186.9.2829-2840.2004; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; KIMURA M, 1995, J MOL BIOL, V248, P756, DOI 10.1006/jmbi.1995.0258; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Langley JM, 2001, AM J INFECT CONTROL, V29, P94, DOI 10.1067/mic.2001.111537; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Marschall J, 2009, INFECT CONT HOSP EP, V30, P1050, DOI 10.1086/606165; Mathai D, 2001, DIAGN MICR INFEC DIS, V40, P129, DOI 10.1016/S0732-8893(01)00254-1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt JH, 2005, CURR PROTOC MICROBIO, V1; Miller JH., 1972, EXPT MOL GENETICS; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Sligl W, 2006, INT J INFECT DIS, V10, P320, DOI 10.1016/j.ijid.2005.07.003; Sohn AH, 2001, J PEDIATR-US, V139, P821, DOI 10.1067/mpd.2001.119442; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; TARKKANEN AM, 1990, MOL MICROBIOL, V4, P1353, DOI 10.1111/j.1365-2958.1990.tb00714.x; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Yang J, 2005, MICROBIOL-SGM, V151, P1199, DOI 10.1099/mic.0.27734-0; Yang J, 2009, J MOL BIOL, V394, P591, DOI 10.1016/j.jmb.2009.10.033; Yasuno K, 2001, J MOL BIOL, V306, P213, DOI 10.1006/jmbi.2000.4369; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	63	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79038	10.1371/journal.pone.0079038	http://dx.doi.org/10.1371/journal.pone.0079038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244411	Green Published, gold			2022-12-25	WOS:000327143800023
J	Zaleskiewicz, T; Gasiorowska, A; Kesebir, P				Zaleskiewicz, Tomasz; Gasiorowska, Agata; Kesebir, Pelin			Saving Can Save from Death Anxiety: Mortality Salience and Financial Decision-Making	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; SELF-ESTEEM; CONSPICUOUS CONSUMPTION; MATERIALISM; THOUGHTS; ACCESSIBILITY; VALIDATION; THREAT	Four studies tested the idea that saving money can buffer death anxiety and constitute a more effective buffer than spending money. Saving can relieve future-related anxiety and provide people with a sense of control over their fate, thereby rendering death thoughts less threatening. Study 1 found that participants primed with both saving and spending reported lower death fear than controls. Saving primes, however, were associated with significantly lower death fear than spending primes. Study 2 demonstrated that mortality primes increase the attractiveness of more frugal behaviors in save-or-spend dilemmas. Studies 3 and 4 found, in two different cultures (Polish and American), that the activation of death thoughts prompts people to allocate money to saving as opposed to spending. Overall, these studies provided evidence that saving protects from existential anxiety, and probably more so than spending.	[Zaleskiewicz, Tomasz; Gasiorowska, Agata] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland; [Kesebir, Pelin] Univ Colorado, Colorado Springs, CO 80907 USA	SWPS University of Social Sciences & Humanities; University of Colorado System; University of Colorado at Colorado Springs	Zaleskiewicz, T (corresponding author), Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland.	tzaleskiewicz@swps.edu.pl	Gasiorowska, Agata/AAM-1514-2020	Gasiorowska, Agata/0000-0002-3354-1095; Zaleskiewicz, Tomasz/0000-0002-4232-6151	Polish Ministry of Science and Higher Education [NN106 1332 37]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Tomasz Zaleskiewicz and Agata Gasiorowska involvement in the study was supported by the Polish Ministry of Science and Higher Education grant no. NN106 1332 37; http://www.nauka.gov.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt J, 2004, J CONSUM PSYCHOL, V14, P198, DOI 10.1207/s15327663jcp1403_2; Bakshi GS, 1996, AM ECON REV, V86, P133; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Dechesne M, 2000, EUR J SOC PSYCHOL, V30, P813, DOI 10.1002/1099-0992(200011/12)30:6<813::AID-EJSP17>3.0.CO;2-M; Diener E., 2008, HAPPINESS UNLOCKING; Dittmar H., 2011, PSYCHOL STUD, V56, P71, DOI [DOI 10.1007/S12646-011-0065-2, 10.1007/s12646-011-0065-2]; Dittmar H., 2010, CONSUMER CULTURE IDE; Dittmar H, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P745, DOI 10.1007/978-1-4419-7988-9_31; Dittmar H, 2010, BRIT J PSYCHOL, V101, P751, DOI 10.1348/000712609X484658; Fromm Erich, 1976, HAVE BE; FROST RO, 1993, BEHAV RES THER, V31, P367, DOI 10.1016/0005-7967(93)90094-B; Furnham Adrian., 1998, PSYCHOL MONEY; Gailliot MT, 2006, J PERS SOC PSYCHOL, V91, P49, DOI 10.1037/0022-3514.91.1.49; Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Griskevicius V, 2007, J PERS SOC PSYCHOL, V93, P85, DOI 10.1037/0022-3514.93.1.85; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524; Hirschberger G, 2002, EUR J SOC PSYCHOL, V32, P609, DOI 10.1002/ejsp.110; HIRSCHMAN EC, 1990, J CONSUM RES, V17, P31, DOI 10.1086/208534; Kasser M, 2013, METAANALYSIS M UNPUB; Kasser T, 2000, PSYCHOL SCI, V11, P348, DOI 10.1111/1467-9280.00269; Kasser T., 2004, PSYCHOL CONSUMER CUL, P11, DOI [10.1037/10658-002, DOI 10.1037/10658-002]; Kasser T, 2011, SOC PERSONAL PSYCHOL, V5, P865, DOI 10.1111/j.1751-9004.2011.00396.x; Kasser Tim., 2003, HIGH PRICE MAT; Kesebir P., 2012, OXFORD LIB PSYCHOL O, P43, DOI [10.1093/oxfordhb/9780195399820.013.0004, DOI 10.1093/OXFORDHB/9780195399820.013.0004]; Kivetz R, 2006, J CONSUM RES, V33, P273, DOI 10.1086/506308; Lea Stephen E. G., 1987, INDIVIDUAL EC SURVEY; Liu W, 2007, ORGAN BEHAV HUM DEC, V102, P212, DOI 10.1016/j.obhdp.2006.02.004; LUNT PK, 1991, J ECON PSYCHOL, V12, P621, DOI 10.1016/0167-4870(91)90003-C; Maheswaran D, 2004, J CONSUM PSYCHOL, V14, P213, DOI 10.1207/s15327663jcp1403_3; Mandel N, 1999, ADV CONSUM RES, V26, P527; Maslow A.H., 1954, MOTIVATION PERSONALI; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590; Pryor J.H., 2007, AM FRESHMAN 40 YEAR; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T., 2010, HDB SOCIAL PSYCHOL, P724, DOI DOI 10.1002/9780470561119.SOCPSY001020; Rindfleisch A, 2009, J CONSUM RES, V36, P1, DOI 10.1086/595718; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schimel J, 2007, J PERS SOC PSYCHOL, V92, P789, DOI 10.1037/0022-3514.92.5.789; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; SOLOMON S, 1991, ADV EXP SOC PSYCHOL, V24, P93; Solomon Sheldon, 2004, PSYCHOL CONSUMER CUL, P127, DOI [10.1037/10658-008, DOI 10.1037/10658-008]; Stillman TF, 2012, J ECON PSYCHOL, V33, P1, DOI 10.1016/j.joep.2011.08.012; Sundie JM, 2011, J PERS SOC PSYCHOL, V100, P664, DOI 10.1037/a0021669; TEMPLER DI, 1970, J GEN PSYCHOL, V82, P165, DOI 10.1080/00221309.1970.9920634; The Futures Company, 2009, UND CONS ATT SAV 200; TNS Poland, 2012, POST POL WOB OSZCZ K; WARNERYD KE, 1989, J ECON PSYCHOL, V10, P515, DOI 10.1016/0167-4870(89)90041-x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yalom ID., 1980, EXISTENTIAL PSYCHOTH; Zaleskiewicz T, 2013, J ECON PSYCHOL, V36, P55, DOI 10.1016/j.joep.2013.02.008	56	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79407	10.1371/journal.pone.0079407	http://dx.doi.org/10.1371/journal.pone.0079407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244497	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800073
J	Fagan, RL; Wu, M; Chedin, F; Brenner, C				Fagan, Rebecca L.; Wu, Meng; Chedin, Frederic; Brenner, Charles			An Ultrasensitive High Throughput Screen for DNA Methyltransferase 1-Targeted Molecular Probes	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; EPIGENETIC REGULATION; METHYLATION; INHIBITORS; CANCER; IDENTIFICATION; FUTURE; CELLS; TUMORIGENESIS; EXPRESSION	DNA methyltransferase 1 (DNMT1) is the enzyme most responsible for epigenetic modification of human DNA and the intended target of approved cancer drugs such as 5-aza-cytidine and 5-aza-2'-deoxycytidine. 5-aza nucleosides have complex mechanisms of action that require incorporation into DNA, and covalent trapping and proteolysis of DNMT isozymes. Direct DNMT inhibitors are needed to refine understanding of the role of specific DNMT isozymes in cancer etiology and, potentially, to improve cancer prevention and treatment. Here, we developed a high throughput pipeline for identification of direct DNMT1 inhibitors. The components of this screen include an activated form of DNMT1, a restriction enzyme-coupled fluorigenic assay performed in 384 well plates with a z-factor of 0.66, a counter screen against the restriction enzyme, a screen to eliminate DNA intercalators, and a differential scanning fluorimetry assay to validate direct binders. Using the Microsource Spectrum collection of 2320 compounds, this screen identified nine compounds with dose responses ranging from 300 nM to 11 mu M, representing at least two different pharmacophores with DNMT1 inhibitory activity. Seven of nine inhibitors identified exhibited two to four-fold selectivity for DNMT1 versus DNMT3A.	[Fagan, Rebecca L.; Wu, Meng; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Chedin, Frederic] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of Iowa; University of California System; University of California Davis; University of California System; University of California Davis	Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Wu, Meng/F-3958-2010; Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Wu, Meng/0000-0003-2222-0736; Chedin, Frederic/0000-0002-1306-5335; Switzer, Rebecca/0000-0003-0591-2538	National Cancer Institute [HHSN261200433000C, R01CA75954]; National Institutes of Health [GM094299]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094299] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by contract HHSN261200433000C and grant R01CA75954 from the National Cancer Institute and a generous gift from the Roy J. Carver Foundation to CB, grant GM094299 from the National Institutes of Health to FC and an American Cancer Society postdoctoral fellowship to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaning K, 2013, BIOORG MED CHEM LETT, V23, P3620, DOI 10.1016/j.bmcl.2013.04.003; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Ceccaldi A, 2013, ACS CHEM BIOL, V8, P543, DOI 10.1021/cb300565z; Ceccaldi A, 2011, CHEMBIOCHEM, V12, P1337, DOI 10.1002/cbic.201100130; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Eads CA, 2002, CANCER RES, V62, P1296; Eglen RM, 2011, J BIOMOL SCREEN, V16, P1137, DOI 10.1177/1087057111417871; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang J, 2013, ONCOGENE IN PRESS; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kilgore JA, 2013, J BIOL CHEM, V288, P19673, DOI 10.1074/jbc.M112.443895; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma HM, 2013, CHEMOSPHERE, V90, P1023, DOI 10.1016/j.chemosphere.2012.07.063; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Mishra N, 2001, P NATL ACAD SCI USA, V98, P2628, DOI 10.1073/pnas.051507098; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Wan KF, 2009, CELL CYCLE, V8, P3943, DOI 10.4161/cc.8.23.10114; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78752	10.1371/journal.pone.0078752	http://dx.doi.org/10.1371/journal.pone.0078752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236046	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700043
J	He, N; Duan, S; Ding, YY; Rou, KM; McGoogan, JM; Jia, MH; Yang, YC; Wang, JB; Montaner, JSG; Wu, ZY				He, Na; Duan, Song; Ding, Yingying; Rou, Keming; McGoogan, Jennifer M.; Jia, Manhong; Yang, Yuecheng; Wang, Jibao; Montaner, Julio S. G.; Wu, Zunyou		China Natl HIV Prevention Study Gr	Antiretroviral Therapy Reduces HIV Transmission in Discordant Couples in Rural Yunnan, China	PLOS ONE			English	Article							HORMONAL CONTRACEPTIVES; SERODISCORDANT COUPLES; RESISTANCE MUTATIONS; HETEROSEXUAL RISK; HEPATITIS-B; PREVENTION; PREVALENCE; INFECTION; INITIATION; SYPHILIS	Background: Although HIV treatment as prevention (TasP) via early antiretroviral therapy (ART) has proven to reduce transmissions among HIV-serodiscordant couples, its full implementation in developing countries remains a challenge. In this study, we determine whether China's current HIV treatment program prevents new HIV infections among discordant couples in rural China. Methods: A prospective, longitudinal cohort study was conducted from June 2009 to March 2011, in rural Yunnan. A total of 1,618 HIV-discordant couples were eligible, 1,101 were enrolled, and 813 were followed for an average of 1.4 person-years (PY). Routine ART was prescribed to HIV-positive spouses according to eligibility (CD4<350 cells/mu l). Seroconversion was used to determine HIV incidence. Results: A total of 17 seroconversions were documented within 1,127 PY of follow-up, for an overall incidence of 1.5 per 100 PY. Epidemiological and genetic evidence confirmed that all 17 seroconverters were infected via marital secondary sexual transmission. Having an ART-experienced HIV-positive partner was associated with a lower rate of seroconvertion compared with having an ART-naive HIV-positive partner (0.8 per 100 PY vs. 2.4 per 100 PY, HR = 0.34, 95% CI = 0.12-0.97, p = 0.0436). While we found that ART successfully suppressed plasma viral load to <400 copies/ml in the majority of cases (85.0% vs. 19.5%, p<0.0001 at baseline), we did document five seroconversions among ART-experienced subgroup. Conclusions: ART is associated with a 66% reduction in HIV incidence among discordant couples in our sample, demonstrating the effectiveness of China's HIV treatment program at preventing new infections, and providing support for earlier ART initiation and TasP implementation in this region.	[He, Na; Ding, Yingying] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Minist Educ, Shanghai 200433, Peoples R China; Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Duan, Song; Yang, Yuecheng; Wang, Jibao] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan Province, Peoples R China; [Rou, Keming; McGoogan, Jennifer M.; Wu, Zunyou] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Jia, Manhong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan Province, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China.	wuzy@263.net	ding, yy/HHS-9589-2022	Liu, Enwu/0000-0003-2580-3523	Chinese Ministry of Health [2008ZX10001-016]	Chinese Ministry of Health	The study was supported by the National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health (Grant No. 2008ZX10001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE DATABASE SY; Arora P, 2011, SEX TRANSM INFECT, V87, P516, DOI 10.1136/sextrans-2011-050203; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, JAIDS-J ACQ IMM DEF, V56, pE101, DOI 10.1097/QAI.0b013e3182041968; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Granich R, 2011, CURR HIV RES, V9, P355, DOI 10.2174/157016211798038551; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Han J, 2009, INT J STD AIDS, V20, P249, DOI 10.1258/ijsa.2008.008480; Han XX, 2007, AIDS RES HUM RETROV, V23, P357, DOI 10.1089/aid.2006.0094; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Montaner J, 2011, JAIDS-J ACQ IMM DEF, V56, pE101, DOI 10.1097/QAI.0b013e318202e41d; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Tu YQ, 2009, TRANSFUSION, V49, P1865, DOI 10.1111/j.1537-2995.2009.02219.x; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Zang CP, 2011, CHINESE MED J-PEKING, V124, P1890, DOI 10.3760/cma.j.issn.0366-6999.2011.12.022; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	33	47	64	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77981	10.1371/journal.pone.0077981	http://dx.doi.org/10.1371/journal.pone.0077981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236010	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700007
J	Qin, HX; Bollag, WB				Qin, Haixia; Bollag, Wendy B.			The Caveolin-1 Scaffolding Domain Peptide Decreases Phosphatidylglycerol Levels and Inhibits Calcium-Induced Differentiation in Mouse Keratinocytes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHOLIPASE-D; EPIDERMAL DIFFERENTIATION; TERMINAL DIFFERENTIATION; FUNCTIONAL INTERACTION; EXTRACELLULAR CALCIUM; MEMBRANE ATTACHMENT; SENSING RECEPTOR; SKIN HYDRATION; HAIR FOLLICLE	Phospholipase D2 (PLD2) has been found localized in low-density caveolin-rich membrane microdomains. Our previous study suggested that PLD2 and aquaporin 3 (AQP3) interact in these domains to inhibit keratinocyte proliferation and promote differentiation by cooperating to produce phosphatidylglycerol. To examine the effect of membrane microdomain localization on the PLD2/AQP3 signaling module and keratinocyte proliferation and differentiation, we treated mouse keratinocytes with 3 mu M cell-permeable caveolin-1 scaffolding domain peptide or a negative control peptide and stimulated cell differentiation using a moderately elevated extracellular calcium concentration (125 uM) to maximally promote differentiation and phosphatidylglycerol production. Cell proliferation, differentiation, total PLD activity, phosphatidylglycerol levels, and AQP3 activity were monitored. The caveolin-1 scaffolding domain peptide itself had no effect on phosphatidylglycerol levels or keratinocyte proliferation or differentiation but prevented the changes induced by a moderately elevated calcium concentration, whereas a negative control did not. The caveolin-1 scaffolding domain peptide had little effect on total PLD activity or glycerol uptake (AQP3 activity). We conclude that the caveolin-1 scaffolding domain peptide disrupts the functional association between AQP3 and PLD2 and prevents both the inhibited proliferation and the stimulated differentiation in response to elevated extracellular calcium levels. The interaction of caveolin-1 and PLD2 is indirect (i.e., lipid mediated); together with the proliferation-promoting effects of caveolin-1 knockout on epidermal keratinocytes, we propose that the caveolin-1 scaffolding domain pepetide exerts a dominant-negative effect on caveolin-1 to alter lipid rafts in these cells.	[Bollag, Wendy B.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Qin, Haixia; Bollag, Wendy B.] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Med Coll Georgia, Dept Med Dermatol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Cell Biol & Anat, Augusta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollag, WB (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA USA.	WB@gru.edu		Bollag, Wendy/0000-0003-3146-162X	National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases) [AR45212]; Veterans Administration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045212, R29AR045212] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by award #AR45212 from the National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases). WBB is supported by a Research Career Scientist and a Merit Award from the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Banno Y, 2002, J BIOCHEM, V131, P301, DOI 10.1093/oxfordjournals.jbchem.a003103; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.20095; Bollag W B, 1998, Methods Mol Biol, V105, P151; Bollag WB, 2007, J INVEST DERMATOL, V127, P2823, DOI 10.1038/sj.jid.5700921; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Campbell L, 2002, BRIT J DERMATOL, V147, P701, DOI 10.1046/j.1365-2133.2002.05009.x; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Forslind B, 1987, Acta Derm Venereol Suppl (Stockh), V134, P1; Frohman MA, 1999, CHEM PHYS LIPIDS, V98, P127, DOI 10.1016/S0009-3084(99)00025-0; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Griner RD, 1999, J BIOL CHEM, V274, P4663, DOI 10.1074/jbc.274.8.4663; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hara M, 2003, P NATL ACAD SCI USA, V100, P7360, DOI 10.1073/pnas.1230416100; Hara M, 2002, J BIOL CHEM, V277, P46616, DOI 10.1074/jbc.M209003200; Hara-Chikuma M, 2005, BIOL CELL, V97, P479; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; HENNINGS H, 1983, J CELL PHYSIOL, V116, P265, DOI 10.1002/jcp.1041160303; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; LEE E, 1991, CARCINOGENESIS, V12, P1651, DOI 10.1093/carcin/12.9.1651; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; MENON GK, 1992, CELL TISSUE RES, V270, P503, DOI 10.1007/BF00645052; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MENON GK, 1994, J INVEST DERMATOL, V102, P789, DOI 10.1111/1523-1747.ep12377921; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; Nozawa Y, 2002, BBA-MOL CELL BIOL L, V1585, P77, DOI 10.1016/S1388-1981(02)00327-X; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V290, pH46, DOI 10.1152/ajpheart.00769.2005; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PILLAI S, 1991, J CELL PHYSIOL, V146, P94, DOI 10.1002/jcp.1041460113; PUNNONEN K, 1993, J INVEST DERMATOL, V101, P719, DOI 10.1111/1523-1747.ep12371682; Qin HX, 2011, ARCH BIOCHEM BIOPHYS, V508, P138, DOI 10.1016/j.abb.2011.01.014; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Roelandt T, 2009, J INVEST DERMATOL, V129, P927, DOI 10.1038/jid.2008.328; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; SEVERS NJ, 1988, J CELL SCI, V90, P341; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; SU MJ, 1994, J BIOL CHEM, V269, P14723; Trimmer C, 2013, AM J TRANSL RES, V5, P80; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2012, J INVEST DERMATOL, V132, P2350, DOI 10.1038/jid.2012.159; Tu CL, 1999, J INVEST DERMATOL, V113, P340, DOI 10.1046/j.1523-1747.1999.00698.x; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Voss KE, 2011, ARCH DERMATOL RES, V303, P591, DOI 10.1007/s00403-011-1136-x; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; YUSPA SH, 1974, EXP CELL RES, V86, P95, DOI 10.1016/0014-4827(74)90653-3; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zheng XJ, 2003, BBA-MOL CELL RES, V1643, P25, DOI 10.1016/j.bbamcr.2003.08.006; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	70	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80946	10.1371/journal.pone.0080946	http://dx.doi.org/10.1371/journal.pone.0080946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236206	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700209
J	Scicluna, BP; van ' t Veer, C; Nieuwdorp, M; Felsmann, K; Wlotzka, B; Stroes, ESG; van der Poll, T				Scicluna, Brendon P.; van ' t Veer, Cornelis; Nieuwdorp, Max; Felsmann, Karen; Wlotzka, Britta; Stroes, Erik S. G.; van der Poll, Tom			Role of Tumor Necrosis Factor-alpha in the Human Systemic Endotoxin-Induced Transcriptome	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; INTRAVENOUS ENDOTOXIN; GENE-EXPRESSION; IRAK-M; RECEPTOR; TOLERANCE; MODELS; INFECTIONS; INDUCTION; NETWORKS	TNF alpha has been implicated in the pathogenesis of various inflammatory diseases. Different strategies to inhibit TNF alpha in patients with sepsis and chronic inflammatory conditions have shown contrasting outcomes. Although TNF alpha inhibitors are widely used in clinical practice, the impact of TNF alpha antagonism on white blood cell gene expression profiles during acute inflammation in humans in vivo has not been assessed. We here leveraged the established model of human endotoxemia to examine the effect of the TNF alpha antagonist, etanercept, on the genome-wide transcriptional responses in circulating leukocytes induced by intravenous LPS administration in male subjects. Etanercept pre-treatment resulted in a markedly dampened transcriptional response to LPS. Gene co-expression network analysis revealed this LPS-induced transcriptome can be categorized as TNF alpha responsive and non-responsive modules. Highly significant TNF alpha responsive modules include NF-kB signaling, antiviral responses and T-cell mediated responses. Within these TNF alpha responsive modules we delineate fundamental genes involved in epigenetic modifications, transcriptional initiation and elongation. Thus, we provide comprehensive information about molecular pathways that might be targeted by therapeutic interventions that seek to inhibit TNF alpha activity during human inflammatory diseases.	[Scicluna, Brendon P.; van ' t Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Scicluna, Brendon P.; van ' t Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Nieuwdorp, Max; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Felsmann, Karen; Wlotzka, Britta] SIRS Lab GmbH, Jena, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scicluna, BP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.scicluna@amc.uva.nl	Scicluna, Brendon/T-8112-2018	Scicluna, Brendon/0000-0003-2826-0341	CTMM Netherlands	CTMM Netherlands	This work was supported by CTMM Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lorente JA, 2005, SHOCK, V24, P107, DOI 10.1097/01.shk.0000191343.21228.78; MAEKAWA T, 1989, J BIOL CHEM, V264, P14591; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; SUFFREDINI AF, 1995, J IMMUNOL, V155, P5038; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; vanderPoll T, 1997, BLOOD, V89, P3727; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11847; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	50	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79051	10.1371/journal.pone.0079051	http://dx.doi.org/10.1371/journal.pone.0079051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236088	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700086
J	Detert, JA; Adams, EL; Lescher, JD; Lyons, JA; Moyer, JR				Detert, Julia A.; Adams, Erin L.; Lescher, Jacob D.; Lyons, Jeri-Anne; Moyer, James R., Jr.			Pretreatment with Apoaequorin Protects Hippocampal CA1 Neurons from Oxygen-Glucose Deprivation	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; TUMOR-NECROSIS-FACTOR; AGING-RELATED CHANGES; AGE-RELATED-CHANGES; IN-VITRO ISCHEMIA; BRAIN-INJURY; INTRACELLULAR CALCIUM; CEREBRAL-ISCHEMIA; MESSENGER-RNA; CALBINDIN D-28K	Ischemic stroke affects,795,000 people each year in the U.S., which results in an estimated annual cost of $73.7 billion. Calcium is pivotal in a variety of neuronal signaling cascades, however, during ischemia, excess calcium influx can trigger excitotoxic cell death. Calcium binding proteins help neurons regulate/buffer intracellular calcium levels during ischemia. Aequorin is a calcium binding protein isolated from the jellyfish Aequorea victoria, and has been used for years as a calcium indicator, but little is known about its neuroprotective properties. The present study used an in vitro rat brain slice preparation to test the hypothesis that an intra-hippocampal infusion of apoaequorin (the calcium binding component of aequorin) protects neurons from ischemic cell death. Bilaterally cannulated rats received an apoaequorin infusion in one hemisphere and vehicle control in the other. Hippocampal slices were then prepared and subjected to 5 minutes of oxygen-glucose deprivation (OGD), and cell death was assayed by trypan blue exclusion. Apoaequorin dose-dependently protected neurons from OGD - doses of 1% and 4% (but not 0.4%) significantly decreased the number of trypan blue-labeled neurons. This effect was also time dependent, lasting up to 48 hours. This time dependent effect was paralleled by changes in cytokine and chemokine expression, indicating that apoaequorin may protect neurons via a neuroimmunomodulatory mechanism. These data support the hypothesis that pretreatment with apoaequorin protects neurons against ischemic cell death, and may be an effective neurotherapeutic.	[Detert, Julia A.; Adams, Erin L.; Lescher, Jacob D.; Moyer, James R., Jr.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Lescher, Jacob D.; Moyer, James R., Jr.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Lyons, Jeri-Anne] Univ Wisconsin, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Adams, Erin L.] Quincy Biosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Moyer, JR (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	jrmoyer@uwm.edu			Quincy Bioscience	Quincy Bioscience	Quincy Bioscience funded this work (http://quincybioscience.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelHamid KM, 1997, NEUROSCIENCE, V81, P673, DOI 10.1016/S0306-4522(97)00162-0; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; Celio MR, 1996, GUIDEBOOK CALCIUM BI, P15; CHARD PS, 1995, P NATL ACAD SCI USA, V92, P5144, DOI 10.1073/pnas.92.11.5144; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi JH, 2010, CELL MOL NEUROBIOL, V30, P1, DOI 10.1007/s10571-009-9425-z; Cobbold PH, 1991, CELLULAR CALCIUM PRA, P55; Cronberg T, 2005, BRAIN RES, V1049, P120, DOI 10.1016/j.brainres.2005.05.003; deJong GI, 1996, NEUROBIOL AGING, V17, P459, DOI 10.1016/0197-4580(96)00030-9; DERENZIS FA, 1973, STAIN TECHNOL, V48, P135, DOI 10.3109/10520297309116602; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; DUBINSKY JM, 1993, NEUROSCI LETT, V150, P129, DOI 10.1016/0304-3940(93)90518-P; Fan YF, 2007, J CEREBR BLOOD F MET, V27, P719, DOI 10.1038/sj.jcbfm.9600373; FREUND TF, 1990, EXP BRAIN RES, V83, P55; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Gary DS, 2000, MOL BRAIN RES, V75, P89, DOI 10.1016/S0169-328X(99)00299-5; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HADLEY MN, 1989, NEUROSURGERY, V25, P63, DOI 10.1227/00006123-198907000-00011; Hasko G, 1998, BRIT J PHARMACOL, V124, P1099, DOI 10.1038/sj.bjp.0701934; HOF PR, 1991, EXP NEUROL, V111, P293, DOI 10.1016/0014-4886(91)90096-U; Hwang IK, 2003, BRAIN RES, V971, P250, DOI 10.1016/S0006-8993(03)02480-6; Hwang IK, 2006, BRAIN RES, V1106, P197, DOI 10.1016/j.brainres.2006.05.098; IACOPINO A, 1992, MOL BRAIN RES, V13, P251, DOI 10.1016/0169-328X(92)90033-8; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Khachaturian Z.S., 1984, HDB STUDIES PSYCHIAT, P7; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Klapstein GJ, 1998, NEUROSCIENCE, V85, P361, DOI 10.1016/S0306-4522(97)00632-5; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krzywkowski P, 1996, LIFE SCI, V59, P421, DOI 10.1016/0024-3205(96)00321-9; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Levin SG, 2011, EXP NEUROL, V232, P329, DOI 10.1016/j.expneurol.2011.09.004; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; LLEDO PM, 1992, NEURON, V9, P943, DOI 10.1016/0896-6273(92)90246-A; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; LYSKO PG, 1989, BRAIN RES, V499, P258, DOI 10.1016/0006-8993(89)90773-7; Mahesh VB, 2006, MOL CELL ENDOCRINOL, V246, P1, DOI 10.1016/j.mce.2005.11.017; Mallard C, 2007, SEMIN FETAL NEONAT M, V12, P280, DOI 10.1016/j.siny.2007.01.014; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; Mikkonen M, 1999, NEUROSCIENCE, V92, P515, DOI 10.1016/S0306-4522(99)00047-0; Moran DL, 2013, FOOD CHEM TOXICOL, V57, P1, DOI 10.1016/j.fct.2013.02.047; Moyer JR, 2011, NEUROBIOL AGING, V32, P1693, DOI 10.1016/j.neurobiolaging.2009.10.001; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; MOYER JR, 2007, ADV TECHNIQUES PATCH, V38, P169; NEWMAN GC, 1989, J NEUROSCI METH, V28, P23, DOI 10.1016/0165-0270(89)90006-X; Nikonenko I, 2005, MOL PHARMACOL, V68, P84, DOI 10.1124/mol.104.010066; Oh MM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.002.2010; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Pera J, 2004, J NEUROSCI RES, V78, P132, DOI 10.1002/jnr.20232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POHORECKI R, 1990, BRAIN RES, V528, P133, DOI 10.1016/0006-8993(90)90205-P; RALEYSUSMAN KM, 1990, BRAIN RES, V515, P27, DOI 10.1016/0006-8993(90)90572-S; RAMI A, 1992, J NEUROSCI RES, V31, P89, DOI 10.1002/jnr.490310113; Sama Diana M, 2013, Ageing Res Rev, V12, P982, DOI 10.1016/j.arr.2013.05.008; Shimomura O, 1996, BIOCHEM BIOPH RES CO, V221, P77, DOI 10.1006/bbrc.1996.0548; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMON RP, 1993, NEUROSCI LETT, V163, P135, DOI 10.1016/0304-3940(93)90364-Q; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; SUTHERLAND MK, 1993, MOL BRAIN RES, V18, P32, DOI 10.1016/0169-328X(93)90171-K; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; TAYLOR CP, 1995, J NEUROSCI METH, V59, P121, DOI 10.1016/0165-0270(94)00202-R; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toma S, 2005, PROTEIN SCI, V14, P409, DOI 10.1110/ps.041067805; TYMIANSKI M, 1993, NEURON, V11, P221, DOI 10.1016/0896-6273(93)90180-Y; TYMIANSKI M, 1994, J CEREBR BLOOD F MET, V14, P911, DOI 10.1038/jcbfm.1994.122; UEMATSU D, 1991, NEUROLOGY, V41, P88, DOI 10.1212/WNL.41.1.88; Urra X, 2013, J NEUROL, V260, P1687, DOI 10.1007/s00415-013-6919-x; VILLA A, 1994, EUR J NEUROSCI, V6, P1491, DOI 10.1111/j.1460-9568.1994.tb01010.x; Wang XK, 2000, J CEREBR BLOOD F MET, V20, P15, DOI 10.1097/00004647-200001000-00004; Wang XK, 2000, J NEUROSCI RES, V59, P238, DOI 10.1002/(SICI)1097-4547(20000115)59:2<238::AID-JNR10>3.0.CO;2-G; WHITTINGHAM TS, 1984, J NEUROSCI, V4, P793; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5; Xu GP, 2002, BRAIN RES, V952, P153, DOI 10.1016/S0006-8993(02)02988-8; Yang J, 2013, J NEUROCHEM, V124, P523, DOI 10.1111/jnc.12111; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028	93	3	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79002	10.1371/journal.pone.0079002	http://dx.doi.org/10.1371/journal.pone.0079002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244400	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600092
J	Du, CYQ; Choi, RCY; Zheng, KYZ; Dong, TTX; Lau, DTW; Tsim, KWK				Du, Crystal Y. Q.; Choi, Roy C. Y.; Zheng, Ken Y. Z.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.			Yu Ping Feng San, an Ancient Chinese Herbal Decoction Containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, Regulates the Release of Cytokines in Murine Macrophages	PLOS ONE			English	Article							DANGGUI-BUXUE-TANG; NF-KAPPA-B; ANGELICAE-SINENSIS; NO PRODUCTION; CELLS; ERYTHROPOIETIN; EXPRESSION; COMPONENTS; MEDICINE; ALPHA	Yu Ping Feng San (YPFS), a Chinese herbal decoction, is composed of Astragali Radix (AR; Huangqi), Atractylodis Macrocephalae Rhizoma (AMR; Baizhu) and Saposhnikoviae Radix (SR; Fangfeng) in a weight ratio of 1:2:1. Clinically, YPFS has been widely used to regulate immune functions; however, the action mechanism of it is not known. Here, we addressed this issue by providing detail analyses of chemical and biological properties of YPFS. By using rapid resolution liquid chromatography coupled with mass spectrometry, fifteen chemicals deriving from different herbs of YPFS were determined, and which served as a control for the standardization of the herbal extract of YPFS. In general, the amounts of chosen chemical markers were higher in a preparation of YPFS as compared to that of single herb or two-herb compositions. In order to reveal the immune functions of YPFS, the standardized extract was applied onto cultured murine macrophages. The treatment of YPFS stimulated the mRNA and protein expressions of pro-inflammatory cytokines via activation of NF-kappa B by enhancing I kappa B alpha degradation. In contrast, the application of YPFS suppressed the expressions of pro-inflammatory cytokines significantly in the lipopolysaccharide (LPS)-induced chronic inflammation model. In addition, YPFS could up regulate the phagocytic activity in cultured macrophages. These results therefore supported the bi-directional immunemodulatory roles of YPFS in regulating the releases of cytokines from macrophages.	[Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Du, Crystal Y. Q.; Zheng, Ken Y. Z.] Hanshan Normal Univ, Dept Biol, Chaozhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hanshan Normal University	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Du, Crystal Yingqing/AAH-5824-2020	Du, Crystal Yingqing/0000-0003-1353-4477; Lau, Tai Wai David/0000-0002-3443-1808; Zheng, Yuzhong/0000-0001-7208-0642; Tsim, Karl/0000-0003-4808-1674	 [661110];  [662911];  [663012];  [UIM/208];  [UIM/214];  [GHP/030/09SZ];  [Z0315];  [TUYF12SC03];  [GHP/032/09SZ]	; ; ; ; ; ; ; ; 	This research was supported by Research Grants (661110, 662911, 663012, UIM/208, UIM/214, GHP/030/09SZ, Z0315 and TUYF12SC03 to KWKT and GHP/032/09SZ to RCYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ashley JW, 2011, ASSAY DRUG DEV TECHN, V9, P40, DOI 10.1089/adt.2010.0307; Chen X, 2000, J Tradit Chin Med, V20, P302; Chiu SC, 2009, PHYTOTHER RES, V23, P363, DOI 10.1002/ptr.2633; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Dong HY, 2008, NAT PROD RES, V22, P1418, DOI 10.1080/14786410801931629; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Gao QT, 2008, PLANTA MED, V74, P392, DOI 10.1055/s-2008-1034322; Gao QT, 2007, FEBS LETT, V581, P233, DOI 10.1016/j.febslet.2006.12.018; Gao QT, 2006, PLANTA MED, V72, P1227, DOI 10.1055/s-2006-947186; Gao Qiutao, 2007, Chin Med, V2, P12, DOI 10.1186/1749-8546-2-12; Guo WX, 2012, INFLAMMATION, V35, P1764, DOI 10.1007/s10753-012-9495-9; Hong M, 2011, J PHARMACEUT BIOMED, V54, P87, DOI 10.1016/j.jpba.2010.08.016; Hoo RLC, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-67; Huang HL, 2005, J ETHNOPHARMACOL, V97, P21, DOI 10.1016/j.jep.2004.09.058; Kang SR, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/248592; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KISO Y, 1985, PLANTA MED, V51, P97, DOI 10.1055/s-2007-969416; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lee JC, 2007, PHYTOMEDICINE, V14, P390, DOI 10.1016/j.phymed.2006.09.012; Li CQ, 2007, PHYTOTHER RES, V21, P347, DOI 10.1002/ptr.2040; Lv T, 2006, WORLD J GASTROENTERO, V12, P2195, DOI 10.3748/wjg.v12.i14.2195; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Ning Lian, 2002, Zhongguo Zhongyao Zazhi, V27, P50; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; SAKURAI T, 1994, BIOL PHARM BULL, V17, P1364, DOI 10.1248/bpb.17.1364; STRUGALA GJ, 1985, DIGESTION, V32, P255, DOI 10.1159/000199246; Tai J, 2007, ONCOL REP, V18, P227; Tanton DW, 2007, DRUG FREE APPROACH H; Toda S, 1998, PHYTOTHER RES, V12, P59, DOI 10.1002/(SICI)1099-1573(19980201)12:1&lt;59::AID-PTR182&gt;3.0.CO;2-R; WU DZ, 1999, PHARM CLIN CHIN MAT, V15, P3; Wu JH, 2010, J NUTR BIOCHEM, V21, P613, DOI 10.1016/j.jnutbio.2009.03.010; Xue Bao-yun, 2000, Zhongguo Zhongyao Zazhi, V25, P297; You Y, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-54; Yu L, 2000, CHINESE J NEPHROLOGY, V16, P282; Yu S, 2012, EVID-BASED COMPL ALT, V2012; Zhang XP, 2007, J PANCREAS, V8, P704; Zhao B, 2012, J ASIAN NAT PROD RES, V14, P886, DOI 10.1080/10286020.2012.702756; Zheng KYZ, 2011, J AGR FOOD CHEM, V59, P1697, DOI 10.1021/jf104018u; Zheng KYZ, 2010, J ETHNOPHARMACOL, V132, P259, DOI 10.1016/j.jep.2010.08.029	41	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78622	10.1371/journal.pone.0078622	http://dx.doi.org/10.1371/journal.pone.0078622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244327	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600037
J	Lee, WY; Tolar, P				Lee, Wing-Yiu; Tolar, Pavel			Activation of the B Cell Receptor Leads to Increased Membrane Proximity of the Ig alpha Cytoplasmic Domain	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NON-ITAM TYROSINE; ANTIGEN RECEPTOR; LIVING CELLS; BETA; COMPLEX; BINDING; MICROCLUSTERS; ASSOCIATION; INITIATION	Binding of antigen to the B cell receptor (BCR) induces conformational changes in BCR's cytoplasmic domains that are concomitant with phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs). Recently, reversible folding of the CD3 epsilon and xi chain ITAMs into the plasma membrane has been suggested to regulate T cell receptor signaling. Here we show that the Ig alpha and Ig beta cytoplasmic domains of the BCR do not associate with plasma membrane in resting B cells. However, antigen binding and ITAM phosphorylation specifically increased membrane proximity of Ig alpha, but not Ig beta. Thus, BCR activation is accompanied by asymmetric conformational changes, possibly promoting the binding of Ig alpha and Ig beta to differently localized signaling complexes.	[Lee, Wing-Yiu; Tolar, Pavel] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Tolar, P (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	ptolar@nimr.mrc.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Tolar, Pavel/0000-0003-4693-7299	Medical Research Council UK [U117597138]; MRC [MC_U117597138] Funding Source: UKRI; Medical Research Council [MC_U117597138] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by Medical Research Council UK, Unit Programme number U117597138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kraus M, 1999, IMMUNITY, V11, P537, DOI 10.1016/S1074-7613(00)80129-6; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; Reichlin A, 2004, J EXP MED, V199, P855, DOI 10.1084/jem.20031140; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Schamel WWA, 2000, MOL IMMUNOL, V37, P253, DOI 10.1016/S0161-5890(00)00025-0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Siegers GM, 2006, INT IMMUNOL, V18, P1385, DOI 10.1093/intimm/dxl072; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Torres RM, 1999, IMMUNITY, V11, P527, DOI 10.1016/S1074-7613(00)80128-4; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WIENANDS J, 1995, INT IMMUNOL, V7, P1701, DOI 10.1093/intimm/7.11.1701; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79148	10.1371/journal.pone.0079148	http://dx.doi.org/10.1371/journal.pone.0079148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244439	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600114
J	Poczobutt, JM; Gijon, M; Amin, J; Hanson, D; Li, H; Walker, D; Weiser-Evans, M; Lu, X; Murphy, RC; Nemenoff, RA				Poczobutt, Joanna M.; Gijon, Miguel; Amin, Jay; Hanson, Dwight; Li, Howard; Walker, Deandra; Weiser-Evans, Mary; Lu, Xian; Murphy, Robert C.; Nemenoff, Raphael A.			Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; EXPRESSION; PHOSPHORYLATION; MACROPHAGES; METABOLISM; ACTIVATION; DEFICIENT; RECEPTORS; ROLES	Eicosanoids are bioactive lipid mediators derived from arachidonic acid(1) (AA), which is released by cytosolic phospholipase A(2) (cPLA(2)). AA is metabolized through three major pathways, cyclooxygenase (COX), lipoxygenase (LO) and cytochrome P450, to produce a family of eicosanoids, which individually have been shown to have pro-or anti-tumorigenic activities in cancer. However, cancer progression likely depends on complex changes in multiple eicosanoids produced by cancer cells and by tumor microenvironment and a systematic examination of the spectrum of eicosanoids in cancer has not been performed. We used liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) to quantitate eicosanoids produced during lung tumor progression in an orthotopic immunocompetent mouse model of lung cancer, in which Lewis lung carcinoma (LLC) cells are injected into lungs of syngeneic mice. The presence of tumor increased products of both the cyclooxygenase and the lipoxygenase pathways in a time-dependent fashion. Comparing tumors grown in cPLA(2) knockout vs wild-type mice, we demonstrated that prostaglandins (PGE(2), PGD(2) and PGF(2a)) were produced by both cancer cells and the tumor microenvironment (TME), but leukotriene (LTB4, LTC4, LTD4, LTE4) production required cPLA(2) expression in the TME. Using flow cytometry, we recovered tumor-associated neutrophils and 2 types of tumor-associated macrophages from tumor-bearing lungs and we defined their distinct eicosanoid profiles by LC/MS/MS. The combination of flow cytometry and LC/MS/MS unravels the complexity of eicosanoid production in lung cancer and provides a rationale to develop therapeutic strategies that target select cell populations to inhibit specific classes of eicosanoids.	[Poczobutt, Joanna M.; Amin, Jay; Hanson, Dwight; Li, Howard; Walker, Deandra; Weiser-Evans, Mary; Nemenoff, Raphael A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Gijon, Miguel; Murphy, Robert C.; Nemenoff, Raphael A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Lu, Xian] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Li, Howard] Vet Affairs Med Ctr, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nemenoff, RA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	Raphael.Nemenoff@ucdenver.edu	Li, Howard/AAM-3544-2021	Li, Howard/0000-0002-1230-2941	NIH [R01 CA162226 R01 CA108610 P50 CA058187]; NATIONAL CANCER INSTITUTE [R01CA108610, P50CA058187, R01CA162226, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH R01 CA162226 R01 CA108610 P50 CA058187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; GRONICH J, 1994, J CLIN INVEST, V93, P1224, DOI 10.1172/JCI117076; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Hida T, 1998, CANCER RES, V58, P3761; Horn L, 2009, EXPERT OPIN THER TAR, V13, P675, DOI 10.1517/14728220902915567; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Keith RL, 2002, CANCER RES, V62, P734; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028133; Meyer AM, 2004, CARCINOGENESIS, V25, P1517, DOI 10.1093/carcin/bgh150; Moody TW, 2001, ANTICANCER RES, V21, P1749; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Soriano AF, 1999, CANCER RES, V59, P6178; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wolff H, 1998, CANCER RES, V58, P4997	37	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79633	10.1371/journal.pone.0079633	http://dx.doi.org/10.1371/journal.pone.0079633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244531	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600139
J	Yang, Y; Wei, FX; Zhuo, R; Fan, FF; Liu, HH; Zhang, C; Ma, L; Jiang, ML; Zhang, XY				Yang, Yang; Wei, Fuxiang; Zhuo, Rui; Fan, Fangfang; Liu, Huahua; Zhang, Chen; Ma, Li; Jiang, Mulan; Zhang, Xiaoyu			Enhancing the Laccase Production and Laccase Gene Expression in the White-Rot Fungus Trametes velutina 5930 with Great Potential for Biotechnological Applications by Different Metal Ions and Aromatic Compounds	PLOS ONE			English	Article							CERIPORIOPSIS-SUBVERMISPORA; TRANSCRIPTION; PUBESCENS; BIOREMEDIATION; INDUSTRIAL; ACE1; PCR	Laccase is useful for various biotechnological and industrial applications. The white-rot fungus Trametes velutina 5930 and its laccase, isolated from the Shennongjia Nature Reserve in China by our laboratory, has great potential for practical application in environmental biotechnology. However, the original level of laccase produced by Trametes velutina 5930 was relatively low in the absence of any inducer. Therefore, in order to enhance the laccase production by Trametes velutina 5930 and make better use of this fungus in the field of environmental biotechnology, the regulation of laccase production and laccase gene expression in Trametes velutina 5930 were investigated in this study. Different metal ions such as Cu2+ and Fe2+ could stimulate the laccase synthesis and laccase gene transcription in Trametes velutina 5930. Some aromatic compounds structurally related to lignin, such as tannic acid, syringic acid, cinnamic acid, gallic acid and guaiacol, could also enhance the level of laccase activity and laccase gene transcription. We also found that there existed a positive synergistic effect of aromatic compound and metal ion on the laccase production and laccase gene transcription in Trametes velutina 5930. Taken together, our study may contribute to the improvement of laccase productivity by Trametes velutina 5930.	[Yang, Yang; Wei, Fuxiang; Zhuo, Rui; Fan, Fangfang; Liu, Huahua; Zhang, Chen; Ma, Li; Zhang, Xiaoyu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Yang; Zhuo, Rui; Fan, Fangfang; Jiang, Mulan] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Oil Crops Biol, Minist Agr China, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yang, Y (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	yangyang@mail.hust.edu.cn; zhangxiaoyu@mail.hust.edu.cn	Zhang, xiaoyu/A-6515-2015; fan, fang/GQY-9173-2022; Zhang, xiaoyu/GXA-3206-2022; Fan, Fang/GRO-2696-2022; Zhuo, Rui/AFS-3081-2022	Zhuo, Rui/0000-0002-7119-2850; Wei, Fuxiang/0000-0002-6200-6219	National Natural Sciences Foundation of China [31070069, 31370122, 31170104]; National High Technology Research and Development Program of China [2012AA022301D]; Fundamental Research Funds for the Central Universities [HUST 2013TS082]; Major State Basic Research Development Program of China [2014CB138301]; Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program of China(National Basic Research Program of China); Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China	This work was supported by the National Natural Sciences Foundation of China (numbers 31070069, 31370122 and 31170104), National High Technology Research and Development Program of China (number 2012AA022301D), The Fundamental Research Funds for the Central Universities (HUST 2013TS082), Major State Basic Research Development Program of China (2014CB138301), Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Cambria MT, 2011, APPL BIOCHEM BIOTECH, V163, P415, DOI 10.1007/s12010-010-9049-2; Carbajo JM, 2002, CAN J MICROBIOL, V48, P1041, DOI 10.1139/W02-107; Colao MC, 2003, APPL MICROBIOL BIOT, V63, P153, DOI 10.1007/s00253-003-1429-x; Collins PJ, 1997, APPL ENVIRON MICROB, V63, P3444, DOI 10.1128/AEM.63.9.3444-3450.1997; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Cullen D, 2004, MYCOTA, V3, P249; De Souza CGM, 2004, J BASIC MICROB, V44, P129; Elisashvili V, 2009, J BIOTECHNOL, V144, P37, DOI 10.1016/j.jbiotec.2009.06.020; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Galhaup C, 2001, APPL MICROBIOL BIOT, V56, P225, DOI 10.1007/s002530100636; Gonzalez T, 2003, APPL ENVIRON MICROB, V69, P7083, DOI 10.1128/AEM.69.12.7083-7090.2003; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Manubens A, 2007, FEMS MICROBIOL LETT, V275, P139, DOI 10.1111/j.1574-6968.2007.00874.x; Alvarez JM, 2009, FUNGAL GENET BIOL, V46, P104, DOI 10.1016/j.fgb.2008.10.002; Osma JF, 2007, CHEMOSPHERE, V67, P1677, DOI 10.1016/j.chemosphere.2006.11.051; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Saparrat M, 2010, FUNGAL BIOL-UK, V114, P999, DOI 10.1016/j.funbio.2010.09.010; Sethuraman A, 1998, CAN J MICROBIOL, V44, P872, DOI 10.1139/cjm-44-9-872; Soden DM, 2001, MICROBIOL-SGM, V147, P1755, DOI 10.1099/00221287-147-7-1755; Strong PJ, 2011, CRIT REV ENV SCI TEC, V41, P373, DOI 10.1080/10643380902945706; Terron MC, 2004, FUNGAL GENET BIOL, V41, P954, DOI 10.1016/j.fgb.2004.07.002; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; THORVALDSEN JL, 1993, J BIOL CHEM, V268, P12512; Wang SM, 2007, APPL ENVIRON MICROB, V73, P5048, DOI 10.1128/AEM.02973-06; Xiao YZ, 2006, APPL MICROBIOL BIOT, V71, P493, DOI 10.1007/s00253-005-0188-2; Yang Y, 2011, BIOCHEM ENG J, V57, P13, DOI 10.1016/j.bej.2011.07.006	32	42	52	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79307	10.1371/journal.pone.0079307	http://dx.doi.org/10.1371/journal.pone.0079307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244475	gold, Green Submitted, Green Published			2022-12-25	WOS:000327221600123
J	Olsson, F; Schmidt, S; Althoff, V; Munter, LM; Jin, SB; Rosqvist, S; Lendahl, U; Multhaup, G; Lundkvist, J				Olsson, Fredrik; Schmidt, Staffan; Althoff, Veit; Munter, Lisa M.; Jin, Shaobo; Rosqvist, Susanne; Lendahl, Urban; Multhaup, Gerd; Lundkvist, Johan			Characterization of Intermediate Steps in Amyloid Beta (A beta) Production under Near-native Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Amyloid Precursor Protein; Intramembrane Proteolysis; Secretases	GAMMA-SECRETASE MODULATORS; AGE-OF-ONSET; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; A-BETA-42; TARGET; DEPOSITION; MUTATIONS; NSAIDS; MODEL	Background: The 42 amino acid long amyloid beta peptide (A42) plays a pivotal role in Alzheimer disease. Results: A novel assay was developed and enabled us to describe the process of 42 production and modulation. Conclusion: A42 is generated through different pathways, which are differently affected by disease causing mutations and anti-amyloidogenic drugs. Significance: The data provide key information for therapeutic development in Alzheimer disease. Processing of the amyloid precursor protein (APP) by -secretase results in generation of A peptides of different lengths ranging from 51 to 30 residues. Accumulation of A and in particular A42 is enhanced by familial Alzheimer disease (FAD) causing mutations in APP and is believed to play a pivotal role. The molecular mechanism underlying normal A production, the impact of FAD mutations on this process and how anti-amyloidogenic -secretase modulators (GSMs) cause a selective decrease in A40 and A42 and an increase in shorter A peptides, however, is poorly understood. By using a combined immuno- and LC-MS-based assay we identify several major intermediates, i.e. 3- and 4-peptides that line up head to head across the entire APP transmembrane sequence from A51 to A31/A30 and from A49 to A30/31. FAD APP mutations displayed a relative increase in 3- and 4-peptides from A48 to A38 compared with A49 to A37. These findings correlate with an increase in the A42/40 ratio. GSMs caused a decrease in A40 and A42 and an increase in A37 and A38 paralleled by an increase of the intermediates A40-38 and A42-39. Collectively, these data provide a thorough characterization of all intermediate steps in A production in native cell membranes and provide key mechanistic insights to genetic and pharmacological modulation of A generation.	[Olsson, Fredrik; Schmidt, Staffan; Rosqvist, Susanne; Lundkvist, Johan] AstraZeneca iMED CNS Pain, S-15185 Sodertalje, Sweden; [Althoff, Veit; Multhaup, Gerd] Free Univ Berlin, Berlin, Germany; [Munter, Lisa M.; Multhaup, Gerd] McGill Univ, Montreal, PQ, Canada; [Jin, Shaobo; Lendahl, Urban] Karolinska Inst, S-17177 Stockholm, Sweden	AstraZeneca; Free University of Berlin; McGill University; Karolinska Institutet	Multhaup, G (corresponding author), AstraZeneca iMED CNS Pain, S-15185 Sodertalje, Sweden.	gerhard.multhaup@mcgill.ca; johan.lundkvist@alzecure.org		Munter, Lisa/0000-0001-5736-1462; Lendahl, Urban/0000-0001-9543-8141	Deutsche Forschungsgemeinschaft (DFG) [MU901, SFB740]; Hans und Ilse Breuer foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hans und Ilse Breuer foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (MU901; SFB740) and the Hans und Ilse Breuer foundation (to V. A.).	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Duering M, 2005, NEUROBIOL AGING, V26, P785, DOI 10.1016/j.neurobiolaging.2004.08.002; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	23	73	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1540	1550		10.1074/jbc.M113.498246	http://dx.doi.org/10.1074/jbc.M113.498246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24225948	Green Published, hybrid			2022-12-25	WOS:000332401700029
J	Chauzat, MP; Cauquil, L; Roy, L; Franco, S; Hendrikx, P; Ribiere-Chabert, M				Chauzat, Marie-Pierre; Cauquil, Laura; Roy, Lise; Franco, Stephanie; Hendrikx, Pascal; Ribiere-Chabert, Magali			Demographics of the European Apicultural Industry	PLOS ONE			English	Article							BEE COLONY LOSSES; NATIONAL-SURVEY; UNITED-STATES; EXPOSURE; APIS; US	Over the last few years, many European and North American countries have reported a high rate of disorders (mortality, dwindling and disappearance) affecting honeybee colonies (Apis mellifera). Although beekeeping has become an increasingly professional activity in recent years, the beekeeping industry remains poorly documented in Europe. The European Union Reference Laboratory for Honeybee Health sent a detailed questionnaire to each Member State, in addition to Kosovo and Norway, to determine the demographics and state of their beekeeping industries. Based on data supplied by the National Reference Laboratory for honeybee diseases in each European country, a European database was created to describe the beekeeping industry including the number and types of beekeepers, operation size, industry production, and health (notifiable diseases, mortalities). The total number of beekeepers in Europe was estimated at 620 000. European honey production was evaluated at around 220 000 tons in 2010. The price of honey varied from 1.5 to 40 (sic)/kg depending on the country and on the distribution network. The estimated colony winter mortality varied from 7 to 28% depending on the country and the origin of the data (institutional survey or beekeeping associations). This survey documents the high heterogeneity of the apicultural industry within the European Union. The high proportion of non-professional beekeepers and the small mean number of colonies per beekeeper were the only common characteristics at European level. The tremendous variation in European apicultural industries has implication for any comprehensive epidemiological or economic analysis of the industry. This variability needs to be taken into account for such analysis as well as for future policy development. The industry would be served if beekeeping registration was uniformly implemented across member states. Better information on the package bee and queen production would help in understanding the ability of the industry to replace lost honey bee stocks.	[Chauzat, Marie-Pierre; Cauquil, Laura; Franco, Stephanie; Ribiere-Chabert, Magali] French Agcy Food Environm & Occupat Hlth & Safety, Honeybee Pathol Unit, European Union & Natl Reference Lab Honeybee Hlth, Sophia Antipolis, France; [Roy, Lise] French Agcy Food Environm & Occupat Hlth & Safety, Epidemiol Unit, Lyon, France; [Chauzat, Marie-Pierre; Hendrikx, Pascal] French Agcy Food Environm & Occupat Hlth & Safety, Sci Affairs Dept Labs, Epidemiol Surveillance Unit, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Chauzat, MP (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Honeybee Pathol Unit, European Union & Natl Reference Lab Honeybee Hlth, Sophia Antipolis, France.	marie-pierre.chauzat@anses.fr	, Roy/G-5648-2017	, Roy/0000-0001-8833-1717	European Union; ANSES	European Union(European Commission); ANSES	The EURL for bee health was supported by the European Union and by ANSES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.154r; Bacon SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047689; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Brown MA, 2002, BEE WORLD, V83, P151, DOI 10.1080/0005772X.2002.11099558; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chauzat MP, 2013, BEE WORLD        MAR, P11; Crane E, 2004, BEE WORLD, V85, P6, DOI 10.1080/0005772X.2004.11099604; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Daberkow S, 2009, J ECON ENTOMOL, V102, P868, DOI 10.1603/029.102.0304; Deforce K, 2010, J ARCHAEOL SCI, V37, P337, DOI 10.1016/j.jas.2009.09.045; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; European Commission, 1997, OFFICIAL J; European Commission, 2010, COMM COMM EUR PARL C; European Commission, 2004, OFFICIAL J; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Haubruge Eric, 2006, Notes Fauniques de Gembloux, V59, P3; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Lindstrom A, 2008, APIDOLOGIE, V39, P515, DOI 10.1051/apido:2008032; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; MURILHAS A M, 2004, EURBEE NEWSLETTER, V2, P7; Nguyen BK, 2010, J APICULT RES, V49, P337, DOI 10.3896/IBRA.1.49.4.07; Nguyen BK, 2010, J APICULT RES, V49, P97, DOI 10.3896/IBRA.1.49.1.15; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; PHAMDELEGUE MH, 1987, BIOCHIMIE, V69, P661, DOI 10.1016/0300-9084(87)90186-6; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; The European Commission, 2011, COMMISSION REGULATIO, V15, P1; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanengelsdorp D, 2013, J APICULT RES, V52; VANENGELSDORP D, 2011, HONEY BEE COLONY HLT, P237; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vannier P, 1997, VET MICROBIOL, V55, P167, DOI 10.1016/S0378-1135(96)01298-9; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931	43	75	78	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79018	10.1371/journal.pone.0079018	http://dx.doi.org/10.1371/journal.pone.0079018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236084	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700082
J	Elliott, SJ; Wilf, P; Walter, RC; Merritts, DJ				Elliott, Sara J.; Wilf, Peter; Walter, Robert C.; Merritts, Dorothy J.			Subfossil Leaves Reveal a New Upland Hardwood Component of the Pre-European Piedmont Landscape, Lancaster County, Pennsylvania	PLOS ONE			English	Article							FOLIAR SURFACE-FEATURES; CHESAPEAKE BAY; WOODY-PLANTS; RIPARIAN VEGETATION; MID-ATLANTIC; RESTORATION; EROSION; FOREST; SEDIMENTATION; DISTURBANCE	Widespread deforestation, agriculture, and construction of milldams by European settlers greatly influenced valley-bottom stream morphology and riparian vegetation in the northeastern USA. The former broad, tussock-sedge wetlands with small, anastomosing channels were converted into today's incised, meandering streams with unstable banks that support mostly weedy, invasive vegetation. Vast accumulations of fine-grained "legacy" sediments that blanket the regional valley-bottom Piedmont landscape now are being reworked from stream banks, significantly impairing the ecological health of downstream water bodies, most notably the Chesapeake Bay. However, potential restoration is impaired by lack of direct knowledge of the pre-settlement riparian and upslope floral ecosystems. We studied the subfossil leaf flora of Denlingers Mill, an obsolete (breached) milldam site in southeastern Pennsylvania that exhibits a modern secondary forest growing atop thin soils, above bedrock outcrops immediately adjacent to a modified, incised stream channel. Presumably, an overhanging old-growth forest also existed on this substrate until the early 1700s and was responsible for depositing exceptionally preserved, minimally transported subfossil leaves into hydric soil strata, which immediately underlie post-European settlement legacy sediments. We interpret the eleven identified species of the subfossil assemblage to primarily represent a previously unknown, upland Red Oak-American Beech mixed hardwood forest. Some elements also appear to belong to a valley-margin Red Maple-Black Ash swamp forest, consistent with preliminary data from a nearby site. Thus, our results add significantly to a more complete understanding of the pre-European settlement landscape, especially of the hardwood tree flora. Compared with the modern forest, it is apparent that both lowland and upslope forests in the region have been modified significantly by historical activities. Our study underscores that generally overlooked subfossil leaves can provide important, local, temporally constrained paleoecological data, with much potential value in this case for stream and wetland restoration decisions in the mid-Atlantic region.	[Elliott, Sara J.; Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Walter, Robert C.; Merritts, Dorothy J.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Franklin & Marshall College	Wilf, P (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	pwilf@psu.edu	Walter, Robert/AAD-7642-2020	Walter, Robert/0000-0001-8761-5355; Wilf, Peter/0000-0001-6813-1937	Geological Society of America [9590-11]; Pennsylvania State University Department of Geosciences; David and Lucile Packard Fellowship; NSF [EAR-0844253]	Geological Society of America; Pennsylvania State University Department of Geosciences; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF))	This study was supported by a Geological Society of America Student Research Grant (number 9590-11, www.geosociety.org) and the P.D. Krynine Memorial Fund, Pennsylvania State University Department of Geosciences (SJE); a David and Lucile Packard Fellowship (PW, www.packard.org); and NSF EAR-0844253 to RW Graham (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SUSTAIN; [Anonymous], 1950, GRAYS MANUAL BOT; Argus G.W., 2006, GUIDE IDENTIFICATION; Asch Sidell N., 2008, NEW YORK STATE B MUS, V512, P29; BAKER R G, 1990, Journal of the Iowa Academy of Science, V97, P167; Baker R.G., 1993, Holocene, V3, P314, DOI 10.1177/095968369300300403; Banks W.S.L., 2009, SOURCES TRANSPORT ST; Barclay R.S., 2012, CUTICLE DATABASE PRO; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Bennion H, 2011, J PALEOLIMNOL, V45, P533, DOI 10.1007/s10933-010-9419-3; BILBY RE, 1980, ECOLOGY, V61, P1107, DOI 10.2307/1936830; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BIRKS HH, 1978, NEW PHYTOL, V80, P455, DOI 10.1111/j.1469-8137.1978.tb01579.x; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Boesch DF, 2001, J ENVIRON QUAL, V30, P303, DOI 10.2134/jeq2001.302303x; BURNHAM RJ, 1992, PALEOBIOLOGY, V18, P30, DOI 10.1017/S0094837300012203; BURNHAM RJ, 1993, PALAIOS, V8, P376, DOI 10.2307/3515267; Carpenter RJ, 2005, INT J PLANT SCI, V166, P843, DOI 10.1086/431806; Chumbley CA, 1989, THESIS U IOWA; Cogbill CV, 2000, RHODORA, V102, P250; Coladonato M., 1991, FIRE EFFECTS INFORM; COSTA JE, 1975, GEOL SOC AM BULL, V86, P1281, DOI 10.1130/0016-7606(1975)86&lt;1281:EOAOEA&gt;2.0.CO;2; Danzeglocke U, 2011, CALPAL 2007ONLINE; Davies-Vollum KS, 1998, PALAIOS, V13, P28, DOI 10.2307/3515279; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Douglass I., 1991, EARTH TRANSFORMED HU, P215; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; eFloras, 2008, MISS BOT GARD; Ellis D, 2009, MANUAL LEAF ARCHITEC; Fenneman N.M., 1938, PHYSIOGRAPHY E US; FERGUSON DK, 1985, REV PALAEOBOT PALYNO, V46, P117, DOI 10.1016/0034-6667(85)90041-7; Fike J, 1999, TERRESTRIAL PALUSTRI; FISRWG (Federal Interagency Stream Research Working Group), 2008, STREAM CORR REST PRI; Fleming GP, 1999, BANISTERIA, V13, P67; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Gleason H.A., 1963, MANUAL VASCULAR PLAN; Gottschalk LC, 1945, GEOGR REV, V35, P219, DOI 10.2307/211476; Gutshall M, 2004, BACK FUTURE STREAM C; HARDIN JW, 1986, BRITTONIA, V38, P133, DOI 10.2307/2807266; HARDIN JW, 1985, B TORREY BOT CLUB, V112, P11, DOI 10.2307/2996100; HARDIN JW, 1979, B TORREY BOT CLUB, V106, P313, DOI 10.2307/2560358; Hartranft J.L., 2011, SUSTAIN, V24, P24; HICKEY LJ, 1975, ANN MO BOT GARD, V62, P538, DOI 10.2307/2395267; Hilgartner W, 2010, EC SOC AM ANN M PITT; Hilgartner WB, 2006, HOLOCENE, V16, P479, DOI 10.1191/0959683606hl938rp; Johnson PS, 1992, SILVICS N AM, P1219; Keeton WS, 2007, ECOL APPL, V17, P852, DOI 10.1890/06-1172; KELLER EA, 1979, EARTH SURF PROC LAND, V4, P361, DOI 10.1002/esp.3290040406; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kenney MA, 2012, J AM WATER RESOUR AS, V48, P603, DOI 10.1111/j.1752-1688.2011.00635.x; Lemon James T., 2002, BEST POOR MANS COUNT; Little E. L., 1988, AUDUBON SOC FIELD GU; LORIMER CG, 1994, J FOREST, V92, P33; Mann M.E., 2002, ENCYCLOP GLOB ENV CH, V1, P504; McQuilkin RA, 1992, SILVICS N AM, V2, P1366; Merritts D., 2010, SEDIMENT NUTR LOADS; Merritts D, 2003, COLONIAL MILL PONDS; Merritts D, 2010, WATER POWERED MILLIN; Merritts D, 2013, REV ENG GEOL, V21, P183, DOI 10.1130/2013.4121(14); Merritts D, 2011, PHILOS T R SOC A, V369, P976, DOI 10.1098/rsta.2010.0335; Middleton A.P., 1953, TOBACCO COAST MARITI; MILLER BB, 1994, QUATERNARY RES, V41, P350, DOI 10.1006/qres.1994.1040; Miller CL, 2011, THESIS PENNSYVANIA S; Miller CL, 2010, GEOL SOC AM ANN M DE, V42, P606; MOSS JH, 1978, J GEOL, V86, P1, DOI 10.1086/649652; Niemitz J, 2013, GEOLOGY, V41, P47, DOI 10.1130/G33547.1; Orr CH, 2002, THESIS U WISCONSIN; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer M, 2007, RESTOR ECOL, V15, P472, DOI 10.1111/j.1526-100X.2007.00243.x; PENNOCK JR, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P139; Pizzuto J, 2009, GEOLOGY, V37, P19, DOI 10.1130/G25207A.1; Rhoads A.F., 2007, PLANTS PENNSYLVANIA; Rhoads AF, 2005, TREES OF PENNSYLVANIA: A COMPLETE REFERENCE GUIDE, P1; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Sander IL, 1990, AGR HDB, V2, P1401; Schenk ER, 2009, J AM WATER RESOUR AS, V45, P597, DOI 10.1111/j.1752-1688.2009.00308.x; Shafroth PB, 2002, ECOL APPL, V12, P107, DOI 10.1890/1051-0761(2002)012[0107:RVRTAD]2.0.CO;2; Sibley D.A., 2009, SIBLEY GUIDE TREES; SIMON A, 1989, WATER RESOUR BULL, V25, P1177; SPICER RA, 1989, ADV BOT RES, V16, P95; Springer GS, 2010, HOLOCENE, V20, P275, DOI 10.1177/0959683609350395; Stanley EH, 2003, FRONT ECOL ENVIRON, V1, P15, DOI 10.1890/1540-9295(2003)001[0015:TOTEEO]2.0.CO;2; Stanley EH, 2002, BIOSCIENCE, V52, P693, DOI 10.1641/0006-3568(2002)052[0693:AGPONR]2.0.CO;2; Stinchcomb GE, 2011, GEOLOGY, V39, P363, DOI 10.1130/G31596.1; United States Department of Agriculture Natural Resources Conservation Service, 2011, PLANTS DAT; Virginia Tech Forest Resources and Environmental Conservation Tree ID Database, 2010, BLACKSB VIRG TECH DE; Voli M., 2009, WATER RES IMPACT, V11, P11; Walter R., 2007, ESTIMATING VOLUME NU; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Waters T. F., 1995, SEDIMENT STREAMS SOU; WESTERVELT K, 2006, GUIDE NATURAL COMMUN; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wing SL, 1995, PALAIOS, V10, P551, DOI 10.2307/3515094; Work PT, 2005, PALAEOGEOGR PALAEOCL, V223, P204, DOI 10.1016/j.palaeo.2005.04.005; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	96	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79317	10.1371/journal.pone.0079317	http://dx.doi.org/10.1371/journal.pone.0079317			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236120	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700119
J	Wang, YH; Sun, YP; Li, D; Zhang, L; Wang, KM; Zuo, Y; Gartner, TK; Liu, JL				Wang, Yanhua; Sun, Yueping; Li, Ding; Zhang, Lin; Wang, Kemin; Zuo, Yong; Gartner, T. Kent; Liu, Junling			Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis	PLOS ONE			English	Article							THROMBUS FORMATION; CELL INVASIVENESS; TUMOR-GROWTH; IN-VIVO; IDENTIFICATION; ANGIOGENESIS; PROGRESSION; RECEPTOR; ADENOCARCINOMA; AGGREGATION	The involvement of platelets in tumor progression is well recognized. The depletion of circulating platelets or pharmacologic inhibitors of platelet activation decreases the metastatic potential of circulating tumor cells in metastasis mouse models. The platelet ADP receptor P2Y12 amplifies the initial hemostatic responses activated by a variety of platelet agonists and stabilizes platelet aggregation, playing a crucial role in granule secretion, integrin activation and thrombus formation. However, the relationship between P2Y12 and tumor progression is not clear. In our study, the Lewis Lung Carcinoma (LLC) spontaneous metastatic mouse model was used to evaluate the role of P2Y12 in metastasis. The results demonstrated that P2Y12 deficiency significantly reduced pulmonary metastasis. Further studies indicated that P2Y12 deficiency diminished the ability of LLC cells to induce platelet shape change and release of active TGF beta 1 by a non-contact dependent mechanism resulting in a diminished, platelet-induced EMT-like transformation of the LLC cells, and that transformation probably is a prerequisite of LLC cell metastasis. Immunohistochemical analyses indicated an obvious P2Y12 deficiency related attenuation of recruitment of VEGFR1+ bone marrow derived cell clusters, and extracellular matrix fibronectin deposition in lungs, which presumably are required for pre-metastatic niche formation. In contrast to the LLC cells, non-epithelial melanoma B16 cells induced platelet aggregation in a cell number and P2Y12-dependent manner. Also, a platelet induced EMT-like transformation of B16 cells is dependent on P2Y12. In agreement with the LLC cell model, platelet P2Y12 deficiency also results in significantly less lung metastasis in the B16 melanoma experimental metastasis model. These results demonstrate that P2Y12 is a safe drug target for anti-thrombotic therapy, and that P2Y12 may serve as a new target for inhibition of tumor metastasis.	[Wang, Yanhua; Sun, Yueping; Li, Ding; Zhang, Lin; Wang, Kemin; Zuo, Yong; Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	Shanghai Jiao Tong University; University of Memphis	Liu, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China.	liujl@shsmu.edu.cn			National Natural Science Foundation of China [81030039]; Program for New Century Excellent Talents in University [NCET-08-0351]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation; Shanghai Committee of Science and Technology [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported, in part, by Program of National Natural Science Foundation of China (81030039 to J. Liu), the Program for New Century Excellent Talents in University (NCET-08-0351 to J. Liu), Shanghai Municipal Education Commission and Shanghai Education Development Foundation, Shanghai Committee of Science and Technology (11DZ2260200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Feng WY, 2011, BLOOD, V117, P3893, DOI 10.1182/blood-2010-08-304808; GASIC GJ, 1973, INT J CANCER, V11, P704, DOI 10.1002/ijc.2910110322; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; HONN KV, 1982, SCIENCE, V217, P540, DOI 10.1126/science.7046053; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; Kato Y, 1997, CANCER RES, V57, P3040; Kaul Sanjay, 2010, Arch Intern Med, V170, P1010, DOI 10.1001/archinternmed.2010.139; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Liu JL, 2006, BLOOD, V108, P2596, DOI 10.1182/blood-2006-01-011817; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Rickles FR, 1998, HAEMOSTASIS, V28, P43; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Serebruany V, 2010, AM J THER; Serebruany VL, 2009, AM J MED, V122, P407, DOI 10.1016/j.amjmed.2008.11.023; Sierko E, 2004, SEMIN THROMB HEMOST, V30, P95; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; TERRANOVA VP, 1986, P NATL ACAD SCI USA, V83, P465, DOI 10.1073/pnas.83.2.465; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TZANAKAKIS GN, 1991, J SURG ONCOL, V48, P45, DOI 10.1002/jso.2930480109; van Gestel MA, 2003, ARTERIOSCL THROM VAS, V23, P518, DOI 10.1161/01.ATV.0000057809.32354.22	43	63	69	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80780	10.1371/journal.pone.0080780	http://dx.doi.org/10.1371/journal.pone.0080780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236201	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700204
J	Araneda, L; Sim, SC; Bae, JJ; Chakraborty, N; Curley, J; Chang, T; Inoue, M; Warnke, S; Jung, G				Araneda, Loreto; Sim, Sung-Chur; Bae, Jin-Joo; Chakraborty, Nanda; Curley, Joe; Chang, Taehyun; Inoue, Maiko; Warnke, Scott; Jung, Geunhwa			Comparative Genome Analysis between Agrostis stolonifera and Members of the Pooideae Subfamily, including Brachypodium distachyon	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; CHROMOSOMAL REARRANGEMENTS; SSR MARKERS; RICE; RESISTANCE; MODEL; WHEAT; QTL; CONSTRUCTION; SEQUENCES	Creeping bentgrass (Agrostis stolonifera, allotetraploid 2n = 4x = 28) is one of the major cool-season turfgrasses. It is widely used on golf courses due to its tolerance to low mowing and aggressive growth habit. In this study, we investigated genome relationships of creeping bentgrass relative to the Triticeae (a consensus map of Triticum aestivum, T. tauschii, Hordeum vulgare, and H. spontaneum), oat, rice, and ryegrass maps using a common set of 229 EST-RFLP markers. The genome comparisons based on the RFLP markers revealed large-scale chromosomal rearrangements on different numbers of linkage groups (LGs) of creeping bentgrass relative to the Triticeae (3 LGs), oat (4 LGs), and rice (8 LGs). However, we detected no chromosomal rearrangement between creeping bentgrass and ryegrass, suggesting that these recently domesticated species might be closely related, despite their memberships to different Pooideae tribes. In addition, the genome of creeping bentgrass was compared with the complete genome sequence of Brachypodium distachyon in Pooideae subfamily using both sequences of the above-mentioned mapped EST-RFLP markers and sequences of 8,470 publicly available A. stolonifera ESTs (AgEST). We discovered large-scale chromosomal rearrangements on six LGs of creeping bentgrass relative to B. distachyon. Also, a total of 24 syntenic blocks based on 678 orthologus loci were identified between these two grass species. The EST orthologs can be utilized in further comparative mapping of Pooideae species. These results will be useful for genetic improvement of Agrostis species and will provide a better understanding of evolution within Pooideae species.	[Araneda, Loreto; Inoue, Maiko; Jung, Geunhwa] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Sim, Sung-Chur] Sejong Univ, Dept Bioresources Engn, Seoul, South Korea; [Bae, Jin-Joo] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Chakraborty, Nanda; Curley, Joe] Syngenta Seeds Inc, Stanton, MN USA; [Chang, Taehyun] Kyungpook Natl Univ, Sch Ecol & Environm Syst, Sangju, South Korea; [Warnke, Scott] USDA ARS, Floral & Nursery Plants Res Unit, Beltsville, MD USA	University of Massachusetts System; University of Massachusetts Amherst; Sejong University; University of Wisconsin System; University of Wisconsin Madison; Syngenta; Kyungpook National University; United States Department of Agriculture (USDA)	Jung, G (corresponding author), Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.	jung@umass.edu	Chang, Taehyun/S-1364-2019	Sim, Sung-Chur/0000-0001-7672-6260	United States Golf Association; National Institute of Food and Agriculture; United States Department of Agriculture; Massachusetts Agricultural Experiment Station; Stockbridge School of Agriculture [MAS00925]	United States Golf Association; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture(United States Department of Agriculture (USDA)); Massachusetts Agricultural Experiment Station; Stockbridge School of Agriculture	This work was supported by the United States Golf Association, National Institute of Food and Agriculture, United States Department of Agriculture, the Massachusetts Agricultural Experiment Station and the Stockbridge School of Agriculture under Project Number MAS00925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bonos SA, 2002, CROP SCI, V42, P192, DOI 10.2135/cropsci2002.0192; Chakraborty N, 2006, THEOR APPL GENET, V113, P1421, DOI 10.1007/s00122-006-0387-y; Chakraborty N, 2005, THEOR APPL GENET, V111, P795, DOI 10.1007/s00122-005-2065-x; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Drader T, 2010, GENOME, V53, P406, DOI [10.1139/G10-014, 10.1139/g10-014]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Feltus FA, 2006, PLANT PHYSIOL, V140, P1183, DOI 10.1104/pp.105.074203; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gaut BS, 2002, NEW PHYTOL, P154; He SB, 2009, CROP SCI, V49, P2285, DOI 10.2135/cropsci2009.01.0034; Jones ES, 2002, GENOME, V45, P282, DOI 10.1139/G01-144; JONES K., 1956, Journal of Genetics, V54, P394, DOI 10.1007/BF02982955; JONES K., 1956, Journal of Genetics, V54, P377, DOI 10.1007/BF02982954; JONES K., 1956, Journal of Genetics, V54, P370, DOI 10.1007/BF02982953; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Pacurar DI, 2009, NOT BOT HORTI AGROBO, V37, P17; Pfeifer M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/pp.112.207282; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Renvoize S. A., 1992, Grass evolution and domestication., P3; Rotter D, 2007, MOL GENET GENOMICS, V278, P197, DOI 10.1007/s00438-007-0240-2; Rotter D, 2010, GENET RESOUR CROP EV, V57, P1065, DOI 10.1007/s10722-010-9548-6; Rotter D, 2009, CROP SCI, V49, P1609, DOI 10.2135/cropsci2008.12.0714; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schejbel B, 2008, PLANT BREEDING, V127, P368, DOI 10.1111/j.1439-0523.2007.01477.x; Sim S, 2007, PHYTOPATHOLOGY, V97, P767, DOI 10.1094/PHYTO-97-6-0767; Sim S, 2005, THEOR APPL GENET, V110, P1011, DOI 10.1007/s00122-004-1916-1; Sim SC, 2009, GENOME, V52, P431, DOI [10.1139/G09-019, 10.1139/g09-019]; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Studer B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-177; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; VANDEYNZE AE, 1995, MOL GEN GENET, V248, P744, DOI 10.1007/BF02191715; VANDEYNZE AE, 1995, GENOME, V38, P45, DOI 10.1139/g95-006; VANDEYNZE AE, 1995, MOL GEN GENET, V249, P349, DOI 10.1007/BF00290536; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang Z, 2005, CROP SCI, V45, P399, DOI 10.2135/cropsci2005.0399; Warnke SE, 1998, CROP SCI, V38, P801, DOI 10.2135/cropsci1998.0011183X003800030030x; Watson L., 1992, The grass genera of the world.; Watson L., 1990, REPROD VERSATILITY G, P1	48	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79425	10.1371/journal.pone.0079425	http://dx.doi.org/10.1371/journal.pone.0079425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244501	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600130
J	Cammarota, S; Falconio, LM; Bruzzese, D; Catapano, AL; Casula, M; Citarella, A; De Luca, L; Flacco, ME; Manzoli, L; Masulli, M; Menditto, E; Mezzetti, A; Riegler, S; Novellino, E; Riccardi, G				Cammarota, Simona; Falconio, Lucio Marcello; Bruzzese, Dario; Catapano, Alberico Luigi; Casula, Manuela; Citarella, Anna; De Luca, Luigi; Flacco, Maria Elena; Manzoli, Lamberto; Masulli, Maria; Menditto, Enrica; Mezzetti, Andrea; Riegler, Salvatore; Novellino, Ettore; Riccardi, Gabriele			Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study	PLOS ONE			English	Article							REGULAR HUMAN INSULIN; POSTPRANDIAL HYPERGLYCEMIA; DIABETIC-PATIENTS; GLYCEMIC CONTROL; GLUCOSE CONTROL; BLOOD-GLUCOSE; NPH INSULIN; TYPE-2; HYPOGLYCEMIA; REDUCTION	Background: Few studies are available evaluating the impact of rapid-acting insulin analogues on long-term diabetes outcomes. Our aim was to compare the use of rapid-acting insulin analogues versus human regular insulin in relation to the occurrence of diabetic complications in a cohort of diabetic patients through the analysis of administrative databases. Methods: A population-based cohort study was conducted using administrative data from four local health authorities in the Abruzzo Region (900,000 inhabitants). Diabetic patients free of macrovascular disease at baseline and treated either with human regular insulin or rapid-acting insulin analogues were followed for a maximum of 3 years. The incidence of diabetic complications was ascertained by hospital discharge claims. Hazard ratios (HRs) and 95% CIs of any diabetic complication and macrovascular, microvascular and metabolic complications were estimated separately using Cox proportional hazard models adjusted for patients' characteristics and anti-diabetic drug use. Propensity score matching was also used to adjust for significant difference in the baseline characteristics between the two treatment groups. Results: A total of 2,286 patients were included: 914 receiving human regular insulin and 1,372 rapid-acting insulin analogues. During the follow-up, 286 (31.3%) incident events occurred in the human regular insulin group and 235 (17.1%) in the rapid-acting insulin analogue group. After propensity score-based matched-pair analyses, rapid-acting insulin analogues users had a HR of 0.73 (0.58-0.92) for any diabetes-related complication and HRs of 0.73 (0.55-0.93) and 0.55 (0.32-0.96) for macrovascular and metabolic complications respectively, as compared with human regular insulin users. No difference between the two groups was found for microvascular complications. Conclusions: Our findings suggest that the use of rapid-acting insulin analogues is associated with a lower risk of cardiovascular and metabolic complications compared with human regular insulin use.	[Cammarota, Simona; Falconio, Lucio Marcello; De Luca, Luigi; Menditto, Enrica; Riegler, Salvatore; Novellino, Ettore] Univ Naples Federico II, Ctr Pharmacoecon & Drug Utilizat CIRFF, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Prevent Med Sci, Naples, Italy; [Catapano, Alberico Luigi; Casula, Manuela] Univ Milan, Dept Pharmacol Sci, Epidemiol & Prevent Pharmacol Ctr SEFAP, Milan, Italy; [Catapano, Alberico Luigi] Multimed IRCCS, SS Giovanni, Milan, Italy; [Citarella, Anna] Karolinska Inst, Dept Med, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Flacco, Maria Elena; Manzoli, Lamberto] Univ G dAnnunzio, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy; [Masulli, Maria; Riccardi, Gabriele] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Mezzetti, Andrea] Univ G dAnnunzio, Clin Res Ctr, Chieti, Italy	University of Naples Federico II; University of Naples Federico II; University of Milan; IRCCS Multimedica; Karolinska Institutet; G d'Annunzio University of Chieti-Pescara; University of Naples Federico II; G d'Annunzio University of Chieti-Pescara	Riccardi, G (corresponding author), Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy.	riccardi@unina.it	de Luca, Luigi/F-6577-2012; Manzoli, Lamberto/K-1895-2018; Catapano, alberico/AAC-2827-2019; Flacco, Maria Elena/E-3306-2017; Casula, Manuela/AAC-4470-2019	de Luca, Luigi/0000-0002-1638-0429; Manzoli, Lamberto/0000-0002-8129-9344; Catapano, alberico/0000-0002-7593-2094; Flacco, Maria Elena/0000-0003-1404-4314; Casula, Manuela/0000-0002-5124-5361; Bruzzese, Dario/0000-0001-9911-4646; Novellino, Ettore/0000-0002-2181-2142; orlando, valentina/0000-0002-8209-8878; menditto, enrica/0000-0001-8633-5650	"Federico II" University of Naples, Italy	"Federico II" University of Naples, Italy	The study was supported by funds provided by "Federico II" University of Naples, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JH, 1997, DIABETES, V46, P265, DOI 10.2337/diabetes.46.2.265; Annuzzi G, 2001, NUTR METAB CARDIOVAS, V11, P168; Brod M, 2012, CURR MED RES OPIN, V28, P1947, DOI 10.1185/03007995.2012.743457; Cammarota S, 2014, NUTR METAB CARDIOVAS, V24, P10, DOI 10.1016/j.numecd.2013.04.002; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dailey G, 2004, DIABETES CARE, V27, P2363, DOI 10.2337/diacare.27.10.2363; Giorda C, 2006, DIABETIC MED, V23, P377, DOI 10.1111/j.1464-5491.2006.01851.x; Gough SCL, 2007, DIABETES RES CLIN PR, V77, P1, DOI 10.1016/j.diabres.2006.10.015; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Heller S, 2002, INT J OBESITY, V26, pS31, DOI 10.1038/sj.ijo.0802175; Hermansen K, 2004, DIABETOLOGIA, V47, P622, DOI 10.1007/s00125-004-1365-z; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Kress S, 2012, INT J CLIN PHARM TH, V50, P821, DOI 10.5414/CP201653; Lakey WC, 2013, DIABETOLOGIA, V56, P1226, DOI 10.1007/s00125-013-2890-4; Lindholm A, 1999, DIABETES CARE, V22, P801, DOI 10.2337/diacare.22.5.801; Lo-Ciganic Weihsuan, 2011, J Diabetes Sci Technol, V5, P486; Mannucci E, 2009, DIABETES OBES METAB, V11, P53, DOI 10.1111/j.1463-1326.2008.00934.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; POTTER J, 1982, BRIT MED J, V285, P1180, DOI 10.1136/bmj.285.6349.1180; Raz I, 2011, DIABETES CARE, V34, P1511, DOI 10.2337/dc10-2375; Raz I, 2009, DIABETES CARE, V32, P381, DOI 10.2337/dc08-1671; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; *UKPDS GROUP, 1998, LANCET, V352, P37853, DOI DOI 10.1016/S0140-6736(98)07019-6.PUBMED:9742976; UY J, 2012, OBESITY SILVER SPRIN, V5, P1; 2007, EUR HEART J SC, P90415	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79762	10.1371/journal.pone.0079762	http://dx.doi.org/10.1371/journal.pone.0079762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244557	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900051
J	Gustchina, E; Li, M; Ghirlando, R; Schuck, P; Louis, JM; Pierson, J; Rao, P; Subramaniam, S; Gustchina, A; Clore, GM; Wlodawer, A				Gustchina, Elena; Li, Mi; Ghirlando, Rodolfo; Schuck, Peter; Louis, John M.; Pierson, Jason; Rao, Prashant; Subramaniam, Sriram; Gustchina, Alla; Clore, G. Marius; Wlodawer, Alexander			Complexes of Neutralizing and Non-Neutralizing Affinity Matured Fabs with a Mimetic of the Internal Trimeric Coiled-Coil of HIV-1 gp41	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY; DESIGN; ULTRACENTRIFUGATION; INHIBITORS; ACCURACY; POTENT; ENTRY	A series of mini-antibodies (monovalent and bivalent Fabs) targeting the conserved internal trimeric coiled-coil of the N-heptad repeat (N-HR) of HIV-1 gp41 has been previously constructed and reported. Crystal structures of two closely related monovalent Fabs, one (Fab 8066) broadly neutralizing across a wide panel of HIV-1 subtype B and C viruses, and the other (Fab 8062) non-neutralizing, representing the extremes of this series, were previously solved as complexes with 5-Helix, a gp41 pre-hairpin intermediate mimetic. Binding of these Fabs to covalently stabilized chimeric trimers of N-peptides of HIV1 gp41 (named (CCIZN36)(3) or 3-H) has now been investigated using X-ray crystallography, cryo-electron microscopy, and a variety of biophysical methods. Crystal structures of the complexes between 3-H and Fab 8066 and Fab 8062 were determined at 2.8 and 3.0 angstrom resolution, respectively. Although the structures of the complexes with the neutralizing Fab 8066 and its non-neutralizing counterpart Fab 8062 were generally similar, small differences between them could be correlated with the biological properties of these antibodies. The conformations of the corresponding CDRs of each antibody in the complexes with 3-H and 5-Helix are very similar. The adaptation to a different target upon complex formation is predominantly achieved by changes in the structure of the trimer of N-HR helices, as well as by adjustment of the orientation of the Fab molecule relative to the N-HR in the complex, via rigid-body movement. The structural data presented here indicate that binding of three Fabs 8062 with high affinity requires more significant changes in the structure of the N-HR trimer compared to binding of Fab 8066. A comparative analysis of the structures of Fabs complexed to different gp41 intermediate mimetics allows further evaluation of biological relevance for generation of neutralizing antibodies, as well as provides novel structural insights into immunogen design.	[Gustchina, Elena; Louis, John M.; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Li, Mi; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA; [Li, Mi] SAIC Frederick, Basic Res Program, Frederick, MD USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, NIH, Lab Cellular Imaging & Macromol Biophys, Bethesda, MD USA; [Pierson, Jason] FEI Co, Hillsboro, OR USA; [Rao, Prashant; Subramaniam, Sriram] NCI, Ctr Canc Res, Cell Biol Lab, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Thermo Fisher Scientific; FEI Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gustchina, A (corresponding author), NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA.	gustchia@mail.nih.gov; mariusc@mail.nih.gov; wlodawer@nih.gov	Clore, G. Marius/A-3511-2008; Schuck, Peter/AAA-6888-2020; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Schuck, Peter/0000-0002-8859-6966; Clore, G Marius/0000-0003-3809-1027; Subramaniam, Sriram/0000-0003-4231-4115; Louis, John M/0000-0002-0052-1899	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Programs of the NIDDK; Intramural Research Programs of the NIBIB; National Cancer Institute, Center for Cancer Research; AIDS Targeted Antiviral Program of the Office of the Director of the NIH; Federal funds from the National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029038, ZIADK033007] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Programs of the NIDDK; Intramural Research Programs of the NIBIB; National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIDS Targeted Antiviral Program of the Office of the Director of the NIH; Federal funds from the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the use of beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. This project was supported in part by the Intramural Research Programs of the NIDDK (to G. M. C), NIBIB (to P. S.), and the National Cancer Institute, Center for Cancer Research (to S. S. and A. W.), by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to S. S. and G. M. C.), and with Federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E (to M. L.). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJORATH J, 1995, J BIOL CHEM, V270, P22081, DOI 10.1074/jbc.270.38.22081; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Bianchi E, 2010, P NATL ACAD SCI USA, V107, P10655, DOI 10.1073/pnas.1004261107; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Gustchina E, 2009, VIROLOGY, V393, P112, DOI 10.1016/j.virol.2009.07.019; Harris AK, 2013, J VIROL, V87, P7191, DOI 10.1128/JVI.03284-12; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Karle IL, 2003, P NATL ACAD SCI USA, V100, P13946, DOI 10.1073/pnas.2336106100; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson JK, 2008, IEEE T DIELECT EL IN, V15, P1, DOI 10.1109/T-DEI.2008.4446730; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	43	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78187	10.1371/journal.pone.0078187	http://dx.doi.org/10.1371/journal.pone.0078187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244293	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900010
J	Isberg, V; Paine, J; Leth-Petersen, S; Kristensen, JL; Gloriam, DE				Isberg, Vignir; Paine, James; Leth-Petersen, Sebastian; Kristensen, Jesper L.; Gloriam, David E.			Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors	PLOS ONE			English	Article							DRUG DEVELOPMENT; HALLUCINOGENS; DERIVATIVES; AGONISTS; ANALOGS; BIOLOGY; POTENT; PROBES; ROLES	Serotonergic ligands have proven effective drugs in the treatment of migraine, pain, obesity, and a wide range of psychiatric and neurological disorders. There is a clinical need for more highly 5-HT2 receptor subtype-selective ligands and the most attention has been given to the phenethylamine class. Conformationally constrained phenethylamine analogs have demonstrated that for optimal activity the free lone pair electrons of the 2-oxygen must be oriented syn and the 5-oxygen lone pairs anti relative to the ethylamine moiety. Also the ethyl linker has been constrained providing information about the bioactive conformation of the amine functionality. However, combined 1,2-constriction by cyclization has only been tested with one compound. Here, we present three new 1,2-cyclized phenylethylamines, 9-11, and describe their synthetic routes. Ligand docking in the 5-HT2B crystal structure showed that the 1,2-heterocyclized compounds can be accommodated in the binding site. Conformational analysis showed that 11 can only bind in a higher-energy conformation, which would explain its absent or low affinity. The amine and 2-oxygen interactions with D3.32 and S3.36, respectively, can form but shift the placement of the core scaffold. The constraints in 9-11 resulted in docking poses with the 4-bromine in closer vicinity to 5.46, which is polar only in the human 5-HT2A subtype, for which 9-11 have the lowest affinity. The new ligands, conformational analysis and docking expand the structure-activity relationships of constrained phenethylamines and contributes towards the development of 5-HT2 receptor subtype-selective ligands.	[Isberg, Vignir; Paine, James; Leth-Petersen, Sebastian; Kristensen, Jesper L.; Gloriam, David E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen	Gloriam, DE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	david.gloriam@sund.ku.dk	Kristensen, Jesper/AAP-4439-2021; Kristensen, Jesper/E-3581-2010; Gloriam, David E./A-1904-2011; Isberg, Vignir/A-2882-2011	Kristensen, Jesper/0000-0002-5613-1267; Kristensen, Jesper/0000-0002-5613-1267; Gloriam, David E./0000-0002-4299-7561; Isberg, Vignir/0000-0002-1042-040X	Carlsberg Foundation; Lundbeck-Foundation	Carlsberg Foundation(Carlsberg Foundation); Lundbeck-Foundation(Lundbeckfonden)	VI and JP were supported by the Lundbeck- and DEG by the Carlsberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLID; [Anonymous], 2012, SITEMAP; [Anonymous], 2013, MAESTR; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Braden MR, 2007, MOL PHARMACOL, V72, P1200, DOI 10.1124/mol.107.039255; Braden MR, 2007, BIOPHYSICAL BASIS HA; BRADSHER CK, 1978, J ORG CHEM, V43, P3800, DOI 10.1021/jo00413a047; Chambers JJ, 2001, J MED CHEM, V44, P1003, DOI 10.1021/jm000491y; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Goadsby P J, 2007, Handb Exp Pharmacol, P129; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Gray JA, 2007, MOL PSYCHIATR, V12, P904, DOI 10.1038/sj.mp.4002062; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Katzman MA, 2009, CNS DRUGS, V23, P103, DOI 10.2165/00023210-200923020-00002; McLean TH, 2006, J MED CHEM, V49, P5794, DOI 10.1021/jm060656o; Moltzen EK, 2006, CURR TOP MED CHEM, V6, P1801, DOI 10.2174/156802606778249810; Monte AP, 1996, J MED CHEM, V39, P2953, DOI 10.1021/jm960199j; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nichols DE, 1995, MED CHEM RES, V5; Parker MA, 1998, J MED CHEM, V41, P5148, DOI 10.1021/jm9803525; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; SELANDER H, 1972, ACTA CHEM SCAND, V26, P2433, DOI 10.3891/acta.chem.scand.26-2433; Wacker D., 2013, SCIENCE; Whiteside MS, 2002, BIOORGAN MED CHEM, V10, P3301, DOI 10.1016/S0968-0896(02)00209-2; Wubbels GG, 2008, J ORG CHEM, V73, P1925, DOI 10.1021/jo702468d	30	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78515	10.1371/journal.pone.0078515	http://dx.doi.org/10.1371/journal.pone.0078515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244317	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900022
J	Shigaki, K; Wang, Z; Tanimoto, J; Fukuda, E				Shigaki, Keizo; Wang, Zhen; Tanimoto, Jun; Fukuda, Eriko			Effect of Initial Fraction of Cooperators on Cooperative Behavior in Evolutionary Prisoner's Dilemma Game	PLOS ONE			English	Article							NETWORKS; DYNAMICS; COEVOLUTION; INVASION; STRATEGY	We investigate the influence of initial fraction of cooperators on the evolution of cooperation in spatial prisoner's dilemma games. Compared with the results of heterogeneous networks, we find that there is a relatively low initial fraction of cooperators to guarantee higher equilibrium cooperative level. While this interesting phenomenon is contrary to the commonly shared knowledge that higher initial fraction of cooperators can provide better environment for the evolution of cooperation. To support our outcome, we explore the time courses of cooperation and find that the whole course can be divided into two sequent stages: enduring (END) and expanding (EXP) periods. At the end of END period, thought there is a limited number of cooperator clusters left for the case of low initial setup, these clusters can smoothly expand to hold the whole system in the EXP period. However, for high initial fraction of cooperators, superfluous cooperator clusters hinder their effective expansion, which induces many remaining defectors surrounding the cooperator clusters. Moreover, through intensive analysis, we also demonstrate that when the tendency of three cooperation cluster characteristics (cluster size, cluster number and cluster shape) are consistent within END and EXP periods, the state that maximizes cooperation can be favored.	[Shigaki, Keizo; Tanimoto, Jun; Fukuda, Eriko] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon, Hong Kong, Peoples R China	Kyushu University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wang, Z (corresponding author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan.	zhenwang0@gmail.com; tanimoto@cm.kyushu-u.ac.jp		Tanimoto, Jun/0000-0002-4092-3219	JSPS [23651156]; Kurata-Hitachi Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurata-Hitachi Foundation	This work was supported by the Grant-in-Aid for Scientific Research by JSPS, awarded to Prof. Tanimoto (#23651156) and by the Kurata-Hitachi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio C, 2012, PHYS REV E, V85; [Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Cheng HY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123014; Cong R, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/3/030203; Du WB, 2009, PHYSICA A, V388, P5005, DOI 10.1016/j.physa.2009.08.026; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Genki I, 2013, PLOS ONE, V8; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Lozada M, 2011, J THEOR BIOL, V289, P12, DOI 10.1016/j.jtbi.2011.08.016; Maynard-Smith J, 1995, NATURE, V374, P227; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Mendeli HV, 2001, PHYS REV E, V64, P05915; Miyaji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071961; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Shigaki K, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/40008; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Suzuki S, 2011, J THEOR BIOL, V287, P42, DOI 10.1016/j.jtbi.2011.07.019; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanabe S, 2012, J THEOR BIOL, V293, P151, DOI 10.1016/j.jtbi.2011.10.020; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wang Z, 2011, PHYSICA A, V390, P1234, DOI 10.1016/j.physa.2010.12.003; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu G, 2008, CHINESE PHYS LETT, V25, P2307, DOI 10.1088/0256-307X/25/6/105; Wu Z.-X., 2009, PHYS REV E, V80; Xia CY, 2012, PHYSICA A, V391, P6440, DOI 10.1016/j.physa.2012.07.065; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2012, CHAOS SOLITON FRACT, V45, P1239, DOI 10.1016/j.chaos.2012.06.014; Xu ZJ, 2010, J THEOR BIOL, V264, P19, DOI 10.1016/j.jtbi.2010.01.025; Yang HX, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/10006; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023; Zhang J, 2011, PHYSICA A, V390, P2258, DOI 10.1016/j.physa.2011.02.045; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	62	45	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76942	10.1371/journal.pone.0076942	http://dx.doi.org/10.1371/journal.pone.0076942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244270	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900004
J	Balogh, P; Szabo, A; Katz, S; Liko, I; Patocs, A; Kiss, AL				Balogh, Petra; Szabo, Arnold; Katz, Sandor; Liko, Istvan; Patocs, Attila; Kiss, Anna L.			Estrogen Receptor Alpha Is Expressed in Mesenteric Mesothelial Cells and Is Internalized in Caveolae upon Freund's Adjuvant Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; TGF-BETA; ER-ALPHA; MESSENGER-RNA; BREAST-CANCER; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; PATHWAY ACTIVATION; MCF-7 CELLS	Transformation of epithelial cells into connective tissue cells (epithelial-mesenchymal transition, EMT) is a complex mechanism involved in tumor metastasis, and in normal embryogenesis, while type II EMT is mainly associated with inflammatory events and tissue regenaration. In this study we examined type II EMT at the ultrastructural and molecular level during the inflammatory process induced by Freund's adjuvant treatment in rat mesenteric mesothelial cells. We found that upon the inflammatory stimulus mesothelial cells lost contact with the basal lamina and with each other, and were transformed into spindle-shaped cells. These morphological changes were accompanied by release of interleukins IL-1alpha, -1beta and IL-6 and by secretion of transforming growth factor beta (TGF-beta) into the peritoneal cavity. Mesothelial cells also expressed estrogen receptor alpha (ER-alpha) as shown by immunolabeling at the light and electron microscopical levels, as well as by quantitative RT-PCR. The mRNA level of ER-alpha showed an inverse correlation with the secretion of TGF-beta. At the cellular and subcellular levels ER-alpha was colocalized with the coat protein caveolin-1 and was found in the plasma membrane of mesothelial cells, in caveolae close to multivesicular bodies (MVBs) or in the membrane of these organelles, suggesting that ER-alpha is internalized via caveola-mediated endocytosis during inflammation. We found asymmetric, thickened, electron dense areas on the limiting membrane of MVBs (MVB plaques) indicating that these sites may serve as platforms for collecting and organizing regulatory proteins. Our morphological observations and biochemical data can contribute to form a potential model whereby ER-alpha and its caveola-mediated endocytosis might play role in TGF-beta induced type II EMT in vivo.	[Balogh, Petra; Szabo, Arnold; Katz, Sandor; Kiss, Anna L.] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Liko, Istvan] R Gedeon Plc, Pharmacol & Drug Safety Res, Budapest, Hungary; [Patocs, Attila] HSA SE Lendulet Hereditary Endocrine Tumors Res G, Budapest, Hungary	Semmelweis University	Balogh, P (corresponding author), Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary.	balogh.petra@med.semmelweis-univ.hu		Szabo, Arnold/0000-0001-7685-9231; Liko, Istvan/0000-0001-7668-4726; Patocs, Attila/0000-0001-7506-674X	OTKA: Hungarian Scientific Research Fund; KTIA-AIK: Research and Technology Innovation Fund; National Developmental Agency; TAMOP: Hungary's Renewal Program	OTKA: Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); KTIA-AIK: Research and Technology Innovation Fund; National Developmental Agency; TAMOP: Hungary's Renewal Program	This work was funded by "OTKA: Hungarian Scientific Research Fund," "KTIA-AIK: Research and Technology Innovation Fund, National Developmental Agency," "TAMOP: Hungary's Renewal Program, National Developmental Agency.: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; [Anonymous], 2010, NIH INTR GUIDL 2010; Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Baran J, 2007, J CELL COMMUN SIGNAL, V1, P195, DOI 10.1007/s12079-008-0017-3; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DOUVDEVANI A, 1994, KIDNEY INT, V46, P993, DOI 10.1038/ki.1994.359; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feldmann M., 2001, CYTOKINE REFERENCE, P291, DOI DOI 10.1006/RWCY.2000.0204; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Katz S, 2012, PATHOL ONCOL RES, V18, P641, DOI 10.1007/s12253-011-9489-1; Katz S, 2011, APMIS, V119, P782, DOI 10.1111/j.1600-0463.2011.02803.x; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; OFFNER FA, 1995, CYTOKINE, V7, P542, DOI 10.1006/cyto.1995.0073; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Planas-Silva MD, 2007, J STEROID BIOCHEM, V104, P11, DOI 10.1016/j.jsbmb.2006.09.039; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; TOPLEY N, 1993, KIDNEY INT, V43, P226, DOI 10.1038/ki.1993.36; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008	69	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79508	10.1371/journal.pone.0079508	http://dx.doi.org/10.1371/journal.pone.0079508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244516	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327143800087
J	Dey, M; Patra, S; Su, LY; Segall, AM				Dey, Mamon; Patra, Sukanya; Su, Leo Y.; Segall, Anca M.			Tumor Cell Death Mediated by Peptides That Recognize Branched Intermediates of DNA Replication and Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SITE-SPECIFIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; CYTOCHROME-C; TYROSINE RECOMBINASES; HOLLIDAY JUNCTIONS; COLORECTAL-CANCER; PROSTATE-CANCER; INHIBITORS; DAMAGE	Effective treatments for cancer are still needed, both for cancers that do not respond well to current therapeutics and for cancers that become resistant to available treatments. Herein we investigated the effect of a structure-selective d-amino acid peptide wrwycr that binds replication fork mimics and Holliday Junction (HJs) intermediates of homologous recombination (HR) in vitro, and inhibits their resolution by HJ-processing enzymes. We predicted that treating cells with HJ-binding compounds would lead to accumulation of DNA damage. As cells repair endogenous or exogenous DNA damage, collapsed replication forks and HJ intermediates will accumulate and serve as targets for the HJ-binding peptides. Inhibiting junction resolution will lead to further accumulation of DNA breaks, eventually resulting in amplification of the damage and causing cell death. Both peptide wrwycr and the related wrwyrggrywrw entered cancer cells and reduced cell survival in a dose-and time-dependent manner. Early markers for DNA damage, gamma H2AX foci and 53BP1 foci, increased with dose and/or time exposure to the peptides. DNA breaks persisted at least 48 h, and both checkpoint proteins Chk1 and Chk2 were activated. The passage of the cells from S to G2/M was blocked even after 72 h. Apoptosis, however, was not induced in either HeLa or PC3 cells. Based on colony-forming assays, about 35% peptide-induced cytotoxicity was irreversible. Finally, sublethal doses of peptide wrwycr (50-100 mu M) in conjunction with sublethal doses of several DNA damaging agents (etoposide, doxorubicin, and HU) reduced cell survival at least additively and sometimes synergistically. Taken together, the results suggest that the peptides merit further investigation as proof-of-principle molecules for a new class of anti-cancer therapeutics, in particular in combination with other DNA damaging therapies.	[Segall, Anca M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Segall, AM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	asegall@mail.sdsu.edu		Segall, Anca/0000-0002-8454-5248	National Institutes of Health [R01 AI058253, R21 AI061351]; pilot project; National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program [U54CA132384, U54CA132379]; NATIONAL CANCER INSTITUTE [U54CA132384, U54CA132379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058253, R21AI061351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project; National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants R01 AI058253 and R21 AI061351 to AMS, and also funded in part by a pilot project to AMS and WIlliam Wachsman that was part of the National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program, grants U54CA132384 (PIs Klonoff and Maloy) and U54CA132379 (PIs Navarro and Carethers). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Barakat K, 2012, CURR TOP MED CHEM, V12, P1376, DOI 10.2174/156802612801319070; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Calderon-Montano JM, 2012, PHARMACOL REP, V64, P1515, DOI 10.1016/S1734-1140(12)70949-0; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Chan SC, 1998, J PEPT SCI, V4, P413, DOI 10.1002/(SICI)1099-1387(1998110)4:7<413::AID-PSC160>3.3.CO;2-X; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Evers B, 2010, TRENDS PHARMACOL SCI, V31, P372, DOI 10.1016/j.tips.2010.06.001; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Firsanov DV, 2011, CLIN EPIGENETICS, V2, P283, DOI 10.1007/s13148-011-0044-4; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GINGRICH JR, 1991, J UROLOGY, V146, P915, DOI 10.1016/S0022-5347(17)37960-0; Goldstein JC, 2005, AGING CELL, V4, P217, DOI 10.1111/j.1474-9726.2005.00163.x; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gunderson CW, 2009, J BACTERIOL, V191, P2169, DOI 10.1128/JB.01559-08; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hwang SL, 2013, BIOCHEM BIOPH RES CO, V430, P1246, DOI 10.1016/j.bbrc.2012.12.066; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jarver P, 2006, BBA-BIOMEMBRANES, V1758, P260, DOI 10.1016/j.bbamem.2006.02.012; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kepple KV, 2008, NUCLEIC ACIDS RES, V36, P5319, DOI 10.1093/nar/gkn512; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; Lassmann M, 2010, J NUCL MED, V51, P1318, DOI 10.2967/jnumed.109.071357; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; Lossaint G, 2011, ONCOGENE, V30, P4261, DOI 10.1038/onc.2011.135; McKeage K, 2012, DRUGS, V72, P1559, DOI 10.2165/11209660-000000000-00000; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Ozcan L, 2012, CURR ATHEROSCLER REP; Pilatus U, 1997, MAGNET RESON MED, V37, P825, DOI 10.1002/mrm.1910370605; Raftery L, 2010, CANCER J, V16, P214, DOI 10.1097/PPO.0b013e3181ddc5ac; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rajeev L, 2007, J BIOL CHEM, V282, P31228, DOI 10.1074/jbc.M705370200; Ranjit DK, 2010, BIOORG MED CHEM LETT, V20, P4531, DOI 10.1016/j.bmcl.2010.06.029; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rideout MC, 2013, PEPTIDES, V40, P112, DOI 10.1016/j.peptides.2012.12.025; Rideout MC, 2011, MOL DIVERS, V15, P989, DOI 10.1007/s11030-011-9333-2; Rideout MC, 2013, PEPTIDES; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Su LY, 2010, ANTIMICROB AGENTS CH, V54, P1888, DOI 10.1128/AAC.01610-09; Su LY, 2009, EFFECTS HOLLIDAY JUN, P1; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Thede GL, 2011, J BACTERIOL, V193, P2149, DOI 10.1128/JB.01296-10; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WHARTON W, 1978, CANCER RES, V38, P3764; Yitzhaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044896; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	65	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78751	10.1371/journal.pone.0078751	http://dx.doi.org/10.1371/journal.pone.0078751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244353	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800012
J	Eisenring, CV; Neidert, MC; Bove, DS; Held, L; Sarnthein, J; Krayenbuhl, N				Eisenring, Christian Valentin; Neidert, Marian Christoph; Bove, Daniel Sabanes; Held, Leonhard; Sarnthein, Johannes; Krayenbuhl, Niklaus			Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP VENOUS THROMBOSIS; INTRACRANIAL MENINGIOMAS; BRAIN-TUMORS; PROPHYLAXIS; PREVENTION; HEMORRHAGE; SAFETY	Background: Meningiomas are associated with the highest postoperative rate of venous thromboembolic events (VTE) among all intracranial tumors. The aim of this study is to compare two entirely different VTE prophylaxis regimens in 724 consecutive patients undergoing meningioma surgery. Methods: Two cohorts at a single institution treated with different regimens to prevent VTE were reviewed retrospectively. Cohort A (n = 482; 314 females, mean age 57 years, range: 11-87 years) received our institutional regimen during the years 1999-2006, consisting of low-molecular-weight heparin (LMWH) and compression stockings. For cohort B (n = 242; 163 females, mean age 56.8 years, range: 16-90 years), during the years 2008-2010, the management included intraoperative 10 degrees-20 degrees leg elevation with intermittent pneumatic compression (IPC), heparin and LMWH administration. We compared the incidence of the endpoints pulmonary embolism (PE), deep venous thrombosis (DVT), hemorrhage and death, taking into account several known associated risk factors. Results: For all endpoints, we observed a more favorable outcome with the new regimen. The difference in incidence of PEs (cohort A: 38/482, 8%; cohort B: 6/242, 2.5%) reached statistical significance (p = 0.002). In general, patients with skull base meningiomas had a higher risk for PE (OR 2.77). Regarding VTE prophylaxis, an adjusted subgroup analysis suggests that the new regimen is particularly beneficial for patients with skull base meningiomas. Conclusions: We recommend perioperative prophylaxis using a management composed of intraoperative leg-elevation, IPC, early heparin administration and LMWH to reduce the risk for PE.	[Eisenring, Christian Valentin; Neidert, Marian Christoph; Sarnthein, Johannes; Krayenbuhl, Niklaus] Univ Spital Zurich, Neurochirurg Klin, Zurich, Switzerland; [Bove, Daniel Sabanes; Held, Leonhard] Univ Zurich, Inst Sozial & Praventivmed, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Krayenbuhl, N (corresponding author), Univ Spital Zurich, Neurochirurg Klin, Zurich, Switzerland.	niklaus.krayenbuehl@usz.ch	Held, Leonhard/E-8159-2010; Sarnthein, Johannes/E-7959-2010; Eisenring, Christian/GLU-7719-2022	Held, Leonhard/0000-0002-8686-5325; Sarnthein, Johannes/0000-0001-9141-381X; Eisenring, Christian/0000-0002-0208-3220; Krayenbuehl, Niklaus/0000-0003-1089-221X				Agnelli G, 1999, THROMB HAEMOSTASIS, V82, P925; ALMEFTY O, 1991, MENINGIOMAS; Black P, 1998, ACTA NEUROCHIR, V140, P1013, DOI 10.1007/s007010050209; Black Peter, 2007, Clin Neurosurg, V54, P91; Cage TA, 2009, J NEURO-ONCOL, V93, P151, DOI 10.1007/s11060-009-9886-4; Carman TL, 2003, SOUTH MED J, V96, P17, DOI 10.1097/01.SMJ.0000047628.44490.B2; Caroli M, 2005, J NEUROSURG, V102, P290, DOI 10.3171/jns.2005.102.2.0290; Chaichana KL, 2013, NEUROL RES, V35, P206, DOI 10.1179/1743132812Y.0000000126; Chen CM, 2011, NEUROSURG REV, V34, P281, DOI 10.1007/s10143-011-0321-x; Chibbaro S, 2008, SURG NEUROL, V70, P117, DOI 10.1016/j.surneu.2007.06.081; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerber DE, 2007, CANCER, V109, P300, DOI 10.1002/cncr.22405; Gerlach R, 2003, NEUROSURGERY, V53, P1028, DOI 10.1227/01.NEU.0000088565.15719.22; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Greenberg M.S, 2010, HDB NEUROSURGERY; Keller E, 2011, NEUROINTENSIV, P810; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Koray Ozduman RF, 2010, ACTA NEUROCHIR, V800; Macdonald RL, 1999, NEUROSURGERY, V45, P245, DOI 10.1097/00006123-199908000-00008; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Raabe A, 2000, ZBL NEUROCHIR, V61, P103, DOI 10.1055/s-2000-8267; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7; Riffaud L, 2007, PRESSE MED, V36, P197, DOI 10.1016/j.lpm.2006.11.009; Roser F, 2007, J CLIN NEUROSCI, V14, P224, DOI 10.1016/j.jocn.2005.12.004; Samandouras G., 2010, NEUROSURGEONS HDB; SAWAYA R, 1984, NEUROSURGERY, V15, P566, DOI 10.1227/00006123-198410000-00019; SAWAYA R, 1989, J NEUROSURG, V70, pA314; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Stienen M N, 2010, Praxis (Bern 1994), V99, P1479, DOI 10.1024/1661-8157/a000321; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12183	32	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79170	10.1371/journal.pone.0079170	http://dx.doi.org/10.1371/journal.pone.0079170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244441	Green Published, gold			2022-12-25	WOS:000327143800036
J	Heard, I; Tondeur, L; Arowas, L; Res, MF; Demazoin, MC; Favre, M				Heard, Isabelle; Tondeur, Laura; Arowas, Laurence; Res, Michael Falguie; Demazoin, Marie-Christine; Favre, Michel			Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; INTRAEPITHELIAL NEOPLASIA; NORMAL CYTOLOGY; PREVALENCE; WOMEN; GRADE; METAANALYSIS; AGE; WORLDWIDE; LESIONS	Background: Knowledge of prevalence rates and distribution of human papillomavirus (HPV) genotypes prior high HPV vaccine coverage is necessary to assess its expected impact on HPV ecology and on cervical lesions and cancers. Methods: Residual specimens of cervical cytology (N = 6,538) were obtained from 16 sites participating in organised cervical cancer screening pilot programs throughout France, anonymised and tested for HPV DNA using the PapilloCheck (R) genotyping test. Samples were stratified according to age of women and cytological grades. Results: The age-standardised prevalence rates of HPV 16 and/or 18 (with or without other high-risk types) was 47.2% (95% Confidence Interval, CI: 42.4-52.1) in high-grade squamous intraepithelial lesions (HSILs), 20.2% in low-grade SIL (95% CI: 16.7-23.7) and 3.9% (95% CI: 2.8-5.1) in normal cytology. Overall HR HPV were detected in 13.7% (95% I CI: 11.7-15.6) of normal cytology. In women below 30 years of age, 64% of HSILs were associated with HPV16 and/ or 18. In our study population, HPV16 was the most commonly detected type in all cervical grades with prevalence rates ranking from 3.0% in normal cytology to 50.9% in HSILs. HPV16 was also detected in 54% (27/50) of invasive cervical cancers including 5 adenocarcinomas. Conclusion: HPV16 was strongly associated with cervical precancer and cancer. The high prevalence rates of HPV16/18 infection among women below 30 years of age with HSILs suggests that the impact of vaccination would be primarily observed among young women.	[Heard, Isabelle; Arowas, Laurence; Res, Michael Falguie; Demazoin, Marie-Christine; Favre, Michel] Inst Pasteur, French HPV Reference Lab, Paris, France; [Heard, Isabelle] Univ Paris 06, Grp Hosp Pitie Salpetriere, INSERM U943, Paris, France; [Tondeur, Laura] Inst Pasteur, Emerging Dis Epidemiol Expertise Unit, Paris, France; [Favre, Michel] Inst Pasteur, Genet Papillomavirus & Human Canc Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Heard, I (corresponding author), Inst Pasteur, French HPV Reference Lab, Paris, France.	isabelle.heard@pasteur.fr			Institut Pasteur; French Institut National du Cancer [2010-05]; French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV)	Institut Pasteur(European Commission); French Institut National du Cancer(Institut National du Cancer (INCA) France); French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV)	This study was funded by the Institut Pasteur and by grants from the French Institut National du Cancer (INCa no 2010-05) and by the French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2009, J WOMENS HEALTH, V18, P1341, DOI 10.1089/jwh.2008.1223; Arbyn M, 2009, CANCER EPIDEM BIOMAR, V18, P321, DOI 10.1158/1055-9965.EPI-08-0510; Baandrup L, 2012, GYNECOL ONCOL, V124, P281, DOI 10.1016/j.ygyno.2011.10.020; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gravitt PE, 2013, J INFECT DIS, V207, P272, DOI 10.1093/infdis/jis660; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Pretet JL, 2008, GYNECOL ONCOL, V110, P179, DOI 10.1016/j.ygyno.2008.04.012; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79372	10.1371/journal.pone.0079372	http://dx.doi.org/10.1371/journal.pone.0079372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244490	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800066
J	Jin, EH; Zhang, E; Ko, Y; Sim, WS; Moon, DE; Yoon, KJ; Hong, JH; Lee, WH				Jin, Eun-Heui; Zhang, Enji; Ko, Youngkwon; Sim, Woo Seog; Moon, Dong Eon; Yoon, Keon Jung; Hong, Jang Hee; Lee, Won Hyung			Genome-Wide Expression Profiling of Complex Regional Pain Syndrome	PLOS ONE			English	Article							NEUROPATHIC PAIN; GENE-EXPRESSION; METALLOPROTEINASES; NERVE; MEDIATORS; TISSUE; PHASE	Complex regional pain syndrome (CRPS) is a chronic, progressive, and devastating pain syndrome characterized by spontaneous pain, hyperalgesia, allodynia, altered skin temperature, and motor dysfunction. Although previous gene expression profiling studies have been conducted in animal pain models, there genome-wide expression profiling in the whole blood of CRPS patients has not been reported yet. Here, we successfully identified certain pain-related genes through genome-wide expression profiling in the blood from CRPS patients. We found that 80 genes were differentially expressed between 4 CRPS patients (2 CRPS I and 2 CRPS II) and 5 controls (cut-off value: 1.5-fold change and p<0.05). Most of those genes were associated with signal transduction, developmental processes, cell structure and motility, and immunity and defense. The expression levels of major histocompatibility complex class I A subtype (HLA-A29.1), matrix metalloproteinase 9 (MMP9), alanine aminopeptidase N (ANPEP), L-histidine decarboxylase (HDC), granulocyte colony-stimulating factor 3 receptor (G-CSF3R), and signal transducer and activator of transcription 3 (STAT3) genes selected from the microarray were confirmed in 24 CRPS patients and 18 controls by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). We focused on the MMP9 gene that, by qRT-PCR, showed a statistically significant difference in expression in CRPS patients compared to controls with the highest relative fold change (4.0+/-1.23 times and p = 1.4x10(-4)). The up-regulation of MMP9 gene in the blood may be related to the pain progression in CRPS patients. Our findings, which offer a valuable contribution to the understanding of the differential gene expression in CRPS may help in the understanding of the pathophysiology of CRPS pain progression.	[Jin, Eun-Heui; Lee, Won Hyung] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Taejon, South Korea; [Zhang, Enji; Ko, Youngkwon; Lee, Won Hyung] Chungnam Natl Univ, Dept Anesthesia & Pain Med, Taejon, South Korea; [Sim, Woo Seog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Moon, Dong Eon] Catholic Univ, Coll Med, Dept Anaesthesiol & Pain Med, Seoul, South Korea; [Yoon, Keon Jung] Catholic Univ, Coll Med, Dept Anaesthesiol & Pain Med, Seoul, South Korea; [Hong, Jang Hee] Chungnam Natl Univ, Coll Med, Dept Phamacol, Taejon, South Korea; [Jin, Eun-Heui; Hong, Jang Hee; Lee, Won Hyung] Chungnam Natl Univ Hosp, Clin Trials Ctr, Taejon, South Korea	Chungnam National University; Chungnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea; Chungnam National University; Chungnam National University; Chungnam National University Hospital	Jin, EH (corresponding author), Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Taejon, South Korea.	sowha1219@hotmail.com; whlee@cnu.ac.kr		Hong, Jang-Hee/0000-0002-0623-5455; Ko, YoungKwon/0000-0002-0178-6346	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A070001]; Chungnam National University Hospital Research Fund	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Chungnam National University Hospital Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A070001) and Chungnam National University Hospital Research Fund, 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backonja MM, 2008, J NEUROIMMUNOL, V195, P157, DOI 10.1016/j.jneuroim.2008.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett G, 1998, PAIN, V77, P315, DOI 10.1016/S0304-3959(98)00114-6; Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; CUNHA FQ, 1991, BRIT J PHARMACOL, V104, P765, DOI 10.1111/j.1476-5381.1991.tb12502.x; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Hirden RN, 2006, CLIN J PAIN, V22, P415; Imamura K, 2008, HEADACHE, V48, P135, DOI 10.1111/j.1526-4610.2007.00958.x; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Ko J, 2002, J BIOCHEM MOL BIOL, V35, P420; Kramer HH, 2011, PAIN, V152, P285, DOI 10.1016/j.pain.2010.09.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WY, 2002, EUR J NEUROSCI, V15, P1037, DOI 10.1046/j.1460-9568.2002.01940.x; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; van de Beek WJT, 2003, PAIN, V103, P93, DOI 10.1016/S0304-3959(02)00444-X; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Wong GY, 1997, HAND CLIN, V13, P319; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yoshida A, 2005, EUR J PHARMACOL, V522, P55, DOI 10.1016/j.ejphar.2005.08.037	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79435	10.1371/journal.pone.0079435	http://dx.doi.org/10.1371/journal.pone.0079435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244504	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800076
J	Jing, D; Li, FJ; Jiang, MG; Cai, J; Wu, Y; Xie, KN; Wu, XM; Tang, C; Liu, J; Guo, W; Shen, GH; Luo, EP				Jing, Da; Li, Feijiang; Jiang, Maogang; Cai, Jing; Wu, Yan; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping			Pulsed Electromagnetic Fields Improve Bone Microstructure and Strength in Ovariectomized Rats through a Wnt/Lrp5/beta-Catenin Signaling-Associated Mechanism	PLOS ONE			English	Article							INDUCED OSTEOPOROSIS; KNEE OSTEOARTHRITIS; FRACTURE REPAIR; RANK; MASS; OSTEOCLASTOGENESIS; STIMULATION; OSTEOBLASTS; METABOLISM; DISORDERS	Growing evidence has demonstrated that pulsed electromagnetic field (PEMF), as an alternative noninvasive method, could promote remarkable in vivo and in vitro osteogenesis. However, the exact mechanism of PEMF on osteopenia/osteoporosis is still poorly understood, which further limits the extensive clinical application of PEMF. In the present study, the efficiency of PEMF on osteoporotic bone microarchitecture and bone quality together with its associated signaling pathway mechanisms was systematically investigated in ovariectomized (OVX) rats. Thirty rats were equally assigned to the Control, OVX and OVX+PEMF groups. The OVX+PEMF group was subjected to daily 8-hour PEMF exposure with 15 Hz, 2.4 mT (peak value). After 10 weeks, the OVX+PEMF group exhibited significantly improved bone mass and bone architecture, evidenced by increased BMD, Tb.N, Tb.Th and BV/TV, and suppressed Tb.Sp and SMI levels in the MicroCT analysis. Three-point bending test suggests that PEMF attenuated the biomechanical strength deterioration of the OVX rat femora, evidenced by increased maximum load and elastic modulus. RT-PCR analysis demonstrated that PEMF exposure significantly promoted the overall gene expressions of Wnt1, LRP5 and b-catenin in the canonical Wnt signaling, but did not exhibit obvious impact on either RANKL or RANK gene expressions. Together, our present findings highlight that PEMF attenuated OVX-induced deterioration of bone microarchitecture and strength in rats by promoting the activation of Wnt/LRP5/b-catenin signaling rather than by inhibiting RANKL-RANK signaling. This study enriches our basic knowledge to the osteogenetic activity of PEMF, and may lead to more efficient and scientific clinical application of PEMF in inhibiting osteopenia/osteoporosis.	[Jing, Da; Li, Feijiang; Jiang, Maogang; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Cai, Jing] Fourth Mil Med Univ, Dept Endocrinol, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Yan] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shen, GH (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.	ghlulu@fmmu.edu.cn; luoerping@fmmu.edu.cn	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China [50377044, 51077128, 31000381]; Doctoral Thesis Foundation of the Fourth Military Medical University [2012D01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Thesis Foundation of the Fourth Military Medical University	The authors acknowledge support from the National Natural Science Foundation of China (grant numbers 50377044, 51077128, and 31000381) and the Doctoral Thesis Foundation of the Fourth Military Medical University (number 2012D01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623; BASSETT CAL, 1974, SCIENCE, V184, P575; BASSETT CAL, 1974, ANN NY ACAD SCI, V238, P242, DOI 10.1111/j.1749-6632.1974.tb26794.x; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; Campbell GM, 2008, OSTEOPOROSIS INT, V19, P1409, DOI 10.1007/s00198-008-0581-7; Chang K, 2003, BIOELECTROMAGNETICS, V24, P189, DOI 10.1002/bem.10078; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eyres KS, 1996, BONE, V18, P505, DOI 10.1016/8756-3282(96)00070-1; Ferreri SL, 2011, BONE, V48, P1095, DOI 10.1016/j.bone.2011.01.002; Garland D E, 1999, J Spinal Cord Med, V22, P239; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Jiang GZ, 2008, J BONE MINER METAB, V26, P130, DOI 10.1007/s00774-007-0811-7; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2010, BONE, V46, P487, DOI 10.1016/j.bone.2009.09.021; Kamei Y, 2005, J NUTR SCI VITAMINOL, V51, P110, DOI 10.3177/jnsv.51.110; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Ke HZ, 1998, BONE, V23, P249, DOI 10.1016/S8756-3282(98)00102-1; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Ko BS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/367698; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; Miyagawa K, 2011, J BONE MINER METAB, V29, P422, DOI 10.1007/s00774-010-0241-9; Musette P, 2010, OSTEOPOROSIS INT, V21, P723, DOI 10.1007/s00198-009-1097-5; Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rizzoli R, 2011, CALCIFIED TISSUE INT, V89, P91, DOI 10.1007/s00223-011-9499-8; RUBIN CT, 1989, J BONE JOINT SURG AM, V71A, P411, DOI 10.2106/00004623-198971030-00016; Shen WW, 2010, BIOELECTROMAGNETICS, V31, P113, DOI 10.1002/bem.20535; TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504; Thamsborg G, 2005, OSTEOARTHR CARTILAGE, V13, P575, DOI 10.1016/j.joca.2005.02.012; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang J, 2002, REV SCI INSTRUM, V73, P2175, DOI 10.1063/1.1471352; We SR, 2013, RHEUMATOLOGY, V52, P815, DOI 10.1093/rheumatology/kes063; Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756	47	47	52	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79377	10.1371/journal.pone.0079377	http://dx.doi.org/10.1371/journal.pone.0079377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244491	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800067
J	Li, V; Chui, L; Louie, L; Simor, A; Golding, GR; Louie, M				Li, Vincent; Chui, Linda; Louie, Lisa; Simor, Andrew; Golding, George R.; Louie, Marie			Cost-Effectiveness and Efficacy of spa, SCCmec, and PVL Genotyping of Methicillin-Resistant Staphylococcus aureus as Compared to Pulsed-Field Gel Electrophoresis	PLOS ONE			English	Article							EPIDEMIOLOGIC SURVEILLANCE; RAPID IDENTIFICATION; ECONOMIC BURDEN; TYPING METHODS; IMPACT; MEC	Pulsed-field gel electrophoresis (PFGE) is a valuable molecular typing assay used for methicillin-resistant Staphylococcus aureus (MRSA) surveillance and genotyping. However, there are several limitations associated with PFGE. In Alberta, Canada, the significant increase in the number of MRSA isolates submitted to the Provincial Laboratory for Public Health (ProvLab) for PFGE typing led to the need for an alternative genotyping method. In this study, we describe the transition from PFGE to Staphylococcus protein A (spa), Staphylococcal cassette chromosome (SCCmec), and Panton-Valentine leukocidin (PVL) typing. A total of 1915 clinical MRSA isolates collected from 2005 to 2009 were used to develop and validate an algorithm for assigning PFGE epidemic types using spa, SCCmec, and PVL typing and the resulting data was used to populate a new Alberta MRSA typing database. An additional 12620 clinical MRSA isolates collected from 2010 to 2012 as part of ongoing routine molecular testing at ProvLab were characterized using the new typing algorithm and the Alberta MRSA typing database. Switching to spa, SCCmec, and PVL from PFGE typing substantially reduced hands-on and turn-around times while maintaining historical PFGE epidemic type designations. This led to an approximate $77,000 reduction in costs from 2010 to 2012. PFGE typing is still required for a small subset of MRSA isolates that have spa types that are rare, novel, or associated with more than one PFGE epidemic type.	[Li, Vincent; Chui, Linda] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Chui, Linda] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Louie, Lisa; Simor, Andrew] Sunnybrook Hlth Sci Ctr, Dept Microbiol, Toronto, ON M4N 3M5, Canada; [Golding, George R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Louie, Marie] Prov Lab Publ Hlth, Calgary, AB, Canada; [Louie, Marie] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Alberta; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Public Health Agency of Canada; University of Calgary	Chui, L (corresponding author), Prov Lab Publ Hlth, Edmonton, AB, Canada.	Linda.Chui@albertahealthservices.ca			Alberta Health	Alberta Health	Alberta Health provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Golding George R, 2008, Can J Infect Dis Med Microbiol, V19, P273; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holland JL, 2000, J CLIN MICROBIOL, V38, P4108, DOI 10.1128/JCM.38.11.4108-4113.2000; Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871; Kock R, 2010, EURO SURVEILL, V15; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lee BY, 2013, CLIN MICROBIOL INFEC, V19, P528, DOI 10.1111/j.1469-0691.2012.03914.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Simor AE, 2002, J INFECT DIS, V186, P652, DOI 10.1086/342292; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Tang YW, 2000, J CLIN MICROBIOL, V38, P1347, DOI 10.1128/JCM.38.4.1347-1351.2000; Trindade P. A., 2003, Braz J Infect Dis, V7, P32, DOI 10.1590/S1413-86702003000100005	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79149	10.1371/journal.pone.0079149	http://dx.doi.org/10.1371/journal.pone.0079149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244440	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800035
J	Bom, RJM; van der Helm, JJ; Bruisten, SM; Grunberg, AW; Sabajo, LOA; van der Loeff, MFS; de Vries, HJC				Bom, Reinier J. M.; van der Helm, Jannie J.; Bruisten, Sylvia M.; Gruenberg, Antoon W.; Sabajo, Leslie O. A.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.			The Role of Surinamese Migrants in the Transmission of Chlamydia trachomatis between Paramaribo, Suriname and Amsterdam, The Netherlands	PLOS ONE			English	Article							DISPARITIES; INFECTIONS; PATTERNS; HIV	The large Surinamese migrant population in the Netherlands is a major risk group for urogenital Chlamydia trachomatis infection. Suriname, a former Dutch colony, also has a high prevalence of C. trachomatis. Surinamese migrants travel extensively between the Netherlands and Suriname. Our objective was to assess whether the Surinamese migrants in the Netherlands form a bridge population facilitating transmission of C. trachomatis between Suriname and the Netherlands. If so, joint prevention campaigns involving both countries might be required. Between March 2008 and July 2010, participants were recruited at clinics in Paramaribo, Suriname and in Amsterdam, the Netherlands. Participants were grouped as native Surinamese, native Dutch, Surinamese migrant, Dutch migrant, or Other, based on country of residence and country of birth of the participant and of their parents. Risk behavior, such as sexual mixing between ethnic groups, was recorded and C. trachomatis positive samples were typed through multilocus sequence typing (MLST). A minimum spanning tree of samples from 426 participants showed four MLST clusters. The MLST strain distribution of Surinamese migrants differed significantly from both the native Surinamese and Dutch populations, but was not an intermediate state between these two populations. Sexual mixing between the Surinamese migrants and the Dutch and Surinamese natives occurred frequently. Yet, the MLST cluster distribution did not differ significantly between participants who mixed and those who did not. Sexual mixing occurred between Surinamese migrants in Amsterdam and the native populations of Suriname and the Netherlands. These migrants, however, did not seem to form an effective bridge population for C. trachomatis transmission between the native populations. Although our data do not seem to justify the need for joint campaigns to reduce the transmission of C. trachomatis strains between both countries, intensified preventive campaigns to decrease the C. trachomatis burden are required, both in Suriname and in the Netherlands.	[Bom, Reinier J. M.; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van der Helm, Jannie J.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Dept Res, Amsterdam, Netherlands; [van der Helm, Jannie J.; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [Bruisten, Sylvia M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Gruenberg, Antoon W.] Lobi Fdn, Paramaribo, Suriname; [Sabajo, Leslie O. A.] Minist Hlth, Dermatol Serv, Paramaribo, Suriname, Suriname; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim; de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	de Vries, HJC (corresponding author), Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands.	h.j.devries@amc.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Helm, Jannie/0000-0002-4288-9544	Public Health Service of Amsterdam (GGD Amsterdam) [RD 2369]; AGIS healthcare insurance (RWZ), The Netherlands [1417000]	Public Health Service of Amsterdam (GGD Amsterdam); AGIS healthcare insurance (RWZ), The Netherlands(Netherlands Government)	This work was supported by the Public Health Service of Amsterdam (GGD Amsterdam, grant nr R&D 2369), and AGIS healthcare insurance (RWZ grant nr 1417000), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Aral SO, 2008, LANCET, V372, P337, DOI 10.1016/S0140-6736(08)61118-6; Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Fenton K, 1997, BRIT MED J, V314, P1703, DOI 10.1136/bmj.314.7096.1703; Ford K, 2002, SEX TRANSM DIS, V29, P13, DOI 10.1097/00007435-200201000-00003; Heijman TLJ, 2007, SEX TRANSM DIS, V34, P508, DOI 10.1097/01.olq.0000251209.52901.c3; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; The World Bank, SUR; Trienekens SC, 2012, 2010510012012 RIVM N; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; van Veen MG, 2010, SEX TRANSM DIS, V37, P416, DOI 10.1097/OLQ.0b013e3181cfcb34	17	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77977	10.1371/journal.pone.0077977	http://dx.doi.org/10.1371/journal.pone.0077977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236009	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700006
J	Chen, SX; Shen, XQ; Cheng, SQ; Li, PP; Du, JN; Chang, YX; Meng, HW				Chen, Shuxia; Shen, Xiaoqing; Cheng, Siqiong; Li, Panpan; Du, Junna; Chang, Yanxia; Meng, Huanwen			Evaluation of Garlic Cultivars for Polyphenolic Content and Antioxidant Properties	PLOS ONE			English	Article							ALLIUM-SATIVUM L.; IN-VITRO ANTIOXIDANT; INFRARED-SPECTROSCOPY; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; CAPACITY; ONION; FLAVONOIDS; VIVO	Two phenolic compound parameters (total phenolic and flavonoid contents) and 5 antioxidant parameters (DPPH [2, 2diphenyl- 1-picrylhydrazyl] radical scavenging activity, HRSC (hydroxyl radical scavenging capacity), FRAP (ferric ion reducing antioxidant power), CUPRAC (cupric ion reducing antioxidant capacity), and MCA (metal chelating activity) were measured in bulbs and bolts of 43 garlic cultivars. The bulbs of cultivar '74-x' had the highest phenolic content (total phenolic, flavonoids) and the strongest antioxidant capacity (DPPH, FRAP, and CUPRAC), followed by bulbs of cultivar 'Hanzhong purple'; the bulbs of cultivar 'Gailiang' had the lowest phenolic content and antioxidant capacity (FRAP, CUPRAC, MCA). The bolts of 'Hanzhong purple' also had higher phenolic content. Principal components analysis (PCA) separated the cultivars into 3 groups according to phenolic and flavonoid contents and strength of antioxidant activity. The first group had higher HRSC, FRAP, and flavonoid content; the second group had higher total phenolic content and MCA; some cultivars in the third group had higher HRSC and FRAP. All 8 test garlic bulb extracts successfully prevented Human Vascular Endothelial Cell death and significantly prevented reactive-oxygen species (ROS) formation in oxidative stress model, in which cultivar '74-x' had highest protection capability, following by cultivar 'Hanzhong purple', and the bulbs of cultivar 'No. 105 from Korea' had the lower protection capability against cell death and ROS formation. The protection capability in vivo of these garlic cultivars was consistent with their phenolic content and antioxidant capacity.	[Chen, Shuxia; Shen, Xiaoqing; Cheng, Siqiong; Du, Junna; Chang, Yanxia; Meng, Huanwen] Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Peoples R China; [Li, Panpan] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Chen, SX (corresponding author), Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Peoples R China.	shuxiachen@nwsuaf.edu.cn			National Natural Science Foundation of China [31071813]; National public welfare sectors (Agriculture) special research [200903018-7]; Northwest AF University [QN2011088]; Yulin City Science and Technology Bureau Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National public welfare sectors (Agriculture) special research; Northwest AF University; Yulin City Science and Technology Bureau Project	This work was supported by National Natural Science Foundation of China (No. 31071813), the National public welfare sectors (Agriculture) special research (200903018-7), Basic Scientific Research Fund from Northwest A&F University (No. QN2011088), and Yulin City Science and Technology Bureau Project. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjali Bhatt, 2013, Free Radicals and Antioxidants, V3, P30, DOI 10.1016/j.fra.2013.03.003; Apak R, 2008, MICROCHIM ACTA, V160, P413, DOI 10.1007/s00604-007-0777-0; Batcioglu K, 2012, EUR REV MED PHARMACO, V16, P47; Corzo-Martinez M, 2007, TRENDS FOOD SCI TECH, V18, P609, DOI 10.1016/j.tifs.2007.07.011; Dong QA, 2010, CHEM-BIOL INTERACT, V188, P31, DOI 10.1016/j.cbi.2010.06.006; Fenercioglu AK, 2010, J ENDOCRINOL INVEST, V33, P118, DOI 10.3275/6564; Ide N, 1997, J PHARM PHARMACOL, V49, P908, DOI 10.1111/j.2042-7158.1997.tb06134.x; Jastrzebski Z, 2007, FOOD CHEM TOXICOL, V45, P1626, DOI 10.1016/j.fct.2007.02.028; Kamenetsky R., 2007, Horticultural Reviews, V33, P123, DOI 10.1002/9780470168011.ch2; Khar A, 2011, FOOD CHEM, V128, P988, DOI 10.1016/j.foodchem.2011.04.004; Kim JS, 2013, J FUNCT FOODS, V5, P80, DOI 10.1016/j.jff.2012.08.006; Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016; LAWSON LD, 1996, GARLIC SCI THERAPEUT, P37; LU GY, 2001, RELATIONSHIP ECOTYPE, V29, P55; Lu GY, 1994, J CHANGJIANG VEGETAB, V2, P33; Lu XN, 2011, J AGR FOOD CHEM, V59, P5215, DOI 10.1021/jf201254f; Beato VM, 2011, PLANT FOOD HUM NUTR, V66, P218, DOI 10.1007/s11130-011-0236-2; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Morihara N, 2010, PHYTOTHER RES, V24, P602, DOI 10.1002/ptr.3008; Nencini C, 2011, PLANT FOOD HUM NUTR, V66, P11, DOI 10.1007/s11130-010-0204-2; Nuutila AM, 2003, FOOD CHEM, V81, P485, DOI 10.1016/S0308-8146(02)00476-4; Pardo JE, 2007, J FOOD QUALITY, V30, P609, DOI 10.1111/j.1745-4557.2007.00146.x; Park JH, 2009, PLANT FOOD HUM NUTR, V64, P244, DOI 10.1007/s11130-009-0132-1; Prakash D, 2007, FOOD CHEM, V102, P1389, DOI 10.1016/j.foodchem.2006.06.063; Prasad K, 1996, MOL CELL BIOCHEM, V154, P55, DOI 10.1007/BF00248461; Queiroz YS, 2009, FOOD CHEM, V115, P371, DOI 10.1016/j.foodchem.2008.11.105; Sellappan S, 2002, J AGR FOOD CHEM, V50, P5338, DOI 10.1021/jf020333a; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sterling SJ, 1997, ACTA HORTIC, V555, P63; Volk GM, 2009, HORTSCIENCE, V44, P1238, DOI 10.21273/HORTSCI.44.5.1238; WATERER D, 1994, CAN J PLANT SCI, V74, P611, DOI 10.4141/cjps94-110; Weiss N, 2013, J ETHNOPHARMACOL, V145, P162, DOI 10.1016/j.jep.2012.10.045; Xu BM, 2009, MODERN AGR SCI TECHN, V1, P19; Yiannakopoulou EC, 2012, J CARDIOVASC PHARM T, V17, P366, DOI 10.1177/1074248412447109; Yin MC, 1998, J AGR FOOD CHEM, V46, P4097, DOI 10.1021/jf980344x; Zhang CY, 2008, J AGR FOOD CHEM, V56, P8268, DOI 10.1021/jf801830z	36	66	69	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79730	10.1371/journal.pone.0079730	http://dx.doi.org/10.1371/journal.pone.0079730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232741	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700156
J	Clerc, P; Young, CA; Bordt, EA; Grigore, AM; Fiskum, G; Polster, BM				Clerc, Pascaline; Young, Christina A.; Bordt, Evan A.; Grigore, Alina M.; Fiskum, Gary; Polster, Brian M.			Magnesium Sulfate Protects Against the Bioenergetic Consequences of Chronic Glutamate Receptor Stimulation	PLOS ONE			English	Article							SPARE RESPIRATORY CAPACITY; TRAUMATIC BRAIN-INJURY; NEURONAL CULTURES; OXIDATIVE STRESS; EXCITOTOXICITY; CALCIUM; DEATH; ACTIVATION; APOPTOSIS; MITOCHONDRIA	Extracellular glutamate is elevated following brain ischemia or trauma and contributes to neuronal injury. We tested the hypothesis that magnesium sulfate (MgSO4, 3 mM) protects against metabolic failure caused by excitotoxic glutamate exposure. Rat cortical neuron preparations treated in medium already containing a physiological concentration of Mg2+ (1 mM) could be segregated based on their response to glutamate (100 mu M). Type I preparations responded with a decrease or small transient increase in oxygen consumption rate (OCR). Type II neurons responded with >50% stimulation in OCR, indicating a robust response to increased energy demand without immediate toxicity. Pre-treatment with MgSO4 improved the initial bioenergetic response to glutamate and ameliorated subsequent loss of spare respiratory capacity, measured following addition of the uncoupler FCCP, in Type I but not Type II neurons. Spare respiratory capacity in Type I neurons was also improved by incubation with MgSO4 or NMDA receptor antagonist MK801 in the absence of glutamate treatment. This finding indicates that the major difference between Type I and Type II preparations is the amount of endogenous glutamate receptor activity. Incubation of Type II neurons with 5 mM glutamate prior to excitotoxic (100 mM) glutamate exposure recapitulated a Type I phenotype. MgSO4 protected against an excitotoxic glutamate-induced drop in neuronal ATP both with and without prior 5 mu M glutamate exposure. Results indicate that MgSO4 protects against chronic moderate glutamate receptor stimulation and preserves cellular ATP following treatment with excitotoxic glutamate.	[Polster, Brian M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Polster, BM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institute of Neurological Disorders and Stroke; National Institutes of Health [R01NS064978, P01HD016596]; National Institute of Child Health and Human Development/; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development/(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Neurological Disorders and Stroke/the National Institutes of Health (www.nih.gov, grant number R01NS064978) and by the National Institute of Child Health and Human Development/the National Institutes of Health (www.nih.gov, grant number P01HD016596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Deshpande LS, 2008, EUR J PHARMACOL, V583, P73, DOI 10.1016/j.ejphar.2008.01.025; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Gleichmann M, 2009, J NEUROCHEM, V109, P644, DOI 10.1111/j.1471-4159.2009.05997.x; Greene MF, 2003, NEW ENGL J MED, V348, P275, DOI 10.1056/NEJMp020166; Hallak M, 1998, MAGNESIUM RES, V11, P117; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Kovac S, 2012, J CELL SCI, V125, P1796, DOI 10.1242/jcs.099176; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Panov A, 1996, BIOCHEMISTRY-US, V35, P427, DOI 10.1021/bi952101t; Rodriguez-Zavala JS, 1998, J BIOL CHEM, V273, P7850, DOI 10.1074/jbc.273.14.7850; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu Minhui, 2002, Chin J Traumatol, V5, P361; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022	31	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79982	10.1371/journal.pone.0079982	http://dx.doi.org/10.1371/journal.pone.0079982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236167	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700168
J	Cui, X; Chopp, M; Zacharek, A; Ning, RZ; Ding, XS; Roberts, C; Chen, JL				Cui, Xu; Chopp, Michael; Zacharek, Alex; Ning, Ruizhuo; Ding, Xiaoshuang; Roberts, Cynthia; Chen, Jieli			Endothelial Nitric Oxide Synthase Regulates White Matter Changes via the BDNF/TrkB Pathway after Stroke in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; GROWTH-FACTOR; UP-REGULATION; FACTOR BDNF; BRAIN; CELLS; ASTROCYTES; ISCHEMIA; OLIGODENDROCYTES; ACTIVATION	Stroke induced white matter (WM) damage is associated with neurological functional deficits, but the underlying mechanisms are not well understood. In this study, we investigate whether endothelial nitric oxide synthase (eNOS) affects WM-damage post-stroke. Adult male wild-type (WT) and eNOS knockout (eNOS(-/-)) mice were subjected to middle cerebral artery occlusion. Functional evaluation, infarct volume measurement, immunostaining and primary cortical cell culture were performed. To obtain insight into the mechanisms underlying the effects of eNOS(-/-) on WM-damage, measurement of eNOS, brain-derived neurotrophic factor (BDNF) and its receptor TrkB in vivo and in vitro were also performed. No significant differences were detected in the infarction volume, myelin density in the ipsilateral striatal WM-bundles and myelin-based protein expression in the cerebral ischemic border between WT and eNOS(-/-) mice. However, eNOS(-/-) mice showed significantly: 1) decreased functional outcome, concurrent with decreases of total axon density and phosphorylated high-molecular weight neurofilament density in the ipsilateral striatal WM-bundles. Correlation analysis showed that axon density is significantly positive correlated with neurological functional outcome; 2) decreased numbers of oligodendrocytes / oligodendrocyte progenitor cells in the ipsilateral striatum; 3) decreased synaptophysin, BDNF and TrkB expression in the ischemic border compared with WT mice after stroke (n = 12/group, p < 0.05). Primary cortical cell culture confirmed that the decrease of neuronal neurite outgrowth in the neurons derived from eNOS(-/-) mice is mediated by the reduction of BDNF/TrkB (n = 6/group, p < 0.05). Our data show that eNOS plays a critical role in WM-damage after stroke, and eNOS(-/-)-induced decreases in the BDNF/TrkB pathway may contribute to increased WM-damage, and thereby decrease functional outcome.	[Cui, Xu; Chopp, Michael; Zacharek, Alex; Ning, Ruizhuo; Ding, Xiaoshuang; Roberts, Cynthia; Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Cui, Xu/0000-0002-6937-6191	National Institute on Aging [RO1 AG031811, RO1 AG037506, 1R41NS064708]; American Heart Association [09GRNT2300151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS064708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031811, R01AG037506] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging RO1 AG031811 (JC) (http://www.nia.nih.gov/), National Institute on Aging RO1 AG037506 (M. C.) and 1R41NS064708 (JC) (http://www.ninds.nih.gov/), and American Heart Association grant 09GRNT2300151 (JC) (http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix JJP, 2006, EUR NEUROL, V56, P74, DOI 10.1159/000095543; Alix JJP, 2011, NEUROLOGY, V76, P397, DOI 10.1212/WNL.0b013e3182088273; Amin-Hanjani S, 2001, STROKE, V32, P980, DOI 10.1161/01.STR.32.4.980; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bakiri Y, 2011, J PHYSIOL-LONDON, V589, P559, DOI 10.1113/jphysiol.2010.201376; Barna M, 1996, VIROLOGY, V223, P331, DOI 10.1006/viro.1996.0484; Ben Achour S, 2012, NEUROCHEM RES, V37, P2464, DOI 10.1007/s11064-012-0807-0; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Chen JL, 2009, STROKE, V40, P2532, DOI 10.1161/STROKEAHA.108.545095; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen MJ, 2006, BRAIN RES BULL, V68, P257, DOI 10.1016/j.brainresbull.2005.08.013; Cui X, 2009, NEUROSCIENCE, V159, P744, DOI 10.1016/j.neuroscience.2008.12.055; Cui X, 2012, CELL TRANSPLANT; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Djalali S, 2005, J NEUROCHEM, V92, P616, DOI 10.1111/j.1471-4159.2004.02911.x; Du YZ, 2006, J NEUROSCI RES, V84, P1692, DOI 10.1002/jnr.21080; Du YZ, 2003, DEV NEUROSCI-BASEL, V25, P116, DOI 10.1159/000072261; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Dziewulska D, 2004, FOLIA NEUROPATHOL, V42, P75; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Gabbott PLA, 1996, BRAIN RES, V714, P135, DOI 10.1016/0006-8993(95)01509-4; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hernandez R, 2004, NEUROSCIENCE, V126, P879, DOI 10.1016/j.neuroscience.2004.04.010; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kovalchuk Y, 2004, CURR OPIN NEUROBIOL, V14, P558, DOI 10.1016/j.conb.2004.08.014; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Madinier A, 2013, NEUROSCIENCE, V231, P169, DOI 10.1016/j.neuroscience.2012.11.054; Matthias GKaE, 2008, ENOS STROKE PREVENTI, P537; McIver SR, 2010, NEUROSCIENCE, V169, P1364, DOI 10.1016/j.neuroscience.2010.04.070; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; PERSSON LA, 1981, J NEUROCYTOL, V10, P169, DOI 10.1007/BF01257965; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; RUDGE JS, 1995, J NEUROSCI, V15, P6856; Runyan SA, 2009, EXP NEUROL, V216, P95, DOI 10.1016/j.expneurol.2008.11.015; Shi XZ, 2010, BRAIN RES, V1317, P257, DOI 10.1016/j.brainres.2009.12.061; Sozmen EG, 2009, J NEUROSCI METH, V180, P261, DOI 10.1016/j.jneumeth.2009.03.017; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang H, 2006, EUR J NEUROSCI, V23, P1665, DOI 10.1111/j.1460-9568.2006.04682.x; Wiencken AE, 1999, GLIA, V26, P280; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yuhanna IS, 1999, AM J RESP CELL MOL, V21, P629, DOI 10.1165/ajrcmb.21.5.3749; Zheng J, 1999, ENDOCRINOLOGY, V140, P1399, DOI 10.1210/en.140.3.1399	60	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80358	10.1371/journal.pone.0080358	http://dx.doi.org/10.1371/journal.pone.0080358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236179	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700180
J	Dehnhard, N; Ludynia, K; Poisbleau, M; Demongin, L; Quillfeldt, P				Dehnhard, Nina; Ludynia, Katrin; Poisbleau, Maud; Demongin, Laurent; Quillfeldt, Petra			Good Days, Bad Days: Wind as a Driver of Foraging Success in a Flightless Seabird, the Southern Rockhopper Penguin	PLOS ONE			English	Article							EUDYPTES-CHRYSOCOME-CHRYSOCOME; BREEDING SUCCESS; POPULATION TRENDS; DIET COMPOSITION; C.-CHRYSOCOME; KING PENGUINS; EL-NINO; ISLAND; PRODUCTIVITY; SURVIVAL	Due to their restricted foraging range, flightless seabirds are ideal models to study the short-term variability in foraging success in response to environmentally driven food availability. Wind can be a driver of upwelling and food abundance in marine ecosystems such as the Southern Ocean, where wind regime changes due to global warming may have important ecological consequences. Southern rockhopper penguins (Eudyptes chrysocome) have undergone a dramatic population decline in the past decades, potentially due to changing environmental conditions. We used a weighbridge system to record daily foraging mass gain (the difference in mean mass of adults leaving the colony in the morning and returning to the colony in the evening) of adult penguins during the chick rearing in two breeding seasons. We related the day-to-day variability in foraging mass gain to ocean wind conditions (wind direction and wind speed) and tested for a relationship between wind speed and sea surface temperature anomaly (SSTA). Foraging mass gain was highly variable among days, but did not differ between breeding seasons, chick rearing stages (guard and creche) and sexes. It was strongly correlated between males and females, indicating synchronous changes among days. There was a significant interaction of wind direction and wind speed on daily foraging mass gain. Foraging mass gain was highest under moderate to strong winds from westerly directions and under weak winds from easterly directions, while decreasing under stronger easterly winds and storm conditions. Ocean wind speed showed a negative correlation with daily SSTA, suggesting that winds particularly from westerly directions might enhance upwelling and consequently the prey availability in the penguins' foraging areas. Our data emphasize the importance of small-scale, wind-induced patterns in prey availability on foraging success, a widely neglected aspect in seabird foraging studies, which might become more important with increasing changes in climatic variability.	[Dehnhard, Nina; Ludynia, Katrin; Poisbleau, Maud; Demongin, Laurent; Quillfeldt, Petra] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell am Bodensee, Germany; [Ludynia, Katrin] Univ Cape Town, Anim Demog Unit, ZA-7925 Cape Town, South Africa; [Poisbleau, Maud; Demongin, Laurent] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Quillfeldt, Petra] Univ Giessen, Behav Ecol & Ecophysiol Grp, D-35390 Giessen, Germany	Max Planck Society; University of Cape Town; University of Antwerp; Justus Liebig University Giessen	Dehnhard, N (corresponding author), Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell am Bodensee, Germany.	dehnhard@orn.mpg.de	Dehnhard, Nina/H-6160-2016; Poisbleau, Maud/B-9968-2014; Quillfeldt, Petra/A-9549-2009	Dehnhard, Nina/0000-0002-4182-2698; Poisbleau, Maud/0000-0002-0729-3251; Quillfeldt, Petra/0000-0002-4450-8688; Ludynia, Katrin/0000-0002-0353-1929; Chiaradia, Andre/0000-0002-6178-4211	Deutsche Forschungsgemeinschaft (DFG) [Qu 148/1-ff]; Overseas Territories Environment Programme (OTEP) [FAL 603]; Environmental Studies Budget grant from the Falkland Islands Government	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Overseas Territories Environment Programme (OTEP); Environmental Studies Budget grant from the Falkland Islands Government	This study was funded by a grant provided by the Deutsche Forschungsgemeinschaft (DFG, Qu 148/1-ff), Overseas Territories Environment Programme (OTEP, FAL 603) and an Environmental Studies Budget grant from the Falkland Islands Government. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ahrens C. D., 2011, ESSENTIALS METEOROLO; Arkhipkin A, 2010, FISH RES, V105, P156, DOI 10.1016/j.fishres.2010.03.022; Auth TD, 2011, FISH OCEANOGR, V20, P314, DOI 10.1111/j.1365-2419.2011.00586.x; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Baylis AMM, 2013, POLAR BIOL, V36, P1007, DOI 10.1007/s00300-013-1324-6; Birdlife International, 2010, P INT WORKSH ED 3 5; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 1998, CONDOR, V100, P245, DOI 10.2307/1370265; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Clarke JR, 2001, POLAR BIOL, V24, P16, DOI 10.1007/s003000000168; Clausen AP, 2002, AQUAT CONSERV, V12, P51, DOI 10.1002/aqc.476; Croxall J. P., 1999, Marine Ornithology, V27, P1; CROXALL JP, 1985, J ZOOL, V206, P485; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; CUNNINGHAM DM, 1994, EMU, V94, P27, DOI 10.1071/MU9940027; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Dehnhard N, 2013, AQUAT CONSERV, V23, P777, DOI 10.1002/aqc.2331; Erwin CA, 2007, MAR ECOL PROG SER, V331, P255, DOI 10.3354/meps331255; Frederiksen M, 2007, MAR ECOL PROG SER, V350, P137, DOI 10.3354/meps07126; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Fyfe JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025332; HEATH RGM, 1985, J ZOOL, V205, P91; Lagadeuc Y, 1997, J PLANKTON RES, V19, P1183, DOI 10.1093/plankt/19.9.1183; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Ludynia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050429; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Matley JK, 2012, MAR ECOL PROG SER, V450, P219, DOI 10.3354/meps09561; MONTEVECCHI WA, 1995, MAR ECOL PROG SER, V117, P1, DOI 10.3354/meps117001; Morrison KW, 2009, CONDOR, V111, P433, DOI 10.1525/cond.2009.080099; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; PIEROTTI R, 1990, BIOSCIENCE, V40, P568, DOI 10.2307/1311297; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Putz K, 2003, WATERBIRDS, V26, P169, DOI 10.1675/1524-4695(2003)026[0169:ROHRPP]2.0.CO;2; Putz K, 2001, POLAR BIOL, V24, P793, DOI 10.1007/s003000100293; Quilifeldt P, 2007, J AVIAN BIOL, V38, P298, DOI 10.1111/j.2007.0908-8857.03846.x; Quillfeldt P, 2001, ANTARCT SCI, V13, P400, DOI 10.1017/S0954102001000566; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Rey AR, 2007, IBIS, V149, P826; Rey AR, 2005, POLAR BIOL, V28, P132, DOI 10.1007/s00300-004-0668-3; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Stearns S.C., 1992, pi; STRANGE I J, 1982, Gerfaut, V72, P137; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; THOMPSON KR, 1994, ANTARCT SCI, V6, P269, DOI 10.1017/S0954102094000404; Upton J, 2002, AQUAT CONSERV, V12, P15, DOI 10.1002/aqc.496; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Williams T.D., 1995, PENGUINS; Wilson Rory P., 1999, Marine Ornithology, V27, P85; Wood S, 2013, PACKAGE MGCV R PACKA; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Zuur Alain F., 2009, P1	62	32	32	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79487	10.1371/journal.pone.0079487	http://dx.doi.org/10.1371/journal.pone.0079487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236139	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700138
J	Cano, ARG; Fernandez, MH; Alvarez-Sierra, MA				Gomez Cano, Ana Rosa; Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.			Dietary Ecology of Murinae (Muridae, Rodentia): A Geometric Morphometric Approach	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; PHYLOGENY; SHAPE; PATTERNS; CLIMATE; TRENDS; DIVERSIFICATION; REGION	Murine rodents represent a highly diverse group, which displays great ecological versatility. In the present paper we analyse the relationship between dental morphology, on one hand, using geometric morphometrics based upon the outline of first upper molar and the dietary preference of extant murine genera, on the other. This ecomorphological study of extant murine rodents demonstrates that dietary groups can be distinguished with the use of a quantitative geometric morphometric approach based on first upper molar outline. A discriminant analysis of the geometric morphometric variables of the first upper molars enables us to infer the dietary preferences of extinct murine genera from the Iberian Peninsula. Most of the extinct genera were omnivore; only Stephanomys showed a pattern of dental morphology alike that of the herbivore genera.	[Gomez Cano, Ana Rosa; Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Cano, ARG (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain.	argomez@ucm.es	Gómez Cano, Ana Rosa/G-9332-2014; Fernández, Manuel Hernández/I-5012-2013	Gómez Cano, Ana Rosa/0000-0001-5351-4185; Fernández, Manuel Hernández/0000-0001-5640-9647; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887	Spanish Ministry of Tecnology and Science [CGL2006-01773/BTE, CGL-2008-05813-C02-01/BTE, CGL-2010-19116/BOS, CGL-2011-28877/BTE]; Spanish Ministry of Education in the program of Formacion de Profesorado Universitario	Spanish Ministry of Tecnology and Science; Spanish Ministry of Education in the program of Formacion de Profesorado Universitario(German Research Foundation (DFG))	This research was supported by projects of the Spanish Ministry of Tecnology and Science CGL2006-01773/BTE, CGL-2008-05813-C02-01/BTE, CGL-2010-19116/BOS and CGL-2011-28877/BTE, as well as by a predoctoral contract of the Spanish Ministry of Education in the program of Formacion de Profesorado Universitario to A. R. G. C. During this study, M. H. F. availed of a UCM contract from the Ramon y Cajal Program, belonging to the Spanish Ministry of Education and Science. This research is a contribution by the research group UCM-910607 on Evolution of Cenozoic Mammals and Continental Palaeoenvironments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auffray Jean-Christophe, 2009, Kasetsart Journal Natural Sciences, V43, P83; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; Carrion JS, 2010, J ARID ENVIRON, V74, P731, DOI 10.1016/j.jaridenv.2008.11.014; Carrion JS, 2010, REV PALAEOBOT PALYNO, V162, P227, DOI 10.1016/j.revpalbo.2010.07.002; Casanovas-Vilar I, 2011, J HUM EVOL, V61, P42, DOI 10.1016/j.jhevol.2011.01.003; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Costeur L, 2007, GEOBIOS-LYON, V40, P775, DOI 10.1016/j.geobios.2007.07.001; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; Cucchi T, 2006, ZOOTAXA, P1; Dam JA Van, 1997, GEOLOGICA ULTRAIECTI, V156; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Garcia-Alix A, 2008, PALAEOGEOGR PALAEOCL, V265, P214, DOI 10.1016/j.palaeo.2008.04.005; Cano ARG, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-94; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P78; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hautier L, 2012, J MORPHOL, V273, P1319, DOI 10.1002/jmor.20061; Hernandez Fernandez M, 2005, ANALISIS PALEOCLIMAT; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Ledevin R, 2010, BIOL J LINN SOC, V100, P681, DOI 10.1111/j.1095-8312.2010.01445.x; Lopez-Martinez N., 1998, Journal of Mammalian Evolution, V5, P185, DOI 10.1023/A:1020508428859; Martin SA., 2010, DENT ADAPTATION MURI; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P230, DOI 10.1016/j.palaeo.2011.02.003; McGuire J, 2009, QUATERN INT, P1; Mein P, 2009, SCRIPTA GEOLOGICA, V103, P41; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Miljutin Andrei, 2011, Acta Zoologica Lituanica, V21, P192, DOI 10.2478/v10043-011-0024-0; Misonne X, 1969, BELGUIQUE ANN SERIE, V8, P1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 1999, J BIOGEOGRAPHY; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renvoise E, 2009, EVOLUTION, V63, P1327, DOI 10.1111/j.1558-5646.2009.00639.x; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Rohlf FJ, 2010, TPSDIG2 THIN PLATE S; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Sanz de Siria Catalan A., 1994, ACTA GEOL HISP, V29, P169; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sese C., 2006, Estudios Geologicos (Madrid), V62, P429; Swiderski Donald L., 2000, Hystrix, V11, P49; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; van Dam JA, 1999, PALAEOGEOGR PALAEOCL, V151, P267, DOI 10.1016/S0031-0182(99)00015-2; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; van Zon L, 2011, SEASONALITY SURVAIVA; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; VRBA ES, 1980, S AFR J SCI, V76, P61; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141	62	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79080	10.1371/journal.pone.0079080	http://dx.doi.org/10.1371/journal.pone.0079080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236090	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000327254700088
J	Laguerre, M; Sabi, E; Daly, M; Stockley, J; Nurden, P; Pillois, X; Nurden, AT				Laguerre, Michel; Sabi, Essa; Daly, Martina; Stockley, Jacqueline; Nurden, Paquita; Pillois, Xavier; Nurden, Alan T.			Molecular Dynamics Analysis of a Novel beta 3 Pro189Ser Mutation in a Patient with Glanzmann Thrombasthenia Differentially Affecting alpha IIb beta 3 and alpha v beta 3 Expression	PLOS ONE			English	Article							INTEGRIN BETA(3) GENE; GLYCOPROTEIN-IIIA; ALPHA-IIB; EXTRACELLULAR SEGMENT; MISSENSE MUTATIONS; CRYSTAL-STRUCTURE; COMPLEX; SUBUNIT; PLATELETS; RECEPTOR	Mutations in ITGA2B and ITGB3 cause Glanzmann thrombasthenia, an inherited bleeding disorder in which platelets fail to aggregate when stimulated. Whereas an absence of expression or qualitative defects of alpha IIb beta 3 mainly affect platelets and megakaryocytes, alpha v beta 3 has a widespread tissue distribution. Little is known of how amino acid substitutions of beta 3 comparatively affect the expression and structure of both integrins. We now report computer modelling including molecular dynamics simulations of extracellular head domains of alpha IIb beta 3 and alpha v beta 3 to determine the role of a novel b3 Pro189Ser (P163S in the mature protein) substitution that abrogates alpha IIb beta 3 expression in platelets while allowing synthesis of alpha v beta 3. Transfection of wild-type and mutated integrins in CHO cells confirmed that only alpha v beta 3 surface expression was maintained. Modeling initially confirmed that replacement of alpha II beta by alpha v in the dimer results in a significant decrease in surface contacts at the subunit interface. For alpha IIb beta 3, the presence of beta 3S163 specifically displaces an alpha-helix starting at position 259 and interacting with beta 3R261 while there is a moderate 11% increase in intra-subunit H-bonds and a very weak decrease in the global H-bond network. In contrast, for alpha v beta 3, S163 has different effects with b3R261 coming deeper into the propeller with a 43% increase in intra-subunit H-bonds but with little effect on the global H-bond network. Compared to the WT integrins, the P163S mutation induces a small increase in the inter-subunit fluctuations for alpha IIb beta 3 but a more rigid structure for alpha v beta 3. Overall, this mutation stabilizes alpha v beta 3 despite preventing alpha IIb beta 3 expression.	[Laguerre, Michel] Inst Europeen Chim & Biol, Pessac, France; [Sabi, Essa; Daly, Martina; Stockley, Jacqueline] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Nurden, Paquita; Nurden, Alan T.] Hop Xavier Arnozan, Plateforme Technol & Innovat Biomed, Pessac, France; [Nurden, Paquita] Hop La Timone, Ctr Hosp Univ Marseille, Marseille, France; [Pillois, Xavier] Hop Haut Leveque, INSERM, U1034, Pessac, France	University of Sheffield; CHU Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Nurden, AT (corresponding author), Hop Xavier Arnozan, Plateforme Technol & Innovat Biomed, Pessac, France.	Nurdenat@gmail.com		Stockley, Jacqueline/0000-0001-6601-5107	Genoscope d'Evry [Nu AP07/08.42]; INSERM [ANR-08-GENO-028-03]	Genoscope d'Evry; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was financed by contract Nu AP07/08.42 with the Genoscope d'Evry and from INSERM (ANR-08-GENO-028-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambo H, 1998, BIOCHEM BIOPH RES CO, V251, P763, DOI 10.1006/bbrc.1998.9526; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calvete J, 1999, BIOCHEM J, V74, P63; COLLER BS, 1991, BLOOD, V78, P2603; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DJAFFAR I, 1993, HUM MOL GENET, V2, P2183, DOI 10.1093/hmg/2.12.2183; Filizola M, 2004, J BIOL CHEM, V279, P24624, DOI 10.1074/jbc.M400243200; Fiore M, 2012, HAEMOPHILIA, V18, pe201, DOI 10.1111/j.1365-2516.2011.02744.x; GEORGE JN, 1990, BLOOD, V75, P1383; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Hauschner H, 2010, BLOOD, V115, P4542, DOI 10.1182/blood-2009-10-251066; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson DE, 1998, THROMB HAEMOSTASIS, V80, P42, DOI 10.1055/s-0037-1615136; Jacquelin B, 2003, J THROMB HAEMOST, V1, P573, DOI 10.1046/j.1538-7836.2003.00107.x; Jallu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047304; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Mansour W, 2011, J THROMB HAEMOST, V9, P192, DOI 10.1111/j.1538-7836.2010.04087.x; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2012, J BIOL CHEM, V287, P8879, DOI 10.1074/jbc.M111.311043; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Nelson EJR, 2005, J THROMB HAEMOST, V3, P2773, DOI 10.1111/j.1538-7836.2005.01593.x; Nurden AT, 2013, SEMIN THROMB HEMOST, V39, P642, DOI 10.1055/s-0033-1353393; Nurden AT, 2012, EXPERT REV HEMATOL, V5, P487, DOI [10.1586/EHM.12.46, 10.1586/ehm.12.46]; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden AT, 2002, PLATELETS, V13, P101, DOI 10.1080/09537100220122466; NURDEN AT, 1985, BLOOD, V65, P1021; NURDEN P, 1995, J CLIN INVEST, V95, P1612, DOI 10.1172/JCI117835; Nurden P, 2004, BLOOD, V104, P107, DOI 10.1182/blood-2003-11-3842; Poujol C, 1997, BRIT J HAEMATOL, V96, P823, DOI 10.1046/j.1365-2141.1997.d01-2109.x; Tadokoro S, 2002, BLOOD, V99, P931, DOI 10.1182/blood.V99.3.931; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; Ward CM, 2000, BLOOD, V96, P161, DOI 10.1182/blood.V96.1.161.013k50_161_169; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78683	10.1371/journal.pone.0078683	http://dx.doi.org/10.1371/journal.pone.0078683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236036	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700033
J	Liang, P; Feng, B; Zhou, XG; Gao, XW				Liang, Pei; Feng, Bing; Zhou, Xuguo; Gao, Xiwu			Identification and Developmental Profiling of microRNAs in Diamondback Moth, Plutellaxylostella (L.)	PLOS ONE			English	Article							REVEALS; TRANSCRIPTOME; PREDICTION; MANAGEMENT; INSIGHTS; RNAS	MicroRNAs (miRNAs) are a group of small RNAs involved in various biological processes through negative regulation of mRNAs at the post-transcriptional level. Although miRNA profiles have been documented in over two dozen insect species, few are agricultural pests. In this study, both conserved and novel miRNAs in the diamondback moth, Plutella xylostella L., a devastating insect pest of cruciferous crops worldwide, were documented. High-throughput sequencing of a small RNA library constructed from a mixed life stages of P. xylostella, including eggs, 1st to 4th (last) instar larvae, pupae and adults, identified 384 miRNAs, of which 174 were P. xylostella specific. In addition, temporal expressions of 234 miRNAs at various developmental stages were investigated using a customized microarray analysis. Among the 91 differentially expressed miRNAs, qRT-PCR analysis was used to validate highly expressed miRNAs at each stage. The combined results not only systematically document miRNA profiles in an agriculturally important insect pest, but also provide molecular targets for future functional analysis and, ultimately, genetic-based pest control practice.	[Liang, Pei; Feng, Bing; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; gaoxiwu@263.net.cn	Liang, Pei/S-7748-2019	Liang, Pei/0000-0002-3083-8918	National Basic Research Programme of China [2012CB114103]; National Natural Science Foundation of China [30671389, 30971941, 31171873]	National Basic Research Programme of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Programme of China (2012CB114103), and the National Natural Science Foundation of China (30671389, 30971941, 31171873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Luo QB, 2008, J GENET GENOMICS, V35, P349, DOI 10.1016/S1673-8527(08)60051-X; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sathyamurthy G, 2010, INT J INSECT SCI, V2, P1; Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Smibert P, 2010, SEMIN CELL DEV BIOL, V21, P745, DOI 10.1016/j.semcdb.2010.03.001; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Tang BZ, 2011, PESTIC BIOCHEM PHYS, V101, P80, DOI 10.1016/j.pestbp.2011.08.003; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	41	28	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78787	10.1371/journal.pone.0078787	http://dx.doi.org/10.1371/journal.pone.0078787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236051	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700048
J	Montefusco, S; Esposito, R; D'Andrea, L; Monti, MC; Dunne, C; Dolan, B; Tosco, A; Marzullo, L; Clyne, M				Montefusco, Sandro; Esposito, Roberta; D'Andrea, Luca; Monti, Maria Chiara; Dunne, Ciara; Dolan, Brendan; Tosco, Alessandra; Marzullo, Liberato; Clyne, Marguerite			Copper Promotes TFF1-Mediated Helicobacter pylori Colonization	PLOS ONE			English	Article							TREFOIL PROTEIN TFF1; GASTRIC-CANCER; SIGNALING PATHWAYS; MUCOSA; MUTATIONS; INTERACTS; INVASION; MUC5AC; CELLS	The trefoil peptides (TFF1, TFF2 and TFF3) are a family of small highly conserved proteins that play an essential role in epithelial regeneration within the gastrointestinal tract, where they are mainly expressed. TFF1 expression is strongly induced after mucosal injury and it has been proposed that tff1 functions as a gastric tumor suppressor gene. Several studies confirm that tff1 expression is frequently lost in gastric cancer because of deletions, mutations or methylation of the tff1 promoter. Infection by Helicobacter pylori (H. pylori) results in chronic gastritis and it can lead to the development of gastric or duodenal ulcers. Moreover, it is known that there is a strong link to the development of gastric cancer. It has been shown that H. pylori interacts with the dimeric form of TFF1 and that the rough form of lipopolysaccharide mediates this interaction. We have previously reported that the carboxy-terminus of TFF1 is able to specifically bind copper ions (Cu) and that Cu binding favours the homodimerization of the peptide, thus enhancing its motogenic activity. Here, we report that the Cu-TFF1 cuprocomplex promotes adherence of H. pylori to epithelial cells. Adherence of H. pylori to gastric adenocarcinoma cells, AGS AC1 cells, induced to hyper-express TFF1 was enhanced compared to noninduced cells. Copper further promoted this interaction. A H. pylori mutant unable to bind TFF1 did not show enhanced infection of induced cells. Cu treatment induced a thickening of the mucus layer produced by the colorectal adenocarcinoma mucus secreting, goblet cells, HT29-E12 and promoted H. pylori colonisation. Finally, SPR analysis shows that the C-terminus of TFF1, involved in the binding of copper, is also able to selectively bind H. pylori RF-LPS.	[Montefusco, Sandro; Esposito, Roberta; Tosco, Alessandra; Marzullo, Liberato] Univ Salerno, Dept Pharm, Div Biomed Arturo Leone, Fisciano, SA, Italy; [D'Andrea, Luca] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Div Chem & Chem Technol Luigi Gomez Paloma, Fisciano, SA, Italy; [Dunne, Ciara; Dolan, Brendan; Clyne, Marguerite] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Salerno; University College Dublin	Marzullo, L (corresponding author), Univ Salerno, Dept Pharm, Div Biomed Arturo Leone, Fisciano, SA, Italy.	marzullo@unisa.it	Dolan, Brendan/AAE-6544-2022; Marzullo, Liberato/C-4408-2008; Clyne, Marguerite M/H-4179-2012; Dolan, Brendan/AAK-6817-2021; Tosco, Alessandra/F-6773-2011	Dolan, Brendan/0000-0001-9062-3882; Marzullo, Liberato/0000-0001-6133-4483; Clyne, Marguerite M/0000-0003-2547-9129; Dolan, Brendan/0000-0001-9062-3882; Tosco, Alessandra/0000-0002-5443-1565; D'ANDREA, LUCA DOMENICO/0000-0002-2589-216X	University of Salerno Intramural funds FARB; Project NUME-MiPAAF; MIUR	University of Salerno Intramural funds FARB; Project NUME-MiPAAF; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following grants: University of Salerno Intramural funds FARB, Project NUME-MiPAAF, and MIUR PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens I, 2001, PHARM RES-DORDR, V18, P1138, DOI 10.1023/A:1010974909998; Chandan V, 2007, BIOCHEM CELL BIOL, V85, P582, DOI 10.1139/O07-056; Clyne M, 2004, P NATL ACAD SCI USA, V101, P7409, DOI 10.1073/pnas.0308489101; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Dolan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047300; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Keely S, 2008, PHARM RES-DORDR, V25, P1193, DOI 10.1007/s11095-007-9501-3; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Reeves EP, 2008, GASTROENTEROLOGY, V135, P2043, DOI 10.1053/j.gastro.2008.08.049; Ruchaud-Sparagano MH, 2004, CELL MOL LIFE SCI, V61, P1946, DOI 10.1007/s00018-004-4124-x; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Siu LS, 2004, PEPTIDES, V25, P745, DOI 10.1016/j.peptides.2004.01.024; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Tosco A, 2010, CELL MOL LIFE SCI, V67, P1943, DOI 10.1007/s00018-010-0309-7; Tosco A, 2010, GENES NUTR, V5, P1, DOI 10.1007/s12263-009-0153-2; Tosco A, 2007, PEPTIDES, V28, P1461, DOI 10.1016/j.peptides.2007.06.004; Toyonaga Atsushi, 2000, Kurume Medical Journal, V47, P25, DOI 10.2739/kurumemedj.47.25; Van de Bovenkamp JHB, 2003, HELICOBACTER, V8, P521, DOI 10.1046/j.1523-5378.2003.00173.x; Vestergaard EM, 2010, INT J CANCER, V127, P1857, DOI 10.1002/ijc.25209; Waidner B, 2005, J BACTERIOL, V187, P4683, DOI 10.1128/JB.187.13.4683-4688.2005; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Westley BR, 2005, BIOCHEMISTRY-US, V44, P7967, DOI 10.1021/bi047287n; Yio X, 2006, GASTROENTEROLOGY, V130, P1696, DOI 10.1053/j.gastro.2006.01.040	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79455	10.1371/journal.pone.0079455	http://dx.doi.org/10.1371/journal.pone.0079455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236136	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700135
J	Narva, E; Pursiheimo, JP; Laiho, A; Rahkonen, N; Emani, MR; Viitala, M; Laurila, K; Sahla, R; Lund, R; Lahdesmaki, H; Jaakkola, P; Lahesmaa, R				Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta			Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels	PLOS ONE			English	Article							INDUCIBLE FACTOR; SELF-RENEWAL; C-MYC; TUMOR-SUPPRESSOR; HIF-ALPHA; PROLYL HYDROXYLATION; PROTEIN STABILITY; HUMAN FIBROBLASTS; SURFACE-ANTIGENS; DIFFERENTIATION	Low oxygen tension (hypoxia) contributes critically to pluripotency of human embryonic stem cells (hESCs) by preventing spontaneous differentiation and supporting self-renewal. However, it is not well understood how hESCs respond to reduced oxygen availability and what are the molecular mechanisms maintaining pluripotency in these conditions. In this study we characterized the transcriptional and molecular responses of three hESC lines (H9, HS401 and HS360) on short (2 hours), intermediate (24 hours) and prolonged (7 days) exposure to low oxygen conditions (4% O-2). In response to prolonged hypoxia the expression of pluripotency surface marker SSEA-3 was increased. Furthermore, the genome wide gene-expression analysis revealed that a substantial proportion (12%) of all hypoxia-regulated genes in hESCs, were directly linked to the mechanisms controlling pluripotency or differentiation. Moreover, transcription of MYC oncogene was induced in response to continuous hypoxia. At the protein level MYC was stabilized through phosphorylation already in response to a short hypoxic exposure. Total MYC protein levels remained elevated throughout all the time points studied. Further, MYC protein expression in hypoxia was affected by silencing HIF2 alpha, but not HIF1 alpha. Since MYC has a crucial role in regulating pluripotency we propose that induction of sustained MYC expression in hypoxia contributes to activation of transcriptional programs critical for hESC self-renewal and maintenance of enhanced pluripotent state.	[Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta] Turku Univ, Turku Ctr Biotechnol, Turku, Finland; [Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Jaakkola, Panu] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Laurila, Kirsti; Sahla, Roosa; Lahdesmaki, Harri] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Espoo, Finland	University of Turku; Abo Akademi University; University of Turku; Aalto University	Lahesmaa, R (corresponding author), Turku Univ, Turku Ctr Biotechnol, Turku, Finland.	riitta.lahesmaa@btk.fi	Kallionpää, Roosa/AAY-4816-2020; Närvä, Elisa Maarit/AAA-4885-2022; Emani, Maheswara Reddy/AAM-3500-2020; Jaakkola, Panu M/B-4355-2012; Lund, Riikka J/F-7320-2014; Lund, Riikka/K-2441-2019; Lund, Riikka/AAW-7853-2020	Kallionpää, Roosa/0000-0003-0146-0060; Närvä, Elisa Maarit/0000-0003-0517-9436; Lund, Riikka/0000-0002-1068-5918; Jaakkola, Panu/0000-0002-2365-4985; Maheswara Reddy, Emani/0000-0002-3455-1818	ESTOOLS consortium under the Sixth Research Framework Programme of the European Union; JDRF; Academy of Finland [116713]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research [250114]; Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Ida Montin Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation	ESTOOLS consortium under the Sixth Research Framework Programme of the European Union; JDRF(Juvenile Diabetes Research Foundation); Academy of Finland(Academy of Finland); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Ida Montin Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by ESTOOLS consortium under the Sixth Research Framework Programme of the European Union (www.estools.eu), JDRF (jdrf.org), The Academy of Finland (116713), the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research, 2012-2017, Decision 250114 (http://www.aka.fi/eng), The Finnish Cancer Organizations (https://cancer-fi.directo.fi), Turku Graduate School of Biomedical Sciences (http://www.tubs.utu.fi), Ida Montin Foundation (www.idamontininsaatio.fi), Orion-Farmos Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio), and Finnish Cultural Foundation (http://www.skr.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bae D, 2011, STEM CELLS DEV; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez R, 2011, ANGEW CHEM INT EDIT, V50, P11181, DOI 10.1002/anie.201103909; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Katoh M, 2007, INT J ONCOL, V31, P461; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Minchenko OH, 2005, ACTA BIOCHIM POL, V52, P881; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narva E, 2010, NAT BIOTECHNOL; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; R Core Team, 2022, R LANG ENV STAT COMP; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Ross HH, 2012, EXP NEUROL; Salvagiotto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017829; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Studer L, 2000, J NEUROSCI, V20, P7377; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zuo CQ, 2009, INT J MOL MED, V23, P811, DOI 10.3892/ijmm_00000197	72	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78847	10.1371/journal.pone.0078847	http://dx.doi.org/10.1371/journal.pone.0078847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236059	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700056
J	Park, SJ; Choi, NK; Park, KH; Woo, SJ				Park, Sang Jun; Choi, Nam-Kyoung; Park, Kyu Hyung; Woo, Se Joon			Five Year Nationwide Incidence of Rhegmatogenous Retinal Detachment Requiring Surgery in Korea	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; EPIDEMIOLOGIC CHARACTERISTICS; POPULATION; MYOPIA; PREVALENCE; MINNESOTA; SCOTLAND; CHINA; AGE	Purpose: To define the incidence and demographic characteristics of rhegmatogenous retinal detachment (RRD) requiring surgery in Korea. Design: Nationwide population-based retrospective study. Methods: Patients who underwent surgery for RRD from 2007 to 2011 were retrospectively identified using the diagnostic code for RRD and the surgical codes for retinal detachment surgeries in the national claim database. The average incidence rate of RRD during the 5-year period was estimated using the population data of the 2010 Census in Korea. Results: A total of 24,928 surgically treated RRD cases were identified. The average incidence of surgery requiring RRD was 10.39 cases per 100,000 person-years [95% confidence interval (CI), 10.26-10.52). The incidence in men (11.32 cases per 100,000 person-years; 95% CI:11.13-11.51) was significantly higher than that in women (9.47 cases per 100,000 person-years; 95% CI:9.29-9.64) (p<0.001). The incidence of surgery requiring RRD showed a bimodal distribution across age groups, with one peak (28.55 cases per 100,000 person-years; 95% CI:27.46-29.67)representing patients between 65 and 69 years of age and the second peak (approximately 8.5 per 100,000 person-years) representing patients between 20 and 29 years of age. The male-to-female ratio was approximately 1.0 for the peak-incidence age groups, whereas the ratio was higher for the other age groups. Conclusions: The incidence of RRD in the Korean population was similar to that reported previously, with the peak incidence being lower than that in the Caucasian population. The age-specific RRD incidence pattern in Korea followed a bimodal distribution.	[Park, Sang Jun; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Seoul Natl Univ Coll Med, Dept Ophthalmol, Songnam, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Seoul Natl Univ Coll Med, Dept Ophthalmol, Songnam, South Korea.	sejoon1@snu.ac.kr	Park, Sang Jun/C-3234-2015	Park, Sang Jun/0000-0003-0542-2758	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Kore [A111161]; Korean government (MEST) [2012R1A2A2A02012821]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Kore; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by grants from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant No. A111161), and the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST, No. 2012R1A2A2A02012821). The grant did not have any specific role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	AKIBA J, 1993, OPHTHALMOLOGY, V100, P1384; Anton A, 2009, OPHTHAL EPIDEMIOL, V16, P231, DOI [10.1080/09286580903000476, 10.3109/09286580903000476]; CAMBIAGGI A, 1964, AM J OPHTHALMOL, V58, P642, DOI 10.1016/0002-9394(64)91383-2; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Ghazi NG, 2002, EYE, V16, P411, DOI 10.1038/sj.eye.6700197; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; LAATIKAINEN L, 1985, ACTA OPHTHALMOL, V63, P59; Lee YK, 2013, OSTEOPOROSIS INT, V24, P707, DOI 10.1007/s00198-012-2016-8; Lee YK, 2012, OSTEOPOROSIS INT, V23, P1859, DOI 10.1007/s00198-011-1833-5; Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Limeira-Soares PH, 2007, EYE, V21, P348, DOI 10.1038/sj.eye.6702202; Los LI, 2012, OPHTHALMOLOGY; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; Mitry D, 2011, OPHTHALMOLOGY, V118, P1429, DOI 10.1016/j.ophtha.2010.11.031; Mitry D, 2011, BRIT J OPHTHALMOL, V95, P365, DOI 10.1136/bjo.2009.172296; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Polkinghorne PJ, 2004, CLIN EXP OPHTHALMOL, V32, P159, DOI 10.1111/j.1442-9071.2004.00003.x; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; SASAKI K, 1995, GRAEF ARCH CLIN EXP, V233, P772; SCHEPENS CL, 1961, ARCH OPHTHALMOL-CHIC, V66, P631, DOI 10.1001/archopht.1961.00960010633006; TORNQUIST R, 1987, ACTA OPHTHALMOL, V65, P213; WILKES SR, 1982, AM J OPHTHALMOL, V94, P670, DOI 10.1016/0002-9394(82)90013-7; Wong TY, 1999, ARCH OPHTHALMOL-CHIC, V117, P379, DOI 10.1001/archopht.117.3.379; YONEMOTO J, 1994, GRAEF ARCH CLIN EXP, V232, P67, DOI 10.1007/BF00171665; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zou H, 2002, RETINA-J RET VIT DIS, V22, P294, DOI 10.1097/00006982-200206000-00007	30	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80174	10.1371/journal.pone.0080174	http://dx.doi.org/10.1371/journal.pone.0080174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236173	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700174
J	Sanchez-Vidaurre, S; Cruz, MJ; Gomez-Olles, S; Morell, F; Munoz, X				Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier			Sputum Inflammatory Profile Before and After Specific Inhalation Challenge in Individuals with Suspected Occupational Asthma	PLOS ONE			English	Article							ISOCYANATE-INDUCED ASTHMA; WORK-RELATED ASTHMA; AIRWAY INFLAMMATION; TOLUENE DIISOCYANATE; CELL COUNTS; AGENTS; EXPOSURE; LEUKOTRIENES; EOSINOPHILIA; STATEMENT	Background: The aim of this study was to establish the sputum inflammatory profile and changes in levels of leukotriene B-4 (LTB4) and a panel of Th1/Th2 cytokines in subjects with suspected occupational asthma (OA) following specific inhalation challenge (SIC) to high-molecular-weight (HMW) and low-molecular-weight (LMW) agents. Material and Methods: Fifty-one consecutive subjects undergoing SIC for suspected OA were enrolled. Sputum induction was performed the day before and 24 h after exposure to the offending agent. Total and differential cell counts were assessed. LTB4 and a 10 Th1/Th2 cytokines were measured in sputum supernatant. Results: Thirty-four patients tested positive to SIC and were diagnosed with OA (in 10 due to HMW agents and in 24 to LMW agents). SIC was negative in 17 subjects. As compared to baseline an increase was found in the percentage of sputum eosinophils and neutrophils, and in IL-10 concentration after SIC (p = 0.0078, p = 0.0195, and p = 0.046, respectively), and a decrease was seen in LTB4 level (p = 0.0078) in patients with OA due to HMW agents. An increase in the percentage of sputum neutrophils after SIC (p = 0.0040) was observed in subjects without OA exposed to LMW agents. IL-8 levels after SIC were higher in patients without OA compared with patients with OA (p = 0.0146). Conclusion: When conducting airway inflammation studies in OA, patients should be divided according to the causal agent (HMW or LMW). In OA patients exposed to HMW agents, an increase in the number of neutrophils can be found in parallel to the increase of eosinophils, although this does not contradict an IgE-mediated mechanism. Exposure to LMW agents can result in increased neutrophilic inflammation in patients with airway diseases unrelated to OA. There is variability in the responses observed in patients with OA exposed to LMW agents.	[Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier] Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain; [Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier] CIBER Enfermedades Resp Ciberes, Barcelona, Spain; [Sanchez-Vidaurre, Sara] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Immunol, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain.	mj.cruz@vhir.org	Cruz, Maria Jesus/I-9073-2014; Muñoz, Xavier/I-9009-2014	Cruz, Maria Jesus/0000-0001-9759-5466; Munoz, Xavier/0000-0002-8693-022X; Morell Brotad, Ferran/0000-0002-7206-4543	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]; FIS [PI05100]; Sociedad Espanola de Patologia Respiratoria (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); Societat Catalana de Pneumologia (SOCAP)	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Sociedad Espanola de Patologia Respiratoria (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); Societat Catalana de Pneumologia (SOCAP)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). This project was supported by the FIS PI05100 (Instituto de Salud Carlos III), the Sociedad Espanola de Patologia Respiratoria (SEPAR), the Fundacio Catalana de Pneumologia (FUCAP), and the Societat Catalana de Pneumologia (SOCAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks DE, 2007, CURR OPIN PULM MED, V13, P131, DOI 10.1097/MCP.0b013e32802c7d0f; BERNSTEIN IL, 1999, ASTHMA WORKPLACE, P1; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Bettiol J, 2002, ALLERGY, V57, P1145, DOI 10.1034/j.1398-9995.2002.23586.x; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Burge PS, 2012, OCCUP MED-OXFORD, V62, P129, DOI 10.1093/occmed/kqr211; Cruz MJ, 2012, CURR OPIN ALLERGY CL, V12, P119, DOI 10.1097/ACI.0b013e328351137c; Di Franco A, 1998, RESP MED, V92, P550; Dudek W, 2009, INT J OCCUP MED ENV, V22, P293, DOI 10.2478/v10001-009-0022-7; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fernandez-Nieto M, 2009, CHEST, V136, P1308, DOI 10.1378/chest.09-0103; Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Henneberger PK, 2011, AM J RESP CRIT CARE, V184, P368, DOI 10.1164/rccm.812011ST; Lemiere C, 2004, CLIN EXP ALLERGY, V34, P1684, DOI 10.1111/j.1365-2222.2004.02102.x; Lemiere C, 2002, J ALLERGY CLIN IMMUN, V110, P641, DOI 10.1067/mai.2002.128806; Lemiere C, 2001, J ALLERGY CLIN IMMUN, V107, P1063, DOI 10.1067/mai.2001.115486; Lemiere C, 2000, J ALLERGY CLIN IMMUN, V106, P1163; Lemiere C, 2010, CHEST, V137, P617, DOI 10.1378/chest.09-2081; MAESTRELLI P, 1994, CLIN EXP ALLERGY, V24, P29, DOI 10.1111/j.1365-2222.1994.tb00913.x; Mapp CE, 2009, CLIN EXP ALLERGY, V39, P812, DOI 10.1111/j.1365-2222.2009.03215.x; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Morell F, 2002, MED CLIN-BARCELONA, V3, P23; Munoz X, 2004, OCCUP ENVIRON MED, V61, P861, DOI 10.1136/oem.2004.013177; Munoz X, 2009, RESPIRATION, V78, P455, DOI 10.1159/000235817; Pala G, 2011, CLIN TOXICOL, V49, P506, DOI 10.3109/15563650.2011.590141; Park HS, 1999, CLIN EXP ALLERGY, V29, P1395; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Prince P, 2012, CHEST, V141, P1522, DOI 10.1378/chest.11-1134; Quirce S, 2008, ALLERGY, V63, P137, DOI 10.1111/j.1398-9995.2007.01525.x; SAMPSON AP, 1995, ARCH DIS CHILD, V73, P221, DOI 10.1136/adc.73.3.221; Sanchez-Vidaurre S, 2012, ANN ALLERG ASTHMA IM, V108, P151, DOI 10.1016/j.anai.2011.12.010; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Vandenplas O, 2009, ALLERGY, V64, P754, DOI 10.1111/j.1398-9995.2008.01896.x; Vandenplas O, 2011, ALLERGY ASTHMA IMMUN, V3, P157, DOI 10.4168/aair.2011.3.3.157; ZOCCA E, 1990, J APPL PHYSIOL, V68, P1576, DOI 10.1152/jappl.1990.68.4.1576	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78304	10.1371/journal.pone.0078304	http://dx.doi.org/10.1371/journal.pone.0078304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236015	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700012
J	Shehadeh, LA; Sharma, S; Pessanha, M; Wei, JQ; Liu, J; Yuan, HJ; Rodrigues, CO; Scherr, M; Tsinoremas, NF; Bishopric, NH				Shehadeh, Lina A.; Sharma, Salil; Pessanha, Monica; Wei, Jian Qin; Liu, Jing; Yuan, Huijun; Rodrigues, Claudia O.; Scherr, Michaela; Tsinoremas, Nicholas F.; Bishopric, Nanette H.			MicroRNA-20a Constrains p300-Driven Myocardial Angiogenic Transcription by Direct Targeting of p300	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARDIAC-HYPERTROPHY; VASCULAR INTEGRITY; PRESSURE-OVERLOAD; HEART-FAILURE; EXPRESSION; INHIBITION; CLUSTER; HYPOXIA; CELL	Objective: To characterize downstream effectors of p300 acetyltransferase in the myocardium. Background: Acetyltransferase p300 is a central driver of the hypertrophic response to increased workload, but its biological targets and downstream effectors are incompletely known. Methods and Results: Mice expressing a myocyte-restricted transgene encoding acetyltransferase p300, previously shown to develop spontaneous hypertrophy, were observed to undergo robust compensatory blood vessel growth together with increased angiogenic gene expression. Chromatin immunoprecipitation demonstrated binding of p300 to the enhancers of the angiogenic regulators Angpt1 and Egln3. Interestingly, p300 overexpression in vivo was also associated with relative upregulation of several members of the anti-angiogenic miR-17 similar to 92 cluster in vivo. Confirming this finding, both miR-17-3p and miR-20a were upregulated in neonatal rat ventricular myocytes following adenoviral transduction of p300. Relative expression of most members of the 17,92 cluster was similar in all 4 cardiac chambers and in other organs, however, significant downregulation of miR-17-3p and miR-20a occurred between 1 and 8 months of age in both wt and tg mice. The decline in expression of these microRNAs was associated with increased expression of VEGFA, a validated miR-20a target. In addition, miR-20a was demonstrated to directly repress p300 expression through a consensus binding site in the p300 3'UTR. In vivo transduction of p300 resulted in repression both of p300 and of p300-induced angiogenic transcripts. Conclusion: p300 drives an angiogenic transcription program during hypertrophy that is fine-tuned in part through direct repression of p300 by miR-20a.	[Shehadeh, Lina A.; Wei, Jian Qin; Liu, Jing; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA; [Sharma, Salil; Pessanha, Monica; Yuan, Huijun; Rodrigues, Claudia O.; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol Pharmacol, Miami, FL 33136 USA; [Sharma, Salil; Pessanha, Monica; Yuan, Huijun; Rodrigues, Claudia O.; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Cellular Pharmacol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Tsinoremas, Nicholas F.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Scherr, Michaela] Hannover Med Sch, Dept Hematol Hemostasis & Oncol, Hannover, Germany	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Hannover Medical School	Bishopric, NH (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA.	n.bishopric@miami.edu			National Institutes of Health (NIH) [R-01-HL71094]; Florida Heart Research Institute (NHB); Fondation Leducq Transatlantic Network of Excellence [05-CVD-02]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071094, F32HL083673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute (NHB); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH) (R-01-HL71094 to NHB), the Florida Heart Research Institute (NHB), and the Fondation Leducq Transatlantic Network of Excellence 05-CVD-02 (NHB), as well as a Predoctoral Fellowship (SS) and a Scientist Development Grant (LS) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1985, AM J PHYSIOL, V248, pH883, DOI 10.1152/ajpheart.1985.248.6.H883; ANVERSA P, 1979, LAB INVEST, V40, P341; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Choi YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004042; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; MARCUS ML, 1987, CIRCULATION, V75, P19; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pessanha MG, 2000, VIRCHOWS ARCH, V437, P667; RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38; Rodrigues CO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024013; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Slepak TI, 2001, J BIOL CHEM, V276, P7575, DOI 10.1074/jbc.M004625200; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tillmanns J, 2008, P NATL ACAD SCI USA, V105, P1668, DOI 10.1073/pnas.0706315105; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Urbich C, BLOOD, V115, P4944; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	49	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79133	10.1371/journal.pone.0079133	http://dx.doi.org/10.1371/journal.pone.0079133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236097	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700095
J	Skuk, VG; Schweinberger, SR				Skuk, Verena G.; Schweinberger, Stefan R.			Adaptation Aftereffects in Vocal Emotion Perception Elicited by Expressive Faces and Voices	PLOS ONE			English	Article							SEX-DIFFERENCES; AUDITORY ADAPTATION; CROSSMODAL BINDING; FEAR; RECOGNITION; IDENTIFICATION; IDENTITY; SIGNALS; SPEECH; GENDER	The perception of emotions is often suggested to be multimodal in nature, and bimodal as compared to unimodal (auditory or visual) presentation of emotional stimuli can lead to superior emotion recognition. In previous studies, contrastive aftereffects in emotion perception caused by perceptual adaptation have been shown for faces and for auditory affective vocalization, when adaptors were of the same modality. By contrast, crossmodal aftereffects in the perception of emotional vocalizations have not been demonstrated yet. In three experiments we investigated the influence of emotional voice as well as dynamic facial video adaptors on the perception of emotion-ambiguous voices morphed on an angry-to-happy continuum. Contrastive aftereffects were found for unimodal (voice) adaptation conditions, in that test voices were perceived as happier after adaptation to angry voices, and vice versa. Bimodal (voice + dynamic face) adaptors tended to elicit larger contrastive aftereffects. Importantly, crossmodal (dynamic face) adaptors also elicited substantial aftereffects in male, but not in female participants. Our results (1) support the idea of contrastive processing of emotions (2), show for the first time crossmodal adaptation effects under certain conditions, consistent with the idea that emotion processing is multimodal in nature, and (3) suggest gender differences in the sensory integration of facial and vocal emotional stimuli.	[Skuk, Verena G.; Schweinberger, Stefan R.] Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Thuringia, Germany; [Skuk, Verena G.; Schweinberger, Stefan R.] Univ Jena, DFG Res Unit, Person Percept Inst Psychol, Jena, Thuringia, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Skuk, VG (corresponding author), Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Thuringia, Germany.	verena.skuk@uni-jena.de	Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft (DFG) [Schw 511/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de) to S. R. S. (grant reference Schw 511/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 1998, J COGNITIVE NEUROSCI, V10, P109; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2013, COGNITION EMOTION, DOI DOI 10.1080/026999300378824; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Boersma P., 2020, PRAAT DOING PHONETIC; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Calvert GA, 1998, TRENDS COGN SCI, V2, P247, DOI 10.1016/S1364-6613(98)01189-9; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Dael N, 2012, EMOTION, V12, P1085, DOI 10.1037/a0025737; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Elmes DG, 1981, METHODS EXPT PSYCHOL; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Hagan CC, 2009, P NATL ACAD SCI USA, V106, P20010, DOI 10.1073/pnas.0905792106; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Kawahara H, 2009, DEV EXPLORATORY RES, P111; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Montepare J, 1999, J NONVERBAL BEHAV, V23, P133, DOI 10.1023/A:1021435526134; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schweinberger SR, 2008, CURR BIOL, V18, P684, DOI 10.1016/j.cub.2008.04.015; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Sebe N, 2006, INT C PATT RECOG, P1136; Skuk VG, 2013, HEARING RES, V296, P131, DOI 10.1016/j.heares.2012.11.004; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Wolff N, NEUROSCIENC IN PRESS; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zaske R, 2011, HEARING RES, V282, P283, DOI 10.1016/j.heares.2011.06.008; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011; Zaske R, 2009, EUR J NEUROSCI, V30, P527, DOI 10.1111/j.1460-9568.2009.06839.x	42	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81691	10.1371/journal.pone.0081691	http://dx.doi.org/10.1371/journal.pone.0081691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236215	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700218
J	Yu, C; Smith, LB				Yu, Chen; Smith, Linda B.			Joint Attention without Gaze Following: Human Infants and Their Parents Coordinate Visual Attention to Objects through Eye-Hand Coordination	PLOS ONE			English	Article							FINE-GRAINED SENSITIVITY; HEAD; MOVEMENTS; COGNITION; DIRECTION; VIEW; CONVERSATION; EXPERIENCE; DYNAMICS; TRACKING	The coordination of visual attention among social partners is central to many components of human behavior and human development. Previous research has focused on one pathway to the coordination of looking behavior by social partners, gaze following. The extant evidence shows that even very young infants follow the direction of another's gaze but they do so only in highly constrained spatial contexts because gaze direction is not a spatially precise cue as to the visual target and not easily used in spatially complex social interactions. Our findings, derived from the moment-to-moment tracking of eye gaze of one-year-olds and their parents as they actively played with toys, provide evidence for an alternative pathway, through the coordination of hands and eyes in goal-directed action. In goal-directed actions, the hands and eyes of the actor are tightly coordinated both temporally and spatially, and thus, in contexts including manual engagement with objects, hand movements and eye movements provide redundant information about where the eyes are looking. Our findings show that one-year-olds rarely look to the parent's face and eyes in these contexts but rather infants and parents coordinate looking behavior without gaze following by attending to objects held by the self or the social partner. This pathway, through eye-hand coupling, leads to coordinated joint switches in visual attention and to an overall high rate of looking at the same object at the same time, and may be the dominant pathway through which physically active toddlers align their looking behavior with a social partner.	[Yu, Chen; Smith, Linda B.] Indiana Univ, Dept Psychol & Brain Sci, Cognit Sci Program, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Yu, C (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Cognit Sci Program, Bloomington, IN 47405 USA.	chenyu@indiana.edu			National Science Foundation [BCS 0924248]; National Institutes of Health [R01HD074601, R21 EY017843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY017843] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Science Foundation Grant BCS 0924248 and by National Institutes of Health Grant R01HD074601 and R21 EY017843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW, 2001, J MEM LANG, V44, P169, DOI 10.1006/jmla.2000.2752; Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Angus D, 2012, IEEE T VIS COMPUT GR, V18, P988, DOI 10.1109/TVCG.2011.100; Aslin RN, 2009, OPTOMETRY VISION SCI, V86, P561, DOI 10.1097/OPX.0b013e3181a76e96; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Baron-Cohen S., 1997, MALADAPTED MIND CLAS, P207; Brooks R, 2005, DEVELOPMENTAL SCI, V8, P535, DOI 10.1111/j.1467-7687.2005.00445.x; Carpenter M, 1998, AUTISM RES; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Corkum V, 1998, DEV PSYCHOL, V34, P28, DOI 10.1037/0012-1649.34.1.28; Dale R, 2011, FRONTIERS COGNITION, V2; Deckner DF, 2003, INFANCY, V4, P201, DOI 10.1207/S15327078IN0402_03; Doherty MJ, 2009, J EXP CHILD PSYCHOL, V104, P296, DOI 10.1016/j.jecp.2009.06.004; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Farroni T, 2000, VIS COGN, V7, P705, DOI 10.1080/13506280050144399; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; Frank M, 2012, MEASURING CHILDRENS; Garrod S., 2007, OXFORD HDB PSYCHOLIN, P443; Horstmann A, 2005, EXP BRAIN RES, V167, P187, DOI 10.1007/s00221-005-0038-6; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Jones SS, 2005, INFANT BEHAV DEV, V28, P194, DOI 10.1016/j.infbeh.2005.02.003; Kannass KN, 2006, J COGN DEV, V7, P381, DOI 10.1207/s15327647jcd0703_8; Kraut RE, 2003, HUM-COMPUT INTERACT, V18, P13, DOI 10.1207/S15327051HCI1812_2; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Loomis JM, 2008, PERCEPTION, V37, P1443, DOI 10.1068/p5896; Meltzoff AN, 2007, GAZE FOLLOWING ITS D; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Olofson EL, 2011, COGNITION, V118, P258, DOI 10.1016/j.cognition.2010.11.012; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Stavropoulos KK, 2013, J CHILD PSYCHOL PSYC; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Ullman S, 2012, P NATL ACAD SCI USA, V109, P18215, DOI 10.1073/pnas.1207690109; Vecera S. P., 1995, Visual Cognition, V2, P59, DOI 10.1080/13506289508401722; Vida M., 2012, J VISION, V12, P634, DOI DOI 10.1167/12.9.634; Vida MD, 2012, J EXP CHILD PSYCHOL, V112, P243, DOI 10.1016/j.jecp.2012.02.002; Vida MD, 2012, J EXP CHILD PSYCHOL, V111, P299, DOI 10.1016/j.jecp.2011.08.009; WEST MJ, 1987, DEV PSYCHOBIOL, V20, P549, DOI 10.1002/dev.420200508; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437	44	95	95	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79659	10.1371/journal.pone.0079659	http://dx.doi.org/10.1371/journal.pone.0079659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236151	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700150
J	Chow, AKM; Ng, L; Lam, CSC; Wong, SKM; Wan, TMH; Cheng, NSM; Yau, TCC; Poon, RTP; Pang, RWC				Chow, Ariel Ka-Man; Ng, Lui; Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Cheng, Nathan Shiu-Man; Yau, Thomas Chung-Cheung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi			The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LONG-TERM SAFETY; PHASE-III; PROTEIN EXPRESSION; LIVER-CANCER; STEM-CELLS; APOPTOSIS; SURVIVAL; EFFICACY; INSIGHTS	Acquired resistance towards sorafenib treatment was found in HCC patients, which results in poor prognosis. To investigate the enhanced metastatic potential of sorafenib resistance cells, sorafenib-resistant (SorR) cell lines were established by long-term exposure of the HCC cells to the maximum tolerated dose of sorafenib. Cell proliferation assay and qPCR of ABC transporter genes (ABCC1-3) were first performed to confirm the resistance of cells. Migration and invasion assays, and immunoblotting analysis on the expression of epithelial to mesenchymal transition (EMT) regulatory proteins were performed to study the metastatic potential of SorR cells. The expression of CD44 and CD133 were studied by flow cytometry and the gene expressions of pluripotency factors were studied by qPCR to demonstrate the enrichment of cancer stem cells (CSCs) in SorR cells. Control (CTL) and SorR cells were also injected orthotopically to the livers of NOD-SCID mice to investigate the development of lung metastasis. Increased expressions of ABCC1-3 were found in SorR cells. Enhanced migratory and invasive abilities of SorR cells were observed. The changes in expression of EMT regulatory proteins demonstrated an activation of the EMT process in SorR cells. Enriched proportion of CD44(+) and CD44(+) CD133(+) cells were also observed in SorR cells. All (8/8) mice injected with SorR cells demonstrated lung metastasis whereas only 1/8 mouse injected with CTL cells showed lung metastasis. HCC cells with sorafenib resistance demonstrated a higher metastatic potential, which may be due to the activated EMT process. Enriched CSCs were also demonstrated in the sorafenib resistant cells. This study suggests that advanced HCC patients with acquired sorafenib resistance may have enhanced tumor growth or distant metastasis, which raises the concern of long-term sorafenib treatment in advanced HCC patients who have developed resistance of sorafenib.	[Chow, Ariel Ka-Man; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi] Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Chow, Ariel Ka-Man; Ng, Lui; Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Cheng, Nathan Shiu-Man; Yau, Thomas Chung-Cheung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi] Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Pang, RWC (corresponding author), Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Ng, Lui/AAG-4397-2019; Wan, Timothy/AAA-2432-2021; Chow, Ariel/HGF-2363-2022; Yau, Thomas Chung Cheung/B-3429-2011	Ng, Lui/0000-0002-9010-2654; Wan, Timothy/0000-0002-9235-2913; Yau, Thomas Chung Cheung/0000-0002-7114-0305; Chow, Ariel/0000-0002-5729-5415; /0000-0003-2801-5717	Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong	Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong	This study is supported by the Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2011, CLIN LUNG CANCER, V12, P212, DOI 10.1016/j.cllc.2011.03.021; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Birchmeier W, 1995, EXS, V74, P1; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chow AKM, 2012, CURR CANCER DRUG TAR, V12, P1233; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ezzoukhry Z, 2012, INT J CANCER, V131, P2961, DOI 10.1002/ijc.27604; Fuchs CS, 2002, CANCER, V94, P3186, DOI 10.1002/cncr.10607; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Gish RG, 2007, J CLIN ONCOL, V25, P3069, DOI 10.1200/JCO.2006.08.4046; Hoffmann K, 2010, ANTICANCER RES, V30, P4503; Hutson TE, 2010, EUR J CANCER, V46, P2432, DOI 10.1016/j.ejca.2010.06.121; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lopez PM, 2006, ALIMENT PHARM THER, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x; Masugi Y, 2010, HUM PATHOL, V41, P1061, DOI 10.1016/j.humpath.2010.01.016; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Nakano M, 2013, ONCOLOGY-BASEL, V84, P108, DOI 10.1159/000342650; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Pang RWC, 2012, CURR CANCER DRUG TAR, V12, P1081; Signoriello S, 2012, SCI WORLD J, DOI 10.1100/2012/564706; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tai WT, 2012, MOL CANCER THER, V11, P452, DOI 10.1158/1535-7163.MCT-11-0412; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Xin HW, 2013, GUT, V62, P1777, DOI 10.1136/gutjnl-2012-303261; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yao X, 2012, ONCOTARGETS THER, V5, P255, DOI 10.2147/OTT.S36213; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	39	82	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78675	10.1371/journal.pone.0078675	http://dx.doi.org/10.1371/journal.pone.0078675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244338	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600047
J	Lin, YS; Chen, YJ; Cohen, SN; Cheng, TH				Lin, Yu-Shiuan; Chen, Yin-Ju; Cohen, Stanley N.; Cheng, Tzu-Hao			Identification of TSG101 Functional Domains and p21 Loci Required for TSG101-Mediated p21 Gene Regulation	PLOS ONE			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; HUMAN BREAST; TRANSCRIPTIONAL REGULATION; ABERRANT TRANSCRIPTS; PROTEIN; CANCER; EXPRESSION; OVEREXPRESSION; ACTIVATION	TSG101 (tumor susceptibility gene 101) is a multi-domain protein known to act in the cell nucleus, cytoplasm, and periplasmic membrane. Remarkably, TSG101, whose location within cells varies with the stage of the cell cycle, affects biological events as diverse as cell growth and proliferation, gene expression, cytokinesis, and endosomal trafficking. The functions of TSG101 additionally are recruited for viral and microvesicle budding and for intracellular survival of invading bacteria. Here we report that the TSG101 protein also interacts with and down-regulates the promoter of the p21 CIP1/WAF1 tumor suppressor gene, and identify a p21 locus and TSG101 domains that mediate this interaction. TSG101 deficiency in Saos-2 human osteosarcoma cells was accompanied by an increased abundance of p21 mRNA and protein and the retardation of cell proliferation. A cis-acting element in the p21 promoter that interacts with TSG101 and is required for promoter repression was located using chromatin immunoprecipitation (ChIP) analysis and p21-driven luciferase reporter gene expression, respectively. Additional analysis of TSG101 deletion mutants lacking specific domains established the role of the central TSG101 domains in binding to the p21 promoter and demonstrated the additional essentiality of the TSG101 C-terminal steadiness box (SB) in the repression of p21 promoter activity. Neither binding of TSG101 to the p21 promoter nor repression of this promoter required the TSG101 N-terminal UEV domain, which mediates the ubiquitin-recognition functions of TSG101 and its actions as a member of ESCRT endocytic trafficking complexes, indicating that regulation of the p21 promoter by TSG101 is independent of its role in such trafficking.	[Lin, Yu-Shiuan; Chen, Yin-Ju; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	National Yang Ming Chiao Tung University; Stanford University	Cheng, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	thcheng@ym.edu.tw			National Science Council [NSC-93-2320-B-010-026, NSC-102-2325-B-010-017]; 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China; National Foundation for Cancer Research	National Science Council(Ministry of Science and Technology, Taiwan); 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China; National Foundation for Cancer Research	This work was supported by the National Science Council (NSC-93-2320-B-010-026 and NSC-102-2325-B-010-017) and the 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China to THC and by an award from the National Foundation for Cancer Research to SNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2001, J BIOL CHEM, V276, P25813, DOI 10.1074/jbc.M102240200; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Carney ME, 1998, J SOC GYNECOL INVEST, V5, P281, DOI 10.1016/s1071-5576(98)00018-5; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen YJ, 1999, EUR J CANCER, V35, P302, DOI 10.1016/S0959-8049(98)00356-6; Cheng TH, 2000, GENE DEV, V14, P452; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Feng GH, 2000, CANCER RES, V60, P1736; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hampl M, 1998, BIOCHEM BIOPH RES CO, V248, P753, DOI 10.1006/bbrc.1998.9038; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hsu HS, 2011, ANN SURG ONCOL, V18, P1469, DOI 10.1245/s10434-010-1428-y; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kameyama T, 2012, NUCLEIC ACIDS RES, V40, P7896, DOI 10.1093/nar/gks520; Kao CL, 2009, CANCER LETT, V286, P250, DOI 10.1016/j.canlet.2009.05.031; Klaes R, 1999, EUR J CANCER, V35, P733, DOI 10.1016/S0959-8049(99)00016-7; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee MP, 1997, CANCER RES, V57, P3131; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Lin PM, 1998, BRIT J HAEMATOL, V102, P753, DOI 10.1046/j.1365-2141.1998.00815.x; Liu FL, 2010, MOL BIOL REP, V37, P2829, DOI 10.1007/s11033-009-9835-5; Liu RT, 2002, ONCOGENE, V21, P4830, DOI 10.1038/sj.onc.1205612; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; McDonald B, 2008, MOL BIOL CELL, V19, P754, DOI 10.1091/mbc.E07-09-0957; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moyret-Lalle C, 2001, CANCER RES, V61, P486; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Oh Y, 1998, ONCOGENE, V17, P1141, DOI 10.1038/sj.onc.1202029; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Sun ZJ, 1999, CANCER-AM CANCER SOC, V86, P689, DOI 10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P; Teng SC, 2004, J BIOL CHEM, V279, P14649, DOI 10.1074/jbc.M308842200; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; WALDMAN T, 1995, CANCER RES, V55, P5187; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; Willeke F, 1998, MOL CARCINOGEN, V23, P195; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337; Zhu G, 2004, INT J CANCER, V109, P541, DOI 10.1002/ijc.20014	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79674	10.1371/journal.pone.0079674	http://dx.doi.org/10.1371/journal.pone.0079674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244542	gold, Green Published			2022-12-25	WOS:000327221600145
J	Matsubara, K; Malay, AD; Curtis, FA; Sharples, GJ; Heddle, JG				Matsubara, Kazuko; Malay, Ali D.; Curtis, Fiona A.; Sharples, Gary J.; Heddle, Jonathan G.			Structural and Functional Characterization of the Red beta Recombinase from Bacteriophage lambda	PLOS ONE			English	Article							DNA-BINDING; HOMOLOGOUS RECOMBINATION; DOMAIN-STRUCTURE; RAD52; PROTEIN; EXONUCLEASE; SEQUENCE; IDENTIFICATION; MECHANISM; INVASION	The Red system of bacteriophage lambda is responsible for the genetic rearrangements that contribute to its rapid evolution and has been successfully harnessed as a research tool for genome manipulation. The key recombination component is Red beta, a ring-shaped protein that facilitates annealing of complementary DNA strands. Red beta shares functional similarities with the human Rad52 single-stranded DNA (ssDNA) annealing protein although their evolutionary relatedness is not well established. Alignment of Rad52 and Red beta sequences shows an overall low level of homology, with 15% identity in the N-terminal core domains as well as important similarities with the Rad52 homolog Sak from phage ul36. Key conserved residues were chosen for mutagenesis and their impact on oligomer formation, ssDNA binding and annealing was probed. Two conserved regions were identified as sites important for binding ssDNA; a surface basic cluster and an intersubunit hydrophobic patch, consistent with findings for Rad52. Surprisingly, mutation of Red beta residues in the basic cluster that in Rad52 are involved in ssDNA binding disrupted both oligomer formation and ssDNA binding. Mutations in the equivalent of the intersubunit hydrophobic patch in Rad52 did not affect Red beta oligomerization but did impair DNA binding and annealing. We also identified a single amino acid substitution which had little effect on oligomerization and DNA binding but which inhibited DNA annealing, indicating that these two functions of Red beta can be separated. Taken together, the results provide fresh insights into the structural basis for Red beta function and the important role of quaternary structure.	[Matsubara, Kazuko; Malay, Ali D.; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan; [Curtis, Fiona A.; Sharples, Gary J.] Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England	RIKEN; Durham University	Heddle, JG (corresponding author), RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan.	heddle@riken.jp	Sharples, Gary/B-8638-2016; Heddle, Jonathan/AAP-7167-2020; Heddle, Jonathan G/H-4586-2014; Malay, Ali/N-9136-2015	Sharples, Gary/0000-0003-2495-0062; Malay, Ali/0000-0003-0885-5524	RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan); Biotechnology and Biological Sciences Research Council [BB/C514523/1, BB/FO20503/1]; Biotechnology and Biological Sciences Research Council [BB/F020503/1] Funding Source: researchfish; BBSRC [BB/F020503/1] Funding Source: UKRI	RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was suported by RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan)(www.riken.go.jp/en/) funding to JGH and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grants BB/C514523/1 and BB/FO20503/1 to GJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CASSUTO E, 1971, NATURE-NEW BIOL, V229, P13, DOI 10.1038/newbio229013a0; CHIU SK, 1990, J BIOL CHEM, V265, P21262; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Hillyar C.R., 2012, BIOSCI HORIZ, V5, DOI [DOI 10.1093/biohorizons/hzs001, 10.1093/biohorizons/hzs001]; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Karakousis G, 1998, J MOL BIOL, V276, P721, DOI 10.1006/jmbi.1997.1573; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Lloyd JA, 2005, J MOL BIOL, V345, P239, DOI 10.1016/j.jmb.2004.10.065; Lloyd JA, 2002, J BIOL CHEM, V277, P46172, DOI 10.1074/jbc.M207262200; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Murphy KC, 2012, ADV VIRUS RES, V83, P367, DOI 10.1016/B978-0-12-394438-2.00008-6; Mythili E, 1996, GENE, V182, P81, DOI 10.1016/S0378-1119(96)00518-5; Nardozzi JD, 2012, J BIOL CHEM, V287, P37259, DOI 10.1074/jbc.M112.389965; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Ranatunga W, 2001, J BIOL CHEM, V276, P15876, DOI 10.1074/jbc.M011747200; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Rybalchenko N, 2004, P NATL ACAD SCI USA, V101, P17056, DOI 10.1073/pnas.0408046101; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Scaltriti E, 2010, J STRUCT BIOL, V170, P462, DOI 10.1016/j.jsb.2009.12.021; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stahl MM, 1997, GENETICS, V147, P961; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu ZR, 2006, J BIOL CHEM, V281, P25205, DOI 10.1074/jbc.M512450200; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	49	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78869	10.1371/journal.pone.0078869	http://dx.doi.org/10.1371/journal.pone.0078869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244379	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000327221600075
J	Peri, E; Frati, F; Salerno, G; Conti, E; Colazza, S				Peri, Ezio; Frati, Francesca; Salerno, Gianandrea; Conti, Eric; Colazza, Stefano			Host Chemical Footprints Induce Host Sex Discrimination Ability in Egg Parasitoids	PLOS ONE			English	Article							TRISSOLCUS-BASALIS HYMENOPTERA; NEZARA-VIRIDULA; FORAGING BEHAVIOR; INFOCHEMICAL USE; PLANT; CUES; PENTATOMIDAE; SPECIFICITY; KAIROMONES; LOCATION	Trissolcus egg parasitoids, when perceiving the chemical footprints left on a substrate by pentatomid host bugs, adopt a motivated searching behaviour characterized by longer searching time on patches were signals are present. Once in contact with host chemical footprints, Trissolcus wasps search longer on traces left by associated hosts rather than non-associated species, and, in the former case, they search longer on traces left by females than males. Based on these evidences, we hypothesized that only associated hosts induce the ability to discriminate host sex in wasps. To test this hypothesis we investigated the ability of Trissolcus basalis, T. brochymenae, and Trissolcus sp. to distinguish female from male Nezara viridula, Murgantia histrionica, and Graphosoma semipunctatum footprints. These three pentatomid bugs were selected according to variable association levels. Bioassays were conducted on filter paper sheets, and on Brassica oleracea (broccoli) leaves. The results confirmed our hypothesis showing that wasps spent significantly more time on female rather than male traces left by associated hosts on both substrates. No differences were observed in the presence of traces left by non-associated hosts. The ecological consequences for parasitoid host location behaviour are discussed.	[Peri, Ezio; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Frati, Francesca; Salerno, Gianandrea; Conti, Eric] Univ Perugia, Dipartimento Sci Agr & Ambientali, I-06100 Perugia, Italy	University of Palermo; University of Perugia	Peri, E (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	ezio.peri@unipa.it	Conti, Eric/G-6400-2014; Salerno, Gianandrea/G-9296-2011	Salerno, Gianandrea/0000-0002-8357-7598; colazza, stefano/0000-0001-8023-7814; PERI, Ezio/0000-0002-1095-7258; Frati, Francesca/0000-0002-9891-9757				Alborn HT, 1995, J CHEM ECOL, V21, P1697, DOI 10.1007/BF02033670; ANDOW DA, 1990, OECOLOGIA, V82, P162, DOI 10.1007/BF00323530; Borges M, 2003, PHYSIOL ENTOMOL, V28, P349, DOI 10.1111/j.1365-3032.2003.00350.x; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Colazza S., 1999, 12 INT ENT INS WORKS; Colazza S, 2007, J CHEM ECOL, V33, P1405, DOI 10.1007/s10886-007-9300-7; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Colazza S, 2009, NATURWISSENSCHAFTEN, V96, P975, DOI 10.1007/s00114-009-0548-3; Conti E, 2004, BIOL CONTROL, V29, P435, DOI 10.1016/j.biocontrol.2003.08.009; Conti E, 2003, J CHEM ECOL, V29, P115, DOI 10.1023/A:1021980614512; Conti E, 2010, J EXP BIOL, V213, P3911, DOI 10.1242/jeb.045922; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Eigenbrode SD, 2002, INTEGR COMP BIOL, V42, P1091, DOI 10.1093/icb/42.6.1091; ESPELIE KE, 1991, ARCH INSECT BIOCHEM, V17, P223, DOI 10.1002/arch.940170406; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Frati F, 2013, INSECT SCI, V20, P753, DOI 10.1111/j.1744-7917.2012.01575.x; Gentry GL, 2006, ENTOMOL EXP APPL, V121, P115, DOI 10.1111/j.1570-8703.2006.00472.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; KOTLER BP, 1995, EVOL ECOL, V9, P18, DOI 10.1007/BF01237693; Lo Giudice D, 2011, J CHEM ECOL, V37, P622, DOI 10.1007/s10886-011-9957-9; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; McAuslane HJ, 2000, FLA ENTOMOL, V83, P428, DOI 10.2307/3496718; Meiners T, 2000, ENTOMOL EXP APPL, V95, P151, DOI 10.1023/A:1004098802806; Meiners T, 2013, CHEM ECOLOGY INSECT, P191, DOI DOI 10.1002/9781118409589.CH9; OBRYCKI JJ, 1986, INTERACTIONS PLANT R, P61; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Powell W, 1998, BIOL CONTROL, V11, P104, DOI 10.1006/bcon.1997.0584; Powell W, 2003, PEST MANAG SCI, V59, P149, DOI 10.1002/ps.550; Puente ME, 2008, J CHEM ECOL, V34, P945, DOI 10.1007/s10886-008-9471-x; Rogers ME, 2002, ENTOMOL EXP APPL, V102, P307, DOI 10.1023/A:1019537701902; Romeis J, 1998, ENTOMOL EXP APPL, V87, P275, DOI 10.1023/A:1003275419997; Rostas M, 2008, NATURWISSENSCHAFTEN, V95, P997, DOI 10.1007/s00114-008-0411-y; Safavi M., 1968, Entomophaga, V13, P381; Salerno G, 2006, EUR J ENTOMOL, V103, P311, DOI 10.14411/eje.2006.040; Salerno G, 2009, J EXP BIOL, V212, P1825, DOI 10.1242/jeb.028308; Salerno G, 2012, INVERTEBR BIOL, V131, P144, DOI 10.1111/j.1744-7410.2012.00258.x; Schreiber SJ, 2002, EVOL ECOL RES, V4, P701; StatSoft, 2001, STAT PER WINDOWS USE; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vinson S. B., 1977, Biological control by augmentation of natural enemies. Insect and mite control with parasites and predators., P237; Vinson S.B., 1991, Redia, V74, P15; Vinson SB, 2010, PROG BIOL CONTROL, V9, P25, DOI 10.1007/978-1-4020-9110-0_2; Vinson SB, 1998, BIOL CONTROL, V11, P79, DOI 10.1006/bcon.1997.0601; Zar J. H., 2009, BIOSTATISTICAL ANAL	48	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79054	10.1371/journal.pone.0079054	http://dx.doi.org/10.1371/journal.pone.0079054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244417	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600103
J	Salomon, C; Kobayashi, M; Ashman, K; Sobrevia, L; Mitchell, MD; Rice, GE				Salomon, Carlos; Kobayashi, Miharu; Ashman, Keith; Sobrevia, Luis; Mitchell, Murray D.; Rice, Gregory E.			Hypoxia-Induced Changes in the Bioactivity of Cytotrophoblast-Derived Exosomes	PLOS ONE			English	Article							EXTRAVILLOUS TROPHOBLAST CELLS; BREAST-CANCER CELLS; NORMAL-PREGNANCY; IN-VITRO; INVASION; PREECLAMPSIA; OXYGEN; INHIBITION; TRIMESTER; MECHANISM	Migration of extravillous trophoblasts (EVT) into decidua and myometrium is a critical process in the conversion of maternal spiral arterioles and establishing placenta perfusion. EVT migration is affected by cell-to-cell communication and oxygen tension. While the release of exosomes from placental cells has been identified as a significant pathway in materno-fetal communication, the role of placental-derived exosomes in placentation has yet to be established. The aim of this study was to establish the effect of oxygen tension on the release and bioactivity of cytotrophoblast (CT)-derived exosomes on EVT invasion and proliferation. CT were isolated from first trimester fetal tissue (n = 12) using a trypsin-deoxyribonucleasedispase/ Percoll method. CT were cultured under 8%, 3% or 1% O2 for 48 h. Exosomes from CT-conditioned media were isolated by differential and buoyant density centrifugation. The effect of oxygen tension on exosome release (mg exosomal protein/10(6)cells/48 h) and bioactivity were established. HTR-8/SVneo (EVT) were used as target cells to establish the effect (bioactivity) of exosomes on invasion and proliferation as assessed by real-time, live-cell imaging (Incucyte (TM)). The release and bioactivity of CT-derived exosomes were inversely correlated with oxygen tension (p<0.001). Under low oxygen tensions (i.e. 1% O2), CT-derived exosomes promoted EVT invasion and proliferation. Proteomic analysis of exosomes identified oxygen-dependent changes in protein content. We propose that in response to changes in oxygen tension, CTs modify the bioactivity of exosomes, thereby, regulating EVT phenotype. Exosomal induction of EVT migration may represent a normal process of placentation and/or an adaptive response to placental hypoxia.	[Salomon, Carlos; Kobayashi, Miharu; Ashman, Keith; Sobrevia, Luis; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Brisbane, Qld, Australia; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol, Santiago, Chile	University of Queensland; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Brisbane, Qld, Australia.	c.salomongallo@uq.edu.au	Sobrevia, Luis/H-9608-2016; Salomon, Carlos F/L-2167-2013; Mitchell, Murray/A-8639-2010; RICE, GREGORY E/F-2412-2010	Salomon, Carlos F/0000-0003-4474-0046; Mitchell, Murray/0000-0002-6167-7176; RICE, GREGORY E/0000-0001-7177-0246; Sobrevia, Luis/0000-0001-5802-2243	University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC; CIEF grant (University of Queensland); Department of Employment, Economic Development and Innovation, Queensland Government; Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; CONICYT [ACT-73 PIA]; FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC	University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIEF grant (University of Queensland); Department of Employment, Economic Development and Innovation, Queensland Government; Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government(Australian GovernmentDepartment of Industry, Innovation and Science); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC	CS holds a Postdoctoral Fellowship at The University of Queensland Centre for Clinical Research, Brisbane, Australia. GER was in receipt of an NHMRC Principal Research Fellowship. The work described herein was partially funded by a CIEF grant (University of Queensland), a Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government) and a Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government). This investigation was supported by CONICYT (ACT-73 PIA, Pasantia Doctoral en el Extranjero BECAS Chile), FONDECYT (1110977). CS holds CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Crocker IP, 2005, J PATHOL, V206, P476, DOI 10.1002/path.1801; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1998, BLOOD, V91, P3300, DOI 10.1182/blood.V91.9.3300.3300_3300_3307; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Lash GE, 2006, BIOL REPROD, V74, P403, DOI 10.1095/biolreprod.105.047332; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Lyall F, 2006, AUST NZ J OBSTET GYN, V46, P266, DOI 10.1111/j.1479-828X.2006.00589.x; Maloyan A, 2012, PLACENTA, V33, P456, DOI 10.1016/j.placenta.2012.01.016; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Soares MJ, 2012, J REPROD DEVELOP, V58, P283, DOI 10.1262/jrd.2011-039; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thon JN, 2012, BLOOD, V120, P1975, DOI 10.1182/blood-2012-04-420968; Vitoratos N, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/145487; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zhang HC, 2012, STEM CELLS DEV; Zhao HB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099937	37	113	117	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79636	10.1371/journal.pone.0079636	http://dx.doi.org/10.1371/journal.pone.0079636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244532	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600140
J	Zhang, YW; Zhang, LH; Zhao, XN; Huang, SJ; Zhao, JM				Zhang, Yanwen; Zhang, Lihui; Zhao, Xingnan; Huang, Shengjun; Zhao, Jimin			Effects of Tidal Action on Pollination and Reproductive Allocation in an Estuarine Emergent Wetland Plant-Sagittaria graminea (Alismataceae)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; TRADE-OFFS; LATIFOLIA ALISMATACEAE; CLONAL GROWTH; ASEXUAL REPRODUCTION; RESOURCE-ALLOCATION; GENETIC DIVERSITY; AQUATIC PLANT; POPULATIONS; PLASTICITY	In estuarine wetlands, the daily periodic tidal activity has a profound effect on plant growth and reproduction. We studied the effects of tidal action on pollination and reproductive allocation of Sagittaria graminea. Results showed that the species had very different reproductive allocation in tidal and non-tidal habitats. In the tidal area, seed production was only 9.7% of that in non-tidal habitat, however, plants produced more male flowers and nearly twice the corms compared to those in non-tidal habitat. An experiment showed that the time available for effective pollination determined the pollination rate and pollen deposition in the tidal area. A control experiment suggested that low pollen deposition from low visitation frequency is not the main cause of very low seed sets or seed production in this plant in tidal habitat. The negative effects of tides (water) on pollen germination may surpass the influence of low pollen deposition from low visitation frequency. The length of time from pollen deposition to flower being submerged by water affected pollen germination rate on stigmas; more than three hours is necessary to allow pollen germination and complete fertilization to eliminate the risk of pollen grains being washed away by tidal water.	[Zhang, Yanwen; Huang, Shengjun] Eastern Liaoning Univ, Dept Biol, Dandong, Peoples R China; [Zhang, Yanwen; Zhang, Lihui; Zhao, Xingnan; Zhao, Jimin] Changchun Normal Univ, Dept Biol, Changchun, Peoples R China	Liaodong University; Changchun Normal University	Zhang, YW (corresponding author), Eastern Liaoning Univ, Dept Biol, Dandong, Peoples R China.	yanwen0209@163.com			National Science Foundation of China [30970200, 30970554]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China to Yanwen Zhang (30970200) and to Jimin Zhao (30970554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin Andrew H., 2004, Urban Ecosystems, V7, P125, DOI 10.1023/B:UECO.0000036265.86125.34; Bishop EJ, 2010, BOTANY, V88, P231, DOI 10.1139/B10-005; Brown JS, 2005, AM J BOT, V92, P495, DOI 10.3732/ajb.92.3.495; Cain ML, 1997, J ECOL, V85, P883, DOI 10.2307/2960609; CAIN ML, 1995, CAN J BOT, V73, P505, DOI 10.1139/b95-051; CHEPLICK GP, 1995, AM J BOT, V82, P621, DOI 10.2307/2445420; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Eckert CG, 2000, CAN J BOT, V78, P437, DOI 10.1139/b00-019; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Han B, 2011, J SYST EVOL, V49, P379, DOI 10.1111/j.1759-6831.2011.00141.x; Harder LD, 2005, P ROY SOC B-BIOL SCI, V272, P2651, DOI 10.1098/rspb.2005.3268; Hnatiuk R.J., 1990, CENSUS AUSTR VASCULA; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Kearns C. A., 1993, TECHNIQUES POLLINATI; Lambertini C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-52; Liu F, 2008, PLANT ECOL, V199, P217, DOI 10.1007/s11258-008-9426-x; Liu F, 2009, PLANT SYST EVOL, V277, P61, DOI 10.1007/s00606-008-0103-2; Mao YY, 2009, NEW PHYTOL, V183, P892, DOI 10.1111/j.1469-8137.2009.02925.x; Martins EP, 2000, TRENDS ECOL EVOL, V15, P296, DOI 10.1016/S0169-5347(00)01880-2; Mendez M, 1999, PLANT BIOLOGY, V1, P115, DOI 10.1055/s-2007-978497; Mendoza A, 1998, AM J BOT, V85, P521, DOI 10.2307/2446436; Mitchell RJ, 1997, OECOLOGIA, V109, P382, DOI 10.1007/s004420050097; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Neely JS, 2006, THESIS WASHINGTON ST; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Piquot Y, 1998, OIKOS, V82, P139, DOI 10.2307/3546924; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Reekie EG, 1999, LIFE HIST EVOLUTION; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Reusch TBH, 2000, HEREDITY, V85, P459, DOI 10.1046/j.1365-2540.2000.00783.x; Ronsheim ML, 2000, AM J BOT, V87, P1769, DOI 10.2307/2656827; Saikkonen K, 1998, ECOLOGY, V79, P1620, DOI 10.1890/0012-9658(1998)079[1620:IEOPAH]2.0.CO;2; Sarkissian TS, 2001, ECOLOGY, V82, P360, DOI 10.1890/0012-9658(2001)082[0360:GVISLA]2.0.CO;2; Sullivan G, 1994, THESIS BINGHAMTON U; Suzuki A, 2001, NEW PHYTOL, V152, P307, DOI 10.1046/j.0028-646X.2001.00251.x; Thiele J, 2009, BASIC APPL ECOL, V10, P340, DOI 10.1016/j.baae.2008.04.002; Thompson FL, 2004, J EVOLUTION BIOL, V17, P581, DOI 10.1111/j.1420-9101.2004.00701.x; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Van Drunen WE, 2012, NEW PHYTOL, V196, P606, DOI 10.1111/j.1469-8137.2012.04260.x; van Kleunen M, 2002, EVOLUTION, V56, P2168, DOI 10.1554/0014-3820(2002)056[2168:ELHESO]2.0.CO;2; Wang XF, 2002, ANN BOT-LONDON, V89, P791, DOI 10.1093/aob/mcf136; Wang XF, 2001, ALCHERINGA, V25, P155; Wang XF, 2006, AQUAT BOT, V85, P233, DOI 10.1016/j.aquabot.2006.05.005; Wang XF, 2012, NEW PHYTOL, V193, P253, DOI 10.1111/j.1469-8137.2011.03912.x; Wang Xiao-Fan, 1998, Acta Botanica Yunnanica, V20, P315; WIKBERG S, 1995, OIKOS, V72, P293, DOI 10.2307/3546232; Yatskievych K., 2000, FIELD GUIDE INDIANA; Zhang YW, 2008, ECOL RES, V23, P873, DOI 10.1007/s11284-007-0451-3; Zhang Yan-Wen, 2010, Wuhan Zhiwuxue Yanjiu, V28, P631, DOI 10.3724/SP.J.1142.2010.50631; Zhang YW, 2011, J LIAODONG U, V18, P39; Zhao XN, 2011, THESIS NE NORMAL U	52	4	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78956	10.1371/journal.pone.0078956	http://dx.doi.org/10.1371/journal.pone.0078956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244393	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600086
J	Ekvall, MT; Bianco, G; Linse, S; Linke, H; Backman, J; Hansson, LA				Ekvall, Mikael T.; Bianco, Giuseppe; Linse, Sara; Linke, Heiner; Backman, Johan; Hansson, Lars-Anders			Three-Dimensional Tracking of Small Aquatic Organisms Using Fluorescent Nanoparticles	PLOS ONE			English	Article							PARTIAL MIGRATION; QUANTUM DOTS; MATE; COPEPODS; DELIVERY; BEHAVIOR; 3D	Tracking techniques are vital for the understanding of the biology and ecology of organisms. While such techniques have provided important information on the movement and migration of large animals, such as mammals and birds, scientific advances in understanding the individual behaviour and interactions of small (mm-scale) organisms have been hampered by constraints, such as the sizes of existing tracking devices, in existing tracking methods. By combining biology, chemistry and physics we here present a method that allows three-dimensional (3D) tracking of individual mm-sized aquatic organisms. The method is based on in-vivo labelling of the organisms with fluorescent nanoparticles, so-called quantum dots, and tracking of the organisms in 3D via the quantum-dot fluorescence using a synchronized multiple camera system. It allows for the efficient and simultaneous study of the behaviour of one as well as multiple individuals in large volumes of observation, thus enabling the study of behavioural interactions at the community scale. The method is non-perturbing we demonstrate that the labelling is not affecting the behavioural response of the organisms - and is applicable over a wide range of taxa, including cladocerans as well as insects, suggesting that our methodological concept opens up for new research fields on individual behaviour of small animals. Hence, this offers opportunities to focus on important biological, ecological and behavioural questions never before possible to address.	[Ekvall, Mikael T.; Bianco, Giuseppe; Hansson, Lars-Anders] Lund Univ, Dept Biol, Lund, Sweden; [Linse, Sara] Lund Univ, Dept Chem, Lund, Sweden; [Linke, Heiner] Lund Univ, Nanometer Struct Consortium NmC LU, Lund, Sweden; [Linke, Heiner] Lund Univ, Lund, Sweden; [Backman, Johan] Lund Univ, Dept Biol, Ctr Anim Movement Res, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Ekvall, MT (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Mikael.Ekvall@biol.lu.se	Linke, Heiner/A-5825-2010; Hansson, Lars-Anders/HCI-2735-2022	Linke, Heiner/0000-0003-4451-4006; Ekvall, Mikael/0000-0002-4452-0580; Linse, Sara/0000-0001-9629-7109; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council (VR) [621-2010-5404]; Centre for Animal Movement Research (CAnMove) through the Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University; Royal Physiographic Society in Lund	Swedish Research Council (VR)(Swedish Research Council); Centre for Animal Movement Research (CAnMove) through the Linnaeus grant from the Swedish Research Council; Lund University; Royal Physiographic Society in Lund	This study was founded by the Swedish Research Council (VR) (http://www.vr.se) for project funding to L.-A. H. (grant nr: 621-2010-5404) and the Centre for Animal Movement Research (CAnMove) through the Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University. Funding was also received from the Royal Physiographic Society in Lund (http://www.fysiografen.se/) through a grant to M. T. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bagoien E, 2005, MAR ECOL PROG SER, V300, P105, DOI 10.3354/meps300105; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Bianco G, 2013, LIMNOL OCEANOGR-METH, V11, P278, DOI 10.4319/lom.2013.11.278; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Burger W, 2004, DIGITAL IMAGE PROCES; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Doall MH, 1998, PHILOS T ROY SOC B, V353, P681, DOI 10.1098/rstb.1998.0234; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2009, PHOTOCH PHOTOBIO SCI, V8, P1266, DOI 10.1039/b908825c; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; HAYS GC, 1995, LIMNOL OCEANOGR, V40, P469, DOI 10.4319/lo.1995.40.3.0469; Ji MY, 2012, J MOL HISTOL, V43, P517, DOI 10.1007/s10735-012-9424-0; Kim KS, 2012, NANOMED-NANOTECHNOL, V8, P1070, DOI 10.1016/j.nano.2012.05.014; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013516; Liu Y, 2012, BIOCHEM BIOPH RES CO, V425, P769, DOI 10.1016/j.bbrc.2012.07.150; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Salditt Tim, 2002, J Biotechnol, V90, P55; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Strickler JR, 1998, PHILOS T R SOC B, V353, P671, DOI 10.1098/rstb.1998.0233; Titelman J, 2001, MAR ECOL PROG SER, V213, P203, DOI 10.3354/meps213203; Tsuda A, 1998, PHILOS T ROY SOC B, V353, P713, DOI 10.1098/rstb.1998.0237; Usami M, 2004, ULTRA SMALL RFID CHI, P241	29	36	36	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78498	10.1371/journal.pone.0078498	http://dx.doi.org/10.1371/journal.pone.0078498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244316	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900021
J	Kahles, A; Sarqume, F; Savolainen, P; Arvestad, L				Kahles, Andre; Sarqume, Fahad; Savolainen, Peter; Arvestad, Lars			Excap: Maximization of Haplotypic Diversity of Linked Markers	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CODING REGION; MTDNA; IDENTIFICATION; SEQUENCE; GENOME	Genetic markers, defined as variable regions of DNA, can be utilized for distinguishing individuals or populations. As long as markers are independent, it is easy to combine the information they provide. For nonrecombinant sequences like mtDNA, choosing the right set of markers for forensic applications can be difficult and requires careful consideration. In particular, one wants to maximize the utility of the markers. Until now, this has mainly been done by hand. We propose an algorithm that finds the most informative subset of a set of markers. The algorithm uses a depth first search combined with a branch-and-bound approach. Since the worst case complexity is exponential, we also propose some data-reduction techniques and a heuristic. We implemented the algorithm and applied it to two forensic caseworks using mitochondrial DNA, which resulted in marker sets with significantly improved haplotypic diversity compared to previous suggestions. Additionally, we evaluated the quality of the estimation with an artificial dataset of mtDNA. The heuristic is shown to provide extensive speedup at little cost in accuracy.	[Kahles, Andre] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm Bioinformat Ctr, Stockholm, Sweden; [Sarqume, Fahad] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Savolainen, Peter] KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Stockholm, Sweden; [Arvestad, Lars] Stockholm Univ, Swedish eSci Res Ctr, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Arvestad, Lars] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; Royal Institute of Technology; Stockholm University; Swedish e-Science Research Centre (SeRC); Royal Institute of Technology	Arvestad, L (corresponding author), Stockholm Univ, Swedish eSci Res Ctr, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden.	arve@nada.su.se	Kahles, Andre/ABB-8343-2020	Kahles, Andre/0000-0002-3411-0692; Arvestad, Lars/0000-0001-5341-1733	Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW); Knuth and Alice Wallenberg Foundation	Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW); Knuth and Alice Wallenberg Foundation	The work of AK was funded through a scholarship of the Klaus Murmann Fellowship Programme of the Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW). PS is a Royal Academy of Sciences Research Fellow supported by a grant from the Knuth and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson H, 2007, FORENSIC SCI INT-GEN, V1, P35, DOI 10.1016/j.fsigen.2006.10.002; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anjum GM, 2010, ELECTROPHORESIS, V31, P309, DOI 10.1002/elps.200900325; Coble MD, 2006, INT J LEGAL MED, V120, P27, DOI 10.1007/s00414-005-0044-z; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026723; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCL ACIDS RES; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lutz S, 1996, INT J LEGAL MED, V109, P205, DOI 10.1007/BF01225519; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Ruiz-Pesini E, 2006, NUCL ACIDS RES; Szibor R, 2000, FORENSIC SCI INT, V113, P71, DOI 10.1016/S0379-0738(00)00266-8	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79012	10.1371/journal.pone.0079012	http://dx.doi.org/10.1371/journal.pone.0079012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244403	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900030
J	Li, QT; Zhang, PX; Yin, XF; Han, N; Kou, YH; Deng, JX; Jiang, BG				Li, Qing Tian; Zhang, Pei Xun; Yin, Xiao Feng; Han, Na; Kou, Yu Hui; Deng, Jiu Xu; Jiang, Bao Guo			Functional Recovery of Denervated Skeletal Muscle with Sensory or Mixed Nerve Protection: A Pilot Study	PLOS ONE			English	Article							SCHWANN-CELL DENERVATION; PERIPHERAL-NERVE; NEUROTROPHIC FACTOR; CONTRIBUTING FACTORS; SATELLITE CELLS; STEM-CELLS; RAT MODEL; REGENERATION; REPAIR; REINNERVATION	Functional recovery is usually poor following peripheral nerve injury when reinnervation is delayed. Early innervation by sensory nerve has been indicated to prevent atrophy of the denervated muscle. It is hypothesized that early protection with sensory axons is adequate to improve functional recovery of skeletal muscle following prolonged denervation of mixed nerve injury. In this study, four groups of rats received surgical denervation of the tibial nerve. The proximal and distal stumps of the tibial nerve were ligated in all animals except for those in the immediate repair group. The experimental groups underwent denervation with nerve protection of peroneal nerve (mixed protection) or sural nerve (sensory protection). The experimental and unprotected groups had a stage II surgery in which the trimmed proximal and distal tibial nerve stumps were sutured together. After 3 months of recovery, electrophysiological, histological and morphometric parameters were assessed. It was detected that the significant muscle atrophy and a good preserved structure of the muscle were observed in the unprotected and protective experimental groups, respectively. Significantly fewer numbers of regenerated myelinated axons were observed in the sensory-protected group. Enhanced recovery in the mixed protection group was indicated by the results of the muscle contraction force tests, regenerated myelinated fiber, and the results of the histological analysis. Our results suggest that early axons protection by mixed nerve may complement sensory axons which are required for promoting functional recovery of the denervated muscle natively innervated by mixed nerve.	[Li, Qing Tian; Zhang, Pei Xun; Yin, Xiao Feng; Han, Na; Kou, Yu Hui; Deng, Jiu Xu; Jiang, Bao Guo] Peking Univ, Peoples Hosp, Dept Trauma & Orthopead, Beijing 100871, Peoples R China	Peking University	Zhang, PX (corresponding author), Peking Univ, Peoples Hosp, Dept Trauma & Orthopead, Beijing 100871, Peoples R China.	zhangpeixun@126.com; jiangbaoguo@vip.sina.com			National Natural Science Fund [31171150, 31271284, 81171146, 30971526, 30801169]; Beijing City Science and Technology New Star Classification [A-2008-10]; Educational Ministry New Century Excellent Talents Support Project [BMU 20110270]; National 973 Program [2014CB542206]; National Natural Science Youth Science Fund [31100860]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Beijing City Science and Technology New Star Classification; Educational Ministry New Century Excellent Talents Support Project; National 973 Program(National Basic Research Program of China); National Natural Science Youth Science Fund	This study was supported by National Natural Science Fund (31171150, 31271284, 81171146, 30971526, 30801169), Beijing City Science and Technology New Star Classification (A-2008-10), Educational Ministry New Century Excellent Talents Support Project (BMU 20110270), National 973 Program (2014CB542206) and National Natural Science Youth Science Fund (31100860). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; Aydin MA, 2004, PLAST RECONSTR SURG, V113, P1712, DOI 10.1097/01.PRS.0000118049.93654.CA; Bain JR, 2008, J NEUROSURG, V109, P955, DOI 10.3171/JNS/2008/109/11/0955; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155; Colbert SH, 2008, HAND CLIN, V24, P341, DOI 10.1016/j.hcl.2008.07.001; Dedkov EI, 2003, J HISTOCHEM CYTOCHEM, V51, P853, DOI 10.1177/002215540305100701; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fujiwara T, 2007, J NEUROSURG, V107, P821, DOI 10.3171/JNS-07/10/0821; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hoke A, 2000, NEUROREPORT, V11, P1651; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Hynes NM, 1997, J RECONSTR MICROSURG, V13, P337, DOI 10.1055/s-2007-1006413; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kale SS, 2011, J HAND SURG-AM, V36A, P1631, DOI 10.1016/j.jhsa.2011.06.029; Kawabuchi M, 2001, ANAT RECORD, V264, P183, DOI 10.1002/ar.1159; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Rueger MA, 2008, NEUROSCI LETT, V434, P253, DOI 10.1016/j.neulet.2008.01.073; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Soler-Martin C, 2012, NEUROPATH APPL NEURO, V38, P61, DOI 10.1111/j.1365-2990.2011.01178.x; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Veltri K, 2005, J RECONSTR MICROSURG, V21, P57, DOI 10.1055/s-2005-862783; Yoshimura K, 2002, PLAST RECONSTR SURG, V109, P212, DOI 10.1097/00006534-200201000-00032; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1; Zhao CN, 2004, J NEUROTRAUM, V21, P1468, DOI 10.1089/neu.2004.21.1468; Zuijdendorp HM, 2010, J PLAST RECONSTR AES, V63, P1949, DOI 10.1016/j.bjps.2010.01.018	37	58	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79746	10.1371/journal.pone.0079746	http://dx.doi.org/10.1371/journal.pone.0079746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244555	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900050
J	Tian, ZC; Liu, GY; Yin, H; Luo, JX; Guan, GQ; Luo, J; Xie, JR; Shen, H; Tian, MY; Zheng, JF; Yuan, XS; Wang, FF				Tian, Zhan-Cheng; Liu, Guang-Yuan; Yin, Hong; Luo, Jian-Xun; Guan, Gui-Quan; Luo, Jin; Xie, Jun-Ren; Shen, Hui; Tian, Mei-Yuan; Zheng, Jin-feng; Yuan, Xiao-song; Wang, Fang-fang			RPS8-a New Informative DNA Marker for Phylogeny of Babesia and Theileria Parasites in China	PLOS ONE			English	Article							UNNAMED BOVINE BABESIA; GENOME SEQUENCE; TRANSMISSION; EVOLUTION; GENE; PATHOGEN; SHEEP; SPP.	Piroplasmosis is a serious debilitating and sometimes fatal disease. Phylogenetic relationships within piroplasmida are complex and remain unclear. We compared the intron-exon structure and DNA sequences of the RPS8 gene from Babesia and Theileria spp. isolates in China. Similar to 18S rDNA, the 40S ribosomal protein S8 gene, RPS8, including both coding and non-coding regions is a useful and novel genetic marker for defining species boundaries and for inferring phylogenies because it tends to have little intra-specific variation but considerable inter-specific difference. However, more samples are needed to verify the usefulness of the RPS8 (coding and non-coding regions) gene as a marker for the phylogenetic position and detection of most Babesia and Theileria species, particularly for some closely related species.	[Tian, Zhan-Cheng; Liu, Guang-Yuan; Yin, Hong; Luo, Jian-Xun; Guan, Gui-Quan; Luo, Jin; Xie, Jun-Ren; Shen, Hui; Tian, Mei-Yuan; Zheng, Jin-feng; Yuan, Xiao-song; Wang, Fang-fang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Tian, ZC (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	tianzhancheng@caas.cn; liuguangyuan2002@sina.com	Luo, jian/HGE-7331-2022; Yin, Hong/AAC-5784-2020		National Natural Sciences Foundation of China [31201899, 30972182]; Natural Science Foundation of Gansu Province [096RJZA128]; Science Fund for Creative Research Groups Of Gansu Province [1210RJIA006]; Key Project of Gansu Province [092NKDA031]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province; Science Fund for Creative Research Groups Of Gansu Province(Science Fund for Creative Research Groups); Key Project of Gansu Province	This work was supported, in part, by the National Natural Sciences Foundation of China (numbers 31201899 and 30972182), the Natural Science Foundation of Gansu Province (number 096RJZA128), the Science Fund for Creative Research Groups Of Gansu Province (number 1210RJIA006), Key Project of Gansu Province (092NKDA031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MTEP, 2006, ANN NY ACAD SCI, V1081, P509, DOI 10.1196/annals.1373.076; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bai Q., 1990, Chinese Journal of Veterinary Medicine, V16, P2; Bai Q., 1991, CHIN J VET SCI TECHN, V1, P20; Bai Q., 1987, CHIN J VET SCI TECHN, V9, P25; Bai Qi, 1994, Chinese Journal of Veterinary Science & Technology, V24, P9; Bai Qi, 2002, Acta Veterinaria et Zootechnica Sinica, V33, P73; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Chen K, 2010, BIOPHYS J, V99, P3930, DOI 10.1016/j.bpj.2010.09.062; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Criado-Fornelio A, 2003, VET PARASITOL, V114, P173, DOI 10.1016/S0304-4017(03)00141-9; DRUMMOND AJ, 2009, GENEIOUS V4 7; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 2004, INFERRING PHYLOGENIE, P90415, DOI DOI 10.1016/J.YMPEV.2004.07.003; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gou HT, 2012, ACTA TROP, V124, P92, DOI 10.1016/j.actatropica.2012.07.001; Guan G.Q., 2001, J CHIN VET SCI TECHN, V31, P35; Guan GQ, 2002, PARASITOL RES, V88, pS22, DOI 10.1007/s00436-001-0564-5; Guan GQ, 2009, EXP PARASITOL, V122, P261, DOI 10.1016/j.exppara.2009.05.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kuttler K.L., 1988, P1; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; Liu AH, 2010, EXP PARASITOL, V126, P476, DOI 10.1016/j.exppara.2010.05.024; Luo Jin, 2011, Scientia Agricultura Sinica, V44, P3694; Luo JX, 1997, TROP ANIM HEALTH PRO, V29, p4S, DOI 10.1007/BF02632906; Luo JX, 2005, VET PARASITOL, V133, P1, DOI 10.1016/j.vetpar.2005.02.014; Luo JX, 2005, PARASITOL RES, V95, P145, DOI 10.1007/s00436-004-1268-4; Luo JX, 2003, VET PARASITOL, V116, P115, DOI 10.1016/S0304-4017(03)00262-0; Luo JX, 2006, CHIN J PARASITOL PAR, V24, pS48; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; SCHEIN E, 1981, TROPENMED PARASITOL, V32, P223; Schnittger L, 2003, PARASITOL RES, V91, P398, DOI 10.1007/s00436-003-0979-2; Tian ZC, 2013, INFECT GENET EVOL, V18, P13, DOI 10.1016/j.meegid.2013.04.002; Tian ZC, 2013, INFECT GENET EVOL, V13, P36, DOI 10.1016/j.meegid.2012.09.001; Vishwanath P, 2004, MOL PHYLOGENET EVOL, V33, P615, DOI 10.1016/j.ympev.2004.07.003; Voigt O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-69; Yin H, 1997, TROP ANIM HEALTH PRO, V29, p11S, DOI 10.1007/BF02632908; Yin H, 1996, VET PARASITOL, V67, P89, DOI 10.1016/S0304-4017(96)01022-9; Yin H, 2002, PARASITOL RES, V88, pS25, DOI 10.1007/s00436-001-0565-4; Yin Hong, 1997, Chinese Journal of Veterinary Science & Technology, V27, P7; Yin H, 2007, PARASITOL RES, V101, pS191	48	21	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79860	10.1371/journal.pone.0079860	http://dx.doi.org/10.1371/journal.pone.0079860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244571	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900056
J	Wu, ZY; Song, LX; Liu, SQ; Huang, DJ				Wu, Ziyun; Song, Lixia; Liu, Shao Quan; Huang, Dejian			Independent and Additive Effects of Glutamic Acid and Methionine on Yeast Longevity	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIC RESTRICTION; DIETARY RESTRICTION; STRESS RESISTANCE; RHESUS-MONKEYS; BUDDING YEAST; EXTENSION; SURVIVAL; SCH9	It is established that glucose restriction extends yeast chronological and replicative lifespan, but little is known about the influence of amino acids on yeast lifespan, although some amino acids were reported to delay aging in rodents. Here we show that amino acid composition greatly alters yeast chronological lifespan. We found that non-essential amino acids (to yeast) methionine and glutamic acid had the most significant impact on yeast chronological lifespan extension, restriction of methionine and/or increase of glutamic acid led to longevity that was not the result of low acetic acid production and acidification in aging media. Remarkably, low methionine, high glutamic acid and glucose restriction additively and independently extended yeast lifespan, which could not be further extended by buffering the medium (pH 6.0). Our preliminary findings using yeasts with gene deletion demonstrate that glutamic acid addition, methionine and glucose restriction prompt yeast longevity through distinct mechanisms. This study may help to fill a gap in yeast model for the fast developing view that nutrient balance is a critical factor to extend lifespan.	[Wu, Ziyun; Liu, Shao Quan; Huang, Dejian] Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore; [Wu, Ziyun; Song, Lixia; Liu, Shao Quan; Huang, Dejian] Natl Univ Singapore Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; National University of Singapore	Huang, DJ (corresponding author), Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore.	chmhdj@nus.edu.sg	Liu, shao quan/D-3172-2016; Huang, Dejian/A-7439-2010; Wu, Ziyun/C-1592-2009	Liu, shao quan/0000-0003-0868-2731; Wu, Ziyun/0000-0001-8239-1890; Huang, Dejian/0000-0002-2305-3960	National University of Singapore Virtual Institute for the Study of Aging (VISA) [R-143-000-437-290]	National University of Singapore Virtual Institute for the Study of Aging (VISA)	The authors are grateful for the financial support of National University of Singapore Virtual Institute for the Study of Aging (VISA) (grant number: R-143-000-437-290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Javitt DC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002804; Jiang JC, 2000, FASEB J, V14, P2135; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lee YJ, 2012, J BIOL CHEM, V287, P44221, DOI 10.1074/jbc.M112.375360; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Mirisola MG, 2012, CELL CYCLE, V11, P3532, DOI 10.4161/cc.22042; Murakami C, 2012, CELL CYCLE, V11, P3087, DOI 10.4161/cc.21465; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; ORENTREICH N, 1993, J NUTR, V123, P269; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064448; Wu ZY, 2011, EXP GERONTOL, V46, P915, DOI 10.1016/j.exger.2011.08.002; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	56	53	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79319	10.1371/journal.pone.0079319	http://dx.doi.org/10.1371/journal.pone.0079319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244480	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900036
J	Yi, H; Dey, S; Kumaran, S; Lee, SG; Krishnan, HB; Jez, JM				Yi, Hankuil; Dey, Sanghamitra; Kumaran, Sangaralingam; Lee, Soon Goo; Krishnan, Hari B.; Jez, Joseph M.			Structure of Soybean Serine Acetyltransferase and Formation of the Cysteine Regulatory Complex as a Molecular Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Crystal Structure; Enzyme Structure; Plant Biochemistry; Plant Molecular Biology	O-ACETYLSERINE SULFHYDRYLASE; SULFUR ASSIMILATION PATHWAY; ARABIDOPSIS-THALIANA; GENE-FAMILY; SYNTHASE COMPLEX; ESCHERICHIA-COLI; HIGHER-PLANTS; GLUTATHIONE SYNTHESIS; CATALYTIC MECHANISM; EXPRESSION ANALYSIS	Background: Serine acetyltransferase (SAT) catalyzes the limiting step in cysteine biosynthesis. Results: Analysis of soybean SAT provides insight into catalysis and protein-protein interactions. Conclusion: Key structural features are required for catalysis and formation of a stable macromolecular complex. Significance: A new role for protein complex formation in plant cysteine biosynthesis is proposed. Serine acetyltransferase (SAT) catalyzes the limiting reaction in plant and microbial biosynthesis of cysteine. In addition to its enzymatic function, SAT forms a macromolecular complex with O-acetylserine sulfhydrylase. Formation of the cysteine regulatory complex (CRC) is a critical biochemical control feature in plant sulfur metabolism. Here we present the 1.75-3.0 resolution x-ray crystal structures of soybean (Glycine max) SAT (GmSAT) in apoenzyme, serine-bound, and CoA-bound forms. The GmSAT-serine and GmSAT-CoA structures provide new details on substrate interactions in the active site. The crystal structures and analysis of site-directed mutants suggest that His(169) and Asp(154) form a catalytic dyad for general base catalysis and that His(189) may stabilize the oxyanion reaction intermediate. Glu(177) helps to position Arg(203) and His(204) and the 1c-2c loop for serine binding. A similar role for ionic interactions formed by Lys(230) is required for CoA binding. The GmSAT structures also identify Arg(253) as important for the enhanced catalytic efficiency of SAT in the CRC and suggest that movement of the residue may stabilize CoA binding in the macromolecular complex. Differences in the effect of cold on GmSAT activity in the isolated enzyme versus the enzyme in the CRC were also observed. A role for CRC formation as a molecular chaperone to maintain SAT activity in response to an environmental stress is proposed for this multienzyme complex in plants.	[Yi, Hankuil] Chungnam Natl Univ, Dept Biol Sci, Taejon 305764, South Korea; [Dey, Sanghamitra] Presidency Univ, Dept Biol Sci, Kolkata 700073, W Bengal, India; [Kumaran, Sangaralingam] CSIR, Sect 39A, Inst Microbial Technol, Chandigarh 160036, India; [Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Krishnan, Hari B.] Univ Missouri, Plant Genet Res Unit, USDA, ARS,Dept Agron, Columbia, MO 65211 USA	Chungnam National University; Presidency University, Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Washington University (WUSTL); United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Dey, Sanghamitra/AAV-7921-2021	Lee, Soon Goo/0000-0002-1541-8587	United States Department of Agriculture [NRI-2005-02518]; ARS [ARS-0424526] Funding Source: Federal RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture Grant NRI-2005-02518 (to J. M. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog O, 2008, BIOPOLYMERS, V89, P354, DOI 10.1002/bip.20866; Amtmann A., 2009, Current Opinion in Plant Biology, V12, P275, DOI 10.1016/j.pbi.2009.04.014; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Blaszczyk A, 1999, PLANT J, V20, P237, DOI 10.1046/j.1365-313x.1999.00596.x; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; BOGDANOVA N, 1995, FEBS LETT, V358, P43, DOI 10.1016/0014-5793(94)01392-E; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; COOK PF, 1978, J BIOL CHEM, V253, P7874; Droux M, 2003, PLANT PHYSIOL BIOCH, V41, P619, DOI 10.1016/S0981-9428(03)00083-4; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Freeman JL, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-63; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Guan R, 2008, BIOCHEMISTRY-US, V47, P6322, DOI 10.1021/bi800075c; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Howarth JR, 2003, PLANT MOL BIOL, V51, P589, DOI 10.1023/A:1022349623951; Howarth JR, 1997, BBA-GENE STRUCT EXPR, V1350, P123, DOI 10.1016/S0167-4781(96)00213-8; Hubberten HM, 2012, PLANT J, V70, P666, DOI 10.1111/j.1365-313X.2012.04905.x; Nguyen HC, 2012, J EXP BOT, V63, P5991, DOI 10.1093/jxb/ers253; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jez JM, 2013, CURR OPIN STRUC BIOL, V23, P302, DOI 10.1016/j.sbi.2013.02.011; Johnson CM, 2004, BIOCHEMISTRY-US, V43, P15534, DOI 10.1021/bi048450h; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Kim WS, 2012, PLANTA, V235, P13, DOI 10.1007/s00425-011-1487-8; Kocsy G, 2001, PHYSIOL PLANTARUM, V113, P158, DOI 10.1034/j.1399-3054.2001.1130202.x; Kocsy G, 2000, PLANTA, V210, P295, DOI 10.1007/PL00008137; Kocsy G, 2000, PLANTA, V211, P528, DOI 10.1007/s004250000308; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; LEU LS, 1994, BIOCHEMISTRY-US, V33, P2667, DOI 10.1021/bi00175a040; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McManus MT, 2005, PHYTOCHEMISTRY, V66, P1407, DOI 10.1016/j.phytochem.2005.04.034; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murillo M, 1995, CELL MOL BIOL RES, V41, P425; Na GN, 2011, J BIOL CHEM, V286, P40423, DOI 10.1074/jbc.M111.247411; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Noji M, 2001, PLANT CELL PHYSIOL, V42, P627, DOI 10.1093/pcp/pce078; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Roberts MA, 1996, PLANT MOL BIOL, V30, P1041, DOI 10.1007/BF00020814; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; RUFFET ML, 1995, EUR J BIOCHEM, V227, P500, DOI 10.1111/j.1432-1033.1995.tb20416.x; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Shin R, 2011, FEBS LETT, V585, P143, DOI 10.1016/j.febslet.2010.11.025; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Tabe L, 2010, J EXP BOT, V61, P721, DOI 10.1093/jxb/erp338; Taguchi S, 2000, APPL ENVIRON MICROB, V66, P1410, DOI 10.1128/AEM.66.4.1410-1415.2000; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Thoden JB, 2012, BIOCHEMISTRY-US, V51, P3433, DOI 10.1021/bi300197h; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P2699, DOI 10.1021/bi802313n; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2012, J BIOL CHEM, V287, P27941, DOI 10.1074/jbc.M112.372656; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; Yi H, 2012, PHYTOCHEMISTRY, V83, P15, DOI 10.1016/j.phytochem.2012.08.003; Yi H, 2012, PLANT CELL, V24, P2696, DOI 10.1105/tpc.112.098954; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112	81	28	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36463	36472		10.1074/jbc.M113.527143	http://dx.doi.org/10.1074/jbc.M113.527143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225955	Green Published, hybrid			2022-12-25	WOS:000328883400027
J	Bursztyka, P; Saffray, D; Lafont-Lecuelle, C; Brin, A; Pageat, P				Bursztyka, Piotr; Saffray, Dominique; Lafont-Lecuelle, Celine; Brin, Antoine; Pageat, Patrick			Chemical Compounds Related to the Predation Risk Posed by Malacophagous Ground Beetles Alter Self-Maintenance Behavior of Naive Slugs (Deroceras reticulatum)	PLOS ONE			English	Article							PARDOSA-MILVINA ARANEAE; PTEROSTICHUS-MELANARIUS COLEOPTERA; FRESH-WATER SNAILS; CARABID BEETLES; ANTIPREDATOR BEHAVIOR; GENERALIST PREDATOR; MOLLUSCICIDAL BAITS; BIOLOGICAL-CONTROL; LYMNAEA-STAGNALIS; TERRESTRIAL SLUG	Evidence that terrestrial gastropods are able to detect chemical cues from their predators is obvious yet scarce, despite the scientific relevance of the topic to enhancing our knowledge in this area. This study examines the influence of cuticular extracts from predacious ground beetles (Carabus auratus, Carabus hispanus, Carabus nemoralis and Carabus coriaceus), and a neutral insect species (Musca domestica) on the shelter-seeking behavior of naive slugs (Deroceras reticulatum). Slugs, known to have a negative phototactic response, were exposed to light, prompting them to make a choice between either a shelter treated with a cuticular extract or a control shelter treated with pure ethyl alcohol. Their behavioral responses were recorded for one hour in order to determine their first shelter choice, their final position, and to compare the percentage of time spent in the control shelters with the time spent in the treated shelters. The test proved to be very effective: slugs spent most of the experiment in a shelter. They spent significantly more time in the control shelter than in the shelter treated with either C. nemoralis (Z = 2.43; p = 0.0151; Wilcoxon matched-pairs signed-ranks test) or C. coriaceus cuticular extracts (Z = 3.31; p<0.01; Wilcoxon matched-pairs signed-ranks test), with a seemingly stronger avoidance effect when presented with C. coriaceus extracts. The other cuticular extracts had no significant effect on any of the behavioral items measured. Although it cannot be entirely excluded that the differences observed, are partly due to the intrinsic properties of the vehicle employed to build the cuticular extracts, the results suggest that slugs can innately discriminate amongst different potential predators and adjust their behavioral response according to the relevance of the threat conveyed by their predator's chemical cues.	[Bursztyka, Piotr; Saffray, Dominique; Lafont-Lecuelle, Celine; Pageat, Patrick] Res Inst Semiochem & Appl Ethol, Dept Agron Aquaculture, St Saturnin Les Apt, Vaucluse, France; [Bursztyka, Piotr; Brin, Antoine] Engn Sch Purpan, Biodiversite Syst Agr & Nat UMR Dynafor 1201, Toulouse, Haute Garonne, France		Bursztyka, P (corresponding author), Res Inst Semiochem & Appl Ethol, Dept Agron Aquaculture, St Saturnin Les Apt, Vaucluse, France.	p.bursztyka@group-irsea.com		Brin, Antoine/0000-0003-3479-3005				Altena C. O. v. R., 1960, Basteria, V24, P21; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Armsworth CG, 2005, ANIM BEHAV, V69, P805, DOI 10.1016/j.anbehav.2004.07.009; ASTERAKI EJ, 1993, ENTOMOPHAGA, V38, P193, DOI 10.1007/BF02372553; Ayre K, 2001, J APPL ENTOMOL, V125, P389, DOI 10.1046/j.1439-0418.2001.00568.x; Ayre K, 1995, THESIS U NEWCASTLE U; BAILEY SER, 1991, ANN APPL BIOL, V119, P163, DOI 10.1111/j.1744-7348.1991.tb04855.x; Barker G. M., 2002, MOLLUSCS CROP PESTS; Barker GM, 2004, NATURAL ENEMIES TERR, DOI [10.1079/9780851993195.0000, DOI 10.1079/9780851993195.0000]; Barnes MC, 2002, J INSECT BEHAV, V15, P269, DOI 10.1023/A:1015493118836; Bell RD, 2006, ETHOLOGY, V112, P903, DOI 10.1111/j.1439-0310.2006.01244.x; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; BOURNE NB, 1988, J MOLLUS STUD, V54, P327, DOI 10.1093/mollus/54.3.327; Chapman R. F., 1998, INSECTS STRUCTURE FU, P636; Chapman RF., 1998, INSECTS STRUCTURE FU, P478; CHASE R, 1982, J COMP PHYSIOL, V148, P225, DOI 10.1007/BF00619129; CHASE R, 1986, CHEM SENSES, V11, P411, DOI 10.1093/chemse/11.4.411; Chivers DP, 1996, ANIM BEHAV, V52, P315, DOI 10.1006/anbe.1996.0177; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Corfield GS, 2008, J VET EMERG CRIT CAR, V18, P68, DOI 10.1111/j.1476-4431.2007.00271.x; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; DAINTON BH, 1985, J EXP BIOL, V118, P439; DAINTON BH, 1954, J EXP BIOL, V31, P188; DAINTON BH, 1954, J EXP BIOL, V31, P165; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; DEYRUPOLSEN I, 1986, MALACOLOGIA, V27, P307; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DIGWEED SC, 1994, COLEOPTS BULL, V48, P361; EAKIN RM, 1975, AM ZOOL, V15, P851; EDMUNDS M, 1974, DEFENCE ANIMAL SURVE; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Gawleta N, 2005, APIDOLOGIE, V36, P325, DOI 10.1051/apido:2005018; Grewal PS, 2001, BIOL CONTROL, V22, P72, DOI 10.1006/bcon.2001.0958; GRUTTKE H, 1994, SERIES ENTOM, V51, P299; Guy AG, 2008, ANIM BEHAV, V76, P585, DOI 10.1016/j.anbehav.2008.04.004; HAMILTON PV, 1984, ANIM BEHAV, V32, P51, DOI 10.1016/S0003-3472(84)80323-1; Hara T.J., 1992, Fish and Fisheries Series, V6, P1; Hatteland BA, 2010, B ENTOMOL RES, V100, P559, DOI 10.1017/S0007485309990629; HENGEVELD R, 1980, NETH J ZOOL, V30, P555, DOI 10.1163/002829679X00188; HOMEIDA A M, 1982, Journal of Veterinary Pharmacology and Therapeutics, V5, P77, DOI 10.1111/j.1365-2885.1982.tb00500.x; Hommay G, 2003, ANN APPL BIOL, V142, P333, DOI 10.1111/j.1744-7348.2003.tb00258.x; Hommay G, 1998, ANN APPL BIOL, V132, P167, DOI 10.1111/j.1744-7348.1998.tb05193.x; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; Johnson Ian P., 1992, P144; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; KENNEDY PJ, 1994, SERIES ENTOM, V51, P439; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; Kiesecker JM, 1996, ANIM BEHAV, V52, P1237, DOI 10.1006/anbe.1996.0271; Kiss L, 2005, J MOLLUS STUD, V71, P221, DOI 10.1093/mollus/eyi030; KOHN AJ, 1961, AM ZOOL, V1, P291; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; LABAUNE C., 1999, COURRIER SCI PARC NA, V3, P102; Lefcort H, 2006, J ETHOL, V24, P97, DOI 10.1007/s10164-005-0168-0; Lehmann LM, 2004, ETHOLOGY, V110, P323, DOI 10.1111/j.1439-0310.2004.00972.x; LEWIS R D, 1969, Malacologia, V7, P295; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LYTH M, 1982, J MOLLUS STUD, V48, P214; Mair J, 2002, BIOCONTROL SCI TECHN, V12, P325, DOI 10.1080/09583150220128112; Mair J, 2001, AGR FOREST ENTOMOL, V3, P99, DOI 10.1046/j.1461-9563.2001.00093.x; Martin TJ, 1986, P 1986 BRIGHT CROP P, P441; McKemey AR, 2001, BIOCONTROL SCI TECHN, V11, P81, DOI 10.1080/09583150020029763; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; NEWELL PF, 1966, MED BIOL ILLUS, V16, P146; Newell PF, 1968, MEASUREMENT ENV FACT, P141; NIEMELA JK, 1994, ECOGRAPHY, V17, P166, DOI 10.1111/j.1600-0587.1994.tb00090.x; Nordlund DA, 1976, J CHEM ECOL, V2, P211, DOI 10.1007/BF00987744; Oberholzer F, 2003, BIOCONTROL SCI TECHN, V13, P99, DOI 10.1080/0958315021000054421; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; PAKARINEN E, 1994, J MOLLUS STUD, V60, P19, DOI 10.1093/mollus/60.1.19; PAKARINEN E, 1994, J MOLLUS STUD, V60, P149, DOI 10.1093/mollus/60.2.149; Persons MH, 2001, J CHEM ECOL, V27, P2493, DOI 10.1023/A:1013679532070; Persons MH, 2001, ANIM BEHAV, V61, P43, DOI 10.1006/anbe.2000.1594; Puttlitz MH, 1999, ETHOLOGY, V105, P449, DOI 10.1046/j.1439-0310.1999.00416.x; Riecken U, 1996, ANN ZOOL FENN, V33, P109; ROLLO CD, 1994, NATURWISSENSCHAFTEN, V81, P409, DOI 10.1007/BF01132695; ROLLO CD, 1991, MALACOLOGIA, V33, P199; ROLLO CD, 1995, ENVIRON ENTOMOL, V24, P116, DOI 10.1093/ee/24.1.116; Rostas M, 2009, J CHEM ECOL, V35, P20, DOI 10.1007/s10886-009-9590-z; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; Sih A., 1987, PREDATION DIRECT IND; Skodowski J.J.W., 2005, P 11 EUR CAR M AARH, P291; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; SOUTH A, 1992, TERRESTRIAL SLUGS BI; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Stout JC, 1998, BEHAV ECOL SOCIOBIOL, V43, P317, DOI 10.1007/s002650050497; Sturani M., 1962, Memorie della Societa Entomologica Italiana, V41, P85; Symondson W. O. C., 1989, Monograph - British Crop Protection Council, P295; Symondson William O.C., 2004, P37, DOI 10.1079/9780851993195.0037; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Symondson WOC, 2002, ECOLOGY, V83, P137, DOI 10.2307/2680127; SYMONDSON WOC, 1993, ANN APPL BIOL, V123, P449, DOI 10.1111/j.1744-7348.1993.tb04107.x; Symondson WOC, 1996, J APPL ECOL, V33, P741, DOI 10.2307/2404945; SYMONDSON WOC, 1994, ENTOMOPHAGA, V39, P323, DOI 10.1007/BF02373037; Talarico F, 2007, J ZOOL SYST EVOL RES, V45, P33, DOI 10.1111/j.1439-0469.2006.00394.x; Turin H, 2003, GENUS CARABUS EUROPE, P141; Turner AM, 1996, ANIM BEHAV, V51, P747, DOI 10.1006/anbe.1996.0079; Turner AM, 2006, ANIM BEHAV, V72, P1443, DOI 10.1016/j.anbehav.2006.05.010; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VERMEIJ GJ, 1982, AM NAT, V120, P701, DOI 10.1086/284025; WAHLE RA, 1992, OIKOS, V65, P52, DOI 10.2307/3544887; WAREING DR, 1985, J MOLLUS STUD, V51, P257; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wisenden BD, 2001, ANIM BEHAV, V62, P761, DOI 10.1006/anbe.2001.1797; Witjes S, 2009, J CHEM ECOL, V35, P1320, DOI 10.1007/s10886-009-9720-7; Woelfling Mirko, 2009, Communicative & Integrative Biology, V2, P353; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zaitseva O V, 1999, Neurosci Behav Physiol, V29, P581, DOI 10.1007/BF02461151; Zaitseva O V, 1994, Neurosci Behav Physiol, V24, P47, DOI 10.1007/BF02355652; Zieger MV, 2009, ACTA ZOOL-STOCKHOLM, V90, P189, DOI 10.1111/j.1463-6395.2008.00369.x	120	6	6	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79361	10.1371/journal.pone.0079361	http://dx.doi.org/10.1371/journal.pone.0079361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244487	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800064
J	Hess, D; Brucker, C; Hegner, F; Balmert, A; Bleckmann, H				Hess, David; Bruecker, Christoph; Hegner, Franziska; Balmert, Alexander; Bleckmann, Horst			Vortex Formation with a Snapping Shrimp Claw	PLOS ONE			English	Article								Snapping shrimp use one oversized claw to generate a cavitating high speed water jet for hunting, defence and communication. This work is an experimental investigation about the jet generation. Snapping shrimp (Alpheus-bellulus) were investigated by using an enlarged transparent model reproducing the closure of the snapper claw. Flow inside the model was studied using both High-Speed Particle Image Velocimetry (HS-PIV) and flow visualization. During claw closure a channel-like cavity was formed between the plunger and the socket featuring a nozzle-type contour at the orifice. Closing the mechanism led to the formation of a leading vortex ring with a dimensionless formation number of approximate Delta T*approximate to 4. This indicates that the claw might work at maximum efficiency, i.e. maximum vortex strength was achieved by a minimum of fluid volume ejected. The subsequent vortex cavitation with the formation of an axial reentrant jet is a reasonable explanation for the large penetration depth of the water jet. That snapping shrimp can reach with their claw-induced flow. Within such a cavitation process, an axial reentrant jet is generated in the hollow cylindrical core of the cavitated vortex that pushes the front further downstream and whose length can exceed the initial jet penetration depth by several times.	[Hess, David; Bruecker, Christoph; Hegner, Franziska] Tech Univ Freiberg, Inst Mech & Fluid Dynam, Freiberg, Saxony, Germany; [Balmert, Alexander; Bleckmann, Horst] Univ Bonn, Inst Zool, Bonn, North Rhine Wes, Germany	Technical University Freiberg; University of Bonn	Hess, D (corresponding author), Tech Univ Freiberg, Inst Mech & Fluid Dynam, Freiberg, Saxony, Germany.	David.Hess@imfd.tu-freiberg.de		Bruecker, Christoph/0000-0001-5834-3020	Deutsche Forschungsgemeinschaft [BR 1494/16-1, BL 242/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study is funded by the Deutsche Forschungsgemeinschaft: BR 1494/16-1 and BL 242/17-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt REA, 2002, ANNU REV FLUID MECH, V34, P143, DOI 10.1146/annurev.fluid.34.082301.114957; Belyakov GV, 2005, J EXPT THEORETICAL P, V102, P862; Brooks WK, 1891, MEM NAT AKAD SCI WAS, V5, P319; Dabiri JO, 2005, J FLUID MECH, V538, P111, DOI 10.1017/S002211200500515X; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Gharib M, 1998, J FLUID MECH, V360, P121, DOI 10.1017/S0022112097008410; Herberholz J, 1999, J COMP PHYSIOL A, V185, P41, DOI 10.1007/s003590050364; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Vogel S, 1996, LIFE MOVING FLUIDS P; VOLZ P., 1938, ZEITSCHR MORPH U OKOL TIERE, V34, P272, DOI 10.1007/BF00408760	10	14	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e77120	10.1371/journal.pone.0077120	http://dx.doi.org/10.1371/journal.pone.0077120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244273	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000327143800002
J	Ji, R; Yu, HX; Fu, Q; Chen, HD; Ye, WF; Li, SH; Lou, YG				Ji, Rui; Yu, Haixin; Fu, Qiang; Chen, Hongdan; Ye, Wenfeng; Li, Shaohui; Lou, Yonggen			Comparative Transcriptome Analysis of Salivary Glands of Two Populations of Rice Brown Planthopper, Nilaparvata lugens, That Differ in Virulence	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; ALKALINE-PHOSPHATASE; CHEMOSENSORY PROTEINS; ACYRTHOSIPHON-PISUM; PROTEOMIC ANALYSIS; DEFENSE RESPONSES; MYZUS-PERSICAE; PHLOEM SAP; EXPRESSION; IDENTIFICATION	Background: The brown planthopper (BPH), Nilaparvata lugens (Stal), a destructive rice pest in Asia, can quickly overcome rice resistance by evolving new virulent populations. Herbivore saliva plays an important role in plant-herbivore interactions, including in plant defense and herbivore virulence. However, thus far little is known about BPH saliva at the molecular level, especially its role in virulence and BPH-rice interaction. Methodology/Principal Findings: Using cDNA amplification in combination with Illumina short-read sequencing technology, we sequenced the salivary-gland transcriptomes of two BPH populations with different virulence; the populations were derived from rice variety TN1 (TN1 population) and Mudgo (M population). In total, 37,666 and 38,451 unigenes were generated from the salivary glands of these populations, respectively. When combined, a total of 43,312 unigenes were obtained, about 18 times more than the number of expressed sequence tags previously identified from these glands. Gene ontology annotations and KEGG orthology classifications indicated that genes related to metabolism, binding and transport were significantly active in the salivary glands. A total of 352 genes were predicted to encode secretory proteins, and some might play important roles in BPH feeding and BPH-rice interactions. Comparative analysis of the transcriptomes of the two populations revealed that the genes related to 'metabolism,' 'digestion and absorption,' and 'salivary secretion' might be associated with virulence. Moreover, 67 genes encoding putative secreted proteins were differentially expressed between the two populations, suggesting these genes may contribute to the change in virulence. Conclusions/Significance: This study was the first to compare the salivary-gland transcriptomes of two BPH populations having different virulence traits and to find genes that may be related to this difference. Our data provide a rich molecular resource for future functional studies on salivary glands and will be useful for elucidating the molecular mechanisms underlying BPH feeding and virulence differences.	[Ji, Rui; Yu, Haixin; Chen, Hongdan; Ye, Wenfeng; Lou, Yonggen] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Qiang] China Natl Rice Res Inst, Res & Dev Ctr Rice Prod Technol, Hangzhou, Zhejiang, Peoples R China; [Li, Shaohui] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Lou, YG (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	yglou@zju.edu.cn	Ye, Wenfeng/ACL-7903-2022	Ye, Wenfeng/0000-0003-0750-3236; Ji, Rui/0000-0003-2920-5766	National Basic Research Program of China [2010CB126200]; Innovation Research Team Program of the National Natural Science Foundation of China [31021003]; China Agriculture Research System [CARS-01-25]	National Basic Research Program of China(National Basic Research Program of China); Innovation Research Team Program of the National Natural Science Foundation of China; China Agriculture Research System	The study was jointly sponsored by the National Basic Research Program of China (2010CB126200; http://www.most.gov.cn/index.htm), the Innovation Research Team Program of the National Natural Science Foundation of China (31021003; http://www.nsfc.gov.cn/Portal0/default152.htm), and the China Agriculture Research System (CARS-01-25; http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2012, INSECT BIOCHEM MOLEC, V42, P796, DOI 10.1016/j.ibmb.2012.07.008; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; CLARIDGE MF, 1984, ENTOMOL EXP APPL, V36, P107, DOI 10.1007/BF00569950; CLARIDGE MF, 1980, ENTOMOL EXP APPL, V27, P23, DOI 10.1007/BF00377236; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; DENHOLLANDER J, 1981, ENTOMOL EXP APPL, V29, P76, DOI 10.1007/BF00300752; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Feng GH, 1996, INSECT BIOCHEM MOLEC, V26, P419, DOI 10.1016/0965-1748(95)00087-9; Funk CJ, 2001, ARCH INSECT BIOCHEM, V46, P165, DOI 10.1002/arch.1026; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; GIVOVICH A, 1994, J CHEM ECOL, V20, P1923, DOI 10.1007/BF02066233; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hayashi H, 2000, AUST J PLANT PHYSIOL, V27, P489; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Konishi H, 2009, APPL ENTOMOL ZOOL, V44, P525, DOI 10.1303/aez.2009.525; KUMAR D, 1980, Z MIKROSK ANAT FORSC, V94, P669; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutti NS, 2006, THESIS KANSAS STATE; Nathan SS, 2007, PESTIC BIOCHEM PHYS, V88, P260, DOI 10.1016/j.pestbp.2006.12.004; Nathan SS, 2006, PESTIC BIOCHEM PHYS, V84, P98, DOI 10.1016/j.pestbp.2005.05.006; Ngernyuang N, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0138; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Ross MK, 2010, J PESTIC SCI, V35, P257, DOI 10.1584/jpestics.R10-07; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Shukle RH, 2009, J INSECT PHYSIOL, V55, P104, DOI 10.1016/j.jinsphys.2008.10.008; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P13; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P13; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P195; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P67; Sogawa K., 1965, Japanese Journal of Applied Entomology and Zoology, V9, P275; SRIVASTAVA J P, 1967, Applied Entomology and Zoology, V2, P85; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tang M, 2010, APPL ENVIRON MICROB, V76, P1740, DOI 10.1128/AEM.02240-09; Tenberge KB, 1999, MYCOL RES, V103, P1103, DOI 10.1017/S095375629800820X; Tunaz H, 2004, COMP BIOCHEM PHYS B, V139, P27, DOI 10.1016/j.cbpc.2004.05.010; Wang X, 2006, THESIS ZHEJIANG U; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yan Y, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.0109; Zhang MJ, 2010, APPL BIOCHEM BIOTECH, V160, P1407, DOI 10.1007/s12010-009-8602-3	77	59	69	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79612	10.1371/journal.pone.0079612	http://dx.doi.org/10.1371/journal.pone.0079612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244529	Green Published, Green Submitted			2022-12-25	WOS:000327143800093
J	Ma, QQ; Song, HX; Zhou, SQ; Yang, WQ; Li, DS; Chen, JS				Ma, Qing-qing; Song, Hui-xing; Zhou, Shi-qiang; Yang, Wan-qin; Li, De-sheng; Chen, Jin-song			Genetic Structure in Dwarf Bamboo (Bashania fangiana) Clonal Populations with Different Genet Ages	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; PLANT; DYNAMICS; TRAITS; AFLP; MARKERS; REPENS; LONG; SIZE	Amplified fragment length polymorphism (AFLP) fingerprints were used to reveal genotypic diversity of dwarf bamboo (Bashania fangiana) clonal populations with two different genet ages (<= 30 years versus >70 years) at Wolong National Natural Reserve, Sichuan province, China. We generated AFLP fingerprints for 96 leaf samples, collected at 30 m intervals in the two populations, using ten selective primer pairs. A total of 92 genotypes were identified from the both populations. The mean proportion of distinguishable genotypes (G/N) was 0.9583 (0.9375 to 0.9792) and Simpson's index of diversity (D) was 0.9982 (0.9973 to 0.9991). So, two B. fangiana populations were multiclonal and highly diverse. The largest single clone may occur over a distance of about 30 m. Our results demonstrated that the genotypic diversity and genet density of B. fangiana clonal population did not change significantly (47 versus 45) with genet aging and low partitioned genetic differentiation was between the two populations (Gst = 0.0571). The analysis of molecular variance consistently showed that a large proportion of the genetic variation (87.79%) existed among the individuals within populations, whereas only 12.21% were found among populations. In addition, the high level of genotypic diversity in the two populations implies that the further works were needed to investigate the reasons for the poor seed set in B. fangiana after flowering.	[Ma, Qing-qing; Song, Hui-xing] Sichuan Agr Univ, Sch Landscape Architecture, Wenjiang, Sichuan, Peoples R China; [Zhou, Shi-qiang; Li, De-sheng] China Conservat & Res Ctr Giant Panda, Wenchuan, Sichuan, Peoples R China; [Yang, Wan-qin] Sichuan Agr Univ, Inst Ecol Forestry, Wenjiang, Sichuan, Peoples R China; [Chen, Jin-song] Sichuan Normal Univ, Coll Life Sci, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Normal University	Song, HX (corresponding author), Sichuan Agr Univ, Sch Landscape Architecture, Wenjiang, Sichuan, Peoples R China.	Huixingsong@aliyun.com; cjs74@163.com	Shiqiang, Zhou/G-1331-2019	Shiqiang, Zhou/0000-0002-5537-3205	National Science Fund of China [31170502]; Key Projects in the National Science & Technology Pillar Program [2011BAC09B05]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program	This research was supported by National Science Fund of China (31170502) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAC09B05). In this study, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P869, DOI 10.2307/2260154; ANTONOVICS J, 1984, EVOLUTION, V38, P103, DOI 10.1111/j.1558-5646.1984.tb00263.x; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Campbell J. J. N., 1983, J AM BAMBOO SOC, V4, P1; COOK RE, 1983, AM SCI, V71, P244; DESTEVEN D, 1989, J ECOL, V77, P579, DOI 10.2307/2260771; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; FAGER EW, 1972, AM NAT, V106, P293, DOI 10.1086/282772; Grabherr G, 1997, ECOSY WORLD, V3, P97; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Harper J. L, 1977, POPULATION BIOL PLAN; HARTNETT DC, 1985, J ECOL, V73, P407, DOI 10.2307/2260483; HARTNETT DC, 1987, AM J BOT, V74, P1239, DOI 10.2307/2444159; Isagi Y, 2004, MOL ECOL, V13, P2017, DOI 10.1111/j.1365-294X.2004.02197.x; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Koshy KC, 2001, CURR SCI INDIA, V81, P375; Li XL, 2001, ACTA PHYTOTAXON SIN, V39, P433; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; MAKITA A, 1992, ECOL RES, V7, P245, DOI 10.1007/BF02347093; McLellan AJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P185; Miyazaki Y, 2009, J PLANT RES, V122, P523, DOI 10.1007/s10265-009-0241-9; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Numata M., 1970, Biological Conservation, V2, P227, DOI 10.1016/0006-3207(70)90120-5; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Oinonen E., 1967, ACTA FOR FENN, V83, P1, DOI DOI 10.14214/AFF.7180; PIELOU E C, 1969, P286; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pornon A, 1997, PLANT ECOL, V130, P1, DOI 10.1023/A:1009724216796; Schaller G.B., 1985, GIANT PANDAS WOLONG; SCHMID B, 1990, EVOL TREND PLANT, V4, P25; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Shiqiang Z, 1996, J BAMBOO RES, V4, P9; SIMMONDS N W, 1980, Kew Bulletin, V35, P235, DOI 10.2307/4114566; SOANE ID, 1979, NEW PHYTOL, V82, P557, DOI 10.1111/j.1469-8137.1979.tb02682.x; Sole M, 2004, INT J PLANT SCI, V165, P437, DOI 10.1086/382801; Stocklin J, 2009, BOT HELV, V119, P125, DOI 10.1007/s00035-009-0065-1; Suyama Y, 2000, MOL ECOL, V9, P901, DOI 10.1046/j.1365-294x.2000.00943.x; TAYLOR AH, 1987, J APPL ECOL, V24, P419, DOI 10.2307/2403884; TAYLOR DR, 1988, AM J BOT, V75, P401, DOI 10.2307/2443987; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Till-Bottraud I, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P23; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; Verburg R, 2000, PLANT BIOLOGY, V2, P646, DOI 10.1055/s-2000-16633; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WATKINSON AR, 1993, J ECOL, V81, P707, DOI 10.2307/2261668; WIDEN B, 1994, FOLIA GEOBOT PHYTOTX, V29, P245, DOI 10.1007/BF02803799; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang HQ, 2012, INT J MOL SCI, V13, P4446, DOI 10.3390/ijms13044446; ZHANG W, 1990, Forest Research, V3, P250; Zisheng Q, 1993, BAMBOO WOLONG GIANT	59	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78784	10.1371/journal.pone.0078784	http://dx.doi.org/10.1371/journal.pone.0078784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244360	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800018
J	Anwar, T; Gourinath, S				Anwar, Tamanna; Gourinath, Samudrala			Analysis of the Protein Phosphotome of Entamoeba histolytica Reveals an Intricate Phosphorylation Network	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; SUPERFAMILY; TARGETS; PREDICTION; INTERPRO; KINASES; FAMILY; WEB	Phosphorylation is the most common mechanism for the propagation of intracellular signals. Protein phosphatases and protein kinases play a dynamic antagonistic role in protein phosphorylation. Protein phosphatases make up a significant fraction of eukaryotic proteome. In this article, we report the identification and analysis of protein phosphatases in the intracellular parasite Entamoeba histolytica. Based on an in silico analysis, we classified 250 non-redundant protein phosphatases in E. histolytica. The phosphotome of E. histolytica is 3.1% of its proteome and 1.3 times of the human phosphotome. In this extensive study, we identified 42 new putative phosphatases (39 hypothetical proteins and 3 pseudophosphatases). The presence of pseudophosphatases may have an important role in virulence of E. histolytica. A comprehensive phosphotome analysis of E. histolytica shows spectacular low similarity to human phosphatases, making them potent candidates for drug target.	[Anwar, Tamanna; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sgourinath@mail.jnu.ac.in			University Grants Commission (Government of India)	University Grants Commission (Government of India)(University Grants Commission, India)	The authors are thankful to University Grants Commission (Government of India) for providing the funds for this project under Dr. D. S. Kothari postdoctoral fellowship scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Altman A, 2002, CURR DIR AUTOIMMUN, P186; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Beresford NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-457; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Brenchley R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-434; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kedzierski L, 2004, ARCH IMMUNOL THER EX, V52, P104; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lotter H, 2006, ARCH MED RES, V37, P292, DOI 10.1016/j.arcmed.2005.09.004; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mulder NJ, 2008, MOL BIOTECHNOL, V38, P165, DOI 10.1007/s12033-007-9003-x; Mustelin Tomas, 2007, V365, P9; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Stauffer W, 2003, CURR OPIN INFECT DIS, V16, P479, DOI 10.1097/00001432-200310000-00016; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78714	10.1371/journal.pone.0078714	http://dx.doi.org/10.1371/journal.pone.0078714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236039	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700036
J	Lee, CH; Shieh, YS; Tsai, CS; Hung, YJ; Tsai, YT; Lin, CY				Lee, Chien-Hsing; Shieh, Yi-Shing; Tsai, Chien-Sung; Hung, Yi-Jen; Tsai, Yi-Ting; Lin, Chih-Yuan			Plasma Concentrations Predict Aortic Expression of Growth-Arrest-Specific Protein 6 in Patients Undergoing Coronary Artery Bypass Grafting	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KINASE RECEPTOR AXL; PHOSPHATE-INDUCED CALCIFICATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE KINASE; ENDOTHELIAL-CELLS; TYRO-3 FAMILY; SOLUBLE FORM; GAS6; INFLAMMATION	Aims: The tyrosine kinase receptor Axl is expressed in the vasculature, and growth arrest-specific protein 6 (Gas6) is its ligand. Plasma Gas6 levels have been shown to be associated with endothelial dysfunction markers and cardiovascular events. We set out to determine the plasma Gas6 levels in patients undergoing coronary artery bypass grafting (CABG) and investigate the expression of Gas6 and Axl in the aorta. Methods and Results: Immunoassays were used to investigate plasma Gas6 levels in CABG patients (n = 19) and control subjects (n = 20). The expression of Gas6 and Axl in the injured aorta were examined by reverse transcription-polymerase chain reactions, real-time reverse transcription-polymerase chain reactions, western blotting, and immunohistochemical staining. Plasma Gas6 levels were significantly lower in CABG patients than in matched control subjects. In CABG patients, plasma Gas6 levels were negatively correlated with fasting glucose, E-selectin, and vascular cell adhesion molecule-1 levels. The levels predicted the operative mortality rate and were positively correlated with plasma soluble Axl (sAxl) levels and Gas6 expression in the aorta. Moreover, Gas6 expression was positively correlated with Axl expression in the aorta. Conclusion: We concluded that plasma Gas6 is associated with fasting glucose, endothelial dysfunction markers, sAxl values, and vascular Gas6 expression in CABG patients, and it predicts the operative mortality of these patients. These findings suggest that the Gas6/Axl system is crucial in vascular biology.	[Lee, Chien-Hsing; Hung, Yi-Jen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Shieh, Yi-Shing] Natl Def Med Ctr, Triserv Gen Hosp, Dept Oral Diag & Pathol, Taipei, Taiwan; [Tsai, Chien-Sung; Tsai, Yi-Ting; Lin, Chih-Yuan] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Lin, CY (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.	linrock@ms26.hinet.net			National Science Council [NSC 98-2314-B016-013, NSC 99-2314-B-016-011-MY2, NSC 100-2314-B-016 -026 -MY3]; Tri-Service General Hospital in Taiwan [TSGH-C100-012-S02, TSGH-C101-035, TSGH-C101-007-012-S02]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital in Taiwan	This work was supported by the National Science Council (NSC 98-2314-B016-013, NSC 99-2314-B-016-011-MY2, NSC 100-2314-B-016 -026 -MY3) and Tri-Service General Hospital (TSGH-C100-012-S02, TSGH-C101-035, TSGH-C101-007-012-S02) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Avanzi GC, 1998, BLOOD, V91, P2334, DOI 10.1182/blood.V91.7.2334.2334_2334_2340; Cavet ME, 2008, ARTERIOSCL THROM VAS, V28, P886, DOI 10.1161/ATVBAHA.108.162693; Clauser S, 2012, THROMB HAEMOSTASIS, V107, P140, DOI 10.1160/TH11-05-0368; D'Arcangelo D, 2002, CIRC RES, V91, pE4, DOI 10.1161/01.RES.0000036753.50601.E9; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Ekman C, 2010, CLIN BIOCHEM, V43, P873, DOI 10.1016/j.clinbiochem.2010.04.006; Ekman C, 2010, CLIN BIOCHEM, V43, P110, DOI 10.1016/j.clinbiochem.2009.07.025; Fernandez-Fernandez L, 2008, THROMB HAEMOSTASIS, V100, P604, DOI 10.1160/TH08-04-0253; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gheita TA, 2012, J CLIN IMMUNOL, V32, P1279, DOI 10.1007/s10875-012-9743-7; Gibot S, 2007, CRIT CARE, V11, DOI 10.1186/cc5158; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hsiao FC, 2013, J CLIN ENDOCR METAB, V98, pE267, DOI 10.1210/jc.2012-3179; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hurtado B, 2011, THROMB HAEMOSTASIS, V105, P873, DOI 10.1160/TH10-10-0630; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Kim HA, 2013, J CLIN IMMUNOL, V33, P143, DOI 10.1007/s10875-012-9765-1; Kim H, 2012, J CELL MOL MED, V16, P273, DOI 10.1111/j.1582-4934.2011.01294.x; Kobayashi KJ, 2009, J CARDIAC SURG, V24, P637, DOI 10.1111/j.1540-8191.2009.00906.x; Konishi A, 2004, J BIOL CHEM, V279, P28766, DOI 10.1074/jbc.M401977200; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Korshunov VA, 2007, HYPERTENSION, V50, P1057, DOI 10.1161/HYPERTENSIONAHA.107.096289; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lutgens E, 2008, J PATHOL, V216, P55, DOI 10.1002/path.2381; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Melaragno MG, 1998, CIRC RES, V83, P697, DOI 10.1161/01.RES.83.7.697; Metzler B, 2012, THROMB HAEMOSTASIS, V108, P1065, DOI 10.1160/TH11-06-0399; Nakano T, 1996, FEBS LETT, V387, P78, DOI 10.1016/0014-5793(96)00395-X; Nyberg P, 1997, EUR J BIOCHEM, V246, P147, DOI 10.1111/j.1432-1033.1997.t01-2-00147.x; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Taggart DP, 2005, BMJ-BRIT MED J, V330, P785, DOI 10.1136/bmj.330.7494.785; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79452	10.1371/journal.pone.0079452	http://dx.doi.org/10.1371/journal.pone.0079452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236135	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700134
J	Marietta, EV; Gomez, AM; Yeoman, C; Tilahun, AY; Clark, CR; Luckey, DH; Murray, JA; White, BA; Kudva, YC; Rajagopalan, G				Marietta, Eric V.; Gomez, Andres M.; Yeoman, Carl; Tilahun, Ashenafi Y.; Clark, Chad R.; Luckey, David H.; Murray, Joseph A.; White, Bryan A.; Kudva, Yogish C.; Rajagopalan, Govindarajan			Low Incidence of Spontaneous Type 1 Diabetes in NonObese Diabetic Mice Raised on Gluten-Free Diets Is Associated with Changes in the Intestinal Microbiome	PLOS ONE			English	Article							CELIAC-DISEASE; EXPOSURE; RISK; TRIGGER; WHEAT	Human and animal studies strongly suggest that dietary gluten could play a causal role in the etiopathogenesis of type 1 diabetes (T1D). However, the mechanisms have not been elucidated. Recent reports indicate that the intestinal microbiome has a major influence on the incidence of T1D. Since diet is known to shape the composition of the intestinal microbiome, we investigated using non-obese diabetic (NOD) mice whether changes in the intestinal microbiome could be attributed to the pro-and anti-diabetogenic effects of gluten-containing and gluten-free diets, respectively. NOD mice were raised on gluten-containing chows (GCC) or gluten-free chows (GFC). The incidence of diabetes was determined by monitoring blood glucose levels biweekly using a glucometer. Intestinal microbiome composition was analyzed by sequencing 16S rRNA amplicons derived from fecal samples. First of all, GCC-fed NOD mice had the expected high incidence of hyperglycemia whereas NOD mice fed with a GFC had significantly reduced incidence of hyperglycemia. Secondly, when the fecal microbiomes were compared, Bifidobacterium, Tannerella, and Barnesiella species were increased (p = 0.03, 0.02, and 0.02, respectively) in the microbiome of GCC mice, where as Akkermansia species was increased (p = 0.02) in the intestinal microbiomes of NOD mice fed GFC. Thirdly, both of the gluten-free chows that were evaluated, either egg white based (EW-GFC) or casein based (C-GFC), significantly reduced the incidence of hyperglycemia. Interestingly, the gut microbiome from EW-GFC mice was similar to C-GFC mice. Finally, adding back gluten to the gluten-free diet reversed its anti-diabetogenic effect, reduced Akkermansia species and increased Bifidobacterium, Tannerella, and Barnesiella suggesting that the presence of gluten is directly responsible for the pro-diabetogenic effects of diets and it determines the gut microflora. Our novel study thus suggests that dietary gluten could modulate the incidence of T1D by changing the gut microbiome.	[Marietta, Eric V.; Tilahun, Ashenafi Y.; Clark, Chad R.; Luckey, David H.; Rajagopalan, Govindarajan] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Marietta, Eric V.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Gomez, Andres M.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Yeoman, Carl] Montana State Univ, Coll Agr, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Kudva, Yogish C.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; Mayo Clinic	Marietta, EV (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	marietta.eric@mayo.edu; rajagopalan.govindarajan@Mayo.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879	Iacocca Foundation; NIH R01 grant [DK071003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003] Funding Source: NIH RePORTER; Office Of The Director [1443108] Funding Source: National Science Foundation	Iacocca Foundation; NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by grants from the Iacocca Foundation (GR) and NIH R01 grant (DK071003) (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barera G, 2002, PEDIATRICS, V109, P833, DOI 10.1542/peds.109.5.833; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; BOTTAZZO GF, 1978, BRIT MED J, V2, P165, DOI 10.1136/bmj.2.6131.165; de Goffau MC, 2012, FECAL MICROBIOTA COM; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELLIOTT RB, 1984, DIABETOLOGIA, V26, P297, DOI 10.1007/BF00283653; Erb-Downward JR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00774; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Ludvigsson JF, 2006, DIABETES CARE, V29, P2483, DOI 10.2337/dc06-0794; MAKI M, 1984, ARCH DIS CHILD, V59, P739, DOI 10.1136/adc.59.8.739; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Neu J, 2010, ENDOCRIN METAB CLIN, V39, P563, DOI 10.1016/j.ecl.2010.05.008; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Schmid S, 2004, DIABETOLOGIA, V47, P1130; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Van Belle TL, 2012, J AUTOIMMUNITY; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63	26	87	93	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78687	10.1371/journal.pone.0078687	http://dx.doi.org/10.1371/journal.pone.0078687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236037	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700034
J	Negandhi, K; Laurion, I; Whiticar, MJ; Galand, PE; Xu, XM; Lovejoy, C				Negandhi, Karita; Laurion, Isabelle; Whiticar, Michael J.; Galand, Pierre E.; Xu, Xiaomei; Lovejoy, Connie			Small Thaw Ponds: An Unaccounted Source of Methane in the Canadian High Arctic	PLOS ONE			English	Article							ION-SOURCE DEVELOPMENT; ORGANIC-CARBON; ARCHAEAL COMMUNITIES; NORTHERN LAKES; LENA DELTA; PERMAFROST; CO2; EMISSIONS; PATHWAYS; SEQUENCE	Thawing permafrost in the Canadian Arctic tundra leads to peat erosion and slumping in narrow and shallow runnel ponds that surround more commonly studied polygonal ponds. Here we compared the methane production between runnel and polygonal ponds using stable isotope ratios, C-14 signatures, and investigated potential methanogenic communities through high-throughput sequencing archaeal 16S rRNA genes. We found that runnel ponds had significantly higher methane and carbon dioxide emissions, produced from a slightly larger fraction of old carbon, compared to polygonal ponds. The methane stable isotopic signature indicated production through acetoclastic methanogenesis, but gene signatures from acetoclastic and hydrogenotrophic methanogenic Archaea were detected in both polygonal and runnel ponds. We conclude that runnel ponds represent a source of methane from potentially older C, and that they contain methanogenic communities able to use diverse sources of carbon, increasing the risk of augmented methane release under a warmer climate.	[Negandhi, Karita; Laurion, Isabelle] Ctr Northern Studies CEN, Quebec City, PQ, Canada; [Whiticar, Michael J.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Galand, Pierre E.] Univ Paris 06, LECOB, Observat Oceanol, UMR 8222, Banyuls Sur Mer, France; [Galand, Pierre E.] CNRS, LECOB, Observat Oceanol, UMR 8222, Banyuls Sur Mer, France; [Xu, Xiaomei] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Lovejoy, Connie] Univ Laval, Dept Biol, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada; [Lovejoy, Connie] Takuvik, CNRS, UMI 3376, Quebec City, PQ, Canada	University of Victoria; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of California System; University of California Irvine; Laval University	Lovejoy, C (corresponding author), Univ Laval, Dept Biol, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada.	connie.lovejoy@bio.ulaval.ca	Lovejoy, Connie/A-3756-2008; Galand, Pierre/A-1429-2014	Lovejoy, Connie/0000-0001-8027-2281; Galand, Pierre/0000-0002-2238-3247; Negandhi, Karita/0000-0002-2463-3414; Laurion, Isabelle/0000-0001-8694-3330	National Research and Engineering Council (NSERC) Canada; ArcticNet; Canadian International Polar Year (IPY); Keck Carbon Cycle AMS Facility	National Research and Engineering Council (NSERC) Canada; ArcticNet; Canadian International Polar Year (IPY); Keck Carbon Cycle AMS Facility	Funding for the study was primarily from the National Research and Engineering Council (NSERC) Canada, including grants to LL, CL, and MJW. Additional support was from ArcticNet, the Canadian International Polar Year (IPY). Parks Canada and The Polar Continental Shelf Project provided logistic support. XX had support from the Keck Carbon Cycle AMS Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnizova A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004237; Anthony KMW, 2010, LIMNOL OCEANOGR-METH, V8, P592, DOI 10.4319/lom.2010.8.0592; Barber RD, 2011, J BACTERIOL, V193, P3668, DOI 10.1128/JB.05031-11; Barbier BA, 2012, FEMS MICROBIOL ECOL, V82, P287, DOI 10.1111/j.1574-6941.2012.01332.x; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Borrel G, 2012, INT J SYST EVOL MICR, V62, P1625, DOI 10.1099/ijs.0.034538-0; Borrel G, 2011, RES MICROBIOL, V162, P832, DOI 10.1016/j.resmic.2011.06.004; Breton J, 2009, CAN J FISH AQUAT SCI, V66, P1635, DOI 10.1139/F09-108; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Chappaz A, 2008, GEOCHIM COSMOCHIM AC, V72, P170, DOI 10.1016/j.gca.2007.10.014; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Comeau AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00604; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Fortier D, 2004, CAN J EARTH SCI, V41, P997, DOI 10.1139/E04-031; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Grosse G, 2011, J GEOPHYS RES, V116, P2005; Grosse G., 2008, 9 INT CONFERENCNCE P, P551; Guillemette F, 2011, LIMNOL OCEANOGR, V56, P734, DOI 10.4319/lo.2011.56.2.0734; HAMILTON JD, 1994, J GEOPHYS RES-ATMOS, V99, P1495, DOI 10.1029/93JD03020; HESSLEIN RH, 1991, AIR-WATER MASS TRANSFER, P413; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hoj L, 2008, ISME J, V2, P37, DOI 10.1038/ismej.2007.84; Hornibrook ERC, 1997, GEOCHIM COSMOCHIM AC, V61, P745, DOI 10.1016/S0016-7037(96)00368-7; Juottonen H., 2008, THESIS; Karadagli F, 2007, BIODEGRADATION, V18, P453, DOI 10.1007/s10532-006-9078-2; Kobabe S, 2004, FEMS MICROBIOL ECOL, V50, P13, DOI 10.1016/j.femsec.2004.05.003; Laurion I, 2010, LIMNOL OCEANOGR, V55, P115, DOI 10.4319/lo.2010.55.1.0115; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Michmerhuizen CM, 1996, LIMNOL OCEANOGR, V41, P985, DOI 10.4319/lo.1996.41.5.0985; Muster S, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17301; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; Pouliot J, 2009, ENVIRON MICROBIOL, V11, P687, DOI 10.1111/j.1462-2920.2008.01846.x; Roehm CL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000863; Rowland J., 2010, EOS T AM GEOPHYS UNI, V91, P229, DOI [10.1029/2010EO260001, DOI 10.1029/2010E0260001]; Sachs T, 2008, J GEOPHYS RES, V113, P2005; Sakai S, 2009, APPL ENVIRON MICROB, V75, P4892, DOI 10.1128/AEM.02835-08; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Shirokova LS, 2013, BIOGEOCHEMISTRY, V113, P573, DOI 10.1007/s10533-012-9790-4; Smith LC, 2007, PERMAFROST PERIGLAC, V18, P201, DOI 10.1002/ppp.581; Southon J, 2007, NUCL INSTRUM METH B, V259, P88, DOI 10.1016/j.nimb.2007.01.147; Southon JR, 2004, RADIOCARBON, V46, P33, DOI 10.1017/S0033822200039321; STAINTON MP, 1977, CAN FISH MAR SERV MI, V25; Tank SE, 2009, ECOSYSTEMS, V12, P144, DOI 10.1007/s10021-008-9213-5; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Wagner D, 2005, ENVIRON MICROBIOL, V7, P1582, DOI 10.1111/j.1462-2920.2005.00849.x; Wagner D, 2007, GLOBAL CHANGE BIOL, V13, P1089, DOI 10.1111/j.1365-2486.2007.01331.x; Walter KM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000569; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036; Xu X, 2012, 21 RAD C PAR; Xu XM, 2007, NUCL INSTRUM METH B, V259, P320, DOI 10.1016/j.nimb.2007.01.175; Zimov S. A, 2001, NATO SCI SERIES, V76, P511, DOI [10.1007/978-94-010-0684-2_35., DOI 10.1007/978-94-010-0684-2_]; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zona D, 2008, AGU FALL M	59	54	55	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78204	10.1371/journal.pone.0078204	http://dx.doi.org/10.1371/journal.pone.0078204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236014	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327254700011
J	Rathleff, CR; Baird, WN; Olesen, JL; Roos, EM; Rasmussen, S; Rathleff, MS				Rathleff, Camilla Rams; Baird, William Neill; Olesen, Jens Lykkegaard; Roos, Ewa Maria; Rasmussen, Sten; Rathleff, Michael Skovdal			Hip and Knee Strength Is Not Affected in 12-16 Year Old Adolescents with Patellofemoral Pain - A Cross-Sectional Population-Based Study	PLOS ONE			English	Article							FOOT ORTHOSES EFFICACY; INDIVIDUALS; INSTRUMENT; LIGAMENT; INJURY	Background: One of the rationales behind using strength training in the treatment of adolescents with Patellofemoral Pain (PFP) is that reduced strength of the lower extremity is a risk factor for PFP and a common deficit. This rationale is based on research conducted on adolescents >15 years of age but has never been investigated among young adolescents with PFP. Objectives: To compare isometric muscle strength of the lower extremity among adolescents with PFP compared to age- and gender-matched pain-free adolescents. Methods: In 2011 a population-based cohort (APA2011-cohort) consisting of 768 adolescents aged 12-15 years from 8 local schools was formed. In September 2012, all adolescents who reported knee pain in September 2011 were offered a clinical examination if they still had knee pain. From these, 20 adolescents (16 females) were diagnosed with PFP. Pain-free adolescents from the APA2011-cohort (n = 20) were recruited on random basis as age-and gender-matched pairs. Primary outcome was isometric knee extension strength normalized to body weight (%BW) and blinded towards subject information. Secondary outcomes included knee flexion, hip abduction/adduction and hip internal/external rotation strength. Demographic data included Knee Injury and Osteoarthritis Outcome Score (KOOS) and symptom duration. Results: Adolescents with PFP reported long symptom duration and significantly worse KOOS scores compared to pain-free adolescents. There were no significant differences in isometric knee extension strength (Delta 0.3% BW, p = 0.97), isometric knee flexion strength (Delta 0.4% BW, p = 0.84) or different measures of hip strength (Delta 0.4 to 1.1% BW, p>0.35). Conclusion: Young symptomatic adolescents with PFP between 12 and 16 years of age did not have decreased isometric muscle strength of the knee and hip. These results question the rationale of targeting strength deficits in the treatment of adolescents with PFP. However, strength training may still be an effective treatment for those individuals with PFP suffering from strength deficits.	[Rathleff, Camilla Rams; Rasmussen, Sten; Rathleff, Michael Skovdal] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Baird, William Neill; Olesen, Jens Lykkegaard] Aalborg Univ Hosp, Dept Rheumatol, Aalborg, Denmark; [Roos, Ewa Maria] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark; [Rathleff, Michael Skovdal] Aarhus Univ, HEALTH, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Aarhus University	Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	misr@rn.dk	Rasmussen, Sten/N-3916-2013; Roos, Ewa M/A-5416-2012	Rasmussen, Sten/0000-0002-8664-352X; Roos, Ewa M/0000-0001-5425-2199; Olesen, Jes/0000-0002-6712-2702; Rathleff, Michael Skovdal/0000-0003-1173-0335	Obelske Family Foundation; Association of Danish Physiotherapists Research Fund; Danish Rheumatism Association	Obelske Family Foundation; Association of Danish Physiotherapists Research Fund; Danish Rheumatism Association	Obelske Family Foundation, The Association of Danish Physiotherapists Research Fund, Danish Rheumatism Association are acknowledged for their funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Barton CJ, 2011, BRIT J SPORT MED, V45, P697, DOI 10.1136/bjsm.2010.077644; Barton CJ, 2011, MED SCI SPORT EXER, V43, P1603, DOI 10.1249/MSS.0b013e318211c45d; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blond L, 1998, Acta Orthop Belg, V64, P393; Boling MC, 2009, AM J SPORT MED, V37, P2108, DOI 10.1177/0363546509337934; Burstrom K, 2011, EUR J PUBLIC HEALTH, V21, P171, DOI 10.1093/eurpub/ckq037; Carry PM, 2010, ORTHOPEDICS, V33, P498, DOI 10.3928/01477447-20100526-16; Cichanowski HR, 2007, MED SCI SPORT EXER, V39, P1227, DOI 10.1249/mss.0b013e3180601109; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Collins NJ, 2013, BRIT J SPORT MED, V47, P227, DOI 10.1136/bjsports-2012-091696; Collins NJ, 2012, SPORTS MED, V42, P31, DOI 10.2165/11594460-000000000-00000; Cowan SM, 2002, MED SCI SPORT EXER, V34, P1879, DOI 10.1097/00005768-200212000-00004; Devereaux M D, 1984, Br J Sports Med, V18, P18; Duvigneaud N, 2008, ISOKINET EXERC SCI, V16, P213, DOI 10.3233/IES-2008-0311; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; FAIRBANK JCT, 1984, J BONE JOINT SURG BR, V66, P685, DOI 10.1302/0301-620X.66B5.6501361; Ireland ML, 2003, J ORTHOP SPORT PHYS, V33, P671, DOI 10.2519/jospt.2003.33.11.671; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Lankhorst NE, 2013, BRIT J SPORT MED, V47, P193, DOI 10.1136/bjsports-2011-090369; Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3; Luhmann SJ, 2008, J CHILD ORTHOP, V2, P269, DOI 10.1007/s11832-008-0104-2; Magalhaes E, 2010, J ORTHOP SPORT PHYS, V40, P641, DOI 10.2519/jospt.2010.3120; Molgaard C, 2011, J AM PODIAT MED ASSN, V101, P215, DOI 10.7547/1010215; Piva SR, 2005, J ORTHOP SPORT PHYS, V35, P793, DOI 10.2519/jospt.2005.35.12.793; Rathleff MS, 2013, MED SCI SPORT EXER, V45, P1730, DOI 10.1249/MSS.0b013e318292be30; Rathleff MS, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-225; Rathleff MS, 2013, J ORTHOP SPORT PHYS, V43, P414, DOI 10.2519/jospt.2013.4383; Rathleff MS, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-9; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thomee R, 1999, SPORTS MED, V28, P245, DOI 10.2165/00007256-199928040-00003; Uziel Yosef, 2007, Pediatr Rheumatol Online J, V5, P5, DOI 10.1186/1546-0096-5-5; van Linschoten R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4074; VANLINSCHOTEN R, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4074; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; WHITELAW GP, 1989, CLIN ORTHOP RELAT R, P234; Willson JD, 2008, AM J SPORT MED, V36, P1587, DOI 10.1177/0363546508315592	38	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79153	10.1371/journal.pone.0079153	http://dx.doi.org/10.1371/journal.pone.0079153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236101	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700099
J	van der Meijden, A; Coelho, PL; Sousa, P; Herrel, A				van der Meijden, Arie; Coelho, Pedro Lobo; Sousa, Pedro; Herrel, Anthony			Choose Your Weapon: Defensive Behavior Is Associated with Morphology and Performance in Scorpions	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; CONFIDENCE-INTERVALS; BITE PERFORMANCE; EVOLUTION; VENOM; BUTHIDAE; PHYLOGENY; ARACHNIDA; PATTERNS; LIZARDS	Morphology can be adaptive through its effect on performance of an organism. The effect of performance may, however, be modulated by behavior; an organism may choose a behavioral option that does not fully utilize its maximum performance. Behavior may therefore be decoupled from morphology and performance. To gain insight into the relationships between these levels of organization, we combined morphological data on defensive structures with measures of defensive performance, and their utilization in defensive behavior. Scorpion species show significant variation in the morphology and performance of their main defensive structures; their chelae (pincers) and the metasoma ("tail") carrying the stinger. Our data show that size-corrected pinch force varies to almost two orders of magnitude among species, and is correlated with chela morphology. Chela and metasoma morphology are also correlated to the LD50 of the venom, corroborating the anecdotal rule that dangerously venomous scorpions can be recognized by their chelae and metasoma. Analyses of phylogenetic independent contrasts show that correlations between several aspects of chela and metasoma morphology, performance and behavior are present. These correlations suggest co-evolution of behavior with morphology and performance. Path analysis found a performance variable (pinch force) to partially mediate the relationship between morphology (chela aspect ratio) and behavior (defensive stinger usage). We also found a correlation between two aspects of morphology: pincer finger length correlates with the relative "thickness" (aspect ratio) of the metasoma. This suggests scorpions show a trade-off between their two main weapon complexes: the metasoma carrying the stinger, and the pedipalps carrying the chelae.	[van der Meijden, Arie; Coelho, Pedro Lobo; Sousa, Pedro] CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7179, F-75231 Paris, France	Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	van der Meijden, A (corresponding author), CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal.	mail@arievandermeijden.nl	van der Meijden, Arie/AAD-5199-2019; Sousa, Pedro/N-3015-2013; Lobo-Coelho, Pedro/D-5277-2014; Herrel, Anthony/C-3712-2013	Sousa, Pedro/0000-0002-5859-9656; Lobo-Coelho, Pedro/0000-0001-5889-8579; Herrel, Anthony/0000-0003-0991-4434; van der Meijden, Arie/0000-0002-1317-5382	FCT [PTDC/BIA-BEC/104644/2008, PTDC/BIA-EVF/2687/2012, SFRH/BPD/48042/2008]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT I&D grants to AvdM (PTDC/BIA-BEC/104644/2008 and PTDC/BIA-EVF/2687/2012). AvdM has been supported by FCT postdoctoral fellowship SFRH/BPD/48042/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Blomberg S, 2003, EVOLUTION; BRODIE ED, 1993, EVOLUTION, V47, P844, DOI 10.1111/j.1558-5646.1993.tb01238.x; Bruford Michael W., 1992, P225; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Cox RM, 2010, EVOLUTION, V64, P1321, DOI 10.1111/j.1558-5646.2009.00906.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fet Elizabeth V., 2003, Revista Iberica de Aracnologia, V8, P69; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gantenbein B, 2000, REV SUISSE ZOOL, V107, P213, DOI 10.5962/bhl.part.80126; Garland T, 1999, ANIM BEHAV, V58, P77, DOI 10.1006/anbe.1999.1132; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Garland Theodore Jr., 1994, P240; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; GWEE MCE, 1993, TOXICON, V31, P1305, DOI 10.1016/0041-0101(93)90403-6; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Habermehl G. G., 1994, GIFT TIERE IHRE WAFF; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2009, PHYSIOL BIOCHEM ZOOL, V82, P680, DOI 10.1086/605935; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Irschick DJ, 2005, EVOLUTION, V59, P1579; ISMAIL M, 1974, TOXICON, V12, P75, DOI 10.1016/0041-0101(74)90102-0; Kleber J. J., 1999, DTSCH ARZTEBLATT, V96, pA1711; Kovarik F., 2009, ILLUSTRATED CATALOG; LAMORAL B H, 1979, Annals of the Natal Museum, V23, P497; Leeming J, 2003, SCORPIONS SO AFRICA; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Lourenco Wilson R., 2004, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P165; Lourenco WR, 2005, REV SUISSE ZOOL, V112, P145, DOI 10.5962/bhl.part.80291; Lourenco WR, 2003, REV SUISSE ZOOL, V110, P875, DOI 10.5962/bhl.part.80218; Maddison WP, 2009, MESQUITE MODULAR SYS; NEWLANDS G, 1985, Koedoe, P35; NEWLANDS G, 1969, African Wildlife, V23, P147; Nisani Z, 2012, TOXICON, V147, P509; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; PALKA J, 1967, Z VERGL PHYSIOL, V55, P286; Polis G.A., 1990, P247; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Sells PG, 2003, TOXICON, V42, P115, DOI 10.1016/S0041-0101(03)00125-9; Shulov A., 1960, Arch Inst Pasteur Alger, V38, P117; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sobel M. E., 1982, SOCIOLOGICAL METHODO; Soleglad Michael E., 2011, Euscorpius, V112, P1; Soper D. S., 2013, SOBEL TEST CALCULATO; Sousa P, 2012, J ZOOL, V288, P66, DOI 10.1111/j.1469-7998.2012.00925.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Tallarovic SK, 2000, J INSECT BEHAV, V13, P827, DOI 10.1023/A:1007858400402; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VACHON M, 1968, Monitore Zoologico Italiano, V2, P81; Vachon M., 1952, ETUDES SCORPIONS; van der Meijden A, 2010, J ZOOL, V280, P319, DOI 10.1111/j.1469-7998.2009.00628.x; van der Meijden A, 2012, J EXP BIOL, V215, P3411, DOI 10.1242/jeb.072926; van der Meijden A, 2012, J ANAT, V220, P423, DOI 10.1111/j.1469-7580.2012.01485.x; Vanhooydonck B, 2003, FUNCT ECOL, V17, P160, DOI 10.1046/j.1365-2435.2003.00716.x; Vonk FJ, 2008, NATURE, V454, P630, DOI 10.1038/nature07178; Warburg MR, 1998, J ETHOL, V16, P115, DOI 10.1007/BF02769290; Young BA, 2007, J EXP ZOOL PART A, V307A, P18, DOI 10.1002/jez.a.341; ZLOTKIN E, 1971, TOXICON, V9, P1, DOI 10.1016/0041-0101(71)90037-7; Zlotkin E., 1978, NEUROTOXIC ACTION PE, P227	70	31	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78955	10.1371/journal.pone.0078955	http://dx.doi.org/10.1371/journal.pone.0078955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236075	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700072
J	Walenta, E; Pessentheiner, AR; Pelzmann, HJ; Deutsch, A; Goeritzer, M; Kratky, D; Hackl, H; Oh, DY; Prokesch, A; Bogner-Strauss, JG				Walenta, Evelyn; Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Deutsch, Alexander; Goeritzer, Madeleine; Kratky, Dagmar; Hackl, Hubert; Oh, Da Young; Prokesch, Andreas; Bogner-Strauss, Juliane G.			alpha/beta-Hydrolase Domain Containing Protein 15 (ABHD15) - an Adipogenic Protein Protecting from Apoptosis	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; OBESITY; MICE; PREADIPOCYTES; REVEALS; PATHWAY; GLUCOSE	Our knowledge about adipocyte metabolism and development is steadily growing, yet many players are still undefined. Here, we show that alpha/beta-hydrolase domain containing protein 15 (Abhd15) is a direct and functional target gene of peroxisome proliferator-activated receptor gamma (PPAR gamma), the master regulator of adipogenesis. In line, Abhd15 is mainly expressed in brown and white adipose tissue and strongly upregulated during adipogenesis in various murine and human cell lines. Stable knockdown of Abhd15 in 3T3-L1 cells evokes a striking differentiation defect, as evidenced by low lipid accumulation and decreased expression of adipocyte marker genes. In preconfluent cells, knockdown of Abhd15 leads to impaired proliferation, which is caused by apoptosis, as we see an increased SubG1 peak, caspase 3/7 activity, and BAX protein expression as well as a reduction in anti-apoptotic BCL-2 protein. Furthermore, apoptosis-inducing amounts of palmitic acid evoke a massive increase of Abhd15 expression, proposing an apoptosis-protecting role for ABHD15. On the other hand, in mature adipocytes physiological (i.e. non-apoptotic) concentrations of palmitic acid down-regulate Abhd15 expression. Accordingly, we found that the expression of Abhd15 in adipose tissue is reduced in physiological situations with high free fatty acid levels, like high-fat diet, fasting, and aging as well as in genetically obese mice. Collectively, our results position ABHD15 as an essential component in the development of adipocytes as well as in apoptosis, thereby connecting two substantial factors in the regulation of adipocyte number and size. Together with its intricate regulation by free fatty acids, ABHD15 might be an intriguing new target in obesity and diabetes research.	[Walenta, Evelyn; Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Deutsch, Alexander] Med Univ Graz, Div Hematol, Graz, Austria; [Goeritzer, Madeleine; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Hackl, Hubert] Med Univ Innsbruck, Bioctr, Div Bioinformat, A-6020 Innsbruck, Austria; [Oh, Da Young] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Graz University of Technology; Graz University of Technology; Medical University of Graz; Medical University of Graz; Medical University of Innsbruck; University of California System; University of California San Diego	Bogner-Strauss, JG (corresponding author), Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Kratky, Dagmar/ABF-5699-2021; Deutsch, Alexander AJ/F-2168-2010; Hackl, Hubert/B-3168-2018; PROKESCH, ANDREAS/B-6786-2019	Deutsch, Alexander AJ/0000-0003-0914-2809; Hackl, Hubert/0000-0003-4055-3841; Bogner-Strauss, Juliane/0000-0003-2459-0124; Pessentheiner, Ariane/0000-0002-5010-9528; PROKESCH, ANDREAS/0000-0002-8487-7103; Kratky, Dagmar/0000-0003-1357-7573	Austrian Science Fund FWF [W1226, P24143]; Austrian Science Fund (FWF) [P 24143, F 3004] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (DK-MCD W1226 and P24143). http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Ahren B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Chavez JA, 2006, BIOCHEM BIOPH RES CO, V342, P1218, DOI 10.1016/j.bbrc.2006.02.091; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hakim-Weber Robab, 2011, BMC Res Notes, V4, P157, DOI 10.1186/1756-0500-4-157; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Prokesch A, 2011, NUCLEIC ACIDS RES, V39, P3224, DOI 10.1093/nar/gkq1289; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Rohana A, 2011, WORLD ACAD SCI ENG T, P1; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SAGER G, 1985, BIOCHEM PHARMACOL, V34, P2812, DOI 10.1016/0006-2952(85)90584-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Sloan C, 2011, DIABETES, V60, P1424, DOI 10.2337/db10-1106; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79134	10.1371/journal.pone.0079134	http://dx.doi.org/10.1371/journal.pone.0079134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236098	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700096
J	Yoshida, N; Oda, M; Kuroda, Y; Katayama, Y; Okikawa, Y; Masunari, T; Fujiwara, M; Nishisaka, T; Sasaki, N; Sadahira, Y; Mihara, K; Asaoku, H; Matsui, H; Seto, M; Kimura, A; Arihiro, K; Sakai, A				Yoshida, Noriaki; Oda, Miyo; Kuroda, Yoshiaki; Katayama, Yuta; Okikawa, Yoshiko; Masunari, Taro; Fujiwara, Megumu; Nishisaka, Takashi; Sasaki, Naomi; Sadahira, Yoshito; Mihara, Keichiro; Asaoku, Hideki; Matsui, Hirotaka; Seto, Masao; Kimura, Akiro; Arihiro, Koji; Sakai, Akira			Clinical Significance of sIL-2R Levels in B-Cell Lymphomas	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SOLUBLE INTERLEUKIN-2-RECEPTOR; PROGNOSTIC INDEX; HODGKIN LYMPHOMA; LEUKEMIA; MATRIX-METALLOPROTEINASE-9; ANGIOGENESIS; PROGRESSION; EXPRESSION; RITUXIMAB	Elevated soluble interleukin-2 receptor (sIL-2R) in sera is observed in patients with malignant lymphoma (ML). Therefore, sIL-2R is commonly used as a diagnostic and prognostic marker for ML, but the mechanisms responsible for the increase in sIL-2R levels in patients with B-cell lymphomas have not yet been elucidated. We first hypothesized that lymphoma cells expressing IL-2R and some proteinases such as matrix metalloproteinases (MMPs) in the tumor microenvironment can give rise to increased sIL-2R in sera. However, flow cytometric studies revealed that few lymphoma cells expressed IL-2R a chain (CD25) in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), and most CD25-expressing cells in the tumor were T-cells. Distinct correlations between CD25 expression on B-lymphoma cells and sIL-2R levels were not observed. We then confirmed that MMP-9 plays an important role in producing sIL-2R in functional studies. Immunohistochemical (IHC) analysis also revealed that MMP-9 is mainly derived from tumor-associated macrophages (TAMs). We therefore evaluated the number of CD68 and CD163 positive macrophages in the tumor microenvironment using IHC analysis. A positive correlation between the levels of sIL-2R in sera and the numbers of CD68 positive macrophages in the tumor microenvironment was confirmed in FL and extranodal DLBCL. These results may be useful in understanding the pathophysiology of B-cell lymphomas.	[Yoshida, Noriaki; Kuroda, Yoshiaki; Mihara, Keichiro; Kimura, Akiro; Sakai, Akira] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Yoshida, Noriaki; Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; [Yoshida, Noriaki; Seto, Masao] Nagoya Univ, Grad Sch Med, Aichi Canc Ctr, Res Inst,Dept Canc Genet, Nagoya, Aichi 4648601, Japan; [Oda, Miyo; Arihiro, Koji] Hiroshima Univ, Dept Anat Pathol, Hiroshima, Japan; [Katayama, Yuta; Asaoku, Hideki] Hiroshima Red Cross Hosp, Dept Internal Med, Hiroshima, Japan; [Katayama, Yuta; Fujiwara, Megumu; Asaoku, Hideki] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Okikawa, Yoshiko] Natl Hosp Org Kure Med Ctr, Dept Hematol, Kure, Japan; [Masunari, Taro] Chugoku Cent Hosp, Dept Hematol, Fukuyama, Hiroshima, Japan; [Fujiwara, Megumu] Hiroshima Red Cross Hosp, Dept Pathol, Hiroshima, Japan; [Nishisaka, Takashi] Hiroshima Prefecture Hosp, Dept Lab Pathol, Hiroshima, Japan; [Sasaki, Naomi] Kure Kyosai Hosp, Dept Pathol, Kure, Japan; [Sadahira, Yoshito] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Matsui, Hirotaka] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Matsui, Hirotaka] Hiroshima Univ, Res Inst Radiat Biol & Med, Leukemia Program Project, Hiroshima, Japan; [Kimura, Akiro] Kure Kyosai Hosp, Dept Lab Med, Kure, Japan; [Sakai, Akira] Fukushima Med Univ, Dept Radiat Life Sci, Fukushima, Japan	Hiroshima University; Aichi Cancer Center; Aichi Cancer Center; Nagoya University; Hiroshima University; Kawasaki Medical School; Hiroshima University; Hiroshima University; Fukushima Medical University	Yoshida, N (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan.	nyoshida@aichi-cc.jp; sakira@fmu.ac.jp	Mihara, Keichiro/L-5167-2019; Katayama, Yuta/AAB-7409-2022	Katayama, Yuta/0000-0001-5054-9104	Hiroshima Lymphoma Study Group; Grants-in-Aid for Scientific Research [24591397] Funding Source: KAKEN	Hiroshima Lymphoma Study Group; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Hiroshima Lymphoma Study Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueznay NEH, 2007, CLIN EXP IMMUNOL, V150, P114, DOI 10.1111/j.1365-2249.2007.03464.x; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; AMBROSETTI A, 1993, INT J CLIN LAB RES, V23, P34, DOI 10.1007/BF02592278; Arcaini L, 2010, BRIT J HAEMATOL, V149, P455, DOI 10.1111/j.1365-2141.2009.08065.x; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Canioni D, 2008, J CLIN ONCOL, V26, P440, DOI 10.1200/JCO.2007.12.8298; De Paiva CS, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-31; Ennishi D, 2009, ANN ONCOL, V20, P526, DOI 10.1093/annonc/mdn677; Federico Massimo, 2009, Curr Hematol Malig Rep, V4, P202, DOI 10.1007/s11899-009-0027-0; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Goto N, 2012, ANN HEMATOL, V91, P705, DOI 10.1007/s00277-011-1363-4; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hayashibara T, 2002, BRIT J HAEMATOL, V116, P94, DOI 10.1046/j.1365-2141.2002.03255.x; KAMIHIRA S, 1994, CANCER, V73, P2753, DOI 10.1002/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Liu D, 2012, PLOS ONE, V7; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mori N, 2002, BLOOD, V99, P1341, DOI 10.1182/blood.V99.4.1341; Morito T, 2009, CANCER SCI, V100, P1255, DOI 10.1111/j.1349-7006.2009.01167.x; Murakami S, 2004, FRONT BIOSCI-LANDMRK, V9, P3085, DOI 10.2741/1461; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; YASUDA N, 1988, BLOOD, V71, P1021	38	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78730	10.1371/journal.pone.0078730	http://dx.doi.org/10.1371/journal.pone.0078730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236041	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700038
J	Cakir, B; Kilickaya, O				Cakir, Birsen; Kilickaya, Ozan			Whole-Genome Survey of the Putative ATP-Binding Cassette Transporter Family Genes in Vitis vinifera	PLOS ONE			English	Article							PLANT ABC TRANSPORTERS; RESISTANCE-ASSOCIATED PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; CONDUCTANCE REGULATOR CFTR; HEAVY-METAL RESISTANCE; DROSOPHILA-WHITE GENE; ACID BETA-OXIDATION; ARABIDOPSIS-THALIANA; MULTIDRUG-RESISTANCE; PLEIOTROPIC DRUG	The ATP-binding cassette (ABC) protein superfamily constitutes one of the largest protein families known in plants. In this report, we performed a complete inventory of ABC protein genes in Vitis vinifera, the whole genome of which has been sequenced. By comparison with ABC protein members of Arabidopsis thaliana, we identified 135 putative ABC proteins with 1 or 2 NBDs in V. vinifera. Of these, 120 encode intrinsic membrane proteins, and 15 encode proteins missing TMDs. V. vinifera ABC proteins can be divided into 13 subfamilies with 79 "full-size,'' 41 "half-size,'' and 15 "soluble'' putative ABC proteins. The main feature of the Vitis ABC superfamily is the presence of 2 large subfamilies, ABCG (pleiotropic drug resistance and white-brown complex homolog) and ABCC (multidrug resistance-associated protein). We identified orthologs of V. vinifera putative ABC transporters in different species. This work represents the first complete inventory of ABC transporters in V. vinifera. The identification of Vitis ABC transporters and their comparative analysis with the Arabidopsis counterparts revealed a strong conservation between the 2 species. This inventory could help elucidate the biological and physiological functions of these transporters in V. vinifera.	[Cakir, Birsen] Ege Univ, Fac Agr, Dept Hort, Izmir, Turkey; [Kilickaya, Ozan] Ege Univ, Dept Biotechnol, Grad Sch Nat & Appl Sci, Izmir, Turkey	Ege University; Ege University	Cakir, B (corresponding author), Ege Univ, Fac Agr, Dept Hort, Izmir, Turkey.	birsencakir@hotmail.com	Kılıçkaya, Ozan/J-7416-2015	Kılıçkaya, Ozan/0000-0003-2710-2149				Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; Bairoch A, 1992, NUCL ACIDS RES, V20; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bunting KD, 2002, STEM CELLS, V20, P274, DOI 10.1634/stemcells.20-3-274; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Chen HM, 1996, AM J HUM GENET, V59, P66; Crouzet J, 2006, FEBS LETT, V580, P1123, DOI 10.1016/j.febslet.2005.12.043; Datta RS, 2009, NUCLEIC ACIDS RES, V37, pW84, DOI 10.1093/nar/gkp373; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Footitt S, 2006, J EXP BOT, V57, P2805, DOI 10.1093/jxb/erl045; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Kaneda M, 2011, J EXPT BOT; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Moons A, 2003, FEBS LETT, V553, P370, DOI 10.1016/S0014-5793(03)01060-3; Moons A, 2008, PLANTA, V229, P53, DOI 10.1007/s00425-008-0810-5; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Smart CC, 1996, J BIOL CHEM, V271, P19351, DOI 10.1074/jbc.271.32.19351; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tamura K, 2011, MOL BIOL EVOLUTION; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ukitsu H, 2007, PLANT CELL PHYSIOL, V48, P1524, DOI 10.1093/pcp/pcm139; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Windsor B, 2003, NAT BIOTECHNOL, V21, P428, DOI 10.1038/nbt809; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yamaguchi H, 2002, J EXP BOT, V53, P727, DOI 10.1093/jexbot/53.369.727; Young J, 1999, BBA-BIOMEMBRANES, V1461, P177, DOI 10.1016/S0005-2736(99)00158-3; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	83	39	45	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78860	10.1371/journal.pone.0078860	http://dx.doi.org/10.1371/journal.pone.0078860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244377	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600073
J	Ensoy, C; Aerts, M; Welby, S; Van der Stede, Y; Faes, C				Ensoy, Chellafe; Aerts, Marc; Welby, Sarah; Van der Stede, Yves; Faes, Christel			A Dynamic Spatio-Temporal Model to Investigate the Effect of Cattle Movements on the Spread of Bluetongue BTV-8 in Belgium	PLOS ONE			English	Article							NORTH-WESTERN EUROPE; INFECTIOUS-DISEASES; VIRUS SEROTYPE-8; RISK; EPIDEMIOLOGY; TRANSMISSION; TIME; FRAMEWORK; FARMS	When Bluetongue Virus Serotype 8 (BTV-8) was first detected in Northern Europe in 2006, several guidelines were immediately put into place with the goal to protect farms and stop the spreading of the disease. This however did not prevent further rapid spread of BTV-8 across Northern Europe. Using information on the 2006 Bluetongue outbreak in cattle farms in Belgium, a spatio-temporal transmission model was formulated. The model quantifies the local transmission of the disease between farms within a municipality, the short-distance transmission between farms across neighbouring municipalities and the transmission as a result of cattle movement. Different municipality-level covariates such as farm density, land composition variables, temperature and precipitation, were assessed as possibly influencing each component of the transmission process. Results showed a significant influence of the different covariates in each model component, particularly the significant effect of temperature and precipitation values in the number of infected farms. The model which allowed us to predict the dynamic spreading of BTV for different movement restriction scenarios, also affirmed the significant impact of cattle movement in the 2006 BTV outbreak pattern. Simulation results further showed the importance of considering the size of restriction zones in the formulation of guidelines for animal infectious diseases.	[Ensoy, Chellafe; Aerts, Marc; Faes, Christel] Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Welby, Sarah; Van der Stede, Yves] Vet & Agrochem Res Ctr, Brussels, Belgium; [Van der Stede, Yves] Univ Ghent, Lab Vet Immunol, Merelbeke, Belgium	Hasselt University; Ghent University	Ensoy, C (corresponding author), Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium.	chellafe.ensoy@uhasselt.be	Faes, Christel/E-1384-2017; Van der Stede, Yves/I-4626-2016	Faes, Christel/0000-0002-1878-9869; Van der Stede, Yves/0000-0001-7294-3698	IAP Research Network P7/06 of the Belgian State (Belgian Science Policy); Flemish Research Council [G064710]	IAP Research Network P7/06 of the Belgian State (Belgian Science Policy); Flemish Research Council(FWO)	Support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy) and the Flemish Research Council (G064710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Bivand RS, 2008, USE R, P1; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Di Gialleonardo L, 2011, RES VET SCI, V91, P316, DOI 10.1016/j.rvsc.2010.12.017; Diekmann O, 2000, MATH METHODOLOGY INF; Faes C, 2013, PREV VET MED, V110, P149, DOI 10.1016/j.prevetmed.2012.11.026; FAO, 2001, STAT FOOD AGR; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Held L, 2005, STAT MODEL, V5, P187, DOI 10.1191/1471082X05st098oa; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Hooten MB, 2010, SPAT SPATIO-TEMPORAL, V1, P177, DOI 10.1016/j.sste.2010.03.003; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; Kupferschmidt K, 2012, NEW ANIMAL VIRUS TAK; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; Peeters A., 2010, COUNTRY PASTURE FORA; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2004, REV SCI TECH OIE, V23, P761, DOI 10.20506/rst.23.3.1515; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schley D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005481; Schrodle B, 2012, BIOMETRICS, V68, P736, DOI 10.1111/j.1541-0420.2011.01717.x; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Turner J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00319; Vandenbussche F, 2008, VET MICROBIOL, V129, P15, DOI 10.1016/j.vetmic.2007.10.029; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; WARD MP, 1995, PREV VET MED, V24, P129, DOI 10.1016/0167-5877(94)00458-U; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	32	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78591	10.1371/journal.pone.0078591	http://dx.doi.org/10.1371/journal.pone.0078591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244324	gold, Green Published			2022-12-25	WOS:000327221600034
J	He, WJ; Xie, QH; Wang, YY; Chen, J; Zhao, M; Davis, LS; Breyer, MD; Gu, GQ; Hao, CM				He, Wenjuan; Xie, Qionghong; Wang, Yingying; Chen, Jing; Zhao, Min; Davis, Linda S.; Breyer, Matthew D.; Gu, Guoqiang; Hao, Chuan-Ming			Generation of a Tenascin-C-CreER2 Knockin Mouse Line for Conditional DNA Recombination in Renal Medullary Interstitial Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; TENASCIN; EXPRESSION; CYCLOOXYGENASE-2; HYPERTENSION; SURVIVAL; KIDNEY; ADULT; RATS	Renal medullary interstitial cells (RMIC) are specialized fibroblast-like cells that exert important functions in maintaining body fluid homeostasis and systemic blood pressure. Here, we generated a RMIC specific tenascin-C promoter driven inducible CreER2 knockin mouse line with an EGFP reporter. Similar as endogenous tenascin-C expression, the reporter EGFP expression in the tenascin-C-CreER2(+/-) mice was observed in the inner medulla of the kidney, and co-localized with COX2 but not with AQP2 or AQP1, suggesting selective expression in RMICs. After recombination (tenascin-C-CreER2(+/-)/ROSA26-lacZ(+/-) mice + tamoxifen), beta-gal activity was restricted to the cells in the inner medulla of the kidney, and didn't colocalize with AQP2, consistent with selective Cre recombinase activity in RMICs. Cre activity was not obvious in other major organs or without tamoxifen treatment. This inducible RMIC specific Cre mouse line should therefore provide a novel tool to manipulate genes of interest in RMICs.	[Xie, Qionghong; Chen, Jing; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China; [He, Wenjuan] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [He, Wenjuan; Wang, Yingying; Zhao, Min; Davis, Linda S.; Hao, Chuan-Ming] Vanderbilt Univ, Med Ctr, Sch Med, Div Nephrol, Nashville, TN 37232 USA; [Breyer, Matthew D.] Eli Lilly & Co, Lilly Res Labs, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Gu, Guoqiang] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Fudan University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Vanderbilt University; Eli Lilly; Vanderbilt University	Hao, CM (corresponding author), Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China.	chuanminghao@fudan.edu.cn	wang, yingying/GRS-3058-2022; Chen, Jing/AAM-2184-2021	Breyer, Matthew/0000-0003-1880-371X	Natural Science Foundation of China [81130075]; National Basic Research Program of China [2011CB94001]; NIH [R01 DK071876985];  [985III-YFX0302]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	Funding was provided by Natural Science Foundation of China 81130075, National Basic Research Program of China 2011CB94001, NIH R01 DK071876985, and Project of China 985III-YFX0302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599; Brellier F, 2009, SCAND J MED SCI SPOR, V19, P511, DOI 10.1111/j.1600-0838.2009.00916.x; BULGER RE, 1967, LAB INVEST, V16, P124; BULGER RE, 1966, AM J ANAT, V118, P685, DOI 10.1002/aja.1001180302; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hao CM, 2004, HYPERTENSION, V44, P396, DOI 10.1161/01.HYP.0000140925.73081.4c; Harris RC, 2002, J HYPERTENS, V20, pS3; Haugan K, 1997, J PHARMACOL EXP THER, V280, P1415; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Mackie EJ, 1999, J CELL SCI, V112, P3847; NATALI PG, 1991, INT J CANCER, V47, P811, DOI 10.1002/ijc.2910470603; Tompers DM, 2004, STEM CELLS, V22, P243, DOI 10.1634/stemcells.22-3-243; Truong LD, 1996, NEPHRON, V72, P579, DOI 10.1159/000188943	20	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79839	10.1371/journal.pone.0079839	http://dx.doi.org/10.1371/journal.pone.0079839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244568	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600154
J	Inanobe, A; Nakagawa, A; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Kurachi, Yoshihisa			Conformational Changes Underlying Pore Dilation in the Cytoplasmic Domain of Mammalian Inward Rectifier K+ Channels	PLOS ONE			English	Article							G-BETA-GAMMA; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; MECHANISM; PIP2; SUBUNIT; BINDING; G(BETA-GAMMA)	The cytoplasmic domain of inward rectifier K+ (Kir) channels associates with cytoplasmic ligands and undergoes conformational change to control the gate present in its transmembrane domain. Ligand-operated activation appears to cause dilation of the pore at the cytoplasmic domain. However, it is still unclear how the cytoplasmic domain supports pore dilation and how alterations to this domain affect channel activity. In the present study, we focused on 2 spatially adjacent residues, i.e., Glu236 and Met313, of the G protein-gated Kir channel subunit Kir3.2. In the closed state, these pore-facing residues are present on adjacent beta D and beta H strands, respectively. We mutated both residues, expressed them with the m(2)-muscarinic receptor in Xenopus oocytes, and measured the acetylcholine-dependent K+ currents. The dose-response curves of the Glu236 mutants tended to be shifted to the right. In comparison, the slopes of the concentration-dependent curves were reduced and the single-channel properties were altered in the Met313 mutants. The introduction of arginine at position 236 conferred constitutive activity and caused a leftward shift in the conductance-voltage relationship. The crystal structure of the cytoplasmic domain of the mutant showed that the arginine contacts the main chains of the beta H and beta I strands of the adjacent subunit. Because the beta H strand forms a beta sheet with the beta I and beta D strands, the immobilization of the pore-forming beta sheet appears to confer unique properties to the mutant. These results suggest that the G protein association triggers pore dilation at the cytoplasmic domain in functional channels, and the pore-constituting structural elements contribute differently to these conformational changes.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Lab Supramol Crystallog, Suita, Osaka 565, Japan	Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C23590301, 22136002]; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AI was supported by a Grant-in-Aid for Scientific Research (C23590301) and YK by a Grant-in-Aid for Scientific Research on Innovative Areas (22136002) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hosoya Y, 1996, J GEN PHYSIOL, V108, P485, DOI 10.1085/jgp.108.6.485; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 1999, J NEUROSCI, V19, P1006; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Inanobe A, 2011, J BIOL CHEM, V286, P41801, DOI 10.1074/jbc.M111.278531; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Inanobe A, 2010, J BIOL CHEM, V285, P38517, DOI 10.1074/jbc.M110.161703; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Medina I, 2000, J BIOL CHEM, V275, P29709, DOI 10.1074/jbc.M004989200; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; YAMADA M, 1994, BIOCHEM BIOPH RES CO, V200, P1484, DOI 10.1006/bbrc.1994.1618; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	47	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79844	10.1371/journal.pone.0079844	http://dx.doi.org/10.1371/journal.pone.0079844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244570	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600155
J	Wilson, BJ; Nicholas, FW; James, JW; Wade, CM; Raadsma, HW; Thomson, PC				Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Raadsma, Herman W.; Thomson, Peter C.			Genetic Correlations among Canine Hip Dysplasia Radiographic Traits in a Cohort of Australian German Shepherd Dogs, and Implications for the Design of a More Effective Genetic Control Program	PLOS ONE			English	Article							BREEDING VALUES; ELBOW DYSPLASIA; SELECTION; LOCI; OSTEOARTHRITIS; POPULATIONS; ROTTWEILERS; LAXITY; JOINTS	Canine hip dysplasia (CHD) is a common musculoskeletal disease in pedigree dog populations. It can cause severe pain and dysfunction which may require extensive medication and/or surgical treatment and often ultimately requires humane euthanasia. CHD has been found to be moderately heritable and, given its impact on welfare, should be considered an imperative breeding priority. The British Veterinary Association/Kennel Club scoring method is one of several measures used to assess the genetic propensity of potential breeding stock for dysplastic changes to the hips based on radiographic examination. It is a complex measure composed of nine ordinal traits, intended to evaluate both early and late dysplastic changes. It would be highly desirable if estimated breeding values (EBVs) for these nine traits were consolidated into a simpler, EBV-based, selection index more easily usable by breeders. A multivariate analysis on the phenotype scores from an Australian cohort of 13,124 German Shepherd Dogs (GSDs) returned genetic correlations between 0.48-0.97 for the nine traits which fell into two trait groups, Group 1 reflecting early changes ("laxity") and Group 2 reflecting late changes ("osteoarthritis"). Principal components analysis of the ordinal EBVs suggested the same pattern, with strong differentiation between "laxity" and "osteoarthritis" traits in the second component. Taking account of all results, we recommend interim use of two selection indexes: the first being the average of ordinal EBVs for "laxity" traits and the second being the average of ordinal EBVs for "osteoarthritis" traits. The correlation between these two selection indexes (0.771-0.774) is sufficiently less than unity enabling the selection of dogs with different genetic propensity for laxity and for osteoarthritic CHD changes in GSDs; this may also be applicable in other breeds. Dogs with low propensity for severe osteoarthritic change in the presence of laxity may be of interest both in molecular research and breeding programs.	[Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Raadsma, Herman W.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Wilson, BJ (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bethany.wilson@sydney.edu.au	Nicholas, Frank William/AAE-5566-2022; Nicholas, Frank/AGY-8318-2022; Thomson, Peter/V-7290-2019	Nicholas, Frank William/0000-0002-9178-3965; Nicholas, Frank/0000-0002-9178-3965; Thomson, Peter/0000-0003-4428-444X; Wade, Claire/0000-0003-3413-4771				Biery DN, 2006, BSAVA MANUAL CANINE, P119; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; GUNAWAN B, 1986, AUST J AGR RES, V37, P539, DOI 10.1071/AR9860539; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; HAYES JF, 1981, BIOMETRICS, V37, P483, DOI 10.2307/2530561; Hedberg K, 2000, REV HD SCHEME NBC M; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; MORGAN JP, 2000, HEREDITARY BONE JOIN, P109; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; POPOVITCH CA, 1995, J AM VET MED ASSOC, V206, P648; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Thomson PC, 2010, VET J, V183, P243, DOI 10.1016/j.tvjl.2009.12.002; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Willis M.B., 1989, GENETICS DOG; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wilson BJ, 2013, PLOS ONE UNPUB; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	32	6	6	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78929	10.1371/journal.pone.0078929	http://dx.doi.org/10.1371/journal.pone.0078929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244386	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900027
J	Chen, X; Makarewicz, JM; Knauf, JA; Johnson, LK; Fagin, JA				Chen, X.; Makarewicz, J. M.; Knauf, J. A.; Johnson, L. K.; Fagin, J. A.			Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition	ONCOGENE			English	Article						RAS; papilloma; farnesyl transferase inhibitor	WILD-TYPE RAS; H-RAS; PROTEIN TRANSFERASE; N-RAS; MOUSE SKIN; K-RAS; ACTIVATING MUTATIONS; GENE; CARCINOMAS; EXPRESSION	RAS-driven malignancies remain a major therapeutic challenge. The two-stage 7,12-dimethylbenz(a) anthracene (DMBA)/12-o-tetradecanoylphorbol-13-acetate (TPA) model of mouse skin carcinogenesis has been used to study mechanisms of epithelial tumor development by oncogenic Hras. We used mice with an Hras(G12V) knock-in allele to elucidate the early events after Hras activation, and to evaluate the therapeutic effectiveness of farnesyltransferase inhibition (FTI). Treatment of Caggs-Cre/FR-Hras(G12V) mice with TPA alone was sufficient to trigger papilloma development with a shorter latency and an similar to 10-fold greater tumor burden than DMBA/TPA-treated WT-controls. Hras(G12V) allele copy number was increased in all papillomas induced by TPA. DMBA/TPA treatment of Hras(G12V) knock-in mice induced an even greater incidence of papillomas, which either harbored Hras(G12V) amplification or developed an Hras(Q61L) mutation in the second allele. Laser-capture microdissection of normal skin, hyperplastic skin and papillomas showed that amplification occurred only at the papilloma stage. HRAS-mutant allelic imbalance was also observed in human cancer cell lines, consistent with a requirement for augmented oncogenic HRAS signaling for tumor development. The FTI SCH66336 blocks HRAS farnesylation and delocalizes it from the plasma membrane. NRAS and KRAS are not affected as they are alternatively prenylated. When tested in lines harboring HRAS, NRAS or KRAS mutations, SCH66336 delocalized, inhibited signaling and preferentially inhibited growth only of HRAS-mutant lines. Treatment with SCH66336 also induced near-complete regression of papillomas of TPA-treated Hras(G12V) knock-in mice. These data suggest that farnesyl transferase inhibitors should be reevaluated as targeted agents for human HRAS-driven cancers, such as those of bladder, thyroid and other epithelial lineages.	[Chen, X.; Makarewicz, J. M.; Knauf, J. A.; Fagin, J. A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY USA; [Knauf, J. A.; Fagin, J. A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Johnson, L. K.] Sloan Kettering Inst, New York, NY USA; [Fagin, J. A.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Fagin, JA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 296,Zuckerman Bldg,ZRC 504, New York, NY 10065 USA.	Faginj@mskcc.org		Makarewicz, Jacek/0000-0003-2557-2817; Knauf, Jeffrey/0000-0003-4456-8792; chen, xu/0000-0003-2524-4979	NIH [RO1-CA72597, T32-DK07313]; Margot Rosenberg Pulitzer Foundation; Byrne Fund; Lefkofsky Family Foundation; NATIONAL CANCER INSTITUTE [P50CA172012, R01CA072597, R01CA050706, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margot Rosenberg Pulitzer Foundation; Byrne Fund; Lefkofsky Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants RO1-CA72597 and T32-DK07313, the Margot Rosenberg Pulitzer Foundation, the Byrne Fund and the Lefkofsky Family Foundation. We are indebted to the Molecular Cytology and Comparative Pathology Core facilities of Memorial Sloan Kettering Cancer Center. We are also grateful to Dr. Paul Kirschmeier and W Robert Bishop (formerly of Schering-Plough) for providing us with SCH 66336.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Ashar HR, 2001, EXP CELL RES, V262, P17, DOI 10.1006/excr.2000.5076; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Bastian BC, 2000, AM J PATHOL, V157, P967, DOI 10.1016/S0002-9440(10)64609-3; Bernhard EJ, 1998, CANCER RES, V58, P1754; Bishop WR, 1995, J BIOL CHEM, V270, P30611, DOI 10.1074/jbc.270.51.30611; Boichard A, 2012, J CLIN ENDOCR METAB, V97, pE2031, DOI 10.1210/jc.2012-2092; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; BUCHMANN A, 1991, CANCER RES, V51, P4097; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; Diaz R, 2002, CANCER RES, V62, P4514; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Harousseau JL, 2009, BLOOD, V114, P1166, DOI 10.1182/blood-2009-01-198093; Hayes TK, 2013, CANCER DISCOV, V3, P24, DOI 10.1158/2159-8290.CD-12-0521; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Johnson BE, 2004, CLIN CANCER RES, V10, p4254S, DOI 10.1158/1078-0432.CCR-040016; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Moura MM, 2011, J CLIN ENDOCR METAB, V96, pE863, DOI 10.1210/jc.2010-1921; NAMBA H, 1990, J CLIN ENDOCR METAB, V71, P223, DOI 10.1210/jcem-71-1-223; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rao S, 2004, J CLIN ONCOL, V22, P3950, DOI 10.1200/JCO.2004.10.037; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schuhmacher AJ, 2008, J CLIN INVEST, V118, P2169, DOI [10.1172/JCI3438S, 10.1172/JCI34385]; SEPPLORENZINO L, 1995, CANCER RES, V55, P5302; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang FL, 1997, J BIOL CHEM, V272, P10232; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	46	32	37	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5442	5449		10.1038/onc.2013.489	http://dx.doi.org/10.1038/onc.2013.489			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240680	Green Accepted			2022-12-25	WOS:000345120700006
J	Ries, MI; Ali, H; Lankhorst, PP; Hankemeier, T; Bovenberg, RAL; Driessen, AJM; Vreeken, RJ				Ries, Marco I.; Ali, Hazrat; Lankhorst, Peter P.; Hankemeier, Thomas; Bovenberg, Roel A. L.; Driessen, Arnold J. M.; Vreeken, Rob J.			Novel Key Metabolites Reveal Further Branching of the Roquefortine/Meleagrin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Anticancer Drug; Fungi; Natural Product Biosynthesis; Secondary Metabolism; Toxins	PENICILLIUM; ALKALOIDS; DIKETOPIPERAZINE; NEOXALINE; NITRONES	Metabolic profiling and structural elucidation of novel secondary metabolites obtained from derived deletion strains of the filamentous fungus Penicillium chrysogenum were used to reassign various previously ascribed synthetase genes of the roquefortine/meleagrin pathway to their corresponding products. Next to the structural characterization of roquefortine F and neoxaline, which are for the first time reported for P. chrysogenum, we identified the novel metabolite roquefortine L, including its degradation products, harboring remarkable chemical structures. Their biosynthesis is discussed, questioning the exclusive role of glandicoline A as key intermediate in the pathway. The results reveal that further enzymes of this pathway are rather unspecific and catalyze more than one reaction, leading to excessive branching in the pathway with meleagrin and neoxaline as end products of two branches.	[Ries, Marco I.; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Acad Ctr Drug Res, Div Analyt Biosci, NL-2333 CC Leiden, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9747 AG Groningen, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [Lankhorst, Peter P.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, NL-2613 AX Delft, Netherlands; [Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, NL-2333 CC Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Synthet Biol & Cell Engn, NL-9747 AG Groningen, Netherlands	University of Groningen; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Vreeken, RJ (corresponding author), Leiden Acad Ctr Drug Res, Div Analyt Biosci, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	vreekenrj@lacdr.leidenuniv.nl	Vreeken, Rob/AAA-4563-2021; Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019; Hankemeier, Thomas/V-5407-2019	Hankemeier, Thomas/0000-0001-7871-2073; Driessen, Arnold J.M./0000-0001-9258-9104; Vreeken, Rob/0000-0003-3568-1371; Lankhorst, Peter/0000-0002-0373-5673	Perspective Genbiotics program; Stichting toegepaste wetenschappen (STW); Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; STW	Perspective Genbiotics program; Stichting toegepaste wetenschappen (STW)(Technologiestichting STW); Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); STW(Technologiestichting STW)	This work was supported by the Perspective Genbiotics program subsidized by Stichting toegepaste wetenschappen (STW) and (co)financed by the Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.; Supported by the STW.	Ali H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065328; Cashman JR, 1999, J PHARMACOL EXP THER, V288, P1251; Clark B, 2005, J NAT PROD, V68, P1661, DOI 10.1021/np0503101; Du L, 2010, J ANTIBIOT, V63, P165, DOI 10.1038/ja.2010.11; Du L, 2009, TETRAHEDRON, V65, P1033, DOI 10.1016/j.tet.2008.11.078; Koolen HHF, 2012, NAT PROD RES, V26, P2013, DOI 10.1080/14786419.2011.639070; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Floyd RA, 2011, ANTI-CANCER AGENT ME, V11, P373; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; HIRANO A, 1979, J ANTIBIOT, V32, P781, DOI 10.7164/antibiotics.32.781; Kato N, 2009, CHEMBIOCHEM, V10, P920, DOI 10.1002/cbic.200800787; Koizumi Y, 2004, BBA-MOL CELL RES, V1693, P47, DOI 10.1016/j.bbamcr.2004.04.013; Kozlovsky AG, 1994, APPL BIOCHEM MICRO+, V30; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Overy DP, 2006, BIOCHEM SYST ECOL, V34, P345, DOI 10.1016/j.bse.2005.10.010; Overy DP, 2005, J CHEM ECOL, V31, P2373, DOI 10.1007/s10886-005-7107-y; Rodriguez RJ, 1999, DRUG METAB DISPOS, V27, P880; SCOTT PM, 1976, EXPERIENTIA, V32, P140, DOI 10.1007/BF01937728; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; Sun H, 2007, J PHARMACOL EXP THER, V322, P843, DOI 10.1124/jpet.107.121723; Vinokurova NG, 2003, APPL BIOCHEM MICRO+, V39, P403, DOI 10.1023/A:1024576703367; Weber SS, 2012, APPL ENVIRON MICROB, V78, P7107, DOI 10.1128/AEM.01529-12	23	37	43	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37289	37295		10.1074/jbc.M113.512665	http://dx.doi.org/10.1074/jbc.M113.512665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225953	Green Published, hybrid			2022-12-25	WOS:000329189700045
J	Iascone, DM; Padidam, S; Pyfer, MS; Zhang, XH; Zhao, LJ; Chin, J				Iascone, Daniel M.; Padidam, Sneha; Pyfer, Mark S.; Zhang, Xiaohong; Zhao, Lijuan; Chin, Jeannie			Impairments in Neurogenesis Are Not Tightly Linked to Depressive Behavior in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURAL STEM-CELLS; DEPLETION; DEFICITS; NEURONS	Alzheimer's disease (AD), the most common cause of dementia, is also associated with depression. Although the precise mechanisms that lead to depression in AD are unknown, the impairments in adult hippocampal neurogenesis observed in AD may play a role. Adult-born neurons play a critical role in regulating both cognition and mood, and reduced hippocampal neurogenesis is associated with depression in other neurological disorders. To assess the relationship between Alzheimer's disease, neurogenesis, and depression, we studied human amyloid precursor protein (hAPP) transgenic mice, a well-characterized model of AD. We report that reductions in hippocampal neurogenesis are evident early in disease progression in hAPP mice, but a mild depressive phenotype manifests only in later stages of disease. We found that hAPP mice exhibited a reduction in BrdU-positive cells in the subgranular zone of the dentate gyrus in the hippocampus, as well as a reduction in doublecortin-expressing cells, relative to nontransgenic controls at 5-7 months of age. These alterations in neurogenesis appeared to worsen with age, as the magnitude of reduction in doublecortin-expressing cells was greater in hAPP mice at 13-15 months of age. Only 13-15 month old hAPP mice exhibited depressive behavior in the tail suspension test. However, mice at both age groups exhibited deficits in spatial memory, which was observed in the Morris water maze test for hippocampus-dependent memory. These findings indicate that neurogenesis impairments are accompanied by cognitive deficits, but are not tightly linked to depressive behavior in hAPP mice.	[Chin, Jeannie] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Chin, J (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.	Jeannie.Chin@jefferson.edu		Chin, Jeannie/0000-0001-9902-3744; Iascone, Daniel Maxim/0000-0002-8629-7639	Alzheimer's Association [NIRG-11-205769]; Margaret Q. Landenberger Research Foundation	Alzheimer's Association(Alzheimer's Association); Margaret Q. Landenberger Research Foundation	The Chin lab is grateful for support from the Alzheimer's Association grant NIRG-11-205769 (www.alz.org) and the Margaret Q. Landenberger Research Foundation (no public URL), from whom funds were used to partially support lab staff and animal maintenance during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Becker C, 2008, MOL PSYCHIATR, V13, P1079, DOI 10.1038/sj.mp.4002097; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; David DJ, 2010, NEUROSCIENTIST, V16, P578, DOI 10.1177/1073858409360281; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Holtzman DM, 2011, SCI TRANSL MED, V3; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rodriguez JJ, 2011, J ANAT, V219, P78, DOI 10.1111/j.1469-7580.2011.01343.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Tarawneh R, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A006148; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79651	10.1371/journal.pone.0079651	http://dx.doi.org/10.1371/journal.pone.0079651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244537	Green Published, gold			2022-12-25	WOS:000327143800095
J	Dietz, P; Ulrich, R; Dalaker, R; Striegel, H; Franke, AG; Lieb, K; Simon, P				Dietz, Pavel; Ulrich, Rolf; Dalaker, Robert; Striegel, Heiko; Franke, Andreas G.; Lieb, Klaus; Simon, Perikles			Associations between Physical and Cognitive Doping - A Cross-Sectional Study in 2.997 Triathletes	PLOS ONE			English	Article							ANABOLIC-STEROID USE; RANDOMIZED-RESPONSE; NUTRITIONAL SUPPLEMENTS; DRUG-USE; FITNESS-SPORTS; CAFFEINE; PREVALENCE; ENHANCEMENT; ILLICIT; PERFORMANCE	Purpose: This study assessed, for the first time, prevalence estimates for physical and cognitive doping within a single collective of athletes using the randomized response technique (RRT). Furthermore, associations between the use of legal and freely available substances to improve physical and cognitive performance (enhancement) and illicit or banned substances to improve physical and cognitive performance (doping) were examined. Methods: An anonymous questionnaire using the unrelated question RRT was used to survey 2,997 recreational triathletes in three sports events (Frankfurt, Regensburg, and Wiesbaden) in Germany. Prior to the survey, statistical power analyses were performed to determine sample size. Logistic regression was used to predict physical and cognitive enhancement and the bootstrap method was used to evaluate differences between the estimated prevalences of physical and cognitive doping. Results: 2,987 questionnaires were returned (99.7%). 12-month prevalences for physical and cognitive doping were 13.0% and 15.1%, respectively. The prevalence estimate for physical doping was significantly higher in athletes who also used physical enhancers, as well as in athletes who took part in the European Championship in Frankfurt compared to those who did not. The prevalence estimate for cognitive doping was significantly higher in athletes who also used physical and cognitive enhancers. Moreover, the use of physical and cognitive enhancers were significantly associated and also the use of physical and cognitive doping. Discussion: The use of substances to improve physical and cognitive performance was associated on both levels of legality (enhancement vs. doping) suggesting that athletes do not use substances for a specific goal but may have a general propensity to enhance. This finding is important for understanding why people use such substances. Consequently, more effective prevention programs against substance abuse and doping could be developed.	[Dietz, Pavel; Dalaker, Robert; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Dis Prevent, D-55122 Mainz, Germany; [Striegel, Heiko] Univ Tubingen, Dept Sports Med, Tubingen, Germany; [Franke, Andreas G.; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Ulrich, Rolf] Univ Tubingen, Dept Psychol, Tubingen, Germany	Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Dis Prevent, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Simon, Perikles D/B-2293-2013; Ulrich, Rolf/A-9372-2012	Simon, Perikles D/0000-0002-7996-4034; Ulrich, Rolf/0000-0001-8443-2705; Dietz, Pavel/0000-0002-8390-0594	World Anti-Doping Agency (WADA) [09M5]; Initiative PRO Humanities and Social Sciences (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany	World Anti-Doping Agency (WADA); Initiative PRO Humanities and Social Sciences (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany	This project has been carried out with the support of the World Anti-Doping Agency (WADA) (grant number: 09M5) and the Initiative PRO Humanities and Social Sciences 2015 (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, STAGES PATHWAYS DRUG, DOI [DOI 10.1017/CBO9780511499777.003, 10.1017/CBO9780511499777]; Arvary D, 2000, NEW ENGL J MED, V342, P1532, DOI 10.1056/NEJM200005183422018; Backhouse SH, 2013, SCAND J MED SCI SPOR, V23, P244, DOI 10.1111/j.1600-0838.2011.01374.x; Braun H, 2009, INT J SPORT NUTR EXE, V19, P97, DOI 10.1123/ijsnem.19.1.97; BUCKLEY WE, 1988, JAMA-J AM MED ASSOC, V260, P3441; Burns NR, 2006, HUM PSYCHOPHARM CLIN, V21, P27, DOI 10.1002/hup.739; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; Deutsche Angestellten Krankenkasse (DAK), 2009, GES 2009 AN ARB SCHW; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-102; Geyer H, 2008, J MASS SPECTROM, V43, P892, DOI 10.1002/jms.1452; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; HUGHES JR, 1992, AM J PSYCHIAT, V149, P33; International Triathlon Union (ITU), 2012, ANT; Kanayama G, 2001, PSYCHOTHER PSYCHOSOM, V70, P137, DOI 10.1159/000056238; Killgore WDS, 2009, SLEEP, V32, P205, DOI 10.1093/sleep/32.2.205; Klaber M, 2010, DOPING FITNESS STUDI; Knez WL, 2010, INT J SPORT NUTR EXE, V20, P507, DOI 10.1123/ijsnem.20.6.507; Kohler M, 2010, DRUG TEST ANAL, V2, P533, DOI 10.1002/dta.186; Korkia P, 1997, INT J SPORTS MED, V18, P557, DOI 10.1055/s-2007-972681; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lentillon-Kaestner V, 2010, SCAND J MED SCI SPOR, V20, P336, DOI 10.1111/j.1600-0838.2009.00885.x; Lieberman HR, 2001, NUTR REV, V59, P91, DOI 10.1111/j.1753-4887.2001.tb06995.x; LITTLE RJA, 1982, J AM STAT ASSOC, V77, P237, DOI 10.2307/2287227; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Mayet A, 2012, ADDICT BEHAV, V37, P160, DOI 10.1016/j.addbeh.2011.09.012; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Niess A M, 2007, Ther Umsch, V64, P181, DOI 10.1024/0040-5930.64.3.181; Papadopoulos FC, 2006, EUR J EPIDEMIOL, V21, P307, DOI 10.1007/s10654-006-0018-6; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; Repantis D., 2009, POIESIS PRAXIS, V6, P139, DOI [DOI 10.1007/S10202-008-0060-4, 10.1007/s10202-008-0060-4]; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Simon P, 2006, ADDICTION, V101, P1640, DOI 10.1111/j.1360-0443.2006.01568.x; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Striegel H, 2006, INT J SPORTS MED, V27, P236, DOI 10.1055/s-2005-865648; Striegel H, 2006, DRUG ALCOHOL DEPEN, V81, P11, DOI 10.1016/j.drugalcdep.2005.05.013; Striegel H, 2010, DRUG ALCOHOL DEPEN, V106, P230, DOI 10.1016/j.drugalcdep.2009.07.026; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Tscholl P, 2010, AM J SPORT MED, V38, P133, DOI 10.1177/0363546509344071; Ulrich R, 2012, PSYCHOL METHODS, V17, P623, DOI 10.1037/a0029314; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; World Anti-Doping Agency (WADA), 2012, PROH LIST 2013; World Triathlon Corporation (WTC), 2012, WORLD TRIATHL CORP L	51	37	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78702	10.1371/journal.pone.0078702	http://dx.doi.org/10.1371/journal.pone.0078702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236038	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700035
J	Han, L; Tang, MX; Ti, Y; Wang, ZH; Wang, J; Ding, WY; Wang, H; Zhang, Y; Zhang, W; Zhong, M				Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming			Overexpressing STAMP2 Improves Insulin Resistance in Diabetic ApoE(-/-)/LDLR-/- Mice via Macrophage Polarization Shift in Adipose Tissues	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BROWN ADIPOCYTES; TNF-ALPHA; OBESITY; INFLAMMATION; ADIPOGENESIS; EXPRESSION	STAMP2 is a counterregulator of inflammation and insulin resistance. The aim of this study is to investigate whether activation of STAMP2 improves insulin resistance by regulating macrophage polarization in adipose tissues. The diabetic ApoE(-/-)/LDLR-/- mouse model was induced by high-fat diet and low-dose streptozotocin. Samples were obtained from epididymal, subcutaneous and brown adipose tissues. Infiltration of M1/M2 macrophages and inflammatory cytokines were investigated by immunohistochemistry. We then used gene overexpression to investigate the effect of STAMP2 on macrophages infiltration and polarization and inflammatory cytokines expression. Our results showed that infiltration of macrophages, the ratio of M1/M2 macrophages and the expression of pro-inflammatory cytokines were enhanced and STAMP2 was downregulated in adipose tissues of diabetic ApoE(-/-)/LDLR-/- mice compared with control mice. STAMP2 gene overexpression could significantly reduce macrophages infiltration, the ratio of M1/M2 macrophages and the expression of pro-inflammatory cytokines in epididymal and brown adipose tissues, improving insulin resistance. Our results suggested that STAMP2 gene overexpression may improve insulin resistance via regulating macrophage polarization in visceral and brown adipose tissues.	[Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Peoples R China; [Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Chinese Minist Publ Hlth, Jinan, Peoples R China; [Han, Lu; Ti, Yun; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Tang, Meng-Xiong] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Peoples R China; [Wang, Zhi-Hao] Shandong Univ, Qilu Hosp, Dept Geriatr Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhong, M (corresponding author), Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Peoples R China.	zhongmingzm@gmail.com			Key Technologies R & D Program of Shandong Province [2010G0020262]; Independent Innovation Foundation of Shandong University [2012JC034]; Natural Science Foundation of Shandong Province [ZR2009CM022, ZR2009CM025]; National Natural Science Foundation of China [30971215, 81070192, 81070141, 81100605, 81270352, 81270287]; National Basic Research Program of China (973 Program) [2012CB722406]	Key Technologies R & D Program of Shandong Province; Independent Innovation Foundation of Shandong University; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the research grants from Key Technologies R & D Program of Shandong Province (2010G0020262), the Independent Innovation Foundation of Shandong University (2012JC034), the Natural Science Foundation of Shandong Province (ZR2009CM022, ZR2009CM025), the National Natural Science Foundation of China (30971215, 81070192, 81070141, 81100605, 81270352 and 81270287) and the National Basic Research Program of China (973 Program, Grant No.: 2012CB722406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; EVANS DJ, 1984, METABOLISM, V33, P68, DOI 10.1016/0026-0495(84)90164-1; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hammarstedt A, 2007, BIOCHEM BIOPH RES CO, V357, P700, DOI 10.1016/j.bbrc.2007.03.202; HEIBRONN L, 2004, INT J OBES RELAT S4, V28, pS12; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nisoli E, 1997, CELL DEATH DIFFER, V4, P771, DOI 10.1038/sj.cdd.4400292; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	25	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78903	10.1371/journal.pone.0078903	http://dx.doi.org/10.1371/journal.pone.0078903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236066	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700063
J	Padmashali, R; You, H; Karnik, N; Lei, P; Andreadis, ST				Padmashali, Roshan; You, Hui; Karnik, Nikhila; Lei, Pedro; Andreadis, Stelios T.			Adherens Junction Formation Inhibits Lentivirus Entry and Gene Transfer	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; HUMAN EPIDERMAL-KERATINOCYTES; POLARIZED EPITHELIAL-CELLS; STEM-CELLS; ALPHA-CATENIN; IN-VIVO; RHINOVIRUS INFECTION; AIRWAY EPITHELIUM; CADHERIN	Although cellular signaling pathways that affect lentivirus infection have been investigated, the role of cell-cell interactions in lentiviral gene delivery remains elusive. In the course of our studies we observed that lentiviral gene transfer was a strong function of the position of epithelial cells within colonies. While peripheral cells were transduced efficiently, cells in the center of colonies were resistant to gene transfer. In addition, gene delivery was enhanced significantly under culture conditions that disrupted adherens junctions (AJ) but decreased upon AJ formation. In agreement, gene knockdown and gain-of-function approaches showed that a-catenin, a key component of the AJ complex prevented lentivirus gene transfer. Using a doxycycline regulatable system we showed that expression of dominant negative E-cadherin enhanced gene transfer in a dose-dependent manner. In addition, dissolution of AJ by doxycycline increased entry of lentiviral particles into the cell cytoplasm in a dose-dependent manner. Taken together our results demonstrate that AJ formation renders cells non-permissive to lentiviral gene transfer and may facilitate development of simple means to enhance gene delivery or combat virus infection.	[Padmashali, Roshan; You, Hui; Karnik, Nikhila; Lei, Pedro; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA; [Andreadis, Stelios T.] SUNY Buffalo, Dept Biomed Engn, Amherst, NY USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Andreadis, ST (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.	sandread@buffalo.edu	Lei, Pedro/U-1027-2019		National Science Foundation [CBET-0853993]	National Science Foundation(National Science Foundation (NSF))	Funding came from the National Science Foundation (CBET-0853993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Bajaj BG, 2005, MOL THER, V11, P969, DOI 10.1016/j.ymthe.2004.10.023; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Castellani S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/103976; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cmielewski P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-84; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Dahl U, 1996, DEVELOPMENT, V122, P2895; Delorme-Axford E, 2011, VIRUSES-BASEL, V3, P2462, DOI 10.3390/v3122462; Etienne-Manneville Sandrine, 2012, Subcell Biochem, V60, P225, DOI 10.1007/978-94-007-4186-7_10; Fu JD, 2008, STEM CELLS DEV, V17, P315, DOI 10.1089/scd.2007.0114; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kafri Tal, 2004, Methods Mol Biol, V246, P367; Knudsen KA, 1998, J CELL BIOCHEM, P168; Kremer KL, 2007, J GENE MED, V9, P362, DOI 10.1002/jgm.1025; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee MH, 2011, J VIROL, V85, P2657, DOI 10.1128/JVI.01765-10; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Naldini L, 1999, THROMB HAEMOSTASIS, V82, P552; Nelson WJ, 1996, TRENDS CELL BIOL, V6, P325, DOI 10.1016/0962-8924(96)30040-8; Nieman MT, 1999, J CELL SCI, V112, P1621; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ruetze M, 2010, INTEGR BIOL-UK, V2, P241, DOI 10.1039/b926147h; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Schelhaas M, 2003, J GEN VIROL, V84, P2473, DOI 10.1099/vir.0.19226-0; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Spear PG, 2002, DEV CELL, V3, P462, DOI 10.1016/S1534-5807(02)00298-8; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; SUPERTI F, 1987, J GEN VIROL, V68, P387, DOI 10.1099/0022-1317-68-2-387; TEMMGROVE CJ, 1994, J CELL SCI, V107, P2951; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Tomei AA, 2008, AM J PHYSIOL-LUNG C, V294, pL79, DOI 10.1152/ajplung.00062.2007; Tudor D, 2007, CELL PROLIFERAT, V40, P706, DOI 10.1111/j.1365-2184.2007.00467.x; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vogelmann R, 2004, CURR OPIN CELL BIOL, V16, P86, DOI 10.1016/j.ceb.2003.12.002; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79265	10.1371/journal.pone.0079265	http://dx.doi.org/10.1371/journal.pone.0079265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236116	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700115
J	Zhang, DD; Ding, HY; Liu, LL; Hou, XL; Sun, GY; Li, L; Liu, YZ; Zhou, CL; Gu, RL; Luo, YJ				Zhang, Dandan; Ding, Haiyan; Liu, Lili; Hou, Xinlin; Sun, Guoyu; Li, Lei; Liu, Yunzhe; Zhou, Congle; Gu, Ruolei; Luo, Yuejia			The Prognostic Value of Amplitude-Integrated EEG in Full-Term Neonates with Seizures	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PREDICTIVE-VALUE; PRETERM INFANTS; NEUROLOGIC EXAMINATION; BIRTH ASPHYXIA; ELECTROENCEPHALOGRAPHY; AEEG; HYPOTHERMIA; NEWBORN; BORN	Neonatal seizures pose a high risk for adverse outcome in survived infants. While the prognostic value of amplitude-integrated electroencephalogram (aEEG) is well established in neonates with encephalopathy and asphyxia, neonatal seizure studies focusing on the direct correlation between early aEEG measurement and subsequent neurologic outcome are scarce. In this study, the prognostic value of aEEG features was systematically analyzed in 143 full-term neonates to identify prognostic indicators of neurodevelopmental outcome. Neonatal aEEG features of background pattern, cyclicity, and seizure activity, as well as the etiology of neonatal seizures, were significantly associated with neurodevelopmental outcome at one year of age. aEEG background pattern was highly associated with neurologic outcomes (chi(2) = 116.9), followed by aEEG cyclicity (chi(2) = 87.2) and seizure etiology (chi(2) = 79.3). Multiple linear regression showed that the four predictors explained 71.2% of the variation in neurological outcome, with standardized beta coefficients of 0.44, 0.24, 0.22, and 0.14 for the predictors of aEEG background pattern, cyclicity, etiology, and aEEG seizure activity, respectively. This clinically applicable scoring system based on etiology and three aEEG indices would allow pediatricians to assess the risk for neurodevelopmental impairment and facilitate an early intervention in newborns developing seizures.	[Zhang, Dandan; Liu, Yunzhe; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Ding, Haiyan] Tsinghua Univ, Dept Biomed Engn, Beijing 100084, Peoples R China; [Liu, Lili; Hou, Xinlin; Sun, Guoyu; Zhou, Congle] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Li, Lei] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing, Peoples R China; [Gu, Ruolei] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Shenzhen University; Tsinghua University; Peking University; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Hou, XL (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	houxinlin@gmail.com	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172; ?, ?/0000-0003-0859-1880	National Natural Science Foundation of China [31300867, 31300847, 91132704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31300867; 31300847; 91132704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; Bowen JR, 2010, PEDIATR RES, V67, P538, DOI 10.1203/PDR.0b013e3181d4ecda; Dlugos D, 2007, NEUROLOGY, V69, P1812, DOI 10.1212/01.wnl.0000279344.82107.7b; EKEN P, 1995, ARCH DIS CHILD-FETAL, V73, pF75, DOI 10.1136/fn.73.2.F75; El-Dib M, 2009, PEDIATR NEUROL, V41, P315, DOI 10.1016/j.pediatrneurol.2009.05.002; Garfinkle J, 2011, EUR J PAEDIATR NEURO, V15, P222, DOI 10.1016/j.ejpn.2010.11.002; Gesell A, 1940, 1 5 YEARS LIFE PRESC; Glass HC, 2012, PEDIATR NEUROL, V46, P111, DOI 10.1016/j.pediatrneurol.2011.11.006; Glass HC, 2009, CURR TREAT OPTION NE, V11, P405, DOI 10.1007/s11940-009-0045-1; Hellstrom-Westas L., 2008, ATLAS AMPLITUDE INTE, V2nd; Hellstrom-Westas L., 2006, NEOREVIEWS, DOI [DOI 10.1542/NEO.7-2-E76, 10.1542/neo.7-2-e76]; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Kidokoro H, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0030-1270479; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Malik Bushra Abdul, 2005, J Coll Physicians Surg Pak, V15, P786; Massaro AN, 2012, NEONATOLOGY, V102, P197, DOI 10.1159/000339570; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Okumura A, 2009, BRAIN DEV-JPN, V31, P766, DOI 10.1016/j.braindev.2008.11.009; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Pisani F, 2012, PEDIATR RES, V72, P186, DOI 10.1038/pr.2012.66; Pisani F, 2009, PEDIATRICS, V124, pE580, DOI 10.1542/peds.2008-2087; Shah DK, 2012, ARCH DIS CHILD-FETAL, V97, pF65, DOI 10.1136/adc.2009.169508; Shalak LF, 2003, PEDIATRICS, V111, P351, DOI 10.1542/peds.111.2.351; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Spitzmiller RE, 2007, J CHILD NEUROL, V22, P1069, DOI 10.1177/0883073807306258; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; ter Horst H, 2004, PEDIATR RES, V55, P1026, DOI 10.1203/01.pdr.0000127019.52562.8c; ter Horst HJ, 2010, ACTA PAEDIATR, V99, P194, DOI 10.1111/j.1651-2227.2009.01567.x; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; Toet MC, 2006, PEDIATRICS, V117, P333, DOI 10.1542/peds.2005-0987; Udani V, 2008, INDIAN PEDIATR, V45, P739; van der Heide MJ, 2012, EARLY HUM DEV, V88, P33, DOI 10.1016/j.earlhumdev.2011.06.012; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; Vasiljevic B, 2012, VOJNOSANIT PREGL, V69, P492; Volpe J.J., 2008, NEUROLOGY NEWBORN; Zhang DD, 2011, PEDIATRICS, V127, pE1280, DOI 10.1542/peds.2010-2833	37	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78960	10.1371/journal.pone.0078960	http://dx.doi.org/10.1371/journal.pone.0078960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236076	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700073
J	Ma, CC; Dong, X; Li, RD; Liu, L				Ma, Chengcheng; Dong, Xiao; Li, Rudong; Liu, Lei			A Computational Study Identifies HIV Progression-Related Genes Using mRMR and Shortest Path Tracing	PLOS ONE			English	Article							IMMUNE ACTIVATION; T-CELLS; INFECTION; EXPRESSION; PREDICTION; APOPTOSIS; TISSUE; ACID; CD4; CLASSIFICATION	Since statistical relationships between HIV load and CD4+ T cell loss have been demonstrated to be weak, searching for host factors contributing to the pathogenesis of HIV infection becomes a key point for both understanding the disease pathology and developing treatments. We applied Maximum Relevance Minimum Redundancy (mRMR) algorithm to a set of microarray data generated from the CD4+ T cells of viremic non-progressors (VNPs) and rapid progressors (RPs) to identify host factors associated with the different responses to HIV infection. Using mRMR algorithm, 147 gene had been identified. Furthermore, we constructed a weighted molecular interaction network with the existing protein-protein interaction data from STRING database and identified 1331 genes on the shortest-paths among the genes identified with mRMR. Functional analysis shows that the functions relating to apoptosis play important roles during the pathogenesis of HIV infection. These results bring new insights of understanding HIV progression.	[Ma, Chengcheng; Dong, Xiao; Li, Rudong] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Ma, Chengcheng; Dong, Xiao; Li, Rudong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dong, Xiao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fudan University	Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	liulei@scbit.org	Li, Rudong/HGA-8169-2022		Ministry of Science and Technology Grant of P.R. China [2012AA02A602]	Ministry of Science and Technology Grant of P.R. China	This work was funded by a Ministry of Science and Technology Grant of P.R. China. No. 2012AA02A602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bakri Y, 2001, J IMMUNOL, V166, P3780, DOI 10.4049/jimmunol.166.6.3780; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Chapuis AG, 2000, NAT MED, V6, P762, DOI 10.1038/77489; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Csardi N., 2006, INT J COMP SYST, V1695, P1; De Jay N, 2013, BIOINFORMATICS; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Janneh O, 2009, J ANTIMICROB CHEMOTH, V64, P1002, DOI 10.1093/jac/dkp335; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Knox C, 2011, VIRUS RES, V160, P15, DOI 10.1016/j.virusres.2011.06.013; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007; Mundra PA, 2010, IEEE T NANOBIOSCI, V9, P31, DOI 10.1109/TNB.2009.2035284; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rizzardi GP, 2002, J CLIN INVEST, V109, P681, DOI 10.1172/JCI200214522; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78057	10.1371/journal.pone.0078057	http://dx.doi.org/10.1371/journal.pone.0078057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244287	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600015
J	McFarland, BC; Hong, SW; Rajbhandari, R; Twitty, GB; Gray, GK; Yu, H; Benveniste, EN; Nozell, SE				McFarland, Braden C.; Hong, Suk W.; Rajbhandari, Rajani; Twitty, George B., Jr.; Gray, G. Kenneth; Yu, Hao; Benveniste, Etty N.; Nozell, Susan E.			NF-kappa B-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma	PLOS ONE			English	Article							SIGNAL TRANSDUCER; CANCER; INHIBITION; GROWTH; EGFR; INTERLEUKIN-6; EXPRESSION; AZD1480; GLIOMAS; DIFFERENTIATION	Glioblastoma (GBM) is the most aggressive, neurologically destructive and deadly tumor of the central nervous system (CNS). In GBM, the transcription factors NF-kappa B and STAT3 are aberrantly activated and associated with tumor cell proliferation, survival, invasion and chemoresistance. In addition, common activators of NF-kappa B and STAT3, including TNF-alpha and IL-6, respectively, are abundantly expressed in GBM tumors. Herein, we sought to elucidate the signaling crosstalk that occurs between the NF-kappa B and STAT3 pathways in GBM tumors. Using cultured GBM cell lines as well as primary human GBM xenografts, we elucidated the signaling crosstalk between the NF-kappa B and STAT3 pathways utilizing approaches that either a) reduce NF-kappa B p65 expression, b) inhibit NF-kappa B activation, c) interfere with IL-6 signaling, or d) inhibit STAT3 activation. Using the clinically relevant human GBM xenograft model, we assessed the efficacy of inhibiting NF-kappa B and/or STAT3 alone or in combination in mice bearing intracranial xenograft tumors in vivo. We demonstrate that TNF-alpha-induced activation of NF-kappa B is sufficient to induce IL-6 expression, activate STAT3, and elevate STAT3 target gene expression in GBM cell lines and human GBM xenografts in vitro. Moreover, the combined inhibition of NF-kappa B and STAT3 signaling significantly increases survival of mice bearing intracranial tumors. We propose that in GBM, the activation of NF-kappa B ensures subsequent STAT3 activation through the expression of IL-6. These data verify that pharmacological interventions to effectively inhibit the activity of both NF-kappa B and STAT3 transcription factors must be used in order to reduce glioma size and aggressiveness.	[McFarland, Braden C.; Hong, Suk W.; Rajbhandari, Rajani; Twitty, George B., Jr.; Gray, G. Kenneth; Yu, Hao; Benveniste, Etty N.; Nozell, Susan E.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	McFarland, BC (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	bdcox@uab.edu		McFarland, Braden C./0000-0002-7517-9688; Gray, G. Kenneth/0000-0003-4969-670X	National Institutes of Health [T32NS048039, R01CA158534, R01CA138517]; American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri; Southeastern Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA158534, P50CA097247, R01CA138517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri; Southeastern Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by grants from the National Institutes of Health (T32NS048039 to B. C. M., R01CA158534 to E.N.B., and R01CA138517 to S.E.N.); American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri to B. C. M. (www.abta.org); and Southeastern Brain Tumor Foundation funding to E.N.B. (www.sbtf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella NS, 2006, J NEUROSCI METH, V153, P183, DOI 10.1016/j.jneumeth.2005.10.026; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kesanakurti D, 2012, ONCOGENE, DOI [10.1038/onc.2012.546, DOI 10.1038/0NC.2012.546.[]; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; McFarland BC, 2011, MOL CANCER THER, V10, P2384, DOI 10.1158/1535-7163.MCT-11-0480; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Repovic P, 2003, ONCOGENE, V22, P8117, DOI 10.1038/sj.onc.1206922; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Tchirkov A, 2007, BRIT J CANCER, V96, P474, DOI 10.1038/sj.bjc.6603586; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhao XY, 2011, J NEURO-ONCOL, V102, P367, DOI 10.1007/s11060-010-0346-y	51	92	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78728	10.1371/journal.pone.0078728	http://dx.doi.org/10.1371/journal.pone.0078728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244348	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600055
J	Wang, ZL; Hou, J; Lu, LL; Qi, ZH; Sun, JM; Gao, W; Meng, J; Wang, Y; Sun, HZ; Gu, HY; Xin, YH; Guo, XM; Yang, G				Wang, Ziliang; Hou, Jing; Lu, Lili; Qi, Zihao; Sun, Jianmin; Gao, Wen; Meng, Jiao; Wang, Yan; Sun, Huizhen; Gu, Hongyu; Xin, Yuhu; Guo, Xiaomao; Yang, Gong			Small Ribosomal Protein Subunit S7 Suppresses Ovarian Tumorigenesis through Regulation of the PI3K/AKT and MAPK Pathways	PLOS ONE			English	Article							CANCER GROWTH; CELL-CYCLE; P53; ACTIVATION; EXPRESSION; APOPTOSIS; BINDING; MODEL; GENE; MDM2	Small ribosomal protein subunit S7 (RPS7) has been reported to be associated with various malignancies, but the role of RPS7 in ovarian cancer remains unclear. In this study, we found that silencing of RPS7 by a specific shRNA promoted ovarian cancer cell proliferation, accelerated cell cycle progression, and slightly reduced cell apoptosis and response to cisplatin treatment. Knockdown of RPS7 resulted in increased expression of P85 alpha, P110 alpha, and AKT2. Although the basal levels of ERK1/2, MEK1/2, and P38 were inconsistently altered in ovarian cancer cells, the phosphorylated forms of MEK1/2 (Ser217/221), ERK1/2 (Thr202/Tyr204), JNK1/2 (Thr183/Tyr185), and P38 (Thr180/Tyr182) were consistently reduced after RPS7 was silenced. Both the in vitro anchorage-independent colony formation and in vivo animal tumor formation capability of cells were enhanced after RPS7 was depleted. We also showed that silencing of RPS7 enhanced ovarian cancer cell migration and invasion. In sum, our results suggest that RPS7 suppresses ovarian tumorigenesis and metastasis through PI3K/AKT and MAPK signal pathways. Thus, RPS7 may be used as a potential marker for diagnosis and treatment of ovarian cancer.	[Wang, Ziliang; Qi, Zihao; Meng, Jiao; Wang, Yan; Sun, Huizhen; Gu, Hongyu; Xin, Yuhu; Yang, Gong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Canc Inst, Shanghai 200433, Peoples R China; [Hou, Jing; Guo, Xiaomao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Sun, Jianmin; Gao, Wen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Gynecol Oncol, Shanghai 200433, Peoples R China; [Lu, Lili] Shanghai Normal Univ, Life & Environm Sci Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Normal University	Guo, XM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Radiat Oncol, Shanghai 200433, Peoples R China.	guoxm1800@126.com; yanggong@fudan.edu.cn			National Nature Science Foundation of China [91129721]; Young Backbone Foundation of Fudan University [11L-38B]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Backbone Foundation of Fudan University	This work was supported by National Nature Science Foundation of China (#91129721) for Gong Yang and Young Backbone Foundation of Fudan University (11L-38B) for Ziliang Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1984, IN VITRO CELL DEV B, V20, P743; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; Bee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022672; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chien CC, 2012, GASTROENTEROLOGIST, V2012; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Gou YW, 2010, BIOCHEM BIOPH RES CO, V393, P788, DOI 10.1016/j.bbrc.2010.02.083; Guo XY, 2011, J CELL MOL MED, V15, P296, DOI 10.1111/j.1582-4934.2009.00969.x; Kobayashi T, 2006, INT J MOL MED, V18, P161; Kobayashi Y, 2010, J TOXICOL SCI, V35, P827, DOI 10.2131/jts.35.827; KONDOH N, 1992, CANCER RES, V52, P791; Li CD, 2012, MOL CELL BIOCHEM, V370, P127, DOI 10.1007/s11010-012-1404-x; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Morgan RJ, 2012, J NATL COMPR CANC NE, V10, P1339, DOI 10.6004/jnccn.2012.0140; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221; Wu Li-Ming, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P344; Wu Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026401; Yang G, 2003, ONCOGENE, V22, P5694, DOI 10.1038/sj.onc.1206858; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang G, 2011, CLIN CANCER RES, V17, P2181, DOI 10.1158/1078-0432.CCR-10-3265; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	29	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79117	10.1371/journal.pone.0079117	http://dx.doi.org/10.1371/journal.pone.0079117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244431	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600110
J	Duan, JP; Xu, HF; Guo, HZ; O'Brochta, DA; Wang, F; Ma, SY; Zhang, LY; Zha, XF; Zhao, P; Xia, QY				Duan, Jianping; Xu, Hanfu; Guo, Huizhen; O'Brochta, David A.; Wang, Feng; Ma, Sanyuan; Zhang, Liying; Zha, Xingfu; Zhao, Ping; Xia, Qingyou			New Insights into the Genomic Organization and Splicing of the Doublesex Gene, a Terminal Regulator of Sexual Differentiation in the Silkworm Bombyx mori	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RNA-BINDING; LETHAL; EVOLUTION; CHROMOSOME; MECHANISM; HONEYBEE; REVEALS; ENCODES; PROTEIN	Sex-determination mechanisms differ among organisms. The primary mechanism is diverse, whereas the terminal regulator is relatively-conserved. We analyzed the transcripts of the Bombyx mori doublesex gene (Bmdsx), and reported novel results concerning the genomic organization and expression of Bmdsx. Bmdsx consists of nine exons and eight introns, of which two exons are novel and have not been reported previously. Bmdsx transcripts are spliced to generate seventeen alternatively-spliced forms and eleven putative trans-spliced variants. Thirteen of the alternatively-spliced forms and five of the putative trans-spliced forms are reported here for the first time. Sequence analysis predicts that ten female-specific, six male-specific splice forms and one splice form found in males and females will result in four female-specific, two male-specific Dsx proteins and one Dsx protein common to males and females. The Dsx proteins are expected to be functional and regulate downstream target genes. Some of the predicted Dsx proteins are described here for the first time. Therefore the expression of the dsx gene in B. mori results in a variety of cis- and trans-spliced transcripts and multiple Dsx proteins. These findings show that in B. mori there is a complicated pattern of dsx splicing, and that the regulation of splicing and sex-specific functions of lepidopteran dsx have evolved complexity.	[Duan, Jianping; Xu, Hanfu; Guo, Huizhen; Wang, Feng; Ma, Sanyuan; Zhang, Liying; Zha, Xingfu; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Duan, Jianping] Nanyang Normal Univ, Henan Prov Key Lab Funiu Mt Insect Biol, Nanyang, Peoples R China; [O'Brochta, David A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	Southwest University - China; Nanyang Normal College; University System of Maryland; University of Maryland College Park	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Feng/P-7961-2019; Ma, Sanyuan/L-8057-2019	Wang, Feng/0000-0001-7633-8284; Ma, Sanyuan/0000-0002-0364-5686; Xia, Qingyou/0000-0002-9263-2886; Zha, Xingfu/0000-0003-2085-5260	Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306]; National Natural Science Foundation of China [31000981]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306] (http://www.most.gov.cn/) and the National Natural Science Foundation of China [31000981] (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Bopp D, 1996, DEVELOPMENT, V122, P971; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Duan JP, 2013, BIOCHEM BIOPH RES CO, V431, P630, DOI 10.1016/j.bbrc.2012.12.062; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fujii T, 2007, SEMIN CELL DEV BIOL, V18, P379, DOI 10.1016/j.semcdb.2007.02.008; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Niimi T, 2006, GENOME, V49, P263, DOI 10.1139/G05-108; ONEIL MT, 1992, GENETICS, V131, P113; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Penalva LOF, 1996, GENETICS, V144, P1653; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Shao W, 2012, RNA, V18, P1395, DOI 10.1261/rna.029751.111; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Shukla JN, 2010, INSECT BIOCHEM MOLEC, V40, P672, DOI 10.1016/j.ibmb.2010.06.008; Shukla JN, 2011, GENETICA, V139, P23, DOI 10.1007/s10709-010-9479-3; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Suzuki MG, 2010, MOL CELL BIOL, V30, P5776, DOI 10.1128/MCB.00444-10; Suzuki MG, 2010, J GENET, V89, P357, DOI 10.1007/s12041-010-0047-5; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Vincent S, 2001, CELL, V106, P399, DOI 10.1016/S0092-8674(01)00468-8; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Wang Z, 2009, INSECT MOL BIOL, V18, P795, DOI 10.1111/j.1365-2583.2009.00943.x; Willhoeft U, 1996, GENETICS, V144, P737; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	48	9	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79703	10.1371/journal.pone.0079703	http://dx.doi.org/10.1371/journal.pone.0079703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244545	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900044
J	Fu, GH; Bai, ZY; Xia, JH; Liu, F; Liu, P; Yue, GH				Fu, Gui Hong; Bai, Zhi Yi; Xia, Jun Hong; Liu, Feng; Liu, Peng; Yue, Gen Hua			Analysis of Two Lysozyme Genes and Antimicrobial Functions of Their Recombinant Proteins in Asian Seabass	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; C-TYPE LYSOZYME; ORANGE-SPOTTED GROUPER; LYTIC ACTIVITY; MOLECULAR-CLONING; LINKAGE MAP; EXPRESSION PATTERN; GROWTH TRAITS; CDNA CLONING; SEQUENCE	Lysozymes are important proteins of the innate immune system for the defense against bacterial infection. We cloned and analyzed chicken-type (c-type) and goose-type (g-type) lysozymes from Asian seabass (Lates calcarifer). The deduced amino acid sequence of the c-type lysozyme contained 144 residues and possessed typical structure residues, conserved catalytic residues (Glu(50) and Asp(67)) and a "GSTDYGIFQINS" motif. The deduced g-type lysozyme contained 187 residues and possessed a goose egg white lysozyme (GEWL) domain containing three conserved catalytic residues (Glu(71), Asp(84), Asp(95)) essential for catalytic activity. Real time quantitative PCR (qRT-PCR) revealed that the two lysozyme genes were constitutively expressed in all the examined tissues. The c-type lysozyme was most abundant in liver, while the g-type lysozyme was predominantly expressed in intestine and weakly expressed in muscle. The c-type and g-type transcripts were up-regulated in the kidney, spleen and liver in response to a challenge with Vibrio harveyi. The up-regulation of the c-type lysozyme was much stronger than that of the g-type lysozyme in kidney and spleen. The recombinant proteins of the c-type and g-type lysozymes showed lytic activities against the bacterial pathogens Vibrio harveyi and Photobacterium damselae in a dosage-dependent manner. We identified single nucleotide polymorphisms (SNPs) in the two lysozyme genes. There were significant associations of these polymorphisms with resistance to the big belly disease. These results suggest that the c-and g-type genes play an important role in resistance to bacterial pathogens in fish. The SNP markers in the two genes associated with the resistance to bacterial pathogens may facilitate the selection of Asian seabass resistant to bacterial diseases.	[Fu, Gui Hong; Bai, Zhi Yi; Xia, Jun Hong; Liu, Feng; Liu, Peng; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Yue, Gen Hua] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Bai, Zhi Yi] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China	National University of Singapore; National University of Singapore; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation Singapore [NRF-CRP002-001]	National Research Foundation Singapore(National Research Foundation, Singapore)	This research is supported by the National Research Foundation Singapore under its Competitive Research Program (CRP Award number NRF-CRP002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fernandez-Trujillo MA, 2008, FISH SHELLFISH IMMUN, V25, P697, DOI 10.1016/j.fsi.2008.08.004; Beintema J J, 1996, EXS, V75, P75; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; DAUTIGNY A, 1991, J MOL EVOL, V32, P187, DOI 10.1007/BF02515392; Gibson-Kueh S, 2004, J FISH DIS, V27, P731, DOI 10.1111/j.1365-2761.2004.00594.x; Harikrishnan R, 2011, FISH SHELLFISH IMMUN, V31, P588, DOI 10.1016/j.fsi.2011.06.019; He CB, 2012, COMP BIOCHEM PHYS B, V162, P34, DOI 10.1016/j.cbpb.2012.02.002; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Hikima J, 1997, MOL MAR BIOL BIOTECH, V6, P339; Hikima J, 2001, BBA-GENE STRUCT EXPR, V1520, P35, DOI 10.1016/S0167-4781(01)00248-2; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; Holtje J V, 1996, EXS, V75, P65; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; Jimenez-Cantizano RM, 2008, FISH SHELLFISH IMMUN, V25, P57, DOI 10.1016/j.fsi.2007.12.009; Jolles J, 2008, EUR J BIOCHEM, V54, P19; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Larsen AN, 2009, FISH SHELLFISH IMMUN, V26, P122, DOI 10.1016/j.fsi.2008.03.021; Li H, 2008, FISH SHELLFISH IMMUN, V25, P143, DOI 10.1016/j.fsi.2008.04.001; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; Liu F, 2002, MECH DEVELOP, V113, P69, DOI 10.1016/S0925-4773(01)00658-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai WJ, 2009, PROG NAT SCI-MATER, V19, P837, DOI 10.1016/j.pnsc.2008.10.008; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Park SI, 2009, FISH PATHOL, V44, P19, DOI 10.3147/jsfp.44.19; Sarder MRI, 2001, DEV COMP IMMUNOL, V25, P37, DOI 10.1016/S0145-305X(00)00040-9; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Savan R, 2003, FISH SHELLFISH IMMUN, V15, P263, DOI 10.1016/S1050-4648(02)00159-6; Sha ZX, 2012, FISH SHELLFISH IMMUN, V32, P914, DOI 10.1016/j.fsi.2012.01.010; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Sun BJ, 2006, AQUACULTURE, V252, P106, DOI 10.1016/j.aquaculture.2005.07.046; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Wang LL, 2007, AQUAC RES, V38, P409, DOI 10.1111/j.1365-2109.2007.01683.x; Wei SN, 2012, FISH SHELLFISH IMMUN, V33, P186, DOI 10.1016/j.fsi.2012.03.027; Whang I, 2011, FISH SHELLFISH IMMUN, V30, P532, DOI 10.1016/j.fsi.2010.11.025; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148; Ye X, 2010, DEV COMP IMMUNOL, V34, P501, DOI 10.1016/j.dci.2009.12.009; Yin ZX, 2003, DIS AQUAT ORGAN, V55, P117, DOI 10.3354/dao055117; Yu LP, 2013, FISH SHELLFISH IMMUN, V34, P46, DOI 10.1016/j.fsi.2012.10.007; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Yue GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052721; Zhang SH, 2012, DEV COMP IMMUNOL, V36, P241, DOI 10.1016/j.dci.2011.06.014; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zheng WB, 2007, IMMUNOL LETT, V113, P107, DOI 10.1016/j.imlet.2007.08.001; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	53	36	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79743	10.1371/journal.pone.0079743	http://dx.doi.org/10.1371/journal.pone.0079743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244553	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900049
J	Kumakura, N; Otsuki, H; Tsuzuki, M; Takeda, A; Watanabe, Y				Kumakura, Naoyoshi; Otsuki, Hiroka; Tsuzuki, Masayuki; Takeda, Atsushi; Watanabe, Yuichiro			Arabidopsis AtRRP44A Is the Functional Homolog of Rrp44/Dis3, an Exosome Component, Is Essential for Viability and Is Required for RNA Processing and Degradation	PLOS ONE			English	Article							CYTOPLASMIC MESSENGER-RNA; TURNIP CRINKLE VIRUS; HUMAN PM-SCL; RIBOSOMAL-RNA; YEAST EXOSOME; POSTEMBRYONIC DEVELOPMENT; ARTIFICIAL MICRORNAS; DECAPPING PROTEINS; STRESS GRANULES; QUALITY CONTROL	The RNA exosome is a multi-subunit complex that is responsible for 3' to 5' degradation and processing of cellular RNA. Rrp44/Dis3 is the catalytic center of the exosome in yeast and humans. However, the role of Rrp44/Dis3 homologs in plants is still unidentified. Here, we show that Arabidopsis AtRRP44A is the functional homolog of Rrp44/Dis3, is essential for plant viability and is required for RNA processing and degradation. We characterized AtRRP44A and AtRRP44B/SOV, two predicted Arabidopsis Rrp44/Dis3 homologs. AtRRP44A could functionally replace S. cerevisiae Rrp44/Dis3, but AtRRP44B/SOV could not. rrp44a knock-down mutants showed typical phenotypes of exosome function deficiency, 5.8S rRNA 3' extension and rRNA maturation by-product over-accumulation, but rrp44b mutants did not. Conversely, AtRRP44B/SOV mutants showed elevated levels of a selected mRNA, on which rrp44a did not have detectable effects. Although T-DNA insertion mutants of AtRRP44B/SOV had no obvious phenotype, those of AtRRP44A showed defects in female gametophyte development and early embryogenesis. These results indicate that AtRRP44A and AtRRP44B/SOV have independent roles for RNA turnover in plants.	[Kumakura, Naoyoshi; Otsuki, Hiroka; Tsuzuki, Masayuki; Takeda, Atsushi; Watanabe, Yuichiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	solan@bio.c.u-tokyo.ac.jp	Kumakura, Naoyoshi/T-4348-2019; Perry, George/A-8611-2009; Kumakura, Naoyoshi/G-3146-2016	Kumakura, Naoyoshi/0000-0003-0259-2444; Perry, George/0000-0002-6547-0172; Kumakura, Naoyoshi/0000-0003-0259-2444; Watanabe, Yuichiro/0000-0002-7139-4903; Tsuzuki, Masayuki/0000-0002-0642-1143	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23012008, J1307-57091]; Japan Society for the Promotion of Science for young scientists [10J09702]; Grants-in-Aid for Scientific Research [24658283] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Science Research on Priority Areas (Grant No. 23012008 to YW, URL: http://www.bio.nagoya-u.ac.jp/similar to yas/tokutei_plant_meristems/) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Grant-in-Aid for Scientific Research on Priority Areas, "Perceptive Plants", (J1307-57091 to YW, URL: http://esplant.net) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The Japan Society for the Promotion of Science for young scientists (No. 10J09702 to NK, URL: http://kaken.nii.ac.jp/d/p/10J09702/2010/3/ja.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Golisz A, 2013, NUCLEIC ACIDS RES, V41, P6232, DOI 10.1093/nar/gkt296; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; HEATON LA, 1989, VIROLOGY, V170, P214, DOI 10.1016/0042-6822(89)90368-1; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Iwasaki S, 2007, FEBS LETT, V581, P2455, DOI 10.1016/j.febslet.2007.04.051; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moreno AB, 2013, NUCLEIC ACIDS RES, V41, P4699, DOI 10.1093/nar/gkt152; Motomura K, 2012, RNA BIOL, V9, P644, DOI 10.4161/rna.19877; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Perea-Resa C, 2012, PLANT CELL, V24, P4930, DOI 10.1105/tpc.112.103697; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yang M, 2013, PLANT PHYSIOL, V161, P165, DOI 10.1104/pp.112.206706; Zhang WP, 2010, P NATL ACAD SCI USA, V107, P15981, DOI 10.1073/pnas.1007060107	49	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79219	10.1371/journal.pone.0079219	http://dx.doi.org/10.1371/journal.pone.0079219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244451	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900035
J	Kershaw, RM; Siddiqui, YH; Roberts, D; Jayaraman, PS; Gaston, K				Kershaw, R. M.; Siddiqui, Y. H.; Roberts, D.; Jayaraman, P-S; Gaston, K.			PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin	ONCOGENE			English	Article						HHex; PRH; cell migration; invasion; breast cancer; prostate cancer	MOUSE SKIN CARCINOGENESIS; RICH HOMEODOMAIN PROTEIN; MESSENGER-RNA TRANSPORT; VEGF-SIGNALING GENES; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; EXPRESSION; HEX; CANCER; DIFFERENTIATION	PRH/HHex (proline-rich homeodomain protein) is a transcription factor that controls cell proliferation and cell differentiation in a variety of tissues. Aberrant subcellular localisation of PRH is associated with breast cancer and thyroid cancer. Further, in blast crisis chronic myeloid leukaemia, and a subset of acute myeloid leukaemias, PRH is aberrantly localised and its activity is downregulated. Here we show that PRH is involved in the regulation of cell migration and cancer cell invasion. We show for the first time that PRH is expressed in prostate cells and that a decrease in PRH protein levels increases the migration of normal prostate epithelial cells. We show that a decrease in PRH protein levels also increases the migration of normal breast epithelial cells. Conversely, PRH overexpression inhibits cell migration and cell invasion by PC3 and DU145 prostate cancer cells and MDA-MB-231 breast cancer cells. Previous work has shown that the transforming growth factor-b co-receptor Endoglin inhibits the migration of prostate and breast cancer cells. Here we show that PRH can bind to the Endoglin promoter in immortalised prostate and breast cells. PRH overexpression in these cells results in increased Endoglin protein expression, whereas PRH knockdown results in decreased Endoglin protein expression. Moreover, we demonstrate that Endoglin overexpression abrogates the increased migration shown by PRH knockdown cells. Our data suggest that PRH controls the migration of multiple epithelial cell lineages in part at least through the direct transcriptional regulation of Endoglin. We discuss these results in terms of the functions of PRH in normal cells and the mislocalisation of PRH seen in multiple cancer cell types.	[Kershaw, R. M.; Roberts, D.; Jayaraman, P-S] Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham, W Midlands, England; [Siddiqui, Y. H.; Gaston, K.] Univ Bristol, Sch Biochem, Bristol B17 8QB, Avon, England	University of Birmingham; University of Bristol	Gaston, K (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol B17 8QB, Avon, England.	kevin.gaston@bristol.ac.uk	Gaston, Kevin/K-9237-2019	Gaston, Kevin/0000-0002-7349-5513; SIDDIQUI, YUSRA/0000-0001-7231-4736; /0000-0002-6500-9095	Breast Cancer Campaign project grant; University of Bristol; Charles Wallace Pakistan Trust; MRC	Breast Cancer Campaign project grant; University of Bristol; Charles Wallace Pakistan Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Professor Norman J Maitland (University of York) for PNT2-C2 cells and useful discussions, Professor Kate Nobes (University of Bristol) for access to live cell imaging, Professor Clare Isacke (Institute of Cancer Research) for the Endoglin expression vector, Professor Harry Mellor (University of Bristol) and Professor Roy Bicknell (University of Birmingham) for HUVECs and useful discussions, and Professor Carmelo Bernabeu (Centro de Investigaciones Biologicas, Madrid) for Endoglin-luciferase reporter constructs. We are grateful to Laura A V Rodriguez and Xin Yang for technical assistance. This work was funded by a Breast Cancer Campaign project grant to PSJ and KG. YHS is grateful to the University of Bristol for a PhD Scholarship and to the Charles Wallace Pakistan Trust for additional support. DR is grateful to the MRC for a PhD studentship.	Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; BERTHON P, 1995, INT J ONCOL, V6, P333; Botella LM, 2001, J BIOL CHEM, V276, P34486, DOI 10.1074/jbc.M011611200; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Craft CS, 2007, ONCOGENE, V26, P7240, DOI 10.1038/sj.onc.1210533; D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; Denson LA, 2000, AM J PHYSIOL-GASTR L, V279, pG347, DOI 10.1152/ajpgi.2000.279.2.G347; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; George A, 2003, ONCOGENE, V22, P6764, DOI 10.1038/sj.onc.1206822; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Kassouf W, 2004, PROSTATE CANCER P D, V7, P105, DOI 10.1038/sj.pcan.4500716; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Ma C, 2008, CSH PROTOCOLS; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nakagawa T, 2003, ARTERIOSCL THROM VAS, V23, P231, DOI 10.1161/01.ATV.0000052670.55321.87; Noy P, 2012, NUCLEIC ACIDS RES, V40, P9008, DOI 10.1093/nar/gks687; Noy P, 2012, LEUKEMIA RES, V36, P1434, DOI 10.1016/j.leukres.2012.07.013; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; Oxmann D, 2008, ONCOGENE, V27, P3567, DOI 10.1038/sj.onc.1211025; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Pimanda JE, 2008, BLOOD, V112, P4512, DOI 10.1182/blood-2008-05-157560; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Quintanilla M, 2003, ONCOGENE, V22, P5976, DOI 10.1038/sj.onc.1206841; Romero D, 2010, CARCINOGENESIS, V31, P359, DOI 10.1093/carcin/bgp217; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Soufi A, 2006, J MOL BIOL, V358, P943, DOI 10.1016/j.jmb.2006.02.020; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Williams H, 2008, J MOL BIOL, V383, P10, DOI 10.1016/j.jmb.2008.08.004; Wong VCL, 2008, INT J CANCER, V123, P2816, DOI 10.1002/ijc.23882	42	17	17	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5592	5600		10.1038/onc.2013.496	http://dx.doi.org/10.1038/onc.2013.496			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24240683	Green Accepted			2022-12-25	WOS:000346088700003
J	Kryza, T; Achard, C; Parent, C; Marchand-Adam, S; Guillon-Munos, A; Iochmann, S; Korkmaz, B; Respaud, R; Courty, Y; Heuze-Vourc'h, N				Kryza, Thomas; Achard, Carole; Parent, Christelle; Marchand-Adam, Sylvain; Guillon-Munos, Audrey; Iochmann, Sophie; Korkmaz, Brice; Respaud, Renaud; Courty, Yves; Heuze-Vourc'h, Nathalie			Angiogenesis stimulated by human kallikrein-related peptidase 12 acting via a platelet-derived growth factor B-dependent paracrine pathway	FASEB JOURNAL			English	Article						proteolysis; processing; extracellular matrix; vascular endothelial growth factor; hypoxia	REGULATE PERICYTE RECRUITMENT; INTEGRAL MEMBRANE-PROTEINS; CELL LUNG-CANCER; GENE-EXPRESSION; PDGF-B; ENDOTHELIAL-CELLS; BREAST-CANCER; LYMPHATIC METASTASIS; PROTEOLYTIC CLEAVAGE; SYSTEMIC-SCLEROSIS	KLK12, a kallikrein peptidase, is thought to take part in the control of angiogenesis. Our analysis of the secretome of endothelial cells (ECs) that had been treated with KLK12 showed that KLK12 converts the extracellular matrix- or membrane-bound precursor of platelet-derived growth factor B (PDGF-B) into a soluble form. Both PDGF-B and vascular endothelial growth factor A (VEGF-A) take part in the induction of angiogenesis by KLK12 in a coculture model of angiogenesis that mimics endothelial tubule formation. We used a cellular approach to analyze the interplay between KLK12, PDGF-B, and VEGF-A and showed that release of PDGF-B by KLK12 leads to the fibroblast-mediated secretion of VEGF-A. This then stimulates EC differentiation and the formation of capillary tube-like structures. Thus, KLK12 favors the interaction of ECs and stromal cells. The released PDGF-B acts as a paracrine factor that modulates VEGF-A secretion by stromal cells, which ultimately leads to angiogenesis. Moreover, the genes encoding KLK12 and PDGFB are both expressed in ECs and up-regulated in tumor cells kept under hypoxic conditions, which is consistent with the physiological involvement of KLK12 in PDGF-B maturation.Kryza, T., Achard, C., Parent, C., Marchand-Adam, S., Guillon-Munos, A., Iochmann, S., Korkmaz, B., Respaud, R., Courty, Y., Heuze-Vourc'h, N. Angiogenesis stimulated by human kallikrein-related peptidase 12 acting via a platelet-derived growth factor B-dependent paracrine pathway.	[Kryza, Thomas; Parent, Christelle; Iochmann, Sophie; Heuze-Vourc'h, Nathalie] Univ Tours, Equipe Accueil EA 6305, Tours, France; [Marchand-Adam, Sylvain] Univ Tours, Unite Mixte Rech UMR 1100, Tours, France; [Marchand-Adam, Sylvain; Iochmann, Sophie; Korkmaz, Brice; Courty, Yves] Univ Tours, Inst Univ Technol IUT Tours, Tours, France; [Respaud, Renaud] Univ Tours, EA 6306, Tours, France; [Kryza, Thomas; Parent, Christelle; Marchand-Adam, Sylvain; Guillon-Munos, Audrey; Iochmann, Sophie; Korkmaz, Brice; Courty, Yves; Heuze-Vourc'h, Nathalie] Ctr Etud Pathol Resp, UMR 1100, Tours, France; [Kryza, Thomas; Parent, Christelle; Marchand-Adam, Sylvain; Guillon-Munos, Audrey; Iochmann, Sophie; Korkmaz, Brice; Courty, Yves; Heuze-Vourc'h, Nathalie] Ctr Etud Pathol Resp, EA 6305, Tours, France; [Achard, Carole] INSERM, UMR 892, Tours, France; [Achard, Carole] CNRS, UMR 6299, Nantes, France; [Achard, Carole] Univ Nantes, Nantes, France; [Marchand-Adam, Sylvain; Korkmaz, Brice; Courty, Yves] INSERM, UMR 1100, Tours, France; [Marchand-Adam, Sylvain] CHRU Tours, Serv Pneumol, Tours, France; [Respaud, Renaud] CHRU Tours, Serv Pharm, Tours, France	Universite de Tours; Universite de Tours; Universite de Tours; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; CHU Tours	Heuze-Vourc'h, N (corresponding author), Fac Med Tours, CEPR INSERM U1100, EA 6305, 10 Blvd Tonnelle, F-37032 Tours, France.	nathalie.vourch@med.univ-tours.fr	Kryza, Thomas/AAX-7681-2020; Respaud, Renaud/E-8858-2017; HEUZE-VOURC'H, Nathalie/P-8081-2016	Kryza, Thomas/0000-0003-1668-8551; Respaud, Renaud/0000-0003-0515-7165; IOCHMANN, Sophie/0000-0002-4877-895X; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; Courty, Yves/0000-0003-3694-8517; marchand-adam, sylvain/0000-0002-9522-3738; KORKMAZ, BRICE/0000-0002-5159-8706; Parent, Christelle/0000-0001-8086-4690	Region Centre (KalliCaP); Ligue Contre le Cancer (Indre, Indre-et-Loire, ME-et-Loire, Morbihan, and Sarthe)	Region Centre (KalliCaP)(Region Centre-Val de Loire); Ligue Contre le Cancer (Indre, Indre-et-Loire, ME-et-Loire, Morbihan, and Sarthe)	The authors thank Christophe Epinette (Universite de Tours, Tours, France) for technical assistance with HPLC and the Plateforme de Spectrometrie de Masse et Proteomique du Centre de Biophysique Moleculaire (Orleans, France) for mass spectrometry analysis. The English text was edited by Dr. Owen Parkes. N.H.-V. and Y.C. hold grants from the Region Centre (KalliCaP, 2009-2011) and the Ligue Contre le Cancer (Indre, Indre-et-Loire, ME-et-Loire, Morbihan, and Sarthe).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bertolotti E, 2013, J MORPHOL, V274, P956, DOI 10.1002/jmor.20155; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Betsholtz C, 2004, CURR OPIN NEPHROL HY, V13, P45, DOI 10.1097/00041552-200401000-00007; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; BROGI E, 1994, CIRCULATION, V90, P649, DOI 10.1161/01.CIR.90.2.649; BRONZERT DA, 1987, P NATL ACAD SCI USA, V84, P5763, DOI 10.1073/pnas.84.16.5763; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Distler JHW, 2003, Q J NUCL MED, V47, P149; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Donnem T, 2011, CLIN LUNG CANCER, V12, P106, DOI 10.1016/j.cllc.2011.03.005; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Eissa A, 2011, J BIOL CHEM, V286, P687, DOI 10.1074/jbc.M110.125310; Emanueli C, 2004, CIRCULATION, V110, P1638, DOI 10.1161/01.CIR.0000142051.36244.83; Etulain J, 2013, BRIT J PHARMACOL, V170, P255, DOI 10.1111/bph.12250; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; Furuya M, 2005, VASC HEALTH RISK MAN, V1, P277, DOI 10.2147/vhrm.2005.1.4.277; Gabant G, 2008, METHODS, V46, P54, DOI 10.1016/j.ymeth.2008.10.021; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; Giusti B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2002; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hamilton BS, 2013, J BIOL CHEM, V288, P17399, DOI 10.1074/jbc.M112.440362; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Horii K, 2007, MOL CANCER RES, V5, P383, DOI 10.1158/1541-7786.MCR-06-0226; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Kawai T, 1997, LAB INVEST, V77, P431; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kodama M, 2010, CANCER SCI, V101, P1984, DOI 10.1111/j.1349-7006.2010.01639.x; Kryza T, 2013, BIOL CHEM, V394, P385, DOI 10.1515/hsz-2012-0291; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; Lederle W, 2006, AM J PATHOL, V169, P1767, DOI 10.2353/ajpath.2006.060120; Lin YS, 2011, SPECTROCHIM ACTA A, V79, P1552, DOI 10.1016/j.saa.2011.04.087; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; McGinnis LM, 2012, NAT MED, V18, P22, DOI 10.1038/nm.2623; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Senger D.R., 2011, COLD SPRING HARB PER, V3; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Sotiropoulou G, 2010, BIOL CHEM, V391, P321, DOI 10.1515/BC.2010.036; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; SOYOMBO AA, 1994, J BIOL CHEM, V269, P17734; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Talieri M, 2012, TUMOR BIOL, V33, P1075, DOI 10.1007/s13277-012-0347-x; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Veveris-Lowe TL, 2007, SEMIN THROMB HEMOST, V33, P87, DOI 10.1055/s-2006-958467; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yao YY, 2013, LAB INVEST, V93, P577, DOI 10.1038/labinvest.2013.48; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zhao EH, 2012, WORLD J GASTROENTERO, V18, P6597, DOI 10.3748/wjg.v18.i45.6597	69	24	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					740	751		10.1096/fj.13-237503	http://dx.doi.org/10.1096/fj.13-237503			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24225148				2022-12-25	WOS:000331072200021
J	Jacobson, JM; Yin, J; Kitov, PI; Mulvey, G; Griener, TP; James, MNG; Armstrong, G; Bundle, DR				Jacobson, Jared M.; Yin, Jiang; Kitov, Pavel I.; Mulvey, George; Griener, Tom P.; James, Michael N. G.; Armstrong, Glen; Bundle, David R.			The Crystal Structure of Shiga Toxin Type 2 with Bound Disaccharide Guides the Design of a Heterobifunctional Toxin Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; B-SUBUNIT; IN-VIVO; BINDING; VEROTOXIN-1; ASSOCIATION; TRANSPORT	Shiga toxin type 2 (Stx2a) is clinically most closely associated with enterohemorrhagic E. coli O157:H7-mediated hemorrhagic colitis that sometimes progresses to hemolytic-uremic syndrome. The ability to express the toxin has been acquired by other Escherichia coli strains, and outbreaks of food poisoning have caused significant mortality rates as, for example, in the 2011 outbreak in northern Germany. Stx2a, an AB(5) toxin, gains entry into human cells via the glycosphingolipid receptor Gb(3). We have determined the first crystal structure of a disaccharide analog of Gb(3) bound to the B-5 pentamer of Stx2a holotoxin. In this Gb(3) analog, alpha-GalNAc replaces the terminal alpha-Gal residue. This co-crystal structure confirms previous inferences that two of the primary binding sites identified in the B-5 pentamer of Stx1 are also functional in Stx2a. This knowledge provides a rationale for the synthesis and evaluation of heterobifunctional antagonists for E. coli toxins that target Stx2a. Incorporation of GalNAc Gb(3) trisaccharide in a heterobifunctional ligand with an attached pyruvate acetal, a ligand for human amyloid P component, and conjugation to poly[acrylamide-co-(3-azidopropylmethacrylamide)] produced a polymer that neutralized Stx2a in a mouse model of Shigatoxemia.	[Jacobson, Jared M.; Kitov, Pavel I.; Bundle, David R.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Yin, Jiang; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Mulvey, George; Griener, Tom P.; Armstrong, Glen] Univ Calgary, Alberta Glyc Ctr, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4Z6, Canada	University of Alberta; University of Alberta; University of Calgary	Bundle, DR (corresponding author), Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada.	dave.bundle@ualberta.ca	Kitov, Pavel/J-3714-2014	James, Michael/0000-0002-5978-4562	Centres Program grant from Alberta Innovates, Technology Futures; Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada	Centres Program grant from Alberta Innovates, Technology Futures; Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada	This work was supported by a Centres Program grant from Alberta Innovates, Technology Futures.; Supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada.	ARMSTRONG GD, 1991, J INFECT DIS, V164, P1160, DOI 10.1093/infdis/164.6.1160; Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dasgupta S, 2014, ANGEW CHEM INT EDIT, V53, P1510, DOI 10.1002/anie.201309436; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Griener TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021457; Hong SW, 2011, ARCH PHARM RES, V34, P127, DOI 10.1007/s12272-011-0115-2; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Jacobson JM, 2013, CARBOHYD RES, V378, P4, DOI 10.1016/j.carres.2013.05.010; Kale RR, 2008, ANGEW CHEM INT EDIT, V47, P1265, DOI 10.1002/anie.200703680; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kitov PI, 2008, P NATL ACAD SCI USA, V105, P16837, DOI 10.1073/pnas.0804919105; Kitov PI, 2008, ANGEW CHEM INT EDIT, V47, P672, DOI 10.1002/anie.200704064; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kitova EN, 2007, GLYCOBIOLOGY, V17, P1127, DOI 10.1093/glycob/cwm081; Kitova EN, 2001, GLYCOBIOLOGY, V11, P605, DOI 10.1093/glycob/11.7.605; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Matsuoka K, 1999, TETRAHEDRON LETT, V40, P7839, DOI 10.1016/S0040-4039(99)01632-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paton AW, 2006, NAT REV MICROBIOL, V4, P193, DOI 10.1038/nrmicro1349; Rojas RLG, 2010, CLIN VACCINE IMMUNOL, V17, P529, DOI 10.1128/CVI.00495-09; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; Snedeker KG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-144; Solomon D, 2005, ORG LETT, V7, P4369, DOI 10.1021/ol051529+; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Watanabe M, 2006, INFECT IMMUN, V74, P1984, DOI 10.1128/IAI.74.3.1984-1988.2006; Watanabe-Takahashi M, 2010, INFECT IMMUN, V78, P177, DOI 10.1128/IAI.01022-09; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828	48	20	21	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					885	894		10.1074/jbc.M113.518886	http://dx.doi.org/10.1074/jbc.M113.518886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24225957	Green Published, hybrid			2022-12-25	WOS:000330541200024
J	Chien, CY; Chen, RH				Chien, Chen-Ying; Chen, Rey-Huei			Cdc48 Chaperone and Adaptor Ubx4 Distribute the Proteasome in the Nucleus for Anaphase Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Cell Cycle; Mitosis; Molecular Chaperone; Proteasome	PROTEIN-DEGRADATION; AAA-ATPASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; ENDOPLASMIC-RETICULUM; MITOTIC ANAPHASE; 26S PROTEASOME; AURORA B; YEAST; UBIQUITIN	Background: Anaphase progression requires efficient degradation of mitotic regulators. Results: Mutations in the chaperone Cdc48-Ubx4 perturb anaphase proteolysis and proteasome distribution. Conclusion: Cdc48-Ubx4 maintains an optimal level of proteasomes for anaphase proteolysis. Significance: The molecular chaperone Cdc48-Ubx4 links proteasome mobilization with mitosis. The cell cycle transition is driven by abrupt degradation of key regulators. While ubiquitylation of these proteins has been extensively studied, the requirement for the proteolytic step is less understood. By analyzing the cell cycle function of Cdc48 in the budding yeast Saccharomyces cerevisiae, we found that double mutations in Cdc48 and its adaptor Ubx4 cause mitotic arrest with sustained Clb2 and Cdc20 proteins that are normally degraded in anaphase. The phenotype is neither caused by spindle checkpoint activation nor a defect in the assembly or the activity of the ubiquitylation machinery and the proteasome. Interestingly, the 26S proteasome is mislocalized into foci, which are colocalized with nuclear envelope anchor Sts1 in cdc48-3 ubx4 cells. Moreover, genetic analysis reveals that ubx4 deletion mutant dies in the absence of Rpn4, a transcriptional activator for proteasome subunits, and the proteasome chaperone Ump1, indicating that an optimal level of the proteasome is required for survival. Overexpression of Rpn4 indeed can rescue cell growth and anaphase proteolysis in cdc48-3 ubx4 cells. Biochemical analysis further shows that Ubx4 interacts with the proteasome. Our data propose that Cdc48-Ubx4 acts on the proteasome and uses the chaperone activity to promote its nuclear distribution, thereby optimizing the proteasome level for efficient degradation of mitotic regulators.	[Chien, Chen-Ying; Chen, Rey-Huei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Chen, Rey-Huei] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Chen, RH (corresponding author), Acad Sinica, Inst Mol Biol, 128 Sec 2,Acad Rd, Taipei 11529, Taiwan.	rhchen@imb.sinica.edu.tw	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137	Academia Sinica; National Science Council, Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Academia Sinica and National Science Council, Taiwan.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; HOUMAN F, 1994, MOL CELL BIOL, V14, P6350, DOI 10.1128/MCB.14.9.6350; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MOIR D, 1982, GENETICS, V100, P547; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; SAMEJIMA I, 1994, MOL CELL BIOL, V14, P6361, DOI 10.1128/MCB.14.9.6361; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schuyler SC, 2009, METHODS MOL BIOL, V545, P271, DOI 10.1007/978-1-60327-993-2_17; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864	38	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37180	37191		10.1074/jbc.M113.513598	http://dx.doi.org/10.1074/jbc.M113.513598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225956	Green Published, hybrid			2022-12-25	WOS:000329189700036
J	Taib, B; Bouyakdan, K; Hryhorczuk, C; Rodaros, D; Fulton, S; Alquier, T				Taib, Bouchra; Bouyakdan, Khalil; Hryhorczuk, Cecile; Rodaros, Demetra; Fulton, Stephanie; Alquier, Thierry			Glucose Regulates Hypothalamic Long-chain Fatty Acid Metabolism via AMP-activated Kinase (AMPK) in Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Astrocytes; Fatty Acid Oxidation; Glucose Metabolism; Hypothalamus; Neural Metabolism; Fatty Acid Esterification; Oleate; Palmitate	PROTEIN-KINASE; MALONYL-COA; CARNITINE PALMITOYLTRANSFERASE; FOOD-INTAKE; ENDOPLASMIC-RETICULUM; INSULIN-SECRETION; DEVELOPING BRAIN; MESSENGER-RNA; OLEIC-ACID; ENERGY	Hypothalamic controls of energy balance rely on the detection of circulating nutrients such as glucose and long-chain fatty acids (LCFA) by the mediobasal hypothalamus (MBH). LCFA metabolism in the MBH plays a key role in the control of food intake and glucose homeostasis, yet it is not known if glucose regulates LCFA oxidation and esterification in the MBH and, if so, which hypothalamic cell type(s) and intracellular signaling mechanisms are involved. The aim of this study was to determine the impact of glucose on LCFA metabolism, assess the role of AMP-activated Kinase (AMPK), and to establish if changes in LCFA metabolism and its regulation by glucose vary as a function of the kind of LCFA, cell type, and brain region. We show that glucose inhibits palmitate oxidation via AMPK in hypothalamic neuronal cell lines, primary hypothalamic astrocyte cultures, and MBH slices ex vivo but not in cortical astrocytes and slice preparations. In contrast, oleate oxidation was not affected by glucose or AMPK inhibition in MBH slices. In addition, our results show that glucose increases palmitate, but not oleate, esterification into neutral lipids in neurons and MBH slices but not in hypothalamic astrocytes. These findings reveal for the first time the metabolic fate of different LCFA in the MBH, demonstrate AMPK-dependent glucose regulation of LCFA oxidation in both astrocytes and neurons, and establish metabolic coupling of glucose and LCFA as a distinguishing feature of hypothalamic nuclei critical for the control of energy balance.	[Taib, Bouchra; Bouyakdan, Khalil; Hryhorczuk, Cecile; Rodaros, Demetra; Fulton, Stephanie; Alquier, Thierry] Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H3T 1J4, Canada; [Taib, Bouchra; Alquier, Thierry] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Bouyakdan, Khalil; Alquier, Thierry] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Hryhorczuk, Cecile] Univ Montreal, Dept Physiol, Montreal, PQ H3T 1J4, Canada; [Fulton, Stephanie] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Alquier, T (corresponding author), CRCHUM Tour Viger, 900 St Denis, Montreal, PQ H2X 0A9, Canada.	thierry.alquier@umontreal.ca	Alquier, Thierry/Z-1917-2019	Alquier, Thierry/0000-0001-8171-802X	Canadian Institutes of Health Research [MOP115042]; Fonds de Recherche Quebec-Sante; Societe Francophone du Diabete; Diabete Quebec; Canadian Foundation for Innovation; University of Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec-Sante; Societe Francophone du Diabete; Diabete Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Montreal	This work was supported by grants from the Canadian Institutes of Health Research (MOP115042), Fonds de Recherche Quebec-Sante, Societe Francophone du Diabete, Diabete Quebec, and Canadian Foundation for Innovation (to T. A.).; Supported by a doctoral fellowship from Diabete Quebec and University of Montreal.	Alquier T, 2007, ENDOCRINOLOGY, V148, P1367, DOI 10.1210/en.2006-1039; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Beall C, 2012, DIABETOLOGIA, V55, P2432, DOI 10.1007/s00125-012-2617-y; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; BEVERLY JL, 1991, AM J PHYSIOL, V261, pR339, DOI 10.1152/ajpregu.1991.261.2.R339; Blazquez C, 1999, J NEUROCHEM, V73, P1674, DOI 10.1046/j.1471-4159.1999.731674.x; Borg ML, 2012, J PHYSIOL-LONDON, V590, P4377, DOI 10.1113/jphysiol.2012.233288; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; EDMOND J, 1992, CAN J PHYSIOL PHARM, V70, pS118, DOI 10.1139/y92-253; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Fioramonti X, 2004, DIABETES, V53, P2767, DOI 10.2337/diabetes.53.11.2767; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gao S, 2013, PHYSIOL BEHAV, V122, P17, DOI 10.1016/j.physbeh.2013.07.014; Gao S, 2013, PHYSIOL BEHAV, V118, P165, DOI 10.1016/j.physbeh.2013.03.030; Gao S, 2011, AM J PHYSIOL-REG I, V301, pR209, DOI 10.1152/ajpregu.00092.2011; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gavillet M, 2008, GLIA, V56, P975, DOI 10.1002/glia.20671; Guillod-Maximin E, 2004, J NEUROENDOCRINOL, V16, P464, DOI 10.1111/j.1365-2826.2004.01185.x; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; KASSER TR, 1985, AM J PHYSIOL, V248, pR447, DOI 10.1152/ajpregu.1985.248.4.R447; Kawashima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036335; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; KIMES AS, 1983, BRAIN RES, V274, P291, DOI 10.1016/0006-8993(83)90707-2; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lanfray D, 2013, DIABETES, V62, P801, DOI 10.2337/db11-0785; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Madadi G, 2008, BIOCHEM BIOPH RES CO, V376, P694, DOI 10.1016/j.bbrc.2008.09.054; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Sanz C, 2007, J ENDOCRINOL, V193, P259, DOI 10.1677/JOE-06-0146; Schwinkendorf DR, 2011, INT J OBESITY, V35, P336, DOI 10.1038/ijo.2010.159; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Wang R, 2006, J NEUROPHYSIOL, V95, P1491, DOI 10.1152/jn.00697.2005; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yi CX, 2011, NEUROENDOCRINOLOGY, V93, P143, DOI 10.1159/000324888	69	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37216	37229		10.1074/jbc.M113.506238	http://dx.doi.org/10.1074/jbc.M113.506238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240094	Green Published, hybrid			2022-12-25	WOS:000329189700039
J	Broggi, S; Martegani, E; Colombo, S				Broggi, Serena; Martegani, Enzo; Colombo, Sonia			Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PREDOMINANT RAS ACTIVATION; RAS/CAMP PATHWAY; YEAST; CAMP; LOCALIZATION; PKA; GLUCOSE; STRESS; CELL	Using an eGFP-RBD3 probe, which specifically binds Ras-GTP, we recently showed that the fluorescent probe was localized to the plasma membrane and to the nucleus in wild type cells growing exponentially on glucose medium, indicating the presence of active Ras in these cellular compartments. To investigate the nuclear function of Ras-GTP, we generated a strain where Ras2 is fused to the nuclear export signal (NES) from the HIV virus, in order to exclude this protein from the nucleus. Our results show that nuclear active Ras2 is required for invasive growth development in haploid yeast, while the expression of the NES-Ras2 protein does not cause growth defects either on fermentable or non-fermentable carbon sources and does not influence protein kinase A (PKA) activity related phenotypes analysed. Moreover, we show that the cAMP/PKA pathway controls invasive growth influencing the localization of active Ras. In particular, we show that PKA activity plays a role in the localization of active Ras and influences the ability of the cells to invade the agar: high PKA activity leads to a predominant nuclear accumulation of active Ras and induces invasive growth, while low PKA activity leads to plasma membrane localization of active Ras and to a defective invasive growth phenotype.	[Broggi, Serena; Martegani, Enzo; Colombo, Sonia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Martegani, Enzo; Colombo, Sonia] SysBio Ctr Syst Biol, Milan, Italy	University of Milano-Bicocca	Colombo, S (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	Sonia.Colombo@unimib.i		Martegani, Enzo/0000-0001-9196-4224; Migliaccio, Antimo/0000-0002-4197-2055; Colombo, Sonia/0000-0001-5104-508X	UniCellsys; Program SysBioNet, Italian Roadmap Research Infrastructure	UniCellsys; Program SysBioNet, Italian Roadmap Research Infrastructure	This work was supported by UniCellsys and by founding of Program SysBioNet, Italian Roadmap Research Infrastructure 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; Belotti F, 2011, FEBS LETT, V585, P3914, DOI 10.1016/j.febslet.2011.10.032; Broggi S, 2013, INT J BIOCHEM CELL B, V45, P384, DOI 10.1016/j.biocel.2012.10.013; Casado C, 2011, BIOCHEM J, V438, P523, DOI 10.1042/BJ20110607; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen RE, 2010, GENETICS, V185, P855, DOI 10.1534/genetics.110.115808; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Dong JA, 2011, FEBS LETT, V585, P1127, DOI 10.1016/j.febslet.2011.03.057; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hu Y, 2010, FEMS YEAST RES, V10, P177, DOI 10.1111/j.1567-1364.2009.00598.x; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lorenz MC, 2000, GENETICS, V154, P609; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Magherini F, 2006, INT J BIOCHEM CELL B, V38, P444, DOI 10.1016/j.biocel.2005.10.004; MITSUZAWA H, 1993, GENETICS, V135, P321; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; PURWIN C, 1986, J BIOL CHEM, V261, P8744; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tisi R, 2008, BBA-MOL CELL RES, V1783, P2363, DOI 10.1016/j.bbamcr.2008.09.004; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; WILSON RB, 1993, FEBS LETT, V325, P191, DOI 10.1016/0014-5793(93)81071-7	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79274	10.1371/journal.pone.0079274	http://dx.doi.org/10.1371/journal.pone.0079274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244466	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800052
J	Giamberardino, A; Labib, M; Hassan, EM; Tetro, JA; Springthorpe, S; Sattar, SA; Berezovski, MV; DeRosa, MC				Giamberardino, Amanda; Labib, Mahmoud; Hassan, Eman M.; Tetro, Jason A.; Springthorpe, Susan; Sattar, Syed A.; Berezovski, Maxim V.; DeRosa, Maria C.			Ultrasensitive Norovirus Detection Using DNA Aptasensor Technology	PLOS ONE			English	Article							APTAMERS; BINDING; SERVER	DNA aptamers were developed against murine norovirus (MNV) using SELEX (Systematic Evolution of Ligands by EXponential enrichment). Nine rounds of SELEX led to the discovery of AG3, a promising aptamer with very high affinity for MNV as well as for lab-synthesized capsids of a common human norovirus (HuNoV) outbreak strain (GII.3). Using fluorescence anisotropy, AG3 was found to bind with MNV with affinity in the low picomolar range. The aptamer could cross-react with HuNoV though it was selected against MNV. As compared to a non-specific DNA control sequence, the norovirus-binding affinity of AG3 was about a million-fold higher. In further tests, the aptamer also showed nearly a million-fold higher affinity for the noroviruses than for the feline calicivirus (FCV), a virus similar in size and structure to noroviruses. AG3 was incorporated into a simple electrochemical sensor using a gold nanoparticle-modified screen-printed carbon electrode (GNPs-SPCE). The aptasensor could detect MNV with a limit of detection of approximately 180 virus particles, for possible on-site applications. The lead aptamer candidate and the aptasensor platform show promise for the rapid detection and identification of noroviruses in environmental and clinical samples.	[Giamberardino, Amanda; Hassan, Eman M.; DeRosa, Maria C.] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada; [Labib, Mahmoud; Berezovski, Maxim V.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Tetro, Jason A.; Springthorpe, Susan; Sattar, Syed A.] Univ Ottawa, Ctr Res Environm Microbiol, Ottawa, ON, Canada	Carleton University; University of Ottawa; University of Ottawa	Sattar, SA (corresponding author), Univ Ottawa, Ctr Res Environm Microbiol, Ottawa, ON, Canada.	syed.sattar@uottawa.ca; maxim.berezvoski@uottawa.ca; maria.derosa@carleton.ca	Berezovski, Maxim V./F-8961-2012; Labib, Mahmoud/P-2267-2014; Labib, Mahmoud/ABB-1104-2021; Berezovski, Maxim V./N-1247-2019	Berezovski, Maxim V./0000-0003-0514-599X; Labib, Mahmoud/0000-0003-4565-2056; Labib, Mahmoud/0000-0003-4565-2056; Berezovski, Maxim V./0000-0003-0514-599X; Tetro, Jason/0000-0001-8759-7281	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP); Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF); Ontario Ministry for Research and Innovation (MRI)	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Ontario Ministry for Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario)	Sources of Funding: Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP), Natural Sciences and Engineering Research Council (NSERC), the Canada Foundation for Innovation (CFI), the Ontario Research Fund (ORF), Ontario Ministry for Research and Innovation (MRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Cho HS, 2012, ACS NANO, V6, P7607, DOI 10.1021/nn203833d; Cruz-Toledo J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas006; Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7; Gasparac R, 2004, J AM CHEM SOC, V126, P12270, DOI 10.1021/ja0458221; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Koo HL, 2010, DISCOV MED, V10, P61; Labib M, 2012, ANAL CHEM, V84, P1813, DOI 10.1021/ac203412m; Labib M, 2011, ANALYST, V136, P708, DOI 10.1039/c0an00741b; Lapierre MA, 2003, ANAL CHEM, V75, P6327, DOI 10.1021/ac0349429; Luttermann C, 1995, CALICIVIRUSES MOL CE, P146; McKeague M., 2011, ENV BIOSENSORS, P17, DOI DOI 10.5772/22350; McKeague M., 2012, J NUCLEIC ACIDS, V2012, DOI DOI 10.1155/2012/748913; Mergny J. L., 2009, CURR PROTOC NUCL ACI; Negri P, 2011, CHEM COMMUN, V47, P8635, DOI 10.1039/c0cc05433j; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Radi AE, 2006, J AM CHEM SOC, V128, P117, DOI 10.1021/ja053121d; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhang J, 2007, CHEM COMMUN, P1154, DOI 10.1039/b615742d; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	71	74	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79087	10.1371/journal.pone.0079087	http://dx.doi.org/10.1371/journal.pone.0079087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244426	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800028
J	Timon-Gomez, A; Proft, M; Pascual-Ahuir, A				Timon-Gomez, Alba; Proft, Markus; Pascual-Ahuir, Amparo			Differential Regulation of Mitochondrial Pyruvate Carrier Genes Modulates Respiratory Capacity and Stress Tolerance in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; EXPRESSION; METABOLISM; PROTEINS	Mpc proteins are highly conserved from yeast to humans and are necessary for the uptake of pyruvate at the inner mitochondrial membrane, which is used for leucine and valine biosynthesis and as a fuel for respiration. Our analysis of the yeast MPC gene family suggests that amino acid biosynthesis, respiration rate and oxidative stress tolerance are regulated by changes in the Mpc protein composition of the mitochondria. Mpc2 and Mpc3 are highly similar but functionally different: Mpc2 is most abundant under fermentative non stress conditions and important for amino acid biosynthesis, while Mpc3 is the most abundant family member upon salt stress or when high respiration rates are required. Accordingly, expression of the MPC3 gene is highly activated upon NaCl stress or during the transition from fermentation to respiration, both types of regulation depend on the Hog1 MAP kinase. Overexpression experiments show that gain of Mpc2 function leads to a severe respiration defect and ROS accumulation, while Mpc3 stimulates respiration and enhances tolerance to oxidative stress. Our results identify the regulated mitochondrial pyruvate uptake as an important determinant of respiration rate and stress resistance.	[Timon-Gomez, Alba; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Dept Biotechnol, E-46071 Valencia, Spain; [Proft, Markus] CSIC, Inst Biol Mol & Celular Plantas, Dept Mech Plant Stress Responses, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Proft, M (corresponding author), CSIC, Inst Biol Mol & Celular Plantas, Dept Mech Plant Stress Responses, Valencia, Spain.	mproft@ibmcp.upv.es; apascual@ibmcp.upv.es	Timon, Alba/AAD-6495-2020; Proft, Markus/K-2323-2014; Pascual-ahuir, Amparo/K-1338-2014	Timon, Alba/0000-0001-9811-8557; Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Economia y Competitividad grant [BFU2011-23326]; JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas	Ministerio de Economia y Competitividad grant(Spanish Government); JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas	This work was supported by Ministerio de Economia y Competitividad grant BFU2011-23326 to M.P.; A.T.-G. was supported by a JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Martinez-Montanes F, 2010, OMICS, V14, P619, DOI 10.1089/omi.2010.0046; Martinez-Pastor M, 2010, OMICS, V14, P541, DOI 10.1089/omi.2010.0020; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Pan Y, 2011, EXP GERONTOL, V46, P847, DOI 10.1016/j.exger.2011.08.007; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79405	10.1371/journal.pone.0079405	http://dx.doi.org/10.1371/journal.pone.0079405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244496	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800072
J	Borgella, S; Fievet, N; Huynh, BT; Ibitokou, S; Hounguevou, G; Affedjou, J; Sagbo, JC; Houngbegnon, P; Guezo-Mevo, B; Massougbodji, A; Luty, AJF; Cot, M; Deloron, P				Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Ibitokou, Samad; Hounguevou, Gbetognon; Affedjou, Jacqueline; Sagbo, Jean-Claude; Houngbegnon, Parfait; Guezo-Mevo, Blaise; Massougbodji, Achille; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe			Impact of Pregnancy-Associated Malaria on Infant Malaria Infection in Southern Benin	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; BIRTH-WEIGHT; PLACENTAL INFECTION; WOMEN; INFLAMMATION; RESPONSES; EXPOSURE; RISK	Background: Infants of mothers with placental Plasmodium falciparum infections at delivery are themselves more susceptible to malaria attacks or to infection in early life. Methodology/Principal Findings: To assess the impact of either the timing or the number of pregnancy-associated malaria (PAM) infections on the incidence of parasitemia or malaria attacks in infancy, we followed 218 mothers through pregnancy (monthly visits) up to delivery and their infants from birth to 12 months of age (fortnightly visits), collecting detailed clinical and parasitological data. After adjustment on location, mother's age, birth season, bed net use, and placental malaria, infants born to a mother with PAM during the third trimester of pregnancy had a significantly increased risk of infection (OR [95% CI]: 4.2 [1.6; 10.5], p = 0.003) or of malaria attack (4.6 [1.7; 12.5], p = 0.003). PAM during the first and second trimesters had no such impact. Similarly significant results were found for the effect of the overall number of PAM episodes on the time to first parasitemia and first malaria attack (HR [95% CI]: 2.95 [1.58; 5.50], p = 0.001 and 3.19 [1.59; 6.38], p = 0.001) respectively. Conclusions/Significance: This study highlights the importance of protecting newborns by preventing repeated episodes of PAM in their mothers.	[Borgella, Sophie; Fievet, Nadine] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe] Inst Rech Dev, UMR 216, Paris, France; [Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Ibitokou, Samad; Hounguevou, Gbetognon; Affedjou, Jacqueline; Sagbo, Jean-Claude; Houngbegnon, Parfait; Guezo-Mevo, Blaise; Massougbodji, Achille; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, PRES, Paris, France	University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fievet, N (corresponding author), Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin.	fievet@ird.fr	Deloron, Philippe/G-6305-2010; Luty, Adrian/CAH-2547-2022; Cot, Michel/E-7633-2011	Deloron, Philippe/0000-0003-4705-2484; Cot, Michel/0000-0003-3014-4294; Luty, Adrian John Frederick/0000-0001-8830-3425; Huynh, Bich-Tram/0000-0001-6340-9557; Fievet, Nadine/0000-0003-2272-9794	European 7th Framework Programme [200889]	European 7th Framework Programme(European Commission)	This paper describes work undertaken in the context of the STOPPAM project, 'Strategies To Prevent Pregnancy Associated Malaria'. STOPPAM is a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme, contract number: 200889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STRATEGIC FRAMEWORK; Baiz N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-87; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Cottrell G, 2005, AM J TROP MED HYG, V73, P1112, DOI 10.4269/ajtmh.2005.73.1112; Cottrell G, 2009, REV EPIDEMIOL SANTE, V57, P361, DOI 10.1016/j.respe.2009.04.011; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dent A, 2006, J IMMUNOL, V177, P7139, DOI 10.4049/jimmunol.177.10.7139; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Faris PD, 2002, J CLIN EPIDEMIOL, V55, P184, DOI 10.1016/S0895-4356(01)00433-4; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Jusko TA, 2012, ENVIRON HEALTH PERSP, V120, P595, DOI 10.1289/ehp.1104229; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mens PF, 2010, EUR J OBSTET GYN R B, V152, P126, DOI 10.1016/j.ejogrb.2010.05.013; Moore SE, 2005, NESTLE NUTR WORKS SE, V55, P153; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Salomon LJ, 2010, ULTRASOUND OBST GYN, V35, P385, DOI 10.1002/uog.7623; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; van den Biggelaar AHJ, 2010, CLIN EXP IMMUNOL, V160, P42, DOI 10.1111/j.1365-2249.2010.04137.x; World Health Organization, 2011, IR DEF AN ASS PREV C	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80624	10.1371/journal.pone.0080624	http://dx.doi.org/10.1371/journal.pone.0080624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236190	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700193
J	Chen, J; Wei, DY; Zhao, YR; Liu, XY; Zhang, J				Chen, Jie; Wei, Deying; Zhao, Yueran; Liu, Xiaoyan; Zhang, Jie			Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; PROMOTER HYPERMETHYLATION; FIBULIN 1; EXPRESSION; GROWTH; INVASION; METHYLATION; INDUCTION; PROTEIN; ROLES	Objective: This study was to explore the role of EFEMP1 in ovarian tumor progression and its relationship with prognosis of ovarian carcinoma. Methods: EFEMP1 mRNA and protein expressions in normal ovarian tissue, ovarian tumor, high invasive subclones and low invasive subclones were evaluated by immunohistochemistry and real time RT-PCR. Serum EFEMP1 levels in patients with ovarian tumor were measured by ELISA assay. To assess the angiogenic properties of EFEMP1, VEGF and tumor microvessel density were analyzed in ovarian carcinoma by immunohistochemistry. Results: EFEMP1 expression was up-regulated in ovarian carcinoma, positively correlated with MVD and VEGF, and its overexpression and high serum levels were significantly associated with high stage, low differentiation, lymph node metastasis and poor prognosis of ovarian cancer. EFEMP1 expression was also found to be over-expressed in the highly invasive subclones compared with the low invasive subclones. Conclusion: EFEMP1 is a newly identified gene over-expressed in ovarian cancer, associated with poor clinicopathologic features and promotes angiogenesis. This study shows that EFEMP1 may serve as a new prognostic factor and a therapeutic target for patients with ovarian cancer in the future.	[Chen, Jie] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wei, Deying] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Liu, Xiaoyan] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Zhao, Yueran; Zhang, Jie] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wei, DY (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China.	hl922@163.com; zhangjie19630711@163.com			Shandong University [2012TS088]; National Nature Science Foundation of China [81202056]	Shandong University; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant-in-aid for scientific research from Shandong University (2012TS088) and National Nature Science Foundation of China (81202056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Bardin A, 2005, ENDOCRINOLOGY, V146, P760, DOI 10.1210/en.2004-1239; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Brun JL, 2000, GYNECOL ONCOL, V78, P21, DOI 10.1006/gyno.2000.5805; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen J, 2012, J CELL PHYSIOL, V227, P3629, DOI 10.1002/jcp.24069; Chen J, 2009, J CANCER RES CLIN, V135, P909, DOI 10.1007/s00432-008-0526-8; Chen LX, 2009, ONCOL REP, V21, P917, DOI 10.3892/or_00000304; Cheng YY, 2008, BRIT J CANCER, V99, P2083, DOI 10.1038/sj.bjc.6604760; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Coticchia Christine M, 2008, J Natl Compr Canc Netw, V6, P795; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Greene LM, 2003, BRIT J CANCER, V88, P871, DOI 10.1038/sj.bjc.6600802; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hu Z, 2011, UROL ONCOL-SEMIN ORI, V29, P430, DOI 10.1016/j.urolonc.2009.06.004; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Omasu F, 2005, ELECTROPHORESIS, V26, P1163, DOI 10.1002/elps.200410182; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398	35	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78783	10.1371/journal.pone.0078783	http://dx.doi.org/10.1371/journal.pone.0078783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236050	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700047
J	Gunther, ALB; Walz, H; Kroke, A; Wudy, SA; Riedel, C; von Kries, R; Joslowski, G; Remer, T; Cheng, G; Buyken, AE				Guenther, Anke L. B.; Walz, Helena; Kroke, Anja; Wudy, Stefan A.; Riedel, Christina; von Kries, Ruediger; Joslowski, Gesa; Remer, Thomas; Cheng, Guo; Buyken, Anette E.			Breastfeeding and Its Prospective Association with Components of the GH-IGF-Axis, Insulin Resistance and Body Adiposity Measures in Young Adulthood - Insights from Linear and Quantile Regression Analysis	PLOS ONE			English	Article							GROWTH-FACTOR-I; FORMULA-FED INFANTS; CHILDHOOD OBESITY; ANTHROPOMETRIC MEASUREMENTS; BLOOD-PRESSURE; PROTEIN-INTAKE; RISK-FACTORS; DISEASE; HEALTH; LIFE	Background: Breastfeeding may lower chronic disease risk by long-term effects on hormonal status and adiposity, but the relations remain uncertain. Objective: To prospectively investigate the association of breastfeeding with the growth hormone-(GH) insulin-like growth factor- (IGF) axis, insulin sensitivity, body composition and body fat distribution in younger adulthood (18-37 years). Design: Data from 233 (54% female) participants of a German cohort, the Dortmund Nutritional and Anthropometric Longitudinally Designed (DONALD) Study, with prospective data on infant feeding were analyzed. Multivariable linear as well as quantile regression were performed with full breastfeeding (not: <= 2, short: 3-17, long: >17 weeks) as exposure and adult IGF-I, IGF binding proteins (IGFBP) -1, -2, -3, homeostasis model assessment of insulin resistance (HOMA-IR), fat mass index, fat-free mass index, and waist circumference as outcomes. Results: After adjustment for early life and socio-economic factors, women who had been breastfed longer displayed higher adult IGFBP-2 (p(trend) = 0.02) and lower values of HOMA-IR (p(trend) = 0.004). Furthermore, in women breastfeeding duration was associated with a lower mean fat mass index (p(trend) = 0.01), fat-free mass index (ptrend = 0.02) and waist circumference (p(trend) = 0.004) in young adulthood. However, there was no relation to IGF-I, IGFBP-1 and IGFBP-3 (all p(trend) >0.05). Associations for IGFBP-2 and fat mass index were more pronounced at higher, for waist circumference at very low or high percentiles of the distribution. In men, there was no consistent relation of breastfeeding with any outcome. Conclusions: Our data suggest that breastfeeding may have long-term, favorable effects on extremes of adiposity and insulin metabolism in women, but not in men. In both sexes, breastfeeding does not seem to induce programming of the GH-IGF-axis.	[Guenther, Anke L. B.; Walz, Helena; Kroke, Anja; Cheng, Guo] Fulda Univ Appl Sci, Dept Nutr Food & Consumer Sci, Fulda, Germany; [Wudy, Stefan A.] Univ Giessen, Ctr Child & Adolescent Med, Lab Translat Hormone Analyt Pediat Endocrinol, Peptide Hormone Res Unit, D-35390 Giessen, Germany; [Riedel, Christina; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Joslowski, Gesa; Remer, Thomas; Buyken, Anette E.] Univ Bonn, DONALD Study Res Inst Child Nutr, IEL Nutr Epidemiol, Bonn, Germany; [Cheng, Guo] West China Sch Publ Hlth, Chengdu, Peoples R China	Justus Liebig University Giessen; University of Munich; University of Bonn	Gunther, ALB (corresponding author), Fulda Univ Appl Sci, Dept Nutr Food & Consumer Sci, Fulda, Germany.	anke.guenther@he.hs-fulda.de	Wudy, Stefan/ABC-7173-2020	Sobotzki, Christina/0000-0002-0956-0050; Cheng, Guo/0000-0002-0945-5728	Wereld Kanker Onderzoek Fonds (WCRF NL) as part of the WCRF International grant programme [2010/248]; Kompetenznetz Adipositas (Competence Network Obesity); Federal Ministry of Education and Research, Germany [FKZ: 01GI1121A]; Ministry of Science and Research of North Rhine Westphalia, Germany	Wereld Kanker Onderzoek Fonds (WCRF NL) as part of the WCRF International grant programme; Kompetenznetz Adipositas (Competence Network Obesity); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Ministry of Science and Research of North Rhine Westphalia, Germany	This analysis was funded by the Wereld Kanker Onderzoek Fonds (WCRF NL), grant no. 2010/248, as part of the WCRF International grant programme (www.wcrf-nl.org). The quantile regression analysis was supported by the Kompetenznetz Adipositas (Competence Network Obesity) funded by the Federal Ministry of Education and Research, Germany, FKZ: 01GI1121A (www.kompetenznetz-adipositas.de). The DONALD Study is supported by the Ministry of Science and Research of North Rhine Westphalia, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2009, J NUTR, V139, p408S, DOI 10.3945/jn.108.097808; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Beyerlein A, 2008, OBESITY, V16, P2730, DOI 10.1038/oby.2008.432; Beyerlein A, 2011, AM J CLIN NUTR, V94, p1772S, DOI 10.3945/ajcn.110.000547; BLUM WF, 1986, ACTA ENDOCRINOL-COP, V111, P271, DOI 10.1530/acta.0.1110271; Burgers AMG, 2011, J CLIN ENDOCR METAB, V96, P2912, DOI 10.1210/jc.2011-1377; Buyken AE, 2012, BUNDESGESUNDHEITSBLA, V55, P875, DOI 10.1007/s00103-012-1503-6; Buyken AE, 2008, AM J CLIN NUTR, V87, P1964, DOI 10.1093/ajcn/87.6.1964; Chellakooty M, 2006, J CLIN ENDOCR METAB, V91, P820, DOI 10.1210/jc.2005-0950; Closa-Monasterolo R, 2011, AM J CLIN NUTR, V94, p1920S, DOI 10.3945/ajcn.110.001123; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Cope MB, 2008, OBES REV, V9, P594, DOI 10.1111/j.1467-789X.2008.00504.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; FERRARIO M, 1995, INT J OBESITY, V19, P449; Fewtrell MS, 2011, P NUTR SOC, V70, P472, DOI 10.1017/S0029665111000589; Fogelholm M, 1997, EUR J CLIN NUTR, V51, P495, DOI 10.1038/sj.ejcn.1600448; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Horta BL, 2007, EVIDENCE LONG TERM E; Joslowski G, 2013, J NUTR, V143, P1147, DOI 10.3945/jn.113.175877; KlipsteinGrobusch K, 1997, INT J EPIDEMIOL, V26, pS174, DOI 10.1093/ije/26.suppl_1.S174; Koletzko B, 2009, AM J CLIN NUTR, V89, pS1502, DOI 10.3945/ajcn.2009.27113D; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7; Larnkjaer A, 2012, CURR OPIN CLIN NUTR, V15, P285, DOI 10.1097/MCO.0b013e328351c472; Larnkjaer A, 2009, GROWTH HORM IGF RES, V19, P82, DOI 10.1016/j.ghir.2008.06.003; Lawlor DA, 2005, ARCH DIS CHILD, V90, P582, DOI 10.1136/adc.2004.055335; Lohmann TG, 1988, ANTHROPOMETRIC STAND; LUCAS A, 1980, LANCET, V1, P1267; Madsen AL, 2011, GROWTH HORM IGF RES, V21, P199, DOI 10.1016/j.ghir.2011.05.003; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Manco M, 2011, J AM COLL NUTR, V30, P29, DOI 10.1080/07315724.2011.10719941; MARKS GC, 1989, AM J EPIDEMIOL, V130, P578, DOI 10.1093/oxfordjournals.aje.a115372; Martin RM, 2013, JAMA-J AM MED ASSOC, V309, P1005, DOI 10.1001/jama.2013.167; Martin RM, 2011, NESTLE NUTR WORKS SE, V67, P79, DOI 10.1159/000325577; Martin RM, 2005, CLIN ENDOCRINOL, V62, P728, DOI 10.1111/j.1365-2265.2005.02287.x; Martin RM, 2005, J EPIDEMIOL COMMUN H, V59, P121, DOI 10.1136/jech.2003.018952; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murphy MJ, 2004, PEDIATRICS, V113, P82, DOI 10.1542/peds.113.1.82; Nelson MC, 2005, EPIDEMIOLOGY, V16, P247, DOI 10.1097/01.ede.0000152900.81355.00; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Owen CG, 2011, P NUTR SOC, V70, P478, DOI 10.1017/S0029665111000590; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Savino F, 2005, ACTA PAEDIATR, V94, P531, DOI 10.1080/08035250510027642; Socha P, 2005, ADV EXP MED BIOL, V569, P159; Socha P, 2011, AM J CLIN NUTR, V94, p1776S, DOI 10.3945/ajcn.110.000596; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Voigt M, 2010, Z GEBURTSH NEONATOL, V214, P24, DOI 10.1055/s-0029-1241833; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002	53	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79436	10.1371/journal.pone.0079436	http://dx.doi.org/10.1371/journal.pone.0079436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236134	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700133
J	Kukimoto, I; Maehama, T; Sekizuka, T; Ogasawara, Y; Kondo, K; Kusumoto-Matsuo, R; Mori, S; Ishii, Y; Takeuchi, T; Yamaji, T; Takeuchi, F; Hanada, K; Kuroda, M				Kukimoto, Iwao; Maehama, Tomohiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kondo, Kazunari; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Ishii, Yoshiyuki; Takeuchi, Takamasa; Yamaji, Toshiyuki; Takeuchi, Fumihiko; Hanada, Kentaro; Kuroda, Makoto			Genetic Variation of Human Papillomavirus Type 16 in Individual Clinical Specimens Revealed by Deep Sequencing	PLOS ONE			English	Article							LONG CONTROL REGION; NEXT-GENERATION; CERVICAL-CANCER; DNA; INTEGRATION; DIVERSITY; VARIANTS; E6	Viral genetic diversity within infected cells or tissues, called viral quasispecies, has been mostly studied for RNA viruses, but has also been described among DNA viruses, including human papillomavirus type 16 (HPV16) present in cervical precancerous lesions. However, the extent of HPV genetic variation in cervical specimens, and its involvement in HPV-induced carcinogenesis, remains unclear. Here, we employ deep sequencing to comprehensively analyze genetic variation in the HPV16 genome isolated from individual clinical specimens. Through overlapping full-circle PCR, approximately 8-kb DNA fragments covering the whole HPV16 genome were amplified from HPV16-positive cervical exfoliated cells collected from patients with either low-grade squamous intraepithelial lesion (LSIL) or invasive cervical cancer (ICC). Deep sequencing of the amplified HPV16 DNA enabled de novo assembly of the full-length HPV16 genome sequence for each of 7 specimens (5 LSIL and 2 ICC samples). Subsequent alignment of read sequences to the assembled HPV16 sequence revealed that 2 LSILs and 1 ICC contained nucleotide variations within E6, E1 and the non-coding region between E5 and L2 with mutation frequencies of 0.60% to 5.42%. In transient replication assays, a novel E1 mutant found in ICC, E1 Q381E, showed reduced ability to support HPV16 origin-dependent replication. In addition, partially deleted E2 genes were detected in 1 LSIL sample in a mixed state with the intact E2 gene. Thus, the methods used in this study provide a fundamental framework for investigating the influence of HPV somatic genetic variation on cervical carcinogenesis.	[Kukimoto, Iwao; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Ishii, Yoshiyuki; Takeuchi, Takamasa; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Maehama, Tomohiko; Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Kondo, Kazunari] NTT Med Ctr Tokyo, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kanto Medical Center NTT EC	Kukimoto, I (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	ikuki@niid.go.jp	Maehama, Tomohiko/AAX-8926-2020; Kukimoto, I/I-3995-2019; kondo, kazunari/AGE-0558-2022; Maehama, Tomohiko/HGB-4896-2022	Kukimoto, I/0000-0001-9080-1642; kondo, kazunari/0000-0002-2662-4626; Maehama, Tomohiko/0000-0002-9685-2317; Sekizuka, Tsuyoshi/0000-0002-1302-5472; Hanada, Kentaro/0000-0003-1383-2781	Japanese Ministry of Education, Culture, Sports, and Science; Ministry of Health, Labor, Welfare, and Technology; Mitsubishi Foundation	Japanese Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, Welfare, and Technology(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, and Science; by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor, Welfare, and Technology; and by a grant from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Molina A, 2013, J GEN VIROL, V94, P393, DOI 10.1099/vir.0.045807-0; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fradet-Turcotte A, 2010, VIROLOGY, V399, P65, DOI 10.1016/j.virol.2009.12.026; Fu LP, 2004, J INFECT DIS, V190, P1303, DOI 10.1086/423855; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kajitani N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00152; KANDA T, 1987, JPN J CANCER RES, V78, P103; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kondo Kazunari, 2012, Open Virol J, V6, P277, DOI 10.2174/1874357901206010277; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin QQ, 1998, INT J CANCER, V75, P484, DOI 10.1002/(SICI)1097-0215(19980130)75:3<484::AID-IJC25>3.0.CO;2-7; Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2; McBride AA, 2008, ADV VIRUS RES, V72, P155, DOI 10.1016/S0065-3527(08)00404-1; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MELENDY T, 1995, J VIROL, V69, P7857, DOI 10.1128/JVI.69.12.7857-7867.1995; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miura S, 2006, INT J CANCER, V119, P2713, DOI 10.1002/ijc.22195; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Titolo S, 2000, J VIROL, V74, P7349, DOI 10.1128/JVI.74.16.7349-7361.2000; van Velzen M, 2012, J INFECT DIS, V205, P1539, DOI 10.1093/infdis/jis237; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; *WHO, 2009, WNOIVB1012 WHO; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; YEE C, 1985, AM J PATHOL, V119, P361; Zou NX, 2000, J VIROL, V74, P3761, DOI 10.1128/JVI.74.8.3761-3770.2000; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	51	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80583	10.1371/journal.pone.0080583	http://dx.doi.org/10.1371/journal.pone.0080583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236186	Green Published, gold			2022-12-25	WOS:000327254700187
J	Li, F; Zhang, XM; Hu, RB; Wu, FQ; Ma, JH; Meng, Y; Fu, YF				Li, Fang; Zhang, Xiaomei; Hu, Ruibo; Wu, Faqiang; Ma, Jinhua; Meng, Ying; Fu, YongFu			Identification and Molecular Characterization of FKF1 and GI Homologous Genes in Soybean	PLOS ONE			English	Article							F-BOX PROTEINS; ARABIDOPSIS CIRCADIAN CLOCK; FLOWERING-LOCUS-T; MAP-BASED CLONING; GIGANTEA GENE; CONFORMATIONAL-CHANGES; GROWTH HABIT; EXPRESSION; CONSTANS; THALIANA	In Arabidopsis, FKF1 (FLAVIN BINDING, KELCH REPEAT, F-BOX1) and GI (GIGANTEA) play important roles in flowering pathway through regulating daytime CO (CONSTANS) expression, and such a function is conserved across plants studied. But related reports are limited for soybean. In this study, we cloned FKF1 and GI homologs in soybean, and named as GmFKF1, GmFKF2, GmGI1, GmGI2, and GmGI3, respectively. GmGI1 had two alternative splicing forms, GmGI1 alpha and GmGI1 beta. GmFKF1/2 transcripts were diurnally regulated, with a peak at zeitgeber time 12 (ZT12) in long days and at ZT10 in short days. The diurnal phases between GmGIs transcript levels greatly differed. GmGI2 expression was regulated by both the circadian clock and photoperiod. But the rhythmic phases of GmGI1 and GmGI3 expression levels were mainly conferred by long days. GmFKFs shared similar spatio-temporal expression profiles with GmGIs in all of the tissue/organs in different developmental stages in both LD and SD. Both GmFKF and GmGI proteins were targeted to the nucleus. Yeast two hybrid assays showed GmFKF1/GmFKF2 interacted with GmGI1/GmGI2/GmCDF1 (CYCLING DOF FACTOR CDF1 homolog in soybean); and the LOV (Light, Oxygen, or Voltage) domain in GmFKF1/GmFKF2 played an important role in these interactions. N-terminus of GmGI2 was sufficient to mediate its interaction with GmCDF1. Interestingly, N-terminus not full of GmGI3 interacted with GmFKF1/GmFKF2/GmCDF1. Ectopic over-expression of the GmFKF1 or GmFKF2 in Arabidopsis enhanced flowering in SD. Collectively, GmFKF and GmGI in soybean had conserved functional domains at DNA sequence level, but specific characters at function level with their homologs in other plants.	[Li, Fang; Zhang, Xiaomei; Wu, Faqiang; Ma, Jinhua; Meng, Ying; Fu, YongFu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Hu, Ruibo] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, CAS Key Lab Biofuels, Shandong Prov Key Lab Energy Genet, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Fu, YF (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	fufu19cn@163.com	Hu, Ruibo/P-3471-2018	Hu, Ruibo/0000-0001-6299-5320	973 Program [2010CB125906]; Transgenic program [2011ZX08009-001, 2011ZX08004-005]; 863 program [2013AA102602]; National Natural Science Founds [31000681]	973 Program(National Basic Research Program of China); Transgenic program; 863 program(National High Technology Research and Development Program of China); National Natural Science Founds	This work was partly supported by 973 Program (2010CB125906), Transgenic program (2011ZX08009-001 and 2011ZX08004-005), 863 program (2013AA102602), and the National Natural Science Founds (31000681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Andrade MA, 2001, PLANT MOL BIOL, V46, P603, DOI 10.1023/A:1010650809272; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bendix C, 2013, PLANT CELL ENVIRON, V36, P1379, DOI 10.1111/pce.12067; Black MM, 2011, PROTEIN EXPRES PURIF, V76, P197, DOI 10.1016/j.pep.2010.11.009; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Edwards J, 2010, PLANT J, V63, P651, DOI 10.1111/j.1365-313X.2010.04269.x; Eitoku T, 2007, J MOL BIOL, V371, P1290, DOI 10.1016/j.jmb.2007.06.035; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Higuchi Y, 2011, PLANT CELL PHYSIOL, V52, P638, DOI 10.1093/pcp/pcr023; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kim MY, 2012, J BIOSCIENCES, V37, P857, DOI 10.1007/s12038-012-9252-0; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Nakasone Y, 2010, BIOPHYS J, V99, P3831, DOI 10.1016/j.bpj.2010.10.005; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Paltiel J, 2006, PLANTA, V224, P1255, DOI 10.1007/s00425-006-0305-1; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Penfield S, 2009, PLANT CELL, V21, P1722, DOI 10.1105/tpc.108.064022; Pineiro M, 2013, PLANT SCI, V198, P98, DOI [10.1016/j.plantsci.2012.10.005, 10.1016/j.pla]; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Serikawa M, 2008, PLANT PHYSIOL, V146, P1952, DOI 10.1104/pp.107.114611; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Sung S, 2006, J EXP BOT, V57, P3369, DOI 10.1093/jxb/erl105; Takase T, 2011, PLANT J, V67, P608, DOI 10.1111/j.1365-313X.2011.04618.x; Taylor A, 2010, PLANT CELL PHYSIOL, V51, P1638, DOI 10.1093/pcp/pcq120; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu FQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027737; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yasuhara M, 2004, J EXP BOT, V55, P2015, DOI 10.1093/jxb/erh226; Yon F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-172; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105; Zhao XY, 2005, PLANT MOL BIOL, V58, P53, DOI 10.1007/s11103-005-4162-2	82	16	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79036	10.1371/journal.pone.0079036	http://dx.doi.org/10.1371/journal.pone.0079036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236086	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700084
J	Peng, CFJ; Wikramanayake, AH				Peng, ChiehFu Jeff; Wikramanayake, Athula H.			Differential Regulation of Disheveled in a Novel Vegetal Cortical Domain in Sea Urchin Eggs and Embryos: Implications for the Localized Activation of Canonical Wnt Signaling	PLOS ONE			English	Article							NUCLEAR BETA-CATENIN; STICHOPUS-CALIFORNICUS ECHINODERMATA; SYNAPTULA HYDRIFORMIS HOLOTHUROIDEA; NEMATOSTELLA-VECTENSIS; DEVELOPMENTAL BIOLOGY; UNFERTILIZED EGG; BASAL BODIES; CELL FATE; POLARITY; AXIS	Pattern formation along the animal-vegetal (AV) axis in sea urchin embryos is initiated when canonical Wnt (cWnt) signaling is activated in vegetal blastomeres. The mechanisms that restrict cWnt signaling to vegetal blastomeres are not well understood, but there is increasing evidence that the egg's vegetal cortex plays a critical role in this process by mediating localized "activation" of Disheveled (Dsh). To investigate how Dsh activity is regulated along the AV axis, sea urchin-specific Dsh antibodies were used to examine expression, subcellular localization, and post-translational modification of Dsh during development. Dsh is broadly expressed during early sea urchin development, but immunolocalization studies revealed that this protein is enriched in a punctate pattern in a novel vegetal cortical domain (VCD) in the egg. Vegetal blastomeres inherit this VCD during embryogenesis, and at the 60-cell stage Dsh puncta are seen in all cells that display nuclear beta-catenin. Analysis of Dsh post-translational modification using two-dimensional Western blot analysis revealed that compared to Dsh pools in the bulk cytoplasm, this protein is differentially modified in the VCD and in the 16-cell stage micromeres that partially inherit this domain. Dsh localization to the VCD is not directly affected by disruption of microfilaments and microtubules, but unexpectedly, microfilament disruption led to degradation of all the Dsh pools in unfertilized eggs over a period of incubation suggesting that microfilament integrity is required for maintaining Dsh stability. These results demonstrate that a pool of differentially modified Dsh in the VCD is selectively inherited by the vegetal blastomeres that activate cWnt signaling in early embryos, and suggests that this domain functions as a scaffold for localized Dsh activation. Localized cWnt activation regulates AV axis patterning in many metazoan embryos. Hence, it is possible that the VCD is an evolutionarily conserved cytoarchitectural domain that specifies the AV axis in metazoan ova.	[Peng, ChiehFu Jeff; Wikramanayake, Athula H.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Wikramanayake, AH (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	athula@miami.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2000, DEV BIOL, V218, P1, DOI 10.1006/dbio.1999.9553; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Asano Y, 2001, CELL MOTIL CYTOSKEL, V48, P245, DOI 10.1002/cm.1013; BAER K. E. v., 1834, ARCH ANAT PHYSL, V1, P481; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bince Joanna M., 2008, V469, P201, DOI 10.1007/978-1-60327-469-2_15; Bince Joanna M., 2008, V469, P213, DOI 10.1007/978-1-60327-469-2_16; Boveri T., 1901, ZOOLOGISCHE JB UCHER, V14, P630; Boveri T., 1901, VERHANDLUNGEN PHYSIK, V34, P145; BOYLE JA, 1989, DEV BIOL, V134, P72, DOI 10.1016/0012-1606(89)90079-1; Byrum C.A., 2004, P33; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Croce J, 2011, DEVELOPMENT, V138, P3297, DOI 10.1242/dev.058792; Croce JC, 2006, SEMIN CELL DEV BIOL, V17, P168, DOI 10.1016/j.semcdb.2006.04.004; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DiCarlo M, 1996, BIOCHEM BIOPH RES CO, V229, P511; Egana AL, 2007, MOL REPROD DEV, V74, P76, DOI 10.1002/mrd.20511; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Foissner I, 2007, PLANT CELL PHYSIOL, V48, P585, DOI 10.1093/pcp/pcm030; Frick JE, 1996, BIOL BULL-US, V191, P168, DOI 10.2307/1542920; Frick JE, 1996, INVERTEBR BIOL, V115, P46, DOI 10.2307/3226941; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Henry JQ, 2008, DEV BIOL, V317, P368, DOI 10.1016/j.ydbio.2008.02.042; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; HORSTADIUS S, 1950, EXP CELL RES, V1, P188, DOI 10.1016/0014-4827(50)90031-0; Imai K, 2000, DEVELOPMENT, V127, P3009; KUMBUREGAMA S, 2007, SIGNAL TRANSDUCT, V7, P164, DOI DOI 10.1002/SITA.200600127; Kumburegama S, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-2; KURAISHI R, 1994, DEVELOPMENT, V120, P2619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Leonard JD, 2007, DEV BIOL, V306, P50, DOI 10.1016/j.ydbio.2007.02.041; Lhomond G, 2012, DEVELOPMENT, V139, P816, DOI 10.1242/dev.072215; Lillie FR, 1909, BIOL BULL-US, V16, P54, DOI 10.2307/1536026; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MARK EL, 1881, B MUS COMP ZOOL HARV, V9, P173; Martindale Mark Q., 2013, Biological Theory, V8, P253; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; MARUYAMA YK, 1985, J EXP ZOOL, V236, P155, DOI 10.1002/jez.1402360206; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; SCHROEDER TE, 1991, DEV BIOL, V144, P240, DOI 10.1016/0012-1606(91)90418-3; SCHROEDER TE, 1985, DEV GROWTH DIFFER, V27, P311; SCHROEDER TE, 1980, DEV BIOL, V79, P428, DOI 10.1016/0012-1606(80)90128-1; SCHROEDER TE, 1980, EXP CELL RES, V128, P490, DOI 10.1016/0014-4827(80)90088-9; SMILEY S, 1985, BIOL BULL, V169, P342, DOI 10.2307/1541487; SMILEY S, 1988, BIOL BULL, V175, P79, DOI 10.2307/1541895; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stack C, 2006, DEV DYNAM, V235, P1042, DOI 10.1002/dvdy.20695; Stamateris RE, 2010, GENE EXPR PATTERNS, V10, P60, DOI 10.1016/j.gep.2009.10.004; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; VACQUIER VD, 1975, DEV BIOL, V43, P62, DOI 10.1016/0012-1606(75)90131-1; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Weitzel HE, 2004, DEVELOPMENT, V131, P2947, DOI 10.1242/dev.01152; Wessel GM, 1999, BIOESSAYS, V21, P459, DOI 10.1002/(SICI)1521-1878(199906)21:6<459::AID-BIES3>3.0.CO;2-Y; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; WIKRAMANAYAKE AH, 1995, DEVELOPMENT, V121, P1497; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Wilt FH, 2004, METHOD CELL BIOL, V74, P273; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Wourms JP., 1987, REPRODUCTION MARINE, P50	80	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80693	10.1371/journal.pone.0080693	http://dx.doi.org/10.1371/journal.pone.0080693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236196	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700199
J	Srinivasan, M; Wang, Y; Sheets, A				Srinivasan, Manoj; Wang, Yang; Sheets, Alison			People Bouncing on Trampolines: Dramatic Energy Transfer, a Table-Top Demonstration, Complex Dynamics and a Zero Sum Game	PLOS ONE			English	Article							WALKING; MODEL; OPTIMIZATION	Jumping on trampolines is a popular backyard recreation. In some trampoline games (e. g., "seat drop war"), when two people land on the trampoline with only a small time-lag, one person bounces much higher than the other, as if energy has been transferred from one to the other. First, we illustrate this energy-transfer in a table-top demonstration, consisting of two balls dropped onto a mini-trampoline, landing almost simultaneously, sometimes resulting in one ball bouncing much higher than the other. Next, using a simple mathematical model of two masses bouncing passively on a massless trampoline with no dissipation, we show that with specific landing conditions, it is possible to transfer all the kinetic energy of one mass to the other through the trampoline - in a single bounce. For human-like parameters, starting with equal energy, the energy transfer is maximal when one person lands approximately when the other is at the bottom of her bounce. The energy transfer persists even for very stiff surfaces. The energy-conservative mathematical model exhibits complex non-periodic long-term motions. To complement this passive bouncing model, we also performed a game-theoretic analysis, appropriate when both players are acting strategically to steal the other player's energy. We consider a zero-sum game in which each player's goal is to gain the other player's kinetic energy during a single bounce, by extending her leg during flight. For high initial energy and a symmetric situation, the best strategy for both subjects (minimax strategy and Nash equilibrium) is to use the shortest available leg length and not extend their legs. On the other hand, an asymmetry in initial heights allows the player with more energy to gain even more energy in the next bounce. Thus synchronous bouncing unstable is unstable both for passive bouncing and when leg lengths are controlled as in game-theoretic equilibria.	[Srinivasan, Manoj; Wang, Yang; Sheets, Alison] Ohio State Univ, Columbus, OH 43210 USA	Ohio State University	Srinivasan, M (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	srinivasan.88@osu.edu	Srinivasan, Manoj/E-8751-2011	Srinivasan, Manoj/0000-0002-7811-3617				Berry MV, 1981, EUROPEAN J PHYS, V2; Black GB, 2003, CAN J SURG, V46, P199; Blajer W, 2003, MULTIBODY SYST DYN, V10, P289, DOI 10.1023/A:1025991618087; Bryson A.E., 2018, APPL OPTIMAL CONTROL, P90, DOI 10.1201/9781315137667-3; Chatterjee A, 1999, NONLINEAR DYNAM, V20, P159, DOI 10.1023/A:1008397905242; Chatterjee A, 1997, THESIS CORNELL U; Chiappori PA, 2002, AM ECON REV, V92, P1138, DOI 10.1257/00028280260344678; Chvatal V., 1983, LINEAR PROGRAMMING; Cross R, 2007, AM J PHYS, V75, P1009, DOI 10.1119/1.2772286; Davis Morton D., 2012, GAME THEORY NONTECHN; Dublin University Trampoline Club, 2011, SEAT DROP WARS DUBL; Esposito PW, 2009, CURR SPORT MED REP, V8, P273, DOI 10.1249/JSR.0b013e3181b8f60a; Fax JA, 2004, IEEE T AUTOMAT CONTR, V49, P1465, DOI 10.1109/TAC.2004.834433; Ferguson TS, 2013, GAME THEORY; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gilet T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.014501; Gilet T, 2009, J FLUID MECH, V625, P167, DOI 10.1017/S0022112008005442; Goldstein H., 2002, CLASSICAL MECH, Vthird; Guckenheimer J, 2013, APPL MATH SCI, V42; Hairer E., 2006, GEOMETRIC NUMERICAL, V31; Isaacs R., 1999, DIFFERENTIAL GAMES M; Ivanov AP, 1995, PMM-J APPL MATH MEC+, V59, P887, DOI 10.1016/0021-8928(95)00122-0; MEISS JD, 1992, REV MOD PHYS, V64, P795, DOI 10.1103/RevModPhys.64.795; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Osborne M.J., 1994, COURSE GAME THEORY; Pattar U, 2002, RESONANCE, V7, P67; Poundstone W., 1992, PHYS TODAY, V45, P73; Raghavan T., 1994, HDB GAME THEORY EC A, V2, P735; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sheets AL, 2009, J BIOMECH, V42, P1685, DOI 10.1016/j.jbiomech.2009.04.014; Smith J.M., 1993, EVOLUTION THEORY GAM; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Srinivasan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066609; TUFILLARO NB, 1992, EXPT APPROACH NONLIN; USTA, 2004, US TUMBL TRAMP ASS S; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; WOODWARD GA, 1992, PEDIATRICS, V89, P849	40	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78645	10.1371/journal.pone.0078645	http://dx.doi.org/10.1371/journal.pone.0078645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236029	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700026
J	Tanneeru, K; Guruprasad, L				Tanneeru, Karunakar; Guruprasad, Lalitha			Ponatinib Is a Pan-BCR-ABL Kinase Inhibitor: MD Simulations and SIE Study	PLOS ONE			English	Article							SOLVATED INTERACTION ENERGY; CHRONIC MYELOID-LEUKEMIA; LIGAND-BINDING AFFINITIES; BOUNDARY-ELEMENT METHOD; PARTICLE MESH EWALD; CLINICAL RESISTANCE; TYROSINE KINASE; IMATINIB RESISTANCE; P-LOOP; MUTATIONS	BCR-ABL kinase domain inhibition can be used to treat chronic myeloid leukemia. The inhibitors such as imatinib, dasatinib and nilotinib are effective drugs but are resistant to some BCR-ABL mutations. The pan-BCR-ABL kinase inhibitor ponatinib exhibits potent activity against native, T315I, and all other clinically relevant mutants, and showed better inhibition than the previously known inhibitors. We have studied the molecular dynamics simulations and calculated solvated interaction energies of native and fourteen mutant BCR-ABL kinases (M244V, G250E, Q252H, Y253F, Y253H, E255K, E255V, T315A, T315I, F317L, F317V, M351T, F359V and H396P) complexed with ponatinib. These studies revealed that the interactions between ponatinib and individual residues in BCR-ABL kinase are also affected due to the remote residue mutations. We report that some residues, Met244, Lys245, Gln252, Gly254, Leu370 and Leu298 do not undergo any conformational changes, while the fluctuations in residues from P-loop, beta 3-, beta 5-strands and alpha C-helix are mainly responsible for ponatinib binding to native and all mutant BCR-ABL kinases. Our work provides the molecular mechanisms of native and mutant BCR-ABL kinases inhibition by ponatinib at atomic level that has not been studied before.	[Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in	Tanneeru, Karunakar/C-8200-2019; Tanneeru, Karunakar/C-8946-2016	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	CSIR, Government of India [02(0036)/11/EMR-II]	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR, Government of India, No. 02(0036)/11/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PB, 1992, BAILLIERE CLIN HAEM, V5, P897, DOI 10.1016/S0950-3536(11)80051-X; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Chen W, 2004, BIOPHYS J, V87, P3035, DOI 10.1529/biophysj.104.049494; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DALEY GQ, 1991, ADV CANCER RES, V57, P151; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker Brian J, 2002, Hematology Am Soc Hematol Educ Program, P111; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Goldman JM, 2001, BLOOD, V98, P2039, DOI 10.1182/blood.V98.7.2039; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Lill MA, 2011, J CHEM INF MODEL, V51, P2680, DOI 10.1021/ci200191m; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pendergast A M, 1987, Baillieres Clin Haematol, V1, P1001, DOI 10.1016/S0950-3536(87)80036-7; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sulea T, 2011, J CHEM INF MODEL, V51, P2066, DOI 10.1021/ci2000242; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	52	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78556	10.1371/journal.pone.0078556	http://dx.doi.org/10.1371/journal.pone.0078556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236021	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700018
J	Bojan, M; Lopez-Lopez, V; Pouard, P; Falissard, B; Journois, D				Bojan, Mirela; Lopez-Lopez, Vanessa; Pouard, Philippe; Falissard, Bruno; Journois, Didier			Limitations of Early Serum Creatinine Variations for the Assessment of Kidney Injury in Neonates and Infants with Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CONGENITAL HEART-DISEASE; CRITICALLY-ILL CHILDREN; PERITONEAL-DIALYSIS; CARDIOPULMONARY BYPASS; CARDIOTHORACIC SURGERY; RETROSPECTIVE ANALYSIS; FLUID ACCUMULATION; RIFLE CRITERIA; RISK-FACTORS	Background: Changes in kidney function, as assessed by early and even small variations in serum creatinine (Delta sCr), affect survival in adults following cardiac surgery but such associations have not been reported in infants. This raises the question of the adequate assessment of kidney function by early Delta sCr in infants undergoing cardiac surgery. Methodology: The ability of Delta sCr within 2 days of surgery to assess the severity of kidney injury, accounted for by the risk of 30-day mortality, was explored retrospectively in 1019 consecutive neonates and infants. Patients aged <= 10 days were analyzed separately because of the physiological improvement in glomerular filtration early after birth. The Kml algorithm, an implementation of k-means for longitudinal data, was used to describe creatinine kinetics, and the receiver operating characteristic and the reclassification methodology to assess discrimination and the predictive ability of the risk of death. Results: Three clusters of Delta sCr were identified: in 50% of all patients creatinine decreased, in 41.4% it increased slightly, and in 8.6% it rose abruptly. Mortality rates were not significantly different between the first and second clusters, 1.6% [0.0-4.1] vs 5.9% [1.9-10.9], respectively, in patients aged <= 10 days, and 1.6% [0.5-3.0] vs 3.8% [1.9-6.0] in older ones. Mortality rates were significantly higher when creatinine rose abruptly, 30.3% [15.1-46.2] in patients aged <= 10 days, and 15.1% [5.9-25.5] in older ones. However, only 41.3% of all patients who died had an abrupt increase in creatinine. Delta sCr improved prediction in survivors, but not in patients who died, and did not improve discrimination over a clinical mortality model. Conclusions: The present results suggest that a postoperative decrease in creatinine represents the normal course in neonates and infants with cardiac surgery, and that early creatinine variations lack sensitivity for the assessment of the severity of kidney injury.	[Bojan, Mirela; Lopez-Lopez, Vanessa; Pouard, Philippe] Necker Enfants Malades Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France; [Falissard, Bruno] Univ Paris 11, INSERM, U669, Paris, France; [Falissard, Bruno; Journois, Didier] Paris Descartes Univ, Paris, France; [Falissard, Bruno] Hop Paul Brousse, AP HP, Paris, France; [Journois, Didier] Georges Pompidou European Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Bojan, M (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France.	mirela.bojan@nck.aphp.fr	Didier, Journois/J-3074-2019	Didier, Journois/0000-0003-1096-7373				Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Baker SG, 2003, J NATL CANCER I, V95, P511, DOI 10.1093/jnci/95.7.511; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BJORNSSON TD, 1979, CLIN PHARMACOKINET, V4, P200, DOI 10.2165/00003088-197904030-00003; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Boer DP, 2010, PEDIATR NEPHROL, V25, P2107, DOI 10.1007/s00467-010-1533-y; Boigner H, 2004, ANN THORAC SURG, V77, P61, DOI 10.1016/S0003-4975(03)01490-5; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Chan KL, 2003, ANN THORAC SURG, V76, P1443, DOI 10.1016/S0003-4975(03)01026-9; Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006; Diskin CJ, 2007, ANN CLIN BIOCHEM, V44, P16, DOI 10.1258/000456307779595940; Drukker A, 2002, CURR OPIN PEDIATR, V14, P175, DOI 10.1097/00008480-200204000-00006; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Genolini C, 2011, COMPUT METH PROG BIO, V104, pE112, DOI 10.1016/j.cmpb.2011.05.008; Gillespie RS, 2004, PEDIATR NEPHROL, V19, P1394, DOI 10.1007/s00467-004-1655-1; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Guzzetta NA, 2009, ANESTH ANALG, V108, P448, DOI 10.1213/ane.0b013e318194007a; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; KERN FH, 1992, ANN THORAC SURG, V54, P541, DOI 10.1016/0003-4975(92)90451-9; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lolekha PH, 2001, J CLIN LAB ANAL, V15, P116, DOI 10.1002/jcla.1013; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morgan CJ, 2013, J PEDIATR-US, V162, P120, DOI 10.1016/j.jpeds.2012.06.054; Ostermann ME, 2005, INTENS CARE MED, V31, P250, DOI 10.1007/s00134-004-2523-y; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Pedersen KR, 2008, KIDNEY INT, V73, pS81, DOI 10.1038/sj.ki.5002607; Pedersen KR, 2007, ACTA ANAESTH SCAND, V51, P1344, DOI 10.1111/j.1399-6576.2007.01379.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pottel H, 2008, CLIN CHIM ACTA, V396, P49, DOI 10.1016/j.cca.2008.06.017; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Szekely A, 2008, PEDIATR ANESTH, V18, P151, DOI 10.1111/j.1460-9592.2007.02398.x; Thompson LD, 2001, J THORAC CARDIOV SUR, V122, P220, DOI 10.1067/mtc.2001.114937; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79308	10.1371/journal.pone.0079308	http://dx.doi.org/10.1371/journal.pone.0079308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244476	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600124
J	Kammer, TW; Sumrall, CD; Zamora, S; Ausich, WI; Deline, B				Kammer, Thomas W.; Sumrall, Colin D.; Zamora, Samuel; Ausich, William I.; Deline, Bradley			Oral Region Homologies in Paleozoic Crinoids and Other Plesiomorphic Pentaradial Echinoderms	PLOS ONE			English	Article							CAMBRIAN KAILI BIOTA; PHYLOGENETIC IMPLICATIONS; GUIZHOU PROVINCE; PELMATOZOAN ARMS; BURGESS SHALE; ORDOVICIAN; EOCRINOIDS; EVOLUTION; ORIGIN; EDRIOASTEROIDEA	The phylogenetic relationships between major groups of plesiomorphic pentaradial echinoderms, the Paleozoic crinoids, blastozoans, and edrioasteroids, are poorly understood because of a lack of widely recognized homologies. Here, we present newly recognized oral region homologies, based on the Universal Elemental Homology model for skeletal plates, in a wide range of fossil taxa. The oral region of echinoderms is mainly composed of the axial, or ambulacral, skeleton, which apparently evolved more slowly than the extraxial skeleton that forms the majority of the body. Recent phylogenetic hypotheses have focused on characters of the extraxial skeleton, which may have evolved too rapidly to preserve obvious homologies across all these groups. The axial skeleton conserved homologous suites of characters shared between various edrioasteroids and specific blastozoans, and between other blastozoans and crinoids. Although individual plates can be inferred as homologous, no directly overlapping suites of characters are shared between edrioasteroids and crinoids. Six different systems of mouth (peristome) plate organization (Peristomial Border Systems) are defined. These include four different systems based on the arrangement of the interradially-positioned oral plates and their peristomial cover plates, where PBS A1 occurs only in plesiomorphic edrioasteroids, PBS A2 occurs in plesiomorphic edrioasteroids and blastozoans, and PBS A3 and PBS A4 occur in blastozoans and crinoids. The other two systems have radially-positioned uniserial oral frame plates in construction of the mouth frame. PBS B1 has both orals and uniserial oral frame plates and occurs in edrioasterid and possibly edrioblastoid edrioasteroids, whereas PBS B2 has exclusively uniserial oral frame plates and is found in isorophid edrioasteroids and imbricate and gogiid blastozoans. These different types of mouth frame construction offer potential synapomorphies to aid in parsimony-based phylogenetics for exploring branching order among stem groups on the echinoderm tree of life.	[Kammer, Thomas W.] W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA; [Sumrall, Colin D.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Zamora, Samuel] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Ausich, William I.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Deline, Bradley] Univ West Georgia, Dept Geosci, Carrollton, GA USA	West Virginia University; University of Tennessee System; University of Tennessee Knoxville; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; Ohio State University; University System of Georgia; University of West Georgia	Kammer, TW (corresponding author), W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA.	tkammer@wvu.edu	Zamora, Samuel/ABC-9333-2021	Zamora, Samuel/0000-0002-3917-4628	National Science Foundation [1036356, 1036260, 1036416]; Smithsonian Institution; Direct For Biological Sciences [1036356] Funding Source: National Science Foundation; Division Of Environmental Biology [1322141] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This publication has been supported by the National Science Foundation (www.nsf.gov) collaborative project Assembling the Echinoderm Tree of Life by grants 1036356 (West Virginia University), 1036260 (University of Tennessee), 1036416 (The Ohio State University), and Research Award Opportunity Supplements to National Science Foundation grants 1036416 and 1036356 (University of West Georgia). SZ was supported by the Springer Fund of the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausich WI, 1998, J PALEONTOL, V72, P499, DOI 10.1017/S0022336000024276; Ausich WI, 2000, LETHAIA, V33, P92; Ausich WI, 1998, PALAEONTOLOGY, V41, P193; Ausich William I., 1998, University of Kansas Paleontological Contributions New Series, V9, P1; BASSLER RAY S., 1950, JOUR WASHINGTON ACAD SCI, V40, P273; Bather F. A., 1899, Report British Association, V1898, P916; Bather FA, 1914, GEOLOGICAL MAGAZINE, V2, P259; Bather FA, 1914, GEOLOGICAL MAGAZINE, V2, P211; Beaver H.H., 1967, ECHINODERMATA, V2, p[S297, 1]; Bell B.M, 1976, STUDY N AM EDRIOASTE; BELL BM, 1978, J PALEONTOL, V52, P243; BELL BM, 1976, J PALEONTOL, V50, P1001; BOCKELIE JF, 1984, PALAEONTOLOGY, V27, P1; BRANSON E. B., 1940, JOUR PALEONTOL, V14, P89; BRETT CE, 1983, J PALEONTOL, V57, P627; Brochu Christopher A., 2008, Paleontological Society Papers, V14, P185; Carpenter P. H., 1884, ZOOLOGY, V11, P1; Clausen S, 2008, J PALEONTOL, V82, P737, DOI 10.1666/06-067.1; Clausen S, 2009, LETHAIA, V42, P283, DOI 10.1111/j.1502-3931.2008.00145.x; Conrad T.A., 1842, J ACAD NATURAL SCI P, V8, P183; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Donovan S.K., 1989, Palaeontographical Society Monographs (London), V142, P69; Donovan S.K, 1986, MONOGRAPH PALAEONTOG, V138, P1; ECKERT JD, 1987, CAN J EARTH SCI, V24, P860, DOI 10.1139/e87-085; Foerste A.F., 1938, GEOL SOC AM BULL, V49, P212; GOLDRING W, 1923, NEW YORK STATE MUSEU, V16; Guensburg T. E., 1994, FIELDIANA GEOLOGY, V29; Guensburg TE, 2001, GEOLOGY, V29, P131, DOI 10.1130/0091-7613(2001)029<0131:ECNEFT>2.0.CO;2; Guensburg TE, 2013, GEOLOGICAL SOC AM AB, V45, P10; Guensburg TE, 2007, ANN PALEONTOL, V93, P277, DOI 10.1016/j.annpal.2007.09.005; Guensburg Thomas E., 2003, Bulletins of American Paleontology, V364, P1; Guensburg TE, 2012, J PALEONTOL, V86, P455, DOI 10.1666/11-097.1; Guensburg TE, 2010, LETHAIA, V43, P432, DOI 10.1111/j.1502-3931.2010.00220.x; Guensburg TE, 2009, J PALEONTOL, V83, P350, DOI 10.1666/08-090.1; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Kesling R.V., 1968, TREATISE INVERTE BRA, V1, pS85; KESLING ROBERT V., 1960, CONTR MUS PALAEONTOL UNIV MICHIGAN, V15, P139; LANE NG, 1982, J PALEONTOL, V56, P244; LANE NG, 1982, J PALEONTOL, V56, P103; Lane NG, 1978, GEOLOGICAL SOC AM U, V2, pT301; Meek F.B., 1871, AM J SCI 3, V2, P295; Mooi R, 1998, AM ZOOL, V38, P965; Mooi R, 2008, ANNU REV ECOL EVOL S, V39, P43, DOI 10.1146/annurev.ecolsys.39.110707.173521; Moore RC, 1978, ECHINODERMATA, V2, P1; Owen D. D., 1850, J ACAD NATURAL SCI P, V2, P89; Parsley R.L., 1982, University of Kansas Paleontological Contributions Monograph, V1, P280; Parsley RL, 2006, J PALEONTOL, V80, P1058, DOI 10.1666/0022-3360(2006)80[1058:LSEITB]2.0.CO;2; PATTERSON C, 1988, MOL BIOL EVOL, V5, P603; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Regnault S, 2007, ANN PALEONTOL, V93, P215, DOI 10.1016/j.annpal.2007.06.005; Rozhnov S.V., 2002, PALEONTOL J+, V36, pS525; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; SINCLAIR GW, 1945, AM MIDL NAT, V34, P707, DOI 10.2307/2421094; SMITH A B, 1990, Memoirs of the Queensland Museum, V28, P715; SMITH AB, 1984, PALAEONTOLOGY, V27, P431; Smith AB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1197; Springer F, 1920, SMITHSONIAN I PUBLIC, V2501, P1; SPRINKLE J, 1976, SYST ZOOL, V25, P83, DOI 10.2307/2412783; SPRINKLE J, 1975, J PALEONTOL, V49, P1062; SPRINKLE J, 1982, U KANSAS PALEONTOLOG, V1, P1; Sprinkle J, 2012, GEOLOGICAL SOC AM AB, V7, P136; SPRINKLE J, 1973, SPECIAL PUBLICATION, P1; Sprinkle J, 2006, CAN J EARTH SCI, V43, P303, DOI 10.1139/E05-107; Sprinkle James, 2011, Palaeontographica Canadiana, V31, P169; Sprinkle J, 2011, J PALEONTOL, V85, P250, DOI 10.1666/10-072.1; Sumrall CD, 2003, PALAEONTOLOGY, V46, P113, DOI 10.1111/1475-4983.00290; SUMRALL CD, 1993, LETHAIA, V26, P289, DOI 10.1111/j.1502-3931.1993.tb01534.x; Sumrall CD, 2012, ACTA PALAEONTOLOGICA, DOI [10.4202/app.2011.0120, DOI 10.4202/APP.2011.0120]; Sumrall CD, 2007, PALEOBIOLOGY, V33, P149, DOI 10.1666/06053.1; Sumrall Colin D., 1999, P409; Sumrall CD, 2012, J PALEONTOL, V86, P956, DOI 10.1666/12-029R.1; Sumrall CD, 2011, J SYST PALAEONTOL, V9, P425, DOI 10.1080/14772019.2010.499137; Sumrall Colin D., 1997, Paleontological Society Papers, V3, P267; Sumrall CD, 2010, ECHINODERMS: DURHAM, P269; Sumrall Colin D., 2008, P229; Ubaghs G., 1978, pT58; Ubaghs G., 1963, NOTES MEMOIRES SERVI, V172, P25; Ubaghs G., 1967, TREATISE INVERTEBRAT, V1, pU4; Ubaghs G, 1969, 38 U KANS PAL CONTR; Ubaghs G, 1967, TREATISE INVERTEBRAT, VS, pS455; Wachsmuth C., 1897, HARVARD COLL MUSEUM, V20; Wanner J., 1916, PERMISCHEN ECHINODER, V11, P1; Whiteaves J. F., 1897, Canad Rec, Vvii, P287; Whiteaves J. F., 1887, CONTRIBUTIONS CANADI, V1, P91; WOOD E, 1909, US NATL MUSEUM B, V64; Zamora S., 2011, P ROYAL SOC B, V279, P293; Zamora S, 2013, ACTA PALAEONTOL POL, V58, P545, DOI 10.4202/app.2011.0152; Zamora S, 2013, PALAEONTOLOGY, V56, P421, DOI 10.1111/j.1475-4983.2012.01209.x; Zhao Y, 1994, ACTA PALAEONTOLOGI S, V38, P1; Zhao YL, 2010, J PALEONTOL, V84, P668, DOI 10.1666/09-159.1	91	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77989	10.1371/journal.pone.0077989	http://dx.doi.org/10.1371/journal.pone.0077989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244284	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600012
J	Poojari, C; Strodel, B				Poojari, Chetan; Strodel, Birgit			Stability of Transmembrane Amyloid beta-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific A beta 42 Mutations	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PARTICLE MESH EWALD; FORMS ION CHANNELS; DYNAMICS SIMULATIONS; PROTEIN FIBRILLOGENESIS; CONFORMATIONAL-CHANGES; CEREBRAL-HEMORRHAGE; LIPID-MEMBRANES; FORCE-FIELD; OLIGOMERS	Interactions of the amyloid beta-protein (A beta) with neuronal cell membranes, leading to the disruption of membrane integrity, are considered to play a key role in the development of Alzheimer's disease. Natural mutations in A beta(42), such as the Arctic mutation (E22G) have been shown to increase A beta(42) aggregation and neurotoxicity, leading to the early-onset of Alzheimer's disease. A correlation between the propensity of A beta(42) to form protofibrils and its effect on neuronal dysfunction and degeneration has been established. Using rational mutagenesis of the A beta(42) peptide it was further revealed that the aggregation of different A beta(42) mutants in lipid membranes results in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also have a variable ability to disrupt bilayer integrity. To further test the connection between A beta(42) mutation and peptide-membrane interactions, we perform molecular dynamics simulations of membrane-inserted A beta(42) variants (wild-type and E22G, D23G, E22G/D23G, K16M/K28M and K16M/E22G/D23G/K28M mutants) as beta-sheet monomers and tetramers. The effects of charged residues on transmembrane A beta(42) stability and membrane integrity are analyzed at atomistic level. We observe an increased stability for the E22G A beta(42) peptide and a decreased stability for D23G compared to wild-type A beta(42), while D23G has the largest membrane-disruptive effect. These results support the experimental observation that the altered toxicity arising from mutations in A beta is not only a result of the altered aggregation propensity, but also originates from modified A beta interactions with neuronal membranes.	[Poojari, Chetan; Strodel, Birgit] Forschungszentrum Julich, Inst Complex Syst Struct Biochem, D-52425 Julich, Germany; [Strodel, Birgit] Univ Dusseldorf, Inst Theoret & Computat Chem, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Strodel, B (corresponding author), Forschungszentrum Julich, Inst Complex Syst Struct Biochem, D-52425 Julich, Germany.	b.strodel@fz-juelich.de	Strodel, Birgit/H-5449-2013	Strodel, Birgit/0000-0002-8734-7765; Poojari, Chetan/0000-0001-6575-221X	Julich Supercomputing Centre [JICS62]; Research Centre Julich	Julich Supercomputing Centre; Research Centre Julich	Sources of funding: Research Centre Julich (http://www.fz-juelich.de), Computing time grant JICS62 from the Julich Supercomputing Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Arce FT, 2011, SOFT MATTER, V7, P5267, DOI 10.1039/c1sm05162h; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Broeckhoven Christine V., 1990, SCIENCE, V248, P1120; Buchsteiner A, 2010, BBA-BIOMEMBRANES, V1798, P1969, DOI 10.1016/j.bbamem.2010.06.024; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Clements A, 1996, J NEUROCHEM, V66, P740; Cordomi A, 2007, J PHYS CHEM B, V111, P7052, DOI 10.1021/jp0707788; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis CH, 2010, PROTEINS, V78, P2533, DOI 10.1002/prot.22763; Davis CH, 2009, J PHYS CHEM B, V113, P14480, DOI 10.1021/jp905889z; Davis CH, 2009, BIOPHYS J, V96, P785, DOI 10.1016/j.bpj.2008.09.053; de Planque MRR, 2007, J MOL BIOL, V368, P982, DOI 10.1016/j.jmb.2007.02.063; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friedman R, 2011, BIOCHEM J, V438, P415, DOI 10.1042/BJ20110369; Friedman R, 2010, J PHYS CHEM LETT, V1, P471, DOI 10.1021/jz900318t; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto M., 2004, SOC NEUR ABSTR, V218, P214; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krone MG, 2008, J MOL BIOL, V381, P221, DOI 10.1016/j.jmb.2008.05.069; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lau TL, 2006, J MOL BIOL, V356, P759, DOI 10.1016/j.jmb.2005.11.091; LEE JP, 1995, BIOCHEMISTRY-US, V34, P5191, DOI 10.1021/bi00015a033; Lemkul JA, 2008, ARCH BIOCHEM BIOPHYS, V470, P54, DOI 10.1016/j.abb.2007.11.004; Lemkul JA, 2013, BIOCHEMISTRY-US, V52, P4971, DOI 10.1021/bi400562x; Lemkul JA, 2011, PROTEIN SCI, V20, P1530, DOI 10.1002/pro.678; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pifer PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016248; Poojari C, 2013, BBA-BIOMEMBRANES, V1828, P327, DOI 10.1016/j.bbamem.2012.09.001; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Sepulveda FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011820; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Straub JE, 2002, ACCOUNTS CHEM RES, V35, P473, DOI 10.1021/ar010031e; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Wales D. J., 2020, CAMBRIDGE CLUSTER DA; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Xiao DQ, 2012, J MOL BIOL, V421, P537, DOI 10.1016/j.jmb.2011.12.035; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhao J, 2011, LANGMUIR, V27, P14876, DOI 10.1021/la2027913; Zhao LN, 2011, J PHYS CHEM B, V115, P12247, DOI 10.1021/jp2065985	105	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78399	10.1371/journal.pone.0078399	http://dx.doi.org/10.1371/journal.pone.0078399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244308	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900014
J	Troynikov, V; Whitten, A; Gorfine, H; Putys, Z; Jakubaviciute, E; Lozys, L; Dainys, J				Troynikov, Vladimir; Whitten, Athol; Gorfine, Harry; Putys, Zilvinas; Jakubaviciute, Egle; Lozys, Linas; Dainys, Justas			Cormorant Catch Concerns for Fishers: Estimating the Size-Selectivity of a Piscivorous Bird	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; GREAT CORMORANT; YELLOW PERCH; PREDATION; POPULATIONS; LAKE; DIET; WALLEYE; MORTALITY; DENSITY	Conflict arises in fisheries worldwide when piscivorous birds target fish species of commercial value. This paper presents a method for estimating size selectivity functions for piscivores and uses it to compare predation selectivities of Great Cormorants (Phalacrocorax carbo sinensis L. 1758) with that of gill-net fishing on a European perch (Perca fluviatilis L. 1758) population in the Curonian Lagoon, Lithuania. Fishers often regard cormorants as an unwanted "satellite species'', but the degree of direct competition and overlap in size-specific selectivity between fishers and cormorants is unknown. This study showed negligible overlap in selectivity between Great Cormorants and legal-sized commercial nets. The selectivity estimation method has general application potential for use in conjunction with population dynamics models to assess fish population responses to size-selective fishing from a wide range of piscivorous predators.	[Troynikov, Vladimir; Whitten, Athol; Gorfine, Harry] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Gorfine, Harry; Putys, Zilvinas; Jakubaviciute, Egle; Lozys, Linas; Dainys, Justas] Nat Res Ctr, Lab Marine Ecol, Vilnius, Lithuania	University of Melbourne; Nature Research Center - Lithuania	Gorfine, H (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	hgorfine@unimelb.edu.au	Gorfine, Harry/GOE-3967-2022	Gorfine, Harry/0000-0001-6933-3389	Research Council of Lithuania [LEK-24/2010]; Department of Zoology, University of Melbourne	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Department of Zoology, University of Melbourne(University of Melbourne)	This study was supported by a grant from the Research Council of Lithuania under its programme 'Lithuania Ecosystems: Climate change and environmental impact' (grant no. LEK-24/2010). H. Gorfine, V. Troynikov and A. Whitten were partly supported by research funding from the Department of Zoology, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjers K, 2006, BOREAL ENVIRON RES, V11, P13; Andersen SM, 2007, ICES J MAR SCI, V64, P1235, DOI 10.1093/icesjms/fsm092; Brian SD, 2010, J GREAT LAKES RES, V36, P215, DOI 10.1016/j.jglr.2010.02.001; Britton J.R., 2003, P14; Carss DN, 1997, P 4 EUR C CORM 1 3 N, P197; Cech M, 2008, WATERBIRDS, V31, P438; Coutin P.C., 2003, P196; Dalton CM, 2009, CAN J FISH AQUAT SCI, V66, P177, DOI 10.1139/F08-198; DENIE H, 1995, ARDEA, V83, P115; Diana JS, 2006, J GREAT LAKES RES, V32, P306, DOI 10.3394/0380-1330(2006)32[306:DICPTS]2.0.CO;2; DIRKSEN S, 1995, ARDEA, V83, P167; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Engstrom H, 2003, VOGELWELT S, V124, P187; Eschbaum R., 2003, P72; Fielder DG, 2008, J GREAT LAKES RES, V34, P506, DOI 10.3394/0380-1330(2008)34[506:EOFCTT]2.0.CO;2; Fielder DG, 2010, J GREAT LAKES RES, V36, P207, DOI 10.1016/j.jglr.2009.12.015; Gremillet D, 2006, MAR BIOL, V148, P1081, DOI 10.1007/s00227-005-0130-2; Hollowed AB, 2000, ICES J MAR SCI, V57, P279, DOI 10.1006/jmsc.1999.0637; Irwin BJ, 2008, CAN J FISH AQUAT SCI, V65, P1366, DOI 10.1139/F08-062; KIRKWOOD GP, 1986, AUST J MAR FRESH RES, V37, P689; Kloskowski J, 2011, EUR J WILDLIFE RES, V57, P295, DOI 10.1007/s10344-010-0426-5; Krohn WB, 1995, COLON WATERBIRD, V18, P99, DOI 10.2307/1521529; Lehikoinen A, 2005, WATERBIRDS, V28, P511, DOI 10.1675/1524-4695(2005)28[511:PADOTG]2.0.CO;2; Leopold MF, 1998, J SEA RES, V40, P93, DOI 10.1016/S1385-1101(98)00028-8; Lilliendahl K, 2006, MAR BIOL, V149, P979, DOI 10.1007/s00227-006-0259-7; LINN IJ, 1992, J APPL ECOL, V29, P619, DOI 10.2307/2404470; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Millar RB, 1997, ICES J MAR SCI, V54, P471, DOI 10.1006/jmsc.1996.0196; Mustamaki N, 2014, AMBIO, V43, P325, DOI 10.1007/s13280-013-0429-z; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Putys Zilvinas, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0031-6; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rudstam LG, 2004, ECOL APPL, V14, P149, DOI 10.1890/03-5010; Steffens W, 2010, BULG J AGRIC SCI, V16, P322; Stewart DC, 2005, J ZOOL, V267, P191, DOI 10.1017/S0952836905007387; SUTER W, 1995, J APPL ECOL, V32, P29, DOI 10.2307/2404413; Svagzdys A, 2006, ZUVININKYSTE LIETUVO, V6, P195; Takahashi T, 2006, FISHERIES SCI, V72, P477, DOI 10.1111/j.1444-2906.2006.01175.x; Thoresson G., 1993, GUIDELINES COASTAL M, V1993, P1; Troynikov VS, 2011, J FISH BIOL, V79, P1940, DOI 10.1111/j.1095-8649.2011.03135.x; Van Eerden MR, 2003, VOGELWELT S, V124, P277; VANEERDEN MR, 1995, ARDEA, V83, P1; Wires L.R., 2003, VOGELWELT, V124, P389; Wires L.R., 2001, STATUS DOUBLE CRESTE; Yorio P, 2010, BIRD CONSERV INT, V20, P320, DOI 10.1017/S0959270910000286; Zydelis R, 2008, HYDROBIOLOGIA, V611, P45, DOI 10.1007/s10750-008-9460-7	47	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e77518	10.1371/journal.pone.0077518	http://dx.doi.org/10.1371/journal.pone.0077518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244277	Green Published, gold			2022-12-25	WOS:000327162900007
J	Kwak, Y; Jeong, J; Lee, S; Park, YU; Lee, SA; Han, DH; Kim, JH; Ohshima, T; Mikoshiba, K; Suh, YH; Cho, S; Park, SK				Kwak, Yongdo; Jeong, Jaehoon; Lee, Saebom; Park, Young-Un; Lee, Seol-Ae; Han, Dong-Hee; Kim, Joung-Hun; Ohshima, Toshio; Mikoshiba, Katsuhiko; Suh, Yoo-Hun; Cho, Sehyung; Park, Sang Ki			Cyclin-dependent Kinase 5 (Cdk5) Regulates the Function of CLOCK Protein by Direct Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Circadian Rhythms; Clock Genes; Neuroscience; Protein Phosphorylation; CLOCK; Cdk5; Molecular Clock	MAMMALIAN CIRCADIAN CLOCK; SEASONAL AFFECTIVE-DISORDER; SUPRACHIASMATIC NUCLEUS; DARK THERAPY; POSTTRANSLATIONAL REGULATION; CULTURED FIBROBLASTS; BIPOLAR DISORDER; GENE-EXPRESSION; ACTIVITY RHYTHM; TRANSCRIPTION	Circadian rhythm is a biological rhythm governing physiology and behavior with a period of approximate to 24 h. At the molecular level, circadian output is controlled by a molecular clock composed of positive and negative feedback loops in transcriptional and post-translational processes. CLOCK is a transcription factor known as a central component of the molecular clock feedback loops generating circadian oscillation. Although CLOCK is known to undergo multiple post-translational modifications, the knowledge of their entities remains limited. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine-threonine kinase that is involved in various neuronal processes. Here, we report that Cdk5 is a novel regulator of CLOCK protein. Cdk5 phosphorylates CLOCK at the Thr-451 and Thr-461 residues in association with transcriptional activation of CLOCK. The Cdk5-dependent regulation of CLOCK function is mediated by alterations of its stability and subcellular distribution. These results suggest that Cdk5 is a novel regulatory component of the core molecular clock machinery.	[Kwak, Yongdo; Jeong, Jaehoon; Lee, Saebom; Park, Young-Un; Lee, Seol-Ae; Kim, Joung-Hun; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Suh, Yoo-Hun] Seoul Natl Univ, Ctr Alzheimers Dementia, Natl Creat Res Initiat, Dept Pharmacol,Coll Med, Seoul 110799, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu 711873, South Korea; [Han, Dong-Hee; Cho, Sehyung] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Seoul 130701, South Korea; [Han, Dong-Hee; Cho, Sehyung] Kyung Hee Univ, Dept Physiol, Seoul 130701, South Korea	Pohang University of Science & Technology (POSTECH); Waseda University; RIKEN; Seoul National University (SNU); Korea Brain Research Institute (KBRI); Kyung Hee University; Kyung Hee University	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	skpark@postech.ac.kr	Mikoshiba, Katsuhiko/N-7943-2015		Korean government (MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200]; NRF of Korea [2012K2A1A2033117]; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP [2031-415]	Korean government (MSIP); NRF of Korea; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP	This work was supported by grants (NRF-2012R1A2A2A01012923 and NRF-2012R1A4A1028200) from the Korean government (MSIP) and also supported under the framework of international cooperation program managed by the NRF of Korea (2012K2A1A2033117) and the Korea Brain Research Institute (KBRI) Basic Research Program of MSIP (2031-415).	Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barbini B, 2005, BIPOLAR DISORD, V7, P98, DOI 10.1111/j.1399-5618.2004.00166.x; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; Chen PC, 2005, NEUROPSYCHOPHARMACOL, V30, P538, DOI 10.1038/sj.npp.1300604; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Dalgleish T, 1996, BRIT J CLIN PSYCHOL, V35, P163, DOI 10.1111/j.2044-8260.1996.tb01174.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Engmann O, 2011, BRAIN, V134, P2408, DOI 10.1093/brain/awr155; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gomez-Bernal G, 2009, MED HYPOTHESES, V72, P105, DOI 10.1016/j.mehy.2008.08.008; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Jung HS, 2003, NEUROREPORT, V14, P15, DOI 10.1097/00001756-200301200-00003; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko J, 2001, J NEUROSCI, V21, P6758; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mongrain V., 2011, PLOS ONE, V6; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Munoz JP, 2007, J CELL BIOCHEM, V100, P738, DOI 10.1002/jcb.21041; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Phelps J, 2008, MED HYPOTHESES, V70, P224, DOI 10.1016/j.mehy.2007.05.026; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSENTHAL NE, 1986, CLIN NEUROPHARMACOL, V9, P193; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Zhao WN, 2007, NAT CELL BIOL, V9, P268, DOI 10.1038/ncb1539; Zhu WL, 2012, INT J NEUROPSYCHOPH, V15, P795, DOI 10.1017/S1461145711000915	59	20	28	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36878	36889		10.1074/jbc.M113.494856	http://dx.doi.org/10.1074/jbc.M113.494856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235147	hybrid, Green Published			2022-12-25	WOS:000329189700011
J	Qin, C; Yang, B; Melvin, TM; Fan, ZX; Zhao, Y; Briffa, KR				Qin, Chun; Yang, Bao; Melvin, Thomas M.; Fan, Zexin; Zhao, Yan; Briffa, Keith R.			Radial Growth of Qilian Juniper on the Northeast Tibetan Plateau and Potential Climate Associations	PLOS ONE			English	Article							ARID NORTHWESTERN CHINA; TREE-RING CHRONOLOGY; SABINA-PRZEWALSKII; ALTITUDINAL GRADIENT; HEIHE RIVER; MOUNTAINS; ELEVATION; VARIABILITY; RECONSTRUCTION; PATTERNS	There is controversy regarding the limiting climatic factor for tree radial growth at the alpine treeline on the northeastern Tibetan Plateau. In this study, we collected 594 increment cores from 331 trees, grouped within four altitude belts spanning the range 3550 to 4020 m.a.s.l. on a single hillside. We have developed four equivalent ring-width chronologies and shown that there are no significant differences in their growth-climate responses during 1956 to 2011 or in their longer-term growth patterns during the period AD 1110-2011. The main climate influence on radial growth is shown to be precipitation variability. Missing ring analysis shows that tree radial growth at the uppermost treeline location is more sensitive to climate variation than that at other elevations, and poor tree radial growth is particularly linked to the occurrence of serious drought events. Hence water limitation, rather than temperature stress, plays the pivotal role in controlling the radial growth of Sabina przewalskii Kom. at the treeline in this region. This finding contradicts any generalisation that tree-ring chronologies from high-elevation treeline environments are mostly indicators of temperature changes.	[Qin, Chun; Yang, Bao] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China; [Melvin, Thomas M.; Briffa, Keith R.] Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Fan, Zexin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zhao, Yan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University of East Anglia; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yang, B (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China.	yangbao@lzb.ac.cn	Fan, Ze-Xin/ABG-7176-2020; Yang, Bao/O-1541-2013; Fan, Zexin/E-2344-2016; Qin, Chun/G-3720-2013; Zhao, Yan/B-1785-2014; Qin, Chun/F-9738-2018	Fan, Ze-Xin/0000-0003-4623-6783; Fan, Zexin/0000-0003-4623-6783; Qin, Chun/0000-0003-3115-2376; Zhao, Yan/0000-0003-1693-9795; Qin, Chun/0000-0003-3115-2376; Briffa, Keith/0000-0003-3323-3639	NSFC [41002050, 41071130]; Interdisciplinary Innovation Team project of the Chinese Academy of Sciences [29Y329B91]; NERC [NE/G018863/1]; K.C. Wong Education Foundation, Hong Kong; Natural Environment Research Council [NE/G018863/1] Funding Source: researchfish	NSFC(National Natural Science Foundation of China (NSFC)); Interdisciplinary Innovation Team project of the Chinese Academy of Sciences; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); K.C. Wong Education Foundation, Hong Kong; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was jointly funded by the NSFC (Grant No. 41002050, 41071130), and Interdisciplinary Innovation Team project of the Chinese Academy of Sciences (29Y329B91). KRB and TMM acknowledge support from NERC (NE/G018863/1). Bao Yang gratefully acknowledges the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, TIME SERIES ANAL APP; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F, 2001, AMBIO, V30, P162, DOI 10.1639/0044-7447(2001)030[0162:AYTRCF]2.0.CO;2; Biondi F, 2002, PAGES NEWS, V10, P1; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Carrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022813; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER., 1991, METHODS DENDROCHRONO; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Esper J, 2003, TREE-RING RES, V59, P81; Esper J, 2008, FOREST ECOL MANAG, V255, P3783, DOI 10.1016/j.foreco.2008.03.015; Esper J, 2007, TREES-STRUCT FUNCT, V21, P141, DOI 10.1007/s00468-006-0104-0; Fang KY, 2009, TREES-STRUCT FUNCT, V23, P1321, DOI 10.1007/s00468-009-0373-5; Fritts H. C., 1969, Tree-Ring Bulletin, V29, P15; Fritts H. C., 1976, TREE RINGS CLIMATE; Gou XH, 2012, DENDROCHRONOLOGIA, V30, P121, DOI 10.1016/j.dendro.2011.05.002; He MH, 2013, TREES-STRUCT FUNCT, V27, P429, DOI 10.1007/s00468-012-0813-5; Hughes MK, 2003, CLIMATIC CHANGE, V59, P233, DOI 10.1023/A:1024464909332; Kang SY, 2013, QUATERN INT, V283, P85, DOI 10.1016/j.quaint.2012.03.011; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; LaMarche V. C. Jr., 1974, Tree-ring Bulletin, V34, P1; LAMARCHE VC, 1974, SCIENCE, V183, P1043, DOI 10.1126/science.183.4129.1043; Li ZS, 2012, TREES-STRUCT FUNCT, V26, P1373, DOI 10.1007/s00468-012-0712-9; Liang EY, 2006, FOREST ECOL MANAG, V236, P268, DOI 10.1016/j.foreco.2006.09.016; Liang EY, 2010, TREES-STRUCT FUNCT, V24, P363, DOI 10.1007/s00468-009-0406-0; Morales MS, 2004, ECOLOGY, V85, P3080, DOI 10.1890/04-0139; Peng JF, 2008, DENDROCHRONOLOGIA, V26, P87, DOI 10.1016/j.dendro.2007.10.003; Qin C, 2011, GLOBAL PLANET CHANGE, V75, P143, DOI 10.1016/j.gloplacha.2010.10.013; Qin C, 2010, GLOBAL PLANET CHANGE, V72, P192, DOI 10.1016/j.gloplacha.2010.04.005; Rinn F, 2003, TSAP WIN TIME SERIES; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Splechtna BE, 2000, ANN FOREST SCI, V57, P89; Stoker Michael, 1996, V70, P1; WANG T, 2005, TREES-STRUCT FUNCT, V19, P735, DOI DOI 10.1007/s00468-005-0003-9; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069065; Yang B, 2012, HOLOCENE, V22, P773, DOI 10.1177/0959683611430411; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang B, 2010, HOLOCENE, V20, P1235, DOI 10.1177/0959683610371997; Zhang YX, 2011, DENDROCHRONOLOGIA, V29, P185, DOI 10.1016/j.dendro.2010.11.001; Zhang YX, 2011, CHINESE SCI BULL, V56, P1518, DOI 10.1007/s11434-011-4456-5; Zheng Yong-hong, 2009, Yingyong Shengtai Xuebao, V20, P507; Zhu HF, 2008, CHINESE SCI BULL, V53, P3914, DOI 10.1007/s11434-008-0400-8	46	22	25	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79362	10.1371/journal.pone.0079362	http://dx.doi.org/10.1371/journal.pone.0079362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244488	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327143800065
J	Carpenter, RL; Han, W; Paw, I; Lo, HW				Carpenter, Richard L.; Han, Woody; Paw, Ivy; Lo, Hui-Wen			HER2 Phosphorylates and Destabilizes Pro-Apoptotic PUMA, Leading to Antagonized Apoptosis in Cancer Cells	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; BCL-X-L; SURVIVAL SIGNALS; COLON-CANCER; P53; EXPRESSION; GENE; ONCOGENE; DEATH; IDENTIFICATION	HER2 is overexpressed in 15-20% of breast cancers. HER2 overexpression is known to reduce apoptosis but the underlying mechanisms for this association remain unclear. To elucidate the mechanisms for HER2-mediated survival, we investigated the relationship between HER2 and p53 upregulated modulator of apoptosis (PUMA), a potent apoptosis inducer. Our results showed that HER2 interacts with PUMA, which was independent of HER2 activation. In addition, we observed that HER2 interacted with PUMA in both mitochondrial and non-mitochondrial compartments. We next examined whether HER2 phosphorylates PUMA. Notably, PUMA tyrosine phosphorylation has never been reported. Using an intracellular assay, we found PUMA to be phosphorylated in breast cancer cells with activated HER2. Via cell-free HER2 kinase assay, we observed that PUMA was directly phosphorylated by HER2. Activation of HER2 decreased PUMA protein half-life. To identify which of the three tyrosines within PUMA are targeted by HER2, we generated three PUMA non-phosphorylation mutants each with a single Tyr -> Phe substitution. Results indicated that each PUMA single mutant had lost some, but not all phosphorylation by HER2 indicating that HER2 targets all three tyrosines. Consequently, we created an additional PUMA mutant with all three tyrosines mutated (TM-PUMA) that could not be phosphorylated by HER2. Importantly, TM-PUMA was found to have a longer half-life than PUMA. An inverse association was observed between HER2 and PUMA in 93 invasive breast carcinoma samples. We further found that TM-PUMA suppressed growth of breast cancer cells to a greater degree than PUMA. Also, TM-PUMA had a stronger propensity to induce apoptosis than PUMA. Together, our results demonstrate, for the first time, that PUMA can be tyrosine phosphorylated and that HER2-mediated phosphorylation destabilizes PUMA protein. The HER2-PUMA interplay represents a novel mechanism by which PUMA is regulated and a new molecular basis for HER2-mediated growth and survival of cancer cells.	[Carpenter, Richard L.; Han, Woody; Paw, Ivy; Lo, Hui-Wen] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Lo, Hui-Wen] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA; [Lo, Hui-Wen] Duke Univ, Sch Med, Duke Ctr RNA Biol, Durham, NC USA	Duke University; Duke University; Duke University	Lo, HW (corresponding author), Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA.	huiwen.lo@duke.edu		Carpenter, Richard/0000-0001-9986-6493	National Institutes of Health [K01-CA118423]; United States Department of Defense [W81XWH-11-1-0600]; Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences; NATIONAL CANCER INSTITUTE [K01CA118423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant K01-CA118423, and W81XWH-11-1-0600 from the United States Department of Defense, the Pediatric Brain Tumor Foundation, the Beez Foundation and the Intramural Division of Surgical Sciences Dani P. Bolognesi, Ph.D. Award and Clarence Gardner, Ph.D. Award (to H-WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Cao XY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-26; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Faris M, 1998, J IMMUNOL, V160, P134; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Hoque MO, 2003, CANCER LETT, V199, P75, DOI 10.1016/S0304-3835(03)00344-6; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kumar R, 1996, CLIN CANCER RES, V2, P1215; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Liu YJ, 2009, MOL THER, V17, P1509, DOI 10.1038/mt.2009.43; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Middelburg R, 2005, CLIN CANCER RES, V11, P1863, DOI 10.1158/1078-0432.CCR-04-1372; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Roberts CG, 2011, ONCOGENE, V30, P3186, DOI 10.1038/onc.2011.36; Sandow JJ, 2012, CELL DEATH DIFFER, V19, P633, DOI 10.1038/cdd.2011.131; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Siziopikou KP, 2005, APPL IMMUNOHISTO M M, V13, P14, DOI 10.1097/00129039-200503000-00003; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Society A.C., 2013, CANC FACTS FIG 2013; Tuna M, 2005, ONCOGENE, V24, P1648, DOI 10.1038/sj.onc.1208345; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Wang R, 2009, BREAST CANCER RES TR, V117, P45, DOI 10.1007/s10549-008-0163-6; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yee KS, 2008, APOPTOSIS, V13, P87, DOI 10.1007/s10495-007-0140-2; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78836	10.1371/journal.pone.0078836	http://dx.doi.org/10.1371/journal.pone.0078836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236056	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700053
J	Cuomo, O; Rispoli, V; Leo, A; Politi, GB; Vinciguerra, A; di Renzo, G; Cataldi, M				Cuomo, Ornella; Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro			The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							LONG-TERM TREATMENT; SPREADING DEPRESSION; CALCIUM-CHANNELS; UCB L059; RELEASE; MODEL; EPILEPSY; DEPOLARIZATION; ETHOSUXIMIDE; INHIBITION	The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, cerebral hemorrhage and neurotrauma. In these conditions, non-convulsive seizures (NCSs) propagate from the core of the focal lesion into perilesional tissue, enlarging the damaged area and promoting epileptogenesis. Here, we explore whether Lev neuroprotective effect is accompanied by changes in NCS generation or propagation. In particular, we performed continuous EEG recordings before and after the permanent occlusion of the middle cerebral artery (pMCAO) in rats that received Lev (100 mg/kg) or its vehicle immediately before surgery. Both in Lev-treated and in control rats, EEG activity was suppressed after pMCAO. In control but not in Lev-treated rats, EEG activity reappeared approximately 30-45 min after pMCAO. It initially consisted in single spikes and, then, evolved into spike-and-wave and polyspike-and-wave discharges. In Lev-treated rats, only rare spike events were observed and the EEG power was significantly smaller than in controls. Approximately 24 hours after pMCAO, EEG activity increased in Lev-treated rats because of the appearance of polyspike events whose power was, however, significantly smaller than in controls. In rats sacrificed 24 hours after pMCAO, the ischemic lesion was approximately 50% smaller in Lev-treated than in control rats. A similar neuroprotection was observed in rats sacrificed 72 hours after pMCAO. In conclusion, in rats subjected to pMCAO, a single Lev injection suppresses NCS occurrence for at least 24 hours. This electrophysiological effect could explain the long lasting reduction of ischemic brain damage caused by this drug.	[Cuomo, Ornella; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy; [Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	University of Naples Federico II; Magna Graecia University of Catanzaro	Cataldi, M (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy.	cataldi@unina.it	Cataldi, Mauro/AAB-3642-2019; Leo, Antonio/AAC-4052-2020; Di Renzo, Gian C./P-3819-2017; Vinciguerra, Antonio/AAA-8094-2019	Cataldi, Mauro/0000-0001-7787-3406; Leo, Antonio/0000-0002-0061-1608; Di Renzo, Gian C./0000-0003-4467-240X; Vinciguerra, Antonio/0000-0003-0746-4935; CUOMO, ORNELLA/0000-0002-6459-2530	UCB Pharma; Ricerca Finalizzata [RF-FSL-352059]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [PON_01602, 20089BARSR_002]; European Community; European Social Fund; Regione Calabria	UCB Pharma(UCB Pharma SA); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale; European Community(European Commission); European Social Fund(European Social Fund (ESF)); Regione Calabria(Regione Calabria)	The present study was partially supported by a research grant by UCB Pharma. The funding company did not have any role in designing, performing or analyzing the data but approved both the initial protocol and the final manuscript. This economical support does not alter our adherence to all the PLOS ONE policies on sharing data and materials. Additional support was received from the following grants: Ricerca Finalizzata 2009 [Grant RF-FSL-352059], and Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [Grants PON_01602 and 20089BARSR_002]. A. L. is recipient of a Ph.D. fellowship grant from the European Community, the European Social Fund and the Regione Calabria.	Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Cataldi M, 2005, J PHARMACOL EXP THER, V313, P720, DOI 10.1124/jpet.104.079327; Cataldi M, 2013, CURR NEUROPHARMACOL, V11, P276, DOI 10.2174/1570159X11311030004; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Clark WM, 1997, NEUROL RES, V19, P641; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Crepeau AZ, 2010, EXPERT REV NEUROTHER, V10, P159, DOI [10.1586/ern.10.5, 10.1586/ERN.10.3]; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Cuomo O, 2007, STROKE, V38, P3272, DOI 10.1161/STROKEAHA.107.488486; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Fukuyama K, 2012, NEUROSCI LETT, V518, P69, DOI 10.1016/j.neulet.2012.03.056; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lukyanetz EA, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.2002.24501.x; Lynch BA, 2003, P NATL ACAD SCI USA, V26, P9861; Margineanu DG, 2009, SEIZURE-EUR J EPILEP, V18, P453, DOI 10.1016/j.seizure.2009.01.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Nagarkatti N, 2008, NEUROSCI LETT, V436, P289, DOI 10.1016/j.neulet.2008.02.076; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Pignataro G, 2012, NEUROBIOL DIS, V45, P616, DOI 10.1016/j.nbd.2011.10.007; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Stratton SC, 2003, EPILEPSY RES, V53, P95, DOI 10.1016/S0920-1211(02)00254-1; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80852	10.1371/journal.pone.0080852	http://dx.doi.org/10.1371/journal.pone.0080852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236205	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700208
J	Guo, SQ; Cui, YL; He, LS; Zhang, L; Cao, Z; Zhang, W; Zhang, R; Tan, GY; Wang, BM; Cui, LW				Guo, Suqin; Cui, Yongliang; He, Lishan; Zhang, Liang; Cao, Zhen; Zhang, Wei; Zhang, Rui; Tan, Guiyu; Wang, Baomin; Cui, Liwang			Development of a Specific Monoclonal Antibody-Based ELISA to Measure the Artemether Content of Antimalarial Drugs	PLOS ONE			English	Article							MICROBIAL TRANSFORMATION; ARTEMISININ; MALARIA; ACID	Artemether is one of the artemisinin derivatives that are active ingredients in antimalarial drugs. Counterfeit and substandard antimalarial drugs have become a serious problem, which demands reliable analytical tools and implementation of strict regulation of drug quality. Structural similarity among artemisinin analogs is a challenge to develop immunoassays that are specific to artemisinin derivatives. To produce specific antibodies to artemether, we used microbial fermentation of artemether to obtain 9-hydroxyartemether, which was subsequently used to prepare a 9-O-succinylartemether hapten for conjugation with ovalbumin as the immunogen. A monoclonal antibody (mAb), designated as 2G12E1, was produced with high specificity to artemether. 2G12E1 showed low cross reactivities to dihydroartemisinin, artemisinin, artesunate and other major antimalarial drugs. An indirect competitive enzyme linked immunosorbent assay (icELISA) developed showed a concentration causing 50% of inhibition for artemether as 3.7 ng mL(-1) and a working range of 0.7-19 ng mL(-1). The icELISA was applied for determination of artemether content in different commercial drugs and the results were comparable to those determined by high-performance liquid chromatography analysis. In comparison with reported broad cross activity of anti-artemisinin mAbs, the most notable advantage of the 2G12E1-based ELISA is its high specificity to artemether only.	[Guo, Suqin; Cui, Yongliang; He, Lishan; Zhang, Liang; Cao, Zhen; Zhang, Wei; Zhang, Rui; Tan, Guiyu; Wang, Baomin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	China Agricultural University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, BM (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	wbaomin@263.net; luc2@psu.edu		Cao, Zhen/0000-0003-1259-6107	United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health [U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health (U19AI089672). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourashed EA, 1996, J NAT PROD, V59, P251, DOI 10.1021/np960060b; [Anonymous], 1986, CHIN J PHARM ANAL; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Diawara HZ, 2011, J PHARMACEUT BIOMED, V56, P7, DOI 10.1016/j.jpba.2011.04.012; Duthaler U, 2011, J MASS SPECTROM, V46, P172, DOI 10.1002/jms.1883; Eggelte TA, 1999, AM J TROP MED HYG, V61, P449, DOI 10.4269/ajtmh.1999.61.449; Ferreira JFS, 1996, PHYTOCHEMISTRY, V41, P97, DOI 10.1016/0031-9422(95)00542-0; He SP, 2009, ANAL BIOANAL CHEM, V393, P1297, DOI 10.1007/s00216-008-2527-5; HUFFORD CD, 1995, J NAT PRODUCTS, V58, P751, DOI 10.1021/np50119a016; Ioset JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007270; JAZIRI M, 1993, PHYTOCHEMISTRY, V33, P821, DOI 10.1016/0031-9422(93)85282-V; Kokwaro G, 2007, EXPERT OPIN PHARMACO, V8, P75, DOI 10.1517/14656566.8.1.75; Lamalle Caroline, 2012, Electrophoresis, V33, P1669, DOI 10.1002/elps.201100621; Mohamed SS, 1999, J CHROMATOGR B, V731, P251, DOI 10.1016/S0378-4347(99)00232-7; PERATA P, 1990, J PLANT GROWTH REGUL, V9, P1, DOI 10.1007/BF02041934; Song Z-Y, 1985, ACTA PHARMACOL SIN, V20, P610; Tanaka H, 2007, PLANTA MED, V73, P1127, DOI 10.1055/s-2007-981560; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhang Y, 1982, ACTA PHARMACOL SIN, V3, P9; Zhang Y, 2011, J CRYST GROWTH, V314, P185, DOI 10.1016/j.jcrysgro.2010.10.165; Zhao J, 2006, ANAL BIOANAL CHEM, V386, P1735, DOI 10.1007/s00216-006-0780-z	21	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79154	10.1371/journal.pone.0079154	http://dx.doi.org/10.1371/journal.pone.0079154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236102	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700100
J	Kingma, JG; Simard, D; Voisine, P; Rouleau, JR				Kingma, John G.; Simard, Denys; Voisine, Pierre; Rouleau, Jacques R.			Influence of Cardiac Decentralization on Cardioprotection	PLOS ONE			English	Article							CORONARY ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-PERFUSION RESERVE; ISCHEMIC-HEART-DISEASE; NEURONAL-ACTIVITY; INFARCT SIZE; BLOOD-FLOW; SYMPATHETIC INNERVATION; ANESTHETIZED DOGS; COLLATERAL FLOW; CONSCIOUS DOG	The role of cardiac nerves on development of myocardial tissue injury after acute coronary occlusion remains controversial. We investigated whether acute cardiac decentralization (surgical) modulates coronary flow reserve and myocardial protection in preconditioned dogs subject to ischemia-reperfusion. Experiments were conducted on four groups of anesthetised, open-chest dogs (n = 32): 1-controls (CTR, intact cardiac nerves), 2-ischemic preconditioning (PC; 4 cycles of 5-min IR), 3-cardiac decentralization (CD) and 4-CD+ PC; all dogs underwent 60-min coronary occlusion and 180-min reperfusion. Coronary blood flow and reactive hyperemic responses were assessed using a blood volume flow probe. Infarct size (tetrazolium staining) was related to anatomic area at risk and coronary collateral blood flow (microspheres) in the anatomic area at risk. Post-ischemic reactive hyperemia and repayment-to-debt ratio responses were significantly reduced for all experimental groups; however, arterial perfusion pressure was not affected. Infarct size was reduced in CD dogs (18.6 +/- 4.3; p = 0.001, data are mean +/- SD) compared to 25.265.5% in CTR dogs and was less in PC dogs as expected (13.5 +/- 3.2 vs. 25.2 +/- 5.5%; p = 0.001); after acute CD, PC protection was conserved (11.6 +/- 3.4 vs. 18.6 +/- 4.3%; p = 0.02). In conclusion, our findings provide strong evidence that myocardial protection against ischemic injury can be preserved independent of extrinsic cardiac nerve inputs.	[Kingma, John G.; Rouleau, Jacques R.] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Simard, Denys] Inst Univ Cardiol & Pneumol Quebec, Res Ctr, Quebec City, PQ, Canada; [Voisine, Pierre] Univ Laval, Dept Chirurg, Quebec City, PQ, Canada	Laval University; Laval University	Kingma, JG (corresponding author), Univ Laval, Dept Med, Pavillon Ferdinand Vandry,1050 Ave Med, Quebec City, PQ G1K 7P4, Canada.	john.kingma@fmed.ulaval.ca						Ardell JL, 2009, AM J PHYSIOL-REG I, V297, pR470, DOI 10.1152/ajpregu.90821.2008; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Armour JA, 1998, AM J PHYSIOL-REG I, V274, pR939, DOI 10.1152/ajpregu.1998.274.4.R939; ARMOUR JA, 1986, CAN J PHYSIOL PHARM, V64, P1038, DOI 10.1139/y86-177; ARMOUR JA, 1991, REFLEX CONTROL CIRCU, P1; Arora, 2000, Curr Interv Cardiol Rep, V2, P188; BARBER MJ, 1983, CIRCULATION, V67, P787, DOI 10.1161/01.CIR.67.4.787; Bulow HP, 2003, NUCL MED COMMUN, V24, P233, DOI 10.1097/01.mnm.0000061044.24401.6d; Canty JM, 2003, CIRC RES, V93, P796, DOI 10.1161/01.RES.0000100845.27406.FB; Cardinal R, 2009, AUTON NEUROSCI-BASIC, V145, P55, DOI 10.1016/j.autneu.2008.11.007; DAE MW, 1991, J AM COLL CARDIOL, V17, P1416, DOI 10.1016/S0735-1097(10)80156-1; Juarez-Orozco LE, 2013, EUR J NUCL MED MOL I, V40, P1148, DOI 10.1007/s00259-013-2394-y; Fallavollita JA, 2010, J NUCL CARDIOL, V17, P1107, DOI 10.1007/s12350-010-9292-5; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Huang CH, 2003, CIRC RES, V93, P866, DOI 10.1161/01.RES.0000097762.64561.D2; HUANG MH, 1993, AM J PHYSIOL, V265, pR659, DOI 10.1152/ajpregu.1993.265.3.R659; HUANG MH, 1994, CARDIOVASC RES, V28, P636, DOI 10.1093/cvr/28.5.636; Huang Ming-He, 1993, Integrative Physiological and Behavioral Science, V28, P5, DOI 10.1007/BF02691196; JONES CE, 1978, AM HEART J, V95, P738, DOI 10.1016/0002-8703(78)90504-5; JONES CE, 1978, AM J PHYSIOL, V235, pH429, DOI 10.1152/ajpheart.1978.235.4.H429; JUGDUTT BI, 1979, CIRCULATION, V60, P1141, DOI 10.1161/01.CIR.60.5.1141; Kaeffer N, 1996, AM J PHYSIOL-HEART C, V271, pH842, DOI 10.1152/ajpheart.1996.271.3.H842; Kember G, 2013, PHYSIOL GENOMICS, V45, P638, DOI 10.1152/physiolgenomics.00027.2013; Kingma JG, 2005, J THROMB THROMBOLYS, V19, P201, DOI 10.1007/s11239-005-1201-4; Kingma JG, 2011, CARDIOVASC RES, V89, P384, DOI 10.1093/cvr/cvq306; Kudej RK, 2006, CIRC RES, V99, P1270, DOI 10.1161/01.RES.0000251282.79411.44; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; LAVALLEE M, 1985, CIRC RES, V57, P383, DOI 10.1161/01.RES.57.3.383; Mentzer RM, 1999, ANN SURG, V229, P643, DOI 10.1097/00000658-199905000-00006; MIURA T, 1989, JPN HEART J, V30, P695; Murphy DA, 2000, ANN THORAC SURG, V69, P1769, DOI 10.1016/S0003-4975(00)01240-6; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLSSON RA, 1975, CIRC RES, V37, P263, DOI 10.1161/01.RES.37.3.263; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V283, pH1099, DOI 10.1152/ajpheart.00270.2002; Reffelmann T, 2002, AM J PHYSL HEART CIR; REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; RICHARD V, 1994, CIRCULATION, V89, P1254, DOI 10.1161/01.CIR.89.3.1254; Rouleau JR, 2002, AUTON NEUROSCI-BASIC, V97, P12, DOI 10.1016/S1566-0702(02)00002-4; Shen YT, 2000, ARTERIOSCL THROM VAS, V20, P2309, DOI 10.1161/01.ATV.20.10.2309; Smith FM, 2001, AM J PHYSIOL-HEART C, V281, pH1919, DOI 10.1152/ajpheart.2001.281.5.H1919; Tio RA, 2009, J NUCL MED, V50, P214, DOI 10.2967/jnumed.108.054395	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79190	10.1371/journal.pone.0079190	http://dx.doi.org/10.1371/journal.pone.0079190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236106	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700104
J	Luo, XY; Gao, ZH; Shi, T; Cheng, ZM; Zhang, Z; Ni, ZJ				Luo, Xiaoyan; Gao, Zhihong; Shi, Ting; Cheng, Zongming; Zhang, Zhen; Ni, Zhaojun			Identification of miRNAs and Their Target Genes in Peach (Prunus persica L.) Using High-Throughput Sequencing and Degradome Analysis	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; SMALL RNAS; REGULATED MICRORNAS; PARALLEL ANALYSIS; SIRNA BIOGENESIS; PLANT MICRORNAS; ARABIDOPSIS; EXPRESSION; PREDICTION; POPULUS	MicroRNAs play critical roles in various biological and metabolic processes. The function of miRNAs has been widely studied in model plants such as Arabidopsis and rice. However, the number of identified miRNAs and related miRNA targets in peach (Prunus persica) is limited. To understand further the relationship between miRNAs and their target genes during tissue development in peach, a small RNA library and three degradome libraries were constructed from three tissues for deep sequencing. We identified 117 conserved miRNAs and 186 novel miRNA candidates in peach by deep sequencing and 19 conserved miRNAs and 13 novel miRNAs were further evaluated for their expression by RT-qPCR. The number of gene targets that were identified for 26 conserved miRNA families and 38 novel miRNA candidates, were 172 and 87, respectively. Some of the identified miRNA targets were abundantly represented as conserved miRNA targets in plant. However, some of them were first identified and showed important roles in peach development. Our study provides information concerning the regulatory network of miRNAs in peach and advances our understanding of miRNA functions during tissue development.	[Luo, Xiaoyan; Gao, Zhihong; Shi, Ting; Cheng, Zongming; Zhang, Zhen; Ni, Zhaojun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, ZH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	gaozhihong@njau.edu.cn		Shi, Ting/0000-0002-0955-016X	National Science Foundation of China [31101526]; project of 948; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of 948; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors gratefully acknowledge the National Science Foundation of China (31101526) and the project of 948 and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for funding part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gao ZH, 2012, MOL CELLS, V34, P239, DOI 10.1007/s10059-012-0004-7; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lenz Dorina, 2011, BMC Res Notes, V4, P483, DOI 10.1186/1756-0500-4-483; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Naqvi AR, 2012, J CELL PHYSIOL, V227, P3163, DOI 10.1002/jcp.24052; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pantaleo V, 2010, PLANT J; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang XW, 2010, MOL BIOTECHNOL, V44, P61, DOI 10.1007/s12033-009-9204-6; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang YP, 2012, MOL BIOL REP, V39, P1975, DOI 10.1007/s11033-011-0944-6; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu JK, 2008, P NATL ACAD SCI USA, V105, P9851, DOI 10.1073/pnas.0805207105; Zhu JK, 2008, CLONING CHARACTERIZA; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	24	27	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79090	10.1371/journal.pone.0079090	http://dx.doi.org/10.1371/journal.pone.0079090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236092	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700090
J	Maier, LJ; Liechti, ME; Herzig, F; Schaub, MP				Maier, Larissa J.; Liechti, Matthias E.; Herzig, Fiona; Schaub, Michael P.			To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students	PLOS ONE			English	Article							COLLEGE-STUDENTS; NONMEDICAL USE; PHARMACOLOGICAL NEUROENHANCEMENT; COGNITIVE ENHANCEMENT; ADHD MEDICATIONS; ILLICIT USE; STIMULANTS; HEALTHY; PREVALENCE; METHYLPHENIDATE	Background: Neuroenhancement is the use of substances by healthy subjects to enhance mood or cognitive function. The prevalence of neuroenhancement among Swiss university students is unknown. Investigating the prevalence of neuroenhancement among students is important to monitor problematic use and evaluate the necessity of prevention programs. Study aim: To describe the prevalence of the use of prescription medications and drugs of abuse for neuroenhancement among Swiss university students. Method: In this cross-sectional study, students at the University of Zurich, University of Basel, and Swiss Federal Institute of Technology Zurich were invited via e-mail to participate in an online survey. Results: A total of 28,118 students were contacted, and 6,275 students completed the survey. Across all of the institutions, 13.8% of the respondents indicated that they had used prescription drugs (7.6%) or drugs of abuse including alcohol (7.8%) at least once specifically for neuroenhancement. The most frequently used prescription drugs for neuroenhancement were methylphenidate (4.1%), sedatives (2.7%), and beta-blockers (1.2%). Alcohol was used for this purpose by 5.6% of the participants, followed by cannabis (2.5%), amphetamines (0.4%), and cocaine (0.2%). Arguments for neuroenhancement included increased learning (66.2%), relaxation or sleep improvement (51.2%), reduced nervousness (39.1%), coping with performance pressure (34.9%), increased performance (32.2%), and experimentation (20%). Neuroenhancement was significantly more prevalent among more senior students, students who reported higher levels of stress, and students who had previously used illicit drugs. Although "soft enhancers", including coffee, energy drinks, vitamins, and tonics, were used daily in the month prior to an exam, prescription drugs or drugs of abuse were used much less frequently. Conclusions: A significant proportion of Swiss university students across most academic disciplines reported neuroenhancement with prescription drugs and drugs of abuse. However, these substances are rarely used on a daily basis and more sporadically used prior to exams.	[Maier, Larissa J.; Schaub, Michael P.] Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland; [Maier, Larissa J.; Schaub, Michael P.] WHO Collaborating Ctr, Zurich, Switzerland; [Liechti, Matthias E.] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Dept Biomed, CH-4031 Basel, Switzerland; [Liechti, Matthias E.] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Liechti, Matthias E.] Univ Basel, Basel, Switzerland; [Herzig, Fiona] Univ Zurich, Div Psychopathol & Clin Intervent, Zurich, Switzerland	University of Zurich; World Health Organization; University of Basel; University of Basel; University of Basel; University of Zurich	Maier, LJ (corresponding author), Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland.	larissa.maier@isgf.uzh.ch	Maier, Larissa/P-8669-2014; Schaub, Michael P./ABF-9468-2021; Maier, Larissa J/C-2922-2017	Maier, Larissa/0000-0002-4302-0488; Schaub, Michael P./0000-0002-8375-4005; Maier, Larissa J/0000-0002-4302-0488				Arria AM, 2008, PHARMACOTHERAPY, V28, P156, DOI 10.1592/phco.28.2.156; Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Bell S, 2013, NEUROETHICS-NETH, V6, P197, DOI 10.1007/s12152-012-9153-9; BRUGGISSER M, 2012, SCHWEIZ RUNDSCH MED, V101, P299; Bruggisser M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13267; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; Eckhardt A, 2011, HUMAN ENHANCEMENT, DOI [10.3218/3404-2., DOI 10.3218/3404-2]; Eickenhorst P, 2012, J PSYCHOACTIVE DRUGS, V44, P418, DOI 10.1080/02791072.2012.736845; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Forstl H, 2009, NERVENARZT, V80, P840, DOI 10.1007/s00115-009-2801-6; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Franke AG, 2012, PSYCHIAT PRAX, V39, P174, DOI 10.1055/s-0031-1298900; Gmel G., 2012, SUCHTMONITORING SCHW; Grebner S, 2010, STRESS BEI SCHWEIZER; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hildt E, 2011, NERVENHEILKUNDE, V30, P833; Ilieva I, 2013, NEUROPHARMACOLOGY, V64, P496, DOI 10.1016/j.neuropharm.2012.07.021; Kaloyanides KB, 2007, PHARMACOTHERAPY, V27, P666, DOI 10.1592/phco.27.5.666; Kordt M, 2009, DAK GESUNDHEITSREPOR; Kuhne R., 2011, SCHWEIZERISCHE ARZTE, V92, P1295; Mache S, 2012, WIEN MED WOCHENSCHR, V162, P262, DOI [10.1007/s10354-012-0115-y, 10.1007/s10354-012-0144-6]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Normann C, 2008, EUR ARCH PSY CLIN N, V258, P110, DOI 10.1007/s00406-008-5022-2; Novak SP, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-32; Ott R, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13707; Partridge B, 2013, DRUG ALCOHOL REV, V32, P295, DOI 10.1111/dar.12005; Quednow B.B, 2010, SUCHTMAGAZIN, V36, P19; Quednow BB, 2010, BIOSOCIETIES, V5, P153, DOI 10.1057/biosoc.2009.13; Repantis D, 2011, PSYCHOPHARMAKOLOGISC; Repantis D, 2009, VERBESSERUNG MENSCHE, P63; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sucht Schweiz, 2012, DOP ALLT; Sussman S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-15; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Wulf MA, 2012, ETHIK MED, V24, P29, DOI 10.1007/s00481-011-0137-9	43	116	120	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77967	10.1371/journal.pone.0077967	http://dx.doi.org/10.1371/journal.pone.0077967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236008	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327254700005
J	Nakano, S; Morizane, Y; Makisaka, N; Suzuki, T; Togawa, T; Tsukimura, T; Kawashima, I; Sakuraba, H; Shibasaki, F				Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko; Suzuki, Toshihiro; Togawa, Tadayasu; Tsukimura, Takahiro; Kawashima, Ikuo; Sakuraba, Hitoshi; Shibasaki, Futoshi			Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of alpha-Galactosidase A Protein Levels in Serum and Plasma	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; POLYMERASE-CHAIN-REACTION; FABRY-DISEASE; ANTIBODY-FORMATION; ANTIGEN-DETECTION; AGALSIDASE-ALPHA; GENE; MUTATIONS; AMPLIFICATION; EXPRESSION	Fabry disease is an X-linked genetic disorder caused by defects in the a-galactosidase A (GLA) gene, and heterogeneous mutations lead to quantitative and/or qualitative defects in GLA protein in male patients with Fabry disease. Random X-chromosomal inactivation modifies the clinical and biochemical features of female patients with Fabry disease. Functional polymorphisms have been frequently reported in recent times, and these increase the difficulty of understanding the pathogenetic basis of the disease. To date, GLA protein level has been measured using an enzyme-linked immunosorbent assay (ELISA). However, ELISA is not highly sensitive due to the high background noise. In this paper, we introduce a novel application of the immuno-polymerase chain reaction (PCR) method (termed Multiple Simultaneous Tag [MUSTag]) for measurement of the GLA protein level in blood samples. We compared the sensitivities of the MUSTag method with plates or magnetic beads with those of ELISA for recombinant human GLA and found that the apparent maximal sensitivity was higher for the former than for the latter. We then measured the GLA concentrations in serum and plasma from male patients with classic Fabry disease (Male Fabry), females with Fabry disease (Female Fabry), male subjects harboring the functional polymorphism p. E66Q (E66Q), and control (Control) subjects. Our results revealed that compared to the MUSTag plate and ELISA, the MUSTag beads assay afforded a clearer estimation of the GLA protein levels in the serum and plasma with minimal or no background noise, although all the methods could differentiate between the Male Fabry, E66Q, and Control groups. The Female Fabry group showed characteristic heterogeneity, which was consistent with the X-linked inheritance. This novel method is expected to be useful for the sensitive determination of GLA level in blood and elucidation of the pathogenetic basis of Fabry disease.	[Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko; Kawashima, Ikuo; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Tokyo 113, Japan; [Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko] Synthera Technol Co Ltd, Tokyo, Japan; [Suzuki, Toshihiro; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan; [Togawa, Tadayasu; Tsukimura, Takahiro] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Meiji Pharmaceutical University; Meiji Pharmaceutical University; Meiji Pharmaceutical University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion [09-15]; Japan Society for the Promotion of Science (JSPS ID) [23659527]; Special Foundation of Tokyo Metropolitan Government;  [07831860];  [09811230];  [10868930];  [11930174]	Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS ID); Special Foundation of Tokyo Metropolitan Government; ; ; ; 	This work was supported by the Program for Research on Intractable Diseases of Health and Labor Science Research (HS); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion (ID: 09-15, HS); the Japan Society for the Promotion of Science (JSPS ID: 23659527, HS); the Grant-in-Aid for Exploratory Research (ID: 07831860, 09811230, 10868930, 11930174, FS); and a Special Foundation of Tokyo Metropolitan Government (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2003, BIOCHEM BIOPH RES CO, V308, P240, DOI 10.1016/S0006-291X(03)01364-0; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; Chen L, 2010, CIRCULATION, V122, P910, DOI 10.1161/CIRCULATIONAHA.109.931931; Deegan PB, 2012, J INHERIT METAB DIS, V35, P227, DOI 10.1007/s10545-011-9400-y; Desnick R, 2001, ALPHA GALACTOSIDASE; Doi K, 2012, J HUM GENET, V57, P575, DOI 10.1038/jhg.2012.68; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fervenza FC, 2008, BIOL-TARGETS THER, V2, P823; Fuller M, 2004, CLIN CHEM, V50, P1979, DOI 10.1373/clinchem.2004.037937; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; ISHII S, 1994, BBA-PROTEIN STRUCT M, V1204, P265, DOI 10.1016/0167-4838(94)90017-5; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim NH, 2010, BIOCHEM BIOPH RES CO, V391, P1500, DOI 10.1016/j.bbrc.2009.12.101; Kitagawa T, 2008, PEDIATR NEPHROL, V23, P1461, DOI 10.1007/s00467-008-0846-6; Lee BH, 2010, J HUM GENET, V55, P512, DOI 10.1038/jhg.2010.58; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Niemeyer CM, 2005, TRENDS BIOTECHNOL, V23, P208, DOI 10.1016/j.tibtech.2005.02.006; Niemeyer CM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng090; Ohashi T, 2008, MOL GENET METAB, V94, P313, DOI 10.1016/j.ymgme.2008.03.008; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; OKUMIYA T, 1995, HUM GENET, V95, P557; Rombach SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047805; RUZICKA V, 1993, SCIENCE, V260, P698, DOI 10.1126/science.8480182; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Sims PW, 2000, ANAL BIOCHEM, V281, P230, DOI 10.1006/abio.2000.4578; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Togawa T, 2012, MOL GENET METAB, V105, P615, DOI 10.1016/j.ymgme.2012.01.010; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275; ZHOU H, 1993, NUCLEIC ACIDS RES, V21, P6038, DOI 10.1093/nar/21.25.6038	34	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78588	10.1371/journal.pone.0078588	http://dx.doi.org/10.1371/journal.pone.0078588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236025	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700022
J	Santos, KS; Stephano, MA; Marcelino, JR; Ferreira, VMR; Rocha, T; Caricati, C; Higashi, HG; Moro, AM; Kalil, JE; Malaspina, O; Castro, FFM; Palma, MS				Santos, Keity Souza; Stephano, Marco Antonio; Marcelino, Jose Roberto; Resende Ferreira, Virginia Maria; Rocha, Thalita; Caricati, Celso; Higashi, Hisako Gondo; Moro, Ana Maria; Kalil, Jorge Elias; Malaspina, Osmar; Morato Castro, Fabio Fernandes; Palma, Mario Sergio			Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees	PLOS ONE			English	Article							APIS-MELLIFERA VENOM; PHOSPHOLIPASE A(2); LETHALITY; MELITTIN	Victims of massive bee attacks become extremely ill, presenting symptoms ranging from dizziness and headache to acute renal failure and multiple organ failure that can lead to death. Previous attempts to develop specific antivenom to treat these victims have been unsuccessful. We herein report a F(ab)'(2)-based antivenom raised in horse as a potential new treatment for victims of multiple bee stings. The final product contains high specific IgG titers and is effective in neutralizing toxic effects, such as hemolysis, cytotoxicity and myotoxicity. The assessment of neutralization was revised and hemolysis, the primary toxic effect of these stings, was fully neutralized in vivo for the first time.	[Santos, Keity Souza; Resende Ferreira, Virginia Maria; Kalil, Jorge Elias; Morato Castro, Fabio Fernandes] Univ Sao Paulo, Sch Med, FMUSP, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Santos, Keity Souza; Resende Ferreira, Virginia Maria; Moro, Ana Maria; Kalil, Jorge Elias; Malaspina, Osmar; Morato Castro, Fabio Fernandes; Palma, Mario Sergio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Stephano, Marco Antonio] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Marcelino, Jose Roberto] Butantan Inst, Div Hyperimmune Plasmas, Sao Paulo, Brazil; [Rocha, Thalita] Univ Sao Francisco, Sch Med, BR-12900000 Braganca Paulista, SP, Brazil; [Caricati, Celso] Butantan Inst, Special Pilot Lab Res & Dev Vet Immunobiol, Sao Paulo, Brazil; [Higashi, Hisako Gondo] Inst Technol Parana, Curitiba, Parana, Brazil; [Moro, Ana Maria] Butantan Inst, Lab Biopharmaceut Anim Cells, Sao Paulo, Brazil; [Santos, Keity Souza; Kalil, Jorge Elias; Morato Castro, Fabio Fernandes] Univ Sao Paulo, Sch Med, Heart Inst InCor, LIM 19, Sao Paulo, Brazil; [Malaspina, Osmar; Palma, Mario Sergio] Univ Sao Paulo State UNESP, Ctr Study Social Insects, Inst Biosci, Dept Biol, Rio Claro, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Sao Francisco; Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Universidade Estadual Paulista	Palma, MS (corresponding author), Inst Invest Immunol INCT, Sao Paulo, Brazil.	mspalma@rc.unesp.br	Rocha, Thalita/T-6408-2019; Palma, Mario Sergio/E-7800-2012; Santos, Keity/M-9401-2015; Souza, Keity/AEX-0817-2022; Fapesp, Biota/F-8655-2017; Rocha, Thalita/I-4729-2014; Castro, Fabio FM/C-1082-2017; Palma, Mario/N-3903-2019; Moro, Ana Maria/A-5134-2012; Santos, Keity Souza/Q-5704-2019; Castro, Fabio/AAP-5433-2020; Stephano, Marco/H-3980-2013; Malaspina, Osmar/AAL-9167-2021; KALIL, JORGE/C-8029-2012	Rocha, Thalita/0000-0002-2731-9586; Palma, Mario Sergio/0000-0002-7363-8211; Souza, Keity/0000-0001-5271-4011; Fapesp, Biota/0000-0002-9887-8449; Rocha, Thalita/0000-0002-2731-9586; Castro, Fabio FM/0000-0002-6211-5773; Moro, Ana Maria/0000-0002-0650-7764; Santos, Keity Souza/0000-0001-5271-4011; Stephano, Marco/0000-0003-2927-0584; Malaspina, Osmar/0000-0002-1650-257X; KALIL, JORGE/0000-0001-8415-4274	FAPESP/BIOprospecTA [2011/51684-1]; CNPq (INCT-III); FINEP (CT-BIOTEC-Anticorpos -MCTFINEP); National Research Council of Brazil-CNPq; Butantan Institute; CAPES	FAPESP/BIOprospecTA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (INCT-III)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP (CT-BIOTEC-Anticorpos -MCTFINEP); National Research Council of Brazil-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Butantan Institute; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from FAPESP/BIOprospecTA (2011/51684-1), CNPq (INCT-iii) and FINEP (CT-BIOTEC-Anticorpos -MCTFINEP 01/2003). JEK, OM and MSP were awarded a research grant from the National Research Council of Brazil-CNPq. KSS was awarded PhD fellowship from Butantan Institute, and VMRF has a PhD student fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Christensen P. A., 1968, P437; COVELL DG, 1986, CANCER RES, V46, P3969; de Oliveira F A, 2000, Rev Soc Bras Med Trop, V33, P403, DOI 10.1590/S0037-86822000000400012; de Roodt Adolfo R, 2005, Gac Med Mex, V141, P215; Delori P, 1977, B I PASTEUR, V74, P6; Ewan PW, 1998, BRIT MED J, V316, P1442, DOI 10.1136/bmj.316.7142.1442; Ferreira RS, 2010, TOXICON, V56, P355, DOI 10.1016/j.toxicon.2010.03.023; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; FRANCA FOS, 1994, Q J MED, V87, P269; Ismail M, 1996, TOXICON, V34, P1011, DOI 10.1016/0041-0101(96)00055-4; Jones RGA, 1999, AM J TROP MED HYG, V61, P361, DOI 10.4269/ajtmh.1999.61.361; Kerr W.E., 1967, S AFR BEE J, V39, P3; Kolecki P, 1999, ANN EMERG MED, V33, P114, DOI 10.1016/S0196-0644(99)70428-2; Lee YJ, 2007, CHEM-BIOL INTERACT, V169, P189, DOI 10.1016/j.cbi.2007.06.036; Leon G, 1997, TOXICON, V35, P1627, DOI 10.1016/S0041-0101(97)00034-2; LONGROWE KO, 1994, TOXICON, V32, P165, DOI 10.1016/0041-0101(94)90105-8; MCKENNA WR, 1992, PEDIATR ASTHMA ALLER, V6, P275, DOI 10.1089/pai.1992.6.275; Mejia-Velez G, 2010, NEFROLOGIA, V30, P531, DOI 10.3265/Nefrologia.pre2010.May.10269; OCONNOR R, 1980, J CHEM EDUC, V57, P206, DOI 10.1021/ed057p206; Ownby CL, 1997, TOXICON, V35, P67, DOI 10.1016/S0041-0101(96)00078-5; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; Pope CG, 1939, BRIT J EXP PATHOL, V20, P132; Prado M, 2009, REV PANAM SALUD PUBL, V25, P389, DOI 10.1590/S1020-49892009000500002; Robertson ML, 1998, EMERGEN MED, V10, P5; Rocha T, 2007, TOXICON, V50, P589, DOI 10.1016/j.toxicon.2007.05.003; SCHUMACHER MJ, 1990, AM J TROP MED HYG, V43, P79, DOI 10.4269/ajtmh.1990.43.79; SCHUMACHER MJ, 1995, ARCH INTERN MED, V155, P2038, DOI 10.1001/archinte.155.19.2038; Schumacher MJ, 1996, AM J TROP MED HYG, V55, P197, DOI 10.4269/ajtmh.1996.55.197; Souza BM, 2005, PEPTIDES, V26, P2157, DOI 10.1016/j.peptides.2005.04.026; SPIVAK M, 1991, AFRICAN HONEYBEE; Winston M. L., 1992, KILLER BEES AFRICANI; WINSTON ML, 1994, Q J MED, V87, P263	32	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79971	10.1371/journal.pone.0079971	http://dx.doi.org/10.1371/journal.pone.0079971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236166	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700167
J	Grimaldi, A; Balestrieri, ML; D'Onofrio, N; Di Domenico, G; Nocera, C; Lamberti, M; Tonini, G; Zoccoli, A; Santini, D; Caraglia, M; Pantano, F				Grimaldi, Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Di Domenico, Gilda; Nocera, Cosimo; Lamberti, Monica; Tonini, Giuseppe; Zoccoli, Alice; Santini, Daniele; Caraglia, Michele; Pantano, Francesco			The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence	PLOS ONE			English	Article							PHASE-I TRIAL; PROGENITOR CELLS; TUMOR VASCULATURE; MAMMALIAN TARGET; MYELOID CELLS; GROWTH-FACTOR; CANCER; ANGIOGENESIS; MTOR; CHEMOTHERAPY	Endothelial Progenitor Cells (EPCs), a minor subpopulation of the mononuclear cell fraction in peripheral blood, play a critical role in cancer development as they contribute to angiogenesis-mediated pathological neovascularization. In response to tumor cytokines, including VEGF, EPCs mobilize from the bone marrow into the peripheral circulation and move to the tumor bed where they incorporate into sprouting neovessels. In the present study, we evaluated the effects of everolimus (Afinitor, Novartis), a rapamycin analogue, alone or in combination with chloroquine, a 4-alkylamino substituted quinoline family member, one of the autophagy inhibitors, on EPCs biological functions. We found that either everolimus or chloroquine induce growth inhibition on EPCs in a dose-dependent manner after 72 h from the beginning of incubation. The combined administration of the two drugs to EPC was synergistic in inducing growth inhibition; in details, the maximal pharmacological synergism between everolimus and chloroquine in inducing growth inhibition on EPCs cells was recorded when chloroquine was administered 24 h before everolimus. Moreover, we have studied the mechanisms of cell death induced by the two agents alone or in combination on EPCs and we have found that the synergistic effect of combination on EPC growth inhibition was paralleled by increased apoptosis induction and reduced autophagy. These effects occurred together with biochemical features that are typical of reduced autophagic death such as increased co-immunoprecipitation between Beclin 1 and Bcl-2. Chloroquine antagonized the inhibition of the activity of AktR4EBP1 axis mediated by everolimus and at the same time it blocked the feed-back activation of Erk-1/2 induced by RAD in EPCs. These data suggest a new strategy in order to block angiogenesis in tumours in which this process plays a key role in both the sustainment and spreading of cancer cells.	[Grimaldi, Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Caraglia, Michele] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Di Domenico, Gilda; Nocera, Cosimo] S Giovanni Bosco Naples, Ctr Blood Transfus, Naples, Italy; [Lamberti, Monica] Univ Naples 2, Dept Expt Med, Sect Igiene Med Lavoro & Med Legale, Naples, Italy; [Tonini, Giuseppe; Zoccoli, Alice; Santini, Daniele; Pantano, Francesco] Campus Biomed Univ, Translat Oncol PRABB, Rome, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University Campus Bio-Medico - Rome Italy	Caraglia, M (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	michele.caraglia@unina2.it	Caraglia, Michele/AFY-9729-2022; D'Onofrio, Nunzia/M-2081-2019; Caraglia, Michele/N-5670-2015; Caraglia, Michele/AAK-4569-2020; Pantano, Francesco/D-8459-2012	Caraglia, Michele/0000-0003-2408-6091; D'Onofrio, Nunzia/0000-0002-5300-9530; Caraglia, Michele/0000-0003-2408-6091; Caraglia, Michele/0000-0003-2408-6091; Pantano, Francesco/0000-0002-2894-9686; Tonini, Giuseppe/0000-0003-4442-8677; Zoccoli, Alice/0000-0003-1991-1667; Balestrieri, Maria Luisa/0000-0001-6001-1789; Santini, Daniele/0000-0002-9118-3337	PRIN "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales"; FIRB "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers"	PRIN "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales"; FIRB "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers"	The authors are grateful to PRIN 2009 "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales" and FIRB 2011 "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers" for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, ONCOLOGIST, V15, P236, DOI 10.1634/theoncologist.2009-0141; Banerjee S, 2012, ATHEROSCLEROSIS, V225, P91, DOI 10.1016/j.atherosclerosis.2012.08.025; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9; Bertolini Francesco, 2012, Methods Mol Biol, V904, P165, DOI 10.1007/978-1-61779-943-3_14; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Curran MP, 2012, PEDIATR DRUGS, V14, P51, DOI 10.2165/11207730-000000000-00000; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Ding YT, 2008, PATHOBIOLOGY, V75, P265, DOI 10.1159/000151706; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Franco R, 2011, CANCER BIOL THER, V11, P609, DOI 10.4161/cbt.11.6.14672; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Igreja C, 2007, HAEMATOLOGICA, V92, P469, DOI 10.3324/haematol.10723; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johnson BE, 2007, CLIN CANCER RES, V13, p4628S, DOI 10.1158/1078-0432.CCR-07-0717; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mancuso P, 2010, MICROVASC RES, V79, P224, DOI 10.1016/j.mvr.2010.02.007; Masuda H, 2013, TRENDS CARDIOVAS MED, V23, P99, DOI 10.1016/j.tcm.2012.09.007; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miriuka SG, 2006, AM J TRANSPLANT, V6, P2069, DOI 10.1111/j.1600-6143.2006.01433.x; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Naik RP, 2008, BREAST CANCER RES TR, V107, P133, DOI 10.1007/s10549-007-9519-6; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rosich L, 2012, CLIN CANCER RES, V18, P5278, DOI 10.1158/1078-0432.CCR-12-0351; Rossi M, 2012, CURR CANCER DRUG TAR, V12, P757, DOI 10.2174/156800912802429300; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Smolewski P, 2006, ANTI-CANCER DRUG, V17, P487, DOI 10.1097/00001813-200606000-00001; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tertil M, 2010, CURR PHARM DESIGN, V16, P3877, DOI 10.2174/138161210794454969; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yim Kein-Leong, 2012, Cancer Manag Res, V4, P207, DOI 10.2147/CMAR.S25979; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8	62	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79658	10.1371/journal.pone.0079658	http://dx.doi.org/10.1371/journal.pone.0079658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244540	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600143
J	Nurmi, K; Virkanen, J; Rajamaki, K; Niemi, K; Kovanen, PT; Eklund, KK				Nurmi, Katariina; Virkanen, Juhani; Rajamaki, Kristiina; Niemi, Katri; Kovanen, Petri T.; Eklund, Kari K.			Ethanol Inhibits Activation of NLRP3 and AIM2 Inflammasomes in Human Macrophages- A Novel Anti-Inflammatory Action of Alcohol	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; NF-KAPPA-B; CATHEPSIN-B; NALP3 INFLAMMASOME; OXIDATIVE STRESS; GENE-EXPRESSION; CONSUMPTION; INTERLEUKIN-1-BETA	Objective: In the pathogenesis of coronary atherosclerosis, local macrophage-driven inflammation and secretion of proinflammatory cytokines, interleukin-1 beta (IL-1 beta) in particular, are recognized as key factors. Moderate alcohol consumption is associated with a reduced risk of coronary artery disease mortality. Here we examined in cultured human macrophages whether ethanol modulates the intracellular processes involved in the secretion of IL-1 beta. Results: Ethanol decreased dose-dependently the production of mature IL-1b induced by activators of the NLRP3 inflammasome, i.e. ATP, cholesterol crystals, serum amyloid A and nigericin. Ethanol had no significant effect on the expression of NLRP3 or IL1 beta mRNA in LPS-primed macrophages. Moreover, secretion of IL-1 beta was decreased in parallel with reduction of caspase-1 activation, demonstrating that ethanol inhibits inflammasome activation instead of synthesis of pro-IL-1 beta. Acetaldehyde, a highly reactive metabolite of ethanol, had no effect on the ATP-induced IL-1 beta secretion. Ethanol also attenuated the secretion of IL-1 beta triggered by synthetic double-stranded DNA, an activator of the AIM2 inflammasome. Ethanol conferred the inhibitory functions by attenuating the disruption of lysosomal integrity and ensuing leakage of the lysosomal protease cathepsin B and by reducing oligomerization of ASC. Conclusion: Ethanol-induced inhibition of the NLRP3 inflammasome activation in macrophages may represent a biological pathway underlying the protective effect of moderate alcohol consumption on coronary heart disease.	[Nurmi, Katariina; Rajamaki, Kristiina; Niemi, Katri; Kovanen, Petri T.; Eklund, Kari K.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Virkanen, Juhani] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Eklund, Kari K.] Univ Helsinki, Cent Hosp, Dept Med, Div Rheumatol, Helsinki, Finland	Wihuri Research Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Nurmi, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	katariina.nurmi@helsinki.fi		Nurmi, Katariina/0000-0001-5406-5334; Rajamaki, Kristiina/0000-0001-5151-1220	Wihuri Research Institute; Ida Montin Foundation; Maire Lisko Foundation	Wihuri Research Institute; Ida Montin Foundation; Maire Lisko Foundation	The study was supported by Wihuri Research Institute, maintained by the Jenny and Antti Wihuri Foundation. The study was also supported by grants from Ida Montin Foundation and Maire Lisko Foundation (K Nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabi S, 1999, J IMMUNOL, V162, P7441; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Costanzo S, 2010, J AM COLL CARDIOL, V55, P1339, DOI 10.1016/j.jacc.2010.01.006; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Cui JH, 2002, ANN NY ACAD SCI, V957, P308, DOI 10.1111/j.1749-6632.2002.tb02931.x; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hutson JL, 1999, J PATHOL, V188, P197, DOI 10.1002/(SICI)1096-9896(199906)188:2<197::AID-PATH295>3.0.CO;2-M; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Inokuchi T, 2008, CYTOKINE, V42, P198, DOI 10.1016/j.cyto.2008.01.001; International Organization for Standardization, 2003, 1729422003 ISO; Jin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035505; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KNIGHT CG, 1980, BIOCHEM J, V189, P447, DOI 10.1042/bj1890447; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Oak S, 2006, J IMMUNOL, V176, P7628, DOI 10.4049/jimmunol.176.12.7628; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Raum E, 2007, INT J CARDIOL, V121, P224, DOI 10.1016/j.ijcard.2006.08.104; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; Vazquez-Agell M, 2007, J NUTR, V137, P2279, DOI 10.1093/jn/137.10.2279	62	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78537	10.1371/journal.pone.0078537	http://dx.doi.org/10.1371/journal.pone.0078537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244322	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600032
J	Zhang, B; Li, Y; Zheng, XD; Zuo, XB; Zhou, FS; Liang, B; Zhu, J; Li, P; Ding, YT; Huang, ZL; Wang, BZ; Chen, ZD				Zhang, Bo; Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao; Huang, Zhonglian; Wang, Benzhong; Chen, Zhendong			A Common Variant in the SIAH2 Locus Is Associated with Estrogen Receptor-Positive Breast Cancer in the Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; DOWN-REGULATION; RISK VARIANT; IDENTIFIES 2; LIGASE; METAANALYSIS; GENETICS; HYPOXIA; ALLELES	Background: Genome-wide association studies (GWAS) have identified many loci associated with breast cancer risk. These studies have primarily been conducted in populations of European descent. Objective: To determine whether previously reported susceptibility loci in other ethnic groups are also risk factors for breast cancer in a Chinese population. Method: We genotyped 21 previously reported single nucleotide polymorphisms (SNPs) within a female Chinese cohort of 1203 breast cancer cases and 2525 healthy controls using the Sequenom iPlex platform. Fourteen SNPs passed the quality control test. These SNPs were subjected to statistical analysis for the entire cohort and were further analyzed for estrogen receptor (ER) status. The associations of the SNPs with disease susceptibility were assessed using logistic regression, adjusting for age. The Bonferroni correction was used to conservatively account for multiple testing, and the threshold for statistical significance was P<3.57x10(-3) (0.05/14). Result: Although none of the SNPs showed an overall association with breast cancer, an analysis of the ER status of the breast cancer patients revealed that the SIAH2 locus (rs6788895; P = 5.73 x 10(-4), odds ratio [OR] = 0.81) is associated with ER-positive breast cancer. Conclusion: A common variant in the SIAH2 locus is associated with ER-positive breast cancer in the Chinese Han population. The replication of published GWAS results in other ethnic groups provides important information regarding the genetic etiology of breast cancer.	[Zhang, Bo; Huang, Zhonglian; Chen, Zhendong] Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Anhui, Peoples R China; [Zhang, Bo] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; Anhui Med Univ, Dept Dermatol & Venereol, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Wang, Benzhong] Anhui Med Univ, Dept Galactophore Surg, Hosp 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhang, B (corresponding author), Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Anhui, Peoples R China.	alvinbo@163.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Youth Program of National Natural Science Foundation of China(2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barzan D, 2013, EUR J HUM GENET, DOI [10.1038/ejhg.2013.38, DOI 10.1038/EJHG.2013.38.[]; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elgazzar S, 2012, J HUM GENET, V57, P766, DOI 10.1038/jhg.2012.108; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kulakosky PC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290137; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79365	10.1371/journal.pone.0079365	http://dx.doi.org/10.1371/journal.pone.0079365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244489	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600127
J	Tammaro, M; Barr, P; Ricci, B; Yan, H				Tammaro, Margaret; Barr, Peri; Ricci, Brett; Yan, Hong			Replication-Dependent and Transcription-Dependent Mechanisms of DNA Double-Strand Break Induction by the Topoisomerase 2-Targeting Drug Etoposide	PLOS ONE			English	Article							II-BETA; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CLEAVABLE COMPLEXES; MLL TRANSLOCATIONS; END RESECTION; REPAIR; ALPHA; GENE; PROLIFERATION	Etoposide is a DNA topoisomerase 2-targeting drug widely used for the treatment of cancer. The cytoxicity of etoposide correlates with the generation of DNA double-strand breaks (DSBs), but the mechanism of how it induces DSBs in cells is still poorly understood. Catalytically, etoposide inhibits the re-ligation reaction of Top2 after it nicks the two strands of DNA, trapping it in a cleavable complex consisting of two Top2 subunits covalently linked to the 5' ends of DNA (Top2cc). Top2cc is not directly recognized as a true DSB by cells because the two subunits interact strongly with each other to hold the two ends of DNA together. In this study we have investigated the cellular mechanisms that convert Top2ccs into true DSBs. Our data suggest that there are two mechanisms, one dependent on active replication and the other dependent on proteolysis and transcription. The relative contribution of each mechanism is affected by the concentration of etoposide. We also find that Top2 alpha is the major isoform mediating the replication-dependent mechanism and both Top2 alpha and Top2 mediate the transcription-dependent mechanism. These findings are potentially of great significance to the improvement of etoposide's efficacy in cancer therapy.	[Tammaro, Margaret; Barr, Peri; Ricci, Brett; Yan, Hong] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Yan, H (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Hong_Yan@fccc.edu			National Institute of Health [R01 GM57962-02, 2 R01 GM057962-12A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057962] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institute of Health (http://nih.gov/) to H.Y. (R01 GM57962-02 and 2 R01 GM057962-12A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanati I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008104; Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; AUSTIN CA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P283, DOI 10.1016/0167-4781(93)90215-Y; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Cornarotti M, 1996, MOL PHARMACOL, V50, P1463; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; DARPA P, 1990, CANCER RES, V50, P6919; de Campos-Nebel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012541; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Fan JR, 2008, DNA REPAIR, V7, P452, DOI 10.1016/j.dnarep.2007.12.002; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Goswami PC, 1996, MOL CELL BIOL, V16, P1500; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1988, CANCER RES, V48, P3230; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Kornberg A., 1992, DNA REPLICATION; LONG BH, 1985, CANCER RES, V45, P3106; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; OLIVE PL, 1993, INT J RADIAT BIOL, V64, P349, DOI 10.1080/09553009314551531; Pommier Y., 2011, CANC CHEMOTHERAPY BI, P392; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Smith MA, 1999, J CLIN ONCOL, V17, P569, DOI 10.1200/JCO.1999.17.2.569; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; TAN KB, 1992, CANCER RES, V52, P231; Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200	50	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79202	10.1371/journal.pone.0079202	http://dx.doi.org/10.1371/journal.pone.0079202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244448	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900034
J	Cai, JF; Guo, S; Lomasney, JW; Roberts, MF				Cai, Jingfei; Guo, Su; Lomasney, Jon W.; Roberts, Mary F.			Ca2+-independent Binding of Anionic Phospholipids by Phospholipase C delta 1 EF-hand Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Glycerophospholipid; Membrane Enzymes; NMR; Phospholipase C; Phospholipid Vesicle; Site-directed Mutagenesis	DEPENDENT PROTEIN-KINASE; CA2+ OSCILLATIONS; CRYSTAL-STRUCTURE; ACTIVATION; DIACYLGLYCEROL; HOMOLOGY; PLC; CALCIUM; ZETA; IDENTIFICATION	Recombinant EF-hand domain of phospholipase C 1 has a moderate affinity for anionic phospholipids in the absence of Ca2+ that is driven by interactions of cationic and hydrophobic residues in the first EF-hand sequence. This region of PLC 1 is missing in the crystal structure. The relative orientation of recombinant EF with respect to the bilayer, established with NMR methods, shows that the N-terminal helix of EF-1 is close to the membrane interface. Specific mutations of EF-1 residues in full-length PLC 1 reduce enzyme activity but not because of disturbing partitioning of the protein onto vesicles. The reduction in enzymatic activity coupled with vesicle binding studies are consistent with a role for this domain in aiding substrate binding in the active site once the protein is transiently anchored at its target membrane.	[Cai, Jingfei; Guo, Su; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Lomasney, Jon W.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Lomasney, Jon W.] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA	Boston College; Northwestern University; Northwestern University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu			National Institutes of Health [R01 GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60418 (to M. F. R.).	Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; ELLIS MV, 1993, EUR J BIOCHEM, V213, P339, DOI 10.1111/j.1432-1033.1993.tb17767.x; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Kamat Asha, 1997, Cytokine and Growth Factor Reviews, V8, P109, DOI 10.1016/S1359-6101(97)00003-8; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kobayashi M, 2005, ARCH BIOCHEM BIOPHYS, V440, P191, DOI 10.1016/j.abb.2005.06.014; Kobayashi M, 2004, BIOCHEMISTRY-US, V43, P7522, DOI 10.1021/bi035966c; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lomasney JW, 1999, J BIOL CHEM, V274, P21995, DOI 10.1074/jbc.274.31.21995; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; NAKASHIMA S, 1995, BIOCHEM BIOPH RES CO, V211, P364, DOI 10.1006/bbrc.1995.1822; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Roberts M. F., 1998, PHOSPHOINOSITIDES CH, V718, P137; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; Saunders CM, 2002, DEVELOPMENT, V129, P3533; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Swann K, 2006, SEMIN CELL DEV BIOL, V17, P264, DOI 10.1016/j.semcdb.2006.03.009; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438	36	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37277	37288		10.1074/jbc.M113.512186	http://dx.doi.org/10.1074/jbc.M113.512186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235144	Green Published, hybrid			2022-12-25	WOS:000329189700044
J	Gabel, K; Schmitt, J; Schulz, S; Nather, DJ; Soppa, J				Gaebel, Katrin; Schmitt, Jessica; Schulz, Sebastian; Naether, Daniela J.; Soppa, Joerg			A Comprehensive Analysis of the Importance of Translation Initiation Factors for Haloferax volcanii Applying Deletion and Conditional Depletion Mutants	PLOS ONE			English	Article							MESSENGER-RNA; MECHANISMS; CONSTRUCTION; EVOLUTION; GENES; DECAY; EIF2	Translation is an important step in gene expression. The initiation of translation is phylogenetically diverse, since currently five different initiation mechanisms are known. For bacteria the three initiation factors IF1 - IF3 are described in contrast to archaea and eukaryotes, which contain a considerably higher number of initiation factor genes. As eukaryotes and archaea use a non-overlapping set of initiation mechanisms, orthologous proteins of both domains do not necessarily fulfill the same function. The genome of Haloferax volcanii contains 14 annotated genes that encode (subunits of) initiation factors. To gain a comprehensive overview of the importance of these genes, it was attempted to construct single gene deletion mutants of all genes. In 9 cases single deletion mutants were successfully constructed, showing that the respective genes are not essential. In contrast, the genes encoding initiation factors aIF1, aIF2 gamma, aIF5A, aIF5B, and aIF6 were found to be essential. Factors aIF1A and aIF2 beta are encoded by two orthologous genes in H. volcanii. Attempts to generate double mutants failed in both cases, indicating that also these factors are essential. A translatome analysis of one of the single aIF2 beta deletion mutants revealed that the translational efficiency of the second ortholog was enhanced tenfold and thus the two proteins can replace one another. The phenotypes of the single deletion mutants also revealed that the two aIF1As and aIF2 beta s have redundant but not identical functions. Remarkably, the gene encoding aIF2 alpha, a subunit of aIF2 involved in initiator tRNA binding, could be deleted. However, the mutant had a severe growth defect under all tested conditions. Conditional depletion mutants were generated for the five essential genes. The phenotypes of deletion mutants and conditional depletion mutants were compared to that of the wild-type under various conditions, and growth characteristics are discussed.	[Gaebel, Katrin; Schmitt, Jessica; Schulz, Sebastian; Naether, Daniela J.; Soppa, Joerg] Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Soppa, J (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (Deutsche Forschungsgemeinschaft) [So 264/19-1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This project was funded by the German Research Council (Deutsche Forschungsgemeinschaft) through project So 264/19-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Benelli D, 2003, MOL MICROBIOL, V50, P635, DOI 10.1046/j.1365-2958.2003.03721.x; Benelli D, 2011, BIOCHEM SOC T, V39, P89, DOI 10.1042/BST0390089; Benelli D, 2009, RES MICROBIOL, V160, P493, DOI 10.1016/j.resmic.2009.06.003; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Boelens R, 2002, CURR PROTEIN PEPT SC, V3, P107, DOI 10.2174/1389203023380765; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dambeck M, 2008, ARCH MICROBIOL, V190, P341, DOI 10.1007/s00203-008-0379-1; Dev K, 2009, J MOL BIOL, V392, P701, DOI 10.1016/j.jmb.2009.07.030; Dmitriev SE, 2011, J MOL BIOL, V413, P106, DOI 10.1016/j.jmb.2011.08.026; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hasenohrl D, 2009, RNA, V15, P2288, DOI 10.1261/rna.1662609; Hasenohrl D, 2006, RNA, V12, P674, DOI 10.1261/rna.2289306; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Hernandez G, 2010, TRENDS BIOCHEM SCI, V35, P63, DOI 10.1016/j.tibs.2009.10.009; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hundt S, 2007, J BACTERIOL, V189, P6936, DOI 10.1128/JB.00559-07; Jantzer K, 2011, FEMS MICROBIOL LETT, V322, P123, DOI 10.1111/j.1574-6968.2011.02341.x; Komar AA, 2012, GENE, V502, P75, DOI 10.1016/j.gene.2012.04.039; Kozak M, 2002, MAMM GENOME, V13, P401, DOI 10.1007/s00335-002-4002-5; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; La Teana A, 2013, BIOCHEM SOC T, V41, P350, DOI 10.1042/BST20120300; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Milon P, 2012, NAT STRUCT MOL BIOL, V19, P609, DOI 10.1038/nsmb.2285; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; Pedulla N, 2005, NUCLEIC ACIDS RES, V33, P1804, DOI 10.1093/nar/gki321; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Soppa J, 2011, BIOCHEM SOC T, V39, P150, DOI 10.1042/BST0390150; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e77188	10.1371/journal.pone.0077188	http://dx.doi.org/10.1371/journal.pone.0077188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244275	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800003
J	Pinto, VB; Burden, R; Wagner, A; Moran, EE; Lee, CH				Pinto, Valerian B.; Burden, Robert; Wagner, Allyn; Moran, Elizabeth E.; Lee, Che-Hung			The Development of an Experimental Multiple Serogroups Vaccine for Neisseria meningitidis	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; OUTER-MEMBRANE PROTEIN; MENINGOCOCCAL MENINGITIS; GROUP-B; EPIDEMIOLOGY; DETERMINANT; STRAINS	A native outer membrane vesicles (NOMV) vaccine was developed from three antigenically diverse strains of Neisseria meningitidis that express the L1,8, L2, and L3,7 lipooligosaccharide (LOS) immunotypes, and whose synX, and lpxL1 genes were deleted.. Immunogenicity studies in mice showed that the vaccine induced bactericidal antibody against serogroups B, C, W, Y and X N. meningitidis strains. However, this experimental NOMV vaccine was not effective against serogroup A N. meningitidis strains. N. meningitidis capsular polysaccharide (PS) from serogroups A, C, W and Y were effective at inducing bactericidal antibody when conjugated to either tetanus toxoid or the fHbp1-fHbp2 fusion protein fHbp(1+2). The combination of the NOMV vaccine and the N. meningitidis serogroup A capsular polysaccharide (MAPS) protein conjugate was capable of inducing bactericidal antibodies against a limited number of N. meningitidis strains from serogroups A, B, C, W, Y and X tested in this study.	[Pinto, Valerian B.; Burden, Robert; Wagner, Allyn; Moran, Elizabeth E.] WRAIR, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA; [Lee, Che-Hung] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	Walter Reed Army Institute of Research (WRAIR); US Food & Drug Administration (FDA)	Pinto, VB (corresponding author), WRAIR, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA.	vpinto21@msn.com			Military Infectious Disease Research Program	Military Infectious Disease Research Program	This work was supported by the Military Infectious Disease Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMAND J, 1982, J BIOL STAND, V10, P335, DOI 10.1016/S0092-1157(82)80010-3; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bratcher HB, 2012, FUTURE MICROBIOL, V7, P873, DOI [10.2217/fmb.12.62, 10.2217/FMB.12.62]; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Christensen H, 2010, 17 INT PATH NEISS C, P41; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; FINNE J, 1983, LANCET, V2, P355; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOTSCHLICH EC, 1969, J EXP MED, V129, P1349, DOI 10.1084/jem.129.6.1349; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; JONES DM, 1992, MICROB PATHOGENESIS, V13, P219, DOI 10.1016/0882-4010(92)90022-G; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; MORAN EE, 1994, INFECT IMMUN, V62, P5290, DOI 10.1128/IAI.62.12.5290-5295.1994; Moran EE, 2012, CLIN VACCINE IMMUNOL, V19, P659, DOI 10.1128/CVI.00070-12; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mutonga DM, 2009, AM J TROP MED HYG, V80, P619; Pajon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066536; Pillai S, 2005, VACCINE, V23, P2206, DOI 10.1016/j.vaccine.2005.01.056; Pinto VB, 2011, VACCINE, V29, P7752, DOI 10.1016/j.vaccine.2011.07.124; Reisinger KS, 2009, CLIN VACCINE IMMUNOL, V16, P1810, DOI 10.1128/CVI.00207-09; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Van Den Dobbelsteen G, 2004, 14 INT PATH NEISS C, P153; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006; Zollinger WD, 2009, CLIN VACCINE IMMUNOL, V16, P1789, DOI 10.1128/CVI.00255-09	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79304	10.1371/journal.pone.0079304	http://dx.doi.org/10.1371/journal.pone.0079304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244473	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800058
J	Yan, N; Chen, N; Zhu, HH; Zhang, JG; Sim, M; Ma, Y; Wang, W				Yan, Na; Chen, Ning; Zhu, Honghua; Zhang, Jianguo; Sim, Moira; Ma, Yu; Wang, Wei			High-Frequency Stimulation of Nucleus Accumbens Changes in Dopaminergic Reward Circuit	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VENTRAL TEGMENTAL AREA; COCAINE-INDUCED REINSTATEMENT; ALCOHOL-PREFERRING AA; IN-VIVO MICRODIALYSIS; AVOIDING ANA RATS; EXTRACELLULAR GLUTAMATE; ELECTRICAL-STIMULATION; GLOBUS-PALLIDUS; RECEPTOR ACTIVATION	Deep brain stimulation (DBS) of the nucleus accumbens (NAc) is a potential remedial therapy for drug craving and relapse, but the mechanism is poorly understood. We investigated changes in neurotransmitter levels during high frequency stimulation (HFS) of the unilateral NAc on morphine-induced rats. Sixty adult Wistar rats were randomized into five groups: the control group (administration of saline), the morphine-only group (systematic administration of morphine without electrode implantation), the morphine-sham-stimulation group (systematic administration of morphine with electrode implantation but not given stimulation), the morphine-stimulation group (systematic administration of morphine with electrode implantation and stimulation) and the saline-stimulation group (administration of saline with electrode implantation and stimulation). The stimulation electrode was stereotaxically implanted into the core of unilateral NAc and microdialysis probes were unilaterally lowered into the ipsilateral ventral tegmental area (VTA), NAc, and ventral pallidum (VP). Samples from microdialysis probes in the ipsilateral VTA, NAc, and VP were analyzed for glutamate (Glu) and gamma-aminobutyric acid (GABA) by high-performance liquid chromatography (HPLC). The levels of Glu were increased in the ipsilateral NAc and VP of morphine-only group versus control group, whereas Glu levels were not significantly changed in the ipsilateral VTA. Furthermore, the levels of GABA decreased significantly in the ipsilateral NAc, VP, and VTA of morphine only group when compared with control group. The profiles of increased Glu and reduced GABA in morphine-induced rats suggest that the presence of increased excitatory neurotransmission in these brain regions. The concentrations of the Glu significantly decreased while the levels of GABA increased in ipsilateral VTA, NAc, and VP in the morphine-stimulation group compared with the morphine-only group. No significant changes were seen in the morphine-sham stimulation group compared with the morphine-only group. These findings indicated that unilateral NAc stimulation inhibits the morphine induced rats associated hyperactivation of excitatory neurotransmission in the mesocorticolimbic reward circuit.	[Yan, Na; Wang, Wei] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Beijing, Peoples R China; [Chen, Ning] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhu, Honghua] Sixth People Hosp Jinan, Dept Gastroenterol, Jinan, Peoples R China; [Zhang, Jianguo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Sim, Moira; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Syst & Intervent Res Ctr Hlth, Perth, WA, Australia; [Ma, Yu] Tsinghua Univ, Yuquan Hosp, Beijing 100084, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Edith Cowan University; Tsinghua University	Ma, Y (corresponding author), Tsinghua Univ, Yuquan Hosp, Beijing 100084, Peoples R China.	lymayu@163.com; wei.wanf@ecu.edu.au	yan, na/HDM-3747-2022; liu, li/HGC-0900-2022	wang, wei/0000-0002-1430-1360	National Natural Science Foundation of China [81070901, 81141013, 31070727]; Beijing Nova Program [2008B043]; Australia-China Sciences Research Foundation [ACSRF06444]; National "12th Five-Year" Plan for Science and Technology Support, China [2012BAI37B03]; Beijing Outstanding Talents Project [2011D003034000019]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Australia-China Sciences Research Foundation(Australian Government); National "12th Five-Year" Plan for Science and Technology Support, China; Beijing Outstanding Talents Project; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	This work was supported by grants from the National Natural Science Foundation of China (No. 81070901, No. 81141013, 31070727), Beijing Nova Program (2008B043), the Australia-China Sciences Research Foundation (ACSRF06444), National "12th Five-Year" Plan for Science and Technology Support, China (2012BAI37B03). Dr. Yu Ma was supported by the Beijing Outstanding Talents Project (No. 2011D003034000019) and Prof Wei Wang was supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MA, 2009, BRAIN RES, V1288, P95, DOI 10.1016/j.brainres.2009.06.100; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Caille S, 2004, EUR J NEUROSCI, V20, P593, DOI 10.1111/j.1460-9568.2004.03497.x; Comer SD, 2007, PSYCHOPHARMACOLOGY, V193, P235, DOI 10.1007/s00213-007-0775-2; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Dahchour A, 2000, ALCOHOL ALCOHOLISM, V35, P548, DOI 10.1093/alcalc/35.6.548; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Fattore L, 2005, PHARMACOL BIOCHEM BE, V81, P343, DOI 10.1016/j.pbb.2005.01.031; Fecteau S, 2010, SUBST USE MISUSE, V45, P1766, DOI 10.3109/10826084.2010.482434; Gao GD, 2003, STEREOT FUNCT NEUROS, V81, P96, DOI 10.1159/000075111; Haberler C, 2000, ANN NEUROL, V48, P372, DOI 10.1002/1531-8249(200009)48:3<372::AID-ANA12>3.0.CO;2-0; Hao Y, 2005, BRAIN RES, V1040, P191, DOI 10.1016/j.brainres.2005.01.072; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Hiller A, 2007, J NEUROSCI METH, V159, P286, DOI 10.1016/j.jneumeth.2006.07.023; Hu WH, 2011, MED SCI MONITOR, V17, pBR153, DOI 10.12659/MSM.881802; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Karimi Sara, 2011, Iranian Biomedical Journal, V15, P92; Kemppainen H, 2010, ALCOHOL ALCOHOLISM, V45, P111, DOI 10.1093/alcalc/agp086; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, CLIN NEUROSCI RES, V5, P89, DOI 10.1016/j.cnr.2005.08.005; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Leite-Morris KA, 2004, J PHARMACOL EXP THER, V308, P667, DOI 10.1124/jpet.103.058412; Li TL, 2004, NEUROSCI LETT, V371, P117, DOI 10.1016/j.neulet.2004.08.050; Li X, 2009, NEUROPSYCHOPHARMACOL, V34, P1783, DOI 10.1038/npp.2008.236; Lian J, 2003, J PHYSIOL-LONDON, V547, P427, DOI 10.1113/jphysiol.2002.033209; Liu HY, 2008, ADDICT BIOL, V13, P40, DOI 10.1111/j.1369-1600.2007.00088.x; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; McFarland K, 2003, J NEUROSCI, V23, P3531; Moser A, 2003, NEUROSCI LETT, V341, P57, DOI 10.1016/S0304-3940(03)00133-2; Noori HR, 2012, ADDICT BIOL, V17, P827, DOI 10.1111/j.1369-1600.2012.00485.x; Ojanen SP, 2007, EUR J PHARMACOL, V559, P38, DOI 10.1016/j.ejphar.2006.11.046; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Paxions G, 1997, RAT BRAIN STEREOTAXI; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Schiller Y, 2007, J NEUROPHYSIOL, V97, P1887, DOI 10.1152/jn.00514.2006; Sizemore GM, 2000, PSYCHOPHARMACOLOGY, V150, P391, DOI 10.1007/s002130000456; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027; STEKETEE JD, 1992, PROG NEURO-PSYCHOPH, V16, P237, DOI 10.1016/0278-5846(92)90075-P; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Tokuyama S, 2001, NEUROCHEM INT, V39, P103, DOI 10.1016/S0197-0186(01)00019-5; Tomkins DM, 2001, CAN MED ASSOC J, V164, P817; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Wang XF, 2011, EUR J PHARMACOL, V650, P200, DOI 10.1016/j.ejphar.2010.09.071; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Windels F, 2003, J NEUROSCI RES, V72, P259, DOI 10.1002/jnr.10577; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wydra K, 2013, ADDICT BIOL, V18, P307, DOI 10.1111/adb.12031; Xu JW, 2005, CHIN J STEREOTACT FU, V18, P140; Yang TT, 2004, SYNAPSE, V51, P83, DOI 10.1002/syn.10290	56	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79318	10.1371/journal.pone.0079318	http://dx.doi.org/10.1371/journal.pone.0079318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244479	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800062
J	Kahana-Edwin, S; Stark, M; Kassir, Y				Kahana-Edwin, Smadar; Stark, Michal; Kassir, Yona			Multiple MAPK Cascades Regulate the Transcription of IME1, the Master Transcriptional Activator of Meiosis Saccharomyces cerevisiae	PLOS ONE			English	Article							KINASE SIGNALING SPECIFICITY; ZINC-FINGER PROTEIN; BUDDING YEAST; OSMOTIC-STRESS; PSEUDOHYPHAL DIFFERENTIATION; BIDIRECTIONAL PROMOTERS; NEGATIVE REGULATORS; POSITIVE REGULATOR; GENE ENCODES; HOG1 KINASE	The choice between alternative developmental pathways is primarily controlled at the level of transcription. Induction of meiosis in budding yeasts in response to nutrient levels provides a system to investigate the molecular basis of cellular decision-making. In Saccharomyces cerevisiae, entry into meiosis depends on multiple signals converging upon IME1, the master transcriptional activator of meiosis. Here we studied the regulation of the cis-acting regulatory element Upstream Activation Signal (UAS)ru, which resides within the IME1 promoter. Guided by our previous data acquired using a powerful high-throughput screening system, here we provide evidence that UASru is regulated by multiple stimuli that trigger distinct signal transduction pathways as follows: (i) The glucose signal inhibited UASru activity through the cyclic AMP (cAMP/protein kinase A (PKA) pathway, targeting the transcription factors (TFs), Com2 and Sko1; (ii) high osmolarity activated UASru through the Hog1/mitogen-activated protein kinase (MAPK) pathway and its corresponding TF Sko1; (iii) elevated temperature increased the activity of UASru through the cell wall integrity pathway and the TFs Swi4/Mpk1 and Swi4/Mlp1; (iv) the nitrogen source repressed UASru activity through Sum1; and (v) the absence of a nitrogen source was detected and transmitted to UASru by the Kss1 and Fus3 MAPK pathways through their respective downstream TFs, Ste12/Tec1 and Ste12/Ste12 as well as by their regulators Dig1/2. These signaling events were specific to UASru; they did not affect the mating and filamentation response elements that are regulated by MAPK pathways. The complex regulation of UASru through all the known vegetative MAPK pathways is unique to S. cerevisiae and is specific for IME1, likely because it is the master regulator of gametogenesis.	[Kahana-Edwin, Smadar; Stark, Michal; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Kassir, Y (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il	Stark, Michal/AFL-9651-2022; Stark, Michal/AAH-1763-2022	Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696; Kahana-Edwin, Smadar/0000-0002-2869-4310	ISF - Israel Science Foundation	ISF - Israel Science Foundation(Israel Science Foundation)	This study was funded by the ISF - Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Chou S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.47; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; FIELDS S, 1987, MOL CELL BIOL, V7, P3818, DOI 10.1128/MCB.7.10.3818; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Houser JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.18; Kahana S, 2010, GENETICS, V186, P829, DOI 10.1534/genetics.110.122200; Kainth P, 2009, METHODS, V48, P258, DOI 10.1016/j.ymeth.2009.02.015; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1976, GENETICS, V82, P187; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KRISAK L, 1994, GENE DEV, V8, P2151, DOI 10.1101/gad.8.18.2151; Kupiec M., 1997, MOL CELLULAR BIOL YE, P889; Leza MA, 1999, GENETICS, V151, P531; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Miller J.H., 1972, EXPT MOL GENETICS; Mintzer KA, 1999, CELL SIGNAL, V11, P127, DOI 10.1016/S0898-6568(98)00044-8; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; NEHLIN JO, 1992, NUCLEIC ACIDS RES, V20, P5271, DOI 10.1093/nar/20.20.5271; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SHERMAN A, 1993, MOL GEN GENET, V237, P375, DOI 10.1007/BF00279441; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	65	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78920	10.1371/journal.pone.0078920	http://dx.doi.org/10.1371/journal.pone.0078920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236068	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700065
J	Mesri, M; Birse, C; Heidbrink, J; McKinnon, K; Brand, E; Bermingham, CL; Feild, B; FitzHugh, W; He, T; Ruben, S; Moore, PA				Mesri, Mehdi; Birse, Charlie; Heidbrink, Jenny; McKinnon, Kathy; Brand, Erin; Bermingham, Candy Lee; Feild, Brian; FitzHugh, William; He, Tao; Ruben, Steve; Moore, Paul A.			Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; THY-1 CD90; GENES; VASCULATURE; ADHESION; VESSELS; B7-H3; CD146	Genomic and proteomic analysis of normal and cancer tissues has yielded abundant molecular information for potential biomarker and therapeutic targets. Considering potential advantages in accessibility to pharmacological intervention, identification of targets resident on the vascular endothelium within tumors is particularly attractive. By employing mass spectrometry (MS) as a tool to identify proteins that are over-expressed in tumor-associated endothelium relative to normal cells, we aimed to discover targets that could be utilized in tumor angiogenesis cancer therapy. We developed proteomic methods that allowed us to focus our studies on the discovery of cell surface/secreted proteins, as they represent key antibody therapeutic and biomarker opportunities. First, we isolated endothelial cells (ECs) from human normal and kidney cancer tissues by FACS using CD146 as a marker. Additionally, dispersed human colon and lung cancer tissues and their corresponding normal tissues were cultured ex-vivo and their endothelial content were preferentially expanded, isolated and passaged. Cell surface proteins were then preferentially captured, digested with trypsin and subjected to MS-based proteomic analysis. Peptides were first quantified, and then the sequences of differentially expressed peptides were resolved by MS analysis. A total of 127 unique non-overlapped (157 total) tumor endothelial cell over-expressed proteins identified from directly isolated kidney-associated ECs and those identified from ex-vivo cultured lung and colon tissues including known EC markers such as CD146, CD31, and VWF. The expression analyses of a panel of the identified targets were confirmed by immunohistochemistry (IHC) including CD146, B7H3, Thy-1 and ATP1B3. To determine if the proteins identified mediate any functional role, we performed siRNA studies which led to previously unidentified functional dependency for B7H3 and ATP1B3.	[Mesri, Mehdi; Birse, Charlie; Heidbrink, Jenny; McKinnon, Kathy; Brand, Erin; Bermingham, Candy Lee; Feild, Brian; FitzHugh, William; He, Tao; Ruben, Steve; Moore, Paul A.] Celera, Alameda, CA USA		Birse, C (corresponding author), Celera, Alameda, CA USA.	mesrim@mail.nih.gov			Celera	Celera	The authors have the following interests. This study was funded by and performed at Celera, the employer of all authors during the course of these studies. Celera has 3 issued US patents to declare: 7,582,441, 8,110,373, and 8,334,106, describing associations of Na-K ATPase beta3 protein in various malignant states. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahlskog J, 2006, Q J NUCL MED MOL IM, V50, P296; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1; Castronovo V, 2006, MOL CELL PROTEOMICS, V5, P2083, DOI 10.1074/mcp.M600164-MCP200; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; CLARKE MSF, 1991, ELECTROPHORESIS, V12, P500, DOI 10.1002/elps.1150120708; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; He J, 2011, MOL CELL PROTEOMICS; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Lee WS, 1998, CIRC RES, V82, P845; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Ohga N, 2012, AM J PATHOL; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Saalbach A, 2002, MICROVASC RES, V64, P86, DOI 10.1006/mvre.2002.2401; SASAKI K, 1991, CELL TISSUE RES, V265, P503, DOI 10.1007/BF00340873; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Semenza GL, 2008, NEW ENGL J MED, V358, P2066, DOI 10.1056/NEJMcibr0800272; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; St Croix B, 2000, SCIENCE, V289, P1197; Tuzmen Sukru, 2007, Methods Mol Biol, V353, P177; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827	34	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78885	10.1371/journal.pone.0078885	http://dx.doi.org/10.1371/journal.pone.0078885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236063	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700060
J	Rao, M; Vogelzang, A; Kaiser, P; Schuerer, S; Kaufmann, SHE; Gengenbacher, M				Rao, Martin; Vogelzang, Alexis; Kaiser, Peggy; Schuerer, Stefanie; Kaufmann, Stefan H. E.; Gengenbacher, Martin			The Tuberculosis Vaccine Candidate Bacillus Calmette-Guerin Delta ureC::hly Coexpressing Human Interleukin-7 or-18 Enhances Antigen-Specific T Cell Responses in Mice	PLOS ONE			English	Article							GAMMA-INTERFERON PRODUCTION; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY; RATIONAL DESIGN; BCG; INFECTION; BIOLOGY; LYMPHOCYTES; EXPRESSION; STRATEGIES	Bacillus Calmette-Guerin (BCG), the only approved tuberculosis vaccine, provides only limited protection. Previously, we generated a recombinant derivative (BCG Delta ureC::hly), which secretes the pore-forming toxin listeriolysin O (LLO) of Listeria monocytogenes. This vaccine shows superior protection against tuberculosis in preclinical models and is safe in humans. Here we describe two new vaccine strains which express human interleukin-7 (hIL)-7 or hIL-18 in the genetic background of BCG Delta ureC::hly to modulate specific T cell immunity. Both strains exhibited an uncompromised in vitro growth pattern, while inducing a proinflammatory cytokine profile in human dendritic cells (DCs). Human DCs harbouring either strain efficiently promoted secretion of IL-2 by autologous T cells in a coculture system, suggesting superior immunogenicity. BALB/c mice vaccinated with BCG Delta ureC::hly, BCG Delta ureC::hly_hIL7 or BCG Delta ureC::hly_hIL18 developed a more robust Th1 response than after vaccination with parental BCG. Both strains provided significantly better protection than BCG in a murine Mycobacterium tuberculosis challenge model but efficacy remained comparable to that afforded by BCG Delta ureC::hly. We conclude that expression of hIL-7 or hIL-18 enhanced specific T cell responses but failed to improve protection over BCG Delta ureC:: hly in mice.	[Rao, Martin; Vogelzang, Alexis; Kaiser, Peggy; Schuerer, Stefanie; Kaufmann, Stefan H. E.; Gengenbacher, Martin] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de; gengenbacher@mpiib-berlin.mpg.de	Vogelzang, Alexis/C-5440-2017; Gengenbacher, Martin/C-6876-2015; Rao, Martin/B-8996-2015; Kaufmann, Stefan HE/I-5454-2014	Gengenbacher, Martin/0000-0002-0208-5920; Rao, Martin/0000-0002-0579-1097; Vogelzang, Alexis/0000-0002-2921-1755; Kaufmann, Stefan HE/0000-0001-9866-8268	European 7th Framework Program NEWTBVAC [HEALTH-F3-2009-241745]	European 7th Framework Program NEWTBVAC	This work received financial support from the European 7th Framework Program NEWTBVAC (HEALTH-F3-2009-241745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; APPASAMY PM, 1993, CANCER INVEST, V11, P487, DOI 10.3109/07357909309018880; Arama C, 2012, VACCINE, V30, P5578, DOI 10.1016/j.vaccine.2011.09.054; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Biet F, 2002, INFECT IMMUN, V70, P6549, DOI 10.1128/IAI.70.12.6549-6557.2002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; FENNELLY GJ, 1995, J INFECT DIS, V172, P698, DOI 10.1093/infdis/172.3.698; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Grode L, 2013, VACCINE; Hess J, 1998, P NATL ACAD SCI USA, V95, P5299, DOI 10.1073/pnas.95.9.5299; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jaiswal AI, 1996, INT IMMUNOL, V8, P275, DOI 10.1093/intimm/8.2.275; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kaufmann SHE, 2012, CURR OPIN BIOTECH, V23, P900, DOI 10.1016/j.copbio.2012.03.007; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; LANGERMANN S, 1994, J EXP MED, V180, P2277, DOI 10.1084/jem.180.6.2277; Lin WW, 2012, INFECT IMMUN, V80, P2771, DOI 10.1128/IAI.06195-11; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Murray PJ, 1996, P NATL ACAD SCI USA, V93, P934, DOI 10.1073/pnas.93.2.934; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Norton Brianna L, 2012, Infect Drug Resist, V5, P163, DOI 10.2147/IDR.S29180; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; ODONNELL MA, 1994, INFECT IMMUN, V62, P2508, DOI 10.1128/IAI.62.6.2508-2514.1994; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Reece ST, 2008, INT J MED MICROBIOL, V298, P143, DOI 10.1016/j.ijmm.2007.07.004; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; SEHGAL PB, 1987, SCIENCE, V235, P731, DOI 10.1126/science.3492764; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054	55	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78966	10.1371/journal.pone.0078966	http://dx.doi.org/10.1371/journal.pone.0078966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236077	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700074
J	Yang, CH; Lin, YD; Chuang, LY; Chen, JB; Chang, HW				Yang, Cheng-Hong; Lin, Yu-Da; Chuang, Li-Yeh; Chen, Jin-Bor; Chang, Hsueh-Wei			MDR-ER: Balancing Functions for Adjusting the Ratio in Risk Classes and Classification Errors for Imbalanced Cases and Controls Using Multifactor-Dimensionality Reduction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PARTICLE SWARM OPTIMIZATION; GENE-GENE INTERACTIONS; SNP-SNP INTERACTION; BREAST-CANCER; ENVIRONMENT INTERACTIONS; SUSCEPTIBILITY; HYPERTENSION; EPISTASIS; DISEASE	Background: Determining the complex relationship between diseases, polymorphisms in human genes and environmental factors is challenging. Multifactor dimensionality reduction (MDR) has proven capable of effectively detecting statistical patterns of epistasis. However, MDR has its weakness in accurately assigning multilocus genotypes to either high-risk and low-risk groups, and does generally not provide accurate error rates when the case and control data sets are imbalanced. Consequently, results for classification error rates and odds ratios (OR) may provide surprising values in that the true positive (TP) value is often small. Methodology/Principal Findings: To address this problem, we introduce a classifier function based on the ratio between the percentage of cases in case data and the percentage of controls in control data to improve MDR (MDR-ER) for multilocus genotypes to be classified correctly into high-risk and low-risk groups. In this study, a real data set with different ratios of cases to controls (1:4) was obtained from the mitochondrial D-loop of chronic dialysis patients in order to test MDR-ER. The TP and TN values were collected from all tests to analyze to what degree MDR-ER performed better than MDR. Conclusions/Significance: Results showed that MDR-ER can be successfully used to detect the complex associations in imbalanced data sets.	[Yang, Cheng-Hong; Lin, Yu-Da] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Chen, Jin-Bor] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Internal Med,Div Nephrol,Mitochondrial Res U, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; I Shou University; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, LY (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	chuang@isu.edu.tw; changhw@kmu.edu.tw	Yang, Cheng-Hong/K-2438-2019; Chang, Hsueh-Wei/C-9654-2009; Lin, Yu-da/M-7946-2013	Chang, Hsueh-Wei/0000-0003-0068-2366; Lin, Yu-da/0000-0001-5100-6072	National Science Council [NSC102-2221-E-151-024-MY3, NSC100-2221-E-151-049-MY3, NSC102-2622-E-151-003-CC3, NSC 102-2622-B-037-003-CC2]; Kaohsiung Chang Gung Memorial Hospital [CMRPG850271, CMRPG850272, CMRPG850242, CMRPG850252]; Department of Health, Executive Yuan, Taiwan, Republic of China [DOH102-TD-C-111-002]; National Sun Yat-Sen University-KMU Joint Research Project [NSYSU-KMU 102-034]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Executive Yuan, Taiwan, Republic of China; National Sun Yat-Sen University-KMU Joint Research Project	This study was supported by grants from the National Science Council (NSC102-2221-E-151-024-MY3, NSC100-2221-E-151-049-MY3, NSC102-2622-E-151-003-CC3, NSC 102-2622-B-037-003-CC2), from Kaohsiung Chang Gung Memorial Hospital (CMRPG850271, CMRPG850272, CMRPG850242, and CMRPG850252), from the Department of Health, Executive Yuan, Taiwan, Republic of China (DOH102-TD-C-111-002), and from the National Sun Yat-Sen University-KMU Joint Research Project (#NSYSU-KMU 102-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Chang HW, 2009, COMPUT BIOL CHEM, V33, P114, DOI 10.1016/j.compbiolchem.2008.07.029; Chen JB, 2013, MITOCHONDRI IN PRESS; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chuang LY, 2012, EUR J CANCER PREV, V21, P336, DOI 10.1097/CEJ.0b013e32834e31f6; Chuang LY, 2012, PLOS ONE, V7; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Gui J, 2011, ANN HUM GENET, V75, P20, DOI 10.1111/j.1469-1809.2010.00624.x; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Meindl A, 2009, BREAST CARE, V4, P93, DOI 10.1159/000211991; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Wu SJ, 2013, MOL BIOL REP, V40, P4227, DOI 10.1007/s11033-013-2504-8; Yang CH, 2013, IEEE ACM T COMPUT BI, V10, P361, DOI 10.1109/TCBB.2013.27; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang CH, 2009, CANCER EPIDEMIOL, V33, P147, DOI 10.1016/j.canep.2009.07.001; Yang PY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S10; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821	35	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79387	10.1371/journal.pone.0079387	http://dx.doi.org/10.1371/journal.pone.0079387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236125	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700124
J	Encarnacion-Luevano, A; Rojas-Soto, OR; Sigala-Rodriguez, JJ				Encarnacion-Luevano, Alondra; Rojas-Soto, Octavio R.; Jesus Sigala-Rodriguez, J.			Activity Response to Climate Seasonality in Species with Fossorial Habits: A Niche Modeling Approach Using the Lowland Burrowing Treefrog (Smilisca fodiens)	PLOS ONE			English	Article							ECOLOGICAL NICHES; ANURAN AMPHIBIANS; DISTRIBUTIONS; EVOLUTION; BEHAVIOR; BIRDS; EXTINCTIONS; ECTOTHERMS; PHYSIOLOGY; PATTERNS	The importance of climatic conditions in shaping the geographic distribution of amphibian species is mainly associated to their high sensitivity to environmental conditions. How they cope with climate gradients through behavioral adaptations throughout their distribution is an important issue due to the ecological and evolutionary implications for population viability. Given their low dispersal abilities, the response to seasonal climate changes may not be migration, but behavioral and physiological adaptations. Here we tested whether shifts in climatic seasonality can predict the temporal variation of surface activity of the fossorial Lowland Burrowing Treefrog (Smilisca fodiens) across its geographical distribution. We employed Ecological Niche Modeling (ENM) to perform a monthly analysis of spatial variation of suitable climatic conditions (defined by the July conditions, the month of greatest activity), and then evaluated the geographical correspondence of monthly projections with the occurrence data per month. We found that the species activity, based on the species' occurrence data, corresponds with the latitudinal variation of suitable climatic conditions. Due to the behavioral response of this fossorial frog to seasonal climate variation, we suggest that precipitation and temperature have played a major role in the definition of geographical and temporal distribution patterns, as well as in shaping behavioral adaptations to local climatic conditions. This highlights the influence of macroclimate on shaping activity patterns and the important role of fossorials habits to meet the environmental requirements necessary for survival.	[Encarnacion-Luevano, Alondra; Jesus Sigala-Rodriguez, J.] Univ Autonoma Aguascalientes, Dept Biol, Aguascalientes, Mexico; [Rojas-Soto, Octavio R.] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico	Universidad Autonoma de Aguascalientes; Instituto de Ecologia - Mexico	Rojas-Soto, OR (corresponding author), Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.edu.mx	Rojas-Soto, Octavio/Q-6252-2018; Sigala-Rodríguez, J. Jesus/B-3617-2013	Rojas-Soto, Octavio/0000-0002-0201-1454; Sigala-Rodríguez, J. Jesus/0000-0002-5895-1568; Encarnacion-Luevano, Alondra/0000-0003-1930-375X	Consejo Nacional de Ciencia y Tecnologia [373460]; Universidad Autonoma de Aguascalientes	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Autonoma de Aguascalientes	Funding provided by Consejo Nacional de Ciencia y Tecnologia Grant number 373460(http://www.conacyt.gob.mx) and Universidad Autonoma de Aguascalientes (www.uaa.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Barve N, 2008, TOOL PARTIAL ROC; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Booth DT, 2006, CAN J ZOOL, V84, P832, DOI 10.1139/Z06-062; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; DUELLMAN W. E., 1966, NEOTROPICAL HYLID FR; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman WE, 1999, PATTERNS DISTRIBUTIO; ESRI, 1999, ARCVIEWGIS V 3 2; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; GABRIEL W, 1992, J EVOLUTION BIOL, V5, P41, DOI 10.1046/j.1420-9101.1992.5010041.x; Garmer M, 2010, IRR VARIOUS COEFFICI; Grinnell J., 1917, Auk Cambridge Mass, V34; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOFFMAN J, 1989, OECOLOGIA, V81, P510, DOI 10.1007/BF00378961; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Lutterschmidt DI, 2006, CAN J ZOOL, V84, P771, DOI 10.1139/Z06-043; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003; Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032; Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2011, ECOLOGICAL NICHES GE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rojas-Soto OR, 2003, J BIOGEOGR, V30, P449, DOI 10.1046/j.1365-2699.2003.00836.x; Santos-Barrera G, 2010, IUCN 2012 IUCN RED L; SCACHETTIPEREIR.R, 2002, DESKTOP GARP; Sears MW, 2011, INTEGR COMP BIOL, V51, P662, DOI 10.1093/icb/icr113; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Solomon S, 2007, CONTRIBUTION WORKING; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sullivan BK, 1996, GREAT BASIN NAT, V56, P38, DOI 10.5962/bhl.part.4107; Weatherhead PJ, 2012, J THERM BIOL, V37, P273, DOI 10.1016/j.jtherbio.2011.03.008; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882	52	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78290	10.1371/journal.pone.0078290	http://dx.doi.org/10.1371/journal.pone.0078290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244301	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600024
J	Mohri, T; Ueno, M; Nagahama, Y; Gong, ZY; Asano, M; Oshima, H; Oshima, M; Fujio, Y; Takakura, N				Mohri, Tomomi; Ueno, Masaya; Nagahama, Yumi; Gong, Zhi-Yuan; Asano, Masahide; Oshima, Hiroko; Oshima, Masanobu; Fujio, Yasushi; Takakura, Nobuyuki			Requirement of SLD5 for Early Embryogenesis	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; STEM-CELL NICHE; CHROMOSOMAL DNA; XENOPUS-LAEVIS; GINS COMPLEX; CDC45; IDENTIFICATION; MAINTENANCE; EXPRESSION; MCM2-7	SLD5 forms a GINS complex with PSF1, PSF2 and PSF3, which is essential for the initiation of DNA replication in lower eukaryotes. Although these components are conserved in mammals, their biological function is unclear. We show here that targeted disruption of SLD5 in mice causes a defect in cell proliferation in the inner cell mass, resulting in embryonic lethality at the peri-implantation stage, indicating that SLD5 is essential for embryogenesis. Moreover, this phenotype of SLD5 mutant mice is quite similar compared with that of PSF1 mutant mice. We have previously reported that haploinsufficiency of PSF1 resulted in failure of acute proliferation of bone marrow hematopoietic stem cells (HSCs) during reconstitution of bone marrow ablated by 5-FU treatment. Since SLD5 was highly expressed in bone marrow, we investigated its involvement in bone marrow reconstitution after bone marrow ablation as observed in PSF1 heterozygous mutant mice. However, heterozygous deletion of the SLD5 gene was found not to significantly affect bone marrow reconstitution. On the other hand, abundant SLD5 expression was observed in human cancer cell lines and heterozygous deletion of the gene attenuated tumor progression in a murine model of spontaneous gastric cancer. These indicated that requirement and dependency of SLD5 for cell proliferation is different in different cell types.	[Mohri, Tomomi; Ueno, Masaya; Nagahama, Yumi; Gong, Zhi-Yuan; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Mohri, Tomomi; Fujio, Yasushi] Osaka Univ, Lab Clin Sci & Biomed, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Inst Expt Anim, Kanazawa, Ishikawa, Japan; [Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Osaka University; Osaka University; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp	Oshima, Masanobu/F-9958-2014; Fujio, Yasushi/H-3421-2017; UENO, Masaya/D-8464-2015	Oshima, Masanobu/0000-0002-3304-0004; Fujio, Yasushi/0000-0003-0828-2930; UENO, Masaya/0000-0001-9177-8640	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (M.U. and N.T.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gouge CA, 2010, BIOCHEM BIOPH RES CO, V400, P145, DOI 10.1016/j.bbrc.2010.08.033; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kong LY, 2006, BIOCHEM BIOPH RES CO, V339, P1204, DOI 10.1016/j.bbrc.2005.11.136; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nagahama Y, 2010, CANCER RES, V70, P1215, DOI 10.1158/0008-5472.CAN-09-3662; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Ueno M, 2009, BLOOD, V113, P555, DOI 10.1182/blood-2008-01-136879; Walter BE, 2004, GENE EXPR PATTERNS, V5, P81, DOI 10.1016/j.modgep.2004.06.005; Walter BE, 2008, MOL VIS, V14, P906; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78961	10.1371/journal.pone.0078961	http://dx.doi.org/10.1371/journal.pone.0078961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244394	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600087
J	Nookala, AR; Shah, A; Noel, RJ; Kumar, A				Nookala, Anantha R.; Shah, Ankit; Noel, Richard J.; Kumar, Anil			HIV-1 Tat-Mediated Induction of CCL5 in Astrocytes Involves NF-kappa B, AP-1, C/EBP alpha and C/EBP gamma Transcription Factors and JAK, PI3K/Akt and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVATED PROTEIN-KINASE; INTERLEUKIN-6 GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; TNF-ALPHA; RANTES/CCL5 EXPRESSION; ACETYLCYSTEINE AMIDE; CYTOKINE PRODUCTION	The incidence of HIV-associated neurological disorders (HAND) has increased during recent years even though the highly active antiretroviral therapy (HAART) has significantly curtailed the virus replication and increased the life expectancy among HIV-1 infected individuals. These neurological deficits have been attributed to HIV proteins including HIV-1 Tat. HIV-1 Tat is known to up-regulate CCL5 expression in mouse astrocytes, but the mechanism of up-regulation is not known. The present study was undertaken with the objective of determining the mechanism(s) underlying HIV-1 Tat-mediated expression of CCL5 in astrocytes. SVGA astrocytes were transiently transfected with a plasmid encoding Tat, and expression of CCL5 was studied at the mRNA and protein levels using real time RT-PCR and multiplex cytokine bead array, respectively. HIV-1 Tat showed a time-dependent increase in the CCL5 expression with peak mRNA and protein levels, observed at 1 h and 48 h post-transfection, respectively. In order to explore the mechanism(s), pharmacological inhibitors and siRNA against different pathway(s) were used. Pre-treatment with SC514 (NF-kappa B inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kappa B in CCL5 expression. These results were further confirmed by knockdown of the respective genes using siRNA. Furthermore, p38 MAPK was found to be involved since the knockdown of p38d but not other isoforms showed partial reduction in CCL5 induction. This was further confirmed at transcriptional level that AP-1, C/EBP alpha and C/EBP gamma were involved in CCL5 up-regulation.	[Nookala, Anantha R.; Shah, Ankit; Kumar, Anil] UMKC Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA; [Noel, Richard J.] Ponce Sch Med & Hlth Sci, Dept Biochem, Ponce, PR USA	University of Missouri System; University of Missouri Kansas City	Kumar, A (corresponding author), UMKC Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA.	kumaran@umkc.edu	Nookala, Anantha Ram/ABV-0636-2022; KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022; Nookala, Anantha Ram/ABT-0475-2022		National Institute on Drug Abuse [DA025528, DA025011]; National Institute on Alcohol Abuse and Alcoholism [AA020806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050, S10RR027668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011) and National Institute on Alcohol Abuse and Alcoholism (AA020806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Aukrust P, 1998, J INFECT DIS, V177, P1091, DOI 10.1086/517402; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Bartosik-Psujek H, 2005, EUR J NEUROL, V12, P49, DOI 10.1111/j.1468-1331.2004.00951.x; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066268; Christo PP, 2009, J NEUROL SCI, V287, P79, DOI 10.1016/j.jns.2009.09.002; Conant K, 1996, J VIROL, V70, P1384, DOI 10.1128/JVI.70.3.1384-1389.1996; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fessele S, 2001, FASEB J, V15, P577; Fotheringham JA, 2012, J VIROL, V86, P10308, DOI 10.1128/JVI.00853-12; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999; GOURDOU I, 1990, CR ACAD SCI III-VIE, V311, P149; GRIFFIN DE, 1991, NEUROLOGY, V41, P69, DOI 10.1212/WNL.41.1.69; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim TA, 2003, J IMMUNOL, V170, P2629, DOI 10.4049/jimmunol.170.5.2629; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kruman II, 1999, AM J PATHOL, V155, P39, DOI 10.1016/S0002-9440(10)65096-1; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Letendre SL, 1999, J INFECT DIS, V180, P310, DOI 10.1086/314866; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mamik MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045596; MASTROIANNI CM, 1992, J NEUROL NEUROSUR PS, V55, P219, DOI 10.1136/jnnp.55.3.219; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125; Qin B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2644; Qiu L, 2009, IMMUNOLOGY, V128, pe325, DOI 10.1111/j.1365-2567.2008.02966.x; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Rentzos M, 2007, ACTA NEUROL SCAND, V116, P374, DOI 10.1111/j.1600-0404.2007.00894.x; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shea LM, 1996, J IMMUNOL, V157, P3902; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Uckun FM, 2002, DRUG METAB DISPOS, V30, P74, DOI 10.1124/dmd.30.1.74; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Wong CK, 2005, CLIN EXP IMMUNOL, V139, P90, DOI 10.1111/j.1365-2249.2005.02678.x	83	27	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78855	10.1371/journal.pone.0078855	http://dx.doi.org/10.1371/journal.pone.0078855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244375	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600071
J	Yang, JJ; Yuan, PF; Wen, DQ; Sheng, Y; Zhu, SY; Yu, YZ; Gao, X; Wei, WS				Yang, Junjiao; Yuan, Pengfei; Wen, Dingqiao; Sheng, Ying; Zhu, Shiyou; Yu, Yuezhou; Gao, Xiang; Wei, Wensheng			ULtiMATE System for Rapid Assembly of Customized TAL Effectors	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY	Engineered TAL-effector nucleases (TALENs) and TALE-based constructs have become powerful tools for eukaryotic genome editing. Although many methods have been reported, it remains a challenge for the assembly of designer-based TALE repeats in a fast, precise and cost-effective manner. We present an ULtiMATE (USER-based Ligation Mediated Assembly of TAL Effector) system for speedy and accurate assembly of customized TALE constructs. This method takes advantage of uracil-specific excision reagent (USER) to create multiple distinct sticky ends between any neighboring DNA fragments for specific ligation. With pre-assembled templates, multiple TALE DNA-binding domains could be efficiently assembled in order within hours with minimal manual operation. This system has been demonstrated to produce both functional TALENs for effective gene knockout and TALE-mediated gene-specific transcription activation (TALE-TA). The feature of both ease-of-operation and high efficiency of ULtiMATE system makes it not only an ideal method for biologic labs, but also an approach well suited for large-scale assembly of TALENs and any other TALE-based constructions.	[Yang, Junjiao; Yuan, Pengfei; Wen, Dingqiao; Sheng, Ying; Zhu, Shiyou; Yu, Yuezhou; Wei, Wensheng] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Gao, Xiang] Peking Univ, Dept Elect, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Wei, WS (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Wei, Wensheng/AAF-1325-2020	Yang, Junjiao/0000-0003-4844-2492; Wen, Dingqiao/0000-0001-8229-2294; Wei, Wensheng/0000-0002-8053-2423	Major State Basic Research Development Program of China [2010CB911800]; National Science Foundation of China [NSFC31070115, NSFC31170126]; 985 Project of Peking University; Peking-Tsinghua Center for Life Sciences	Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 985 Project of Peking University(Peking University); Peking-Tsinghua Center for Life Sciences	This work was supported in part by the Major State Basic Research Development Program of China (grant number 2010CB911800), the National Science Foundation of China (grant numbers NSFC31070115, NSFC31170126), and a grant of the 985 Project of Peking University and Peking-Tsinghua Center for Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SCHMIDBURGK JL, 2012, NAT BIOTECHNOL; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	20	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75649	10.1371/journal.pone.0075649	http://dx.doi.org/10.1371/journal.pone.0075649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24228087	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900054
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, S.; Feferman, L.; Tobacman, J. K.			Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects	ONCOGENE			English	Article						chondroitin sulfate; arylsulfatase B; galectin-3; versican; glycosaminoglycan	FORMYLGLYCINE-GENERATING ENZYME; GROWTH-FACTOR RECEPTOR; STAGE PROSTATE-CANCER; EPITHELIAL-CELLS; BINDING SITE; IN-VITRO; ACTIVATION; N-ACETYLGALACTOSAMINE-4-SULFATASE; OVEREXPRESSION; PROGRESSION	Arylsulfatase B (N-acetylgalactosamine-4-sulfatase; ARSB) removes 4-sulfate groups from chondroitin-4-sulfate (C4S) and dermatan sulfate and is required for their degradation. In human prostate stromal and epithelial cells, when ARSB was silenced, C4S, versican and versican promoter activity increased, and the galectin-3 that co-immunoprecipitated with C4S declined. Galectin-3 silencing inhibited the ARSB-silencing-induced increases in versican and versican promoter due to effects on the AP-1-binding site in the versican promoter. These findings demonstrate for the first time the transcriptional mechanism whereby ARSB can regulate expression of an extracellular matrix proteoglycan with C4S attachments. In addition, following ARSB silencing, C4S that co-immunoprecipitated with versican increased, whereas co-immunoprecipitated EGFR declined, total EGFR increased and exogenous EGF-induced cell proliferation increased, suggesting profound effects of ARSB on vital cell processes.	[Bhattacharyya, S.; Feferman, L.; Tobacman, J. K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, S.; Feferman, L.; Tobacman, J. K.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 South Wood St,CSN 440 M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu			NCRR NIH HHS [UL1 RR029879] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, CLIN CHIM ACTA, V380, P122, DOI 10.1016/j.cca.2007.01.021; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2010, BBA-MOL BASIS DIS, V1802, P472, DOI 10.1016/j.bbadis.2010.01.014; Bhattacharyya S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-303; Bhattacharyya S, 2010, AM J RESP CELL MOL, V42, P51, DOI 10.1165/rcmb.2008-0482OC; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; Christianson TM, 2004, BIOCHEM J, V382, P581, DOI 10.1042/BJ20040447; Domenzain-Reyna C, 2009, J BIOL CHEM, V284, P12306, DOI 10.1074/jbc.M807108200; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Ferrero GB, 2008, MOL GENET METAB, V94, P139, DOI 10.1016/j.ymgme.2007.10.010; Hann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020859; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Kotlo K, 2013, GLYCOCONJUGATE J, V30, P667, DOI 10.1007/s10719-013-9468-8; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Rao GJ, 1994, BIOCHIM BIOPHYS ACTA, V788, P58; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Ricciardelli C, 1997, CLIN CANCER RES, V3, P983; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; Sakko AJ, 2003, CANCER RES, V63, P4786; Sharma G, 2013, PEDIATR PULM, V48, P236, DOI 10.1002/ppul.22567; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; WANG L, 1995, BIOCHEM BIOPH RES CO, V217, P292, DOI 10.1006/bbrc.1995.2777; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; WOJCZYK B, 1986, BIOL CELL, V57, P147, DOI 10.1111/j.1768-322X.1986.tb00471.x; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yoo BC, 2009, CELL MOL LIFE SCI, V66, P350, DOI 10.1007/s00018-009-8562-3; Yoo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057415	41	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5467	5476		10.1038/onc.2013.483	http://dx.doi.org/10.1038/onc.2013.483			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240681	Green Accepted			2022-12-25	WOS:000345120700009
J	Lai, WL; Hung, WY; Ching, YP				Lai, W. L.; Hung, W. Y.; Ching, Y. P.			The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase	ONCOGENE			English	Article						ATM; TAX1BP2; HCC and phosphorylation	DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; PROTEIN; P53; PHOSPHORYLATION; ACTIVATION; CANCER; IDENTIFICATION	DNA damage repair response is a crucial process for cancer prevention. One of the key regulators of this process is ataxia telangiectasia mutated (ATM) kinase, which modulates the p53 level by direct and indirect phosphorylation. Recent data showed that ATM also localizes at the centrosome, but the function remains elusive. TAX1BP2 was initially identified as a novel centrosomal protein that interacts directly with the human T-cell leukemia virus type 1 (HTLV-1)-encoded oncoprotein, Tax, and inhibits centrosome overduplication. Subsequently, TAX1BP2 was found to be a tumor suppressor in hepatocellular carcinoma, and accumulation of TAX1BP2 was observed upon chemotherapeutic drug treatment. Here, we provide evidence that TAX1BP2 is a direct phosphorylation substrate of ATM. The protein level of TAX1BP2 is significantly upregulated in response to DNA damaging agents. Serine-922 of TAX1BP2 is the phosphorylation site of ATM, and such phosphorylation modulates the protein stability, ubiquitination and tumor suppressor activity of TAX1BP2. Taken together, we demonstrate for the first time that TAX1BP2 is a novel effector of ATM in DNA damage response and delineated a new mechanism by which ATM stabilizes the tumor suppressor TAX1BP2.	[Lai, W. L.; Hung, W. Y.; Ching, Y. P.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Ching, Y. P.] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Ching, Y. P.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Ching, YP (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Room L1-43,Fac Med Bldg, Pokfulam, Hong Kong, Peoples R China.	ypching@hku.hk		CHING, Yick Pang/0000-0002-6461-8358	Hong Kong Health and Medical Research Fund [12110872]; Hong Kong Research Grant Council (HKU) [763509, 7/CRF/09]; SK Yee Medical Research Fund; University of Hong Kong [201209176008]	Hong Kong Health and Medical Research Fund; Hong Kong Research Grant Council (HKU)(University of Hong KongHong Kong Research Grants Council); SK Yee Medical Research Fund; University of Hong Kong(University of Hong Kong)	We are very grateful to Prof Jin DY for providing the HA-p38-expressing plasmid, Prof SW Tsao for providing the anti-Chk1 and anti-Chk2 antibodies and Dr MS Huen for providing the FLAG-ubiquitin-expressing plasmid. Financial support was received from the Hong Kong Health and Medical Research Fund (No. 12110872), the Hong Kong Research Grant Council (HKU 763509 and 7/CRF/09), the SK Yee Medical Research Fund 2011 (to YPC) and The University of Hong Kong (Small Project Funding 201209176008 to WLL).	Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lai WL, 2012, HEPATOLOGY, V56, P1770, DOI 10.1002/hep.25851; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Teoh N, 2010, GASTROENTEROLOGY, V138, P1155, DOI 10.1053/j.gastro.2009.11.008; Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	16	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5303	5309		10.1038/onc.2013.481	http://dx.doi.org/10.1038/onc.2013.481			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24240686				2022-12-25	WOS:000345120400008
J	Ranieri, M; Tamma, G; Di Mise, A; Vezzoli, G; Soldati, L; Svelto, M; Valenti, G				Ranieri, Marianna; Tamma, Grazia; Di Mise, Annarita; Vezzoli, Giuseppe; Soldati, Laura; Svelto, Maria; Valenti, Giovanna			Excessive Signal Transduction of Gain-of-Function Variants of the Calcium-Sensing Receptor (CaSR) Are Associated with Increased ER to Cytosol Calcium Gradient	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPOCALCEMIA; CA2+-SENSING RECEPTOR; R990G POLYMORPHISM; EXTRACELLULAR DOMAIN; PLASMA-MEMBRANE; MUTATION; GENE; HYPERCALCIURIA; OSCILLATIONS; TRAFFICKING	In humans, gain-of-function mutations of the calcium-sensing receptor (CASR) gene are the cause of autosomal dominant hypocalcemia or type 5 Bartter syndrome characterized by an abnormality of calcium metabolism with low parathyroid hormone levels and excessive renal calcium excretion. Functional characterization of CaSR activating variants has been so far limited at demonstrating an increased sensitivity to external calcium leading to lower Ca-EC50. Here we combine high resolution fluorescence based techniques and provide evidence that for the efficiency of calcium signaling system, cells expressing gain-of-function variants of CaSR monitor cytosolic and ER calcium levels increasing the expression of the Sarco-Endoplasmic Reticulum Calcium-ATPase (SERCA) and reducing expression of Plasma Membrane Calcium-ATPase (PMCA). Wild-type CaSR (hCaSR-wt) and its gain-of-function (hCaSR-R990G; hCaSR-N124K) variants were transiently transfected in HEK-293 cells. Basal intracellular calcium concentration was significantly lower in cells expressing hCaSR-wt and its gain of function variants compared to mock. In line, FRET studies using the D1ER probe, which detects [Ca2+]ER directly, demonstrated significantly higher calcium accumulation in cells expressing the gain of function CaSR variants compared to hCaSR-wt. Consistently, cells expressing activating CaSR variants showed a significant increase in SERCA activity and expression and a reduced PMCA expression. This combined parallel regulation in protein expression increases the ER to cytosol calcium gradient explaining the higher sensitivity of CaSR gain-of-function variants to external calcium. This control principle provides a general explanation of how cells reliably connect (and exacerbate) receptor inputs to cell function.	[Ranieri, Marianna; Tamma, Grazia; Di Mise, Annarita; Svelto, Maria; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Vezzoli, Giuseppe] Hosp San Raffaele, Inst Sci, Nephrol & Dialysis Unit, I-20132 Milan, Italy; [Soldati, Laura] Univ Milan, Dept Hlth Sci, Milan, Italy; [Svelto, Maria; Valenti, Giovanna] Univ Bari, Ctr Excellence Genom & Prote GEBCA, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Universita degli Studi di Bari Aldo Moro	Valenti, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	giovanna.valenti@uniba.it	Di Mise, Annarita/AAP-4176-2020; Ranieri, Marianna/J-9421-2018; Vezzoli, Giuseppe/J-4147-2018; Tamma, Grazia/F-8823-2016; Svelto, Maria/P-6186-2014	Ranieri, Marianna/0000-0003-3118-5813; Vezzoli, Giuseppe/0000-0003-4481-5693; Tamma, Grazia/0000-0002-8890-0278; VALENTI, GIOVANNA/0000-0003-0233-0778; Soldati, Laura/0000-0002-3447-1172; Svelto, Maria/0000-0002-5584-9541; DI MISE, Annarita/0000-0002-8132-4917				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1482, DOI 10.1210/me.2011-1370; Brown EM, 2009, ENDOCRIN METAB CLIN, V38, P437, DOI 10.1016/j.ecl.2009.01.001; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chattopadhyay N, 2006, MOL GENET METAB, V89, P189, DOI 10.1016/j.ymgme.2006.07.003; Corbetta S, 2006, EUR J ENDOCRINOL, V155, P687, DOI 10.1530/eje.1.02286; Demarchi F, 2007, CELL CYCLE, V6, P136; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Falchetti A, 2012, EUR J ENDOCRINOL, V166, P933, DOI 10.1530/EJE-11-0953; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Hu JX, 2002, J BONE MINER RES, V17, P1461, DOI 10.1359/jbmr.2002.17.8.1461; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, PLOS ONE, V7; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Richard C, 2010, J BONE MINER RES, V25, P1627, DOI 10.1002/jbmr.58; SHULL GE, 1988, J BIOL CHEM, V263, P8646; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Terranegra A, 2010, J MOL ENDOCRINOL, V45, P245, DOI 10.1677/JME-10-0034; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Theman TA, 2009, J BONE MINER RES, V24, P964, DOI 10.1359/JBMR.081233; Valenti G, CELL PHYSL BIOCH, V26, P901; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; Vezzoli G, 2002, J AM SOC NEPHROL, V13, P2517, DOI 10.1097/01.ASN.0000030077.72157.D2; Ward DT, EUR J ENDOCRINOL, V169, pK1; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	45	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79113	10.1371/journal.pone.0079113	http://dx.doi.org/10.1371/journal.pone.0079113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244430	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800030
J	Hamashima, C; Ogoshi, K; Okamoto, M; Shabana, M; Kishimoto, T; Fukao, A				Hamashima, Chisato; Ogoshi, Kazuei; Okamoto, Mikizo; Shabana, Michiko; Kishimoto, Takuji; Fukao, Akira			A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan	PLOS ONE			English	Article							STOMACH-CANCER; POPULATION; PROGRAM; ASSOCIATION; PREFECTURE	Aims: Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second leading cause of cancer death worldwide. In Asian countries, the burden of gastric cancer has remained, and cancer screening is normally expected to reduce gastric cancer death. We conducted a community-based, case-control study to evaluate the reduction of mortality from gastric cancer by endoscopic screening. Methods: Case subjects were defined as individuals who had died of gastric cancer between 2003 and 2006 in 4 cities in Tottori Prefecture, and between 2006 and 2010 in Niigata City, Japan. Up to 6 control subjects were matched by sex, birth year (+/- 3 years), and the residence of each corresponding case subject from the population lists in the study areas. Control subjects were required to be disease-free at the time when the corresponding case subjects were diagnosed as having gastric cancer. The odds ratios (ORs) were calculated for those who had participated in endoscopic or radiographic screening before the reference date when the case subjects were diagnosed as having gastric cancer, compared with subjects who had never participated in any screening. Conditional logistic-regression models for matched sets were used to estimate the ORs and 95% confidence intervals (CIs). Results: The case subjects consisted of 288 men and 122 women for case subjects, with 2,292 matched control subjects. Compared with those who had never been screened before the date of diagnosis of gastric cancer in the case subjects, the ORs within 36 months from the date of diagnosis were 0.695 (95% CI: 0.489-0.986) for endoscopic screening and 0.865 (95% CI : 0.631-1.185) for radiographic screening. Conclusions: The results suggest a 30% reduction in gastric cancer mortality by endoscopic screening compared with no screening within 36 months before the date of diagnosis of gastric cancer.	[Hamashima, Chisato] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Assessment & Management Div, Tokyo 104, Japan; [Ogoshi, Kazuei] Niigata Canc Ctr Hosp, Niigata, Japan; [Okamoto, Mikizo] Tottori Univ, Fac Med, Dept Social Med, Div Hlth Adm & Promot, Yonago, Tottori 683, Japan; [Shabana, Michiko] San in Rosai Hosp, Dept Internal Med, Yonago, Tottori, Japan; [Kishimoto, Takuji] Tottori Univ, Fac Med, Dept Social Med, Div Environm & Prevent Med, Yonago, Tottori 683, Japan; [Fukao, Akira] Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata, Yamagata, Japan	National Cancer Center - Japan; Tottori University; Tottori University; Yamagata University	Hamashima, C (corresponding author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Assessment & Management Div, Tokyo 104, Japan.	chamashi@ncc.go.jp	Hamashima, Chisato/AAI-3061-2021		Ministry of Health, Labor and Welfare of Japan [15-3, 20-9]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grant-in-Aid for Cancer Control from Ministry of Health, Labor and Welfare of Japan (Grant number 15-3 and 20-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Yohsuke, 1995, Japanese Journal of Gastroenterology, V92, P836; Cronin KA, 1998, J NATL CANCER I, V90, P498, DOI 10.1093/jnci/90.7.498; FUKAO A, 1995, INT J CANCER, V60, P45, DOI 10.1002/ijc.2910600106; FUKAO A, 1992, TOHOKU J EXP MED, V166, P459, DOI 10.1620/tjem.166.459; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Hamashima Chisato, 2003, Asian Pac J Cancer Prev, V4, P39; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; International Agency for Research on Cancer, 2008, GLOBOCAN 2008; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Lee SJ, 2012, BMJ-BRIT MED J, V345, pe8441; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Matsumoto S, 2007, WORLD J GASTROENTERO, V13, P4316, DOI 10.3748/wjg.v13.i32.4316; Ministry of Health Labour and Welfare of Japan, 2010, NAT SURV CANC SCREEN; Ministry of Health Welfare and Labour., 2007, JAP ETH GUID EP STUD; Ministry of Health Welfare and Labour, 2006, PAT BEH SURV 2005; MORRISON AS, 1982, AM J EPIDEMIOL, V115, P6; MOSS SM, 1991, INT J EPIDEMIOL, V20, P1, DOI 10.1093/ije/20.1.1; Nam JH, 2012, CANCER-AM CANCER SOC, V118, P4953, DOI 10.1002/cncr.27495; Ogoshi K, 2010, JPN J ENDOSC FORUM D, V26, P5; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; PISANI P, 1994, BRIT J CANCER, V69, P1102, DOI 10.1038/bjc.1994.216; Riecken B, 2002, PREV MED, V34, P22, DOI 10.1006/pmed.2001.0925; Shabana M., 2010, JPN J CANC DIAGN, V17, P229; Tsubono Y, 1999, J GASTROENTEROL MASS, V37, P182; Wahrendorf J, 1993, Eur J Cancer Prev, V2, P221, DOI 10.1097/00008469-199305000-00005	25	94	101	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79088	10.1371/journal.pone.0079088	http://dx.doi.org/10.1371/journal.pone.0079088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236091	Green Published, gold			2022-12-25	WOS:000327254700089
J	Hyodo, H; Terao, A; Furukawa, J; Sakamoto, N; Yurimoto, H; Satoh, S; Iwai, H				Hyodo, Hiromi; Terao, Azusa; Furukawa, Jun; Sakamoto, Naoya; Yurimoto, Hisayoshi; Satoh, Shinobu; Iwai, Hiroaki			Tissue Specific Localization of Pectin-Ca2+ Cross-Linkages and Pectin Methyl-Esterification during Fruit Ripening in Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							CELL-WALL; METHYLESTERASE GENE; GOLGI-APPARATUS; SIDE-CHAINS; CDNA-CLONE; IDENTIFICATION; CALCIUM; METHYLTRANSFERASE; EXPRESSION; POLYGALACTURONASE	Fruit ripening is one of the developmental processes accompanying seed development. The tomato is a well-known model for studying fruit ripening and development, and the disassembly of primary cell walls and the middle lamella, such as through pectin de-methylesterified by pectin methylesterase (PE) and depolymerization by polygalacturonase (PG), is generally accepted to be one of the major changes that occur during ripening. Although many reports of the changes in pectin during tomato fruit ripening are focused on the relation to softening of the pericarp or the Blossom-end rot by calcium (Ca2+) deficiency disorder, the changes in pectin structure and localization in each tissues during tomato fruit ripening is not well known. In this study, to elucidate the tissue-specific role of pectin during fruit development and ripening, we examined gene expression, the enzymatic activities involved in pectin synthesis and depolymerisation in fruit using biochemical and immunohistochemical analyses, and uronic acids and calcium (Ca)-bound pectin were determined by secondary ion-microprobe mass spectrometry. These results show that changes in pectin properties during fruit development and ripening have tissue-specific patterns. In particular, differential control of pectin methyl-esterification occurs in each tissue. Variations in the cell walls of the pericarp are quite different from that of locular tissues. The Ca-binding pectin and hairy pectin in skin cell layers are important for intercellular and tissue-tissue adhesion. Maintenance of the globular form and softening of tomato fruit may be regulated by the arrangement of pectin structures in each tissue.	[Hyodo, Hiromi; Terao, Azusa; Furukawa, Jun; Satoh, Shinobu; Iwai, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sakamoto, Naoya; Yurimoto, Hisayoshi] Hokkaido Univ, Creat Res Inst CRIS, Sapporo, Hokkaido, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Sapporo, Hokkaido, Japan	University of Tsukuba; Hokkaido University; Hokkaido University	Iwai, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	iwai.hiroaki.gb@u.tsukuba.ac.jp	Iwai, Hiroaki/B-3171-2014; Yurimoto, Hisayoshi/S-9938-2018; Furukawa, Jun/D-4293-2016	Yurimoto, Hisayoshi/0000-0003-0702-0533; 	 [18075004];  [24114006]; Grants-in-Aid for Scientific Research [25800299, 25440125] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (18075004) and a Grant-in-Aid for Scientific Research on Innovative Areas (24114006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Massih RM, 2003, PLANTA, V216, P502, DOI 10.1007/s00425-002-0861-y; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Braccini I, 2005, BIOMACROMOLECULES, V6, P1322, DOI 10.1021/bm049457h; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; DEMARTY M, 1984, PLANT CELL ENVIRON, V7, P441, DOI 10.1111/j.1365-3040.1984.tb01434.x; Dharmapuri S, 2002, FEBS LETT, V519, P30, DOI 10.1016/S0014-5793(02)02699-6; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Fang YP, 2008, CARBOHYD POLYM, V72, P334, DOI 10.1016/j.carbpol.2007.08.021; Fraeye I, 2009, FOOD HYDROCOLLOID, V23, P2069, DOI 10.1016/j.foodhyd.2009.03.022; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goubet F, 1998, PLANT PHYSIOL, V116, P337, DOI 10.1104/pp.116.1.337; GRIERSON D, 1986, NUCLEIC ACIDS RES, V14, P8595, DOI 10.1093/nar/14.21.8595; HAGERMAN AE, 1986, J AGR FOOD CHEM, V34, P440, DOI 10.1021/jf00069a015; HALL LN, 1994, PLANT MOL BIOL, V25, P313, DOI 10.1007/BF00023246; HARRIMAN RW, 1991, PLANT PHYSIOL, V97, P80, DOI 10.1104/pp.97.1.80; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Ishikawa M, 2000, PLANTA, V210, P782, DOI 10.1007/s004250050680; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Milner Y., 1967, CARBOHYD RES, V4, P359, DOI DOI 10.1016/S0008-6215(00)80191-3; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; NATH P, 2007, STEWART POSTHARVEST, V3, P1, DOI DOI 10.2212/SPR.2007.2.6; Phan TD, 2007, PLANT PHYSIOL, V144, P1960, DOI 10.1104/pp.107.096347; Popper ZA, 2005, ANN BOT-LONDON, V96, P91, DOI 10.1093/aob/mci153; Powell ALT, 2003, J AGR FOOD CHEM, V51, P7450, DOI 10.1021/jf034165d; PRESSEY R, 1982, J FOOD BIOCHEM, V6, P57, DOI 10.1111/j.1745-4514.1982.tb00296.x; QI XY, 1995, PLANT PHYSIOL, V108, P1691, DOI 10.1104/pp.108.4.1691; RAY J, 1988, EUR J BIOCHEM, V174, P119, DOI 10.1111/j.1432-1033.1988.tb14070.x; Rose JK, 2003, PLANT CELL WALL, V8, P264, DOI DOI 10.1002/9781119312994.APR0075; Rose JKC, 2004, CURR OPIN PLANT BIOL, V7, P296, DOI 10.1016/j.pbi.2004.03.013; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; SEYMOUR GB, 1987, PHYTOCHEMISTRY, V26, P3137, DOI 10.1016/S0031-9422(00)82457-7; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Smith DL, 2002, PLANT PHYSIOL, V129, P1755, DOI 10.1104/pp.011025; STAEHELIN LA, 1995, ANNU REV PLANT PHYS, V46, P261, DOI 10.1146/annurev.pp.46.060195.001401; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; TIEMAN DM, 1992, PLANT CELL, V4, P667, DOI 10.1105/tpc.4.6.667; Vignon MR, 2004, CARBOHYD RES, V339, P123, DOI 10.1016/j.carres.2003.09.023; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; YURIMOTO H, 2003, APPL SURF SCI, V793, P203; ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	59	34	37	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78949	10.1371/journal.pone.0078949	http://dx.doi.org/10.1371/journal.pone.0078949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236073	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700070
J	Muzny, CA; Sunesara, IR; Kumar, R; Mena, LA; Griswold, ME; Martin, DH; Lefkowitz, EJ; Schwebke, JR				Muzny, Christina A.; Sunesara, Imran R.; Kumar, Ranjit; Mena, Leandro A.; Griswold, Michael E.; Martin, David H.; Lefkowitz, Elliot J.; Schwebke, Jane R.			Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; TRANSMITTED INFECTIONS; GARDNERELLA-VAGINALIS; GRAM STAIN; FLORA; METRONIDAZOLE; PREVALENCE; DIAGNOSIS; CONTRACEPTION	Background: The pathogenesis of bacterial vaginosis (BV) remains elusive. BV may be more common among women who have sex with women (WSW). The objective of this study was to use 454 pyrosequencing to investigate the vaginal microbiome of WSW, women who have sex with women and men (WSWM), and women who have sex with men (WSM) with BV to determine if there are differences in organism composition between groups that may inform new hypotheses regarding the pathogenesis of BV. Methods: Vaginal swab specimens from eligible women with BV at the Mississippi State Department of Health STD Clinic were used. After DNA extraction, 454 pyrosequencing of PCR-amplified 16S rRNA gene sequences was performed. Sequence data was classified using the Ribosomal Database Program classifer. Complete linkage clustering analysis was performed to compare bacterial community composition among samples. Differences in operational taxonomic units with an abundance of >= 2% between risk behavior groups were determined. Alpha and beta diversity were measured using Shannon's Index implemented in QIIME and Unifrac analysis, respectively. Results: 33 WSW, 35 WSWM, and 44 WSM were included. The vaginal bacterial communities of all women clustered into four taxonomic groups with the dominant taxonomic group in each being Lactobacillus, Lachnospiraceae, Prevotella, and Sneathia. Regarding differences in organism composition between risk behavior groups, the abundance of Atopobium (relative ratio (RR)=0.24; 95%CI 0.11-0.54) and Parvimonas (RR=0.33; 95%CI 0.11-0.93) were significantly lower in WSW than WSM, the abundance of Prevotella was significantly higher in WSW than WSWM (RR=1.77; 95%CI 1.10-2.86), and the abundance of Atopobium (RR=0.41; 95%CI 0.18-0.88) was significantly lower in WSWM than WSM. Overall, WSM had the highest diversity of bacterial taxa. Conclusion: The microbiology of BV among women in different risk behavior groups is heterogeneous. WSM in this study had the highest diversity of bacterial taxa. Additional studies are needed to better understand these differences.	[Muzny, Christina A.; Sunesara, Imran R.; Schwebke, Jane R.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA; [Sunesara, Imran R.; Griswold, Michael E.] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Kumar, Ranjit; Lefkowitz, Elliot J.] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Mena, Leandro A.; Schwebke, Jane R.] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA; [Martin, David H.] Louisiana State Univ, Hlth Sci Ctr, Div Infect Dis, New Orleans, LA 70112 USA; [Lefkowitz, Elliot J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Mississippi Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Alabama System; University of Alabama Birmingham	Schwebke, JR (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA.	edswiatlo@gmail.com		Lefkowitz, Elliot/0000-0002-4748-4925; Muzny, Christina/0000-0002-4005-3858	UAB Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000165]; National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH); American Sexually Transmitted Diseases Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER	UAB Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences (NCATS); National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH); American Sexually Transmitted Diseases Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Bioinformatics support for this study was made possible by the UAB Center for Clinical and Translational Science grant number UL1TR000165 from the National Center for Advancing Translational Sciences (NCATS) and the National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH). Christina Muzny is partially supported by a Developmental Award from the American Sexually Transmitted Diseases Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Aroutcheva A, 2008, ANAEROBE, V14, P256, DOI 10.1016/j.anaerobe.2008.08.002; Bailey JV, 2004, SEX TRANSM INFECT, V80, P244, DOI 10.1136/sti.2003.007641; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards A, 1990, Int J STD AIDS, V1, P178; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Evans BA, 1998, SEX TRANSM INFECT, V74, P45, DOI 10.1136/sti.74.1.45; Falsen E, 1999, INT J SYST BACTERIOL, V49, P217, DOI 10.1099/00207713-49-1-217; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; FLEURY F J, 1981, Clinical Obstetrics and Gynecology, V24, P407, DOI 10.1097/00003081-198106000-00008; Flynn TR, 2012, J ORAL MAXIL SURG, V70, P1854, DOI 10.1016/j.joms.2011.09.009; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; JousimiesSomer H, 1997, CLIN INFECT DIS, V25, pS78, DOI 10.1086/516227; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marrazzo JM, 2012, J INFECT DIS, V205, P1580, DOI 10.1093/infdis/jis242; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Marrazzo JM, 2001, INT J STD AIDS, V12, P41, DOI 10.1258/0956462011916721; Martin David H, 2012, Trans Am Clin Climatol Assoc, V123, P242; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McCaffrey M, 1999, INT J STD AIDS, V10, P305, DOI 10.1258/0956462991914168; Mitchell C, 2011, SEX TRANSM DIS, V38, P1137, DOI 10.1097/OLQ.0b013e31822e6121; Moi H, 1990, Int J STD AIDS, V1, P86; Muzny CA, 2013, CURR INFECT DIS REP, V15, P130, DOI 10.1007/s11908-013-0318-4; Muzny CA, 2011, SEX TRANSM DIS, V38, P1118, DOI 10.1097/OLQ.0b013e31822e6179; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Pinto VM, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000191493.43865.2a; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rein M., 1983, CURRENT CLIN TOPICS, V4, P281; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2009, J INFECT DIS, V200, P1633, DOI 10.1086/648093; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	70	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80254	10.1371/journal.pone.0080254	http://dx.doi.org/10.1371/journal.pone.0080254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236175	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700176
J	Ronchetti, SA; Miler, EA; Duvilanski, BH; Cabilla, JP				Ronchetti, Sonia A.; Miler, Eliana A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.			Cadmium Mimics Estrogen-Driven Cell Proliferation and Prolactin Secretion from Anterior Pituitary Cells	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER CELL; ER-ALPHA; GENE-EXPRESSION; RECEPTOR-ALPHA; IN-VITRO; GLAND; CONTAMINATION; MECHANISMS; HORMONE	Cadmium (Cd) is a heavy metal of considerable occupational and environmental concern affecting wildlife and human health. Recent studies indicate that Cd, like other heavy metals, can mimic effects of 17 beta-estradiol (E2) involving E2 receptor (ER) activation. Lactotrophs, the most abundant cell type in anterior pituitary gland, are the main target of E2, which stimulates cell proliferation and increases prolactin secretion through ER alpha. The aim of this work was to examine whether Cd at nanomolar concentrations can induce cell proliferation and prolactin release in anterior pituitary cells in culture and whether these effects are mediated through ERs. Here we show that 10 nM Cd was able to stimulate lactotroph proliferation in anterior pituitary cell cultures from female Wistar rats and also in GH3 lactosomatotroph cell line. Proliferation of somatotrophs and gonadotrophs were not affected by Cd exposure. Cd promoted cell cycle progression by increasing cyclins D1, D3 and c-fos expression. Cd enhanced prolactin synthesis and secretion. Cd E2-like effects were blocked by the pure ERs antagonist ICI 182,780 supporting that Cd acts through ERs. Further, both Cd and E2 augmented full-length ER alpha expression and its 46 kDa-splicing variant. In addition, when co-incubated Cd was shown to interact with E2 by inducing ER alpha mRNA expression which indicates an additive effect between them. This study shows for the first time that Cd at nanomolar concentration displays xenoestrogenic activities by inducing cell growth and stimulating prolactin secretion from anterior pituitary cells in an ERs-dependent manner. Cd acting as a potent xenoestrogen can play a key role in the aetiology of different pathologies of the anterior pituitary and in estrogen-responsive tissues which represent considerable risk to human health.	[Ronchetti, Sonia A.; Miler, Eliana A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1668]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5536]; Universidad de Buenos Aires [B052]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1668), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5536) and Universidad de Buenos Aires (B052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, ENDOCRINOLOGY, V138, P2128, DOI 10.1210/en.138.5.2128; Aquino NB, 2012, J ENVIRON SCI HEAL C, V30, P189, DOI 10.1080/10590501.2012.705159; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Cabrera C, 1998, Rev Environ Contam Toxicol, V154, P55; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; CHEN HT, 1987, ENDOCRINOLOGY, V120, P247, DOI 10.1210/endo-120-1-247; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; FECHNER P, 2011, PLOS ONE, V6, P23048, DOI DOI 10.1371/J0URNAL.P0NE.0023048.PUBMED:21829690; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Hofer N, 2010, ARCH TOXICOL, V84, P541, DOI 10.1007/s00204-010-0524-x; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kah M, 2012, J TOXICOL ENV HEAL B, V15, P348, DOI 10.1080/10937404.2012.705107; Lafuente A, 1999, TOXICOL LETT, V110, P209, DOI 10.1016/S0378-4274(99)00159-9; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Martin MB, 2002, ENDOCRINOLOGY, V143, P263, DOI 10.1210/en.143.1.263; MAURER RA, 1990, PROG CLIN BIOL RES, V322, P159; Miler EA, 2010, HUM EXP TOXICOL, V29, P873, DOI 10.1177/0960327110362703; Mitchner NA, 1998, ENDOCRINOLOGY, V139, P3976, DOI 10.1210/en.139.9.3976; Montanari M, 2006, CELL DEATH DIFFER, V13, P1052, DOI 10.1038/sj.cdd.4401932; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; NISWENDER GD, 1969, P SOC EXP BIOL MED, V130, P793, DOI 10.3181/00379727-130-33657; Poliandri AHB, 2006, FREE RADICAL BIO MED, V40, P679, DOI 10.1016/j.freeradbiomed.2005.09.021; Poliandri AHB, 2003, TOXICOL APPL PHARM, V190, P17, DOI 10.1016/S0041-008X(03)00191-1; Qian X, 1998, ENDOCRINOLOGY, V139, P2058, DOI 10.1210/en.139.4.2058; Rousseau J, 2002, GEN COMP ENDOCR, V126, P175, DOI 10.1006/gcen.2002.7789; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shupnik MA, 2002, J NEUROENDOCRINOL, V14, P85, DOI 10.1046/j.0007-1331.2001.00744.x; Siewit CL, 2010, MOL ENDOCRINOL, V24, P981, DOI 10.1210/me.2009-0410; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; Spady TJ, 1999, ENDOCRINE, V11, P217, DOI 10.1385/ENDO:11:3:217; Steinmetz R, 1997, ENDOCRINOLOGY, V138, P1780, DOI 10.1210/en.138.5.1780; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Takiguchi Masufumi, 2006, Environmental Sciences, V13, P107; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; Teng J, 2008, ENDOCR-RELAT CANCER, V15, P351, DOI 10.1677/erc.1.01255; Velardez MO, 2003, EUR J ENDOCRINOL, V148, P89, DOI 10.1530/eje.0.1480089; Wade MG, 1997, REPROD TOXICOL, V11, P791, DOI 10.1016/S0890-6238(97)00062-2; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	48	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81101	10.1371/journal.pone.0081101	http://dx.doi.org/10.1371/journal.pone.0081101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236210	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700213
J	Carville, A; Evans, TI; Reeves, RK				Carville, Angela; Evans, Tristan I.; Reeves, R. Keith			Characterization of Circulating Natural Killer Cells in Neotropical Primates	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CLASS-I MOLECULES; NK CELLS; MONOCLONAL-ANTIBODIES; COMMON MARMOSETS; RHESUS-MONKEYS; SIV INFECTION; LYMPHOCYTES; CHIMERISM; RECEPTORS	Despite extensive use of nonhuman primates as models for infectious diseases and reproductive biology, imprecise phenotypic and functional definitions exist for natural killer (NK) cells. This deficit is particularly significant in the burgeoning use of small, less expensive New World primate species. Using polychromatic flow cytometry, we identified peripheral blood NK cells as CD3-negative and expressing a cluster of cell surface molecules characteristic of NK cells (i.e., NKG2A, NKp46, NKp30) in three New World primate species - common marmosets, cotton-top tamarins, and squirrel monkeys. We then assessed subset distribution using the classical NK markers, CD56 and CD16. In all species, similar to Old World primates, only a minor subset of NK cells was CD56+, and the dominant subset was CD56-CD16+. Interestingly, CD56+ NK cells were primarily cytokine-secreting cells, whereas CD56-CD16+ NK cells expressed significantly greater levels of intracellular perforin, suggesting these cells might have greater potential for cytotoxicity. New World primate species, like Old World primates, also had a minor CD56-CD16- K cell subset that has no obvious counterpart in humans. Herein we present phenotypic profiles of New World primate NK cell subpopulations that are generally analogous to those found in humans. This conservation among species should support the further use of these species for biomedical research.	[Carville, Angela; Evans, Tristan I.; Reeves, R. Keith] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA	Harvard University	Reeves, RK (corresponding author), Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough Campus, Southborough, MA 01772 USA.	roger_reeves@hms.harvard.edu			NEPRC (NIH) [P51 OD011103]; CHAVI/HVTN (NIH) [U19 AI067854]; NIAID (NIH) [R21 AI101170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R21AI101170] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	NEPRC (NIH); CHAVI/HVTN (NIH); NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NEPRC base grant (NIH grant P51 OD011103), and CHAVI/HVTN Early Career Investigator (NIH grant U19 AI067854) and NIAID grants (NIH grant R21 AI101170), both to RKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averdam A, 2007, J IMMUNOL, V178, P7151, DOI 10.4049/jimmunol.178.11.7151; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; BIASSONI R, 2009, CURRENT PROTOCOLS IM; Bimber B, 2008, IMMUNOL RES, V40, P235, DOI 10.1007/s12026-007-8010-0; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Colantonio AD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001316; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009; Fogli M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000101; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; Huang Y, 2008, J IMMUNOL, V180, P2367, DOI 10.4049/jimmunol.180.4.2367; Jacob JR, 2004, J GEN VIROL, V85, P2525, DOI 10.1099/vir.0.80036-0; Kalkunte S, 2008, AM J REPROD IMMUNOL, V59, P425, DOI 10.1111/j.1600-0897.2008.00595.x; LaBonte ML, 2001, IMMUNOL REV, V183, P25, DOI 10.1034/j.1600-065x.2001.1830103.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435; Marvanova M, 2003, FASEB J, V17, P929, DOI 10.1096/fj.02-0681fje; MASSACESI L, 1995, ANN NEUROL, V37, P519, DOI 10.1002/ana.410370415; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; NEUBAUER RH, 1983, J IMMUNOL, V130, P1323; NEUBAUER RH, 1982, J IMMUNOGENET, V9, P209; NEUBAUER RH, 1981, J IMMUNOGENET, V8, P433; NIBLACK GD, 1977, IMMUNOLOGY, V32, P257; Ohta S, 2008, IMMUNOLOGY, V123, P566, DOI 10.1111/j.1365-2567.2007.02727.x; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2010, J MED PRIMATOL, V39, P194, DOI 10.1111/j.1600-0684.2010.00432.x; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Reeves RK, 2011, EUR J IMMUNOL, V41, P1070, DOI 10.1002/eji.201040832; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Reeves RK, 2009, AIDS RES HUM RETROV, V25, P1313, DOI 10.1089/aid.2009.0053; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Rutjens E, 2010, EUR J IMMUNOL; Rutjens E, 2007, J IMMUNOL, V178, P1702, DOI 10.4049/jimmunol.178.3.1702; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Yaguchi M, 2009, NEUROSCI RES, V65, P384, DOI 10.1016/j.neures.2009.08.016; Yoshida T, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00128	45	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78793	10.1371/journal.pone.0078793	http://dx.doi.org/10.1371/journal.pone.0078793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244365	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600063
J	Danion, F				Danion, Frederic			Superposition of Automatic and Voluntary Aspects of Grip Force Control in Humans during Object Manipulation	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; PRECISION GRIP; PARKINSONS-DISEASE; BASAL GANGLIA; ARM MOVEMENTS; LOAD FORCE; GRASPING FORCES; POWER GRIP; COORDINATION; HAND	When moving grasped objects, people automatically modulate grip force (GF) with movement-dependent load force (LF) in order to prevent object slip. However, GF can also be modulated voluntarily as when squeezing an object. Here we investigated possible interactions between automatic and voluntary GF control. Participants were asked to generate horizontal cyclic movements (between 0.6 and 2.0 Hz) of a hand-held object that was restrained by an elastic band such that the load force (LF) reached a peak once per movement cycle, and to simultaneously squeeze the object at each movement reversal (i.e., twice per cycle). Participants also performed two control tasks in which they either only moved (between 0.6 and 2.0 Hz) or squeezed (between 1.2 and 4.0 Hz) the object. The extent to which GF modulation in the simultaneous task could be predicted from the two control tasks was assessed using power spectral analyses. At all frequencies, the GF power spectra from the simultaneous task exhibited two prominent components that occurred at the cycle frequency (f) and at twice this frequency (2f), whereas the spectra from the movement and squeeze control task exhibited only single peaks at f and 2f, respectively. At lower frequencies, the magnitudes of both frequency components in the simultaneous task were similar to the magnitudes of the corresponding components in the control tasks. However, as frequency increased, the magnitudes of both components in the simultaneous task were greater than the magnitudes of the corresponding control task components. Moreover, the phase relationship between the f components of GF and LF began to drift from the value observed in the movement control task. Overall these results suggest that, at lower movement frequencies, voluntary and automatic GF control processes operate at different hierarchical levels. Several mechanisms are discussed to account for interaction effects observed at higher movement frequencies.	[Danion, Frederic] CNRS, Inst Neurosci Timone, Marseille, France; [Danion, Frederic] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Danion, F (corresponding author), CNRS, Inst Neurosci Timone, Marseille, France.	frederic.danion@univ-amu.fr	Danion, Frederic/ABS-1799-2022	Danion, Frederic/0000-0003-4296-7300				Aschersleben G, 2001, EXP BRAIN RES, V136, P331, DOI 10.1007/s002210000562; Billon M, 1996, EXP BRAIN RES, V110, P117; Boecker H, 2005, NEUROIMAGE, V25, P243, DOI 10.1016/j.neuroimage.2004.10.027; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Butler JE, 2007, RESP PHYSIOL NEUROBI, V159, P115, DOI 10.1016/j.resp.2007.06.006; Chvatal SA, 2012, J NEUROSCI, V32, P12237, DOI 10.1523/JNEUROSCI.6344-11.2012; Collins DF, 1998, J PHYSIOL-LONDON, V508, P635, DOI 10.1111/j.1469-7793.1998.00635.x; Danion F, 2004, EXP BRAIN RES, V158, P109, DOI 10.1007/s00221-004-1882-5; Danion F, 1997, EXP BRAIN RES, V116, P525, DOI 10.1007/PL00005781; Danion F, 2007, CLIN NEUROPHYSIOL, V118, P146, DOI 10.1016/j.clinph.2006.09.009; Danion F, 2007, J NEUROSCI, V27, P12839, DOI 10.1523/JNEUROSCI.3110-07.2007; Danion F, 2010, J EXP PSYCHOL HUMAN, V36, P1684, DOI 10.1037/a0020672; de Freitas PB, 2009, EXP BRAIN RES, V194, P605, DOI 10.1007/s00221-009-1738-0; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P2978, DOI 10.1152/jn.00958.2002; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; FORSSBERG H, 1979, J NEUROPHYSIOL, V42, P936, DOI 10.1152/jn.1979.42.4.936; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Gomi H, 2008, CURR OPIN NEUROBIOL, V18, P558, DOI 10.1016/j.conb.2008.11.002; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Halder P, 2007, HUM BRAIN MAPP, V28, P69, DOI 10.1002/hbm.20262; Jaric S, 2006, EXP BRAIN RES, V168, P88, DOI 10.1007/s00221-005-0070-6; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Keisker B, 2009, HUM BRAIN MAPP, V30, P2453, DOI 10.1002/hbm.20676; KILBREATH SL, 1994, J PHYSIOL-LONDON, V479, P487, DOI 10.1113/jphysiol.1994.sp020312; LATASH ML, 1991, BIOL CYBERN, V65, P401, DOI 10.1007/BF00216974; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Nowak DA, 2004, EXP BRAIN RES, V157, P241, DOI 10.1007/s00221-004-1839-8; Nowak DA, 2002, BEHAV NEUROSCI, V116, P837, DOI 10.1037//0735-7044.116.5.837; Nowak DA, 2006, EXP BRAIN RES, V173, P650, DOI 10.1007/s00221-006-0409-7; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Robertson JW, 2012, J BIOMECH, V45, P1580, DOI 10.1016/j.jbiomech.2012.04.020; Serrien DJ, 2001, EUR J NEUROSCI, V13, P1825, DOI 10.1046/j.0953-816x.2001.01548.x; Serrien DJ, 2001, EXP BRAIN RES, V136, P417, DOI 10.1007/s002210000620; Serrien DJ, 2001, NEUROPSYCHOLOGIA, V39, P1379, DOI 10.1016/S0028-3932(01)00081-1; Shim JK, 2005, J NEUROPHYSIOL, V93, P3649, DOI 10.1152/jn.01262.2004; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Sternad D, 2002, EXP BRAIN RES, V147, P162, DOI 10.1007/s00221-002-1219-1; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Venkadesan M, 2007, J BIOMECH, V40, P1653, DOI 10.1016/j.jbiomech.2007.01.022; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; Zatsiorsky VM, 2004, ROBOTICA, V22, P231, DOI 10.1017/S0263574703005344	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79341	10.1371/journal.pone.0079341	http://dx.doi.org/10.1371/journal.pone.0079341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244483	Green Published, gold			2022-12-25	WOS:000327221600126
J	Du, ZY; Dou, XB; Huang, CY; Gao, J; Hu, LF; Zhu, JZ; Qian, Y; Dou, MH; Fan, CL				Du, Zhongyan; Dou, Xiaobing; Huang, Chenyun; Gao, Jia; Hu, Linfeng; Zhu, Jiazhen; Qian, Ying; Dou, Minhua; Fan, Chunlei			Preparation, Drug Releasing Property and Pharmacodynamics of Soy Isoflavone-Loaded Chitosan Microspheres	PLOS ONE			English	Article							SENESCENCE-ACCELERATED MICE; INDUCED AGING MODEL; RATS; IMPAIRMENTS; MECHANISM	Soybean isoflavone (SIF) has anti-aging properties and many other biological functions; however, SIF is difficult to reach higher blood concentration due to its rapid metabolism. Therefore, it is of great value to design and produce a sustained-release formulation that is able to maintain a stable level of plasma concentrations. In this paper, soybean isoflavone sustained-release microsphere from chitosan and sodium alginate was prepared successfully. The important factors that determined the quality of the microspheres were the sodium alginate concentration in solution B, the ratio of soybean isoflavone to chitosan and the mixing speed. The relative yield, encapsulation efficiency and drug loading capability of SIF were much higher than the existing commercial formulations. In real gastrointestinal conditions, compared with the non-sustained release group, the release rate of SIF slowed down and the reaction time was prolonged. Animal experiments showed that sustained-release microspheres intensified the anti-aging potentials of SIF. Compared with the Non-sustained release (NSR) group mice, oral SIF/CHI microsphere treated mice were better in the Morris Water Maze Test (MWMT), the MDA level in the both plasma and brain of the sustained release(SR) group mice decreased, and SOD content was remarkably improved.	[Du, Zhongyan; Dou, Xiaobing; Huang, Chenyun; Hu, Linfeng; Qian, Ying; Dou, Minhua; Fan, Chunlei] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Jia] Zhejiang Chinese Med Univ, Coll Management, Hangzhou, Zhejiang, Peoples R China; [Zhu, Jiazhen] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Dou, XB (corresponding author), Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	xbdou77@hotmail.com			National Natural Science Foundation of China [81241145]; Natural Science Foundation of Zhejiang Province, China [LY12C07002]; Public Health Department of Zhejiang Province, China [2013KYA138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Public Health Department of Zhejiang Province, China	The study was financially supported by grants from National Natural Science Foundation of China (Project Codes: 81241145), and the Natural Science Foundation of Zhejiang Province, China (Project Code: LY12C07002). (Public Health Department of Zhejiang Province, China (Project Code: 2013KYA138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2012, TOXICOL LETT, V213, P220, DOI 10.1016/j.toxlet.2012.07.007; Atambay M, 2008, SAUDI MED J, V29, P87; Basaria S, 2009, J ENDOCRINOL INVEST, V32, P150, DOI 10.1007/BF03345705; Cai ShaoFei, 2011, Chinese Journal of Biochemical Pharmaceutics, V32, P315; Cakatay U, 2010, AGING MALE, V13, P51, DOI 10.3109/13685530903236470; Chang C, 1999, CHIN PHAR M J, V34, P796; Ding BJ, 2011, INT J DEV NEUROSCI, V29, P537, DOI 10.1016/j.ijdevneu.2011.04.002; Fukuishi N, 2001, INT ARCH ALLERGY IMM, V126, P140, DOI 10.1159/000049505; Goycoolea FM, 2009, BIOMACROMOLECULES, V10, P1736, DOI 10.1021/bm9001377; Hasegawa-Ishii S, 2011, NEUROPATHOLOGY, V31, P20, DOI 10.1111/j.1440-1789.2010.01126.x; Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P2686, DOI 10.1016/j.fct.2009.07.032; [黄岚 Huang Lan], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P1481; Jia Min, 2007, Zhong Yao Cai, V30, P185; Jiang Cai-Bin, 2007, Zhongguo Zhong Yao Za Zhi, V32, P906; Li S., 2002, J CHINESE CLIN MED, V3, P1; [李术宝 Li Shubao], 2012, [河北农业大学学报, Journal of Agricultural University of Hebei], V35, P79; Lien TF, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-15; Liu J, 2009, J BIOL CHEM, V284, P19564, DOI 10.1074/jbc.M109.005959; Luo Yun, 2012, Yaoxue Xuebao, V47, P256; Messina Mark J, 2002, Nutr Clin Care, V5, P272; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Pengc L, 1998, J MARINE SCI, V5, P21; Polkowski K, 2000, Acta Pol Pharm, V57, P223; Roehrs M, 2009, NEPHROL DIAL TRANSPL, V24, P2212, DOI 10.1093/ndt/gfp001; Tafaghodi M, 2006, J BIOMAT SCI-POLYM E, V17, P909, DOI 10.1163/156856206777996880; Wan C, 2008, S CHINA J PREV MED, V34, P30; Wang L, 2007, J SHANXI MED U, V38, P523; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Yang H, 2011, BRAIN COGNITION, V76, P206, DOI 10.1016/j.bandc.2010.10.008; Yoo DY, 2012, NEUROCHEM RES, V37, P223, DOI 10.1007/s11064-011-0597-9; Yoshiara LY, 2012, INT J FOOD SCI NUTR, V63, P978, DOI 10.3109/09637486.2012.690026; [张超兰 Zhang Chaolan], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P57; Zhao GJ, 1999, J FUNCTIONAL POLYM, V1, P65	33	3	4	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79698	10.1371/journal.pone.0079698	http://dx.doi.org/10.1371/journal.pone.0079698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244544	gold, Green Submitted, Green Published			2022-12-25	WOS:000327221600147
J	Lopes, FR; Jjingo, D; da Silva, CRM; Andrade, AC; Marraccini, P; Teixeira, JB; Carazzolle, MF; Pereira, GAG; Pereira, LFP; Vanzela, ALL; Wang, L; Jordan, IK; Carareto, CMA				Lopes, Fabricio R.; Jjingo, Daudi; da Silva, Carlos R. M.; Andrade, Alan C.; Marraccini, Pierre; Teixeira, Joao B.; Carazzolle, Marcelo F.; Pereira, Goncalo A. G.; Pereira, Luiz Filipe P.; Vanzela, Andre L. L.; Wang, Lu; King Jordan, I.; Carareto, Claudia M. A.			Transcriptional Activity, Chromosomal Distribution and Expression Effects of Transposable Elements in Coffea Genomes	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; EVOLUTION; RETROTRANSPOSONS; ACTIVATION; TOBACCO; ORIGIN; GENES; DATABASE; REVEALS; ARABICA	Plant genomes are massively invaded by transposable elements (TEs), many of which are located near host genes and can thus impact gene expression. In flowering plants, TE expression can be activated (de-repressed) under certain stressful conditions, both biotic and abiotic, as well as by genome stress caused by hybridization. In this study, we examined the effects of these stress agents on TE expression in two diploid species of coffee, Coffea canephora and C. eugenioides, and their allotetraploid hybrid C. arabica. We also explored the relationship of TE repression mechanisms to host gene regulation via the effects of exonized TE sequences. Similar to what has been seen for other plants, overall TE expression levels are low in Coffea plant cultivars, consistent with the existence of effective TE repression mechanisms. TE expression patterns are highly dynamic across the species and conditions assayed here are unrelated to their classification at the level of TE class or family. In contrast to previous results, cell culture conditions per se do not lead to the de-repression of TE expression in C. arabica. Results obtained here indicate that differing plant drought stress levels relate strongly to TE repression mechanisms. TEs tend to be expressed at significantly higher levels in non-irrigated samples for the drought tolerant cultivars but in drought sensitive cultivars the opposite pattern was shown with irrigated samples showing significantly higher TE expression. Thus, TE genome repression mechanisms may be finely tuned to the ideal growth and/or regulatory conditions of the specific plant cultivars in which they are active. Analysis of TE expression levels in cell culture conditions underscored the importance of nonsense-mediated mRNA decay (NMD) pathways in the repression of Coffea TEs. These same NMD mechanisms can also regulate plant host gene expression via the repression of genes that bear exonized TE sequences.	[Lopes, Fabricio R.; Carareto, Claudia M. A.] Univ Estadual Paulista, Univ Estadual Paulista Julio de Mesquita Filho, Dept Biol, Sao Jose do Rio Preto, Brazil; [Jjingo, Daudi; Wang, Lu; King Jordan, I.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [da Silva, Carlos R. M.; Vanzela, Andre L. L.] Univ Estadual Londrina, Dept Biol Geral, Londrina, Brazil; [Andrade, Alan C.; Marraccini, Pierre; Teixeira, Joao B.] Empresa Brasileira Pesquisa Agr Recursos Genet &, Brasilia, DF, Brazil; [Marraccini, Pierre] Ctr Cooperat Int Rech Agron Dev, UMR AGAP, Montpellier, France; [Carazzolle, Marcelo F.; Pereira, Goncalo A. G.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil; [Pereira, Luiz Filipe P.] Empresa Brasileira Pesquisa Agr Cafe, Brasilia, DF, Brazil; [King Jordan, I.] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Universidade Estadual Paulista; University System of Georgia; Georgia Institute of Technology; Universidade Estadual de Londrina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Carareto, CMA (corresponding author), Univ Estadual Paulista, Univ Estadual Paulista Julio de Mesquita Filho, Dept Biol, Sao Jose do Rio Preto, Brazil.	carareto@ibilce.unesp.br	Andrade, Alan Carvalho/C-7722-2012; Pereira, Gonçalo A. G./B-7944-2012; UNICAMP, CCES -/J-7787-2015; Carareto, Claudia M/D-2814-2012; Carazzolle, Marcelo Falsarella/C-6503-2012; Pereira, Luiz Filipe P/G-1606-2012; Marraccini, Pierre/C-1211-2015	Andrade, Alan Carvalho/0000-0001-7128-3472; Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Pereira, Luiz Filipe P/0000-0002-2075-9941; Carareto, Claudia Marcia Aparecida/0000-0002-0298-1354; Pereira, Luiz Filipe Protasio/0000-0002-4872-6607; Vanzela, Andre/0000-0002-2442-2211; Marraccini, Pierre/0000-0001-7637-6811	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/05894-1, 2007/55985-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement	This study was funded by grants provided by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/05894-1 to CMAC and fellowship 2007/55985-0 to FRL) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ( to CMAC). The authors thank the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement for the grant (ATP project "Plasticite phenotypique des perennes sous contrainte hydrique au champ" to PM and ACA) that permitted the study of C. arabica cultivars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bacci M, 2005, GENET MOL BIOL, V28, P634, DOI 10.1590/S1415-47572005000400019; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Biemont C, 2009, TRENDS GENET, V25, P333, DOI 10.1016/j.tig.2009.05.006; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cenci A, 2012, PLANT MOL BIOL, V78, P135, DOI 10.1007/s11103-011-9852-3; Courtial B, 2001, MOL GENET GENOMICS, V265, P32, DOI 10.1007/s004380000387; de Araujo PG, 2005, PLANT J, V44, P707, DOI 10.1111/j.1365-313X.2005.02579.x; Dubreuil-Tranchant C, 2011, INT J EVOL BIOL, V2011; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Ferrao R.G., 2000, REV CERES, V273, P555; Freire L. P., 2013, Coffee Science, V8, P17; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Guyot R, 2009, BMC PLANT BIOL, V25, P9; Hamon P, 2011, MOL GENET GENOMICS, V285, P447, DOI 10.1007/s00438-011-0617-0; Heslop-Harrison J. S., 1991, Technique, a Journal of Methods in Cell and Molecular Biology, V3, P109; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lashermes Philippe, 2008, V1, P203; Leroy Thierry, 2006, Braz. J. Plant Physiol., V18, P229, DOI 10.1590/S1677-04202006000100016; Lin CW, 2005, THEOR APPL GENET, V112, P114, DOI 10.1007/s00122-005-0112-2; Lopes FR, 2008, MOL GENET GENOMICS, V279, P385, DOI 10.1007/s00438-008-0319-4; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Marraccini P, 2012, J EXP BOT, V63, P4191, DOI 10.1093/jxb/ers103; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Mondego JMC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-30; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Piriyapongsa J, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-31; POUTEAU S, 1991, EMBO J, V10, P1911, DOI 10.1002/j.1460-2075.1991.tb07717.x; Rossi M, 2001, GENET MOL BIOL, V24, P147, DOI 10.1590/S1415-47572001000100020; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Vicient CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-601; Voytas DF, 1998, NAT GENET, V20, P6, DOI 10.1038/1652; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yuyama PM, 2012, GENOME, V55, P825, DOI 10.1139/gen-2012-0081; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang J, 1999, GENETICS, V153, P1403	49	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78931	10.1371/journal.pone.0078931	http://dx.doi.org/10.1371/journal.pone.0078931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244387	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600081
J	Qian, ZH; Ren, L; Ding, Y; Hutchinson, JR; Ren, LQ				Qian, Zhihui; Ren, Lei; Ding, Yun; Hutchinson, John R.; Ren, Luquan			A Dynamic Finite Element Analysis of Human Foot Complex in the Sagittal Plane during Level Walking	PLOS ONE			English	Article							INVERSE DYNAMICS; BIOMECHANICAL RESPONSES; CLINICAL-APPLICATIONS; GAIT ANALYSIS; HEEL-PAD; MODEL; STRESSES; KINEMATICS; ANKLE; ARCH	The objective of this study is to develop a computational framework for investigating the dynamic behavior and the internal loading conditions of the human foot complex during locomotion. A subject-specific dynamic finite element model in the sagittal plane was constructed based on anatomical structures segmented from medical CT scan images. Three-dimensional gait measurements were conducted to support and validate the model. Ankle joint forces and moment derived from gait measurements were used to drive the model. Explicit finite element simulations were conducted, covering the entire stance phase from heel-strike impact to toe-off. The predicted ground reaction forces, center of pressure, foot bone motions and plantar surface pressure showed reasonably good agreement with the gait measurement data over most of the stance phase. The prediction discrepancies can be explained by the assumptions and limitations of the model. Our analysis showed that a dynamic FE simulation can improve the prediction accuracy in the peak plantar pressures at some parts of the foot complex by 10%-33% compared to a quasi-static FE simulation. However, to simplify the costly explicit FE simulation, the proposed model is confined only to the sagittal plane and has a simplified representation of foot structure. The dynamic finite element foot model proposed in this study would provide a useful tool for future extension to a fully muscle-driven dynamic three-dimensional model with detailed representation of all major anatomical structures, in order to investigate the structural dynamics of the human foot musculoskeletal system during normal or even pathological functioning.	[Qian, Zhihui; Ren, Lei; Ren, Luquan] Jilin Univ, Key Lab Bion Engn, Changchun 130023, Peoples R China; [Ren, Lei] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England; [Ding, Yun] Jilin Univ, Editorial Dept Journal Bion Engn, Changchun 130023, Peoples R China; [Hutchinson, John R.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England	Jilin University; University of Manchester; Jilin University; University of London; University of London Royal Veterinary College	Ren, LQ (corresponding author), Jilin Univ, Key Lab Bion Engn, Changchun 130023, Peoples R China.	lei.ren@manchester.ac.uk	ren, luquan/AAB-3592-2020; Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	International Cooperation Project of National Natural Science Foundation of China [50920105504]; Biotechnology and Biological Sciences Research Council [BB/H002782/1]; National Natural Science Foundation of China [51105167]; Fundamental Research Founds of China [Z201105]; National Science Foundation of China [51290290, 51290292]; scientific and technological development planning project of Jilin Province [20130522187JH];  [2013M530985]; BBSRC [BB/H002782/1] Funding Source: UKRI	International Cooperation Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Founds of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological development planning project of Jilin Province; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the International Cooperation Project of National Natural Science Foundation of China (No. 50920105504), a Biotechnology and Biological Sciences Research Council Grant (No. BB/H002782/1), the Project of National Natural Science Foundation of China (No. 51105167), the Fundamental Research Founds of China (No. Z201105), the Key project of National Science Foundation of China (No, 51290290 & 51290292)? the postdoctoral project (No, 2013M530985) and the scientific and technological development planning project of Jilin Province (No, 20130522187JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ABAQUS US MAN VERS 6; Cahouet V, 2002, J BIOMECH, V35, P1507, DOI 10.1016/S0021-9290(02)00176-8; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; CARRIER DR, 1994, SCIENCE, V265, P651, DOI 10.1126/science.8036513; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Chen WP, 2001, CLIN BIOMECH, V16, P614, DOI 10.1016/S0268-0033(01)00047-X; Cheung J.T.-M., 2008, SPORT ORTHOP SPORT T, V23, P264, DOI [10.1016/j.orthtr.2007.11.001, DOI 10.1016/J.ORTHTR.2007.11.001]; Cheung JTM, 2008, MED ENG PHYS, V30, P269, DOI 10.1016/j.medengphy.2007.05.002; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Cheung JTM, 2004, CLIN BIOMECH, V19, P839, DOI 10.1016/j.clinbiomech.2004.06.002; CHU TM, 1995, MED ENG PHYS, V17, P372, DOI 10.1016/1350-4533(95)97317-I; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; Dai XQ, 2006, CLIN BIOMECH, V21, P314, DOI 10.1016/j.clinbiomech.2005.10.002; Erdemir A, 2006, J BIOMECH, V39, P1279, DOI 10.1016/j.jbiomech.2005.03.007; Gefen A, 2000, J BIOMECH ENG-T ASME, V122, P630, DOI 10.1115/1.1318904; Halloran JP, 2010, J BIOMECH, V43, P2810, DOI 10.1016/j.jbiomech.2010.05.036; Halloran JP, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005333; Hannah I, 2012, PROCEDIA ENGINEER, V34, P278, DOI 10.1016/j.proeng.2012.04.048; HICKS JH, 1954, J ANAT, V88, P25; Hsu YC, 2008, ANN BIOMED ENG, V36, P1345, DOI 10.1007/s10439-008-9516-x; Isvilanonda V, 2012, CLIN BIOMECH, V27, P837, DOI 10.1016/j.clinbiomech.2012.05.005; Jacob S, 1999, J REHABIL RES DEV, V36, P252; Jacob S, 1996, MECH RES COMMUN, V23, P387, DOI 10.1016/0093-6413(96)00036-5; Jenkyn TR, 2007, J BIOMECH, V40, P3271, DOI 10.1016/j.jbiomech.2007.04.008; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Ker RF, 1996, J EXP BIOL, V199, P1501; Kuo AD, 1998, J BIOMECH ENG-T ASME, V120, P148, DOI 10.1115/1.2834295; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; Miller-Young JE, 2002, J BIOMECH, V35, P1523, DOI 10.1016/S0021-9290(02)00090-8; Nester CJ, 2007, J BIOMECH, V40, P1927, DOI 10.1016/j.jbiomech.2006.09.008; Patil KM, 1996, MED BIOL ENG COMPUT, V34, P280, DOI 10.1007/BF02511238; QIAN ZH, 2010, P 6 WORLD C BIOM SIN, V31, P297; Ren L., 2005, P INT SOC BIOM 20 C; Ren L, 2008, J BIONIC ENG, V5, P175, DOI 10.1016/S1672-6529(08)60022-0; Ren L, 2008, J BIOMECH, V41, P2750, DOI 10.1016/j.jbiomech.2008.06.001; Ren L, 2010, J BIOMECH, V43, P194, DOI 10.1016/j.jbiomech.2009.09.027; SCOTT SH, 1993, J BIOMECH, V26, P1091, DOI 10.1016/S0021-9290(05)80008-9; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; Wu LJ, 2007, CLIN BIOMECH, V22, P221, DOI 10.1016/j.clinbiomech.2006.09.009; Yarnitzky G, 2006, J BIOMECH, V39, P2673, DOI 10.1016/j.jbiomech.2005.08.021	40	38	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79424	10.1371/journal.pone.0079424	http://dx.doi.org/10.1371/journal.pone.0079424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244500	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600129
J	Ruhs, PA; Boni, L; Fuller, GG; Inglis, RF; Fischer, P				Ruehs, Patrick A.; Boeni, Lukas; Fuller, Gerald G.; Inglis, R. Fredrik; Fischer, Peter			In-Situ Quantification of the Interfacial Rheological Response of Bacterial Biofilms to Environmental Stimuli	PLOS ONE			English	Article							BETA-LACTOGLOBULIN FIBRILS; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI; DISPLACEMENT; RESISTANCE; STRENGTH; LIQUID/LIQUID; REQUIRES; SHEAR; DROP	Understanding the numerous factors that can affect biofilm formation and stability remain poorly understood. One of the major limitations is the accurate measurement of biofilm stability and cohesiveness in real-time when exposed to changing environmental conditions. Here we present a novel method to measure biofilm strength: interfacial rheology. By culturing a range of bacterial biofilms on an air-liquid interface we were able to measure their viscoelastic growth profile during and after biofilm formation and subsequently alter growth conditions by adding surfactants or changing the nutrient composition of the growth medium. We found that different bacterial species had unique viscoelastic growth profiles, which was also highly dependent on the growth media used. We also found that we could reduce biofilm formation by the addition of surfactants or changing the pH, thereby altering the viscoelastic properties of the biofilm. Using this technique we were able to monitor changes in viscosity, elasticity and surface tension online, under constant and varying environmental conditions, thereby providing a complementary method to better understand the dynamics of both biofilm formation and dispersal.	[Ruehs, Patrick A.; Boeni, Lukas; Fischer, Peter] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland; [Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Inglis, R. Fredrik] ETH, Dept Environm Sci, Zurich, Switzerland; [Inglis, R. Fredrik] ETH, Dept Environm Microbiol, Zurich, Switzerland; [Inglis, R. Fredrik] EAWAG, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Ruhs, PA (corresponding author), ETH, Dept Hlth Sci & Technol, Zurich, Switzerland.	patrick.ruehs@hest.ethz.ch	Fischer, Peter/A-8740-2011; Rühs, Patrick/H-2090-2014; Boni, Lukas/B-2690-2015	Fischer, Peter/0000-0002-2992-5037; Boni, Lukas/0000-0003-4958-0037; Fuller, Gerald/0000-0002-2924-053X	ETH Zurich [ETHIIRA TH 32-1]	ETH Zurich(ETH Zurich)	P.R. acknowledges financial support by ETH Zurich (Project ETHIIRA TH 32-1: Amyloid Protein Fibers at Surfaces and Interfaces). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, BIOTECHNOL BIOENG, V105, P924, DOI 10.1002/bit.22605; Ahimou F, 2007, APPL ENVIRON MICROB, V73, P2897, DOI 10.1128/AEM.02388-06; Angelini TE, 2009, P NATL ACAD SCI USA, V106, P18109, DOI 10.1073/pnas.0905890106; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chen X, 2000, WATER RES, V34, P4229, DOI 10.1016/S0043-1354(00)00187-1; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dueholm MS, 2010, MOL MICROBIOLOGY, V77; Erni P, 2003, REV SCI INSTRUM, V74, P4916, DOI 10.1063/1.1614433; Erni P, 2011, SOFT MATTER, V7, P7586, DOI 10.1039/c1sm05263b; Ferri JK, 2010, ADV COLLOID INTERFAC, V161, P29, DOI 10.1016/j.cis.2010.08.002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLEMMING HC, 1993, WATER SCI TECHNOL, V27, P1; Freer EM, 2004, J ADHESION, V80, P481, DOI 10.1080/00218460490477143; Gunning PA, 2004, FOOD HYDROCOLLOID, V18, P509, DOI 10.1016/j.foodhyd.2003.08.008; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liggieri L, 2010, CURR OPIN COLLOID IN, V15, P256, DOI 10.1016/j.cocis.2010.02.003; Loglio G, 2001, STUD INTERF SCI, V11, P439, DOI 10.1016/S1383-7303(01)80038-7; Maldonado-Valderrama J, 2008, LANGMUIR, V24, P6759, DOI 10.1021/la800551u; Maldonado-Valderrama J, 2010, CURR OPIN COLLOID IN, V15, P271, DOI 10.1016/j.cocis.2009.12.004; Mezzenga R, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046601; Nakano M, 1992, MOL GEN GENETICS MGG, V232; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Roth S, 2000, J AGR FOOD CHEM, V48, P1491, DOI 10.1021/jf990976z; Ruhs PA, 2013, J RHEOL, V57, P1003, DOI 10.1122/1.4802051; Ruhs PA, 2012, LANGMUIR, V28, P12536, DOI 10.1021/la3026705; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Sagis LMC, 2011, REV MOD PHYS, V83, P1367, DOI 10.1103/RevModPhys.83.1367; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Trejo M, 2013, P NATL ACAD SCI USA, V110, P2011, DOI 10.1073/pnas.1217178110; Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049	45	61	61	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78524	10.1371/journal.pone.0078524	http://dx.doi.org/10.1371/journal.pone.0078524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244319	Green Published, gold			2022-12-25	WOS:000327221600029
J	Chen, TF; Wu, D; Moskaluk, CA; Fu, Z				Chen, Tufeng; Wu, Di; Moskaluk, Christopher A.; Fu, Zheng			Distinct Expression Patterns of ICK/MAK/MOK Protein Kinases in the Intestine Implicate Functional Diversity	PLOS ONE			English	Article							CELL-ASSOCIATED-KINASE; EPITHELIAL-CELLS; MAP KINASE; STEM-CELLS; RETINITIS-PIGMENTOSA; MOLECULAR-CLONING; CILIARY LENGTH; GENE; IDENTIFY; MICE	ICK/MRK (intestinal cell kinase/MAK-related kinase), MAK (male germ cell-associated kinase), and MOK (MAPK/MAK/MRK-overlapping kinase) are closely related serine/threonine protein kinases in the protein kinome. The biological functions and regulatory mechanisms of the ICK/MAK/MOK family are still largely elusive. Despite significant similarities in their catalytic domains, they diverge markedly in the sequence and structural organization of their C-terminal non-catalytic domains, raising the question as to whether they have distinct, overlapping, or redundant biological functions. In order to gain insights into their biological activities and lay a fundamental groundwork for functional studies, we investigated the spatio-temporal distribution patterns and the expression dynamics of ICK/MAK/MOK protein kinases in the intestine. We found that ICK/MAK/MOK proteins display divergent expression patterns along the duodenum-to-colon axis and during postnatal murine development. Furthermore, they are differentially partitioned between intestinal epithelium and mesenchyme. A significant increase in the protein level of ICK, but not MAK, was induced in human primary colon cancer specimens. ICK protein level was up-regulated whereas MOK protein level was down-regulated in mouse intestinal adenomas as compared with their adjacent normal intestinal mucosa. These data suggest distinct roles for ICK/MAK/MOK protein kinases in the regulation of intestinal neoplasia. Taken together, our findings demonstrate that the expressions of ICK/MAK/MOK proteins in the intestinal tract can be differentially and dynamically regulated, implicating a significant functional diversity within this group of protein kinases.	[Chen, Tufeng; Wu, Di; Fu, Zheng] Univ Virginia, Dept Med, Charlottesville, VA 22903 USA; [Chen, Tufeng; Wu, Di; Fu, Zheng] Univ Virginia, Digest Hlth Res Ctr, Charlottesville, VA USA; [Moskaluk, Christopher A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Chen, Tufeng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; University of Virginia; University of Virginia; Sun Yat Sen University	Fu, Z (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22903 USA.	zf6n@virginia.edu			National Institutes of Health [DK082614]; American Cancer Society Institutional Research Grant ACS-IRG [81-001-21]; Science and Technology Department of Guangdong Province, China [2010B060900030]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research Grant ACS-IRG(American Cancer Society); Science and Technology Department of Guangdong Province, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK082614 (to Z. F.) and also by a New Investigator Award (to Z. F.) from American Cancer Society Institutional Research Grant ACS-IRG #81-001-21 (Bender, T.P., University of Virginia). T.C. is a visiting scholar and partially supported by the funding program No.2010B060900030 from Science and Technology Department of Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1995, ONCOGENE, V11, P2187; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BLADT F, 1993, DIFFERENTIATION, V53, P115, DOI 10.1111/j.1432-0436.1993.tb00651.x; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; JENKINS AP, 1994, GUT, V35, P1765, DOI 10.1136/gut.35.12.1765; JINNO A, 1993, MOL CELL BIOL, V13, P4146, DOI 10.1128/MCB.13.7.4146; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013344; Lenaerts K, 2006, J PROTEOME RES, V5, P2113, DOI 10.1021/pr060183+; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Raul F, 1996, P NUTR SOC, V55, P279, DOI 10.1079/PNS19960029; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Uesaka T, 2004, FEBS LETT, V573, P147, DOI 10.1016/j.febslet.2004.07.070; Wang LY, 2011, ONCOGENE; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79359	10.1371/journal.pone.0079359	http://dx.doi.org/10.1371/journal.pone.0079359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244486	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900039
J	Rozenberg, JM; Bhattacharya, P; Chatterjee, R; Glass, K; Vinson, C				Rozenberg, Julian M.; Bhattacharya, Paramita; Chatterjee, Raghunath; Glass, Kimberly; Vinson, Charles			Combinatorial Recruitment of CREB, C/EBP beta and c-Jun Determines Activation of Promoters upon Keratinocyte Differentiation	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; INVOLUCRIN GENE PROMOTER; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; IN-VITRO; CHROMATIN ACCESSIBILITY; MEDIATED TRANSCRIPTION; SKIN TUMORIGENESIS; CELL-SURVIVAL; ONCOGENIC RAS	Background: Transcription factors CREB, C/EBP beta and Jun regulate genes involved in keratinocyte proliferation and differentiation. We questioned if specific combinations of CREB, C/EBP beta and c-Jun bound to promoters correlate with RNA polymerase II binding, mRNA transcript levels and methylation of promoters in proliferating and differentiating keratinocytes. Results: Induction of mRNA and RNA polymerase II by differentiation is highest when promoters are bound by C/EBP beta alone, C/EBP beta together with c-Jun, or by CREB, C/EBP beta and c-Jun, although in this case CREB binds with low affinity. In contrast, RNA polymerase II binding and mRNA levels change the least upon differentiation when promoters are bound by CREB either alone or in combination with C/EBP beta or c-Jun. Notably, promoters bound by CREB have relatively high levels of RNA polymerase II binding irrespective of differentiation. Inhibition of C/EBP beta or c-Jun preferentially represses mRNA when gene promoters are bound by corresponding transcription factors and not CREB. Methylated promoters have relatively low CREB binding and, accordingly, those which are bound by C/EBP beta are induced by differentiation irrespective of CREB. Composite "Half and Half'' consensus motifs and co localizing consensus DNA binding motifs are overrepresented in promoters bound by the combination of corresponding transcription factors. Conclusion: Correlational and functional data describes combinatorial mechanisms regulating the activation of promoters. Colocalization of C/EBP beta and c-Jun on promoters without strong CREB binding determines high probability of activation upon keratinocyte differentiation.	[Rozenberg, Julian M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bhattacharya, Paramita] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India; [Chatterjee, Raghunath] Indian Stat Inst, Div Biol Sci, Human Genet Unit, Kolkata, India; [Glass, Kimberly] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA; [Vinson, Charles] NCI, Lab Metab, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Saha Institute of Nuclear Physics; Indian Statistical Institute; Indian Statistical Institute Kolkata; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vinson, C (corresponding author), NCI, Lab Metab, Bethesda, MD 20892 USA.	vinsonc@dc37a.nci.nih.gov	Rozenberg, Julian M/M-8561-2018; Chatterjee, Raghunath/H-3236-2013; Chatterjee, Raghunath/AAF-4959-2021	Chatterjee, Raghunath/0000-0002-4602-0838; Rozenberg, Julian/0000-0002-7627-5217; Glass, Kimberly/0000-0003-4394-5779	National Institutes of Health, Bethesda, Maryland USA; NIH; NATIONAL CANCER INSTITUTE [ZIABC005271] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was performed and funded by the National Institutes of Health, Bethesda, Maryland USA. The source of funding was intramural budget of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Chatterjee R, 2012, G3-GENES GENOM GENET, V2, P1243, DOI 10.1534/g3.112.004002; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Cui TX, 2008, J ENDOCRINOL, V196, P89, DOI 10.1677/JOE-07-0169; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flammer JR, 2006, BIOCHEMISTRY-US, V45, P9615, DOI 10.1021/bi052521a; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Manna PR, 2009, MOL CELL ENDOCRINOL, V302, P1, DOI 10.1016/j.mce.2008.12.009; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Rozenberg J, 2009, MOL CANCER RES, V7, P654, DOI 10.1158/1541-7786.MCR-08-0011; Rutberg SE, 1999, ONCOGENE, V18, P1569, DOI 10.1038/sj.onc.1202463; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Smith C, 2004, BIOCHEM J, V380, P757, DOI 10.1042/BJ20040077; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Tran NQ, 2004, BIOCHEM J, V381, P267, DOI 10.1042/BJ20031653; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	53	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78179	10.1371/journal.pone.0078179	http://dx.doi.org/10.1371/journal.pone.0078179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244291	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900009
J	Ma, JH; Nakagawa, Y; Kojima, I; Shibata, H				Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi			Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes (vol 289, pg 133, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]	1	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24030	24031		10.1074/jbc.A113.533240	http://dx.doi.org/10.1074/jbc.A113.533240			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24240093	Green Accepted, hybrid			2022-12-25	WOS:000341505600003
J	Kim, HJ; Kim, JG; Moon, MY; Park, SH; Park, JB				Kim, Hee-Jun; Kim, Jae-Gyu; Moon, Mi-Young; Park, Seol-Hye; Park, Jae-Bong			I kappa B Kinase gamma/Nuclear Factor-kappa B-Essential Modulator (IKK gamma/NEMO) Facilitates RhoA GTPase Activation, which, in Turn, Activates Rho-associated Kinase ( ROCK) to Phosphorylate IKK beta in Response to Transforming Growth Factor (TGF)-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Inflammation; NF-kB Transcription Factor; Rhoa; Transforming Growth Factor Beta (TGFbeta)	NUCLEAR FACTOR-KB; SIGNALING PATHWAYS; DISSOCIATION INHIBITOR; INDEPENDENT PATHWAYS; PROTEIN; FAMILY; APOPTOSIS; DOMAIN; NEMO; BINDING	Background: TGF-1 activates RhoA and nuclear factor-B (NF-B), but the activation mechanism was not clearly elucidated. Results: IKK disrupts RhoA-Rho guanine nucleotide dissociation inhibitor (RhoGDI) complex, facilitating GTP binding to RhoA, resulting in IKK phosphorylation by ROCK. Conclusion: IKK facilitates RhoA activation, which in turn activates NF-B. Significance: We found the new mechanism of IKK to activate RhoA and NF-B by TGF-1. Transforming growth factor (TGF)-1 plays several roles in a variety of cellular functions. TGF-1 transmits its signal through Smad transcription factor-dependent and -independent pathways. It was reported that TGF-1 activates NF-B and RhoA, and RhoA activates NF-B in several kinds of cells in a Smad-independent pathway. However, the activation molecular mechanism of NF-B by RhoA upon TGF-1 has not been clearly elucidated. We observed that RhoA-GTP level was increased by TGF-1 in RAW264.7 cells. RhoA-GDP and RhoGDI were bound to N- and C-terminal domains of IKK, respectively. Purified IKK facilitated GTP binding to RhoA complexed with RhoGDI. Furthermore, Dbs, a guanine nucletotide exchange factor of RhoA much more enhanced GTP binding to RhoA complexed with RhoGDI in the presence of IKK. Indeed, si-IKK abolished RhoA activation in response to TGF-1 in cells. However, TGF-1 stimulated the release of RhoA-GTP from IKK and Rho-associated kinase (ROCK), an active RhoA effector protein, directly phosphorylated IKK in vitro, whereas TGF-1-activated kinase 1 activated RhoA upon TGF-1 stimulation. Taken together, our data indicate that IKK facilitates RhoA activation via a guanine nucletotide exchange factor, which in turn activates ROCK to phosphorylate IKK, leading to NF-B activation that induced the chemokine expression and cell migration upon TGF-1.	[Kim, Hee-Jun; Kim, Jae-Gyu; Moon, Mi-Young; Park, Seol-Hye; Park, Jae-Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea	Hallym University	Park, JB (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea.	jbpark@hallym.ac.kr			National Research Foundation of Korea; Ministry of Education; Ministry of Science, Information Communication Technology, and Future Planning [NRF-2013R1A1A2A10006114, MRC-2010-0009180]; Hallym University [HRF-S-41]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Ministry of Science, Information Communication Technology, and Future Planning; Hallym University	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, the Ministry of Science, Information Communication Technology, and Future Planning (Grants NRF-2013R1A1A2A10006114 and MRC-2010-0009180) and Hallym University (Grant HRF-S-41).	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Ear T, 2010, J IMMUNOL, V184, P3897, DOI 10.4049/jimmunol.0902958; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hippenstiel S, 2000, BLOOD, V95, P3044; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/MCB.24.10.4487-4501.2004; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Moon MY, 2013, J CELL PHYSIOL, V228, P2119, DOI 10.1002/jcp.24383; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Papadimitriou E, 2011, CELL PHYSIOL BIOCHEM, V28, P229, DOI 10.1159/000331734; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shimizu S, 2007, MOL HUM REPROD, V13, P181, DOI 10.1093/molehr/gal113; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yeh YY, 2008, BIOCHEM PHARMACOL, V75, P1292, DOI 10.1016/j.bcp.2007.11.017; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	54	29	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1429	1440		10.1074/jbc.M113.520130	http://dx.doi.org/10.1074/jbc.M113.520130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24240172	Green Published, hybrid			2022-12-25	WOS:000332401700020
J	Kang, NY; Cho, C; Kim, J				Kang, Na Young; Cho, Chuloh; Kim, Jungmook			Inducible Expression of Arabidopsis Response Regulator 22 (ARR22), a Type-C ARR, in Transgenic Arabidopsis Enhances Drought and Freezing Tolerance	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; REDUNDANT NEGATIVE REGULATORS; RESPONSE REGULATORS; CYTOKININ-RECEPTOR; TRANSCRIPTION FACTOR; OSMOTIC-STRESS; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; ECTOPIC EXPRESSION; LEAF SENESCENCE	The Arabidopsis two-component signaling system, which is comprised of sensor histidine kinases, histidine phosphotransfer proteins, and response regulators, mediates cytokinin response as well as various other plant responses including abiotic stress responses. Arabidopsis response regulators (ARRs) are classified into type-A, -B, and -C. Although the roles of type-A and -B ARRs are well established in Arabidopsis plant signaling, roles of type-C ARRs, ARR22 and ARR24, remain elusive. ARR22, a preferentially cytosolic protein, interacts with certain Arabidopsis histidine phosphotransfer proteins (AHPs) and displays phosphatase activity on AHP5. ARR22 is induced by cold and dehydration. Here, we show that inducible overexpression of ARR22 in Arabidopsis enhanced dehydration, drought, and cold tolerance in a dexamethasone-dependent manner, whereas mutation of the putative phospho-accepting Asp to Asn in ARR22 (ARR22(D74N)) abolished these tolerance phenotypes. Overexpression of ARR22 decreased electrolyte leakage in dehydration-, drought-, or cold-stressed transgenic Arabidopsis plants compared with that of ARR22(D74N) or compared with wild-type plants. Transpiration rates and stomatal apertures were not affected by ARR22 overexpression. No significant difference in both dehydration and freezing tolerance was observed between wild-type and arr22 mutants with or without cytokinin preincubation, consistent with the lack of phenotypes of arr22 mutants in their vegetative development. Meta-profile analyses of the microarray data on ARR22-responsive genes indicate that ARR22 modulates expression of a variety of abiotic stress-responsive genes, which might contribute to increasing drought and freezing tolerance. Taken together, these results suggest that ARR22 plays a positive role in the stress tolerance response in part via enhancing cell membrane integrity and that phospho-histidine phosphatase activity of ARR22 may be required for this function.	[Kim, Jungmook] Chonnam Natl Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea; Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, J (corresponding author), Chonnam Natl Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea.	jungmkim@chonnam.ac.kr		Kim, Jungmook/0000-0003-1735-5564	World Class University project [R31-2009-000-20025-0]; Basic Science Research Program through the National Research Foundation of Korea [2010-0022850]; Ministry of Education, Science and Technology of Korea; Next Generation BioGreen 21 Program, RDA, Republic of Korea [PJ00823]	World Class University project; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next Generation BioGreen 21 Program, RDA, Republic of Korea	This work was supported by grants from the World Class University project (R31-2009-000-20025-0), the Basic Science Research Program through the National Research Foundation of Korea (2010-0022850) funded by the Ministry of Education, Science and Technology of Korea, and the Next Generation BioGreen 21 Program (PJ00823), RDA, Republic of Korea to J. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Gattolin S, 2006, J EXP BOT, V57, P4225, DOI 10.1093/jxb/erl205; Go YS, 2012, PLANT J, V72, P791, DOI 10.1111/j.1365-313X.2012.05120.x; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jefferson R.A, 1991, PLANT MOL BIOL, pB14; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jeon J, 2013, PLANT PHYSIOL, V161, P408, DOI 10.1104/pp.112.207621; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kang NY, 2012, J PLANT PHYSIOL, V169, P1382, DOI 10.1016/j.jplph.2012.05.007; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawaoka A, 2003, PLANT PHYSIOL, V132, P1177, DOI 10.1104/pp.102.019794; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kim J, 2007, J PLANT BIOL, V50, P139, DOI 10.1007/BF03030622; Kim J, 2013, MOL PLANT, V6, P15, DOI 10.1093/mp/sss151; Kim J, 2008, PLANT SIGNAL BEHAV, V3, P348, DOI 10.4161/psb.3.5.5375; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; Lee DJ, 2008, PLANTA, V227, P577, DOI 10.1007/s00425-007-0640-x; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Lee DJ, 2009, J EXP BOT, V60, P3935, DOI 10.1093/jxb/erp230; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; NES WD, 1981, J NAT PROD, V44, P377, DOI 10.1021/np50016a001; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Nishiyama R, 2013, P NATL ACAD SCI USA, V110, P4840, DOI 10.1073/pnas.1302265110; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peters C, 2010, PLANT CELL, V22, P2642, DOI 10.1105/tpc.109.071720; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Pils B, 2009, PLANT PHYSIOL, V151, P782, DOI 10.1104/pp.109.139188; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Suzuki M, 2006, PLANT CELL PHYSIOL, V47, P565, DOI 10.1093/pcp/pcj031; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; VANLOON LC, 1985, PLANT MOL BIOL, V4, P111, DOI 10.1007/BF02418757; Wang YF, 2010, CHEM BIODIVERS, V7, P2623, DOI 10.1002/cbdv.200900406; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wielopolska A, 2005, PLANT BIOTECHNOL J, V3, P583, DOI 10.1111/j.1467-7652.2005.00149.x; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012	87	28	30	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79248	10.1371/journal.pone.0079248	http://dx.doi.org/10.1371/journal.pone.0079248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244460	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800048
J	Mitchell, CA; Kalies, S; Cizmar, T; Heisterkamp, A; Torrance, L; Roberts, AG; Gunn-Moore, FJ; Dholakia, K				Mitchell, Claire A.; Kalies, Stefan; Cizmar, Tomas; Heisterkamp, Alexander; Torrance, Lesley; Roberts, Alison G.; Gunn-Moore, Frank J.; Dholakia, Kishan			Femtosecond Optoinjection of Intact Tobacco BY-2 Cells Using a Reconfigurable Photoporation Platform	PLOS ONE			English	Article							PLANT-CELLS; OPTICAL TRANSFECTION; GENE-TRANSFER; LASER-PULSES; DELIVERY; SINGLE; MICROINJECTION; PROTEINS; MANIPULATION; EXPRESSION	A tightly-focused ultrashort pulsed laser beam incident upon a cell membrane has previously been shown to transiently increase cell membrane permeability while maintaining the viability of the cell, a technique known as photoporation. This permeability can be used to aid the passage of membrane-impermeable biologically-relevant substances such as dyes, proteins and nucleic acids into the cell. Ultrashort-pulsed lasers have proven to be indispensable for photoporating mammalian cells but they have rarely been applied to plant cells due to their larger sizes and rigid and thick cell walls, which significantly hinders the intracellular delivery of exogenous substances. Here we demonstrate and quantify femtosecond optical injection of membrane impermeable dyes into intact BY-2 tobacco plant cells growing in culture, investigating both optical and biological parameters. Specifically, we show that the long axial extent of a propagation invariant ("diffraction-free") Bessel beam, which relaxes the requirements for tight focusing on the cell membrane, outperforms a standard Gaussian photoporation beam, achieving up to 70% optoinjection efficiency. Studies on the osmotic effects of culture media show that a hypertonic extracellular medium was found to be necessary to reduce turgor pressure and facilitate molecular entry into the cells.	[Mitchell, Claire A.; Dholakia, Kishan] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland; [Kalies, Stefan] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Cizmar, Tomas] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Heisterkamp, Alexander] Univ Jena, Inst Appl Opt, Jena, Germany; [Torrance, Lesley; Roberts, Alison G.] James Hutton Inst, Dundee, Scotland; [Torrance, Lesley; Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews; Friedrich Schiller University of Jena; James Hutton Institute; University of St Andrews	Mitchell, CA (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland.	cm97@st-andrews.ac.uk	Heisterkamp, Alexander/V-5376-2017; Cizmar, Tomas/E-7428-2019	Heisterkamp, Alexander/0000-0001-8770-0859; Cizmar, Tomas/0000-0002-5813-3602; Dholakia, Kishan/0000-0001-6534-9009; Gunn-Moore, Francis James/0000-0003-3422-3387; Mitchell, Claire/0000-0001-9960-2340; Kalies, Stefan/0000-0003-3025-264X; Torrance, Lesley/0000-0001-8327-1276	UK Engineering and Physical Sciences Research Council; James Hutton Institute; EPSRC [EP/J01771X/1, EP/H045368/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H045368/1, EP/J01771X/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); James Hutton Institute; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the UK Engineering and Physical Sciences Research Council, the James Hutton Institute, R. S. MacDonald, Dr. E. Killick and the "BRAINS" 600th Anniversary appeal for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak M, 2013, NAT PROTOC, V8, P1216, DOI 10.1038/nprot.2013.071; Antkowiak M, 2010, J BIOPHOTONICS, V3, P696, DOI 10.1002/jbio.201000052; Awazu K, 2002, NUCL INSTRUM METH A, V483, P571, DOI 10.1016/S0168-9002(02)00384-4; Badr YA, 2005, PHOTOCH PHOTOBIO SCI, V4, P803, DOI 10.1039/b503658e; BARONEPEL O, 1988, PLANTA, V175, P389, DOI 10.1007/BF00396345; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; BECK WILLIAM A., 1929, TRANS AMER MIEROSCOP SOC, V48, P204, DOI 10.2307/3222213; Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Brown CTA, 2008, J BIOPHOTONICS, V1, P183, DOI 10.1002/jbio.200810011; CAMPBELL N, 1996, BIOLOGY; Cappelleri DJ, 2010, JALA-J LAB AUTOM, V15, P329, DOI 10.1016/j.jala.2010.03.003; Chakravarty P, 2010, NAT NANOTECHNOL, V5, P607, DOI [10.1038/nnano.2010.126, 10.1038/NNANO.2010.126]; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; Cizmar T, 2010, NAT PHOTONICS, V4, P388, DOI 10.1038/NPHOTON.2010.85; DURNIN J, 1987, PHYS REV LETT, V58, P1499, DOI 10.1103/PhysRevLett.58.1499; DURNIN J, 1987, J OPT SOC AM A, V4, P651, DOI 10.1364/JOSAA.4.000651; Ferrando M, 2001, J FOOD ENG, V49, P115, DOI 10.1016/S0260-8774(00)00218-1; Geelen DNV, 2001, PLANT PHYSIOL, V127, P1375, DOI 10.1104/pp.010708; GOUDRIAAN J, 1979, ANN BOT-LONDON, V43, P783, DOI 10.1093/oxfordjournals.aob.a085693; Granath KA., 1958, J COLLOID SCI, V13, P308; Gu L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662887; GUO YD, 1995, PHYSIOL PLANTARUM, V93, P19, DOI 10.1034/j.1399-3054.1995.930104.x; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Heinemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058604; HUNOLD R, 1994, PLANT J, V5, P593, DOI 10.1046/j.1365-313X.1994.5040593.x; INDEBETOUW G, 1989, J OPT SOC AM A, V6, P150, DOI 10.1364/JOSAA.6.000150; Kajiyama S, 2006, BIOTECHNOL BIOENG, V93, P325, DOI 10.1002/bit.20709; Kajiyama S, 2008, J BIOSCI BIOENG, V106, P194, DOI 10.1263/jbb.106.194; Kalies S, 2013, J BIOPHOTONICS, V9, P1, DOI [10.1002/jbio.201200200, DOI 10.1002/JBI0.201200200]; Kohli V, 2005, BIOTECHNOL BIOENG, V92, P889, DOI 10.1002/bit.20689; Ladenburg D, 1988, NATURWISSENSCHAFTEN, V36, P1; LeBlanc ML, 2013, OPT EXPRESS, V21, P14662, DOI 10.1364/OE.21.014662; Lei M, 2008, J NEUROSCI METH, V174, P215, DOI 10.1016/j.jneumeth.2008.07.006; Lodish H, 2000, MOL CELL BIOL; Marchington RF, 2010, BIOMED OPT EXPRESS, V1, P527, DOI 10.1364/BOE.1.000527; Matsuoka H, 2005, J BIOTECHNOL, V116, P185, DOI 10.1016/j.jbiotec.2004.10.010; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mthunzi P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430733; Nagata T, 2004, BIOTECHNOL AGRIC FOR, V53, P1; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; Rendall HA, 2012, LAB CHIP, V12, P4816, DOI 10.1039/c2lc40708f; Rounds CM, 2011, PLANT PHYSIOL, V157, P175, DOI 10.1104/pp.111.182196; Rudhall AP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00858; Schinkel H, 2008, BIOTECHNOL BIOENG, V99, P244, DOI 10.1002/bit.21549; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMIT JAM, 1992, MACROMOLECULES, V25, P3585, DOI 10.1021/ma00039a044; Stevenson D, 2006, OPT EXPRESS, V14, P7125, DOI 10.1364/OE.14.007125; Stevenson DJ, 2010, J R SOC INTERFACE, V7, P863, DOI 10.1098/rsif.2009.0463; Stiles W, 1994, PRINCIPLES PLANT PHY; Tirlapur UK, 1999, PLANT J, V20, P363, DOI 10.1046/j.1365-313X.1999.t01-1-00603.x; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Torres-Mapa ML, 2011, BIOMED OPT EXPRESS, V2, P1564, DOI 10.1364/BOE.2.001564; TRAAS JA, 1987, J CELL BIOL, V105, P387, DOI 10.1083/jcb.105.1.387; Tsampoula X, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766835; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; WEBER G, 1990, PHYSIOL PLANTARUM, V79, P190, DOI 10.1111/j.1399-3054.1990.tb05885.x; Wu FS, 1999, PLANT CELL REP, V18, P381, DOI 10.1007/s002990050590; WU FS, 1995, PLANT SCI, V104, P201, DOI 10.1016/0168-9452(94)04023-A; Wymer CL, 1997, PLANT J, V12, P229, DOI 10.1046/j.1365-313X.1997.12010229.x; Yao CP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253320; Zeira E, 2003, MOL THER, V8, P342, DOI 10.1016/S1525-0016(03)00184-9	63	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79235	10.1371/journal.pone.0079235	http://dx.doi.org/10.1371/journal.pone.0079235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244456	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800046
J	Vincent, HA; Phillips, JO; Henderson, CA; Roberts, AJ; Stone, CM; Mardle, CE; Butt, LE; Gowers, DM; Pickford, AR; Callaghan, AJ				Vincent, Helen A.; Phillips, Jack O.; Henderson, Charlotte A.; Roberts, Adam J.; Stone, Carlanne M.; Mardle, Charlotte E.; Butt, Louise E.; Gowers, Darren M.; Pickford, Andrew R.; Callaghan, Anastasia J.			An Improved Method for Surface Immobilisation of RNA: Application to Small Non-Coding RNA - mRNA Pairing	PLOS ONE			English	Article							VIBRIO-CHOLERAE; ESCHERICHIA-COLI; OLIGORIBONUCLEOTIDE SYNTHESIS; HELICOBACTER-PYLORI; GENE-EXPRESSION; OUTER-MEMBRANE; ANTISENSE RNA; SOLUBLE-RNA; HFQ; BINDING	Characterisation of RNA and its intermolecular interactions is increasing in importance as the inventory of known RNA functions continues to expand. RNA-RNA interactions are central to post-transcriptional gene regulation mechanisms in bacteria, and the interactions of bacterial small non-coding RNAs (sRNAs) with their mRNA targets are the subject of much current research. The technology of surface plasmon resonance (SPR) is an attractive approach to studying these interactions since it is highly sensitive, and allows interaction measurements to be recorded in real-time. Whilst a number of approaches exist to label RNAs for surface-immobilisation, the method documented here is simple, quick, efficient, and utilises the high-affinity streptavidin-biotin interaction. Specifically, we ligate a biotinylated nucleotide to the 39 end of RNA using T4 RNA ligase. Although this is a previously recognised approach, we have optimised the method by our discovery that the incorporation of four or more adenine nucleotides at the 39 end of the RNA (a poly-A-tail) is required in order to achieve high ligation efficiencies. We use this method within the context of investigating small non-coding RNA (sRNA) mRNA interactions through the application of surface technologies, including quantitative SPR assays. We first focus on validating the method using the recently characterised Escherichia coli sRNA-mRNA pair, MicA-ompA, specifically demonstrating that the addition of the poly-A-tail to either RNA does not affect its subsequent binding interactions with partner molecules. We then apply this method to investigate the novel interactions of a Vibrio cholerae Qrr sRNA with partner mRNAs, hapR and vca0939; RNA-RNA pairings that are important in mediating pathogenic virulence. The calculated binding parameters allow insights to be drawn regarding sRNA-mRNA interaction mechanisms.	[Callaghan, Anastasia J.] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England	University of Portsmouth; University of Portsmouth	Callaghan, AJ (corresponding author), Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England.	Anastasia.Callaghan@port.ac.uk	Vincent, Helen/GZK-3422-2022; Pickford, Andy/AGB-6901-2022; Gowers, Darren/U-5947-2019	Pickford, Andy/0000-0002-7237-0030; Roberts, Adam/0000-0002-6834-549X; Gowers, Darren Matthew/0000-0001-7604-012X; Butt, Louise/0000-0003-2422-1046	Biotechnology and Biological Sciences Research Council [BB/F013140/1, BB/I532988/1]; Higher Education Innovation Fund through the University of Portsmouth; European Commission [249154]; Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary; BBSRC [BB/I532988/1, BB/F013140/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Innovation Fund through the University of Portsmouth; European Commission(European CommissionEuropean Commission Joint Research Centre); Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [BB/F013140/1 and BB/I532988/1 to AJC]; an award from the Higher Education Innovation Fund through the University of Portsmouth [to AJC]; a Marie Curie Reintegration Grant from the European Commission, FP7 [249154 to HAV] and an Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary (to CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Andrade JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052866; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bardill JP, 2011, MOL MICROBIOL, V80, P1381, DOI 10.1111/j.1365-2958.2011.07655.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; Carpousis AJ, 2003, GENE DEV, V17, P2351, DOI 10.1101/gad.1147003; Caruthers MH, 2011, BIOCHEM SOC T, V39, P575, DOI 10.1042/BST0390575; Cech TR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006742; Cole K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh085; ENGLAND TE, 1978, BIOCHEMISTRY-US, V17, P2069, DOI 10.1021/bi00604a008; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025; Gao XX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng143; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Henderson CA, 2013, RNA, V19, P1089, DOI 10.1261/rna.034595.112; Henderson CA, 2013, NUCLEIC ACIDS RES, V41, P3386, DOI 10.1093/nar/gkt008; Henriksson-Peltola P, 2007, NUCLEIC ACIDS RES, V35, P3181, DOI 10.1093/nar/gkm172; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kugel JF, 2012, TRENDS BIOCHEM SCI, V37, P144, DOI 10.1016/j.tibs.2011.12.003; Kurschat WC, 2005, RNA, V11, P1909, DOI 10.1261/rna.2170705; Lalaouna D, 2013, BBA-GENE REGUL MECH, V1829, P742, DOI 10.1016/j.bbagrm.2013.02.013; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li SK, 2013, RNA, V19, P74, DOI 10.1261/rna.034116.112; LINGNER J, 1993, NUCLEIC ACIDS RES, V21, P2917, DOI 10.1093/nar/21.12.2917; Matos RG, 2010, PROTEIN J, V29, P394, DOI 10.1007/s10930-010-9265-1; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Paredes E, 2011, METHODS, V54, P251, DOI 10.1016/j.ymeth.2011.02.008; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; RICHARDSON RW, 1983, NUCLEIC ACIDS RES, V11, P6167, DOI 10.1093/nar/11.18.6167; Rieder R, 2012, RNA BIOL, V9, P520, DOI 10.4161/rna.20331; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Salim NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013028; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shetty S, 2013, NUCLEIC ACIDS RES, V41, P2526, DOI 10.1093/nar/gks1318; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Vicens Q, 2009, J INCL PHENOM MACRO, V65, P171, DOI 10.1007/s10847-009-9609-7; Viegas SC, 2011, NUCLEIC ACIDS RES, V39, P2918, DOI 10.1093/nar/gkq1239; Vincent HA, 2012, NUCLEIC ACIDS RES, V40, P8698, DOI 10.1093/nar/gks582; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79142	10.1371/journal.pone.0079142	http://dx.doi.org/10.1371/journal.pone.0079142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244437	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800034
J	Zdebik, AA; Mahmood, F; Stanescu, HC; Kleta, R; Bockenhauer, D; Russell, C				Zdebik, Anselm A.; Mahmood, Fahad; Stanescu, Horia C.; Kleta, Robert; Bockenhauer, Detlef; Russell, Claire			Epilepsy in kcnj10 Morphant Zebrafish Assessed with a Novel Method for Long-Term EEG Recordings	PLOS ONE			English	Article							SENSORINEURAL DEAFNESS; EAST SYNDROME; SEIZURE SUSCEPTIBILITY; CHANNEL GENE; MUTATIONS; TUBULOPATHY; ATAXIA; ASSOCIATION; EXPRESSION; MODEL	We aimed to develop and validate a reliable method for stable long-term recordings of EEG activity in zebrafish, which is less prone to artifacts than current invasive techniques. EEG activity was recorded with a blunt electrolyte-filled glass pipette placed on the zebrafish head mimicking surface EEG technology in man. In addition, paralysis of agarose-embedded fish using D-tubocurarine excluded movement artifacts associated with epileptic activity. This non-invasive recording technique allowed recordings for up to one hour and produced less artifacts than impaling the zebrafish optic tectum with a patch pipette. Paralyzed fish survived, and normal heartbeat could be monitored for over 1h. Our technique allowed the demonstration of specific epileptic activity in kcnj10a morphant fish (a model for EAST syndrome) closely resembling epileptic activity induced by pentylenetetrazol. This new method documented that seizures in the zebrafish EAST model were ameliorated by pentobarbitone, but not diazepam, validating its usefulness. In conclusion, non-invasive recordings in paralyzed EAST syndrome zebrafish proved stable, reliable and robust, showing qualitatively similar frequency spectra to those obtained from pentylenetetrazol-treated fish. This technique may prove particularly useful in zebrafish epilepsy models that show infrequent or conditional seizure activity.	[Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Mahmood, Fahad; Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biol Sci, London, England; [Zdebik, Anselm A.; Stanescu, Horia C.; Kleta, Robert; Bockenhauer, Detlef] UCL, Ctr Nephrol, London, England; [Kleta, Robert; Bockenhauer, Detlef] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London; University of London; University College London	Zdebik, AA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	a.zdebik@ucl.ac.uk	Bockenhauer, Detlef/AAF-6495-2020; Mahmood, Fahad/ABD-1829-2020; Russell, Claire/A-4879-2012	Bockenhauer, Detlef/0000-0001-5878-941X; Mahmood, Fahad/0000-0003-1776-8828; Russell, Claire/0000-0002-6748-9301	Peter Samuel Trust Fund [939]; David and Elaine Potter Charitable Foundation; Grocers' Charity; St Peter's Trust for Kidney, Bladder and Prostate Research; Kids Kidney Research and Garfield Weston Foundation; EU FP7 program [305608]; Royal Veterinary College (RVC); RVC	Peter Samuel Trust Fund; David and Elaine Potter Charitable Foundation; Grocers' Charity; St Peter's Trust for Kidney, Bladder and Prostate Research; Kids Kidney Research and Garfield Weston Foundation(Kidney Research UK (KRUK)); EU FP7 program(European Commission); Royal Veterinary College (RVC); RVC	UCL work was supported by grants from the Peter Samuel Trust Fund (grant number 939) (to AAZ), the David and Elaine Potter Charitable Foundation and Grocers' Charity (to RK), St Peter's Trust for Kidney, Bladder and Prostate Research (to AAZ, DB and RK), Kids Kidney Research and Garfield Weston Foundation (to DB and RK), and by the EU FP7 program (EURenOmics grant agreement number 305608 (to DB, RK)). Funding for FM was provided via a doctoral training grant from the Royal Veterinary College (RVC) (to CR). Funding for consumables and animals at the RVC (to CR and FM) was provided by a RVC start-up grant (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandulik S, 2011, PFLUG ARCH EUR J PHY, V461, P423, DOI 10.1007/s00424-010-0915-0; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Bauzano-Poley E, 2001, REV NEUROLOGIA, V32, P365, DOI 10.33588/rn.3204.2000513; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Freudenthal B, 2011, NEPHRON PHYSIOL, V119, pP40, DOI 10.1159/000330250; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Mahmood F, 2013, DIS MODEL MECH, V6, P652, DOI 10.1242/dmm.009480; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Pineda R, 2011, J NEUROSCI METH, V200, P20, DOI 10.1016/j.jneumeth.2011.06.001; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Thompson DA, 2011, J PHYSIOL-LONDON, V589, P1681, DOI 10.1113/jphysiol.2010.198531; Westmoreland BF, 1996, MAYO CLIN PROC, V71, P501, DOI 10.4065/71.5.501	20	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79765	10.1371/journal.pone.0079765	http://dx.doi.org/10.1371/journal.pone.0079765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244558	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800099
J	Becker, S; Ceko, M; Louis-Foster, M; Elfassy, NM; Leyton, M; Shir, Y; Schweinhardt, P				Becker, Susanne; Ceko, Marta; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Leyton, Marco; Shir, Yoram; Schweinhardt, Petra			Dopamine and Pain Sensitivity: Neither Sulpiride nor Acute Phenylalanine and Tyrosine Depletion Have Effects on Thermal Pain Sensations in Healthy Volunteers	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; CATECHOLAMINE SYNTHESIS; PARKINSONS-DISEASE; TEMPORAL SUMMATION; DOUBLE-BLIND; AMINO-ACIDS; EFFECT SIZE; ANTINOCICEPTIVE ACTIONS; FIBROMYALGIA PATIENTS; WORKING-MEMORY	Based on animal studies and some indirect clinical evidence, dopamine has been suggested to have anti-nociceptive effects. Here, we investigated directly the effects of increased and decreased availability of extracellular dopamine on pain perception in healthy volunteers. In Study 1, participants ingested, in separate sessions, a placebo and a low dose of the centrally acting D2-receptor antagonist sulpiride, intended to increase synaptic dopamine via predominant pre-synaptic blockade. No effects were seen on thermal pain thresholds, tolerance, or temporal summation. Study 2 used the acute phenylalanine and tyrosine depletion (APTD) method to transiently decrease dopamine availability. In one session participants ingested a mixture that depletes the dopamine amino acid precursors, phenylalanine and tyrosine. In the other session they ingested a nutritionally balanced control mixture. APTD led to a small mood-lowering response following aversive thermal stimulation, but had no effects on the perception of cold, warm, or pain stimuli. In both studies the experimental manipulation of dopaminergic neurotransmission was successful as indicated by manipulation checks. The results contradict proposals that dopamine has direct anti-nociceptive effects in acute experimental pain. Based on dopamine's well-known role in reward processing, we hypothesize that also in the context of pain, dopamine acts on stimulus salience and might play a role in the initiation of avoidance behavior rather than having direct antinociceptive effects in acute experimental pain.	[Becker, Susanne; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Schweinhardt, Petra] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Becker, Susanne; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Schweinhardt, Petra] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Becker, Susanne] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Ceko, Marta] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; [Leyton, Marco; Schweinhardt, Petra] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Leyton, Marco] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada; [Shir, Yoram] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Alan Edwards Pain Management Unit, Montreal, PQ, Canada	McGill University; McGill University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; McGill University; McGill University; Concordia University - Canada; McGill University	Becker, S (corresponding author), McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada.	susanne.becker@zi-mannheim.de	Schweinhardt, Petra/AAC-6797-2021; Becker, Susanne/F-7209-2019; Ceko, Marta/AAD-2011-2022; Leyton, Marco/AAY-7557-2020	Becker, Susanne/0000-0002-5681-4084; Leyton, Marco/0000-0002-1243-2252; CEKO, MARTA/0000-0001-8679-8145; Schweinhardt, Petra/0000-0003-4837-6595	International Association for the Study of Pain (IASP); German Research Foundation [BE4309/2-1]; Canadian Institutes for Health Research [MOP-102636]	International Association for the Study of Pain (IASP); German Research Foundation(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the International Association for the Study of Pain (IASP) (no grant number) http://www.iasp-pain.org; The German Research Foundation, BE4309/2-1, http://www.dfg.de/en/; Canadian Institutes for Health Research, MOP-102636, http://www.cihr-irsc.gc.ca/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; ALFREDSSON G, 1984, PSYCHOPHARMACOLOGY, V84, P237, DOI 10.1007/BF00427452; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016/j.expneurol.2007.03.010; BARASI S, 1987, BRIT J PHARMACOL, V90, P15, DOI 10.1111/j.1476-5381.1987.tb16820.x; Becker S, EUR J NEUROSCI; Becker S, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/741746; BENFENATI F, 1981, NEUROSCI LETT, V26, P289, DOI 10.1016/0304-3940(81)90147-6; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Brooks AM, 2013, TRENDS COGN SCI, V17, P281, DOI 10.1016/j.tics.2013.04.001; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; CARLSSON A, 1978, N-S ARCH PHARMACOL, V303, P157, DOI 10.1007/BF00508062; Cevoli S, 2006, EUR J NEUROL, V13, P1009, DOI 10.1111/j.1468-1331.2006.01415.x; Choi SJ, 2009, PHYSIOL BEHAV, V98, P156, DOI 10.1016/j.physbeh.2009.05.004; CLARKE PBS, 1992, BRAIN RES, V580, P106, DOI 10.1016/0006-8993(92)90932-Y; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COSTALL B, 1980, EUR J PHARMACOL, V63, P347, DOI 10.1016/0014-2999(80)90265-4; Coull JT, 2012, J NEUROSCI, V32, P16704, DOI 10.1523/JNEUROSCI.1258-12.2012; Daskalakis ZJ, 2008, J PSYCHOPHARMACOL, V22, P203, DOI 10.1177/0269881107084002; Dellapina E, 2011, MOVEMENT DISORD, V26, P153, DOI 10.1002/mds.23406; DICKEY RP, 1972, NEW ENGL J MED, V286, P843; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Gierthmuhlen J, 2010, MOVEMENT DISORD, V25, P1195, DOI 10.1002/mds.23128; GIRODO M, 1979, COGNITIVE THER RES, V3, P23, DOI 10.1007/BF01172716; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Granot M, 2006, PAIN, V122, P295, DOI 10.1016/j.pain.2006.02.003; Graven-Nielsen T, 2000, PAIN, V85, P483, DOI 10.1016/S0304-3959(99)00308-5; Hagelberg N, 2004, EUR J PHARMACOL, V500, P187, DOI 10.1016/j.ejphar.2004.07.024; Hagelberg N, 2003, PAIN, V106, P43, DOI 10.1016/S0304-3959(03)00275-6; Hagelberg N, 2003, PAIN, V101, P149, DOI 10.1016/S0304-3959(02)00323-8; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; HORN PT, 1982, J CARDIOVASC PHARM, V4, P668, DOI 10.1097/00005344-198207000-00020; Jarcho JM, 2012, PAIN, V153, P744, DOI 10.1016/j.pain.2012.01.002; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; KENDLER KS, 1982, EUR J PHARMACOL, V79, P217, DOI 10.1016/0014-2999(82)90627-6; Kuroki T, 1999, J PHARMACOL EXP THER, V288, P774; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leyton M, 2004, NEUROPSYCHOPHARMACOL, V29, P427, DOI 10.1038/sj.npp.1300328; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Loggia ML, 2008, J PAIN, V9, P784, DOI 10.1016/j.jpain.2008.03.014; LORR M, 1982, J PERS ASSESS, V46, P432, DOI 10.1207/s15327752jpa4604_16; Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3; Malt EA, 2003, J AFFECT DISORDERS, V75, P77, DOI 10.1016/S0165-0327(02)00025-3; Marsala SZ, 2011, J NEUROL, V258, P627, DOI 10.1007/s00415-010-5812-0; MCCLELLAND GR, 1990, BRIT J CLIN PHARMACO, V30, P795, DOI 10.1111/j.1365-2125.1990.tb05444.x; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; McTavish SFB, 1999, PSYCHOPHARMACOLOGY, V141, P182, DOI 10.1007/s002130050823; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2008, PSYCHOPHARMACOLOGY, V196, P157, DOI 10.1007/s00213-007-0947-0; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Montgomery AJ, 2003, AM J PSYCHIAT, V160, P1887, DOI 10.1176/appi.ajp.160.10.1887; Nandhagopal R, 2010, PAIN MED, V11, P834, DOI 10.1111/j.1526-4637.2010.00866.x; Nielsen J, 1998, EUR J PAIN, V2, P329, DOI 10.1016/S1090-3801(98)90031-3; OCONNOR SE, 1982, GEN PHARMACOL-VASC S, V13, P185, DOI 10.1016/0306-3623(82)90088-X; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Pecina S, 2003, J NEUROSCI, V23, P9395; Potvin S, 2009, SYNAPSE, V63, P390, DOI 10.1002/syn.20616; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; PUECH AJ, 1978, EUR J PHARMACOL, V50, P291, DOI 10.1016/0014-2999(78)90134-6; Saade NE, 1997, BRAIN RES, V751, P1, DOI 10.1016/S0006-8993(96)01164-X; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Shimizu T, 2004, PAIN, V110, P246, DOI 10.1016/j.pain.2004.03.038; SMIT AJ, 1990, EUR J CLIN PHARMACOL, V39, P221, DOI 10.1007/BF00315100; Soares BG, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001162, 10.1002/14651858.CD001162, DOI 10.1002/14651858.CD001162.PUBMED:10796605]; Sommer C, 2012, SCHMERZ, V26, P297, DOI 10.1007/s00482-012-1172-2; Sorensen J, 1995, SCAND J RHEUMATOL, V24, P360; Sorensen J, 1997, J RHEUMATOL, V24, P1615; STANDISHBARRY HMAS, 1983, PSYCHOPHARMACOLOGY, V81, P258, DOI 10.1007/BF00427274; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Tomori L, 1992, Acta Pharm Hung, V62, P39; Treister R, 2013, NEUROSCI LETT, V548, P115, DOI 10.1016/j.neulet.2013.05.041; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Vrshek-Schallhorn S, 2013, PHARMACOL BIOCHEM BE, V105, P51, DOI 10.1016/j.pbb.2013.01.013; WESTERINK BHC, 1989, NEUROSCI LETT, V99, P197, DOI 10.1016/0304-3940(89)90289-9; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	93	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80766	10.1371/journal.pone.0080766	http://dx.doi.org/10.1371/journal.pone.0080766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236199	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700202
J	Brown, LL; Acevedo, B; Fisher, HE				Brown, Lucy L.; Acevedo, Bianca; Fisher, Helen E.			Neural Correlates of Four Broad Temperament Dimensions: Testing Predictions for a Novel Construct of Personality	PLOS ONE			English	Article							PREFRONTAL CORTEX; SEX-DIFFERENCES; ROMANTIC LOVE; HUMAN BRAIN; ORBITOFRONTAL CORTEX; GENERAL INTELLIGENCE; DECISION-MAKING; SUICIDE VICTIMS; TRAITS; NEUROANATOMY	Four suites of behavioral traits have been associated with four broad neural systems: the 1) dopamine and related norepinephrine system; 2) serotonin; 3) testosterone; 4) and estrogen and oxytocin system. A 56-item questionnaire, the Fisher Temperament Inventory (FTI), was developed to define four temperament dimensions associated with these behavioral traits and neural systems. The questionnaire has been used to suggest romantic partner compatibility. The dimensions were named: Curious/Energetic; Cautious/Social Norm Compliant; Analytical/Tough-minded; and Prosocial/Empathetic. For the present study, the FTI was administered to participants in two functional magnetic resonance imaging studies that elicited feelings of love and attachment, near-universal human experiences. Scores for the Curious/Energetic dimension co-varied with activation in a region of the substantia nigra, consistent with the prediction that this dimension reflects activity in the dopamine system. Scores for the Cautious/Social Norm Compliant dimension correlated with activation in the ventrolateral prefrontal cortex in regions associated with social norm compliance, a trait linked with the serotonin system. Scores on the Analytical/Tough-minded scale co-varied with activity in regions of the occipital and parietal cortices associated with visual acuity and mathematical thinking, traits linked with testosterone. Also, testosterone contributes to brain architecture in these areas. Scores on the Prosocial/Empathetic scale correlated with activity in regions of the inferior frontal gyrus, anterior insula and fusiform gyrus. These are regions associated with mirror neurons or empathy, a trait linked with the estrogen/oxytocin system, and where estrogen contributes to brain architecture. These findings, replicated across two studies, suggest that the FTI measures influences of four broad neural systems, and that these temperament dimensions and neural systems could constitute foundational mechanisms in personality structure and play a role in romantic partnerships.	[Brown, Lucy L.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Acevedo, Bianca] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Fisher, Helen E.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Santa Barbara; Rutgers State University New Brunswick	Fisher, HE (corresponding author), Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA.	helenfisher@helenfisher.com	Acevedo, Bianca/AAV-1627-2021	Acevedo, Bianca/0000-0001-6603-7218	W. Burghardt Turner Fellowship; Psychology Department at Stony Brook University; National Science Foundation [0958171]	W. Burghardt Turner Fellowship; Psychology Department at Stony Brook University; National Science Foundation(National Science Foundation (NSF))	This research was partially supported by funding from the W. Burghardt Turner Fellowship to BA, the Psychology Department at Stony Brook University, and a post-doctoral fellowship to BA grant No. 0958171 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-20; Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Acevedo BP, 2013, BASES ADULT IN PRESS; Allport GW, 1936, J PERS SOC PSY, V41, P916; ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Arango V, 1997, ANN NY ACAD SCI, V836, P269, DOI 10.1111/j.1749-6632.1997.tb52365.x; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P305; Cattell R. B., 1993, 16 FACTOR QUESTIONNA; Cattell RB, 1943, J ABNORM SOC PSYCH, V38, P476, DOI 10.1037/h0054116; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; CLARK AS, 1988, ENDOCRINOLOGY, V123, P932, DOI 10.1210/endo-123-2-932; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa P. T., 1992, REVISED NEO PERSONAL, DOI [10.1007/978-0-387-79948-3_2000, DOI 10.1007/978-0-387-79948-3_2000]; Davis KL., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI [DOI 10.1080/15294145.2003.10773410, 10.1080/15294145.2003.10773410]; Depue R.A., 2005, MAJOR THEORIES PERSO, V2nd, P391; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; DONOHEW L, 1991, COMMUNIC, P209; Ehringer H, 1998, Parkinsonism Relat Disord, V4, P53, DOI 10.1016/S1353-8020(98)00012-1; Eysenck H. J., 1985, EYSENCK PERSONALITY; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Feis DL, 2013, NEUROIMAGE, V70, P250, DOI 10.1016/j.neuroimage.2012.12.068; Fisher H., 2009, WHY HIM WHY HER; Fisher HE, 2010, PERS INDIV DIFFER, V49, P773, DOI 10.1016/j.paid.2010.06.027; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Furnham A., 2006, EUR J PERSONALITY, V2, P67, DOI [10.1002/per.2410020106, DOI 10.1002/PER.2410020106]; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; Golimbet VE, 2004, MOL BIOL+, V38, P337, DOI 10.1023/B:MBIL.0000032202.83988.09; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hanggi J, 2010, J COGNITIVE NEUROSCI, V22, P139, DOI 10.1162/jocn.2008.21175; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kwee IL, 2003, J NEUROL, V250, P525, DOI 10.1007/s00415-003-1028-x; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Levin JM, 1998, AM J PSYCHIAT, V155, P434, DOI 10.1176/ajp.155.3.434; LINDVALL O, 1974, BRAIN RES, V81, P325, DOI 10.1016/0006-8993(74)90947-0; LINDVALL O, 1974, ACTA PHYSIOL SCAND, P1; LOGUE AW, 1986, APPETITE, V7, P109, DOI 10.1016/S0195-6663(86)80012-5; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 2002, DIGIT RATIO POINTER, P24; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; McGuinness D, 1976, EXPLORATIONS SEX DIF, P21; Nunez JL, 2003, J NEUROBIOL, V56, P293, DOI 10.1002/neu.10236; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Riceberg JS, 2012, J NEUROSCI, V32, P16402, DOI 10.1523/JNEUROSCI.0776-12.2012; Riemann R, 1997, J PERS, V65, P449, DOI 10.1111/j.1467-6494.1997.tb00324.x; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roberts BW, 2006, PSYCHOL BULL, V132, P29, DOI 10.1037/0033-2909.132.1.29; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; Salinas J, 2012, GENDER MED, V9, P44, DOI 10.1016/j.genm.2012.01.003; SCHIERMAN MJ, 1985, PERS INDIV DIFFER, V6, P599, DOI 10.1016/0191-8869(85)90009-1; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steiner AP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00131; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; Volkow ND, 1996, J NUCL MED, V37, P1242; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Zeki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015802; Zuckerman M., 2005, PSYCHOBIOLOGY PERSON; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	85	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78734	10.1371/journal.pone.0078734	http://dx.doi.org/10.1371/journal.pone.0078734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236043	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700040
J	Kruger, K; Gessner, DK; Seimetz, M; Banisch, J; Ringseis, R; Eder, K; Weissmann, N; Mooren, FC				Krueger, Karsten; Gessner, Denise K.; Seimetz, Michael; Banisch, Jasmin; Ringseis, Robert; Eder, Klaus; Weissmann, Norbert; Mooren, Frank C.			Functional and Muscular Adaptations in an Experimental Model for Isometric Strength Training in Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE ADAPTATIONS; VOLUNTARY EXERCISE; LOADING CONTROL; RESISTANCE; ENDURANCE; FIBER; YOUNG; HYPERTROPHY; INTENSITY; ACTIN	Exercise training induces muscular adaptations that are highly specific to the type of exercise. For a systematic study of the differentiated exercise adaptations on a molecular level mouse models have been used successfully. The aim of the current study was to develop a suitable mouse model of isometric strength exercise training characterized by specific adaptations known from strength training. C57BL/6 mice performed an isometric strength training (ST) for 10 weeks 5 days/week. Additionally, either a sedentary control group (CT) or a regular endurance training group (ET) groups were used as controls. Performance capacity was determined by maximum holding time (MHT) and treadmill spirometry, respectively. Furthermore, muscle fiber types and diameter, muscular concentration of phosphofructokinase 1 (PFK), succinate dehydrogenase (SDHa), and glucose transporter type 4 (GLUT4) were determined. In a further approach, the effect of ST on glucose intolerance was tested in diabetic mice. In mice of the ST group we observed an increase of MHT in isometric strength tests, a type II fiber hypertrophy, and an increased GLUT4 protein content in the membrane fraction. In contrast, in mice of the ET group an increase of VO2max, a shift to oxidative muscle fiber type and an increase of oxidative enzyme content was measured. Furthermore strength training was effective in reducing glucose intolerance in mice fed a high fat diet. An effective murine strength training model was developed and evaluated, which revealed marked differences in adaptations known from endurance training. This approach seems also suitable to test for therapeutical effects of strength training.	[Krueger, Karsten; Banisch, Jasmin; Mooren, Frank C.] Univ Giessen, Inst Sports Sci, Dept Sports Med, D-35390 Giessen, Germany; [Gessner, Denise K.; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany; [Seimetz, Michael; Weissmann, Norbert] Univ Giessen & Marburg Lung Ctr, Excellence Cluster Cardiopulm Syst ECCPS, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Kruger, K (corresponding author), Univ Giessen, Inst Sports Sci, Dept Sports Med, D-35390 Giessen, Germany.	karsten.krueger@sport.uni-giessen.de	Ringseis, Robert/AAH-1509-2021; krueger, karsten/A-3062-2015	Weissmann, Norbert/0000-0003-2675-3871; Kruger, Karsten/0000-0003-1506-8254				Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Booth FW, 1998, ACTA PHYSIOL SCAND, V162, P343, DOI 10.1046/j.1365-201X.1998.0326e.x; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; CARTEE GD, 1994, MED SCI SPORT EXER, V26, P577; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Diaz-Herrera P, 2001, J ORTHOPAED RES, V19, P229, DOI 10.1016/S0736-0266(00)00031-0; Diaz-Herrera P, 2001, HISTOL HISTOPATHOL, V16, P29, DOI 10.14670/HH-16.29; Farup J, 2012, J STRENGTH COND RES, V26, P398, DOI 10.1519/JSC.0b013e318225a26f; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Konhilas JP, 2005, AM J PHYSIOL-HEART C, V289, pH455, DOI 10.1152/ajpheart.00085.2005; Kruger K, 2008, BRAIN BEHAV IMMUN, V22, P324, DOI 10.1016/j.bbi.2007.08.008; Kruger K, 2009, AM J PHYSIOL-REG I, V296, pR1518, DOI 10.1152/ajpregu.90994.2008; LaPier TLK, 2001, AM J HYPERTENS, V14, P708; Lee S, 2012, DIABETES, V29; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Loimaala A, 2009, AM J CARDIOL, V103, P972, DOI 10.1016/j.amjcard.2008.12.026; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Ngo KTA, 2012, ACTA PHYSIOL, V205, P133, DOI 10.1111/j.1748-1716.2011.02379.x; Nicastro H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/457065; Pasini E, 2012, EXP GERONTOL, V47, P23, DOI 10.1016/j.exger.2011.10.003; Ringseis R, 2011, MOL NUTR FOOD RES; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026; Verdijk LB, 2009, J SPORT SCI, V27, P59, DOI 10.1080/02640410802428089; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Yano H, 1997, JPN J PHYSIOL, V47, P139, DOI 10.2170/jjphysiol.47.139	38	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79069	10.1371/journal.pone.0079069	http://dx.doi.org/10.1371/journal.pone.0079069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236089	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700087
J	Schmidt, VJ; Hilgert, JG; Covi, JM; Weis, C; Wietbrock, JO; de Wit, C; Horch, RE; Kneser, U				Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Weis, Christian; Wietbrock, Johanna O.; de Wit, Cor; Horch, Raymund E.; Kneser, Ulrich			High Flow Conditions Increase Connexin43 Expression in a Rat Arteriovenous and Angioinductive Loop Model	PLOS ONE			English	Article							GAP-JUNCTION COMMUNICATION; ANGIOGENESIS; MIGRATION; DILATIONS; CELLS; ENDOTHELIUM; ARTERIOLES; MATRIX	Gap junctions are involved in vascular growth and their expression pattern is modulated in response to hemodynamic conditions. They are clusters of intercellular channels formed by connexins (Cx) of which four subtypes are expressed in the cardiovascular system, namely Cx37, Cx40, Cx43 and Cx45. We hypothesize that high flow conditions affect vascular expression of Cx in vivo. To test this hypothesis, flow hemodynamics and subsequent changes in vascular expression of Cx were studied in an angioinductive rat arteriovenous (AV) loop model. Fifteen days after interposition of a femoral vein graft between femoral artery and vein encased in a fibrin-filled chamber strong neovascularization was evident that emerged predominantly from the graft. Blood flow through the grafted vessel was enhanced similar to 4.5-fold accompanied by increased pulsatility exceeding arterial levels. Whereas Cx43 protein expression in the femoral vein is negligible at physiologic flow conditions as judged by immunostaining its expression was enhanced in the endothelium of the venous graft exposed to these hemodynamic changes for 5 days. This was most likely due to enhanced transcription since Cx43 mRNA increased likewise, whereas Cx37 mRNA expression remained unaffected and Cx40 mRNA was reduced. Although enhanced Cx43 expression in regions of high flow in vivo has already been demonstrated, the arteriovenous graft used in the present study provides a reliable model to verify an association between Cx43 expression and high flow conditions in vivo that was selective for this Cx. We conclude that enhancement of blood flow and its oscillation possibly associated with the transition from laminar to more turbulent flow induces Cx43 expression in a vein serving as an AV loop. It is tempting to speculate that this upregulation is involved in the vessel formation occuring in this model as Cx43 was suggested to be involved in angiogenesis.	[Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany; [Schmidt, Volker J.; Wietbrock, Johanna O.; Kneser, Ulrich] Heidelberg Univ, Dept Hand Plast & Reconstruct Surg, BG Unfallklin Ludwigshafen, Heidelberg, Germany; [Weis, Christian] Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany; [de Wit, Cor] Univ Lubeck, Dept Physiol, Lubeck, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; University of Lubeck	Schmidt, VJ (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.	schmidtvolker@gmx.net	de Wit, Cor/A-5560-2009; Horch, Raymund E./H-8128-2019	de Wit, Cor/0000-0003-4621-0399; Horch, Raymund E./0000-0002-6561-2353	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg [TP J-15]	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg (to VJS, TP J-15, www.izkf.med.uni-erlangen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2007, MOL MED, V13, P480, DOI 10.2119/2007-00057.Arkudas; Arkudas A, 2010, TISSUE ENG PART C-ME, V16, P1503, DOI 10.1089/ten.tec.2010.0016; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Boettcher M, 2011, HYPERTENSION, V57, P802, DOI 10.1161/HYPERTENSIONAHA.110.165894; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cowan DB, 1998, CIRC RES, V82, P786, DOI 10.1161/01.RES.82.7.786; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; de Wit C, 2004, NEWS PHYSIOL SCI, V19, P148, DOI 10.1152/nips.01520.2004; de Wit C, 2010, CARDIOVASC RES, V85, P604, DOI 10.1093/cvr/cvp340; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; EROL OO, 1979, SURG FORUM, V30, P530; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Gartner C, 2012, PHARMACOL RES, V65, P347, DOI 10.1016/j.phrs.2011.11.012; Gustafsson F, 2003, HISTOCHEM CELL BIOL, V119, P139, DOI 10.1007/s00418-002-0493-0; Hill CE, 2012, J CARDIOVASC PHARM; Hong T, 1998, J ANAT, V192, P583, DOI 10.1046/j.1469-7580.1998.19240583.x; Inai T, 2009, ANAT SCI INT, V84, P237, DOI 10.1007/s12565-009-0029-y; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Jia GH, 2008, J MOL CELL CARDIOL, V44, P882, DOI 10.1016/j.yjmcc.2008.03.002; Jobs A, 2012, HYPERTENSION, V60, P1422, DOI 10.1161/HYPERTENSIONAHA.112.201194; Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Polykandriotis E, 2008, MICROVASC RES, V75, P25, DOI 10.1016/j.mvr.2007.04.003; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Rummery NM, 2002, ARTERIOSCL THROM VAS, V22, P1427, DOI 10.1161/01.ATV.0000028814.45706.E5; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Schmidt VJ, 2008, PHARMACOL REP, V60, P68; Schmidt VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042287; Vorderwulbecke BJ, 2011, AM J PHYSL HEART CIR; Wang HH, 2008, CARDIOVASC RES, V79, P509, DOI 10.1093/cvr/cvn112; Wolfle SE, 2007, CIRC RES, V101, P1292, DOI 10.1161/CIRCRESAHA.107.163279	36	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78782	10.1371/journal.pone.0078782	http://dx.doi.org/10.1371/journal.pone.0078782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236049	Green Published, gold			2022-12-25	WOS:000327254700046
J	Sutter, AG; Palanisamy, AP; Kurtz, N; Spyropoulos, DD; Chavin, KD				Sutter, Alton G.; Palanisamy, Arun P.; Kurtz, Nichole; Spyropoulos, Demetri D.; Chavin, Kenneth D.			Efficient Method of Genotyping Ob/Ob Mice Using High Resolution Melting Analysis	PLOS ONE			English	Article							LEP(OB) MUTATION; LEPTIN; GENE; PCR; ASSAY; SNP	Objective: Direct health care costs of obesity continue to grow throughout the world and research on obesity disease models are on the rise. The ob/ob mouse is a well-characterized model of obesity and associated risk factors. Successful breeding and backcrossing onto different backgrounds are essential to create knockout models. Ob/ob mice are sterile and heterozygotes must be identified by genotyping to maintain breeding colonies. Several methods are employed to detect the ob mutant allele, a single nucleotide polymorphism (SNP). Gel based methods are time consuming and inconsistent, and non-gel based assays rely upon expensive and complex reagents or instruments. A fast, high-throughput, cost effective, and consistent method to identify Lep(ob) mutation is much needed. Design and Methods: Primers to produce an amplicon for High Resolution Melting Analysis (HRM) of the Lep(ob) SNP were designed and validated. Results: Fluorescence normalized high resolution melting curve plots delineated ob/+, ob/ob, and WT genotypes. Genotypes were also confirmed phenotypically. Conclusions: HRM of the Lep(ob) SNP allows closed-tube identification of the Lep(ob) mutation using a real-time PCR machine now common to most labs/departments. Advantages of this method include assay sensitivity/accuracy, low cost dyes, less optimization, and cost effectiveness as compared to other genotyping techniques.	[Sutter, Alton G.; Palanisamy, Arun P.; Kurtz, Nichole; Chavin, Kenneth D.] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Spyropoulos, Demetri D.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Palanisamy, Arun/I-7712-2019; Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682				Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen WJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-45; Chung WK, 1997, OBES RES, V5, P183, DOI 10.1002/j.1550-8528.1997.tb00291.x; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; Ellett JD, 2009, OBESITY, V17, P402, DOI 10.1038/oby.2008.443; Haller EW, 1999, AM J PHYSIOL-ENDOC M, V276, pE762, DOI 10.1152/ajpendo.1999.276.4.E762; Hill HR, 2010, J MOL DIAGN, V12, P368, DOI 10.2353/jmoldx.2010.090147; Hirasawa T, 1997, EXP ANIM TOKYO, V46, P75, DOI 10.1538/expanim.46.75; Jackson, 2012, GENOTYPING PROTOCOLS; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Namae M, 1998, LAB ANIM SCI, V48, P103; Oler AT, 2008, J LIPID RES, V49, P1126, DOI 10.1194/jlr.D800002-JLR200; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Sinthuwiwat T, 2008, MOL CELL PROBE, V22, P329, DOI 10.1016/j.mcp.2008.07.004; Trevaskis JL, 2005, ENDOCRINOLOGY, V146, P4257, DOI 10.1210/en.2005-0492	16	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78840	10.1371/journal.pone.0078840	http://dx.doi.org/10.1371/journal.pone.0078840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236058	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700055
J	Gevorkian, SG; Allahverdyan, AE; Gevorgyan, DS; Simonian, AL; Hu, CK				Gevorkian, Sasun G.; Allahverdyan, Armen E.; Gevorgyan, David S.; Simonian, Aleksandr L.; Hu, Chin-Kun			Stabilization and Anomalous Hydration of Collagen Fibril under Heating	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; THERMAL-STABILITY; GLASS-TRANSITION; TENDON COLLAGEN; I COLLAGEN; WATER; HELIX; TEMPERATURE; PROTEINS; DENATURATION	Background: Type I collagen is the most common protein among higher vertebrates. It forms the basis of fibrous connective tissues (tendon, chord, skin, bones) and ensures mechanical stability and strength of these tissues. It is known, however, that separate triple-helical collagen macromolecules are unstable at physiological temperatures. We want to understand the mechanism of collagen stability at the intermolecular level. To this end, we study the collagen fibril, an intermediate level in the collagen hierarchy between triple-helical macromolecule and tendon. Methodology/ Principal Finding: When heating a native fibril sample, its Young's modulus decreases in temperature range 20-58 degrees C due to partial denaturation of triple-helices, but it is approximately constant at 58-75 degrees C, because of stabilization by inter-molecular interactions. The stabilization temperature range 58-75 degrees C has two further important features: here the fibril absorbs water under heating and the internal friction displays a peak. We relate these experimental findings to restructuring of collagen triple-helices in fibril. A theoretical description of the experimental results is provided via a generalization of the standard Zimm-Bragg model for the helix-coil transition. It takes into account intermolecular interactions of collagen triple-helices in fibril and describes water adsorption via the Langmuir mechanism. Conclusion/Significance: We uncovered an inter-molecular mechanism that stabilizes the fibril made of unstable collagen macromolecules. This mechanism can be relevant for explaining stability of collagen.	[Gevorkian, Sasun G.; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Gevorkian, Sasun G.; Allahverdyan, Armen E.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Gevorgyan, David S.] Sci Technol Ctr Organ & Pharmaceut Chem, Inst Fine Organ Chem, Yerevan, Armenia; [Simonian, Aleksandr L.] Auburn Univ, Mat Res & Educ Ctr, Auburn, AL 36849 USA	Academia Sinica - Taiwan; Yerevan Physics Institute; National Academy of Sciences of Armenia; Scientific Technological Center of Organic & Pharmaceutical Chemistry - NAS RA; Auburn University System; Auburn University	Hu, CK (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	huck@phys.sinica.edu.tw		Hu, Chin-Kun/0000-0002-3620-8319; Gevorkian, Sasun/0000-0003-1785-8700	Volkswagenstiftung [NSC 96-2911-M 001-003-MY3, AS-95-TP-A07]; National Center for Theoretical Sciences in Taiwan, NFSAT [TFP-12-02]; ANSEF [Molbio 2747]	Volkswagenstiftung(Volkswagen); National Center for Theoretical Sciences in Taiwan, NFSAT; ANSEF	The work was supported by Volkswagenstiftung, grants NSC 96-2911-M 001-003-MY3 and AS-95-TP-A07, National Center for Theoretical Sciences in Taiwan, NFSAT grant no. TFP-12-02, and ANSEF grant Molbio 2747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdyan AE, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/53002; Badasyan AV, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216564; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; Bhat RB, 1985, J SOUND VIBRATION, V102, P271; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Bull HB, 1944, J AM CHEM SOC, V66, P1499, DOI 10.1021/ja01237a025; COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523; David R, 1979, BIOPHYSIQUE GEN; DAWSON B, 1968, J MECH ENG SCI, V10, P381, DOI 10.1243/JMES_JOUR_1968_010_060_02; Doig AJ, 2002, BIOPHYS CHEM, V101, P281, DOI 10.1016/S0301-4622(02)00170-9; Donohue MD, 1998, ADV COLLOID INTERFAC, V76, P137, DOI 10.1016/S0001-8686(98)00044-X; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; ESIPOVA NG, 1981, BIOFIZIKA+, V26, P355; ESIPOVA NG, 1973, DOKL AKAD NAUK SSSR+, V211, P234; Esipova NG, 1957, BIOFIZIKA, V2, P445; FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7; Fratzl P., 2008, COLLAGEN STRUCTURE M; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gevorkian SG, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/23001; Gevorkian SG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048101; GEVORKIAN SG, 1983, BIOFIZIKA+, V28, P944; Ghosh K, 2009, J AM CHEM SOC, V131, P2306, DOI 10.1021/ja808136x; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; HALY AR, 1971, BIOPOLYMERS, V10, P1681, DOI 10.1002/bip.360100921; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Kapoor D, 1998, J MACROMOL SCI PHYS, VB37, P723, DOI 10.1080/00222349808212413; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lavis D., 1999, STAT MECH LATTICE SY, V1; LEIKIN S, 1994, P NATL ACAD SCI USA, V91, P276, DOI 10.1073/pnas.91.1.276; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Maleev AY, 1974, BIOPOLYMERS, V13, P2409; Mesropyan I, 2006, BIOFIZIKA+, V51, P151; MICHNA H, 1984, CELL TISSUE RES, V236, P465; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miles CA, 2001, BIOPHYS J, V80, P1480, DOI 10.1016/S0006-3495(01)76120-6; MOROZOV VN, 1981, BIOPOLYMERS, V20, P451, DOI 10.1002/bip.1981.360200304; MOROZOV VN, 1985, BIOPOLYMERS, V24, P1785, DOI 10.1002/bip.360240909; Mreshvili GM, 1978, BIOPHYSICS-USSR, V23, P717; Nikolaeva T. I., 2007, Biophysics, V52, P191, DOI 10.1134/S000635090702008X; Parry DA, 1984, ULTRASTRUCTURE CONNE, P34; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; PINERI MH, 1978, BIOPOLYMERS, V17, P2799, DOI 10.1002/bip.1978.360171205; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; QIAN H, 1992, J PHYS CHEM-US, V96, P3987, DOI 10.1021/j100189a015; Sandler U, 2000, PHYS REV B, V61, P16, DOI 10.1103/PhysRevB.61.16; SKOLNICK J, 1982, MACROMOLECULES, V15, P303, DOI 10.1021/ma00230a021; Sneppen K., 2005, PHYS MOL BIOL; Starikov EB, 1997, PHYS REP, V284, P2; Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n; Tsereteli GI, 2000, J THERM ANAL CALORIM, V62, P89, DOI 10.1023/A:1010110727782	57	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78526	10.1371/journal.pone.0078526	http://dx.doi.org/10.1371/journal.pone.0078526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244320	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600030
J	Niarchou, A; Alexandridou, A; Athanasiadis, E; Spyrou, G				Niarchou, Anastasia; Alexandridou, Anastasia; Athanasiadis, Emmanouil; Spyrou, George			C-PAmP: Large Scale Analysis and Database Construction Containing High Scoring Computationally Predicted Antimicrobial Peptides for All the Available Plant Species	PLOS ONE			English	Article							PROTEIN; CLASSIFICATION; SOFTWARE	Background: Antimicrobial peptides are a promising alternative to conventional antibiotics. Plants are an important source of such peptides; their pharmacological properties are known since antiquity. Access to relevant information, however, is not straightforward, as there are practically no major repositories of experimentally validated and/or predicted plant antimicrobial peptides. PhytAMP is the only database dedicated to plant peptides with confirmed antimicrobial action, holding 273 entries. Data on such peptides can be otherwise retrieved from generic repositories. Description: We present C-PAmP, a database of computationally predicted plant antimicrobial peptides. C-PAmP contains 15,174,905 peptides, 5-100 amino acids long, derived from 33,877 proteins of 2,112 plant species in UniProtKB/Swiss-Prot. Its web interface allows queries based on peptide/protein sequence, protein accession number and species. Users can view the corresponding predicted peptides along with their probability score, their classification according to the Collection of Anti-Microbial Peptides (CAMP), and their PhytAMP id where applicable. Moreover, users can visualise protein regions with a high concentration of predicted antimicrobial peptides. In order to identify potential antimicrobial peptides we used a classification algorithm, based on a modified version of the pseudo amino acid concept. The classifier tested all subsequences ranging from 5 to 100 amino acids of the plant proteins in UniProtKB/Swiss-Prot and stored those classified as antimicrobial with a high probability score (>90%). Its performance measures across a 10-fold cross-validation are more than satisfactory (accuracy: 0.91, sensitivity: 0.93, specificity: 0.90) and it succeeded in classifying 99.5% of the PhytAMP peptides correctly. Conclusions: We have compiled a major repository of predicted plant antimicrobial peptides using a highly performing classification algorithm. Our repository is accessible from the web and supports multiple querying options to optimise data retrieval. We hope it will greatly benefit drug design research by significantly limiting the range of plant peptides to be experimentally tested for antimicrobial activity.	[Niarchou, Anastasia; Alexandridou, Anastasia; Athanasiadis, Emmanouil; Spyrou, George] Acad Athens, Biomed Res Fdn, Athens, Greece	Academy of Athens	Spyrou, G (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	gspyrou@bioacademy.gr	Athanasiadis, Emmanouil I./AAZ-8809-2021	Athanasiadis, Emmanouil I./0000-0002-2771-5562				Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kovaleva V, 2009, PEPTIDES, V30, P2136, DOI 10.1016/j.peptides.2009.08.007; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piotto SP, 2012, INT J ANTIMICROB AG, V39, P346, DOI 10.1016/j.ijantimicag.2011.12.003; Platt JC, 2000, ADV NEUR IN, P61; Ponty Y, 2006, BIOINFORMATICS, V22, P1534, DOI 10.1093/bioinformatics/btl113; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Rogozhin EA, 2011, PLANT PHYSIOL BIOCH, V49, P131, DOI 10.1016/j.plaphy.2010.10.008; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wu TF, 2004, J MACH LEARN RES, V5, P975; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	32	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79728	10.1371/journal.pone.0079728	http://dx.doi.org/10.1371/journal.pone.0079728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244550	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600148
J	Warrington, NM; Howe, LD; Wu, YY; Timpson, NJ; Tilling, K; Pennell, CE; Newnham, J; Davey-Smith, G; Palmer, LJ; Beilin, LJ; Lye, SJ; Lawlor, DA; Briollais, L				Warrington, Nicole M.; Howe, Laura D.; Wu, Yan Yan; Timpson, Nicholas J.; Tilling, Kate; Pennell, Craig E.; Newnham, John; Davey-Smith, George; Palmer, Lyle J.; Beilin, Lawrence J.; Lye, Stephen J.; Lawlor, Debbie A.; Briollais, Laurent			Association of a Body Mass Index Genetic Risk Score with Growth throughout Childhood and Adolescence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; FTO GENE; ADIPOSITY; OBESITY; LOCI; BMI; CHILDREN; WEIGHT; METAANALYSIS	Background: While the number of established genetic variants associated with adult body mass index (BMI) is growing, the relationships between these variants and growth during childhood are yet to be fully characterised. We examined the association between validated adult BMI associated single nucleotide polymorphisms (SNPs) and growth trajectories across childhood. We investigated the timing of onset of the genetic effect and whether it was sex specific. Methods: Children from the ALSPAC and Raine birth cohorts were used for analysis (n = 9,328). Genotype data from 32 adult BMI associated SNPs were investigated individually and as an allelic score. Linear mixed effects models with smoothing splines were used for longitudinal modelling of the growth parameters and measures of adiposity peak and rebound were derived. Results: The allelic score was associated with BMI growth throughout childhood, explaining 0.58% of the total variance in BMI in females and 0.44% in males. The allelic score was associated with higher BMI at the adiposity peak (females = 0.0163 kg/m(2) per allele, males = 0.0123 kg/m(2) per allele) and earlier age (-0.0362 years per allele in males and females) and higher BMI (0.0332 kg/m(2) per allele in females and 0.0364 kg/m(2) per allele in males) at the adiposity rebound. No gene: sex interactions were detected for BMI growth. Conclusions: This study suggests that known adult genetic determinants of BMI have observable effects on growth from early childhood, and is consistent with the hypothesis that genetic determinants of adult susceptibility to obesity act from early childhood and develop over the life course.	[Warrington, Nicole M.; Pennell, Craig E.; Newnham, John] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Wu, Yan Yan; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent] Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Howe, Laura D.; Timpson, Nicholas J.; Davey-Smith, George; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Tilling, Kate] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Palmer, Lyle J.] Univ Toronto, Ontario Inst Canc Res, Toronto, ON, Canada; [Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Bristol; University of Bristol; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Western Australia	Briollais, L (corresponding author), Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON, Canada.	laurent@lunenfeld.ca	Study, Raine/G-9547-2015; Attrill, Lauren/V-1688-2018; Warrington, Nicole/P-4868-2014; Timpson, Nicholas John/O-7548-2015; Pennell, Craig/ABD-6902-2020; Tilling, Kate/AAY-1578-2021; Briollais, Laurent/A-2941-2013; Palmer, Lyle John/N-1948-2019; Lye, Stephen J/E-7269-2013; Wu, Yanyan/H-1356-2017; Davey Smith, George/A-7407-2013; Fox, Laura J/C-6249-2016; Palmer, Lyle John/K-3196-2014	Warrington, Nicole/0000-0003-4195-775X; Timpson, Nicholas John/0000-0002-7141-9189; Pennell, Craig/0000-0002-0937-6165; Palmer, Lyle John/0000-0002-1628-3055; Lye, Stephen J/0000-0002-3305-4406; Wu, Yanyan/0000-0003-1553-1392; Davey Smith, George/0000-0002-1407-8314; Palmer, Lyle John/0000-0002-1628-3055; Tilling, Kate/0000-0002-1010-8926; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Howe, Laura/0000-0003-3357-2796; Newnham, John/0000-0001-9983-7457	UK Medical Research Council; Wellcome Trust [092731]; University of Bristol; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; MRC [G1002375, MC_UU_12013/3, MC_UU_12013/1, MC_UU_12013/5, G0600705] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, MC_UU_12013/3, MC_PC_15018, G1002375, MC_UU_12013/1, G0600705] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following funding bodies and institutions. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The following Institutions provide funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Curtin University and Women and Infants Research Foundation. This study was supported by project grants from the National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209) and the Canadian Institutes of Health Research (Grant ID MOP-82893). NM Warrington is funded by an Australian Postgraduate Award from the Australian Government of Innovation, Industry, Science and Research and a Raine Study PhD Top-Up Scholarship. LD Howe is funded by a UK Medical Research Council Population Health Scientist fellowship (G1002375). LD Howe, NJ Timpson, K Tilling, G Davey-Smith and DA Lawlor all work in a Centre that receives core funding from the University of Bristol and the UK Medical Research Council (Grant ref: G0600705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2008, PHYSIOL BEHAV, V94, P8, DOI 10.1016/j.physbeh.2007.11.016; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boyd A, 2012, INT J EPIDEMIOL; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; COMUZZIE AG, 1993, AM J HUM BIOL, V5, P725, DOI 10.1002/ajhb.1310050616; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; Dvornyk V, 2012, HUM REPROD UPDATE, V18, P198, DOI 10.1093/humupd/dmr050; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; He Q, 2002, OBES RES, V10, P135, DOI 10.1038/oby.2002.22; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108; Sovio U, 2009, ATHEROSCLEROSIS, V207, pE4, DOI 10.1016/j.atherosclerosis.2009.09.039; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053897; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	46	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79547	10.1371/journal.pone.0079547	http://dx.doi.org/10.1371/journal.pone.0079547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244521	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600133
J	Egoavil, C; Alenda, C; Castillejo, A; Paya, A; Peiro, G; Sanchez-Heras, AB; Castillejo, MI; Rojas, E; Barbera, VM; Ciguenza, S; Lopez, JA; Pinero, O; Roman, MJ; Martinez-Escoriza, JC; Guarinos, C; Perez-Carbonell, L; Aranda, FI; Soto, JL				Egoavil, Cecilia; Alenda, Cristina; Castillejo, Adela; Paya, Artemio; Peiro, Gloria; Sanchez-Heras, Ana-Beatriz; Castillejo, Maria-Isabel; Rojas, Estefania; Barbera, Victor-Manuel; Cigueenza, Sonia; Lopez, Jose-Antonio; Pinero, Oscar; Roman, Maria-Jose; Martinez-Escoriza, Juan-Carlos; Guarinos, Carla; Perez-Carbonell, Lucia; Aranda, Francisco-Ignacio; Soto, Jose-Luis			Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; LOWER UTERINE SEGMENT; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; FAMILY-HISTORY; WOMEN; RISK; MUTATIONS; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS	Background: Lynch syndrome (LS) is a hereditary condition that increases the risk for endometrial and other cancers. The identification of endometrial cancer (EC) patients with LS has the potential to influence life-saving interventions. We aimed to study the prevalence of LS among EC patients in our population. Methods: Universal screening for LS was applied for a consecutive series EC. Tumor testing using microsatellite instability (MSI), immunohistochemistry (IHC) for mismatch-repair (MMR) protein expression and MLH1-methylation analysis, when required, was used to select LS-suspicious cases. Sequencing of corresponding MMR genes was performed. Results: One hundred and seventy-three EC (average age, 63 years) were screened. Sixty-one patients (35%) had abnormal IHC or MSI results. After MLH1 methylation analysis, 27 cases were considered suspicious of LS. From these, 22 were contacted and referred for genetic counseling. Nineteen pursued genetic testing and eight were diagnosed of LS. Mutations were more frequent in younger patients (<50 yrs). Three cases had either intact IHC or MSS and reinforce the need of implement the EC screening with both techniques. Conclusion: The prevalence of LS among EC patients was 4.6% (8/173); with a predictive frequency of 6.6% in the Spanish population. Universal screening of EC for LS is recommended.	[Egoavil, Cecilia; Alenda, Cristina; Paya, Artemio; Peiro, Gloria; Rojas, Estefania; Cigueenza, Sonia; Lopez, Jose-Antonio; Pinero, Oscar; Roman, Maria-Jose; Martinez-Escoriza, Juan-Carlos; Aranda, Francisco-Ignacio] Alicante Univ Hosp, Alicante, Spain; [Egoavil, Cecilia; Guarinos, Carla; Perez-Carbonell, Lucia] Alicante Univ Hosp, Res Lab, Alicante, Spain; [Castillejo, Adela; Castillejo, Maria-Isabel; Barbera, Victor-Manuel; Soto, Jose-Luis] Elche Univ Hosp, Mol Genet Lab, Elche, Spain; [Sanchez-Heras, Ana-Beatriz] Elche Univ Hosp, Genet Counselling Canc Unit, Elche, Spain	General University Hospital of Alicante; General University Hospital of Alicante	Soto, JL (corresponding author), Elche Univ Hosp, Mol Genet Lab, Elche, Spain.	sotomartinez.jl@gmail.com	Alenda, Cristina/AAR-3433-2020; Castillo, Adela Castillejo/AAD-3477-2020; Egoavil, Cecilia/ABG-8531-2020; Soto, José Luis/AAC-6520-2020; Martinez Escoriza, Juan Carlos/C-8272-2016; Egoavil, Cecilia/X-5134-2018; Aranda, F. Ignacio/H-5029-2011; Payá, Artemio/AFX-6518-2022; ARANDA, FRANCISCO I/L-5525-2015	Castillo, Adela Castillejo/0000-0002-9581-6285; Egoavil, Cecilia/0000-0003-0166-4901; Martinez Escoriza, Juan Carlos/0000-0002-9509-9941; Egoavil, Cecilia/0000-0003-0166-4901; Aranda, F. Ignacio/0000-0003-2338-2286; ARANDA, FRANCISCO I/0000-0003-2338-2286; Castillejo Castillo, Maria Isabel/0000-0002-4545-6429; Rojas Calvente, Estefania/0000-0001-6004-525X; Soto, Jose Luis/0000-0003-0234-9188; Barbera, Victor-Manuel/0000-0002-4012-6973; Alenda, Cristina/0000-0002-0560-1759	Conselleria Sanidad Comunidad Valenciana, Spain [AP/177/10]; Biomedical Research Foundation of the Alicante University Hospital [PI14/2006, NI02/2011]; Biomedical Research Foundation of the Elche University Hospital, Spain [FIBElx-CO11/03]	Conselleria Sanidad Comunidad Valenciana, Spain; Biomedical Research Foundation of the Alicante University Hospital; Biomedical Research Foundation of the Elche University Hospital, Spain	This study was supported by Conselleria Sanidad Comunidad Valenciana, Spain (AP/177/10) (http://www.san.gva.es/); Biomedical Research Foundations of the Alicante University Hospital (PI14/2006 and NI02/2011) (http://www.dep19.san.gva.es/); and the Elche University Hospital, Spain (FIBElx-CO11/03) (http://www.dep20.san.gva.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Barrow E, 2013, FAM CANCER, V12, P229, DOI 10.1007/s10689-013-9615-1; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; Chongsuvivatwong Virasakdi, 2012, EP EP CALC R PACK VE; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Cook LS, 2013, GYNECOL ONCOL, V130, P334, DOI 10.1016/j.ygyno.2013.04.053; Deng GR, 1999, CANCER RES, V59, P2029; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Folkins AK, 2013, HISTOPATHOLOGY, V62, P2, DOI 10.1111/his.12028; Gruber SB, 1996, CANCER EPIDEM BIOMAR, V5, P411; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2007, CANCER RES, V67, P9603, DOI 10.1158/0008-5472.CAN-07-2308; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hitchins MP, 2009, J MED GENET, V46, P793, DOI 10.1136/jmg.2009.068122; Jover R, 2004, AM J CLIN PATHOL, V122, P389, DOI 10.1309/V9PGK2Y260VFVULR; Kwon JS, 2011, J CLIN ONCOL, V29, P2247, DOI 10.1200/JCO.2010.32.9979; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Lu KH, 2005, OBSTET GYNECOL, V105, P569, DOI 10.1097/01.AOG.0000154885.44002.ae; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; LYNCH HT, 1977, CANCER, V40, P1849, DOI 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U; Masuda K, 2012, ONCOL REP, V28, P1537, DOI 10.3892/or.2012.2008; MECKLIN JP, 1986, DIS COLON RECTUM, V29, P160, DOI 10.1007/BF02555012; Mills AM, 2012, INT J GYNECOL PATHOL, V31, P463, DOI 10.1097/PGP.0b013e31824a1dad; Mojtahed A, 2011, MODERN PATHOL, V24, P1004, DOI 10.1038/modpathol.2011.55; Moline J, 2013, GYNECOL ONCOL, V130, P121, DOI 10.1016/j.ygyno.2013.04.022; Ou JH, 2008, HUM MUTAT, V29, P1337, DOI 10.1002/humu.20907; Peiro G, 2013, HUM PATHOL, V44, P218, DOI 10.1016/j.humpath.2012.05.008; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Perez-Carbonell L, 2010, J MOL DIAGN, V12, P498, DOI 10.2353/jmoldx.2010.090212; Resnick K, 2009, OBSTET GYNECOL, V114, P530, DOI 10.1097/AOG.0b013e3181b11ecc; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ryan P, 2012, CANCER-AM CANCER SOC, V118, P681, DOI 10.1002/cncr.26323; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Shia J, 2003, AM J SURG PATHOL, V27, P1407, DOI 10.1097/00000478-200311000-00002; Shia JR, 2009, AM J SURG PATHOL, V33, P1639, DOI 10.1097/PAS.0b013e3181b15aa2; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Tavassoli FA, 2003, PATHOLOGY GENETICS T, P217; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Westin SN, 2008, J CLIN ONCOL, V26, P5965, DOI 10.1200/JCO.2008.18.6296; Win AK, 2013, JNCI-J NATL CANCER I, V105, P274, DOI 10.1093/jnci/djs525	44	82	83	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79737	10.1371/journal.pone.0079737	http://dx.doi.org/10.1371/journal.pone.0079737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244552	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900048
J	Ma, PX; Schwarten, M; Schneider, L; Boeske, A; Henke, N; Lisak, D; Weber, S; Mohrluder, J; Stoldt, M; Strodel, B; Methner, A; Hoffmann, S; Weiergraber, OH; Willbold, D				Ma, Peixiang; Schwarten, Melanie; Schneider, Lars; Boeske, Alexandra; Henke, Nadine; Lisak, Dmitrij; Weber, Stephan; Mohrlueder, Jeannine; Stoldt, Matthias; Strodel, Birgit; Methner, Axel; Hoffmann, Silke; Weiergraeber, Oliver H.; Willbold, Dieter			Interaction of Bcl-2 with the Autophagy-related GABA(A) Receptor-associated Protein (GABARAP) BIOPHYSICAL CHARACTERIZATION AND FUNCTIONAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Bcl-2; NMR; Protein-Protein Interactions; GABARAP; LC3; Lipidation	CELL-DEATH; JNK1-MEDIATED PHOSPHORYLATION; NMR-SPECTROSCOPY; BREAST-CANCER; BINDING MODE; BH4 DOMAIN; APOPTOSIS; MITOCHONDRIAL; SYSTEM; LC3	Apoptosis and autophagy are fundamental homeostatic processes in eukaryotic organisms fulfilling essential roles in development and adaptation. Recently, the anti-apoptotic factor Bcl-2 has been reported to also inhibit autophagy, thus establishing a potential link between these pathways, but the mechanistic details are only beginning to emerge. Here we show that Bcl-2 directly binds to the phagophore-associated protein GABARAP. NMR experiments revealed that the interaction critically depends on a three-residue segment (EWD) of Bcl-2 adjacent to the BH4 region, which is anchored to one of the two hydrophobic pockets on the GABARAP molecule. This is at variance with the majority of GABARAP interaction partners identified previously, which occupy both hydrophobic pockets simultaneously. Bcl-2 affinity could also be detected for GEC1, but not for other mammalian Atg8 homologs. Finally, we provide evidence that overexpression of Bcl-2 inhibits lipidation of GABARAP, a key step in autophagosome formation, possibly via competition with the lipid conjugation machinery. These results support the regulatory role of Bcl-2 in autophagy and define GABARAP as a novel interaction partner involved in this intricate connection.	[Weber, Stephan; Mohrlueder, Jeannine; Stoldt, Matthias; Strodel, Birgit; Hoffmann, Silke; Weiergraeber, Oliver H.; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Ma, Peixiang; Schwarten, Melanie; Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Ma, Peixiang; Schwarten, Melanie; Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, BMFZ, D-40225 Dusseldorf, Germany; [Schneider, Lars; Henke, Nadine; Lisak, Dmitrij; Methner, Axel] Univ Dusseldorf, Neurol Klin, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Weiergraber, OH (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany.	o.h.weiergraeber@fz-juelich.de; d.willbold@fz-juelich.de	Schwarten, Melanie/G-6407-2013; Stoldt, Matthias/G-5738-2013; Weiergräber, Oliver H./G-8940-2013; Willbold, Dieter/A-6280-2013; Strodel, Birgit/H-5449-2013; Ma, Peixiang/AAU-4825-2021; Mohrlüder, Jeannine/G-9458-2013; Hoffmann, Silke/H-5059-2013	Schwarten, Melanie/0000-0001-8920-9668; Stoldt, Matthias/0000-0002-5060-4844; Weiergräber, Oliver H./0000-0002-2410-3691; Willbold, Dieter/0000-0002-0065-7366; Strodel, Birgit/0000-0002-8734-7765; Mohrlüder, Jeannine/0000-0002-9922-2986; Hoffmann, Silke/0000-0003-1414-8957; Nickel, Nadine/0000-0002-0609-0735; ma, peixiang/0000-0001-6794-1663; Methner, Axel/0000-0002-8774-0057	Deutscher Akademischer Austauschdienst (DAAD); International Helmholtz Research School BioSoft; Deutsche Forschungsgemeinschaft (DFG) [Me 1922/9-1, Wi 1472/5]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Helmholtz Research School BioSoft; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a fellowship of the Deutscher Akademischer Austauschdienst (DAAD) (to P. M.), a fellowship of the International Helmholtz Research School BioSoft (to M. Schwarten), and Deutsche Forschungsgemeinschaft (DFG) Grants Me 1922/9-1 (to A. M.) and Wi 1472/5 (to D. W.).	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Conus S, 2000, EMBO J, V19, P1534, DOI 10.1093/emboj/19.7.1534; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hallin U, 2006, NEUROBIOL DIS, V21, P478, DOI 10.1016/j.nbd.2005.08.013; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Keller R., 2004, COMPUTER AIDED RESON, V1; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klebig C, 2005, CANCER RES, V65, P394; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Ma PX, 2010, CHEMBIOCHEM, V11, P1967, DOI 10.1002/cbic.201000354; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mohrluder J, 2007, BIOCHEMISTRY-US, V46, P14537, DOI 10.1021/bi7018145; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Mohrluder J, 2009, FEBS J, V276, P4989, DOI 10.1111/j.1742-4658.2009.07207.x; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Otter I, 1998, J BIOL CHEM, V273, P6110, DOI 10.1074/jbc.273.11.6110; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Roberts SS, 2009, PATHOL ONCOL RES, V15, P645, DOI 10.1007/s12253-009-9165-x; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stangler T, 2002, J BIOL CHEM, V277, P13363, DOI 10.1074/jbc.C200050200; Stangler T, 2001, J BIOMOL NMR, V21, P183, DOI 10.1023/A:1012416810974; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thielmann Y, 2008, CHEMBIOCHEM, V9, P1767, DOI 10.1002/cbic.200800117; Thielmann Y, 2009, PROTEINS, V77, P637, DOI 10.1002/prot.22477; Thielmann Y, 2009, MOL BIOSYST, V5, P575, DOI 10.1039/b900425d; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Trisciuoglio D, 2013, NEOPLASIA, V15, P315, DOI 10.1593/neo.121392; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wales D. J., 2003, ENERGY LANDSCAPES; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Weiergraber OH, 2008, J MOL BIOL, V381, P1320, DOI 10.1016/j.jmb.2008.06.086; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	64	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37204	37215		10.1074/jbc.M113.528067	http://dx.doi.org/10.1074/jbc.M113.528067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240096	hybrid, Green Published			2022-12-25	WOS:000329189700038
J	Rakshambikai, R; Srinivasan, N; Nishant, KT				Rakshambikai, Ramaswamy; Srinivasan, Narayanaswamy; Nishant, Koodali Thazath			Structural Insights into Saccharomyces cerevisiae Msh4-Msh5 Complex Function Using Homology Modeling	PLOS ONE			English	Article							REPAIR PROTEIN MUTS; DNA MISMATCH-REPAIR; DOUBLE-STRAND BREAK; RECOGNIZES HOLLIDAY JUNCTIONS; MULTIPLE SEQUENCE ALIGNMENTS; CHROMOSOME SYNAPSIS; MEIOTIC CHROMOSOMES; CROSSING-OVER; I-TASSER; MEIOSIS	The Msh4-Msh5 protein complex in eukaryotes is involved in stabilizing Holliday junctions and its progenitors to facilitate crossing over during Meiosis I. These functions of the Msh4-Msh5 complex are essential for proper chromosomal segregation during the first meiotic division. The Msh4/5 proteins are homologous to the bacterial mismatch repair protein MutS and other MutS homologs (Msh2, Msh3, Msh6). Saccharomyces cerevisiae msh4/5 point mutants were identified recently that show two fold reduction in crossing over, compared to wild-type without affecting chromosome segregation. Three distinct classes of msh4/5 point mutations could be sorted based on their meiotic phenotypes. These include msh4/5 mutations that have a) crossover and viability defects similar to msh4/5 null mutants; b) intermediate defects in crossing over and viability and c) defects only in crossing over. The absence of a crystal structure for the Msh4-Msh5 complex has hindered an understanding of the structural aspects of Msh4-Msh5 function as well as molecular explanation for the meiotic defects observed in msh4/5 mutations. To address this problem, we generated a structural model of the S. cerevisiae Msh4-Msh5 complex using homology modeling. Further, structural analysis tailored with evolutionary information is used to predict sites with potentially critical roles in Msh4-Msh5 complex formation, DNA binding and to explain asymmetry within the Msh4-Msh5 complex. We also provide a structural rationale for the meiotic defects observed in the msh4/5 point mutations. The mutations are likely to affect stability of the Msh4/5 proteins and/or interactions with DNA. The Msh4-Msh5 model will facilitate the design and interpretation of new mutational data as well as structural studies of this important complex involved in meiotic chromosome segregation.	[Rakshambikai, Ramaswamy; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Nishant, Koodali Thazath] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram, Kerala, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		KT, Nishant/0000-0002-4342-7501	IISER-TVM intramural funds; Wellcome Trust-DBT India Alliance Intermediate Fellowship; Department of Biotechnology, Government of India	IISER-TVM intramural funds; Wellcome Trust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	KTN is supported by IISER-TVM intramural funds and a Wellcome Trust-DBT India Alliance Intermediate Fellowship. This research is supported by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jiricny J, 2000, CURR BIOL, V10, pR788, DOI 10.1016/S0960-9822(00)00772-7; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee SD, 2007, J MOL BIOL, V366, P53, DOI 10.1016/j.jmb.2006.10.099; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Marsischky GT, 1999, J BIOL CHEM, V274, P7200, DOI 10.1074/jbc.274.11.7200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001083; Novak JE, 2001, GENETICS, V158, P1013; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Santucci-Darmanin S, 2002, HUM MOL GENET, V11, P1697, DOI 10.1093/hmg/11.15.1697; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Segura J, 2012, BIOINFORMATICS, V28, P1845, DOI 10.1093/bioinformatics/bts269; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Snowden T, 2008, J BIOL CHEM, V283, P145, DOI 10.1074/jbc.M704060200; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tseng Q, 2011, ACTA CRYSTALLOGR F, V67, P947, DOI 10.1107/S1744309111019300; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; von Grotthuss M, 2003, PROTEINS, V53, P418, DOI 10.1002/prot.10547; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	79	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78753	10.1371/journal.pone.0078753	http://dx.doi.org/10.1371/journal.pone.0078753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244354	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000327143800013
J	Robert, J; Weber, B; Frese, L; Emmert, MY; Schmidt, D; von Eckardstein, A; Rohrer, L; Hoerstrup, SP				Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Schmidt, Doerthe; von Eckardstein, Arnold; Rohrer, Lucia; Hoerstrup, Simon P.			A Three-Dimensional Engineered Artery Model for In Vitro Atherosclerosis Research	PLOS ONE			English	Article							LIPOPROTEIN TRANSPORT; ENDOTHELIAL-CELLS; BLOOD-VESSELS; COCULTURE; RETENTION; MONOCYTES; HEART	The pathogenesis of atherosclerosis involves dysfunctions of vascular endothelial cells and smooth muscle cells as well as blood borne inflammatory cells such as monocyte-derived macrophages. In vitro experiments towards a better understanding of these dysfunctions are typically performed in two-dimensional cell culture systems. However, these models lack both the three-dimensional structure and the physiological pulsatile flow conditions of native arteries. We here describe the development and initial characterization of a tissue engineered artery equivalent, which is composed of human primary endothelial and smooth muscle cells and is exposed to flow in vitro. Histological analyses showed formation of a dense tissue composed of a tight monolayer of endothelial cells supported by a basement membrane and multiple smooth muscle cell layers. Both low (LDL) and high density lipoproteins (HDL) perfused through the artery equivalent were recovered both within endothelial cells and in the sub-endothelial intima. After activation of the endothelium with either tumour necrosis factor alpha (TNF alpha) or LDL, monocytes circulated through the model were found to adhere to the activated endothelium and to transmigrate into the intima. In conclusion, the described tissue engineered human artery equivalent model represents a significant step towards a relevant in vitro platform for the systematic assessment of pathogenic processes in atherosclerosis independently of any systemic factors.	[Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, Clin Cardiovasc Surg, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, Dept Surg Res, CH-8091 Zurich, Switzerland; [Robert, Jerome; von Eckardstein, Arnold; Rohrer, Lucia] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; von Eckardstein, Arnold; Rohrer, Lucia; Hoerstrup, Simon P.] Univ Zurich, Zurich Ctr Integrated Human Physiol, Zurich, Switzerland; [Schmidt, Doerthe] Univ Zurich Hosp, Ctr Cardiovasc, Dept Cardiol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Hoerstrup, SP (corresponding author), Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland.	simon_philipp.hoerstrup@usz.ch	Robert, Jerome/C-6226-2018	Robert, Jerome/0000-0002-2847-9362; Weber, Benedikt/0000-0002-7217-4590	Zurich Integrative Human Physiology (ZIHP); Swiss National Science Foundation [310030-143992, 31003A-130836/I, 320030-122273]	Zurich Integrative Human Physiology (ZIHP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grant from Zurich Integrative Human Physiology (ZIHP) to Arnold von Eckardstein, Simon Hoerstrup and Lucia Rohrer and by grants from the Swiss National Science Foundation to Simon Hoerstrup [310030-143992], Arnold von Eckardstein [31003A-130836/I.] and Benedikt Weber [320030-122273]. The funders had no role in study <INF>d</INF>esign, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2000, J BIOL CHEM, V275, P10256, DOI 10.1074/jbc.275.14.10256; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GMELIGMEYLING F, 1980, J IMMUNOL METHODS, V33, P1, DOI 10.1016/0022-1759(80)90077-0; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; NAVAB M, 1988, J CLIN INVEST, V82, P1853, DOI 10.1172/JCI113802; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmidt D, 2006, ANN THORAC SURG, V82, P1465, DOI 10.1016/j.athoracsur.2006.05.066; Shen G, 2003, CELL RES, V13, P335, DOI 10.1038/sj.cr.7290178; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takaku M, 1999, ARTERIOSCL THROM VAS, V19, P2330, DOI 10.1161/01.ATV.19.10.2330; Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; Wada Y, 2000, YONSEI MED J, V41, P740, DOI 10.3349/ymj.2000.41.6.740; Weber B, 2012, BIOMATERIALS, V33, P4031, DOI 10.1016/j.biomaterials.2011.11.087; Weissman B A, 2001, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0713s05; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012	30	33	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79821	10.1371/journal.pone.0079821	http://dx.doi.org/10.1371/journal.pone.0079821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244566	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000327143800101
J	Bradley, J; Rehman, AM; Schwabe, C; Vargas, D; Monti, F; Ela, C; Riloha, M; Kleinschmidt, I				Bradley, John; Rehman, Andrea M.; Schwabe, Christopher; Vargas, Daniel; Monti, Feliciano; Ela, Camilo; Riloha, Matilde; Kleinschmidt, Immo			Reduced Prevalence of Malaria Infection in Children Living in Houses with Window Screening or Closed Eaves on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							DAR-ES-SALAAM; RISK-FACTORS; SATELLITE VILLAGES; RESIDUAL LIFE; RURAL TOWN; ENTRY; VECTORS; TRANSMISSION; INTERVENTIONS; INSECTICIDE	Background: Previous studies demonstrated that fewer mosquitoes enter houses which are screened or have closed eaves. There is little evidence about the effect on malaria infection in humans that changes in house construction may have. This study examines the impact of protective housing improvements on malaria infection on Bioko Island. Methodology/Principal Findings: Data from the annual malaria indicator surveys between 2009 and 2012 were used to assess trends in housing characteristics and their effect on RDT confirmed malaria infection in household members. Odds ratios were adjusted for socio-economic status of the household. 22726 children between the ages of 2 and 14 years were tested for P. falciparum. Prevalence of infection in those living in houses with open eaves was 23.0% compared to 18.8% for those living in houses with closed eaves (OR = 0.81, 95% CI 0.67 - 0.98). The prevalence of infection for children in screened houses was 9.1% versus 20.1% for those living in unscreened houses (OR = 0.44, 95% CI 0.27 - 0.71). The proportion of houses with closed eaves increased from 66.0% in 2009 to 74.3% in 2012 (test for trend p = 0.01). The proportion of screened houses remained unchanged over time at 1.3%. Conclusion/Significance: As a malaria control intervention, house modification has the advantages that it is not affected by the growing threat of insecticide resistance; it protects all household members equally and at all times while indoors; and it offers protection against a number of vector borne diseases. The study provides evidence in support of efforts to regulate or encourage housing improvements which impede vector access into residences as part of an integrated vector control approach to complement existing measures which have been only partially successful in reducing malaria transmission in some parts of Bioko.	[Bradley, John; Rehman, Andrea M.; Kleinschmidt, Immo] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Vargas, Daniel; Monti, Feliciano] Med Care Dev Int, Malabo, Guinea; [Ela, Camilo; Riloha, Matilde] Minist Hlth & Social Welf, Malabo, Guinea	University of London; London School of Hygiene & Tropical Medicine	Bradley, J (corresponding author), London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England.	john.bradley@lshtm.ac.uk	Rehman, Andrea M/H-1351-2015; Rehman, Andrea/AAP-3172-2020; Vargas-Pacherrez, Daniel/N-9349-2016	Rehman, Andrea M/0000-0001-9967-5822; Rehman, Andrea/0000-0001-9967-5822; Vargas-Pacherrez, Daniel/0000-0003-0989-1199; Bradley, John/0000-0002-9449-4608	Marathon Oil Corporation; government of EG; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Marathon Oil Corporation; government of EG; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by a private sector consortium led by Marathon Oil Corporation and the government of EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYD MARK F., 1926, AMER JOUR TROP MED, V6, P157; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; DOBSON MJ, 1997, CONTOURS DEATH DIS E, P1; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Kirby MJ, 2010, AM J TROP MED HYG, V83, P965, DOI 10.4269/ajtmh.2010.10-0311; Kirby MJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-41; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Maharaj R, 2004, J MED ENTOMOL, V41, P130, DOI 10.1603/0022-2585-41.1.130; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Ogoma SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-221; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; StataCorp, 2011, STAT STAT SOFTW REL; *STATACORP LP, 2011, STAT SURV DAT REF MA; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; WHO, 2012, WORLD MALARIA REPORT 2012, P1; *WHO, 2012, LOB PLAN INS RES MAN	34	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80626	10.1371/journal.pone.0080626	http://dx.doi.org/10.1371/journal.pone.0080626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236191	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000327254700194
J	Dellicour, S; Desai, M; Mason, L; Odidi, B; Aol, G; Phillips-Howard, PA; Laserson, KF; ter Kuile, FO				Dellicour, Stephanie; Desai, Meghna; Mason, Linda; Odidi, Beatrice; Aol, George; Phillips-Howard, Penelope A.; Laserson, Kayla F.; ter Kuile, Feiko O.			Exploring Risk Perception and Attitudes to Miscarriage and Congenital Anomaly in Rural Western Kenya	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE; HEALTH; PREVALENCE; MORTALITY; RATES	Background: Understanding the socio-cultural context and perceptions of adverse pregnancy outcomes is important for informing the best approaches for public health programs. This article describes the perceptions, beliefs and health-seeking behaviours of women from rural western Kenya regarding congenital anomalies and miscarriages. Methods: Ten focus group discussions (FGDs) were undertaken in a rural district in western Kenya in September 2010. The FGDs included separate groups consisting of adult women of childbearing age, adolescent girls, recently pregnant women, traditional birth attendants and mothers of children with a birth defect. Participants were selected purposively. A deductive thematic framework approach using the questions from the FGD guides was used to analyse the transcripts. Results: There was substantial overlap between perceived causes of miscarriages and congenital anomalies and these were broadly categorized into two groups: biomedical and cultural. The biomedical causes included medications, illnesses, physical and emotional stresses, as well as hereditary causes. Cultural beliefs mostly related to the breaking of a taboo or not following cultural norms. Mothers were often stigmatised and blamed following miscarriage, or the birth of a child with a congenital anomaly. Often, women did not seek care following miscarriage unless there was a complication. Most reported that children with a congenital anomaly were neglected either because of lack of knowledge of where care could be sought or because these children brought shame to the family and were hidden from society. Conclusion: The local explanatory model of miscarriage and congenital anomalies covered many perceived causes within biomedical and cultural beliefs. Some of these fuelled stigmatisation and blame of the mother. Understanding of these beliefs, improving access to information about the possible causes of adverse outcomes, and greater collaboration between traditional healers and healthcare providers may help to reduce stigma and increase access to formal healthcare providers.	[Dellicour, Stephanie; Desai, Meghna; Odidi, Beatrice] Ctr Dis Control & Prevent CDC Res & Publ Hlth Col, Malaria Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya; [Dellicour, Stephanie; Mason, Linda; Phillips-Howard, Penelope A.; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Desai, Meghna; Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Aol, George] Ctr Dis Control & Prevent Res & Publ Hlth Collabo, Int Emerging Infect Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya; [Aol, George] Kenya Res & Publ Hlth Collaborat, Kisumu, Nyanza Province, Kenya; [Laserson, Kayla F.] Ctr Dis Control & Prevent Res & Publ Hlth Col, Kenya Med Res Inst, Hlth & Demog Surveillance Syst Branch, Kisumu, Nyanza Province, Kenya	Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Kenya Medical Research Institute	Dellicour, S (corresponding author), Ctr Dis Control & Prevent CDC Res & Publ Hlth Col, Malaria Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya.	s.dellicour@liverpool.ac.uk		Phillips-Howard, Penelope A/0000-0003-1018-116X	US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation; US CDC; MRC [G1100677] Funding Source: UKRI; Medical Research Council [G1100677] Funding Source: researchfish	US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funding source was the US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through a cooperative agreement with Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya. SD is partly funded by the Malaria in Pregnancy Consortium which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. SD is also grateful to the US CDC for salary support through a cooperative agreement between the Division of Parasitic Diseases and Malaria (Centers for Disease Control and Prevention, USA) and the Malaria Epidemiology Unit of the Child and Reproductive Health group, Liverpool School of Tropical Medicine held by FOtK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Baird P A, 1999, Community Genet, V2, P9, DOI 10.1159/000016177; Bale JR, 2003, REDUCING BIRTH DEFEC; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dyer SJ, 2007, J PSYCHOSOM OBST GYN, V28, P69, DOI 10.1080/01674820701409959; EDMONDS LD, 1993, TERATOLOGY, V48, P647, DOI 10.1002/tera.1420480606; Filippi V, 1997, TROP MED INT HEALTH, V2, P47, DOI 10.1046/j.1365-3156.1997.d01-126.x; Hausmann-Muela S, 1998, ANTHR MED, P5; Howson CP, 2008, CONTROLLING BIRTH DE; KEMRI/CDC, 2009, KEMRI CDC HLTH DEM S; Kenya National Bureau of Statistics (KNBS), 2010, MACR I KENY DEM HLTH; Kgwatalala G, 2009, HLTH SEEKING BEHAV P; LANDRINE H, 1994, J BEHAV MED, V17, P181, DOI 10.1007/BF01858104; Leininger M M, 1991, NLN Publ, P373; Minhas RS, 2007, UNIV TOR MED J, V84; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; OKUNADE AO, 1981, CHILD CARE HLTH DEV, V7, P187, DOI 10.1111/j.1365-2214.1981.tb00836.x; Olasoji HO, 2007, BRIT J ORAL MAX SURG, V45, P302, DOI 10.1016/j.bjoms.2006.09.005; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Rahman M, 2010, INT PERSPECT SEX R H, V36, P170, DOI 10.1363/3617010; Reardon DC, 2002, SOUTH MED J, V95, P834, DOI 10.1097/00007611-200295080-00011; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; UN, 2010, WORLD POP PROSP 2010; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC	27	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80551	10.1371/journal.pone.0080551	http://dx.doi.org/10.1371/journal.pone.0080551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236185	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000327254700186
J	Galtier, MN; Touboul, J				Galtier, Mathieu N.; Touboul, Jonathan			Macroscopic Equations Governing Noisy Spiking Neuronal Populations with Linear Synapses	PLOS ONE			English	Article							GAP-JUNCTIONS; NETWORKS; MODELS	Deriving tractable reduced equations of biological neural networks capturing the macroscopic dynamics of sub-populations of neurons has been a longstanding problem in computational neuroscience. In this paper, we propose a reduction of large-scale multi-population stochastic networks based on the mean-field theory. We derive, for a wide class of spiking neuron models, a system of differential equations of the type of the usual Wilson-Cowan systems describing the macroscopic activity of populations, under the assumption that synaptic integration is linear with random coefficients. Our reduction involves one unknown function, the effective non-linearity of the network of populations, which can be analytically determined in simple cases, and numerically computed in general. This function depends on the underlying properties of the cells, and in particular the noise level. Appropriate parameters and functions involved in the reduction are given for different models of neurons: McKean, Fitzhugh-Nagumo and Hodgkin-Huxley models. Simulations of the reduced model show a precise agreement with the macroscopic dynamics of the networks for the first two models.	[Galtier, Mathieu N.] Jacobs Univ, Bremen, Germany; [Touboul, Jonathan] UPMC, CIRB Coll France, CNRS, INSERM,MEMOLIFE PSL,UMR 7421,U1050,ED 158,Math Ne, Paris, France; [Touboul, Jonathan] INRIA Rocquencourt, BANG Lab, Paris, France	Jacobs University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Galtier, MN (corresponding author), Jacobs Univ, Bremen, Germany.	m.galtier@jacobs-university.de; jonathan.touboul@college-de-france.fr			Amarsi project (FP7-ICT) [24833]; INRIA	Amarsi project (FP7-ICT); INRIA	MNG is funded by the Amarsi project (FP7-ICT #24833). JT is funded by INRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S., 1972, SYST MAN CYBERNET; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Ananthanarayanan R, 2009, HIGH PERF COMP NETW, px1; [Anonymous], 2012, HUMAN BRAIN PROJECT; Bressloff PC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/3/033001; Bressloff PC, 2009, SIAM J APPL MATH, V70, P1488, DOI 10.1137/090756971; Brunel N, 2003, NEURAL COMPUT, V15, P2281, DOI 10.1162/089976603322362365; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Buzsaki G., 2004, RHYTHMS BRAIN; Coombes S, 2008, SIAM J APPL DYN SYST, V7, P1101, DOI 10.1137/070707579; Coombes S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148102; Coombes S, 2001, PHYSICA D, V160, P173, DOI 10.1016/S0167-2789(01)00352-9; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Ermentrout B, 1987, SIMULATING ANAL ANIM, V14; Ermentrout G., 2010, MATH FDN NEUROSCIENC, V35; ERMENTROUT GB, 1980, SIAM J APPL MATH, V38, P1, DOI 10.1137/0138001; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; FitzHugh R, MATH MODELS EXCITATI; Gerstner W., 2002, SPIKING NEURON MODEL; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Izhikevich E., 2005, SIMULATION LARGE SCA; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MCKEAN HP, 1970, ADV MATH, V4, P209, DOI 10.1016/0001-8708(70)90023-X; Nykamp DQ, 2000, J COMPUT NEUROSCI, V8, P19, DOI 10.1023/A:1008912914816; Quininao C, 2013, PREPRINT; RINZEL J, 1992, NEURAL COMPUT, V4, P534, DOI 10.1162/neco.1992.4.4.534; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Touboul J, 2011, ARXIV11082414V1; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78917	10.1371/journal.pone.0078917	http://dx.doi.org/10.1371/journal.pone.0078917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236067	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700064
J	Pascual, G; Sotomayor, S; Rodriguez, M; Bayon, Y; Bellon, JM				Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Bayon, Yves; Bellon, Juan M.			Behaviour of a New Composite Mesh for the Repair of Full-Thickness Abdominal Wall Defects in a Rabbit Model	PLOS ONE			English	Article							ADHESION FORMATION; POLYPROPYLENE MESH; PROSTHETIC MESH; TISSUE-RESPONSE; HERNIA REPAIR; PREVENTION; SEPRAMESH; MIGRATION	Introduction: Composite biomaterials designed for the repair of abdominal wall defects are composed of a mesh component and a laminar barrier in contact with the visceral peritoneum. This study assesses the behaviour of a new composite mesh by comparing it with two latest-generation composites currently used in clinical practice. Methods: Defects (7x5cm) created in the anterior abdominal wall of New Zealand White rabbits were repaired using a polypropylene mesh and the composites: Physiomesh (TM); Ventralight (TM) and a new composite mesh with a three-dimensional macroporous polyester structure and an oxidized collagen/chitosan barrier. Animals were sacrificed on days 14 and 90 postimplant. Specimens were processed to determine host tissue incorporation, gene/protein expression of neo-collagens (RT-PCR/immunofluorescence), macrophage response (RAM-11-immunolabelling) and biomechanical resistance. On postoperative days 7/14, each animal was examined laparoscopically to quantify adhesions between the visceral peritoneum and implant. Results: The new composite mesh showed the lowest incidence of seroma in the short term. At each time point, the mesh surface covered with adhesions was greater in controls than composites. By day 14, the implants were fully infiltrated by a loose connective tissue that became denser over time. At 90 days, the peritoneal mesh surface was lined with a stable mesothelium. The new composite mesh induced more rapid tissue maturation than Physiomesh (TM), giving rise to a neoformed tissue containing more type I collagen. In Ventralight (TM) the macrophage reaction was intense and significantly greater than the other composites at both follow-up times. Tensile strengths were similar for each biomaterial. Conclusions: All composites showed optimal peritoneal behaviour, inducing good peritoneal regeneration and scarce postoperative adhesion formation. A greater foreign body reaction was observed for Ventralight (TM). All composites induced good collagen deposition accompanied by optimal tensile strength. The three-dimensional macroporous structure of the new composite mesh may promote rapid tissue regeneration within the mesh.	[Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Bellon, Juan M.] Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain; [Bayon, Yves] Covidien Sofradim Prod, Trevoux, France	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; Covidien	Bellon, JM (corresponding author), Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.	juanm.bellon@uah.es	; PASCUAL, GEMMA/M-6564-2016	Sotomayor Nunez, Sandra/0000-0003-4998-762X; BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384	company COVIDIEN	company COVIDIEN	The authors have a financial research grant with the company COVIDIEN. The funders had no role in study design, data collection and analysis and decision to publish.	AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312; Anurov MV, 2012, HERNIA, V16, P199, DOI 10.1007/s10029-011-0877-y; BALIQUE JG, 2005, HERNIA, V9, P68, DOI DOI 10.1007/S10029-004-0300-Z.PUBMED:15578245; Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X; Bellon JM, 1996, J AM COLL SURGEONS, V183, P11; Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618; Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069; Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0; Bendavid R, 1997, HERNIA, V1, P5, DOI [10.1007/BF02426380, DOI 10.1007/BF02426380]; Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024; Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008; Chelala E, 2010, HERNIA, V14, P123, DOI 10.1007/s10029-010-0637-4; Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122; Deeken CR, 2012, HERNIA, V16, P69, DOI 10.1007/s10029-011-0854-5; Deeken CR, 2012, SURG ENDOSC, V26, P566, DOI 10.1007/s00464-011-1899-3; Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4; Dinsmore RC, 1999, AM SURGEON, V65, P383; Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004; Gray SH, 2008, SURG CLIN N AM, V88, P17, DOI 10.1016/j.suc.2007.11.007; Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020; Hernandez B, 2011, J MECH BEHAV BIOMED, V4, P392, DOI 10.1016/j.jmbbm.2010.11.012; Hernandez-Gascon B, 2012, J MECH BEHAV BIOMED, V5, P257, DOI 10.1016/j.jmbbm.2011.09.005; Hoer J, 2002, CHIRURG, V73, P881, DOI 10.1007/s00104-002-0539-9; Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003; Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Konerding MA, 2012, MED ENG PHYS, V34, P806, DOI 10.1016/j.medengphy.2011.09.022; Konerding MA, 2011, MED ENG PHYS, V33, P789, DOI 10.1016/j.medengphy.2011.01.010; Lambrecht J, 2011, HERNIA, V15, P473, DOI 10.1007/s10029-011-0817-x; Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012; Matthews BD, 2002, AM SURGEON, V68, P936; Moreno-Egea A, 2010, SURG ENDOSC, V24, P359, DOI 10.1007/s00464-009-0573-5; Moussi A, 2012, HERNIA, V16, P215, DOI 10.1007/s10029-010-0734-4; Ott V, 2005, Hernia, V9, P103, DOI 10.1007/s10029-004-0271-0; Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Savioz D, 1997, EUR J SURG, V163, P631; SCHEIN M, 1995, J AM COLL SURGEONS, V180, P745; Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446; Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8; Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6; van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017; WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104; Yang F, 2013, AM J SURG, V205, P15, DOI 10.1016/j.amjsurg.2012.04.007	44	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80647	10.1371/journal.pone.0080647	http://dx.doi.org/10.1371/journal.pone.0080647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236192	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700195
J	Strand, M; Micchelli, CA				Strand, Marie; Micchelli, Craig A.			Regional Control of Drosophila Gut Stem Cell Proliferation: EGF Establishes GSSC Proliferative Set Point & Controls Emergence from Quiescence	PLOS ONE			English	Article							MIDGUT; MAINTAIN; ACID	Adult stem cells vary widely in their rates of proliferation. Some stem cells are constitutively active, while others divide only in response to injury. The mechanism controlling this differential proliferative set point is not well understood. The anterior-posterior (A/P) axis of the adult Drosophila midgut has a segmental organization, displaying physiological compartmentalization and region-specific epithelia. These distinct midgut regions are maintained by defined stem cell populations with unique division schedules, providing an excellent experimental model with which to investigate this question. Here, we focus on the quiescent gastric stem cells (GSSCs) of the acidic copper cell region (CCR), which exhibit the greatest period of latency between divisions of all characterized gut stem cells, to define the molecular basis of differential stem cell activity. Our molecular genetic analysis demonstrates that the mitogenic EGF signaling pathway is a limiting factor controlling GSSC proliferation. We find that under baseline conditions, when GSSCs are largely quiescent, the lowest levels of EGF ligands in the midgut are found in the CCR. However, acute epithelial injury by enteric pathogens leads to an increase in EGF ligand expression in the CCR and rapid expansion of the GSSC lineage. Thus, the unique proliferative set points for gut stem cells residing in physiologically distinct compartments are governed by regional control of niche signals along the A/P axis.	[Strand, Marie; Micchelli, Craig A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Micchelli, CA (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.	micchelli@wustl.edu			NIH [R01 DK095871]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH R01 DK095871; http://www2.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; Dubreuil RR, 2004, INT J BIOCHEM CELL B, V36, P745, DOI 10.1016/j.biocel.2003.07.004; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Li HJ, 2013, CELL REP, V4, P10, DOI 10.1016/j.celrep.2013.05.040; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; McNulty M, 2001, CELL TISSUE RES, V304, P383, DOI 10.1007/s004410100371; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Poulsen D. F., 1952, Experimental Cell Research New York Supplement, VNo. 2, P161; POULSON D. F., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P541; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Strand M, 2011, P NATL ACAD SCI USA, V108, P17696, DOI 10.1073/pnas.1109794108; Strasburger M, 1932, Z WISS ZOOL ABT A, V140, P539; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Zheng Leizhen, 2004, Gastric Cancer, V7, P61	29	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80608	10.1371/journal.pone.0080608	http://dx.doi.org/10.1371/journal.pone.0080608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236188	Green Published, gold			2022-12-25	WOS:000327254700191
J	Tilley, A; Lopez-Angarita, J; Turner, JR				Tilley, Alexander; Lopez-Angarita, Juliana; Turner, John R.			Diet Reconstruction and Resource Partitioning of a Caribbean Marine Mesopredator Using Stable Isotope Bayesian Modelling	PLOS ONE			English	Article							STINGRAY DASYATIS-AMERICANA; SOUTHERN STINGRAY; FEEDING-HABITS; ONTOGENIC CHANGES; FOOD-WEB; DELTA-N-15; NICHE; COMMUNITIES; POPULATIONS; ASSUMPTIONS	The trophic ecology of epibenthic mesopredators is not well understood in terms of prey partitioning with sympatric elasmobranchs or their effects on prey communities, yet the importance of omnivores in community trophic dynamics is being increasingly realised. This study used stable isotope analysis of N-15 and C-13 to model diet composition of wild southern stingrays Dasyatis americana and compare trophic niche space to nurse sharks Ginglymostoma cirratum and Caribbean reef sharks Carcharhinus perezi on Glovers Reef Atoll, Belize. Bayesian stable isotope mixing models were used to investigate prey choice as well as viable Diet-Tissue Discrimination Factors for use with stingrays. Stingray delta N-15 values showed the greatest variation and a positive relationship with size, with an isotopic niche width approximately twice that of sympatric species. Shark species exhibited comparatively restricted delta N-15 values and greater delta C-13 variation, with very little overlap of stingray niche space. Mixing models suggest bivalves and annelids are proportionally more important prey in the stingray diet than crustaceans and teleosts at Glovers Reef, in contrast to all but one published diet study using stomach contents from other locations. Incorporating gut contents information from the literature, we suggest diet-tissue discrimination factors values of Delta N-15 approximate to 2.7 parts per thousand and Delta C-13 approximate to 0.9 parts per thousand for stingrays in the absence of validation experiments. The wide trophic niche and lower trophic level exhibited by stingrays compared to sympatric sharks supports their putative role as important base stabilisers in benthic systems, with the potential to absorb trophic perturbations through numerous opportunistic prey interactions.	[Tilley, Alexander; Turner, John R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Tilley, Alexander; Lopez-Angarita, Juliana] Talking Oceans Fdn, Bogota, Colombia; [Lopez-Angarita, Juliana] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Bangor University; University of York - UK	Tilley, A (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	alex@talkingoceans.co.uk	Tilley, Alexander/P-2431-2019	Tilley, Alexander/0000-0002-6363-0945; Lopez-Angarita, Juliana/0000-0002-8725-0795	Ulysses S. Seal Conservation Award from the Minnesota Zoo	Ulysses S. Seal Conservation Award from the Minnesota Zoo	This research was funded in part by the Ulysses S. Seal Conservation Award from the Minnesota Zoo and received logistical support from the Glovers Reef Research Station (Wildlife Conservation Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AA, 2009, J MAR BIOL ASSOC UK, V89, P1147, DOI 10.1017/S0025315409000058; Arthur KE, 2008, MAR ECOL PROG SER, V362, P303, DOI 10.3354/meps07440; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bigelow H.B., 1953, FISHES W N ATLANTIC; Bowman R.E., 2000, NMFSNE155 NOAA, DOI DOI 10.1093/icesjms/fsp225; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CORTES E, 1990, COPEIA, P204; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cummings DO, 2010, MAR ECOL PROG SER, V419, P211, DOI 10.3354/meps08827; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; FROESE R, 2000, FISHBASE 2000 CONCEP; GILLIAM D, 1993, B MAR SCI, V52, P1007; Grijalba Bendeck Marcela, 2007, Bol. Invest. Mar. Cost., V36, P251; Henningsen AD, 2000, COPEIA, P826; Howarth LM, 2014, FISH FISH, V15, P690, DOI 10.1111/faf.12041; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Hussey NE, 2011, LIMNOL OCEANOGR-METH, V9, P524, DOI 10.4319/lom.2011.9.524; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Hussey NE, 2010, J ANIM ECOL, V79, P184, DOI 10.1111/j.1365-2656.2009.01623.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LIN GH, 1991, AQUAT BOT, V40, P333, DOI 10.1016/0304-3770(91)90079-K; Lopez-Garro A., 2009, REV CIENC MAR COSTER, V1, P145, DOI DOI 10.15359/revmar.1.8; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Gorman EJ, 2008, OECOLOGIA, V158, P557, DOI 10.1007/s00442-008-1165-0; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; O'Shea OR, 2012, MAR FRESHWATER RES, V63, P189, DOI 10.1071/MF11180; PAN-Tiburones, 2015, PLAN ACC NAC CONS MA; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; PRESTON T, 1983, ANALYST, V108, P971, DOI 10.1039/an9830800971; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Saglam H, 2010, CAH BIOL MAR, V51, P37; SMITH JW, 1985, ESTUARIES, V8, P305, DOI 10.2307/1351491; SMITH KN, 1992, J EXP MAR BIOL ECOL, V157, P3, DOI 10.1016/0022-0981(92)90070-Q; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; SNELSON FF, 1981, ESTUARIES, V4, P110, DOI 10.2307/1351673; STOKES MD, 1992, J FISH BIOL, V41, P1043, DOI 10.1111/j.1095-8649.1992.tb02732.x; Thrush SE, 1999, AUST J ECOL, V24, P344, DOI 10.1046/j.1442-9993.1999.00981.x; Tilley A, 2013, MAR ECOL PROG SER, V482, P169, DOI 10.3354/meps10285; Tilley A, 2013, AQUAT CONSERV, V23, P202, DOI 10.1002/aqc.2317; VALENTINE JF, 1994, J EXP MAR BIOL ECOL, V178, P181, DOI 10.1016/0022-0981(94)90035-3; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Ward-Campbell BMS, 2005, ENVIRON BIOL FISH, V72, P251, DOI 10.1007/s10641-004-1744-9; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wetherbee BM, 2004, CRC MAR BIOL SER, P225	62	41	42	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79560	10.1371/journal.pone.0079560	http://dx.doi.org/10.1371/journal.pone.0079560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236144	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700143
J	Vitevitch, MS; Sereno, J; Jongman, A; Goldstein, R				Vitevitch, Michael S.; Sereno, Joan; Jongman, Allard; Goldstein, Rutherford			Speaker Sex Influences Processing of Grammatical Gender	PLOS ONE			English	Article							INFORMATION; MODEL	Spoken words carry linguistic and indexical information to listeners. Abstractionist models of spoken word recognition suggest that indexical information is stripped away in a process called normalization to allow processing of the linguistic message to proceed. In contrast, exemplar models of the lexicon suggest that indexical information is retained in memory, and influences the process of spoken word recognition. In the present study native Spanish listeners heard Spanish words that varied in grammatical gender (masculine, ending in -o, or feminine, ending in -a) produced by either a male or a female speaker. When asked to indicate the grammatical gender of the words, listeners were faster and more accurate when the sex of the speaker "matched'' the grammatical gender than when the sex of the speaker and the grammatical gender "mismatched.'' No such interference was observed when listeners heard the same stimuli, but identified whether the speaker was male or female. This finding suggests that indexical information, in this case the sex of the speaker, influences not just processes associated with word recognition, but also higher-level processes associated with grammatical processing. This result also raises questions regarding the widespread assumption about the cognitive independence and automatic nature of grammatical processes.	[Vitevitch, Michael S.; Goldstein, Rutherford] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Sereno, Joan; Jongman, Allard] Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Vitevitch, MS (corresponding author), Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA.	mvitevit@ku.edu	jongman, allard/A-8377-2009	jongman, allard/0000-0002-7384-2036; Sereno, Joan/0000-0002-1227-7715; Vitevitch, Michael/0000-0002-1209-0838	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803, T32DC000052] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abercrombie D., 1967, ELEMENTS GEN PHONETI; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Corbett GG, 2005, WORLD ATLAS LANGUAGE, P134; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Johnson Keith, 1997, TALKER VARIABILITY S, P145, DOI DOI 10.1017/S1366728914000790; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Moore CB, 1997, J ACOUST SOC AM, V102, P1864, DOI 10.1121/1.420092; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; Nygaard LC, 2002, MEM COGNITION, V30, P583, DOI 10.3758/BF03194959; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; Pierrehumbert JB, 2002, PHONOL PHONET, V4-1, P101; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pisoni David, 1997, TALKER VARIABILITY S, P9; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schiller NO, 2003, PSYCHOPHYSIOLOGY, V40, P869, DOI 10.1111/1469-8986.00105; Sebastian Galles N, 2000, LEXESP LEXICO INFORM; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Vitevitch MS, 2011, Q J EXP PSYCHOL, V64, P1484, DOI 10.1080/17470218.2011.578749	22	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79701	10.1371/journal.pone.0079701	http://dx.doi.org/10.1371/journal.pone.0079701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236155	Green Published, gold			2022-12-25	WOS:000327254700154
J	Yamamoto, H; Maruo, T; Majima, T; Ishizaki, H; Tanaka-Okamoto, M; Miyoshi, J; Mandai, K; Takai, Y				Yamamoto, Hideaki; Maruo, Tomohiko; Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun; Mandai, Kenji; Takai, Yoshimi			Genetic Deletion of Afadin Causes Hydrocephalus by Destruction of Adherens Junctions in Radial Glial and Ependymal Cells in the Midbrain	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; TIGHT JUNCTIONS; ADHESION MOLECULE; NERVOUS-SYSTEM; MOTILE CILIA; MUTANT MICE; E-CADHERIN; NECTIN; MOUSE; POLARITY	Adherens junctions (AJs) play a role in mechanically connecting adjacent cells to maintain tissue structure, particularly in epithelial cells. The major cell-cell adhesion molecules at AJs are cadherins and nectins. Afadin binds to both nectins and alpha-catenin and recruits the cadherin-beta-catenin complex to the nectin-based cell-cell adhesion site to form AJs. To explore the role of afadin in radial glial and ependymal cells in the brain, we generated mice carrying a nestin-Cre-mediated conditional knockout (cKO) of the afadin gene. Newborn afadin-cKO mice developed hydrocephalus and died neonatally. The afadin-cKO brain displayed enlarged lateral ventricles and cerebral aqueduct, resulting from stenosis of the caudal end of the cerebral aqueduct and obliteration of the ventral part of the third ventricle. Afadin deficiency further caused the loss of ependymal cells from the ventricular and aqueductal surfaces. During development, radial glial cells, which terminally differentiate into ependymal cells, scattered from the ventricular zone and were replaced by neurons that eventually covered the ventricular and aqueductal surfaces of the afadin-cKO midbrain. Moreover, the denuded ependymal cells were only occasionally observed in the third ventricle and the cerebral aqueduct of the afadin-cKO midbrain. Afadin was co-localized with nectin-1 and N-cadherin at AJs of radial glial and ependymal cells in the control midbrain, but these proteins were not concentrated at AJs in the afadin-cKO midbrain. Thus, the defects in the afadin-cKO midbrain most likely resulted from the destruction of AJs, because AJs in the midbrain were already established before afadin was genetically deleted. These results indicate that afadin is essential for the maintenance of AJs in radial glial and ependymal cells in the midbrain and is required for normal morphogenesis of the cerebral aqueduct and ventral third ventricle in the midbrain.	[Yamamoto, Hideaki; Maruo, Tomohiko; Mandai, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan; [Yamamoto, Hideaki; Maruo, Tomohiko; Mandai, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Yamamoto, Hideaki; Maruo, Tomohiko; Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun; Mandai, Kenji; Takai, Yoshimi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Majima, Takashi; Takai, Yoshimi] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka, Japan; [Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST); Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mandai, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan.	ytakai@med.kobe-u.ac.jp; mandai@med.kobe-u.ac.jp		Tanaka-Okamoto, Miki/0000-0002-6429-7662; Mandai, Kenji/0000-0002-0115-6635	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science; Yasuda Medical Foundation	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yasuda Medical Foundation	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology", the Targeted Proteins Research Program, Grants-in-Aid for Scientific Research on Innovative Areas ("Brain Environment" and "Neural Diversity and Neocortical Organization") (for K. M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grants-in-Aid for Scientific Research (S) (for Y.T.) and (C) (for K. M.) from the Japan Society for the Promotion of Science, and the grants (for Y.T.) from the Yasuda Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Cinalli G, 2011, CHILD NERV SYST, V27, P1621, DOI 10.1007/s00381-011-1546-2; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; Del Bigio MR, 2000, J NEUROPATH EXP NEUR, V59, P946, DOI 10.1093/jnen/59.11.946; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kuramitsu K, 2008, GENES CELLS, V13, P797, DOI 10.1111/j.1365-2443.2008.01206.x; Kurita S., 2013, J BIOL CHEM; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mandai K, 2013, PROG MOL BIOL TRANSL, V116, P433, DOI 10.1016/B978-0-12-394311-8.00019-4; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Ohtoshi Akihira, 2008, Cerebrospinal Fluid Res, V5, P16, DOI 10.1186/1743-8454-5-16; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paez P, 2007, J NEUROPATH EXP NEUR, V66, P1082, DOI 10.1097/nen.0b013e31815c1952; Perez-Figares JM, 2001, MICROSC RES TECHNIQ, V52, P591, DOI 10.1002/1097-0029(20010301)52:5<591::AID-JEMT1043>3.0.CO;2-7; PRASAD R, 1993, CANCER RES, V53, P5624; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Silva-Alvarez C, 2005, NEUROCHEM RES, V30, P1227, DOI 10.1007/s11064-005-8794-z; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Socci DJ, 1999, EXP NEUROL, V155, P109, DOI 10.1006/exnr.1998.6969; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019; Wyss L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045619; Yamada T, GENES TOCCE IN PRESS; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	67	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80356	10.1371/journal.pone.0080356	http://dx.doi.org/10.1371/journal.pone.0080356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236178	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700179
J	Zanon, A; Rakovic, A; Blankenburg, H; Doncheva, NT; Schwienbacher, C; Serafin, A; Alexa, A; Weichenberger, CX; Albrecht, M; Klein, C; Hicks, AA; Pramstaller, PP; Domingues, FS; Pichler, I				Zanon, Alessandra; Rakovic, Aleksandar; Blankenburg, Hagen; Doncheva, Nadezhda T.; Schwienbacher, Christine; Serafin, Alice; Alexa, Adrian; Weichenberger, Christian X.; Albrecht, Mario; Klein, Christine; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene			Profiling of Parkin-Binding Partners Using Tandem Affinity Purification	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN INTERACTION NETWORKS; GENE ONTOLOGY; DISEASE GENES; MITOCHONDRIAL PATHOLOGY; FUNCTIONAL SIMILARITY; UBIQUITIN LIGASE; CELL-DEATH; DROSOPHILA; MUTATIONS	Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting approximately 1-2% of the general population over age 60. It is characterized by a rather selective loss of dopaminergic neurons in the substantia nigra and the presence of a-synuclein-enriched Lewy body inclusions. Mutations in the Parkin gene (PARK2) are the major cause of autosomal recessive early-onset parkinsonism. The Parkin protein is an E3 ubiquitin ligase with various cellular functions, including the induction of mitophagy upon mitochondrial depolarizaton, but the full repertoire of Parkin-binding proteins remains poorly defined. Here we employed tandem affinity purification interaction screens with subsequent mass spectrometry to profile binding partners of Parkin. Using this approach for two different cell types (HEK293T and SH-SY5Y neuronal cells), we identified a total of 203 candidate Parkin-binding proteins. For the candidate proteins and the proteins known to cause heritable forms of parkinsonism, protein-protein interaction data were derived from public databases, and the associated biological processes and pathways were analyzed and compared. Functional similarity between the candidates and the proteins involved in monogenic parkinsonism was investigated, and additional confirmatory evidence was obtained using published genetic interaction data from Drosophila melanogaster. Based on the results of the different analyses, a prioritization score was assigned to each candidate Parkin-binding protein. Two of the top ranking candidates were tested by co-immunoprecipitation, and interaction to Parkin was confirmed for one of them. New candidates for involvement in cell death processes, protein folding, the fission/fusion machinery, and the mitophagy pathway were identified, which provide a resource for further elucidating Parkin function.	[Zanon, Alessandra; Blankenburg, Hagen; Schwienbacher, Christine; Serafin, Alice; Weichenberger, Christian X.; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Zanon, Alessandra; Blankenburg, Hagen; Schwienbacher, Christine; Serafin, Alice; Weichenberger, Christian X.; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Rakovic, Aleksandar; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany; [Doncheva, Nadezhda T.; Alexa, Adrian; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Albrecht, Mario] Univ Med Greifswald, Inst Biometr & Med Informat, Dept Bioinformat, Greifswald, Germany; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	European Academy of Bozen-Bolzano; University of Lubeck; University of Lubeck; Max Planck Society; Greifswald Medical School; Krankenhaus Bozen; University of Lubeck	Domingues, FS (corresponding author), Cambridge Ltd, Illumina, Cambridge, England.	francisco.domingues@eurac.edu; irene.pichler@eurac.edu	Klein, Christine/AGK-8003-2022; Albrecht, Mario/B-6694-2008; Pramstaller, Peter P/C-2357-2008; Hicks, Andrew Anthony/E-9518-2017	Albrecht, Mario/0000-0002-3103-9624; Hicks, Andrew Anthony/0000-0001-6320-0411; Zanon, Alessandra/0000-0003-2204-6176; Pramstaller, Peter P/0000-0002-9831-8302; Weichenberger, Christian X./0000-0002-2176-0274; Doncheva, Nadezhda T./0000-0002-8806-6850; Pichler, Irene/0000-0001-8251-0757; Domingues, Francisco/0000-0003-4567-4562; Blankenburg, Hagen/0000-0002-6058-1818; Klein, Christine/0000-0003-2102-3431	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; German Federal Ministry of Education and Research through the German National Genome Research Network; Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; German Federal Ministry of Education and Research through the German National Genome Research Network; Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction	The study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. Part of this study was also funded by the German Federal Ministry of Education and Research through the German National Genome Research Network and the Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Fernandes C, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-17; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Marras C, 2012, NEUROLOGY, V78, P1016, DOI 10.1212/WNL.0b013e31824d58ab; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Mukamel Z, 2004, J BIOL CHEM, V279, P36732, DOI 10.1074/jbc.M400041200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	70	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78648	10.1371/journal.pone.0078648	http://dx.doi.org/10.1371/journal.pone.0078648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244333	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600042
J	Bertrand, C; Pignalosa, A; Wanecq, E; Rancoule, C; Batut, A; Deleruyelle, S; Lionetti, L; Valet, P; Castan-Laurell, I				Bertrand, Chantal; Pignalosa, Angelica; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Lionetti, Lilla; Valet, Philippe; Castan-Laurell, Isabelle			Effects of Dietary Eicosapentaenoic Acid (EPA) Supplementation in High-Fat Fed Mice on Lipid Metabolism and Apelin/APJ System in Skeletal Muscle	PLOS ONE			English	Article							UP-REGULATES APELIN; INSULIN-RESISTANT MICE; INDUCED OBESE MICE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; SECRETION; GLUCOSE; LEPTIN	Various studies have shown that eicosapentaenoic acid (EPA) has beneficial effects on obesity and associated disorders. Apelin, the ligand of APJ receptor also exerts insulin-sensitizing effects especially by improving muscle metabolism. EPA has been shown to increase apelin production in adipose tissue but its effects in muscle have not been addressed. Thus, the effects of EPA supplementation (36 g/kg EPA) in high-fat diet (HFD) (45% fat, 20% protein, 35% carbohydrate) were studied in mice with focus on muscle lipid metabolism and apelin/APJ expression. Compared with HFD mice, HFD+EPA mice had significantly less weight gain, fat mass, lower blood glucose, insulinemia and hepatic steatosis after 10 weeks of diet. In addition, EPA prevented muscle metabolism alterations since intramuscular triglycerides were decreased and beta-oxidation increased. In soleus muscles of HFD+EPA mice, apelin and APJ expression were significantly increased compared to HFD mice. However, plasma apelin concentrations in HFD and HFD+EPA mice were similar. EPA-induced apelin expression was confirmed in differentiated C2C12 myocytes but in this model, apelin secretion was also increased in response to EPA treatment. In conclusion, EPA supplementation in HFD prevents obesity and metabolic alterations in mice, especially in skeletal muscle. Since EPA increases apelin/APJ expression in muscle, apelin may act in a paracrine/autocrine manner to contribute to these benefical effects.	[Bertrand, Chantal; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Valet, Philippe; Castan-Laurell, Isabelle] INSERM, U1048, Toulouse 4, France; [Bertrand, Chantal; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Valet, Philippe; Castan-Laurell, Isabelle] Univ Toulouse, UPS, Inst Malad Metabol & Cardiovasc, Toulouse, France; [Pignalosa, Angelica; Lionetti, Lilla] Univ Naples Federico II, Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Naples Federico II	Castan-Laurell, I (corresponding author), INSERM, U1048, Toulouse 4, France.	isabelle.castan@inserm.fr	Lionetti, Lilla/AAM-1756-2021; Valet, Philippe/N-7472-2017	Lionetti, Lilla/0000-0002-4059-8030; Valet, Philippe/0000-0001-6520-7393; Castan-Laurell, Isabelle/0000-0002-0488-9789	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The funder is INSERM and has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andre A, 2011, BR J NUTR, P1; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Berta J, 2010, J THORAC ONCOL, V5, P1120, DOI 10.1097/JTO.0b013e3181e2c1ff; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brasky TM, 2013, JNCI-J NATL CANCER I, V105, P1132, DOI 10.1093/jnci/djt174; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Di Minno MND, 2012, WORLD J GASTROENTERO, V18, P5839, DOI 10.3748/wjg.v18.i41.5839; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Fan CN, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-31; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Jones TE, 2003, AM J PHYSIOL-ENDOC M, V284, pE96, DOI 10.1152/ajpendo.00316.2002; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; LILLINGTON JM, 1981, CLIN CHIM ACTA, V111, P91, DOI 10.1016/0009-8981(81)90425-3; Lorente-Cebrian S, 2010, MOL NUTR FOOD RES, V54, pS104, DOI 10.1002/mnfr.200900522; Mazzucotelli A, 2008, REGUL PEPTIDES, V150, P33, DOI 10.1016/j.regpep.2008.04.003; Murata M, 2000, BIOCHEM BIOPH RES CO, V270, P343, DOI 10.1006/bbrc.2000.2424; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; Perez-Echarri N, 2009, BRIT J NUTR, V101, P1059, DOI 10.1017/S0007114508048307; Perez-Matute P, 2005, AM J PHYSIOL-REG I, V288, pR1682, DOI 10.1152/ajpregu.00727.2004; Pope GR, 2012, PEPTIDES, V33, P139, DOI 10.1016/j.peptides.2011.12.005; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Reseland JE, 2001, J LIPID RES, V42, P743; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Wang XL, 2012, PEPTIDES, V33, P298, DOI 10.1016/j.peptides.2011.12.015; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Yamamoto T, 2011, BBA-GEN SUBJECTS, V1810, P853, DOI 10.1016/j.bbagen.2011.05.004	41	41	44	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78874	10.1371/journal.pone.0078874	http://dx.doi.org/10.1371/journal.pone.0078874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244380	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900026
J	Dierikx, CM; van der Goot, JA; Smith, HE; Kant, A; Mevius, DJ				Dierikx, Cindy M.; van der Goot, Jeanet A.; Smith, Hilde E.; Kant, Arie; Mevius, Dik J.			Presence of ESBL/AmpC -Producing Escherichia coli in the Broiler Production Pyramid: A Descriptive Study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ANTIMICROBIAL AGENTS; RESISTANCE; CHICKENS; POULTRY; ENTEROBACTERIACEAE; EPIDEMIOLOGY; TRANSMISSION; HUMANS; IMPACT	Broilers and broiler meat products are highly contaminated with extended spectrum beta-lactamase (ESBL) or plasmid-mediated AmpC beta-lactamase producing Escherichia coli and are considered to be a source for human infections. Both horizontal and vertical transmission might play a role in the presence of these strains in broilers. As not much is known about the presence of these strains in the whole production pyramid, the epidemiology of ESBL/AmpC-producing E. coli in the Dutch broiler production pyramid was examined. Cloacal swabs of Grandparent stock (GPS) birds (one(-)/two-days (breed A and B), 18 and 31 weeks old (breed A)), one-day old Parent stock birds (breed A and B) and broiler chickens of increasing age (breed A) were selectively cultured to detect ESBL/AmpC-producing isolates. ESBL/AmpC-producing isolates were found at all levels in the broiler production pyramid in both broiler breeds examined. Prevalence was already relatively high at the top of the broiler production pyramid. At broiler farms ESBL/AmpC producing E. coli were still present in the environment of the poultry house after cleaning and disinfection. Feed samples taken in the poultry house also became contaminated with ESBL/AmpC producing E. coli after one or more production weeks. The prevalence of ESBL/AmpC-positive birds at broiler farms increased within the first week from 0-24% to 96-100% independent of the use of antibiotics and stayed 100% until slaughter. In GPS breed A, prevalence at 2 days, 18 weeks and 31 weeks stayed below 50% except when beta-lactam antibiotics were administered. In that case prevalence increased to 100%. Interventions minimizing ESBL/AmpC contamination in broilers should focus on preventing horizontal and vertical spread, especially in relation to broiler production farms.	[Dierikx, Cindy M.; Kant, Arie; Mevius, Dik J.] CVI, Dept Bacteriol, Lelystad, Netherlands; [Dierikx, Cindy M.; Kant, Arie; Mevius, Dik J.] CVI, TSEs, Lelystad, Netherlands; [van der Goot, Jeanet A.] CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands; [Smith, Hilde E.] CVI, Dept Infect Biol, Lelystad, Netherlands; [Mevius, Dik J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University	Dierikx, CM (corresponding author), CVI, Dept Bacteriol, Lelystad, Netherlands.	Cindy.Dierikx@wur.nl			Dutch Ministry of Economic Affairs [WOT-01-002-003, WOT-01-002-003.04]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was financially supported by the Dutch Ministry of Economic Affairs (Grant numbers WOT-01-002-003 and WOT-01-002-003.04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlet G, 2006, MICROBES INFECT, V8, P1945, DOI 10.1016/j.micinf.2005.12.029; Bortolaia V, 2010, VET MICROBIOL, V142, P379, DOI 10.1016/j.vetmic.2009.10.024; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; COLOE PJ, 1984, J HYG-CAMBRIDGE, V92, P79, DOI 10.1017/S0022172400064056; da Costa PM, 2008, MICROB DRUG RESIST, V14, P299, DOI 10.1089/mdr.2008.0859; Diarra MS, 2007, APPL ENVIRON MICROB, V73, P6566, DOI 10.1128/AEM.01086-07; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dierikx CM, 2012, J ANTIMICROB CHEMOTH; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Egea P, 2011, EUR J CLIN MICROBIOL, V30, P1045, DOI 10.1007/s10096-011-1168-3; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Giovanardi D, 2005, AVIAN PATHOL, V34, P313, DOI 10.1080/03079450500179046; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P1244, DOI 10.1093/jac/dkn093; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; MAMBER SW, 1985, APPL ENVIRON MICROB, V50, P638, DOI 10.1128/AEM.50.3.638-648.1985; MARAN, 2012, MON ANT RES ANT US A; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Niki M, 2011, INFECTION, V39, P467, DOI 10.1007/s15010-011-0128-2; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peek HW, 2011, VET QUART, V31, P143, DOI 10.1080/01652176.2011.605247; Persoons D, 2011, EPIDEMIOL INFECT, V139, P765, DOI 10.1017/S0950268810001524; Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Saleha AA, 2009, INT J POUL SCI; Smet A, 2011, J APPL MICROBIOL, V110, P541, DOI 10.1111/j.1365-2672.2010.04907.x; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; SVA (National Veterinary Institute), 2010, SWED VET ANT RES MON	33	144	144	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79005	10.1371/journal.pone.0079005	http://dx.doi.org/10.1371/journal.pone.0079005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244401	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900029
J	Motegi, C; Nagata, T; Miki, T; Weinbauer, MG; Legendre, L; Rassoulzadegan, F				Motegi, Chiaki; Nagata, Toshi; Miki, Takeshi; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun			Interactive Effects of Viral and Bacterial Production on Marine Bacterial Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; COMMUNITY COMPOSITION; MICROBIAL DIVERSITY; INDUCED MORTALITY; DISTURBANCE; VIRUSES; BACTERIOPLANKTON; DIVERSIFICATION; BIOMASS; COMPETITION	A general model of species diversity predicts that the latter is maximized when productivity and disturbance are balanced. Based on this model, we hypothesized that the response of bacterial diversity to the ratio of viral to bacterial production (VP/BP) would be dome-shaped. In order to test this hypothesis, we obtained data on changes in bacterial communities (determined by terminal restriction fragment length polymorphism of 16S rRNA gene) along a wide VP/BP gradient (more than two orders of magnitude), using seawater incubations from NW Mediterranean surface waters, i.e., control and treatments with additions of phosphate, viruses, or both. In December, one dominant Operational Taxonomic Unit accounted for the major fraction of total amplified DNA in the phosphate addition treatment (75 +/- 20%, +/- S.D.), but its contribution was low in the phosphate and virus addition treatment (23 +/- 19%), indicating that viruses prevented the prevalence of taxa that were competitively superior in phosphate-replete conditions. In contrast, in February, the single taxon predominance in the community was held in the phosphate addition treatment even with addition of viruses. We observed statistically robust dome-shaped response patterns of bacterial diversity to VP/BP, with significantly high bacterial diversity at intermediate VP/BP. This was consistent with our model-based hypothesis, indicating that bacterial production and viral-induced mortality interactively affect bacterial diversity in seawater.	[Motegi, Chiaki; Nagata, Toshi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Motegi, Chiaki; Nagata, Toshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Motegi, Chiaki; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun] Univ Paris 06, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Motegi, Chiaki; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun] CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Miki, Takeshi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	University of Tokyo; Kyoto University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Taiwan University	Motegi, C (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	chiaki.motegi@takuvik.ulaval.ca	Weinbauer, Markus/ABC-7017-2020; Miki, Takeshi/F-8189-2010	Weinbauer, Markus/0000-0002-7697-5571; Miki, Takeshi/0000-0002-2452-8681	Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie Paris 6, France; Japan Society for the Promotion of Science [18631007, 20310010]; 21st Century Center of Excellence (COE) program (Kyoto University); project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie Paris 6, France; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE) program (Kyoto University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite	Financial support was provided by: the Centre National de la Recherche Scientifique and the Universite Pierre et Marie Curie Paris 6, France, to the Laboratoire d'Oceanographie de Villefranche; the Japan Society for the Promotion of Science, through grants 18631007 and 20310010 awarded to T.N.; and the 21st Century Center of Excellence (COE) program (Kyoto University). The project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite awarded to M. G. W. also contributed to this research. Travel expenses of C. M. to France were supported by the Kyoto University Foundation and the College doctoral franco-japonais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Ausubel FM, 1994, CURRENT PROTOCOLS MO; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Hewson I, 2007, DEEP-SEA RES PT I, V54, P811, DOI 10.1016/j.dsr.2007.02.003; Hewson I, 2007, MICROB ECOL, V53, P631, DOI 10.1007/s00248-006-9148-3; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Jara VC, 2006, MAR ECOL PROG SER, V308, P37, DOI 10.3354/meps308037; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; Kadmon R, 2006, AM NAT, V167, P939, DOI 10.1086/504602; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Kirchman D, 2001, METHOD MICROBIOL, V30, P227, DOI 10.1016/S0580-9517(01)30047-8; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Ludwig JA, 1988, STAT ECOLOGY; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Miki T, 2008, MAR ECOL PROG SER, V366, P1, DOI 10.3354/meps07597; Moeseneder MM, 2001, LIMNOL OCEANOGR, V46, P95, DOI 10.4319/lo.2001.46.1.0095; Motegi C, 2009, LIMNOL OCEANOGR, V54, P1901, DOI 10.4319/lo.2009.54.6.1901; Moyer CL, 1996, APPL ENVIRON MICROB, V62, P2501, DOI 10.1128/AEM.62.7.2501-2507.1996; Proulx M, 1998, ECOLOGY, V79, P2581, DOI 10.1890/0012-9658(1998)079[2581:ROGIOP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schwalbach MS, 2004, AQUAT MICROB ECOL, V34, P117, DOI 10.3354/ame034117; Sintes E, 2013, FEMS MICROBIOL ECOL, V83, P413, DOI 10.1111/1574-6941.12003; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Winter C, 2004, APPL ENVIRON MICROB, V70, P804, DOI 10.1128/AEM.70.2.804-813.2004; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zhang R, 2007, ENVIRON MICROBIOL, V9, P3008, DOI 10.1111/j.1462-2920.2007.01410.x; Zuur Alain F., 2009, P1	46	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76800	10.1371/journal.pone.0076800	http://dx.doi.org/10.1371/journal.pone.0076800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244268	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900002
J	Joshi, M; Duan, D; Drew, D; Jia, ZM; Davis, D; Campbell, RL; Allingham, JS				Joshi, Monika; Duan, Da; Drew, Doran; Jia, Zhimeng; Davis, Darlene; Campbell, Robert L.; Allingham, John S.			Kar3Vik1 Mechanochemistry Is Inhibited by Mutation or Deletion of the C Terminus of the Vik1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinesin; Mechanotransduction; Microtubules; Molecular Dynamics; Molecular Motors; ATPase; Kar3; Motility; Neck Mimic; Vik1	KINESIN MOTOR PROTEIN; END-DIRECTED KINESIN; CRYSTAL-STRUCTURE; FORCE GENERATION; DRIVES MOTILITY; ONE HEAD; MICROTUBULES; PROCESSIVITY; MECHANISM; DOMAIN	Force production by kinesins has been linked to structural rearrangements of the N and C termini of their motor domain upon nucleotide binding. In recent crystal structures, the Kar3-associated protein Vik1 shows unexpected homology to these conformational states even though it lacks a nucleotide-binding site. This conservation infers a degree of commonality in the function of the N- and C-terminal regions during the mechanochemical cycle of all kinesins and kinesin-related proteins. We tested this inference by examining the functional effects on Kar3Vik1 of mutating or deleting residues in Vik1 that are involved in stabilizing the C terminus against the core and N terminus of the Vik1 motor homology domain (MHD). Point mutations at two moderately conserved residues near the Vik1 C terminus impaired microtubule gliding and microtubule-stimulated ATP turnover by Kar3Vik1. Deletion of the seven C-terminal residues inhibited Kar3Vik1 motility much more drastically. Interestingly, none of the point mutants seemed to perturb the ability of Kar3Vik1 to bind microtubules, whereas the C-terminal truncation mutant did. Molecular dynamics simulations of these C-terminal mutants showed distinct root mean square fluctuations in the N-terminal region of the Vik1 MHD that connects it to Kar3. Here, the degree of motion in the N-terminal portion of Vik1 highly correlated with that in the C terminus. These observations suggest that the N and C termini of the Vik1 MHD form a discrete folding motif that is part of a communication pathway to the nucleotide-binding site of Kar3.	[Joshi, Monika; Duan, Da; Drew, Doran; Jia, Zhimeng; Davis, Darlene; Campbell, Robert L.; Allingham, John S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Allingham, JS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Rm 652, Kingston, ON K7L 3N6, Canada.	allinghj@queensu.ca	Jia, Zhimeng/GRI-9437-2022; Allingham, John/AAW-9262-2020; Jia, Zhimeng/AAS-9450-2021	Jia, Zhimeng/0000-0001-8156-5553; Jia, Zhimeng/0000-0001-8156-5553; Campbell, Robert/0000-0002-5473-5876	Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Institutes of Health Research (CIHR; to J. S. A.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.e04-10-0935; Amos LA, 2007, J CELL SCI, V120, P3919, DOI 10.1242/jcs.016931; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Cope J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053792; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Duan D, 2012, J BIOL CHEM, V287, P40292, DOI 10.1074/jbc.M112.416529; Duan D, 2012, PROTEINS, V80, P1016, DOI 10.1002/prot.24004; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Gonzalez MA, 2013, J STRUCT BIOL, V184, P335, DOI 10.1016/j.jsb.2013.09.020; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hesse WR, 2013, BIOPHYS J, V104, P1969, DOI 10.1016/j.bpj.2013.03.051; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2020, PYMOL; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Subramanian R, 2007, J GEN PHYSIOL, V130, P445, DOI 10.1085/jgp.200709866; Szczesna E, 2012, FEBS LETT, V586, P854, DOI 10.1016/j.febslet.2012.02.011; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	55	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36957	36970		10.1074/jbc.M113.492264	http://dx.doi.org/10.1074/jbc.M113.492264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240171	Green Published, hybrid			2022-12-25	WOS:000329189700018
J	Li, J; Zhou, X; Huang, L; Fu, X; Liu, J; Zhang, XW; Sun, YY; Zuo, MX				Li, Jie; Zhou, Xin; Huang, Li; Fu, Xin; Liu, Jin; Zhang, Xinwen; Sun, Yingyu; Zuo, Mingxue			Alteration of CaBP Expression Pattern in the Nucleus Magnocellularis following Unilateral Cochlear Ablation in Adult Zebra Finches	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; CALCIUM-BINDING PROTEINS; LATERAL LEMNISCAL NUCLEI; BENGALESE FINCHES; NEURON NUMBER; BARN OWL; CALRETININ IMMUNOREACTIVITY; AFFERENT INFLUENCES; CALBINDIN D-28K; DEVELOPING RATS	Songbirds have the rare ability of auditory-vocal learning and maintenance. Up to now, the organization and function of the nucleus magnocellularis (NM), the first relay of the avian ascending auditory pathway is largely based on studies in non-vocal learning species, such as chickens and owls. To investigate whether NM exhibits different histochemical properties associated with auditory processing in songbirds, we examined the expression patterns of three calcium-binding proteins (CaBPs), including calretinin (CR), parvalbumin (PV) and calbindin-D28k (CB), and their relations to auditory inputs in NM in adult zebra finches. We found enriched and co-localized immunostaining of CR, PV and CB in the majority of NM neurons, without neuronal population preference. Furthermore, they were sensitive to adult deafferentation with differential plasticity patterns. After unilateral cochlear removal, CR staining in the ipsilateral NM decreased appreciably at 3 days after surgery, and continued to decline thereafter. PV staining showed down-regulation first at 3 days, but subsequently recovered slightly. CB staining did not significantly decrease until 7 days after surgery. Our findings suggest that the three CaBPs might play distinct roles in association with auditory processing in zebra finches. These results are in contrast to the findings in the NM of chickens where CR is the predominant CaBP and deafferentation had no apparent effect on its expression. Further extended studies in other avian species are required to establish whether the difference in CaBP patterns in NM is functionally related to the different auditory-vocal behaviors.	[Li, Jie; Zhou, Xin; Fu, Xin; Liu, Jin; Sun, Yingyu; Zuo, Mingxue] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Li; Zhang, Xinwen] Hainan Normal Univ, Dept Biol, Haikou, Peoples R China	Beijing Normal University; Hainan Normal University	Sun, YY (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Coll Life Sci, Beijing 100875, Peoples R China.	sunyingyu@bnu.edu.cn			 [30970360];  [30870307];  [31071923];  [30860087]	; ; ; 	Yingyu Sun (grant 30970360), Mingxue Zuo (grant 30870307 and 31071923) and Xinwen Zhang (grant 30860087). [http://www.nsfc.gov.cn] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Alvarado JC, 2005, NEUROSCIENCE, V136, P957, DOI 10.1016/j.neuroscience.2005.04.022; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Belekhova M G, 2008, Zh Evol Biokhim Fiziol, V44, P302; BORN DE, 1991, BRAIN RES, V557, P37, DOI 10.1016/0006-8993(91)90113-A; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; BRAUN K, 1990, PROG HISTOCHEM CYTOC, V21, pU1; Caicedo A, 1996, ANAT EMBRYOL, V194, P465; Caicedo A, 1997, J COMP NEUROL, V378, P1, DOI 10.1002/(SICI)1096-9861(19970203)378:1<1::AID-CNE1>3.0.CO;2-8; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; CARR CE, 1990, J NEUROSCI, V10, P3227; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chudinova TV, 2012, BRAIN RES, V1473, P87, DOI 10.1016/j.brainres.2012.07.022; Couchman K, 2010, J NEUROSCI, V30, P17111, DOI 10.1523/JNEUROSCI.1760-10.2010; Edmonds JL, 1999, HEARING RES, V127, P62, DOI 10.1016/S0378-5955(98)00180-4; Forster CR, 2000, J COMP NEUROL, V416, P173, DOI 10.1002/(SICI)1096-9861(20000110)416:2<173::AID-CNE4>3.0.CO;2-V; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; FRISINA RD, 1995, HEARING RES, V85, P53, DOI 10.1016/0378-5955(95)00029-4; Fuentes-Santamaria V, 2005, J COMP NEUROL, V483, P458, DOI 10.1002/cne.20437; Fukui I, 2004, J NEUROSCI, V24, P7514, DOI 10.1523/JNEUROSCI.0566-04.2004; Garcia-Calero E, 2013, J COMP NEUROL, V521, P326, DOI 10.1002/cne.23174; Harris JA, 2006, HEARING RES, V216, P127, DOI 10.1016/j.heares.2006.03.016; HASHISAKI GT, 1989, J COMP NEUROL, V283, P465, DOI 10.1002/cne.902830402; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2135, DOI 10.1002/cne.22324; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2109, DOI 10.1002/cne.22334; Kubke MF, 1999, J COMP NEUROL, V415, P189, DOI 10.1002/(SICI)1096-9861(19991213)415:2<189::AID-CNE4>3.0.CO;2-E; Kubke MF, 2002, HEARING RES, V164, P19, DOI 10.1016/S0378-5955(01)00387-2; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Logerot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020686; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; MARLER P, 1977, J COMP PHYSIOL PSYCH, V91, P8, DOI 10.1037/h0077303; Monsivais P, 2000, J NEUROSCI, V20, P2954; MOORE DR, 1990, J COMP NEUROL, V302, P810, DOI 10.1002/cne.903020412; Mostafapour SP, 2000, J COMP NEUROL, V426, P561, DOI 10.1002/1096-9861(20001030)426:4<561::AID-CNE5>3.0.CO;2-G; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Okanoya K, 1997, J NEUROBIOL, V33, P343; Park DL, 1998, HEARING RES, V126, P84, DOI 10.1016/S0378-5955(98)00157-9; Parks TN, 1997, J COMP NEUROL, V383, P112; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Pinaud R, 2007, J CHEM NEUROANAT, V34, P1, DOI 10.1016/j.jchemneu.2007.03.005; Por A, 2005, BRAIN RES, V1039, P63, DOI 10.1016/j.brainres.2005.01.057; ROGERS JH, 1989, NEUROSCIENCE, V31, P697, DOI 10.1016/0306-4522(89)90434-X; RUBEL EW, 1990, J NEUROBIOL, V21, P169, DOI 10.1002/neu.480210112; Smittkamp SE, 2005, HEARING RES, V204, P48, DOI 10.1016/j.heares.2004.12.011; Smittkamp SE, 2003, HEARING RES, V175, P101, DOI 10.1016/S0378-5955(02)00714-1; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Stack KE, 2000, BRAIN RES, V873, P135, DOI 10.1016/S0006-8993(00)02476-8; SULLIVAN WE, 1984, J NEUROSCI, V4, P1787; Teramitsu I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008548; Tierney TS, 1997, J COMP NEUROL, V387, P421; Tschida KA, 2012, NEURON, V73, P1028, DOI 10.1016/j.neuron.2011.12.038; VATER M, 1994, J COMP NEUROL, V341, P534, DOI 10.1002/cne.903410409; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Wild JM, 2010, J COMP NEUROL, V518, P2149, DOI 10.1002/cne.22325; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WINSKY L, 1995, J COMP NEUROL, V354, P564, DOI 10.1002/cne.903540407; Woolley SMN, 2004, ANN NY ACAD SCI, V1016, P208, DOI 10.1196/annals.1298.017; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Woolley SMN, 2002, J NEUROSCI, V22, P7774; Woolley SMN, 1999, J NEUROSCI, V19, P358, DOI 10.1523/JNEUROSCI.19-01-00358.1999; Yan K, 2010, J COMP NEUROL, V518, P3409, DOI 10.1002/cne.22428	68	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79297	10.1371/journal.pone.0079297	http://dx.doi.org/10.1371/journal.pone.0079297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244471	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800057
J	Mias, C; Coatrieux, C; Denis, C; Genet, G; Seguelas, MH; Laplace, N; Rouzaud-Laborde, C; Calise, D; Parini, A; Cussac, D; Pathak, A; Senard, JM; Gales, C				Mias, Celine; Coatrieux, Christelle; Denis, Colette; Genet, Gaeel; Seguelas, Marie-Helene; Laplace, Nathalie; Rouzaud-Laborde, Charlotte; Calise, Denis; Parini, Angelo; Cussac, Daniel; Pathak, Atul; Senard, Jean-Michel; Gales, Celine			Cardiac Fibroblasts Regulate Sympathetic Nerve Sprouting and Neurocardiac Synapse Stability	PLOS ONE			English	Article							GROWTH-FACTOR SYNTHESIS; MYOCARDIAL-INFARCTION; HEART-FAILURE; CELL; MECHANISMS; EXPRESSION; SURVIVAL; SYSTEM; NGF; NEUROTROPHINS	Sympathetic nervous system (SNS) plays a key role in cardiac homeostasis and its deregulations always associate with bad clinical outcomes. To date, little is known about molecular mechanisms regulating cardiac sympathetic innervation. The aim of the study was to determine the role of fibroblasts in heart sympathetic innervation. RT-qPCR and western-blots analysis performed in cardiomyocytes and fibroblasts isolated from healthy adult rat hearts revealed that Pro-Nerve growth factor (NGF) and pro-differentiating mature NGF were the most abundant neurotrophins expressed in cardiac fibroblasts while barely detectable in cardiomyocytes. When cultured with cardiac fibroblasts or fibroblast-conditioned medium, PC12 cells differentiated into/sympathetic-like neurons expressing axonal marker Tau-1 at neurites in contact with cardiomyocytes. This was prevented by anti-NGF blocking antibodies suggesting a paracrine action of NGF secreted by fibroblasts. When co-cultured with cardiomyocytes to mimic neurocardiac synapse, differentiated PC12 cells exhibited enhanced norepinephrine secretion as quantified by HPLC compared to PC12 cultured alone while co-culture with fibroblasts had no effect. However, when supplemented to PC12-cardiomyocytes co-culture, fibroblasts allowed long-term survival of the neurocardiac synapse. Activated fibroblasts (myofibroblasts) isolated from myocardial infarction rat hearts exhibited significantly higher mature NGF expression than normal fibroblasts and also promoted PC12 cells differentiation. Within the ischemic area lacking cardiomyocytes and neurocardiac synapses, tyrosine hydroxylase immunoreactivity was increased and associated with local anarchical and immature sympathetic hyperinnervation but tissue norepinephrine content was similar to that of normal cardiac tissue, suggesting depressed sympathetic function. Collectively, these findings demonstrate for the first time that fibroblasts are essential for the setting of cardiac sympathetic innervation and neurocardiac synapse stability. They also suggest that neurocardiac synapse functionality relies on a triptych with tight interaction between sympathetic nerve endings, cardiomyocytes and fibroblasts. Deregulations of this triptych may be involved in pathophysiology of cardiac diseases.	[Mias, Celine; Coatrieux, Christelle; Denis, Colette; Genet, Gaeel; Seguelas, Marie-Helene; Rouzaud-Laborde, Charlotte; Parini, Angelo; Cussac, Daniel; Pathak, Atul; Senard, Jean-Michel; Gales, Celine] Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc, U1048, F-31062 Toulouse, France; [Calise, Denis] Inst Natl Sante & Rech Med, Dept Microsurg, UMS006, Toulouse, France; [Laplace, Nathalie; Pathak, Atul; Senard, Jean-Michel] Ctr Hosp Univ Toulouse, Dept Pharmacol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Gales, C (corresponding author), Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc, U1048, F-31062 Toulouse, France.	celine.gales@inserm.fr	Denis, Colette/U-5267-2017; Pathak, Atul/ABC-5223-2020; Cussac, Daniel/AAP-1544-2020; Denis, Colette/K-1571-2019	Pathak, Atul/0000-0001-6151-0096; Denis, Colette/0000-0002-8376-8351; Mias, Celine/0000-0001-8055-8255; GENET, Gael/0000-0003-0016-5887; Senard, Jean-Michel/0000-0001-7679-1281; Cussac, Daniel/0000-0002-7227-898X; Parini, Angelo/0000-0002-9848-8838; GALES, Celine/0000-0002-4938-1583	Societe Francaise d'Hypertension Arterielle (SFHTA)	Societe Francaise d'Hypertension Arterielle (SFHTA)	This work was supported by grant from Societe Francaise d'Hypertension Arterielle (SFHTA) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2001, J MOL CELL CARDIOL, V33, P461, DOI 10.1006/jmcc.2000.1319; BAKHIT C, 1991, BRAIN RES, V560, P76, DOI 10.1016/0006-8993(91)91217-O; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; El-Helou V, 2008, J APPL PHYSIOL, V104, P150, DOI 10.1152/japplphysiol.00663.2007; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Esler M, 2010, J APPL PHYSIOL, V108, P227, DOI 10.1152/japplphysiol.00832.2009; Fanciulli A, 2013, EUR J NEUROL; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; FURUKAWA S, 1990, CEREBROVAS BRAIN MET, V2, P328; FURUKAWA Y, 1986, J BIOL CHEM, V261, P6039; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hasan W, 2006, BRAIN RES, V1124, P142, DOI 10.1016/j.brainres.2006.09.054; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; Hiltunen JO, 2001, J PATHOL, V194, P247, DOI 10.1002/path.878; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Ieda M, 2008, CURR MED CHEM, V15, P1731, DOI 10.2174/092986708784872339; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Kimura K, 2007, CIRC RES, V100, P1755, DOI 10.1161/01.RES.0000269828.62250.ab; Kimura K, 2012, CIRC RES, V110, P325, DOI 10.1161/CIRCRESAHA.111.257253; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LANGER A, 1995, J AM COLL CARDIOL, V25, P610, DOI 10.1016/0735-1097(94)00459-4; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorentz CU, 2011, AUTON NEUROSCI-BASIC, V164, P13, DOI 10.1016/j.autneu.2011.05.002; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Maule S, 2006, AM J HYPERTENS, V19, P1049, DOI 10.1016/j.amjhyper.2006.02.016; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Parrish DC, 2010, EXP PHYSIOL, V95, P304, DOI 10.1113/expphysiol.2009.049965; Pelat M, 2002, J HYPERTENS, V20, P957, DOI 10.1097/00004872-200205000-00031; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; SCHWARTZ JP, 1980, P NATL ACAD SCI-BIOL, V77, P1154, DOI 10.1073/pnas.77.2.1154; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Wernli G, 2009, BASIC RES CARDIOL, V104, P681, DOI 10.1007/s00395-009-0033-3; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	49	15	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79068	10.1371/journal.pone.0079068	http://dx.doi.org/10.1371/journal.pone.0079068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244423	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800025
J	van der Groen, O; van der Burg, E; Lunghi, C; Alais, D				van der Groen, Onno; van der Burg, Erik; Lunghi, Claudia; Alais, David			Touch Influences Visual Perception with a Tight Orientation-Tuning	PLOS ONE			English	Article							SPATIAL-FREQUENCY; RECEPTIVE-FIELDS; SIMPLE CELLS; CORTEX; ACTIVATION; ATTENTION; SELECTIVITY; VISION; AREAS; ORGANIZATION	Stimuli from different sensory modalities are thought to be processed initially in distinct unisensory brain areas prior to convergence in multisensory areas. However, signals in one modality can influence the processing of signals from other modalities and recent studies suggest this cross-modal influence may occur early on, even in 'unisensory' areas. Some recent psychophysical studies have shown specific cross-modal effects between touch and vision during binocular rivalry, but these cannot completely rule out a response bias. To test for genuine cross-modal integration of haptic and visual signals, we investigated whether congruent haptic input could influence visual contrast sensitivity compared to incongruent haptic input in three psychophysical experiments using a two-interval, two-alternative forced-choice method to eliminate response bias. The initial experiment demonstrated that contrast thresholds for a visual grating were lower when exploring a haptic grating that shared the same orientation compared to an orthogonal orientation. Two subsequent experiments mapped the orientation and spatial frequency tunings for the congruent haptic facilitation of vision, finding a clear orientation tuning effect but not a spatial frequency tuning. In addition to an increased contrast sensitivity for iso-oriented visual-haptic gratings, we found a significant loss of sensitivity for orthogonally oriented visual-haptic gratings. We conclude that the tactile influence on vision is a result of a tactile input to orientation-tuned visual areas.	[van der Groen, Onno] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van der Burg, Erik; Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Lunghi, Claudia] Univ Florence, Dept Neurosci Psychol Pharmacol & Child Hlth, Florence, Italy; [Lunghi, Claudia] Natl Res Council CNR, Inst Neurosci, Pisa, Italy	Vrije Universiteit Amsterdam; University of Sydney; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	van der Groen, O (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	vandergroen@gmail.com	van der Groen, Onno/B-1858-2017; Lunghi, Claudia/C-7274-2014	van der Groen, Onno/0000-0002-4509-7518; Lunghi, Claudia/0000-0003-3811-5404	Australian Research Council [DP12101474, DP130102336]; Discovery Early Career Research Award [DE130101663]; Italian Ministry of Universities and Research (PRIN); EC project "STANIB" (FP7 ERC)	Australian Research Council(Australian Research Council); Discovery Early Career Research Award(Australian Research Council); Italian Ministry of Universities and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EC project "STANIB" (FP7 ERC)	This research was funded by the Australian Research Council, grant number DP12101474, and Australian Research Council, Discovery Project (DP130102336) to DA, Discovery Early Career Research Award (DE130101663) to EVdB, and the Italian Ministry of Universities and Research (PRIN2009) and by EC project "STANIB" (FP7 ERC) supporting CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2011, J NEUROPHYSIOL, V106, P2108, DOI 10.1152/jn.00540.2011; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2003, J NEUROSCI, V23, P4005; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Falchier A, 2002, J NEUROSCI, V22, P5749; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fu KMG, 2003, J NEUROSCI, V23, P7510; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Graham NVS, 2001, VISUAL PATTERN ANAL; HUBEL D. H., 1962, J PHYSL, V160; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kleiner M, 2007, PERCEPTION, V36, P14; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Lunghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058754; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Melzer P, 2001, HUM BRAIN MAPP, V14, P186, DOI 10.1002/hbm.1051; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Mohr HM, 2009, NEUROIMAGE, V47, P384, DOI 10.1016/j.neuroimage.2009.03.045; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nasr S, 2012, J NEUROSCI, V32, P14921, DOI 10.1523/JNEUROSCI.2036-12.2012; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 1997, NEUROREPORT, P8; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Taylor-Clarke M, 2004, NEUROSCI LETT, V354, P22, DOI 10.1016/j.neulet.2003.09.068; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Van der Burg E, 2008, J EXPT PSYCHOL HUMAN, V34; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025277; Woodhead ZVJ, 2011, CEREB CORTEX, V21, P2307, DOI 10.1093/cercor/bhr008; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	69	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79558	10.1371/journal.pone.0079558	http://dx.doi.org/10.1371/journal.pone.0079558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244523	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800091
J	Skarn, M; Baroy, T; Stratford, EW; Myklebost, O				Skarn, Magne; Baroy, Tale; Stratford, Eva Wessel; Myklebost, Ola			Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells	PLOS ONE			English	Article							MESSENGER-RNAS; EXPRESSION; METHYLATION; GENES; DNA; TRANSCRIPTION; IDENTIFICATION; BINDING; TISSUE; ACTIVATION	The transcripts encoded by the microRNA mir-142 gene are highly active in hematopoietic cells, but expressed at low levels in many other cell types. Treatment with the demethylating agent 5-Aza-'9-deoxycytidine increased both the 1,636 nucleotide primary transcript and mature miR-142-5p/3p in mesenchymal cells, indicating that mir-142 is epigenetically repressed by DNA methylation. The transcription start site was determined to be located 1,205 base pairs upstream of the precursor sequence within a highly conserved CpG island. In addition, a second CpG island overlapped with the precursor. A TATA-box, several promoter-proximal elements and enrichment of conserved transcription factor binding sites within the first 100 base pairs upstream of the transcription start site, suggests that this region represents the core/proximal mir-142 promoter. Moreover, both CpG islands were heavily methylated in mesenchymal cells, having low levels of miR-142-5p/3p, and unmethylated in hematopoietic cells where both miRNAs were abundantly expressed. We show that treatment with 5-Aza-'9-deoxycytidine significantly reduced the DNA methylation of the upstream CpG island, which led to increased expression, and that in vitro DNA methylation of the upstream region of the mir-142 precursor repressed its transcriptional activity. When overexpressed, miR-142-5p/3p reduced proliferation of cells with epigenetic silencing of endogenous mir-142. This finding is interesting as miR-142-5p/3p have been reported to be deregulated in tumors of mesenchymal origin. We provide the first experimental evidence that transcription of mir-142 is directly repressed by DNA methylation. In addition, we discovered that the antisense strand of mir-142 might act as a precursor for functional mature antisense miRNAs. Thus, our study expands the current knowledge about the regulation of mir-142 and function of miR-142-5p/3p, and adds novel insight into the rapidly increasing field of microRNA regulation.	[Skarn, Magne; Baroy, Tale; Stratford, Eva Wessel; Myklebost, Ola] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Stratford, Eva Wessel] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Myklebost, Ola] Oslo Univ Hosp, Norwegian Stem Cell Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Skarn, M (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	magne.skarn@rr-research.no	Stratford, Eva/M-7002-2017	Stratford, Eva/0000-0001-6312-5781; Baroy, Tale/0000-0002-6796-7959	Norwegian Cancer Society; Norwegian Stem Cell Centre; Research Council of Norway	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Stem Cell Centre; Research Council of Norway(Research Council of Norway)	The study was supported by the Norwegian Cancer Society and the Norwegian Stem Cell Centre (funded by the Research Council of Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Bookout AL, 2001, HIGH THROUGHPUT REAL; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Ding S, 2012, ARTHRITIS RHEUM-US, V64, P2953, DOI 10.1002/art.34505; Dohi O, 2013, INT J ONCOL, V42, P411, DOI 10.3892/ijo.2012.1724; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griswold MD, 2001, BIOL REPROD, V64, P602, DOI 10.1095/biolreprod64.2.602; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Kwanhian W, 2012, CANCER MED-US, V1, P141, DOI 10.1002/cam4.29; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pizzinat N, 1999, BIOCHEM PHARMACOL, V58, P1735, DOI 10.1016/S0006-2952(99)00270-1; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stratford Eva W., 2012, Sarcoma, V2012, P148614, DOI 10.1155/2012/148614; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Suzuki H, 2011, CANC RES; Takai Daiya, 2003, In Silico Biology, V3, P235; Tenstad E, 2010, LAB CHIP, V10, P1401, DOI 10.1039/b926738g; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Venkatesh B, 2005, BIOESSAYS, V27, P100, DOI 10.1002/bies.20134; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wang F, MOL BIOL REP, P1; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhang PY, 2012, CANCER RES, V72, P1751, DOI 10.1158/0008-5472.CAN-11-3027	84	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79231	10.1371/journal.pone.0079231	http://dx.doi.org/10.1371/journal.pone.0079231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236112	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700111
J	Abou Ammar, G; Tryono, R; Doll, K; Karlovsky, P; Deising, HB; Wirsel, SGR				Abou Ammar, Ghada; Tryono, Reno; Doell, Katharina; Karlovsky, Petr; Deising, Holger B.; Wirsel, Stefan G. R.			Identification of ABC Transporter Genes of Fusarium graminearum with Roles in Azole Tolerance and/or Virulence	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; MULTIDRUG-RESISTANCE; HEAD BLIGHT; BOTRYTIS-CINEREA; MYCOSPHAERELLA-GRAMINICOLA; CULTIVAR RESISTANCE; GIBBERELLA-ZEAE; WHEAT; FUNGICIDE; SENSITIVITY	Fusarium graminearum is a plant pathogen infecting several important cereals, resulting in substantial yield losses and mycotoxin contamination of the grain. Triazole fungicides are used to control diseases caused by this fungus on a worldwide scale. Our previous microarray study indicated that 15 ABC transporter genes were transcriptionally upregulated in response to tebuconazole treatment. Here, we deleted four ABC transporter genes in two genetic backgrounds of F. graminearum representing the DON (deoxynivalenol) and the NIV (nivalenol) trichothecene chemotypes. Deletion of FgABC3 and FgABC4 belonging to group I of ABC-G and to group V of ABC-C subfamilies of ABC transporters, respectively, considerably increased the sensitivity to the class I sterol biosynthesis inhibitors triazoles and fenarimol. Such effects were specific since they did not occur with any other fungicide class tested. Assessing the contribution of the four ABC transporters to virulence of F. graminearum revealed that, irrespective of their chemotypes, deletion mutants of FgABC1 (ABC-C subfamily group V) and FgABC3 were impeded in virulence on wheat, barley and maize. Phylogenetic context and analyses of mycotoxin production suggests that FgABC3 may encode a transporter protecting the fungus from host-derived antifungal molecules. In contrast, FgABC1 may encode a transporter responsible for the secretion of fungal secondary metabolites alleviating defence of the host. Our results show that ABC transporters play important and diverse roles in both fungicide resistance and pathogenesis of F. graminearum.	[Abou Ammar, Ghada; Tryono, Reno; Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Doell, Katharina; Karlovsky, Petr] Univ Gottingen, Mol Phytopathol & Mycotoxin Res Sect, D-37073 Gottingen, Germany; [Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Interdisziplinares Zentrum Nutzpflanzenforsch, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; University of Gottingen; Martin Luther University Halle Wittenberg	Wirsel, SGR (corresponding author), Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	stefan.wirsel@landw.uni-halle.de		Deising, Holger Bruno/0000-0001-5789-4269; Wirsel, Stefan/0000-0003-2043-9494; Karlovsky, Petr/0000-0002-6532-5856	Islamic Development Bank [57/SYR/P29]; Deutscher Akademischer Austauschdienst [A/09/75891]; Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN)	Islamic Development Bank(Islamic Development Bank); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN)	This work was supported by stipends provided by the Islamic Development Bank (GAA, 57/SYR/P29) and the Deutscher Akademischer Austauschdienst (RT, A/09/75891). The work received additional support from the Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo TO, 2007, FOOD ADDIT CONTAM, V24, P993, DOI 10.1080/02652030701317285; Adejumo TO, 2007, INT J FOOD MICROBIOL, V116, P350, DOI 10.1016/j.ijfoodmicro.2007.02.009; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Becher R, 2013, MYCOTA IN PRESS, DOI [10.1007/1978-1003-1642-36821-36829_36828, DOI 10.1007/1978-1003-1642-36821-36829_36828]; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Becher R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-52; Becher R, 2010, PHYTOPATHOLOGY, V100, P444, DOI 10.1094/PHYTO-100-5-0444; Blandino M, 2012, FIELD CROP RES, V133, P139, DOI 10.1016/j.fcr.2012.04.004; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P368, DOI 10.1094/MPMI-09-10-0198; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148, DOI 10.1128/MMBR.53.1.148-170.1989; Fleissner A, 2002, MOL PLANT MICROBE IN, V15, P102, DOI 10.1094/MPMI.2002.15.2.102; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Hayashi K, 2002, PESTIC BIOCHEM PHYS, V73, P110, DOI 10.1016/S0048-3575(02)00015-9; Hulvey J, 2012, APPL ENVIRON MICROB, V78, P6674, DOI 10.1128/AEM.00417-12; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kang ZS, 2001, PEST MANAG SCI, V57, P491, DOI 10.1002/ps.310; Kim Y, 2013, GENOMICS, V101, P354, DOI 10.1016/j.ygeno.2013.04.003; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Klix MB, 2007, CROP PROT, V26, P683, DOI 10.1016/j.cropro.2006.06.006; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Lee S, 2011, CURR GENET, V57, P343, DOI 10.1007/s00294-011-0352-4; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Nakaune R, 1998, APPL ENVIRON MICROB, V64, P3983; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; Paul PA, 2010, PHYTOPATHOLOGY, V100, P160, DOI 10.1094/PHYTO-100-2-0160; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Skov J, 2004, PHYSIOL MOL PLANT P, V64, P245, DOI 10.1016/j.pmpp.2004.09.005; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Stergiopoulos I, 2003, MOL PLANT MICROBE IN, V16, P689, DOI 10.1094/MPMI.2003.16.8.689; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; Willyerd KT, 2012, PLANT DIS, V96, P957, DOI 10.1094/PDIS-09-11-0763; Yin Y, 2009, PHYTOPATHOLOGY, V99, P487, DOI 10.1094/PHYTO-99-5-0487; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zwiers LH, 2003, MOL GENET GENOMICS, V269, P499, DOI 10.1007/s00438-003-0855-x	45	58	60	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79042	10.1371/journal.pone.0079042	http://dx.doi.org/10.1371/journal.pone.0079042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244413	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600100
J	Hong, MG; Krauss, RS				Hong, Mingi; Krauss, Robert S.			Rescue of Holoprosencephaly in Fetal Alcohol-Exposed Cdon Mutant Mice by Reduced Gene Dosage of Ptch1	PLOS ONE			English	Article							4 BRAZILIAN PATIENTS; SONIC HEDGEHOG; CRANIOFACIAL MORPHOGENESIS; RISK-FACTORS; VENTRAL FOREBRAIN; SHH; MUTATIONS; EXPRESSION; PHENOTYPE; RECEPTOR	Holoprosencephaly (HPE) is a commonly occurring developmental defect in which midline patterning of the forebrain and midface is disrupted. Sonic hedgehog (SHH) signaling is required during multiple stages of rostroventral midline development, and heterozygous mutations in SHH pathway components are associated with HPE. However, clinical presentation of HPE is highly variable, and carriers of heterozygous mutations often lack apparent defects. It is therefore thought that such mutations must interact with more common modifiers, genetic and/or environmental. We have modeled this scenario in mice. Cdon mutant mice have a largely subthreshold defect in SHH signaling, rendering them sensitive to a wide spectrum of HPE phenotypes by additional hits that are themselves insufficient to produce HPE, including transient in utero exposure to ethanol. These variable HPE phenotypes may arise in embryos that fail to reach a threshold level of SHH signaling at a specific developmental stage. To provide evidence for this possibility, here we tested the effect of removing one copy of the negative regulator Ptch1 from Cdon(-/-) embryos and compared their response to ethanol with that of Cdon(-/-); Ptch1(+/+) embryos. Ptch1 heterozygosity decreased the penetrance of HPE in this system by>75%. The major effect of reduced Ptch1 gene dosage was on penetrance, as those Cdon(-/-); Ptch1(+/-) embryos that displayed HPE did not show major differences in phenotype from Cdon(-/-); Ptch1(+/+) embryos with ethanol-induced HPE. Our findings are consistent with the notion that even in an etiologically complex model of HPE, the level of SHH pathway activity is rate-limiting. Furthermore, the clinical outcome of an individual carrying a SHH pathway mutation will likely reflect the sum effect of both deleterious and protective modifier alleles and their interaction with non-genetic risk factors like fetal alcohol exposure.	[Hong, Mingi; Krauss, Robert S.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Krauss, RS (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	Robert.Krauss@mssm.edu			NIH [R01AA018825]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant R01AA018825 to RSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999; Hu D, 1999, DEVELOPMENT, V126, P4873; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson CY, 2010, AM J MED GENET C, V154C, P73, DOI 10.1002/ajmg.c.30242; Kiecker C, 2001, CURR OPIN NEUROBIOL, V11, P27, DOI 10.1016/S0959-4388(00)00170-7; Krauss Robert S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000440; Lindstrom E, 2006, HUMAN MUTATION, V27, P215; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mercier S, 2011, J MED GENET, V48, P752, DOI 10.1136/jmedgenet-2011-100339; Miller EA, 2010, AM J MED GENET C, V154C, P62, DOI 10.1002/ajmg.c.30244; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Mulieri PJ, 2002, DEV DYNAM, V223, P379, DOI 10.1002/dvdy.10063; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2584, DOI 10.1002/ajmg.a.31369; Ribeiro LA, 2010, AM J MED GENET A, V152A, P1688, DOI 10.1002/ajmg.a.33466; Roessler E, 2012, MOL GENET METAB, V105, P658, DOI 10.1016/j.ymgme.2012.01.005; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Shiota K, 2010, AM J MED GENET C, V154C, P22, DOI 10.1002/ajmg.c.30248; Solomon BD, 2010, AM J MED GENET C, V154C, P133, DOI 10.1002/ajmg.c.30240; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Warr N, 2008, HUM MOL GENET, V17, P2986, DOI 10.1093/hmg/ddn197; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79269	10.1371/journal.pone.0079269	http://dx.doi.org/10.1371/journal.pone.0079269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244464	gold, Green Submitted, Green Published			2022-12-25	WOS:000327221600121
J	Leondaritis, G; Siokos, J; Skaripa, I; Galanopoulou, D				Leondaritis, George; Siokos, John; Skaripa, Irini; Galanopoulou, Dia			Genome-Wide Analysis of the Phosphoinositide Kinome from Two Ciliates Reveals Novel Evolutionary Links for Phosphoinositide Kinases in Eukaryotic Cells	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-PHOSPHATE KINASE; TETRAHYMENA; PARAMECIUM; MEMBRANE; PROTEINS; BIOINFORMATICS; 4-PHOSPHATE; METABOLISM; EXPRESSION; INSIGHTS	Background: The complexity of phosphoinositide signaling in higher eukaryotes is partly due to expansion of specific families and types of phosphoinositide kinases (PIKs) that can generate all phosphoinositides via multiple routes. This is particularly evident in the PI3Ks and PIPKs, and it is considered an evolutionary trait associated with metazoan diversification. Yet, there are limited comprehensive studies on the PIK repertoire of free living unicellular organisms. Methodology/Principal Findings: We undertook a genome-wide analysis of putative PIK genes in two free living ciliated cells, Tetrahymena and Paramecium. The Tetrahymena thermophila and Paramecium tetraurelia genomes were probed with representative kinases from all families and types. Putative homologs were verified by EST, microarray and deep RNA sequencing database searches and further characterized for domain structure, catalytic efficiency, expression patterns and phylogenetic relationships. In total, we identified and characterized 22 genes in the Tetrahymena thermophila genome and 62 highly homologues genes in Paramecium tetraurelia suggesting a tight evolutionary conservation in the ciliate lineage. Comparison to the kinome of fungi reveals a significant expansion of PIK genes in ciliates. Conclusions/Significance: Our study highlights four important aspects concerning ciliate and other unicellular PIKs. First, ciliate-specific expansion of PI4KIII-like genes. Second, presence of class I PI3Ks which, at least in Tetrahymena, are associated with a metazoan-type machinery for PIP3 signaling. Third, expansion of divergent PIPK enzymes such as the recently described type IV transmembrane PIPKs. Fourth, presence of possible type II PIPKs and presumably inactive PIKs (hence, pseudo-PIKs) not previously described. Taken together, our results provide a solid framework for future investigation of the roles of PIKs in ciliates and indicate that novel functions and novel regulatory pathways of phosphoinositides may be more widespread than previously thought in unicellular organisms.	[Leondaritis, George] Univ Thessaly, Sch Med, Dept Pharmacol, Larisa, Greece; [Leondaritis, George; Siokos, John; Skaripa, Irini; Galanopoulou, Dia] Univ Athens, Dept Chem, Biochem Lab, GR-10680 Athens, Greece	University of Thessaly; National & Kapodistrian University of Athens	Leondaritis, G (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London, England.	georgios.leondaritis@kcl.ac.uk			University of Athens [KA 11109]	University of Athens	This work was partially supported by a University of Athens grant (KA 11109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akematsu T., 2012, JPN J PROTOZOOL, V45, P1; Anantharaman V, 2007, ANNU REV MICROBIOL, V61, P453, DOI 10.1146/annurev.micro.61.080706.093309; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Boss Wendy E., 2006, V39, P181; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bright LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001155; Brown JR, 2011, BMC EVOL BIOL, V5, p[11, 14]; Clarke Jonathan H, 2012, Adv Biol Regul, V52, P40; Cox SSE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-45; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Deli D, 2008, J EUKARYOT MICROBIOL, V55, P343, DOI 10.1111/j.1550-7408.2008.00329.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Engelmann JA, 2006, NAT REV GENETICS, V7, P606; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Galvao RM, 2008, BIOCHEM J, V409, P117, DOI 10.1042/BJ20070959; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hinchliffe KA, 2002, BIOCHEM J, V363, P563, DOI 10.1042/0264-6021:3630563; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kloppel C, 2009, EUR J CELL BIOL, V88, P577, DOI 10.1016/j.ejcb.2009.05.002; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Ladenburger EM, 2009, MOL CELL BIOL, V29, P3605, DOI 10.1128/MCB.01592-08; Leber W, 2009, INT J PARASITOL, V39, P645, DOI 10.1016/j.ijpara.2008.11.015; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Leondaritis G, 2000, LIPIDS, V35, P525, DOI 10.1007/s11745-000-552-8; Leondaritis G, 2005, BBA-MOL CELL RES, V1745, P330, DOI 10.1016/j.bbamcr.2005.06.011; Leondaritis George, 2011, Communicative & Integrative Biology, V4, P576, DOI 10.4161/cib.4.5.16295; Leondaritis G, 2011, EUKARYOT CELL, V10, P412, DOI 10.1128/EC.00272-10; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1337, DOI 10.1094/MPMI-19-1337; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Nusblat AD, 2012, METHOD CELL BIOL, V109, P141, DOI 10.1016/B978-0-12-385967-9.00006-2; Plattner H, 2010, PROTIST, V161, P497, DOI 10.1016/j.protis.2010.05.001; Plattner H, 2010, INT REV CEL MOL BIO, V280, P79, DOI 10.1016/S1937-6448(10)80003-6; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Ryals PE, 1999, J EUKARYOT MICROBIOL, V46, P77, DOI 10.1111/j.1550-7408.1999.tb04587.x; Ryals PE, 2009, ACTA PROTOZOOL, V48, P191; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; SUCHARD SJ, 1989, J PROTOZOOL, V36, P185, DOI 10.1111/j.1550-7408.1989.tb01072.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turkewitz Aaron P, 2011, Small GTPases, V2, P222; Turkewitz AP, 2004, TRAFFIC, V5, P63, DOI 10.1046/j.1600-0854.2003.00155.x; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yakisich JS, 2004, CELL DEATH DIFFER, V11, P1146, DOI 10.1038/sj.cdd.4401473	58	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78848	10.1371/journal.pone.0078848	http://dx.doi.org/10.1371/journal.pone.0078848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244373	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600070
J	Ye, WM; Giblin-Davis, RM				Ye, Weimin; Giblin-Davis, Robin M.			Molecular Characterization and Development of Real-Time PCR Assay for Pine-Wood Nematode Bursaphelenchus xylophilus (Nematoda: Parasitaphelenchidae)	PLOS ONE			English	Article							DIAGNOSTIC METHOD; SPECIES NEMATODA; SATELLITE DNA; B.-MUCRONATUS; 1ST REPORT; IDENTIFICATION; APHELENCHOIDIDAE; SAMPLES; RFLP; N.	Bursaphelenchus xylophilus, the pine-wood nematode (PWN), is the causal agent of pine wilt disease, one of the most damaging emerging pest problems to forests around the world. It is native to North America where it causes relatively minor damage to native conifers but is labeled an EPPO-A-2 pest and a quarantine nematode for many countries outside of the United States because of its potential for destruction to their native conifers. Exports of wood logs and commodities involving softwood packaging materials now require a lab test for the presence/absence of this regulated nematode species. We characterized the DNA sequences on the ribosomal DNA small subunit, large subunit D2/D3, internal transcribed spacer (ITS) and mitochondrial DNA cytochrome oxidase subunit one on the aphelenchid species and described the development of a real-time-PCR method for rapid and accurate identification of PWN targeting the ITS-1. A total of 97 nematode populations were used to evaluate the specificity and sensitivity of this assay, including 45 populations of B. xylophilus and 36 populations of 21 other species of Bursaphelenchus which belong to the abietinus, cocophilus, eggersi, fungivorus, hofmanni, kevini, leoni, sexdentati, and xylophilus groups and one unassigned group from a total of 13 groups in the genus Bursaphelenchus; 15 populations of Aphelenchoides besseyi, A. fragariae, Aphelenchoides species and Aphelenchus avenae; and one population of mixed nematode species from a soil sample. This assay proved to be specific to B. xylophilus only and was sensitive to a single nematode specimen regardless of the life stages present. This approach provides rapid species identification necessary to comply with the zero-tolerance export regulations.	[Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC 27699 USA; [Giblin-Davis, Robin M.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	State University System of Florida; University of Florida	Ye, WM (corresponding author), North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC 27699 USA.	weimin.ye@ncagr.gov		Giblin-Davis, Robin/0000-0002-8861-8678	North Carolina Tobacco Trust Fund Commission [2011-029-13]; United States Department of Defense; USDA/APHIS/PPQ [10-8100-1587-CA, 11-8100-1621-CA]	North Carolina Tobacco Trust Fund Commission; United States Department of Defense(United States Department of Defense); USDA/APHIS/PPQ(United States Department of Agriculture (USDA))	This work was supported by the North Carolina Tobacco Trust Fund Commission (Grant Number: 2011-029-13). It was initially supported by the United States Department of Defense and USDA/APHIS/PPQ (Project numbers: 10-8100-1587-CA and 11-8100-1621-CA) on a separate project which set the stage for the research leading to the development of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinion, finding conclusion or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view and policies of the North Carolina Tobacco Trust Fund Commission.	ABAD P, 1991, PARASITOLOGY, V102, P303, DOI 10.1017/S0031182000062636; Braasch H., 2011, Journal of Nematode Morphology and Systematics, V14, P77; Braasch H., 2009, Journal of Nematode Morphology and Systematics, V12, P65; Braasch Helen, 1999, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V51, P312; Braasch H, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P139, DOI 10.1007/978-1-4020-8455-3_12; Braasch Helen, 1995, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V47, P310; Burgermeister W, 2005, RUSS J NEMATOL, V13, P29; Burgermeister W, 2009, NEMATOLOGY, V11, P649, DOI 10.1163/156854108/399182; Cao AX, 2005, PHYTOPATHOLOGY, V95, P566, DOI 10.1094/PHYTO-95-0566; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; Chang Ruey-Jang, 1996, Taiwan Journal of Forest Science, V11, P201; Chen FM, 2011, FOREST PATHOL, V41, P376, DOI 10.1111/j.1439-0329.2010.00693.x; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; DWINELL LD, 1993, PLANT DIS, V77, P846, DOI 10.1094/PD-77-0846A; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Francois C, 2007, MOL PLANT PATHOL, V8, P803, DOI [10.1111/j.1364-3703.2007.00434.x, 10.1111/J.1364-3703.2007.00434.X]; Hoyer Ute, 1998, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V50, P273; Huang L, 2010, EUR J PLANT PATHOL, V127, P89, DOI 10.1007/s10658-009-9574-4; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Iwahori H, 1998, FUND APPL NEMATOL, V21, P655; Jiang LQ, 2005, RUSS J NEMATOL, V13, P115; Kang JS, 2009, NEMATOLOGY, V11, P289, DOI 10.1163/156854109X429619; Kang JS, 2004, NEMATOLOGY, V6, P279, DOI 10.1163/1568541041217915; Kanzaki N, 2012, NEMATOLOGY, V14, P395, DOI 10.1163/156854111X602974; Karssen G., 2013, Bulletin OEPP, V43, P105, DOI [10.1111/epp.12024, 10.1111/]; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Knowles K., 1983, FOREST CHRON, V59, P40; Leal I, 2005, NEMATOLOGY, V7, P833, DOI 10.1163/156854105776186398; Leal I, 2013, FOREST PATHOL, V43, P104, DOI 10.1111/efp.12003; Leal I, 2007, NEMATOLOGY, V9, P351, DOI 10.1163/156854107781352098; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Matsunaga K, 2004, NEMATOLOGY, V6, P273, DOI 10.1163/1568541041217960; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nunn G. B., 1992, THESIS U NOTTINGHAM; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Steiner G, 1934, J AGRIC RES, V48, P0949; Takeuchi Yuko, 2009, Japanese Journal of Nematology, V39, P9, DOI 10.3725/jjn.39.9; Tzean SS, 1997, PINE WOOD NEMATODE; Wang JinCheng, 2006, Acta Phytopathologica Sinica, V36, P281; WEBSTER J M, 1990, Revue de Nematologie, V13, P255; Yano, 1913, SANRINKOHO, V4, P1; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhuo K, 2011, FOREST PATHOL, V41, P66, DOI 10.1111/j.1439-0329.2009.00638.x	47	24	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78804	10.1371/journal.pone.0078804	http://dx.doi.org/10.1371/journal.pone.0078804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244367	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600065
J	Hu, P; Li, B; Zhang, WH; Li, YJ; Li, G; Jiang, XN; Wdzieczak-Bakala, J; Liu, JM				Hu, Ping; Li, Bin; Zhang, Wenhua; Li, Yijian; Li, Guang; Jiang, Xinnong; Wdzieczak-Bakala, Joanna; Liu, Jianmiao			AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; ANGIOGENESIS IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; PROLYL OLIGOPEPTIDASE; TETRAPEPTIDE ACSDKP; ACETYL; OVEREXPRESSION; METASTASIS; DOWNSTREAM; INHIBITOR	The natural tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) is generated from the N-terminus of thymosin-beta 4 through enzymatic cleavage by prolyl oligopeptidase (POP). AcSDKP regulation of proliferation of different cells is implicated in hematopoiesis and angiogenesis. This tetrapeptide present in almost all cells was recently detected at elevated concentrations in neoplastic diseases. However, previously reported in vitro and in vivo studies indicate that AcSDKP does not contribute to the pathogenesis of cancers. Here we show that exogenous AcSDKP exerts no effect on the proliferation of actively dividing malignant cells. Using S17092, a specific POP inhibitor (POPi), to suppress the biosynthesis of AcSDKP in U87-MG glioblastoma cells characterized by high intracellular levels of this peptide, we found that all tested doses of POPi resulted in an equally effective depletion of AcSDKP, which was not correlated with the dose-dependent decreases in the proliferation rate of treated cells. Interestingly, addition of exogenous AcSDKP markedly reversed the reduction in the proliferation of U87-MG cells treated with the highest dose of POPi, and this effect was associated with activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway. However, extracellular-regulated protein kinase (ERK) activation was unaltered by S17092 and AcSDKP co-treatment. Knockdown of individual PI3K catalytic subunits revealed that p110 alpha and p110 beta contributed differently to AcSDKP regulation of U87-MG cell proliferation. Disruption of p110a expression by small interfering RNA (siRNA) abrogated AcSDKP-stimulated Akt phosphorylation, whereas knockdown of p110 beta expression exhibited no such effect. Our findings indicate for the first time that the PI3KCA/Akt pathway mediates AcSDKP regulation of cell proliferation and suggest a role for this ubiquitous intracellular peptide in cell survival.	[Hu, Ping; Li, Bin; Zhang, Wenhua; Li, Yijian; Li, Guang; Jiang, Xinnong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys,Sino France Lab Drug Screenin, Wuhan 430074, Hubei, Peoples R China; [Wdzieczak-Bakala, Joanna; Liu, Jianmiao] CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	Huazhong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Liu, JM (corresponding author), CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France.	miao_l@yahoo.com		Li, Guang/0000-0003-4277-9844	National Science Foundation of China [30901816]; Ministry of Science and Technology [2012CB518000]; Program of Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program of Introducing Talents of Discipline to the Universities of the Ministry of Education	This work was supported by the National Science Foundation of China (grant 30901816), the Ministry of Science and Technology (grant 2012CB518000) and the Program of Introducing Talents of Discipline to the Universities of the Ministry of Education (grant B08029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNET D, 1992, EXP HEMATOL, V20, P1165; Boutonnat J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-120; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cavasin MA, 2004, HYPERTENSION, V43, P1140, DOI 10.1161/01.HYP.0000126172.01673.84; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kanasaki K, 2006, BIOCHEM BIOPH RES CO, V342, P758, DOI 10.1016/j.bbrc.2006.02.019; Kusinski M, 2006, LANGENBECK ARCH SURG, V391, P9, DOI 10.1007/s00423-005-0014-4; LAURET E, 1989, EXP HEMATOL, V17, P1081; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; Liu JM, 2008, ANTICANCER RES, V28, P2813; Liu JM, 2010, ANN NY ACAD SCI, V1194, P53, DOI 10.1111/j.1749-6632.2010.05488.x; Liu JM, 2003, BLOOD, V101, P3014, DOI 10.1182/blood-2002-07-2315; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Petit A, 2000, BRIT J PHARMACOL, V130, P1613, DOI 10.1038/sj.bjp.0703440; Pokharel S, 2002, HYPERTENSION, V40, P155, DOI 10.1161/01.HYP.0000025880.56816.FA; Rhaleb NE, 2001, HYPERTENSION, V37, P827, DOI 10.1161/01.HYP.37.3.827; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schulz I, 2002, EUR J BIOCHEM, V269, P5813, DOI 10.1046/j.1432-1033.2002.03297.x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Wymann MP, 1996, MOL CELL BIOL, V16, P1722	29	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79321	10.1371/journal.pone.0079321	http://dx.doi.org/10.1371/journal.pone.0079321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244481	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900037
J	Liu, M; Wang, Q; Liu, F; Cheng, XF; Wu, XL; Wang, H; Wu, MQ; Ma, Y; Wang, GJ; Hao, HP				Liu, Miao; Wang, Qiong; Liu, Fang; Cheng, Xuefang; Wu, Xiaolan; Wang, Hong; Wu, Mengqiu; Ma, Ying; Wang, Guangji; Hao, Haiping			UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells	PLOS ONE			English	Article							HUMAN LIVER; TOBACCO CARCINOGEN; QUINONE REDUCTION; BETA-LAPACHONE; IN-VITRO; GLUCURONIDATION; IDENTIFICATION; METABOLISM; EXPRESSION; APOPTOSIS	Background and Purpose: NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subsequent UDP-glucuronosyltransferases (UGTs) catalyzed glucuronidation is the dominant metabolic pathway of tanshinone IIA (TSA), a promising anti-cancer agent. UGTs are positively expressed in various tumor tissues and play an important role in the metabolic elimination of TSA. This study aims to explore the role of UGT1A in determining the intracellular accumulation and the resultant apoptotic effect of TSA. Experimental Approach: We examined TSA intracellular accumulation and glucuronidation in HT29 (UGT1A positive) and HCT116 (UGT1A negative) human colon cancer cell lines. We also examined TSA-mediated reactive oxygen species (ROS) production, cytotoxicity and apoptotic effect in HT29 and HCT116 cells to investigate whether UGT1A levels are directly associated with TSA anti-cancer effect. UGT1A siRNA or propofol, a UGT1A9 competitive inhibitor, was used to inhibit UGT1A expression or UGT1A9 activity. Key Results: Multiple UGT1A isoforms are positively expressed in HT29 but not in HCT116 cells. Cellular S9 fractions prepared from HT29 cells exhibit strong glucuronidation activity towards TSA, which can be inhibited by propofol or UGT1A siRNA interference. TSA intracellular accumulation in HT29 cells is much lower than that in HCT116 cells, which correlates with high expression levels of UGT1A in HT29 cells. Consistently, TSA induces less intracellular ROS, cytotoxicity, and apoptotic effect in HT29 cells than those in HCT116 cells. Pretreatment of HT29 cells with UGT1A siRNA or propofol can decrease TSA glucuronidation and simultaneously improve its intracellular accumulation, as well as enhance TSA anti-cancer effect. Conclusions and Implications: UGT1A can compromise TSA cytotoxicity via reducing its intracellular exposure and switching the NQO1-triggered redox cycle to metabolic elimination. Our study may shed a light in understanding the cellular pharmacokinetic and molecular mechanism by which UGTs determine the chemotherapy effects of drugs that are UGTs' substrates.	[Liu, Miao; Wang, Qiong; Liu, Fang; Cheng, Xuefang; Wu, Xiaolan; Wang, Hong; Wu, Mengqiu; Ma, Ying; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Hao, Haiping/L-8265-2019; Wu, Mengqiu/HHS-9267-2022	Hao, Haiping/0000-0003-2522-7546; Wu, Mengqiu/0000-0001-9488-5572; Liu, Miao/0000-0002-7975-6702; Wang, Hong/0000-0002-6192-3082	Foundation for the Author of National Excellent Doctoral Dissertation of China [200979]; Natural Science Foundation of China [91029746, 81273586]; Natural Science Foundation of Jiangsu province [BK2011065, BK2012026]; Program for New Century Excellent Talents in University [NCET-09-0770]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by a Foundation for the Author of National Excellent Doctoral Dissertation of China (Grant 200979), Natural Science Foundation of China (Grants 91029746 and 81273586), Natural Science Foundation of Jiangsu province (Grants BK2011065 and BK2012026), and the Program for New Century Excellent Talents in University (Grant NCET-09-0770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M. C., 2011, BIOCHEM PHARMACOL, V81, P60; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bowalgaha K, 2007, DRUG METAB DISPOS, V35, P363, DOI 10.1124/dmd.106.013052; Bushey RT, 2013, DRUG METAB DISPOS, V41, P170, DOI 10.1124/dmd.112.049171; Cheng XF, 2012, MOL PHARMACEUT, V9, P3476, DOI 10.1021/mp300296m; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cummings J, 2003, CANCER RES, V63, P8443; Desai AA, 2003, PHARMACOGENETICS, V13, P517, DOI 10.1097/00008571-200308000-00010; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hao HP, 2007, CURR DRUG METAB, V8, P137, DOI 10.2174/138920007779816011; Hao HP, 2006, PLANTA MED, V72, P1311, DOI 10.1055/s-2006-951698; Innocenti F, 2001, DRUG METAB DISPOS, V29, P686; Izumi K, 2012, MOL CARCINOG; Jiang BH, 2009, FOOD CHEM TOXICOL, V47, P1538, DOI 10.1016/j.fct.2009.03.038; Lewis AM, 2005, MOL CARCINOGEN, V43, P215, DOI 10.1002/mc.20107; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; Lu Q, 2009, INT J MOL MED, V24, P773, DOI 10.3892/ijmm_00000291; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Southwood HT, 2007, CHEM RES TOXICOL, V20, P1520, DOI 10.1021/tx700188x; Starlard-Davenport A, 2008, STEROIDS, V73, P611, DOI 10.1016/j.steroids.2008.01.019; Strassburg CP, 1997, CANCER RES, V57, P2979; Su CC, 2008, INT J MOL MED, V22, P847, DOI 10.3892/ijmm_00000094; Sun D, 2007, DRUG METAB DISPOS, V35, P2006, DOI 10.1124/dmd.107.017145; Tang YJ, 2012, J BIOL CHEM, V287, P14960, DOI 10.1074/jbc.M111.320093; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wang QO, 2010, DRUG METAB DISPOS, V38, P1132, DOI 10.1124/dmd.109.031864; Zhang ZC, 2009, BIOCHEM PHARMACOL, V78, P1316, DOI 10.1016/j.bcp.2009.06.110	34	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79172	10.1371/journal.pone.0079172	http://dx.doi.org/10.1371/journal.pone.0079172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244442	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800037
J	Moncla, LH; Ross, TM; Dinis, JM; Weinfurter, JT; Mortimer, TD; Schultz-Darken, N; Brunner, K; Capuano, SV; Boettcher, C; Post, J; Johnson, M; Bloom, CE; Weiler, AM; Friedrich, TC				Moncla, Louise H.; Ross, Ted M.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Schultz-Darken, Nancy; Brunner, Kevin; Capuano, Saverio V., III; Boettcher, Carissa; Post, Jennifer; Johnson, Michael; Bloom, Chalise E.; Weiler, Andrea M.; Friedrich, Thomas C.			A Novel Nonhuman Primate Model for Influenza Transmission	PLOS ONE			English	Article							MARMOSET CALLITHRIX-JACCHUS; COMMON MARMOSET; A VIRUS; CROSS-REACTIVITY; ANIMAL-MODELS; H1N1; INFECTION; ANTIBODIES; FERRETS; PATHOGENESIS	Studies of influenza transmission are necessary to predict the pandemic potential of emerging influenza viruses. Currently, both ferrets and guinea pigs are used in such studies, but these species are distantly related to humans. Nonhuman primates (NHP) share a close phylogenetic relationship with humans and may provide an enhanced means to model the virological and immunological events in influenza virus transmission. Here, for the first time, it was demonstrated that a human influenza virus isolate can productively infect and be transmitted between common marmosets (Callithrix jacchus), a New World monkey species. We inoculated four marmosets with the 2009 pandemic virus A/California/07/2009 (H1N1pdm) and housed each together with a naive cage mate. We collected bronchoalveolar lavage and nasal wash samples from all animals at regular intervals for three weeks post-inoculation to track virus replication and sequence evolution. The unadapted 2009 H1N1pdm virus replicated to high titers in all four index animals by 1 day post-infection. Infected animals seroconverted and presented human-like symptoms including sneezing, nasal discharge, labored breathing, and lung damage. Transmission occurred in one cohabitating pair. Deep sequencing detected relatively few genetic changes in H1N1pdm viruses replicating in any infected animal. Together our data suggest that human H1N1pdm viruses require little adaptation to replicate and cause disease in marmosets, and that these viruses can be transmitted between animals. Marmosets may therefore be a viable model for studying influenza virus transmission.	[Moncla, Louise H.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Friedrich, Thomas C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Moncla, Louise H.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Schultz-Darken, Nancy; Brunner, Kevin; Capuano, Saverio V., III; Boettcher, Carissa; Post, Jennifer; Johnson, Michael; Weiler, Andrea M.; Friedrich, Thomas C.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Ross, Ted M.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53706 USA; [Ross, Ted M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA; [Bloom, Chalise E.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vaccine & Gene Therapy Institute of Florida	Friedrich, TC (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	thomasf@primate.wisc.edu		Mortimer, Tatum/0000-0001-6255-690X; Weinfurter, Jason/0000-0001-8076-2598; Friedrich, Thomas/0000-0001-9831-6895; Ross, Ted/0000-0003-1947-7469	PATH Vaccine Solutions; NIH National Research Service Award [T32 GM07215]; National Science Foundation Graduate Research Fellowship [DGE-0718123]; NIH [RR000167/OD011106]; Research Facilities Improvement Program [RR015459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	PATH Vaccine Solutions; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by PATH Vaccine Solutions in a sponsored research award to Ted M. Ross. Louise H. Moncla and Tatum D. Mortimer were supported by NIH National Research Service Award T32 GM07215. Jorge M. Dinis was supported by National Science Foundation Graduate Research Fellowship DGE-0718123. This study was conducted in a facility supported in part by NIH grant RR000167/OD011106, which was constructed with additional support from Research Facilities Improvement Program grants RR015459-01 and RR020141-01 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brok HPM, 2001, CYTOMETRY, V45, P294, DOI 10.1002/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C; Carcione D, 2011, EUROSURVEILLANCE, V16, P1; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carter DM, 2013, J VIROL, V87, P1400, DOI 10.1128/JVI.02257-12; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chang H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000606; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edenborough KM, 2012, J VIROL, V86, P12544, DOI 10.1128/JVI.00859-12; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ince WL, 2013, J VIROL, V87, P4330, DOI 10.1128/JVI.02749-12; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jagessar SA, 2012, J NEUROIMMUNE PHARM, V7, P557, DOI 10.1007/s11481-012-9384-x; Jagessar SA, 2012, EUR J IMMUNOL, V42, P217, DOI 10.1002/eji.201141863; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Kap YS, 2010, J IMMUNOL, V185, P3990, DOI 10.4049/jimmunol.1001393; Kireta S, 2005, CELL IMMUNOL, V236, P115, DOI 10.1016/j.cellimm.2005.08.017; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Leibovitch E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003138; Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neubert R, 1995, LIFE SCI, V58, P317, DOI 10.1016/0024-3205(95)02291-0; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; NIH, 2013, NIH NONH PRIM REAG R; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Riecke K, 2000, J MED PRIMATOL, V29, P343, DOI 10.1034/j.1600-0684.2000.290506.x; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Smither S.J., 2013, INT J EXP PATHOL; TAJIMA F, 1983, GENETICS, V105, P437; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12	47	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78750	10.1371/journal.pone.0078750	http://dx.doi.org/10.1371/journal.pone.0078750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244352	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327143800011
J	Nordgren, M; Karlsson, T; Svensson, M; Koczy, J; Josephson, A; Olson, L; Tingstrom, A; Brene, S				Nordgren, Max; Karlsson, Tobias; Svensson, Maria; Koczy, Josefin; Josephson, Anna; Olson, Lars; Tingstroem, Anders; Brene, Stefan			Orchestrated Regulation of Nogo Receptors, Lotus, AMPA Receptors and BDNF in an ECT Model Suggests Opening and Closure of a Window of Synaptic Plasticity	PLOS ONE			English	Article							ADULT-RAT HIPPOCAMPUS; INDUCED RETROGRADE-AMNESIA; MESSENGER-RNA; ELECTROCONVULSIVE STIMULATION; GLUTAMATE RECEPTORS; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; DEPRESSED-PATIENTS; PRECURSOR PROTEIN; GLOBAL-ISCHEMIA	Electroconvulsive therapy (ECT) is an efficient and relatively fast acting treatment for depression. However, one severe side effect of the treatment is retrograde amnesia, which in certain cases can be long-term. The mechanisms behind the antidepressant effect and the amnesia are not well understood. We hypothesized that ECT causes transient downregulation of key molecules needed to stabilize synaptic structure and to prevent Ca2+ influx, and a simultaneous increase in neurotrophic factors, thus providing a short time window of increased structural synaptic plasticity. Here we followed regulation of NgR1, NgR3, LOTUS, BDNF, and AMPA subunits GluR1 and GluR2 flip and flop mRNA levels in hippocampus at 2, 4, 12, 24, and 72 hours after a single episode of induced electroconvulsive seizures (ECS) in rats. NgR1 and LOTUS mRNA levels were transiently downregulated in the dentate gyrus 2, 4, 12 and 4, 12, 24 h after ECS treatment, respectively. GluR2 flip, flop and GluR1 flop were downregulated at 4 h. GluR2 flip remained downregulated at 12 h. In contrast, BDNF, NgR3 and GluR1 flip mRNA levels were upregulated. Thus, ECS treatment induces a transient regulation of factors important for neuronal plasticity. Our data provide correlations between ECS treatment and molecular events compatible with the hypothesis that both effects and side effects of ECT may be caused by structural synaptic rearrangements.	[Nordgren, Max; Brene, Stefan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Karlsson, Tobias; Koczy, Josefin; Josephson, Anna; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Maria; Tingstroem, Anders] Univ Lund Hosp, Wallenberg Neurosci Ctr, Psychiat Neuromodulat Unit, S-22185 Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Skane University Hospital	Brene, S (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	stefan.brene@ki.se			Swedish Research Council [3474]; ERC [322744]; Swedish Brain Power; Karolinska Distinguished Professor Award; Karolinska institutet Foundations; Karolinska StratNeuro program	Swedish Research Council(Swedish Research CouncilEuropean Commission); ERC(European Research Council (ERC)European Commission); Swedish Brain Power; Karolinska Distinguished Professor Award; Karolinska institutet Foundations(Karolinska Institutet); Karolinska StratNeuro program	Swedish Research Council grant no 3474, ERC grant no. 322744, Swedish Brain Power, The Karolinska Distinguished Professor Award, Karolinska institutet Foundations, the Karolinska StratNeuro program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Altman J, 1997, DEV CEREBELLAR SYSTE; Andrade C, 2008, J NEURAL TRANSM, V115, P1063, DOI 10.1007/s00702-008-0063-2; Andrade C, 2008, J PSYCHIATR RES, V42, P837, DOI 10.1016/j.jpsychires.2007.08.009; Andrade C, 2012, J NEURAL TRANSM, V119, P337, DOI 10.1007/s00702-011-0712-8; Angelucci F, 2002, J ECT, V18, P138, DOI 10.1097/00124509-200209000-00005; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Buffo A, 2000, J NEUROSCI, V20, P2275; CAVALHEIRO EA, 1982, ELECTROEN CLIN NEURO, V53, P581, DOI 10.1016/0013-4694(82)90134-1; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Hellsten J, 2005, BIOL PSYCHIAT, V58, P871, DOI 10.1016/j.biopsych.2005.05.023; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsu R., 2007, PLOS ONE, V2, P1234, DOI [10.1371/journal.pone.0001234, DOI 10.1371/JOURNAL.PONE.0001234]; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Karlsson TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060892; Karlsson TE, 2013, J ALZHEIMERS DIS, V33, P145, DOI 10.3233/JAD-2012-120493; Lamont SR, 2001, BRAIN RES, V893, P53, DOI 10.1016/S0006-8993(00)03287-X; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Luo J, 2011, J ANESTH, V25, P657, DOI 10.1007/s00540-011-1199-z; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Merkl A, 2009, EXP NEUROL, V219, P20, DOI 10.1016/j.expneurol.2009.04.027; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Nations KR, 2012, J PSYCHOPHARMACOL, V26, P1525, DOI 10.1177/0269881112458728; Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Novak G, 2006, BRAIN RES, V1120, P161, DOI 10.1016/j.brainres.2006.08.071; Pagnin D, 2004, J ECT, V20, P13, DOI 10.1097/00124509-200403000-00004; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Paxinos G, 1994, ATLAS DEV RAT NERVOU; Paxinos G, 1998, RAT BRAIN; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Peng XM, 2011, J NEUROCHEM, V119, P1183, DOI 10.1111/j.1471-4159.2011.07520.x; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEWART C, 1994, NEUROREPORT, V5, P1041, DOI 10.1097/00001756-199405000-00006; Su XWW, 2009, PSYCHOPHARMACOLOGY, V206, P215, DOI 10.1007/s00213-009-1598-0; Vaidya VA, 1999, NEUROSCIENCE, V89, P157, DOI 10.1016/S0306-4522(98)00289-9; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Zhou XD, 2011, FASEB J, V25, P3146, DOI 10.1096/fj.11-184325; Zhu HY, 2007, HUM PATHOL, V38, P426, DOI 10.1016/j.humpath.2006.09.010	64	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78778	10.1371/journal.pone.0078778	http://dx.doi.org/10.1371/journal.pone.0078778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244357	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800016
J	Pujari, R; Eligar, SM; Kumar, N; Barkeer, S; Reddy, V; Swamy, BM; Inamdar, SR; Shastry, P				Pujari, Radha; Eligar, Sachin M.; Kumar, Natesh; Barkeer, Srikanth; Reddy, Vishwanath; Swamy, Bale M.; Inamdar, Shashikala R.; Shastry, Padma			Rhizoctonia Bataticola Lectin (RBL) Induces Caspase-8-Mediated Apoptosis in Human T-Cell Leukemia Cell Lines but Not in Normal CD3 and CD34 Positive Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SIGNALING PATHWAYS; OBLIMERSEN SODIUM; BCL-2 ANTISENSE; CANCER-CELLS; HUMAN PBMC; BINDING; DEATH; FAS	We have previously demonstrated immunostimulatory activity of a fungal lectin, Rhizoctonia bataticola lectin (RBL), towards normal human peripheral blood mononuclear cells. The present study aimed to explore the anticancer activities of RBL using human leukemic T-cell lines, Molt-4, Jurkat and HuT-78. RBL exhibited significant binding (>90%) to the cell membrane that was effectively inhibited by complex glycoproteins such as mucin (97% inhibition) and asialofetuin (94% inhibition) but not simple sugars such as N-acetyl-D-galactosamine, glucose and sucrose. RBL induced a dose and time dependent inhibition of proliferation and induced cytotoxicity in the cell lines. The percentage of apoptotic cells, as determined by hypodiploidy, was 33% and 42% in Molt-4 and Jurkat cells, respectively, compared to 3.11% and 2.92% in controls. This effect was associated with a concomitant decrease in the G0/G1 population. Though initiator caspase-8 and -9 were activated upon exposure to RBL, inhibition of caspase-8 but not caspase-9 rescued cells from RBL-induced apoptosis. Mechanistic studies revealed that RBL induced cleavage of Bid, loss of mitochondrial membrane potential and activation of caspase-3. The expression of the anti-apoptotic proteins Bcl-2 and Bcl-X was down regulated without altering the expression of pro-apoptotic proteins- Bad and Bax. In contrast to leukemic cells, RBL did not induce apoptosis in normal PBMC, isolated CD3+ve cells and undifferentiated CD34+ve hematopoietic stem and progenitor cells (HSPCs). The findings highlight the differential effects of RBL on transformed and normal hematopoietic cells and suggest that RBL may be explored for therapeutic applications in leukemia.	[Pujari, Radha; Kumar, Natesh; Shastry, Padma] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Eligar, Sachin M.; Barkeer, Srikanth; Reddy, Vishwanath; Swamy, Bale M.; Inamdar, Shashikala R.] Karnatak Univ, Dept Biochem, Dharwad, Karnataka, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Karnatak University	Shastry, P (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune, Maharashtra, India.	padma@nccs.res.in		Barkeer, Srikanth/0000-0001-9540-9033	DST-India; NCCS, Pune, India	DST-India(Department of Science & Technology (India)); NCCS, Pune, India	The project was partly funded by DST-India and the remaining by the in-house funding of NCCS, Pune, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; Bhutia SK, 2008, TOXICOL IN VITRO, V22, P344, DOI 10.1016/j.tiv.2007.09.016; BOGDANOV AA, 1989, EXP CELL RES, V181, P362, DOI 10.1016/0014-4827(89)90094-3; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chan YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038961; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Dharmu I, 2007, IN VITRO CELL DEV-AN, V43, P306, DOI 10.1007/s11626-007-9055-z; Durand G, 2000, CLIN CHEM, V46, P795; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Eligar SM, 2013, J GLYCOBIOL, pS1, DOI [10. 4172/2168-958X. S1-001, DOI 10.4172/2168-958X.S1-001]; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Flotho C, 2006, BLOOD, V108, P1050, DOI 10.1182/blood-2006-01-0322; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jones DT, 2001, BLOOD, V98, P2800, DOI 10.1182/blood.V98.9.2800; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kang TB, 2007, J BIOCHEM MOL BIOL, V40, P959; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li YR, 2008, BBA-GEN SUBJECTS, V1780, P51, DOI 10.1016/j.bbagen.2007.09.004; Liang Y, 2009, BIOCHEM BIOPH RES CO, V386, P437, DOI 10.1016/j.bbrc.2009.06.054; Liu B, 2009, BBA-GEN SUBJECTS, V1790, P840, DOI 10.1016/j.bbagen.2009.04.020; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Liu MJ, 2005, CANCER CHEMOTH PHARM, V55, P79, DOI 10.1007/s00280-004-0849-3; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANN KK, 1994, EUR J CELL BIOL, V65, P145; Mata JF, 2010, PEDIATR BLOOD CANCER, V55, P100, DOI 10.1002/pbc.22463; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nagre NN, 2010, GLYCOCONJUGATE J, V27, P375, DOI 10.1007/s10719-010-9285-2; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; O'Brien SM, 2005, J CLIN ONCOL, V23, P7697, DOI 10.1200/JCO.2005.02.4364; O'Brien S, 2007, J CLIN ONCOL, V25, P1114, DOI 10.1200/JCO.2006.07.1191; Pujari R, 2012, BIOCHEM BIOPH RES CO, V419, P708, DOI 10.1016/j.bbrc.2012.02.084; Pujari R, 2010, BBA-GEN SUBJECTS, V1800, P1268, DOI 10.1016/j.bbagen.2010.09.003; Sangeetha VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029383; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Sleiman RJ, 1998, BRIT J CANCER, V77, P40, DOI 10.1038/bjc.1998.7; STANLEY P, 1981, CELL, V23, P763, DOI 10.1016/0092-8674(81)90440-2; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Wang CL, 2012, CELL BIOCH BIOPHYS; Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2; ZANETTA JP, 1992, HISTOCHEM J, V24, P791, DOI 10.1007/BF01046351; Zhao JK, 2009, TOXICON, V53, P360, DOI 10.1016/j.toxicon.2008.12.009	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79311	10.1371/journal.pone.0079311	http://dx.doi.org/10.1371/journal.pone.0079311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244478	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800061
J	Steen, VM; Nepal, C; Ersland, KM; Holdhus, R; Naevdal, M; Ratvik, SM; Skrede, S; Havik, B				Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte			Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1	PLOS ONE			English	Article							BIPOLAR-DISORDER; SYNAPSE ELIMINATION; DRUG-NAIVE; RNA-SEQ; GENOME; MYELINATION; ASSOCIATION; POPULATION; PLASTICITY; MOLECULES	Recent meta-analyses of schizophrenia genome-wide association studies (GWASs) have identified the CUB and SUSHI multiple domains 1 (CSMD1) gene as a statistically strong risk factor. CSMD1 is a complement control-related protein suggested to inhibit the classical complement pathway, being expressed in developing neurons. However, expression of CSMD1 is largely uncharacterized and relevance for behavioral phenotypes is not previously demonstrated. Here, we assess neuropsychological behaviors of a Csmd1 knockout (KO) mouse in a selection of standard behavioral tests. Deregulation of neuropsychological responses were observed in both the open field and the elevated plus maze tests, in which KO mice spent 55% and 33% less time than WT littermate mice in open areas, respectively. Altered behaviors were also observed in tail suspension and to higher acoustic stimuli, for which Csmd1 KO mice showed helplessness and moderate increase in startle amplitude, respectively. Furthermore, Csmd1 KO mice also displayed increased weight-gain and glucose tolerance, similar to a major phenotype of the metabolic syndrome that also has been associated to the human CSMD1 locus. Consistent with a role in the control of behaviors, Csmd1 was found highly expressed in the central nervous system (CNS), and with some expression in visceral fat and ovary, under tissue-specific control by a novel promoter-associated lncRNA. In summary, disruption of Csmd1 induces behaviors reminiscent of blunted emotional responses, anxiety and depression. These observations suggest an influence of the CSMD1 schizophrenia susceptibility gene on psychopathology and endophenotypes of the negative symptom spectra.	[Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Univ Bergen, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, Bergen, Norway; [Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Havik, B (corresponding author), Univ Bergen, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway.	bjarte.haavik@uib.no	Skrede, Silje/AAA-4453-2019; Nepal, Chirag/K-5866-2019	Ersland, Kari Merete/0000-0003-3674-4151; Nepal, Chirag/0000-0001-8402-3805	Research Council of Norway (Psykisk Helse Grant) [186001]; Research Council of Norway (FUGE Grant) [151904, 183327]; Bergen Medical Research Foundation (BMFS); Kristian Gerhard Jebsen Foundation; Helse Vest RHF; Dr. Einar Martens Fund	Research Council of Norway (Psykisk Helse Grant); Research Council of Norway (FUGE Grant); Bergen Medical Research Foundation (BMFS); Kristian Gerhard Jebsen Foundation; Helse Vest RHF; Dr. Einar Martens Fund	This study was supported by the Research Council of Norway (Psykisk Helse Grant No. 186001 and the FUGE Grant Nos. 151904 and 183327), Bergen Medical Research Foundation (BMFS), The Kristian Gerhard Jebsen Foundation, Helse Vest RHF and Dr. Einar Martens Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; de Morentin PBM, 2011, REV ENDOCR METAB DIS, V12, P127, DOI 10.1007/s11154-011-9165-5; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Dernovsek MZ, 2009, PSYCHIAT DANUB, V21, P43; Distler MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051235; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; Ferno J, 2011, FRONT BIOSCI-LANDMRK, V16, P49, DOI 10.2741/3675; Friddle CJ, 2003, COLD SPRING HARB SYM, V68, P311, DOI 10.1101/sqb.2003.68.311; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Juutinen J, 2008, EUR PSYCHIAT, V23, P521, DOI 10.1016/j.eurpsy.2008.06.002; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kirkpatrick B, 2012, SCHIZOPHRENIA BULL, V38, P280, DOI 10.1093/schbul/sbq058; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Matsui M, 2013, ACS CHEM BIOL, V8, P122, DOI 10.1021/cb300490j; Nock Nora L, 2009, BMC Proc, V3 Suppl 7, pS50; Ramos PS, 2012, ARTHRITIS RHEUM-US, V64, P4060, DOI 10.1002/art.34663; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ritsner MS, 2007, QUALITY LIFE IMPAIRM, P388; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Schulze TG, 2012, WORLD J BIOL PSYCHIA, P1; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sun PC, 2001, GENOMICS, V75, P17, DOI 10.1006/geno.2001.6587; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Thakore JH, 2002, INT J OBESITY, V26, P137, DOI 10.1038/sj.ijo.0801840; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217	47	43	48	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79501	10.1371/journal.pone.0079501	http://dx.doi.org/10.1371/journal.pone.0079501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244513	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800084
J	Bao, LM; Gao, C; Li, MM; Chen, Y; Lin, WQ; Yang, YJ; Han, N; Bian, HW; Zhu, MY; Wang, JH				Bao, Lieming; Gao, Chen; Li, Miaomiao; Chen, Yong; Lin, Weiqiang; Yang, Yanjun; Han, Ning; Bian, Hongwu; Zhu, Muyuan; Wang, Junhui			Biomonitoring of Non-Dioxin-Like Polychlorinated Biphenyls in Transgenic Arabidopsis Using the Mammalian Pregnane X Receptor System: A Role of Pectin in Pollutant Uptake	PLOS ONE			English	Article							PLANT-MICROBE INTERACTIONS; ORGANIC CONTAMINANTS; GENE-EXPRESSION; RISK-ASSESSMENT; TOBACCO PLANTS; PCBS; PXR; PHYTOREMEDIATION; BIOAVAILABILITY; TRANSFORMATION	Polychlorinated biphenyls (PCBs) are persistent organic pollutants damaging to human health and the environment. Techniques to indicate PCB contamination in planta are of great interest to phytoremediation. Monitoring of dioxin-like PCBs in transgenic plants carrying the mammalian aryl hydrocarbon receptor (AHR) has been reported previously. Herein, we report the biomonitoring of non-dioxin-like PCBs (NDL-PCBs) using the mammalian pregnane X receptor (PXR). In the transgenic Arabidopsis designated NDL-PCB Reporter, the EGFP-GUS reporter gene was driven by a promoter containing 18 repeats of the xenobiotic response elements, while PXR and its binding partner retinoid X receptor (RXR) were coexpressed. Results showed that, in live cells, the expression of reporter gene was insensitive to endogenous lignans, carotenoids and flavonoids, but responded to all tested NDL-PCBs in a dose-and time-dependent manner. Two types of putative PCB metabolites, hydroxy-PCBs and methoxy-PCBs, displayed different activation properties. The vascular tissues seemed unable to transport NDL-PCBs, whereas mutation in QUASIMODO1 encoding a 1,4-galacturonosyltransferase led to reduced PCB accumulation in Arabidopsis, revealing a role for pectin in the control of PCB translocation. Taken together, the reporter system may serve as a useful tool to biomonitor the uptake and metabolism of NDL-PCBs in plants.	[Bao, Lieming; Gao, Chen; Li, Miaomiao; Chen, Yong; Lin, Weiqiang; Yang, Yanjun; Han, Ning; Bian, Hongwu; Zhu, Muyuan; Wang, Junhui] Zhejiang Univ, Coll Life Sci, Inst Genet, Dept Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, JH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Genet, Dept Biotechnol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	junhuiwang@zju.edu.cn			National Natural Science Foundation of China [31170211]; China Agricultural Research system [CARS-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research system	The work was supported by funding from the National Natural Science Foundation of China (grant no. 31170211 to JW) and the China Agricultural Research system (CARS-05 to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2012, TRENDS BIOTECHNOL, V30, P416, DOI 10.1016/j.tibtech.2012.04.004; Abhilash PC, 2009, BIOTECHNOL ADV, V27, P474, DOI 10.1016/j.biotechadv.2009.04.002; Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; Anderson M, 2000, PRACT APPROACH SER, V223, P1; Barber JL, 2002, ENVIRON SCI TECHNOL, V36, P4282, DOI 10.1021/es025623m; Boldt TS, 2004, FEMS MICROBIOL ECOL, V48, P139, DOI 10.1016/j.femsec.2004.01.002; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Brown JF, 2007, TOXICOL SCI, V98, P375, DOI 10.1093/toxsci/kfm122; Burken JG, 1998, ENVIRON SCI TECHNOL, V32, P3379, DOI 10.1021/es9706817; COBBETT CS, 2002, ARABIDOPSIS BOOK, V1, P32; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Cui XY, 2013, ENVIRON POLLUT, V172, P223, DOI 10.1016/j.envpol.2012.09.013; Doty SL, 2008, NEW PHYTOL, V179, P318, DOI 10.1111/j.1469-8137.2008.02446.x; Dronnet VM, 1996, CARBOHYD POLYM, V30, P253, DOI 10.1016/S0144-8617(96)00107-5; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eljarrat E, 2003, TRAC-TREND ANAL CHEM, V22, P655, DOI 10.1016/S0165-9936(03)01001-X; Ficko SA, 2010, SCI TOTAL ENVIRON, V408, P3469, DOI 10.1016/j.scitotenv.2010.04.036; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; Hamorsky KT, 2012, ANAL CHEM, V84, P7648, DOI 10.1021/ac301872u; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jin XF, 2011, PLANT GROWTH REGUL, V65, P127, DOI 10.1007/s10725-011-9582-1; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kodama S, 2007, PLANTA, V227, P37, DOI 10.1007/s00425-007-0592-1; Kodama S, 2009, PLANT BIOTECHNOL J, V7, P119, DOI 10.1111/j.1467-7652.2008.00378.x; Kojima H, 2011, TOXICOLOGY, V280, P77, DOI 10.1016/j.tox.2010.11.008; Komp P, 1997, ENVIRON SCI TECHNOL, V31, P2944, DOI 10.1021/es970141+; Li HS, 2011, CHEMOSPHERE, V84, P943, DOI 10.1016/j.chemosphere.2011.06.007; Liu JY, 2008, CHEMOSPHERE, V73, P1608, DOI 10.1016/j.chemosphere.2008.08.009; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Pu XZ, 2006, TOXICOLOGY, V217, P14, DOI 10.1016/j.tox.2005.08.012; Rezek J, 2008, ENVIRON SCI TECHNOL, V42, P5746, DOI 10.1021/es800445h; Rezek J, 2012, CHEMOSPHERE, V89, P383, DOI 10.1016/j.chemosphere.2012.05.041; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schiewer S, 2008, BIORESOURCE TECHNOL, V99, P1896, DOI 10.1016/j.biortech.2007.03.060; Schuetz EG, 1998, MOL PHARMACOL, V54, P1113, DOI 10.1124/mol.54.6.1113; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Segura A, 2013, CURR OPIN BIOTECH, V24, P467, DOI 10.1016/j.copbio.2012.09.011; She WJ, 2010, GENETICS, V185, P1141, DOI 10.1534/genetics.110.117960; SILBERHORN EM, 1990, CRIT REV TOXICOL, V20, P439, DOI 10.3109/10408449009029331; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sylvestre M, 2013, ENVIRON MICROBIOL, V15, P907, DOI 10.1111/1462-2920.12007; Sylvestre M, 2009, CURR OPIN BIOTECH, V20, P242, DOI 10.1016/j.copbio.2009.01.006; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Tabb MM, 2004, ENVIRON HEALTH PERSP, V112, P163, DOI 10.1289/ehp.6560; Turner K, 2007, ANAL CHEM, V79, P5740, DOI 10.1021/ac0705162; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x; YE QP, 1992, CHEMOSPHERE, V25, P1475, DOI 10.1016/0045-6535(92)90172-N	60	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79428	10.1371/journal.pone.0079428	http://dx.doi.org/10.1371/journal.pone.0079428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236133	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700132
J	do Amaral, MCF; Lee, RE; Costanzo, JP				do Amaral, M. Clara F.; Lee, Richard E., Jr.; Costanzo, Jon P.			Enzymatic Regulation of Glycogenolysis in a Subarctic Population of the Wood Frog: Implications for Extreme Freeze Tolerance	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RANA-SYLVATICA; PSEUDACRIS-TRISERIATA; CRYOPROTECTANT SYNTHESIS; ECTOTHERMIC VERTEBRATES; PHOSPHORYLASE ACTIVITY; GLUCOSE MOBILIZATION; LIVER-GLYCOGEN; CHORUS FROGS; COOLING RATE	The wood frog, Rana sylvatica, from Interior Alaska survives freezing at -16 degrees C, a temperature 10-13 degrees C below that tolerated by its southern conspecifics. We investigated the hepatic freezing response in this northern phenotype to determine if its profound freeze tolerance is associated with an enhanced glucosic cryoprotectant system. Alaskan frogs had a larger liver glycogen reserve that was mobilized faster during early freezing as compared to conspecifics from a cool-temperate region (southern Ohio, USA). In Alaskan frogs the rapid glucose production in the first hours of freezing was associated with a 7-fold increase in glycogen phosphorylase activity above unfrozen frog levels, and the activity of this enzyme was higher than that of frozen Ohioan frogs. Freezing of Ohioan frogs induced a more modest (4-fold) increase in glycogen phosphorylase activity above unfrozen frog values. Relative to the Ohioan frogs, Alaskan frogs maintained a higher total protein kinase A activity throughout an experimental freezing/thawing time course, and this may have potentiated glycogenolysis during early freezing. We found populational variation in the activity and protein level of protein kinase A which suggested that the Alaskan population had a more efficient form of this enzyme. Alaskan frogs modulated their glycogenolytic response by decreasing the activity of glycogen phosphorylase after cryoprotectant mobilization was well under way, thereby conserving their hepatic glycogen reserve. Ohioan frogs, however, sustained high glycogen phosphorylase activity until early thawing and consumed nearly all their liver glycogen. These unique hepatic responses of Alaskan R. sylvatica likely contribute to this phenotype's exceptional freeze tolerance, which is necessary for their survival in a subarctic climate.	[do Amaral, M. Clara F.; Lee, Richard E., Jr.; Costanzo, Jon P.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	do Amaral, MCF (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	figueim@miamioh.edu			Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) [SFRH/BD/63151/2009]; Sigma Xi [G20111015158541]; National Science Foundation [IOS1022788]	Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal); Sigma Xi; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) (SFRH/BD/63151/2009 to M. C. F. A.), Sigma Xi (G20111015158541 to M. C. F. A.) and the National Science Foundation (IOS1022788 to J. P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; CLAUSSEN DL, 1991, AM J PHYSIOL, V261, pR626, DOI 10.1152/ajpregu.1991.261.3.R626; Costanzo JP, 2013, J EXP BIOL, V216, P3461, DOI 10.1242/jeb.089342; Costanzo JP, 2013, J EXP BIOL, V216, P1961, DOI 10.1242/jeb.070268; COSTANZO JP, 1993, CAN J ZOOL, V71, P71, DOI 10.1139/z93-011; COSTANZO JP, 1993, J EXP BIOL, V181, P245; COSTANZO JP, 1992, J EXP ZOOL, V261, P373, DOI 10.1002/jez.1402610403; COSTANZO JP, 1991, J COMP PHYSIOL B, V161, P225, DOI 10.1007/BF00262302; Cowan KJ, 2001, COMP BIOCHEM PHYS B, V130, P565, DOI 10.1016/S1096-4959(01)00467-5; CRERAR MM, 1988, BIOCHIM BIOPHYS ACTA, V971, P72, DOI 10.1016/0167-4889(88)90163-2; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Dinsmore SC, 2008, CAN J ZOOL, V86, P1095, DOI 10.1139/Z08-088; Edwards JR, 2000, COMP BIOCHEM PHYS A, V125, P367, DOI 10.1016/S1095-6433(00)00168-9; Hemmings SJ, 1996, CELL BIOCHEM FUNCT, V14, P139, DOI 10.1002/cbf.661; HERREID CF, 1967, ECOLOGY, V48, P579; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HOFFMANN RJ, 1981, BIOCHEM GENET, V19, P129, DOI 10.1007/BF00486143; Holden CP, 1996, AM J PHYSIOL-REG I, V271, pR1205, DOI 10.1152/ajpregu.1996.271.5.R1205; Holden CP, 1997, J COMP PHYSIOL B, V167, P305, DOI 10.1007/s003600050078; HOLDEN CP, 1993, J COMP PHYSIOL B, V163, P499; Holden CP, 2000, CRYOBIOLOGY, V40, P323, DOI 10.1006/cryo.2000.2252; Holmstrup M, 2007, SOIL BIOL BIOCHEM, V39, P2640, DOI 10.1016/j.soilbio.2007.05.018; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Irwin JT, 2003, J EXP BIOL, V206, P2859, DOI 10.1242/jeb.00500; Jenkins JL, 2005, J THERM BIOL, V30, P485, DOI 10.1016/j.jtherbio.2005.05.008; JOHANSEN K, 1962, ECOLOGY, V43, P146, DOI 10.2307/1932056; Karege F, 2001, BRAIN RES, V903, P86, DOI 10.1016/S0006-8993(01)02409-X; KESSEL B, 1965, ECOLOGY, V46, P206, DOI 10.2307/1935277; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; MacDonald JA, 1999, MAR BIOL, V133, P193, DOI 10.1007/s002270050458; Martof B. S., 1959, AM MIDL NAT, V61, P350, DOI [10.2307/2422506, DOI 10.2307/2422506]; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEHRANI H, 1995, MOL CELL BIOCHEM, V145, P81, DOI 10.1007/BF00925717; MERRITT RB, 1972, AM NAT, V106, P173, DOI 10.1086/282760; METZGER BE, 1968, BIOCHEMISTRY-US, V7, P2021, DOI 10.1021/bi00846a003; Middle LB, 2000, AM ZOOL, V40, P1132; MOMMSEN TP, 1986, CAN J ZOOL, V64, P1110, DOI 10.1139/z86-166; MOMMSEN TP, 1992, GEN COMP ENDOCR, V87, P44, DOI 10.1016/0016-6480(92)90148-D; Nick P, 2013, PLANT J, V75, P309, DOI 10.1111/tpj.12102; Pfister TD, 2006, INSECT BIOCHEM MOLEC, V36, P18, DOI 10.1016/j.ibmb.2005.10.002; POWERS DA, 1991, ANNU REV GENET, V25, P629; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schliess F, 2003, INT REV CYTOL, V225, P187, DOI 10.1016/S0074-7696(05)25005-2; Slotsbo S, 2008, CRYOBIOLOGY, V57, P286, DOI 10.1016/j.cryobiol.2008.09.010; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; STOREY KB, 1984, J COMP PHYSIOL B, V155, P29, DOI 10.1007/BF00688788; Storey KB, 2004, LIFE IN THE FROZEN STATE, P243, DOI 10.1201/9780203647073.ch7; Storey KB, 2004, CRYOBIOLOGY, V48, P134, DOI 10.1016/j.cryobiol.2003.10.008; STOREY KB, 1988, P NATL ACAD SCI USA, V85, P8350, DOI 10.1073/pnas.85.21.8350; STOREY KB, 1994, AM J PHYSIOL, V266, pR1477, DOI 10.1152/ajpregu.1994.266.5.R1477; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; Swanson DL, 1996, J COMP PHYSIOL B, V166, P110, DOI 10.1007/BF00301174; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; VIJAYAN MM, 1994, GEN COMP ENDOCR, V96, P75, DOI 10.1006/gcen.1994.1160; Vornanen M, 2011, J COMP PHYSIOL B, V181, P917, DOI 10.1007/s00360-011-0580-4; Williams JB, 2008, J COMP PHYSIOL B, V178, P365, DOI 10.1007/s00360-007-0229-5; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	58	12	12	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79169	10.1371/journal.pone.0079169	http://dx.doi.org/10.1371/journal.pone.0079169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236105	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700103
J	Flindall, JW; Gonzalez, CLR				Flindall, Jason W.; Gonzalez, Claudia L. R.			On the Evolution of Handedness: Evidence for Feeding Biases	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; HUMAN PRECISION GRIP; HEMISPHERIC-SPECIALIZATION; PREHENSION MOVEMENTS; ACTION ORGANIZATION; MOUTH COORDINATION; KINEMATIC ANALYSIS; INFERIOR PARIETAL; VENTRAL PREMOTOR; MOTOR CORTEX	Many theories have been put forward to explain the origins of right-handedness in humans. Here we present evidence that this preference may stem in part from a right hand advantage in grasping for feeding. Thirteen participants were asked to reach-to-grasp food items of 3 different sizes: SMALL (CheeriosH), MEDIUM (Froot Loops (R)), and LARGE (Oatmeal Squares (R)). Participants used both their right-and left-hands in separate blocks (50 trials each, starting order counterbalanced) to grasp the items. After each grasp, participants either a) ate the food item, or b) placed it inside a bib worn beneath his/her chin (25 trials each, blocked design, counterbalanced). The conditions were designed such that the outward and inward movement trajectories were similar, differing only in the final step of placing it in the mouth or bib. Participants wore Plato liquid crystal goggles that blocked vision between trials. All trials were conducted in closed-loop with 5000 ms of vision. Hand kinematics were recorded by an Optotrak Certus, which tracked the position of three infrared diodes attached separately to the index finger, thumb, and wrist. We found a task (EAT/PLACE) by hand (LEFT/RIGHT) interaction on maximum grip aperture (MGA; the maximum distance between the index finger and thumb achieved during grasp pre-shaping). MGAs were smaller during right-handed movements, but only when grasping with intent to eat. Follow-up tests show that the RIGHT-HAND/EAT MGA was significantly smaller than all other hand/task conditions. Because smaller grip apertures are typically associated with greater precision, our results demonstrate a right-hand advantage for the grasp-to-eat movement. From an evolutionary perspective, early humans may have preferred the hand that could grasp food with more precision, thereby maximizing the likelihood of retrieval, consumption, and consequently, survival.	[Flindall, Jason W.; Gonzalez, Claudia L. R.] Univ Lethbridge, Dept Kinesiol & Phys Educ, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Flindall, JW (corresponding author), Univ Lethbridge, Dept Kinesiol & Phys Educ, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada.	jason.flindall@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [14367]; Canadian Foundation for Innovation (CFI) [45561]; Canada Research Chairs program; University of Lethbridge	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs program(Canada Research Chairs); University of Lethbridge	The current study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Fund # 14367), the Canadian Foundation for Innovation (CFI Fund # 45561), the Canada Research Chairs program, and the University of Lethbridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Armbruster C, 2006, MOTOR CONTROL, V10, P311, DOI 10.1123/mcj.10.4.311; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bonini L, 2012, J NEUROPHYSIOL, V108, P1607, DOI 10.1152/jn.01158.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Borchers S, 2012, RECOGNITION EVERYDAY; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Castiello U, 1998, PERCEPT PSYCHOPHYS, V60, P662, DOI 10.3758/BF03206053; Castiello U, 1998, EXP BRAIN RES, V123, P289, DOI 10.1007/s002210050571; Castiello U, 1997, EXP BRAIN RES, V115, P552, DOI 10.1007/PL00005726; Castiello U., 2000, COGN SYST RES, V1, P89, DOI [10.1016/S1389-0417(99)00011-X, DOI 10.1016/S1389-0417(99)00011-X]; Cochet H, 2012, DEV PSYCHOBIOL, V54, P105, DOI 10.1002/dev.20576; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; CORNWELL KS, 1991, DEV NEUROPSYCHOL, V7, P19, DOI 10.1080/87565649109540475; Cox RFA, 2006, DEVELOPMENTAL SCI, V9, P628, DOI 10.1111/j.1467-7687.2006.00541.x; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Fagard J, 2000, DEVELOPMENTAL SCI, V3, P137, DOI 10.1111/1467-7687.00107; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Flindall JW, 2012, MANUAL ASYMMETRIES K; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; FORSSBERG H, 1992, EXP BRAIN RES, V90, P393; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Gonzalez CLR, 2008, NEUROPSYCHOLOGIA, V46, P624, DOI 10.1016/j.neuropsychologia.2007.09.006; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Goodale M. A, 1990, VISION ACTION CONTRO; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2005, J NEUROPHYSIOL, V94, P4209, DOI 10.1152/jn.01303.2004; Graziano MSA, 2004, EXP BRAIN RES, V155, P30, DOI 10.1007/s00221-003-1701-4; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Harvey M, 2001, BEHAV NEUROL, V13, P17; Hecaen H, 1971, Cortex, V7, P19; Hepper PG, 1998, NEUROPSYCHOLOGIA, V36, P531, DOI 10.1016/S0028-3932(97)00156-5; Hopkins B, 1998, DEV SENSORY MOTOR CO, P189; Hopkins WD, 2005, INT J PRIMATOL, V26, P259, DOI 10.1007/s10764-005-2924-y; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2011, J HUM EVOL, V60, P605, DOI 10.1016/j.jhevol.2010.12.008; Hu Y, 1999, EXP BRAIN RES, V126, P109, DOI 10.1007/s002210050720; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Kaas JH, 2012, EUR J PHYS REHAB MED, V48, P299; Kaas JH, 2011, BRAIN BEHAV EVOLUT, V78, P5, DOI 10.1159/000327973; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Leconte P, 2006, BRAIN COGNITION, V60, P88, DOI 10.1016/j.bandc.2005.09.009; Lew AR, 1997, INFANT BEHAV DEV, V20, P59, DOI 10.1016/S0163-6383(97)90061-8; LEWKOWICZ DJ, 1982, DEV PSYCHOL, V18, P301, DOI 10.1037/0012-1649.18.2.301; MacNeilage Peter F., 2007, Special Topics in Primatology, V5, P58; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; Parma V, 2011, EXP BRAIN RES, V212, P339, DOI 10.1007/s00221-011-2733-9; Parma V, 2011, APPETITE, V56, P249, DOI 10.1016/j.appet.2010.12.013; PETERS M, 1983, MANUAL SPECIALIZATIO, P367; Piaget J., 1953, ORIGIN INTELLIGENCE; Pouydebat E, 2011, BEHAV BRAIN RES, V218, P21, DOI 10.1016/j.bbr.2010.11.021; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Sacrey LAR, 2012, DEV PSYCHOBIOLOGY; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Stone KD, 2012, EXPT BRAIN RES, P1; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Tretriluxana J, 2008, EXP BRAIN RES, V188, P305, DOI 10.1007/s00221-008-1364-2; Vauclair J, 2009, DEVELOPMENTAL SCI, V12, P1060, DOI 10.1111/j.1467-7687.2009.00850.x; Whishaw IQ, 2003, BEHAV BRAIN RES, V146, P31, DOI 10.1016/j.bbr.2003.09.027; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Whitwell RL, 2011, VISION RES, V51, P908, DOI 10.1016/j.visres.2011.02.005; WING AM, 1986, J MOTOR BEHAV, V18, P245; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012	83	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78967	10.1371/journal.pone.0078967	http://dx.doi.org/10.1371/journal.pone.0078967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236078	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700075
J	Gao, S; Hsieh, CL; Zhou, J; Shemshedini, L				Gao, Shuai; Hsieh, Chen-Lin; Zhou, Jun; Shemshedini, Lirim			Zinc Finger 280B Regulates sGC alpha 1 and p53 in Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; COLORECTAL-CANCER; SIGNALING PATHWAY; MDM2; PROTEIN; ACTIVATION; PROGRESSION; EXPRESSION; APOPTOSIS; GENE	The Zinc Finger (ZNF) 280B protein was identified as an unexpected target of an shRNA designed for sGC alpha 1. Further analysis showed that these two proteins are connected in another way, with 280B up-regulation of sGC alpha 1 expression. Knock-down and over-expression experiments showed that 280B serves pro-growth and pro-survival functions in prostate cancer. Surprisingly however, these pro-cancer functions of 280B are not mediated by sGC alpha 1, which itself has similar functions in prostate cancer, but by down-regulated p53. The p53 protein is a second target of 280B in prostate cancer, but unlike sGC alpha 1, p53 is down-regulated by 280B. 280B induces p53 nuclear export, leading to subsequent proteasomal degradation. The protein responsible for p53 regulation by 280B is Mdm2, the E3 ubiquitin ligase that promotes p53 degradation by inducing its nuclear export. We show here that 280B up-regulates expression of Mdm2 in prostate cancer cells, and this regulation is via the Mdm2 promoter. To demonstrate an in vivo relevance to this interaction, expression studies show that 280B protein levels are up-regulated in prostate cancer and these levels correspond to reduced levels of p53. Thus, by enhancing the expression of Mdm2, the uncharacterized 280B protein provides a novel mechanism of p53 suppression in prostate cancer.	[Gao, Shuai; Hsieh, Chen-Lin; Zhou, Jun; Shemshedini, Lirim] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Shemshedini, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	lshemsh@utnet.utoledo.edu		Gao, Shuai/0000-0002-7304-8801	National Institutes of Health (NIH) [R01CA127873-01A1]; NATIONAL CANCER INSTITUTE [R01CA127873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health (NIH) R01CA127873-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Eastham JA, 1995, CLIN CANCER RES, V1, P1111; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064189; Gurova KV, 2002, ONCOGENE, V21, P153, DOI 10.1038/sj.onc.1205001; Hu RZ, 2011, CANCER RES, V71, P6524, DOI 10.1158/0008-5472.CAN-11-0853; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Iijima K, 2012, EUR J IMMUNOL, V42, P3405, DOI 10.1002/eji.201242530; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li J, 2007, BIOCHEM BIOPH RES CO, V363, P895, DOI 10.1016/j.bbrc.2007.08.180; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Osman I, 1999, CLIN CANCER RES, V5, P2082; Qian JQ, 2002, MODERN PATHOL, V15, P35, DOI 10.1038/modpathol.3880487; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Shenk JL, 2001, J BIOL CHEM, V276, P38472, DOI 10.1074/jbc.M103652200; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; YANG CL, 1995, CANCER RES, V55, P4210; Yang L, 2008, CANCER RES, V68, P4321, DOI 10.1158/0008-5472.CAN-08-0407; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192	50	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78766	10.1371/journal.pone.0078766	http://dx.doi.org/10.1371/journal.pone.0078766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236047	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700044
J	Nino, EL; Malka, O; Hefetz, A; Tarpy, DR; Grozinger, CM				Nino, Elina L.; Malka, Osnat; Hefetz, Abraham; Tarpy, David R.; Grozinger, Christina M.			Chemical Profiles of Two Pheromone Glands Are Differentially Regulated by Distinct Mating Factors in Honey Bee Queens (Apis mellifera L.)	PLOS ONE			English	Article							DUFOURS GLAND; GENETIC DIVERSITY; INSEMINATION QUANTITY; MANDIBULAR PHEROMONE; EGG-MARKING; COLONIES; EXPRESSION; FERTILITY; SECRETION; BEHAVIOR	Pheromones mediate social interactions among individuals in a wide variety of species, from yeast to mammals. In social insects such as honey bees, pheromone communication systems can be extraordinarily complex and serve to coordinate behaviors among many individuals. One of the primary mediators of social behavior and organization in honey bee colonies is queen pheromone, which is produced by multiple glands. The types and quantities of chemicals produced differ significantly between virgin and mated queens, and recent studies have suggested that, in newly mated queens, insemination volume or quantity can affect pheromone production. Here, we examine the long-term impact of different factors involved during queen insemination on the chemical composition of the mandibular and Dufour's glands, two of the major sources of queen pheromone. Our results demonstrate that carbon dioxide (an anesthetic used in instrumental insemination), physical manipulation of genital tract (presumably mimicking the act of copulation), insemination substance (saline vs. semen), and insemination volume (1 vs. 8 mu l) all have long-term effects on mandibular gland chemical profiles. In contrast, Dufour's gland chemical profiles were changed only upon insemination and were not influenced by exposure to carbon dioxide, manipulation, insemination substance or volume. These results suggest that the chemical contents of these two glands are regulated by different neuro-physiological mechanisms. Furthermore, workers responded differently to the different mandibular gland extracts in a choice assay. Although these studies must be validated in naturally mated queens of varying mating quality, our results suggest that while the chemical composition of Dufour's gland is associated with mating status, that of the mandibular glands is associated with both mating status and insemination success. Thus, the queen appears to be signaling both status and reproductive quality to the workers, which may impact worker behavior and physiology as well as social organization and productivity of the colony.	[Nino, Elina L.; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Nino, Elina L.; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Malka, Osnat; Hefetz, Abraham] Tel Aviv Univ, Dept Zool, Jerusalem, Israel; [Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Tel Aviv University; University of North Carolina; North Carolina State University	Nino, EL (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	elnino@psu.edu	Hefetz, Abraham/I-3853-2015	Tarpy, David/0000-0001-8601-6094	United States Department of Agriculture-National Research Initiative [2006-35607-16625]; United States-Israel Binational Science Foundation [2007233]	United States Department of Agriculture-National Research Initiative(United States Department of Agriculture (USDA)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This research was supported by the United States Department of Agriculture-National Research Initiative grant 2006-35607-16625 to CMG and DRT, and Grant No. 2007233 from the United States-Israel Binational Science Foundation (BSF) to AH and CMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla F. C., 2001, Brazilian Journal of Biology, V61, P95, DOI 10.1590/S0034-71082001000100013; Al-Qarni Abdulaziz S., 2005, Saudi Journal of Biological Sciences, V12, P39; Al-Qarni AS, 2005, J KING SAUD U, V17, P125; Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; [Anonymous], 2014, PHEROMONES ANIMAL BE; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Blomquist GJ, 2012, PHEROMONE PRODUCTION; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Dussaubat C, 2010, J CHEM ECOL, V36, P522, DOI 10.1007/s10886-010-9786-2; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; Furgala B, 1962, GLEANINGS BEE CULT, V90, P294; Gozansky Tamar Katzav, 1997, Invertebrate Neuroscience, V3, P239; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Grozinger CM, 2007, NATURWISSENSCHAFTEN, V94, P375, DOI 10.1007/s00114-006-0197-8; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2005, BEHAV ECOL SOCIOBIOL, V59, P278, DOI 10.1007/s00265-005-0039-2; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Jaffe R, 2010, NATURWISSENSCHAFTEN, V97, P337, DOI 10.1007/s00114-009-0638-2; Johnson JN, 2010, J INSECT PHYSIOL, V56, P761, DOI 10.1016/j.jinsphys.2010.01.004; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2006, J COMP PHYSIOL A, V192, P737, DOI 10.1007/s00359-006-0110-0; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; KINGAN TG, 1993, J EXP BIOL, V183, P61; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Kocher SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009116; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kotwica J, 2006, J PHYSIOL PHARMACOL, V57, P107; Laidlaw HH., 1997, QUEEN REARING BEE BR; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Martin SJ, 2002, NATURWISSENSCHAFTEN, V89, P528, DOI 10.1007/s00114-002-0367-2; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Mitra A, 2011, NATURWISSENSCHAFTEN, V98, P157, DOI 10.1007/s00114-010-0749-9; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Nino EL, 2011, INSECT MOL BIOL, V20, P387, DOI 10.1111/j.1365-2583.2011.2011.01072.x; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Ortius D, 1999, BEHAV ECOL SOCIOBIOL, V45, P151, DOI 10.1007/s002650050548; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; Park D, 2001, ENVIRON HEALTH PERSP, V109, P669, DOI 10.2307/3454782; Peso M, 2012, INSECT SOC, DOI [10.1007/s00040-012-0275-1: 1-11, DOI 10.1007/S00040-012-0275-1:1-11]; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; Schal C, 1998, AM ZOOL, V38, P382; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; WILLIAMS JL, 1982, ANN ENTOMOL SOC AM, V75, P457, DOI 10.1093/aesa/75.4.457; WINSTON ML, 1989, INSECT SOC, V36, P15, DOI 10.1007/BF02225877; Wolfner MF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001191; Wossler TC, 1999, J INSECT BEHAV, V12, P343, DOI 10.1023/A:1020839505622; Yang MX, 2010, APIDOLOGIE, V41, P54, DOI 10.1051/apido/2009047	76	24	26	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78637	10.1371/journal.pone.0078637	http://dx.doi.org/10.1371/journal.pone.0078637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236028	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700025
J	Rivera, A; Weidberg, N; Pardinas, AF; Gonzalez-Gil, R; Garcia-Florez, L; Acuna, JL				Rivera, Antonella; Weidberg, Nicolas; Pardinas, Antonio F.; Gonzalez-Gil, Ricardo; Garcia-Florez, Lucia; Acuna, J. L.			Role of Upwelling on Larval Dispersal and Productivity of Gooseneck Barnacle Populations in the Cantabrian Sea: Management Implications	PLOS ONE			English	Article							POLLICIPES-POLLICIPES GMELIN; GENETIC-STRUCTURE; LIKELIHOOD-ESTIMATION; MAXIMUM-LIKELIHOOD; SEASCAPE GENETICS; MARINE RESERVE; SOUTHERN BAY; NW SPAIN; RECRUITMENT; PATTERNS	The effect of coastal upwelling on the recruitment and connectivity of coastal marine populations has rarely been characterized to a level of detail to be included into sound fishery management strategies. The gooseneck barnacle (Pollicipes pollicipes) fishery at the Cantabrian Coast (Northern Spain) is located at the fringes of the NW Spanish Upwelling system. This fishery is being co-managed through a fine-scale, interspersed set of protected rocks where each rock receives a distinct level of protection. Such interspersion is potentially beneficial, but the extent to which such spacing is consistent with mean larval dispersal distances is as yet unknown. We have simulated the spread of gooseneck barnacle larvae in the Central Cantabrian Coast using a high-resolution time-series of current profiles measured at a nearshore location. During a year of high upwelling activity (2009), theoretical recruitment success was 94% with peak recruitment predicted 56 km west of the emission point. However, for a year of low upwelling activity (2011) theoretical recruitment success dropped to 15.4% and peak recruitment was expected 13 km east of the emission point. This is consistent with a positive correlation between catch rates and the Integrated Upwelling Index, using a 4-year lag to allow recruits to reach commercial size. Furthermore, a net long-term westward larval transport was estimated by means of mitochondrial cytochrome c oxidase subunit I (COI) sequences for five populations in the Cantabrian Sea. Our results call into question the role of long distance dispersal, driven by the mesoscale processes in the area, in gooseneck barnacle populations and point to the prevalent role of small-scale, asymmetric connectivity more consistent with the typical scale of the co-management process in this fishery.	[Rivera, Antonella; Weidberg, Nicolas; Pardinas, Antonio F.; Gonzalez-Gil, Ricardo; Acuna, J. L.] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Garcia-Florez, Lucia] Consejeria Agroganaderia & Recursos Autoctonos, Ctr Expt Pesquera, Gijon, Spain	University of Oviedo	Rivera, A (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain.	riveralidia@uniovi.es	Rivera, Antonella/AAM-7428-2021; Rivera, Antonella/I-5883-2016; Fernández, José Luis Acuña/I-7482-2016	Rivera, Antonella/0000-0001-8680-9115; Fernández, José Luis Acuña/0000-0003-3306-7212; Gonzalez-Gil, Ricardo/0000-0003-4377-317X; Pardinas, Antonio/0000-0001-6845-7590; Weidberg, Nicolas/0000-0001-5726-518X	Spanish Government through project COSTAS [CTM2006-05588/MAR]; Spanish Government through project DOSMARES [CTM2010-21810-C03-02]; Principality of Asturias Government through project FRENTES [IB08-122]; FPU [AP2010-5376, AP2008-03992]; AFP [BP09038]	Spanish Government through project COSTAS; Spanish Government through project DOSMARES; Principality of Asturias Government through project FRENTES; FPU(Spanish Government); AFP	This work was financed by the Spanish Government through projects COSTAS (CTM2006-05588/MAR, Ministry of Education and Science) and DOSMARES (CTM2010-21810-C03-02, Ministry of Science and Innovation), and by the Principality of Asturias Government through project FRENTES (IB08-122, FICYT). AR and RGG were supported by a FPU fellowship (ref. AP2010-5376 and AP2008-03992, respectively, Ministerio de Educacion de Espana) and AFP by a "Severo Ochoa" FICYT-PCTI fellowship (ref. BP09038, Asturias Regional Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2011, MOL ECOL, V20, P2543, DOI 10.1111/j.1365-294X.2011.05117.x; Bakun A., 1973, COASTAL UPWELLING IN; Bald J, 2006, ECOL MODEL, V194, P306, DOI 10.1016/j.ecolmodel.2005.10.024; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; BERNARD FR, 1988, FISH RES, V6, P287, DOI 10.1016/0165-7836(88)90020-3; Bertsekas D. P., 2002, INTRO PROBABILITY, V1; Bode A, 1996, HYDROBIOLOGIA, V341, P225, DOI 10.1007/BF00014687; Borja A, 2006, ICES J MAR SCI, V63, P626, DOI 10.1016/j.icesjms.2005.12.008; BOTAS JA, 1990, ESTUAR COAST SHELF S, V30, P185, DOI 10.1016/0272-7714(90)90063-W; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; CARLON DB, 1993, J EXP MAR BIOL ECOL, V173, P247, DOI 10.1016/0022-0981(93)90056-T; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruz T, 1999, J CRUSTACEAN BIOL, V19, P260, DOI 10.2307/1549232; Cruz T., 2000, BIOL ECOLOGIA PERCEB; Cruz T, 2010, J EXP MAR BIOL ECOL, V392, P200, DOI 10.1016/j.jembe.2010.04.020; De La Hoz J.J., 1993, Publicaciones Especiales Instituto Espanol de Oceanografia, V11, P65; Domingues CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035794; FARRELL TM, 1991, LIMNOL OCEANOGR, V36, P279, DOI 10.4319/lo.1991.36.2.0279; FERNANDEZ E, 1993, J PLANKTON RES, V15, P619, DOI 10.1093/plankt/15.6.619; Gaines SD, 2003, ECOL APPL, V13, pS32; Gelman A, 1998, STAT SCI, V13, P163; Hastings A, 2003, ECOL APPL, V13, pS65; Haynes R, 1990, POLEWARD FLOW ATLANT; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Isla JA, 2004, ICES J MAR SCI, V61, P526, DOI 10.1016/j.icesjms.2004.03.014; Jacinto D, 2010, ICES J MAR SCI, V67, P19, DOI 10.1093/icesjms/fsp226; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirincich AR, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002611; Largier JL, 2003, ECOL APPL, V13, pS71; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lentz SJ, 2004, J PHYS OCEANOGR, V34, P2444, DOI 10.1175/JPO2644.1; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R, 1970, LECT NOTES MATH, P275; LINDLEY JA, 1994, MAR BIOL, V120, P385, DOI 10.1007/BF00680212; Llope M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002963; Macho G, 2006, THESIS U VIGO; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Molares J, 2003, FISH RES, V65, P485, DOI 10.1016/j.fishres.2003.09.034; MOLARES J, 1994, MAR BIOL, V120, P261, DOI 10.1007/BF00349686; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; NATH HB, 1993, J MATH BIOL, V31, P841, DOI 10.1007/BF00168049; Nielsen R, 2001, GENETICS, V158, P885; Nolasco R, 2013, MAR ECOL PROG SER, V485, P123, DOI 10.3354/meps10324; Orensanz J. M., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P441; Orensanz J.M. Lobo, 2006, Developments in Aquaculture and Fisheries Science, V35, P765; Pavon MC, 2003, THESIS U OVIEDO OVIE; Pineda J, 2002, CONT SHELF RES, V22, P1183, DOI 10.1016/S0278-4343(01)00098-X; PINGREE RD, 1992, DEEP-SEA RES, V39, P1147, DOI 10.1016/0198-0149(92)90062-X; Quinteiro J, 2007, MAR BIOL, V153, P47, DOI 10.1007/s00227-007-0783-0; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Sestelo M, 2011, J SHELLFISH RES, V30, P939, DOI 10.2983/035.030.0336; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Tapia FJ, 2010, ESTUAR COAST SHELF S, V86, P265, DOI 10.1016/j.ecss.2009.11.003; Thompson J, 1978, UPWELLING ECOSYSTEMS, P203; Valde L, 2007, PROG OCEANOGR, V74, P98, DOI 10.1016/j.pocean.2007.04.016; Varela RA, 2005, J MARINE SYST, V54, P97, DOI 10.1016/j.jmarsys.2004.07.006; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1; Weidberg N, 2013, J EXP MAR BIOL ECOL, V442, P47, DOI 10.1016/j.jembe.2013.01.028; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Wolanski E., 1994, PHYS OCEANOGRAPHIC P; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	75	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78482	10.1371/journal.pone.0078482	http://dx.doi.org/10.1371/journal.pone.0078482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236020	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700017
J	Sahle, Y; Hutchings, WK; Braun, DR; Sealy, JC; Morgan, LE; Negash, A; Atnafu, B				Sahle, Yonatan; Hutchings, W. Karl; Braun, David R.; Sealy, Judith C.; Morgan, Leah E.; Negash, Agazi; Atnafu, Balemwal			Earliest Stone-Tipped Projectiles from the Ethiopian Rift Date to > 279,000 Years Ago	PLOS ONE			English	Article							PLEISTOCENE HOMO-SAPIENS; RED-SEA COAST; MIDDLE AWASH; COMPLEX COGNITION; KIBISH FORMATION; DECAY CONSTANTS; KLASIES-RIVER; MODERN HUMANS; SOUTH-AFRICA; VARIABILITY	Projectile weapons (i.e. those delivered from a distance) enhanced prehistoric hunting efficiency by enabling higher impact delivery and hunting of a broader range of animals while reducing confrontations with dangerous prey species. Projectiles therefore provided a significant advantage over thrusting spears. Composite projectile technologies are considered indicative of complex behavior and pivotal to the successful spread of Homo sapiens. Direct evidence for such projectiles is thus far unknown from >80,000 years ago. Data from velocity-dependent microfracture features, diagnostic damage patterns, and artifact shape reported here indicate that pointed stone artifacts from Ethiopia were used as projectile weapons (in the form of hafted javelin tips) as early as >279,000 years ago. In combination with the existing archaeological, fossil and genetic evidence, these data isolate eastern Africa as a source of modern cultures and biology.	[Sahle, Yonatan; Braun, David R.; Sealy, Judith C.] Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa; [Hutchings, W. Karl] Thompson Rivers Univ, Dept Sociol & Anthropol, Kamloops, BC, Canada; [Braun, David R.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Morgan, Leah E.] Scottish Univ Environm Res Ctr, E Kilbride, Lanark, Scotland; [Negash, Agazi] Univ Addis Ababa, Paleoanthropol & Paleoenvironm Program, Addis Ababa, Ethiopia; [Atnafu, Balemwal] Univ Addis Ababa, Dept Earth Sci, Addis Ababa, Ethiopia	University of Cape Town; George Washington University; Scottish Universities Research & Reactor Center; Addis Ababa University; Addis Ababa University	Sahle, Y (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA.	yonatan.chemere@uct.ac.za		Sealy, Judith/0000-0001-5071-8211; Sahle, Yonatan/0000-0003-1098-1685; Morgan, Leah/0000-0001-9930-524X	University of Cape Town's Center for African Origins initiative; Paleontological Scientific Trust (Scatterlings of Africa Program); Wenner-Gren Foundation; Marie Curie Fellowship program; NERC [aif10001] Funding Source: UKRI; Natural Environment Research Council [aif10001] Funding Source: researchfish	University of Cape Town's Center for African Origins initiative; Paleontological Scientific Trust (Scatterlings of Africa Program); Wenner-Gren Foundation; Marie Curie Fellowship program(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	University of Cape Town's Center for African Origins initiative and the Paleontological Scientific Trust (Scatterlings of Africa Program) financially supported research. Wenner-Gren Foundation supported YS's doctoral study. The Marie Curie Fellowship program supported LEM's post-doctoral study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basell LS, 2008, QUATERNARY SCI REV, V27, P2484, DOI 10.1016/j.quascirev.2008.09.010; Beyin A, 2013, QUATERN INT, V300, P195, DOI 10.1016/j.quaint.2013.02.015; Boeda E, 1999, ANTIQUITY, V73, P394, DOI 10.1017/S0003598X00088335; Brooks A, MULTIDISCIP IN PRESS; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; Fischer A., 1984, J DAN ARCHAEOL, V3, P19, DOI DOI 10.1080/0108464X.1984.10589910; Fisher SE, 2013, SCIENCE, V340, P929, DOI 10.1126/science.1236171; Haynes C.V., 1980, CAN J ANTHROPOL, V1, P115; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hutchings WK, 2011, J ARCHAEOL SCI, V38, P1737, DOI 10.1016/j.jas.2011.03.005; Iovita R, 2014, J ARCHAEOL SCI, V48, P73, DOI 10.1016/j.jas.2013.01.031; Klein R., 2002, DAWN HUMAN CULTURE; Kurashina H., 1978, EXAMINATION PREHISTO; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lombard M, 2012, CAMB ARCHAEOL J, V22, P237, DOI 10.1017/S095977431200025X; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Negash A., 2010, SINET ETHIOP J SCI, V33, P21; Negash A, 2011, ARCHAEOMETRY, V53, P661, DOI 10.1111/j.1475-4754.2010.00579.x; Newman K, 2013, J ARCHAEOL SCI, V40, P2614, DOI 10.1016/j.jas.2013.01.023; Pargeter J, 2013, J ARCHAEOL SCI, V40, P4056, DOI 10.1016/j.jas.2013.05.021; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Ravi-Chandar K, 2004, DYNAMIC FRACTURE; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Sano K., 2009, QUARTAR, V56, P67; Shea J, 2001, J ARCHAEOL SCI, V28, P807, DOI 10.1006/jasc.2000.0590; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; Shea JJ, 2012, CURR ANTHROPOL, V53, P130, DOI 10.1086/663334; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Sisk Matthew L, 2011, Int J Evol Biol, V2011, P968012, DOI 10.4061/2011/968012; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Tomenchuk, 1985, THESIS U TORONTO TOR; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Vogel N, 2006, J ARCHAEOL SCI, V33, P1749, DOI 10.1016/j.jas.2006.03.008; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; WENDORF F, 1993, QUATERNARIA NOVA, V3, P39; Wendorf F., 1974, MIDDLE STONE AGE SEQ; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wilkins J, 2012, SCIENCE, V338, P942, DOI 10.1126/science.1227608; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; Yellen John, 2005, Paleoanthropology, V3, P25; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	63	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78092	10.1371/journal.pone.0078092	http://dx.doi.org/10.1371/journal.pone.0078092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236011	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000327254700008
J	Shu, CC; Chatterjee, A; Hu, WS; Ramkrishna, D				Shu, Che-Chi; Chatterjee, Anushree; Hu, Wei-Shou; Ramkrishna, Doraiswami			Role of Intracellular Stochasticity in Biofilm Growth. Insights from Population Balance Modeling	PLOS ONE			English	Article							FAECALIS PLASMID PCF10; PHEROMONE-INDUCIBLE CONJUGATION; CELLULAR-AUTOMATON APPROACH; ENTEROCOCCUS-FAECALIS; GENE-EXPRESSION; STEADY-STATE; ANTIBIOTIC-RESISTANCE; AGGREGATION SUBSTANCE; BACTERIAL PHEROMONE; PERSISTER CELLS	There is increasing recognition that stochasticity involved in gene regulatory processes may help cells enhance the signal or synchronize expression for a group of genes. Thus the validity of the traditional deterministic approach to modeling the foregoing processes cannot be without exception. In this study, we identify a frequently encountered situation, i.e., the biofilm, which has in the past been persistently investigated with intracellular deterministic models in the literature. We show in this paper circumstances in which use of the intracellular deterministic model appears distinctly inappropriate. In Enterococcus faecalis, the horizontal gene transfer of plasmid spreads drug resistance. The induction of conjugation in planktonic and biofilm circumstances is examined here with stochastic as well as deterministic models. The stochastic model is formulated with the Chemical Master Equation (CME) for planktonic cells and Reaction-Diffusion Master Equation (RDME) for biofilm. The results show that although the deterministic model works well for the perfectly-mixed planktonic circumstance, it fails to predict the averaged behavior in the biofilm, a behavior that has come to be known as stochastic focusing. A notable finding from this work is that the interception of antagonistic feedback loops to signaling, accentuates stochastic focusing. Moreover, interestingly, increasing particle number of a control variable could lead to an even larger deviation. Intracellular stochasticity plays an important role in biofilm and we surmise by implications from the model, that cell populations may use it to minimize the influence from environmental fluctuation.	[Shu, Che-Chi; Ramkrishna, Doraiswami] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Chatterjee, Anushree; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities	Ramkrishna, D (corresponding author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.	ramkrish@purdue.edu		Shu, Che-Chi/0000-0002-6930-1050	National Institutes of Health [GM081888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM081888) to WSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVIN E, 1990, WATER SCI TECHNOL, V22, P171, DOI 10.2166/wst.1990.0145; Bae T, 2004, MOL MICROBIOL, V51, P271, DOI 10.1046/j.1365-2958.2003.03832.x; Baras F, 1996, PHYS REV E, V54, P6139, DOI 10.1103/PhysRevE.54.6139; Bensing BA, 1997, MOL MICROBIOL, V24, P295, DOI 10.1046/j.1365-2958.1997.3311709.x; Bradie B, 2006, FRIENDLY INTRO NUMER; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cao Y, 2006, J CHEM PHYS, P124; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; CHUNG JW, 1995, J BACTERIOL, V177, P2118, DOI 10.1128/jb.177.8.2118-2124.1995; Cook L, 2011, MOL MICROBIOL, V81, P1499, DOI 10.1111/j.1365-2958.2011.07786.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dillon R, 1996, J COMPUT PHYS, V129, P57, DOI 10.1006/jcph.1996.0233; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fixen KR, 2007, J BACTERIOL, V189, P1399, DOI 10.1128/JB.01226-06; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hirt H, 2005, J BACTERIOL, V187, P1044, DOI 10.1128/JB.187.3.1044-1054.2005; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kozlowicz BK, 2006, INT J MED MICROBIOL, V296, P141, DOI 10.1016/j.ijmm.2006.01.040; Kozlowicz BK, 2004, MOL MICROBIOL, V54, P520, DOI 10.1111/j.1365-2958.2004.04286.x; Kozlowicz BK, 2006, MOL MICROBIOL, V62, P958, DOI 10.1111/j.1365-2958.2006.05434.x; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.0.CO;2-O; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Ramkrishna D., 2000, POPULATION BALANCES; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; RITTMANN BE, 1980, BIOTECHNOL BIOENG, V22, P2343, DOI 10.1002/bit.260221110; RITTMANN BE, 1992, BIOTECHNOL BIOENG, V39, P914, DOI 10.1002/bit.260390906; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Samoilov MS, 2006, NAT BIOTECHNOL, V24, P1235, DOI 10.1038/nbt1253; SHAH BH, 1977, AICHE J, V23, P897, DOI 10.1002/aic.690230617; Shi K., 2005, Abstracts of the General Meeting of the American Society for Microbiology, V105, P307; Shu CC, 2012, CHEM ENG SCI, V70, P188, DOI 10.1016/j.ces.2011.07.062; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wimpenny JWT, 1997, FEMS MICROBIOL ECOL, V22, P1, DOI 10.1111/j.1574-6941.1997.tb00351.x	66	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79196	10.1371/journal.pone.0079196	http://dx.doi.org/10.1371/journal.pone.0079196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232571	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700105
J	Shutto, Y; Shimada, M; Kitajima, M; Yamabe, H; Saitoh, Y; Saitoh, H; Razzaque, MS				Shutto, Yoshiko; Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki; Saitoh, Yoko; Saitoh, Hisao; Razzaque, Mohammed S.			Inadequate Awareness among Chronic Kidney Disease Patients Regarding Food and Drinks Containing Artificially Added Phosphate	PLOS ONE			English	Article							SOFT-TISSUE CALCIFICATION; SERUM PHOSPHATE; CARDIOVASCULAR-DISEASE; GENETIC-EVIDENCE; METABOLISM; RISK; MORTALITY; CALCIUM; HOMEOSTASIS; TOXICITY	Hyperphosphatemia is an important determinant of morbidity and mortality in patients with chronic kidney disease (CKD). Patients with CKD are advised to consume a low phosphate diet and are often prescribed phosphate-lowering drug therapy. However, commercially processed food and drinks often contain phosphate compounds, but the phosphate level is not usually provided in the ingredient list, which makes it difficult for CKD patients to choose a correct diet. We conducted a survey of the awareness of food/beverages containing artificially added phosphate among CKD patients undergoing hemodialysis. The subjects were 153 patients (77 males and 76 females; average age 56611 years) who were randomly selected from the Dialysis Center of Hirosaki City, Japan. The subjects were provided with a list of questions. The survey results showed that 93% of the subjects were aware of the presence of high sugar content in soda, whereas only 25% were aware of the presence of phosphate (phosphoric acid) in such drinks. Despite 78% of the subjects being aware of the detrimental effects of consumption of a high phosphate diet, 43% drank at least 1 to 5 cans of soda per week and about 17% consumed "fast food" once each week. We also assessed the immediate effects of high-phosphate containing carbonated soda consumption by determining urinary calcium, phosphate, protein and sugar contents in overnight fasted healthy volunteers (n = 55; average age 20.7+/-60.3 years old, 20 males and 35 females). Significantly higher urinary calcium (adjusted using urinary creatinine) excretion was found 2 h after consuming 350 ml of carbonated soda compared to the fasting baseline level (0.156+/-0.01 vs. 0.096+/-0.01, p = 0.001). Our survey results suggest that CKD patients undergoing hemodialysis are not adequately aware of the hidden source of phosphate in their diet, and emphasize the need for educational initiatives to raise awareness of this issue among CKD patients.	[Shutto, Yoshiko] Hirosaki Univ, Grad Sch Hlth Sci, Dept Hlth Promot, Hirosaki, Aomori, Japan; [Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori, Japan; [Saitoh, Yoko; Saitoh, Hisao] Hirosaki Hosp, Oyokyo Kidney Res Inst, Hirosaki, Aomori, Japan; [Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Hirosaki University; Hirosaki University; Harvard University; Harvard School of Dental Medicine	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019		National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel T, 2010, NEPHROL DIAL TRANSPL, V25, P3241, DOI 10.1093/ndt/gfq161; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Econs MJ, 1999, BONE, V25, P131, DOI 10.1016/S8756-3282(99)00108-8; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Fukagawa M, 2006, J BONE MINER METAB, V24, P434, DOI 10.1007/s00774-006-0719-7; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Ketteler M, 2009, BLOOD PURIFICAT, V27, P345, DOI 10.1159/000209247; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z; Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2013, CONTRIB NEPHROL, V180, P74, DOI 10.1159/000346784; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Shutto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029105; Sigrist MK, 2009, J RENAL CARE, V35, P71, DOI 10.1111/j.1755-6686.2009.00064.x; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	31	20	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78660	10.1371/journal.pone.0078660	http://dx.doi.org/10.1371/journal.pone.0078660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236030	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700027
J	Stammler, A; Muller, D; Tabuchi, Y; Konrad, L; Middendorff, R				Stammler, Angelika; Mueller, Dieter; Tabuchi, Yoshiaki; Konrad, Lutz; Middendorff, Ralf			TGF beta s Modulate Permeability of the Blood-Epididymis Barrier in an In Vitro Model	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA-3; TIGHT JUNCTIONS; RAT EPIDIDYMIS; TESTIS BARRIER; CYCLIC-GMP; MICE; EXPRESSION; OCCLUDIN; GROWTH-FACTOR-BETA-1; PROTEINS	The blood-epididymis barrier (BEB) is formed by epithelial tight junctions mediating selective permeability of the epididymal epithelium. Defective barrier function can disturb the balance of the epididymal milieu, which may result in infertility. The stroma of the epididymis contains high amounts of cytokines of the TGF beta family of unknown function. We screened possible effects of all three TGF beta isoforms on paracellular tightness in a BEB in vitro model based on the strongly polarized mouse epididymal epithelial MEPC5 cells in the transwell system. In this model we found a robust transepithelial electrical resistance (TER) of about 840 Omega x cm(2). Effects on the paracellular permeability were evaluated by two methods, TER and FITC-Dextran-based tracer diffusion assays. Both assays add up to corresponding results indicating a time-dependent disturbance of the BEB differentially for the three TGF beta isoforms (TGF beta 3>TGF beta 1>TGF beta 2) in a TGF beta-recetor-1 kinase- and Smad-dependent manner. The tight junction protein claudin-1 was found to be reduced by the treatment with TGF beta s, whereas occludin was not influenced. Epididymal epithelial cells are predominantly responsive to TGF beta s from the basolateral side, suggesting that TGF beta may have an impact on the epididymal epithelium from the stroma in vivo. Our data show for the first time that TGF beta s decrease paracellular tightness in epididymal epithelial cells, thus establishing a novel mechanism of regulation of BEB permeability, which is elementary for sperm maturation and male fertility.	[Stammler, Angelika; Mueller, Dieter; Middendorff, Ralf] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Stammler, Angelika; Konrad, Lutz] Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany; [Tabuchi, Yoshiaki] Toyama Univ, Grad Sch Med Pharmaceut Sci, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Toyama	Konrad, L (corresponding author), Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany.	Lutz.Konrad@gyn.med.uni-giessen.de; Ralf.Middendorff@anatomie.med.uni-giessen.de		Tabuchi, Yoshiaki/0000-0002-6007-6176	state of Hesse, Germany	state of Hesse, Germany	This project is part of LOEWE Focus Group Male Infertility and Urogenital Infections (MIBIE) funded by state of Hesse, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Bomgardner D, 1999, J ANDROL, V20, P375; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cyr DG, 2007, ASIAN J ANDROL, V9, P463, DOI 10.1111/j.1745-7262.2007.00308.x; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desai KV, 1998, CELL TISSUE RES, V294, P271, DOI 10.1007/s004410051177; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dube E, 2010, BIOL REPROD, V82, P1119, DOI 10.1095/biolreprod.109.083196; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gregory M, 2006, MOL REPROD DEV, V73, P580, DOI 10.1002/mrd.20467; Henderson NA, 2006, J ENDOCRINOL, V190, P779, DOI 10.1677/joe.1.06862; Hinton BT, 2011, J ANDROL, V32, P558, DOI 10.2164/jandrol.111.013029; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Middendorff R, 2002, J CLIN ENDOCR METAB, V87, P3486, DOI 10.1210/jc.87.7.3486; Mochizuki T, 2009, BIOSCI BIOTECH BIOCH, V73, P2422, DOI 10.1271/bbb.90383; Muller D, 2010, MOL CELL ENDOCRINOL, V320, P118, DOI 10.1016/j.mce.2010.01.022; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; SHULL MM, 1994, MOL REPROD DEV, V39, P239, DOI 10.1002/mrd.1080390218; Siu ER, 2009, ENDOCRINOLOGY, V150, P3336, DOI 10.1210/en.2008-1741; Tabuchi Y, 2005, BIOCHEM BIOPH RES CO, V329, P812, DOI 10.1016/j.bbrc.2005.02.066; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	39	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80611	10.1371/journal.pone.0080611	http://dx.doi.org/10.1371/journal.pone.0080611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236189	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700192
J	Zhou, ZZ; Li, WN; Song, Y; Wang, LL; Zhang, K; Yang, J; Zhang, W; Su, HC; Zhang, YQ				Zhou, Zhizhong; Li, Weina; Song, Yang; Wang, Lili; Zhang, Kuo; Yang, Jing; Zhang, Wei; Su, Haichuan; Zhang, Yingqi			Growth Differentiation Factor-15 Suppresses Maturation and Function of Dendritic Cells and Inhibits Tumor-Specific Immune Response	PLOS ONE			English	Article							TGF-BETA; CANCER; EXPRESSION; MIC-1; PROGNOSIS; MECHANISM; CARCINOMA	Dendritic cells (DCs) play a key role in the initiation stage of an antigen-specific immune response. A variety of tumor-derived factors (TDFs) can suppress DC maturation and function, resulting in defects in the tumor-specific immune response. To identify unknown TDFs that may suppress DCs maturation and function, we established a high-throughput screening technology based on a human liver tumor T7 phage cDNA library and screened all of the proteins derived from hepatoma cells that potentially interact with immature DCs. Growth/differentiation factor-15 (GDF-15) was detected and chosen for further study. By incubation of DCs cultures with GDF-15, we demonstrate that GDF-15 can inhibit surface protrusion formation during DC maturation; suppress the membrane expression of CD83, CD86 and HLA-DR on DCs; enhance phagocytosis by DCs; reduce IL-12 and elevate TGF-beta 1 secretion by DCs; inhibit T cell stimulation and cytotoxic T lymphocyte (CTL) activation by DCs. By building tumor-bearing mouse models, we demonstrate that GDF-15 can inhibit the ability of DCs to stimulate a tumor-specific immune response in vivo. These results indicate that GDF-15 may be one of the critical molecules that inhibit DC maturation and function and are involved in tumor immune escape. Thus, GDF-15 may be a novel target in tumor immunotherapy.	[Zhou, Zhizhong; Li, Weina; Wang, Lili; Zhang, Wei; Zhang, Yingqi] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Zhou, Zhizhong; Li, Weina; Wang, Lili; Zhang, Wei; Zhang, Yingqi] Fourth Mil Med Univ, Dept Biopharmaceut, Xian 710032, Shaanxi, Peoples R China; [Song, Yang; Yang, Jing; Su, Haichuan] Tangdu Hosp, Dept Oncol, Xian, Shaanxi, Peoples R China; [Zhang, Kuo] Northwest Univ, Sch Life Sci, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an	Zhang, W (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	zhangw90@fmmu.edu.cn; suhc@fmmu.edu.cn; zhangyqh@fmmu.edu.cn	wang, lili/HDL-7210-2022		Natural Science Foundation of China (NSFC) [81171978]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Natural Science Foundation of China (NSFC No 81171978, http://isisn.nsfc.gov.cn/egrantweb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Dong Zhi-wei, 2013, Zhonghua Shao Shang Za Zhi, V29, P41; Fainaru O, 2007, GENES IMMUN, V8, P239, DOI 10.1038/sj.gene.6364380; Fricke I, 2006, IMMUNOL INVEST, V35, P459, DOI 10.1080/08820130600803429; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Li R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-19; Manna PP, 2013, CYTOKINE, V61, P118, DOI 10.1016/j.cyto.2012.09.004; Michielsen AJ, 2012, ONCOIMMUNOLOGY, V1, P751, DOI 10.4161/onci.19570; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Soucek K, 2010, HUM REPROD, V25, P2962, DOI 10.1093/humrep/deq264; Suesskind D, 2012, GRAEF ARCH CLIN EXP, V250, P887, DOI 10.1007/s00417-011-1786-6; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	23	41	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78618	10.1371/journal.pone.0078618	http://dx.doi.org/10.1371/journal.pone.0078618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236027	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700024
J	Atzema, CL; Austin, PC; Wu, LB; Brzozowski, M; Feldman, MJ; McDonnell, M; Mazurik, L				Atzema, Clare L.; Austin, Peter C.; Wu, Libo; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie			Speak Fast, Use Jargon, and Don't Repeat Yourself: A Randomized Trial Assessing the Effectiveness of Online Videos to Supplement Emergency Department Discharge Instructions	PLOS ONE			English	Article							CARE; COMPREHENSION; INFORMATION; QUALITY	Background: Emergency department discharge instructions are variably understood by patients, and in the setting of emergency department crowding, innovations are needed to counteract shortened interaction times with the physician. We evaluated the effect of viewing an online video of diagnosis-specific discharge instructions on patient comprehension and recall of instructions. Methods: In this prospective, single-center, randomized controlled trial conducted between November 2011 and January 2012, we randomized emergency department patients who were discharged with one of 38 diagnoses to either view (after they left the emergency department) a vetted online video of diagnosis-specific discharge instructions, or to usual care. Patients were subsequently contacted by telephone and asked three standardized questions about their discharge instructions; one point was awarded for each correct answer. Using an intention-to-treat analysis, differences between groups were assessed using univariate testing, and with logistic regression that accounted for clustering on managing physician. A secondary outcome measure was patient satisfaction with the videos, on a 10-point scale. Results: Among 133 patients enrolled, mean age was 46.1 (s.d.D. 21.5) and 55% were female. Patients in the video group had 19% higher mean scores (2.5, s.d. 0.7) than patients in the control group (2.1, s.d. 0.8) (p=0.002). After adjustment for patient age, sex, first language, triage acuity score, and clustering, the odds of achieving a fully correct score (3 out of 3) were 3.5 (95% CI, 1.7 to 7.2) times higher in the video group, compared to the control group. Among those who viewed the videos, median rating of the videos was 10 (IQR 8 to 10). Conclusions: In this single-center trial, patients who viewed an online video of their discharge instructions scored higher on their understanding of key concepts around their diagnosis and subsequent care. Those who viewed the videos found them to be a helpful addition to standard care.	[Atzema, Clare L.; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Atzema, Clare L.; Wu, Libo; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Atzema, Clare L.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Atzema, CL (corresponding author), Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada.	clare.atzema@ices.on.ca		Austin, Peter/0000-0003-3337-233X; Atzema, Clare/0000-0002-7236-5522	Academic Physician's Fund (AFP); Department of Emergency Services at Sunnybrook Health Sciences Centre; Department of Medicine, University of Toronto; Sunnybrook Research Institute; Heart and Stroke Foundation	Academic Physician's Fund (AFP); Department of Emergency Services at Sunnybrook Health Sciences Centre; Department of Medicine, University of Toronto(University of Toronto); Sunnybrook Research Institute(University of Toronto); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This project was supported by a grant from the Academic Physician's Fund (AFP). Dr. Atzema is supported by the Practice Plan of the Department of Emergency Services at Sunnybrook Health Sciences Centre, the Department of Medicine, University of Toronto, and the Sunnybrook Research Institute. Dr. Austin is supported by a Career Investigator award from the Heart and Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambulatory and Hospital Care Statistics Branch, 2013, NAT HOSP AMB MED CAR; Atzema CL, 2012, INT J CLIN MED, V3, P758, DOI [10.4236/ijcm.2012.37A133, DOI 10.4236/IJCM.2012.37A133]; AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5; Beveridge R., 1998, IMPLEMENTATION GUIDE; Chan BT, 2001, ATLAS REPORT EMERGEN; Choi S, 2009, SOUTH MED J, V102, P239, DOI 10.1097/SMJ.0b013e318197f319; Clark PA, 2005, PATIENT EDUC COUNS, V59, P56, DOI 10.1016/j.pec.2004.09.010; Clarke Collin, 2005, CJEM, V7, P5; Dalkey NC, 1969, DELPHI METHOD EXPT A; Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS), 2008, REV APP A INT GUID H; Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; Institute of Medicine, 2006, HOSP BAS EM CAR BREA; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Johnson A., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003716; Kawano T, 2013, EMERG MED J; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1111/j.1553-2712.2002.tb01567.x; Mace CA, 1962, PSYCHOL STUDY; Miro O, 1999, Eur J Emerg Med, V6, P105; Papa L, 2008, CAN J EMERG MED, V10, P347; Rhodes KV, 2004, ANN EMERG MED, V44, P262, DOI 10.1016/j.annemergmed.2004.02.035; Rowe B, 2006, FREQUENCY DETERMINEN; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; The World Bank, 2012, INT US PER 100 PEOPL; VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640; Waisman Y, 2003, ISRAEL MED ASSOC J, V5, P567; Waisman Y, 2005, EUR J EMERG MED, V12, P159, DOI 10.1097/00063110-200508000-00003	29	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77057	10.1371/journal.pone.0077057	http://dx.doi.org/10.1371/journal.pone.0077057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244272	gold, Green Submitted, Green Published			2022-12-25	WOS:000327221600006
J	Healy, B; Field, D; O'Connor, PM; Hill, C; Cotter, PD; Ross, RP				Healy, Brian; Field, Des; O'Connor, Paula M.; Hill, Colin; Cotter, Paul D.; Ross, R. Paul			Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives	PLOS ONE			English	Article							PRECURSOR LIPID-II; LANTIBIOTIC NISIN; BIOSYNTHESIS; MODE; PEPTIDES; VARIANT; IDENTIFICATION; BACTERIOCINS; ANTIBIOTICS; IMMUNITY	Nisin A is the most extensively studied lantibiotic and has been used as a preservative by the food industry since 1953. This 34 amino acid peptide contains three dehydrated amino acids and five thioether rings. These rings, resulting from one lanthionine and four methyllanthionine bridges, confer the peptide with its unique structure. Nisin A has two mechanisms of action, with the N-terminal domain of the peptide inhibiting cell wall synthesis through lipid II binding and the C-terminal domain responsible for pore-formation. The focus of this study is the three amino acid 'hinge' region (N 20, M 21 and K 22) which separates these two domains and allows for conformational flexibility. As all lantibiotics are gene encoded, novel variants can be generated through manipulation of the corresponding gene. A number of derivatives in which the hinge region was altered have previously been shown to possess enhanced antimicrobial activity. Here we take this approach further by employing simultaneous, indiscriminate site-saturation mutagenesis of all three hinge residues to create a novel bank of nisin derivative producers. Screening of this bank revealed that producers of peptides with hinge regions consisting of AAK, NAI and SLS displayed enhanced bioactivity against a variety of targets. These and other results suggested a preference for small, chiral amino acids within the hinge region, leading to the design and creation of producers of peptides with hinges consisting of AAA and SAA. These producers, and the corresponding peptides, exhibited enhanced bioactivity against Lactococcus lactis HP, Streptococcus agalactiae ATCC 13813, Mycobacterium smegmatis MC2155 and Staphylococcus aureus RF122 and thus represent the first example of nisin derivatives that possess enhanced activity as a consequence of rational design.	[Healy, Brian; Field, Des; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O'Connor, Paula M.; Hill, Colin; Cotter, Paul D.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University College Cork; Teagasc	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.	c.hill@ucc.ie; paul.cotter@teagasc.ie	Cotter, Paul/B-7781-2008; Field, Des/AAU-6785-2021; Ross, Paul/A-7584-2015; Hill, Colin/A-5611-2012; Cotter, Paul/AAX-5449-2021; STANTON, CATHERINE/A-9549-2015	Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; O'Connor, Paula M./0000-0001-6462-2077; Healy, Brian/0000-0002-8752-0548	Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure [08/RD/C/691]; Science Foundation Investigator award [10/IN.1/B3027]	Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure; Science Foundation Investigator award	This work was financed by a grant from the Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure (08/RD/C/691) and with Science Foundation Investigator award (10/IN.1/B3027). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MOL MICROBIOL, V78, P1077, DOI 10.1111/j.1365-2958.2010.07406.x; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Healy B, 2010, ADV M C M, P22, DOI 10.1079/9781845936570.0022; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Molloy EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058530; Molloy EM, 2012, BIOCHEM SOC T, V40, P1492, DOI 10.1042/BST20120193; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; Nov Y, 2012, APPL ENVIRON MICROB, V78, P258, DOI 10.1128/AEM.06265-11; Plat A, 2011, POLYMERS-BASEL, V3, P1282, DOI 10.3390/polym3031282; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1; Zendo T, 2003, BIOSCI BIOTECH BIOCH, V67, P1616, DOI 10.1271/bbb.67.1616; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P18361, DOI 10.1073/pnas.1210393109	35	53	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79563	10.1371/journal.pone.0079563	http://dx.doi.org/10.1371/journal.pone.0079563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244524	gold, Green Published			2022-12-25	WOS:000327221600134
J	Kneissl, S; Zhou, Q; Schwenkert, M; Cosset, FL; Verhoeyen, E; Buchholz, CJ				Kneissl, Sabrina; Zhou, Qi; Schwenkert, Michael; Cosset, Francois-Loic; Verhoeyen, Els; Buchholz, Christian J.			CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; CHAIN FV ANTIBODY; MEASLES-VIRUS; LENTIVIRAL VECTORS; GENE-TRANSFER; T-CELLS; CYCLE PROGRESSION; TRANSDUCTION; EXPRESSION; ENTRY	B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors. Lately, we demonstrated that lentiviral vectors pseudotyped with modified measles virus (MV) glycoproteins hemagglutinin, responsible for receptor recognition, and fusion protein were able to overcome this transduction block. They use either the natural MV receptors, CD46 and signaling lymphocyte activation molecule (SLAM), for cell entry (MV-LV) or the vector particles were further modified to selectively enter via the CD20 molecule, which is exclusively expressed on B lymphocytes (CD20-LV). It has been shown previously that transduction by MV-LV does not induce B lymphocyte activation. However, if this is also true for CD20-LV is still unknown. Here, we generated a vector specific for another B lymphocyte marker, CD19, and compared its ability to transduce resting B lymphocytes with CD20-LV. The vector (CD19ds-LV) was able to stably transduce unstimulated B lymphocytes, albeit with a reduced efficiency of about 10% compared to CD20-LV, which transduced about 30% of the cells. Since CD20 as well as CD19 are closely linked to the B lymphocyte activation pathway, we investigated if engagement of CD20 or CD19 molecules by the vector particles induces activating stimuli in resting B lymphocytes. Although, activation of B lymphocytes often involves calcium influx, we did not detect elevated calcium levels. However, the activation marker CD71 was substantially up-regulated upon CD20-LV transduction and most importantly, B lymphocytes transduced with CD20-LV or CD19ds-LV entered the G1b phase of cell cycle, whereas untransduced or MV-LV transduced B lymphocytes remained in G0. Hence, CD20 and CD19 targeting vectors induce activating stimuli in resting B lymphocytes, which most likely renders them susceptible for lentiviral vector transduction.	[Kneissl, Sabrina; Zhou, Qi; Buchholz, Christian J.] Paul Ehrlich Inst, Langen, Germany; [Schwenkert, Michael] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Cosset, Francois-Loic; Verhoeyen, Els] Univ Lyon 1, ENS Lyon, Inserm U1111, CIRI,Int Ctr Infectiol Res,EVIR Team,CNRS,UMR5308, F-69365 Lyon, France; [Verhoeyen, Els] Fac Med Nice, INSERM, U895, Ctr Med Mol C3M,Equipe 3, F-06034 Nice, France	Paul Ehrlich Institute; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Buchholz, CJ (corresponding author), Paul Ehrlich Inst, Langen, Germany.	Christian.Buchholz@pei.de	Verhoeyen, Els/AAW-4853-2021; Verhoeyen, Els/H-6360-2016; Cosset, François-Loïc/M-5862-2019	Verhoeyen, Els/0000-0001-9224-5491; Cosset, François-Loïc/0000-0001-8842-3726; Buchholz, Christian/0000-0002-9837-7345	Federal Ministry for Education and Research of Germany as part of Ci3 Cluster [031A024C]; LOEWE Center for Cell and Gene Therapy; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004 [2010]]; China Scholarship Council; DFG Graduiertenkolleg [GRK1172]	Federal Ministry for Education and Research of Germany as part of Ci3 Cluster; LOEWE Center for Cell and Gene Therapy; Hessisches Ministerium fur Wissenschaft und Kunst; China Scholarship Council(China Scholarship Council); DFG Graduiertenkolleg(German Research Foundation (DFG))	This work was supported by grant 031A024C of the Federal Ministry for Education and Research of Germany as part of the Ci3 Cluster and by the LOEWE Center for Cell and Gene Therapy Frankfurt funded by Hessisches Ministerium fur Wissenschaft und Kunst (III L 4-518/17.004 [2010]) to CJB. QZ was supported by the China Scholarship Council and is an associated member of the DFG Graduiertenkolleg GRK1172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Bruenke J, 2005, BRIT J HAEMATOL, V130, P218, DOI 10.1111/j.1365-2141.2005.05414.x; Bucheit AD, 2003, MOL THER, V7, P62, DOI 10.1016/S1525-0016(02)00033-3; Buchholz CJ, 2009, TRENDS BIOTECHNOL, V27, P259, DOI 10.1016/j.tibtech.2009.02.002; Cragg Mark S., 2005, V8, P140; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Frecha C, 2011, J VIROL, V85, P5975, DOI 10.1128/JVI.00324-11; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Frecha C, 2008, BLOOD, V112, P4843, DOI 10.1182/blood-2008-05-155945; Fujimoto M, 2001, J BIOL CHEM, V276, P44820, DOI 10.1074/jbc.M107559200; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Ginaldi L, 1998, J CLIN PATHOL, V51, P364, DOI 10.1136/jcp.51.5.364; GOLAY JT, 1985, J IMMUNOL, V135, P3795; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; ITOH K, 1989, EXP HEMATOL, V17, P145; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Kneissl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046667; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Kugler M, 2009, PROTEIN ENG DES SEL, V22, P135, DOI 10.1093/protein/gzn079; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Li XL, 1997, J IMMUNOL, V158, P5649; Munch RC, 2011, MOL THER, V19, P686, DOI 10.1038/mt.2010.298; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Peipp M, 2004, J IMMUNOL METHODS, V285, P265, DOI 10.1016/j.jim.2003.12.001; PEZZUTTO A, 1987, J IMMUNOL, V138, P2793; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; Serafini M, 2004, VIROLOGY, V325, P413, DOI 10.1016/j.virol.2004.04.038; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zanetti M, 2004, IMMUNOL REV, V199, P264, DOI 10.1111/j.0105-2896.2004.00152.x; Zhou Q, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22566; Zhou Q, 2012, BLOOD, V120, P4334, DOI 10.1182/blood-2012-02-412973; Zhou Q, 2011, VIROLOGY, V413, P149, DOI 10.1016/j.virol.2011.02.010; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79047	10.1371/journal.pone.0079047	http://dx.doi.org/10.1371/journal.pone.0079047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244415	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600102
J	Ren, Z				Ren, Zhong			Reaction Trajectory Revealed by a Joint Analysis of Protein Data Bank	PLOS ONE			English	Article							RESOLUTION CRYSTAL-STRUCTURES; QUATERNARY STRUCTURE; STRUCTURAL-CHANGES; HUMAN HEMOGLOBIN; ALLOSTERIC TRANSITIONS; LIGAND-BINDING; T-STATE; DYNAMICS; INSIGHTS; STEREOCHEMISTRY	Structural motions along a reaction pathway hold the secret about how a biological macromolecule functions. If each static structure were considered as a snapshot of the protein molecule in action, a large collection of structures would constitute a multidimensional conformational space of an enormous size. Here I present a joint analysis of hundreds of known structures of human hemoglobin in the Protein Data Bank. By applying singular value decomposition to distance matrices of these structures, I demonstrate that this large collection of structural snapshots, derived under a wide range of experimental conditions, arrange orderly along a reaction pathway. The structural motions along this extensive trajectory, including several helical transformations, arrive at a reverse engineered mechanism of the cooperative machinery (Ren, companion article), and shed light on pathological properties of the abnormal homotetrameric hemoglobins from alpha-thalassemia. This method of meta-analysis provides a general approach to structural dynamics based on static protein structures in this post genomics era.	[Ren, Zhong] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL 60439 USA; [Ren, Zhong] Renz Res Inc, Westmont, IL USA	University of Chicago	Ren, Z (corresponding author), Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL 60439 USA.	renzresearch@gmail.com			National Institutes of Health, National Center for Research Resources [RR007707]; National Institute of General Medical Sciences [8P41GM103543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103543] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research funding is provided by the National Institutes of Health, National Center for Research Resources (ncrr.nih.gov), under grant number RR007707, and by the National Institute of General Medical Sciences (nigms.nih.gov), under grant number 8P41GM103543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author declares no competing financial interests.	Abbruzzetti S, 2001, CHEM PHYS LETT, V346, P430, DOI 10.1016/S0009-2614(01)01027-2; Adachi S, 2003, P NATL ACAD SCI USA, V100, P7039, DOI 10.1073/pnas.1230629100; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Balasubramanian M, 2009, ACTA CRYSTALLOGR F, V65, P313, DOI 10.1107/S1744309109004503; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P831, DOI 10.1006/jmbi.1994.1192; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P817, DOI 10.1006/jmbi.1994.1191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butts CP, 2011, ORG BIOMOL CHEM, V9, P177, DOI 10.1039/c0ob00479k; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; Dey S, 2011, PROTEINS, V79, P2861, DOI 10.1002/prot.23112; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; Fischer S, 2011, P NATL ACAD SCI USA, V108, P5608, DOI 10.1073/pnas.1011995108; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; GODZIK A, 1993, PROTEIN ENG, V6, P801, DOI 10.1093/protein/6.8.801; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Kidd RD, 2001, PROTEIN SCI, V10, P1739, DOI 10.1110/ps.11701; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kloczkowski Andrzej, 2009, Journal of Structural and Functional Genomics, V10, P67, DOI 10.1007/s10969-009-9062-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kroeger KS, 1997, STRUCTURE, V5, P227, DOI 10.1016/S0969-2126(97)00181-0; LIDDINGTON R, 1988, NATURE, V331, P725, DOI 10.1038/331725a0; Luo HY, 2004, AM J HEMATOL, V77, P384, DOI 10.1002/ajh.20209; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Papadimitriou C. H., 1977, Theoretical Computer Science, V4, P237, DOI 10.1016/0304-3975(77)90012-3; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Rajagopala S, 2004, ACTA CRYSTALLOGR D, V60, P860, DOI 10.1107/S0907444904004160; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ren Z, 2013, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0077363., DOI 10.1371/J0URNAL.P0NE.0077363]; Ren Z, 2013, ACTA CRYSTALLOGR D, V69, P946, DOI 10.1107/S0907444913003454; Ren Z, 2012, P NATL ACAD SCI USA, V109, P107, DOI 10.1073/pnas.1109213108; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Tekpinar M, 2013, PROTEINS, V81, P240, DOI 10.1002/prot.24180; Tsuneshige A, 2004, J BIOL CHEM, V279, P48959, DOI 10.1074/jbc.M405909200; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Wilson J, 1996, J MOL BIOL, V264, P743, DOI 10.1006/jmbi.1996.0674; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Ye JP, 2004, J COMPUT BIOL, V11, P986, DOI 10.1089/cmb.2004.11.986	52	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77141	10.1371/journal.pone.0077141	http://dx.doi.org/10.1371/journal.pone.0077141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244274	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600007
J	Kumar, A; Casey, A; Odingo, J; Kesicki, EA; Abrahams, G; Vieth, M; Masquelin, T; Mizrahi, V; Hipskind, PA; Sherman, DR; Parish, T				Kumar, Anuradha; Casey, Allen; Odingo, Joshua; Kesicki, Edward A.; Abrahams, Garth; Vieth, Michal; Masquelin, Thierry; Mizrahi, Valerie; Hipskind, Philip A.; Sherman, David R.; Parish, Tanya			A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis	PLOS ONE			English	Article								The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis. It is essential for the in vitro growth of M. tuberculosis and for survival of the bacteria in the mouse model of infection. PanC is absent from mammals. We developed an enzyme-based assay to identify inhibitors of PanC, optimized it for high-throughput screening, and tested a large and diverse library of compounds for activity. Two compounds belonging to the same chemical class of 3-biphenyl-4-cyanopyrrole-2-carboxylic acids had activity against the purified recombinant protein, and also inhibited growth of live M. tuberculosis in manner consistent with PanC inhibition. Thus we have identified a new class of PanC inhibitors with whole cell activity that can be further developed.	[Kumar, Anuradha; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Casey, Allen; Odingo, Joshua; Kesicki, Edward A.; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Abrahams, Garth; Mizrahi, Valerie] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Vieth, Michal; Masquelin, Thierry; Hipskind, Philip A.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Center for Infectious Disease Research; University of Cape Town; Eli Lilly	Sherman, DR (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org; tanya.parish@idri.org		Abrahams, Garth/0000-0001-7246-0901	Lilly TB Drug Discovery Initiative; Eli Lilly and Company	Lilly TB Drug Discovery Initiative; Eli Lilly and Company(Eli Lilly)	This work was funded by the Lilly TB Drug Discovery Initiative (http://www.tbdrugdiscovery.org/). Funding for the Lilly TB Drug Discovery Initiative was provided by Eli Lilly and Company. The following authors are employed by Eli Lilly and Company and made the contributions to the paper noted in the authors' contribution - Michal Vieth, Thierry Masquelin, Philip A. Hipskind.	Abrahams GL, 2012, CHEM BIOL, V19, P844, DOI 10.1016/j.chembiol.2012.05.020; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Ciulli A, 2008, CHEMBIOCHEM, V9, P2606, DOI 10.1002/cbic.200800437; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Copeland R.A., 2002, TIGHT BINDING INHIBI, P305; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fernandez MC, 2006, BIOORG MED CHEM LETT, V16, P5057, DOI 10.1016/j.bmcl.2006.07.035; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; GRASSL SM, 1992, J BIOL CHEM, V267, P22902; Hung AW, 2009, ANGEW CHEM INT EDIT, V48, P8452, DOI 10.1002/anie.200903821; NCBI Website, 2004, ASSAY GUIDANCE MANUA; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; VALLARI DS, 1985, J BACTERIOL, V164, P136, DOI 10.1128/JB.164.1.136-142.1985; Velaparthi S, 2008, J MED CHEM, V51, P1999, DOI 10.1021/jm701372r; Vieth M, 2009, J MED CHEM, V52, P6456, DOI 10.1021/jm901147e; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang SS, 2006, BIOCHEMISTRY-US, V45, P1554, DOI 10.1021/bi051873e; Wang SS, 2003, PROTEIN SCI, V12, P1097, DOI 10.1110/ps.0241803; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; World Health Organization, 2011, GLOB TUB CONTR REP 2; Yang YH, 2011, BIOORG MED CHEM LETT, V21, P3943, DOI 10.1016/j.bmcl.2011.05.021; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	25	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e72786	10.1371/journal.pone.0072786	http://dx.doi.org/10.1371/journal.pone.0072786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244263	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900001
J	Villegas-Mendez, A; Findlay, EG; de Souza, JB; Grady, LM; Saris, CJ; Lane, TE; Riley, EM; Couper, KN				Villegas-Mendez, Ana; Findlay, Emily Gwyer; de Souza, J. Brian; Grady, Lisa-Marie; Saris, Christiaan J.; Lane, Thomas E.; Riley, Eleanor M.; Couper, Kevin N.			WSX-1 Signalling Inhibits CD4(+) T Cell Migration to the Liver during Malaria Infection by Repressing Chemokine-Independent Pathways	PLOS ONE			English	Article							RECEPTOR; IL-27; TH1; INFLAMMATION; RECRUITMENT; RESISTANCE; IMMUNOPATHOLOGY; CYCLOPHILIN; CHEMOTAXIS; ACTIVATION	IL-27 is an important and non-redundant regulator of effector T cell accumulation in non-lymphoid tissues during infection. Using malaria as a model systemic pro-inflammatory infection, we demonstrate that the aberrant accumulation of CD4(+) T cells in the liver of infected IL27R(-/-) (WSX-1(-/-)) mice is a result of differences in cellular recruitment, rather than changes in T cell proliferation or cell death. We show that IL-27 both inhibits the migratory capacity of infection-derived CD4(+) T cells towards infection-derived liver cells, but also suppresses the production of soluble liver-derived mediator(s) that direct CD4(+) T cell movement towards the inflamed tissue. Although CCL4 and CCL5 expression was higher in livers of infected WSX-1(-/-) mice than infected WT mice, and hepatic CD4(+) T cells from WSX-1(-/-) mice expressed higher levels of CCR5 than cells from WT mice, migration of CD4(+) T cells to the liver of WSX-1(-/-) mice during infection was not controlled by chemokine (R) signalling. However, anti-IL-12p40 treatment reduced migration of CD4(+) T cells towards infection-derived liver cells, primarily by abrogating the hepatotropic migratory capacity of T cells, rather than diminishing soluble tissue-derived migratory signals. These results indicate that IL-27R signalling restricts CD4(+) T cell accumulation within the liver during infection primarily by suppressing T cell chemotaxis, which may be linked to its capacity to repress Th1 differentiation, as well as by inhibiting the production of soluble, tissue-derived chemotaxins.	[Villegas-Mendez, Ana; Findlay, Emily Gwyer; de Souza, J. Brian; Riley, Eleanor M.; Couper, Kevin N.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Villegas-Mendez, Ana; Grady, Lisa-Marie; Couper, Kevin N.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [de Souza, J. Brian] UCL, Div Infect & Immun, London, England; [Saris, Christiaan J.] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA; [Lane, Thomas E.] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92717 USA	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; University of London; University College London; Amgen; University of California System; University of California Irvine	Couper, KN (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	kevin.couper@manchester.ac.uk	Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Couper, Kevin/0000-0003-4659-8960; Gwyer Findlay, Emily/0000-0002-2311-6589; villegas-mendez, ana/0000-0002-8363-680X	BBSRC [004161, 020950]; Medical Research Council Career Development Award [G0900487]; NIH [RO1 NS041249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041249] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I020950/2, BB/G004161/1] Funding Source: researchfish; Medical Research Council [G0900487] Funding Source: researchfish; BBSRC [BB/G004161/1, BB/I020950/2] Funding Source: UKRI; MRC [G0900487] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the BBSRC (004161 and 020950) and by a Medical Research Council Career Development Award to KNC (G0900487) and by the NIH (RO1 NS041249) to TEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Bancroft AJ, 2004, J IMMUNOL, V172, P7635, DOI 10.4049/jimmunol.172.12.7635; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Dear JW, 2011, J IMMUNOL, V187, P3347, DOI 10.4049/jimmunol.1100165; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Findlay EG, 2013, J IMMUNOL, V190, P4553, DOI 10.4049/jimmunol.1202916; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Oo YH, 2010, J AUTOIMMUN, V34, P45, DOI 10.1016/j.jaut.2009.07.011; Rochman I, 2005, J IMMUNOL, V174, P4761, DOI 10.4049/jimmunol.174.8.4761; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Veckman V, 2003, J LEUKOCYTE BIOL, V74, P395, DOI 10.1189/jlb.0402212; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78486	10.1371/journal.pone.0078486	http://dx.doi.org/10.1371/journal.pone.0078486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244314	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327162900019
J	Leconet, W; Larbouret, C; Chardes, T; Thomas, G; Neiveyans, M; Busson, M; Jarlier, M; Radosevic-Robin, N; Pugniere, M; Bernex, F; Penault-Llorca, F; Pasquet, JM; Pelegrin, A; Robert, B				Leconet, W.; Larbouret, C.; Chardes, T.; Thomas, G.; Neiveyans, M.; Busson, M.; Jarlier, M.; Radosevic-Robin, N.; Pugniere, M.; Bernex, F.; Penault-Llorca, F.; Pasquet, J-M; Pelegrin, A.; Robert, B.			Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy	ONCOGENE			English	Article						RTK; monoclonal antibodies; pancreatic cancer; targeted therapy	TO-MESENCHYMAL TRANSITION; TYROSINE KINASE AXL; THERAPEUTIC TARGET; DRUG-RESISTANCE; MONOCLONAL-ANTIBODY; CELL INVASION; TUMOR-GROWTH; ACTIVATION; EGFR; OVEREXPRESSION	AXL receptor tyrosine kinase (RTK) is implicated in proliferation and invasion of many cancers, particularly in pancreatic ductal adenocarcinoma (PDAC), for which new therapeutic options are urgently required. We investigated whether inhibition of AXL activity by specific monoclonal antibodies (mAbs) is efficient in limiting proliferation and migration of pancreatic cancer cells. Expression of AXL was evaluated by immunohistochemistry in 42 PDAC. The AXL role in oncogenesis was studied using the short hairpin RNA approach in a pancreatic carcinoma cell line. We further generated antihuman AXL mAbs and evaluated their inhibitory effects and the AXL downstream signaling pathways first in vitro, in a panel of pancreatic cancer cell lines and then in vivo, using subcutaneous or orthotopic pancreatic tumor xenografts. AXL receptor was found expressed in 76% (32/ 42) of PDAC and was predominantly present in invasive cells. The AXL-knockdown Panc-1 cells decreased in vitro cell migration, survival and proliferation, and reduced in vivo tumor growth. Two selected anti-AXL mAbs (D9 and E8), which inhibited phosphorylation of AXL and of its downstream target AKT without affecting growth arrest-specific factor 6 (GAS6) binding, induced downexpression of AXL by internalization, leading to an inhibition of proliferation and migration in the four pancreatic cancer cell lines studied. In vivo, treatment by anti-AXL mAbs significantly reduced growth of both subcutaneous and orthotopic pancreatic tumor xenografts independently of their KRAS mutation status. Our in vitro and preclinical in vivo data demonstrate that anti-human AXL mAbs could represent a new approach to the pancreatic cancer immunotherapy.	[Leconet, W.; Larbouret, C.; Chardes, T.; Thomas, G.; Neiveyans, M.; Busson, M.; Pugniere, M.; Bernex, F.; Pelegrin, A.; Robert, B.] Univ Montpellier I, INSERM U896, IRCM, CRLC Val dAurelle Paul Lamarque, Montpellier 5, France; [Jarlier, M.] CRLC Val dAurelle Paul Lamarque, Unite Biostat, F-34298 Montpellier 5, Languedoc Rouss, France; [Radosevic-Robin, N.; Penault-Llorca, F.] Ctr Jean Perrin, Dept Biopathol, F-63011 Clermont Ferrand 1, France; [Radosevic-Robin, N.; Penault-Llorca, F.] Univ Auvergne, ERTICa EA4677, Clermont Ferrand, France; [Pasquet, J-M] Univ Victor Segalen, Hematol Lab, CHU Bordeaux, INSERM U876, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Robert, B (corresponding author), CRLC Val dAurelle Paul Lamarque, IRCM INSERM U896, 208 Rue Apothicaires, F-34298 Montpellier 5, Languedoc Rouss, France.	bruno.robert@inserm.fr	PUGNIERE, Martine/AAD-4315-2020; ROBERT, Bruno/AAB-7581-2020; Pèlegrin, André/J-3167-2016; Leconet, Wilhem/AAH-5681-2020; Chardès, Thierry/B-5420-2019; Pugniere, Martine/T-1355-2017; PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019	PUGNIERE, Martine/0000-0002-2049-2909; ROBERT, Bruno/0000-0001-5573-6945; Chardès, Thierry/0000-0002-1836-7439; Pugniere, Martine/0000-0002-2049-2909; PASQUET, JEAN-MAX/0000-0002-1345-3776; Pelegrin, Andre/0000-0001-9254-2648	INSERM; Oribase Pharma	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Oribase Pharma	We thank Florence Frayssinoux, Sabine Bousquie and Genevieve Heintz for their technical help. We also thank the ICRM animal facility staff and the 'Reseau d'Histologie Experimentale de Montpellier' histology facility for processing our animal tissues and RIO Imaging facilities. This work was supported by INSERM and Oribase Pharma.	Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Gaborit N, 2011, J BIOL CHEM, V286, P11337, DOI 10.1074/jbc.M111.223503; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim EJ, 2011, CURR OPIN GASTROEN, V27, P460, DOI 10.1097/MOG.0b013e328349e31f; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020; Larbouret C, 2007, CLIN CANCER RES, V13, P3356, DOI 10.1158/1078-0432.CCR-06-2302; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mishra A, 2012, MOL CANCER RES, V10, P703, DOI 10.1158/1541-7786.MCR-11-0569; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nelson NJ, 2007, J NATL CANCER I, V99, P1432, DOI 10.1093/jnci/djm180; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Robert B, 1996, CANCER RES, V56, P4758; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Troiani T, 2012, CURR DRUG TARGETS, V13, P802, DOI 10.2174/138945012800564158; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	40	69	78	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5405	5414		10.1038/onc.2013.487	http://dx.doi.org/10.1038/onc.2013.487			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240689	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000345120700002
J	Au, A; Stuyt, JG; Chen, D; Alagramam, K				Au, Adrian; Stuyt, John Gerka; Chen, Daniel; Alagramam, Kumar			Ups and Downs of Viagra: Revisiting Ototoxicity in the Mouse Model	PLOS ONE			English	Article							HEARING-LOSS; C57BL/6J MICE; SILDENAFIL; GENE; DEAFNESS; IMPAIRMENT; INHIBITORS; MUTATIONS; CLARIN-1	Sildenafil citrate (Viagra), a phosphodiesterase 5 inhibitor (PDE5i), is a commonly prescribed drug for erectile dysfunction. Since the introduction of Viagra in 1997, several case reports have linked Viagra to sudden sensorineural hearing loss. However, these studies are not well controlled for confounding factors, such as age and noise-induced hearing loss and none of these reports are based on prospective double-blind studies. Further, animal studies report contradictory data. For example, one study (2008) reported hearing loss in rats after long-term and high-dose exposure to sildenafil citrate. The other study (2012) showed vardenafil, another formulation of PDE5i, to be protective against noise-induced hearing loss in mice and rats. Whether or not clinically relevant doses of sildenafil citrate cause hearing loss in normal subjects (animals or humans) is controversial. One possibility is that PDE5i exacerbates age-related susceptibility to hearing loss in adults. Therefore, we tested sildenafil citrate in C57BL/6J, a strain of mice that displays increased susceptibility to age-related hearing loss, and compared the results to those obtained from the FVB/N, a strain of mice with no predisposition to hearing loss. Six-week-old mice were injected with the maximum tolerated dose of sildenafil citrate (10 mg/kg/day) or saline for 30 days. Auditory brainstem responses (ABRs) were recorded pre- and post injection time points to assess hearing loss. Entry of sildenafil citrate in the mouse cochlea was confirmed by qRT-PCR analysis of a downstream target of the cGMP-PKG cascade. ABR data indicated no statistically significant difference in hearing between treated and untreated mice in both backgrounds. Results show that the maximum tolerated dose of sildenafil citrate administered daily for 4 weeks does not affect hearing in the mouse. Our study gives no indication that Viagra will negatively impact hearing and it emphasizes the need to revisit the issue of Viagra related ototoxicity in humans.	[Au, Adrian; Stuyt, John Gerka; Chen, Daniel; Alagramam, Kumar] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Alagramam, K (corresponding author), Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA.	kna3@case.edu	Au, Adrian/AAE-9654-2019	Au, Adrian/0000-0001-8110-9988	department of Otolaryngology at CWRU	department of Otolaryngology at CWRU	This work was supported by department of Otolaryngology at CWRU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir S, 2012, AM J OTOLARYNGOLOGY; Chance MR, 2010, HUM MOL GENET, V19, P1515, DOI 10.1093/hmg/ddq025; Cheitlin MD, 1999, J AM COLL CARDIOL, V33, P273, DOI 10.1016/S0735-1097(98)00656-1; Falco M, 2007, IMPOTENCE DRUGS MAY; FDA, 2011, INF HEALTHC PROF SIL; FDA, 2007, FDA ANN REV LAB CIAL; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Hampton LL, 2003, HEARING RES, V180, P67, DOI 10.1016/S0378-5955(03)00107-2; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Johnson KR, 2010, HEARING RES, V268, P85, DOI 10.1016/j.heares.2010.05.002; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Keith A, 2000, HEALTH AFFAIR, V19, P147, DOI 10.1377/hlthaff.19.2.147; Khan AS, 2011, LARYNGOSCOPE, V121, P1049, DOI 10.1002/lary.21450; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Mukherjee B, 2007, J LARYNGOL OTOL, V121, P395, DOI 10.1017/S0022215106005512; NIDCD, 2003, NIH PUB; Okuyucu S, 2009, J LARYNGOL OTOL, V123, P718, DOI 10.1017/S002221510900423X; Pfizer, 2012, 2012 FIN REP; Pfizer, 2010, VIAGR; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; SCHWEITZER VG, 1993, LARYNGOSCOPE, V103, P1, DOI 10.1288/00005537-199304000-00001; Uptodate, 2013, SILD DRUG INF; Yoo J, 2013, LARYNGOSCOPE; Zheng QY, 2012, HUM MOL GENET, V21, P2588, DOI 10.1093/hmg/dds084	30	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79226	10.1371/journal.pone.0079226	http://dx.doi.org/10.1371/journal.pone.0079226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244454	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800044
J	Bonyhay, I; Risk, M; Freeman, R				Bonyhay, Istvan; Risk, Marcelo; Freeman, Roy			High-Pass Filter Characteristics of the Baroreflex - A Comparison of Frequency Domain and Pharmacological Methods	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BLOOD-PRESSURE; SPECTRAL-ANALYSIS; SINOAORTIC DENERVATION; PHENYLEPHRINE METHOD; ARTERIAL-PRESSURE; SENSITIVITY; REFLEX; RESPONSES; GAIN	Pharmacological methods to assess baroreflex sensitivity evoke supra-physiological blood pressure changes whereas computational methods use spontaneous fluctuations of blood pressure. The relationships among the different baroreflex assessment methods are still not fully understood. Although strong advocates for each technique exist, the differences between these methods need further clarification. Understanding the differences between pharmacological and spontaneous baroreflex methods could provide important insight into the baroreflex physiology. We compared the modified Oxford baroreflex gain and the transfer function modulus between spontaneous RR interval and blood pressure fluctuations in 18 healthy subjects (age: 39+/-10 yrs., BMI: 26+/-4.9). The transfer function was calculated over the low-frequency range of the RR interval and systolic blood pressure oscillations during random-frequency paced breathing. The average modified Oxford baroreflex gain was lower than the average transfer function modulus (15.7+/-9.2 ms/mmHg vs. 19.4+/-10.5 ms/mmHg, P<0.05). The difference between the two baroreflex measures within the individual subjects comprised a systematic difference (relative mean difference: 20.7%) and a random variance (typical error: 3.9 ms/mmHg). The transfer function modulus gradually increased with the frequency within the low-frequency range (LF), on average from 10.4+/-7.3 ms/mmHg to 21.2+/-9.8 ms/mmHg across subjects. Narrowing the zone of interest within the LF band produced a decrease in both the systematic difference (relative mean difference: 0.5%) and the random variance (typical error: 2.1 ms/mmHg) between the modified Oxford gain and the transfer function modulus. Our data suggest that the frequency dependent increase in low-frequency transfer function modulus between RR interval and blood pressure fluctuations contributes to both the systematic difference (bias) and the random variance (error) between the pharmacological and transfer function baroreflex measures. This finding suggests that both methodological and physiological factors underlie the observed disagreement between the pharmacological and the transfer function method. Thus both baroreflex measures contribute complementary information and can be considered valid methods for baroreflex sensitivity assessment.	[Bonyhay, Istvan; Risk, Marcelo; Freeman, Roy] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Risk, Marcelo] ITBA, Buenos Aires, DF, Argentina; [Risk, Marcelo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bonyhay, I (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	ibonyhay@bidmc.harvard.edu			National Heart, Lung, and Blood Institute [1 R01 HL 59459]; Fundacion Maria Calderon de la Barca, Argentina;  [M01-RR01032]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059459] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fundacion Maria Calderon de la Barca, Argentina; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant 1 R01 HL 59459 from the National Heart, Lung, and Blood Institute and grant M01-RR01032 to Beth Israel Deaconess Medical General Clinical Research Center. MR was supported by Fundacion Maria Calderon de la Barca, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1985, AM J PHYSIOL, V249, pH867, DOI 10.1152/ajpheart.1985.249.4.H867; Badra LJ, 2001, AM J PHYSIOL-HEART C, V280, pH2674, DOI 10.1152/ajpheart.2001.280.6.H2674; Barthel P, 2012, HEART RHYTHM, V9, P1288, DOI 10.1016/j.hrthm.2012.04.017; Bassani T, 2013, AUTON NEUROSCI; Bernardi L, 2011, DIABETES METAB RES R; Blackman R.B., 1959, MEASUREMENT POWER SP; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BURKE SL, 1986, J PHYSIOL-LONDON, V378, P391, DOI 10.1113/jphysiol.1986.sp016226; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chatburn R L, 1996, AANA J, V64, P261; Colombo R, 1999, CLIN SCI, V97, P503, DOI 10.1042/CS19990035; Crandall CG, 2000, AM J PHYSIOL-HEART C, V279, pH2486, DOI 10.1152/ajpheart.2000.279.5.H2486; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; DI RIENZO M, 1991, AM J PHYSIOL, V261, pH1811, DOI 10.1152/ajpheart.1991.261.6.H1811; DiRienzo M, 1996, MED BIOL ENG COMPUT, V34, P133, DOI 10.1007/BF02520018; EBERT TJ, 1992, AM J PHYSIOL, V262, pH1372, DOI 10.1152/ajpheart.1992.262.5.H1372; ECKBERG DL, 1976, J PHYSIOL-LONDON, V258, P769, DOI 10.1113/jphysiol.1976.sp011445; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Farquhar WB, 2000, CIRCULATION, V102, P3086; FARRELL TG, 1992, BRIT HEART J, V67, P129; Frattola A, 1997, DIABETOLOGIA, V40, P1470, DOI 10.1007/s001250050851; Freeman R, 2006, CLIN NEUROPHYSIOL, V117, P716, DOI 10.1016/j.clinph.2005.09.027; FREEMAN R, 1995, MUSCLE NERVE, V18, P74, DOI 10.1002/mus.880180111; Gerritsen J, 2000, CLIN SCI, V99, P371, DOI 10.1042/CS19990374; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hunt BE, 2005, AM J PHYSL REGUL INT; Kawada T, 2003, AM J PHYSIOL-HEART C, V284, pH404, DOI 10.1152/ajpheart.00319.2002; La Rovere MT, 2013, NETH HEART J, V21, P61, DOI 10.1007/s12471-012-0349-8; La Rovere MT, 2011, J HYPERTENS, V29, P1546, DOI 10.1097/HJH.0b013e3283487827; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lipman RD, 2003, HYPERTENSION, V42, P481, DOI 10.1161/01.HYP.0000091370.83602.E6; Ludbrook J, 1997, CLIN EXP PHARMACOL P, V24, P193, DOI 10.1111/j.1440-1681.1997.tb01807.x; Mancia G, 1999, AM J PHYSIOL-HEART C, V276, pH1987, DOI 10.1152/ajpheart.1999.276.6.H1987; Morillo CA, 1997, CIRCULATION, V96, P2509, DOI 10.1161/01.CIR.96.8.2509; Parati G, 2004, HYPERTENSION, V43, pE32, DOI 10.1161/01.HYP.0000126689.12940.cd; Parati G, 2002, CLIN SCI, V103, P89; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Petiot E, 2001, J PHYSIOL-LONDON, V537, P949; Pinna GD, 2005, J AM COLL CARDIOL, V46, P1314, DOI 10.1016/j.jacc.2005.06.062; Pinna GD, 2002, CLIN SCI, V103, P81; Pitzalis MV, 1998, CIRCULATION, V97, P1362, DOI 10.1161/01.CIR.97.14.1362; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; Rosengard-Barlund M, 2011, DIABETES CARE, V34, P2424, DOI 10.2337/dc11-0629; Rudas L, 1999, AM J PHYSIOL-HEART C, V276, pH1691, DOI 10.1152/ajpheart.1999.276.5.H1691; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; Vallais F, 2009, PHYSIOL MEAS, V30, P201, DOI 10.1088/0967-3334/30/2/007; Watkins LL, 1996, HYPERTENSION, V28, P238, DOI 10.1161/01.HYP.28.2.238	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79513	10.1371/journal.pone.0079513	http://dx.doi.org/10.1371/journal.pone.0079513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244518	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800089
J	Kent, E; Neumann, S; Kummer, U; Mendes, P				Kent, Edward; Neumann, Stefan; Kummer, Ursula; Mendes, Pedro			What Can We Learn from Global Sensitivity Analysis of Biochemical Systems?	PLOS ONE			English	Article							ROBUSTNESS; MODELS; BIOLOGY; COPASI	Most biological models of intermediate size, and probably all large models, need to cope with the fact that many of their parameter values are unknown. In addition, it may not be possible to identify these values unambiguously on the basis of experimental data. This poses the question how reliable predictions made using such models are. Sensitivity analysis is commonly used to measure the impact of each model parameter on its variables. However, the results of such analyses can be dependent on an exact set of parameter values due to nonlinearity. To mitigate this problem, global sensitivity analysis techniques are used to calculate parameter sensitivities in a wider parameter space. We applied global sensitivity analysis to a selection of five signalling and metabolic models, several of which incorporate experimentally well-determined parameters. Assuming these models represent physiological reality, we explored how the results could change under increasing amounts of parameter uncertainty. Our results show that parameter sensitivities calculated with the physiological parameter values are not necessarily the most frequently observed under random sampling, even in a small interval around the physiological values. Often multimodal distributions were observed. Unsurprisingly, the range of possible sensitivity coefficient values increased with the level of parameter uncertainty, though the amount of parameter uncertainty at which the pattern of control was able to change differed among the models analysed. We suggest that this level of uncertainty can be used as a global measure of model robustness. Finally a comparison of different global sensitivity analysis techniques shows that, if high-throughput computing resources are available, then random sampling may actually be the most suitable technique.	[Kent, Edward; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Kent, Edward; Mendes, Pedro] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Neumann, Stefan; Kummer, Ursula] Das Ctr Organismal Studies Heidelberg BIOQUANT, Dept Modeling Biol Proc, Heidelberg, Germany; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University	Mendes, P (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	pedro.mendes@manchester.ac.uk		Mendes, Pedro/0000-0001-6507-9168	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G529859, BB/J019259]; European Union [289434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER; BBSRC [BB/J019259/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019259/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	EK thanks Pfizer and Biotechnology and Biological Sciences Research Council (BBSRC) (grant BB/G529859), PM thanks the BBSRC (grants BB/J019259), the European Union Framework Seven Programme (grant 289434, BioPreDyn) and the National Institute of General Medical Sciences (GM080219). UK thanks the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu ZH, 2010, IEEE T MED IMAGING, V29, P1870, DOI 10.1109/TMI.2010.2053044; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hubner K, 2011, FEBS J, V278, P2767, DOI 10.1111/j.1742-4658.2011.08217.x; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jacobsen EW, 2008, IET SYST BIOL, V2, P39, DOI 10.1049/iet-syb:20070008; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Murabito E, 2011, J R SOC INTERFACE, V8, P880, DOI 10.1098/rsif.2010.0540; Quinton-Tulloch MJ, 2011, THESIS U MANCHESTER; Rodriguez-Fernandez M, 2012, INT J ROBUST NONLIN, V22, P1082, DOI 10.1002/rnc.2797; Sahle S, 2008, PHILOS T R SOC A, V366, P3619, DOI 10.1098/rsta.2008.0108; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A., 2008, GLOBAL SENSITIVITY A, DOI [10.1002/9780470725184, DOI 10.1002/9780470725184]; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; Westerhoff HV, 2007, FEBS J, V274, P342; Yue H, 2008, INT J CHEM KINET, V40, P730, DOI 10.1002/kin.20369; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088; Zhou K., 1998, ESSENTIALS ROBUST CO	42	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79244	10.1371/journal.pone.0079244	http://dx.doi.org/10.1371/journal.pone.0079244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244458	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800047
J	Stark, BC; James, ML; Pollard, LW; Sirotkin, V; Lord, M				Stark, Benjamin C.; James, Michael L.; Pollard, Luther W.; Sirotkin, Vladimir; Lord, Matthew			UCS Protein Rng3p Is Essential for Myosin-II Motor Activity during Cytokinesis in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; CAENORHABDITIS-ELEGANS; UNC-45 CHAPERONE; HEAVY-CHAIN; V MYOSINS; CONTRACTILE RING; DOMAIN PROTEIN; BUDDING YEAST; LIGHT-CHAIN; ACTIN	UCS proteins have been proposed to operate as co-chaperones that work with Hsp90 in the de novo folding of myosin motors. The fission yeast UCS protein Rng3p is essential for actomyosin ring assembly and cytokinesis. Here we investigated the role of Rng3p in fission yeast myosin-II (Myo2p) motor activity. Myo2p isolated from an arrested rng3-65 mutant was capable of binding actin, yet lacked stability and activity based on its expression levels and inactivity in ATPase and actin filament gliding assays. Myo2p isolated from a myo2-E1 mutant (a mutant hyper-sensitive to perturbation of Rng3p function) showed similar behavior in the same assays and exhibited an altered motor conformation based on limited proteolysis experiments. We propose that Rng3p is not required for the folding of motors per se, but instead works to ensure the activity of intrinsically unstable myosin-II motors. Rng3p is specific to conventional myosin-II and the actomyosin ring, and is not required for unconventional myosin motor function at other actin structures. However, artificial destabilization of myosin-I motors at endocytic actin patches (using a myo1-E1 mutant) led to recruitment of Rng3p to patches. Thus, while Rng3p is specific to myosin-II, UCS proteins are adaptable and can respond to changes in the stability of other myosin motors.	[Stark, Benjamin C.; Pollard, Luther W.; Lord, Matthew] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [James, Michael L.; Sirotkin, Vladimir] SUNY Upstate Med Univ, Dept Cell & Dev Biol, New York, NY USA	University of Vermont; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lord, M (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	matthew.lord@uvm.edu	Stark, Benjamin/E-6095-2010	Stark, Benjamin/0000-0002-1799-5361; Pollard, Luther/0000-0002-3587-0714	National Institutes of Health-National Institute of General Medical Sciences NIH-GMS [RO1: GM097193]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097193] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of General Medical Sciences NIH-GMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health-National Institute of General Medical Sciences NIH-GMS RO1: GM097193 (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2009, EMBO REP, V10, P186, DOI 10.1038/embor.2008.228; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Attanapola SL, 2009, J CELL SCI, V122, P3856, DOI 10.1242/jcs.053959; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Bezanilla M, 2000, CURR BIOL, V10, P397, DOI 10.1016/S0960-9822(00)00420-6; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Bezanilla M, 2000, MOL BIOL CELL, V11, P79, DOI 10.1091/mbc.11.1.79; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Kaiser CM, 2012, BIOPHYS J, V102, P2212, DOI 10.1016/j.bpj.2012.03.013; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; May KM, 1997, CELL MOTIL CYTOSKEL, V38, P385, DOI 10.1002/(SICI)1097-0169(1997)38:4<385::AID-CM8>3.0.CO;2-2; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motegi F, 1997, FEBS LETT, V420, P161, DOI 10.1016/S0014-5793(97)01510-X; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Sladewski TE, 2009, MOL BIOL CELL, V20, P3941, DOI 10.1091/mbc.E09-04-0346; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Stark BC, 2010, MOL BIOL CELL, V21, P989, DOI 10.1091/mbc.E09-10-0852; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Toi H, 2003, MOL BIOL CELL, V14, P2237, DOI 10.1091/mbc.E02-09-0616; Toya M, 2001, GENES CELLS, V6, P187, DOI 10.1046/j.1365-2443.2001.00414.x; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; Win TZ, 2001, J CELL SCI, V114, P69; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79593	10.1371/journal.pone.0079593	http://dx.doi.org/10.1371/journal.pone.0079593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244528	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800092
J	Alzaid, F; Cheung, HM; Preedy, VR; Sharp, PA				Alzaid, Fawaz; Cheung, Hoi-Man; Preedy, Victor R.; Sharp, Paul A.			Regulation of Glucose Transporter Expression in Human Intestinal Caco-2 Cells following Exposure to an Anthocyanin-Rich Berry Extract	PLOS ONE			English	Article							RAT SMALL-INTESTINE; SUGAR ABSORPTION; DIFFERENTIAL EXPRESSION; DIFFUSIVE COMPONENT; DIETARY POLYPHENOLS; EPITHELIAL-CELLS; APICAL GLUT2; SGLT1; MICE; ENTEROCYTES	Polyphenols contained within plant tissues are consumed in significant amounts in the human diet and are known to influence a number of biological processes. This study investigated the effects of an anthocyanin-rich berry-extract on glucose uptake by human intestinal Caco-2 cells. Acute exposure (15 min) to berry extract (0.125%, w/v) significantly decreased both sodium-dependent (Total uptake) and sodium-independent (facilitated uptake) H-3-D-glucose uptake. In longer-term studies, SGLT1 mRNA and GLUT2 mRNA expression were reduced significantly. Polyphenols are known to interact directly with glucose transporters to regulate the rate of glucose absorption. Our in vitro data support this mechanism and also suggest that berry flavonoids may modulate post-prandial glycaemia by decreasing glucose transporter expression. Further studies are warranted to investigate the longer term effects of berry flavonoids on the management of glycaemia in human volunteers.	[Alzaid, Fawaz; Cheung, Hoi-Man; Preedy, Victor R.; Sharp, Paul A.] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	University of London; King's College London	Preedy, VR (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England.	victor.preedy@kcl.ac.uk; paul.a.sharp@kcl.ac.uk		Sharp, Paul Anthony/0000-0003-3400-6702; Alzaid, Fawaz/0000-0003-3056-3640	Ministry of Higher Education of the state of Kuwait; Arab-British Chamber of Commerce	Ministry of Higher Education of the state of Kuwait; Arab-British Chamber of Commerce	The authors thank the Ministry of Higher Education of the state of Kuwait and the Arab-British Chamber of Commerce for providing a studentship and extra consumables funding, respectively to F. Alzaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; CHANTRET I, 1994, J CELL SCI, V107, P213; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; DEBNAM ES, 1975, J PHYSIOL-LONDON, V246, P181, DOI 10.1113/jphysiol.1975.sp010885; Faria A, 2009, MOL NUTR FOOD RES, V53, P1430, DOI 10.1002/mnfr.200900007; FERRARIS RP, 1993, P NATL ACAD SCI USA, V90, P5868, DOI 10.1073/pnas.90.12.5868; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926; Morgan EL, 2007, J PHYSIOL-LONDON, V580, P593, DOI 10.1113/jphysiol.2006.124768; Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404; Puupponen-Pimia R, 2005, BIOFACTORS, V23, P243, DOI 10.1002/biof.5520230410; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Sharp PA, 1996, GUT, V39, P545, DOI 10.1136/gut.39.4.545; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Torronen R, 2010, BRIT J NUTR, V103, P1094, DOI 10.1017/S0007114509992868; Williams M, 2002, BBA-BIOMEMBRANES, V1559, P179, DOI 10.1016/S0005-2736(01)00449-7; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511	32	87	90	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78932	10.1371/journal.pone.0078932	http://dx.doi.org/10.1371/journal.pone.0078932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236070	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700067
J	Bhattacharyya, S; Saha, S; Giri, K; Lanza, IR; Nair, KS; Jennings, NB; Rodriguez-Aguayo, C; Lopez-Berestein, G; Basal, E; Weaver, AL; Visscher, DW; Cliby, W; Sood, AK; Bhattacharya, R; Mukherjee, P				Bhattacharyya, Sanjib; Saha, Sounik; Giri, Karuna; Lanza, Ian R.; Nair, K. Sreekumar; Jennings, Nicholas B.; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Basal, Eati; Weaver, Amy L.; Visscher, Daniel W.; Cliby, William; Sood, Anil K.; Bhattacharya, Resham; Mukherjee, Priyabrata			Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-SULFIDE; CARDIOVASCULAR EVENTS; GOLD NANOPARTICLES; CELL-PROLIFERATION; MOUSE MODEL; IN-VITRO; H2S; GLUTATHIONE; APOPTOSIS	Background: Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths. Most patients respond initially to platinum-based chemotherapy after surgical debulking, however relapse is very common and ultimately platinum resistance emerges. Understanding the mechanism of tumor growth, metastasis and drug resistant relapse will profoundly impact the therapeutic management of ovarian cancer. Methods/Principal Findings: Using patient tissue microarray (TMA), in vitro and in vivo studies we report a role of of cystathionine-beta-synthase (CBS), a sulfur metabolism enzyme in ovarian carcinoma. We report here that the expression of cystathionine-beta-synthase (CBS), a sulfur metabolism enzyme, is common in primary serous ovarian carcinoma. The in vitro effects of CBS silencing can be reversed by exogenous supplementation with the GSH and H2S producing chemical Na2S. Silencing CBS in a cisplatin resistant orthotopic model in vivo by nanoliposomal delivery of CBS siRNA inhibits tumor growth, reduces nodule formation and sensitizes ovarian cancer cells to cisplatin. The effects were further corroborated by immunohistochemistry that demonstrates a reduction of H&E, Ki-67 and CD31 positive cells in si-RNA treated as compared to scrambled-RNA treated animals. Furthermore, CBS also regulates bioenergetics of ovarian cancer cells by regulating mitochondrial ROS production, oxygen consumption and ATP generation. This study reports an important role of CBS in promoting ovarian tumor growth and maintaining drug resistant phenotype by controlling cellular redox behavior and regulating mitochondrial bioenergetics. Conclusion: The present investigation highlights CBS as a potential therapeutic target in relapsed and platinum resistant ovarian cancer.	[Bhattacharyya, Sanjib; Giri, Karuna] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Saha, Sounik; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Stephenson Canc Ctr, Oklahoma City, OK USA; [Lanza, Ian R.; Nair, K. Sreekumar] Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN USA; [Jennings, Nicholas B.; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Basal, Eati; Cliby, William] Mayo Clin, Coll Med, Dept Obstet & Gynecol, Rochester, MN USA; [Weaver, Amy L.] Mayo Clin, Coll Med, Dept Biostat & Bioinformat, Rochester, MN USA; [Visscher, Daniel W.] Mayo Clin, Coll Med, Dept Pathol, Rochester, MN USA; [Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA	Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA.	Bhattacharya.Resham@mayo.edu; Mukherjee.Priyabrata@mayo.edu	jain, amita/ABA-9223-2020; Bhattacharyya, Sanjib/F-1577-2013; Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108; Lanza, Ian/0000-0002-9858-3384; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Bhattacharyya, Sanjib/0000-0001-8738-7188	National Institutes of Health (NIH) [CA135011, CA136494, CA 157481, CA148747]; Mayo Clinic Women's Cancer Program; NATIONAL CANCER INSTITUTE [P50CA136393, R01CA148747, R01CA136494, R01CA135011, R01CA157481] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Women's Cancer Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health (NIH) CA135011 and CA136494 (PM), CA 157481 (RB), CA148747 (WC) and Mayo Clinic Women's Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lotem J, 1996, P NATL ACAD SCI USA, V93, P9166, DOI 10.1073/pnas.93.17.9166; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Ludwig ML, 1997, ANNU REV BIOCHEM, V66, P269, DOI 10.1146/annurev.biochem.66.1.269; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Martelli A, 2012, CURR MED CHEM, V19, P3325, DOI 10.2174/092986712801215928; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Papa S, 2005, CELL DEATH DIFFER, V12, P1259, DOI 10.1038/sj.cdd.4401694; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Predmore BL, 2010, J CARDIOVASC TRANSL, V3, P487, DOI 10.1007/s12265-010-9201-y; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Singh Simendra, 2012, J Exp Ther Oncol, V9, P303; Stein SJ, 2011, ONCOGENE, V30, P4557, DOI 10.1038/onc.2011.156; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Xiao LC, 2012, INT J MOL MED, V30, P1126, DOI 10.3892/ijmm.2012.1090; Yin FQ, 2013, ONCOL REP, V30, P3, DOI 10.3892/or.2013.2446; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012	50	176	183	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79167	10.1371/journal.pone.0079167	http://dx.doi.org/10.1371/journal.pone.0079167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236104	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700102
J	Chen, S; Zhao, Y; Gou, WF; Zhao, S; Takano, Y; Zheng, HC				Chen, Shuo; Zhao, Yang; Gou, Wen-feng; Zhao, Shuang; Takano, Yasuo; Zheng, Hua-chuan			The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; CANCER; GROWTH; VORINOSTAT; APOPTOSIS; EXPRESSION; LYMPHOMA; SURVIVAL; INVASION; LINES	Histone deacetylase inhibitors (HDACi), such as suberoylanilide hydroxamic acid (SAHA), have been shown to act selectively on gene expression, and are potent inducers of growth arrest, differentiation and apoptosis in various types of cancers in vitro and in vivo. This study aimed to elucidate the anti-tumor effects and molecular mechanisms of SAHA on the aggressive phenotypes of ovarian carcinoma. Two pairs of cell lines (SKOV3 and SKOV3/DDP; HO8910 and HO8910-PM) were exposed to SAHA treatment, and the effects on acetyl-Histone H3 and H4 expression levels were analyzed and compared against the aggressive behaviors of ovarian carcinoma. Our results showed that SAHA suppressed proliferation in both a concentration-and time-dependent manner in all four cell lines; induced S/G2 arrest in SKOV3 and SKOV3/DDP cells; and conversely, induced G(1) arrest in HO8910 and HO8910-PM cells. SAHA treatment induced apoptosis and reduced migration, invasion and lamellipodia formation in the ovarian carcinoma cells; furthermore, SAHA decreased expression of Cyclin B-1 and CDC2P34 mRNA, and downregulated CDC2P34, Erk1/2, CyclinB1 and MMP-9 proteins. In contrast, SAHA increased expression of Caspase-3, p21 and p53 mRNA, and upregulated acetyl-Histones H3 and H4, Caspase-8, and p53 proteins. Basal acetylation of histone H3 and H4 was higher in ovarian carcinoma compared to normal ovarian tissues and benign ovarian tumors, and in borderline tumor than in normal ovarian tissues, and was positively correlated with differentiation and expression of the proliferative marker, Ki-67 (P<0.05).We suggest that SAHA may suppress growth, migration and invasion in ovarian carcinoma cells, including cisplatin-resistant or highly-invasive ovarian cells, by promoting histone acetylation and modulating their phenotype-related molecules. As such, aberrant acetylation of histone H3 and H4 may play an important role in the carcinogenesis and differentiation of ovarian carcinoma.	[Chen, Shuo; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Peoples R China; [Gou, Wen-feng; Zhao, Shuang; Zheng, Hua-chuan] China Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shenyang, Peoples R China; [Takano, Yasuo] Kanagawa Canc Ctr, Clin Canc Inst, Yokohama, Kanagawa 2410815, Japan	China Medical University; China Medical University; Kanagawa Prefectural Cancer Center	Zheng, HC (corresponding author), China Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shenyang, Peoples R China.	zheng_huachuan@hotmail.com		Shuo, Chen/0000-0002-5122-3656; Gou, Wenfeng/0000-0002-4828-4298	Shenyang Science and Technology Grant [F11-264-1-10, F12-277-1-01]; Liaoning Provincial Education Department [L2010633]; Liaoning Science and Technology Grant [2009225008-11]; Natural Scientific Foundation of China [81172371, 81202049]; Ministry of Education, Culture, Sports and Technology of Japan [23659958]; Shenyang Outstanding Talent Foundation of China	Shenyang Science and Technology Grant; Liaoning Provincial Education Department; Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shenyang Outstanding Talent Foundation of China	This study was supported by Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant (F11-264-1-10; F12-277-1-01); the Project Supported by the Scientific Research Fund of Liaoning Provincial Education Department (L2010633); Liaoning Science and Technology Grant (2009225008-11); the Natural Scientific Foundation of China (81172371; 81202049); and the Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan (23659958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yacoub N, 2012, J INVEST DERMATOL, V48, P217; Angelucci A, 2010, GYNECOL ONCOL, V119, P557, DOI 10.1016/j.ygyno.2010.07.036; Bandera CA, 2005, J REPROD MED, V50, P399; Chao KC, 2010, EUR J GYNAECOL ONCOL, V31, P402; Dietrich CS, 2010, GYNECOL ONCOL, V116, P126, DOI 10.1016/j.ygyno.2009.09.039; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Emanuele S, 2007, APOPTOSIS, V12, P1327, DOI 10.1007/s10495-007-0063-y; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; Jin JS, 2012, PATHOL ONCOL RES, V18, P713, DOI 10.1007/s12253-012-9499-7; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kumada T, 2004, MODERN PATHOL, V17, P1141, DOI 10.1038/modpathol.3800165; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lobjois V, 2009, EUR J CANCER, V45, P2402, DOI 10.1016/j.ejca.2009.05.026; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Minardi D, 2009, J CELL MOL MED, V13, P2115, DOI 10.1111/j.1582-4934.2008.00482.x; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Piek JMJ, 2008, ADV EXP MED BIOL, V622, P79, DOI 10.1007/978-0-387-68969-2_7; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Wang LG, 2009, AM J TRANSL RES, V1, P62; Xiao LJ, 2013, ONCOL LETT IN PRESS; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yi X, 2008, BIOCHEM PHARMACOL, V75, P1697, DOI 10.1016/j.bcp.2007.10.035; Zheng HC, 2006, ANTICANCER RES, V26, P3579	30	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79781	10.1371/journal.pone.0079781	http://dx.doi.org/10.1371/journal.pone.0079781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236158	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700158
J	Ehlen, F; Krugel, LK; Vonberg, I; Schoenecker, T; Kuhn, AA; Klostermann, F				Ehlen, Felicitas; Krugel, Lea K.; Vonberg, Isabelle; Schoenecker, Thomas; Kuehn, Andrea A.; Klostermann, Fabian			Intact Lexicon Running Slowly - Prolonged Response Latencies in Patients with Subthalamic DBS and Verbal Fluency Deficits	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; NUCLEUS STIMULATION; BASAL GANGLIA; DECLARATIVE/PROCEDURAL MODEL; NEUROPSYCHOLOGICAL CHANGES; BILATERAL STIMULATION; COGNITIVE FUNCTION; GLOBUS-PALLIDUS; FOLLOW-UP	Background: Verbal Fluency is reduced in patients with Parkinson's disease, particularly if treated with deep brain stimulation. This deficit could arise from general factors, such as reduced working speed or from dysfunctions in specific lexical domains. Objective: To test whether DBS-associated Verbal Fluency deficits are accompanied by changed dynamics of word processing. Methods: 21 Parkinson's disease patients with and 26 without deep brain stimulation of the subthalamic nucleus as well as 19 healthy controls participated in the study. They engaged in Verbal Fluency and (primed) Lexical Decision Tasks, testing phonemic and semantic word production and processing time. Most patients performed the experiments twice, ON and OFF stimulation or, respectively, dopaminergic drugs. Results: Patients generally produced abnormally few words in the Verbal Fluency Task. This deficit was more severe in patients with deep brain stimulation who additionally showed prolonged response latencies in the Lexical Decision Task. Slowing was independent of semantic and phonemic word priming. No significant changes of performance accuracy were obtained. The results were independent from the treatment ON or OFF conditions. Conclusion: Low word production in patients with deep brain stimulation was accompanied by prolonged latencies for lexical decisions. No indication was found that the latter slowing was due to specific lexical dysfunctions, so that it probably reflects a general reduction of cognitive working speed, also evident on the level of Verbal Fluency. The described abnormalities seem to reflect subtle sequelae of the surgical procedure for deep brain stimulation rather than of the proper neurostimulation.	[Ehlen, Felicitas; Krugel, Lea K.; Vonberg, Isabelle; Klostermann, Fabian] Charite, Dept Neurol, Motor & Cognit Grp, D-13353 Berlin, Germany; [Schoenecker, Thomas; Kuehn, Andrea A.] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klostermann, F (corresponding author), Charite, Dept Neurol, Motor & Cognit Grp, D-13353 Berlin, Germany.	fabian.klostermann@charite.de		Kuhn, Andrea A./0000-0002-4134-9060; Ehlen, Felicitas/0000-0003-4595-1822	German Research Foundation [Kl 1276/5 in KFO 247]	German Research Foundation(German Research Foundation (DFG))	The project was supported by the German Research Foundation, Kl 1276/5 in KFO 247. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMDP, 2007, AMDP SYST MAN DOK PS; Apfelbaum KS, 2011, PSYCHON B REV, V18, P141, DOI 10.3758/s13423-010-0039-8; Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Arnott WL, 2001, J CLIN EXP NEUROPSYC, V23, P502, DOI 10.1076/jcen.23.4.502.1224; Aschenbrenner A, 2000, RWT REGENSBURGER WOR; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; Cilia R, 2007, PARKINSONISM RELAT D, V13, P290, DOI 10.1016/j.parkreldis.2006.11.011; Contarino MF, 2007, J NEUROL NEUROSUR PS, V78, P248, DOI 10.1136/jnnp.2005.086660; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Crosson B., 2021, NEUROPSYCHOL REV, V31; De Gaspari D, 2006, PARKINSONISM RELAT D, V12, P289, DOI 10.1016/j.parkreldis.2006.01.001; Dromey C, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/796205; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Herzog J, 2010, NERVENARZT, V81, P669, DOI 10.1007/s00115-010-2938-3; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lefaucheur R, 2012, J NEUROL SCI, V321, P96, DOI 10.1016/j.jns.2012.07.033; Marshall DF, 2012, EUR J NEUROL; McDonald C, 1996, J CLIN EXP NEUROPSYC, V18, P793, DOI 10.1080/01688639608408303; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moretti R, 2003, PARKINSONISM RELAT D, V10, P73, DOI 10.1016/S1353-8020(03)00073-7; Morrison CE, 2004, ARCH CLIN NEUROPSYCH, V19, P165, DOI 10.1016/S0887-6177(03)00004-0; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; NEELY JH, 1976, MEM COGNITION, V4, P648, DOI 10.3758/BF03213230; Obeso I, 2012, BEHAV NEUROL, V25, P111, DOI 10.1155/2012/673610; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Radeau M, 1998, BIOL PSYCHOL, V48, P183, DOI 10.1016/S0301-0511(98)00012-X; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; RUBENSTEIN H, 1970, J VERB LEARN VERB BE, V9, P487, DOI 10.1016/S0022-5371(70)80091-3; Saez-Zea C, 2012, EUR NEUROL, V68, P361, DOI 10.1159/000341380; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schonecker T, 2009, AM J NEURORADIOL, V30, P1914, DOI 10.3174/ajnr.A1741; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Teichmann M, 2008, NEUROPSYCHOLOGIA, V46, P174, DOI 10.1016/j.neuropsychologia.2007.07.022; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Tinaz S, 2006, BRAIN RES, V1067, P239, DOI 10.1016/j.brainres.2005.10.057; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troster AI, 1998, BRAIN COGNITION, V38, P125, DOI 10.1006/brcg.1998.1025; Ullman MT, 2001, J PSYCHOLINGUIST RES, V30, P37, DOI 10.1023/A:1005204207369; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Volkmann J, 2004, J CLIN NEUROPHYSIOL, V21, P6, DOI 10.1097/00004691-200401000-00003; Wallesch C-W., 1988, APHASIA, P256; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Wojtecki L, 2006, ARCH NEUROL-CHICAGO, V63, P1273, DOI 10.1001/archneur.63.9.1273; Yamanaka T, 2012, CLIN NEUROL NEUROSUR, V114, P347, DOI 10.1016/j.clineuro.2011.11.009; York MK, 2009, J NEUROL SCI, V287, P159, DOI 10.1016/j.jns.2009.08.003; Zahodne LB, 2009, J NEUROL, V256, P1321, DOI 10.1007/s00415-009-5121-7; Zangaglia R, 2009, MOVEMENT DISORD, V24, P1621, DOI 10.1002/mds.22603; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	63	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79247	10.1371/journal.pone.0079247	http://dx.doi.org/10.1371/journal.pone.0079247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236114	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700113
J	Omata, W; Ackerman, WE; Vandre, DD; Robinson, JM				Omata, Waka; Ackerman, William E.; Vandre, Dale D.; Robinson, John M.			Trophoblast Cell Fusion and Differentiation Are Mediated by Both the Protein Kinase C and A Pathways	PLOS ONE			English	Article							HUMAN PLACENTA; CYCLIC-AMP; DYSFERLIN; MEMBRANE; GENE; EXPRESSION; MYOPATHY; REPAIR; FER-1	The syncytiotrophoblast of the human placenta is an epithelial barrier that interacts with maternal blood and is a key for the transfer of nutrients and other solutes to the developing fetus. The syncytiotrophoblast is a true syncytium and fusion of progenitor cytotrophoblasts is the cardinal event leading to the formation of this layer. BeWo cells are often used as a surrogate for cytotrophoblasts, since they can be induced to fuse, and then express certain differentiation markers associated with trophoblast syncytialization. Dysferlin, a syncytiotrophoblast membrane repair protein, is up-regulated in BeWo cells induced to fuse by treatment with forskolin; this fusion is thought to occur through cAMP/protein kinase A-dependent mechanisms. We hypothesized that dysferlin may also be up-regulated in response to fusion through other pathways. Here, we show that BeWo cells can also be induced to fuse by treatment with an activator of protein kinase C, and that this fusion is accompanied by increased expression of dysferlin. Moreover, a dramatic synergistic increase in dysferlin expression is observed when both the protein kinase A and protein kinase C pathways are activated in BeWo cells. This synergy in fusion is also accompanied by dramatic increases in mRNA for the placental fusion proteins syncytin 1, syncytin 2, as well as dysferlin. Dysferlin, however, was shown to be dispensable for stimulus-induced BeWo cell syncytialization, since dysferlin knockdown lines fused to the same extent as control cells. The classical trophoblast differentiation marker human chorionic gonadotropin was also monitored and changes in the expression closely parallel that of dysferlin in all of the experimental conditions employed. Thus different biochemical markers of trophoblast fusion behave in concert supporting the hypothesis that activation of both protein kinase C and A pathways lead to trophoblastic differentiation.	[Omata, Waka; Vandre, Dale D.; Robinson, John M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Ackerman, William E.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Robinson, JM (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	robinson.21@osu.edu	Ackerman, William Edward/GRS-5804-2022	Ackerman, William Edward/0000-0001-7366-3903	NIH [HD058084]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by NIH grant HD058084 (J.M.R.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 1997, J CELL SCI, V110, P1073; ANDERSEN B, 1988, J BIOL CHEM, V263, P15578; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; FISCHER SM, 1991, CANCER RES, V51, P850; Gabbe SG, 2012, OBSTET NORMAL PROBLE; Han WQ, 2012, J CELL SCI, V125, P1225, DOI 10.1242/jcs.094565; Hohn HP, 1998, EXP CELL RES, V244, P249, DOI 10.1006/excr.1998.4184; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Karl PI, 1996, BIOCHEM J, V320, P831, DOI 10.1042/bj3200831; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Nishino R, 1991, Nihon Naibunpi Gakkai Zasshi, V67, P666; RITVOS O, 1987, ENDOCRINOLOGY, V120, P1521, DOI 10.1210/endo-120-4-1521; Robinson JM, 2001, HISTOCHEM CELL BIOL, V116, P119; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; Robinson JM, 2009, ANAL BIOCHEM, V387, P87, DOI 10.1016/j.ab.2009.01.012; Rote NS, 2005, PLACENTA, V26, P686, DOI 10.1016/j.placenta.2004.09.003; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190; Walton JR, 2013, HISTOCHEM CELL BIOL, V139, P487, DOI 10.1007/s00418-012-1040-2; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Weller AH, 1997, MUSCLE NERVE, V20, P72, DOI 10.1002/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7	33	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81003	10.1371/journal.pone.0081003	http://dx.doi.org/10.1371/journal.pone.0081003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236208	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700211
J	Simone, D; Bay, DC; Leach, T; Turner, RJ				Simone, Domenico; Bay, Denice C.; Leach, Thorin; Turner, Raymond J.			Diversity and Evolution of Bacterial Twin Arginine Translocase Protein, TatC, Reveals a Protein Secretion System That Is Evolving to Fit Its Environmental Niche	PLOS ONE			English	Article							PERIPLASMIC NITRATE REDUCTASE; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; SIGNAL PEPTIDE; MEMBRANE-PROTEINS; BINDING-SITE; EXPORT; COMPONENT; SEQUENCE; PATHWAY	Background: The twin-arginine translocation (Tat) protein export system enables the transport of fully folded proteins across a membrane. This system is composed of two integral membrane proteins belonging to TatA and TatC protein families and in some systems a third component, TatB, a homolog of TatA. TatC participates in substrate protein recognition through its interaction with a twin arginine leader peptide sequence. Methodology/Principal Findings: The aim of this study was to explore TatC diversity, evolution and sequence conservation in bacteria to identify how TatC is evolving and diversifying in various bacterial phyla. Surveying bacterial genomes revealed that 77% of all species possess one or more tatC loci and half of these classes possessed only tatC and tatA genes. Phylogenetic analysis of diverse TatC homologues showed that they were primarily inherited but identified a small subset of taxonomically unrelated bacteria that exhibited evidence supporting lateral gene transfer within an ecological niche. Examination of bacilli tatCd/tatCy isoform operons identified a number of known and potentially new Tat substrate genes based on their frequent association to tatC loci. Evolutionary analysis of these Bacilli isoforms determined that TatCy was the progenitor of TatCd. A bacterial TatC consensus sequence was determined and highlighted conserved and variable regions within a three dimensional model of the Escherichia coli TatC protein. Comparative analysis between the TatC consensus sequence and Bacilli TatCd/y isoform consensus sequences revealed unique sites that may contribute to isoform substrate specificity or make TatA specific contacts. Synonymous to non-synonymous nucleotide substitution analyses of bacterial tatC homologues determined that tatC sequence variation differs dramatically between various classes and suggests TatC specialization in these species. Conclusions/Significance: TatC proteins appear to be diversifying within particular bacterial classes and its specialization may be driven by the substrates it transports and the environment of its host.	[Simone, Domenico] CNR, Inst Biomembranes & Bioenerget, Bari, Italy; [Bay, Denice C.; Leach, Thorin; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Consiglio Nazionale delle Ricerche (CNR); University of Calgary	Turner, RJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	turnerr@ucalgary.ca	Turner, Raymond J./M-3961-2015; Bay, Denice/D-1682-2016; Simone, Domenico/B-5427-2014	Turner, Raymond J./0000-0002-9263-0776; Bay, Denice/0000-0002-3620-828X; Simone, Domenico/0000-0003-2858-9809	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this work was provided by a grant from the Canadian Institute of Health Research (CIHR) to RJT. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Allen SCH, 2002, J BIOL CHEM, V277, P10362, DOI 10.1074/jbc.M109135200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Butler CS, 2001, FEBS LETT, V500, P71, DOI 10.1016/S0014-5793(01)02577-7; Butler CS, 2000, BIOCHEM J, V352, P859, DOI 10.1042/0264-6021:3520859; Caldelari I, 2008, ARCH MICROBIOL, V189, P597, DOI 10.1007/s00203-008-0356-8; Clark AC, 1999, J MOL BIOL, V285, P1765, DOI 10.1006/jmbi.1998.2402; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Eijlander RT, 2009, J BACTERIOL, V191, P196, DOI 10.1128/JB.01264-08; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2013, ANTIOXID REDOX SIGN, V18, P1159, DOI 10.1089/ars.2012.4664; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Hatzixanthis K, 2005, BIOCHEM SOC T, V33, P124, DOI 10.1042/BST0330124; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Ize B, 2004, J BIOL CHEM, V279, P47543, DOI 10.1074/jbc.M406910200; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mangels D, 2005, J MOL BIOL, V345, P415, DOI 10.1016/j.jmb.2004.10.043; Matos CFRO, 2009, EMBO REP, V10, P474, DOI 10.1038/embor.2009.34; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; OTA T, 1994, MOL BIOL EVOL, V11, P613; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Penfold DW, 2006, FEMS MICROBIOL LETT, V262, P135, DOI 10.1111/j.1574-6968.2006.00333.x; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasmussen T, 2005, DALTON T, P3501, DOI 10.1039/b501846c; Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Tarry M, 2009, J MOL BIOL, V386, P504, DOI 10.1016/j.jmb.2008.12.043; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	76	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78742	10.1371/journal.pone.0078742	http://dx.doi.org/10.1371/journal.pone.0078742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236045	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700042
J	Tonelli, P; Mouret, JB				Tonelli, Paul; Mouret, Jean-Baptiste			On the Relationships between Generative Encodings, Regularity, and Learning Abilities when Evolving Plastic Artificial Neural Networks	PLOS ONE			English	Article							EVOLUTIONARY ROBOTICS; WIRING OPTIMIZATION; BASAL GANGLIA; BRAIN; MODEL	A major goal of bio-inspired artificial intelligence is to design artificial neural networks with abilities that resemble those of animal nervous systems. It is commonly believed that two keys for evolving nature-like artificial neural networks are (1) the developmental process that links genes to nervous systems, which enables the evolution of large, regular neural networks, and (2) synaptic plasticity, which allows neural networks to change during their lifetime. So far, these two topics have been mainly studied separately. The present paper shows that they are actually deeply connected. Using a simple operant conditioning task and a classic evolutionary algorithm, we compare three ways to encode plastic neural networks: a direct encoding, a developmental encoding inspired by computational neuroscience models, and a developmental encoding inspired by morphogen gradients (similar to HyperNEAT). Our results suggest that using a developmental encoding could improve the learning abilities of evolved, plastic neural networks. Complementary experiments reveal that this result is likely the consequence of the bias of developmental encodings towards regular structures: (1) in our experimental setup, encodings that tend to produce more regular networks yield networks with better general learning abilities; (2) whatever the encoding is, networks that are the more regular are statistically those that have the best learning abilities.	[Tonelli, Paul; Mouret, Jean-Baptiste] Univ Paris 06, CNRS, ISIR, UMR 7222, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Mouret, JB (corresponding author), Univ Paris 06, CNRS, ISIR, UMR 7222, Paris, France.	mouret@isir.upmc.fr	Mouret, Jean Baptiste/B-5166-2019; Mouret, Jean-Baptiste/A-9949-2012	Mouret, Jean Baptiste/0000-0002-2513-027X; Mouret, Jean-Baptiste/0000-0002-2513-027X	Agence Nationale de la Recherche; Creadapt [ANR-12-JS03-0009]; EvoNeuro [ANR-09-EMER-005]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Creadapt; EvoNeuro	This work was funded by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) by the grants Creadapt (ANR-12-JS03-0009) and EvoNeuro (ANR-09-EMER-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 2018, REINFORCEMENT LEARNI, DOI 10.1016/S1364-6613(99)01331-5; [Anonymous], 1998, NEURAL NETWORKS COMP; Bongard J, 2002, IEEE C EVOL COMPUTAT, P1872, DOI 10.1109/CEC.2002.1004528; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chalmers DJ, 1990, P 1990 CONN MOD SUMM, P81; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Clune J, 2011, IEEE T EVOLUT COMPUT, V15, P346, DOI 10.1109/TEVC.2010.2104157; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, WIL INT S SYS OPT; Floreano D., 2008, BIOINSPIRED ARTIFICI; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Girard B, 2008, NEURAL NETWORKS, V21, P628, DOI 10.1016/j.neunet.2008.03.009; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grossberg S, 2000, TRENDS COGN SCI, V4, P233, DOI 10.1016/S1364-6613(00)01464-9; Gruau F, 1993, EVOL COMPUT, V1, P213, DOI 10.1162/evco.1993.1.3.213; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; Hayashida M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S13; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hornby GS, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P1729; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; Houk JC, 1995, MODELS INFORMATION P, P249; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Junttila T, 2007, SIAM PROC S, P135; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Katebi H, 2012, TURING 100 EPIC, P181; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Li M., 2008, INTRO KOLMOGOROV COM; Lipson Hod, 2007, Journal of Biological Physics and Chemistry, V7, P125, DOI 10.4024/40701.jbpc.07.04; Mattiussi C, 2007, IEEE T EVOLUT COMPUT, V11, P596, DOI 10.1109/TEVC.2006.886801; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Minsky ML, 1987, PERCEPTRONS EXPANDED; Mouret JB, 2010, P GECCO, P587; Mouret JB, 2011, STUD COMPUT INTELL, V341, P139; Mouret JB, 2009, IEEE C EVOL COMPUTAT, P1161, DOI 10.1109/CEC.2009.4983077; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Niv Y, 2002, ADAPT BEHAV, V10, P5, DOI 10.1177/10597123020101001; Ollion C, 2012, ARTIF LIFE, V13, P407; Peshkin L, 2007, IEEE DATA COMPR CONF, P53; Pfeifer R., 2006, BODY SHAPES WAY WE T; Pinville T, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P259; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Richerson PJ, 2005, HANDBOOK OF EVOLUTION, VOL 2: THE EVOLUTION OF LIVING SYSTEMS (INCLUDING HOMINIDS), P223, DOI 10.1002/9783527619719.ch7; Risi S, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1539; Risi S, 2010, ADAPT BEHAV, V18, P470, DOI 10.1177/1059712310379923; Risi S, 2010, LECT NOTES ARTIF INT, V6226, P533, DOI 10.1007/978-3-642-15193-4_50; Rougier NP, 2006, NEURAL NETWORKS, V19, P573, DOI 10.1016/j.neunet.2005.04.004; Soltoggio A, 2009, P 11 ANN C GEN EV CO, P169; Soltoggio A., 2008, ARTIFICIAL LIFE, VXI, P569; Soltoggio A, 2007, IEEE C EVOL COMPUTAT, P2471, DOI 10.1109/CEC.2007.4424781; Stanley KO, 2009, ARTIF LIFE, V15, P185, DOI 10.1162/artl.2009.15.2.15202; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Urzelai J, 2001, EVOL COMPUT, V9, P495, DOI 10.1162/10636560152642887; Verbancsics P, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1483; Zenil H, 2013, ARXIV13060322	68	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79138	10.1371/journal.pone.0079138	http://dx.doi.org/10.1371/journal.pone.0079138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236099	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700097
J	Chen, YP; Chen, MJ				Chen, Yen-Po; Chen, Ming-Ju			Effects of Lactobacillus kefiranofaciens M1 Isolated from Kefir Grains on Germ-Free Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LACTIC-ACID BACTERIA; MICROBIAL DIVERSITY; COMMENSAL BACTERIA; GUT MICROBIOTA; BARRIER; MODELS; TH1	Lactobacillus kefiranofaciens M1 is a novel probiotic strain that was isolated from kefir grains. Previously, we have demonstrated the immunoregulatory, anti-allergic, anti-asthmatic and anti-colitis abilities of L. kefiranofaciens M1 in a number of in-vitro and in-vivo experiments. However, whether the effects of L. kefiranofaciens M1 are elicited directly on the host or act by regulating the host's microbiota remains unknown. A number of studies have used germ-free or gnotobiotic animals to investigate the relationship between probiotics and colitis; therefore the aim of this study was to investigate the effects of L. kefiranofaciens M1 on germ-free mice. Such an approach should help in determining the direct effects of L. kefiranofaciens M1 on the host itself. Four-week-old female germ-free mice were inoculated intragastrically with 2x10(8) CFU/mouse L. kefiranofaciens M1 once or at 2-day intervals for 14 days. Bacterial colonization, the Th1/Th2 cytokine profile of the mice's splenocytes and the anti-colitis effect of L. kefiranofaciens M1 were investigated. The strongest response in terms of splenic Th1 cytokine IFN-gamma and IL-12 production upon TLR activation was detected in the continuous treatment group when comparing to the single inoculation group and the germ-free control. In addition, continuous inoculation with L. kefiranofaciens M1 was found to ameliorate the symptoms of DSS-induced colitis in germ-free mice. However, L. kefiranofaciens M1 failed to colonize the host. Thus it would seem that L. kefiranofaciens M1 is likely to act directly on the host and not be involved in microbiota regulation.	[Chen, Yen-Po; Chen, Ming-Ju] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Chen, Ming-Ju] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Chen, MJ (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan.	cmj@ntu.edu.tw	Chen, Yen Po/GLQ-6423-2022	Chen, Yen Po/0000-0003-0621-6219; CHEN, MING-JU/0000-0003-4403-6112	National Science Council in Taiwan	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, CRIT REV FOOD SCI, V53, P422, DOI 10.1080/10408398.2010.540360; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; Banasaz M, 2002, APPL ENVIRON MICROB, V68, P3031, DOI 10.1128/AEM.68.6.3031-3034.2002; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Chen KQ, 2011, INT IMMUNOPHARMACOL, V11, P1391, DOI 10.1016/j.intimp.2011.05.003; Chen YP, 2012, J DAIRY SCI, V95, P63, DOI 10.3168/jds.2011-4696; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; dos Santos LM, 2011, MED MICROBIOL IMMUN, V200, P29, DOI 10.1007/s00430-010-0170-1; Gangloff SC, 2004, CLIN REV ALLERG IMMU, V26, P115, DOI 10.1385/CRIAI:26:2:115; Guzel-Seydim ZB, 2011, CRIT REV FOOD SCI, V51, P261, DOI 10.1080/10408390903579029; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hong WS, 2011, J AGR FOOD CHEM, V59, P9022, DOI 10.1021/jf201913x; Hong WS, 2010, J FOOD SCI, V75, pH244, DOI 10.1111/j.1750-3841.2010.01787.x; Hong WS, 2009, INT DAIRY J, V19, P244, DOI 10.1016/j.idairyj.2008.10.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Krumbiegel D, 2007, HUM IMMUNOL, V68, P813, DOI 10.1016/j.humimm.2007.08.001; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Nikolic M, 2012, INT J FOOD MICROBIOL, V158, P155, DOI 10.1016/j.ijfoodmicro.2012.07.015; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Puhl NJ, 2012, ANAEROBE, V18, P67, DOI 10.1016/j.anaerobe.2011.12.007; Ruas-Madiedo P, 2006, J DAIRY SCI, V89, P2355, DOI 10.3168/jds.S0022-0302(06)72307-4; SHARMA R, 1995, GUT, V36, P209, DOI 10.1136/gut.36.2.209; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; THOMPSON GR, 1971, GUT, V12, P230, DOI 10.1136/gut.12.3.230; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Vereecke L, 2011, TRENDS MOL MED, V17, P584, DOI 10.1016/j.molmed.2011.05.011; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wang SY, 2012, FOOD MICROBIOL, V32, P274, DOI 10.1016/j.fm.2012.07.001; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; WOSTMANN BS, 1981, ANNU REV NUTR, V1, P257, DOI 10.1146/annurev.nu.01.070181.001353	39	44	44	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78789	10.1371/journal.pone.0078789	http://dx.doi.org/10.1371/journal.pone.0078789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244362	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600060
J	Seamons, A; Treuting, PM; Brabb, T; Maggio-Price, L				Seamons, Audrey; Treuting, Piper M.; Brabb, Thea; Maggio-Price, Lillian			Characterization of Dextran Sodium Sulfate-Induced Inflammation and Colonic Tumorigenesis in Smad3(-/-) Mice with Dysregulated TGF beta	PLOS ONE			English	Article							BOWEL-DISEASE; NEOPLASTIC PROGRESSION; GALECTIN-3 EXPRESSION; EXPERIMENTAL COLITIS; INTESTINAL CANCER; COLORECTAL-CANCER; MOUSE MODELS; MUTANT MICE; CARCINOGENESIS; INFECTION	There are few mouse models that adequately mimic large bowel cancer in humans or the gastrointestinal inflammation which frequently precedes it. Dextran sodium sulphate (DSS)-induces colitis in many animal models and has been used in combination with the carcinogen azoxymethane (AOM) to induce cancer in mice. Smad3(-/-) mice are deficient in the transforming growth factor beta (TGF beta) signaling molecule, SMAD3, resulting in dysregulation of the cellular pathway most commonly affected in human colorectal cancer, and develop inflammation-associated colon cancer. Previous studies have shown a requirement for a bacterial trigger for the colitis and colon cancer phenotype in Smad3(-/-) mice. Studies presented here in Smad3(-/-) mice detail disease induction with DSS, without the use of AOM, and show a) Smad3(-/-) mice develop a spectrum of lesions ranging from acute and chronic colitis, crypt herniation, repair, dysplasia, adenomatous polyps, disseminated peritoneal adenomucinosis, adenocarcinoma, mucinous adenocarcinoma (MAC) and squamous metaplasia; b) the colon lesions have variable galactin-3 (Mac2) staining c) increased DSS concentration and duration of exposure leads to increased severity of colonic lesions; d) heterozygosity of SMAD3 does not confer increased susceptibility to DSS-induced disease and e) disease is partially controlled by the presence of T and B cells as Smad3(-/-) Rag2(-/-) double knock out (DKO) mice develop a more severe disease phenotype. DSS-induced disease in Smad3(-/-) mice may be a useful animal model to study not only inflammation-driven MAC but other human diseases such as colitis cystica profunda (CCP) and pseudomyxomatous peritonei (PMP).	[Seamons, Audrey; Treuting, Piper M.; Brabb, Thea; Maggio-Price, Lillian] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Maggio-Price, L (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	lmprice@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Seamons, Audrey/0000-0003-2609-1230	CCFA [1579]; AICR [09A136-Rev]	CCFA; AICR	This research was supported in part by CCFA #1579 (L.M.P., http://www.ccfa.org/science-and-professionals/research/grants-fellowships/) and AICR 09A136-Rev (L.M.P., http://www.aicr.org/research/grant/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Arfaoui-Toumi A, 2010, B CANCER, V97, pE1, DOI 10.1684/bdc.2010.1032; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Becker C, 2006, CYTOKINE GROWTH F R, V17, P97, DOI 10.1016/j.cytogfr.2005.09.004; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Boulard O, 2012, J EXP MED, V209, P1309, DOI 10.1084/jem.20120239; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; COOPER HS, 1993, LAB INVEST, V69, P238; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Endo K, 2005, ANTICANCER RES, V25, P3117; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Hale LP, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-4; Hamilton S, 2000, WHO CLASSIFICATION T, P105; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Lencioni KC, 2011, COMPARATIVE MED, V61, P219; Loddenkemper C, 2006, INT J CANCER, V118, P2750, DOI 10.1002/ijc.21729; LOTZ MM, 1993, P NATL ACAD SCI USA, V90, P3466, DOI 10.1073/pnas.90.8.3466; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mladenova D, 2012, IN VIVO, V26, P627; Molavi D, 2008, ADV ANAT PATHOL, V15, P1, DOI 10.1097/PAP.0b013e31815e52aa; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Percy DH, 2007, PATHOLOGY LAB RODENT; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Radosavljevic G, 2012, IMMUNOL RES, V52, P100, DOI 10.1007/s12026-012-8286-6; Ronnett BM, 2001, CANCER, V92, P85, DOI 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R; Ronnett BM, 2003, CME J GYNECOL ONCOL, V8, P192; SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#; Suzuki R, 2005, HISTOL HISTOPATHOL, V20, P483, DOI 10.14670/HH-20.483; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Tokumasa A, 2004, BIOCHEM BIOPH RES CO, V317, P377, DOI 10.1016/j.bbrc.2004.03.047; Tsuboi K, 2007, ANTICANCER RES, V27, P2289; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	55	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79182	10.1371/journal.pone.0079182	http://dx.doi.org/10.1371/journal.pone.0079182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244446	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600116
J	Vos, M; Lovisa, B; Geens, A; Morais, VA; Wagnieres, G; van den Bergh, H; Ginggen, A; De Strooper, B; Tardy, Y; Verstreken, P				Vos, Melissa; Lovisa, Blaise; Geens, Ann; Morais, Vanessa A.; Wagnieres, Georges; van den Bergh, Hubert; Ginggen, Alec; De Strooper, Bart; Tardy, Yanik; Verstreken, Patrik			Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; MITOCHONDRIAL-FUNCTION; DISEASE; DROSOPHILA; PHOSPHORYLATION; DEFICIENCY; MECHANISMS; DEFECTS; THERAPY; FISSION	Mitochondrial electron transport chain (ETC) defects are observed in Parkinson's disease (PD) patients and in PD fly-and mouse-models; however it remains to be tested if acute improvement of ETC function alleviates PD-relevant defects. We tested the hypothesis that 808 nm infrared light that effectively penetrates tissues rescues pink1 mutants. We show that irradiating isolated fly or mouse mitochondria with 808 nm light that is absorbed by ETC-Complex IV acutely improves Complex IV-dependent oxygen consumption and ATP production, a feature that is wavelength-specific. Irradiating Drosophila pink1 mutants using a single dose of 808 nm light results in a rescue of major systemic and mitochondrial defects. Time-course experiments indicate mitochondrial membrane potential defects are rescued prior to mitochondrial morphological defects, also in dopaminergic neurons, suggesting mitochondrial functional defects precede mitochondrial swelling. Thus, our data indicate that improvement of mitochondrial function using infrared light stimulation is a viable strategy to alleviate pink1-related defects.	[Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] VIB Ctr Biol Dis, Louvain, Belgium; [Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium; [Lovisa, Blaise; Tardy, Yanik] Medos Int Sarl, Le Locle, Switzerland; [Lovisa, Blaise; Wagnieres, Georges; van den Bergh, Hubert] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Chem Sci & Engn ISIC, Med Photon Grp, CH-1015 Lausanne, Switzerland; [Ginggen, Alec] Johnson & Johnson Serv Inc, Corp Off Sci & Technol, New Brunswick, NJ USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Johnson & Johnson	Verstreken, P (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	Patrik.verstreken@med.kuleuven.be	Verstreken, Patrik/AAC-7591-2022; de+Strooper, Bart/Z-1638-2019	Verstreken, Patrik/0000-0002-5073-5393; Wagnieres, Georges/0000-0002-9082-3099; Morais, Vanessa/0000-0002-0830-0548	IWT (OO); KU Leuven; ERC StG [260678]; FWO; Methusalem; CTI [14660.1 PFLS-LS, 13758.1 PFFLE-ES]; R'EQUIP program [206021_128677]; J. Jacobi Trust; Swiss National Science Foundation [205320 147141/1]; Hercules and Francqui Foundations; IUAP of BELSPO; VIB as well as a fellowships from IWT; Research fund KU Leuven (PDM)	IWT (OO); KU Leuven(KU Leuven); ERC StG; FWO(FWO); Methusalem; CTI; R'EQUIP program; J. Jacobi Trust; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hercules and Francqui Foundations; IUAP of BELSPO; VIB as well as a fellowships from IWT; Research fund KU Leuven (PDM)	Support was provided by IWT (O&O), research fund KU Leuven, ERC StG (260678), FWO grants, Methusalem grant, the CTI (14660.1 PFLS-LS and 13758.1 PFFLE-ES), the R'EQUIP program (206021_128677), the J. Jacobi Trust, the Swiss National Science Foundation (205320 147141/1), the Hercules and Francqui Foundations, an IUAP of BELSPO and VIB as well as a fellowships from IWT, Research fund KU Leuven (PDM) and FWO to MV. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; Esposito G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003478; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liu S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001237; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pecina P, 2004, PHYSIOL RES, V53, pS213; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x; Varghese M, 2009, J NEUROL SCI, V279, P39, DOI 10.1016/j.jns.2008.12.021; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Volkmann J, 2004, J CLIN NEUROPHYSIOL, V21, P6, DOI 10.1097/00004691-200401000-00003; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zhang HY, 2009, LASER MED SCI, V24, P549, DOI 10.1007/s10103-008-0609-4; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	38	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78562	10.1371/journal.pone.0078562	http://dx.doi.org/10.1371/journal.pone.0078562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244323	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600033
J	Chen, P; Ong, RTH; Tay, WT; Sim, XL; Ali, M; Xu, HY; Suo, C; Liu, JJ; Chia, KS; Vithana, E; Young, TL; Aung, T; Lim, WY; Khor, CC; Cheng, CY; Wong, TY; Teo, YY; Tai, ES				Chen, Peng; Ong, Rick Twee-Hee; Tay, Wan-Ting; Sim, Xueling; Ali, Mohammad; Xu, Haiyan; Suo, Chen; Liu, Jianjun; Chia, Kee-Seng; Vithana, Eranga; Young, Terri L.; Aung, Tin; Lim, Wei-Yen; Khor, Chiea-Chuen; Cheng, Ching-Yu; Wong, Tien-Yin; Teo, Yik-Ying; Tai, E-Shyong			A Study Assessing the Association of Glycated Hemoglobin A(1C) (HbA(1C)) Associated Variants with HbA(1C), Chronic Kidney Disease and Diabetic Retinopathy in Populations of Asian Ancestry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ETHNIC-DIFFERENCES; RISK-FACTORS; SUSCEPTIBILITY LOCI; NATIONAL-HEALTH; GLUCOSE; METAANALYSIS; PREVALENCE; COMPONENTS; EFFICIENCY	Glycated hemoglobin A(1C) (HbA(1C)) level is used as a diagnostic marker for diabetes mellitus and a predictor of diabetes associated complications. Genome-wide association studies have identified genetic variants associated with HbA(1C) level. Most of these studies have been conducted in populations of European ancestry. Here we report the findings from a meta-analysis of genome-wide association studies of HbA(1C) levels in 6,682 non-diabetic subjects of Chinese, Malay and South Asian ancestries. We also sought to examine the associations between HbA(1C) associated SNPs and microvascular complications associated with diabetes mellitus, namely chronic kidney disease and retinopathy. A cluster of 6 SNPs on chromosome 17 showed an association with HbA(1C) which achieved genome-wide significance in the Malays but not in Chinese and Asian Indians. No other variants achieved genome-wide significance in the individual studies or in the meta-analysis. When we investigated the reproducibility of the findings that emerged from the European studies, six loci out of fifteen were found to be associated with HbA(1C) with effect sizes similar to those reported in the populations of European ancestry and P-value <= 0.05. No convincing associations with chronic kidney disease and retinopathy were identified in this study.	[Chen, Peng; Ong, Rick Twee-Hee; Sim, Xueling; Xu, Haiyan; Suo, Chen; Chia, Kee-Seng; Lim, Wei-Yen; Khor, Chiea-Chuen; Cheng, Ching-Yu; Teo, Yik-Ying; Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tay, Wan-Ting; Vithana, Eranga; Aung, Tin; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Khor, Chiea-Chuen] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Ali, Mohammad; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Liu, Jianjun; Khor, Chiea-Chuen; Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Vithana, Eranga; Aung, Tin; Khor, Chiea-Chuen; Cheng, Ching-Yu; Wong, Tien-Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien-Yin; Tai, E-Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore; [Young, Terri L.] Duke Univ, Ctr Human Genet, Med Ctr, Durham, NC USA; [Tai, E-Shyong] Duke NUS Grad Med Sch, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; National University of Singapore; National University of Singapore; Duke University; National University of Singapore; National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	statyy@nus.edu.sg; e_shyong_tai@nuhs.edu.sg	Chen, Peng/E-5546-2015; Sim, Xueling/AAZ-6652-2020; Wong, Tien Yin/AAC-9724-2020; Cheng, Ching-Yu/Y-2229-2019; Liu, Jianjun/AAK-4989-2020	Chen, Peng/0000-0002-1422-4641; Sim, Xueling/0000-0002-1233-7642; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Liu, Jianjun/0000-0002-3255-3019	Yong Loo Lin School of Medicine; National University Health System; Life Sciences Institute from the National University of Singapore; National Research Foundation [NRF-RF-2010-05]; National Medical Research Council of Singapore; Biomedical Research Council of Singapore; National Medical Research Council [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council [08/1/35/19/550, 09/1/35/19/616]	Yong Loo Lin School of Medicine(National University of Singapore); National University Health System; Life Sciences Institute from the National University of Singapore(National University of Singapore); National Research Foundation; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This project acknowledges the support of the Yong Loo Lin School of Medicine, the National University Health System and the Life Sciences Institute from the National University of Singapore. The authors also acknowledge the support from the National Research Foundation (NRF-RF-2010-05), National Medical Research Council of Singapore (under the clinician scientist award, Singapore Translational Research Investigator Award and individual research grant schemes) and the Biomedical Research Council of Singapore (under the individual research grants scheme). SiMES, SINDI and SCES were funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008; CG/SERI/2010) and Biomedical Research Council (grants 08/1/35/19/550, 09/1/35/19/616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Franklin CS, 2010, ANN HUM GENET, V74, P471, DOI 10.1111/j.1469-1809.2010.00607.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grimsby JL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-30; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li C, 2008, GENET EPIDEMIOL, V32, P387, DOI 10.1002/gepi.20312; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Ong RTH, 2012, EUR J HUM GENET, V20, P1300, DOI 10.1038/ejhg.2012.88; Pare G, 2008, PLOS GENET, V4, DOI DOI 10.1007/s00726-014-1889-6; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ryu J, 2012, HUM MUTAT, V33, P655, DOI 10.1002/humu.22040; Sabanayagam C, 2009, DIABETOLOGIA, V52, P1279, DOI 10.1007/s00125-009-1360-5; Sabanayagam C, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-86; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Simonis-Bik AMC, 2008, TWIN RES HUM GENET, V11, P597, DOI 10.1375/twin.11.6.597; Sobrin L, 2011, INVEST OPHTH VIS SCI, V52, P7593, DOI 10.1167/iovs.11-7510; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Tanhauserova V, 2013, CLIN CHEM LAB MED, P1; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng YF, 2012, OPHTHALMOLOGY, V119, P2119, DOI 10.1016/j.ophtha.2012.04.027	41	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79767	10.1371/journal.pone.0079767	http://dx.doi.org/10.1371/journal.pone.0079767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244560	Green Published, gold			2022-12-25	WOS:000327162900052
J	Le Drean, G; Haure-Mirande, V; Ferrier, L; Bonnet, C; Hulin, P; de Coppet, P; Segain, JP				Le Drean, Gwenola; Haure-Mirande, Vianney; Ferrier, Laurent; Bonnet, Christian; Hulin, Philippe; de Coppet, Pierre; Segain, Jean-Pierre			Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway	FASEB JOURNAL			English	Article						adipocytes; actin cytoskeleton; barrier; adipokines	HIGH-FAT DIET; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INTESTINAL PERMEABILITY; INDUCED OBESITY; ACTIN CYTOSKELETON; GUT MICROBIOTA; CELLS; BARRIER; PROTEIN	Proinflammatory cytokines produced by immune cells play a central role in the increased intestinal epithelial permeability during inflammation. Expansion of visceral adipose tissue (VAT) is currently considered a consequence of intestinal inflammation. Whether VAT per se plays a role in early modifications of intestinal barrier remains unknown. The aim of this study was to demonstrate the direct role of adipocytes in regulating paracellular permeability of colonic epithelial cells (CECs). We show in adult rats born with intrauterine growth retardation, a model of VAT hypertrophy, and in rats with VAT graft on the colon, that colonic permeability was increased without any inflammation. This effect was associated with altered expression of tight junction (TJ) proteins occludin and ZO-1. In coculture experiments, adipocytes decreased transepithelial resistance (TER) of Caco-2 CECs and induced a disorganization of ZO-1 on TJs. Intraperitoneal administration of leptin to lean rats increased colonic epithelial permeability and altered ZO-1 expression and organization. Treatment of HT29-19A CECs with leptin, but not adiponectin, dose-dependently decreased TER and altered TJ and F-actin cytoskeleton organization through a RhoA-ROCK-dependent pathway. Our data show that adipocytes and leptin directly alter TJ function in CECs and suggest that VAT could impair colonic epithelial barrier.Le Drean, G., Haure-Mirande, V., Ferrier, L., Bonnet, C., Hulin, P., de Coppet, P., Segain, J.-P. Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway.	[Le Drean, Gwenola; Haure-Mirande, Vianney; Bonnet, Christian; de Coppet, Pierre; Segain, Jean-Pierre] Univ Nantes, INRA, UMR 1280, IMAD,CRNH, F-44093 Nantes, France; [Ferrier, Laurent] INRA, UMR ToxAlim 1331, Grp Neurogastroenterol & Nutr, F-31931 Toulouse, France; [Hulin, Philippe] Nantes Univ MicroPICell, Cellular & Tissular Imaging Core Facil, Nantes, France	INRAE; Nantes Universite; INRAE	Le Drean, G (corresponding author), Univ Nantes, INRA, UMR 1280, CHU Hotel Dieu, Pl Alexis Ricordeau, F-44093 Nantes, France.	gwenola.ledrean@univ-nantes.fr	Haure-Mirande, Jean-Vianney/AAS-9570-2020	Haure-Mirande, Jean-Vianney/0000-0002-5748-9666; Ferrier, Laurent/0000-0003-2981-7375	National League against Cancer (LNCC); French Nutrition Society (SFN); SanTDige; Institut National de la Recherche Agronomique (INRA); Region of Pays de la Loire	National League against Cancer (LNCC); French Nutrition Society (SFN); SanTDige; Institut National de la Recherche Agronomique (INRA); Region of Pays de la Loire(Region Pays de la Loire)	The authors thank Guillaume Poupeau for its surgical expertise and Prof. Dominique Darmaun for reviewing the manuscript. This work was funded by the National League against Cancer (LNCC), the French Nutrition Society (SFN), and SanTDige. V.H.-M. is a recipient of a doctoral fellowship from the Institut National de la Recherche Agronomique (INRA) and the Region of Pays de la Loire. The authors declare no conflicts of interest.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Aparicio T, 2005, GUT, V54, P1136, DOI 10.1136/gut.2004.060533; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; AUGERON C, 1984, CANCER RES, V44, P3961; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Batra A, 2009, INFLAMM BOWEL DIS, V15, P1897, DOI 10.1002/ibd.20937; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Drew JE, 2007, AM J PHYSIOL-GASTR L, V293, pG682, DOI 10.1152/ajpgi.00231.2007; Drew JE, 2012, P NUTR SOC, V71, P175, DOI 10.1017/S0029665111003259; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; El Homsi M, 2007, AM J PHYSIOL-GASTR L, V293, pG365, DOI 10.1152/ajpgi.00091.2007; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Gambero A, 2007, INFLAMM BOWEL DIS, V13, P1357, DOI 10.1002/ibd.20222; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Lalles JP, 2012, J NUTR BIOCHEM, V23, P1490, DOI 10.1016/j.jnutbio.2011.10.001; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Orozco-Solis R, 2009, PHYSIOL BEHAV, V96, P481, DOI 10.1016/j.physbeh.2008.11.016; Padidar S, 2011, DIGEST DIS SCI, V56, P1028, DOI 10.1007/s10620-010-1394-z; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Segain JP, 2007, J IMMUNOL, V179, P901, DOI 10.4049/jimmunol.179.2.901; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Waterland RA, 2006, J PEDIATR-US, V149, pS137, DOI 10.1016/j.jpeds.2006.06.064; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Zeidan A, 2007, J PHARMACOL EXP THER, V322, P1110, DOI 10.1124/jpet.107.122440; Zilberfarb V, 1997, J CELL SCI, V110, P801; Zulian A, 2012, GUT, V61, P86, DOI 10.1136/gutjnl-2011-300391	48	45	45	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1059	1070		10.1096/fj.13-234203	http://dx.doi.org/10.1096/fj.13-234203			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24243887				2022-12-25	WOS:000335324800004
J	Neuhaus, A; Kooshapur, H; Wolf, J; Meyer, NH; Madl, T; Saidowsky, J; Hambruch, E; Lazam, A; Jung, M; Sattler, M; Schliebs, W; Erdmann, R				Neuhaus, Alexander; Kooshapur, Hamed; Wolf, Janina; Meyer, N. Helge; Madl, Tobias; Saidowsky, Juergen; Hambruch, Eva; Lazam, Anissa; Jung, Martin; Sattler, Michael; Schliebs, Wolfgang; Erdmann, Ralf			A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peroxisomes; Protein Dynamics; Protein Motifs; Protein Structure; Protein Targeting; Protein-Protein Interactions; Subcellular Organelles	PTS1 RECEPTOR PEX5P; N-TERMINAL DOMAIN; BINDING-SITES; SH3 DOMAIN; STRUCTURAL BASIS; MEMBRANE; BIOGENESIS; ASSOCIATION; MACHINERY; COMPLEXES	Protein import into peroxisomes relies on the import receptor Pex5, which recognizes proteins with a peroxisomal targeting signal 1 (PTS1) in the cytosol and directs them to a docking complex at the peroxisomal membrane. Receptor-cargo docking occurs at the membrane-associated protein Pex14. In human cells, this interaction is mediated by seven conserved diaromatic penta-peptide motifs (WXXX(F/Y) motifs) in the N-terminal half of Pex5 and the N-terminal domain of Pex14. A systematic screening of a Pex5 peptide library by ligand blot analysis revealed a novel Pex5-Pex14 interaction site of Pex5. The novel motif composes the sequence LVAEF with the evolutionarily conserved consensus sequence LVXEF. Replacement of the amino acid LVAEF sequence by alanines strongly affects matrix protein import into peroxisomes in vivo. The NMR structure of a complex of Pex5-(57-71) with the Pex14-N-terminal domain showed that the novel motif binds in a similar -helical orientation as the WXXX(F/Y) motif but that the tryptophan pocket is now occupied by a leucine residue. Surface plasmon resonance analyses revealed 33 times faster dissociation rates for the LVXEF ligand when compared with a WXXX(F/Y) motif. Surprisingly, substitution of the novel motif with the higher affinity WXXX(F/Y) motif impairs protein import into peroxisomes. These data indicate that the distinct kinetic properties of the novel Pex14-binding site in Pex5 are important for processing of the peroxisomal targeting signal 1 receptor at the peroxisomal membrane. The novel Pex14-binding site may represent the initial tethering site of Pex5 from which the cargo-loaded receptor is further processed in a sequential manner.	[Neuhaus, Alexander; Wolf, Janina; Saidowsky, Juergen; Hambruch, Eva; Lazam, Anissa; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany; [Kooshapur, Hamed; Meyer, N. Helge; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Kooshapur, Hamed; Meyer, N. Helge; Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Chair Biomol NMR, D-85747 Garching, Germany; [Jung, Martin] Univ Saarland, D-66421 Homburg, Germany	Ruhr University Bochum; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Saarland University	Sattler, M (corresponding author), Helmholtz Zentrum, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de; ralf.erdmann@rub.de	Jung, Martin/D-2207-2012; Madl, Tobias/B-1682-2012; Sattler, Michael/A-2407-2012; Kooshapur, Hamed/H-4622-2019; Jung, Martin/AAM-4547-2021	Jung, Martin/0000-0002-1482-7020; Madl, Tobias/0000-0002-9725-5231; Sattler, Michael/0000-0002-1594-0527; Jung, Martin/0000-0002-1482-7020; Meyer, Niels Helge/0000-0003-1018-4942; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [FOR1905, GRK1721, SFB594]; European Commission [FP7 NMI3, 226507]; Technische Universitat Munchen Graduate School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Technische Universitat Munchen Graduate School	This work was supported in part by Deutsche Forschungsgemeinschaft Grants FOR1905 (to R. E. and M. S.), GRK1721 (to M. S.), and SFB594 (to M. S.) and European Commission Grant FP7 NMI3, 226507 (to M. S.).; Supported by the Technische Universitat Munchen Graduate School.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Choe J, 2003, BIOCHEMISTRY-US, V42, P10915, DOI 10.1021/bi034248n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Goddard TD, 2007, SPARKY VERSION 3; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Huybrechts SJ, 2008, J MED GENET, V45, P376, DOI 10.1136/jmg.2007.056697; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Madrid KP, 2005, BIOCHEM J, V391, P105, DOI 10.1042/BJ20050328; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pires JR, 2003, J MOL BIOL, V326, P1427, DOI 10.1016/S0022-2836(03)00039-1; Platta HW, 2013, CELL MOL LIFE SCI, V70, P1393, DOI 10.1007/s00018-012-1136-9; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; Stanley WA, 2004, J SYNCHROTRON RADIAT, V11, P490, DOI 10.1107/S090904950402504X; Su JR, 2009, P NATL ACAD SCI USA, V106, P417, DOI 10.1073/pnas.0808681106; Williams C, 2005, FEBS LETT, V579, P3416, DOI 10.1016/j.febslet.2005.05.011	33	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					437	448		10.1074/jbc.M113.499707	http://dx.doi.org/10.1074/jbc.M113.499707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235149	hybrid, Green Published			2022-12-25	WOS:000329370900038
J	Mercer, RCC; Ma, L; Watts, JC; Strome, R; Wohlgemuth, S; Yang, J; Cashman, NR; Coulthart, MB; Schmitt-Ulms, G; Jhamandas, JH; Westaway, D				Mercer, Robert C. C.; Ma, Li; Watts, Joel C.; Strome, Robert; Wohlgemuth, Serene; Yang, Jing; Cashman, Neil R.; Coulthart, Michael B.; Schmitt-Ulms, Gerold; Jhamandas, Jack H.; Westaway, David			The Prion Protein Modulates A-type K+ Currents Mediated by Kv4.2 Complexes through Dipeptidyl Aminopeptidase-like Protein 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Membrane Proteins; Potassium Channels; Prions; Protein Cross-linking	STRESS-INDUCIBLE PROTEIN-1; CELLULAR PRION; POTASSIUM CHANNELS; NULL MICE; PRP; DPP6; EXCITABILITY; RECEPTOR; ASSOCIATION; EXPRESSION	Widely expressed in the adult central nervous system, the cellular prion protein (PrPC) is implicated in a variety of processes, including neuronal excitability. Dipeptidyl aminopeptidase-like protein 6 (DPP6) was first identified as a PrPC interactor using in vivo formaldehyde cross-linking of wild type (WT) mouse brain. This finding was confirmed in three cell lines and, because DPP6 directs the functional assembly of K+ channels, we assessed the impact of WT and mutant PrPC upon Kv4.2-based cell surface macromolecular complexes. Whereas a Gerstmann-Straussler-Scheinker disease version of PrP with eight extra octarepeats was a loss of function both for complex formation and for modulation of Kv4.2 channels, WT PrPC, in a DPP6-dependent manner, modulated Kv4.2 channel properties, causing an increase in peak amplitude, a rightward shift of the voltage-dependent steady-state inactivation curve, a slower inactivation, and a faster recovery from steady-state inactivation. Thus, the net impact of wt PrPC was one of enhancement, which plays a critical role in the down-regulation of neuronal membrane excitability and is associated with a decreased susceptibility to seizures. Insofar as previous work has established a requirement for WT PrPC in the A-dependent modulation of excitability in cholinergic basal forebrain neurons, our findings implicate PrPC regulation of Kv4.2 channels as a mechanism contributing to the effects of oligomeric A upon neuronal excitability and viability.	[Mercer, Robert C. C.; Wohlgemuth, Serene; Yang, Jing; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Mercer, Robert C. C.; Ma, Li; Wohlgemuth, Serene; Jhamandas, Jack H.; Westaway, David] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2M8, Canada; [Ma, Li; Jhamandas, Jack H.; Westaway, David] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2M8, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2M8, Canada; [Watts, Joel C.; Strome, Robert; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Cashman, Neil R.] Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Coulthart, Michael B.] Publ Hlth Agcy Canada, Canadian Creutzfeldt Jakob Dis Surveillance Syst, Ottawa, ON K1A0K9, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Toronto; University of British Columbia; Public Health Agency of Canada	Jhamandas, JH (corresponding author), Univ Alberta, Heritage Med Res Ctr 530, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca; david.westaway@ualberta.ca	Mercer, Robert/E-1973-2016	Watts, Joel/0000-0002-2604-2925; Mercer, Robert/0000-0001-6029-511X; Wohlgemuth, Serene/0000-0001-7287-0935	PrioNet Network Centres of Excellence; Alberta Prion Research Institute [APRI 200600070]; Alberta Innovates-Health Solutions [AHFMR 201000628, AHFMR 201100104]; Canadian Institutes of Health Research [MOP36377, 93601]; Canadian Foundation for Innovation	PrioNet Network Centres of Excellence; Alberta Prion Research Institute; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by grants from the PrioNet Network Centres of Excellence, Alberta Prion Research Institute Grant APRI 200600070, Alberta Innovates-Health Solutions Grant AHFMR 201000628, Canadian Institutes of Health Research Grants MOP36377 and 93601, and the Canadian Foundation for Innovation.; Recipient of Alberta Innovates-Health Solutions Scholarship AHFMR 201100104.	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Fogh I, 2011, NEUROBIOL AGING, V32, P966, DOI 10.1016/j.neurobiolaging.2009.05.014; Fransen E, 2010, HIPPOCAMPUS, V20, P877, DOI 10.1002/hipo.20694; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Hinnell C, 2011, NEUROLOGY, V76, P485, DOI 10.1212/WNL.0b013e31820a0ab2; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Hough RB, 1998, P NATL ACAD SCI USA, V95, P13800, DOI 10.1073/pnas.95.23.13800; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Laplanche JL, 1999, BRAIN, V122, P2375, DOI 10.1093/brain/122.12.2375; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1995, NEURODEGENERATION, V4, P113; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Marionneau C, 2009, CHANNELS, V3, P284; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McHugh PC, 2012, NEUROCHEM INT, V61, P672, DOI 10.1016/j.neuint.2012.07.002; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Powell AD, 2008, J NEUROSCI, V28, P3877, DOI 10.1523/JNEUROSCI.0675-08.2008; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; WHITTINGTON MA, 1995, NAT GENET, V9, P197, DOI 10.1038/ng0295-197; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	76	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37241	37255		10.1074/jbc.M113.488650	http://dx.doi.org/10.1074/jbc.M113.488650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225951	hybrid, Green Published			2022-12-25	WOS:000329189700041
J	Yamamoto, H; Shikanai, T				Yamamoto, Hiroshi; Shikanai, Toshiharu			In Planta Mutagenesis of Src Homology 3 Domain-like Fold of NdhS, a Ferredoxin-binding Subunit of the Chloroplast NADH Dehydrogenase-like Complex in Arabidopsis A CONSERVED ARG-193 PLAYS A CRITICAL ROLE IN FERREDOXIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Electron Transport; Photosynthesis; Protein-Protein Interactions	CYCLIC ELECTRON-TRANSPORT; PHOTOSYSTEM-I; RESPIRATORY COMPLEX; SUPERCOMPLEX FORMATION; EFFICIENT OPERATION; QUANTUM YIELD; FLOW; PGR5; IDENTIFICATION; FLUORESCENCE	Background: NdhS is a ferredoxin-binding subunit of chloroplast NADH dehydrogenase-like (NDH) complex. Results: Mutagenesis of the Src homology 3-like domain of NdhS revealed that its positively charged pocket is required for high affinity binding of ferredoxin. Conclusion: The positive charge of Arg-193 plays a critical role in electrostatic interaction with ferredoxin. Significance: Our results provide insights into the evolution of the electron input module of chloroplast NDH. Chloroplast NADH dehydrogenase-like (NDH) complex mediates cyclic electron transport around photosystem I and chlororespiration in angiosperms. The Src homology 3 domain (SH3)-like fold protein NdhS/CRR31 is an NDH subunit that is necessary for high affinity binding of ferredoxin, indicating that chloroplast NDH functions as a ferredoxin:plastoquinone oxidoreductase. However, the mechanism of the interaction between NdhS and ferredoxin is unclear. In this study, we analyzed their interaction in planta by using site-directed mutagenesis of NdhS. In general, binding of ferredoxin to its target proteins depends on electrostatic interaction. In silico analysis predicted the presence of a positively charged pocket in the SH3-like domain of NdhS, where nine charged residues are highly conserved among plants. Systematic alteration of these sites with neutral glutamine revealed that only arginine 193 was required for high NDH activity in vivo. Further replacement of arginine 193 with negatively charged aspartate or glutamate or hydrophobic alanine significantly decreased the efficiency of ferredoxin-dependent plastoquinone reduction by NDH in ruptured chloroplasts. Similar results were obtained in in vivo analyses of NDH activity and electron transport. From these results, we propose that the positive charge of arginine 193 in the SH3-like domain of NdhS is critical for electrostatic interaction with ferredoxin in vivo.	[Yamamoto, Hiroshi; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Yamamoto, Hiroshi; Shikanai, Toshiharu] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Shikanai, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	shikanai@pmg.bot.kyoto-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020	Yamamoto, Hiroshi/0000-0002-1739-1226	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22114509, 22247005]; Grants-in-Aid for Scientific Research [25251032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants 22114509 and 22247005 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barth P, 1998, BIOCHEMISTRY-US, V37, P16233, DOI 10.1021/bi981379t; Barth P, 2000, J BIOL CHEM, V275, P7030, DOI 10.1074/jbc.275.10.7030; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Finel M, 1998, TRENDS BIOCHEM SCI, V23, P412, DOI 10.1016/S0968-0004(98)01276-6; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hase Toshiharu, 2006, V24, P477; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hertle AP, 2013, MOL CELL, V49, P511, DOI 10.1016/j.molcel.2012.11.030; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Kishan KVR, 2005, CURR PROTEIN PEPT SC, V6, P143, DOI 10.2174/1389203053545444; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; Miyake C, 2009, PLANT CELL PHYSIOL, V50, P730, DOI 10.1093/pcp/pcp032; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Okegawa Y, 2008, PLANT CELL PHYSIOL, V49, P825, DOI 10.1093/pcp/pcn055; Peng LW, 2011, PLANT PHYSIOL, V155, P1629, DOI 10.1104/pp.110.171264; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Sugimoto K, 2013, PLANT CELL PHYSIOL, V54, P1525, DOI 10.1093/pcp/pct098; Suorsa M, 2012, PLANT CELL, V24, P2934, DOI 10.1105/tpc.112.097162; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Weerakoon DR, 2008, J BACTERIOL, V190, P915, DOI 10.1128/JB.01647-07; XU Q, 1994, J BIOL CHEM, V269, P21512; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; YU L, 1993, PLANT PHYSIOL, V103, P171, DOI 10.1104/pp.103.1.171	46	49	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36328	36337		10.1074/jbc.M113.511584	http://dx.doi.org/10.1074/jbc.M113.511584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225949	Green Published, hybrid			2022-12-25	WOS:000328883400015
J	Messiaen, AS; Forier, K; Nelis, H; Braeckmans, K; Coenye, T				Messiaen, Anne-Sophie; Forier, Katrien; Nelis, Hans; Braeckmans, Kevin; Coenye, Tom			Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BACTERICIDAL EFFICACY; RESISTANT STRAINS; ENHANCED ACTIVITY; AMINOGLYCOSIDES; MECHANISM; AMIKACIN	Due to the intrinsic resistance of Burkholderia cepacia complex (Bcc) to many antibiotics and the production of a broad range of virulence factors, lung infections by these bacteria, primarily occurring in cystic fibrosis (CF) patients, are very difficult to treat. In addition, the ability of Bcc organisms to form biofilms contributes to their persistence in the CF lung. As Bcc infections are associated with poor clinical outcome, there is an urgent need for new effective therapies to treat these infections. In the present study, we investigated whether liposomal tobramycin displayed an increased anti-biofilm effect against Bcc bacteria compared to free tobramycin. Single particle tracking (SPT) was used to study the transport of positively and negatively charged nanospheres in Bcc biofilms as a model for the transport of liposomes. Negatively charged nanospheres became immobilized in close proximity of biofilm cell clusters, while positively charged nanospheres interacted with fiber-like structures, probably eDNA. Based on these data, encapsulation of tobramycin in negatively charged liposomes appeared promising for targeted drug delivery. However, the anti-biofilm effect of tobramycin encapsulated into neutral or anionic liposomes did not increase compared to that of free tobramycin. Probably, the fusion of the anionic liposomes with the negatively charged bacterial surface of Bcc bacteria was limited by electrostatic repulsive forces. The lack of a substantial anti-biofilm effect of tobramycin encapsulated in neutral liposomes could be further investigated by increasing the liposomal tobramycin concentration. However, this was hampered by the low encapsulation efficiency of tobramycin in these liposomes.	[Messiaen, Anne-Sophie; Nelis, Hans; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Tom.Coenye@Ugent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Braeckmans, Kevin/HCH-3119-2022	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Braeckmans, Kevin/0000-0002-7993-6295; Forier, Katrien/0000-0002-7003-3612	Interuniversity Attraction Poles Programme; Belgian Science Policy Office; Ghent University	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Ghent University(Ghent University)	This research has been funded by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office and by a concerted action grant by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulac C, 1998, J ANTIMICROB CHEMOTH, V41, P35, DOI 10.1093/jac/41.1.35; Braeckmans K, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Braeckmans K, 2010, NANO LETT, V10, P4435, DOI 10.1021/nl103264u; Brennan AL, 2002, CURR OPIN INFECT DIS, V15, P175, DOI 10.1097/00001432-200204000-00013; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Council of European, 2021, BRIT PHARMACOPOEIA, V10th; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cystic Fibrosis Foundation, 2011, ANN DAT REP CTR DIR; Forier K, 2013, NANOMEDICINE-UK, V8, P935, DOI [10.2217/NNM.12.129, 10.2217/nnm.12.129]; GIWERCMAN B, 1991, ANTIMICROB AGENTS CH, V35, P1008, DOI 10.1128/AAC.35.5.1008; Halwani M, 2007, J ANTIMICROB CHEMOTH, V60, P760, DOI 10.1093/jac/dkm289; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Li ZL, 2008, J AEROSOL MED PULM D, V21, P245, DOI 10.1089/jamp.2008.0686; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Mugabe C, 2006, INT J PHARMACEUT, V307, P244, DOI 10.1016/j.ijpharm.2005.10.005; Mugabe C, 2005, J ANTIMICROB CHEMOTH, V55, P269, DOI 10.1093/jac/dkh518; Mugabe C, 2006, ANTIMICROB AGENTS CH, V50, P2016, DOI 10.1128/AAC.01547-05; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Omri A, 2002, BIOCHEM PHARMACOL, V64, P1407, DOI 10.1016/S0006-2952(02)01346-1; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Seidler M, 2010, FEMS YEAST RES, V10, P492, DOI 10.1111/j.1567-1364.2010.00618.x; Sousa Silvia A, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/607575; Symens N, 2011, MOL PHARMACEUT, V8, P1757, DOI 10.1021/mp200120v; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC	31	66	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79220	10.1371/journal.pone.0079220	http://dx.doi.org/10.1371/journal.pone.0079220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244452	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800043
J	Osman, KA; Tang, B; Wang, YP; Chen, JH; Yu, F; Li, L; Han, XS; Zhang, ZX; Yan, JB; Zheng, YL; Yue, B; Qiu, FZ				Osman, Khalid A.; Tang, Bin; Wang, Yaping; Chen, Juanhua; Yu, Feng; Li, Liu; Han, Xuesong; Zhang, Zuxin; Yan, Jianbin; Zheng, Yonglian; Yue, Bing; Qiu, Fazhan			Dynamic QTL Analysis and Candidate Gene Mapping for Waterlogging Tolerance at Maize Seedling Stage	PLOS ONE			English	Article							ZEA-MAYS L.; QUANTITATIVE TRAIT LOCI; ADVENTITIOUS ROOT-FORMATION; DEVELOPMENTAL BEHAVIOR; AERENCHYMA FORMATION; FLOODING CONDITIONS; PLANT HEIGHT; LINKAGE MAP; IDENTIFICATION; RICE	Soil waterlogging is one of the major abiotic stresses adversely affecting maize growth and yield. To identify dynamic expression of genes or quantitative trait loci (QTL), QTL associated with plant height, root length, root dry weight, shoot dry weight and total dry weight were identified via conditional analysis in a mixed linear model and inclusive composite interval mapping method at three respective periods under waterlogging and control conditions. A total of 13, 19 and 23 QTL were detected at stages 3D|0D (the period during 0-3 d of waterlogging), 6D|3D and 9D|6D, respectively. The effects of each QTL were moderate and distributed over nine chromosomes, singly explaining 4.14-18.88% of the phenotypic variation. Six QTL (ph6-1, rl1-2, sdw4-1, sdw7-1, tdw4-1 and tdw7-1) were identified at two consistent stages of seedling development, which could reflect a continuous expression of genes; the remaining QTL were detected at only one stage. Thus, expression of most QTL was influenced by the developmental status. In order to provide additional evidence regarding the role of corresponding genes in waterlogging tolerance, mapping of Expressed Sequence Tags markers and microRNAs were conducted. Seven candidate genes were observed to co-localize with the identified QTL on chromosomes 1, 4, 6, 7 and 9, and may be important candidate genes for waterlogging tolerance. These results are a good starting point for understanding the genetic basis for selectively expressing of QTL in different stress periods and the common genetic control mechanism of the co-localized traits.	[Osman, Khalid A.; Tang, Bin; Wang, Yaping; Chen, Juanhua; Yu, Feng; Li, Liu; Han, Xuesong; Zhang, Zuxin; Yan, Jianbin; Zheng, Yonglian; Yue, Bing; Qiu, Fazhan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University	Qiu, FZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	qiufazhan@gmail.com	Yan, JianBin/AAE-3494-2022	Yu, Feng/0000-0001-5077-8003; yue, bing/0000-0002-2552-1668	National Natural Science Foundation of China [31071428]; Fundamental Research Funds for the Central University [2012SC12, 2013PY027]; Natural Science Funds for Distinguished Young Scholar of Hubei Province [2012FFA014]; National High Technology Research and Development Program of China [2012AA101104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; Natural Science Funds for Distinguished Young Scholar of Hubei Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (31071428), the Fundamental Research Funds for the Central University (no. 2012SC12 and no. 2013PY027), the Natural Science Funds for Distinguished Young Scholar of Hubei Province (2012FFA014), the National High Technology Research and Development Program of China (2012AA101104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; [Anonymous], 2003, STUDIES PHYSIOGENETI; Atchley WR, 1997, GENETICS, V147, P765; Cai HG, 2012, THEOR APPL GENET, V125, P1313, DOI 10.1007/s00122-012-1915-6; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Ghassemi F, 1995, SALINISATION LAND WA, P1; Han YP, 2011, THEOR APPL GENET, V122, P1481, DOI 10.1007/s00122-011-1547-2; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Huang J, 2012, PLANT MOL BIOL, V80, P337, DOI 10.1007/s11103-012-9955-5; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Jeppe R, 2003, TRENDS PLANT SCI, V8, P552; Karimova M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1037; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li JC, 2012, THEOR APPL GENET, V124, P1339, DOI 10.1007/s00122-012-1791-0; Li YB, 2007, PLANT BREEDING, V126, P541, DOI 10.1111/j.1439-0523.2007.01409.x; Littel R, 1987, GENOMICS; Littell R.C., 1991, SAS SYSTEM LINEAR MO, V3rd; Liu GF, 2009, THEOR APPL GENET, V118, P443, DOI 10.1007/s00122-008-0911-3; Liu JC, 2008, PLANT SOIL, V305, P253, DOI 10.1007/s11104-008-9562-z; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu YZ, 2010, AGR SCI CHINA, V9, P362, DOI 10.1016/S1671-2927(09)60105-X; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039786; Lopez CE, 2007, GENOME, V50, P1078, DOI 10.1139/G07-087; Mano Y, 2007, PLANT SOIL, V295, P103, DOI 10.1007/s11104-007-9266-9; Mano Y, 2006, PLANT PROD SCI, V9, P176, DOI 10.1626/pps.9.176; Mano Y, 2005, BREEDING SCI, V55, P343, DOI 10.1270/jsbbs.55.343; Mano Y, 2005, EUPHYTICA, V142, P33, DOI 10.1007/s10681-005-0449-2; Mano Y, 2008, BREEDING SCI, V58, P217, DOI 10.1270/jsbbs.58.217; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Mano Y, 2012, MOL BREEDING, V29, P137, DOI 10.1007/s11032-010-9532-z; Mano Y, 2009, BREEDING SCI, V59, P427, DOI 10.1270/jsbbs.59.427; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Mikkilineni V, 2003, THEOR APPL GENET, V106, P1326, DOI 10.1007/s00122-003-1190-7; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Patterson C, 2002, SCI STKE, V116, P4; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; Rahman H, 2011, GENET MOL RES, V10, P889, DOI 10.4238/vol10-2gmr1139; Rathore TR, 1998, P 2 AS REG MAIZ WORK, P23; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; St Burgos M, 2001, EUPHYTICA, V122, P287, DOI 10.1023/A:1012945902299; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Tang B, 2010, AGR SCI CHINA, V9, P651, DOI 10.1016/S1671-2927(09)60140-1; Teng W, 2009, HEREDITY, V102, P372, DOI 10.1038/hdy.2008.108; VanToai TT, 2001, CROP SCI, V41, P1247, DOI 10.2135/cropsci2001.4141247x; Wang Z, 2010, EUPHYTICA, V174, P447, DOI 10.1007/s10681-010-0166-3; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wu P, 2000, THEOR APPL GENET, V100, P1295, DOI 10.1007/s001220051438; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yan JB, 2003, CHINESE SCI BULL, V48, P2601, DOI 10.1360/03wc0044; Yan JQ, 1998, GENETICS, V150, P1257; Zaidi PH, 2004, FIELD CROP RES, V90, P189, DOI 10.1016/j.fcr.2004.03.002; Zhai LH, 2013, PHYSIOL PLANTARUM, V147, P181, DOI 10.1111/j.1399-3054.2012.01653.x; Zhang XB, 2013, PLANT MOL BIOL REP, V31, P594, DOI 10.1007/s11105-012-0526-3; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhang ZX, 2005, RUSS J PLANT PHYSL+, V52, P43, DOI 10.1007/s11183-005-0007-8; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215; ZHU J, 1995, GENETICS, V141, P1633; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	66	48	50	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79305	10.1371/journal.pone.0079305	http://dx.doi.org/10.1371/journal.pone.0079305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244474	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800059
J	Tsoumani, KT; Drosopoulou, E; Mavragani-Tsipidou, P; Mathiopoulos, KD				Tsoumani, Konstantina T.; Drosopoulou, Elena; Mavragani-Tsipidou, Penelope; Mathiopoulos, Kostas D.			Molecular Characterization and Chromosomal Distribution of a Species-Specific Transcribed Centromeric Satellite Repeat from the Olive Fruit Fly, Bactrocera oleae	PLOS ONE			English	Article							REAL-TIME PCR; GLAND POLYTENE CHROMOSOMES; IN-SITU HYBRIDIZATION; DROSOPHILA-MELANOGASTER; CYTOGENETIC ANALYSIS; DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; COPY-NUMBER; DNA; GENUS	Satellite repetitive sequences that accumulate in the heterochromatin consist a large fraction of a genome and due to their properties are suggested to be implicated in centromere function. Current knowledge of heterochromatic regions of Bactrocera oleae genome, the major pest of the olive tree, is practically nonexistent. In our effort to explore the repetitive DNA portion of B. oleae genome, a novel satellite sequence designated BoR300 was isolated and cloned. The present study describes the genomic organization, abundance and chromosomal distribution of BoR300 which is organized in tandem, forming arrays of 298 bp-long monomers. Sequence analysis showed an AT content of 60.4%, a CENP-B like-motif and a high curvature value based on predictive models. Comparative analysis among randomly selected monomers demonstrated a high degree of sequence homogeneity (88% - 97%) of BoR300 repeats, which are present at approximately 3,000 copies per haploid genome accounting for about 0.28% of the total genomic DNA, based on two independent qPCR approaches. In addition, expression of the repeat was also confirmed through RT-PCR, by which BoR300 transcripts were detected in both sexes. Fluorescence in situ hybridization (FISH) of BoR300 on mitotic metaphases and polytene chromosomes revealed signals to the centromeres of two out of the six chromosomes which indicated a chromosome-specific centromeric localization. Moreover, BoR300 is not conserved in the closely related Bactrocera species tested and it is also absent in other dipterans, but it's rather restricted to the B. oleae genome. This feature of species-specificity attributed to BoR300 satellite makes it a good candidate as an identification probe of the insect among its relatives at early development stages.	[Tsoumani, Konstantina T.; Mathiopoulos, Kostas D.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Drosopoulou, Elena; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki AUTH, Dept Genet Dev & Mol Biol, Thessaloniki, Greece	University of Thessaly; Aristotle University of Thessaloniki	Mathiopoulos, KD (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	kmathiop@bio.uth.gr	DROSOPOULOU, ELENA/N-2176-2015; Mathiopoulos, Kostas/K-9548-2019; Drosopoulou, Elena/AAX-6493-2020	Mathiopoulos, Kostas/0000-0002-2875-5697; Drosopoulou, Elena/0000-0001-9805-0572	Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly	Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly	This research was partially supported by the Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Augustinos AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-618; Bizzaro D, 1996, CHROMOSOME RES, V4, P392, DOI 10.1007/BF02257275; BONACCORSI S, 1991, GENETICS, V129, P177; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; DIAZ MO, 1981, CELL, V24, P649, DOI 10.1016/0092-8674(81)90091-X; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Drosopoulou E, 2009, GENOME, V52, P210, DOI [10.1139/G08-110, 10.1139/g08-110]; FITZGERALD DJ, 1994, J BIOL CHEM, V269, P21303; Gabrieli P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017747; Galian J, 2003, GENOME, V46, P213, DOI 10.1139/G02-126; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kakani EG, 2013, B ENTOMOL RES, V103, P36, DOI 10.1017/S0007485312000478; King LM, 1997, MOL BIOL EVOL, V14, P1088, DOI 10.1093/oxfordjournals.molbev.a025718; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Kuhn GCS, 2005, GENE, V349, P77, DOI 10.1016/j.gene.2004.11.032; Kuhn GCS, 2003, HEREDITAS, V139, P161, DOI 10.1111/j.1601-5223.2003.01797.x; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lorite P, 2002, GENE, V297, P113, DOI 10.1016/S0378-1119(02)00875-2; Mavragani-Tsipidou P, 2002, GENETICA, V116, P45, DOI 10.1023/A:1020907624816; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Palomeque T, 2008, HEREDITY, V100, P564, DOI 10.1038/hdy.2008.24; Pezer Z, 2011, PROG MOL SUBCELL BIO, V51, P161, DOI 10.1007/978-3-642-16502-3_8; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Stimpson KM, 2010, CURR OPIN CELL BIOL, V22, P772, DOI 10.1016/j.ceb.2010.07.002; Stratikopoulos EE, 2002, CHROMOSOME RES, V10, P287, DOI 10.1023/A:1016567624117; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsoumani KT, 2012, J APPL ENTOMOL, V136, P626, DOI 10.1111/j.1439-0418.2011.01684.x; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Ugarkovic D, 1996, MOL BIOL EVOL, V13, P1059, DOI 10.1093/oxfordjournals.molbev.a025668; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; Usakin L, 2007, GENETICS, V176, P1343, DOI 10.1534/genetics.107.071720; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zambetaki A, 1995, GENOME, V38, P1070, DOI 10.1139/g95-143; Zambetaki A, 1999, GENOME, V42, P744, DOI 10.1139/gen-42-4-744	46	17	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79393	10.1371/journal.pone.0079393	http://dx.doi.org/10.1371/journal.pone.0079393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244494	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800070
J	Dehmer, M; Mueller, LAJ; Emmert-Streib, F				Dehmer, Matthias; Mueller, Laurin A. J.; Emmert-Streib, Frank			Quantitative Network Measures as Biomarkers for Classifying Prostate Cancer Disease States: A Systems Approach to Diagnostic Biomarkers	PLOS ONE			English	Article							GENE-EXPRESSION; TOPOLOGICAL INDEXES; INFORMATION-CONTENT; ENTROPY MEASURES; IN-VITRO; GRAPHS; COMPLEXITY; DISCRIMINATION; CELLS; VIVO	Identifying diagnostic biomarkers based on genomic features for an accurate disease classification is a problem of great importance for both, basic medical research and clinical practice. In this paper, we introduce quantitative network measures as structural biomarkers and investigate their ability for classifying disease states inferred from gene expression data from prostate cancer. We demonstrate the utility of our approach by using eigenvalue and entropy-based graph invariants and compare the results with a conventional biomarker analysis of the underlying gene expression data.	[Dehmer, Matthias; Mueller, Laurin A. J.] UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Germany; [Emmert-Streib, Frank] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Computat Biol & Machine Learning Lab, Belfast, Antrim, North Ireland	Queens University Belfast	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Germany.	matthias.dehmer@umit.at; v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P22029-N13). The authors also thank the 'Zentraler Informatikdienst' of the Technical University of Vienna for providing computing resources to perform large scale computations on the Phoenix Cluster. Also, Matthias Dehmer and Laurin Mueller thank the Standortagentur Tirol for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; [Anonymous], [No title captured]; Arias CR, 2012, SCI WORLD J, P24873; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CHEN JY, 2009, BMC GENOMICS, P10; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dehmer M, 2012, ADV COMPUTATIONAL MA; Dehmer M., 2011, APPL STAT NETWORK BI; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emmert-Streib F, 2007, J COMPUT BIOL, P14; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harary F., 1969, GRAPH THEORY; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jain K.K, 2010, HDB BIOMARKERS; Janezic D, 2007, MATH CHEM MONOGRAPHS; Jin GX, 2008, J PROTEOME RES, V7, P4013, DOI 10.1021/pr8002886; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Korner J., 1973, T 6 PRAG C INF THEOR, P411; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Massoner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055207; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; Meyer D., 2012, E1071 MISC FUNCTIONS; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Mowshowitz A, 2010, SYMMETRY, V21, P321; Mowshowitz A, 2012, ENTROPY-SWITZ, V14, P559, DOI 10.3390/e14030559; Mueller LAJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-492; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Rahman M. R., 2011, TECHNICAL REPORT; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Wang YS, 2011, ADV MAT SCI ENG-BOCA, P1; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77602	10.1371/journal.pone.0077602	http://dx.doi.org/10.1371/journal.pone.0077602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236006	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700002
J	Lim, S; Peshenko, IV; Dizhoor, AM; Ames, JB				Lim, Sunghyuk; Peshenko, Igor V.; Dizhoor, Alexander M.; Ames, James B.			Structural Insights for Activation of Retinal Guanylate Cyclase by GCAP1	PLOS ONE			English	Article							NEURONAL CALCIUM SENSOR; CA2+-DEPENDENT CONFORMATIONAL-CHANGES; MYRISTOYL GROUP; PROTEINS GCAPS; CA2+-BINDING PROTEINS; MOLECULAR-STRUCTURE; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; LARGER PROTEINS; BINDING	Guanylyl cyclase activating protein 1 (GCAP1), a member of the neuronal calcium sensor (NCS) subclass of the calmodulin superfamily, confers Ca2+-sensitive activation of retinal guanylyl cyclase 1 (RetGC1) upon light activation of photoreceptor cells. Here we present NMR assignments and functional analysis to probe Ca2+-dependent structural changes in GCAP1 that control activation of RetGC. NMR assignments were obtained for both the Ca2+-saturated inhibitory state of GCAP1 versus a GCAP1 mutant (D144N/D148G, called EF4mut), which lacks Ca2+ binding in EF-hand 4 and models the Ca2+-free/Mg2+-bound activator state of GCAP1. NMR chemical shifts of backbone resonances for Ca2+-saturated wild type GCAP1 are overall similar to those of EF4mut, suggesting a similar main chain structure for assigned residues in both the Ca2+-free activator and Ca2+-bound inhibitor states. This contrasts with large Ca2+-induced chemical shift differences and hence dramatic structural changes seen for other NCS proteins including recoverin and NCS-1. The largest chemical shift differences between GCAP1 and EF4mut are seen for residues in EF4 (S141, K142, V145, N146, G147, G149, E150, L153, E154, M157, E158, Q161, L166), but mutagenesis of EF4 residues (F140A, K142D, L153R, L166R) had little effect on RetGC1 activation. A few GCAP1 residues in EF-hand 1 (K23, T27, G32) also show large chemical shift differences, and two of the mutations (K23D and G32N) each decrease the activation of RetGC, consistent with a functional conformational change in EF1. GCAP1 residues at the domain interface (V77, A78, L82) have NMR resonances that are exchange broadened, suggesting these residues may be conformationally dynamic, consistent with previous studies showing these residues are in a region essential for activating RetGC1.	[Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbames@ucdavis.edu		Dizhoor, Alexander/0000-0001-6770-9186	NIH [EY012347, EY11522, RR11973]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH grants EY012347 (J.B.A.), EY11522 (A. M. D.) and RR11973 (UC Davis NMR). The URL for NIH is www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 2000, METHOD ENZYMOL, V316, P121; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Behnen P, 2010, BIOL CHEM, V391, P631, DOI 10.1515/BC.2010.063; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Lim S, 2013, BIOMOL NMR ASSIGN, V7, P39, DOI 10.1007/s12104-012-9373-2; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, J BIOL CHEM, V279, P50342, DOI 10.1074/jbc.M408683200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Valentine KG, 2003, BIOCHEMISTRY-US, V42, P6333, DOI 10.1021/bi0206816; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu XZ, 2011, PROTEINS, V79, P1910, DOI 10.1002/prot.23014; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547	69	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81822	10.1371/journal.pone.0081822	http://dx.doi.org/10.1371/journal.pone.0081822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236217	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700220
J	Meyer, K; Korz, V				Meyer, Katrin; Korz, Volker			Estrogen Receptor alpha Functions in the Regulation of Motivation and Spatial Cognition in Young Male Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACTOR MESSENGER-RNA; SYNAPTIC PLASTICITY; STEROID-HORMONES; MEDIAL AMYGDALA; BRAIN; BETA; MEMORY; HIPPOCAMPUS; EXPRESSION	Estrogenic functions in regulating behavioral states such as motivation, mood, anxiety, and cognition are relatively well documented in female humans and animals. In males, however, although the entire enzymatic machinery for producing estradiol and the corresponding receptors are present, estrogenic functions have been largely neglected. Therefore, and as a follow-up study to previous research, we sub-chronically applied a specific estrogen receptor alpha (ER alpha) antagonist in young male rats before and during a spatial learning task (holeboard). The male rats showed a dose-dependent increase in motivational, but not cognitive, behavior. The expression of hippocampal steroid receptor genes, such as glucocorticoid (GR), mineralocorticoid (MR), androgen (AR), and the estrogen receptor ER alpha but not ER beta was dose-dependently reduced. The expression of the aromatase but not the brain-derived neurotrophic factor (BDNF) encoding gene was also suppressed. Reduced gene expression and increased behavioral performance converged at an antagonist concentration of 7.4 mu mol. The hippocampal and blood serum hormone levels (corticosterone, testosterone, and 17 beta-estradiol) did not differ between the experimental groups and controls. We conclude that steroid receptors (and BDNF) act in a concerted, network-like manner to affect behavior and mutual gene expression. Therefore, the isolated view on single receptor types is probably insufficient to explain steroid effects on behavior. The steroid network may keep motivation in homeostasis by supporting and constraining the behavioral expression of motivation.	[Meyer, Katrin] Leibniz Inst Neurobiol, Magdeburg, Germany; [Meyer, Katrin; Korz, Volker] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany; [Korz, Volker] Ctr Behav Neurosci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Korz, V (corresponding author), Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany.	volker.korz@ovgu.de			federal state of Saxony-Anhalt; Center for Behavioral Brain Studies [FKZ: 1211080005]	federal state of Saxony-Anhalt; Center for Behavioral Brain Studies	This work was funded by the federal state of Saxony-Anhalt and the "European Regional Development Fund" (ERDF 2007-2013; Center for Behavioral Brain Studies; FKZ: 1211080005)(http:// www.med.uni-magdeburg.de/neuromd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fester L, 2006, J NEUROCHEM, V97, P1136, DOI 10.1111/j.1471-4159.2006.03809.x; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Hajszan T, 2007, PROG BRAIN RES, V163, P399, DOI 10.1016/S0079-6123(07)63023-4; Han XX, 2013, J NEUROSCI, V33, P2671, DOI 10.1523/JNEUROSCI.4937-12.2013; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lagunas N, 2011, HORM BEHAV, V59, P581, DOI 10.1016/j.yhbeh.2011.02.014; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 1998, NEUROSCIENCE, V82, P957; MACLUSKY NJ, 1979, BRAIN RES, V178, P129, DOI 10.1016/0006-8993(79)90093-3; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; MCEWEN BS, 1975, J STEROID BIOCHEM, V6, P971, DOI 10.1016/0022-4731(75)90337-4; MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393; MCEWEN BS, 1988, J STEROID BIOCHEM, V30, P179, DOI 10.1016/0022-4731(88)90091-X; Meyer K, 2013, HORM BEHAV, V63, P376, DOI 10.1016/j.yhbeh.2012.12.002; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Neese SL, 2010, HORM BEHAV, V58, P878, DOI 10.1016/j.yhbeh.2010.08.017; Nomura M, 2006, EUR J NEUROSCI, V23, P1860, DOI 10.1111/j.1460-9568.2006.04703.x; Paisley JC, 2012, HORM BEHAV, V62, P50, DOI 10.1016/j.yhbeh.2012.04.018; Perlman WR, 2005, BIOL PSYCHIAT, V58, P812, DOI 10.1016/j.biopsych.2005.04.047; Ranhotra HS, 2012, J RECEPT SIG TRANSD, V32, P47, DOI 10.3109/10799893.2011.647350; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; Savatier J, 2010, BIOCHEMISTRY-US, V49, P772, DOI 10.1021/bi9013006; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Scharfman HE, 2006, FRONT NEUROENDOCRIN, V27, P415, DOI 10.1016/j.yfrne.2006.09.004; Schulz K, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00187; Scordalakes EM, 2003, BEHAV NEUROSCI, V117, P38, DOI 10.1037/0735-7044.117.1.38; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Spencer-Segal JL, 2012, NEUROSCIENCE, V202, P131, DOI 10.1016/j.neuroscience.2011.11.035; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Takeshita H, 1976, Yonago Acta Med, V20, P125; Tetel MJ, 2010, BBA-GEN SUBJECTS, V1800, P1084, DOI 10.1016/j.bbagen.2010.01.008; Uzakov S, 2005, LEARN MEMORY, V12, P165, DOI 10.1101/lm.89305; Wu TW, 2011, BRAIN RES, V1379, P34, DOI 10.1016/j.brainres.2011.01.034; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851	51	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79303	10.1371/journal.pone.0079303	http://dx.doi.org/10.1371/journal.pone.0079303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236119	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700118
J	Moore, AM; Patel, S; Forsberg, KJ; Wang, B; Bentley, G; Razia, Y; Qin, X; Tarr, PI; Dantas, G				Moore, Aimee M.; Patel, Sanket; Forsberg, Kevin J.; Wang, Bin; Bentley, Gayle; Razia, Yasmin; Qin, Xuan; Tarr, Phillip I.; Dantas, Gautam			Pediatric Fecal Microbiota Harbor Diverse and Novel Antibiotic Resistance Genes	PLOS ONE			English	Article							BACTEROIDES CONJUGATIVE TRANSPOSON; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; HEALTHY-CHILDREN; CLINICAL ISOLATE; GUT MICROBIOTA; TIGECYCLINE; BACTERIA; PLASMID	Emerging antibiotic resistance threatens human health. Gut microbes are an epidemiologically important reservoir of resistance genes (resistome), yet prior studies indicate that the true diversity of gut-associated resistomes has been underestimated. To deeply characterize the pediatric gut-associated resistome, we created metagenomic recombinant libraries in an Escherichia coli host using fecal DNA from 22 healthy infants and children (most without recent antibiotic exposure), and performed functional selections for resistance to 18 antibiotics from eight drug classes. Resistance-conferring DNA fragments were sequenced (Illumina HiSeq 2000), and reads assembled and annotated with the PARFuMS computational pipeline. Resistance to 14 of the 18 antibiotics was found in stools of infants and children. Recovered genes included chloramphenicol acetyltransferases, drug-resistant dihydrofolate reductases, rRNA methyltransferases, transcriptional regulators, multidrug efflux pumps, and every major class of beta-lactamase, aminoglycoside-modifying enzyme, and tetracycline resistance protein. Many resistance-conferring sequences were mobilizable; some had low identity to any known organism, emphasizing cryptic organisms as potentially important resistance reservoirs. We functionally confirmed three novel resistance genes, including a 16S rRNA methylase conferring aminoglycoside resistance, and two tetracycline-resistance proteins nearly identical to a bifidobacterial MFS transporter (B. longum s. longum JDM301). We provide the first report to our knowledge of resistance to folate-synthesis inhibitors conferred by a predicted Nudix hydrolase (part of the folate synthesis pathway). This functional metagenomic survey of gut-associated resistomes, the largest of its kind to date, demonstrates that fecal resistomes of healthy children are far more diverse than previously suspected, that clinically relevant resistance genes are present even without recent selective antibiotic pressure in the human host, and that cryptic gut microbes are an important resistance reservoir. The observed transferability of gut-associated resistance genes to a gram-negative (E. coli) host also suggests that the potential for gut-associated resistomes to threaten human health by mediating antibiotic resistance in pathogens warrants further investigation.	[Moore, Aimee M.; Patel, Sanket; Forsberg, Kevin J.; Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Moore, Aimee M.; Razia, Yasmin; Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Patel, Sanket; Wang, Bin; Bentley, Gayle; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Razia, Yasmin] Childrens Hosp & Reg Med Ctr, Dept Pediat, Div Gastroenterol, Seattle, WA USA; [Qin, Xuan] Seattle Childrens Hosp, Dept Microbiol, Seattle, WA USA; [Qin, Xuan] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Dantas, G (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.	Dantas@wustl.edu		Dantas, Gautam/0000-0003-0455-8370; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; National Institutes of Health (NIH) [A14799-S01]; National Institutes of Health [5P30 DK052574]; NIH [T32 HD043010-08]; National Science Foundation [DGE-1143954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards to G. D. through the Children's Discovery Institute (MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, and the National Academies Keck Futures Initiatives (Synthetic Biology - SB2). Sample collection and curation was supported by National Institutes of Health (NIH) grants (A14799-S01) to P. I. T. and National Institutes of Health Grant 5P30 DK052574 (to Washington University Digestive Diseases Research Core Center Biobank). A. M. M. was supported by an NIH T32 fellowship (T32 HD043010-08; PI. Dr. Alan Schwartz), K.J.F. is a National Science Foundation graduate research fellow (DGE-1143954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Bacic M, 2005, J BACTERIOL, V187, P2858, DOI 10.1128/JB.187.8.2858-2869.2005; Bartha NA, 2011, INT J ANTIMICROB AG, V38, P522, DOI 10.1016/j.ijantimicag.2011.07.010; Bartoloni A, 2006, EMERG INFECT DIS, V12, P907, DOI 10.3201/eid1206.051258; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Cheng QI, 2000, J BACTERIOL, V182, P4035, DOI 10.1128/JB.182.14.4035-4043.2000; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE; Coco A, 2010, PEDIATRICS, V125, P214, DOI 10.1542/peds.2009-1115; Copp HL, 2011, PEDIATRICS, V127, P1027, DOI 10.1542/peds.2010-3465; Dominguez E, 2002, MICROB DRUG RESIST, V8, P321, DOI 10.1089/10766290260469589; Eggesbo M, 2011, APMIS, V119, P17, DOI 10.1111/j.1600-0463.2010.02688.x; Erwin AL, 2006, INFECT IMMUN, V74, P6226, DOI 10.1128/IAI.00722-06; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; GAMBINO L, 1993, J BACTERIOL, V175, P2888, DOI 10.1128/JB.175.10.2888-2894.1993; Geng JN, 2011, J BACTERIOL, V193, P5596, DOI 10.1128/JB.05670-11; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Guimaraes B, 2009, MICROB DRUG RESIST, V15, P211, DOI 10.1089/mdr.2009.0910; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Inc SI, 2000, SAS 9 1 3 HELP DOC; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; Klaus SMJ, 2005, J BIOL CHEM, V280, P5274, DOI 10.1074/jbc.M413759200; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koutsolioutsou A, 2001, ANTIMICROB AGENTS CH, V45, P38, DOI 10.1128/AAC.45.1.38-43.2001; Kronvall G, 2006, J ANTIMICROB CHEMOTH, V57, P498, DOI 10.1093/jac/dki489; Liu G, 2007, JPN J INFECT DIS, V60, P295; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; Mitsou EK, 2010, BENEF MICROBES, V1, P297, DOI 10.3920/BM2010.0007; Pagotto F, 2000, PLASMID, V43, P24, DOI 10.1006/plas.1999.1431; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P2166, DOI 10.1128/AAC.05796-11; Peterson G, 2011, MICROB PATHOGENESIS, V51, P1, DOI 10.1016/j.micpath.2011.03.002; Qin X, 2006, ANTIMICROB AGENTS CH, V50, P3325, DOI 10.1128/AAC.00548-06; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rose WE, 2006, PHARMACOTHERAPY, V26, P1099, DOI 10.1592/phco.26.8.1099; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schmitz FJ, 2001, J ANTIMICROB CHEMOTH, V48, P935, DOI 10.1093/jac/48.6.935; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Wang YP, 2004, J BACTERIOL, V186, P2548, DOI 10.1128/JB.186.9.2548-2557.2004; Wei YX, 2012, WORLD J GASTROENTERO, V18, P479, DOI 10.3748/wjg.v18.i5.479; Williams DJ, 2011, PEDIATRICS, V128, pE479, DOI 10.1542/peds.2010-3681; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zhang L, 2011, APPL ENVIRON MICROB, V77, P7134, DOI 10.1128/AEM.05087-11	54	115	118	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78822	10.1371/journal.pone.0078822	http://dx.doi.org/10.1371/journal.pone.0078822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236055	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700052
J	Renne, U; Langhammer, M; Brenmoehl, J; Walz, C; Zeissler, A; Tuchscherer, A; Piechotta, M; Wiesner, RJ; Bielohuby, M; Hoeflich, A				Renne, Ulla; Langhammer, Martina; Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Tuchscherer, Armin; Piechotta, Marion; Wiesner, Rudolf J.; Bielohuby, Maximilian; Hoeflich, Andreas			Lifelong Obesity in a Polygenic Mouse Model Prevents Age- and Diet-Induced Glucose Intolerance- Obesity Is No Road to Late-Onset Diabetes in Mice	PLOS ONE			English	Article							LONG-TERM SELECTION; STRAIN FZT-DU; METABOLICALLY BENIGN; GENETIC-DETERMINANTS; ANIMAL-MODEL; GROWTH; LINES; FAT; MELLITUS; WEIGHT	Aims/Hypothesis: Visceral obesity holds a central position in the concept of the metabolic syndrome characterized by glucose intolerance in humans. However, until now it is unclear if obesity by itself is responsible for the development of glucose intolerance. Methods: We have used a novel polygenic mouse model characterized by genetically fixed obesity (DU6) and addressed age-and high fat diet-dependent glucose tolerance. Results: Phenotype selection over 146 generations increased body weight by about 2.7-fold in male 12-week DU6 mice (P<0.0001) if compared to unselected controls (Fzt:DU). Absolute epididymal fat mass was particularly responsive to weight selection and increased by more than 5-fold (P<0.0001) in male DU6 mice. At an age of 6 weeks DU6 mice consumed about twice as much food if compared to unselected controls (P<0.001). Absolute food consumption was higher at all time points measured in DU6 mice than in Fzt: DU mice. Between 6 and 12 weeks of age, absolute food intake was reduced by 15% in DU6 mice (P<0.001) but not in Fzt: DU mice. In both mouse lines feeding of the high fat diet elevated body mass if compared to the control diet (P<0.05). In contrast to controls, DU6 mice did not display high fat diet-induced increases of epididymal and renal fat. Control mice progressively developed glucose intolerance with advancing age and even more in response to the high fat diet. In contrast, obese DU6 mice did neither develop a glucose intolerant phenotype with progressive age nor when challenged with a high fat diet. Conclusions/Interpretation: Our results from a polygenic mouse model demonstrate that genetically pre-determined and life-long obesity is no precondition of glucose intolerance later in life.	[Renne, Ulla; Langhammer, Martina; Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol, Lab Mouse Genet, Dummerstorf, Germany; [Tuchscherer, Armin] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Livestock Genet & Breeding Unit, Dummerstorf, Germany; [Piechotta, Marion] Univ Vet Med, Clin Cattle, Hannover, Germany; [Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bielohuby, Maximilian] Klinikum Univ, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol, Cell Signaling Unit, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Veterinary Medicine Hannover, Foundation; University of Cologne; University of Cologne; University of Cologne; University of Munich; Forschungsinstitut fur Nutztierbiologie (FBN)	Hoeflich, A (corresponding author), Leibniz Inst Farm Anim Biol, Lab Mouse Genet, Dummerstorf, Germany.	hoeflich@fbn-dummerstorf.de	Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Hoeflich, Andreas/0000-0003-2018-2836	Deutsche Forschungsgemeinschaft [DFG H0 2003/6-1]; Europaischer Sozialfond	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Europaischer Sozialfond	AH was supported by grants from the Deutsche Forschungsgemeinschaft (DFG H0 2003/6-1) and from the Europaischer Sozialfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan MF, 2004, OBES RES, V12, P1397, DOI 10.1038/oby.2004.176; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Brenmoehl J, 2013, MED SCI SPORT EXER, V45, P841, DOI 10.1249/MSS.0b013e31827e0fca; Brockmann GA, 2001, FASEB J, V15, P978, DOI 10.1096/fj.00-0391com; Bunger L, 1998, GENET RES, V72, P93, DOI 10.1017/S0016672398003401; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Ehrich TH, 2003, OBES RES, V11, P1400, DOI 10.1038/oby.2003.189; Falkenberg H, 2000, ARCH TIERZUCHT, V43, P513, DOI 10.5194/aab-43-513-2000; Fernandez-Twinn DS, 2010, ANN NY ACAD SCI, V1212, P78, DOI 10.1111/j.1749-6632.2010.05798.x; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Klein M, 1999, J ANIM PHYSIOL AN N, V81, P75, DOI 10.1046/j.1439-0396.1999.812197.x; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Renne U, 2003, J EXP ANIM SCI, V42, P218, DOI 10.1016/S0939-8600(03)80004-4; Ritter S, 2012, POSTGRAD MED, V124, P168, DOI 10.3810/pgm.2012.07.2578; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; SAS INSTITUTE INC, 2009, SAS STAT 9 2 US GUID; SCHULER L, 1985, ARCH TIERZUCHT, V28, P357; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Suzuki W, 1999, EXP ANIM TOKYO, V48, P181, DOI 10.1538/expanim.48.181; Timtchenko D, 1999, INT J OBESITY, V23, P586, DOI 10.1038/sj.ijo.0800872; UEDA H, 1995, DIABETOLOGIA, V38, P503, DOI 10.1007/BF00400717; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WOLF E, 1991, GROWTH DEVELOP AGING, V55, P225; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79788	10.1371/journal.pone.0079788	http://dx.doi.org/10.1371/journal.pone.0079788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236159	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700159
J	Vartanian, LR; Sokol, N; Herman, CP; Polivy, J				Vartanian, Lenny R.; Sokol, Nicole; Herman, C. Peter; Polivy, Janet			Social Models Provide a Norm of Appropriate Food Intake for Young Women	PLOS ONE			English	Article							CONSUMPTION; OTHERS; EAT	It is often assumed that social models influence people's eating behavior by providing a norm of appropriate food intake, but this hypothesis has not been directly tested. In three experiments, female participants were exposed to a low-intake model, a high-intake model, or no model (control condition). Experiments 1 and 2 used a remote-confederate manipulation and were conducted in the context of a cookie taste test. Experiment 3 used a live confederate and was conducted in the context of a task during which participants were given incidental access to food. Participants also rated the extent to which their food intake was influenced by a variety of factors (e. g., hunger, taste, how much others ate). In all three experiments, participants in the low-intake conditions ate less than did participants in the high-intake conditions, and also reported a lower perceived norm of appropriate intake. Furthermore, perceived norms of appropriate intake mediated the effects of the social model on participants' food intake. Despite the observed effects of the social models, participants were much more likely to indicate that their food intake was influenced by taste and hunger than by the behavior of the social models. Thus, social models appear to influence food intake by providing a norm of appropriate eating behavior, but people may be unaware of the influence of a social model on their behavior.	[Vartanian, Lenny R.; Sokol, Nicole] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Herman, C. Peter; Polivy, Janet] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of New South Wales Sydney; University of Toronto	Vartanian, LR (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	lvartanian@psy.unsw.edu.au		Herman, C. Peter/0000-0001-5738-6803; Polivy, Janet/0000-0003-3997-8586; Vartanian, Lenny/0000-0001-8238-6151	Australian Research Council [DP110101124]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP110101124) (arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cruwys T, 2012, APPETITE, V58, P754, DOI 10.1016/j.appet.2011.12.002; Exline JJ, 2012, J SOC CLIN PSYCHOL, V31, P169, DOI 10.1521/jscp.2012.31.2.169; Feeney JR, 2011, EAT BEHAV, V12, P75, DOI 10.1016/j.eatbeh.2010.09.007; GOLDMAN SJ, 1991, APPETITE, V17, P129, DOI 10.1016/0195-6663(91)90068-4; Herman CP, 2005, PHYSIOL BEHAV, V86, P762, DOI 10.1016/j.physbeh.2005.08.064; Herman CP, 2005, APPETITE, V45, P108, DOI 10.1016/j.appet.2005.03.013; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hermans RCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031027; Hermans RCJ, 2012, BRIT J NUTR, V107, P588, DOI 10.1017/S0007114511003278; Hermans RCJ, 2009, APPETITE, V53, P135, DOI 10.1016/j.appet.2009.05.004; Louis W, 2007, J SOC PSYCHOL, V147, P57, DOI 10.3200/SOCP.147.1.57-74; McFerran B, 2010, J CONSUM RES, V36, P915, DOI 10.1086/644611; POLIVY J, 1979, J PERS, V47, P100, DOI 10.1111/j.1467-6494.1979.tb00617.x; Povey R, 1999, PSYCHOL HEALTH, V14, P991, DOI 10.1080/08870440008407363; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Robinson E, 2013, APPETITE, V65, P20, DOI 10.1016/j.appet.2013.01.010; Robinson E, 2011, APPETITE, V56, P747, DOI 10.1016/j.appet.2011.03.001; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Salvy SJ, 2008, APPETITE, V50, P514, DOI 10.1016/j.appet.2007.10.009; Salvy SJ, 2007, APPETITE, V49, P92, DOI 10.1016/j.appet.2006.12.004; Spanos S, 2013, HLTH PSYCHO IN PRESS; Vartanian LR, 2008, HEALTH PSYCHOL, V27, P533, DOI 10.1037/0278-6133.27.5.533; Vartanian LR, 2007, APPETITE, V48, P265, DOI 10.1016/j.appet.2006.10.008; [No title captured]	28	48	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79268	10.1371/journal.pone.0079268	http://dx.doi.org/10.1371/journal.pone.0079268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236117	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700116
J	Stead, LF; Egan, P; Devery, A; Conway, C; Daly, C; Berri, S; Wood, H; Belvedere, O; Papagiannopoulos, K; Ryan, A; Rabbitts, P				Stead, Lucy F.; Egan, Philip; Devery, Aoife; Conway, Caroline; Daly, Catherine; Berri, Stefano; Wood, Henry; Belvedere, Ornella; Papagiannopoulos, Kostas; Ryan, Anderson; Rabbitts, Pamela			An Integrated Inspection of the Somatic Mutations in a Lung Squamous Cell Carcinoma Using Next-Generation Sequencing	PLOS ONE			English	Article							CANCER; P53; TOBACCO; BRCA2; SMOKING; GENOME; NEVER; SPECTRUM; VARIANTS; PATTERNS	Squamous cell carcinoma (SCC) of the lung kills over 350,000 people annually worldwide, and is the main lung cancer histotype with no targeted treatments. High-coverage whole-genome sequencing of the other main subtypes, small-cell and adenocarcinoma, gave insights into carcinogenic mechanisms and disease etiology. The genomic complexity within the lung SCC subtype, as revealed by The Cancer Genome Atlas, means this subtype is likely to benefit from a more integrated approach in which the transcriptional consequences of somatic mutations are simultaneously inspected. Here we present such an approach: the integrated analysis of deep sequencing data from both the whole genome and whole transcriptome (coding and non-coding) of LUDLU-1, a SCC lung cell line. Our results show that LUDLU-1 lacks the mutational signature that has been previously associated with tobacco exposure in other lung cancer subtypes, and suggests that DNA-repair efficiency is adversely affected; LUDLU-1 contains somatic mutations in TP53 and BRCA2, allelic imbalance in the expression of two cancer-associated BRCA1 germline polymorphisms and reduced transcription of a potentially endogenous PARP2 inhibitor. Functional assays were performed and compared with a control lung cancer cell line. LUDLU-1 did not exhibit radiosensitisation or an increase in sensitivity to PARP inhibitors. However, LUDLU-1 did exhibit small but significant differences with respect to cisplatin sensitivity. Our research shows how integrated analyses of high-throughput data can generate hypotheses to be tested in the lab.	[Stead, Lucy F.; Egan, Philip; Conway, Caroline; Daly, Catherine; Berri, Stefano; Wood, Henry; Belvedere, Ornella; Rabbitts, Pamela] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Devery, Aoife; Ryan, Anderson] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Papagiannopoulos, Kostas] St James Univ Hosp, Dept Thorac Surg, Leeds, W Yorkshire, England	University of Leeds; University of Oxford; Saint James's University Hospital	Rabbitts, P (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.	p.rabbitts@leeds.ac.uk	Ryan, Anderson J/O-7701-2015; Stead, Lucy Frances/H-7378-2019; RYAN, Anderson/ACG-0319-2022	Ryan, Anderson J/0000-0001-6241-7969; Stead, Lucy Frances/0000-0002-9550-4150; RYAN, Anderson/0000-0001-6241-7969; Berri, Stefano/0000-0001-7530-7611; Wood, Henry/0000-0003-3009-5904; Papagiannopoulos, Konstantinos/0000-0002-7088-8004	Yorkshire Cancer Research [L341PG]; Leeds Teaching Hospitals Charitable Foundation; Betty Woolsey Bequest for Thoracic Research; Medical Research Council [MC_PC_12006] Funding Source: researchfish; MRC [MC_PC_12006] Funding Source: UKRI	Yorkshire Cancer Research; Leeds Teaching Hospitals Charitable Foundation; Betty Woolsey Bequest for Thoracic Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Yorkshire Cancer Research, grant number L341PG to P. R. (http://yorkshirecancerresearch.org.uk), the Leeds Teaching Hospitals Charitable Foundation, and the Betty Woolsey Bequest for Thoracic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Alexandrov LB, 2013, NATURE, V502, DOI 10.1038/nature12666; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Boffetta P, 2001, INT J CANCER, V94, P591, DOI 10.1002/ijc.1507; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Complete Genomics Incorporated, 2012, CGAT METH SOFTW V1 3; de Marinisa F, 2008, ONCOLOGIST, V13, P14, DOI 10.1634/theoncologist.13-S1-14; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; GRENMAN R, 1989, INT J CANCER, V44, P131, DOI 10.1002/ijc.2910440123; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han YY, 2010, CANCER-AM CANCER SOC, V116, P940, DOI 10.1002/cncr.24747; Heller WD, 1998, J CLIN EPIDEMIOL, V51, P211, DOI 10.1016/S0895-4356(97)00279-5; International Agency for Research on Cancer (IARC), 2007, CANC INCIDENCE 5 CON, V9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Johnson N, 2007, HUM MOL GENET, V16, P1051, DOI 10.1093/hmg/ddm050; Ju YS, 2011, GENOME RES; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lewis SJ, 2003, BIOMARKERS, V8, P218, DOI 10.1080/1354750031000120125; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li K, 2010, ONCOTARGET, V1; Liu J, 2012, GENOME RES; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Pfeifer G, 2002, ONCOGENE, V21, P17; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts A, 2011, BIOINFORMATICS; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stead LF, 2012, NEOPLASIA, V14, P1075, DOI 10.1593/neo.121380; Stordal B, 2007, IUBMB LIFE, V59, P696, DOI 10.1080/15216540701636287; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; The Cancer Genome Project, 2012, CANC GEN CENS; The MARIE-GENICA Consortium, 2010, BREAST CANC RES TREA, V120, P10; Thilly W, 1980, GENE LOCUS MUTATION; Thu KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033003; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Yoon JH, 2001, CANCER RES, V61, P7110	59	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78823	10.1371/journal.pone.0078823	http://dx.doi.org/10.1371/journal.pone.0078823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244370	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600067
J	Peng, ZH; Zhang, CL; Zhang, Y; Hu, T; Mu, SH; Li, XP; Gao, J				Peng, Zhenhua; Zhang, Chunling; Zhang, Ying; Hu, Tao; Mu, Shaohua; Li, Xueping; Gao, Jian			Transcriptome Sequencing and Analysis of the Fast Growing Shoots of Moso Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; GENOME-WIDE ANALYSIS; ARF GENE FAMILY; MOLECULAR CHARACTERIZATION; INTERNODE ELONGATION; ARABIDOPSIS-THALIANA; ROOT TRANSCRIPTOME; CELL ELONGATION; SERIAL ANALYSIS; REGULATED GENE	Background: The moso bamboo, a large woody bamboo with the highest ecological, economic, and cultural value of all bamboos, has one of the highest growth speeds in the world. Genetic research into moso bamboo has been scarce, partly because of the lack of previous genomic resources. In the present study, for the first time, we performed de novo transcriptome sequencing and mapped to the moso bamboo genomic resources (reference genome and genes) to produce a comprehensive dataset for the fast growing shoots of moso bamboo. Results: The fast growing shoots mixed with six different heights and culms after leaf expansion of moso bamboo transcriptome were sequenced using the Illumina HiSeq (TM) 2000 sequencing platform, respectively. More than 80 million reads including 65,045,670 and 68,431,884 clean reads were produced in the two libraries. More than 81% of the reads were matched to the reference genome, and nearly 50% of the reads were matched to the reference genes. The genes with log 2 ratio > 2 or < -2 (P < 0.001) were characterized as the most differentially expressed genes. 6,076 up-regulated and 4,613 down-regulated genes were classified into functional categories. Candidate genes which mainly involved transcript factors, plant hormones, cell cycle regulation, cell wall metabolism and cell morphogenesis genes were further analyzed and they may form a network that regulates the fast growth of moso bamboo shoots. Conclusion: Firstly, our data provides the most comprehensive transcriptomic resource for moso bamboo to date. Candidate genes have been identified and they are potentially involved in the growth and development of moso bamboo. The results give a better insight into the mechanisms of moso bamboo shoots rapid growth and provide gene resources for improving plant growth.	[Peng, Zhenhua; Zhang, Chunling; Zhang, Ying; Hu, Tao; Mu, Shaohua; Li, Xueping; Gao, Jian] State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, J (corresponding author), State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China.	gaojian@icbr.ac.cn			State Forestry Administration '948' project of China [2012-4-49]; National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research" [2013AA102607-4]	State Forestry Administration '948' project of China; National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research"(National High Technology Research and Development Program of China)	This project was supported by the the State Forestry Administration '948' project of China (2012-4-49) and National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research" (grant No. 2013AA102607-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Adachi S, 2009, DEV BIOL, V329, P306, DOI 10.1016/j.ydbio.2009.03.002; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Byun YJ, 2009, PLANTA, V229, P1181, DOI 10.1007/s00425-009-0903-9; Chang ST, 2000, J WOOD SCI, V46, P40, DOI 10.1007/BF00779551; Chen CY, 2010, PHYTOCHEMISTRY, V71, P1270, DOI 10.1016/j.phytochem.2010.05.011; Chen TH, 2009, PHYTOCHEMISTRY, V70, P25, DOI 10.1016/j.phytochem.2008.10.004; Chiu WB, 2006, NEW PHYTOL, V170, P53, DOI 10.1111/j.1469-8137.2005.01638.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; Das M, 2005, ANN BOT-LONDON, V95, P835, DOI 10.1093/aob/mci088; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Ekman DR, 2003, PLANT PHYSIOL, V133, P1397, DOI 10.1104/pp.103.028019; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fizames C, 2004, PLANT PHYSIOL, V134, P67, DOI 10.1104/pp.103.030536; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Gao ZhiMin, 2010, Scientia Silvae Sinicae, V46, P45; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Genovesi V, 2008, J EXP BOT, V59, P875, DOI 10.1093/jxb/ern013; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Hsieh LS, 2011, MOL BIOL REP, V38, P283, DOI 10.1007/s11033-010-0106-2; Hsieh LS, 2010, PHYTOCHEMISTRY, V71, P1999, DOI 10.1016/j.phytochem.2010.09.019; Hsieh LS, 2010, PROTEIN EXPRES PURIF, V71, P224, DOI 10.1016/j.pep.2010.01.009; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jiang ZeHui, 2012, Scientia Silvae Sinicae, V48, P159; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; LEE C. L., 1960, ACTA BOT SINICA, V9, P76; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Lin JX, 2002, PHYSIOL PLANTARUM, V114, P296, DOI 10.1034/j.1399-3054.2002.1140216.x; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu MY, 2012, PLOS ONE, V10, P1; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Maria DL, 2011, BMC GENOMICS, V30, P1471; Miedes E, 2011, J PLANT PHYSIOL, V168, P196, DOI 10.1016/j.jplph.2010.06.029; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; MURPHY RJ, 1992, IAWA BULL, V13, P403, DOI 10.1163/22941932-90001296; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; PHILLIPS AL, 1994, PLANT MOL BIOL, V24, P603, DOI 10.1007/BF00023557; Poroyko V, 2005, PLANT PHYSIOL, V138, P1700, DOI 10.1104/pp.104.057638; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Sabelli PA, 2009, PLANT SCI, V177, P540, DOI 10.1016/j.plantsci.2009.09.012; Sauret-Gueto S, 2012, PLANT J, V69, P628, DOI 10.1111/j.1365-313X.2011.04817.x; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Science Press, 2006, PHYLLOSTACHYS, V22, P163; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Shani Z, 2006, PLANT CELL REP, V25, P1067, DOI 10.1007/s00299-006-0167-9; Sharma RK, 2008, GENOME, V51, P91, DOI 10.1139/g07-101; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YJ, 2006, PROTEOMICS, V6, P5898, DOI 10.1002/pmic.200600278; Xie LQ, 2011, J EXP BOT, V62, P4495, DOI 10.1093/jxb/err164; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhong RQ, 2002, PLANT CELL, V14, P165, DOI 10.1105/tpc.010278; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhou MB, 2011, PLANT MOL BIOL REP, V29, P224, DOI 10.1007/s11105-010-0222-0; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	94	73	94	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78944	10.1371/journal.pone.0078944	http://dx.doi.org/10.1371/journal.pone.0078944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244391	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900028
J	Philips, ST; Hildenbrand, ZL; Oravecz-Wilson, KI; Foley, SB; Mgbemena, VE; Ross, TS				Philips, S. T.; Hildenbrand, Z. L.; Oravecz-Wilson, K. I.; Foley, S. B.; Mgbemena, V. E.; Ross, T. S.			Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells	ONCOGENE			English	Article						myeloproliferation; Imatinib; arsenic	HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOID-LEUKEMIA; HUNTINGTIN-INTERACTING PROTEIN-1; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; RECEPTOR-BETA; CML PATIENTS; QUIESCENT; GENE	Myeloproliferative neoplasms (MPNs) such as chronic myelogenous (CML) and chronic myelomonocytic leukemias (CMML) are frequently induced by tyrosine kinase oncogenes. Although these MPNs are sensitive to tyrosine kinase inhibitors such as imatinib, patients often relapse upon withdrawal of therapy. We used a model of MPN, which is induced by co-expression of the oncoproteins HIP1/PDGFbR (H/P) and AML1/ETO from their endogenous loci, to examine the mechanisms of disease development and recurrence following imatinib withdrawal. Although the MPN displayed a full hematologic response to imatinib, 100% of the diseased mice relapsed upon drug withdrawal. MPN persistence was not due to imatinib resistance mutations in the H/P oncogene or massive gene expression changes. Within 1 week of imatinib treatment, more than 98% of gene expression changes induced by the oncogenes in isolated hematopoietic stem and progenitor cells (lineage(-)Sca-1(+)c-Kit(+) immunophenotype) normalized. Supplementation of imatinib with granulocyte colony-stimulating factor or arsenic trioxide reduced MPN-initiating cell frequencies and the combination of imatinib with arsenic trioxide cured a large fraction of mice with MPNs. In contrast, no mice in the imatinibtreated control cohorts were cured. These data suggest that treatment with a combination of arsenic trioxide and imatinib can eliminate refractory MPN-initiating cells and reduce disease relapse.	[Philips, S. T.; Hildenbrand, Z. L.; Foley, S. B.; Mgbemena, V. E.; Ross, T. S.] Univ Texas Dallas, SW Med Ctr, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Oravecz-Wilson, K. I.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan	Ross, TS (corresponding author), Univ Texas Dallas, SW Med Ctr, Dept Internal Med, Div Hematol Oncol, 5323 Harry Hines Blvd,ND3-214, Dallas, TX 75390 USA.	Theo.Ross@utsouthwestern.edu		Ross, Theodora/0000-0002-9166-1802	Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; TSR holds the Jeanne Ann Plitt Professorship in Breast Cancer Research; H Ben and Isabelle T Decherd Chair in Internal Medicine at UT Southwestern Medical Center; Leukemia and Lymphoma Society Scholar;  [CBTG CA009676];  [R01 CA82363-03];  [R01 CA098730-01]; NATIONAL CANCER INSTITUTE [T32CA124334, R01CA098730, R01CA082363, T32CA009676] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); TSR holds the Jeanne Ann Plitt Professorship in Breast Cancer Research; H Ben and Isabelle T Decherd Chair in Internal Medicine at UT Southwestern Medical Center; Leukemia and Lymphoma Society Scholar(Leukemia and Lymphoma Society); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bob Rooney, Luke Peterson, Phil (Zhe) Guan, Ivan Maillard, Yipin Wu and Alice Gauvin for their intellectual input and technical assistance. This work was supported by the following grants: CBTG CA009676 (STP), R01 CA82363-03 (TSR) and R01 CA098730-01 (TSR), and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (TSR). TSR holds the Jeanne Ann Plitt Professorship in Breast Cancer Research and the H Ben and Isabelle T Decherd Chair in Internal Medicine at UT Southwestern Medical Center. TSR was supported as a Leukemia and Lymphoma Society Scholar during the time this work was completed.	Agarwal A, 2012, BLOOD, V120, P2658, DOI 10.1182/blood-2011-05-355396; Ames HM, 2013, MOL CELL BIOL, V33, P3580, DOI 10.1128/MCB.00473-13; Antman KH, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_2-1; Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Connor RF, 2006, LEUKEMIA RES, V30, P1249, DOI 10.1016/j.leukres.2006.02.020; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; David M, 2007, BLOOD, V109, P61, DOI 10.1182/blood-2006-05-024828; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Drummond MW, 2009, LEUKEMIA, V23, P1199, DOI 10.1038/leu.2009.43; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Grand FH, 2004, CANCER RES, V64, P7216, DOI 10.1158/0008-5472.CAN-04-2005; Graves CW, 2008, CANCER RES, V68, P1064, DOI 10.1158/0008-5472.CAN-07-5892; Grossmann V, 2011, LEUKEMIA, V25, P557, DOI 10.1038/leu.2010.298; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Huang HJ, 1999, CANCER RES, V59, P2981; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; Kavalerchik E, 2008, J CLIN ONCOL, V26, P2911, DOI 10.1200/JCO.2008.17.5745; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lee KH, 2000, J IMMUNOL, V165, P4970, DOI 10.4049/jimmunol.165.9.4970; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Provenzano JD, 2013, CASE REP HEMATOL, V2013, DOI 10.1155/2013/709164; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Ross TS, 1998, BLOOD, V91, P4419, DOI 10.1182/blood.V91.12.4419.412k43_4419_4426; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Strout MP, 1999, ANN HEMATOL, V78, P251, DOI 10.1007/s002770050511; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Vainio P, 2011, ONCOTARGET, V2, P1176; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011; Zuccolo J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009369	49	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5379	5390		10.1038/onc.2013.484	http://dx.doi.org/10.1038/onc.2013.484			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24240679	Green Accepted			2022-12-25	WOS:000345120600008
J	Alibaud, L; Pawelczyk, J; Gannoun-Zaki, L; Singh, VK; Rombouts, Y; Drancourt, M; Dziadek, J; Guerardel, Y; Kremer, L				Alibaud, Laeticia; Pawelczyk, Jakub; Gannoun-Zaki, Laila; Singh, Vipul K.; Rombouts, Yoann; Drancourt, Michel; Dziadek, Jaroslaw; Guerardel, Yann; Kremer, Laurent			Increased Phagocytosis of Mycobacterium marinum Mutants Defective in Lipooligosaccharide Production A STRUCTURE-ACTIVITY RELATIONSHIP STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Glycolipid Structure; Macrophages; Mass Spectrometry (MS); Mycobacterium; Phagocytosis; Acanthamoeba; Lipooligosaccharide; Thin Layer Chromatography	TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; CELL-WALL; TUBERCULOSIS; BIOSYNTHESIS; ANTIGENS; GLYCOPEPTIDOLIPIDS; IDENTIFICATION; INACTIVATION; PATHOGENESIS; MANNOSIDES	Mycobacterium marinum is a waterborne pathogen responsible for tuberculosis-like infections in ectotherms and is an occasional opportunistic human pathogen. In the environment, M. marinum also interacts with amoebae, which may serve as a natural reservoir for this microorganism. However, the description of mycobacterial determinants in the early interaction with macrophages or amoebae remains elusive. Lipooligosaccharides (LOSs) are cell surface-exposed glycolipids capable of modulating the host immune system, suggesting that they may be involved in the early interactions of M. marinum with macrophages. Herein, we addressed whether LOS composition affects the uptake of M. marinum by professional phagocytes. Mutants with various truncated LOS variants were generated, leading to the identification of several previously uncharacterized biosynthetic genes (wbbL2, MMAR_2321, and MMAR_2331). Biochemical and structural approaches allowed resolving the structures of LOS precursors accumulating in this set of mutants. These strains with structurally defined LOS profiles were then used to infect both macrophages and Acanthamoebae. An inverse correlation between LOS completeness and uptake of mycobacteria by phagocytes was found, allowing the proposal of three mutant classes: class I (papA4), devoid of LOS and highly efficiently phagocytosed; class II, accumulating only early LOS intermediates (wbbL2 and MMAR_2331) and efficiently phagocytosed but less than class I mutants; class III, lacking LOS-IV (losA, MMAR_2319, and MMAR_2321) and phagocytosed similarly to the control strain. These results indicate that phagocytosis is conditioned by the LOS pattern and that the LOS pathway used by M. marinum in macrophages is conserved during infection of amoebae.	[Kremer, Laurent] Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Pawelczyk, Jakub; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, PL-93231 Lodz, Poland; [Singh, Vipul K.; Drancourt, Michel] Fac Med Marseille, INSERM 1095, IRD 198, Unite Rech Malad Infect & Trop Emergentes,UMR CNR, F-13005 Marseille, France; [Rombouts, Yoann; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kremer, L (corresponding author), Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr	Singh, Vipul Kumar/AAA-9302-2020; Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Dziadek, Jaroslaw/0000-0003-1427-884X; Gannoun, Laila/0000-0002-9644-1083; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; Singh, Vipul Kumar/0000-0002-7146-7279	French National Research Agency [ANR-10-MIDI-009]; InfectioPole Sud Foundation; European Regional Development Fund under Operational Programme Innovative Economy Grant [POIG.01.01.02-10-107/09]	French National Research Agency(French National Research Agency (ANR)); InfectioPole Sud Foundation; European Regional Development Fund under Operational Programme Innovative Economy Grant	This work was supported by French National Research Agency Grant ANR-10-MIDI-009 (ZebraFlam) (to L. K.), the InfectioPole Sud Foundation (to V. K. S.), and the European Regional Development Fund under Operational Programme Innovative Economy Grant POIG.01.01.02-10-107/09 (to J. D. and J. P.).	Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Chavadi SS, 2011, J BIOL CHEM, V286, P24616, DOI 10.1074/jbc.M111.247601; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; GILLERON M, 1995, GLYCOCONJUGATE J, V12, P298, DOI 10.1007/BF00731333; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; HERMANSSON K, 1993, CARBOHYD RES, V248, P199, DOI 10.1016/0008-6215(93)84127-R; HUNTER SW, 1985, BIOCHEMISTRY-US, V24, P2798, DOI 10.1021/bi00332a030; HUNTER SW, 1988, BIOCHEMISTRY-US, V27, P1549, DOI 10.1021/bi00405a023; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; Mills JA, 2004, J BIOL CHEM, V279, P43540, DOI 10.1074/jbc.M407782200; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200	44	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					215	228		10.1074/jbc.M113.525550	http://dx.doi.org/10.1074/jbc.M113.525550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235141	Green Published, hybrid			2022-12-25	WOS:000329370900019
J	Ma, JH; Nakagawa, Y; Kojima, I; Shibata, H				Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi			Prolonged Insulin Stimulation Down-regulates GLUT4 through Oxidative Stress-mediated Retromer Inhibition by a Protein Kinase CK2-dependent Mechanism in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Glut4; Insulin; Membrane Trafficking; Signal Transduction; Retromer	TYROSINE-PHOSPHATASE 1B; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; GLUCOSE TRANSPORTERS; ADIPOSE CONVERSION; STORAGE-VESICLES; TRANSLOCATION; SORTILIN; ACTIVATION; MEMBRANE	Although insulin acutely stimulates glucose uptake by promotion of GLUT4 translocation from intracellular compartments to the plasma membrane in adipocytes and muscles, long term insulin stimulation causes GLUT4 depletion that is particularly prominent in the insulin-responsive GLUT4 storage compartment. This effect is caused mainly by accelerated lysosomal degradation of GLUT4, although the mechanism is not fully defined. Here we show that insulin acutely induced dissociation of retromer components from the low density microsomal membranes of 3T3-L1 adipocytes that was accompanied by disruption of the interaction of Vps35 with sortilin. This insulin effect was dependent on the activity of protein kinase CK2 but not phosphatidylinositol 3-kinase or extracellular signal-regulated kinase 1/2. Knockdown of Vps26 decreased GLUT4 to a level comparable with that with insulin stimulation for 4 h. Vps35 with a mutation in the CK2 phosphorylation motif (Vps35-S7A) was resistant to insulin-induced dissociation from the low density microsomal membrane, and its overexpression attenuated GLUT4 down-regulation with insulin. Furthermore, insulin-generated hydrogen peroxide was an upstream mediator of the insulin action on retromer and GLUT4. These results suggested that insulin-generated oxidative stress switches the GLUT4 sorting direction to lysosomes through inhibition of the retromer function in a CK2-dependent manner.	[Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 3718512, Japan	Gunma University	Shibata, H (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	hshibata@gunma-u.ac.jp			Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan [23591295]	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders" and Grant-in-aid 23591295 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. S.). Parts of this study were presented in abstract form at the 69th Scientific Sessions of the American Diabetes Association, New Orleans, LA, June 5-9, 2009.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1974, P NATL ACAD SCI USA, V71, P4173, DOI 10.1073/pnas.71.10.4173; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; GUY GR, 1993, J BIOL CHEM, V268, P2141; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KONO T, 1977, J BIOL CHEM, V252, P2226; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Maier VH, 2000, DIABETOLOGIA, V43, P1273, DOI 10.1007/s001250051523; MAY JM, 1979, J BIOL CHEM, V254, P2214; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Tamori Y, 1996, BIOCHEM BIOPH RES CO, V220, P740, DOI 10.1006/bbrc.1996.0474; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595	50	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					133	142		10.1074/jbc.M113.533240	http://dx.doi.org/10.1074/jbc.M113.533240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24240093	Green Published, hybrid			2022-12-25	WOS:000329370900012
J	Carluccio, C; Fraternali, F; Salvatore, F; Fornili, A; Zagari, A				Carluccio, Carla; Fraternali, Franca; Salvatore, Francesco; Fornili, Arianna; Zagari, Adriana			Structural Features of the Regulatory ACT Domain of Phenylalanine Hydroxylase	PLOS ONE			English	Article							AMINO-ACID HYDROXYLASES; MOLECULAR-DYNAMICS; MISSENSE MUTATIONS; HYDRATION SITES; PHENYLKETONURIA; PROTEINS; BINDING; SIMULATIONS; STABILITY; WATER	Phenylalanine hydroxylase (PAH) catalyzes the conversion of L-Phe to L-Tyr. Defects in PAH activity, caused by mutations in the human gene, result in the autosomal recessively inherited disease hyperphenylalaninemia. PAH activity is regulated by multiple factors, including phosphorylation and ligand binding. In particular, PAH displays positive cooperativity for L-Phe, which is proposed to bind the enzyme on an allosteric site in the N-terminal regulatory domain (RD), also classified as an ACT domain. This domain is found in several proteins and is able to bind amino acids. We used molecular dynamics simulations to obtain dynamical and structural insights into the isolated RD of PAH. Here we show that the principal motions involve conformational changes leading from an initial open to a final closed domain structure. The global intrinsic motions of the RD are correlated with exposure to solvent of a hydrophobic surface, which corresponds to the ligand binding-site of the ACT domain. Our results strongly suggest a relationship between the Phe-binding function and the overall dynamic behaviour of the enzyme. This relationship may be affected by structure-disturbing mutations. To elucidate the functional implications of the mutations, we investigated the structural effects on the dynamics of the human RD PAH induced by six missense hyperphenylalaninemia-causing mutations, namely p.G46S, p.F39C, p.F39L, p.I65S, p.I65T and p.I65V. These studies showed that the alterations in RD hydrophobic interactions induced by missense mutations could affect the functionality of the whole enzyme.	[Carluccio, Carla; Salvatore, Francesco; Zagari, Adriana] Sca Rl, CEINGE Biotecnol Avanzate, Naples, Italy; [Carluccio, Carla] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Carluccio, Carla; Fraternali, Franca; Fornili, Arianna] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Salvatore, Francesco] SDN Ist Ric Diagnost & Nucl, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of London; King's College London; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Salvatore, F (corresponding author), Sca Rl, CEINGE Biotecnol Avanzate, Naples, Italy.	salvator@unina.it; arianna.fornili@kcl.ac.uk	Fraternali, Franca/D-4410-2011; Fraternali, Franca/C-8912-2009; Salvatore, Francesco/A-1966-2011	Fraternali, Franca/0000-0002-3143-6574; Salvatore, Francesco/0000-0002-2346-3564	Regione Campania (DGRC) [1901]; Ministry of University and Research [PON01_01802 2012]; Leverhulme Trust [F/07 040/AL]	Regione Campania (DGRC)(Regione Campania); Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Leverhulme Trust(Leverhulme Trust)	This study was supported by the Regione Campania (DGRC n. 1901 del 22/12/2009), Grant PON01_01802 2012 from the Ministry of University and Research and by the Leverhulme Trust (F/07 040/AL to AF and FF). The authors have declared that no competing interests exist.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Cerreto M, 2012, CURR GENE THER, V12, P48, DOI 10.2174/156652312799789280; Cerreto M, 2011, BBA-MOL BASIS DIS, V1812, P1435, DOI 10.1016/j.bbadis.2011.07.012; Daniele A, 2008, BBA-MOL BASIS DIS, V1782, P378, DOI 10.1016/j.bbadis.2008.01.012; Daniele A, 2009, FEBS J, V276, P2048, DOI 10.1111/j.1742-4658.2009.06940.x; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 2001, J INHERIT METAB DIS, V24, P213, DOI 10.1023/A:1010371002631; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fitzpatrick PF, 2000, ADV ENZYMOL RAMB, V74, P235; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Fornili A, 2012, METHODS MOL BIOL, V819, P375, DOI 10.1007/978-1-61779-465-0_23; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gersting SW, 2010, J BIOL CHEM, V285, P30686, DOI 10.1074/jbc.M110.124016; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Leandro J, 2011, BBA-MOL BASIS DIS, V1812, P106, DOI 10.1016/j.bbadis.2010.09.015; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; LOUNNAS V, 1994, PROTEINS, V18, P148, DOI 10.1002/prot.340180207; LOUNNAS V, 1994, BIOPHYS J, V66, P601, DOI 10.1016/S0006-3495(94)80835-5; Miranda FF, 2002, J BIOL CHEM, V277, P40937, DOI 10.1074/jbc.M112197200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlick Tamar, 2009, F1000 Biol Rep, V1, P51, DOI 10.3410/B1-51; Schrodinger L.L.C., 2009, PYMOL MOL GRAPHICS S; Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017; Shan JF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002473; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; Siltberg-Liberles J, 2009, AMINO ACIDS, V36, P235, DOI 10.1007/s00726-008-0057-2; SVENSSON E, 1994, J INHERIT METAB DIS, V17, P215, DOI 10.1007/BF00711621; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107	60	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79482	10.1371/journal.pone.0079482	http://dx.doi.org/10.1371/journal.pone.0079482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244510	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800081
J	Jeantet, Y; Cayzac, S; Cho, YH				Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.			beta Oscillation during Slow Wave Sleep and Rapid Eye Movement Sleep in the Electroencephalogram of a Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; THETA OSCILLATIONS; NOCTURNAL SLEEP; WAKE CYCLE; MICE; DEFICITS; STATE; GENE; SYNCHRONIZATION; PHENOTYPE	Study objectives: To search for early abnormalities in electroencephalogram (EEG) during sleep which may precede motor symptoms in a transgenic mouse model of hereditary neurodegenerative Huntington's disease (HD). Design: In the R6/1 transgenic mouse model of HD, rhythmic brain activity in EEG recordings was monitored longitudinally and across vigilance states through the onset and progression of disease. Measurements and results: Mice with chronic electrode implants were recorded monthly over wake-sleep cycles (4 hours), beginning at 9-11 weeks (presymptomatic period) through 6-7 months (symptomatic period). Recording data revealed a unique beta rhythm (20-35 Hz), present only in R6/1 transgenic mice, which evolves in close parallel with the disease. In addition, there was an unusual relationship between this beta oscillation and vigilance states: while nearly absent during the active waking state, the beta oscillation appeared with drowsiness and during slow wave sleep (SWS) and, interestingly, strengthened rather than dissipating when the brain returned to an activated state during rapid eye movement (REM) sleep. Conclusions: In addition to providing a new in vivo biomarker and insight into Huntington's disease pathophysiology, this serendipitous observation opens a window onto the rarely explored neurophysiology of the cortico-basal ganglia circuit during SWS and REM sleep.	[Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.] Univ Bordeaux, Talence, France; [Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Cho, YH (corresponding author), Univ Bordeaux, Talence, France.	yoon.cho@u-bordeaux1.fr			University of Bordeaux 1 (BQR); Agence National de la Recherche [ANR-08-MNPS-019-01]; Hereditary Disease Foundation	University of Bordeaux 1 (BQR); Agence National de la Recherche(French National Research Agency (ANR)); Hereditary Disease Foundation	This work was supported by the University of Bordeaux 1 (BQR), Agence National de la Recherche [ANR-08-MNPS-019-01] and the Hereditary Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Degos B, 2009, CEREB CORTEX, V19, P1616, DOI 10.1093/cercor/bhn199; EMSER W, 1988, J NEUROL, V235, P177, DOI 10.1007/BF00314313; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; Fisher SP, 2013, BRAIN, V136, P2159, DOI 10.1093/brain/awt132; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; GERBRANDT LK, 1978, ELECTROEN CLIN NEURO, V45, P454, DOI 10.1016/0013-4694(78)90290-0; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Jeantet Y, 2003, J NEUROSCI METH, V129, P129, DOI 10.1016/S0165-0270(03)00172-9; Kantor S, 2013, BRAIN, V136, P2147, DOI 10.1093/brain/awt128; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; SILVERMAN D, 1956, ELECTROEN CLIN NEURO, V8, P317, DOI 10.1016/0013-4694(56)90123-7; Snowden JS, 2002, J CLIN EXP NEUROPSYC, V24, P133, DOI 10.1076/jcen.24.2.133.998; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Urrestarazu E, 2009, MOVEMENT DISORD, V24, P254, DOI 10.1002/mds.22351; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781	35	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79509	10.1371/journal.pone.0079509	http://dx.doi.org/10.1371/journal.pone.0079509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244517	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800088
J	Schwilk, DW; Gaetani, MS; Poulos, HM				Schwilk, Dylan W.; Gaetani, Maria S.; Poulos, Helen M.			Oak Bark Allometry and Fire Survival Strategies in the Chihuahuan Desert Sky Islands, Texas, USA	PLOS ONE			English	Article							TROPICAL SAVANNA; NATIONAL-PARK; FOREST; TREES; ECOLOGY; RESISTANCE; MOUNTAINS; STORAGE; PLANTS; TRAIT	Trees may survive fire through persistence of above or below ground structures. Investment in bark aids in above-ground survival while investment in carbohydrate storage aids in recovery through resprouting and is especially important following above-ground tissue loss. We investigated bark allocation and carbohydrate investment in eight common oak (Quercus) species of Sky Island mountain ranges in west Texas. We hypothesized that relative investment in bark and carbohydrates changes with tree age and with fire regime: We predicted delayed investment in bark (positive allometry) and early investment in carbohydrates (negative allometry) under lower frequency, high severity fire regimes found in wetter microclimates. Common oaks of the Texas Trans-Pecos region (Quercus emoryi, Q. gambelii, Q. gravesii, Q. grisea, Q. hypoleucoides, Q. muehlenbergii, and Q. pungens) were sampled in three mountain ranges with historically mixed fire regimes: the Chisos Mountains, the Davis Mountains and the Guadalupe Mountains. Bark thickness was measured on individuals representing the full span of sizes found. Carbohydrate concentration in taproots was measured after initial leaf flush. Bark thickness was compared to bole diameter and allometries were analyzed using major axis regression on log-transformed measurements. We found that bark allocation strategies varied among species that can co-occur but have different habitat preferences. Investment patterns in bark were related to soil moisture preference and drought tolerance and, by proxy, to expected fire regime. Dry site species had shallower allometries with allometric coefficients ranging from less than one (negative allometry) to near one (isometric investment). Wet site species, on the other hand, had larger allometric coefficients, indicating delayed investment to defense. Contrary to our expectation, root carbohydrate concentrations were similar across all species and sizes, suggesting that any differences in below ground storage are likely to be in total volume of storage tissue rather than in carbohydrate concentration.	[Schwilk, Dylan W.; Gaetani, Maria S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Poulos, Helen M.] Wesleyan Univ, Coll Environm, Middletown, CT USA	Texas Tech University System; Texas Tech University; Wesleyan University	Schwilk, DW (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	dylan.schwilk@ttu.edu			Texas Tech University	Texas Tech University	This work was funded by Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; ADAMS DC, 1995, AM MIDL NAT, V134, P99, DOI 10.2307/2426487; Adams DC, 1997, P BIOL SOC WASH, V110, P681; Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Barbaroux C, 2003, NEW PHYTOL, V157, P605, DOI 10.1046/j.1469-8137.2003.00681.x; Barton AM, 1999, FOREST ECOL MANAG, V120, P143, DOI 10.1016/S0378-1127(98)00531-3; Bauer G, 2010, J MATER SCI, V45, P5950, DOI 10.1007/s10853-010-4680-4; Bell TL, 1999, NEW PHYTOL, V144, P143, DOI 10.1046/j.1469-8137.1999.00489.x; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; BERGERON Y, 1991, ECOLOGY, V72, P1980, DOI 10.2307/1941553; Bond W.J., 1996, FIRE PLANTS POPULATI; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Burrows GE, 2002, NEW PHYTOL, V153, P111, DOI 10.1046/j.0028-646X.2001.00299.x; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chatziefstratiou EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070110; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Clarke PJ, 2002, J BIOGEOGR, V29, P677, DOI 10.1046/j.1365-2699.2002.00716.x; COWLING RM, 1987, J APPL ECOL, V24, P645, DOI 10.2307/2403899; Cruz A, 2001, OECOLOGIA, V128, P343, DOI 10.1007/s004420100664; Dathe J, 2013, THESIS TEXAS TU; El Omari B, 2003, PLANT SOIL, V252, P349, DOI 10.1023/A:1024792206369; Fule PZ, 2003, LANDSCAPE ECOL, V18, P465, DOI 10.1023/A:1026012118011; HARE ROBERT C., 1965, J FOREST, V63, P248; HARMON ME, 1984, ECOLOGY, V65, P796, DOI 10.2307/1938052; HARRINGTON MG, 1989, J RANGE MANAGE, V42, P504, DOI 10.2307/3899237; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Jackson JF, 1999, AM NAT, V153, P614, DOI 10.1086/303201; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keeley Jon E., 1998, P219; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lawes MJ, 2011, PLANT ECOL, V212, P2057, DOI 10.1007/s11258-011-9954-7; Lawes MJ, 2011, PLANT ECOL, V212, P1937, DOI 10.1007/s11258-011-9994-z; Lawes MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00204.1; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; Moreira F, 2009, PLANT ECOL, V201, P77, DOI 10.1007/s11258-008-9476-0; MULLER CORNELIUS H, 1940, AMER MIDLAND NAT, V24, P703, DOI 10.2307/2420868; Nixon K. C, 1993, ANN SCIENC FOR VOL, V50, p25s, DOI 10.1051/forest:19930701; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; PETERSON DL, 1986, ENVIRON MANAGE, V10, P797, DOI 10.1007/BF01867732; Pinheiro J., 2011, NLME LINEAR NONLINEA; Poulos HM, 2007, AM J BOT, V94, P809, DOI 10.3732/ajb.94.5.809; Poulos HM, 2013, FOREST ECOL MANAG, V298, P1, DOI 10.1016/j.foreco.2013.02.014; Poulos HM, 2009, CAN J FOREST RES, V39, P1236, DOI 10.1139/X09-052; Poulos HM, 2010, ECOLOGY, V91, P1140, DOI 10.1890/08-1808.1; POWELL A. M., 1997, TREES SHRUBS TRANSPE; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Sakulich J, 2007, FOREST ECOL MANAG, V241, P62, DOI 10.1016/j.foreco.2006.12.029; Sarkar D., 2019, NLME LINEAR NONLINEA; Schwilk DW, 2005, AM J BOT, V92, P404, DOI 10.3732/ajb.92.3.404; Schwilk DW, 2001, OIKOS, V94, P326, DOI 10.1034/j.1600-0706.2001.940213.x; Sparrow AD, 2001, OIKOS, V94, P195, DOI 10.1034/j.1600-0706.2001.t01-1-11319.x; Splat KW, 1962, 193 US FOR SERV SO F; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; van Mantgem P, 2003, FOREST ECOL MANAG, V178, P341, DOI 10.1016/S0378-1127(02)00554-6; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x	65	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79285	10.1371/journal.pone.0079285	http://dx.doi.org/10.1371/journal.pone.0079285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244469	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800055
J	Li, SJ; Wu, CH; Chen, JX; Lu, P; Chen, C; Fu, MH; Fang, J; Gao, J; Zhu, L; Liang, RX; Shen, X; Yang, HJ				Li, Shaojing; Wu, Chuanhong; Chen, Jianxin; Lu, Peng; Chen, Chang; Fu, Meihong; Fang, Jing; Gao, Jian; Zhu, Li; Liang, Rixin; Shen, Xin; Yang, Hongjun			An Effective Solution to Discover Synergistic Drugs for Anti-Cerebral Ischemia from Traditional Chinese Medicinal Formulae	PLOS ONE			English	Article							BILOBA EXTRACT EGB; ARTERY OCCLUSION; GINSENOSIDE-RE; MITOCHONDRIAL DYSFUNCTION; IN-VITRO; STROKE; GENIPOSIDE; BERBERINE; BRAIN; INJURY	Recently, the pharmaceutical industry has shifted to pursuing combination therapies that comprise more than one active ingredient. Interestingly, combination therapies have been used for more than 2500 years in traditional Chinese medicine (TCM). Understanding optimal proportions and synergistic mechanisms of multi-component drugs are critical for developing novel strategies to combat complex diseases. A new multi-objective optimization algorithm based on least angle regression-partial least squares was proposed to construct the predictive model to evaluate the synergistic effect of the three components of a novel combination drug Yi-qi-jie-du formula (YJ), which came from clinical TCM prescription for the treatment of encephalopathy. Optimal proportion of the three components, ginsenosides (G), berberine (B) and jasminoidin (J) was determined via particle swarm optimum. Furthermore, the combination mechanisms were interpreted using PLS VIP and principal components analysis. The results showed that YJ had optimal proportion 3(G): 2(B): 0.5(J), and it yielded synergy in the treatment of rats impaired by middle cerebral artery occlusion induced focal cerebral ischemia. YJ with optimal proportion had good pharmacological effects on acute ischemic stroke. The mechanisms study demonstrated that the combination of G, B and J could exhibit the strongest synergistic effect. J might play an indispensable role in the formula, especially when combined with B for the acute stage of stroke. All these data in this study suggested that in the treatment of acute ischemic stroke, besides restoring blood supply and protecting easily damaged cells in the area of the ischemic penumbra as early as possible, we should pay more attention to the removal of the toxic metabolites at the same time. Mathematical system modeling may be an essential tool for the analysis of the complex pharmacological effects of multi-component drug. The powerful mathematical analysis method could greatly improve the efficiency in finding new combination drug from TCM.	[Li, Shaojing; Wu, Chuanhong; Chen, Chang; Fu, Meihong; Fang, Jing; Zhu, Li; Liang, Rixin; Shen, Xin; Yang, Hongjun] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Chen, Jianxin] Beijing Univ Chinese Med, Informat Ctr, Beijing, Peoples R China; [Lu, Peng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Gao, Jian] Hebei Univ, Coll Pharmaceut Sci, Baoding, Hebei, Peoples R China; [Zhu, Li] Jiangxi Univ Tradit Chinese Med Pharm, Jiangxi Univ Tradit Chinese Med, NanChang, Jiangxi, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Beijing University of Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS; Hebei University; Jiangxi University of Traditional Chinese Medicine	Yang, HJ (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	hongjun0420@vip.sina.com	Chen, Jianxin/G-5881-2015; Chen, Chang/Z-3748-2019	Chen, Jianxin/0000-0003-4067-5638; Chen, Chang/0000-0003-1674-973X	National Natural Science Foundation of China [30901976, 81274133]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" [2012ZX09103-201-055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation"	This work was supported by grants from the National Natural Science Foundation of China (No. 30901976 and No. 81274133) and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (No. 2012ZX09103-201-055). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi OA, 2003, COMPUT CHEM ENG, V27, P143, DOI 10.1016/S0098-1354(02)00034-0; [Anonymous], SWARM INTELLIGENCE; Appice A, 2007, LECT NOTES ARTIF INT, V4701, P502; Benaissa F, 2009, ACTA PHYSIOL HUNG, V96, P213, DOI 10.1556/APhysiol.96.2009.2.6; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Chen C, 2011, PHARM BIOL, V49, P445, DOI 10.3109/13880209.2010.523426; Chen JX, 2012, MOLECULES, V17, P9855, DOI 10.3390/molecules17089855; Chen JX, 2011, J ETHNOPHARMACOL, V134, P919, DOI 10.1016/j.jep.2011.01.048; Chen LM, 2008, J ASIAN NAT PROD RES, V10, P439, DOI 10.1080/10286020801892292; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Draijer M, 2009, LASER MED SCI, V24, P639, DOI 10.1007/s10103-008-0626-3; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Everett H, 2002, J EXP MED, V196, P1127, DOI 10.1084/jem.20011247; Fang KT, 2003, HANDB STAT, V22, P131, DOI 10.1016/S0169-7161(03)22006-X; Gao M, 2008, J ASIAN NAT PROD RES, V10, P551, DOI 10.1080/10286020801966955; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Gilan SS, 2012, CONSTR BUILD MATER, V34, P321, DOI 10.1016/j.conbuildmat.2012.02.038; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; He XL, 2009, BRAIN RES, V1249, P212, DOI 10.1016/j.brainres.2008.10.005; HIRANO K, 1991, DEV GROWTH DIFFER, V33, P451; Hu Jingqing, 2011, Front Med, V5, P203, DOI 10.1007/s11684-011-0138-6; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Iwanami J, 2007, EUR J PHARMACOL, V566, P153, DOI 10.1016/j.ejphar.2007.03.043; Jiang WL, 2010, PHYTOTHER RES, V24, P547, DOI 10.1002/ptr.2978; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Kannan K, 2000, MOL CELL BIOCHEM, V205, P53, DOI 10.1023/A:1007080910396; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kettmann V, 2004, PHARMAZIE, V59, P548; Khanal T, 2012, TOXICOL LETT, V209, P246, DOI 10.1016/j.toxlet.2011.12.017; Koh PO, 2011, AM J CHINESE MED, V39, P971, DOI 10.1142/S0192415X11009342; Koo H, 2004, PLANTA MED, V70, P467, DOI 10.1055/s-2004-818978; Kuo WH, 2004, PHARMACOLOGY, V70, P15, DOI 10.1159/000074238; Le Tran Q, 2003, J ETHNOPHARMACOL, V86, P249, DOI 10.1016/S0378-8741(03)00045-X; Leung KW, 2007, FEBS LETT, V581, P2423, DOI 10.1016/j.febslet.2007.04.055; Li PF, 2009, TRANSPORT REV, V29, P619, DOI 10.1080/01441640902829454; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu TT, 2011, BIOL PHARM BULL, V34, P1319, DOI 10.1248/bpb.34.1319; Ma HM, 2010, ANIM REPROD SCI, V121, P106, DOI 10.1016/j.anireprosci.2010.05.005; Malthouse EC, 1997, COMPUT CHEM ENG, V21, P875, DOI 10.1016/S0098-1354(96)00311-0; Nakaya Yutaka, 2007, J Med Invest, V54, P381, DOI 10.2152/jmi.54.381; Peng J, 2008, J SHANGHAI JIAOTONG, V42, P189; QIN SJ, 1992, COMPUT CHEM ENG, V16, P379, DOI 10.1016/0098-1354(92)80055-E; Radad K, 2011, CNS NEUROSCI THER, V17, P761, DOI 10.1111/j.1755-5949.2010.00208.x; Rudzinski W, 2007, NUCL MED REV, V10, P29; Saraf MK, 2010, PHARMACOL BIOCHEM BE, V97, P192, DOI 10.1016/j.pbb.2010.07.017; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Shen JG, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-8; Shi C, 2010, PLATELETS, V21, P373, DOI 10.3109/09537100903511448; Shi LL, 2011, LIFE SCI, V88, P521, DOI 10.1016/j.lfs.2011.01.011; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sucher NJ, 2006, EPILEPSY BEHAV, V8, P350, DOI 10.1016/j.yebeh.2005.11.015; Suzuki Y, 2001, PLANTA MED, V67, P807, DOI 10.1055/s-2001-18842; Tan CB, 2009, BIOL PHARM BULL, V32, P1359, DOI 10.1248/bpb.32.1359; Tian JW, 2005, NEUROSCI LETT, V374, P92, DOI 10.1016/j.neulet.2004.10.030; Umetrics AB, 2006, MULTI MEGAVARIATE 1, V2; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Xia T, 2002, FEBS LETT, V510, P62, DOI 10.1016/S0014-5793(01)03228-8; Xutian S, 2009, AM J CHINESE MED, V37, P411, DOI 10.1142/S0192415X09006941; Yang HJ, 2009, J BIOL SYST, V17, P329, DOI 10.1142/S0218339009002971; Yang L, 2009, ANAL BIOANAL CHEM, V395, P1441, DOI 10.1007/s00216-009-3121-1; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Zhang G, 2012, INT J MOL MED, V30, P561, DOI 10.3892/ijmm.2012.1030; Zhang HX, 2004, ACTA PHARMACOL SIN, V25, P385; Zhang HX, 2003, NEUROL RES, V25, P471; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhang ZJ, 2006, BRAIN RES, V1123, P188, DOI 10.1016/j.brainres.2006.09.063; Zhang ZJ, 2012, BRAIN RES BULL, V87, P193, DOI 10.1016/j.brainresbull.2011.11.002; Zheng CY, 2008, J NEUROSCI RES, V86, P2432, DOI 10.1002/jnr.21681; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhou XM, 2006, BIOL PHARM BULL, V29, P2502, DOI 10.1248/bpb.29.2502; Zhu Xiao-lei, 2004, Zhongguo Zhongyao Zazhi, V29, P1065; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	85	14	19	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78902	10.1371/journal.pone.0078902	http://dx.doi.org/10.1371/journal.pone.0078902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236065	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700062
J	Bui, TVL; Ross, IL; Jakob, G; Hankamer, B				Bui, Tony V. L.; Ross, Ian L.; Jakob, Gisela; Hankamer, Ben			Impact of Procedural Steps and Cryopreservation Agents in the Cryopreservation of Chlorophyte Microalgae	PLOS ONE			English	Article							PORPHYRA-YEZOENSIS; DIMETHYL-SULFOXIDE; BIOFUEL PRODUCTION; EUKARYOTIC ALGAE; CHLAMYDOMONAS; VIABILITY; VITRIFICATION; CONSERVATION; CONCHOCELIS; CRYOINJURY	The maintenance of traditional microalgae collections based on liquid and solid media is labour intensive, costly and subject to contamination and genetic drift. Cryopreservation is therefore the method of choice for the maintenance of microalgae culture collections, but success is limited for many species. Although the mechanisms underlying cryopreservation are understood in general, many technical variations are present in the literature and the impact of these are not always elaborated. This study describes two-step cryopreservation processes in which 3 microalgae strains representing different cell sizes were subjected to various experimental approaches to cryopreservation, the aim being to investigate mechanistic factors affecting cell viability. Sucrose and dimethyl sulfoxide (DMSO) were used as cryoprotectants. They were found to have a synergistic effect in the recovery of cryopreserved samples of many algal strains, with 6.5% being the optimum DMSO concentration. The effect of sucrose was shown to be due to improved cell survival and recovery after thawing by comparing the effect of sucrose on cell viability before or after cryopreservation. Additional factors with a beneficial effect on recovery were the elimination of centrifugation steps (minimizing cell damage), the reduction of cell concentration (which is proposed to reduce the generation of toxic cell wall components) and the use of low light levels during the recovery phase (proposed to reduce photooxidative damage). The use of the best conditions for each of these variables yielded an improved protocol which allowed the recovery and subsequent improved culture viability of a further 16 randomly chosen microalgae strains. These isolates included species from Chlorellaceae, Palmellaceae, Tetrasporaceae, Palmellopsis, Scenedesmaceae and Chlamydomonadaceae that differed greatly in cell diameter (3-50 mu m), a variable that can affect cryopreservation success. The collective improvement of each of these parameters yielded a cryopreservation protocol that can be applied to a broad range of microalgae.	[Bui, Tony V. L.; Ross, Ian L.; Jakob, Gisela; Hankamer, Ben] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Hankamer, B (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.hankamer@imb.uq.edu.au	Hankamer, Ben D/C-9688-2015; Ross, Ian/A-8622-2011	Hankamer, Ben D/0000-0001-9284-4929; Ross, Ian/0000-0002-2389-4292	Australian Research Council (ARC) [LP0883380]	Australian Research Council (ARC)(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) (http://www.arc.gov.au) Grant LP0883380. A student scholarship for TB was also provided by the ARC. The role of the funders was solely to provide funding for the project and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand JJ, 2004, NOVA HEDWIGIA, V79, P175, DOI 10.1127/0029-5035/2004/0079-0175; Crutchfield ALM, 1999, EUR J PHYCOL, V34, P43; Day JG, 2004, NOVA HEDWIGIA, V79, P191, DOI 10.1127/0029-5035/2004/0079-0191; Day JG, 2000, J APPL PHYCOL, V12, P369, DOI 10.1023/A:1008107229005; Day JG, 1997, J APPL PHYCOL, V9, P121, DOI 10.1023/A:1007991507314; Day JG, 2010, TAXON, V59, P3, DOI 10.1002/tax.591001; DOEBBLER GF, 1966, CRYOBIOLOGY, V3, P2, DOI 10.1016/S0011-2240(66)80144-X; Entwisle JT, 1997, FRESHWATER ALGAE AUS; Fischer G, 2010, BIOMASS BIOENERG, V34, P173, DOI 10.1016/j.biombioe.2009.07.009; Fleck RA, 2006, CRYOBIOLOGY, V52, P261, DOI 10.1016/j.cryobiol.2005.12.003; Forster B, 2005, BBA-BIOENERGETICS, V1709, P45, DOI 10.1016/j.bbabio.2005.05.012; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harding K, 2004, NOVA HEDWIGIA, V79, P207, DOI 10.1127/0029-5035/2004/0079-0207; Harding K, 2008, CRYOLETTERS, V29, P15; Harris EH, 2009, CHLAMYDOMONAS SOURCE, V1; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jain JK, 2006, FERTIL STERIL, V86, P1037, DOI 10.1016/j.fertnstert.2006.07.1478; Jo HY, 2003, ALGAE, V18, P321; Kuji N, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P1001; KUWANO K, 1992, NIPPON SUISAN GAKK, V58, P1793; KUWANO K, 1993, PLANT SCI, V94, P215, DOI 10.1016/0168-9452(93)90022-R; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Nakanishi K, 2012, J APPL PHYCOL, V24, P1381, DOI 10.1007/s10811-012-9790-8; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Osorio HC, 2004, NOVA HEDWIGIA, V79, P227, DOI 10.1127/0029-5035/2004/0079-0227; Palasz AT, 1996, BIOTECHNOL ADV, V14, P127, DOI 10.1016/0734-9750(96)00005-5; Piasecki BP, 2009, CRYOBIOLOGY, V58, P103, DOI 10.1016/j.cryobiol.2008.11.001; SAKAI A, 1991, J PLANT PHYSIOL, V137, P465, DOI 10.1016/S0176-1617(11)80318-4; Schilling S, 2007, BIOCHEM J, V406, P325, DOI 10.1042/BJ20070448; SHIER WT, 1995, IN VITRO CELL DEV-AN, V31, P336, DOI 10.1007/BF02634280; Tanaka JY, 2001, CRYOBIOLOGY, V42, P286, DOI 10.1006/cryo.2001.2334; Taylor R, 1998, J APPL PHYCOL, V10, P481, DOI 10.1023/A:1008094622412; Weng LD, 2011, J CHEM ENG DATA, V56, P3175, DOI 10.1021/je2002607; Xie Y, 2010, J PLAST RECONSTR AES, V63, P482, DOI 10.1016/j.bjps.2008.11.056; YU ZW, 1994, BIOSCIENCE REP, V14, P259, DOI 10.1007/BF01199051; Zhang WJ, 2010, BIOMED MICRODEVICES, V12, P89, DOI 10.1007/s10544-009-9363-z	36	24	28	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78668	10.1371/journal.pone.0078668	http://dx.doi.org/10.1371/journal.pone.0078668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244336	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600045
J	Muller, C; Busignies, V; Mazel, V; Forestier, C; Nivoliez, A; Tchoreloff, P				Muller, Claudia; Busignies, Virginie; Mazel, Vincent; Forestier, Christiane; Nivoliez, Adrien; Tchoreloff, Pierre			Mechanistic Approach to Stability Studies as a Tool for the Optimization and Development of New Products Based on L. rhamnosus Lcr35 (R) in Compliance with Current Regulations	PLOS ONE			English	Article							LACTOBACILLUS-CASEI-RHAMNOSUS; PROBIOTIC BACTERIA; VIABILITY; TEMPERATURE; MODEL; PH	Probiotics are of great current interest in the pharmaceutical industry because of their multiple effects on human health. To beneficially affect the host, an adequate dosage of the probiotic bacteria in the product must be guaranteed from the time of manufacturing to expiration date. Stability test guidelines as laid down by the ICH-Q1A stipulate a minimum testing period of 12 months. The challenge for producers is to reduce this time. In this paper, a mechanistic approach using the Arrhenius model is proposed to predict stability. Applied for the first time to laboratory and industrial probiotic powders, the model was able to provide a reliable mathematical representation of the effects of temperature on bacterial death (R-2>0.9). The destruction rate (k) was determined according to the manufacturing process, strain and storage conditions. The marketed product demonstrated a better stability (k = 0.08 months(-1)) than the laboratory sample (k = 0.80 months(-1)). With industrial batches, k obtained at 6 months of studies was comparable to that obtained at 12 months, evidence of the model's robustness. In addition, predicted values at 12 months were greatly similar (+/- 30%) to those obtained by real-time assessing the model's reliability. This method could be an interesting approach to predict the probiotic stability and could reduce to 6 months the length of stability studies as against 12 (ICH guideline) or 24 months (expiration date).	[Muller, Claudia; Nivoliez, Adrien] Probionov, Dept Rech & Dev, Aurillac, France; [Muller, Claudia; Busignies, Virginie; Mazel, Vincent; Tchoreloff, Pierre] Univ Paris Sud, Lab Mat & Sante EA401, Chatenay Malabry, France; [Forestier, Christiane] Univ Auvergne Clermont 1, UMR CNRS 6023, LMGE, Clermont Ferrand, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Muller, C (corresponding author), Probionov, Dept Rech & Dev, Aurillac, France.	c.muller@probionov.com	Mazel, Vincent/AAJ-2156-2020		ANRT (Association Nationale Recherche Technologie)	ANRT (Association Nationale Recherche Technologie)(French National Research Agency (ANR))	This work was supported by a grant from ANRT (Association Nationale Recherche Technologie) supporting the PhD thesis performed by CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, GUIDELINES EVALUATIO; [Anonymous], 2003, CPMPICH273699 EUR ME; [Anonymous], 2009, CHMOICH16706804 EUR; BERNER D, 2006, SCI PHARM, V74, P137; Carvalho AS, 2004, INT DAIRY J, V14, P835, DOI 10.1016/j.idairyj.2004.02.001; Cerf O, 1996, FOOD RES INT, V29, P219, DOI 10.1016/0963-9969(96)00039-7; Chan ES, 2002, T ICHEM E C, V80; Coudeyras S, 2008, APPL ENVIRON MICROB, V74, P2679, DOI 10.1128/AEM.02286-07; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; DAVEY KR, 1993, J IND MICROBIOL, V12, P172, DOI 10.1007/BF01584187; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Forssten SD, 2011, ANAEROBE, V17, P410, DOI 10.1016/j.anaerobe.2011.04.014; Grzeskowiak L, 2010, BRIT J NUTR, P1; Jennison MW, 1940, J BACTERIOL, V39, P389, DOI 10.1128/JB.39.4.389-397.1940; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kaur IP, 2002, EUR J PHARM SCI, V15, P1, DOI 10.1016/S0928-0987(01)00209-3; Kosin B, 2006, FOOD TECHNOL BIOTECH, V44, P371; Koutsoumanis K, 2006, APPL ENVIRON MICROB, V72, P124, DOI 10.1128/AEM.72.1.124-134.2006; La Saponara V, 2011, COMPOS STRUCT, V93, P2180, DOI 10.1016/j.compstruct.2011.03.005; Madras G, 2001, CHEM ENG SCI, V56, P5085, DOI 10.1016/S0009-2509(01)00186-5; Makinen K, 2012, J BIOTECHNOL, V162, P356, DOI 10.1016/j.jbiotec.2012.07.006; Nivoliez A, 2012, J BIOTECHNOL, V160, P236, DOI 10.1016/j.jbiotec.2012.04.005; Oliveira MN, 2001, INT DAIRY J, V11, P935, DOI 10.1016/S0958-6946(01)00142-X; Ouwehand AC, 1998, INT DAIRY J, V8, P749, DOI 10.1016/S0958-6946(98)00114-9; Petricevic L, 2008, BJOG-INT J OBSTET GY, V115, P1369, DOI 10.1111/j.1471-0528.2008.01882.x; Quigley EMM, 2010, PHARMACOL RES, V61, P213, DOI 10.1016/j.phrs.2010.01.004; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Savini M, 2010, NUTRIENTS, V2, P330, DOI 10.3390/nu2030330; Scheinbach S, 1998, BIOTECHNOL ADV, V16, P581, DOI 10.1016/S0734-9750(98)00002-0; SLATER JG, 1979, J PHARM SCI, V68, P49, DOI 10.1002/jps.2600680117; Sutton S., 2011, J VALID TECHNOL, V17, P42; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Waterman KC, 2005, INT J PHARMACEUT, V293, P101, DOI 10.1016/j.ijpharm.2004.12.013; Waterman KC, 2011, AAPS PHARMSCITECH, V12, P932, DOI 10.1208/s12249-011-9657-3; Zarate G, 2006, PROCESS BIOCHEM, V41, P1779, DOI 10.1016/j.procbio.2006.03.024	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79041	10.1371/journal.pone.0079041	http://dx.doi.org/10.1371/journal.pone.0079041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244412	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600099
J	Tanabe, N; Hoshino, Y; Marumo, S; Kiyokawa, H; Sato, S; Kinose, D; Uno, K; Muro, S; Hirai, T; Yodoi, J; Mishima, M				Tanabe, Naoya; Hoshino, Yuma; Marumo, Satoshi; Kiyokawa, Hirofumi; Sato, Susumu; Kinose, Daisuke; Uno, Kazuko; Muro, Shigeo; Hirai, Toyohiro; Yodoi, Junji; Mishima, Michiaki			Thioredoxin-1 Protects against Neutrophilic Inflammation and Emphysema Progression in a Mouse Model of Chronic Obstructive Pulmonary Disease Exacerbation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AIRWAY INFLAMMATION; INNATE IMMUNE; CT-SCAN; LUNG; RESPONSES; COPD; GLUCOCORTICOIDS; PHOSPHATASE-1; DEXAMETHASONE	Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are characterized by acute enhancement of airway neutrophilic inflammation under oxidative stress and can be involved in emphysema progression. However, pharmacotherapy against the neutrophilic inflammation and emphysema progression associated with exacerbation has not been established. Thioredoxin-1 has anti-oxidative and anti-inflammatory properties and it can ameliorate neutrophilic inflammation through anti-chemotactic effects and prevent cigarette smoke (CS)-induced emphysema. We aimed to determine whether thioredoxin-1 can suppress neutrophilic inflammation and emphysema progression in a mouse model of COPD exacerbation and if so, to reveal the underlying mechanisms. Results: Mice were exposed to CS and then challenged with polyinosine-polycytidylic acid [poly(I: C)], an agonist for virus-induced innate immunity. Airway neutrophilic inflammation, oxidative stress and lung apoptosis were enhanced in smoke-sensitive C57Bl/6, but not in smoke-resistant NZW mice. Exposure to CS and poly(I:C) challenge accelerated emphysema progression in C57Bl/6 mice. Thioredoxin-1 suppressed neutrophilic inflammation and emphysema progression. Poly(I:C) caused early neutrophilic inflammation through keratinocyte-derived chemokine and granulocyte-macrophage colony-stimulating factor (GM-CSF) release in the lung exposed to CS. Late neutrophilic inflammation was caused by persistent GMCSF release, which thioredoxin-1 ameliorated. Thioredoxin-1 enhanced pulmonary mRNA expression of MAP kinase phosphatase 1 (MKP-1), and the suppressive effects of thioredoxin-1 on prolonged GM-CSF release and late neutrophilic inflammation disappeared by inhibiting MKP-1. Conclusion: Using a mouse model of COPD exacerbation, we demonstrated that thioredoxin-1 ameliorated neutrophilic inflammation by suppressing GM-CSF release, which prevented emphysema progression. Our findings deepen understanding of the mechanisms underlying the regulation of neutrophilic inflammation by thioredoxin-1 and indicate that thioredoxin-1 could have potential as a drug to counteract COPD exacerbation.	[Tanabe, Naoya; Hoshino, Yuma; Marumo, Satoshi; Kiyokawa, Hirofumi; Sato, Susumu; Kinose, Daisuke; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 606, Japan; [Yodoi, Junji] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul, South Korea; [Yodoi, Junji] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	Kyoto University; Kyoto University; Ewha Womans University; Ewha Womans University	Hoshino, Y (corresponding author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan.	yuma@kuhp.kyoto-u.ac.jp	Sato, Susumu/R-8976-2019		National Institute of Biomedical Innovation, Japan; World Class University through Ewha Womans University [R31-10010]	National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); World Class University through Ewha Womans University	This work was supported by the Program for the Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation, Japan and by the World Class University Grant R31-10010 through the Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hoshino Y, 2007, AM J RESP CELL MOL, V37, P438, DOI 10.1165/rcmb.2006-0402OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Mercer PF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-151; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sato A, 2008, J PHARMACOL EXP THER, V325, P380, DOI 10.1124/jpet.107.134007; Sato A, 2007, P NATL ACAD SCI USA, V104, P2361, DOI 10.1073/pnas.0607882104; Sato A, 2006, ANTIOXID REDOX SIGN, V8, P1891, DOI 10.1089/ars.2006.8.1891; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Son A, 2009, ANTIOXID REDOX SIGN, V11, P2595, DOI [10.1089/ars.2009.2522, 10.1089/ARS.2009.2522]; TAGAYA Y, 1994, EMBO J, V13, P2244, DOI 10.1002/j.1460-2075.1994.tb06502.x; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Ueda S, 2006, LIFE SCI, V79, P1170, DOI 10.1016/j.lfs.2006.03.026; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Yodoi J, 1987, Adv Exp Med Biol, V213, P139	49	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79016	10.1371/journal.pone.0079016	http://dx.doi.org/10.1371/journal.pone.0079016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244404	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600094
J	Wahlin, KJ; Enke, RA; Fuller, JA; Kalesnykas, G; Zack, DJ; Merbs, SL				Wahlin, Karl J.; Enke, Raymond A.; Fuller, John A.; Kalesnykas, Giedrius; Zack, Donald J.; Merbs, Shannath L.			Epigenetics and Cell Death: DNA Hypermethylation in Programmed Retinal Cell Death	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; RD1 MOUSE; DEGENERATING PHOTORECEPTORS; TERMINAL DIFFERENTIATION; CHICK-EMBRYO; IN-SITU; METHYLATION; ACTIVATION; 5-HYDROXYMETHYLCYTOSINE; CASPASE-3	Background: Vertebrate genomes undergo epigenetic reprogramming during development and disease. Emerging evidence suggests that DNA methylation plays a key role in cell fate determination in the retina. Despite extensive studies of the programmed cell death that occurs during retinal development and degeneration, little is known about how DNA methylation might regulate neuronal cell death in the retina. Methods: The developing chicken retina and the rd1 and rhodopsin-GFP mouse models of retinal degeneration were used to investigate programmed cell death during retinal development and degeneration. Changes in DNA methylation were determined by immunohistochemistry using antibodies against 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). Results: Punctate patterns of hypermethylation paralleled patterns of caspase3-dependent apoptotic cell death previously reported to occur during development in the chicken retina. Degenerating rd1 mouse retinas, at time points corresponding to the peak of rod cell death, showed elevated signals for 5mC and 5hmC in photoreceptors throughout the retina, with the most intense staining observed in the peripheral retina. Hypermethylation of photoreceptors in rd1 mice was associated with TUNEL and PAR staining and appeared to be cCaspase3-independent. After peak rod degeneration, during the period of cone death, occasional hypermethylation was observed in the outer nuclear layer. Conclusion: The finding that cell-specific increases of 5mC and 5hmC immunostaining are associated with the death of retinal neurons during both development and degeneration suggests that changes in DNA methylation may play a role in modulating gene expression during the process of retinal degeneration. During retinal development, hypermethylation of retinal neurons associates with classical caspase-dependent apoptosis as well as caspase-3 independent cell death, while hypermethylation in the rd1 mouse photoreceptors is primarily associated with caspase-3 independent programmed cell death. These findings suggest a previously unrecognized role for epigenetic mechanisms in the onset and/or progression of programed cell death in the retina.	[Wahlin, Karl J.; Fuller, John A.; Zack, Donald J.; Merbs, Shannath L.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Kalesnykas, Giedrius] Univ Eastern Finland, Sch Med, Clin Res Unit, Dept Ophthalmol, Kuopio, Finland; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France; [Enke, Raymond A.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Eastern Finland; UDICE-French Research Universities; Sorbonne Universite; James Madison University	Merbs, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	smerbs@jhmi.edu	Kalesnykas, Giedrius/AAG-4084-2021	Zack, Don/0000-0002-7966-1973; Enke, Raymond/0000-0002-3605-2107; Fuller, John/0000-0002-6587-146X; Wahlin, Karl/0000-0002-0494-8304	National Eye Institute [R21EY018703, R01EY009769]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY018703, T32EY007143, R01EY009769] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Eye Institute (R21EY018703 to S. L. M, and R01EY009769 to D.J.Z.), unrestricted funding from the Research to Prevent Blindness and generous gifts from A. Nixon, the Guerrieri Family Foundation, and Mr. and Mrs. Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Borsello T, 2002, J COMP NEUROL, V453, P361, DOI 10.1002/cne.10411; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chavarria T, 2007, DEV NEUROBIOL, V67, P1777, DOI 10.1002/dneu.20554; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cook B, 1998, J COMP NEUROL, V396, P12, DOI 10.1002/(SICI)1096-9861(19980622)396:1<12::AID-CNE2>3.0.CO;2-L; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Doonan F, 2003, J NEUROSCI, V23, P5723; Fard SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059133; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garnier P, 2003, J NEUROSCI, V23, P7967; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kim DH, 2002, OPHTHALMIC RES, V34, P150, DOI 10.1159/000063659; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LAVAIL MM, 1974, ARCH OPHTHALMOL-CHIC, V91, P394; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mayordomo R, 2003, EUR J NEUROSCI, V18, P1744, DOI 10.1046/j.1460-9568.2003.02891.x; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Merbs SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032602; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Nasonkin IO, 2013, DEVELOPMENT, V140, P1330, DOI 10.1242/dev.086603; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Petkova TD, 2011, VISION RES, V51, P260, DOI 10.1016/j.visres.2010.09.022; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Ragoczy T, 2009, CELL, V137, P205, DOI 10.1016/j.cell.2009.04.006; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rhee KD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.165; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Valenciano AI, 2009, INT J DEV BIOL, V53, P1515, DOI 10.1387/ijdb.072446av; Wahlin KJ, 2008, J COMP NEUROL, V506, P822, DOI 10.1002/cne.21582; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P964, DOI 10.1167/iovs.03-0439; Zencak D, 2013, P NATL ACAD SCI USA, V110, pE593, DOI 10.1073/pnas.1108297110; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440	62	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79140	10.1371/journal.pone.0079140	http://dx.doi.org/10.1371/journal.pone.0079140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244436	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600112
J	Wang, F; Hou, HY; Xu, LQ; Jane, M; Peng, J; Lu, YJ; Zhu, YW; Sun, ZY				Wang, Feng; Hou, Hongyan; Xu, Lingqing; Jane, Munanie; Peng, Jing; Lu, Yanjun; Zhu, Yaowu; Sun, Ziyong			Mycobacterium Tuberculosis-Specific TNF-alpha Is a Potential Biomarker for the Rapid Diagnosis of Active Tuberculosis Disease in Chinese Population	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; INFECTION; HIV; RESPONSES; CYTOKINE	Interferon-gamma release assays (IGRAs) have proven to be useful to accurately detect Mycobacterium tuberculosis (Mtb) infection, but they cannot reliably discriminate between active tuberculosis (TB) and latent tuberculosis infection (LTBI). This study aims to test whether Mtb-specific tumor necrosis factor-alpha (TNF-alpha) could be used as a new tool for the rapid diagnosis of active TB disease. The secretion of TNF-alpha by Mtb-specific antigen-stimulated peripheral blood mononuclear cells (PBMCs) of sixty seven participants was investigated in the study. Our results showed that the total measurement of TNF-alpha secretion by Mtb-specific antigen-stimulated PBMCs is not a good biomarker for active TB diagnosis. However, we found that calculation of Mtb-specific TNF-alpha not only distinguish between active and latent TB infection, but also can differentiate active TB from non-TB patients. Using the cutoff value of 136.9 pg/ml for Mtb-specific TNF-alpha, we were able to differentiate active TB from LTBI. Sensitivity and specificity were 72% and 90.91%. These data suggest that Mtb-specific TNF-alpha could be a potential biomarker for the diagnosis of active TB disease.	[Wang, Feng; Hou, Hongyan; Xu, Lingqing; Jane, Munanie; Peng, Jing; Lu, Yanjun; Zhu, Yaowu; Sun, Ziyong] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Sun, ZY (corresponding author), Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	tjszyong@163.com			Ministry of Health of China [2012zx10004-207]	Ministry of Health of China	This work was supported by the Infectious Diseases Control Project from Ministry of Health of China (2012zx10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatidou V, 2012, EUR J CLIN MICROBIOL, V31, P1285, DOI 10.1007/s10096-011-1524-3; Anandaiah A, 2011, AM J RESP CRIT CARE, V183, P987, DOI 10.1164/rccm.201008-1246CI; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chiappini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046041; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Farnia P, 2002, J CLIN MICROBIOL, V40, P508, DOI 10.1128/JCM.40.2.508-511.2002; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Kupli E, 2008, RESPIRATION, V75, P73, DOI 10.1159/000110744; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Loddenkemper R, 2010, DTSCH ARZTEBL INT, V107, P10, DOI 10.3238/arztebl.2010.0010; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Milburn H, 2007, J ROY SOC MED, V100, P134, DOI 10.1258/jrsm.100.3.134; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Tahhan M, 2003, RESPIRATION, V70, P270, DOI 10.1159/000072008; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tincati Camilla, 2012, Cells, V1, P89, DOI 10.3390/cells1020089	23	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79431	10.1371/journal.pone.0079431	http://dx.doi.org/10.1371/journal.pone.0079431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244502	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600131
J	Klusza, S; Novak, A; Figueroa, S; Palmer, W; Deng, WM				Klusza, Stephen; Novak, Amanda; Figueroa, Shirelle; Palmer, William; Deng, Wu-Min			Prp22 and Spliceosome Components Regulate Chromatin Dynamics in Germ-Line Polyploid Cells	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; EXON JUNCTION COMPLEX; BOX RNA HELICASE; CHROMOSOME TERRITORY ORGANIZATION; MESSENGER-RNA; DROSOPHILA OOGENESIS; SPLICING FACTOR; RIBOSOME BIOGENESIS; NURSE CELLS; SEX-LETHAL	During Drosophila oogenesis, the endopolyploid nuclei of germ-line nurse cells undergo a dramatic shift in morphology as oogenesis progresses; the easily-visible chromosomes are initially polytenic during the early stages of oogenesis before they transiently condense into a distinct '5-blob' configuration, with subsequent dispersal into a diffuse state. Mutations in many genes, with diverse cellular functions, can affect the ability of nurse cells to fully decondense their chromatin, resulting in a '5-blob arrest' phenotype that is maintained throughout the later stages of oogenesis. However, the mechanisms and significance of nurse-cell (NC) chromatin dispersal remain poorly understood. Here, we report that a screen for modifiers of the 5-blob phenotype in the germ line isolated the spliceosomal gene peanuts, the Drosophila Prp22. We demonstrate that reduction of spliceosomal activity through loss of peanuts promotes decondensation defects in NC nuclei during mid-oogenesis. We also show that the Prp38 spliceosomal protein accumulates in the nucleoplasm of nurse cells with impaired peanuts function, suggesting that spliceosomal recycling is impaired. Finally, we reveal that loss of additional spliceosomal proteins impairs the full decondensation of NC chromatin during later stages of oogenesis, suggesting that individual spliceosomal subcomplexes modulate expression of the distinct subset of genes that are required for correct morphology in endopolyploid nurse cells.	[Klusza, Stephen; Novak, Amanda; Figueroa, Shirelle; Palmer, William; Deng, Wu-Min] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Deng, WM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	wumin@bio.fsu.edu	Klusza, Stephen/HGA-8857-2022	Klusza, Stephen/0000-0003-0943-1846; Palmer, William/0000-0002-0348-6339	National Institutes of Health (NIH) [R01 GM072562]; National Science Foundation [IOS-1052333]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072562, R01GM084947] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01 GM072562 (http://www.nih.gov) and National Science Foundation Grant IOS-1052333 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Andersen DS, 2008, J BIOL CHEM, V283, P31256, DOI 10.1074/jbc.M803512200; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Ashton-Beaucage D, 2011, FLY, V5, P224, DOI 10.4161/fly.5.3.15569; Bauer CR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002873; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Caceres L, 2005, DEVELOPMENT, V132, P2345, DOI 10.1242/dev.01820; CASTRILLON DH, 1993, GENETICS, V135, P489; Cauchi Ruben J, 2012, BMC Res Notes, V5, P120, DOI 10.1186/1756-0500-5-120; Cauchi RJ, 2010, EXP CELL RES, V316, P2354, DOI 10.1016/j.yexcr.2010.05.001; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Clelland AK, 2012, J CELL SCI, V125, P2626, DOI 10.1242/jcs.096867; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Dej KJ, 1999, DEVELOPMENT, V126, P293; Deng WM, 2000, CURR BIOL, V10, P683, DOI 10.1016/S0960-9822(00)00514-5; Deng WM, 2001, DEVELOPMENT, V128, P4737; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Glenn LE, 2001, MECH DEVELOP, V102, P181, DOI 10.1016/S0925-4773(01)00314-8; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Guasconi V, 2005, CANCER BIOL THER, V4, P134; Harnicarova A, 2006, EXP CELL RES, V312, P4019, DOI 10.1016/j.yexcr.2006.09.007; Hartl TA, 2008, SCIENCE, V322, P1384, DOI 10.1126/science.1164216; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Koncz C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00009; Koryakov DE, 2004, METH MOL B, V247, P139; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Lee L, 2009, DEV BIOL, V332, P142, DOI 10.1016/j.ydbio.2009.05.553; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Li CX, 2010, MOL BIOL REP, V37, P2347, DOI 10.1007/s11033-009-9740-y; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; McPheeters DS, 2000, NUCLEIC ACIDS RES, V28, P1313, DOI 10.1093/nar/28.6.1313; Mewborn SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014342; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Mitchell NC, 2010, DEVELOPMENT, V137, P2875, DOI 10.1242/dev.049585; Murata S, 2007, THYROID, V17, P489, DOI 10.1089/thy.2006.0328; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; Nagengast AA, 2001, NUCLEIC ACIDS RES, V29, P3841, DOI 10.1093/nar/29.18.3841; Ogienko A A, 2007, Genetika, V43, P1341; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; ONO W, 1994, MOL CELL BIOL, V14, P7611, DOI 10.1128/MCB.14.11.7611; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Salz HK, 2004, GENETICS, V168, P2059, DOI 10.1534/genetics.104.032532; Salz HK, 1996, GENETICS, V144, P95; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; STEINHAUER WR, 1992, GENE DEV, V6, P233, DOI 10.1101/gad.6.2.233; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4	70	3	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79048	10.1371/journal.pone.0079048	http://dx.doi.org/10.1371/journal.pone.0079048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244416	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900032
J	Zaganjor, E; Osborne, JK; Weil, LM; Diaz-Martinez, LA; Gonzales, JX; Singel, SM; Larsen, JE; Girard, L; Minna, JD; Cobb, MH				Zaganjor, E.; Osborne, J. K.; Weil, L. M.; Diaz-Martinez, L. A.; Gonzales, J. X.; Singel, S. M.; Larsen, J. E.; Girard, L.; Minna, J. D.; Cobb, M. H.			Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells	ONCOGENE			English	Article						kinesin; K-Ras; MAPK; ERK; microtubules	ACTIVATED PROTEIN-KINASE; SUPERFAMILY PROTEIN; MEDIATED TRANSFORMATION; MORPHOLOGICAL-CHANGES; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CANCER-CELLS; LUNG-CANCER; K-RAS	We show that expression of the microtubule depolymerizing kinesin KIF2C is induced by transformation of immortalized human bronchial epithelial cells (HBEC) by expression of K-Ras(G12V) and knockdown of p53. Further investigation demonstrates that this is due to the K-Ras/ERK1/2 MAPK pathway, as loss of p53 had little effect on KIF2C expression. In addition to KIF2C, we also found that the related kinesin KIF2A is modestly upregulated in this model system; both proteins are expressed more highly in many lung cancer cell lines compared to normal tissue. As a consequence of their depolymerizing activity, these kinesins increase dynamic instability of microtubules. Depletion of either of these kinesins impairs the ability of cells transformed with mutant K-Ras to migrate and invade matrigel. However, depletion of these kinesins does not reverse the epithelial to mesenchymal transition (EMT) caused by mutant K-Ras. Our studies indicate that increased expression of microtubule destabilizing factors can occur during oncogenesis to support enhanced migration and invasion of tumor cells.	[Zaganjor, E.; Osborne, J. K.; Weil, L. M.; Diaz-Martinez, L. A.; Gonzales, J. X.; Girard, L.; Minna, J. D.; Cobb, M. H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Singel, S. M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Larsen, J. E.; Girard, L.; Minna, J. D.] Hamon Canc Ctr Therapeut Oncol Res, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu	Larsen, Jill E/G-3787-2010	Larsen, Jill E/0000-0001-7806-3931; Cobb, Melanie/0000-0003-0833-5473; Diaz-Martinez, Laura/0000-0002-7226-7068	National Institutes of Health [R37 DK34128, P50CA70907]; Cancer Prevention and Research Institute of Texas (CPRIT); DOD PROSPECT; Longenbaugh Foundation; Robert A. Welch Foundation [I1243]; NIGMS Pharmacological Sciences Training Grant [5-T32 GM007062]; NHMRC Biomedical Fellowship [494511]; TSANZ/Allen & Hanburys Respiratory Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA142543, P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); DOD PROSPECT; Longenbaugh Foundation; Robert A. Welch Foundation(The Welch Foundation); NIGMS Pharmacological Sciences Training Grant; NHMRC Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); TSANZ/Allen & Hanburys Respiratory Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andres Lorente-Rodriguez and Michael Kalwat in the Cobb lab for comments and suggestions and Dionne Ware for administrative assistance. This work was supported by grants from the National Institutes of Health (R37 DK34128 to MHC and P50CA70907 to JDM), grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to JDM, DOD PROSPECT and Longenbaugh Foundation to JDM, and the Robert A. Welch Foundation I1243 to MHC. JKO was supported by NIGMS Pharmacological Sciences Training Grant 5-T32 GM007062. JEL was supported by NHMRC Biomedical Fellowship (494511)TSANZ/Allen & Hanburys Respiratory Research Fellowship.	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Fotiadou PP, 2007, MOL CELL BIOL, V27, P6742, DOI 10.1128/MCB.00234-07; Fukazawa H, 2000, CANCER RES, V60, P2104; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Groth-Pedersen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045381; Harrison RE, 2001, NEOPLASIA, V3, P385, DOI 10.1038/sj.neo.7900180; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; LIAO GJ, 1995, J CELL SCI, V108, P3473; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Maor-Nof M, 2013, CELL REP, V3, P971, DOI 10.1016/j.celrep.2013.03.005; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Olsen MK, 1998, J CELL PHYSIOL, V176, P525, DOI 10.1002/(SICI)1097-4652(199809)176:3<525::AID-JCP9>3.0.CO;2-Q; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P10499, DOI 10.1073/pnas.95.18.10499; Tanuma N, 2009, ONCOGENE, V28, P752, DOI 10.1038/onc.2008.431; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wang CQ, 2010, ORAL ONCOL, V46, P65, DOI 10.1016/j.oraloncology.2009.11.003; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	57	20	20	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5457	5466		10.1038/onc.2013.486	http://dx.doi.org/10.1038/onc.2013.486			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240690	Green Accepted			2022-12-25	WOS:000345120700008
J	Ju, R; Zhuang, ZW; Zhang, JS; Lanahan, AA; Kyriakides, T; Sessa, WC; Simons, M				Ju, Rong; Zhuang, Zhen W.; Zhang, Jiasheng; Lanahan, Anthony A.; Kyriakides, Themis; Sessa, William C.; Simons, Michael			Angiopoietin-2 Secretion by Endothelial Cell Exosomes REGULATION BY THE PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/Akt/ENDOTHELIAL NITRIC OXIDE SYNTHASE (eNOS) AND SYNDECAN-4/SYNTENIN PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Endothelium; Exocytosis; Exosomes; Vascular Biology	PDZ PROTEIN; PKC-ALPHA; TIE2; ANGIOGENESIS; HOMEOSTASIS; ACTIVATION; SYNTENIN; PATHWAY; LIGAND	Angiopoietin-2 (Ang2) is an extracellular protein and one of the principal ligands of Tie2 receptor that is involved in the regulation of vascular integrity, quiescence, and inflammation. The mode of secretion of Ang2 has never been established, however. Here, we provide evidence that Ang2 is secreted from endothelial cells via exosomes and that this process is inhibited by the PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway, whereas it is positively regulated by the syndecan-4/syntenin pathway. Vascular defects in Akt1 null mice arise, in part, because of excessive Ang2 secretion and can be rescued by the syndecan-4 knock-out that reduces extracellular Ang2 levels. This novel mechanism connects three critical signaling pathways: angiopoietin/Tie2, PI3K/Akt/eNOS, and syndecan/syntenin, which play important roles in vascular growth and stabilization.	[Ju, Rong; Zhuang, Zhen W.; Zhang, Jiasheng; Lanahan, Anthony A.; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovasc Med, New Haven, CT 06520 USA; [Kyriakides, Themis] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Simons, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovasc Med, 300 Cedar St, New Haven, CT 06520 USA.	michael.simons@yale.edu	Sessa, William C/B-6844-2011; Simons, Michael/G-8553-2014	Sessa, William C/0000-0001-5759-1938; Simons, Michael/0000-0003-0348-7734	National Institutes of Health [R01 HL062289, PO1 HL107205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289, P01HL107205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants R01 HL062289 (to M. S.) and PO1 HL107205 (to M. S., T. K., and W. C. S.)	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Ju R, 2013, CELL SIGNAL, V25, P101, DOI 10.1016/j.cellsig.2012.09.007; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang MX, 2010, CARDIOVASC RES, V88, P424, DOI 10.1093/cvr/cvq217; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Tsigkos S, 2006, J CELL PHYSIOL, V207, P506, DOI 10.1002/jcp.20592; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	33	65	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					510	519		10.1074/jbc.M113.506899	http://dx.doi.org/10.1074/jbc.M113.506899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235146	hybrid, Green Published			2022-12-25	WOS:000329370900043
J	Park, MH; Park, JY; Lee, HJ; Kim, DH; Park, D; Jeong, HO; Park, CH; Chun, P; Moon, HR; Chung, HY				Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chun, Pusoon; Moon, Hyung Ryong; Chung, Hae Young			Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR alpha/gamma Dual Agonist in db/db Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROLIFERATOR-ACTIVATED RECEPTORS; OBESE ZUCKER RATS; INSULIN-RESISTANCE; METABOLIC ABNORMALITIES; DIABETES-MELLITUS; FATTY LIVER; GAMMA; ALPHA; LEPTIN	Peroxisome proliferator-activated receptor (PPAR) alpha/gamma dual agonists have been developed to alleviate metabolic disorders and have the potential to be used as therapeutic agents for the treatment of type 2 diabetes. In this study, we investigated the effects of a newly synthesized PPAR alpha/gamma dual agonist, 2-[4-(5-chlorobenzo [d] thiazol-2-yl) phenoxy]-2-methylpropanoic acid (MHY908) on type 2 diabetes in vitro and in vivo. To obtain initial evidence that MHY908 acts as a PPAR alpha/gamma dual agonist, ChIP and reporter gene assays were conducted in AC2F rat liver cells, and to investigate the anti-diabetic effects and molecular mechanisms, eight-week-old, male db/db mice were allowed to eat ad libitum, placed on calorie restriction, or administered MHY908 (1 mg or 3 mg/kg/day) mixed in food for 4 weeks. Age-matched male db/m lean mice served as non-diabetic controls. It was found that MHY908 enhanced the binding and transcriptional activity of PPAR alpha and gamma in AC2F cells, and it reduced serum glucose, triglyceride, and insulin levels, however increased adiponectin levels without body weight gain. In addition, MHY908 significantly improved hepatic steatosis by enhancing CPT-1 levels. Remarkably, MHY908 reduced endoplasmic reticulum (ER) stress and c-Jun N-terminal kinase (JNK) activation in the livers of db/db mice, and subsequently reduced insulin resistance. The study shows MHY908 has beneficial effects on type 2 diabetes by simultaneously activating PPAR alpha/gamma and improving ER stress, and suggests that MHY908 could have a potent anti-diabetic effect as a PPAR alpha/gamma dual agonist, and potential for the treatment of type 2 diabetes.	[Park, Min Hi; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging intervent MRCA, Coll Pharm, Pusan, South Korea; [Park, Min Hi; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chung, Hae Young] Pusan Natl Univ, Biochem Lab, Pusan, South Korea; [Park, Ji Young; Lee, Hye Jin; Moon, Hyung Ryong] Pusan Natl Univ, Med Chem Lab, Coll Pharm, Pusan, South Korea; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Inje University	Moon, HR (corresponding author), Pusan Natl Univ, Med Chem Lab, Coll Pharm, Pusan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020	Park, Daeui/0000-0002-9452-5849	National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, no. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdella NA, 2005, DIABETIC MED, V22, P278, DOI 10.1111/j.1464-5491.2004.01405.x; Bailey C J, 2001, Curr Diab Rep, V1, P119, DOI 10.1007/s11892-001-0023-9; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chakrabarti R, 2003, BRIT J PHARMACOL, V140, P527, DOI 10.1038/sj.bjp.0705463; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen W, 2009, BRIT J PHARMACOL, V157, P724, DOI 10.1111/j.1476-5381.2009.00231.x; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Fagerberg B, 2005, DIABETOLOGIA, V48, P1716, DOI 10.1007/s00125-005-1846-8; Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972; Harrity T, 2006, DIABETES, V55, P240, DOI 10.2337/diabetes.55.01.06.db05-0648; Hegarty BD, 2004, ENDOCRINOLOGY, V145, P3158, DOI 10.1210/en.2004-0260; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Kolaczynski JW, 1996, J CLIN ENDOCR METAB, V81, P4162, DOI 10.1210/jc.81.11.4162; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Ljung B, 2002, J LIPID RES, V43, P1855, DOI 10.1194/jlr.M200127-JLR200; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muoio DM, 2004, SCIENCE, V306, P425, DOI 10.1126/science.1104680; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Oakes ND, 2005, AM J PHYSIOL-REG I, V289, pR938, DOI 10.1152/ajpregu.00252.2005; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pickavance LC, 2005, BRIT J PHARMACOL, V144, P308, DOI 10.1038/sj.bjp.0706041; Reifel-Miller A, 2005, MOL ENDOCRINOL, V19, P1593, DOI 10.1210/me.2005-0015; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; SILVERMAN JF, 1989, PATHOL ANNU, V24, P275; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe S, 2003, J BONE MINER METAB, V21, P166, DOI 10.1007/s007740300026; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yajima K, 2003, AM J PHYSIOL-ENDOC M, V284, pE966, DOI 10.1152/ajpendo.00149.2002; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	40	23	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78815	10.1371/journal.pone.0078815	http://dx.doi.org/10.1371/journal.pone.0078815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244369	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800019
J	Chen, XF; Qiu, JR; Yang, DP; Lu, JL; Yan, CY; Zha, XM; Yin, YM				Chen, Xiaofeng; Qiu, Jinrong; Yang, Dapeng; Lu, Jianlei; Yan, Caiyun; Zha, Xiaoming; Yin, Yongmei			MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9	PLOS ONE			English	Article							CANCER METASTASIS; EXPRESSION; TUMOR; ACTIVATION; P53; GENE; ONCOGENE; PATHWAY; DOMAIN; CELLS	The molecular mechanisms that underpin invasive ductal breast cancer (IDC) invasion and metastasis are incompletely understood. The oncogene, mouse double minute 2 (MDM2), has been implicated in the pathogenesis of numerous cancers, where it stimulates the expression of matrix metalloproteinase 9 (MMP9), an important enzyme in the breakdown of the extracellular matrix. However, its role in breast cancer remains poorly understood. This study assessed the clinical significance of MDM2 expression in IDC and used in vitro expression assays to determine the molecular roles of MDM2. Immunohistochemical staining for MMP9 and MDM2 was performed using archived tumor blocks from 321 women who underwent surgical resection for IDC at the First Affiliated Hospital of Nanjing Medical University, China between January 2002 and December 2003. MCF-7 and MDA-MD-231 cell lines were transfected with siRNA targeted against MDM2, or MDM2 was overexpressed using transiently expressed vectors. The invasion, cell migration and proteolytic capabilities of cells that over-or underexpressed MDM2 was then assessed and compared against control cells, in addition to the consequent effects on MMP9 expression using RT-PCR. In vivo, 54.9% and 49.6% of samples were positive for MMP9 and MDM2 expression, respectively, and their expression was significantly correlated (r(2) = 0.171, P = 0.012). Moreover, MDM2 expression was markedly correlated with disease-free survival (HR 2.56, 95% CI 1.02-6.40, P = 0.038). In vitro, MDM2 overexpression significantly enhanced cell invasion, migration and proteolysis compared with control cells, and the converse effects were observed after MDM2-siRNA treatment. MDM2 overexpression induced MMP9 expression in a dose-dependent manner. Taken together, these results suggest that high levels of MDM2 are associated with a poorer prognosis in IDC. This might result from increased tumor invasiveness due to enhanced MMP9 expression causing increased extracellular matrix breakdown.	[Chen, Xiaofeng; Qiu, Jinrong; Yan, Caiyun; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Yang, Dapeng; Lu, Jianlei] Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China; [Zha, Xiaoming] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zha, XM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	zhaxm@medmail.com.cn; ym.yin@hotmail.com			Jiangsu province clinical science and technology projects (clinical research center) [BL 2012008]; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China [81172503]; Jiangsu healthy major project [RC01153]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu province clinical science and technology projects (clinical research center); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu healthy major project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the following Programs: Jiangsu province clinical science and technology projects (clinical research center, BL 2012008); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China (81172503); Jiangsu healthy major project (RC01153); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Carvalho ST, 2011, CLINICS, V66, P607, DOI 10.1590/S1807-59322011000400014; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chau NM, 2004, BREAST CANCER RES, V6, P55, DOI 10.1186/bcr739; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Farina AR, 2002, CELL GROWTH DIFFER, V13, P343; Farina AR, 1998, INT J CANCER, V75, P721; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Guarneri V, 2009, ONCOLOGIST, V14, P645, DOI 10.1634/theoncologist.2009-0078; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jiang Y, 2002, CANCER RES, V62, P1910; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; MACKAY AR, 1992, INVAS METAST, V12, P168; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rayburn ER, 2009, ANTI-CANCER AGENT ME, V9, P882, DOI 10.2174/187152009789124628; Shi W, 2011, MOL CELL BIOCHEM; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vernon AE, 2007, REV ENDOCR METAB DIS, V8, P199, DOI 10.1007/s11154-007-9041-5; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com	42	19	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78794	10.1371/journal.pone.0078794	http://dx.doi.org/10.1371/journal.pone.0078794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236052	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700049
J	Dupuy, A; Valton, J; Leduc, S; Armier, J; Galetto, R; Gouble, A; Lebuhotel, C; Stary, A; Paques, F; Duchateau, P; Sarasin, A; Daboussi, F				Dupuy, Aurelie; Valton, Julien; Leduc, Sophie; Armier, Jacques; Galetto, Roman; Gouble, Agnes; Lebuhotel, Celine; Stary, Anne; Paques, Frederic; Duchateau, Philippe; Sarasin, Alain; Daboussi, Fayza			Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALEN (TM)	PLOS ONE			English	Article							INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; DOUBLE-STRAND BREAKS; GROUP-C; DNA-REPAIR; DAMAGE; EXPRESSION; CONVERSION; PROTEIN	Xeroderma pigmentosum group C (XP-C) is a rare human syndrome characterized by hypersensitivity to UV light and a dramatic predisposition to skin neoplasms. XP-C cells are deficient in the nucleotide excision repair (NER) pathway, a complex process involved in the recognition and removal of DNA lesions. Several XPC mutations have been described, including a founder mutation in North African patients involving the deletion of a TG dinucleotide (Delta TG) located in the middle of exon 9. This deletion leads to the expression of an inactive truncated XPC protein, normally involved in the first step of NER. New approaches used for gene correction are based on the ability of engineered nucleases such as Meganucleases, Zinc-Finger nucleases or TALE nucleases to accurately generate a double strand break at a specific locus and promote correction by homologous recombination through the insertion of an exogenous DNA repair matrix. Here, we describe the targeted correction of the DTG mutation in XP-C cells using engineered meganuclease and TALEN (TM). The methylated status of the XPC locus, known to inhibit both of these nuclease activities, led us to adapt our experimental design to optimize their in vivo efficacies. We show that demethylating treatment as well as the use of TALEN (TM) insensitive to CpG methylation enable successful correction of the Delta TG mutation. Such genetic correction leads to re-expression of the full-length XPC protein and to the recovery of NER capacity, attested by UV-C resistance of the corrected cells. Overall, we demonstrate that nuclease-based targeted approaches offer reliable and efficient strategies for gene correction.	[Dupuy, Aurelie; Valton, Julien; Leduc, Sophie; Paques, Frederic; Duchateau, Philippe; Daboussi, Fayza] Cellectis SA, Paris, France; [Dupuy, Aurelie; Armier, Jacques; Stary, Anne; Sarasin, Alain] Inst Gustave Roussy, Unite Mixte Rech 8200, Villejuif, France; [Galetto, Roman; Gouble, Agnes; Lebuhotel, Celine] Cellectis Therapeut, Paris, France	UNICANCER; Gustave Roussy	Duchateau, P (corresponding author), Cellectis SA, Paris, France.	philippe.duchateau@cellectis.com	stary, anne/GRY-3781-2022	Daboussi, Fayza/0000-0001-7689-7975; Valton, Julien/0000-0003-0826-5401	Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie [Cifre 535/2008]; Association de Recherche sur le Cancer (Villejuif, France)	Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie(French National Research Agency (ANR)); Association de Recherche sur le Cancer (Villejuif, France)	<SUP>T</SUP>his work was supported by Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie, contrat Cifre 535/2008 and Association de Recherche sur le Cancer (Villejuif, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Bergoglio V, 2007, MOL THER, V15, P2186, DOI 10.1038/sj.mt.6300292; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; DAYAGROSJEAN L, 1987, MUTAT RES, V183, P185, DOI 10.1016/0167-8817(87)90061-7; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Ergun SS, 2002, PLAST RECONSTR SURG, V110, P1290, DOI 10.1097/01.PRS.0000025230.84677.C7; Fischer A, 2005, PLOS MED, V2, P22, DOI 10.1371/journal.pmed.0020010; Gram GJ, 1998, J HEMATOTHER, V7, P333, DOI 10.1089/scd.1.1998.7.333; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hoeijmakers JHJ, 2001, MUTAT RES-DNA REPAIR, V485, P43, DOI 10.1016/S0921-8777(00)00079-3; Khan SG, 2006, CARCINOGENESIS, V27, P84, DOI 10.1093/carcin/bgi204; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soufir N, 2010, J INVEST DERMATOL, V130, P1537, DOI 10.1038/jid.2009.409; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Valton J, 2012, J BIOL CHEM, V287, P30139, DOI 10.1074/jbc.M112.379966; Warrick E, 2012, MOL THER, V20, P798, DOI 10.1038/mt.2011.233; Xu KQ, 2012, J BIOL CHEM, V287, P29543, DOI 10.1074/jbc.M112.352302; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zeng L, 1997, GENE THER, V4, P1077, DOI 10.1038/sj.gt.3300495	33	48	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78678	10.1371/journal.pone.0078678	http://dx.doi.org/10.1371/journal.pone.0078678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236034	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700031
J	Gadalla, SM; Pfeiffer, RM; Kristinsson, SY; Bjorkholm, M; Hilbert, JE; Moxley, RT; Landgren, O; Greene, MH				Gadalla, Shahinaz M.; Pfeiffer, Ruth M.; Kristinsson, Sigurdur Y.; Bjorkholm, Magnus; Hilbert, James E.; Moxley, Richard T., III; Landgren, Ola; Greene, Mark H.			Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; CTG REPEAT; SURVIVAL; GENE; EXPANSION; TYPE-1; DEATH	Recent studies show that patients with myotonic dystrophy (DM) have an increased risk of specific malignancies, but estimates of absolute cancer risk accounting for competing events are lacking. Using the Swedish Patient Registry, we identified 1,081 patients with an inpatient and/or outpatient diagnosis of DM between 1987 and 2007. Date and cause of death and date of cancer diagnosis were extracted from the Swedish Cause of Death and Cancer Registries. We calculated non-parametric estimates of absolute cancer risk and cancer mortality accounting for the high non-cancer competing mortality associated with DM. Absolute cancer risk after DM diagnosis was 1.6% (95% CI=0.4-4%), 5% (95% CI=3-9%) and 9% (95% CI=6-13%) at ages 40, 50 and 60 years, respectively. Females had a higher absolute risk of all cancers combined than males: 9% (95% CI=4-14), and 13% (95% CI=9-20) vs. 2% (95% CI=0.7-6) and 4% (95% CI=2-8) by ages 50 and 60 years, respectively) and developed cancer at younger ages (median age =51 years, range=22-74 vs. 57, range=43-84, respectively, p=0.02). Cancer deaths accounted for 10% of all deaths, with an absolute cancer mortality risk of 2% (95% CI=1-4.5%), 4% (95% CI=2-6%), and 6% (95% CI=4-9%) by ages 50, 60, and 70 years, respectively. No gender difference in cancer-specific mortality was observed (p=0.6). In conclusion, cancer significantly contributes to morbidity and mortality in DM patients, even after accounting for high competing DM mortality from non-neoplastic causes. It is important to apply population-appropriate, validated cancer screening strategies in DM patients.	[Gadalla, Shahinaz M.; Greene, Mark H.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kristinsson, Sigurdur Y.; Bjorkholm, Magnus] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Kristinsson, Sigurdur Y.; Bjorkholm, Magnus] Karolinska Inst, Stockholm, Sweden; [Kristinsson, Sigurdur Y.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kristinsson, Sigurdur Y.] Landspitali Natl Univ Hosp, Dept Hematol, Reykjavik, Iceland; [Hilbert, James E.; Moxley, Richard T., III] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Ctr, Rochester, NY 14642 USA; [Landgren, Ola] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Iceland; Landspitali National University Hospital; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greene, MH (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	greenem@mail.nih.gov	Kristinsson, Sigurdur Y/M-2910-2015; Gadalla, Shahinaz M/C-4005-2015; Gadalla, Shahinaz/U-2848-2019	Kristinsson, Sigurdur Y/0000-0002-4964-7476; Gadalla, Shahinaz M/0000-0002-3255-8143; 	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet Foundations; Intramural Research Program of the National Cancer Institute, USA [N02CP31003-3]; University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NIH/U54/NS048843]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Intramural Research Program of the National Cancer Institute, USA; University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Swedish Cancer Society, Stockholm County Council, the Karolinska Institutet Foundations, the Intramural Research Program of the National Cancer Institute, USA (contract N02CP31003-3), and the University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (NIH/U54/NS048843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PATIENTREGISTRET 198; BROOK, 1992, CELL, V69, P385; Das M, 2012, J NEUROL, V259, P2161, DOI 10.1007/s00415-012-6476-8; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gadalla SM, 2011, JAMA-J AM MED ASSOC, V306, P2480, DOI 10.1001/jama.2011.1796; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; Harper PS, 2001, MYOTONIC DYSTROPHY; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Marubini E, 1995, ANAL SURVIVAL DATA C; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Mladenovic J, 2006, EUR J NEUROL, V13, P451, DOI 10.1111/j.1468-1331.2006.01261.x; Mohamed Shirine, 2013, Presse Med, V42, pe281, DOI 10.1016/j.lpm.2013.01.052; Mueller CM, 2009, CANCER CAUSE CONTROL, V20, P2009, DOI 10.1007/s10552-009-9395-y; *NAT BOARD HLTH WE, 2008, CANC INC SWED 2007; Nilsson A C, 1994, Lakartidningen, V91, P603; Organisation for Economic Co-operation and Development (OECD), 2012, LIF EXP BIRTH TOT PO; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Turesson I, 2007, INT J CANCER, V121, P2260, DOI 10.1002/ijc.22912; Vihola A, 2010, ACTA NEUROPATHOL, V119, P465, DOI 10.1007/s00401-010-0637-6; Win AK, 2012, MAYO CLIN PROC, V87, P130, DOI 10.1016/j.mayocp.2011.09.005	26	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79851	10.1371/journal.pone.0079851	http://dx.doi.org/10.1371/journal.pone.0079851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236163	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700164
J	Kiyaga, C; Sendagire, H; Joseph, E; McConnell, I; Grosz, J; Narayan, V; Esiru, G; Elyanu, P; Akol, Z; Kirungi, W; Musinguzi, J; Opio, A				Kiyaga, Charles; Sendagire, Hakim; Joseph, Eleanor; McConnell, Ian; Grosz, Jeff; Narayan, Vijay; Esiru, Godfrey; Elyanu, Peter; Akol, Zainab; Kirungi, Wilford; Musinguzi, Joshua; Opio, Alex			Uganda's New National Laboratory Sample Transport System: A Successful Model for Improving Access to Diagnostic Services for Early Infant HIV Diagnosis and Other Programs	PLOS ONE			English	Article							DRIED BLOOD SPOTS	Introduction: Uganda scaled-up Early HIV Infant Diagnosis (EID) when simplified methods for testing of infants using dried blood spots (DBS) were adopted in 2006 and sample transport and management was therefore made feasible in rural settings. Before this time only 35% of the facilities that were providing EID services were reached through the national postal courier system, Posta Uganda. The transportation of samples during this scale-up, therefore, quickly became a challenge and varied from facility to facility as different methods were used to transport the samples. This study evaluates a novel specimen transport network system for EID testing. Methods: A retrospective study was done in mid-2012 on 19 pilot hubs serving 616 health facilities in Uganda. The effect on sample-result turnaround time (TAT) and the cost of DBS sample transport on 876 sample-results was analyzed. Results: The HUB network system provided increased access to EID services ranging from 36% to 51%, drastically reduced transportation costs by 62%, reduced turn-around times by 46.9% and by a further 46.2% through introduction of SMS printers. Conclusions: The HUB model provides a functional, reliable and efficient national referral network against which other health system strengthening initiatives can be built to increase access to critical diagnostic and treatment monitoring services, improve the quality of laboratory and diagnostic services, with reduced turn-around times and improved quality of prevention and treatment programs thereby reducing long-term costs.	[Kiyaga, Charles; Sendagire, Hakim; Esiru, Godfrey; Elyanu, Peter; Akol, Zainab; Kirungi, Wilford; Musinguzi, Joshua; Opio, Alex] Minist Hlth, Kampala, Uganda; [Sendagire, Hakim] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Joseph, Eleanor; McConnell, Ian; Grosz, Jeff; Narayan, Vijay] Clinton Fdn Hlth Access Initiat, Kampala, Uganda	Makerere University	Sendagire, H (corresponding author), Minist Hlth, Kampala, Uganda.	hsendagire@yahoo.com	; Elyanu, Peter James/B-9760-2019	Narayan, Vijay/0000-0003-3890-7321; Elyanu, Peter James/0000-0002-4075-622X	Uganda Ministry of Health; Clinton Foundation Health Access Initiative Uganda	Uganda Ministry of Health; Clinton Foundation Health Access Initiative Uganda	This work was supported by the Uganda Ministry of Health and Clinton Foundation Health Access Initiative Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort Julia E, 2006, Nature, V444 Suppl 1, P19, DOI 10.1038/nature05443; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Ministry of Health-Uganda, 2010, NAT HLTH FAC INV; Ministry of Health-Uganda, 2012, HIV AIDS IND SURV; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; United Nations General Assembly, 2011, POL DECL HIV AIDS IN	6	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78609	10.1371/journal.pone.0078609	http://dx.doi.org/10.1371/journal.pone.0078609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236026	Green Published, gold			2022-12-25	WOS:000327254700023
J	Martin-Garrido, A; Williams, HC; Lee, M; Seidel-Rogol, B; Ci, X; Dong, JT; Lassegue, B; Martin, AS; Griendling, KK				Martin-Garrido, Abel; Williams, Holly C.; Lee, Minyoung; Seidel-Rogol, Bonnie; Ci, Xinpei; Dong, Jin-Tang; Lassegue, Bernard; Martin, Alejandra San; Griendling, Kathy K.			Transforming Growth Factor beta Inhibits Platelet Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation via Akt-Independent, Smad-Mediated Cyclin D1 Downregulation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NEOINTIMAL FORMATION; SIGNAL-TRANSDUCTION; CORONARY-ARTERY; GENE-EXPRESSION; RAT MODEL; INJURY; PDGF; GROWTH-FACTOR-BETA-1; MIGRATION	In adult tissue, vascular smooth muscle cells (VSMCs) exist in a differentiated phenotype, which is defined by the expression of contractile proteins and lack of proliferation. After vascular injury, VSMC adopt a synthetic phenotype associated with proliferation, migration and matrix secretion. The transition between phenotypes is a consequence of the extracellular environment, and in particular, is regulated by agonists such as the pro-differentiating cytokine transforming growth factor beta (TGF beta) and the pro-proliferative cytokine platelet derived growth factor (PDGF). In this study, we investigated the interplay between TGF beta and PDGF with respect to their ability to regulate VSMC proliferation. Stimulation of human aortic VSMC with TGF beta completely blocked proliferation induced by all isoforms of PDGF, as measured by DNA synthesis and total cell number. Mechanistically, PDGF-induced Cyclin D1 mRNA and protein expression was inhibited by TGF beta. TGF beta had no effect on PDGF activation of its receptor and ERK1/2, but inhibited Akt activation. However, constitutively active Akt did not reverse the inhibitory effect of TGF beta on Cyclin D1 expression even though inhibition of the proteasome blocked the effect of TGF beta. siRNA against Smad4 completely reversed the inhibitory effect of TGF beta on PDGF-induced Cyclin D1 expression and restored proliferation in response to PDGF. Moreover, siRNA against KLF5 prevented Cyclin D1 upregulation by PDGF and overexpression of KLF5 partially reversed TGF beta-induced inhibition of Cyclin D1 expression. Taken together, our results demonstrate that KLF5 is required for PDGF-induced Cyclin D1 expression, which is inhibited by TGF beta via a Smad dependent mechanism, resulting in arrest of VSMCs in the G1 phase of the cell cycle.	[Martin-Garrido, Abel; Williams, Holly C.; Lee, Minyoung; Seidel-Rogol, Bonnie; Lassegue, Bernard; Martin, Alejandra San; Griendling, Kathy K.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Ci, Xinpei; Dong, Jin-Tang] Emory Univ, Winship Canc Ctr, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Griendling, KK (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	kgriend@emory.edu	San Martin, Alejandra/HDN-0012-2022	Griendling, Kathy/0000-0002-9456-8582; San Martin, Alejandra/0000-0002-4620-1591; Williams, Holly/0000-0002-1890-1830; Dong, Jin-Tang/0000-0003-2349-5782; Lassegue, Bernard/0000-0003-4924-6506	National Institutes of Health (NIH) [HL38206, HL095070]; NATIONAL CANCER INSTITUTE [R01CA171189] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038206, R29HL038206, P01HL095070, R37HL038206] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL38206 and HL095070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cohen MD, 1997, AM J RESP CELL MOL, V16, P85, DOI 10.1165/ajrcmb.16.1.8998083; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Du JX, 2011, J BIOL CHEM, V286, P40354, DOI 10.1074/jbc.M111.258707; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fukumoto S, 1999, CIRC RES, V85, P985; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kobayashi K, 2005, CIRC RES, V96, P904, DOI 10.1161/01.RES.0000163980.55495.44; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MAJACK RA, 1990, J CELL BIOL, V111, P239, DOI 10.1083/jcb.111.1.239; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MII S, 1993, SURGERY, V114, P464; Morishita R, 1998, CLIN CHEM LAB MED, V36, P529, DOI 10.1515/CCLM.1998.090; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Ruef J, 1999, CIRCULATION, V100, P659, DOI 10.1161/01.CIR.100.6.659; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Team RDC, 2012, LANG ENV STAT COMP; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308	52	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79657	10.1371/journal.pone.0079657	http://dx.doi.org/10.1371/journal.pone.0079657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236150	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700149
J	Niu, XD; Wang, Z; Li, Y; Zhao, ZJ; Liu, JY; Jiang, L; Xu, HR; Li, ZQ				Niu, Xuedun; Wang, Zhi; Li, Yang; Zhao, Zijian; Liu, Jiayin; Jiang, Li; Xu, Haoran; Li, Zhengqiang			"Fish-in-Net", a Novel Method for Cell Immobilization of Zymomonas mobilis	PLOS ONE			English	Article							MESOPOROUS MOLECULAR-SIEVES; ETHANOL-PRODUCTION; ENZYME IMMOBILIZATION; GLUCOSE-CONCENTRATION; HYDROGEN-PRODUCTION; SILICA; SYSTEMS; FERMENTATION; ENCAPSULATION; STABILITY	Background: Inorganic mesoporous materials exhibit good biocompatibility and hydrothermal stability for cell immobilization. However, it is difficult to encapsulate living cells under mild conditions, and new strategies for cell immobilization are needed. We designed a "fish-in-net" approach for encapsulation of enzymes in ordered mesoporous silica under mild conditions. The main objective of this study is to demonstrate the potential of this approach in immobilization of living cells. Methodology/Principal Findings: Zymomonas mobilis cells were encapsulated in mesoporous silica-based materials under mild conditions by using a "fish-in-net" approach. During the encapsulation process, polyethyleneglycol was used as an additive to improve the immobilization efficiency. After encapsulation, the pore size, morphology and other features were characterized by various methods, including scanning electron microscopy, nitrogen adsorption-desorption analysis, transmission electron microscopy, fourier transform infrared spectroscopy, and elemental analysis. Furthermore, the capacity of ethanol production by immobilized Zymomonas mobilis and free Zymomonas mobilis was compared. Conclusions/Significance: In this study, Zymomonas mobilis cells were successfully encapsulated in mesoporous silica-based materials under mild conditions by the "fish-in-net" approach. Encapsulated cells could perform normal metabolism and exhibited excellent reusability. The results presented here illustrate the enormous potential of the "fish-in-net" approach for immobilization of living cells.	[Niu, Xuedun; Wang, Zhi; Li, Yang; Zhao, Zijian; Liu, Jiayin; Xu, Haoran; Li, Zhengqiang] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin Province, Peoples R China; [Niu, Xuedun; Wang, Zhi; Li, Zhengqiang] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Jiang, Li] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Northeast Normal University - China	Li, ZQ (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin Province, Peoples R China.	lzq@jlu.edu.cn			National High Technology Research and Development Program of China ("863' Program) [2006AA02Z232]; Social Development Research Project of Science and Technology Department of Jilin Province [20090404]	National High Technology Research and Development Program of China ("863' Program); Social Development Research Project of Science and Technology Department of Jilin Province	This work was financially supported by the National High Technology Research and Development Program of China ("863' Program, 2006AA02Z232, http://www.863.gov.cn), and Social Development Research Project of Science and Technology Department of Jilin Province (20090404, http://kjt.jl.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan HA, 2011, J MATER CHEM, V15, P3690; Banerjee A, 2011, INT BIODETER BIODEGR, V65, P1052, DOI 10.1016/j.ibiod.2011.04.011; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cabrera S, 1999, ADV MATER, V11, P379, DOI 10.1002/(SICI)1521-4095(199903)11:5<379::AID-ADMA379>3.0.CO;2-6; Chu CY, 2011, INT J HYDROGEN ENERG, V36, P14078, DOI 10.1016/j.ijhydene.2011.04.101; Corma A, 2002, STUD SURF SCI CATAL, V142, P487; Deng W, 2002, MICROPOR MESOPOR MAT, V52, P169, DOI 10.1016/S1387-1811(02)00315-3; Du D, 2005, BIOMATERIALS, V26, P6487, DOI 10.1016/j.biomaterials.2005.03.048; Fan J, 2005, CHEM-EUR J, V11, P5391, DOI 10.1002/chem.200500060; Freeman A, 1998, ENZYME MICROB TECH, V23, P335, DOI 10.1016/S0141-0229(98)00046-5; Fuertes AB, 2004, MICROPOR MESOPOR MAT, V67, P273, DOI 10.1016/j.micromeso.2003.11.012; Genisheva Z, 2011, IND CROP PROD, V34, P979, DOI 10.1016/j.indcrop.2011.03.006; He SY, 2011, BIORESOURCE TECHNOL, V102, P5609, DOI 10.1016/j.biortech.2011.02.030; Jin YL, 1998, FOOD RES INT, V31, P421, DOI 10.1016/S0963-9969(99)00021-6; KING FG, 1982, BIOTECHNOL LETT, V4, P531, DOI 10.1007/BF00131577; Li LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064794; Liu JY, 2012, J HAZARD MATER, V217, P156, DOI 10.1016/j.jhazmat.2012.03.008; Liu NG, 2003, CHEM COMMUN, P1146, DOI 10.1039/b301910a; Manju NJ, 2009, AQUACULTURE, V294, P65, DOI 10.1016/j.aquaculture.2009.05.008; MARGARITIS A, 1983, INT J HYDROGEN ENERG, V8, P281, DOI 10.1016/0360-3199(83)90138-6; MARGARITIS A, 1984, CRC CR REV BIOTECHN, V1, P339; Panesar R, 2011, J CHEM TECHNOL BIOT, V86, P42, DOI 10.1002/jctb.2481; Rogers PL, 2007, ADV BIOCHEM ENG BIOT, V108, P263, DOI 10.1007/10_2007_060; Seol E, 2011, INT J HYDROGEN ENERG, V36, P8681, DOI 10.1016/j.ijhydene.2010.05.118; Sun QY, 2002, J PHYS CHEM B, V106, P11539, DOI 10.1021/jp026011r; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; Takahashi R, 2000, J SOL-GEL SCI TECHN, V17, P7, DOI 10.1023/A:1008753718586; Tao F, 2005, PROCESS BIOCHEM, V40, P183, DOI 10.1016/j.procbio.2003.11.054; Tope AM, 2001, J MOL CATAL B-ENZYM, V16, P17, DOI 10.1016/S1381-1177(01)00040-6; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; Wu ZF, 2010, J MOL CATAL B-ENZYM, V63, P75, DOI 10.1016/j.molcatb.2009.12.012; Yamashita Y, 2008, BIOCHEM ENG J, V42, P314, DOI 10.1016/j.bej.2008.07.013; Yan SB, 2011, J CHEM TECHNOL BIOT, V86, P731, DOI 10.1002/jctb.2581; Yang XY, 2006, ADV MATER, V18, P410, DOI 10.1002/adma.200502003; Yaykasli KO, 2005, J FOOD ENG, V70, P518, DOI 10.1016/j.jfoodeng.2004.10.006; Yiu HHP, 2001, J MOL CATAL B-ENZYM, V15, P81, DOI 10.1016/S1381-1177(01)00011-X; Zhang X, 2005, J MOL CATAL B-ENZYM, V33, P43, DOI 10.1016/j.molcatb.2005.02.001; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	39	15	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79569	10.1371/journal.pone.0079569	http://dx.doi.org/10.1371/journal.pone.0079569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236145	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700144
J	Wang, Y; Chen, JM; Liu, X; Wang, J; Li, LH; Deng, JP; Duan, YY				Wang, Yu; Chen, Jian Mei; Liu, Xi; Wang, Jia; Li, Li Hong; Deng, Jian Ping; Duan, Yun You			Evaluation of the Combined Application of Ultrasound Imaging Techniques for Middle Cerebral Artery Stent Surveillance and Follow-Up Study	PLOS ONE			English	Article							ATHEROSCLEROTIC STENOSIS; PROGRESSION	Objective: In recent years, cerebral artery stenting has become an effective method for the treatment of cerebral artery stenosis. However, methods for assessing efficacy and techniques for follow-up imaging still need to be developed. This study was designed to evaluate the application of transcranial color-coded sonography (TCCS) in assessing stenting of middle cerebral artery (MCA) stenosis. And, two new imaging techniques (vascular enhancement technology (VET) and 3-dimensional (3D) imaging) were tried out and evaluated. Method: We enrolled 43 patients with cerebral artery stenosis for vascular stent implantation. All patients were examined by ultrasonography and confirmed through digital subtraction angiography. The stenosis was imaged and blood flow parameters were analyzed before and after the procedure using TCCS. VET and 3D imaging model were used in part of the patients. Important postoperative hemodynamic changes were noted. Results: 1) Adequate stent image was present in 41 out of 43 patients as detected by postoperative 2-dimensional imaging. Images lacking clarity were obtained in 2 patients. 2) The perioperative and postoperative (one week follow-up) instantaneous blood flow velocity at the site of stenosis was significantly decreased (P<0.05) when compared with preoperative levels. Differences between postoperative (one week follow-up) and preoperative blood flow velocity were significant (P<0.05). Differences in blood flow velocity at long-term follow-up (six months and two years) compared to one-week values were not statistically significant (P>0.05). 3) VET imaging visualizes the MCA lumen and stent morphology clearly. 3D ultrasound can be used for imaging of the stent shape as well as its inner surface. Conclusion: TCCD can be considered a quick and effective clinical detection method to evaluate the intracranial arterial hemodynamics changes before and after stenting treatment for MCA stenosis. New imaging technologies 3D and VET can achieve additional image information.	[Wang, Yu; Chen, Jian Mei; Liu, Xi; Wang, Jia; Duan, Yun You] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China; [Li, Li Hong; Deng, Jian Ping] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, X (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	liuxi2007@fmmu.edu.cn; duanyy@fmmu.edu.cn	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789				Kablak-Ziembicka A, 2010, J ENDOVASC THER, V17, P556, DOI 10.1583/09-2980.1; Kim DE, 2012, STROKE, V43, P1824, DOI 10.1161/STROKEAHA.112.653659; Liu X, 2009, ULTRASOUND MED BIOL, V35, P1502, DOI 10.1016/j.ultrasmedbio.2009.04.005; Moreira T, 2012, CLIN NEUROL NEUROSUR, V114, P922, DOI 10.1016/j.clineuro.2012.02.005; Park Soonchan, 2013, Neurointervention, V8, P9, DOI 10.5469/neuroint.2013.8.1.9; Qu H, 2013, EXP THER MED, V5, P471, DOI 10.3892/etm.2012.805; Schreiber S, 2009, STROKE, V40, pE478, DOI 10.1161/STROKEAHA.109.549378; Shi MC, 2012, NEUROL RES, V34, P153, DOI 10.1179/1743132811Y.0000000065; Turek G, 2012, NEUROL NEUROCHIR POL, V46, P233, DOI 10.5114/ninp.2012.29131; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Zhang L, 2013, J CLIN NEUROSCI, V20, P362, DOI 10.1016/j.jocn.2012.03.033	11	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79410	10.1371/journal.pone.0079410	http://dx.doi.org/10.1371/journal.pone.0079410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236130	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700129
J	Toth, TI; Schmidt, J; Buschges, A; Daun-Gruhn, S				Toth, Tibor Istvan; Schmidt, Joachim; Bueschges, Ansgar; Daun-Gruhn, Silvia			A Neuro-Mechanical Model of a Single Leg Joint Highlighting the Basic Physiological Role of Fast and Slow Muscle Fibres of an Insect Muscle System	PLOS ONE			English	Article							COXAL DEPRESSOR MUSCLES; EXTENSOR TIBIAE MUSCLE; STICK INSECT; FILTER CHARACTERISTICS; NEUROMECHANICAL MODEL; SEARCHING MOVEMENTS; CARAUSIUS-MOROSUS; MOTONEURONS; WALKING; INNERVATION	In legged animals, the muscle system has a dual function: to produce forces and torques necessary to move the limbs in a systematic way, and to maintain the body in a static position. These two functions are performed by the contribution of specialized motor units, i.e. motoneurons driving sets of specialized muscle fibres. With reference to their overall contraction and metabolic properties they are called fast and slow muscle fibres and can be found ubiquitously in skeletal muscles. Both fibre types are active during stepping, but only the slow ones maintain the posture of the body. From these findings, the general hypothesis on a functional segregation between both fibre types and their neuronal control has arisen. Earlier muscle models did not fully take this aspect into account. They either focused on certain aspects of muscular function or were developed to describe specific behaviours only. By contrast, our neuro-mechanical model is more general as it allows functionally to differentiate between static and dynamic aspects of movement control. It does so by including both muscle fibre types and separate motoneuron drives. Our model helps to gain a deeper insight into how the nervous system might combine neuronal control of locomotion and posture. It predicts that (1) positioning the leg at a specific retraction angle in steady state is most likely due to the extent of recruitment of slow muscle fibres and not to the force developed in the individual fibres of the antagonistic muscles; (2) the fast muscle fibres of antagonistic muscles contract alternately during stepping, while co-contraction of the slow muscle fibres takes place during steady state; (3) there are several possible ways of transition between movement and steady state of the leg achieved by varying the time course of recruitment of the fibres in the participating muscles.	[Toth, Tibor Istvan; Daun-Gruhn, Silvia] Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany; [Schmidt, Joachim; Bueschges, Ansgar] Univ Cologne, Dept Anim Physiol, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Daun-Gruhn, S (corresponding author), Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany.	sgruhn@uni-koeln.de		Daun, Silvia/0000-0001-7342-1015	Emmy Noether Programme [DA 1182/1-1]	Emmy Noether Programme(German Research Foundation (DFG))	Funding provided by Emmy Noether Programme DA 1182/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	BALLANTYNE D, 1981, J COMP PHYSIOL, V143, P111, DOI 10.1007/BF00606074; Bassler D, 1996, J EXP BIOL, V199, P2169; BASSLER U, 1991, BIOL CYBERN, V65, P507, DOI 10.1007/BF00204664; Bassler U, 1996, J EXP BIOL, V199, P2185; Berg E, 2013, J EXP BIOL, V216, P1064, DOI 10.1242/jeb.076406; Blumel M, 2012, BIOL CYBERN, V106, P559, DOI 10.1007/s00422-012-0530-6; Blumel M, 2012, BIOL CYBERN, V106, P543, DOI 10.1007/s00422-012-0531-5; Blumel M, 2012, BIOL CYBERN, V106, P573, DOI 10.1007/s00422-011-0460-8; DUCH C, 1995, J EXP BIOL, V198, P1963; Gabriel JP, 2003, J NEUROBIOL, V56, P237, DOI 10.1002/neu.10237; Godlewska E, 2012, THESIS U COLOGNE GER; Goldammer J, 2012, J COMP NEUROL, V520, P230, DOI 10.1002/cne.22676; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P599, DOI 10.1152/jn.1965.28.3.599; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOYLE G, 1978, J EXP BIOL, V73, P205; ILES JF, 1971, J EXP BIOL, V55, P151; KARG G, 1991, BIOL CYBERN, V64, P329, DOI 10.1007/BF00199597; Kernell D., 2003, Neural Plasticity, V10, P69, DOI 10.1155/NP.2003.69; Knops S, 2013, J NEUROPHYSIOL, V109, P679, DOI 10.1152/jn.00648.2012; Monti RJ, 2001, MUSCLE NERVE, V24, P848, DOI 10.1002/mus.1083.abs; MULLER AR, 1992, J COMP PHYSIOL B, V162, P5, DOI 10.1007/BF00257930; PEARSON KG, 1971, J EXP BIOL, V54, P215; PFLUGER HJ, 1977, J COMP PHYSIOL, V120, P181, DOI 10.1007/BF00619314; Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594; RATHMAYER W, 1985, J EXP BIOL, V116, P291; RATHMAYER W, 1987, AM ZOOL, V27, P1067; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Toth TI, 2012, J NEUROPHYSIOL, V107, P3267, DOI 10.1152/jn.01124.2011; Wilson E, 2013, BIOMECH MODEL MECHAN, V12, P581, DOI 10.1007/s10237-012-0427-2; Wilson E, 2011, BIOL CYBERN, V104, P121, DOI 10.1007/s00422-011-0423-0; WOLF H, 1990, J EXP BIOL, V152, P281; Zakotnik J, 2006, J NEUROSCI, V26, P4995, DOI 10.1523/JNEUROSCI.0161-06.2006	35	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78247	10.1371/journal.pone.0078247	http://dx.doi.org/10.1371/journal.pone.0078247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244298	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600021
J	Goss, EM; Press, CM; Grunwald, NJ				Goss, Erica M.; Press, Caroline M.; Gruenwald, Niklaus J.			Evolution of RXLR-Class Effectors in the Oomycete Plant Pathogen Phytophthora ramorum	PLOS ONE			English	Article							SUDDEN OAK DEATH; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SITES; RESISTANCE GENES; CLONAL LINEAGES; GENOME SEQUENCE; AVIRULENCE; PROTEIN; VIRULENCE; EXPRESSION	Phytophthora plant pathogens contain many hundreds of effectors potentially involved in infection of host plants. Comparative genomic analyses have shown that these effectors evolve rapidly and have been subject to recent expansions. We examined the recent sequence evolution of RXLR-class effector gene families in the sudden oak death pathogen, P. ramorum. We found that P. ramorum RXLR effectors have taken multiple evolutionary paths, including loss or gain of repeated domains, recombination or gene conversion among paralogs, and selection on point mutations. Sequencing of homologs from two subfamilies in P. ramorum's closest known relatives revealed repeated gene duplication and divergence since speciation with P. lateralis. One family showed strong signatures of recombination while the other family has evolved primarily by point mutation. Comparison of a small number of the hundreds of RXLR-class effectors across three clonal lineages of P. ramorum shows striking divergence in alleles among lineages, suggesting the potential for functional differences between lineages. Our results suggest future avenues for examination of rapidly evolving effectors in P. ramorum, including investigation of the functional and coevolutionary significance of the patterns of sequence evolution that we observed.	[Goss, Erica M.; Press, Caroline M.; Gruenwald, Niklaus J.] ARS, Hort Crops Res Lab, Dept Agr, Corvallis, OR USA		Goss, EM (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	emgoss@ufl.edu	Grunwald, Niklaus` J/K-6041-2013	Grunwald, Niklaus` J/0000-0003-1656-7602; Press, Caroline/0000-0003-4741-9776	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS [5358-22000-030-00D]; ARS [ARS-0423109] Funding Source: Federal RePORTER	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided by the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS 5358-22000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; BRASIER CM, 2006, PROGR RES PHYTOPHTHO, P166; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FLOR HH, 1953, PHYTOPATHOLOGY, V43, P624; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2009, PHYTOPATHOLOGY, V99, P792, DOI 10.1094/PHYTO-99-7-0792; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Na R, 2013, MOL PLANT MICROBE IN, V26, P969, DOI 10.1094/MPMI-02-13-0036-R; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Quinn L, 2013, FEMS MICROBIOL LETT, V344, P179, DOI 10.1111/1574-6968.12179; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rozen S, 2000, Methods Mol Biol, V132, P365; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomlinson JA, 2005, APPL ENVIRON MICROB, V71, P6702, DOI 10.1128/AEM.71.11.6702-6710.2005; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Van Poucke Kris, 2012, Fungal Biol, V116, P1178, DOI 10.1016/j.funbio.2012.09.003; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097	65	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79347	10.1371/journal.pone.0079347	http://dx.doi.org/10.1371/journal.pone.0079347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244484	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900038
J	Shu, HKG; Yoon, Y; Hong, S; Xu, KM; Gao, HY; Hao, CH; Torres-Gonzalez, E; Nayra, C; Rojas, M; Shim, H				Shu, Hui-Kuo G.; Yoon, Younghyoun; Hong, Samuel; Xu, Kaiming; Gao, Huiying; Hao, Chunhai; Torres-Gonzalez, Edilson; Nayra, Cardenes; Rojas, Mauricio; Shim, Hyunsuk			Inhibition of the CXCL12/CXCR4-Axis as Preventive Therapy for Radiation-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							LUNG INJURY; PATHOGENESIS; ANTAGONISTS; CELLS; MICE	Background: A devastating late injury caused by radiation is pulmonary fibrosis. This risk may limit the volume of irradiation and compromise potentially curative therapy. Therefore, development of a therapy to prevent this toxicity can be of great benefit for this patient population. Activation of the chemokine receptor CXCR4 by its ligand stromal cell-derived factor 1 (SDF-1/CXCL12) may be important in the development of radiation-induced pulmonary fibrosis. Here, we tested whether MSX-122, a novel small molecule and partial CXCR4 antagonist, can block development of this fibrotic process. Methodology/Principal Findings: The radiation-induced lung fibrosis model used was C57BL/6 mice irradiated to the entire thorax or right hemithorax to 20 Gy. Our parabiotic model involved joining a transgenic C57BL/6 mouse expressing GFP with a wild-type mouse that was subsequently irradiated to assess for migration of GFP+ bone marrow-derived progenitor cells to the irradiated lung. CXCL12 levels in the bronchoalveolar lavage fluid (BALF) and serum after irradiation were determined by ELISA. CXCR4 and CXCL12 mRNA in the irradiated lung was determined by RNase protection assay. Irradiated mice were treated daily with AMD3100, an established CXCR4 antagonist; MSX-122; and their corresponding vehicles to determine impact of drug treatment on fibrosis development. Fibrosis was assessed by serial CTs and histology. After irradiation, CXCL12 levels increased in BALF and serum with a corresponding rise in CXCR4 mRNA within irradiated lungs consistent with recruitment of a CXCR4+ cell population. Using our parabiotic model, we demonstrated recruitment of CXCR4+ bone marrow-derived mesenchymal stem cells, identified based on marker expression, to irradiated lungs. Finally, irradiated mice that received MSX-122 had significant reductions in development of pulmonary fibrosis while AMD3100 did not significantly suppress this fibrotic process. Conclusions/Significance: CXCR4 inhibition by drugs such as MSX-122 may alleviate potential radiation-induced lung injury, presenting future therapeutic opportunities for patients requiring chest irradiation.	[Shu, Hui-Kuo G.; Xu, Kaiming; Gao, Huiying] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Shu, Hui-Kuo G.; Shim, Hyunsuk] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Yoon, Younghyoun; Hong, Samuel; Shim, Hyunsuk] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA; [Hao, Chunhai] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Torres-Gonzalez, Edilson; Nayra, Cardenes; Rojas, Mauricio] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Emory University; Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shu, HKG (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	hgshu@emory.edu; hshim@emory.edu			National Institutes of Health [RC1AI081273, R21HL092518]; NATIONAL CANCER INSTITUTE [R01CA165306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI081273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grants RC1AI081273 and R21HL092518 (to HGS and HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Hallahan DE, 2002, J NATL CANCER I, V94, P733; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haston CK, 1997, CANCER RES, V57, P5286; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Liang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034038; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Plathow C, 2004, INVEST RADIOL, V39, P600, DOI 10.1097/01.rli.0000138134.89050.a5; SCHUETZ AW, 1964, ENDOCRINOLOGY, V75, P383, DOI 10.1210/endo-75-3-383; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; Tsutsumi H, 2007, BIOPOLYMERS, V88, P279, DOI 10.1002/bip.20653; Vujaskovic Z, 1998, EXP LUNG RES, V24, P137, DOI 10.3109/01902149809099578; Watanabe M, 2007, J IMMUNOL, V178, P5888, DOI 10.4049/jimmunol.178.9.5888; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g	18	62	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79768	10.1371/journal.pone.0079768	http://dx.doi.org/10.1371/journal.pone.0079768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244561	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327162900053
J	Rao, MN; Blackwell, T; Redline, S; Punjabi, NM; Barrett-Connor, E; Neylan, TC; Stone, KL				Rao, Madhu N.; Blackwell, Terri; Redline, Susan; Punjabi, Naresh M.; Barrett-Connor, Elizabeth; Neylan, Thomas C.; Stone, Katie L.		Osteoporotic Fractures Men MrOS St	Association between Sleep Duration and 24-Hour Urine Free Cortisol in the MrOS Sleep Study	PLOS ONE			English	Article							SELF-REPORTED SLEEP; OSTEOPOROTIC FRACTURES; DEPRIVATION; ACTIGRAPHY; FREQUENCY; MEN	Context: Short sleep duration is associated with adverse health outcomes, but the mechanisms involved are unknown. It has been postulated that short sleep duration may elevate cortisol levels, but studies have had conflicting results. It is unclear whether these differing findings may be due to methodological issues, such as assessment of sleep duration. Specifically, objective versus subjective methods of measuring habitual sleep duration may account for the conflicting results found in epidemiological studies. Objective: Our goal was to determine whether habitual sleep duration, measured objectively (by actigraphy) and subjectively (by self-report), was associated with 24-hour urine free cortisol (UFC), a measure of integrated cortisol secretion. Our secondary goal was to determine whether slow wave sleep (SWS, determined by polysomnography) was associated with 24-hour UFC. Design/Setting: Cross sectional study of community dwelling older men. Patients/Participants: 325 men (mean age = 76.6 years, SD = 5.5) from the Portland site of the MrOS Sleep Study, who underwent 24-hour urine collection, polysomnography, actigraphy and sleep questionnaire. Primary Outcome: 24-hour UFC. Results: In this study of community dwelling older men, self-reported sleep duration was inversely related to 24-hour UFC levels. Participants reporting <5 hours of habitual sleep had an adjusted mean 24-hour UFC of 29.8 ug, compared to 28.0 ug in participants reporting >5 to <8 hours of sleep 25.5 ug in those reporting >8 hours of habitual sleep. However, sleep duration determined by actigraphy was not associated with 24-hour UFC in either univariable or multivariable regression models. SWS was not associated with 24-hour UFC. Conclusion: Objectively measured (i.e., actigraphic) sleep duration is not associated with 24-hour UFC in these community dwelling older men. This finding, together with prior studies, suggests that elevated levels of integrated cortisol secretion is not the mechanisms by which short sleep duration leads to adverse health outcomes.	[Rao, Madhu N.] Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA; [Blackwell, Terri; Stone, Katie L.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Epidemiol, La Jolla, CA 92093 USA; [Neylan, Thomas C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Rao, MN (corresponding author), Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA.	Madhu.Rao@ucsf.edu	Punjabi, Naresh/EMH-1007-2022		National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Cancer Institute (NCI); National Center for Research Resources (NCRR); NIH Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, R01 HL070839]; NIH Heart, Lung and Blood Institute [K23HL096832]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070837, R01HL070848, R01HL070838, R01HL070839, R01HL070842, R01HL071194, K23HL096832, R01HL070847, R01HL070841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045654, U01AR045580, U01AR045583, U01AR045632, U01AR045614, U01AR045647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018197, U01AG027810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Cancer Institute (NCI), the National Center for Research Resources (NCRR) and NIH Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study "Outcomes of Sleep Disorders in Older Men" under the following grant numbers: R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and R01 HL070839. Dr. Rao received funding from the NIH Heart, Lung and Blood Institute (K23HL096832), which also paid for measurement of 24-hour urine free cortisol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], ACT W US GUID VERS 2; Aron D.C., 2004, BASIC CLIN ENDOCRINO, P362; Blackwell T, 2007, SLEEP, V30, pA346; Blackwell T, 2005, SLEEP, V28, P1599, DOI 10.1093/sleep/28.12.1599; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; BROWN PH, 1991, RESP MED, V85, P511, DOI 10.1016/S0954-6111(06)80269-6; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chapotot F, 2001, NEUROENDOCRINOLOGY, V73, P312, DOI 10.1159/000054648; CONTRERAS LN, 1986, J CLIN ENDOCR METAB, V62, P965, DOI 10.1210/jcem-62-5-965; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; FOLLENIUS M, 1992, SLEEP, V15, P21, DOI 10.1093/sleep/15.1.21; Gatti R, 2009, CLIN BIOCHEM, V42, P1205, DOI 10.1016/j.clinbiochem.2009.04.011; Jean-Louis G, 2001, J NEUROSCI METH, V105, P185, DOI 10.1016/S0165-0270(00)00364-2; KANT GJ, 1984, SLEEP, V7, P142, DOI 10.1093/sleep/7.2.142; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leproult R, 1997, SLEEP, V20, P865; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; National Sleep Foundation, 2011, SLEEP AM POLL; Nicolson N.A., 2008, HDB PHYSL RES METHOD; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Quan SF, 2006, SLEEP MED, V7, P498, DOI 10.1016/j.sleep.2006.02.005; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redline S, 1998, SLEEP, V21, P759; Regestein QR, 2004, MENOPAUSE, V11, P198, DOI 10.1097/01.GME.0000097741.18446.3E; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Stewart J, 1999, SALIVARY CORTISOL ME; Washburn RA, 1999, J SPORT MED PHYS FIT, V39, P336; Zhang JH, 2011, SLEEP, V34, P225, DOI 10.1093/sleep/34.2.225	36	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75205	10.1371/journal.pone.0075205	http://dx.doi.org/10.1371/journal.pone.0075205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24228086	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900037
J	Patel, A; Vought, VE; Swatkoski, S; Viggiano, S; Howard, B; Dharmarajan, V; Monteith, KE; Kupakuwana, G; Namitz, KE; Shinsky, SA; Cotter, RJ; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Swatkoski, Stephen; Viggiano, Susan; Howard, Benny; Dharmarajan, Venkatasubramanian; Monteith, Kelsey E.; Kupakuwana, Gillian; Namitz, Kevin E.; Shinsky, Stephen A.; Cotter, Robert J.; Cosgrove, Michael S.			Automethylation Activities within the Mixed Lineage Leukemia-1 (MLL1) Core Complex Reveal Evidence Supporting a "Two-active Site" Model for Multiple Histone H3 Lysine 4 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI ADA; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; METHYLTRANSFERASE ACTIVITY; DROSOPHILA-TRITHORAX; 11Q23 TRANSLOCATIONS; MOLECULAR REGULATION; PRODUCT SPECIFICITY; GENE-EXPRESSION; KABUKI SYNDROME	The mixed lineage leukemia-1 (MLL1) core complex predominantly catalyzes mono-and dimethylation of histone H3 at lysine 4 (H3K4) and is frequently altered in aggressive acute leukemias. The molecular mechanisms that account for conversion of mono-to dimethyl H3K4 (H3K4me1,2) are not well understood. In this investigation, we report that the suppressor of variegation, enhancer of zeste, trithorax (SET) domains from human MLL1 and Drosophila Trithorax undergo robust intramolecular automethylation reactions at an evolutionarily conserved cysteine residue in the active site, which is inhibited by unmodified histone H3. The location of the automethylation in the SET-I subdomain indicates that the MLL1 SET domain possesses significantly more conformational plasticity in solution than suggested by its crystal structure. We also report that MLL1 methylates Ash2L in the absence of histone H3, but only when assembled within a complex with WDR5 and RbBP5, suggesting a restraint for the architectural arrangement of subunits within the complex. Using MLL1 and Ash2L automethylation reactions as probes for histone binding, we observed that both automethylation reactions are significantly inhibited by stoichiometric amounts of unmethylated histone H3, but not by histones previously mono-, di-, or trimethylated at H3K4. These results suggest that the H3K4me1 intermediate does not significantly bind to the MLL1 SET domain during the dimethylation reaction. Consistent with this hypothesis, we demonstrate that the MLL1 core complex assembled with a catalytically inactive SET domain variant preferentially catalyzes H3K4 dimethylation using the H3K4me1 substrate. Taken together, these results are consistent with a "two-active site" model for multiple H3K4 methylation by the MLL1 core complex.	[Patel, Anamika; Viggiano, Susan; Namitz, Kevin E.; Shinsky, Stephen A.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Vought, Valarie E.; Howard, Benny; Dharmarajan, Venkatasubramanian; Monteith, Kelsey E.; Kupakuwana, Gillian] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Swatkoski, Stephen; Cotter, Robert J.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University; Johns Hopkins University; Johns Hopkins Medicine	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 East Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Namitz, Kevin/0000-0003-4434-1475; Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health Grant from NCI [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 from NCI (to M. S. C.).	Atkinson D. E., 1977, CELLULAR ENERGY META, P32; BAILEY E, 1981, CANCER RES, V41, P2514; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HANCK T, 1993, NUCLEIC ACIDS RES, V21, P303, DOI 10.1093/nar/21.2.303; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Kuhn P, 2009, PROTEIN SCI, V18, P1272, DOI 10.1002/pro.139; Lapko VN, 2002, BIOCHEMISTRY-US, V41, P14645, DOI 10.1021/bi0267700; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Lin YX, 2001, BIOCHEMISTRY-US, V40, P4261, DOI 10.1021/bi002109p; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; MYERS LC, 1995, J BIOL CHEM, V270, P6664, DOI 10.1074/jbc.270.12.6664; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; OLSSON M, 1980, J BIOL CHEM, V255, P569; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; SZILAK L, 1995, GENE, V157, P105, DOI 10.1016/0378-1119(94)00635-6; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	61	19	21	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					868	884		10.1074/jbc.M113.501064	http://dx.doi.org/10.1074/jbc.M113.501064			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24235145	Green Published, hybrid			2022-12-25	WOS:000330541200023
J	Linker, S; Hedges, D				Linker, Sara; Hedges, Dale			Linear Decay of Retrotransposon Antisense Bias across Genes Is Contingent upon Tissue Specificity	PLOS ONE			English	Article							ALU ELEMENTS; L1 RETROTRANSPOSON; TRANSCRIPTION; BINDING; SITES; IDENTIFICATION; ORGANIZATION; EVOLUTION; REPEATS; GENOME	Retrotransposons comprise approximately half of the human genome and contribute to chromatin structure, regulatory motifs, and protein-coding sequences. Since retrotransposon insertions can disrupt functional genetic elements as well as introduce new sequence motifs to a region, they have the potential to affect the function of genes that harbour insertions as well as those nearby. Partly as a result of these effects, the distribution of retrotransposons across the genome is non-uniform and there are observed imbalances in the orientation of insertions with respect to the transcriptional direction of the containing gene. Although some of the factors underlying the observed distributions are understood, much of the variability remains unexplained. Detailed characterization of retrotransposon density in genes could help inform predictions of the functional consequence of de novo as well as polymorphic insertions. In order to characterize the relationship between genes and inserted elements, we have examined the distribution of retrotransposons and their internal motifs within tissue-specific and housekeeping genes. We have identified that the previously established retrotransposon antisense bias decays at a linear rate across genes, resulting in an equal density of sense and antisense retrotransposons near the 3'-UTR. In addition, the decay of antisense bias across genes is less pronounced among tissue-specific genes. Our results provide support for the scenario in which this linear decay in antisense bias is established by natural selection shortly after retrotransposon integration, and that total antisense bias observed is above and beyond any bias introduced by the integration process itself. Finally, we provide an example of a retrotransposon acting as an eQTL on a coincident gene, highlighting one of several possible avenues through which insertions may modulate gene function.	[Linker, Sara] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Hussman Inst Human Genom,Dept Human Genet, Miami, FL 33136 USA; [Hedges, Dale] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA	University of Miami; University System of Ohio; Ohio State University	Hedges, D (corresponding author), Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA.	dale.hedges@osumc.edu			NSF [GRF: 2011132548]	NSF(National Science Foundation (NSF))	This work was supported by NSF GRF: 2011132548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; CHANG C, 2011, FILM COMMENT, V47, P6; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; ENGLANDER EW, 1995, J BIOL CHEM, V270, P10091, DOI 10.1074/jbc.270.17.10091; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FUHRMAN SA, 1981, NUCLEIC ACIDS RES, V9, P6439, DOI 10.1093/nar/9.23.6439; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Grover D, 2003, MOL BIOL EVOL, V20, P1420, DOI 10.1093/molbev/msg153; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026099; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Liu W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001075; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Omar MFM, 2012, PATHOL ONCOL RES, V18, P783, DOI 10.1007/s12253-011-9485-5; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pavlicek A, 2001, GENE, V276, P39, DOI 10.1016/S0378-1119(01)00645-X; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Putku M, 2011, HUM MUTAT, V32, P806, DOI 10.1002/humu.21508; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; ROBINS DM, 1992, GENETICA, V86, P191, DOI 10.1007/BF00133720; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; SHAKHMURADOV I A, 1989, Genetika, V25, P1682; Shephard EA, 2007, BIOCHEM J, V406, P491, DOI 10.1042/BJ20070523; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Wagstaff BJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002842; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yu Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-308; Zingler N, 2005, GENOME RES, V15, P780, DOI 10.1101/gr.3421505	57	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79402	10.1371/journal.pone.0079402	http://dx.doi.org/10.1371/journal.pone.0079402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244495	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800071
J	Mill, DJ; Bito-Onon, JJ; Simms, JA; Li, R; Bartlett, SE				Mill, Douglas J.; Bito-Onon, Jade J.; Simms, Jeffrey A.; Li, Rui; Bartlett, Selena E.			Fischer Rats Consume 20% Ethanol in a Long-Term Intermittent-Access Two-Bottle-Choice Paradigm	PLOS ONE			English	Article							ALCOHOL-DRINKING; ANIMAL-MODELS; NEUROBIOLOGY; DEPRIVATION; STRAINS	The 20% ethanol intermittent-access (IAE) two-bottle-choice drinking procedure has been shown to produce high voluntary ethanol consumption in a number of rat strains. For this study, we applied this procedure to male Fischer (F344) rats, a strain previously reported to exhibit low levels of ethanol consumption. We also subjected these animals to a two-week ethanol-deprivation- period to see if they would exhibit an alcohol deprivation effect (ADE) signified by a transient increase in alcohol consumption following deprivation. Our data show a separation between high and low consuming animals within this strain, with high-consumers exhibiting an escalation in consumption. In contrast, Fischer rats did not show a significant separation between high and low consumers or any significant escalation in consumption, using the 20% ethanol continuous-access two-bottle-choice drinking protocol. Following the two-week deprivation period, animals in the high (but not the low) IAE group exhibited the transient increase in ethanol consumption and preference typically associated with an ADE. Together, the data suggest that the intermittent access protocol is a useful protocol for increasing ethanol consumption.	[Bartlett, Selena E.] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia; [Bartlett, Selena E.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Mill, Douglas J.; Bito-Onon, Jade J.; Simms, Jeffrey A.; Li, Rui] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Bartlett, SE (corresponding author), Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia.	selena.bartlett@qut.edu.au	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958	State of California for Medical Research through University of California San Francisco; Australian Research Council; Department of Defense [W81XWH-10-1-0247]	State of California for Medical Research through University of California San Francisco; Australian Research Council(Australian Research Council); Department of Defense(United States Department of Defense)	This work was supported by funding from the State of California for Medical Research through University of California San Francisco to SEB and Australian Research Council to SEB and the Department of Defense Grant W81XWH-10-1-0247 to SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Ciccocioppo R, 2006, ADDICT BIOL, V11, P339, DOI 10.1111/j.1369-1600.2006.00032.x; GEORGE FR, 1987, PHARMACOL BIOCHEM BE, V27, P379, DOI 10.1016/0091-3057(87)90586-7; Heyser CJ, 1997, ALCOHOL CLIN EXP RES, V21, P784; KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; LI TK, 1984, ALCOHOL CLIN EXP RES, V8, P485; Oster SM, 2006, ALCOHOL, V38, P155, DOI 10.1016/j.alcohol.2006.06.001; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sommer W, 2006, ADDICT BIOL, V11, P289, DOI 10.1111/j.1369-1600.2006.00037.x; Spanagel R, 1999, ALCOHOL ALCOHOLISM, V34, P231, DOI 10.1093/alcalc/34.2.231; Stewart RB, 1997, ALCOHOL HEALTH RES W, V21, P169; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034	15	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79824	10.1371/journal.pone.0079824	http://dx.doi.org/10.1371/journal.pone.0079824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244567	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800102
J	Barboro, P; Borzi, L; Repaci, E; Ferrari, N; Balbi, C				Barboro, Paola; Borzi, Luana; Repaci, Erica; Ferrari, Nicoletta; Balbi, Cecilia			Androgen Receptor Activity Is Affected by Both Nuclear Matrix Localization and the Phosphorylation Status of the Heterogeneous Nuclear Ribonucleoprotein K in Anti-Androgen-Treated LNCaP Cells	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; PROSTATE-CANCER; HNRNP-K; EXPRESSION; BINDING; PROTEINS; IDENTIFICATION; PROGRESSION; DIAGNOSIS; CONTAINS	The androgen receptor (AR) plays a central role in the development and progression of prostate cancer (PCa) and antiandrogen therapy is a standard treatment. Unfortunately, after a few years, the majority of patients progress, developing androgen-independent PCa. AR-driven gene transcription recruits a large number of co-activator/co-repressor complexes; among these, the heterogeneous nuclear ribonucleoprotein K (hnRNP K) directly interacts with and regulates the AR translational apparatus. Here we examined AR and hnRNP K expression in response to the treatment of LNCaP cells with anti-androgen cyproterone acetate (CPA) or bicalutamide (BIC). AR and hnRNP K modulation and compartmentalization were studied by Western blot and confocal microscopy. Phosphate-affinity gel electrophoresis was employed to examine how anti-androgens modified hnRNP K phosphorylation. 10(-6) M CPA significantly stimulated LNCaP proliferation, whereas for 10(-4) M CPA or 10(-5) M BIC an antagonistic effect was observed. After anti-androgen treatment, AR expression was remarkably down-regulated within both the cytoplasm and the nucleus; however, when CPA had an agonist activity, the AR associated with the nuclear matrix (NM) increased approximately 2.5 times. This increase was synchronous with a higher PSA expression, indicating that the NM-associated AR represents the active complex. After BIC treatment, hnRNP K expression was significantly lower in the NM, the protein was hypophosphorylated and the co-localization of AR and hnRNP K decreased. In contrast, CPA as an agonist caused hnRNP K hyperphosphorylation and an increase in the co-localization of two proteins. These findings demonstrate that, in vitro, there is a strong relationship between NM-associated AR and both cell viability and PSA levels, indicating that AR transcriptional activity is critically dependent on its subnuclear localization. Moreover, the agonistic/antagonistic activity of anti-androgens is associated with modifications in hnRNP K phosphorylation, indicating an involvement of this protein in the AR transcriptional activity and likely in the onset of the androgen-independent phenotype.	[Barboro, Paola; Borzi, Luana; Repaci, Erica; Balbi, Cecilia] Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Translat Urol Res Unit, Genoa, Italy; [Ferrari, Nicoletta] Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Mol Oncol & Angiogenesis, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Balbi, C (corresponding author), Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Translat Urol Res Unit, Genoa, Italy.	cecilia.balbi@istge.it	Barboro, Paola/AAE-7144-2019; Ferrari, Nicoletta/AAG-6049-2019; Repaci, Erica/H-6576-2017	Barboro, Paola/0000-0001-9074-9290; Ferrari, Nicoletta/0000-0002-6027-1035; Repaci, Erica/0000-0002-6441-9308	Regione Liguria [563/2009]; Compagnia San Paolo [2009.127]	Regione Liguria(Regione Liguria); Compagnia San Paolo(Compagnia di San Paolo)	This work was partially supported by Regione Liguria (www.regione.liguria.it), grant number 563/2009; Compagnia San Paolo (www.fondazioneintesasanpaoloonlus.org) grant number 2009.127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti I, 2000, J CELL BIOCHEM, V79, P471, DOI 10.1002/1097-4644(20001201)79:3<471::AID-JCB120>3.3.CO;2-F; Barboro P, 2005, ANTICANCER RES, V25, P3999; Barboro P, 2003, J CELL BIOCHEM, V88, P113, DOI 10.1002/jcb.10378; Barboro P, 2002, EXP CELL RES, V279, P202, DOI 10.1006/excr.2002.5605; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barboro P, 2008, CELL ONCOL, V30, P13; Barboro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040617; Barboro P, 2011, PROSTATE, V71, P1466, DOI 10.1002/pros.21366; Barboro P, 2009, EXP CELL RES, V315, P226, DOI 10.1016/j.yexcr.2008.10.017; BARRACK ER, 1983, ENDOCRINOLOGY, V113, P430, DOI 10.1210/endo-113-1-430; Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411; Boccardo F, 2003, PROSTATE, V55, P259, DOI 10.1002/pros.10248; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; BROWN TR, 1986, J CLIN ENDOCR METAB, V62, P542, DOI 10.1210/jcem-62-3-542; BUTTYAN R, 1983, J BIOL CHEM, V258, P4366; Ciarlo M, 2012, INT J CANCER, V131, P582, DOI 10.1002/ijc.26402; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; GONOR SE, 1984, J UROLOGY, V131, P1196, DOI 10.1016/S0022-5347(17)50871-X; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HOZAK P, 1995, J CELL SCI, V108, P635; Jackson DA, 2006, VIRUSES NUCL, P1; KAUFMANN SH, 1991, EXP CELL RES, V192, P524, DOI 10.1016/0014-4827(91)90072-3; Kim D, 2006, MOL CELL BIOL, V26, P2187, DOI 10.1128/MCB.26.6.2187-2201.2006; Kimura Y, 2010, PROTEOMICS, V10, P3884, DOI 10.1002/pmic.201000349; Lin JQ, 1999, CANCER RES, V59, P2891; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Masiello D, 2004, MOL ENDOCRINOL, V18, P2388, DOI 10.1210/me.2003-0436; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Ricci F, 2012, J CANCER RES CLIN, V138, P1379, DOI 10.1007/s00432-012-1216-0; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Zeng CM, 1998, P NATL ACAD SCI USA, V95, P1585, DOI 10.1073/pnas.95.4.1585; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79212	10.1371/journal.pone.0079212	http://dx.doi.org/10.1371/journal.pone.0079212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236111	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700110
J	Deng, BC; Zhou, B; Zhang, SJ; Zhu, Y; Han, LQ; Geng, YZ; Jin, ZN; Liu, HB; Wang, DL; Zhao, YT; Wen, Y; Cui, W; Zhou, Y; Gu, QH; Sun, CM; Lu, X; Wang, W; Wang, Y; Li, CB; Wang, YL; Yao, WQ; Liu, P				Deng, Baocheng; Zhou, Bo; Zhang, Shujun; Zhu, Ying; Han, Leqiang; Geng, Yingzhi; Jin, Zhenan; Liu, Hongbo; Wang, Donglei; Zhao, Yitong; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Sun, Cuiming; Lu, Xu; Wang, Wen; Wang, Yu; Li, Chengbo; Wang, Yanli; Yao, Wenqing; Liu, Pei			Clinical Features and Factors Associated with Severity and Fatality among Patients with Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection in Northeast China	PLOS ONE			English	Article							CONGO HEMORRHAGIC-FEVER; RISK-FACTORS; RIBAVIRIN THERAPY; RENAL SYNDROME; VIRUS; OUTBREAK; OUTCOMES; REGION; TURKEY; ADULTS	Background: In 2009, severe fever with thrombocytopenia syndrome virus (SFTSV) was identified as a novel member of the genus phlebovirus in the Bunyaviridae family in China. The detailed clinical features of cases with SFTSV infection have not been well described, and the risk factors for severity among patients and fatality among severe patients remain to be determined. Methodology/Principal Findings: Clinical and laboratory features of 115 hospitalized patients with SFTSV infection during the period from June 2010 to December 2011 in Northeast China were retrospectively reviewed. We assessed the risk factors associated with severity in confirmed cases and fatality in severe cases by multivariate analysis. One hundred and three (89.6%) of 115 patients presented with multiple organ dysfunction, and 22 (19.1%) of 115 proceeded to the stage of life threatening multiple organ failure. Of the 115 patients, 14 fatalities (12.2%) were reported. Multivariate analysis demonstrated that the independent predictors of risk for severity were: albumin <= 30 g/l (OR, 8.09; 95% CI, 2.58-25.32), APTT >= 66 seconds (OR, 14.28; 95% CI, 3.28-62.24), sodium <= 130 mmol/l (OR, 5.44; 95% CI, 1.38-21.40), and presence of neurological manifestations (OR, 7.70; 95% CI, 1.91-31.12). Among patients with severe disease, presence of acute lung injury/acute respiratory distress syndrome (HR, 4.59; 95% CI, 1.48-14.19) and disseminated intravascular coagulation (HR, 4.24; 95% CI, 1.38-13.03) were independently associated with fatality. Conclusions/Significance: SFTSV infection may present with more severe symptoms and laboratory abnormalities than hitherto reported. Due to infection with a novel bunyavirus, the patients may sufferer multiple organ dysfunction and die of multiple organ failure. In the clinical assessment of any case of SFTS, independent factors relating to prognosis need to be taken into account by clinicians.	[Deng, Baocheng; Wang, Donglei; Zhao, Yitong; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Sun, Cuiming; Lu, Xu; Wang, Wen; Wang, Yu; Li, Chengbo; Wang, Yanli; Liu, Pei] China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China; [Zhou, Bo] China Med Univ, Affiliated Hosp 1, Dept Clin Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Shujun] Kuandian Country Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Zhu, Ying] Dalian Med Univ, Affiliated Hosp 1, Dept Infect Dis, Dalian, Liaoning Provin, Peoples R China; [Han, Leqiang] Dalian Municipal Infect Dis Hosp, Dalian, Liaoning Provin, Peoples R China; [Geng, Yingzhi; Yao, Wenqing] Liaoning Prov CDC, Shenyang, Liaoning Provin, Peoples R China; [Jin, Zhenan] Donggang Infect Dis Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Liu, Hongbo] Liaoning Prov Peoples Hosp, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; Dalian Medical University	Liu, P (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China.	wenqingyao@sina.com; syliupei2013@163.com			Ministry of Science and Technology [2012ZX10004209-005]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by China Mega-Project for Infectious Diseases grants (2012ZX10004209-005) from the Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; Avsic-Zupanc T, 1999, CLIN INFECT DIS, V28, P860, DOI 10.1086/515185; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Castillo C, 2001, CHEST, V120, P548, DOI 10.1378/chest.120.2.548; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Deng B, 2012, J CLIN VIROL; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Ergonul O, 2006, CLIN MICROBIOL INFEC, V12, P551, DOI 10.1111/j.1469-0691.2006.01445.x; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Ergonul O, 2004, CLIN INFECT DIS, V39, P284, DOI 10.1086/422000; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hassan OA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001229; HUGGINS JW, 1991, J INFECT DIS, V164, P1119, DOI 10.1093/infdis/164.6.1119; Li SB, 2011, BIOSCI TRENDS, V5, P273, DOI 10.5582/bst.2011.v5.6.273; Lin JJ, 2012, J CHILD NEUROL; [刘力 Liu Li], 2012, [中华流行病学杂志, Chinese Journal of Epidemiology], V33, P168; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Ministry of Health, 2011, CHIN J CLIN INFECT D, V4, P193; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Parkash O, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-43; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Spoelstra-de Man AME, 2008, INTENS CARE MED, V34, P1160, DOI 10.1007/s00134-008-1089-5; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Tufan ZK, 2011, J INFECTION, V63, P375, DOI 10.1016/j.jinf.2011.07.011; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang Ling-ling, 2012, Zhonghua Xue Ye Xue Za Zhi, V33, P250; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	38	98	115	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80802	10.1371/journal.pone.0080802	http://dx.doi.org/10.1371/journal.pone.0080802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236203	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700206
J	Ferreira, JC; Ferrari, GO; Neves, KR; Cavallari, RT; Dominguez, WV; dos Reis, LM; Graciolli, FG; Oliveira, EC; Liu, SG; Sabbagh, Y; Jorgetti, V; Schiavi, S; Moyses, RMA				Ferreira, Juliana C.; Ferrari, Guaraciaba O.; Neves, Katia R.; Cavallari, Raquel T.; Dominguez, Wagner V.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Oliveira, Elizabeth C.; Liu, Shiguang; Sabbagh, Yves; Jorgetti, Vanda; Schiavi, Susan; Moyses, Rosa M. A.			Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease - Role of Sclerostin?	PLOS ONE			English	Article							PARATHYROID-HORMONE; GENE-EXPRESSION; RENAL OSTEODYSTROPHY; MINERAL DENSITY; FAILURE; TARGET; WNT; PTH; OSTEOCYTES; FRACTURES	High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways. Recent studies have raised the possibility that dysregulation of the osteocyte Wnt/beta-catenin signaling pathway is also involved in chronic kidney disease (CKD)-related bone disease. We investigated the role of dietary phosphate and its possible interaction with this pathway in an experimental model of adynamic bone disease (ABD) in association with CKD and hypoparathyroidism. Partial nephrectomy (Nx) and total parathyroidectomy (PTx) were performed in male Wistar rats. Control rats with normal kidney and parathyroid function underwent sham operations. Rats were divided into three groups and underwent pair-feeding for 8 weeks with diets containing either 0.6% or 1.2% phosphate: sham 0.6%, Nx+PTx 0.6%, and Nx+ PTx 1.2%. In the two Nx+ PTx groups, serum creatinine increased and blood ionized calcium decreased compared with sham control group. They also presented hyperphosphatemia and reduced serum parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) levels. Fractional urinary excretion of phosphate increased in Nx+ PTx 1.2% rats despite lower PTH and FGF23 levels than in sham group. These biochemical changes were accompanied by a decrease in bone formation rates. The Nx+ PTx 1.2% group had lower bone volume (BV/TV), higher osteoblast and osteocyte apoptosis, and higher SOST and Dickkopf-1 gene expression than the Nx +PTx 0.6% group. Nx+ PTx 0.6% rat had very low serum sclerostin levels, and Nx+ PTx 1.2% had intermediate sclerostin levels compared with sham group. Finally, there was a negative correlation between BV/TV and serum sclerostin. These results suggest that high dietary phosphate intake decreases bone volume in an experimental model of CKD-ABD, possibly via changes in SOST expression through a PTH-independent mechanism. These findings could have relevance for the clinical setting of CKD-ABD in patients who low turnover bone disease might be attenuated by optimal control of phosphate intake and/or absorption.	[Ferreira, Juliana C.; Ferrari, Guaraciaba O.; Neves, Katia R.; Cavallari, Raquel T.; Dominguez, Wagner V.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Oliveira, Elizabeth C.; Jorgetti, Vanda; Moyses, Rosa M. A.] Univ Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil; [Liu, Shiguang; Sabbagh, Yves; Schiavi, Susan] Genzyme Corp, Sanofi Genzyme R&D Ctr, Framingham, MA USA	Universidade de Sao Paulo; Sanofi-Aventis; Genzyme Corporation	Moyses, RMA (corresponding author), Univ Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil.	rosa.moyses@uol.com.br	dos Reis, Luciene M/C-7143-2013; Sabbagh, Yves/I-9792-2019; Dominguez, Wagner/AAR-6693-2020; JORGETTI, VANDA/C-9470-2012; Neves, Katia/CAF-1819-2022; Moyses, Rosa M A/F-8268-2012	dos Reis, Luciene M/0000-0001-8476-6780; Sabbagh, Yves/0000-0001-5339-6705; JORGETTI, VANDA/0000-0002-4824-8879; Moyses, Rosa M A/0000-0002-7902-2127	Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/58849-3]; CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303325/2010-0]	Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was performed with grants from Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP, Grant 2008/58849-3) and Genzyme Co. Research in the laboratory of RMM is supported by CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 303325/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Batista DG, 2010, CALCIFIED TISSUE INT, V87, P60, DOI 10.1007/s00223-010-9367-y; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bilezikian JP, 2011, J BONE MINER RES, V26, P2317, DOI 10.1002/jbmr.483; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brandenburg VM, 2008, CLIN KIDNEY J, V1, P135, DOI 10.1093/ndtplus/sfn040; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Coen G, 2005, J NEPHROL, V18, P117; Couttenye MM, 1999, KIDNEY INT, V56, pS70, DOI 10.1046/j.1523-1755.1999.07308.x; de Oliveira RB, 2013, NEPHROL DIAL TRANSPL, V28, P1; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gouveia CHA, 1997, J BONE MINER RES, V12, P2098, DOI 10.1359/jbmr.1997.12.12.2098; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huttunen MM, 2006, J NUTR BIOCHEM, V17, P479, DOI 10.1016/j.jnutbio.2005.09.001; Iwasaki-Ishizuka Y, 2005, NEPHROL DIAL TRANSPL, V20, P1904, DOI 10.1093/ndt/gfh876; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; Malluche HH, 2004, NEPHROL DIAL TRANSPL, V19, pI9, DOI 10.1093/ndt/gfh1002; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; McGartland C, 2003, J BONE MINER RES, V18, P1563, DOI 10.1359/jbmr.2003.18.9.1563; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Salusky IB, 2001, J AM SOC NEPHROL, V12, P1978, DOI 10.1681/ASN.V1291978; Sanchez CP, 2006, PERITON DIALYSIS INT, V26, P43; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Sherrard DJ, 1996, NEPHROL DIAL TRANSPL, V11, P29; Tani Y, 2007, J CLIN BIOCHEM NUTR, V40, P221, DOI 10.3164/jcbn.40.221; Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936	42	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79721	10.1371/journal.pone.0079721	http://dx.doi.org/10.1371/journal.pone.0079721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236156	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700155
J	Govindasamy, D; Kranzer, K; van Schaik, N; Noubary, F; Wood, R; Walensky, RP; Freedberg, KA; Bassett, IV; Bekker, LG				Govindasamy, Darshini; Kranzer, Katharina; van Schaik, Nienke; Noubary, Farzad; Wood, Robin; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.; Bekker, Linda-Gail			Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RISK-FACTORS; HYPERTENSION; COMMUNITY; ACCESS; DETERMINANTS; POPULATION; STRATEGIES; DIAGNOSIS; SERVICES	Background: HIV counseling and testing may serve as an entry point for non-communicable disease screening. Objectives: To determine the yield of newly-diagnosed HIV, tuberculosis (TB) symptoms, diabetes and hypertension, and to assess CD4 count testing, linkage to care as well as correlates of linkage and barriers to care from a mobile testing unit. Methods: A mobile unit provided screening for HIV, TB symptoms, diabetes and hypertension in Cape Town, South Africa between March 2010 and September 2011. The yield of newly-diagnosed cases of these conditions was measured and clients were followed-up between January and November 2011 to assess linkage. Linkage to care was defined as accessing care within one, three or six months post-HIV diagnosis (dependent on CD4 count) and one month post-diagnosis for other conditions. Clinical and socio-demographic correlates of linkage to care were evaluated using Poisson regression and barriers to care were determined. Results: Of 9,806 clients screened, the yield of new diagnoses was: HIV (5.5%), TB suspects (10.1%), diabetes (0.8%) and hypertension (58.1%). Linkage to care for HIV-infected clients, TB suspects, diabetics and hypertensives was: 51.3%, 56.7%, 74.1% and 50.0%. Only disclosure of HIV-positive status to family members or partners (RR=2.6, 95% CI:1.04-6.3, p=0.04) was independently associated with linkage to HIV care. The main barrier to care reported by all groups was lack of time to access a clinic. Conclusion: Screening for HIV, TB symptoms and hypertension at mobile units in South Africa has a high yield but inadequate linkage. After-hours and weekend clinics may overcome a major barrier to accessing care.	[Govindasamy, Darshini; Kranzer, Katharina; van Schaik, Nienke; Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Noubary, Farzad; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Massachusetts General Hospital; Tufts Medical Center; Tufts University; University of Cape Town; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Govindasamy, D (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	gdarsh@gmail.com	Bekker, Linda-Gail/AAZ-8929-2020; Bassett, Ingrid V./ABI-7674-2020; Kranzer, Katharina/O-8845-2014	Bassett, Ingrid V./0000-0001-6920-6080; Kranzer, Katharina/0000-0001-5691-7270; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Allergy and Infectious Disease [3R01AI058736, K24 AI062476]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; Presidents Emergency Plan for AIDS Relief (PEPFAR); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program; Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K24AI062476, R01AI058736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH090326] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Presidents Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program(United States Agency for International Development (USAID)); Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by: the National Institute of Allergy and Infectious Disease: 3R01AI058736, K24 AI062476; the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Mental Health: R01 MH090326, R01 MH073445, the Presidents Emergency Plan for AIDS Relief (PEPFAR); and the Claflin Distinguished Scholar Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mobile testing unit is partially funded by PEPFAR through the Anova Health Institute and the United States Agency for International Development program and received further funding through the Agence Francaise de Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amolloh M, 2011, 18 C RETR OPP INF BO, P1077; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Bertram MY, 2012, SAMJ S AFR MED J, V102, P743, DOI [10.7196/samj.5832, 10.7196/SAMJ.5832]; Cape Western Department of Health, 2009, HIV COUNS TEST PROT; Cape Western Government, 2010, COMPR SERV PLAN IMPL; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Connor M, 2005, SAMJ S AFR MED J, V95, P334; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Grabbe KL, 2010, JAIDS-J ACQ IMM DEF, V54, P317, DOI 10.1097/QAI.0b013e3181ced126; Guariguata L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-44; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Health Department: Republic of South Africa, 2013, S AFR ANT THER GUID; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Human Sciences Research Council, 2013, S AFR NAT HLTH NUTR; International Union Against Tuberculosis and Lung Disease, 2000, TECHN GUID SPUT EX T; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Joint National Hypertension Guideline Working Group, 2006, AFR HYP GUID 2; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Kranzer K, 2011, INT J TUBERC LUNG D, V15, P1077, DOI 10.5588/ijtld.10.0684; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Kundu CK, 2012, J TROP PEDIATRICS, V58, P31, DOI 10.1093/tropej/fmr026; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mbopi-Keou FX, 2007, AIDS, V21, P1994, DOI 10.1097/QAD.0b013e3282f006c3; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Muhamadi L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-184; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mwangemi F, 2010, HIV HLTH SYST PREC V; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; Nglazi M, 2012, J ACQ IMMUN DEF SYND, V59, P281, DOI [10.1097/QAI.0b013e31823e5bee, DOI 10.1097/QAI.0B013E31823E5BEE.PUBMED:22067662]; Nolan M, 2011, 19 INT AIDS C ROM IT; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; Rabkin M, 2011, JAIDS-J ACQ IMM DEF, V57, pS87, DOI 10.1097/QAI.0b013e31821db92a; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; South African Government News Agency, 2012, 20 MILLION S AFR HAV; Steyn K, 1996, E AFR MED J, V73, P758; Steyn K, 2008, SAMJ S AFR MED J, V98, P376; The National HIV Counselling and Testing Campaign Strategy, 2010, POLICY GUIDELINES; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; UNICEF, 2011, CHRON CAR HIV NONC D; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Wall K, 2012, AIDS, V26, P217, DOI 10.1097/QAD.0b013e32834dc593; Wanyenze R, 2011, 16 INT AIDS C TOR CA; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2011, WHO GLOB HIV AIDS RE	62	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80017	10.1371/journal.pone.0080017	http://dx.doi.org/10.1371/journal.pone.0080017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236170	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000327254700171
J	Graca, AP; Bondoso, J; Gaspar, H; Xavier, JR; Monteiro, MC; de la Cruz, M; Oves-Costales, D; Vicente, F; Lage, OM				Graca, Ana Patricia; Bondoso, Joana; Gaspar, Helena; Xavier, Joana R.; Monteiro, Maria Candida; de la Cruz, Mercedes; Oves-Costales, Daniel; Vicente, Francisca; Lage, Olga Maria			Antimicrobial Activity of Heterotrophic Bacterial Communities from the Marine Sponge Erylus discophorus (Astrophorida, Geodiidae)	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; TRITERPENE GLYCOSIDES; DRUG DISCOVERY; SP-NOV.; PHYLOGENETIC ANALYSIS; POLYKETIDE SYNTHASES; MICROBIAL COMMUNITY; ELECTRON-MICROSCOPE; APLYSINA-AEROPHOBA; MEDITERRANEAN-SEA	Heterotrophic bacteria associated with two specimens of the marine sponge Erylus discophorus were screened for their capacity to produce bioactive compounds against a panel of human pathogens (Staphylococcus aureus wild type and methicillin-resistant S. aureus (MRSA), Bacillus subtilis, Pseudomonas aeruginosa, Acinetobacter baumanii, Candida albicans and Aspergillus fumigatus), fish pathogen (Aliivibrio fischeri) and environmentally relevant bacteria (Vibrio harveyi). The sponges were collected in Berlengas Islands, Portugal. Of the 212 isolated heterotrophic bacteria belonging to Alpha-and Gammaproteobacteria, Actinobacteria and Firmicutes, 31% produced antimicrobial metabolites. Bioactivity was found against both Gram positive and Gram negative and clinically and environmentally relevant target microorganisms. Bioactivity was found mainly against B. subtilis and some bioactivity against S. aureus MRSA, V. harveyi and A. fisheri. No antifungal activity was detected. The three most bioactive genera were Pseudovibrio (47.0%), Vibrio (22.7%) and Bacillus (7.6%). Other less bioactive genera were Labrenzia, Acinetobacter, Microbulbifer, Pseudomonas, Gordonia, Microbacterium, Micrococcus and Mycobacterium, Paenibacillus and Staphylococcus. The search of polyketide I synthases (PKS-I) and nonribosomal peptide synthetases (NRPSs) genes in 59 of the bioactive bacteria suggested the presence of PKS-I in 12 strains, NRPS in 3 strains and both genes in 3 strains. Our results show the potential of the bacterial community associated with Erylus discophorus sponges as producers of bioactive compounds.	[Graca, Ana Patricia; Bondoso, Joana; Lage, Olga Maria] Univ Porto, Dept Biol, Fac Sci, P-4100 Oporto, Portugal; [Graca, Ana Patricia; Bondoso, Joana; Lage, Olga Maria] Interdisciplinary Ctr Marine & Environm Res CIMAR, Oporto, Portugal; [Gaspar, Helena] Univ Lisboa Campo Grande, Fac Ciencias, Ctr Quim & Bioquim, Lisbon, Portugal; [Gaspar, Helena] Univ Lisboa Campo Grande, Fac Ciencias, Dept Quim & Bioquim, Lisbon, Portugal; [Xavier, Joana R.] Univ Acores, Polo Acores Dept Biol, InBIO Lab Associado, Ctr Invest Biodiversidade & Recursos Genet,CIBIO, Ponta Delgada, Portugal; [Xavier, Joana R.] CSIC, Ctr Estudis Avancats Blanes, CEAB, Blanes, Girona, Spain; [Monteiro, Maria Candida; de la Cruz, Mercedes; Oves-Costales, Daniel; Vicente, Francisca] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Granada, Spain	Universidade do Porto; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade dos Acores; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Lage, OM (corresponding author), Univ Porto, Dept Biol, Fac Sci, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	olga.lage@fc.up.pt	Bondoso, Joana/C-9365-2015; DE LA CRUZ MORENO, MERCEDES/M-1533-2014; Oves-Costales, Daniel/I-1543-2015; Gaspar, Helena/E-6798-2012; Xavier, Joana/J-8387-2012; Bondoso, Joana/AAX-5602-2020; vicente, francisca/N-5126-2014; Lage, Olga/A-9218-2010	Bondoso, Joana/0000-0002-7501-2335; DE LA CRUZ MORENO, MERCEDES/0000-0002-2389-8576; Oves-Costales, Daniel/0000-0001-9986-4623; Gaspar, Helena/0000-0002-1613-7023; Xavier, Joana/0000-0003-1386-4492; Bondoso, Joana/0000-0002-7501-2335; vicente, francisca/0000-0003-3198-9205; Lage, Olga/0000-0002-3950-3970; Graca, Ana Patricia/0000-0001-5738-0161	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT - Foundation for Science and Technology [PEst-C/MAR/LA0015/2013, PEst-OE/QUI/UI0612/2011, PTDC/QUI-QUI/098053/2008, SFRH/BD/35933/2007, SFRH/BPD/62946/2009]; ERAMUS fellowship; Fundacion MEDINA	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT - Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ERAMUS fellowship; Fundacion MEDINA	This research was supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT - Foundation for Science and Technology, under the projects PEst-C/MAR/LA0015/2013, PEst-OE/QUI/UI0612/2011 and PTDC/QUI-QUI/098053/2008. Ana Patricia Gracia acknowledges an ERAMUS fellowship. Joana Bondoso was financed by FCT - Foundation for Science and Technology (PhD grant SFRH/BD/35933/2007). Joana R. Xavier's research is funded by an FCT - Foundation for Science and Technology postdoctoral fellowship (grant no. SFRH/BPD/62946/2009). In addition, this work was funded by the Fundacion MEDINA, a public-private partnership of Merck Sharp and Dohme of Espana/Universidad de Granada/Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; Afiyatullov SS, 2007, J NAT PROD, V70, P1871, DOI 10.1021/np070319y; AMADE P, 1987, MAR BIOL, V94, P271, DOI 10.1007/BF00392940; Anand TP, 2006, MICROBIOL RES, V161, P252, DOI 10.1016/j.micres.2005.09.002; Antonov AS, 2007, J NAT PROD, V70, P169, DOI 10.1021/np060364q; Antonov AS, 2011, CARBOHYD RES, V346, P2182, DOI 10.1016/j.carres.2011.07.008; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bultel-Ponce V, 1999, MAR BIOTECHNOL, V1, P384, DOI 10.1007/PL00011792; Monteiro MC, 2012, J BIOMOL SCREEN, V17, P542, DOI 10.1177/1087057111433459; CARMELY S, 1989, J NAT PROD, V52, P167, DOI 10.1021/np50061a022; Chen GH, 2000, J ANTIBIOT, V53, P1145, DOI 10.7164/antibiotics.53.1145; Chen YH, 2012, WORLD J MICROB BIOT, V28, P3269, DOI 10.1007/s11274-012-1138-7; Chung YR, 2000, INT J SYST EVOL MICR, V50, P1495, DOI 10.1099/00207713-50-4-1495; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAURIA MV, 1992, TETRAHEDRON, V48, P491, DOI 10.1016/S0040-4020(01)89011-6; Devi P, 2010, MAR DRUGS, V8, P1203, DOI 10.3390/md8041203; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Donnelly A.C., 2006, MARINE NATURAL PRODU; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; Farmer JJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P508, DOI 10.1007/0-387-30746-x_18; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fickers P., 2012, AM J BIOCH BIOTECHNO, V8, P38; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Flemer B, 2012, J APPL MICROBIOL, V112, P289, DOI 10.1111/j.1365-2672.2011.05211.x; Fouad M, 2004, ARKIVOC, P17, DOI 10.3998/ark.5550190.0005.d03; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Gebhardt K, 2002, FEMS MICROBIOL LETT, V217, P199, DOI 10.1111/j.1574-6968.2002.tb11475.x; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Gurgui C, 2010, METHODS MOL BIOL, V668, P247, DOI 10.1007/978-1-60761-823-2_17; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hochmuth T, 2009, PHYTOCHEMISTRY, V70, P1841, DOI 10.1016/j.phytochem.2009.04.010; Hodges TW, 2012, MAR BIOTECHNOL, V14, P270, DOI 10.1007/s10126-011-9410-7; Hooper J. N. A., 2002, SYSTEMA PORIFERA, DOI [10.1007/978-1-4615-0747-5_3, DOI 10.1007/978-1-4615-0747-5_3]; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Isnansetyo A, 2009, J IND MICROBIOL BIOT, V36, P1239, DOI 10.1007/s10295-009-0611-2; Izumida H, 1996, J ANTIBIOT, V49, P76, DOI 10.7164/antibiotics.49.76; JASPARS M, 1994, TETRAHEDRON LETT, V35, P7501, DOI 10.1016/S0040-4039(00)78328-6; Kamat T., 2011, RECENT RES SCI TECHN, V3, P46; Kanagasabhapathy M, 2008, WORLD J MICROB BIOT, V24, P2315, DOI 10.1007/s11274-008-9746-y; Kim DS, 2004, INT J SYST EVOL MICR, V54, P2031, DOI 10.1099/ijs.0.02414-0; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; KOBAYASHI M, 1994, PURE APPL CHEM, V66, P819, DOI 10.1351/pac199466040819; Koopmans M, 2009, MAR DRUGS, V7, P787, DOI 10.3390/md7040787; Kubanek J, 2002, OECOLOGIA, V131, P125, DOI 10.1007/s00442-001-0853-9; Kubanek J, 2001, NAT PROD LETT, V15, P275, DOI 10.1080/10575630108041292; Kubanek J, 2000, MAR ECOL PROG SER, V207, P69, DOI 10.3354/meps207069; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lang S, 2004, MAR BIOTECHNOL, V6, P152, DOI 10.1007/s10126-003-0009-5; Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625; Lo Giudice A, 2007, FEMS MICROBIOL ECOL, V60, P383, DOI 10.1111/j.1574-6941.2007.00300.x; Luis NA, 2006, IDENTIFICATION PHYLO; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Moore BS, 2005, ANTON LEEUW INT J G, V87, P49, DOI 10.1007/s10482-004-6541-0; Muscholl-Silberhorn A, 2008, MICROB ECOL, V55, P94, DOI 10.1007/s00248-007-9255-9; Neilan BA, 1999, J BACTERIOL, V181, P4089, DOI 10.1128/JB.181.13.4089-4097.1999; Nicolai Marisa H., 2007, V28, P491; Nishijima M, 2009, INT J SYST EVOL MICR, V59, P1696, DOI 10.1099/ijs.0.006452-0; OCLARIT JM, 1994, MICROBIOS, V78, P7; Okada Y, 2006, J ORG CHEM, V71, P4884, DOI 10.1021/jo060653j; OlguinUribe G, 1997, J CHEM ECOL, V23, P2507, DOI 10.1023/B:JOEC.0000006663.28348.03; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Phelan RW, 2012, J APPL MICROBIOL, V112, P65, DOI 10.1111/j.1365-2672.2011.05173.x; Quevrain E, 2009, ENVIRON MICROBIOL, V11, P1527, DOI 10.1111/j.1462-2920.2009.01880.x; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Sanchez-Hidalgo M, 2012, ANTON LEEUW INT J G, V102, P361, DOI 10.1007/s10482-012-9746-7; Sandler JS, 2005, TETRAHEDRON, V61, P1199, DOI 10.1016/j.tet.2004.11.039; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Schwedt A, 2011, THESIS U BREMEN MAX; Sertan-de Guzman AA, 2007, FEMS MICROBIOL LETT, V277, P188, DOI 10.1111/j.1574-6968.2007.00950.x; Simmons TL, 2005, MOL CANCER THER, V4, P333; Stead P, 2000, BIOORG MED CHEM LETT, V10, P661, DOI 10.1016/S0960-894X(00)00063-9; Sun W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042847; Takada K, 2002, J NAT PROD, V65, P411, DOI 10.1021/np010480n; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Tupinamba G, 2008, J APPL MICROBIOL, V105, P1044, DOI 10.1111/j.1365-2672.2008.03844.x; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Wagner-Dobler Irene, 2002, Adv Biochem Eng Biotechnol, V74, P207; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wang GY, 2006, J IND MICROBIOL BIOT, V33, P545, DOI 10.1007/s10295-006-0123-2; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Williams PG, 2009, TRENDS BIOTECHNOL, V27, P45, DOI 10.1016/j.tibtech.2008.10.005; Xi LJ, 2012, INT J MOL SCI, V13, P5917, DOI 10.3390/ijms13055917	93	60	63	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78992	10.1371/journal.pone.0078992	http://dx.doi.org/10.1371/journal.pone.0078992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236081	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700079
J	La Mantia, J; Klapste, J; El-Kassaby, YA; Azam, S; Guy, RD; Douglas, CJ; Mansfield, SD; Hamelin, R				La Mantia, Jonathan; Klapste, Jaroslav; El-Kassaby, Yousry A.; Azam, Shofiul; Guy, Robert D.; Douglas, Carl J.; Mansfield, Shawn D.; Hamelin, Richard			Association Analysis Identifies Melampsora xcolumbiana Poplar Leaf Rust Resistance SNPs	PLOS ONE			English	Article							COTTONWOOD POPULUS-TRICHOCARPA; GENOME-WIDE ASSOCIATION; RESTRICTED GENE MIGRATION; POPULATION-STRUCTURE; LARICI-POPULINA; REGIONAL DIFFERENTIATION; LINKAGE DISEQUILIBRIUM; CRYPTIC RELATEDNESS; DISEASE RESISTANCE; HYBRID POPLARS	Populus species are currently being domesticated through intensive time- and resource-dependent programs for utilization in phytoremediation, wood and paper products, and conversion to biofuels. Poplar leaf rust disease can greatly reduce wood volume. Genetic resistance is effective in reducing economic losses but major resistance loci have been race-specific and can be readily defeated by the pathogen. Developing durable disease resistance requires the identification of non-racespecific loci. In the presented study, area under the disease progress curve was calculated from natural infection of Melampsora xcolumbiana in three consecutive years. Association analysis was performed using 412 P. trichocarpa clones genotyped with 29,355 SNPs covering 3,543 genes. We found 40 SNPs within 26 unique genes significantly associated (permutated P<0.05) with poplar rust severity. Moreover, two SNPs were repeated in all three years suggesting non-race-specificity and three additional SNPs were differentially expressed in other poplar rust interactions. These five SNPs were found in genes that have orthologs in Arabidopsis with functionality in pathogen induced transcriptome reprogramming, Ca2+/calmodulin and salicylic acid signaling, and tolerance to reactive oxygen species. The additive effect of non-R gene functional variants may constitute high levels of durable poplar leaf rust resistance. Therefore, these findings are of significance for speeding the genetic improvement of this long-lived, economically important organism.	[La Mantia, Jonathan; Klapste, Jaroslav; El-Kassaby, Yousry A.; Azam, Shofiul; Guy, Robert D.; Hamelin, Richard] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Douglas, Carl J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC, Canada; [Hamelin, Richard] Nat Resources Canada, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Klapste, Jaroslav] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Dendrol & Forest Tree Breeding, Kamycka, Czech Republic	University of British Columbia; University of British Columbia; University of British Columbia; Natural Resources Canada; Czech University of Life Sciences Prague	Hamelin, R (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	richard.hamelin@ubc.ca	Guy, Robert/GPX-8421-2022; El-Kassaby, Yousry A/K-9856-2016; Klapste, Jaroslav/B-6668-2016; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Klapste, Jaroslav/0000-0001-5504-3735; Mansfield, Shawn/0000-0002-0175-554X; Hamelin, Richard/0000-0003-4006-532X	Genome British Columbia [103BIO]; Applied Genomics Innovation Program and Genome Canada [168BIO]	Genome British Columbia; Applied Genomics Innovation Program and Genome Canada	This work was supported by Genome British Columbia (103BIO) Applied Genomics Innovation Program and Genome Canada (168BIO) Large Scale Applied Research Project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bourassa M, 2007, PHYTOPATHOLOGY, V97, P603, DOI 10.1094/PHYTO-97-5-0603; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bresson A, 2011, NEW PHYTOL, V192, P151, DOI 10.1111/j.1469-8137.2011.03786.x; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Chandrashekar M, 1980, PHYTOPATHOLOGY, V71, P421; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dowkiw A, 2003, PHYTOPATHOLOGY, V93, P421, DOI 10.1094/PHYTO.2003.93.4.421; Dowkiw A, 2010, PLANT PATHOL, V59, P523, DOI 10.1111/j.1365-3059.2010.02277.x; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Geraldes A, 2013, MOL ECOL RE IN PRESS; Gerard PR, 2006, PHYTOPATHOLOGY, V96, P1027, DOI 10.1094/PHYTO-96-1027; Gilmour A. R., 2002, ASREML USER GUIDE RE; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Karkkainen HP, 2012, ANN HUM GENET, V76, P510, DOI 10.1111/j.1469-1809.2012.00729.x; Lescot M, 2004, THEOR APPL GENET, V109, P10, DOI 10.1007/s00122-004-1621-0; Levine MN, 1928, PHYTOPATHOLOGY, V18, P7; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Li QZ, 2009, GENET EPIDEMIOL, V33, P432, DOI 10.1002/gepi.20396; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M., 1998, GENETICS ANAL QUANTI; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P981, DOI 10.1094/PHYTO.2001.91.10.981; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Quesada T, 2010, GENETICS, V186, P677, DOI 10.1534/genetics.110.117549; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; RUPE JC, 1982, PHYTOPATHOLOGY, V72, P1587, DOI 10.1094/Phyto-72-1587; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Shin J-H., 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Steenackers J, 1996, BIOMASS BIOENERG, V10, P267, DOI 10.1016/0961-9534(95)00121-2; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Stirnberg P, 2012, PLANT J, V71, P907, DOI 10.1111/j.1365-313X.2012.05038.x; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; WIDIN KD, 1981, EUR J FOREST PATHOL, V11, P438; Xie CY, 2012, CAN J FOREST RES, V42, P400, DOI [10.1139/X11-187, 10.1139/x11-187]; Xie CY, 2009, CAN J FOREST RES, V39, P519, DOI 10.1139/X08-190; Yin TM, 2004, NEW PHYTOL, V164, P95, DOI 10.1111/j.1469-8137.2004.01161.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang J, 2001, PHYTOPATHOLOGY, V91, P1069, DOI 10.1094/PHYTO.2001.91.11.1069; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	55	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78423	10.1371/journal.pone.0078423	http://dx.doi.org/10.1371/journal.pone.0078423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236018	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700015
J	Martin, J; Chong, T; Ferree, PM				Martin, Jennifer; Chong, Trisha; Ferree, Patrick M.			Male Killing Spiroplasma Preferentially Disrupts Neural Development in the Drosophila melanogaster Embryo	PLOS ONE			English	Article							DOSAGE COMPENSATION; BACTERIAL TOXINS; LETHAL MUTATIONS; EXPRESSION; SR; PROTEIN; MSL-2; ELAV	Male killing bacteria such as Spiroplasma are widespread pathogens of numerous arthropods including Drosophila melanogaster. These maternally transmitted bacteria can bias host sex ratios toward the female sex in order to 'selfishly' enhance bacterial transmission. However, little is known about the specific means by which these pathogens disrupt host development in order to kill males. Here we show that a male-killing Spiroplasma strain severely disrupts nervous tissue development in male but not female D. melanogaster embryos. The neuroblasts, or neuron progenitors, form properly and their daughter cells differentiate into neurons of the ventral nerve chord. However, the neurons fail to pack together properly and they produce highly abnormal axons. In contrast, non-neural tissue, such as mesoderm, and body segmentation appear normal during this time, although the entire male embryo becomes highly abnormal during later stages. Finally, we found that Spiroplasma is altogether absent from the neural tissue but localizes within the gut and the epithelium immediately surrounding the neural tissue, suggesting that the bacterium secretes a toxin that affects neural tissue development across tissue boundaries. Together these findings demonstrate the unique ability of this insect pathogen to preferentially affect development of a specific embryonic tissue to induce male killing.	[Ferree, Patrick M.] Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; Scripps Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; Pitzer Coll, WM Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Scripps College; Claremont Colleges; Pitzer College	Ferree, PM (corresponding author), Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA.	pferree@kecksci.claremont.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; BELOTE JM, 1983, GENETICS, V105, P881; BELOTE JM, 1980, GENETICS, V96, P165; Bentley JK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-9; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; COUNCE SJ, 1966, GENETICA, V37, P364, DOI 10.1007/BF01547143; COUNCE SJ, 1961, AM ZOOL, V1, P443; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Haselkorn TS, 2010, FLY, V4, P80, DOI 10.4161/fly.4.1.10883; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KOANA T, 1983, GENETICS, V104, P113; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; McDowell KA, 1996, MECH DEVELOP, V57, P113, DOI 10.1016/0925-4773(96)00517-5; MIYAMOTO C, 1975, GENETICS, V79, P55; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Riparbelli MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030045; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TSUCHIYAMA S, 1978, GENETICS, V89, P711; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; WHITCOMB RF, 1980, ANNU REV MICROBIOL, V34, P677, DOI 10.1146/annurev.mi.34.100180.003333	35	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79368	10.1371/journal.pone.0079368	http://dx.doi.org/10.1371/journal.pone.0079368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236124	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700123
J	Mercado, J; Valenzano, MC; Jeffers, C; Sedlak, J; Cugliari, MK; Papanikolaou, E; Clouse, J; Miao, J; Wertan, NE; Mullin, JM				Mercado, Joanna; Valenzano, Mary Carmen; Jeffers, Cameron; Sedlak, Jason; Cugliari, Marina K.; Papanikolaou, Eleni; Clouse, Jacob; Miao, Jingya; Wertan, Nina E.; Mullin, James M.			Enhancement of Tight Junctional Barrier Function by Micronutrients: Compound-Specific Effects on Permeability and Claudin Composition	PLOS ONE			English	Article							ZINC SUPPLEMENTATION; INTESTINAL BARRIER; EXPRESSION; QUERCETIN; BUTYRATE; OCCLUDIN; KINASE	Amid an increasing number of reports in the literature concerning epithelial barrier enhancement by various nutrient compounds, there has never been a study performing side-by-side comparisons of these agents in a single epithelial model. We compare five nutrient compounds (previously reported in various epithelial models to enhance barrier function) regarding their ability to increase transepithelial electrical resistance (R-t) and decrease transepithelial mannitol permeability (J(m)) across LLC-PK1 renal epithelial cell layers. The effects of these nutrients on the abundance of various tight junctional proteins are also compared. In the overall group of nutrients tested - zinc, indole, quercetin, butyrate and nicotine - only nicotine failed to improve barrier function by either parameter. Nicotine also was without effect on tight junctional proteins. Quercetin simultaneously increased R-t and decreased J(m). Zinc, butyrate and indole only exhibited statistically significant enhancement of R-t. Each of these four effective nutrient compounds had unique patterns of effects on the panel of tight junctional proteins studied. No two compounds produced the same pattern of effects. This unique pattern of effects on tight junctional complex composition by each compound establishes the chance for additive or even synergistic improvement of barrier function by combinations of compounds. A synergistic effect of the combination of quercetin and zinc on R-t is shown.	[Mercado, Joanna; Valenzano, Mary Carmen; Wertan, Nina E.; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA USA; [Jeffers, Cameron; Sedlak, Jason; Cugliari, Marina K.; Papanikolaou, Eleni; Clouse, Jacob; Miao, Jingya] Drexel Univ, Philadelphia, PA 19104 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530; Miao, Jingya/0000-0001-6482-5384	Sharpe Strumia Foundation	Sharpe Strumia Foundation	Funding came from Sharpe Strumia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2009, ANN N Y ACAD SCI; Amasheh M, 2008, J NUTR, V138, P1067, DOI 10.1093/jn/138.6.1067; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bednarczyk J, 2011, ACTA NEUROBIOL EXP, V71, P393; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Catalioto RM, 2011, CURR MED CHEM, V18, P398, DOI 10.2174/092986711794839179; Chuenkitiyanon S, 2010, INT J TOXICOL, V29, P418, DOI 10.1177/1091581810366487; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Li JH, 2011, PEDIATR NEPHROL, V26, P2133, DOI 10.1007/s00467-011-1824-y; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Mullin JM, 2012, J EPITHELIAL BIOL PH, V5, P10; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Rodriguez P, 1996, GUT, V39, P416, DOI 10.1136/gut.39.3.416; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Shimizu M, 2010, BIOSCI BIOTECH BIOCH, V74, P232, DOI 10.1271/bbb.90730; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	31	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78775	10.1371/journal.pone.0078775	http://dx.doi.org/10.1371/journal.pone.0078775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236048	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700045
J	Morgan, K; Rahman, M; Atkinson, M; Zhou, SM; Hill, R; Khanom, A; Paranjothy, S; Brophy, S				Morgan, Kelly; Rahman, Mohammed; Atkinson, Mark; Zhou, Shang-Ming; Hill, Rebecca; Khanom, Ashrafunnesa; Paranjothy, Shantini; Brophy, Sinead			Association of Diabetes in Pregnancy with Child Weight at Birth, Age 12 Months and 5 Years - A Population-Based Electronic Cohort Study	PLOS ONE			English	Article							TYPE-1; HYPERGLYCEMIA; MELLITUS; OBESITY; MOTHERS; PREVALENCE; PREDICTORS; OVERWEIGHT; ADIPOSITY; OUTCOMES	Background: This study examines the effect of diabetes in pregnancy on offspring weight at birth and ages 1 and 5 years. Methods: A population-based electronic cohort study using routinely collected linked healthcare data. Electronic medical records provided maternal diabetes status and offspring weight at birth and ages 1 and 5 years (n=147,773 mother child pairs). Logistic regression models were used to obtain odds ratios to describe the association between maternal diabetes status and offspring size, adjusted for maternal pre-pregnancy weight, age and smoking status. Findings: We identified 1,250 (0.9%) pregnancies with existing diabetes (27.8% with type 1 diabetes), 1,358 with gestational diabetes (0.9%) and 635 (0.4%) who developed diabetes post-pregnancy. Children whose mothers had existing diabetes were less likely to be large at 12 months (OR: 0.7 (95%CI: 0.6, 0.8)) than those without diabetes. Maternal diabetes was associated with high weight at age 5 years in children whose mothers had a high pre-pregnancy weight tertile (gestational diabetes, (OR: 2.1 (95%CI:1.25-3.6)), existing diabetes (OR:1.3(95%CI:1.0 to 1.6)). Conclusion: The prevention of childhood obesity should focus on mothers with diabetes with a high maternal pre-pregnancy weight. We found little evidence that diabetes in pregnancy leads to long term obesity 'programming'.	[Morgan, Kelly; Rahman, Mohammed; Atkinson, Mark; Zhou, Shang-Ming; Hill, Rebecca; Khanom, Ashrafunnesa; Brophy, Sinead] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Paranjothy, Shantini] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Swansea University; Cardiff University	Morgan, K (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	kelly.morgan@swansea.ac.uk	Atkinson, Mark D/K-1813-2013; Zhou, Shang-Ming/A-8443-2008	Atkinson, Mark D/0000-0003-4237-3588; Khanom, Ashrafunnesa/0000-0002-5735-6601; Brophy, Sinead/0000-0001-7417-2858; Zhou, Shang-Ming/0000-0002-0719-9353; Morgan, Kelly/0000-0002-8685-1177	Swansea University; Public Health Wales; National Institute for Social Care and Health Research (NISCHR); NISCHR and was within the DECIPHer centre of excellence for Public Health Research; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Swansea University; Public Health Wales; National Institute for Social Care and Health Research (NISCHR); NISCHR and was within the DECIPHer centre of excellence for Public Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Swansea University, Public Health Wales and the National Institute for Social Care and Health Research (NISCHR). The study was also part of the EPI-screen network funded by NISCHR and was within the DECIPHer centre of excellence for Public Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Baptiste-Roberts K, 2012, MATERN CHILD HLTH J, V16, P125, DOI 10.1007/s10995-011-0756-2; Boerschmann H, 2010, DIABETES CARE, V33, P1845, DOI 10.2337/dc10-0139; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dabelea D, 2001, J PEDIATR ENDOCR MET, V14, P1085; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; de Lusignan S, 2012, DIABETIC MED, V29, P181, DOI 10.1111/j.1464-5491.2011.03419.x; de Onis M, 2010, AM J CLIN NUTR; Diabetes UK, 2012, DIAB UK 2012 KEY STA, P1; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hanna FWF, 2002, DIABETIC MED, V19, P351, DOI 10.1046/j.1464-5491.2002.00684.x; Haroush B, 2003, DIABETIC MED, V21, P103; Hummel S, 2009, DIABETES CARE, V32, P921, DOI [10.2337/dc08-1943, 10.2337/dc09-1379]; Husain MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-24; Lindsay RS, 2010, DIABETES CARE, V33, P1080, DOI 10.2337/dc09-1766; Lindsay RS, 2009, DIABETES, V58, P302, DOI 10.2337/db08-1562; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; National Institute for Health and Care Excellence (NICE), 2008, DIAB PREGN MAN DIAB; Paliya O, 2013, POTENTIAL MECH NUTR, V30, P1; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Pettitt DJ, 2010, DIABETES CARE, V33, P1219, DOI 10.2337/dc09-2384; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Shin Y., 2011, EMPIR SOFTW ENG, P1; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Smith BJ, 2005, DIABETES CARE, V28, P2650, DOI 10.2337/diacare.28.11.2650; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Tobias D, 2012, ARCH INTERN MED, V172, P1; Weiss PAM, 2000, DIABETES CARE, V23, P905, DOI 10.2337/diacare.23.7.905	35	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79803	10.1371/journal.pone.0079803	http://dx.doi.org/10.1371/journal.pone.0079803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236160	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700160
J	Kovalenko, PL; Yuan, LS; Sun, KL; Kunovska, L; Seregin, S; Amalfitano, A; Basson, MD				Kovalenko, Pavlo L.; Yuan, Lisi; Sun, Kelian; Kunovska, Lyudmyla; Seregin, Sergey; Amalfitano, Andrea; Basson, Marc D.			Regulation of Epithelial Differentiation in Rat Intestine by Intraluminal Delivery of an Adenoviral Vector or Silencing RNA Coding for Schlafen 3	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; SHORT-BOWEL SYNDROME; COLON-CANCER CELLS; PARENTERAL-NUTRITION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CYCLIC STRAIN; CACO-2 CELLS; BRUSH-BORDER; MOUSE MODEL	Although we stimulate enterocytic proliferation to ameliorate short gut syndrome or mucosal atrophy, less effort has been directed at enterocytic differentiation. Schlafen 3 (Slfn3) is a poorly understood protein induced during IEC-6 enterocytic differentiation. We hypothesized that exogenous manipulation of Slfn3 would regulate enterocytic differentiation in vivo. Adenoviral vector coding for Slfn3 cDNA (Ad-GFP-Slfn3) or silencing RNA for Slfn3 (siSlfn3) was introduced intraluminally into rat intestine. We assessed Slfn3, villin, sucrase-isomaltase (SI), Dpp4, and Glut2 by qRT-PCR, Western blot, and immunohistochemistry. We also studied Slfn3 and these differentiation markers in atrophic defunctionalized jejunal mucosa and the crypt-villus axis of normal jejunum. Ad-GFP-Slfn3 but not Ad-GFP increased Slfn3, villin and Dpp4 expression in human Caco-2 intestinal epithelial cells. Injecting Ad-GFP-Slfn3 into rat jejunum in vivo increased mucosal Slfn3 mRNA three days later vs. intraluminal Ad-GFP. This Slfn3 overexpression was associated with increases in all four differentiation markers. Injecting siSlfn3 into rat jejunum in vivo substantially reduced Slfn3 and all four intestinal mucosal differentiation markers three days later, as well as Dpp4 specific activity. Endogenous Slfn3 was reduced in atrophic mucosa from a blind-end Rouxen-Y anastomosis in parallel with differentiation marker expression together with AKT and p38 signaling. Slfn3 was more highly expressed in the villi than the crypts, paralleling Glut2, SI and Dpp4. Slfn3 is a key intracellular regulator of rat enterocytic differentiation. Understanding how Slfn3 works may identify targets to promote enterocytic differentiation and maintain mucosal function in vivo, facilitating enteral nutrition and improving survival in patients with mucosal atrophy or short gut syndrome.	[Kovalenko, Pavlo L.; Yuan, Lisi; Sun, Kelian; Kunovska, Lyudmyla; Basson, Marc D.] Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA; [Yuan, Lisi; Basson, Marc D.] John D Dingell Vet Affairs Med Ctr, Res Serv, Detroit, MI USA; [Seregin, Sergey; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Basson, MD (corresponding author), Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA.	marc.basson@hc.msu.edu			NIH [1 R56 DK096137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK096137, R01DK096137] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part by NIH 1 R56 DK096137 (MDB). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPIN M, 1988, MOL ASPECTS MED, V10, P257, DOI 10.1016/0098-2997(88)90012-X; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; Basson MD, 1998, CELL TISSUE RES, V292, P553, DOI 10.1007/s004410051084; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; BROWN HO, 1963, AM J PHYSIOL, V205, P868, DOI 10.1152/ajplegacy.1963.205.5.868; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010; Condamine T, J LEUKOC BIOL, V87, P451; Dahly EM, 2004, J NUTR, V134, P530, DOI 10.1093/jn/134.3.530; DARMOUL D, 1992, J BIOL CHEM, V267, P4824; DUDOUET B, 1987, J CELL BIOL, V105, P359, DOI 10.1083/jcb.105.1.359; Efsen E, 2011, Minerva Gastroenterol Dietol, V57, P405; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Flanigan TL, 2009, J SURG RES, V156, P103, DOI 10.1016/j.jss.2009.03.053; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Gayer CP, 2009, AM J PHYSIOL-GASTR L, V296, pG876, DOI 10.1152/ajpgi.90648.2008; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Gespach C, 2005, ONCOGENE, V24, P7953, DOI 10.1038/sj.onc.1209084; Gross I, 2005, ONCOGENE, V24, P7955, DOI 10.1038/sj.onc.1208945; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; HO SB, 1992, J CELL BIOCHEM, P119; IMAI K, 1992, HUM REPROD, V7, P1189, DOI 10.1093/oxfordjournals.humrep.a137824; Jeppesen PB, 2005, GUT, V54, P1224, DOI 10.1136/gut.2004.061440; Kato M, 2004, J CANCER RES CLIN, V130, P73, DOI 10.1007/s00432-003-0510-2; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Kovalenko PL, 2012, AM J PHYSIOL-GASTR L, V303, pG951, DOI 10.1152/ajpgi.00158.2012; Kovalenko PL, 2012, J SURG RES, V177, P63, DOI 10.1016/j.jss.2012.03.011; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Lee NK, 2008, CELL SIGNAL, V20, P2302, DOI 10.1016/j.cellsig.2008.08.019; Lemieux E, 2011, AM J PHYSIOL-GASTR L, V301, pG719, DOI 10.1152/ajpgi.00508.2010; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; MOLL R, 1987, VIRCHOWS ARCH B, V54, P155, DOI 10.1007/BF02899208; Murali SG, 2005, J NUTR, V135, P2553, DOI 10.1093/jn/135.11.2553; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Niwa T, 2005, J HISTOCHEM CYTOCHEM, V53, P75, DOI 10.1369/jhc.4A6443.2005; Oh PS, 2011, AM J PHYSIOL-GASTR L, V301, pG347, DOI 10.1152/ajpgi.00403.2010; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; POULLAIN MG, 1991, CLIN NUTR, V10, P49, DOI 10.1016/0261-5614(91)90081-M; Quaroni A, 2000, AM J PHYSIOL-CELL PH, V279, pC1045, DOI 10.1152/ajpcell.2000.279.4.C1045; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Salerno-Goncalves R, 2011, GASTROENTEROLOGY, V141, pE18, DOI 10.1053/j.gastro.2011.04.062; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Seetharam P, 2011, SAUDI J GASTROENTERO, V17, P229, DOI 10.4103/1319-3767.82573; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Tan EY, 2006, AM J PHYSIOL-CELL PH, V291, pC433, DOI 10.1152/ajpcell.00238.2005; Turner HL, 2010, GUT MICROBES, V1, P22, DOI 10.4161/gmic.1.1.11427; Walsh MF, 2012, AM J SURG, V204, P598, DOI 10.1016/j.amjsurg.2012.07.004; Weih S, 2012, LANGENBECK ARCH SURG, V397, P1043, DOI 10.1007/s00423-011-0874-8; Yang H, 2003, CRIT CARE MED, V31, P1118, DOI 10.1097/01.CCM.0000053523.73064.8A; YOSHIOKA M, 1991, INT J CANCER, V47, P916, DOI 10.1002/ijc.2910470622; Yuan LS, 2010, AM J PHYSIOL-GASTR L, V298, pG994, DOI 10.1152/ajpgi.00517.2009; Zhang JH, 2003, BIOCHEM BIOPH RES CO, V306, P746, DOI 10.1016/S0006-291X(03)01044-1; Ziegler TR, 2003, GASTROENTEROLOGY, V124, P1950, DOI 10.1016/S0016-5085(03)00405-0	60	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79745	10.1371/journal.pone.0079745	http://dx.doi.org/10.1371/journal.pone.0079745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244554	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600149
J	Tantikanlayaporn, D; Wichit, P; Weerachayaphorn, J; Chairoungdua, A; Chuncharunee, A; Suksamrarn, A; Piyachaturawat, P				Tantikanlayaporn, Duangrat; Wichit, Patsorn; Weerachayaphorn, Jittima; Chairoungdua, Arthit; Chuncharunee, Aporn; Suksamrarn, Apichart; Piyachaturawat, Pawinee			Bone Sparing Effect of a Novel Phytoestrogen Diarylheptanoid from Curcuma comosa Roxb. in Ovariectomized Rats	PLOS ONE			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; ESTROGEN THERAPY; TRABECULAR BONE; FRACTURES; PATHOGENESIS; ACTIVATION; TURNOVER; MECHANISMS; DAIDZEIN; DENSITY	Phytoestrogens have been implicated in the prevention of bone loss in postmenopausal osteoporosis. Recently, an active phytoestrogen from Curcuma comosa Roxb, diarylheptanoid (DPHD), (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol, was found to strongly promote human osteoblast function in vitro. In the present study, we demonstrated the protective effect of DPHD on ovariectomy-induced bone loss (OVX) in adult female Sprague-Dawley rats with 17 beta-estradiol (E-2, 10 mu g/kg Bw) as a positive control. Treatment of OVX animals with DPHD at 25, 50, and 100 mg/kg Bw for 12 weeks markedly increased bone mineral density (BMD) of tibial metaphysis as measured by peripheral Quantitative Computed Tomography (pQCT). Histomorphometric analysis of bone structure indicated that DPHD treatment retarded the ovariectomy-induced deterioration of bone microstructure. Ovariectomy resulted in a marked decrease in trabecular bone volume, number and thickness and these changes were inhibited by DPHD treatment, similar to that seen with E-2. Moreover, DPHD decreased markers of bone turnover, including osteocalcin and tartrate resistant acid phosphatase (TRAP) activity. These results suggest that DPHD has a bone sparing effect in ovariectomy-induced trabecular bone loss and prevents deterioration of bone microarchitecture by suppressing the rate of bone turnover. Therefore, DPHD appears to be a promising candidate for preserving bone mass and structure in the estrogen deficient women with a potential role in reducing postmenopausal osteoporosis.	[Tantikanlayaporn, Duangrat; Wichit, Patsorn; Weerachayaphorn, Jittima; Chairoungdua, Arthit; Piyachaturawat, Pawinee] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand; [Chuncharunee, Aporn] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok, Thailand	Mahidol University; Mahidol University; Ramkhamhaeng University	Piyachaturawat, P (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand.	pawinee.pia@mahidol.ac.th	Piyachaturawat, Pawinee/R-5817-2019; Suksamrarn, Apichart/R-8782-2019; Tantikanlayaporn, Duangrat/AAB-3358-2021	Tantikanlayaporn, Duangrat/0000-0002-1197-4957	Thailand Research Fund (TRF) [PHD/0103/2549]; TRF; Office of the Higher Education Commission; Mahidol University under the National Research and Universities Initiative; National Research Council of Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Office of the Higher Education Commission; Mahidol University under the National Research and Universities Initiative; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study was supported by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (grant PHD/0103/2549 to DT and PP), the Strategic Basic Research Grant of TRF (to PP and to AS), the Office of the Higher Education Commission and Mahidol University under the National Research and Universities Initiative, and The National Research Council of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhukhai K, 2012, J BIOL CHEM, V287, P36168, DOI 10.1074/jbc.M112.344747; Blair HC, 1996, J CELL BIOCHEM, V61, P629, DOI 10.1002/(SICI)1097-4644(19960616)61:4<629::AID-JCB17>3.0.CO;2-A; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Breen SA, 1996, CALCIFIED TISSUE INT, V58, P449, DOI 10.1007/s002239900074; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dang ZC, 2005, TRENDS ENDOCRIN MET, V16, P207, DOI 10.1016/j.tem.2005.05.001; Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; GASSER JA, 1995, BONE, V17, pS145, DOI 10.1016/8756-3282(95)00287-N; Habermann B, 2007, ACTA ORTHOP, V78, P221, DOI 10.1080/17453670710013717; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; LAU KHW, 1987, CLIN CHEM, V33, P458; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Messina MJ, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-17; Ott SM, 2008, CLIN J AM SOC NEPHRO, V3, pS151, DOI 10.2215/CJN.04301206; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Peng XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058361; Piyachaturawat P, 1995, INT J PHARMACOGN, V33, P334, DOI 10.3109/13880209509065388; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Ren P, 2007, PHARMACOLOGY, V79, P129, DOI 10.1159/000098115; Sample SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043215; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Sugimoto E, 2000, BIOCHEM PHARMACOL, V59, P471, DOI 10.1016/S0006-2952(99)00351-2; Suksamrarn A, 2008, BIOORGAN MED CHEM, V16, P6891, DOI 10.1016/j.bmc.2008.05.051; Suntornsaratoon P, 2010, AM J PHYSIOL-ENDOC M, V299, pE426, DOI 10.1152/ajpendo.00134.2010; Tantikanlayaporn D, 2013, PHYTOMEDICINE, V20, P676, DOI 10.1016/j.phymed.2013.02.008; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; Thampithak A, 2009, NEUROSCI LETT, V462, P171, DOI 10.1016/j.neulet.2009.06.094; Urasopon N, 2007, MATURITAS, V56, P322, DOI 10.1016/j.maturitas.2006.09.007; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Weerachayaphorn J, 2011, J ETHNOPHARMACOL, V137, P956, DOI 10.1016/j.jep.2011.06.040; WEINSTEIN RS, 1994, J BONE MINER RES, V9, P1797; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Winuthayanon W, 2009, J AGR FOOD CHEM, V57, P840, DOI 10.1021/jf802702c; WRONSKI TJ, 1988, ENDOCRINOLOGY, V123, P681, DOI 10.1210/endo-123-2-681; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317	40	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78739	10.1371/journal.pone.0078739	http://dx.doi.org/10.1371/journal.pone.0078739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244350	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600057
J	Wang, H; Gao, JE; Zhang, SL; Zhang, MJ; Li, XH				Wang, Hong; Gao, Jian-en; Zhang, Shao-long; Zhang, Meng-jie; Li, Xing-hua			Modeling the Impact of Soil and Water Conservation on Surface and Ground Water Based on the SCS and Visual Modflow	PLOS ONE			English	Article							CLIMATE-CHANGE; RIVER-BASIN; STREAMFLOW; RESOURCES; CATCHMENT; RUNOFF; RECHARGE; SYSTEM	Soil and water conservation measures can impact hydrological cycle, but quantitative analysis of this impact is still difficult in a watershed scale. To assess the effect quantitatively, a three-dimensional finite-difference groundwater flow model (MODFLOW) with a surface runoff model-the Soil Conservation Service (SCS) were calibrated and applied based on the artificial rainfall experiments. Then, three soil and water conservation scenarios were simulated on the sand-box model to assess the effect of bare slope changing to grass land and straw mulching on water volume, hydraulic head, runoff process of groundwater and surface water. Under the 120 mm rainfall, 60 mm/h rainfall intensity, 5 m(2) area, 3 degrees slope conditions, the comparative results indicated that the trend was decrease in surface runoff and increase in subsurface runoff coincided with the land-use converted from bare slope to grass land and straw mulching. The simulated mean surface runoff modulus was 3.64x10(-2) m(3)/m(2)/h in the bare slope scenario, while the observed values were 1.54x10(-2) m(3)/m(2)/h and 0.12x10(-2) m(3)/m(2)/h in the lawn and straw mulching scenarios respectively. Compared to the bare slope, the benefits of surface water reduction were 57.8% and 92.4% correspondingly. At the end of simulation period (T = 396 min), the simulated mean groundwater runoff modulus was 2.82x10(-2) m(3)/m(2)/h in the bare slope scenario, while the observed volumes were 3.46x10(-2) m(3)/m(2)/h and 4.91x10(-2) m(3)/m(2)/h in the lawn and straw mulching scenarios respectively. So the benefits of groundwater increase were 22.7% and 60.4% correspondingly. It was concluded that the soil and water conservation played an important role in weakening the surface runoff and strengthening the underground runoff. Meanwhile the quantitative analysis using a modeling approach could provide a thought for the study in a watershed scale to help decision-makers manage water resources.	[Wang, Hong; Gao, Jian-en] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Jian-en; Zhang, Shao-long; Li, Xing-hua] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en; Zhang, Meng-jie] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Northwest A&F University - China	Gao, JE (corresponding author), Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	gaojianen@126.com			National Technology Support Project [2011BAD31B05]; Natural Science Foundation of China [41371276]; Subject of National Science and Technology Major Project [2009ZX07212-002-003-02]; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project) [A315021304]	National Technology Support Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Subject of National Science and Technology Major Project; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project)	This paper was supported by National Technology Support Project (2011BAD31B05), by Natural Science Foundation of China (41371276), by the Subject of National Science and Technology Major Project (2009ZX07212-002-003-02) and by Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project) (A315021304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2001, HYDROGEOL J, V9, P390, DOI 10.1007/s100400100148; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; BOUGHTON WC, 1989, AUST J SOIL RES, V27, P511, DOI 10.1071/SR9890511; BOUGHTON WC, 1985, J ARID ENVIRON, V9, P13, DOI 10.1016/S0140-1963(18)31268-0; Candela L, 2012, SCI TOTAL ENVIRON, V440, P253, DOI 10.1016/j.scitotenv.2012.06.062; Cho J, 2009, AGR WATER MANAGE, V96, P1, DOI 10.1016/j.agwat.2008.07.005; COOPER JD, 1980, 66 I HYDR; Dams J, 2008, HYDROL EARTH SYST SC, V12, P1369, DOI 10.5194/hess-12-1369-2008; Ferrer J, 2012, SCI TOTAL ENVIRON, V440, P42, DOI 10.1016/j.scitotenv.2012.08.032; FREEZE RA, 1969, WATER RESOUR RES, V5, P153, DOI 10.1029/WR005i001p00153; Guo XJ, 2010, SCI SOIL WATER CONSE, V8, P14; Harbaugh A.W., 1996, USERS DOCUMENTATION; Hill M.C., 2000, MODFLOW 2000, DOI [10.3133/ofr00184, DOI 10.3133/OFR200092]; Hydrogeologic Water, 2005, VISUAL MODFLOW V 4 1; Jain MK, 2006, WATER RESOUR MANAG, V20, P531, DOI 10.1007/s11269-006-3086-1; Kim J, 2013, SCI TOTAL ENVIRON, V452, P181, DOI 10.1016/j.scitotenv.2013.02.005; LAFLEN JM, 1981, T ASAE, V24, P605, DOI 10.13031/2013.34308; [李勉 Li Mian], 2005, [地球科学进展, Advance in Earth Sciences], V20, P74; LI Y, 1997, B SOIL WATER CONSERV, V17, P41; [李裕元 Li Yuyuan], 2004, [水利学报, Journal of Hydraulic Engineering], V0, P48; [李子君 LI Zijun], 2006, [地理科学进展, Progress in geography], V25, P49; Pan P., 2007, LAKE SCI, V19, P710; Paul MJ, 2006, CHINESE GEOGR SCI, V16, P229, DOI 10.1007/s11769-006-0229-5; Pouget L, 2012, SCI TOTAL ENVIRON, V440, P186, DOI 10.1016/j.scitotenv.2012.07.036; [綦俊谕 Qi Junyu], 2011, [地理科学进展, Progress in Geography], V30, P95; Qi S, 2009, T ASABE, V52, P739, DOI 10.13031/2013.27395; Rallison R. E., 1980, S WATERSHED MANAGEME, P912; [冉大川 RAN Dachuan], 2006, [资源科学, Resources science], V28, P93; [任美锷 Ren Meie], 2006, [地球科学进展, Advance in Earth Sciences], V21, P551; Shaanxi Provincial Bureau of Soil and Water Conservation, 1976, SHAANX PROV RUN SED; Shi PJ, 2007, CATENA, V69, P31, DOI 10.1016/j.catena.2006.04.015; Skaggs RW, 2006, NOTES; Sun G, 2004, SRS75198 SO FOR SCI; [唐涛 TANG Tao], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P9; Wang ML, 2004, J WATER RESOURCES RE, V2, P002; WEST LT, 1991, SOIL SCI SOC AM J, V55, P460, DOI 10.2136/sssaj1991.03615995005500020027x; Yellow River Conservancy Commission of MWR, 2010, YELL RIV SED B; Yu B, 1998, J IRRIG DRAIN ENG, V124, P306, DOI 10.1061/(ASCE)0733-9437(1998)124:6(306); Zhang H, 2010, J HYDROL, V392, P136, DOI 10.1016/j.jhydrol.2010.08.002; Zhang WZ, 1983, CALCULATION GROUNDWA; Zhu X., 1960, ACTA PEDOLOGICA SINI, V8, P110; Zhu XM, 1984, B SOIL WATER CONSERV, V1, P15	42	12	12	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79103	10.1371/journal.pone.0079103	http://dx.doi.org/10.1371/journal.pone.0079103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244427	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600108
J	Goyet, L; Nishibayashi, LL; Nazzi, T				Goyet, Louise; Nishibayashi, Leo-Lyuki; Nazzi, Thierry			Early Syllabic Segmentation of Fluent Speech by Infants Acquiring French	PLOS ONE			English	Article							WORD SEGMENTATION; LANGUAGE DISCRIMINATION; CUES; STRESS; STATISTICS; PATTERNS; ABILITY; GERMAN; UNITS	Word form segmentation abilities emerge during the first year of life, and it has been proposed that infants initially rely on two types of cues to extract words from fluent speech: Transitional Probabilities (TPs) and rhythmic units. The main goal of the present study was to use the behavioral method of the Headturn Preference Procedure (HPP) to investigate again rhythmic segmentation of syllabic units by French-learning infants at the onset of segmentation abilities (around 8 months) given repeated failure to find syllabic segmentation at such a young age. The second goal was to explore the interaction between the use of TPs and syllabic units for segmentation by French-learning infants. The rationale was that decreasing TP cues around target syllables embedded in bisyllabic words would block bisyllabic word segmentation and facilitate the observation of syllabic segmentation. In Experiments 1 and 2, infants were tested in a condition of moderate TP decrease; no evidence of either syllabic or bisyllabic word segmentation was found. In Experiment 3, infants were tested in a condition of more marked TP decrease, and a novelty syllabic segmentation effect was observed. Therefore, the present study first establishes early syllabic segmentation in French-learning infants, bringing support from a syllable-based language to the proposal that rhythmic units are used at the onset of segmentation abilities. Second, it confirms that French-learning infants are sensitive to TP cues. Third, it demonstrates that they are sensitive to the relative weight of TP and rhythmic cues, explaining why effects of syllabic segmentation are not observed in context of high TPs. These findings are discussed in relation to theories of word segmentation bootstrapping, and the larger debate about statistically- versus prosodically-based accounts of early language acquisition.	[Goyet, Louise; Nishibayashi, Leo-Lyuki; Nazzi, Thierry] Univ Paris 05, Paris, France; [Nazzi, Thierry] CNRS, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Goyet, L (corresponding author), Univ Paris 05, Paris, France.	louise.goyet@gmail.com; thierry.nazzi@parisdescartes.fr		Nishibayashi, Leo-Lyuki/0000-0001-7991-3213; Nazzi, Thierry/0000-0002-4378-3661	Agence Nationale de la Recherche (ANR) [07-BLAN-0014-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This study was conducted with the support of Agence Nationale de la Recherche (ANR) grant #07-BLAN-0014-01. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D., 1967, ELEMENTS GEN PHONETI; ASLIN RN, 1993, NATO ADV SCI INST SE, V69, P305; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Bernard C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00451; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Curtin S, 2005, COGNITION, V96, P233, DOI 10.1016/j.cognition.2004.08.005; Echols CH, 1997, J MEM LANG, V36, P202, DOI 10.1006/jmla.1996.2483; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Gleitman L., 1982, LANG ACQUIS, P3; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Gonzalez Gomez N, 2013, J SPEECH LA IN PRESS; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; Gout A, 2001, THESIS ECOLE HAUTES; Goyet L, 2010, BRAIN RES, V1332, P75, DOI 10.1016/j.brainres.2010.03.047; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hay JH, 2012, INFANCY, V17, P1; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Hohle B, 2003, DEVELOPMENTAL SCI, V6, P122, DOI 10.1111/1467-7687.00261; Houston DM, 2000, PSYCHON B REV, V7, P504, DOI 10.3758/BF03214363; Houston DM, 2004, LANG COGNITIVE PROC, V19, P97, DOI 10.1080/01690960344000143; Johnson EK, 2001, J MEM LANG, V44, P548, DOI 10.1006/jmla.2000.2755; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Jusczyk PW, 1999, PERCEPT PSYCHOPHYS, V61, P1465, DOI 10.3758/BF03213111; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kern S., 2003, GLOSSA, V85, P48; Kooijman V, 2005, COGNITIVE BRAIN RES, V24, P109, DOI 10.1016/j.cogbrainres.2004.12.009; Kooijman V, 2007, THESIS RADBOUD U NIJ; Kooijman V, 2009, INFANCY, V14, P591, DOI 10.1080/15250000903263957; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2001, COGNITION, V78, P91, DOI 10.1016/S0010-0277(00)00109-8; Mattys SL, 2001, J EXP PSYCHOL HUMAN, V27, P644, DOI 10.1037//0096-1523.27.3.644; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Mersad K, 2012, LANG LEARN DEV, V8, P303, DOI 10.1080/15475441.2011.609106; MORGAN JL, 1995, CHILD DEV, V66, P911, DOI 10.2307/1131789; Morgan JL, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P1; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Nazzi T, 2006, J MEM LANG, V54, P283, DOI 10.1016/j.jml.2005.10.004; Nazzi T, 2005, LANG SPEECH, V48, P279, DOI 10.1177/00238309050480030201; Nazzi T, 2000, J MEM LANG, V43, P1, DOI 10.1006/jmla.2000.2698; Nazzi T, J CHILD LAN IN PRESS; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Newman R, 2006, DEV PSYCHOL, V42, P643, DOI 10.1037/0012-1649.42.4.643; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Polka L, 2012, INFANCY, V17, P198, DOI 10.1111/j.1532-7078.2011.00075.x; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Seidl A, 2006, DEVELOPMENTAL SCI, V9, P565, DOI 10.1111/j.1467-7687.2006.00534.x; Shi RS, 2006, PROC ANN BUCLD, P549; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; van de Weijer J., 1998, THESIS U NIJMEGEN	57	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79646	10.1371/journal.pone.0079646	http://dx.doi.org/10.1371/journal.pone.0079646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244536	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900042
J	Paiva, G; Proenca, DN; Francisco, R; Verissimo, P; Santos, SS; Fonseca, L; Abrantes, IMO; Morais, PV				Paiva, Gabriel; Proenca, Diogo Neves; Francisco, Romeu; Verissimo, Paula; Santos, Susana S.; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.			Nematicidal Bacteria Associated to Pinewood Nematode Produce Extracellular Proteases	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; ENDOPHYTIC BACTERIA; SERRATIA-MARCESCENS; TRAPPING FUNGUS; PATHOGENICITY; IDENTIFICATION; STRAINS; DISEASE; CUTICLE	Bacteria associated with the nematode Bursaphelenchus xylophilus, a pathogen of trees and the causal agent of pine wilt disease (PWD) may play a role in the disease. In order to evaluate their role (positive or negative to the tree), strains isolated from the track of nematodes from infected Pinus pinaster trees were screened, in vitro, for their nematicidal potential. The bacterial products, from strains more active in killing nematodes, were screened in order to identify and characterize the nematicidal agent. Forty-seven strains were tested and, of these, 21 strains showed capacity to produce extracellular products with nematicidal activity. All Burkholderia strains were non-toxic. In contrast, all Serratia strains except one exhibited high toxicity. Nematodes incubated with Serratia strains showed, by SEM observation, deposits of bacteria on the nematode cuticle. The most nematicidal strain, Serratia sp. A88copa13, produced proteases in the supernatant. The use of selective inhibitors revealed that a serine protease with 70 kDa was majorly responsible for the toxicity of the supernatant. This extracellular serine protease is different phylogenetically, in size and biochemically from previously described proteases. Nematicidal assays revealed differences in nematicidal activity of the proteases to different species of Bursaphelenchus, suggesting its usefulness in a primary screen of the nematodes. This study offers the basis for further investigation of PWD and brings new insights on the role bacteria play in the defense of pine trees against B. xylophilus. Understanding all the factors involved is important in order to develop strategies to control B. xylophilus dispersion.	[Paiva, Gabriel; Proenca, Diogo Neves; Francisco, Romeu; Santos, Susana S.; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, Marine & Environm Res Ctr, IMAR, Coimbra, Portugal; [Verissimo, Paula] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Verissimo, Paula; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), Univ Coimbra, Marine & Environm Res Ctr, IMAR, Coimbra, Portugal.	pvmorais@ci.uc.pt	Verissimo, Paula/AAB-2281-2021; Morais, Paula Vasconcelos/C-9756-2014; Francisco, Romeu/I-1080-2012; Santos, Susana Silva/V-3922-2019; Santos, Susana/I-9588-2019; Abrantes, Isabel/CAG-1426-2022; Proença, Diogo Neves/K-1801-2015	Verissimo, Paula/0000-0003-0532-4242; Morais, Paula Vasconcelos/0000-0002-1939-6389; Francisco, Romeu/0000-0002-4643-6075; Abrantes, Isabel/0000-0002-8761-2151; Proença, Diogo Neves/0000-0002-1284-9082; Fonseca, Luis/0000-0001-7405-8916	Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional; FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-CFL/115373/2009, SFRH/BD/61311/2009]	Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional; FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This research was partially supported by Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional, through a national project 'O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' and by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and by national funds through the Fundacao para a Ciencia e Tecnologia (FCT), Portugal, under the project PTDC/AGR-CFL/115373/2009. D.N.P. was supported by FCT, Portugal, graduate fellowship SFRH/BD/61311/2009. G.P. was supported by FCT, Portugal, fellowship PTDC/AGR-CFL/115373/2009. The authors thank A. P. Piedade, FCTUC, Coimbra, Portugal for support at SEM analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Decraemer W, 2003, BIOL REV, V78, P465, DOI 10.1017/S1464793102006115; Doronina NV, 2010, INT J SYST EVOL MICR, V60, P1044, DOI 10.1099/ijs.0.003152-0; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Guo QQ, 2007, J NEMATOL, V39, P243; Hague N. G. M., 1987, Principles and practice of nematode control in crops., P131; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; HIGGINS D, 1999, JAP SHOK SHOT P INT, P23; Huang XW, 2009, CAN J MICROBIOL, V55, P934, DOI [10.1139/W09-045, 10.1139/w09-045]; Huang XW, 2005, RES MICROBIOL, V156, P719, DOI 10.1016/j.resmic.2005.02.006; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Kim HS, 2007, J IND MICROBIOL BIOT, V34, P715, DOI 10.1007/s10295-007-0245-1; Kong LY, 2010, ARCH MICROBIOL, V192, P585, DOI 10.1007/s00203-010-0585-5; KUSUNOKI M, 1987, Annals of the Phytopathological Society of Japan, V53, P622, DOI 10.3186/jjphytopath.53.622; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Llorcz LV, 2002, MYCOL RES, V106, P499, DOI 10.1017/S0953756202005798; Massaoud MK, 2010, APPL ENVIRON MICROB, V76, P6901, DOI 10.1128/AEM.01567-10; Mossialos D, 2000, APPL ENVIRON MICROB, V66, P487, DOI 10.1128/AEM.66.2.487-492.2000; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Niu QH, 2006, APPL MICROBIOL BIOT, V69, P722, DOI 10.1007/s00253-005-0019-5; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Ovcharenko L. P., 2010, Biopolymers and Cell, V26, P279; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; PROENCA DN, 2011, MICR 11 BRAG PORT MI, P90415; SHAHEEN F, 1984, J NEMATOL, V16, P57; Shimazu Mitsuaki, 2009, V6, P141; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; Stirling G. R., 1991, Biological control of plant parasitic nematodes.; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vleesschauwer D, 2007, CAB REV PERSPECT AGR, V2; Wang M, 2006, CAN J MICROBIOL, V52, P130, DOI 10.1139/W05-110; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yuan Weimin, 2011, Weishengwu Xuebao, V51, P1071; Zhang Q, 2005, APPL ENVIRON MICROB, V71, P7716, DOI 10.1128/AEM.71.12.7716-7723.2005; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817	43	42	44	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79705	10.1371/journal.pone.0079705	http://dx.doi.org/10.1371/journal.pone.0079705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244546	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900045
J	Sarrade-Loucheur, A; Xu, SY; Chan, SH				Sarrade-Loucheur, Arthur; Xu, Shuang-yong; Chan, Siu-Hong			The Role of the Methyltransferase Domain of Bifunctional Restriction Enzyme RM.BpuSI in Cleavage Activity	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; MODIFICATION SYSTEM; RECOGNITION SITE; DNA CLEAVAGE; ENDONUCLEASE; SEQUENCE; FAMILY; MMEI; COMPLEX; BINDING	Restriction enzyme (REase) RM.BpuSI can be described as a Type IIS/C/G REase for its cleavage site outside of the recognition sequence (Type IIS), bifunctional polypeptide possessing both methyltransferase (MTase) and endonuclease activities (Type IIC) and endonuclease activity stimulated by S-adenosyl-L-methionine (SAM) (Type IIG). The stimulatory effect of SAM on cleavage activity presents a major paradox: a co-factor of the MTase activity that renders the substrate unsusceptible to cleavage enhances the cleavage activity. Here we show that the RM. BpuSI MTase activity modifies both cleavage substrate and product only when they are unmethylated. The MTase activity is, however, much lower than that of M1. BpuSI and is thought not to be the major MTase for host DNA protection. SAM and sinefungin (SIN) increase the V-max of the RM. BpuSI cleavage activity with a proportional change in Km, suggesting the presence of an energetically more favorable pathway is taken. We further showed that RM. BpuSI undergoes substantial conformational changes in the presence of Ca2+, SIN, cleavage substrate and/or product. Distinct conformers are inferred as the pre-cleavage/cleavage state (in the presence of Ca2+, substrate or both) and MTase state (in the presence of SIN and substrate, SIN and product or product alone). Interestingly, RM. BpuSI adopts a unique conformation when only SIN is present. This SIN-bound state is inferred as a branch point for cleavage and MTase activity and an intermediate to an energetically favorable pathway for cleavage, probably through increasing the binding affinity of the substrate to the enzyme under cleavage conditions. Mutation of a SAM-binding residue resulted in altered conformational changes in the presence of substrate or Ca2+ and eliminated cleavage activity. The present study underscores the role of the MTase domain as facilitator of efficient cleavage activity for RM. BpuSI.	[Sarrade-Loucheur, Arthur; Xu, Shuang-yong; Chan, Siu-Hong] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Chan, SH (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	chan@neb.com		Sarrade-Loucheur, Arthur/0000-0003-3505-2532; Chan, Siu-Hong/0000-0002-9554-7273	New England Biolabs, Inc.	New England Biolabs, Inc.	Authors Shuang-yong Xu and Siu-Hong Chan have an affiliation to a commercial funder of this research (New England Biolabs, Inc.). Author Shuang-yong Xu is an Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BICKLE TA, 1978, P NATL ACAD SCI USA, V75, P3099, DOI 10.1073/pnas.75.7.3099; Bist P, 2001, J MOL BIOL, V310, P93, DOI 10.1006/jmbi.2001.4744; Borgaro JG, 2013, NUCLEIC ACIDS RES, V41, P4198, DOI 10.1093/nar/gkt102; Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2; CHERNOV AV, 1995, NUCLEIC ACIDS RES, V23, P1213, DOI 10.1093/nar/23.7.1213; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; JANULAITIS A, 1983, FEBS LETT, V151, P243, DOI 10.1016/0014-5793(83)80078-7; Jeltsch A, 2000, METH MOL B, V160, P287; Jurenaite-Urbanaviciene S, 2001, NUCLEIC ACIDS RES, V29, P895, DOI 10.1093/nar/29.4.895; Lepikhov K, 2001, NUCLEIC ACIDS RES, V29, P4691, DOI 10.1093/nar/29.22.4691; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; Morgan RD, 2008, NUCLEIC ACIDS RES, V36, P6558, DOI 10.1093/nar/gkn711; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5208, DOI 10.1093/nar/gkp534; Nakonieczna J, 2007, MOL BIOTECHNOL, V37, P127, DOI 10.1007/s12033-007-0034-0; Peakman LJ, 2003, J MOL BIOL, V333, P321, DOI 10.1016/j.jmb.2003.08.042; PETRUSYTE M, 1988, GENE, V74, P89, DOI 10.1016/0378-1119(88)90259-4; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Roberts RJ, 2005, P NATL ACAD SCI USA, V102, P5905, DOI 10.1073/pnas.0500923102; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Shen BW, 2011, NUCLEIC ACIDS RES, V39, P8223, DOI 10.1093/nar/gkr543; Sistla S, 2004, CRIT REV BIOCHEM MOL, V39, P1, DOI 10.1080/10409230490440532; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Zylicz-Stachula A, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-13; Zylicz-Stachula A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-62	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80967	10.1371/journal.pone.0080967	http://dx.doi.org/10.1371/journal.pone.0080967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224063	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400157
J	Kurushima, J; Hayashi, I; Sugai, M; Tomita, H				Kurushima, Jun; Hayashi, Ikue; Sugai, Motoyuki; Tomita, Haruyoshi			Bacteriocin Protein BacL(1) of Enterococcus faecalis Is a Peptidoglycan D-Isoglutamyl-L-lysine Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cell Wall; Enzymes; Hydrolases; Peptidoglycan; Enterococcus faecalis; Bacteriocin	COMPLETE GENOME SEQUENCE; STREPTOCOCCUS-FAECALIS; N-ACETYLGLUCOSAMINIDASE; GENETIC ORGANIZATION; LYTIC ENZYME; DETERMINANT; HEMOLYSIN; IDENTIFICATION; PLASMIDS; CLONING	Enterococcus faecalis strains are commensal bacteria in humans and other animals, and they are also the causative agent of opportunistic infectious diseases. Bacteriocin 41 (Bac41) is produced by certain E. faecalis clinical isolates, and it is active against other E. faecalis strains. Our genetic analyses demonstrated that the extracellular products of the bacL(1) and bacA genes, which are encoded in the Bac41 operon, coordinately express the bacteriocin activity against E. faecalis. In this study, we investigated the molecular functions of the BacL(1) and BacA proteins. Immunoblotting and N-terminal amino acid sequence analysis revealed that BacL(1) and BacA are secreted without any processing. The coincidental treatment with the recombinant BacL(1) and BacA showed complete bacteriocin activity against E. faecalis, but neither BacL(1) nor BacA protein alone showed the bacteriocin activity. Interestingly, BacL(1) alone demonstrated substantial degrading activity against the cell wall fraction of E. faecalis in the absence of BacA. Furthermore, MALDI-TOF MS analysis revealed that BacL(1) has a peptidoglycan d-isoglutamyl-l-lysine endopeptidase activity via a NlpC/P60 homology domain. These results collectively suggest that BacL(1) serves as a peptidoglycan hydrolase and, when BacA is present, results in the lysis of viable E. faecalis cells.	[Kurushima, Jun; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Maebashi, Gunma 3718511, Japan; [Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Lab Bacterial Drug Resistance, Maebashi, Gunma 3718511, Japan; [Hayashi, Ikue] Hiroshima Univ, Fac Dent, Res Facil, Hiroshima 7348551, Japan; [Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Project Res Ctr Nosocomial Infect Dis, Minami Ku, Hiroshima 7348551, Japan; [Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Minami Ku, Hiroshima 7348551, Japan	Gunma University; Gunma University; Hiroshima University; Hiroshima University; Hiroshima University	Tomita, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Bacteriol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	tomitaha@med.gunma-u.ac.jp		Kurushima, Jun/0000-0002-8573-6169	Japanese Ministry of Education, Culture, Sport, Science, and Technology (Gunma University Operation Grants); Japanese Ministry of Health, Labor, and Welfare [H24-Shinkou-Ippan-010, H24-Shokuhin-Ippan-008]; Japanese Ministry of Education, Culture, Sport, Science, and Technology [25870116]; Grants-in-Aid for Scientific Research [25870116] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sport, Science, and Technology (Gunma University Operation Grants); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sport, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sport, Science, and Technology (Grant-in-Aid for Young Scientists (B) 25870116, Gunma University Operation Grants) and the Japanese Ministry of Health, Labor, and Welfare (Grants H24-Shinkou-Ippan-010 and H24-Shokuhin-Ippan-008).	Arai R, 2012, J BIOL CHEM, V287, P44736, DOI 10.1074/jbc.M112.414763; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; CLEWELL DB, 1981, MICROBIOL REV, V45, P409, DOI 10.1128/MMBR.45.3.409-436.1981; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Franz CMAP, 2007, FEMS MICROBIOL REV, V31, P293, DOI 10.1111/j.1574-6976.2007.00064.x; FUJIMOTO S, 1995, J BACTERIOL, V177, P5574, DOI 10.1128/jb.177.19.5574-5581.1995; Fujimoto S, 2001, APPL ENVIRON MICROB, V67, P1262, DOI 10.1128/AEM.67.3.1262-1267.2001; IKE Y, 1992, J BACTERIOL, V174, P8172, DOI 10.1128/JB.174.24.8172-8177.1992; IKE Y, 1990, J BACTERIOL, V172, P155, DOI 10.1128/JB.172.1.155-163.1990; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; IKE Y, 1987, J CLIN MICROBIOL, V25, P1524, DOI 10.1128/JCM.25.8.1524-1528.1987; Inoue T, 2006, ANTIMICROB AGENTS CH, V50, P1202, DOI 10.1128/AAC.50.4.1202-1212.2006; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Martinez-Fleites C, 2009, CARBOHYD RES, V344, P1753, DOI 10.1016/j.carres.2009.06.001; MARTINEZBUENO M, 1994, J BACTERIOL, V176, P6334, DOI 10.1128/jb.176.20.6334-6339.1994; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Pecenkova T, 1997, GENE, V199, P157; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Sambrook J, 2001, MOL CLONING LAB MANU; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; SUGAI M, 1991, ZBL BAKT-INT J MED M, V275, P156; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Todokoro D, 2006, APPL ENVIRON MICROB, V72, P6955, DOI 10.1128/AEM.00934-06; Tomita H, 1997, J BACTERIOL, V179, P7843, DOI 10.1128/jb.179.24.7843-7855.1997; Tomita H, 1996, J BACTERIOL, V178, P3585, DOI 10.1128/jb.178.12.3585-3593.1996; Tomita H., 2010, 3 INT ASM C ENT, P37; Tomita H, 2008, J BACTERIOL, V190, P2075, DOI 10.1128/JB.01056-07; Uchiyama J, 2011, APPL ENVIRON MICROB, V77, P580, DOI 10.1128/AEM.01540-10; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986; Yamashita H, 2011, ANTIMICROB AGENTS CH, V55, P4352, DOI 10.1128/AAC.01274-10; Zheng B, 2009, ANTIMICROB AGENTS CH, V53, P735, DOI 10.1128/AAC.00754-08	39	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36915	36925		10.1074/jbc.M113.506618	http://dx.doi.org/10.1074/jbc.M113.506618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235140	hybrid, Green Published			2022-12-25	WOS:000329189700014
J	Kang, BY; Park, KK; Green, DE; Bijli, KM; Searles, CD; Sutliff, RL; Hart, CM				Kang, Bum-Yong; Park, Kathy K.; Green, David E.; Bijli, Kaiser M.; Searles, Charles D.; Sutliff, Roy L.; Hart, C. Michael			Hypoxia Mediates Mutual Repression between microRNA-27a and PPAR gamma in the Pulmonary Vasculature	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; RANDOMIZED CONTROLLED-TRIALS; SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; EXPRESSION; LUNG; METAANALYSIS; DIFFERENTIATION; ENDOTHELIN-1; ANGIOGENESIS	Pulmonary hypertension (PH) is a serious disorder that causes significant morbidity and mortality. The pathogenesis of PH involves complex derangements in multiple pathways including reductions in peroxisome proliferator-activated receptor gamma (PPAR gamma). Hypoxia, a common PH stimulus, reduces PPAR gamma in experimental models. In contrast, activating PPAR gamma attenuates hypoxia-induced PH and endothelin 1 (ET-1) expression. To further explore mechanisms of hypoxia-induced PH and reductions in PPAR gamma, we examined the effects of hypoxia on selected microRNA (miRNA or miR) levels that might reduce PPAR gamma expression leading to increased ET-1 expression and PH. Our results demonstrate that exposure to hypoxia (10% O-2) for 3-weeks increased levels of miR-27a and ET-1 in the lungs of C57BL/6 mice and reduced PPAR gamma levels. Hypoxia-induced increases in miR-27a were attenuated in mice treated with the PPAR gamma ligand, rosiglitazone (RSG, 10 mg/kg/d) by gavage for the final 10 d of exposure. In parallel studies, human pulmonary artery endothelial cells (HPAECs) were exposed to control (21% O-2) or hypoxic (1% O-2) conditions for 72 h. Hypoxia increased HPAEC proliferation, miR-27a and ET-1 expression, and reduced PPAR gamma expression. These alterations were attenuated by treatment with RSG (10 mu M) during the last 24 h of hypoxia exposure. Overexpression of miR-27a or PPAR gamma knockdown increased HPAEC proliferation and ET-1 expression and decreased PPAR gamma levels, whereas these effects were reversed by miR-27a inhibition. Further, compared to lungs from littermate control mice, miR-27a levels were upregulated in lungs from endothelial-targeted PPAR gamma knockout (ePPAR gamma KO) mice. Knockdown of either SP1 or EGR1 was sufficient to significantly attenuate miR-27a expression in HPAECs. Collectively, these studies provide novel evidence that miR-27a and PPAR gamma mediate mutually repressive actions in hypoxic pulmonary vasculature and that targeting PPAR gamma may represent a novel therapeutic approach in PH to attenuate proliferative mediators that stimulate proliferation of pulmonary vascular cells.	[Hart, C. Michael] Atlanta Vet Affairs Med Ctr, Dept Med, Atlanta, GA USA; Emory Univ, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Hart, CM (corresponding author), Atlanta Vet Affairs Med Ctr, Dept Med, Atlanta, GA USA.	michael.hart3@va.gov		Hart, C. Michael/0000-0002-9145-9938	Veterans Affairs Merit Review Award [1I01BX001910]; NIH [DK 074518, HL102167]; American Heart Association National Scientist Development Grant [13SDG14150004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074518] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by funding from a Veterans Affairs Merit Review Award (1I01BX001910 to CMH), from NIH grants DK 074518 and HL102167 (to CMH and RLS), and from an American Heart Association National Scientist Development Grant (13SDG14150004 to BYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Brock M., 2012, EUR HEART J; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Green David E, 2012, Pulm Circ, V2, P483, DOI 10.4103/2045-8932.105037; Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009; Guo L, 2012, HYPERTENSION, V59, P1006, DOI 10.1161/HYPERTENSIONAHA.111.185413; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hassan T, 2012, EXPERT REV ANTI-INFE, V10, P359, DOI [10.1586/ERI.11.175, 10.1586/eri.11.175]; He B, 2010, CIRC J, V74, P1458, DOI 10.1253/circj.CJ-09-0971; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Joshi Sachindra R, 2011, Pulm Circ, V1, P357, DOI 10.4103/2045-8932.87301; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Lilienfeld DE, 2000, CHEST, V117, P796, DOI 10.1378/chest.117.3.796; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Macchia A, 2007, AM HEART J, V153, P1037, DOI 10.1016/j.ahj.2007.02.037; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; Min S, 2012, GENES IMMUN, V13, P621, DOI 10.1038/gene.2012.45; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Okada M, 2002, FASEB J, V16, P1861, DOI 10.1096/fj.02-0503com; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Ryerson CJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-12; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/867517; White Kevin, 2012, Pulm Circ, V2, P278, DOI 10.4103/2045-8932.101395; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	60	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79503	10.1371/journal.pone.0079503	http://dx.doi.org/10.1371/journal.pone.0079503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244514	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800085
J	Zhang, SW; Li, JJ; Lea, R; Amaya, E; Dorey, K				Zhang, Siwei; Li, Jingjing; Lea, Robert; Amaya, Enrique; Dorey, Karel			A Functional Genome-Wide In Vivo Screen Identifies New Regulators of Signalling Pathways during Early Xenopus Embryogenesis	PLOS ONE			English	Article							MESODERM INDUCTION; TGF-BETA; MAPK PATHWAY; EXPRESSION; GENE; FGF; EMBRYOS; NEURONS; BINDING; ARREST	Embryonic development requires exquisite regulation of several essential processes, such as patterning of tissues and organs, cell fate decisions, and morphogenesis. Intriguingly, these diverse processes are controlled by only a handful of signalling pathways, and mis-regulation in one or more of these pathways may result in a variety of congenital defects and diseases. Consequently, investigating how these signalling pathways are regulated at the molecular level is essential to understanding the mechanisms underlying vertebrate embryogenesis, as well as developing treatments for human diseases. Here, we designed and performed a large-scale gain-of-function screen in Xenopus embryos aimed at identifying new regulators of MAPK/Erk, PI3K/Akt, BMP, and TGF-beta/Nodal signalling pathways. Our gain-of-function screen is based on the identification of gene products that alter the phosphorylation state of key signalling molecules, which report the activation state of the pathways. In total, we have identified 20 new molecules that regulate the activity of one or more signalling pathways during early Xenopus development. This is the first time that such a functional screen has been performed, and the findings pave the way toward a more comprehensive understanding of the molecular mechanisms regulating the activity of important signalling pathways under normal and pathological conditions.	[Zhang, Siwei; Li, Jingjing; Lea, Robert; Amaya, Enrique; Dorey, Karel] Univ Manchester, Fac Life Sci, Healing Fdn Ctr, Manchester, Lancs, England	University of Manchester	Amaya, E (corresponding author), Univ Manchester, Fac Life Sci, Healing Fdn Ctr, Manchester, Lancs, England.	enrique.amaya@manchester.ac.uk; karel.dorey@manchester.ac.uk	Zhang, Siwei/AAM-7361-2021	Zhang, Siwei/0000-0002-1646-063X; Li, Jingjing/0000-0003-4435-7573; Lea, Robert/0000-0003-0522-3601; Amaya, Enrique/0000-0002-1805-8548; Dorey, Karel/0000-0003-0846-5286	Biotechnology and Biological Science Research Council [BB/J005983/1]; Royal Society [55057]; Wellcome Trust [WT082450MA]; Healing Foundation; BBSRC [BB/J005983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005983/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Healing Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant from the Biotechnology and Biological Science Research Council [BB/J005983/1] and a Royal Society Research Grant [ref 55057] to KD, and a Wellcome Trust Programme Grant (WT082450MA) and a project grant from The Healing Foundation to EA. SZ and JL were supported by PhD studentships from The Healing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2002, INT J BIOCHEM CELL B, V34, P699, DOI 10.1016/S1357-2725(01)00150-9; Agius E, 2000, DEVELOPMENT, V127, P1173; Amaya E, 2005, GENOME RES, V15, P1683, DOI 10.1101/gr.3801805; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Callery EM, 2010, DEV BIOL, V340, P75, DOI 10.1016/j.ydbio.2010.01.013; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JA, 2005, MECH DEVELOP, V122, P307, DOI 10.1016/j.mod.2004.11.008; Chung HA, 2004, GENES CELLS, V9, P749, DOI 10.1111/j.1356-9597.2004.00761.x; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Fujitomo T, 2012, CANCER RES, V72, P4110, DOI 10.1158/0008-5472.CAN-12-0159; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Gilchrist MJ, 2004, DEV BIOL, V271, P498, DOI 10.1016/j.ydbio.2004.04.023; Goh SH, 2011, ONCOGENE, V30, P398, DOI 10.1038/onc.2010.422; Greenberg AJ, 2013, LEUKEMIA, V27, P515, DOI 10.1038/leu.2012.232; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hyde CE, 2000, DEVELOPMENT, V127, P1221; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; JONES CM, 1992, DEVELOPMENT, V115, P639; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Komuta Y, 2007, J COMP NEUROL, V503, P454, DOI 10.1002/cne.21401; Lassy RAL, 2000, J BACTERIOL, V182, P2536, DOI 10.1128/JB.182.9.2536-2543.2000; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lou X, 2006, CELL RES, V16, P771, DOI 10.1038/sj.cr.7310093; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Massague J, 2000, GENE DEV, V14, P627; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pollet N, 2000, NUCLEIC ACIDS RES, V28, P139, DOI 10.1093/nar/28.1.139; Rieden PMJID, 2010, DEV DYNAM, V239, P126, DOI 10.1002/dvdy.22020; Rorth P, 1998, DEVELOPMENT, V125, P1049; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schmidt A, 2004, MOL BIOL CELL, V15, p256A; Schohl A, 2002, DEVELOPMENT, V129, P37; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; Smith JC, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002477; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Tsuji Shoji, 2007, Nihon Ronen Igakkai Zasshi, V44, P154; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Uchiyama H, 2001, DEV GROWTH DIFFER, V43, P657; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xing YL, 2012, G3-GENES GENOM GENET, V2, P343, DOI 10.1534/g3.111.001651; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507; Zhong B, 2003, BLOOD, V101, P3240, DOI 10.1182/blood-2001-12-0180; Zhu MY, 2005, GENETICS, V170, P767, DOI 10.1534/genetics.104.039750	81	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79469	10.1371/journal.pone.0079469	http://dx.doi.org/10.1371/journal.pone.0079469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244509	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800080
J	Ma, XZ; Ambus, P; Wang, SP; Wang, YF; Wang, CJ				Ma, Xiuzhi; Ambus, Per; Wang, Shiping; Wang, Yanfen; Wang, Chengjie			Priming of Soil Carbon Decomposition in Two Inner Mongolia Grassland Soils following Sheep Dung Addition: A Study Using C-13 Natural Abundance Approach	PLOS ONE			English	Article							PIG SLURRY; MICROBIAL BIOMASS; SIZE FRACTIONS; NITROUS-OXIDE; N DYNAMICS; CO2; QUANTIFICATION; N2O; MECHANISMS; EMISSIONS	To investigate the effect of sheep dung on soil carbon (C) sequestration, a 152 days incubation experiment was conducted with soils from two different Inner Mongolian grasslands, i.e. a Leymus chinensis dominated grassland representing the climax community (2.1% organic matter content) and a heavily degraded Artemisia frigida dominated community (1.3% organic matter content). Dung was collected from sheep either fed on L. chinensis (C-3 plant with delta C-13= -26.8%; dung delta C-13= -26.2%) or Cleistogenes squarrosa (C-4 plant with delta C-13= -14.6%; dung delta C-13= -15.7%). Fresh C-3 and C-4 sheep dung was mixed with the two grassland soils and incubated under controlled conditions for analysis of C-13-CO2 emissions. Soil samples were taken at days 17, 43, 86, 127 and 152 after sheep dung addition to detect the delta C-13 signal in soil and dung components. Analysis revealed that 16.9% and 16.6% of the sheep dung C had decomposed, of which 3.5% and 2.8% was sequestrated in the soils of L. chinensis and A. frigida grasslands, respectively, while the remaining decomposed sheep dung was emitted as CO2. The cumulative amounts of C respired from dung treated soils during 152 days were 7-8 times higher than in the un-amended controls. In both grassland soils, ca. 60% of the evolved CO2 originated from the decomposing sheep dung and 40% from the native soil C. Priming effects of soil C decomposition were observed in both soils, i.e. 1.4 g and 1.6 g additional soil C kg(-1) dry soil had been emitted as CO2 for the L. chinensis and A. frigida soils, respectively. Hence, the net C losses from L. chinensis and A. frigida soils were 0.6 g and 0.9 g C kg(-1) soil, which was 2.6% and 7.0% of the total C in L. chinensis and A. frigida grasslands soils, respectively. Our results suggest that grazing of degraded Inner Mongolian pastures may cause a net soil C loss due to the positive priming effect, thereby accelerating soil deterioration.	[Ma, Xiuzhi] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Peoples R China; [Ambus, Per] Tech Univ Denmark, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark; [Wang, Shiping] Chinese Acad Sci, Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Dept Life Coll, Beijing, Peoples R China; [Wang, Chengjie] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Technical University of Denmark; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Inner Mongolia Agricultural University	Wang, SP (corresponding author), Chinese Acad Sci, Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing, Peoples R China.	wangship2008@yahoo.cn	Ambus, Per L/B-2514-2015	Ambus, Per L/0000-0001-7580-524X	National Basic Research Program [2010CB833502]; Chinese National Natural Science Foundation [97711001, 31160117, 31260119]	National Basic Research Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by the National Basic Research Program (2010CB833502) and Chinese National Natural Science Foundation (97711001, 31160117, 31260119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers DA, 2007, SOIL BIOL BIOCHEM, V39, P1234, DOI 10.1016/j.soilbio.2006.12.028; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bao S., 2000, SOIL AGROCHEMICAL AN; Bertora C, 2008, SOIL BIOL BIOCHEM, V40, P1999, DOI 10.1016/j.soilbio.2008.03.021; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P159, DOI 10.1016/j.soilbio.2010.09.028; Bol R, 2003, RAPID COMMUN MASS SP, V17, P2585, DOI 10.1002/rcm.1184; Bol R, 2003, SOIL BIOL BIOCHEM, V35, P1411, DOI 10.1016/S0038-0717(03)00235-9; Chantigny MH, 2001, CAN J SOIL SCI, V81, P131, DOI 10.4141/S00-046; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Chen ZZ, 2000, TYPICAL STEPPE ECOSY, P13; Dendooven L, 1998, BIOL FERT SOILS, V26, P224, DOI 10.1007/s003740050371; Dungait JAJ, 2005, ISOT ENVIRON HEALT S, V41, P3, DOI 10.1080/10256010500053516; Dungait JAJ, 2009, ORG GEOCHEM, V40, P1210, DOI 10.1016/j.orggeochem.2009.08.001; Fangueiro D, 2007, SOIL BIOL BIOCHEM, V39, P2608, DOI 10.1016/j.soilbio.2007.05.012; Fangueiro D, 2010, CHEMOSPHERE, V81, P100, DOI 10.1016/j.chemosphere.2010.06.049; Flessa H, 2000, J ENVIRON QUAL, V29, P262, DOI 10.2134/jeq2000.00472425002900010033x; Formanek P, 2004, RAPID COMMUN MASS SP, V18, P897, DOI 10.1002/rcm.1424; Glaser B, 2001, J PLANT NUTR SOIL SC, V164, P467, DOI 10.1002/1522-2624(200110)164:5<467::AID-JPLN467>3.0.CO;2-Q; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Kristiansen SM, 2004, SOIL BIOL BIOCHEM, V36, P99, DOI 10.1016/j.soilbio.2003.07.002; Kuzyakov Y, 1999, AGRIBIOL RES, V52, P25; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2005, RAPID COMMUN MASS SP, V19, P1417, DOI 10.1002/rcm.1938; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2004, J PLANT NUTR SOIL SC, V167, P669, DOI 10.1002/jpln.200421412; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; LIU ZK, 2004, CHINESE J APPL ECOLO, V15, P2255; Lovell RD, 1996, SOIL BIOL BIOCHEM, V28, P291, DOI 10.1016/0038-0717(95)00140-9; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Lupwayi NZ, 1999, BIOL FERT SOILS, V28, P182, DOI 10.1007/s003740050482; Ma XZ, 2007, COMMUN SOIL SCI PLAN, V38, P1589, DOI 10.1080/00103620701378516; Ma XZ, 2006, NEW ZEAL J AGR RES, V49, P285, DOI 10.1080/00288233.2006.9513719; Ohm H, 2007, J PLANT NUTR SOIL SC, V170, P551, DOI 10.1002/jpln.200625087; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P1267, DOI 10.1111/j.1365-2486.2006.01173.x; Rochette P, 2004, SOIL SCI SOC AM J, V68, P1410, DOI 10.2136/sssaj2004.1410; Shen J, 1996, APPL ENVIRON MICROB, V62, P1428, DOI 10.1128/AEM.62.4.1428-1430.1996; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Wang SP, 1997, CHINESE J ANIMAL NUT, V9, P49; WANG Y F, 1998, ACTA AGRESTIA SIN, V6, P299	46	4	6	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78578	10.1371/journal.pone.0078578	http://dx.doi.org/10.1371/journal.pone.0078578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236024	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700021
J	Nakagome, S; Mano, S; Hasegawa, M				Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami			Ancestral Polymorphisms and Sex-Biased Migration Shaped the Demographic History of Brown Bears and Polar Bears	PLOS ONE			English	Article							GENOMIC SEQUENCES REVEAL; GENETIC-VARIATION; DNA POLYMORPHISM; GRIZZLY BEARS; RECOMBINATION; DIVERGENCE; DISTANCE; LINEAGE; URSIDAE; ORIGIN	Recent studies have reported discordant gene trees in the evolution of brown bears and polar bears. Genealogical histories are different among independent nuclear loci and between biparentally inherited autosomal DNA (aDNA) and matrilineal mitochondrial DNA (mtDNA). Based on multi-locus genomic sequences from aDNA and mtDNA, we inferred the population demography of brown and polar bears and found that brown bears have 6 times (aDNA) or more than 14 times (mtDNA) larger population sizes than polar bears and that polar bear lineage is derived from within brown bear diversity. In brown bears, the effective population size ratio of mtDNA to aDNA was at least 0.62, which deviated from the expected value of 0.25, suggesting matriarchal population due to female philopatry and male-biased migration. These results emphasize that ancestral polymorphisms and sex-biased migration may have contributed to conflicting branching patterns in brown and polar bears across aDNA genes and mtDNA.	[Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami] Inst Stat Math, Risk Anal Res Ctr, Tachikawa, Tokyo, Japan; [Mano, Shuhei] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo, Japan; [Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Fudan University	Nakagome, S (corresponding author), Inst Stat Math, Risk Anal Res Ctr, Tachikawa, Tokyo, Japan.	nakagome@ism.ac.jp		Nakagome, Shigeki/0000-0001-9613-975X	Japan Society for the Promotion of Science (JSPS) [24-3234]; JSPS [C22570099]; Grants-in-Aid for Scientific Research [25440219] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.N. was supported as a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) Research Fellow (24-3234). M. H. was supported by Grants-in-Aid for Scientific Research C22570099 from JSPS. The funders had no role in study design, data collection and analysis.	Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Chesser RK, 1996, GENETICS, V144, P1225; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Fukumizu K., 2011, ADV NEURAL INFORM PR, V24, P1549; Griffiths R.C, 2007, GENETREE VERSION 9 0; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Laporte V, 2002, GENETICS, V162, P501; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Nakagome S, STAT APPL G IN PRESS; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WAYNE RK, 1991, MOL BIOL EVOL, V8, P297	31	3	3	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78813	10.1371/journal.pone.0078813	http://dx.doi.org/10.1371/journal.pone.0078813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236053	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700050
J	Zhao, L; Tolbert, WD; Ericksen, B; Zhan, CY; Wu, XJ; Yuan, WR; Li, X; Pazgier, M; Lu, WY				Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Li, Xu; Pazgier, Marzena; Lu, Wuyuan			Single, Double and Quadruple Alanine Substitutions at Oligomeric Interfaces Identify Hydrophobicity as the Key Determinant of Human Neutrophil Alpha Defensin HNP1 Function	PLOS ONE			English	Article							HUMAN BETA-DEFENSINS; PRECURSOR LIPID II; SCANNING MUTAGENESIS; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; BACTERICIDAL ACTIVITY; RESONANCE ASSIGNMENT; FUNGAL DEFENSIN; PANETH CELLS; BINDING	HNP1 is a human alpha defensin that forms dimers and multimers governed by hydrophobic residues, including Tyr(16), Ile(20), Leu(25), and Phe(28). Previously, alanine scanning mutagenesis identified each of these residues and other hydrophobic residues as important for function. Here we report further structural and functional studies of residues shown to interact with one another across oligomeric interfaces: I20A-HNP1 and L25A-HNP1, plus the double alanine mutants I20A/L25A-HNP1 and Y16A/F28A-HNP1, and the quadruple alanine mutant Y16A/I20A/L25A/F28A-HNP1. We tested binding to HIV-1 gp120 and HNP1 by surface plasmon resonance, binding to HIV-1 gp41 and HNP1 by fluorescence polarization, inhibition of anthrax lethal factor, and antibacterial activity using the virtual colony count assay. Similar to the previously described single mutant W26A-HNP1, the quadruple mutant displayed the least activity in all functional assays, followed by the double mutant Y16A/F28A-HNP1. The effects of the L25A and I20A single mutations were milder than the double mutant I20A/L25A-HNP1. Crystallographic studies confirmed the correct folding and disulfide pairing, and depicted an array of dimeric and tetrameric structures. These results indicate that side chain hydrophobicity is the critical factor that determines activity at these positions.	[Zhao, Le; Li, Xu] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Translat Med Ctr, Xian 710049, Peoples R China; [Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Xi'an Jiaotong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Li, X (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Translat Med Ctr, Xian 710049, Peoples R China.	lixu56@mail.xjtu.edu.cn; mpazgier@ihv.umaryland.edu	Lu, Wuyuan/J-8452-2017; Zhan, Changyou/G-3667-2011; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; Tolbert, William/0000-0001-7549-9596; Ericksen, Bryan/0000-0002-8016-8289	National Institutes of Health [AI072732, AI061482]; Xi'an Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xi'an Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI072732 and AI061482 (to W. L.). L.Z. was a Guanghua Scholar supported by Xi'an Jiaotong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BLABER M, 1995, J MOL BIOL, V246, P317, DOI 10.1006/jmbi.1994.0087; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lay FT, 2012, J BIOL CHEM, V287, P19961, DOI 10.1074/jbc.M111.331009; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1985, J BIOL CHEM, V260, P4579; SINGH A, 1988, BIOCHEM BIOPH RES CO, V155, P524, DOI 10.1016/S0006-291X(88)81118-5; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; YU MH, 1995, J MOL BIOL, V249, P388, DOI 10.1006/jmbi.1995.0304; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012; Zhang Y, 2010, J MOL BIOL, V397, P408, DOI 10.1016/j.jmb.2010.01.030; Zhao L, 2012, J BIOL CHEM, V287, P18900, DOI 10.1074/jbc.M112.355255	68	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78937	10.1371/journal.pone.0078937	http://dx.doi.org/10.1371/journal.pone.0078937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236072	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700069
J	Zhong, LR; Estes, S; Artinian, L; Rehder, V				Zhong, Lei Ray; Estes, Stephen; Artinian, Liana; Rehder, Vincent			Nitric Oxide Regulates Neuronal Activity via Calcium-Activated Potassium Channels	PLOS ONE			English	Article							GROWTH CONE FILOPODIA; LYMNAEA-STAGNALIS; VOLUME TRANSMITTER; MEMORY FORMATION; CA2+ SIGNALS; HELISOMA; APLYSIA; EXCITABILITY; MODULATION; SNAIL	Nitric oxide (NO) is an unconventional membrane-permeable messenger molecule that has been shown to play various roles in the nervous system. How NO modulates ion channels to affect neuronal functions is not well understood. In gastropods, NO has been implicated in regulating the feeding motor program. The buccal motoneuron, B19, of the freshwater pond snail Helisoma trivolvis is active during the hyper-retraction phase of the feeding motor program and is located in the vicinity of NO-producing neurons in the buccal ganglion. Here, we asked whether B19 neurons might serve as direct targets of NO signaling. Previous work established NO as a key regulator of growth cone motility and neuronal excitability in another buccal neuron involved in feeding, the B5 neuron. This raised the question whether NO might modulate the electrical activity and neuronal excitability of B19 neurons as well, and if so whether NO acted on the same or a different set of ion channels in both neurons. To study specific responses of NO on B19 neurons and to eliminate indirect effects contributed by other cells, the majority of experiments were performed on single cultured B19 neurons. Addition of NO donors caused a prolonged depolarization of the membrane potential and an increase in neuronal excitability. The effects of NO could mainly be attributed to the inhibition of two types of calcium-activated potassium channels, apamin-sensitive and iberiotoxin-sensitive potassium channels. NO was found to also cause a depolarization in B19 neurons in situ, but only after NO synthase activity in buccal ganglia had been blocked. The results suggest that NO acts as a critical modulator of neuronal excitability in B19 neurons, and that calcium-activated potassium channels may serve as a common target of NO in neurons.	[Zhong, Lei Ray; Estes, Stephen; Artinian, Liana; Rehder, Vincent] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Rehder, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	vrehder@gsu.edu			NSF [0843173]; Brains and Behavior Fellowships; Sigma Xi; GSU; Direct For Biological Sciences [0843173] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Brains and Behavior Fellowships; Sigma Xi; GSU; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF award #0843173 to VR, Brains and Behavior Fellowships to LRZ and SE, Sigma Xi grants-in-aid of research grant, GSU dissertation grant to LRZ. NSF award (http://www.nsf.gov/); Brains and Behavior fellowship (http://neuroscience.gsu.edu/brains_behavior.html); Sigma Xi grants-in-aid of research grant (http://www.sigmaxi.org/programs/giar/); GSU dissertation grant (http://www.gsu.edu/research/funding_opportunities.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Artinian L, 2012, EUR J NEUROSCI, V36, P3333, DOI 10.1111/j.1460-9568.2012.08260.x; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bicker G, 2007, ARCH INSECT BIOCHEM, V64, P43, DOI 10.1002/arch.20161; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; CETINER M, 1993, BRIT J PHARMACOL, V110, P995, DOI 10.1111/j.1476-5381.1993.tb13912.x; ELPHICK MR, 1995, J NEUROSCI, V15, P7653; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Hui K, 2008, EUR J NEUROSCI, V27, P631, DOI 10.1111/j.1460-9568.2008.06023.x; Katzoff A, 2002, J NEUROSCI, V22, P9581; Katzoff A, 2006, J NEUROPHYSIOL, V96, P1247, DOI 10.1152/jn.00056.2006; Kemenes I, 2002, J NEUROSCI, V22, P1414, DOI 10.1523/JNEUROSCI.22-04-01414.2002; Kemenes I, 2006, CURR BIOL, V16, P1269, DOI 10.1016/j.cub.2006.05.049; Kobayashi S, 2000, NEUROSCI LETT, V285, P209, DOI 10.1016/S0304-3940(00)01079-X; Lukowiak K, 2006, RESP PHYSIOL NEUROBI, V154, P61, DOI 10.1016/j.resp.2006.02.009; MATTSON MP, 1987, J NEUROSCI, V7, P4034; Miller N, 2011, J NEUROPHYSIOL, V105, P1642, DOI 10.1152/jn.00827.2010; Miller N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017779; Moroz LL, 2011, FRONT BIOSCI-LANDMRK, V16, P2008, DOI 10.2741/3837; Moroz LL, 2000, MICROSC RES TECHNIQ, V49, P557, DOI 10.1002/1097-0029(20000615)49:6<557::AID-JEMT6>3.0.CO;2-S; MOROZ LL, 1993, NEUROREPORT, V4, P643, DOI 10.1097/00001756-199306000-00010; Murphy AD, 2001, PROG NEUROBIOL, V63, P383, DOI 10.1016/S0301-0082(00)00049-6; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Park JH, 1998, J NEUROSCI, V18, P5463, DOI 10.1523/JNEUROSCI.18-14-05463.1998; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Quinlan EM, 1997, J NEUROPHYSIOL, V78, P812, DOI 10.1152/jn.1997.78.2.812; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; Sadamoto H, 1998, NEUROSCI RES, V32, P57, DOI 10.1016/S0168-0102(98)00066-2; Schrofner S, 2004, BRAIN RES, V999, P98, DOI 10.1016/j.brainres.2003.11.038; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; Susswein AJ, 2012, PROG NEUROBIOL, V97, P304, DOI 10.1016/j.pneurobio.2012.03.004; Torreano PJ, 1997, J NEUROBIOL, V32, P150; Tozer AJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032256; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Trimm KR, 2004, EUR J NEUROSCI, V19, P809, DOI 10.1111/j.0953-816X.2004.03182.x; Turner MB, 2011, BIOL BULL-US, V221, P110, DOI 10.1086/BBLv221n1p110; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; Van Wagenen S, 2001, J NEUROBIOL, V46, P206, DOI 10.1002/1097-4695(20010215)46:3<206::AID-NEU1003>3.3.CO;2-J; Welshhans K, 2005, EUR J NEUROSCI, V22, P3006, DOI 10.1111/j.1460-9568.2005.04490.x; Wilson GW, 2010, EUR J NEUROSCI, V31, P1935, DOI 10.1111/j.1460-9568.2010.07226.x; Zhong LR, 2013, NEUROSCIENCE, V228, P109, DOI 10.1016/j.neuroscience.2012.10.005; Zhong LR, 2013, DEV NEUROBIOL, V73, P487, DOI 10.1002/dneu.22071	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78727	10.1371/journal.pone.0078727	http://dx.doi.org/10.1371/journal.pone.0078727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236040	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700037
J	Aradska, J; Smidak, R; Turkovicova, L; Turna, J; Lubec, G				Aradska, Jana; Smidak, Roman; Turkovicova, Lenka; Turna, Jan; Lubec, Gert			Proteomic Differences between Tellurite-Sensitive and Tellurite-Resistant E.coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; IN-VIVO; REDUCTASE; PHAGE; GLUTATHIONE; TOXICITY; PROTECTS; ROLES	Tellurite containing compounds are in use for industrial processes and increasing delivery into the environment generates specific pollution that may well result in contamination and subsequent potential adverse effects on public health. It was the aim of the current study to reveal mechanism of toxicity in tellurite-sensitive and tellurite-resistant E. coli at the protein level. In this work an approach using gel-based mass spectrometrical analysis to identify a differential protein profile related to tellurite toxicity was used and the mechanism of ter operon-mediated tellurite resistance was addressed. E. coli BL21 was genetically manipulated for tellurite-resistance by the introduction of the resistance-conferring ter genes on the pLK18 plasmid. Potassium tellurite was added to cultures in order to obtain a final 3.9 micromolar concentration. Proteins from tellurite-sensitive and tellurite-resistant E. coli were run on 2-D gel electrophoresis, spots of interest were picked, in-gel digested and subsequently analysed by nano-LC-MS/MS (ion trap). In addition, Western blotting and measurement of enzymatic activity were performed to verify the expression of certain candidate proteins. Following exposure to tellurite, in contrast to tellurite-resistant bacteria, sensitive cells exhibited increased levels of antioxidant enzymes superoxide dismutases, catalase and oxidoreductase YqhD. Cysteine desulfurase, known to be related to tellurite toxicity as well as proteins involved in protein folding: GroEL, DnaK and EF-Tu were upregulated in sensitive cells. In resistant bacteria, several isoforms of four essential Ter proteins were observed and following tellurite treatment the abovementioned protein levels did not show any significant proteome changes as compared to the sensitive control. The absence of general defense mechanisms against tellurite toxicity in resistant bacteria thus provides further evidence that the four proteins of the ter operon function by a specific mode of action in the mechanism of tellurite resistance probably involving protein cascades from antioxidant and protein folding pathways.	[Aradska, Jana; Smidak, Roman; Turkovicova, Lenka; Turna, Jan] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Lubec, Gert] Med Univ Vienna, Dept Pediat, Vienna, Austria	Comenius University Bratislava; Medical University of Vienna	Lubec, G (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at	Turňa, Ján/T-2942-2019; Jánošíková, Lenka/AAP-1185-2021	Turňa, Ján/0000-0001-5813-566X; Lubec, Gert/0000-0002-6333-9461; Lubec, Jana/0000-0003-0657-7647	Aktion Osterreich - Slowakei	Aktion Osterreich - Slowakei	Sponsored by a scholarship grant by the Aktion Osterreich - Slowakei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; BEERS RF, 1952, J BIOL CHEM, V195, P133; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; Boudvillain M, 2013, CURR OPIN MICROBIOL, V16, P118, DOI 10.1016/j.mib.2012.12.003; Burian J, 1998, FOLIA MICROBIOL, V43, P589, DOI 10.1007/BF02816374; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Gao YX, 2013, METALLOMICS, V5, P913, DOI 10.1039/c3mt20279h; Garberg P, 1999, INT J BIOCHEM CELL B, V31, P291, DOI 10.1016/S1357-2725(98)00113-7; Italiani VCS, 2002, MOL MICROBIOL, V44, P181, DOI 10.1046/j.1365-2958.2002.02865.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Kuczynska-Wisnik D, 2010, MICROBIOL-SGM, V156, P148, DOI 10.1099/mic.0.032334-0; Lee C, 2010, J BACTERIOL, V192, P4205, DOI 10.1128/JB.01127-09; Lohmeier-Vogel EM, 2004, APPL ENVIRON MICROB, V70, P7342, DOI 10.1128/AEM.70.12.7342-7347.2004; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; St Denis TG, 2011, PHOTOCHEM PHOTOBIOL, V87, P707, DOI 10.1111/j.1751-1097.2011.00902.x; Sunyer B, 2008, J PROTEOME RES, V7, P5237, DOI 10.1021/pr800594b; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Toptchieva A, 2003, MICROBIOL-SGM, V149, P1285, DOI 10.1099/mic.0.25981-0; Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; Venancio TM, 2010, MOL BIOSYST, V6, P1475, DOI 10.1039/c002567b; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; WHELAN KF, 1995, J BACTERIOL, V177, P5016, DOI 10.1128/jb.177.17.5016-5027.1995; Whelan KF, 1997, J BACTERIOL, V179, P63, DOI 10.1128/jb.179.1.63-71.1997; Yao XH, 2006, BIOMED ENVIRON SCI, V19, P309	36	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78010	10.1371/journal.pone.0078010	http://dx.doi.org/10.1371/journal.pone.0078010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244285	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600013
J	Pachel, C; Mathes, D; Bayer, B; Dienesch, C; Wangorsch, G; Heitzmann, W; Lang, I; Ardehali, H; Ertl, G; Dandekar, T; Wajant, H; Frantz, S				Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Wangorsch, Gaby; Heitzmann, Wolfram; Lang, Isabell; Ardehali, Hossein; Ertl, Georg; Dandekar, Thomas; Wajant, Harald; Frantz, Stefan			Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-INDUCIBLE 14; MONOCYTE CHEMOATTRACTANT PROTEIN-1; B SUBUNIT P50; WEAK INDUCER; NEUTROPHIL DEPLETION; CHEMOKINE RECEPTOR; INTERFERON-GAMMA; APOPTOSIS TWEAK; HEART-FAILURE	Background: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) are upregulated after myocardial infarction (MI) in both humans and mice. They modulate inflammation and the extracellular matrix, and could therefore be important for healing and remodeling after MI. However, the function of TWEAK after MI remains poorly defined. Methods and results: Following ligation of the left coronary artery, mice were injected twice per week with a recombinant human serum albumin conjugated variant of TWEAK (HSA-Flag-TWEAK), mimicking the activity of soluble TWEAK. Treatment with HSA-Flag-TWEAK resulted in significantly increased mortality in comparison to the placebo group due to myocardial rupture. Infarct size, extracellular matrix remodeling, and apoptosis rates were not different after MI. However, HSA-Flag-TWEAK treatment increased infiltration of proinflammatory cells into the myocardium. Accordingly, depletion of neutrophils prevented cardiac ruptures without modulating all-cause mortality. Conclusion: Treatment of mice with HSA-Flag-TWEAK induces myocardial healing defects after experimental MI. This is mediated by an exaggerated neutrophil infiltration into the myocardium.	[Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Heitzmann, Wolfram; Ertl, Georg; Frantz, Stefan] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Heitzmann, Wolfram; Ertl, Georg; Frantz, Stefan] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Wangorsch, Gaby; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Lang, Isabell; Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Ardehali, Hossein] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Northwestern University	Frantz, S (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	frantz_s@ukw.de	Frantz, Stefan/G-1723-2012; Dandekar, Thomas/A-4431-2017; Wajant, Harald/A-3020-2017	Dandekar, Thomas/0000-0003-1886-7625; Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973; Wangorsch, Gaby/0000-0003-3200-5394	Bundesministerium fur Bildung und Forschung [BMBF01 EO1004]; Deutsche Krebshilfe [DKH 109922]; Deutsche Forschungsgemeinschaft [Da 208/12-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by grants of the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004, to Drs Ertl and Frantz), Deutsche Krebshilfe (DKH 109922, to Dr. Wajant) and Deutsche Forschungsgemeinschaft (Da 208/12-1, to Dr. Dandekar/Dr. Wajant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyanova Desislava, 2012, Blood, V119, pe22, DOI 10.1182/blood-2011-10-387308; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; CHARNEY RH, 1992, CIRCULATION, V85, P1483, DOI 10.1161/01.CIR.85.4.1483; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; CURTIS WE, 1993, ANN THORAC SURG, V56, P1069, DOI 10.1016/0003-4975(95)90015-2; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Echeverry R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-45; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frantz S, 2005, FASEB J, V19, P591, DOI 10.1096/fj.04-2459fje; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; Frantz S, 2007, AM J PATHOL, V171, P507, DOI 10.2353/ajpath.2007.061042; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Haile WB, 2010, J CEREBR BLOOD F MET, V30, P1147, DOI 10.1038/jcbfm.2009.280; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; JOLLY SR, 1986, AM HEART J, V112, P682, DOI 10.1016/0002-8703(86)90461-8; Liehn EA, 2008, J CELL MOL MED, V12, P496, DOI 10.1111/j.1582-4934.2007.00194.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARFAINGKOKA A, 1995, J IMMUNOL, V154, P1870; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; McMurray JJV, 2013, EUR HEART J, V34, P158, DOI 10.1093/eurheartj/ehs370; Meier Karen, 2006, Expert Opin Emerg Drugs, V11, P23, DOI 10.1517/14728214.11.1.23; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Muller N, 2010, BIOCHEM BIOPH RES CO, V396, P793, DOI 10.1016/j.bbrc.2010.04.134; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Shi JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054054, 10.1371/journal.pone.0077651]; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Stephan D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-9; TAUB DD, 1995, J IMMUNOL, V155, P3877; Weir RAP, 2010, CYTOKINE, V50, P158, DOI 10.1016/j.cyto.2010.02.020; Zamilpa R, 2011, AM J PHYSIOL-HEART C, V300, pH1418, DOI 10.1152/ajpheart.01002.2010; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922; Zhu LX, 2012, CHINESE MED J-PEKING, V125, P3898, DOI 10.3760/cma.j.issn.0366-6999.2012.21.028; Zidar N, 2005, CARDIOVASC PATHOL, V14, P247, DOI 10.1016/j.carpath.2005.04.002	56	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78938	10.1371/journal.pone.0078938	http://dx.doi.org/10.1371/journal.pone.0078938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244389	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600083
J	Odhiambo, FO; Beynon, CM; Ogwang, S; Hamel, MJ; Howland, O; van Eijk, AM; Norton, R; Amek, N; Slutsker, L; Laserson, KF; De Cock, KM; Phillips-Howard, PA				Odhiambo, Frank O.; Beynon, Caryl M.; Ogwang, Sheila; Hamel, Mary J.; Howland, Olivia; van Eijk, Anne M.; Norton, Robyn; Amek, Nyaguara; Slutsker, Laurence; Laserson, Kayla F.; De Cock, Kevin M.; Phillips-Howard, Penelope A.			Trauma-Related Mortality among Adults in Rural Western Kenya: Characterising Deaths Using Data from a Health and Demographic Surveillance System	PLOS ONE			English	Article							GLOBAL BURDEN; INTERPERSONAL VIOLENCE; WOMENS HEALTH; INJURY; DISEASE; AFRICA; PEOPLE; ADOLESCENTS; QUALITY; ALCOHOL	Background: Information on trauma-related deaths in low and middle income countries is limited but needed to target public health interventions. Data from a health and demographic surveillance system (HDSS) were examined to characterise such deaths in rural western Kenya. Methods And Findings: Verbal autopsy data were analysed. Of 11,147 adult deaths between 2003 and 2008, 447 (4%) were attributed to trauma; 71% of these were in males. Trauma contributed 17% of all deaths in males 15 to 24 years; on a population basis mortality rates were greatest in persons over 65 years. Intentional causes accounted for a higher proportion of male than female deaths (RR 2.04, 1.37-3.04) and a higher proportion of deaths of those aged 15 to 65 than older people. Main causes in males were assaults (n=79, 25%) and road traffic injuries (n=47, 15%); and falls for females (n=17, 13%). A significantly greater proportion of deaths from poisoning (RR 5.0, 2.7-9.4) and assault (RR 1.8, 1.2-2.6) occurred among regular consumers of alcohol than among non-regular drinkers. In multivariate analysis, males had a 4-fold higher risk of death from trauma than females (Adjusted Relative Risk; ARR 4.0; 95% CI 1.7-9.4); risk of a trauma death rose with age, with the elderly at 7-fold higher risk (ARR 7.3, 1.1-49.2). Absence of care was the strongest predictor of trauma death (ARR 12.2, 9.4-15.8). Trauma-related deaths were higher among regular alcohol drinkers (ARR 1.5, 1.1-1.9) compared with non-regular drinkers. Conclusions: While trauma accounts for a small proportion of deaths in this rural area with a high prevalence of HIV, TB and malaria, preventive interventions such as improved road safety, home safety strategies for the elderly, and curbing harmful use of alcohol, are available and could help diminish this burden. Improvements in systems to record underlying causes of death from trauma are required.	[Odhiambo, Frank O.; Ogwang, Sheila; Amek, Nyaguara; Laserson, Kayla F.; De Cock, Kevin M.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Beynon, Caryl M.; Howland, Olivia] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Hamel, Mary J.; Slutsker, Laurence] Ctr Dis Control & Prevent, Dept Parasit Dis, Atlanta, GA USA; [van Eijk, Anne M.; Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Norton, Robyn] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Norton, Robyn] Univ Oxford, Oxford, England; [Laserson, Kayla F.] Ctr Dis Control & Prevent, India Epidem Intelligence Serv Programme, New Delhi, India; [De Cock, Kevin M.] Ctr Dis Control & Prevent, Nairobi, Kenya	Liverpool John Moores University; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool; George Institute for Global Health; University of Sydney; University of Oxford	Odhiambo, FO (corresponding author), KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya.	FOdhiambo@kemricdc.org	van Eijk, Anna Maria/AAQ-9894-2021	Phillips-Howard, Penelope A/0000-0003-1018-116X; Howland, Olivia/0000-0003-4109-7833; van Eijk, Anna Maria/0000-0003-1635-1289	KEMRI/CDC Cooperative Agreement grant; Medical Research Council [G1100677] Funding Source: researchfish; MRC [G1100677] Funding Source: UKRI	KEMRI/CDC Cooperative Agreement grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The HDSS and field staff support has been funded through the KEMRI/CDC Cooperative Agreement grant, with supplemental support from project-specific grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2011, WORLD HLTH STAT; Azetsop J, 2010, PUBLIC HEALTH ETH-UK, V3, P115, DOI 10.1093/phe/phq013; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Bhalla K, 2010, B WORLD HEALTH ORGAN, V88, P831, DOI 10.2471/BLT.09.068809; Borse NN, 2009, INDIAN J MED RES, V129, P321; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2011, B WORLD HEALTH ORGAN, V89, P2, DOI 10.2471/BLT.10.085217; Garrib A, 2011, TROP MED INT HEALTH, V16, P439, DOI 10.1111/j.1365-3156.2011.02730.x; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Lo TQ, 2013, TROP MED INT HEALTH, V18, P506, DOI 10.1111/tmi.12066; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Norman R, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-32; Odero W, 2007, East Afr Med J, V84, P367; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Otieno T, 2004, INJURY, V35, P1228, DOI 10.1016/j.injury.2004.03.013; Papas RK, 2010, AIDS BEHAV, V14, P836, DOI 10.1007/s10461-008-9492-z; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Ranney ML, 2009, INJURY PREV, V15, P36, DOI 10.1136/ip.2008.019547; Rehm J, 2010, DRUG ALCOHOL REV, V29, P426, DOI 10.1111/j.1465-3362.2009.00140.x; Ribeiro PS, 2008, INT J GYNECOL OBSTET, V102, P82, DOI 10.1016/j.ijgo.2008.01.025; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; WHO, 2004, GLOB STAT REP ALC 20; World Health Organization, 2007, WHO GLOB REP FALLP	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79840	10.1371/journal.pone.0079840	http://dx.doi.org/10.1371/journal.pone.0079840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244569	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327162900055
J	Pluchon, PF; Fouqueau, T; Creze, C; Laurent, S; Briffotaux, J; Hogrel, G; Palud, A; Henneke, G; Godfroy, A; Hausner, W; Thomm, M; Nicolas, J; Flament, D				Pluchon, Pierre-Francois; Fouqueau, Thomas; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Hausner, Winfried; Thomm, Michael; Nicolas, Jacques; Flament, Didier			An Extended Network of Genomic Maintenance in the Archaeon Pyrococcus abyssi Highlights Unexpected Associations between Eucaryotic Homologs	PLOS ONE			English	Article							REPLICATION PROTEIN-A; HYPERTHERMOPHILIC ARCHAEON; DNA-POLYMERASES; HETERODIMERIC PRIMASE; HALOPHILIC ARCHAEON; EXCISION-REPAIR; HELICASE; BINDING; FAMILY; MRE11	In Archaea, the proteins involved in the genetic information processing pathways, including DNA replication, transcription, and translation, share strong similarities with those of eukaryotes. Characterizations of components of the eukaryotic-type replication machinery complex provided many interesting insights into DNA replication in both domains. In contrast, DNA repair processes of hyperthermophilic archaea are less well understood and very little is known about the intertwining between DNA synthesis, repair and recombination pathways. The development of genetic system in hyperthermophilic archaea is still at a modest stage hampering the use of complementary approaches of reverse genetics and biochemistry to elucidate the function of new candidate DNA repair gene. To gain insights into genomic maintenance processes in hyperthermophilic archaea, a protein-interaction network centred on informational processes of Pyrococcus abyssi was generated by affinity purification coupled with mass spectrometry. The network consists of 132 interactions linking 87 proteins. These interactions give insights into the connections of DNA replication with recombination and repair, leading to the discovery of new archaeal components and of associations between eucaryotic homologs. Although this approach did not allow us to clearly delineate new DNA pathways, it provided numerous clues towards the function of new molecular complexes with the potential to better understand genomic maintenance processes in hyperthermophilic archaea. Among others, we found new potential partners of the replication clamp and demonstrated that the single strand DNA binding protein, Replication Protein A, enhances the transcription rate, in vitro, of RNA polymerase. This interaction map provides a valuable tool to explore new aspects of genome integrity in Archaea and also potentially in Eucaryotes.	[Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] Univ Bretagne Occidentale, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] CNRS, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Fouqueau, Thomas; Hausner, Winfried; Thomm, Michael] Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; [Nicolas, Jacques] IRISA INRIA, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; University of Regensburg; UDICE-French Research Universities; Universite Paris Saclay	Nicolas, J (corresponding author), IRISA INRIA, Campus Beaulieu, Rennes, France.	Jacques.Nicolas@irisa.fr; dflament@ifremer.fr	Anne, Godfroy/J-9897-2017; LAURENT, Sébastien/ABF-4382-2020; Godfroy, Anne/X-1992-2018; Briffotaux, Julien/AAG-2189-2021; , Protim/C-4687-2012	Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Briffotaux, Julien/0000-0002-0084-5818; Fouqueau, Thomas/0000-0003-1539-093X; Henneke, Ghislaine/0000-0002-2985-5526; flament, didier/0000-0002-9847-2342; Hogrel, Gaelle/0000-0003-4078-0577	Ifremer; French National Research Agency [ANR-07-BLAN-0371]; Brittany regional council, CREATE program [REPAR] [4852]; Deutsche Forschungsgemeinschaft [TH 422/11-1]	Ifremer; French National Research Agency(French National Research Agency (ANR)); Brittany regional council, CREATE program [REPAR](Region Bretagne); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Ifremer; French National Research Agency [ANR-07-BLAN-0371 to D.F.]; Brittany regional council, CREATE program [REPAR No4852 to D.F.]; Deutsche Forschungsgemeinschaft [TH 422/11-1 to M.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Atomi H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00337; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beattie TR, 2011, CURR OPIN CHEM BIOL, V15, P614, DOI 10.1016/j.cbpa.2011.07.017; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Busch CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009045; Chan PP, 2012, NUCLEIC ACIDS RES, V40, pD646, DOI 10.1093/nar/gkr990; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; Creze C, 2012, J BIOL CHEM; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Duxin JP, 2012, J BIOL CHEM, V287, P21980, DOI 10.1074/jbc.M112.359018; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Godfroy A, 2006, METHOD MICROBIOL, V35, P93, DOI 10.1016/S0580-9517(05)35004-5; Gouge J, 2012, J MOL BIOL, V423, P315, DOI 10.1016/j.jmb.2012.07.025; Grogan DW, 2004, CURR ISSUES MOL BIOL, V6, P137; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Hu JC, 2012, NUCLEIC ACIDS RES, V40, P3470, DOI 10.1093/nar/gkr1256; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; King NP, 2008, J MOL BIOL, V380, P181, DOI 10.1016/j.jmb.2008.04.073; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Lin YY, 2008, J BACTERIOL, V190, P5766, DOI 10.1128/JB.01930-07; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; MacNeill SA, 2011, BIOCHEM SOC T, V39, P163, DOI 10.1042/BST0390163; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Palud A, 2008, MOL MICROBIOL, V70, P746, DOI 10.1111/j.1365-2958.2008.06446.x; Pan M, 2011, BIOCHEM SOC T, V39, P20, DOI 10.1042/BST0390020; Perugino G, 2012, J BIOL CHEM, V287, P4222, DOI 10.1074/jbc.M111.308320; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Ren B, 2007, ACTA CRYSTALLOGR F, V63, P406, DOI 10.1107/S1744309107015278; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Richard DJ, 2004, NUCLEIC ACIDS RES, V32, P1065, DOI 10.1093/nar/gkh259; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sartori AA, 2003, J BIOL CHEM, V278, P24563, DOI 10.1074/jbc.M302397200; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shin JH, 2007, J BIOL CHEM, V282, P4908, DOI 10.1074/jbc.M606847200; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Skowyra A, 2012, NUCLEIC ACIDS RES, V40, P1077, DOI 10.1093/nar/gkr838; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108	75	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79707	10.1371/journal.pone.0079707	http://dx.doi.org/10.1371/journal.pone.0079707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244547	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900046
J	Broege, A; Pham, L; Jensen, ED; Emery, A; Huang, TH; Stemig, M; Beppu, H; Petryk, A; O'Connor, M; Mansky, K; Gopalakrishnan, R				Broege, Aaron; Pham, Lan; Jensen, Eric D.; Emery, Ann; Huang, Tsang-Hai; Stemig, Melissa; Beppu, Hideyuki; Petryk, Anna; O'Connor, Michael; Mansky, Kim; Gopalakrishnan, Raj			Bone Morphogenetic Proteins Signal Via SMAD and Mitogen-activated Protein (MAP) Kinase Pathways at Distinct Times during Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone Morphogenetic Protein (BMP); MAP Kinases (MAPKs); Osteoclast; Signal Transduction; BMPRII; Conditional Deletion	KAPPA-B LIGAND; RECEPTOR ACTIVATOR; DIFFERENTIATION; TAK1; CARTILAGE; SURVIVAL; EXPRESSION; DELETION; CELLS; GENE	To investigate the role of bone morphogenetic protein (BMP) signaling in osteoclastogenesis in vivo, we eliminated BMPRII in osteoclasts by creating a BMPRIIfl/fl;lysM-Cre mouse strain. Conditional knock-out (cKO) mice are osteopetrotic when compared with WT controls due to a decrease in osteoclast activity. Bone marrow macrophages (BMMs) isolated from cKO mice are severely inhibited in their capacity to differentiate into mature osteoclasts in the presence of M-CSF and receptor activator of NF-B (RANK) ligand. We also show that BMP noncanonical (MAPK) and canonical (SMAD) pathways are utilized at different stages of osteoclast differentiation. BMP2 induces p38 phosphorylation in pre-fusion osteoclasts and increases SMAD phosphorylation around osteoclast precursor fusion. Phosphorylation of MAPKs was decreased in differentiated BMMs from cKO animals. Treating BMMs with the SMAD inhibitor dorsomorphin confirms the requirement for the canonical pathway around the time of fusion. These results demonstrate the requirement for BMP signaling in osteoclasts for proper bone homeostasis and also explore the complex signaling mechanisms employed by BMP signaling during osteoclast differentiation.	[Broege, Aaron; Pham, Lan; Jensen, Eric D.; Emery, Ann; Stemig, Melissa; Gopalakrishnan, Raj] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Petryk, Anna; O'Connor, Michael] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Petryk, Anna] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mansky, Kim] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Huang, Tsang-Hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan; [Beppu, Hideyuki] Toyama Univ, Dept Clin & Mol Pathol, Toyama 9300887, Japan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Cheng Kung University; University of Toyama	Mansky, K (corresponding author), 16-262B Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	kmansky@umn.edu; gopal007@umn.edu	O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506; Mansky, Kim/0000-0002-2826-5030	National Institutes of Health [R01AR056642, R01AR061352, R01DE016601]; University of Minnesota through NIDCR, National Institutes of Health [T32DE07288, T90DE022732]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056642, R01AR061352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016601, T32DE007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota through NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR056642 (to R. G.); R01AR061352 (to K. M. and E. D. J.); and R01DE016601 (to A. P.).; Supported by the University of Minnesota MinnCResT training grant through the NIDCR, National Institutes of Health Grants T32DE07288 and T90DE022732.	Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fong D, 2013, CELL SIGNAL, V25, P717, DOI 10.1016/j.cellsig.2012.12.003; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Greenblatt MB, 2010, ANN NY ACAD SCI, V1192, P385, DOI 10.1111/j.1749-6632.2009.05222.x; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Okamoto M, 2011, J BONE MINER RES, V26, P2511, DOI 10.1002/jbmr.477; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Pham L, 2011, J CELL BIOCHEM, V112, P793, DOI 10.1002/jcb.23003; Rodriguez JES, 2009, J BONE MINER RES, V24, P1917, DOI [10.1359/jbmr.090507, 10.1359/JBMR.090507]; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	25	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37230	37240		10.1074/jbc.M113.496950	http://dx.doi.org/10.1074/jbc.M113.496950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235143	hybrid, Green Published			2022-12-25	WOS:000329189700040
J	Pathak, P; Li, TG; Chiang, JYL				Pathak, Preeti; Li, Tiangang; Chiang, John Y. L. l			Retinoic Acid-related Orphan Receptor alpha Regulates Diurnal Rhythm and Fasting Induction of Sterol 12 alpha-Hydroxylase in Bile Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Diabetes; Lipid Metabolism; Nuclear Receptors; Obesity	CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLIC-ACID; ROR-ALPHA; GENE-EXPRESSION; PROFILING REVEALS; HUMAN HEPATOCYTES; CIRCADIAN-RHYTHM; RAT-LIVER; INSULIN; TRANSCRIPTION	Sterol 12-hydroxylase (CYP8B1) is required for cholic acid synthesis and plays a critical role in intestinal cholesterol absorption and pathogenesis of cholesterol gallstone, dyslipidemia, and diabetes. In this study we investigated the underlying mechanism of fasting induction and circadian rhythm of CYP8B1 by a cholesterol-activated nuclear receptor and core clock gene retinoic acid-related orphan receptor (ROR). Fasting stimulated, whereas restricted-feeding reduced expression of CYP8B1 mRNA and protein. However, fasting and feeding had little effect on the diurnal rhythm of ROR mRNA expression, but fasting increased ROR protein levels by cAMP-activated protein kinase A-mediated phosphorylation and stabilization of the protein. Adenovirus-mediated gene transduction of ROR to mice strongly induced CYP8B1 expression, and increased liver cholesterol and 12-hydroxylated bile acids in the bile acid pool and serum. A reporter assay identified a functional ROR response element in the CYP8B1 promoter. ROR recruited cAMP response element-binding protein-binding protein (CBP) to stimulate histone acetylation on the CYP8B1 gene promoter. In conclusion, ROR is a key regulator of diurnal rhythm and fasting induction of CYP8B1, which regulates bile acid composition and serum and liver cholesterol levels. Antagonizing ROR activity may be a therapeutic strategy for treating inflammatory diseases such as non-alcoholic fatty liver disease and type 2 diabetes.	[Pathak, Preeti; Li, Tiangang; Chiang, John Y. L. l] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Northeast Ohio Medical University (NEOMED); University of Kansas; University of Kansas Medical Center	Chiang, JYL (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.		Chiang, John Y. L./G-2658-2011	Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [DK44442, DK58379]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058379, R56DK044442, R37DK058379, R01DK044442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.).	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Han SX, 2009, DRUG METAB DISPOS, V37, P469, DOI 10.1124/dmd.108.025155; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li TG, 2009, BBA-MOL CELL BIOL L, V1791, P991, DOI 10.1016/j.bbalip.2009.05.004; LI YC, 1990, J BIOL CHEM, V265, P12012; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Song KH, 2006, HEPATOLOGY, V43, P117, DOI 10.1002/hep.20919; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang J, 2006, BIOCHEM BIOPH RES CO, V342, P1382, DOI 10.1016/j.bbrc.2006.02.108; Wang J, 2006, J LIPID RES, V47, P421, DOI 10.1194/jlr.M500441-JLR200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	42	37	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37154	37165		10.1074/jbc.M113.485987	http://dx.doi.org/10.1074/jbc.M113.485987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24226095	Green Published, hybrid			2022-12-25	WOS:000329189700034
J	Arope, S; Harraghy, N; Pjanic, M; Mermod, N				Arope, Salina; Harraghy, Niamh; Pjanic, Milos; Mermod, Nicolas			Molecular Characterization of a Human Matrix Attachment Region Epigenetic Regulator	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSGENE EXPRESSION; CHROMATIN LOOP; MAR ELEMENTS; CELL-LINES; ORGANIZATION; ASSOCIATION; PREDICTION; PROTEINS; DYNAMICS	Matrix attachment regions (MAR) generally act as epigenetic regulatory sequences that increase gene expression, and they were proposed to partition chromosomes into loop-forming domains. However, their molecular mode of action remains poorly understood. Here, we assessed the possible contribution of the AT-rich core and adjacent transcription factor binding motifs to the transcription augmenting and anti-silencing effects of human MAR 1-68. Either flanking sequences together with the AT-rich core were required to obtain the full MAR effects. Shortened MAR derivatives retaining full MAR activity were constructed from combinations of the AT-rich sequence and multimerized transcription factor binding motifs, implying that both transcription factors and the AT-rich microsatellite sequence are required to mediate the MAR effect. Genomic analysis indicated that MAR AT-rich cores may be depleted of histones and enriched in RNA polymerase II, providing a molecular interpretation of their chromatin domain insulator and transcriptional augmentation activities.	[Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Lausanne, Switzerland; UNIL EPFL, Ctr Biotechnol, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mermod, N (corresponding author), Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Lausanne, Switzerland.	nicolas.mermod@unil.ch	Pjanic, Milos/AAH-1262-2019	Pjanic, Milos/0000-0001-9746-8838	Swiss Commission for Technology and Innovation, Selexis SA; Etat de Vaud	Swiss Commission for Technology and Innovation, Selexis SA; Etat de Vaud	This work was supported by grants from the Swiss Commission for Technology and Innovation, Selexis SA, and by the Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Boulikas T, 1995, INT REV CYTOL, V162A, P279; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Esnault G, 2009, MOL CELL BIOL, V29, P2409, DOI 10.1128/MCB.00779-08; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Galbete JL, 2009, MOL BIOSYST, V5, P143, DOI 10.1039/b813657b; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Girod PA, 2003, N COMP BIOC, V38, P359; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Gorman C, 2009, CELL ENG, V6, P1, DOI 10.1007/978-90-481-2245-5_1; Grandjean M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr436; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Heng HHQ, 2001, CYTOGENET CELL GENET, V93, P155, DOI 10.1159/000056977; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kim JD, 2005, BIOTECHNOL PROGR, V21, P933, DOI 10.1021/bp049598v; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; KLEHR D, 1991, BIOCHEMISTRY-US, V30, P1264, DOI 10.1021/bi00219a015; Kumar R, 2004, MOL CARCINOGEN, V41, P221, DOI 10.1002/mc.20056; KUMAR S, 1986, BIOCHEMISTRY-US, V25, P2055, DOI 10.1021/bi00356a033; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Linnemann AK, 2009, NUCLEIC ACIDS RES, V37, P2779, DOI 10.1093/nar/gkp135; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; PhiVan L, 1996, BIOCHEMISTRY-US, V35, P10735, DOI 10.1021/bi9603783; Pjanic M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-99; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Puttini S, 2009, MOL THER, V17, P19, DOI 10.1038/mt.2008.239; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; VONKRIES JP, 1990, NUCLEIC ACIDS RES, V18, P3881; Wang DM, 1996, J LIPID RES, V37, P2117; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	44	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79262	10.1371/journal.pone.0079262	http://dx.doi.org/10.1371/journal.pone.0079262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244463	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800050
J	Duarte, JH; Di Meglio, P; Hirota, K; Ahlfors, H; Stockinger, B				Duarte, Joao H.; Di Meglio, Paola; Hirota, Keiji; Ahlfors, Helena; Stockinger, Brigitta			Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo	PLOS ONE			English	Article							REGULATORY T-CELLS; AH RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; SELF-TOLERANCE; ROR-GAMMA; ACTIVATION; INDUCTION; LIGAND; DIOXIN	The aryl hydrocarbon receptor (AhR) has been attributed with anti-inflammatory effects in the development of pathological immune responses leading to experimental autoimmune encephalomyelitis (EAE) via the induction of regulatory T cells. In agreement with previously published findings, we find that TCDD administration confers protection from EAE, however, this immuno-modulatory effect was not the consequence of de novo Treg generation, but the inhibition of Th17 cell differentiation. Systemic application of FICZ at the time of immunization also reduced EAE pathology albeit to a lesser degree than TCDD. In vitro Th17 differentiation in the presence of AhR agonists, including TCDD, promoted IL-17 and IL-22 expression, but did not induce Treg differentiation. AhR affinity influenced the amounts of IL-17 and IL-22 protein that was secreted by Th17 cells, but did not seem to affect susceptibility to EAE in vivo. Making use of conditional AhR-deficient mice, we show that the anti-inflammatory effect of TCDD depends on AhR activation in both T cells and dendritic cells, further emphasising the ability of TCDD to interfere with T effector cell differentiation in vivo. The dichotomy between the in vivo and in vitro effects of AhR reveals the complexity of the AhR pathway, which has the capacity of affecting different AhR-expressing cell types involved in mounting immune responses, thus participating in defining their outcome.	[Duarte, Joao H.; Di Meglio, Paola; Hirota, Keiji; Ahlfors, Helena; Stockinger, Brigitta] MRC Natl Inst Med Res, Div Mol Immunol, London, England	MRC National Institute for Medical Research	Stockinger, B (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, London, England.	bstocki@nimr.mrc.ac.uk		Di Meglio, Paola/0000-0002-2066-7780; Ahlfors, Helena/0000-0002-8183-0895; Duarte, Joao H./0000-0001-7186-4947; Hirota, Keiji/0000-0002-4737-0661; Stockinger, Brigitta/0000-0001-8781-336X	ERC [232782]	ERC(European Research Council (ERC)European Commission)	This study is funded by an ERC Advanced Grant (No. 232782) to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bourgeois C, 2006, IMMUNOL LETT, V107, P89, DOI 10.1016/j.imlet.2006.08.001; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Connor KT, 2006, J TOXICOL ENV HEAL B, V9, P147, DOI 10.1080/15287390500196487; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Funatake CJ, 2009, J IMMUNOTOXICOL, V6, P194, DOI 10.1080/15476910903124454; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Miniero R, 2001, CHEMOSPHERE, V43, P839, DOI 10.1016/S0045-6535(00)00442-2; Mitchell KA, 2009, BIOCHEM PHARMACOL, V77, P947, DOI 10.1016/j.bcp.2008.10.028; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; POLAND A, 1994, MOL PHARMACOL, V46, P915; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Schiffenbauer J, 2000, CLIN IMMUNOL, V95, P117, DOI 10.1006/clim.2000.4851; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singh N, 2010, J IMMUNOL, V184, P94, DOI 10.4049/jimmunol.0900753; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993	51	90	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79819	10.1371/journal.pone.0079819	http://dx.doi.org/10.1371/journal.pone.0079819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244565	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800100
J	Palazzo, A; Marconi, S; Specchia, V; Bozzetti, MP; Ivics, Z; Caizzi, R; Marsano, RM				Palazzo, Antonio; Marconi, Simona; Specchia, Valeria; Bozzetti, Maria Pia; Ivics, Zoltan; Caizzi, Ruggiero; Marsano, Rene Massimiliano			Functional Characterization of the Bari1 Transposition System	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; SLEEPING-BEAUTY TRANSPOSON; UNFOLDED PROTEIN RESPONSE; DNA-BINDING DOMAIN; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; SUBCELLULAR-LOCALIZATION; TC1-LIKE TRANSPOSONS; TRANSCRIPTION FACTOR; MARINER TRANSPOSASE	The transposons of the Bari family are mobile genetic elements widespread in the Drosophila genus. However, despite a broad diffusion, virtually no information is available on the mechanisms underlying their mobility. In this paper we report the functional characterization of the Bari elements transposition system. Using the Bari1 element as a model, we investigated the subcellular localization of the transposase, its physical interaction with the transposon, and its catalytic activity. The Bari1 transposase localized in the nucleus and interacted with the terminal sequences of the transposon both in vitro and in vivo, however, no transposition activity was detected in transposition assays. Profiling of mRNAs expressed by the transposase gene revealed the expression of abnormal, internally processed transposase transcripts encoding truncated, catalytically inactive transposase polypeptides. We hypothesize that a post-transcriptional control mechanism produces transposase-derived polypeptides that effectively repress transposition. Our findings suggest further clues towards understanding the mechanisms that control transposition of an important class of mobile elements, which are both an endogenous source of genomic variability and widely used as transformation vectors/biotechnological tools.	[Palazzo, Antonio; Marconi, Simona; Caizzi, Ruggiero; Marsano, Rene Massimiliano] Univ Bari, Dipartimento Biol, Bari, Italy; [Specchia, Valeria; Bozzetti, Maria Pia] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy; [Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	Universita degli Studi di Bari Aldo Moro; University of Salento; Paul Ehrlich Institute	Marsano, RM (corresponding author), Univ Bari, Dipartimento Biol, Bari, Italy.	renemassimiliano.marsano@uniba.it	Specchia, Valeria/AAS-8179-2020; Palazzo, Antonio/AAW-2480-2021; Marsano, René Massimiliano/B-9640-2012; Palazzo, Antonio/AAH-1352-2020	Specchia, Valeria/0000-0002-1051-6014; Marsano, René Massimiliano/0000-0001-8450-1010; Palazzo, Antonio/0000-0003-0961-6832; Caizzi, Ruggiero/0000-0002-4360-2808	EMBO [ASTF 182-2004];  [RBFR10V8K6]	EMBO(European Molecular Biology Organization (EMBO)); 	This work was carried out despite the strong and indiscriminate cut to Italian public research. This work was carried out using residual material from previously approved projects in part from Universita degli Studi di Bari and in part from Ministero dell'Istruzione e Ricerca. VS acknowledges the grant "Futuro in ricerca 2010'' no. RBFR10V8K6. RMM was formerly supported by an EMBO short term fellowship ASTF 182-2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P58, DOI 10.1007/s004380000386; Benjamin B, 2007, GENETICA, V130, P105, DOI 10.1007/s10709-006-0025-2; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BOEHM U, 1995, PLANT J, V7, P441, DOI 10.1046/j.1365-313X.1995.7030441.x; Bouuaert CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053690; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAGGESE C, 1995, GENETICA, V96, P269, DOI 10.1007/BF01439581; CAIZZI R, 1993, GENETICS, V133, P335; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; COLLOMS SD, 1994, NUCLEIC ACIDS RES, V22, P5548, DOI 10.1093/nar/22.25.5548; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Craig NL, 2002, MOBILE DNA, pxviii; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Fischer SEJ, 1999, MOL GEN GENET, V262, P268, DOI 10.1007/PL00008641; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; FRASER MJ, 1985, VIROLOGY, V145, P356, DOI 10.1016/0042-6822(85)90172-2; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Ivics Z, MOB DNA, V1, P25; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; Junakovic N, 1997, GENETICA, V100, P149, DOI 10.1023/A:1018325427405; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lampe DJ, 1998, GENETICS, V149, P179; Liu D, 1998, GENETICS, V149, P693; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Marsano RM, 2005, GENE, V357, P122, DOI 10.1016/j.gene.2005.06.005; Marsano RM, 2003, GENETICA, V117, P281; Marsano RM, 2003, GENE, V307, P167, DOI 10.1016/S0378-1119(03)00458-X; MERRIMAN PJ, 1995, GENETICS, V141, P1425; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Mikitani K, 2000, J BIOL CHEM, V275, P37725, DOI 10.1074/jbc.M005271200; Moschetti R, 1998, GENETICS, V150, P239; Moschetti R, 2008, MOL GENET GENOMICS, V279, P451, DOI 10.1007/s00438-008-0324-7; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ono A, 2002, PLANT MOL BIOL, V50, P599, DOI 10.1023/A:1019970206057; OSBORNE BI, 1995, CURR OPIN CELL BIOL, V7, P406, DOI 10.1016/0955-0674(95)80097-2; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; PRUDHOMME N, 1995, GENETICS, V139, P697; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROCHE SE, 1995, GENE DEV, V9, P1278, DOI 10.1101/gad.9.10.1278; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shao HG, 2001, GENETICS, V159, P1103; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zamparini AL, 2011, DEVELOPMENT, V138, P4039, DOI 10.1242/dev.069187	70	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79385	10.1371/journal.pone.0079385	http://dx.doi.org/10.1371/journal.pone.0079385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244492	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800068
J	Arbiv, A; Yurist-Doutsch, S; Guan, ZQ; Eichler, J				Arbiv, Adi; Yurist-Doutsch, Sophie; Guan, Ziqiang; Eichler, Jerry			AglQ Is a Novel Component of the Haloferax volcanii N-Glycosylation Pathway	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; ARCHAEA; GLYCOPROTEIN	N-glycosylation is a post-translational modification performed by members of all three domains of life. Studies on the halophile Haloferax volcanii have offered insight into the archaeal version of this universal protein-processing event. In the present study, AglQ was identified as a novel component of the pathway responsible for the assembly and addition of a pentasaccharide to select Asn residues of Hfx. volcanii glycoproteins, such as the S-layer glycoprotein. In cells deleted of aglQ, both dolichol phosphate, the lipid carrier used in Hfx. volcanii N-glycosylation, and modified S-layer glycoprotein Asn residues only presented the first three pentasaccharide subunits, pointing to a role for AglQ in either preparing the third sugar for attachment of the fourth pentasaccharide subunit or processing the fourth sugar prior to its addition to the lipid-linked trisaccharide. To better define the precise role of AglQ, shown to be a soluble protein, bioinformatics tools were recruited to identify sequence or structural homologs of known function. Site-directed mutagenesis experiments guided by these predictions identified residues important for AglQ function. The results obtained point to AglQ acting as an isomerase in Hfx. volcanii N-glycosylation.	[Arbiv, Adi; Yurist-Doutsch, Sophie; Eichler, Jerry] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Ben Gurion University; Duke University	Eichler, J (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	jeichler@bgu.ac.il	EICHLER, JERRY/F-2351-2012; Guan, Ziqiang/AAE-5110-2019	EICHLER, JERRY/0000-0001-9409-8026; 	US Army Research Office [W911NF-11-1-520]; Israel Science Foundation [08/11]; LIPID MAPS Large Scale Collaborative Grant from NIH [GM-069338]; Negev-Faran Associates Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	US Army Research Office; Israel Science Foundation(Israel Science Foundation); LIPID MAPS Large Scale Collaborative Grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Negev-Faran Associates Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.E. is supported by the US Army Research Office (W911NF-11-1-520) and by the Israel Science Foundation (grant 08/11). The mass spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. are supported by the LIPID MAPS Large Scale Collaborative Grant number GM-069338 from NIH. S.Y.-D. held a Negev-Faran Associates Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, J BACTERIOL, V190, P3140, DOI 10.1128/JB.00056-08; Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; GHOSH S, 1965, J BIOL CHEM, V240, P1531; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh Takafumi, 2006, Biochem Biophys Res Commun, V344, P253, DOI 10.1016/j.bbrc.2006.03.141; Kaminski L, 2012, BBA-GEN SUBJECTS, V1820, P1664, DOI 10.1016/j.bbagen.2012.06.014; Kaminski L, 2010, ARCHAEA, V2010, DOI 10.1155/2010/315108; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Lichi T, 2004, EUR J BIOCHEM, V271, P1382, DOI 10.1111/j.1432-1033.2004.04050.x; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Plavner N, 2008, J BACTERIOL, V190, P8045, DOI 10.1128/JB.01200-08; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Sprott GD, 2003, BBA-MOL CELL BIOL L, V1633, P179, DOI 10.1016/j.bbalip.2003.08.001; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x; Yurist-Doutsch S, 2009, J BACTERIOL, V191, P3068, DOI 10.1128/JB.01838-08	26	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81782	10.1371/journal.pone.0081782	http://dx.doi.org/10.1371/journal.pone.0081782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236216	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700219
J	Blount, RJ; Djawe, K; Daly, KR; Jarlsberg, LG; Fong, S; Balmes, J; Miller, RF; Walzer, PD; Huang, L				Blount, Robert J.; Djawe, Kpandja; Daly, Kieran R.; Jarlsberg, Leah G.; Fong, Serena; Balmes, John; Miller, Robert F.; Walzer, Peter D.; Huang, Laurence		Int HIV Assoc Opportunistic Pneumo	Ambient Air Pollution Associated with Suppressed Serologic Responses to Pneumocystis jirovecii in a Prospective Cohort of HIV-Infected Patients with Pneumocystis Pneumonia	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; X-LINKED AGAMMAGLOBULINEMIA; DIESEL EXHAUST PARTICLES; HOSPITAL ADMISSIONS; CARINII-PNEUMONIA; RISK-FACTORS; ALVEOLAR MACROPHAGES; ANTIBODY PROPHYLAXIS; MICE; IMMUNIZATION	Background: Ambient air pollution (AAP) may be associated with increased risk for Pneumocystis pneumonia (PCP). The mechanisms underlying this association remain uncertain. Objectives: To determine if real-life exposures to AAP are associated with suppressed IgM antibody responses to P. jirovecii in HIV-infected (HIV+) patients with active PCP, and to determine if AAP, mediated by suppressed serologic responses to Pneumocystis, is associated with adverse clinical outcomes. Methods: We conducted a prospective cohort study in HIV+ patients residing in San Francisco and admitted to San Francisco General Hospital with microscopically confirmed PCP. Our AAP predictors were ambient air concentrations of particulate matter of < 10 mu m in diameter (PM10) and < 2.5 mu m in diameter (PM2.5), nitrogen dioxide (NO2), ozone (O-3), and sulfur dioxide (SO2) measured immediately prior to hospital admission and 2 weeks prior to admission. Our primary outcomes were the IgM serologic responses to four recombinant P. jirovecii major surface glycoprotein (Msg) constructs: MsgC1, MsgC3, MsgC8, and MsgC9. Results: Elevated PM10 and NO2 exposures immediately prior to and two weeks prior to hospital admission were associated with decreased IgM antibody responses to P. jirovecii Msg. For exposures immediately prior to admission, every 10 mu g/m(3) increase in PM10 was associated with a 25 to 35% decrease in IgM responses to Msg (statistically significant for all the Msg constructs), and every 10 ppb increase in NO2 was associated with a 19-45% decrease in IgM responses to Msg (statistically significant for MsgC8 and MsgC9). Similar findings were seen with exposures two weeks prior to admission, but for fewer of the Msg constructs. Conclusions: Real life exposures to PM(1)0 and NO2 were associated with suppressed IgM responses to P. jirovecii Msg in HIV+ patients admitted with PCP, suggesting a mechanism of immunotoxicity by which AAP increases host susceptibility to pulmonary infection.	[Blount, Robert J.; Jarlsberg, Leah G.; Balmes, John; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Djawe, Kpandja; Daly, Kieran R.; Walzer, Peter D.] Univ Cincinnati, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA; [Djawe, Kpandja; Walzer, Peter D.] Univ Cincinnati, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Daly, Kieran R.; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Balmes, John] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Miller, Robert F.] UCL, Inst Epidemiol & Healthcare, Res Dept Infect & Populat Hlth, London, England; [Miller, Robert F.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Fong, Serena; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of California System; University of California Berkeley; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blount, RJ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAE-1590-2019; blount, robert/ABI-5978-2020; Balmes, John/L-6281-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Fong, Serena/0000-0002-9803-3016; Miller, Robert/0000-0003-2067-4291; Blount, Robert/0000-0001-6177-7436; Jarlsberg, Leah/0000-0001-6548-6337	National Institute of Environmental Health Science (NIEHS) [F32ES022582]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007185, K24HL087713, R01HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, T32HL007185, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES022582] Funding Source: NIH RePORTER	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the following: National Institute of Environmental Health Science (NIEHS) www.niehs.nih.gov, F32ES022582(Blount); National Heart, Lung, and Blood Institute (NHLBI) www.nhlbi.nih.gov, T32HL007185 (Sheppard, Nadel, Huang), K24HL087713 (Huang), R01HL090335 (Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hegelan M, 2011, IMMUNOL RES, V49, P173, DOI 10.1007/s12026-010-8180-z; Alibrahim A, 1998, J ALLERGY CLIN IMMUN, V101, P552, DOI 10.1016/S0091-6749(98)70363-X; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Blount RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051545; Cheng MF, 2007, J TOXICOL ENV HEAL A, V70, P2021, DOI 10.1080/15287390701601020; Cheng MF, 2009, INHAL TOXICOL, V21, P1092, DOI 10.3109/08958370902744855; Chiu HF, 2009, INHAL TOXICOL, V21, P32, DOI 10.1080/08958370802441198 ; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Deng XB, 2013, TOXICOL IN VITRO, V27, P1762, DOI 10.1016/j.tiv.2013.05.004; Dittrich AM, 2003, EUR J PEDIATR, V162, P432, DOI 10.1007/s00431-003-1200-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; Empey KM, 2004, INFECT IMMUN, V72, P6211, DOI 10.1128/IAI.72.11.6211-6220.2004; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; FURUTA T, 1985, INFECT IMMUN, V47, P544, DOI 10.1128/IAI.47.2.544-548.1985; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gigliotti F, 1997, J INFECT DIS, V176, P1322, DOI 10.1086/514128; Gigliotti F, 2002, INFECT IMMUN, V70, P1069, DOI 10.1128/IAI.70.3.1069-1074.2002; HARMSEN AG, 1991, J PROTOZOOL, V38, pS44; Harris AM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-93; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Manzo ND, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-43; Marcotte H, 1996, J INFECT DIS, V173, P1034, DOI 10.1093/infdis/173.4.1034; Mei Q, 1998, INFECT IMMUN, V66, P4268; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; SCHWARTZ J, 1994, ARCH ENVIRON HEALTH, V49, P366, DOI 10.1080/00039896.1994.9954989; SCHWARTZ J, 1994, AM J EPIDEMIOL, V139, P589, DOI 10.1093/oxfordjournals.aje.a117048; Schwartz J, 2011, AM J PUBLIC HEALTH, V101, pS88, DOI 10.2105/AJPH.2011.300268; WALZER PD, 1981, J LAB CLIN MED, V97, P820; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803; Wells J, 2006, INFECT IMMUN, V74, P2446, DOI 10.1128/IAI.74.4.2446-2448.2006; Wells J, 2006, INFECT IMMUN, V74, P390, DOI 10.1128/IAI.74.1.390-393.2006; WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834; Zheng MQ, 2001, J CLIN INVEST, V108, P1469, DOI 10.1172/JCI13826; Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC	48	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80795	10.1371/journal.pone.0080795	http://dx.doi.org/10.1371/journal.pone.0080795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236202	gold, Green Published			2022-12-25	WOS:000327254700205
J	Lauters, P; Vercauteren, M; Bolotsky, YL; Godefroit, P				Lauters, Pascaline; Vercauteren, Martine; Bolotsky, Yuri L.; Godefroit, Pascal			Cranial Endocast of the Lambeosaurine Hadrosaurid Amurosaurus riabinini from the Amur Region, Russia	PLOS ONE			English	Article							GROWTH-HORMONE; ENDOCRANIAL CAVITY; NEOCORTEX SIZE; BRAIN SIZE; DINOSAUR; ANATOMY; ORNITHISCHIA; CROCODILES; PHYLOGENY; GIGANTISM	Information on the structure of the brain of the lambeosaurine hadrosaurid dinosaur Amurosaurus riabinini, from the Late Maastrichtian of Blagoveschensk, Far Eastern Russia, is presented based on endocranial casts. The endocasts are compared with physical and digital endocasts of other dinosaurs. The olfactory tract was large. The cerebral hemispheres are enlarged and round, illustrating the important development of this part of the brain in hadrosaurids. The pituitary body is enlarged as well, perhaps prefiguring the large size attained by hadrosaurids. The EQ of Amurosaurus was similar to that of the lambeosaurine dinosaur Hypacrosaurus altispinus and was relatively larger than in most extant non- avian reptiles, including sauropod and ceratopsian dinosaurs. However, it was apparently relatively smaller than those of most theropod dinosaurs. The relatively large size of the cerebrum is consistent with the range and complexity of social behaviors inferred for lambeosaurine dinosaurs.	[Lauters, Pascaline; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Dept Palaeontol, Brussels, Belgium; [Lauters, Pascaline; Vercauteren, Martine] Univ Libre Bruxelles, Serv Anthropol & Genet Humaine, Brussels, Belgium; [Bolotsky, Yuri L.] Russian Acad Sci, Geol & Nat Explorat Inst, Far Eastern Branch, Blagoveshchensk, Russia	Royal Belgian Institute of Natural Sciences; Universite Libre de Bruxelles; Institute of Geology & Nature Management FEB RAS; Russian Academy of Sciences	Lauters, P (corresponding author), Royal Belgian Inst Nat Sci, Dept Palaeontol, Brussels, Belgium.	plauters@ulb.ac.be	Lauters, Pascaline/AAJ-8493-2020		Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This study was realized through the execution of S&T bilateral cooperation agreements on behalf of the Belgian State, Federal Scientific Policy. It constitutes part of a Ph.D. thesis by PL at the Universite Libre de Bruxelles, thanks to a grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler G, 2002, BEST PRACT RES CL EN, V16, P519, DOI 10.1053/beem.2002.0207; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bolotsky Y.L., 1991, GEOLOGY PACIFIC OCEA, P94; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Boulenger G. A., 1881, B ACAD ROYALE BELGIQ, V1, P1; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee S, 2005, LIFE O PAST, P199; COPE E. D., 1869, T AM PHILOS SOC, V14, P1, DOI DOI 10.2307/1005355; Dechaseaux C, 1962, CERVEAUX DANIMAUX DI; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Edinger T, 1942, Q REV BIOL, V17, P31, DOI 10.1086/394644; Edinger T, 1964, PROG BRAIN RES, V6, P147, DOI [10.1016/S0079-6123(08)63721-8, DOI 10.1016/S0079-6123(08)63721-8]; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2006, PALEOBIOLOGY, V32, P109, DOI 10.1666/0094-8373(2006)032[0109:NCHACC]2.0.CO;2; Evans DC, 2005, ACTA PALAEONTOL POL, V50, P617; Evans H. M., 1933, Memoirs of the University of California, V11, P1; FLEISHMAN LJ, 1988, J COMP PHYSIOL A, V163, P441, DOI 10.1007/BF00604898; Forster C.A., 1997, ENCY DINOSAURS, P293; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Galton P.M., 1989, Geologica et Palaeontologica, V23, P217; GELBER SJ, 1992, J PEDIATR-US, V120, P931, DOI 10.1016/S0022-3476(05)81966-3; Giffin E.B., 1989, Journal of Vertebrate Paleontology, V9, P67; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit P, 2009, ACT 4 JORN INT PAL D, P91; Godefroit P, 2012, BERNISSART DINOSAURE, P353; GODEFROIT P, 2001, SCI TERRE, V71, P119; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hopson J.A., 1979, P39; HOPSON J A, 1975, Paleobiology, V1, P21; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hurlburt G.R, 1996, THESIS U TORONTO TOR; Ines Serrano-Branas Claudia, 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P317; Jerison Harry J., 2001, Journal of Vertebrate Paleontology, V21, p65A; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Lauters P, 2012, BERNISSART DINOSAURS, P227; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; LOPIS S, 1968, J CLIN ENDOCR METAB, V28, P393, DOI 10.1210/jcem-28-3-393; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; Nopsca F. von., 1917, CENTRALBLATT MINERAL, V1917, P332; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; PARKS WA, 1923, U TORONTO STUDIES GE, V15, P5; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Rogers SW, 1999, ANAT RECORD, V257, P162; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Saveliev SV, 2012, PALEONTOL J+, V46, P79, DOI 10.1134/S003103011201011X; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Senter P, 2002, PALEOBIOLOGY, V28, P544, DOI 10.1666/0094-8373(2002)028<0544:LOAPSI>2.0.CO;2; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Stephan H., 1960, Zeitschrift fuer Wissenschaftliche Zoologie, V164, P143; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Walker SM, 2004, CROCODILES; WEISHAMPEL DB, 1981, PALEOBIOLOGY, V7, P252, DOI 10.1017/S0094837300004036; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zhou Chang-Fu, 2007, Palaeoworld, V16, P285, DOI 10.1016/j.palwor.2007.07.002; ZIMMERMAN D, 1993, J CLIN ENDOCR METAB, V76, P216, DOI 10.1210/jc.76.1.216	76	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78899	10.1371/journal.pone.0078899	http://dx.doi.org/10.1371/journal.pone.0078899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236064	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700061
J	Li, K; Nataraj, R; Marquardt, TL; Li, ZM				Li, Ke; Nataraj, Raviraj; Marquardt, Tamara L.; Li, Zong-Ming			Directional Coordination of Thumb and Finger Forces during Precision Pinch	PLOS ONE			English	Article							MUSCLES; GRIP; OBJECT; ACTIVATION; SYNERGIES; RESPONSES; MODEL	The human opposable thumb enables the hand to perform dexterous manipulation of objects, which requires well-coordinated digit force vectors. This study investigated the directional coordination of force vectors generated by the thumb and index finger during precision pinch. Fourteen right-handed, healthy subjects were instructed to exert pinch force on an externally stabilized apparatus with the pulps of the thumb and index finger. Subjects applied forces to follow a force-ramp profile that linearly increased from 0 to 12 N and then decreased to 0 N, at a rate of +/- 3 N/s. Directional relationships between the thumb and index finger force vectors were quantified using the coordination angle (CA) between the force vectors. Individual force vectors were further analyzed according to their projection angles (PAs) with respect to the pinch surface planes and the shear angles (SAs) within those planes. Results demonstrated that fingertip force directions were dependent on pinch force magnitude, especially at forces below 2 N. Hysteresis was observed in the force-CA relationship for increasing and decreasing forces and fitted with exponential models. The fitted asymptotic values were 156.0 +/- 6.6 degrees and 150.8 +/- 9.3 degrees for increasing and decreasing force ramps, respectively. The PA of the thumb force vector deviated further from the direction perpendicular to the pinching surface planes than that of the index finger. The SA showed that the index finger force vector deviated in the ulnar-proximal direction, whereas the thumb switched its force between the ulnar-proximal and radial-proximal directions. The findings shed light on the effects of anatomical composition, biomechanical function, and neuromuscular control in coordinating digit forces during precision pinch, and provided insight into the magnitude-dependent force directional control which potentially affects a range of dexterous manipulations.	[Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Dept Orthopaed Surg, Hand Res Lab, Cleveland, OH 44106 USA; Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Dept Orthopaed Surg, Hand Res Lab, Cleveland, OH 44106 USA.	liz4@ccf.org	Li, Weiming/D-9615-2013; Nataraj, Raviraj/G-4535-2010	Li, Weiming/0000-0001-5437-1518; Nataraj, Raviraj/0000-0002-5261-3031; Li, Ke/0000-0002-8660-0116	NIAMS/NIH [R01AR056964]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056964] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Number R01AR056964 from NIAMS/NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J NEUROSCI METH, V179, P224, DOI 10.1016/j.jneumeth.2009.01.031; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; BRAND PW, 1981, J HAND SURG-AM, V6, P209, DOI 10.1016/S0363-5023(81)80072-X; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; Dun SC, 2005, IEEE T INSTRUM MEAS, V54, P2336, DOI 10.1109/TIM.2005.858123; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johanson ME, 2001, J HAND SURG-AM, V26A, P698, DOI 10.1053/jhsu.2001.26188; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Latash ML, 2008, SYNERGY; Li ZM, 2004, MED ENG PHYS, V26, P663, DOI 10.1016/j.medengphy.2004.03.004; Li ZM, 2003, CLIN BIOMECH, V18, P908, DOI 10.1016/S0268-0033(03)00178-5; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Li ZM, 2002, ERGONOMICS, V45, P425, DOI 10.1080/00140130210129673; Marquardt TL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500474; Milner TE, 2002, EXP BRAIN RES, V146, P197, DOI 10.1007/s00221-002-1177-7; Moerchen VA, 2007, EXP BRAIN RES, V180, P367, DOI 10.1007/s00221-007-0864-9; Napier J. R., 1993, HANDS; Parikh PJ, 2012, J APPL PHYSIOL, V112, P1095, DOI 10.1152/japplphysiol.01385.2011; Pearlman JL, 2004, J ORTHOP RES, V22, P306, DOI 10.1016/j.orthres.2003.08.001; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Seo NJ, 2010, EXP BRAIN RES, V202, P891, DOI 10.1007/s00221-010-2193-7; Serina ER, 1998, J BIOMECH, V31, P639, DOI 10.1016/S0021-9290(98)00067-0; Shim JK, 2005, EXP BRAIN RES, V164, P260, DOI 10.1007/s00221-005-2248-3; Singh T, 2012, HUM MOVEMENT SCI, V31, P1379, DOI 10.1016/j.humov.2012.06.008; Smutz WP, 1998, J BIOMECH, V31, P565, DOI 10.1016/S0021-9290(98)00043-8; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; WESTLING G, 1987, EXP BRAIN RES, V66, P128	32	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79400	10.1371/journal.pone.0079400	http://dx.doi.org/10.1371/journal.pone.0079400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236128	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700127
J	Michl, RK; Hentschel, J; Fischer, C; Beck, JF; Mainz, JG				Michl, Ruth K.; Hentschel, Julia; Fischer, Christiane; Beck, James F.; Mainz, Jochen G.			Reduced Nasal Nitric Oxide Production in Cystic Fibrosis Patients with Elevated Systemic Inflammation Markers	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PARANASAL SINUSES; INFECTION; CHILDREN; COLONIZATION; BRONCHIECTASIS; GENOTYPE; DISEASES	Background: Nitric oxide (NO) is produced within the respiratory tract and can be detected in exhaled bronchial and nasal air. The concentration varies in specific diseases, being elevated in patients with asthma and bronchiectasis, but decreased in primary ciliary dyskinesia. In cystic fibrosis (CF), conflicting data exist on NO levels, which are reported unexplained as either decreased or normal. Functionally, NO production in the paranasal sinuses is considered as a location-specific first-line defence mechanism. The aim of this study was to investigate the correlation between upper and lower airway NO levels and blood inflammatory parameters, CF-pathogen colonisation, and clinical data. Methods and Findings: Nasal and bronchial NO concentrations from 57 CF patients were determined using an electrochemical analyser and correlated to pathogen colonisation of the upper and lower airways which were microbiologically assessed from nasal lavage and sputum samples. Statistical analyses were performed with respect to clinical parameters (lung function, BMI), laboratory findings (CRP, leucocytes, total-IgG, fibrinogen), and anti-inflammatory and antibiotic therapy. There were significant correlations between nasal and bronchial NO levels (rho = 0.48, p<0.001), but no correlation between NO levels and specific pathogen colonisation. In patients receiving azithromycin, significantly reduced bronchial NO and a tendency to reduced nasal NO could be found. Interestingly, a significant inverse correlation of nasal NO to CRP (rho = -0.28, p = 0.04) and to leucocytes (rho = -0.41, p = 0.003) was observed. In contrast, bronchial NO levels showed no correlation to clinical or inflammatory parameters. Conclusion: Given that NO in the paranasal sinuses is part of the first-line defence mechanism against pathogens, our finding of reduced nasal NO in CF patients with elevated systemic inflammatory markers indicates impaired upper airway defence. This may facilitate further pathogen acquisition in the sinonasal area, with consequences for lung colonisation and the overall outcome in CF.	[Michl, Ruth K.; Hentschel, Julia; Fischer, Christiane; Beck, James F.; Mainz, Jochen G.] Jena Univ Hosp, Dept Paediat, Jena, Germany	Friedrich Schiller University of Jena	Michl, RK (corresponding author), Jena Univ Hosp, Dept Paediat, Jena, Germany.	Ruth.Michl@med.uni-jena.de	Mainz, Jochen G/AFO-0929-2022	Mainz, Jochen G./0000-0003-3780-7759				Aanaes K, 2013, RHINOLOGY, V51, P222, DOI [10.4193/Rhino12.207, 10.4193/Rhin12.207]; Aanaes K, 2013, AM J RHINOL ALLERGY, V27, pE1, DOI 10.2500/ajra.2013.27.3829; Aanaes K, 2013, J CYST FIBROS, V12, P81, DOI 10.1016/j.jcf.2012.07.001; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 2006, BMI CLASSIFICATION G; BalfourLynn IM, 1996, ARCH DIS CHILD, V75, P319, DOI 10.1136/adc.75.4.319; Bartley J, 1999, AM J RHINOL, V13, P401, DOI 10.2500/105065899781367528; Beiersdorf N, 2012, J CYST FIBROS; Bergoin Cyrille, 2002, J Cyst Fibros, V1, P110, DOI 10.1016/S1569-1993(02)00072-3; Boon M, 2012, EUR J PEDIAT; Corbelli R, 2004, CHEST, V126, P1054, DOI 10.1378/chest.126.4.1054; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Elphick HE, 2001, THORAX, V56, P151, DOI 10.1136/thorax.56.2.151; Grasemann H, 2005, EUR RESPIR J, V25, P62, DOI 10.1183/09031936.04.00086104; Grasemann H, 1997, PEDIATR PULM, V24, P173, DOI 10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O; Grasemann H, 1998, ARCH DIS CHILD, V78, P49, DOI 10.1136/adc.78.1.49; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Ho LP, 1998, EUR RESPIR J, V12, P1290, DOI 10.1183/09031936.98.12061290; Jaffe A, 2005, PROG INFLAM RES, P167; Jobsis Q, 2000, EUR RESPIR J, V16, P95, DOI 10.1034/j.1399-3003.2000.16a17.x; Johansen HK, 2012, J CYST FIBROS, V11, P525, DOI 10.1016/j.jcf.2012.04.011; Kappler M, 2006, THORAX, V61, P684, DOI 10.1136/thx.2005.049536; Keen C, 2007, CHEST, V131, P1857, DOI 10.1378/chest.06-2635; KHARITONOV SA, 1995, AM J RESP CRIT CARE, V151, P1889, DOI 10.1164/ajrccm.151.6.7767536; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Lundberg JON, 1996, ARCH DIS CHILD, V75, P323, DOI 10.1136/adc.75.4.323; Lundberg JON, 1999, THORAX, V54, P947, DOI 10.1136/thx.54.10.947; Mainz JG, 2011, AM J RESP CRIT CARE, V184, P1089, DOI 10.1164/ajrccm.184.9.1089; Mainz JG, 2009, THORAX, V64, P535, DOI 10.1136/thx.2008.104711; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Meng QH, 1998, J PATHOL, V184, P323, DOI 10.1002/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2; Palm JP, 2000, EUR RESPIR J, V16, P236, DOI 10.1034/j.1399-3003.2000.16b09.x; Pitrez PMC, 2005, RESPIROLOGY, V10, P177, DOI 10.1111/j.1440-1843.2005.00649.x; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; Ratjen F, 2012, CHEST; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V203, P209, DOI 10.1006/bbrc.1994.2169; Southern KW, 2004, EUR RESPIR J, V24, P834, DOI 10.1183/09031936.04.00084304; Thomas SR, 2000, CHEST, V117, P1085, DOI 10.1378/chest.117.4.1085; WARREN JB, 1990, BIOCHEM J, V266, P921; Zapletal A, 1987, LUNG FUNCTION CHILDR; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	41	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79141	10.1371/journal.pone.0079141	http://dx.doi.org/10.1371/journal.pone.0079141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236100	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700098
J	Oliva, CF; Damiens, D; Vreysen, MJB; Lempeiere, G; Gilles, J				Oliva, Clelia F.; Damiens, David; Vreysen, Marc J. B.; Lemperiere, Guy; Gilles, Jeremie			Reproductive Strategies of Aedes albopictus (Diptera: Culicidae) and Implications for the Sterile Insect Technique	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; DENGUE VECTOR MOSQUITO; SEMINAL FLUID PROTEINS; MALE MATING SUCCESS; SPERM COMPETITION; SEXUAL RECEPTIVITY; AEGYPTI LINNAEUS; FEMALE MONOGAMY; GLAND PROTEINS; SIZE	Male insects are expected to optimize their reproductive strategy according to the availability of sperm or other ejaculatory materials, and to the availability and reproductive status of females. Here, we investigated the reproductive strategy and sperm management of male and virgin female Aedes albopictus, a mosquito vector of chikungunya and dengue viruses. The dynamics of semen transfer to the female bursa inseminalis and spermathecae were observed. Double-mating experiments were conducted to study the effect of time lapsed or an oviposition event between two copulations on the likelihood of a female double-insemination and the use of sperm for egg fertilization; untreated fertile males and radio-sterilised males were used for this purpose. Multiple inseminations and therefore the possibility of sperm competition were limited to matings closely spaced in time. When two males consecutively mated the same female within a 40 min interval, in ca. 15% of the cases did both males sire progeny. When the intervals between the copulations were longer, all progeny over several gonotrophic cycles were offspring of the first male. The mating behavior of males was examined during a rapid sequence of copulations. Male Ae. albopictus were parceling sperm allocation over several matings; however they would also attempt to copulate with females irrespective of the available sperm supply or accessory gland secretion material. During each mating, they transferred large quantities of sperm that was not stored for egg fertilization, and they attempted to copulate with mated females with a low probability of transferring their genes to the next generation. The outcomes of this study provided in addition some essential insights with respect to the sterile insect technique (SIT) as a vector control method.	[Oliva, Clelia F.; Damiens, David; Vreysen, Marc J. B.; Gilles, Jeremie] IAEA, Joint FAO IAEA Div Nucl Techn Food, Insect Pest Control Lab, A-1400 Vienna, Austria; [Oliva, Clelia F.; Lemperiere, Guy] CNRS, MIVEGEC, Inst Rech Dev, IRD UM1 UM2 224 5290, Montpellier, France; [Oliva, Clelia F.; Lemperiere, Guy] Ctr Rech & Veille Malad Emergentes Ocean Indien, La Reunion, France	International Atomic Energy Agency; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Oliva, CF (corresponding author), Polo Innovaz Genom Genet Biol SCaRL, 4 Piano Polo Unico Med Santa Maria Misericordia, Perugia, Italy.	cleliaoliva@gmail.com		Oliva, Clelia/0000-0001-7728-1654	Reunion Region Council; European Social Funds; Joint FAO/IAEA Division; French Ministry of Health; European Regional Development Fund (ERDF)	Reunion Region Council; European Social Funds(European Social Fund (ESF)); Joint FAO/IAEA Division; French Ministry of Health; European Regional Development Fund (ERDF)(European Commission)	This study was supported by the Reunion Region Council and the European Social Funds through a PhD grant to C.F.O. This work was supported by the Joint FAO/IAEA Division, and was also part of the "SIT feasibility programme" in Reunion, jointly funded by the French Ministry of Health and the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Benedict MQ, 2009, J INSECT PHYSIOL, V55, P197, DOI 10.1016/j.jinsphys.2008.11.003; Boivin G, 2005, OECOLOGIA, V143, P198, DOI 10.1007/s00442-004-1800-3; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Damiens D, 2006, BEHAV ECOL, V17, P138, DOI 10.1093/beheco/arj009; Damiens D, 2005, PHYSIOL ENTOMOL, V30, P241, DOI 10.1111/j.1365-3032.2005.00453.x; Damiens D, 2013, J MED ENTOMOL, V50, P336, DOI 10.1603/ME12212; DAPPLES C C, 1974, International Journal of Insect Morphology and Embryology, V3, P279, DOI 10.1016/0020-7322(74)90023-3; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dottorini T, 2013, FASEB J, V27, P86, DOI 10.1096/fj.12-219444; FOSTER W A, 1975, Journal of Insect Physiology, V21, P1085, DOI 10.1016/0022-1910(75)90120-1; Gavriel S, 2009, J INSECT PHYSIOL, V55, P637, DOI 10.1016/j.jinsphys.2009.04.002; GERBER GH, 1970, CAN ENTOMOL, V102, P358, DOI 10.4039/Ent102358-3; Giglioli M. E. C., 1964, Rivista di Malariologia Rome, V43, P265; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1972, MOSQ NEWS, V32, P219; GWADZ RW, 1970, MOSQ NEWS, V30, P355; HAYNES JW, 1977, J ECON ENTOMOL, V70, P411, DOI 10.1093/jee/70.4.411; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071; Helinski MEH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-9; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; JONES JC, 1973, J INSECT PHYSIOL, V19, P435, DOI 10.1016/0022-1910(73)90118-2; JONES JC, 1967, BIOL BULL, V132, P23, DOI 10.2307/1539874; JONES JC, 1965, J MORPHOL, V117, P401, DOI 10.1002/jmor.1051170306; JONES JC, 1965, BIOL BULL, V129, P134, DOI 10.2307/1539773; JONES JC, 1965, BIOL BULL, V129, P532, DOI 10.2307/1539731; JONES JC, 1968, SCI AM, V218, P108, DOI 10.1038/scientificamerican0468-108; Jones TM, 2001, J INSECT BEHAV, V14, P385, DOI 10.1023/A:1011127514317; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; King BH, 2000, GREAT LAKES ENTOMOL, V33, P117; Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006; Koudelova J, 2001, FLA ENTOMOL, V84, P172, DOI 10.2307/3496164; LACHANCE LE, 1979, ANN ENTOMOL SOC AM, V72, P343, DOI 10.1093/aesa/72.3.343; Landa V., 1960, Acta Societatis Entomologicae Cechoslovenicae, V57, P297; LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; LUM PATRICK T. M., 1961, ANN ENT SOC AMER, V54, P430; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MAHMOOD F, 1982, J MED ENTOMOL, V19, P573, DOI 10.1093/jmedent/19.5.573; Mossinson S, 2003, J INSECT PHYSIOL, V49, P561, DOI 10.1016/S0022-1910(03)00027-1; NADEL H, 1985, ANN ENTOMOL SOC AM, V78, P410, DOI 10.1093/aesa/78.3.410; NORTH DT, 1975, J ECON ENTOMOL, V68, P595, DOI 10.1093/jee/68.5.595; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 1998, J THEOR BIOL, V96, P281; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perez-Staples D, 2013, ENTOMOL EXP APPL, V146, P66, DOI 10.1111/j.1570-7458.2012.01312.x; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; PROSHOLD FI, 1993, J ECON ENTOMOL, V86, P1104, DOI 10.1093/jee/86.4.1104; PROVERBS MD, 1969, ANNU REV ENTOMOL, V14, P81, DOI 10.1146/annurev.en.14.010169.000501; R Development Core Team, 2008, R LANG ENV STAT COMP; Radhakrishnan P, 2009, ANIM BEHAV, V78, P839, DOI 10.1016/j.anbehav.2009.07.002; Ramadan MM, 1991, BIOL CONTROL, V1, P248, DOI 10.1016/1049-9644(91)90074-A; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Sella G, 2003, BIOL J LINN SOC, V78, P149, DOI 10.1046/j.1095-8312.2003.00167.x; Shutt B, 2010, MED VET ENTOMOL, V24, P91, DOI 10.1111/j.1365-2915.2009.00849.x; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; SPIELMAN A, 1964, BIOL BULL, V127, P324, DOI 10.2307/1539230; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Weidhaas DE, 1963, MOSQ NEWS, V23	74	56	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78884	10.1371/journal.pone.0078884	http://dx.doi.org/10.1371/journal.pone.0078884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236062	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700059
J	Pellom, ST; Michalek, RD; Crump, KE; Langston, PK; Juneau, DG; Grayson, JM				Pellom, Samuel Troy; Michalek, Ryan D.; Crump, Katie E.; Langston, P. Kent; Juneau, Daniel G.; Grayson, Jason M.			Increased Cell Surface Free Thiols Identify Effector CD8(+) T Cells Undergoing T Cell Receptor Stimulation	PLOS ONE			English	Article							VIRAL-INFECTION; IN-VIVO; ACTIVATION; LYMPHOCYTES; PROLIFERATION; PERSISTENCE; EXPRESSION; OXIDATION; KLRG1	Recognition of peptide Major Histocompatibility Complexes (MHC) by the T cell receptor causes rapid production of reactive oxygen intermediates (ROI) in naive CD8(+) T cells. Because ROI such as H2O2 are membrane permeable, mechanisms must exist to prevent overoxidation of surface proteins. In this study we used fluorescently labeled conjugates of maleimide to measure the level of cell surface free thiols (CSFT) during the development, activation and differentiation of CD8(+) T cells. We found that during development CSFT were higher on CD8 SP compared to CD4 SP or CD4CD8 DP T cells. After activation CSFT became elevated prior to division but once proliferation started levels continued to rise. During acute viral infection CSFT levels were elevated on antigen-specific effector cells compared to memory cells. Additionally, the CSFT level was always higher on antigen-specific CD8(+) T cells in lymphoid compared to nonlymphoid organs. During chronic viral infection, CSFT levels were elevated for extended periods on antigen-specific effector CD8+ T cells. Finally, CSFT levels on effector CD8(+) T cells, regardless of infection, identified cells undergoing TCR stimulation. Taken together these data suggest that CD8(+) T cells upregulate CSFT following receptor ligation and ROI production during infection to prevent overoxidation of surface proteins.	[Pellom, Samuel Troy] Meharry Med Coll, Lab Lymphocyte Funct, Nashville, TN 37208 USA; [Michalek, Ryan D.] Metabolon Corp, Durham, NC USA; [Crump, Katie E.; Langston, P. Kent; Juneau, Daniel G.; Grayson, Jason M.] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27109 USA	Meharry Medical College; Metabolon; Wake Forest University	Grayson, JM (corresponding author), Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27109 USA.	jgrayson@wakehealth.edu		Langston, Paul/0000-0001-6655-1911	National Institute of Allergy and Infectious Diseases (NIAD) [RO1-AI068952]; NIAID [5T32AI007401-20]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068952, T32AI007401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAD); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAD) grant RO1-AI068952 to J.M.G. K. E. C. and R. D. M. were supported by NIAID grant 5T32AI007401-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; CHAUDHRI G, 1986, J IMMUNOL, V137, P2646; Corral L, 2000, EUR J IMMUNOL, V30, P920, DOI 10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.0.CO;2-P; Crump KE, 2012, EUR J IMMUNOL, V42, P2152, DOI 10.1002/eji.201142289; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Di Rosa F, 1999, J IMMUNOL, V163, P1253; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; Kaur N, 2011, CYTOKINE, V55, P307, DOI [10.1016/j.cyto.2011.04.014., DOI 10.1016/J.CYT0.2011.04.014.PUBMED:21602054]; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; REDELMAN D, 1980, J IMMUNOL, V124, P870; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; SMITH S, 1992, CLIN EXP IMMUNOL, V88, P169; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81134	10.1371/journal.pone.0081134	http://dx.doi.org/10.1371/journal.pone.0081134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236211	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700214
J	Roodveldt, C; Labrador-Garrido, A; Gonzalez-Rey, E; Lachaud, CC; Guilliams, T; Fernandez-Montesinos, R; Benitez-Rondan, A; Robledo, G; Hmadcha, A; Delgado, M; Dobson, CM; Pozo, D				Roodveldt, Cintia; Labrador-Garrido, Adahir; Gonzalez-Rey, Elena; Lachaud, Christian C.; Guilliams, Tim; Fernandez-Montesinos, Rafael; Benitez-Rondan, Alicia; Robledo, Gema; Hmadcha, Abdelkrim; Delgado, Mario; Dobson, Christopher M.; Pozo, David			Preconditioning of Microglia by alpha-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; LEWY BODIES; ACTIVATION; INFLAMMATION; INNATE; EXPRESSION	In recent years, it has become accepted that alpha-synuclein (alpha Syn) has a key role in the microglia-mediated neuroinflammation, which accompanies the development of Parkinson's disease and other related disorders, such as Dementia with Lewy Bodies and Alzheimer's disease. Nevertheless, the cellular and molecular mechanisms underlying its pathological actions, especially in the sporadic forms of the diseases, are not completely understood. Intriguingly, several epidemiological and animal model studies have revealed a link between certain microbial infections and the onset or progression of sporadic forms of these neurodegenerative disorders. In this work, we have characterized the effect of toll-like receptor (TLR) stimulation on primary murine microglial cultures and analysed the impact of priming cells with extracellular wild-type (Wt) alpha Syn on the subsequent TLR stimulation of cells with a set of TLR ligands. By assaying key interleukins and chemokines we report that specific stimuli, in particular Pam3Csk4 (Pam3) and single-stranded RNA40 (ssRNA), can differentially affect the TLR2/1- and TLR7-mediated responses of microglia when pre-conditioned with alpha Syn by augmenting IL-6, MCP-1/CCL2 or IP-10/CXCL10 secretion levels. Furthermore, we report a skewing of alpha Syn-primed microglia stimulated with ssRNA (TLR7) or Pam3 (TLR2/1) towards intermediate but at the same time differential, M1/M2 phenotypes. Finally, we show that the levels and intracellular location of activated caspase-3 protein change significantly in alpha Syn-primed microglia after stimulation with these particular TLR agonists. Overall, we report a remarkable impact of non-aggregated alpha Syn pre-sensitization of microglia on TLR-mediated immunity, a phenomenon that could contribute to triggering the onset of sporadic alpha-synuclein-related neuropathologies.	[Roodveldt, Cintia; Labrador-Garrido, Adahir; Lachaud, Christian C.; Fernandez-Montesinos, Rafael; Benitez-Rondan, Alicia; Hmadcha, Abdelkrim; Pozo, David] Andalusian Ctr Mol Biol & Regenerat Med, CABIMER, Seville, Spain; [Labrador-Garrido, Adahir; Fernandez-Montesinos, Rafael; Pozo, David] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain; [Gonzalez-Rey, Elena; Robledo, Gema; Delgado, Mario] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Guilliams, Tim; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge	Pozo, D (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med, CABIMER, Seville, Spain.	david.pozo@cabimer.es	Roodveldt, Cintia/I-9118-2014; Delgado, Mario/P-1524-2016; GONZALEZ-REY, ELENA/L-3296-2014; Lachaud, Christian Claude/C-2036-2017; Pozo, David/C-2149-2017; Hmadcha, Abdelkrim/T-1173-2019; Fernández-Montesinos, Rafael/ABG-1691-2021	Roodveldt, Cintia/0000-0003-4124-8769; Delgado, Mario/0000-0003-1893-5982; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Lachaud, Christian Claude/0000-0001-8698-4589; Pozo, David/0000-0002-3732-4960; Hmadcha, Abdelkrim/0000-0002-4105-3702; Fernandez, Rafael/0000-0002-5062-4239; Labrador-Garrido, Adahir/0000-0001-5098-9601	Spanish Ministry of Science and Innovation-Carlos III Institute of Health [PS09-2252, CP10/00527]; FEDER funds; Andalusian Ministry of Health, Economy, Science and Innovation [PI-2010-0824, P10-CTS-6928, P11-CTS-8161]; PAIDI Program from the Andalusian Government [CTS-677]; FPU Predoctoral Fellowship from the Spanish Ministry of Education [AP-2009/3816]; Wellcome Trust; UK Medical and Biotechnological and Biological Sciences Research Council; Parkinson's UK; Parkinson&quot;s UK [H-0903] Funding Source: researchfish	Spanish Ministry of Science and Innovation-Carlos III Institute of Health; FEDER funds(European Commission); Andalusian Ministry of Health, Economy, Science and Innovation; PAIDI Program from the Andalusian Government; FPU Predoctoral Fellowship from the Spanish Ministry of Education; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical and Biotechnological and Biological Sciences Research Council; Parkinson's UK(Parkinson's UK); Parkinson&quot;s UK(Parkinson&apos;s UK)	Financial support was provided by the Spanish Ministry of Science and Innovation-Carlos III Institute of Health according to the 'Plan Nacional de I+D+i 2008-2011' (PS09-2252 to DP, and CP10/00527 to CR) with co-funding by FEDER funds, the Andalusian Ministry of Health (PI-2010-0824 to DP), Economy, Science and Innovation (P10-CTS-6928 and P11-CTS-8161 to DP) and the PAIDI Program from the Andalusian Government (CTS-677 to DP). ALG holds a FPU Predoctoral Fellowship from the Spanish Ministry of Education (AP-2009/3816). The work of CMD is supported by the Wellcome Trust and the UK Medical and Biotechnological and Biological Sciences Research Council. TG is supported by Parkinson's UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Beraud Dawn, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS17, DOI 10.1016/S1353-8020(11)70008-6; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Castillo PM, 2008, NANOMEDICINE-UK, V3, P627, DOI 10.2217/17435889.3.5.627; Charlett A, 1999, ACTA NEUROL SCAND, V99, P26; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dobbs SM, 2010, HELICOBACTER, V15, P279, DOI 10.1111/j.1523-5378.2010.00768.x; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Fellner L, 2013, MOL NEUROBIOL, V47, P575, DOI 10.1007/s12035-012-8340-3; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Hakansson A, 2005, MOVEMENT DISORD, V20, P569, DOI 10.1002/mds.20378; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hammond CJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-121; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; McKimmie CS, 2006, J NEUROIMMUNOL, V175, P128, DOI 10.1016/j.jneuroim.2006.03.012; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morrison BE, 2012, J IMMUNOL, V189, P5498, DOI 10.4049/jimmunol.1102150; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Roodveldt C., 2011, INTECH, P57; Roodveldt C, 2012, BIOCHEMISTRY-US, V51, P8771, DOI 10.1021/bi300558q; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Scalzo P, 2011, NEUROIMMUNOMODULAT, V18, P240, DOI 10.1159/000323779; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Takahashi M, 1999, JPN J INFECT DIS, V52, P89; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334, DOI 10.1007/BF03404523; Watson MB, 2012, EXP NEUROL, V237, P318, DOI 10.1016/j.expneurol.2012.06.025; Weller C, 2005, FEMS IMMUNOL MED MIC, V44, P129, DOI 10.1016/j.femsim.2005.01.011; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	76	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79160	10.1371/journal.pone.0079160	http://dx.doi.org/10.1371/journal.pone.0079160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236103	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700101
J	Schaefer, SM; Boylan, JM; van Reekum, CM; Lapate, RC; Norris, CJ; Ryff, CD; Davidson, RJ				Schaefer, Stacey M.; Boylan, Jennifer Morozink; van Reekum, Carien M.; Lapate, Regina C.; Norris, Catherine J.; Ryff, Carol D.; Davidson, Richard J.			Purpose in Life Predicts Better Emotional Recovery from Negative Stimuli	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ALZHEIMER-DISEASE; AFFECTIVE STYLE; STARTLE REFLEX; INFORMATION; RESILIENCE; DEPRESSION; RISK; MODULATION; AMYGDALA	Purpose in life predicts both health and longevity suggesting that the ability to find meaning from life's experiences, especially when confronting life's challenges, may be a mechanism underlying resilience. Having purpose in life may motivate reframing stressful situations to deal with them more productively, thereby facilitating recovery from stress and trauma. In turn, enhanced ability to recover from negative events may allow a person to achieve or maintain a feeling of greater purpose in life over time. In a large sample of adults (aged 36-84 years) from the MIDUS study (Midlife in the U. S., http://www.midus.wisc.edu/), we tested whether purpose in life was associated with better emotional recovery following exposure to negative picture stimuli indexed by the magnitude of the eyeblink startle reflex (EBR), a measure sensitive to emotional state. We differentiated between initial emotional reactivity (during stimulus presentation) and emotional recovery (occurring after stimulus offset). Greater purpose in life, assessed over two years prior, predicted better recovery from negative stimuli indexed by a smaller eyeblink after negative pictures offset, even after controlling for initial reactivity to the stimuli during the picture presentation, gender, age, trait affect, and other well-being dimensions. These data suggest a proximal mechanism by which purpose in life may afford protection from negative events and confer resilience is through enhanced automatic emotion regulation after negative emotional provocation.	[Schaefer, Stacey M.; Lapate, Regina C.; Ryff, Carol D.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Schaefer, Stacey M.; Lapate, Regina C.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Schaefer, Stacey M.; Lapate, Regina C.; Davidson, Richard J.] Univ Wisconsin, Ctr Investigating Healthy Minds, Madison, WI 53706 USA; [Boylan, Jennifer Morozink] Univ Wisconsin, Ctr Womens Hlth & Hlth Dispar Res, Madison, WI 53706 USA; [Ryff, Carol D.] Univ Wisconsin, Inst Aging, Madison, WI 53706 USA; [van Reekum, Carien M.] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Norris, Catherine J.] Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Reading; Swarthmore College	Schaefer, SM (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	smschaefer2@wisc.edu	Boylan, Jennifer/B-9288-2016	Norris, Catherine/0000-0003-3710-7998; Davidson, Richard/0000-0002-8506-4964; van Reekum, Carien M./0000-0002-1516-1101; Boylan, Jennifer/0000-0003-2597-1367	National Institute on Aging [PO1-AG020166]; National Institute on Mental Health [R01 MH043454]; Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC) [P30HD03352]; National Institute of Mental Health [T32MH018931-22]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049302, P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931, R01MH043454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging (PO1-AG020166), the National Institute on Mental Health (R01 MH043454), and the Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC), P30HD03352. J. Morozink Boylan was supported by the National Institute of Mental Health (T32MH018931-22). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Boyle PA, 2012, ARCH GEN PSYCHIAT, V69, P499, DOI 10.1001/archgenpsychiatry.2011.1487; Boyle PA, 2010, AM J GERIAT PSYCHIAT, V18, P1093, DOI 10.1097/JGP.0b013e3181d6c259; Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208; Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BRADLEY MM, 1993, PSYCHOPHYSIOLOGY, V30, P541, DOI 10.1111/j.1469-8986.1993.tb02079.x; Brim OG, 2004, MAC FDN MEN, P1; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Campbell-Sills L, 2006, BEHAV RES THER, V44, P1251, DOI 10.1016/j.brat.2005.10.001; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Davis M., 1999, STARTLE MODIFICATION, P95; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Ehring T, 2008, PERS INDIV DIFFER, V44, P1574, DOI 10.1016/j.paid.2008.01.013; Feder A, 2013, J AFFECT DISORDERS, V147, P156, DOI 10.1016/j.jad.2012.10.027; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Friedman EM, 2007, HEALTH PSYCHOL, V26, P305, DOI 10.1037/0278-6133.26.3.305; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Grillon C, 1998, INT J PSYCHOPHYSIOL, V28, P223, DOI 10.1016/S0167-8760(97)00072-X; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Lang P.J., 2008, INT AFFECTIVE PICTUR; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lewis GJ, 2014, SOC COGN AFFECT NEUR, V9, P615, DOI 10.1093/scan/nst032; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Morozink JA, 2010, HEALTH PSYCHOL, V29, P626, DOI 10.1037/a0021360; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nierenberg AA, 2010, CNS NEUROSCI THER, V16, P208, DOI 10.1111/j.1755-5949.2009.00108.x; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; PAVOT W, 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Roberts NA, 2008, INT J PSYCHOPHYSIOL, V70, P82, DOI 10.1016/j.ijpsycho.2008.06.003; Ryff C, 2012, SOC PERSONAL PSYCHOL, V6, P792, DOI 10.1111/j.1751-9004.2012.00462.x; Ryff CD, 2012, ANNU REV GERONTOL GE, V32, P73, DOI 10.1891/0198-8794.32.73; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; RYFF CD, 1994, PSYCHOL AGING, V9, P195, DOI 10.1037/0882-7974.9.2.195; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Siegle GJ, 2003, COGNITIVE THER RES, V27, P365, DOI 10.1023/A:1023974602357; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2001, BIOL PSYCHIAT, V49, P624, DOI 10.1016/S0006-3223(00)01024-6; Sprengelmeyer R, 2011, J AFFECT DISORDERS, V133, P120, DOI 10.1016/j.jad.2011.04.004; Tassinary LG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P267, DOI 10.1017/CBO9780511546396.012; Taubitz LE, 2013, INT J PSYCHOPHYSIOL, V87, P124, DOI 10.1016/j.ijpsycho.2012.11.002; van Reekum CM, 2007, J COGNITIVE NEUROSCI, V19, P237, DOI 10.1162/jocn.2007.19.2.237; van Reekum CM, 2011, SOC COGN AFFECT NEUR, V6, P177, DOI 10.1093/scan/nsq031; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wood AM, 2010, J AFFECT DISORDERS, V122, P213, DOI 10.1016/j.jad.2009.06.032	53	87	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80329	10.1371/journal.pone.0080329	http://dx.doi.org/10.1371/journal.pone.0080329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236176	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327254700177
J	Fan, JK; Jiang, K; Liu, YJ; Jia, JH				Fan, Junkai; Jiang, Kai; Liu, Yajuan; Jia, Jianhang			Hrs Promotes Ubiquitination and Mediates Endosomal Trafficking of Smoothened in Drosophila Hedgehog Signaling	PLOS ONE			English	Article							C-TERMINAL TAIL; ANIMAL DEVELOPMENT; ESCRT MACHINERY; PRIMARY CILIUM; PHOSPHORYLATION; TRANSDUCTION; CANCER; ENDOCYTOSIS; PROTEINS; RECEPTOR	In Hedgehog (Hh) signaling, the seven-transmembrane protein Smoothened (Smo) acts as a signal transducer that is regulated by phosphorylation, ubiquitination, and cell surface accumulation. However, it is not clear how Smo cell surface accumulation and intracellular trafficking are regulated. Here, we demonstrate that inactivation of Hrs by deletion or RNAi accumulates Smo in the late endosome that is marked by late endosome markers. Inactivation of Hrs enhances the wing defects caused by dominant-negative Smo. We show that Hrs promotes Smo ubiquitination, deleting the ubiquitin-interacting-motif (UIM) in Hrs abolishes the ability of Hrs to regulate Smo ubiquitination. However, the UIM domain neither recognizes the ubiquitinated Smo nor directly interacts with Smo. Hrs lacking UIM domain still downregulates Smo activity even though to a less extent. We have characterized that the N-terminus of Hrs directly interacts with the PKA/CK1 phosphorylation clusters to prevent Smo phosphorylation and activation, indicating an ubiquitin-independent regulation of Smo by Hrs. Finally, we found that knockdown of Tsg101 accumulates Smo that is co-localized with Hrs and other late endosome markers. Taken together, our data indicate that Hrs mediates Smo trafficking in the late endosome by not only promoting Smo ubiquitination but also blocking Smo phosphorylation.	[Fan, Junkai; Jiang, Kai; Liu, Yajuan; Jia, Jianhang] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Jia, JH (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA.	Jianhang.jia@uky.edu		Jia, Jianhang/0000-0002-9313-3843; Jiang, Kai/0000-0002-8507-1945	National Institutes of Health [GM079684]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (GM079684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fan JK, 2012, DEV BIOL, V366, P172, DOI 10.1016/j.ydbio.2012.04.007; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Molnar C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001335; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yang X, 2013, J CELL SCI; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	36	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79021	10.1371/journal.pone.0079021	http://dx.doi.org/10.1371/journal.pone.0079021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244405	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600095
J	Miyauchi, O; Iwase, K; Itoh, K; Kato, M; Seki, N; Braissant, O; Bachmann, C; Shozu, M; Sekiya, S; Osada, H; Takiguchi, M				Miyauchi, Osamu; Iwase, Katsuro; Itoh, Kanako; Kato, Masaki; Seki, Naohiko; Braissant, Olivier; Bachmann, Claude; Shozu, Makio; Sekiya, Souei; Osada, Hisao; Takiguchi, Masaki			Efficient Subtractive Cloning of Genes Activated by Lipopolysaccharide and Interferon gamma in Primary-Cultured Cortical Cells of Newborn Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; INNATE IMMUNITY; MESSENGER-RNA; PERIVENTRICULAR LEUKOMALACIA; MICROARRAY ANALYSIS; PIVOTAL ROLE; EXPRESSION	Innate immune responses play a central role in neuroprotection and neurotoxicity during inflammatory processes that are triggered by pathogen-associated molecular pattern-exhibiting agents such as bacterial lipopolysaccharide (LPS) and that are modulated by inflammatory cytokines such as interferon gamma (IFN gamma). Recent findings describing the unexpected complexity of mammalian genomes and transcriptomes have stimulated further identification of novel transcripts involved in specific physiological and pathological processes, such as the neural innate immune response that alters the expression of many genes. We developed a system for efficient subtractive cloning that employs both sense and antisense cRNA drivers, and coupled it with in-house cDNA microarray analysis. This system enabled effective direct cloning of differentially expressed transcripts, from a small amount (0.5 mu g) of total RNA. We applied this system to isolation of genes activated by LPS and IFN gamma in primary-cultured cortical cells that were derived from newborn mice, to investigate the mechanisms involved in neuroprotection and neurotoxicity in maternal/perinatal infections that cause various brain injuries including periventricular leukomalacia. A number of genes involved in the immune and inflammatory response were identified, showing that neonatal neuronal/glial cells are highly responsive to LPS and IFN gamma. Subsequent RNA blot analysis revealed that the identified genes were activated by LPS and IFN gamma in a cooperative or distinctive manner, thereby supporting the notion that these bacterial and cellular inflammatory mediators can affect the brain through direct but complicated pathways. We also identified several novel clones of apparently non-coding RNAs that potentially harbor various regulatory functions. Characterization of the presently identified genes will give insights into mechanisms and interventions not only for perinatal infection-induced brain damage, but also for many other innate immunity-related brain disorders.	[Miyauchi, Osamu; Iwase, Katsuro; Itoh, Kanako; Takiguchi, Masaki] Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Japan; [Miyauchi, Osamu; Shozu, Makio; Sekiya, Souei; Osada, Hisao] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan; [Kato, Masaki; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan; [Braissant, Olivier; Bachmann, Claude] CHU Vaudois, Lab Cent Chim Clin, CH-1011 Lausanne, Switzerland	Chiba University; Chiba University; Chiba University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Takiguchi, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Japan.	mtak@faculty.chiba-u.jp	Kato, Masaki/B-5846-2018	Kato, Masaki/0000-0002-5184-1841	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Grants-in-Aid for Scientific Research [25670115, 23390048] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Science, Sports, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi-Uehara N, 2006, EXP EYE RES, V83, P849, DOI 10.1016/j.exer.2006.04.012; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Albright AV, 2004, J NEUROIMMUNOL, V157, P27, DOI 10.1016/j.jneuroim.2004.09.007; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Barna M, 1996, VIROLOGY, V223, P331, DOI 10.1006/viro.1996.0484; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chao CC, 1996, GLIA, V16, P276, DOI 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; GALEA E, 1994, J NEUROSCI RES, V37, P406, DOI 10.1002/jnr.490370313; GILLY M, 1992, J IMMUNOL, V148, P3275; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Iwase K, 2000, J BIOL CHEM, V275, P11929, DOI 10.1074/jbc.275.16.11929; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Lee E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-7; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu JA, 2011, P NATL ACAD SCI USA, V108, P4465, DOI 10.1073/pnas.1019020108; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; McKimmie CS, 2006, J NEUROIMMUNOL, V175, P128, DOI 10.1016/j.jneuroim.2006.03.012; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Ohtsuka S, 2004, GENOMICS, V84, P715, DOI 10.1016/j.ygeno.2004.06.012; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Pang Y, 2001, BRAIN RES, V914, P15, DOI 10.1016/S0006-8993(01)02766-4; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SAUNDERS NR, 1977, EXP EYE RES, V25, P523, DOI 10.1016/S0014-4835(77)80046-8; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581; XU J, 1994, J ANAT, V184, P227; Yoshikawa T, 2000, BIOCHEM BIOPH RES CO, V275, P532, DOI 10.1006/bbrc.2000.3330; Yuan TM, 2010, J NEUROIMMUNOL, V229, P16, DOI 10.1016/j.jneuroim.2010.08.008; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang WY, 1999, BRAIN RES, V849, P78, DOI 10.1016/S0006-8993(99)01987-3	79	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79236	10.1371/journal.pone.0079236	http://dx.doi.org/10.1371/journal.pone.0079236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244457	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600118
J	Schlernitzauer, A; Oiry, C; Hamad, R; Galas, S; Cortade, F; Chabi, B; Casas, F; Pessemesse, L; Fouret, G; Feillet-Coudray, C; Cros, G; Cabello, G; Magous, R; Wrutniak-Cabello, C				Schlernitzauer, Audrey; Oiry, Catherine; Hamad, Raphael; Galas, Simon; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cros, Gerard; Cabello, Gerard; Magous, Richard; Wrutniak-Cabello, Chantal			Chicoric Acid Is an Antioxidant Molecule That Stimulates AMP Kinase Pathway in L6 Myotubes and Extends Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FREE FATTY-ACIDS; GLUCOSE-PRODUCTION; MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; STRESS RESISTANCE; CAFFEIC ACID; C. ELEGANS; RESVERATROL; PGC-1-ALPHA	Chicoric acid (CA) is a caffeoyl derivative previously described as having potential anti-diabetic properties. As similarities in cellular mechanism similarities between diabetes and aging have been shown, we explored on L6 myotubes the effect of CA on the modulation of intracellular pathways involved in diabetes and aging. We also determined its influence on lifespan of Caenorhabditis elegans worm (C. elegans). In L6 myotubes, CA was a potent reactive oxygen species (ROS) scavenger, reducing ROS accumulation under basal as well as oxidative stress conditions. CA also stimulated the AMP-activated kinase (AMPK) pathway and displayed various features associated with AMPK activation: CA (a) enhanced oxidative enzymatic defences through increase in glutathion peroxidase (GPx) and superoxide dismutase (SOD) activities, (b) favoured mitochondria protection against oxidative damage through up-regulation of MnSOD protein expression, (c) increased mitochondrial biogenesis as suggested by increases in complex II and citrate synthase activities, along with up-regulation of PGC-1 alpha mRNA expression and (d) inhibited the insulin/Akt/mTOR pathway. As AMPK stimulators (e. g. the anti-diabetic agent meformin or polyphenols such as epigallocatechingallate or quercetin) were shown to extend lifespan in C. elegans, we also determined the effect of CA on the same model. A concentration-dependant lifespan extension was observed with CA (5-100 mu M). These data indicate that CA is a potent antioxidant compound activating the AMPK pathway in L6 myotubes. Similarly to other AMPK stimulators, CA is able to extend C. elegans lifespan, an effect measurable even at the micromolar range. Future studies will explore CA molecular targets and give new insights about its possible effects on metabolic and aging-related diseases.	[Schlernitzauer, Audrey; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cabello, Gerard; Wrutniak-Cabello, Chantal] INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France; [Schlernitzauer, Audrey; Oiry, Catherine; Cros, Gerard; Magous, Richard] CNRS, UMR 5247, IBMM, Montpellier, France; [Hamad, Raphael; Galas, Simon] UFR Pharm, Toxicol Lab, Montpellier, France; [Schlernitzauer, Audrey; Oiry, Catherine; Hamad, Raphael; Galas, Simon; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cros, Gerard; Cabello, Gerard; Magous, Richard; Wrutniak-Cabello, Chantal] Univ Montpellier 1 & 2, Montpellier, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Wrutniak-Cabello, C (corresponding author), INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France.	wrutniak@supagro.inra.fr	Chabi, Beatrice/AAI-6545-2020	Chabi, Beatrice/0000-0002-5604-5668	INRA	INRA	This work was funded by INRA. AS was recipient of The Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Andary C, 2007, Patent, Patent No. [US 20110015140 A1, 20110015140]; Andary C, 2007, Patent, Patent No. [EP2056802 B1, 2056802]; Asano T, 2007, BIOL PHARM BULL, V30, P1610, DOI 10.1248/bpb.30.1610; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRENNER S, 1974, GENETICS, V77, P71; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fink BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004250; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hwang YP, 2013, MOL NUTR FOOD RES, V57, P471, DOI 10.1002/mnfr.201200529; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Lee ES, 2007, BIOCHEM BIOPH RES CO, V361, P854, DOI 10.1016/j.bbrc.2007.07.068; Lee YK, 2010, ONCOL REP, V24, P1471, DOI 10.3892/or_00001007; Lee YK, 2010, ONCOL REP, V24, P1493, DOI 10.3892/or_00001010; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Robb EL, 2008, BIOCHEM BIOPH RES CO, V367, P406, DOI 10.1016/j.bbrc.2007.12.138; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stiernagle Theresa, 2006, WormBook, P1; Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007	73	59	66	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78788	10.1371/journal.pone.0078788	http://dx.doi.org/10.1371/journal.pone.0078788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244361	Green Published, gold			2022-12-25	WOS:000327221600059
J	Zhang, YN; Eigenbrot, C; Zhou, LJ; Shia, S; Li, W; Quan, C; Tom, J; Moran, P; Di Lello, P; Skelton, NJ; Kong-Beltran, M; Peterson, A; Kirchhofer, D				Zhang, Yingnan; Eigenbrot, Charles; Zhou, Lijuan; Shia, Steven; Li, Wei; Quan, Clifford; Tom, Jeffrey; Moran, Paul; Di Lello, Paola; Skelton, Nicholas J.; Kong-Beltran, Monica; Peterson, Andrew; Kirchhofer, Daniel			Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; LDL-RECEPTOR; SECRETED PCSK9; CHOLESTEROL; ANTIBODY; DEGRADATION; COMPLEX; DESIGN; RECOGNITION; ANTAGONISTS	PCSK9 (proprotein convertase subtilisin/kexin type 9) is a negative regulator of the hepatic LDL receptor, and clinical studies with PCSK9-inhibiting antibodies have demonstrated strong LDL-c-lowering effects. Here we screened phage-displayed peptide libraries and identified the 13-amino acid linear peptide Pep2-8 as the smallest PCSK9 inhibitor with a clearly defined mechanism of inhibition that has been described. Pep2-8 bound to PCSK9 with a K-D of 0.7 mu M but did not bind to other proprotein convertases. It fully restored LDL receptor surface levels and LDL particle uptake in PCSK9-treated HepG2 cells. The crystal structure of Pep2-8 bound to C-terminally truncated PCSK9 at 1.85 angstrom resolution showed that the peptide adopted a strand-turn-helix conformation, which is remarkably similar to its solution structure determined by NMR. Consistent with the functional binding site identified by an Ala scan of PCSK9, the structural Pep2-8 contact region of about 400 angstrom(2) largely overlapped with that contacted by the EGF(A) domain of the LDL receptor, suggesting a competitive inhibition mechanism. Consistent with this, Pep2-8 inhibited LDL receptor and EGF(A) domain binding to PCSK9 with IC50 values of 0.8 and 0.4 mu M, respectively. Remarkably, Pep2-8 mimicked secondary structural elements of the EGF(A) domain that interact with PCSK9, notably the beta-strand and a discontinuous short alpha-helix, and it engaged in the same beta-sheet hydrogen bonds as EGF(A) does. Although Pep2-8 itself may not be amenable to therapeutic applications, this study demonstrates the feasibility of developing peptidic inhibitors to functionally relevant sites on PCSK9.	[Zhang, Yingnan; Zhou, Lijuan; Li, Wei; Quan, Clifford; Tom, Jeffrey; Moran, Paul; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Eigenbrot, Charles; Shia, Steven; Di Lello, Paola] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Skelton, Nicholas J.] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Kong-Beltran, Monica; Peterson, Andrew] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com	Zhou, Li/GSE-4531-2022		Department of Energy Office of Biological and Environmental Research; National Institutes of Health; NIGMS [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL), operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, National Institutes of Health, NIGMS (including Grant P41GM103393), and National Center for Research Resources Grant P41RR001209.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andronati SA, 2004, CURR MED CHEM, V11, P1183, DOI 10.2174/0929867043365314; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franklin MC, 2003, BIOCHEMISTRY-US, V42, P8223, DOI 10.1021/bi034227t; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer-Smith H, 2010, CURR MED CHEM, V17, P2168, DOI 10.2174/092986710791299948; Pan B, 2002, J MOL BIOL, V316, P769, DOI 10.1006/jmbi.2001.5370; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang YN, 2012, J MOL BIOL, V422, P685, DOI 10.1016/j.jmb.2012.06.018; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	54	98	116	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					942	955		10.1074/jbc.M113.514067	http://dx.doi.org/10.1074/jbc.M113.514067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24225950	Green Published, hybrid			2022-12-25	WOS:000330541200029
J	Chen, ZW; Pereira, JH; Liu, HB; Tran, HM; Hsu, NSY; Dibble, D; Singh, S; Adams, PD; Sapra, R; Hadi, MZ; Simmons, BA; Sale, KL				Chen, Zhiwei; Pereira, Jose H.; Liu, Hanbin; Tran, Huu M.; Hsu, Nathan S. Y.; Dibble, Dean; Singh, Seema; Adams, Paul D.; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.			Improved Activity of a Thermophilic Cellulase, Cel5A, from Thermotoga maritima on Ionic Liquid Pretreated Switchgrass	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; ENDOGLUCANASE CEL5A; RANDOM MUTAGENESIS; BIOFUELS; BIOMASS; OPTIMIZATION; PLANTS; FUELS	Ionic liquid pretreatment of biomass has been shown to greatly reduce the recalcitrance of lignocellulosic biomass, resulting in improved sugar yields after enzymatic saccharification. However, even under these improved saccharification conditions the cost of enzymes still represents a significant proportion of the total cost of producing sugars and ultimately fuels from lignocellulosic biomass. Much of the high cost of enzymes is due to the low catalytic efficiency and stability of lignocellulolytic enzymes, especially cellulases, under conditions that include high temperatures and the presence of residual pretreatment chemicals, such as acids, organic solvents, bases, or ionic liquids. Improving the efficiency of the saccharification process on ionic liquid pretreated biomass will facilitate reduced enzyme loading and cost. Thermophilic cellulases have been shown to be stable and active in ionic liquids but their activity is typically at lower levels. Cel5A_Tma, a thermophilic endoglucanase from Thermotoga maritima, is highly active on cellulosic substrates and is stable in ionic liquid environments. Here, our motivation was to engineer mutants of Cel5A_Tma with higher activity on 1-ethyl-3-methylimidazolium acetate ([C(2)mim][OAc]) pretreated biomass. We developed a robotic platform to screen a random mutagenesis library of Cel5A_Tma. Twelve mutants with 25-42% improvement in specific activity on carboxymethyl cellulose and up to 30% improvement on ionic-liquid pretreated switchgrass were successfully isolated and characterized from a library of twenty thousand variants. Interestingly, most of the mutations in the improved variants are located distally to the active site on the protein surface and are not directly involved with substrate binding.	[Chen, Zhiwei; Pereira, Jose H.; Liu, Hanbin; Tran, Huu M.; Dibble, Dean; Singh, Seema; Adams, Paul D.; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Chen, Zhiwei; Liu, Hanbin; Tran, Huu M.; Dibble, Dean; Singh, Seema; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Livermore, CA USA; [Pereira, Jose H.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Hsu, Nathan S. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Sale, KL (corresponding author), Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA.	klsale@sandia.gov	Simmons, Blake/N-6022-2016; Adams, Paul David/A-1977-2013	Simmons, Blake/0000-0002-1332-1810; Adams, Paul David/0000-0001-9333-8219	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [B0946381]	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This project also received support from the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense under Grant No. B0946381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Bharadwaj R, 2010, ANAL CHEM, V82, P9513, DOI 10.1021/ac102243f; Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferdjani S, 2011, BIOTECHNOL LETT, V33, P1215, DOI 10.1007/s10529-011-0560-5; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hughes SR, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-10; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; Kim YS, 2000, APPL ENVIRON MICROB, V66, P788, DOI 10.1128/AEM.66.2.788-793.2000; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Lee D, 2007, COMPOSITION HERBACEO; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Li H, 2010, ANNU REV CHEM BIOMOL, V1, P19, DOI 10.1146/annurev-chembioeng-073009-100938; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liu HB, 2010, FEBS LETT, V584, P3431, DOI 10.1016/j.febslet.2010.06.041; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Lloyd TA, 2005, BIORESOURCE TECHNOL, V96, P1967, DOI 10.1016/j.biortech.2005.01.011; Mahadevan SA, 2008, FEMS MICROBIOL LETT, V287, P205, DOI 10.1111/j.1574-6968.2008.01324.x; McCarthy JK, 2004, J BIOL CHEM, V279, P11495, DOI 10.1074/jbc.M305642200; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P1986, DOI 10.1016/j.biortech.2005.01.013; Murashima K, 2002, MOL MICROBIOL, V45, P617, DOI 10.1046/j.1365-2958.2002.03049.x; Navarro D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-58; Ohgren K, 2007, BIORESOURCE TECHNOL, V98, P2503, DOI 10.1016/j.biortech.2006.09.003; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun N, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-39; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; U.S. Department of Energy Biomass Program, BIOM FEEDST COMP PRO; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Warshel A, 2007, BIOCHEMISTRY; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Wiselogel AE, 1996, BIORESOURCE TECHNOL, V56, P103, DOI 10.1016/0960-8524(95)00171-9; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	55	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79725	10.1371/journal.pone.0079725	http://dx.doi.org/10.1371/journal.pone.0079725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244549	Green Published, gold			2022-12-25	WOS:000327143800098
J	Fischer, S; Nolte, I; Schilling, N				Fischer, Stefanie; Nolte, Ingo; Schilling, Nadja			Adaptations in Muscle Activity to Induced, Short-Term Hindlimb Lameness in Trotting Dogs	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; KINEMATIC GAIT ANALYSIS; LONGISSIMUS-DORSI MUSCLES; GROUND REACTION FORCE; 2 SURGICAL TECHNIQUES; PELVIC LIMB; ELECTROMYOGRAPHIC ACTIVITY; SURFACE ELECTROMYOGRAPHY; TREADMILL INCLINATION; MOVEMENT ADAPTATIONS	Muscle tissue has a great intrinsic adaptability to changing functional demands. Triggering more gradual responses such as tissue growth, the immediate responses to altered loading conditions involve changes in the activity. Because the reduction in a limb's function is associated with marked deviations in the gait pattern, understanding the muscular responses in laming animals will provide further insight into their compensatory mechanisms as well as help to improve treatment options to prevent musculoskeletal sequelae in chronic patients. Therefore, this study evaluated the changes in muscle activity in adaptation to a moderate, short-term, weight-bearing hindlimb lameness in two leg and one back muscle using surface electromyography (SEMG). In eight sound adult dogs that trotted on an instrumented treadmill, bilateral, bipolar recordings of the m. triceps brachii, the m. vastus lateralis and the m. longissimus dorsi were obtained before and after lameness was induced. Consistent with the unchanged vertical forces as well as temporal parameters, neither the timing nor the level of activity changed significantly in the m. triceps brachii. In the ipsilateral m. vastus lateralis, peak activity and integrated SEMG area were decreased, while they were significantly increased in the contralateral hindlimb. In both sides, the duration of the muscle activity was significantly longer due to a delayed offset. These observations are in accordance with previously described kinetic and kinematic changes as well as changes in muscle mass. Adaptations in the activity of the m. longissimus dorsi concerned primarily the unilateral activity and are discussed regarding known alterations in trunk and limb motions.	[Fischer, Stefanie; Nolte, Ingo] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Schilling, Nadja] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Schilling, N (corresponding author), Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany.	nadja.schilling@icloud.com			Graduiertenkolleg Biomedizintechnik of the SFB 599; German Research Foundation; Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V.; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt	Graduiertenkolleg Biomedizintechnik of the SFB 599(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V.; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt	This study was supported by the Graduiertenkolleg Biomedizintechnik of the SFB 599 funded by the German Research Foundation (scholarship to SF) and the Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V. (both to IN) as well as the Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052202; Abdelhadi J, 2013, AM J VET RES, V74, P34, DOI 10.2460/ajvr.74.1.34; ALLEN K, 1994, VET COMP ORTHOPAED, V7, P148; Alvarez CBG, 2008, EQUINE VET J, V40, P147, DOI 10.2746/042516408X250184; ARMSTRONG RB, 1982, AM J ANAT, V163, P87, DOI 10.1002/aja.1001630107; Bennett RL, 1996, AM J VET RES, V57, P966; Bockstahler B, 2012, VET SURG, V41, P54, DOI 10.1111/j.1532-950X.2011.00932.x; Bockstahler BA, 2012, AM J VET RES, V73, P1371, DOI 10.2460/ajvr.73.9.1371; Bockstahler BB, 2009, VET SURG, V38, P754, DOI 10.1111/j.1532-950X.2009.00561.x; Boddeker J, 2012, VET COMP ORTHOPAED, V25, P11, DOI 10.3415/VCOT-10-02-0025; Buchner H H, 2001, Equine Vet J Suppl, P122; Buchner HHF, 1996, EQUINE VET J, V28, P63, DOI 10.1111/j.2042-3306.1996.tb01591.x; Buchner HHF, 1996, EQUINE VET J, V28, P71, DOI 10.1111/j.2042-3306.1996.tb01592.x; BUDSBERG SC, 1988, AM J VET RES, V49, P1522; CARLSON H, 1979, ACTA PHYSIOL SCAND, V105, P251, DOI 10.1111/j.1748-1716.1979.tb06338.x; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; Carrier DR, 2006, J EXP BIOL, V209, P2224, DOI 10.1242/jeb.02236; Carroll AM, 2009, J EXP BIOL, V212, P3349, DOI 10.1242/jeb.033639; Chapman AR, 2008, J ELECTROMYOGR KINES, V18, P359, DOI 10.1016/j.jelekin.2005.12.007; Corr S, 2009, IN PRACTICE, V31, P164; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1996, AM J VET RES, V57, P120; DECAMP CE, 1993, AM J VET RES, V54, P627; DUPUIS J, 1994, VET SURG, V23, P1, DOI 10.1111/j.1532-950X.1994.tb00436.x; ENGBERG I, 1969, ACTA PHYSIOL SCAND, V75, P614, DOI 10.1111/j.1748-1716.1969.tb04415.x; ENGLISH AW, 1978, J EXP BIOL, V76, P105; Evans H. W., 1993, Miller's anatomy of the dog., P1; Fischer S, 2013, VET J, V197, P746, DOI 10.1016/j.tvjl.2013.04.009; Goldspink G, 2005, BRIT J SPORT MED, V39, P787, DOI 10.1136/bjsm.2004.015826; Goldspink G, 2002, BIOCHEM SOC T, V30, P285, DOI 10.1042/bst0300285; GOSLOW GE, 1981, J EXP BIOL, V94, P15; Harrison SM, 2012, J EXP BIOL, V215, P2980, DOI 10.1242/jeb.065441; Hasler EM, 1998, J BIOMECH, V31, P253, DOI 10.1016/S0021-9290(97)00119-X; Herzog W, 2003, LANGENBECK ARCH SURG, V388, P305, DOI 10.1007/s00423-003-0402-6; Innes JF, 1998, J SMALL ANIM PRACT, V39, P325, DOI 10.1111/j.1748-5827.1998.tb03723.x; Jevens DJ, 1996, AM J VET RES, V57, P389; JOHNSON JM, 1993, VET CLIN N AM-SMALL, V23, P717, DOI 10.1016/S0195-5616(93)50078-5; Katic N, 2009, AM J VET RES, V70, P118, DOI 10.2460/ajvr.70.1.118; KORVICK DL, 1994, J BIOMECH, V27, P77, DOI 10.1016/0021-9290(94)90034-5; Lamoth CJC, 2004, CLIN BIOMECH, V19, P551, DOI 10.1016/j.clinbiomech.2003.10.006; Lauer SK, 2009, AM J VET RES, V70, P658, DOI 10.2460/ajvr.70.5.658; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka TF, 2004, AM J VET RES, V65, P155, DOI 10.2460/ajvr.2004.65.155; Miller A., 1996, In Practice, V18, P98; Moseley GL, 2004, BRAIN, V127, P2339, DOI 10.1093/brain/awh248; Mostafa AA, 2010, VET SURG, V39, P380, DOI 10.1111/j.1532-950X.2010.00657.x; Nomura S., 1966, Japanese Journal Zootechnical Science, V37, P221; PERRY AK, 1988, J EXP BIOL, V137, P207; Poy NSJ, 2000, AM J VET RES, V61, P974, DOI 10.2460/ajvr.2000.61.974; Ragetly CA, 2010, VET SURG, V39, P513, DOI 10.1111/j.1532-950X.2010.00680.x; RASMUSSEN S, 1978, J MORPHOL, V155, P253, DOI 10.1002/jmor.1051550302; Ritter DA, 2001, J EXP BIOL, V204, P3053; Robert C, 2002, EQUINE VET J, V34, P295; Robert C, 2001, EQUINE VET J, V33, P466, DOI 10.2746/042516401776254745; Robert C, 1999, CELLS TISSUES ORGANS, V165, P113, DOI 10.1159/000016681; RUMPH PF, 1995, VET SURG, V24, P384, DOI 10.1111/j.1532-950X.1995.tb01348.x; RUMPH PF, 1993, AM J VET RES, V54, P365; Sanchez-Bustinduy M, 2010, VET SURG, V39, P523, DOI 10.1111/j.1532-950X.2010.00672.x; Schaeffer PJ, 2013, COMPR PHYSIOL, V3, P289, DOI 10.1002/cphy.c110059; Schilling N, 2010, J EXP BIOL, V213, P1490, DOI 10.1242/jeb.039487; Schilling N, 2009, J EXP BIOL, V212, P1053, DOI 10.1242/jeb.020248; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Scholle HC, 2001, EXP BRAIN RES, V138, P26, DOI 10.1007/s002210100685; Sutherland DH, 2001, GAIT POSTURE, V14, P61, DOI 10.1016/S0966-6362(01)00100-X; TOKURIKI M, 1973, JPN J VET SCI, V35, P525; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; VILENSKY JA, 1994, J ELECTROMYOGR KINES, V4, P181, DOI 10.1016/1050-6411(94)90019-1; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; WENTINK GH, 1978, ANAT EMBRYOL, V152, P261, DOI 10.1007/BF00350524; WENTINK GH, 1976, ACTA ANAT, V96, P70, DOI 10.1159/000144662; Wickler SJ, 2000, J EXP BIOL, V203, P2195; Wickler SJ, 2005, J EXP BIOL, V208, P1191, DOI 10.1242/jeb.01485; Zaneb H, 2009, AM J VET RES, V70, P1129, DOI 10.2460/ajvr.70.9.1129	73	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80987	10.1371/journal.pone.0080987	http://dx.doi.org/10.1371/journal.pone.0080987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236207	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700210
J	Golovliov, I; Twine, SM; Shen, H; Sjostedt, A; Conlan, W				Golovliov, Igor; Twine, Susan M.; Shen, Hua; Sjostedt, Anders; Conlan, Wayne			A Delta clpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia	PLOS ONE			English	Article							LETHAL INHALATIONAL INFECTION; SCHU S4; VIRULENCE; IMMUNITY; AEROSOL; MICE; ESTABLISHMENT; IMMUNIZATION; PROTECTION; PROTEIN	Francisella tularensis subsp. tularensis is a highly virulent pathogen for humans especially if inhaled. Consequently, it is considered to be a potential biothreat agent. An experimental vaccine, F. tularensis live vaccine strain, derived from the less virulent subsp. holarctica, was developed more than 50 years ago, but remains unlicensed. Previously, we developed a novel live vaccine strain, by deleting the chaperonin clpB gene from F. tularensis subsp. tularensis strain, SCHU S4. SCHU S4 Delta clpB was less virulent for mice than LVS and a more effective vaccine against respiratory challenge with wild type SCHU S4. In the current study, we were interested to determine whether a similar mutant on the less virulent subsp. holarctica background would also outperform LVS in terms of safety and efficacy. To this end, clpB was deleted from clinical holarctica strain, FSC200. FSC200 Delta clpB had a significantly higher intranasal LD50 than LVS for BALB/c mice, but replicated to higher numbers at foci of infection after dermal inoculation. Moreover, FSC200 Delta clpB killed SCID mice more rapidly than LVS. However, dermal vaccination of BALB/c mice with the former versus the latter induced greater protection against respiratory challenge with SCHU S4. This increased efficacy was associated with enhanced production of pulmonary IL-17 after SCHU S4 challenge.	[Twine, Susan M.; Shen, Hua; Conlan, Wayne] Natl Res Council Canada, Ottawa, ON, Canada; [Golovliov, Igor; Sjostedt, Anders] Umea Univ, Dept Clin Microbiol Clin Bacteriol, Umea, Sweden	National Research Council Canada; Umea University	Conlan, W (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	wayne.conlan@nrc-cnrc.ca	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	National Research Council Canada	National Research Council Canada	This study was funded by the National Research Council Canada (http://www.nrc-cnrc.gc.ca/eng/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH H, 1961, P SOC EXP BIOL MED, V108, P732, DOI 10.3181/00379727-108-27049; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Eneslatt K, 2011, EUR J IMMUNOL, V41, P974, DOI 10.1002/eji.201040923; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Ireland PM, 2011, MICROBIOL-SGM, V157, P3172, DOI 10.1099/mic.0.052902-0; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lin JS, 2011, J IMMUNOL, V186, P1675, DOI 10.4049/jimmunol.1003303; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Nelson M, 2010, J MED MICROBIOL, V59, P1107, DOI 10.1099/jmm.0.020669-0; Nelson M, 2009, INT J EXP PATHOL, V90, P109, DOI 10.1111/j.1365-2613.2008.00631.x; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine S, 2012, VACCINE, V30, P3634, DOI 10.1016/j.vaccine.2012.03.036	36	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78671	10.1371/journal.pone.0078671	http://dx.doi.org/10.1371/journal.pone.0078671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236032	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700029
J	Jakobsdottir, G; Xu, J; Molin, G; Ahrne, S; Nyman, M				Jakobsdottir, Greta; Xu, Jie; Molin, Goran; Ahrne, Siv; Nyman, Margareta			High-Fat Diet Reduces the Formation of Butyrate, but Increases Succinate, Inflammation, Liver Fat and Cholesterol in Rats, while Dietary Fibre Counteracts These Effects	PLOS ONE			English	Article							GUT MICROBIOTA; ULCERATIVE-COLITIS; METABOLIC SYNDROME; RESISTANT STARCH; GAS-CHROMATOGRAPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; COLONIC-MUCOSA; ACID FORMATION; OBESITY	Introduction: Obesity is linked to type 2 diabetes and risk factors associated to the metabolic syndrome. Consumption of dietary fibres has been shown to have positive metabolic health effects, such as by increasing satiety, lowering blood glucose and cholesterol levels. These effects may be associated with short-chain fatty acids (SCFAs), particularly propionic and butyric acids, formed by microbial degradation of dietary fibres in colon, and by their capacity to reduce low-grade inflammation. Objective: To investigate whether dietary fibres, giving rise to different SCFAs, would affect metabolic risk markers in low-fat and high-fat diets using a model with conventional rats for 2, 4 and 6 weeks. Material and Methods: Conventional rats were administered low-fat or high-fat diets, for 2, 4 or 6 weeks, supplemented with fermentable dietary fibres, giving rise to different SCFA patterns (pectin - acetic acid; guar gum - propionic acid; or a mixture - butyric acid). At the end of each experimental period, liver fat, cholesterol and triglycerides, serum and caecal SCFAs, plasma cholesterol, and inflammatory cytokines were analysed. The caecal microbiota was analysed after 6 weeks. Results and Discussion: Fermentable dietary fibre decreased weight gain, liver fat, cholesterol and triglyceride content, and changed the formation of SCFAs. The high-fat diet primarily reduced formation of SCFAs but, after a longer experimental period, the formation of propionic and acetic acids recovered. The concentration of succinic acid in the rats increased in high-fat diets with time, indicating harmful effect of high-fat consumption. The dietary fibre partly counteracted these harmful effects and reduced inflammation. Furthermore, the number of Bacteroides was higher with guar gum, while noticeably that of Akkermansia was highest with the fibre-free diet.	[Jakobsdottir, Greta; Xu, Jie; Molin, Goran; Ahrne, Siv; Nyman, Margareta] Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden	Lund University	Jakobsdottir, G (corresponding author), Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden.	Greta.Jakobsdottir@appliednutrition.lth.se	Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364; Xu, Jie/0000-0002-9707-502X; Jakobsdottir, Greta/0000-0002-0109-6871	Antidiabetic Food Centre; VINNOVA VINN Excellence Center at Lund University; Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien	Antidiabetic Food Centre; VINNOVA VINN Excellence Center at Lund University; Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien	This study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (http://www.ffsc.lu.se/afc), and Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Becker W, 1999, KOSTVANOR NARINGSINT; Berggren A, 1996, THESIS LUND U LUND; BERGGREN AM, 1995, EUR J CLIN NUTR, V49, pS233; Berggren AM, 1996, BRIT J NUTR, V76, P287, DOI 10.1079/BJN19960032; BJORCK I, 1987, J CEREAL SCI, V6, P159; Branning C, 2009, BR J NUTR, V101, P1; BREUER RI, 1991, DIGEST DIS SCI, V36, P185, DOI 10.1007/BF01300754; Bugianesi E, 2004, DIGEST LIVER DIS, V36, P165, DOI 10.1016/j.dld.2003.12.008; Casas JA, 2000, J SCI FOOD AGR, V80, P1722, DOI 10.1002/1097-0010(20000915)80:12<1722::AID-JSFA708>3.3.CO;2-O; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dandona P, 2006, DRUG DEVELOP RES, V67, P619, DOI 10.1002/ddr.20137; Danisco, 2010, 201011 DAN; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Everard A., 2013, P NATL ACAD SCI US; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; HEATON KW, 1973, LANCET, V2, P1418; Henningsson AM, 2003, BRIT J NUTR, V89, P319, DOI 10.1079/BJN2003782; Henningsson AM, 2002, J NUTR, V132, P3098, DOI 10.1093/jn/131.10.3098; Immerstrand T, 2010, BRIT J NUTR, V104, P364, DOI 10.1017/S0007114510000553; Inagaki A, 2007, J NUTR SCI VITAMINOL, V53, P377, DOI 10.3177/jnsv.53.377; Jakobsdottir G., 2013, BEETLES RUSSIA W EUR, V26, P1; Johansson EV, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-46; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Krebs C. J., 2014, ECOLOGICAL METHODOLO; KRITCHEVSKY D, 1974, J NUTR, V104, P458, DOI 10.1093/jn/104.4.458; Langen MACLV, 2009, INFLAMM BOWEL DIS, V15, P454, DOI 10.1002/ibd.20737; LEVRAT MA, 1994, J NUTR, V124, P531, DOI 10.1093/jn/124.4.531; Luhrs H, 2002, SCAND J GASTROENTERO, V37, P458, DOI 10.1080/003655202317316105; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Mahady SE, 2012, CLIN LIVER DIS, V16, P631, DOI 10.1016/j.cld.2012.05.003; Marcil V, 2003, J NUTR, V133, P2180, DOI 10.1093/jn/133.7.2180; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Moshfegh A, 2005, WHAT WE EAT AM NHANE; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WILSON JN, 1984, ARTERIOSCLEROSIS, V4, P147, DOI 10.1161/01.ATV.4.2.147; World Health Organization, OB OV; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Zhao GH, 2007, J CHROMATOGR B, V846, P202, DOI 10.1016/j.jchromb.2006.09.027; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zoran DL, 1997, J NUTR, V127, P2217, DOI 10.1093/jn/127.11.2217	66	201	211	13	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80476	10.1371/journal.pone.0080476	http://dx.doi.org/10.1371/journal.pone.0080476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236183	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700184
J	Kuo, MC; Lin, SH; Lin, CH; Mao, IC; Chang, SJ; Hsieh, MC				Kuo, Ming-Chun; Lin, Sheng-Hao; Lin, Ching-Hsiung; Mao, I-Chieh; Chang, Shun-Jen; Hsieh, Ming-Chia			Type 2 Diabetes : An Independent Risk Factor for Tuberculosis: A Nationwide Population-Based Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMPACT	Objective: Tuberculosis continues to be a major global health problem. We wanted to investigate whether Type 2 diabetes was a risk factor for tuberculosis in an Asian population. Methods: From Taiwan's National Health Insurance Research Database, we collected data from 31,237 female patients with type 2 diabetes and 92,642 female controls and 32,493 male patients with type 2 diabetes and 96,977 male controls. Cox proportional hazard regression was performed to evaluate independent risk factors for tuberculosis in all patients and to identify risk factors in patients with type 2 diabetes. Results: During the study period, both female (standardized incidence ratio (SIR): 1.40, p<0.01) and male (SIR: 1.48, p<0.01) patients with type 2 diabetes were found to have a significantly higher rate of incident tuberculosis than the control group. Type 2 diabetes (HR: 1.31, 1.23-1.39, p<0.001) was significantly associated with tuberculosis after adjusting sex, age, bronchiectasis, asthma and chronic obstructive lung disease. Conclusions: Patients with type 2 diabetes have a higher risk of tuberculosis compared to control subjects after adjusting for confounding factors. The current diabetes epidemic may lead to a resurgence of tuberculosis in endemic regions. Therefore, preventive measures, including addressing the possibility that type 2 diabetes increase the individual's susceptibility for incident TB, should be taken to further reduce the incidence of tuberculosis.	[Kuo, Ming-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Kuo, Ming-Chun] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Sheng-Hao; Lin, Ching-Hsiung] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Lin, Sheng-Hao] Chang Jung Christian Univ, Coll Hlth Sci, Dept Resp Care, Tainan, Taiwan; [Lin, Ching-Hsiung] Chung Shan Med Univ, Taiwan Sch Med, Taichung, Taiwan; [Lin, Ching-Hsiung] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; [Mao, I-Chieh; Hsieh, Ming-Chia] Changhua Christian Hosp, Dept Internal Med, Div Endocrinol & Metab, Changhua, Taiwan; [Chang, Shun-Jen] Natl Univ Kaohsiung, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan; [Hsieh, Ming-Chia] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; Chang Jung Christian University; Chung Shan Medical University; National Chung Hsing University; Changhua Christian Hospital; National University Kaohsiung; China Medical University Taiwan	Chang, SJ (corresponding author), Natl Univ Kaohsiung, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan.	changsj1104@gmail.com; mingchiah@gmail.com		Lin, Ching-Hsiung/0000-0001-9407-8578				Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bashar M, 2001, CHEST, V120, P1514, DOI 10.1378/chest.120.5.1514; Department of Health, 2004, STOPP TUB ENGL ACT P; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Greenland S, 2008, MODERN EPIDEMIOLOGY, P252; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; John GT, 2001, KIDNEY INT, V60, P1148, DOI 10.1046/j.1523-1755.2001.0600031148.x; Kant L, 2003, IND J TUB, V50, P183; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P534, DOI 10.1016/0962-8479(95)90530-8; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lee MC, 2013, PHARMACOEPIDEMIOL DR; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; WHO, 2012, GLOB TUB CUL REP 201; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237	31	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78924	10.1371/journal.pone.0078924	http://dx.doi.org/10.1371/journal.pone.0078924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236069	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700066
J	Le Tallec, T; Perret, M; Thery, M				Le Tallec, Thomas; Perret, Martine; Thery, Marc			Light Pollution Modifies the Expression of Daily Rhythms and Behavior Patterns in a Nocturnal Primate	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; MICROCEBUS-MURINUS; DEER MICE; DIM LIGHT; FOOD; ILLUMINATION; EVOLUTION; RESPONSES; EXPOSURE; TIME	Among anthropogenic pressures, light pollution altering light/dark cycles and changing the nocturnal component of the environment constitutes a threat for biodiversity. Light pollution is widely spread across the world and continuously growing. However, despite the efforts realized to describe and understand the effects of artificial lighting on fauna, few studies have documented its consequences on biological rhythms, behavioral and physiological functions in nocturnal mammals. To determine the impacts of light pollution on nocturnal mammals an experimental study was conducted on a nocturnal primate, the grey mouse lemur Microcebus murinus. Male mouse lemurs (N = 8) were exposed 14 nights to moonlight treatment and then exposed 14 nights to light pollution treatment. For both treatments, chronobiological parameters related to locomotor activity and core temperature were recorded using telemetric transmitters. In addition, at the end of each treatment, the 14th night, nocturnal and feeding behaviors were explored using an infrared camera. Finally, throughout the study, body mass and daily caloric food intake were recorded. For the first time in a nocturnal primate, light pollution was demonstrated to modify daily rhythms of locomotor activity and core temperature especially through phase delays and increases in core temperature. Moreover, nocturnal activity and feeding behaviors patterns were modified negatively. This study suggests that light pollution induces daily desynchronization of biological rhythms and could lead to seasonal desynchronization with potential deleterious consequences for animals in terms of adaptation and anticipation of environmental changes.	[Le Tallec, Thomas; Perret, Martine; Thery, Marc] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Thery, M (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	thery@mnhn.fr			Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche	Thomas Le Tallec was funded by a PhD grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bedrosian TA, 2011, BIOL LETTERS, V7, P468, DOI 10.1098/rsbl.2010.1108; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier Paul, 2006, P19; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; Boldogh S, 2007, ACTA CHIROPTEROL, V9, P527, DOI 10.3161/1733-5329(2007)9[527:TEOTIO]2.0.CO;2; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; BRILLHART DB, 1991, J MAMMAL, V72, P764, DOI 10.2307/1381840; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cinzano P., 2000, Memorie della Societa Astronomica Italiana, V71, P159; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P, 2001, EARTH MOON PLANETS, V85-6, P517; DAAN S, 1975, OECOLOGIA, V18, P269, DOI 10.1007/BF00345851; Dacke M, 2011, PHILOS T R SOC B, V366, P697, DOI 10.1098/rstb.2010.0191; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Eisenbeis Gerhard, 2006, P281; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Evans JA, 2007, J BIOL RHYTHM, V22, P356, DOI 10.1177/0748730407301988; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Frank Kenneth D., 2006, P305; Gauthreaux Sidney A. Jr., 2006, P67; Genin F, 2003, COMP BIOCHEM PHYS B, V136, P71, DOI 10.1016/S1096-4959(03)00172-6; Giroud S, 2008, AM J PHYSIOL-REG I, V294, pR1958, DOI 10.1152/ajpregu.00794.2007; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haim A, 2005, CHRONOBIOL INT, V22, P59, DOI 10.1081/CBI-200038144; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; Kronfeld-Schor Noga, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Kumlien H. F., 1888, AUK, V5, P325; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Longcore T., 2006, ECOLOGICAL CONSEQUEN, P413; Montevecchi William A., 2006, P94; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Perret M, 2001, AM J PHYSIOL-REG I, V281, pR1925, DOI 10.1152/ajpregu.2001.281.6.R1925; Perret M, 2000, PRIMATOLOGIE, P45; Polak T, 2011, J ZOOL, V285, P21, DOI 10.1111/j.1469-7998.2011.00808.x; Rich C., 2006, ECOLOGICAL CONSEQUEN, P1; Rocher P, 2010, EPHEMERIDES 2012 PAR, P1; Rotics S, 2011, J MAMMAL, V92, P159, DOI 10.1644/10-MAMM-A-112.1; Rotics S, 2011, CHRONOBIOL INT, V28, P70, DOI 10.3109/07420528.2010.525674; Salmon Michael, 2006, P141; Shuboni D, 2010, NEUROSCIENCE, V170, P1172, DOI 10.1016/j.neuroscience.2010.08.009; Smith F.G., 1979, IAU T A, VXVIIA, P218; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Terrien J, 2009, CHRONOBIOL INT, V26, P838, DOI 10.1080/07420520903044281; VASQUEZ RA, 1994, BEHAV ECOL SOCIOBIOL, V34, P375, DOI 10.1007/BF00197008; Zubidat AE, 2007, CHRONOBIOL INT, V24, P269, DOI 10.1080/07420520701284675; Zuur Alain F., 2009, P1	59	43	43	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79250	10.1371/journal.pone.0079250	http://dx.doi.org/10.1371/journal.pone.0079250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236115	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700114
J	Saghizadeh, M; Winkler, MA; Kramerov, AA; Hemmati, DM; Ghiam, CA; Dimitrijevich, SD; Sareen, D; Ornelas, L; Ghiasi, H; Brunken, WJ; Maguen, E; Rabinowitz, YS; Svendsen, CN; Jirsova, K; Ljubimov, AV				Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Hemmati, David M.; Ghiam, Chantelle A.; Dimitrijevich, Slobodan D.; Sareen, Dhruv; Ornelas, Loren; Ghiasi, Homayon; Brunken, William J.; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Jirsova, Katerina; Ljubimov, Alexander V.			A Simple Alkaline Method for Decellularizing Human Amniotic Membrane for Cell Culture	PLOS ONE			English	Article							EX-VIVO EXPANSION; LIMBAL EPITHELIAL TRANSPLANTATION; HUMAN DIABETIC CORNEAS; BASEMENT-MEMBRANE; STEM-CELLS; IV COLLAGEN; INTACT; DIFFERENTIATION; PROLIFERATION; COMPONENTS	Human amniotic membrane is a standard substratum used to culture limbal epithelial stem cells for transplantation to patients with limbal stem cell deficiency. Various methods were developed to decellularize amniotic membrane, because denuded membrane is poorly immunogenic and better supports repopulation by dissociated limbal epithelial cells. Amniotic membrane denuding usually involves treatment with EDTA and/or proteolytic enzymes; in many cases additional mechanical scraping is required. Although ensuring limbal cell proliferation, these methods are not standardized, require relatively long treatment times and can result in membrane damage. We propose to use 0.5 M NaOH to reliably remove amniotic cells from the membrane. This method was used before to lyse cells for DNA isolation and radioactivity counting. Gently rubbing a cotton swab soaked in NaOH over the epithelial side of amniotic membrane leads to nearly complete and easy removal of adherent cells in less than a minute. The denuded membrane is subsequently washed in a neutral buffer. Cell removal was more thorough and uniform than with EDTA, or EDTA plus mechanical scraping with an electric toothbrush, or n-heptanol plus EDTA treatment. NaOH-denuded amniotic membrane did not show any perforations compared with mechanical or thermolysin denuding, and showed excellent preservation of immunoreactivity for major basement membrane components including laminin alpha 2, gamma 1-gamma 3 chains, alpha 1/alpha 2 and alpha 6 type IV collagen chains, fibronectin, nidogen-2, and perlecan. Sodium hydroxide treatment was efficient with fresh or cryopreserved (10% dimethyl sulfoxide or 50% glycerol) amniotic membrane. The latter method is a common way of membrane storage for subsequent grafting in the European Union. NaOH-denuded amniotic membrane supported growth of human limbal epithelial cells, immortalized corneal epithelial cells, and induced pluripotent stem cells. This simple, fast and reliable method can be used to standardize decellularized amniotic membrane preparations for expansion of limbal stem cells in vitro before transplantation to patients.	[Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Hemmati, David M.; Ghiam, Chantelle A.; Rabinowitz, Yaron S.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Eye Program, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Sareen, Dhruv; Ornelas, Loren; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Ghiasi, Homayon; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Biomed Sci, Dept Surg, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Ghiasi, Homayon; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Hemmati, David M.; Ghiam, Chantelle A.; Svendsen, Clive N.; Ljubimov, Alexander V.] Univ Calif Los Angeles, Los Angeles, CA USA; [Dimitrijevich, Slobodan D.] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, New York, NY USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, New York, NY USA; [Maguen, Ezra] Amer Eye Inst, Los Angeles, CA USA; [Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic; [Jirsova, Katerina] Charles Univ Prague, Gen Teaching Hosp, Prague, Czech Republic	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of North Texas System; University of North Texas Health Science Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Charles University Prague; Charles University Prague; General University Hospital Prague	Ljubimov, AV (corresponding author), Cedars Sinai Med Ctr, Eye Program, Los Angeles, CA 90048 USA.	ljubimov@cshs.org	Ljubimov, Alexander V/E-5883-2013; Jirsova, Katerina/B-8301-2012; Ljubimov, Alexander/CAE-9130-2022	Jirsova, Katerina/0000-0002-4625-6701; Brunken, William J/0000-0001-7330-1814; Ljubimov, Alexander/0000-0003-2398-5319	NIH [EY13431, EY023429]; CTSI grant [UL 1RR033176]; Cedars-Sinai Regenerative Medicine Institute grants; Charles University, Prague [PRVOUK-P24/LF1/3]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023429, R01EY013431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI grant; Cedars-Sinai Regenerative Medicine Institute grants; Charles University, Prague; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY13431, EY023429, CTSI grant UL 1RR033176, Cedars-Sinai Regenerative Medicine Institute grants, and PRVOUK-P24/LF1/3 Institutional support program of the Charles University, Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, DRUG DISCOV TODAY, V15, P306, DOI 10.1016/j.drudis.2010.02.001; ALLEN TD, 1988, SCANNING MICROSCOPY, V2, P2067; Baharvand H, 2007, MOL VIS, V13, P1711; Baradaran-rafii A., 2007, IRAN J OPHTHALMIC RE, V2, P58; Baradaran-Rafii A, 2011, OCUL SURF, V9, P163, DOI 10.1016/S1542-0124(11)70026-X; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; Biber Joseph M, 2010, Int Ophthalmol Clin, V50, P25, DOI 10.1097/IIO.0b013e3181e20d64; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064; COUCHMAN JR, 1989, MATRIX, V9, P311, DOI 10.1016/S0934-8832(89)80007-1; DAVIS GE, 1987, SCIENCE, V236, P1106, DOI 10.1126/science.3576223; Melo Gustavo Barreto de, 2007, Arq. Bras. Oftalmol., V70, P407, DOI 10.1590/S0004-27492007000300005; Dietrich-Ntoukas T, 2012, CORNEA, V31, P564, DOI 10.1097/ICO.0b013e3182254b78; Dimitrijevich SD, 2008, INVEST OPHTHALMOL VI, V49; Fatima A, 2006, J POSTGRAD MED, V52, P257; Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013; Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P87; Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Grueterich M, 2003, INVEST OPHTH VIS SCI, V44, P4230, DOI 10.1167/iovs.02-0943; HENDRIX MJC, 1985, CLIN EXP METASTAS, V3, P221, DOI 10.1007/BF01585078; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; INGBER DE, 1986, AM J PATHOL, V122, P129; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Kim J C, 1995, Korean J Ophthalmol, V9, P32; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012; Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539; Kumar PRV, 2009, MUTAT RES-GEN TOX EN, V678, P65, DOI 10.1016/j.mrgentox.2009.06.007; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63; LJUBIMOV AV, 1985, EXP CELL RES, V156, P311, DOI 10.1016/0014-4827(85)90540-3; LJUBIMOV AV, 1995, LAB INVEST, V72, P461; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Martin R, 2007, CLIN EXP OPTOM, V90, P26, DOI 10.1111/j.1444-0938.2006.00083.x; Mason SL, 2011, REGEN MED, V6, P767, DOI [10.2217/rme.11.94, 10.2217/RME.11.94]; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034; Saghizadeh M, 2011, MOL VIS, V17, P2177; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020; Schulze U, 2012, HISTOCHEM CELL BIOL, V138, P243, DOI 10.1007/s00418-012-0943-2; Sejpal K, 2013, JAMA OPHTHALMOL, V131, P731, DOI 10.1001/jamaophthalmol.2013.2308; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039; Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048; SHUKLA I M, 1962, J All India Ophthalmol Soc, V10, P55; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022; Tseng SCG, 2010, CURR MOL MED, V10, P841; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Xiang HY, 2005, AM J IND MED, V48, P57, DOI 10.1002/ajim.20179; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zakaria N, 2010, TISSUE ENG PART C-ME, V16, P921, DOI [10.1089/ten.tec.2009.0634, 10.1089/ten.TEC.2009.0634]; Zhang T, 2013, INVEST OPHTH VIS SCI, V54, P3072, DOI 10.1167/iovs.12-10805	63	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79632	10.1371/journal.pone.0079632	http://dx.doi.org/10.1371/journal.pone.0079632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236148	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700147
J	Chapple, DG; Ritchie, PA				Chapple, David G.; Ritchie, Peter A.			A Retrospective Approach to Testing the DNA Barcoding Method	PLOS ONE			English	Article							SCINCIDAE SPECIES COMPLEX; PARASITOID FLIES DIPTERA; MITOCHONDRIAL-DNA; COMPARATIVE PHYLOGEOGRAPHY; IDENTIFYING SPIDERS; TAXONOMIC REVISION; SKINK; OLIGOSOMA; REPTILIA; GENUS	A decade ago, DNA barcoding was proposed as a standardised method for identifying existing species and speeding the discovery of new species. Yet, despite its numerous successes across a range of taxa, its frequent failures have brought into question its accuracy as a short-cut taxonomic method. We use a retrospective approach, applying the method to the classification of New Zealand skinks as it stood in 1977 (primarily based upon morphological characters), and compare it to the current taxonomy reached using both morphological and molecular approaches. For the 1977 dataset, DNA barcoding had moderate-high success in identifying specimens (78-98%), and correctly flagging specimens that have since been confirmed as distinct taxa (77-100%). But most matching methods failed to detect the species complexes that were present in 1977. For the current dataset, there was moderate-high success in identifying specimens (53-99%). For both datasets, the capacity to discover new species was dependent on the methodological approach used. Species delimitation in New Zealand skinks was hindered by the absence of either a local or global barcoding gap, a result of recent speciation events and hybridisation. Whilst DNA barcoding is potentially useful for specimen identification and species discovery in New Zealand skinks, its error rate could hinder the progress of documenting biodiversity in this group. We suggest that integrated taxonomic approaches are more effective at discovering and describing biodiversity.	[Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Chapple, David G.; Ritchie, Peter A.] Victoria Univ Wellington, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Wellington, New Zealand	Monash University; Victoria University Wellington	Chapple, DG (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	David.Chapple@monash.edu	; Chapple, David/B-9073-2008	Ritchie, Peter/0000-0002-8351-7931; Chapple, David/0000-0002-7720-6280	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington	The study was funded by the Allan Wilson Centre for Molecular Ecology and Evolution, and a University Research Fund grant from Victoria University of Wellington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bell TP, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1882.1.3; Berry O, 2005, BIOL CONSERV, V123, P197, DOI 10.1016/j.biocon.2004.11.007; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Chapple DG, 2008, BIOL J LINN SOC, V95, P388, DOI 10.1111/j.1095-8312.2008.01062.x; Chapple DG, 2008, J HERPETOL, V42, P437, DOI 10.1670/07-110.1; Chapple DG, 2008, NEW ZEAL J ZOOL, V35, P129, DOI 10.1080/03014220809510110; Chapple DG, 2007, NEW ZEAL J ZOOL, V34, P347, DOI 10.1080/03014220709510094; Chapple DG, 2011, ZOOTAXA, P1; Chapple DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034599; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; Chapple DG, 2009, NZ J ZOOLOGY, V36, P59, DOI [10.1080/03014220909510140, DOI 10.1080/03014220909510140]; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Collins RA, 2013, MOL ECOL RESOUR, DOI [10.1111/1755-0998.12046, DOI 10.1111/1755-0998.12046.PUBMED:23280099]; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Daugherty C.M., 1990, Herpetological Monographs, P61; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2011, ENEIOUS V5 4; Dubey S, 2012, J EVOLUTION BIOL, V25, P220, DOI 10.1111/j.1420-9101.2011.02417.x; Dubey S, 2011, BIOL LETTERS, V7, P96, DOI 10.1098/rsbl.2010.0557; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Greaves SNJ, 2008, J BIOGEOGR, V35, P853, DOI 10.1111/j.1365-2699.2007.01848.x; Greaves SNJ, 2007, MOL PHYLOGENET EVOL, V45, P729, DOI 10.1016/j.ympev.2007.06.008; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARDY GS, 1977, NEW ZEAL J ZOOL, V4, P221, DOI 10.1080/03014223.1977.9517956; Hare KM, 2008, MOL PHYLOGENET EVOL, V46, P303, DOI 10.1016/j.ympev.2007.08.012; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hitchmough RA, 2010, NEW ZEAL J ZOOL, V37, P203, DOI 10.1080/03014223.2010.496487; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liggins L, 2008, MOL ECOL, V17, P3668, DOI 10.1111/j.1365-294X.2008.03864.x; Liggins L, 2008, MOL ECOL, V17, P3290, DOI 10.1111/j.1365-294X.2008.03832.x; Meier R, 2004, CLADISTICS, V20, P600; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; O'Neill SB, 2008, MOL PHYLOGENET EVOL, V48, P1168, DOI 10.1016/j.ympev.2008.05.008; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; PATTERSON GB, 1990, J ROY SOC NEW ZEAL, V20, P65, DOI 10.1080/03036758.1990.10426733; Patterson GB, 1997, J ROY SOC NEW ZEAL, V27, P439, DOI 10.1080/03014223.1997.9517547; Patterson GB, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2271.1.4; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rodman JE, 2003, SYST BIOL, V52, P428, DOI 10.1080/10635150390197055; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sambrook J., 1989, MOL CLONING LAB MANU; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SEBERG O, 2004, SYSTEMATIST, V23, P2; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vos ME, 1988, THESIS VICTORIA U WE; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	93	18	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77882	10.1371/journal.pone.0077882	http://dx.doi.org/10.1371/journal.pone.0077882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244283	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600011
J	Lee, S; Ashizawa, AT; Kim, KS; Falk, DJ; Notterpek, L				Lee, Sooyeon; Ashizawa, Ana Tari; Kim, Kwang Sik; Falk, Darin J.; Notterpek, Lucia			Liposomes to Target Peripheral Neurons and Schwann Cells	PLOS ONE			English	Article							CAVEOLAE-MEDIATED ENDOCYTOSIS; CLATHRIN; TRANSPORT; PROTEIN; MICE	While a wealth of literature for tissue-specific liposomes is emerging, optimal formulations to target the cells of the peripheral nervous system (PNS) are lacking. In this study, we asked whether a novel formulation of phospholipid-based liposomes could be optimized for preferential uptake by microvascular endothelia, peripheral neurons and Schwann cells. Here, we report a unique formulation consisting of a phospholipid, a polymer surfactant and cholesterol that result in enhanced uptake by targeted cells. Using fluorescently labeled liposomes, we followed particle internalization and trafficking through a distinct route from dextran and escape from degradative compartments, such as lysosomes. In cultures of non-myelinating Schwann cells, liposomes associate with the lipid raft marker Cholera toxin, and their internalization is inhibited by disruption of lipid rafts or actin polymerization. In contrast, pharmacological inhibition of clathrin-mediated endocytosis does not significantly impact liposome entry. To evaluate the efficacy of liposome targeting in tissues, we utilized myelinating explant cultures of dorsal root ganglia and isolated diaphragm preparations, both of which contain peripheral neurons and myelinating Schwann cells. In these models, we detected preferential liposome uptake into neurons and glial cells in comparison to surrounding muscle tissue. Furthermore, in vivo liposome administration by intramuscular or intravenous injection confirmed that the particles were delivered to myelinated peripheral nerves. Within the CNS, we detected the liposomes in choroid epithelium, but not in myelinated white matter regions or in brain parenchyma. The described nanoparticles represent a novel neurophilic delivery vehicle for targeting small therapeutic compounds, biological molecules, or imaging reagents into peripheral neurons and Schwann cells, and provide a major advancement toward developing effective therapies for peripheral neuropathies.	[Lee, Sooyeon; Ashizawa, Ana Tari; Notterpek, Lucia] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Notterpek, Lucia] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Kim, Kwang Sik] Johns Hopkins Childrens Ctr, Eudowood Div Pediat Infect Dis, Baltimore, MD USA; [Falk, Darin J.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of Florida	Ashizawa, AT (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.	anamtari@ufl.edu; notterpek@ufl.edu			University of Florida Research Opportunity Seed Fund; NIH [NS041012]; Trigeminal Neuralgia Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041012] Funding Source: NIH RePORTER	University of Florida Research Opportunity Seed Fund(University of Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trigeminal Neuralgia Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by University of Florida Research Opportunity Seed Fund, NIH grant NS041012 and the Trigeminal Neuralgia Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chekhonin VP, 2008, B EXP BIOL MED+, V146, P451, DOI 10.1007/s10517-009-0301-0; Chen G, 2012, GLIA, V60, P295, DOI 10.1002/glia.21263; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Frank PG, 2009, CELL TISSUE RES, V335, P41, DOI 10.1007/s00441-008-0659-8; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; Gutierrez-Puente Y, 2003, LEUKEMIA LYMPHOMA, V44, P1979, DOI 10.1080/1042819031000099733; Harris JR, 2010, CHOLRESTEROL MYELIN, P489; Hirling H, 2009, NEUROSCIENCE, V158, P36, DOI 10.1016/j.neuroscience.2008.02.057; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Mikol DD, 1999, GLIA, V27, P39; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rejman J, 2006, J LIPOSOME RES, V16, P237, DOI 10.1080/08982100600848819; Sahay G, 2010, BIOMATERIALS, V31, P1757, DOI 10.1016/j.biomaterials.2009.11.020; Saheki Y, 2012, COLD SPRING HARBOR P, V4; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Tahara K, 2011, EUR J PHARM BIOPHARM, V77, P84, DOI 10.1016/j.ejpb.2010.11.002; Tari AM, 1999, ONCOGENE, V18, P1325, DOI 10.1038/sj.onc.1202422; Tari AM, 2007, INT J ONCOL, V31, P1243; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015	29	18	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78724	10.1371/journal.pone.0078724	http://dx.doi.org/10.1371/journal.pone.0078724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244347	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600054
J	Steiner, AM; Bulaj, G; Puillandre, N				Steiner, Andrew M.; Bulaj, Grzegorz; Puillandre, Nicolas			On the Importance of Oxidative Folding in the Evolution of Conotoxins: Cysteine Codon Preservation through Gene Duplication and Adaptation	PLOS ONE			English	Article							CONE SNAILS; DISULFIDE BRIDGES; IN-VITRO; SUPERFAMILY CONOTOXINS; ENDOPLASMIC-RETICULUM; OMEGA-CONOTOXIN; RAPID EVOLUTION; VENOM PEPTIDES; RICH PEPTIDES; DIVERSIFICATION	Conotoxin genes are among the most rapidly evolving genes currently known; however, despite the well-established hypervariability of the intercysteine loops, the cysteines demonstrate significant conservation, with a site-specific codon bias for each cysteine in a family of conotoxins. Herein we present a novel rationale behind the codon-level conservation of the cysteines that comprise the disulfide scaffold. We analyze cysteine codon conservation using an internal reference and phylogenetic tools; our results suggest that the established codon conservation can be explained as the result of selective pressures linked to the production efficiency and folding of conotoxins, driving the conservation of cysteine at the amino-acid level. The preservation of cysteine has resulted in maintenance of the ancestral codon in most of the daughter lineages, despite the hypervariability of adjacent residues. We propose that the selective pressures acting on the venom components of cone snails involve an interplay of biosynthetic efficiency, activity at the target receptor and the importance of that activity to effective prey immobilization. Functional redundancy in the venom can thus serve as a buffer for the energy expenditure of venom production.	[Steiner, Andrew M.; Bulaj, Grzegorz] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Puillandre, Nicolas] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France	Utah System of Higher Education; University of Utah; Museum National d'Histoire Naturelle (MNHN)	Steiner, AM (corresponding author), Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA.	steiner.andrew@utah.edu			NIH Program Project [GM 48677]; Johnson & Johnson Pharmaceutical Research and Development Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIH Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson Pharmaceutical Research and Development Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Program Project Grant GM 48677. G.B. acknowledges support from the Johnson & Johnson Pharmaceutical Research and Development Funding. We confirm that neither funding agency had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chang D, 2012, MOL BIOL EVOL, V29, P2019, DOI 10.1093/molbev/mss068; Chang SG, 2003, MOL CELLS, V16, P323; Chun JBS, 2012, TOXICON, V60, P83, DOI 10.1016/j.toxicon.2012.03.019; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Conticello SG, 2000, TRENDS GENET, V16, P57, DOI 10.1016/S0168-9525(99)01956-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Duda TF, 2008, MOL ECOL, V17, P3018, DOI 10.1111/j.1365-294X.2008.03804.x; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gowd KH, 2012, BIOPOLYMERS, V98, P212, DOI 10.1002/bip.22047; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Maddison WP, 2017, MESQUITE MODULAR SYS; Mirazimi A, 2000, J VIROL, V74, P8048, DOI 10.1128/JVI.74.17.8048-8052.2000; MYERS RA, 1993, CHEM REV, V93, P1923, DOI 10.1021/cr00021a013; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; OHNO S, 1970, EVOLUTION GENE DUPLI, P59; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Price-Carter M, 1998, BIOCHEMISTRY-US, V37, P9851, DOI 10.1021/bi9803978; PriceCarter M, 1996, BIOCHEMISTRY-US, V35, P15537, DOI 10.1021/bi961574c; Puillandre N, 2010, J MOL EVOL, V70, P190, DOI 10.1007/s00239-010-9321-7; Quinton L, 2009, J PROTEOMICS, V72, P219, DOI 10.1016/j.jprot.2009.01.021; Safavi-Hemami H, 2012, J BIOL CHEM, V287, P34288, DOI 10.1074/jbc.M112.366781; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Schoenfeld RA, 1999, THESIS U UTAH SALT L; Steiner AM, 2011, J PEPT SCI, V17, P1, DOI 10.1002/psc.1283; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Wang Q, 2008, TOXICON, V51, P813, DOI 10.1016/j.toxicon.2007.12.007; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yuan DD, 2007, TOXICON, V49, P1135, DOI 10.1016/j.toxicon.2007.02.011; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78456	10.1371/journal.pone.0078456	http://dx.doi.org/10.1371/journal.pone.0078456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244311	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600027
J	Yan, S; Qiu, L; Ma, K; Zhang, X; Zhao, Y; Zhang, J; Li, X; Hao, X; Li, Z				Yan, S.; Qiu, L.; Ma, K.; Zhang, X.; Zhao, Y.; Zhang, J.; Li, X.; Hao, X.; Li, Z.			FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage	ONCOGENE			English	Article						FATS; ubiquitin linkage; p53; DNA damage; Mdm2	TUMOR-SUPPRESSOR P53; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; FRAGILE SITES; DEGRADATION; EXPRESSION; CANCER; CHAINS; REVEALS; ENZYMES	Ubiquitin linkage is critical in directing the cellular fate of a ubiquitinated protein. Although K48-linked polyubiquitination of p53 leads to its degradation, whether K48-independent ubiquitin linkages are involved in p53 activation remains unknown. Here, we show that FATS acts as a p53 activator by inhibiting Mdm2 binding to p53 and stimulating non-proteolytic polyubiquitination of p53. Knockdown of FATS impairs p53 stabilization and activation in response to DNA damage. Furthermore, the NH2-terminal domain of FATS is sufficient to exhibit ubiquitin ligase (E3) activity and assemble ubiquitin polymers through K11-, K29-and K63-linkages, independently of the ubiquitin-conjugating enzyme (E2). FATS promotes p53-dependent transcription of p21, leading to robust checkpoint response. The E3 activity of FATS is required for promoting p53 stability and activation in response to DNA damage. Our findings reveal K48-linkage-independent non-linear polyubiquitination of p53 as a new barcode for p53 activation.	[Yan, S.; Qiu, L.; Ma, K.; Zhang, X.; Zhao, Y.; Zhang, J.; Li, X.; Li, Z.] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin 300060, Peoples R China; [Yan, S.; Qiu, L.; Ma, K.; Zhang, X.; Zhao, Y.; Zhang, J.; Li, X.; Hao, X.; Li, Z.] Tianjin Med Univ, Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin 300060, Peoples R China	Tianjin Medical University; Tianjin Medical University	Li, Z (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	zhengli@tijmu.edu.cn			Ministry of Science and Technology of China 973-program concept award [2009CB526407]; National Natural Science Foundation of China [81272283]; Tianjin Municipal Science and Technology Foundation [10JCZDJC18600]	Ministry of Science and Technology of China 973-program concept award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Foundation	We are grateful to Dr X Lu (The University of Texas MD Anderson Cancer Center, USA) for providing us with HA-Mdm2 plasmid. This work was supported by grants from Ministry of Science and Technology of China 973-program concept award (2009CB526407 to ZL), National Natural Science Foundation of China (81272283 to ZL), and Tianjin Municipal Science and Technology Foundation (10JCZDJC18600 to ZL).	Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jain AK, 2010, CANCER BIOL THER, V10, P665, DOI 10.4161/cbt.10.7.13445; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Li Z, 2010, ONCOGENE, V29, P2659, DOI 10.1038/onc.2010.19; LUNA RMD, 1995, NATURE, V378, P203; Ma K, 2012, INT J MOL SCI, V13, P11974, DOI 10.3390/ijms130911974; Mahmoud S, 2003, BIOCHEM BIOPH RES CO, V305, P1099, DOI 10.1016/S0006-291X(03)00905-7; Mao JH, 2005, ONCOGENE, V24, P7924, DOI 10.1038/sj.onc.1208926; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tian Y, 2012, LUNG CANCER, V76, P416, DOI 10.1016/j.lungcan.2011.11.009; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang J, 2011, CHINESE MED J-PEKING, V124, P2894, DOI 10.3760/cma.j.issn.0366-6999.2011.18.018; Zhang XF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-244	39	12	13	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5424	5433		10.1038/onc.2013.494	http://dx.doi.org/10.1038/onc.2013.494			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240685				2022-12-25	WOS:000345120700004
J	Whitaker, HC; Shiong, LL; Kay, JD; Gronberg, H; Warren, AY; Seipel, A; Wiklund, F; Thomas, B; Wiklund, P; Miller, JL; Menon, S; Ramos-Montoya, A; Vowler, SL; Massie, C; Egevad, L; Neal, DE				Whitaker, H. C.; Shiong, L. L.; Kay, J. D.; Groenberg, H.; Warren, A. Y.; Seipel, A.; Wiklund, F.; Thomas, B.; Wiklund, P.; Miller, J. L.; Menon, S.; Ramos-Montoya, A.; Vowler, S. L.; Massie, C.; Egevad, L.; Neal, D. E.			N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype	ONCOGENE			English	Article						NAALase; prostate cancer; colon cancer; prognostic; biomarker	PROSTATE-SPECIFIC ANTIGEN; FOCAL ADHESION KINASE; CARBOXYPEPTIDASE-II; CELL-MIGRATION; RADICAL PROSTATECTOMY; RECEPTOR; AGR2; IDENTIFICATION; RECURRENCE; EXPRESSION	N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 (NAALADL2) is a member of the glutamate carboxypeptidase II family, best characterized by prostate-specific membrane antigen (PSMA/NAALAD1). Using immunohistochemistry (IHC), we have shown overexpression of NAALADL2 in colon and prostate tumours when compared with benign tissue. In prostate cancer, NAALADL2 expression was associated with stage and Grade, as well as circulating mRNA levels of the NAALADL2 gene. Overexpression of NAALADL2 was shown to predict poor survival following radical prostatectomy. In contrast to PSMA/ NAALAD1, NAALADL2 was localized at the basal cell surface where it promotes adhesion to extracellular matrix proteins. Using stable knockdown and overexpression cell lines, we have demonstrated NAALADL2-dependent changes in cell migration, invasion and colony-forming potential. Expression arrays of the knockdown and overexpression cell lines have identified nine genes that co-expressed with NAALADL2, which included membrane proteins and genes known to be androgen regulated, including the prostate cancer biomarkers AGR2 and SPON2. Androgen regulation was confirmed in a number of these genes, although NAALADL2 itself was not found to be androgen regulated. NAALADL2 was also found to regulate levels of Ser133 phosphorylated C-AMP-binding protein (CREB), a master regulator of a number of cellular processes involved in cancer development and progression. In combination, these data suggest that changes in expression of NAALADL2 can impact upon a number of pro-oncogenic pathways and processes, making it a useful biomarker for both diagnosis and prognosis.	[Whitaker, H. C.; Shiong, L. L.; Kay, J. D.; Thomas, B.; Ramos-Montoya, A.; Massie, C.; Neal, D. E.] Univ Cambridge, Canc Res UK Cambridge Inst, Urooncol Res Grp, Cambridge CB2 0RE, England; [Whitaker, H. C.] Univ Cambridge, Canc Res UK Cambridge Inst, Canc Res UK Biomarker Initiat, Cambridge CB2 0RE, England; [Groenberg, H.; Wiklund, F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Warren, A. Y.; Miller, J. L.] Univ Cambridge, Canc Res UK Cambridge Inst, Dept Histopathol, Cambridge CB2 0RE, England; [Warren, A. Y.; Miller, J. L.] Univ Cambridge, Canc Res UK Cambridge Inst, ISH Core Facil, Cambridge CB2 0RE, England; [Warren, A. Y.; Miller, J. L.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Seipel, A.; Wiklund, P.; Egevad, L.] Karolinska Inst, Dept Pathol, S-10401 Stockholm, Sweden; [Menon, S.; Vowler, S. L.] Univ Cambridge, Canc Res UK Cambridge Inst, Bioinformat Core Facil, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Karolinska Institutet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Karolinska Institutet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Whitaker, HC (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Canc Res UK Biomarker Initiat, Robinson Way, Cambridge CB2 0RE, England.	Hayley.Whitaker@cruk.cam.ac.uk	Kay, Jonathan/HGE-1248-2022	Neal, David/0000-0002-6033-5086; Wiklund, Peter/0000-0001-6497-4697; Massie, Charlie/0000-0003-2314-4843	University of Cambridge, Cancer Research UK; Hutchison Whampoa Limited; National Institute of Health Research - Cambridge Biomedical Research Centre, Cambridge, UK; National Cancer Research Prostate Cancer: mechanisms of Progression and Treatment (PROMPT) collaborative [G0500966/75466]; Prostate Cancer UK; National Medical Research Council, Singapore; MRC [G0900871] Funding Source: UKRI; Cancer Research UK [22310] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; Prostate Cancer UK [G2012/50] Funding Source: researchfish	University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Hutchison Whampoa Limited; National Institute of Health Research - Cambridge Biomedical Research Centre, Cambridge, UK; National Cancer Research Prostate Cancer: mechanisms of Progression and Treatment (PROMPT) collaborative; Prostate Cancer UK; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Prostate Cancer UK	We would like to acknowledge the support of The University of Cambridge, Cancer Research UK, National Medical Research Council, Singapore and Hutchison Whampoa Limited; the National Institute of Health Research, which funds the Cambridge Biomedical Research Centre, Cambridge, UK; the National Cancer Research Prostate Cancer: mechanisms of Progression and Treatment (PROMPT) collaborative (grant code G0500966/75466), which has funded tissue collections in Cambridge. We would like to thank Prostate Cancer UK for funding a proportion of this work. We are very grateful to the Cancer Research UK Cambridge Institute Genomics Core Facility, Histopathology and ISH Facility, and Bioinformatics and Statistics Core Facility for their assistance with the work in this manuscript. We would also like to thank Erik Sahai (Cancer Research UK London Research Institute) and Ian Mills (Centre for Molecular Medicine Norway) for their helpful discussions in preparing this manuscript.	[Anonymous], 2010, CANC STAT REG; Augustin H, 2013, PROSTATE, V73, P203, DOI 10.1002/pros.22558; Barinka C, 2004, EUR J BIOCHEM, V271, P2782, DOI 10.1111/j.1432-1033.2004.04209.x; Barinka C, 2004, PROTEIN SCI, V13, P1627, DOI 10.1110/ps.04622104; Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Botchorishvili G, 2009, CURR OPIN UROL, V19, P221, DOI 10.1097/MOU.0b013e32832a2d10; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Cao KY, 2007, PROSTATE, V67, P1791, DOI 10.1002/pros.20664; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; D'Amico AV, 1999, J CLIN ONCOL, V17, P168, DOI 10.1200/JCO.1999.17.1.168; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Frigerio B, 2013, EUR J CANCER; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; Ho ME, 2013, MODERN PATHOL, V26, P849, DOI 10.1038/modpathol.2012.238; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Kani K, 2013, PROSTATE, V73, P306, DOI 10.1002/pros.22569; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Lee SF, 2011, J BIOL CHEM, V286, P27447, DOI 10.1074/jbc.M111.243154; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liu TC, 2012, BIOORG MED CHEM LETT, V22, P3931, DOI 10.1016/j.bmcl.2012.04.110; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Osborne JR, 2012, UROL ONCOL, V31, P144; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445; Powell SM, 2006, BIOCHEM SOC T, V34, P1124, DOI 10.1042/BST0341124; Qian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037225; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Silver DA, 1997, CLIN CANCER RES, V3, P81; Smyth G, 2005, LIMMA LINEAR MODELS; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Tonkin ET, 2004, HUM GENET, V115, P139, DOI 10.1007/s00439-004-1134-6; Tradonsky A, 2012, AM J CLIN PATHOL, V137, P918, DOI 10.1309/AJCPF3QWIG8FWXIH; Trojan L, 2005, ANTICANCER RES, V25, P183; Tsuchiya N, 1998, J BIOCHEM-TOKYO, V123, P499; Varisli L, 2012, MOL CELL ENDOCRINOL, V350, P107, DOI 10.1016/j.mce.2011.11.027; Varisli L, 2011, DNA CELL BIOL, V30, P419, DOI 10.1089/dna.2010.1128; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Wayner EA, 2012, PROSTATE, V72, P1023, DOI 10.1002/pros.21508; Whitaker HC, 2007, PROSTATE, V67, P943, DOI 10.1002/pros.20580; Whitaker HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013363; Wu YY, 2008, CELL BIOCHEM FUNCT, V26, P467, DOI 10.1002/cbf.1468; Zheng DQ, 1999, CANCER RES, V59, P1655	54	27	32	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5274	5287		10.1038/onc.2013.464	http://dx.doi.org/10.1038/onc.2013.464			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24240687				2022-12-25	WOS:000345120400005
J	Sun, JW; He, HF; Pillai, S; Xiong, Y; Challa, S; Xu, LY; Chellappan, S; Yang, SY				Sun, Jianwei; He, Huifang; Pillai, Smitha; Xiong, Yin; Challa, Sridevi; Xu, Liyan; Chellappan, Srikumar; Yang, Shengyu			GATA3 Transcription Factor Abrogates Smad4 Transcription Factor-mediated Fascin Overexpression, Invadopodium Formation, and Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Cytoskeleton; GATA; Metastasis; SMAD Transcription Factor	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; TUMOR-METASTASIS; MAMMARY-GLAND; EXPRESSION; GROWTH; DIFFERENTIATION; MIGRATION; PROTEIN; ACTIN	Transforming growth factor (TGF) is a potent and context-dependent regulator of tumor progression. TGF promotes the lung metastasis of basal-like (but not the luminal-like) breast cancer. Here, we demonstrated that fascin, a pro-metastasis actin bundling protein, was a direct target of the canonical TGF-Smad4 signaling pathway in basal-like breast cancer cells. TGF and Smad4 induced fascin overexpression by directly binding to a Smad binding element on the fascin promoter. We identified GATA3, a transcription factor crucial for mammary gland morphogenesis and luminal differentiation, as a negative regulator of TGF- and Smad4-induced fascin overexpression. When ectopically expressed in basal-like breast cancer cells, GATA-3 abrogated TGF- and Smad4-mediated overexpression of fascin and other TGF response genes, invadopodium formation, cell migration, and invasion, suggesting suppression of the canonical TGF-Smad signaling axis. Mechanistically, GATA3 abrogated the canonical TGF-Smad signaling by abolishing interactions between Smad4 and its DNA binding elements, potentially through physical interactions between the N-terminal of GATA3 and Smad3/4 proteins. Our findings provide mechanistic insight into how TGF-mediated cell motility and invasiveness are differentially regulated in breast cancer.	[Sun, Jianwei; He, Huifang; Pillai, Smitha; Chellappan, Srikumar; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Sun, Jianwei; He, Huifang; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Xiong, Yin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Challa, Sridevi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Biol Grad Program, Tampa, FL 33612 USA; [Xu, Liyan] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 515041, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Shantou University	Yang, SY (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, 12902 Magnolia Dr SRB-2, Tampa, FL 33612 USA.	shengyu.yang@moffitt.org	xu, li/GNH-3667-2022	Pillai, Smitha/0000-0001-9718-5010; CHALLA, SRIDEVI/0000-0002-5308-9243	NCI, National Institutes of Health [P30-CA76292-14]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Minjung Kim and Jin Q. Cheng for reagents and cell lines, the Analytic Microscopy Core and Molecular Genomics core at Moffitt Cancer center for assistance with image acquisition and qPCR, and Rasa Hamilton for editorial assistance. The Analytic Microscopy Core and Molecular Genomics Core at Moffitt Cancer Center were supported in part by NCI, National Institutes of Health Grant P30-CA76292-14.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; Chu I. M., 2013, PLOS ONE, V8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kress AK, 2011, BLOOD, V117, P3609, DOI 10.1182/blood-2010-09-305805; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Snyder M, 2011, J BIOL CHEM, V286, P38886, DOI 10.1074/jbc.M111.286245; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186	44	38	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36971	36982		10.1074/jbc.M113.506535	http://dx.doi.org/10.1074/jbc.M113.506535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235142	Green Published, hybrid			2022-12-25	WOS:000329189700019
J	Hoskins, AJ; Arnould, JPY				Hoskins, Andrew J.; Arnould, John P. Y.			Temporal Allocation of Foraging Effort in Female Australian Fur Seals (Arctocephalus pusillus doriferus)	PLOS ONE			English	Article							BREATH-HOLD DIVERS; DIVING BEHAVIOR; NEW-ZEALAND; SEASONAL-CHANGES; MARINE PREDATOR; METABOLIC-RESPONSE; TIME ALLOCATION; PUP PRODUCTION; DYNAMIC ACTION; ENERGETICS	Across an individual's life, foraging decisions will be affected by multiple intrinsic and extrinsic drivers that act at differing timescales. This study aimed to assess how female Australian fur seals allocated foraging effort and the behavioural changes used to achieve this at three temporal scales: within a day, across a foraging trip and across the final six months of the lactation period. Foraging effort peaked during daylight hours (57% of time diving) with lulls in activity just prior to and after daylight. Dive duration reduced across the day (196 s to 168 s) but this was compensated for by an increase in the vertical travel rate (1500-1600 m.h(-1)) and a reduction in postdive duration (111-90 s). This suggests physiological constraints (digestive costs) or prey availability may be limiting mean dive durations as a day progresses. During short trips (<2.9 d), effort remained steady at 55% of time diving, whereas, on long trips (>2.9 d) effort increased up to 2-3 d and then decreased. Dive duration decreased at the same rate in short and long trips, respectively, before stabilising (long trips) between 4-5 d. Suggesting that the same processes (digestive costs or prey availability) working at the daily scale may also be present across a trip. Across the lactation period, foraging effort, dive duration and vertical travel rate increased until August, before beginning to decrease. This suggests that as the nutritional demands of the suckling pup and developing foetus increase, female effort increases to accommodate this, providing insight into the potential constraints of maternal investment in this species.	[Hoskins, Andrew J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	Deakin University	Hoskins, AJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	ajhos@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Australian Research Council; Sea World Research and Rescue Foundation Incorporated; Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Sea World Research and Rescue Foundation Incorporated; Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Funding for this project was provided through research grants from the Australian Research Council, Sea World Research and Rescue Foundation Incorporated, Winifred Violet Scott Charitable Trust and Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1984, AM NAT, V124, P80, DOI 10.1086/284253; Annese DM, 2005, ENVIRON BIOL FISH, V72, P161, DOI 10.1007/s10641-004-0774-7; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 1996, J ZOOL, V239, P769, DOI 10.1111/j.1469-7998.1996.tb05477.x; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; ARONSON RB, 1983, ECOLOGY, V64, P395, DOI 10.2307/1937085; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; Boyd IL, 1997, BEHAV ECOL SOCIOBIOL, V40, P135, DOI 10.1007/s002650050326; BOYD IL, 1992, CAN J ZOOL, V70, P919, DOI 10.1139/z92-131; BOYD IL, 1991, J ANIM ECOL, V60, P577, DOI 10.2307/5299; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; Carpentieri P, 2006, J MAR BIOL ASSOC UK, V86, P853, DOI 10.1017/S0025315406013798; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; Costa D.P., 1986, P79; Costa Daniel P., 1993, Symposia of the Zoological Society of London, V66, P293; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Costa DP, 2000, J EXP BIOL, V203, P3655; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; FRASER WR, 1989, POLAR BIOL, V10, P37; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; GALLIVAN GJ, 1981, COMP BIOCHEM PHYS A, V69, P579, DOI 10.1016/0300-9629(81)93024-3; Gentry R. L., 1982, EQUIPMENT TECHNIQUES; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Gibbens J, 2009, MAR MAMMAL SCI, V25, P573, DOI 10.1111/j.1748-7692.2008.00270.x; HARCOURT RG, 1995, CAN J ZOOL, V73, P678, DOI 10.1139/z95-080; HIGGINS LV, 1993, CAN J ZOOL, V71, P2047, DOI 10.1139/z93-290; Hipfner JM, 2006, CAN J ZOOL, V84, P931, DOI 10.1139/Z06-066; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; KARASOV WH, 1988, BIOSCIENCE, V38, P602, DOI 10.2307/1310825; Kato A, 2003, POLAR BIOL, V26, P389, DOI 10.1007/s00300-003-0493-0; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; Kirkwood R, 2011, AUST J ZOOL, V59, P216, DOI 10.1071/ZO11080; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; Kuiter RH, 1996, GUIDE SEA FISHES AUS; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Littnan Charles L., 2002, Australian Mammalogy, V24, P65; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MARKUSSEN NH, 1994, J COMP PHYSIOL B, V164, P89, DOI 10.1007/BF00301648; Mattlin RH, 1998, CAN J ZOOL, V76, P350, DOI 10.1139/cjz-76-2-350; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; Mori Y, 2004, ECOLOGY, V85, P398, DOI 10.1890/03-4005; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Nichol LM, 1996, CAN J ZOOL, V74, P983, DOI 10.1139/z96-111; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; O'Driscoll RL, 2013, 1 NZ FISH ASS; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Orians G.H., 1979, P155; Overgaard J, 2002, PHYSIOL BIOCHEM ZOOL, V75, P360, DOI 10.1086/342769; Pan ZC, 2005, COMP BIOCHEM PHYS A, V141, P470, DOI 10.1016/j.cbpb.2005.07.003; PEMBERTON D, 1994, WILDLIFE RES, V21, P341, DOI 10.1071/WR9940341; Pinheiro J, 2001, MIXED EFFECTS MODELS; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Core Team, 2012, R LANG ENV STAT COMP; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; RIJNSDORP A, 1981, OECOLOGIA, V50, P391, DOI 10.1007/BF00344982; Rosen DAS, 1997, COMP BIOCHEM PHYS A, V118, P877, DOI 10.1016/S0300-9629(97)00039-X; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; Sparling CE, 2004, EUR RES CET P 18 ANN, V18; Spence-Bailey LM, 2007, J COMP PHYSIOL B, V177, P483, DOI 10.1007/s00360-007-0146-7; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Villegas-Amtmann S, 2012, COMP BIOCHEM PHYS A, V162, P413, DOI 10.1016/j.cbpa.2012.04.019; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; WILLIAMS H, 1993, AUST J MAR FRESH RES, V44, P577; Williams TM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P433, DOI 10.1086/518346; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	88	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79484	10.1371/journal.pone.0079484	http://dx.doi.org/10.1371/journal.pone.0079484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244511	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800082
J	Narola, J; Pandey, SN; Glick, A; Chen, YW				Narola, Jigna; Pandey, Sachchida Nand; Glick, Adam; Chen, Yi-Wen			Conditional Expression of TGF-beta 1 in Skeletal Muscles Causes Endomysial Fibrosis and Myofibers Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DUCHENNE-MUSCULAR-DYSTROPHY; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; MDX-MOUSE; INFLAMMATORY RESPONSE; CELL-DIFFERENTIATION; COLLAGEN-SYNTHESIS; DIAPHRAGM; MICE	To study the effects of transforming growth factor beta 1 (TGF-beta 1) on fibrosis and failure of regeneration of skeletal muscles, we generated a tet-repressible muscle-specific TGF-beta 1 transgenic mouse in which expression of TGF-beta 1 is controlled by oral doxycycline. The mice developed muscle weakness and atrophy after TGF-beta 1 over-expression. We defined the group of mice that showed phenotype within 2 weeks as early onset (EO) and the rest as late onset (LO), which allowed us to further examine phenotypic differences between the groups. While only mice in the EO group showed significant muscle weakness, pathological changes including endomysial fibrosis and smaller myofibers were observed in both groups at two weeks after the TGF-beta 1 was over-expressed. In addition, the size of the myofibers and collagen accumulation were significantly different between the two groups. The amount of latent and active TGF-beta 1 in the muscle and circulation were significantly higher in the EO group compared to the LO or control groups. The up-regulation of the latent TGF-beta 1 indicated that endogenous TGF-beta 1 was induced by the expression of the TGF-beta 1 transgene. Our studies showed that the primary effects of TGF-beta 1 over-expression in skeletal muscles are muscle wasting and endomysial fibrosis. In addition, the severity of the pathology is associated with the total amount of TGF-beta 1 and the expression of endogenous TGF-beta 1. The findings suggest that an auto-feedback loop of TGF-beta 1 may contribute to the severity of phenotypes.	[Narola, Jigna; Pandey, Sachchida Nand; Chen, Yi-Wen] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Glick, Adam] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Chen, Yi-Wen] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Chen, Yi-Wen] George Washington Univ, Dept Pediat, Washington, DC 20052 USA	Children's National Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; George Washington University	Chen, YW (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	ychen@childrensnational.org		Pandey, Sachchida/0000-0002-0567-5344	National Institutes of Health/NICHD [U54HD05317701]; Department of Defense [W81XWH-10-1-0659];  [NIH/NIAMS1R01AR052027];  [NIH/NICHD1R24HD050846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052027] Funding Source: NIH RePORTER	National Institutes of Health/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study is supported by National Institutes of Health/NICHD U54HD05317701, Department of Defense W81XWH-10-1-0659, NIH/NIAMS1R01AR052027 and NIH/NICHD1R24HD050846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; Dale PD, 1997, B MATH BIOL, V59, P1077; GRAINGER DJ, 1994, BIOCHEM J, V299, P227, DOI 10.1042/bj2990227; HATHAWAY MR, 1994, J ANIM SCI, V72, P2001, DOI 10.2527/1994.7282001x; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ishitobi M, 2000, NEUROREPORT, V11, P4033, DOI 10.1097/00001756-200012180-00026; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Lynch GS, 1997, AM J PHYSIOL-CELL PH, V272, pC2063, DOI 10.1152/ajpcell.1997.272.6.C2063; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Nakamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02183; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Noirez P, 2006, J MUSCLE RES CELL M, V27, P1, DOI 10.1007/s10974-005-9014-9; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Rodriguez-Barbero A, 2002, FEBS LETT, V513, P282, DOI 10.1016/S0014-5793(02)02337-2; Rout UK, 2002, FERTIL STERIL, V78, P154, DOI 10.1016/S0015-0282(02)03176-X; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SMITH PEM, 1987, NEW ENGL J MED, V316, P1197, DOI 10.1056/NEJM198705073161906; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845, DOI 10.1152/ajpgi.2000.279.5.G845; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	50	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79356	10.1371/journal.pone.0079356	http://dx.doi.org/10.1371/journal.pone.0079356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244485	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800063
J	Henriksen, C; Kjaer-Sorensen, K; Einholm, AP; Madsen, LB; Momeni, J; Bendixen, C; Oxvig, C; Vilsen, B; Larsen, K				Henriksen, Carina; Kjaer-Sorensen, Kasper; Einholm, Anja Pernille; Madsen, Lone Bruhn; Momeni, Jamal; Bendixen, Christian; Oxvig, Claus; Vilsen, Bente; Larsen, Knud			Molecular Cloning and Characterization of Porcine Na+/K+-ATPase Isoforms alpha 1, alpha 2, alpha 3 and the ATP1A3 Promoter	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; BETA-SUBUNIT GENES; 4TH TRANSMEMBRANE SEGMENT; DE-NOVO MUTATIONS; K+-ATPASE; ALTERNATING HEMIPLEGIA; CRYSTAL-STRUCTURE; NA,K-ATPASE; EXPRESSION; SODIUM	Na+/K+-ATPase maintains electrochemical gradients of Na+ and K+ essential for a variety of cellular functions including neuronal activity. The alpha-subunit of the Na+/K+-ATPase exists in four different isoforms (alpha 1-alpha 4) encoded by different genes. With a view to future use of pig as an animal model in studies of human diseases caused by Na+/K+-ATPase mutations, we have determined the porcine coding sequences of the alpha 1-alpha 3 genes, ATP1A1, ATP1A2, and ATP1A3, their chromosomal localization, and expression patterns. Our ATP1A1 sequence accords with the sequences from several species at five positions where the amino acid residue of the previously published porcine ATP1A1 sequence differs. These corrections include replacement of glutamine 841 with arginine. Analysis of the functional consequences of substitution of the arginine revealed its importance for Na+ binding, which can be explained by interaction of the arginine with the C-terminus, stabilizing one of the Na+ sites. Quantitative real-time PCR expression analyses of porcine ATP1A1, ATP1A2, and ATP1A3 mRNA showed that all three transcripts are expressed in the embryonic brain as early as 60 days of gestation. Expression of alpha 3 is confined to neuronal tissue. Generally, the expression patterns of ATP1A1, ATP1A2, and ATP1A3 transcripts were found similar to their human counterparts, except for lack of alpha 3 expression in porcine heart. These expression patterns were confirmed at the protein level. We also report the sequence of the porcine ATP1A3 promoter, which was found to be closely homologous to its human counterpart. The function and specificity of the porcine ATP1A3 promoter was analyzed in transgenic zebrafish, demonstrating that it is active and drives expression in embryonic brain and spinal cord. The results of the present study provide a sound basis for employing the ATP1A3 promoter in attempts to generate transgenic porcine models of neurological diseases caused by ATP1A3 mutations.	[Henriksen, Carina; Madsen, Lone Bruhn; Momeni, Jamal; Bendixen, Christian; Larsen, Knud] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Henriksen, Carina; Einholm, Anja Pernille; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kjaer-Sorensen, Kasper; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Larsen, K (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark.	Knud.Larsen@agrsci.dk	Kjaer-Sorensen, Kasper/AAF-1457-2020	Vilsen, Bente/0000-0002-4727-9382; Oxvig, Claus/0000-0002-4715-9719	Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation; Aarhus University, HEALTH; Lundbeck Foundation [R118-2012-11726, R48-2009-4638] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat)(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Aarhus University, HEALTH; Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council (to BV), the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat) (to BV), and the Lundbeck Foundation (to BV and APE). CH is supported by a Ph.D. stipend from Aarhus University, HEALTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; BARLETBAS C, 1993, J BIOL CHEM, V268, P11512; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Benfante R, 2005, BIOCHEM J, V386, P63, DOI 10.1042/BJ20041294; Bjerre D, 2006, BIOCHEM BIOPH RES CO, V347, P803, DOI 10.1016/j.bbrc.2006.06.167; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Canfield VA, 2002, MECH DEVELOP, V116, P51, DOI 10.1016/S0925-4773(02)00135-1; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chang CS, 1998, KIDNEY INT, V54, P457, DOI 10.1046/j.1523-1755.1998.00031.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Doganli C, 2012, J CELL SCI, V125, P6166, DOI 10.1242/jcs.115808; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Fontanesi L, 1999, ANIM GENET, V30, P57, DOI 10.1046/j.1365-2052.1999.00407.x; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Gritz SM, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-8; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hansen O, 1998, ACTA PHYSIOL SCAND, V163, P201, DOI 10.1046/j.1365-201X.1998.00345.x; Hawken RJ, 1999, MAMM GENOME, V10, P824, DOI 10.1007/s003359901097; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; HSU YM, 1989, BIOCHEMISTRY-US, V28, P569, DOI 10.1021/bi00428a023; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Kamm C, 2004, MOVEMENT DISORD, V19, P845, DOI 10.1002/mds.20095; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer PL, 1999, ANN NEUROL, V46, P176, DOI 10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2; LAHBIBMANSAIS Y, 1993, GENOMICS, V15, P91, DOI 10.1006/geno.1993.1014; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; PATHAK BG, 1990, GENOMICS, V8, P641, DOI 10.1016/0888-7543(90)90250-X; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; POST RL, 1972, J BIOL CHEM, V247, P6530; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SCHNEIDER BG, 1991, J HISTOCHEM CYTOCHEM, V39, P507, DOI 10.1177/39.4.1848572; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; SHAMRAJ OI, 1991, BIOCHEM BIOPH RES CO, V179, P1434, DOI 10.1016/0006-291X(91)91733-S; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Wang JN, 1996, J CLIN INVEST, V98, P1650, DOI 10.1172/JCI118960; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8; Yerle M, 1998, CYTOGENET CELL GENET, V82, P182, DOI 10.1159/000015095	70	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79127	10.1371/journal.pone.0079127	http://dx.doi.org/10.1371/journal.pone.0079127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236096	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700094
J	Jing, HM; Xia, XM; Suzuki, K; Liu, HB				Jing, Hongmei; Xia, Xiaomin; Suzuki, Koji; Liu, Hongbin			Vertical Profiles of Bacteria in the Tropical and Subarctic Oceans Revealed by Pyrosequencing	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SPATIAL-PATTERNS; COMMUNITIES; SEA; PHYTOPLANKTON; VARIABILITY; DYNAMICS; ECOLOGY; DEPTH	Community composition of Bacteria in the surface and deep water layers were examined at three oceanic sites in the Pacific Ocean separated by great distance, i.e., the South China Sea (SCS) in the western tropical Pacific, the Costa Rica Dome (CRD) in the eastern tropical Pacific and the western subarctic North Pacific (SNP), using high throughput DNA pyrosequencing of the 16S rRNA gene. Bioinformatic analysis rendered a total of 143600 high quality sequences with an average 11967 sequences per sample and mean read length of 449 bp. Phylogenetic analysis showed that Proteobacteria dominated in all shallow and deep waters, with Alphaproteobacteria and Gammaproteobacteria the two most abundant components, and SAR11 the most abundant group at family level in all regions. Cyanobacteria occurred mainly in the surface euphotic layer, and the majority of them in the tropical waters belonged to the GpIIa family including Prochlorococcus and Synechococcus, whilst those associated with Cryptophytes and diatoms were common in the subarctic waters. In general, species richness (Chao1) and diversity (Shannon index H') were higher for the bacterial communities in the intermediate water layers than for those in surface and deep waters. Both NMDS plot and UPGMA clustering demonstrated that bacterial community composition in the deep waters (500 m similar to 2000 m) of the three oceanic regions shared a high similarity and were distinct from those in the upper waters (5 m similar to 100 m). Our study indicates that bacterial community composition in the DOC-poor deep water in both tropical and subarctic regions were rather stable, contrasting to those in the surface water layers, which could be strongly affected by the fluctuations of environmental factors.	[Jing, Hongmei; Xia, Xiaomin; Liu, Hongbin] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Jing, Hongmei] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, Sanya, Peoples R China; [Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Hokkaido University	Liu, HB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	liuhb@ust.hk	Liu, Hongbin/AAV-8862-2020; Suzuki, Koji/GVS-9807-2022; Suzuki, Koji/A-4349-2013; Suzuki, Koji/AAD-2630-2022	Suzuki, Koji/0000-0001-5354-1044; Suzuki, Koji/0000-0001-5354-1044; 	National Basic Research Program ("973" Program) of China [2009CB421203]; University Grants Committee of Hong Kong AoE project [AoE/P-04/04-4-II]; Research Grants Council of Hong Kong [661610, 661912, 661813]; Japan Society for the Promotion of Science [22310002]; Sanya Institute of Deep-sea Science and Engineering; Chinese Academy of Sciences [SIDSSE-BR-201301]; Grants-in-Aid for Scientific Research [22221001] Funding Source: KAKEN	National Basic Research Program ("973" Program) of China(National Basic Research Program of China); University Grants Committee of Hong Kong AoE project; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sanya Institute of Deep-sea Science and Engineering; Chinese Academy of Sciences(Chinese Academy of Sciences); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following funding agencies: National Basic Research Program ("973" Program) of China through grant 2009CB421203, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm; University Grants Committee of Hong Kong AoE project (AoE/P-04/04-4-II) http://www.ugc.edu.hk/eng/ugc/index.htm; Research Grants Council of Hong Kong (661610, 661912 and 661813) http://www.ugc.edu.hk/eng/rgc/about/about.htm; Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science (22310002) http://www.jsps.go.jp/english/e-grants/index.html. In addition, the grant support from Sanya Institute of Deep-sea Science and Engineering. Chinese Academy of Sciences (SIDSSE-BR-201301) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Clarke K., 2001, PRIMER VERSION 5 USE; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Friedline C.J., 2012, BIOGEOSCI DISCUSS, V9, P109, DOI [10.5194/bgd-9-109-2012, DOI 10.5194/BGD-9-109-2012]; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Galand PE, 2012, FEMS MICROBIOL ECOL, V79, P203, DOI 10.1111/j.1574-6941.2011.01209.x; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gallagher JM, 2004, FEMS MICROBIOL ECOL, V47, P249, DOI 10.1016/S0168-6496(03)00281-2; Ghiglione JF, 2008, BIOGEOSCIENCES, V5, P1751, DOI 10.5194/bg-5-1751-2008; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jing HM, 2012, AQUAT MICROB ECOL, V65, P207, DOI 10.3354/ame01546; Kataoka T, 2009, J MARINE SYST, V77, P197, DOI 10.1016/j.jmarsys.2008.12.006; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023214; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Liu HB, 2007, DEEP-SEA RES PT II, V54, P1602, DOI 10.1016/j.dsr2.2007.05.004; Lo Giudice A, 2006, J APPL MICROBIOL, V101, P1039, DOI 10.1111/j.1365-2672.2006.03006.x; Lopez-Garcia P, 2001, FEMS MICROBIOL ECOL, V36, P193, DOI 10.1016/S0168-6496(01)00133-7; Ma Y, 2009, MICROBIOL RES, V164, P624, DOI 10.1016/j.micres.2008.01.001; Moeseneder MM, 2001, J MICROBIOL METH, V44, P159, DOI 10.1016/S0167-7012(00)00247-5; Partensky F., 1999, B I OCEANOGR MONACO, V19, P431; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Suzuki K, 2011, DEEP-SEA RES PT I, V58, P575, DOI 10.1016/j.dsr.2011.03.003; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Worden AZ, 2006, TRENDS MICROBIOL, V14, P331, DOI 10.1016/j.tim.2006.06.008; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	48	36	37	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79423	10.1371/journal.pone.0079423	http://dx.doi.org/10.1371/journal.pone.0079423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236132	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700131
J	Kornhuber, J; Zenses, EM; Lenz, B; Stoessel, C; Bouna-Pyrrou, P; Rehbein, F; Kliem, S; Mossie, T				Kornhuber, Johannes; Zenses, Eva-Maria; Lenz, Bernd; Stoessel, Christina; Bouna-Pyrrou, Polyxeni; Rehbein, Florian; Kliem, Soeren; Moessie, Thomas			Low 2D:4D Values Are Associated with Video Game Addiction	PLOS ONE			English	Article							DIGIT RATIO 2D/4D; FINGER LENGTH RATIO; PRENATAL ANDROGENS; SPATIAL ABILITY; RISK-FACTORS; ALCOHOL-USE; TESTOSTERONE; SEX; INTERNET; 2ND	Androgen-dependent signaling regulates the growth of the fingers on the human hand during embryogenesis. A higher androgen load results in lower 2D:4D (second digit to fourth digit) ratio values. Prenatal androgen exposure also impacts brain development. 2D:4D values are usually lower in males and are viewed as a proxy of male brain organization. Here, we quantified video gaming behavior in young males. We found lower mean 2D: 4D values in subjects who were classified according to the CSAS-II as having at-risk/addicted behavior (n = 27) compared with individuals with unproblematic video gaming behavior (n = 27). Thus, prenatal androgen exposure and a hyper-male brain organization, as represented by low 2D:4D values, are associated with problematic video gaming behavior. These results may be used to improve the diagnosis, prediction, and prevention of video game addiction.	[Kornhuber, Johannes; Lenz, Bernd; Stoessel, Christina; Bouna-Pyrrou, Polyxeni] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Zenses, Eva-Maria; Rehbein, Florian; Kliem, Soeren; Moessie, Thomas] Criminol Res Inst Lower Saxony, Hannover, Germany	University of Erlangen Nuremberg	Kornhuber, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Johannes.kornhuber@uk-erlangen.de	Kliem, Sören/AAB-5196-2020; Kornhuber, Johannes/B-9613-2014	Kliem, Sören/0000-0003-1788-9574; Kornhuber, Johannes/0000-0002-8096-3987; Lenz, Bernd/0000-0001-6086-0924	University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg; Ministry for Science and Culture of Lower Saxony	University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg; Ministry for Science and Culture of Lower Saxony	Funding for this study was provided by intramural grants from the University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg and by the Ministry for Science and Culture of Lower Saxony. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bowman AW, 2006, STAT MODEL, V6, P279, DOI 10.1177/1471082006071848; Bowman AW, 1997, APPL SMOOTHING TECHN; Branas-Garza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060419; Branas-Garza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029842; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brookes H., 2007, J INDIVID DIFFER, V28, P55, DOI DOI 10.1027/1614-0001.28.2.55; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Chai XQJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032816; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; De Neys W, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0037; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Gentile DA, 2011, PEDIATRICS, V127, pE319, DOI 10.1542/peds.2010-1353; Hahn A, 2010, PRAVENTION DIAGNOSTI, P185; Hahn A., 2001, ONLINE MARKTFORSCHUN, P211, DOI [10.1007/978-3-322-99429-5_15, DOI 10.1007/978-3-322-99429-5_15]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2012, AUTISM RES, V5, P221, DOI 10.1002/aur.1230; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2006, PSYCHONEUROENDOCRINO, V31, P30, DOI 10.1016/j.psyneuen.2005.05.009; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Hothorn T, 2013, LAB RECURSIVE PARTIT; Hothorn T., 2010, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; Hussain Z, 2011, ADDICT RES THEORY, V20, P1; JACKSON CP, 1988, ALCOHOL ALCOHOLISM, V23, P305; Kempel P, 2005, INTELLIGENCE, V33, P215, DOI 10.1016/j.intell.2004.11.004; Kerridge BT, 2013, DRUG ALCOHOL DEPEN, V129, P60, DOI 10.1016/j.drugalcdep.2012.09.010; Kim KS, 2010, J KOREAN ACAD NURS, V40, P378, DOI 10.4040/jkan.2010.40.3.378; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2009, ARCH PEDIAT ADOL MED, V163, P937, DOI 10.1001/archpediatrics.2009.159; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019332; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Lenz B, 2012, PROG NEUROBIOL, V96, P136, DOI 10.1016/j.pneurobio.2011.11.001; LEX BW, 1991, HEALTH PSYCHOL, V10, P121, DOI 10.1037/0278-6133.10.2.121; Lin SSJ, 2013, COMPUT HUMAN BEHAV, V18, P411; Lombardo MV, 2012, BIOL PSYCHIAT, V72, P839, DOI 10.1016/j.biopsych.2012.05.027; Luxen MF, 2005, PERS INDIV DIFFER, V39, P959, DOI 10.1016/j.paid.2005.03.016; M/&beta;le T., 2013, SUCHT, V59, P153, DOI [DOI 10.1024/0939-5911.A000247, 10.1024/0939-5911.a000247]; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2010, AM J HUM BIOL, V22, P604, DOI 10.1002/ajhb.21051; Manning JT, 2002, MED HYPOTHESES, V59, P334, DOI 10.1016/S0306-9877(02)00181-0; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Rehbein F, 2013, NERVENARZT, V84, P569, DOI 10.1007/s00115-012-3721-4; Rehbein F, 2011, SUCHTTHERAPIE, V12, P64, DOI 10.1055/s-0031-1275313; Rehbein F, 2013, J MEDIA PSYCHOL-GER, V25, P118, DOI 10.1027/1864-1105/a000093; Rehbein F, 2010, CYBERPSYCH BEH SOC N, V13, P269, DOI 10.1089/cyber.2009.0227; Sanders G, 2005, CORTEX, V41, P789, DOI 10.1016/S0010-9452(08)70297-1; Schmidt A, 2010, ADHS E ADHS SCREENIN; Stevenson JC, 2007, AM J HUM BIOL, V19, P41, DOI 10.1002/ajhb.20571; STRASSER H, 1999, MATH METHODS STAT, V8, P220; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Teatero ML, 2013, J AUTISM DEV DISORD, V43, P2664, DOI 10.1007/s10803-013-1819-6; Von Horn A, 2010, SCAND J PSYCHOL, V51, P31, DOI 10.1111/j.1467-9450.2009.00725.x; Weinstein A, 2012, CURR PSYCHIAT REP, V14, P590, DOI 10.1007/s11920-012-0311-x; Wenzel HG, 2009, PSYCHOL REP, V105, P1237, DOI 10.2466/PR0.105.F.1237-1247; Wolfling K, 2008, PSYCHIAT PRAX, V35, P226, DOI 10.1055/s-2007-986238; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	72	29	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79539	10.1371/journal.pone.0079539	http://dx.doi.org/10.1371/journal.pone.0079539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236143	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700142
J	Liao, CK; Jeng, CJ; Wang, HS; Wang, SH; Wu, JC				Liao, Chih-Kai; Jeng, Chung-Jiuan; Wang, Hwai-Shi; Wang, Shu-Huei; Wu, Jiahn-Chun			Lipopolysaccharide Induces Degradation of Connexin43 in Rat Astrocytes via the Ubiquitin-Proteasome Proteolytic Pathway	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; N-TERMINAL KINASE; DOWN-REGULATION; KAPPA-B; INTERCELLULAR COMMUNICATION; ASTROGLIAL NETWORKS; UP-REGULATION; TNF-ALPHA; P38 MAPK; EXPRESSION	The astrocytic syncytium plays a critical role in maintaining the homeostasis of the brain through the regulation of gap junction intercellular communication (GJIC). Changes to GJIC in response to inflammatory stimuli in astrocytes may have serious effects on the brain. We have previously shown that lipopolysaccharide (LPS) reduces connexin43 (Cx43) expression and GJIC in cultured rat astrocytes via a toll-like receptor 4-mediated signaling pathway. In the present study, treatment of astrocytes with LPS resulted in a significant increase in levels of the phosphorylated forms of stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) -1, -2, and -3 for up to 18 h. An increase in nuclear transcription factor NF-kappa B levels was also observed after 8 h of LPS treatment and was sustained for up to 18 h. The LPS-induced decrease in Cx43 protein levels and inhibition of GJIC were blocked by the SAPK/JNK inhibitor SP600125, but not by the NF-kappa B inhibitor BAY11-7082. Following blockade of de novo protein synthesis by cycloheximide, LPS accelerated Cx43 degradation. Moreover, the LPS-induced downregulation of Cx43 was blocked following inhibition of 26S proteasome activity using the reversible proteasome inhibitor MG132 or the irreversible proteasome inhibitor lactacystin. Immunoprecipitation analyses revealed an increased association of Cx43 with both ubiquitin and E3 ubiquitin ligase Nedd4 in astrocytes after LPS stimulation for 6 h and this effect was prevented by SP600125. Taken together, these results suggest that LPS stimulation leads to downregulation of Cx43 expression and GJIC in rat astrocytes by activation of SAPK/JNK and the ubiquitin-proteasome proteolytic pathway.	[Liao, Chih-Kai; Wang, Shu-Huei] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Jeng, Chung-Jiuan; Wang, Hwai-Shi; Wu, Jiahn-Chun] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University	Wu, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan.	jcwu2@ym.edu.tw		WANG, SHU-HUEI/0000-0002-9208-3135	Taiwan National Science Council [NSC-98-2320-B010-030-MY3, NSC-102-2320-B010-011]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council [grant numbers: NSC-98-2320-B010-030-MY3 and NSC-102-2320-B010-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Bellei B, 2008, EXP DERMATOL, V17, P115, DOI 10.1111/j.1600-0625.2007.00662.x; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chung TH, 2009, INT J BIOCHEM CELL B, V41, P2323, DOI 10.1016/j.biocel.2009.06.001; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Giaume C, 2010, BRAIN RES REV, V63, P160, DOI 10.1016/j.brainresrev.2009.11.005; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Harris JE, 2007, J LEUKOCYTE BIOL, V81, P548, DOI 10.1189/jlb.0806512; Hsiao HJ, 2010, ARCH VIROL, V155, P1107, DOI 10.1007/s00705-010-0693-1; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kim HT, 2005, J NEUROVIROL, V11, P166, DOI 10.1080/13550280590922810; Kimura K, 2010, INVEST OPHTH VIS SCI, V51, P1943, DOI 10.1167/iovs.09-3573; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Panaro MA, 2008, IMMUNOPHARM IMMUNOT, V30, P729, DOI [10.1080/08923970802278557, 10.1080/08923970802278557 ]; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Roscoe WA, 2007, CELL COMMUN ADHES, V14, P57, DOI 10.1080/15419060701459569; Shi RX, 2007, MOL CANCER THER, V6, P1338, DOI 10.1158/1535-7163.MCT-06-0638; Srinivas H, 2005, MOL CELL BIOL, V25, P1054, DOI 10.1128/MCB.25.3.1054-1069.2005; Stanbouly S, 2008, J PHARMACOL EXP THER, V327, P105, DOI 10.1124/jpet.108.140228; Tacheau C, 2008, J CELL PHYSIOL, V216, P438, DOI 10.1002/jcp.21412; Tanahashi H, 2010, ARCH BIOCHEM BIOPHYS, V494, P94, DOI 10.1016/j.abb.2009.11.018; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Zhang FF, 2013, J NEUROSCI RES, V91, P745, DOI 10.1002/jnr.23213; Zhang S, 2011, CELL MOL NEUROBIOL, V31, P111, DOI 10.1007/s10571-010-9560-6; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	44	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79350	10.1371/journal.pone.0079350	http://dx.doi.org/10.1371/journal.pone.0079350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236122	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700121
J	Lotem, J; Levanon, D; Negreanu, V; Leshkowitz, D; Friedlander, G; Groner, Y				Lotem, Joseph; Levanon, Ditsa; Negreanu, Varda; Leshkowitz, Dena; Friedlander, Gilgi; Groner, Yoram			Runx3-mediated Transcriptional Program in Cytotoxic Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HELPER TYPE-1 CELLS; ONLY PROTEIN FHL2; FACTORS T-BET; GENE-EXPRESSION; RUNX PROTEINS; CANCER CELLS; NK CELLS; B-CELLS; RECEPTOR	The transcription factor Runx3 is highly expressed in CD8(+) T and NK cytotoxic lymphocytes and is required for their effective activation and proliferation but molecular insights into the transcription program regulated by Runx3 in these cells are still missing. Using Runx3-ChIP-seq and transcriptome analysis of wild type vs. Runx3(-/-) primary cells we have now identified Runx3-regulated genes in the two cell types at both resting and IL-2-activated states. Runx3-bound genomic regions in both cell types were distantly located relative to gene transcription start sites and were enriched for RUNX and ETS motifs. Bound genomic regions significantly overlapped T-bet and p300-bound enhancer regions in Runx3-expressing Th1 helper cells. Compared to resting cells, IL-2-activated CD8(+) T and NK cells contain three times more Runx3-regulated genes that are common to both cell types. Functional annotation of shared CD8(+) T and NK Runx3-regulated genes revealed enrichment for immune-associated terms including lymphocyte activation, proliferation, cytotoxicity, migration and cytokine production, highlighting the role of Runx3 in CD8(+) T and NK activated cells.	[Lotem, Joseph; Levanon, Ditsa; Negreanu, Varda; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Leshkowitz, Dena; Friedlander, Gilgi] Weizmann Inst Sci, Israel Natl Ctr, Personalized Med Bioinformat Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Groner, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yoram.groner@weizmann.ac.il		Friedlander, Gerard/0000-0002-6854-4261	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from Israel Science Foundation individual grants to YG and D. Levanon. URL: http://isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Arman M, 2009, MOL IMMUNOL, V46, P2226, DOI 10.1016/j.molimm.2009.04.018; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Ben-Ami O, 2013, CELL REP, V4, P1131, DOI 10.1016/j.celrep.2013.08.020; Benson DM, 2009, BLOOD, V113, P2706, DOI 10.1182/blood-2008-05-159285; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; Bluman EM, 1996, BLOOD, V88, P3887, DOI 10.1182/blood.V88.10.3887.bloodjournal88103887; Brady G, 2009, J CELL PHYSIOL, V221, P283, DOI 10.1002/jcp.21880; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Kutlesa S, 2002, J CELL SCI, V115, P4505, DOI 10.1242/jcs.00142; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marusina AI, 2008, J IMMUNOL, V180, P409, DOI 10.4049/jimmunol.180.1.409; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Moretta L, 2001, TRANSPLANT P, V33, P60, DOI 10.1016/S0041-1345(00)02790-1; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pencovich N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064248; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Presnell SR, 2012, J IMMUNOL, V188, P4394, DOI 10.4049/jimmunol.1103352; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shen R, 2002, MOL CELL BIOL, V22, P3230, DOI 10.1128/MCB.22.10.3230-3236.2002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smid M, 2003, BIOINFORMATICS, V19, P2065, DOI 10.1093/bioinformatics/btg282; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tarrant JA, 2002, MOL CELL BIOL, V22, P5006, DOI 10.1128/MCB.22.14.5006-5018.2002; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Xiong YM, 2013, EUR J IMMUNOL, V43, P918, DOI 10.1002/eji.201242944; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	78	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80467	10.1371/journal.pone.0080467	http://dx.doi.org/10.1371/journal.pone.0080467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236182	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700183
J	Miller, AJ; Matasci, N; Schwaninger, H; Aradhya, MK; Prins, B; Zhong, GY; Simon, C; Buckler, ES; Myles, S				Miller, Allison J.; Matasci, Naim; Schwaninger, Heidi; Aradhya, Mallikarjuna K.; Prins, Bernard; Zhong, Gan-Yuan; Simon, Charles; Buckler, Edward S.; Myles, Sean			Vitis Phylogenomics: Hybridization Intensities from a SNP Array Outperform Genotype Calls	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NEXT-GENERATION; PHYLOGENETIC ANALYSIS; ARABIDOPSIS-THALIANA; MOLECULAR PHYLOGENY; ASCERTAINMENT BIAS; LINKAGE MAP; GENOME; ASSOCIATION; EVOLUTION	Understanding relationships among species is a fundamental goal of evolutionary biology. Single nucleotide polymorphisms (SNPs) identified through next generation sequencing and related technologies enable phylogeny reconstruction by providing unprecedented numbers of characters for analysis. One approach to SNP-based phylogeny reconstruction is to identify SNPs in a subset of individuals, and then to compile SNPs on an array that can be used to genotype additional samples at hundreds or thousands of sites simultaneously. Although powerful and efficient, this method is subject to ascertainment bias because applying variation discovered in a representative subset to a larger sample favors identification of SNPs with high minor allele frequencies and introduces bias against rare alleles. Here, we demonstrate that the use of hybridization intensity data, rather than genotype calls, reduces the effects of ascertainment bias. Whereas traditional SNP calls assess known variants based on diversity housed in the discovery panel, hybridization intensity data survey variation in the broader sample pool, regardless of whether those variants are present in the initial SNP discovery process. We apply SNP genotype and hybridization intensity data derived from the Vitis9kSNP array developed for grape to show the effects of ascertainment bias and to reconstruct evolutionary relationships among Vitis species. We demonstrate that phylogenies constructed using hybridization intensities suffer less from the distorting effects of ascertainment bias, and are thus more accurate than phylogenies based on genotype calls. Moreover, we reconstruct the phylogeny of the genus Vitis using hybridization data, show that North American subgenus Vitis species are monophyletic, and resolve several previously poorly known relationships among North American species. This study builds on earlier work that applied the Vitis9kSNP array to evolutionary questions within Vitis vinifera and has general implications for addressing ascertainment bias in array-enabled phylogeny reconstruction.	[Miller, Allison J.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Matasci, Naim] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Matasci, Naim] Univ Arizona, iPlant Collaborat, Tucson, AZ USA; [Schwaninger, Heidi; Zhong, Gan-Yuan; Simon, Charles] Cornell Univ, New York State Agr Expt Stn, USDA, ARS,Plant Genet Resources Unit, Geneva, NY 14456 USA; [Aradhya, Mallikarjuna K.; Prins, Bernard] Univ Calif Davis, USDA, ARS, Davis, CA 95616 USA; [Zhong, Gan-Yuan] Cornell Univ, New York Agr Expt Stn, USDA, ARS,Grape Genet Res Unit, Geneva, NY 14456 USA; [Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Myles, Sean] Dalhousie Univ, Fac Agr, Truro, NS, Canada	Saint Louis University; University of Arizona; University of Arizona; Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of California System; University of California Davis; Cornell University; United States Department of Agriculture (USDA); Cornell University; Dalhousie University	Miller, AJ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	amille75@slu.edu; sean.myles@dal.ca	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Miller, Allison/F-2293-2019	Buckler, Edward/0000-0002-3100-371X; Miller, Allison/0000-0002-2722-9361; Matasci, Naim/0000-0003-4416-048X; Aradhya, Mallikarjuna/0000-0002-2118-7885; Myles, Sean/0000-0001-9754-5987	Canada Research Chairs program; National Sciences and Engineering Research Council of Canada; ARS [ARS-0424615] Funding Source: Federal RePORTER	Canada Research Chairs program(Canada Research Chairs); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This article was written, in part, thanks to funding from the Canada Research Chairs program and the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Aradhya M, 2013, PLANT SYST EVOL, V299, P317, DOI 10.1007/s00606-012-0723-4; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Bradbury IR, 2011, MOL ECOL RESOUR, V11, P218, DOI 10.1111/j.1755-0998.2010.02949.x; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; Carstens B, 2012, SYST BIOL, V61, P713, DOI 10.1093/sysbio/sys050; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Decker J, 2009, RESOLVING EVOLUTION, P1; Didion JP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-34; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014178; Galbraith DW, 2010, BIOSCIENCE, V60, P337, DOI 10.1525/bio.2010.60.5.4; Galet P, 1979, PRACTICAL AMPELOGRAP; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Harrison N, 2011, TAXON, V60, P1552, DOI 10.1002/tax.606002; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hyten DL, 2010, HIGH THROUGHPUT SNP, P1; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Malhi RS, 2011, AM J PRIMATOL, V73, P1031, DOI 10.1002/ajp.20969; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Miller JM, 2012, MOL ECOL RESOUR, V12, P1145, DOI 10.1111/1755-0998.12017; MOORE M O, 1991, SIDA Contributions to Botany, V14, P339; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neves LG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-189; Nielsen R, 2000, GEOCHEM GEOPHSY GEOS, P1; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Peros JP, 2011, J BIOGEOGR, V38, P471, DOI 10.1111/j.1365-2699.2010.02410.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ren H., 2007, FLORA CHINA, P210; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Sacks BN, 2008, MOL ECOL RESOUR, V8, P35, DOI 10.1111/j.1471-8286.2007.01830.x; Shiu SH, 2008, HEREDITY, V100, P141, DOI 10.1038/sj.hdy.6800916; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Trondle D, 2010, AM J BOT, V97, P1168, DOI 10.3732/ajb.0900218; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Wada, 2008, SYST EV VIT; Wan YZ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-141; Wang Y, 2012, MOL ECOL, V21, P974, DOI 10.1111/j.1365-294X.2011.05413.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015	81	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78680	10.1371/journal.pone.0078680	http://dx.doi.org/10.1371/journal.pone.0078680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236035	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700032
J	Noda, T; Kawabata, Y; Arai, N; Mitamura, H; Watanabe, S				Noda, Takuji; Kawabata, Yuuki; Arai, Nobuaki; Mitamura, Hiromichi; Watanabe, Shun			Monitoring Escape and Feeding Behaviours of Cruiser Fish by Inertial and Magnetic Sensors	PLOS ONE			English	Article							PREY CAPTURE; CHUM SALMON; ACCELERATION; PERFORMANCE; KINEMATICS; ANIMALS; SEALS; START; L.	A method was developed and applied for monitoring two types of fast-start locomotion (feeding and escape) of a cruiser fish, Japanese amberjacks Seriola quinqueradiata. A data logger, which incorporated a 3-axis gyroscope, a 3-axis accelerometer and a 3-axis magnetometer, was attached to the five fish. The escape, feeding and routine movements of the fish, which were triggered in tank experiments, were then recorded by the data logger and video cameras. The locomotor variables, calculated based on the high resolution measurements by the data logger (500 Hz), were investigated to accurately detect and classify the types of fast-track behaviour. The results show that fast-start locomotion can be detected with a high precision (0.97) and recall rate (0.96) from the routine movements. Two types of fast-start movements were classified with high accuracy (0.84). Accuracy was greater if the data were obtained from the data logger, which combined an accelerometer, a gyroscope and a magnetometer, than if only an accelerometer (0.80) or a gyroscope (0.66) was used.	[Noda, Takuji; Mitamura, Hiromichi] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Kawabata, Yuuki; Watanabe, Shun] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan; [Arai, Nobuaki] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan	Kyoto University; Nagasaki University; Kyoto University	Noda, T (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	noda@bre.soc.i.kyoto-u.ac.jp	Kawabata, Yuuki/H-4109-2019; Noda, Takuji/W-1420-2019		Japan Society for the Promotion of Science [10J06259]; Special Coordination Funds for Promoting Science and Technology; Japan Science and Technology Agency; Nakajima Foundation [23880023, 21688015]; GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society''	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Nakajima Foundation; GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society''	This research was partly supported by a Research Fellowship from the Japan Society for the Promotion of Science to TN (No. 10J06259), a grant from the Special Coordination Funds for Promoting Science and Technology, funded by The Japan Science and Technology Agency (http://www.jst.go.jp/shincho/), to YK, a Grant-in-Aid for Research Activity start-up to YK (No. 23880023), a Grant-in-Aid for Young Scientists to HM (No. 21688015), a fellowship from the Nakajima Foundation (http://www.nakajimafound.or.jp/) to HM, and the GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society'' (http://www.i.kyoto-u.ac.jp/gcoe/english.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE RW, 1995, J FISH BIOL, V46, P536, DOI 10.1111/j.1095-8649.1995.tb05994.x; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DOMENICI P, 1991, J EXP BIOL, V156, P187; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Fore M, 2011, COMPUT ELECTRON AGR, V76, P240, DOI 10.1016/j.compag.2011.02.003; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Hale ME, 2002, J EXP BIOL, V205, P2005; Hall MA, 1998, AUST COMP S, V20, P181; HARPER DG, 1990, J EXP BIOL, V150, P321; HARPER DG, 1989, J EXP BIOL, V142, P465; Higham TE, 2007, INTEGR COMP BIOL, V47, P82, DOI 10.1093/icb/icm021; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kawabe R, 2003, FISHERIES SCI, V69, P3, DOI 10.1046/j.1444-2906.2003.00581.x; Lefrancois C, 2006, MAR BIOL, V149, P969, DOI 10.1007/s00227-006-0261-0; Madgwick Sebastian O H, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975346, DOI 10.1109/ICORR.2011.5975346; Makiguchi Y, 2012, J FISH BIOL, V80, P2345, DOI 10.1111/j.1095-8649.2012.03293.x; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Noda T, 2012, AQUAT BIOL, V16, P265, DOI 10.3354/ab00448; OBRIEN WJ, 1990, AM SCI, V78, P152; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Tanaka H, 2001, J EXP BIOL, V204, P3895; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; WEBB PW, 1984, AM ZOOL, V24, P107; WEBB PW, 1981, COPEIA, P901; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson A, 2013, NATURE; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79392	10.1371/journal.pone.0079392	http://dx.doi.org/10.1371/journal.pone.0079392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236126	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700125
J	Pfaffinger, PJ				Pfaffinger, Paul J.			A Conserved Pre-Block Interaction Motif Regulates Potassium Channel Activation and N-Type Inactivation	PLOS ONE			English	Article							SHAKER-K+ CHANNEL; ALIGNMENT EDITOR; PROTEIN-KINASE; ION-CHANNEL; CURRENTS; GATE; INHIBITORS; PEPTIDES; RECEPTOR; BINDING	N-type inactivation occurs when the N-terminus of a potassium channel binds into the open pore of the channel. This study examined the relationship between activation and steady state inactivation for mutations affecting the N-type inactivation properties of the Aplysia potassium channel AKv1 expressed in Xenopus oocytes. The results show that the traditional singlestep model for N-type inactivation fails to properly account for the observed relationship between steady state channel activation and inactivation curves. We find that the midpoint of the steady state inactivation curve depends in part on a secondary interaction between the channel core and a region of the N-terminus just proximal to the pore blocking peptide that we call the Inactivation Proximal (IP) region. The IP interaction with the channel core produces a negative shift in the activation and inactivation curves, without blocking the pore. A tripeptide motif in the IP region was identified in a large number of different N-type inactivation domains most likely reflecting convergent evolution in addition to direct descent. Point mutating a conserved hydrophobic residue in this motif eliminates the gating voltage shift, accelerates recovery from inactivation and decreases the amount of pore block produced during inactivation. The IP interaction we have identified likely stabilizes the open state and positions the pore blocking region of the N-terminus at the internal opening to the transmembrane pore by forming a Pre-Block (P state) interaction with residues lining the side window vestibule of the channel.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	paulp@bcm.edu			United States National Institutes of Health [R01GM090029, P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grants R01GM090029 and P30HD024064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich RW, 2001, NATURE, V411, P643, DOI 10.1038/35079705; Barros F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00049; Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; Camacho CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003342; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; Fineberg JD, 2012, J GEN PHYSIOL, V140, P513, DOI 10.1085/jgp.201210869; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; Gonzalez-Perez V, 2012, NATURE, V485, P133, DOI 10.1038/nature10994; Hille, 2001, ION CHANNELS EXCITAB; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Lee TE, 1996, J MEMBRANE BIOL, V151, P225, DOI 10.1007/s002329900073; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Q, 2008, BIOORGAN MED CHEM, V16, P3067, DOI 10.1016/j.bmc.2007.12.031; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; Prince A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062695; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhang ZH, 2004, J BIOL CHEM, V279, P29226, DOI 10.1074/jbc.M403290200; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79891	10.1371/journal.pone.0079891	http://dx.doi.org/10.1371/journal.pone.0079891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236164	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700165
J	Alashti, FA; Minuchehr, Z				Alashti, Fariborz Asghari; Minuchehr, Zarrin			MiRNAs Which Target CD3 Subunits Could Be Potential Biomarkers for Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; MICRORNA SIGNATURES; GASTRIC-CANCER; OVARIAN-CANCER; EXPRESSION; SERUM; PROLIFERATION; METASTASIS	Background: T-cells play an important role in the immune response and are activated in response to the presentation of antigens bound to major histocompatibility complex (MHC) molecules participating with the T-cell receptor (TCR). T-cell receptor complexes also contain four CD3 (cluster of differentiation 3) subunits. The TCR-CD3 complex is vital for T-cell development and plays an important role in intervening cell recognition events. Since microRNAs (miRNAs) are highly stable in blood serum, some of which may target CD3 molecules, they could serve as good biomarkers for early cancer detection. The aim of this study was to see whether there is a relationship between cancers and the amount of miRNAs -targeted CD3 molecules. Methods: Bioinformatics tools were used in order to predict the miRNA targets for these genes. Subsequently, these highly conserved miRNAs were evaluated to see if they are implicated in various kinds of cancers. Consequently, human disease databases were used. According to the latest research, this study attempted to investigate the possible down-or upregulation of miRNAs cancer patients. Results: We identified miRNAs which target genes producing CD3 subunit molecules. The most conserved miRNAs were identified for the CD3G gene, while CD247 and CD3EAP genes had the least number and there were no conserved miRNA associated with the CD3D gene. Some of these miRNAs were found to be responsible for different cancers, following a certain pattern. Conclusions: It is highly likely that miRNAs affect the CD3 molecules, impairing the immune system, recognizing and destroying cancer tumor; hence, they can be used as suitable biomarkers in distinguishing cancer in the very early stages of its development.	[Alashti, Fariborz Asghari; Minuchehr, Zarrin] Natl Inst Genet Engn & Biotechnol, Dept Bioinformat, Tehran, Iran		Alashti, FA (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Bioinformat, Tehran, Iran.	faalashti@yahoo.fr; minuchehr@nigeb.ac.ir		Minuchehr, Zarrin/0000-0002-3734-745X	National Institute of Genetic Engineering and Biotechnology Tehran, Iran [303, 346]	National Institute of Genetic Engineering and Biotechnology Tehran, Iran	This work was supported by the National Institute of Genetic Engineering and Biotechnology Tehran, Iran (Grant number 303 and 346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Bano R, 2011, AFR J BIOTECHNOL, V10, P3633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hauser S, 2012, CANCER EPIDEMIOL, V36, P391, DOI 10.1016/j.canep.2012.04.001; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Huang SD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-51; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ito T, 2011, INT J CANCER, V129, P2134, DOI 10.1002/ijc.25874; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Knowlton DL, 2011, J CANCER, V2, P490, DOI 10.7150/jca.2.490; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin J, 2001, J CELL SCI, V114, P243; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Olaru AV, 2011, HEPATOLOGY, V54, P2089, DOI 10.1002/hep.24591; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Sarma NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050826; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Schwertheim S, 2009, HORM METAB RES, V41, P475, DOI 10.1055/s-0029-1215593; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Sun L, 2009, J UROLOGY, V182, P2242, DOI 10.1016/j.juro.2009.07.034; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang Ping, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P535; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78790	10.1371/journal.pone.0078790	http://dx.doi.org/10.1371/journal.pone.0078790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244363	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600061
J	Bennett, CL; Chen, YZ; Vignali, M; Lo, RS; Mason, AG; Unal, A; Saifee, NPH; Fields, S; La Spada, AR				Bennett, Craig L.; Chen, Yingzhang; Vignali, Marissa; Lo, Russell S.; Mason, Amanda G.; Unal, Asli; Saifee, Nabiha P. Huq; Fields, Stanley; La Spada, Albert R.			Protein Interaction Analysis of Senataxin and the ALS4 L389S Mutant Yields Insights into Senataxin Post-Translational Modification and Uncovers Mutant-Specific Binding with a Brain Cytoplasmic RNA-Encoded Peptide	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OCULOMOTOR APRAXIA TYPE-2; DENDRITIC BC1 RNA; BC200 RNA; POLY(A)-BINDING PROTEIN; TRANSLATIONAL CONTROL; FUNCTIONAL-ROLE; NONCODING RNAS; DNA-REPAIR; FRAGILE-X	Senataxin is a large 303 kDa protein linked to neuron survival, as recessive mutations cause Ataxia with Oculomotor Apraxia type 2 (AOA2), and dominant mutations cause amyotrophic lateral sclerosis type 4 (ALS4). Senataxin contains an amino-terminal protein-interaction domain and a carboxy-terminal DNA/RNA helicase domain. In this study, we focused upon the common ALS4 mutation, L389S, by performing yeast two-hybrid screens of a human brain expression library with control senataxin or L389S senataxin as bait. Interacting clones identified from the two screens were collated, and redundant hits and false positives subtracted to yield a set of 13 protein interactors. Among these hits, we discovered a highly specific and reproducible interaction of L389S senataxin with a peptide encoded by the antisense sequence of a brain-specific non-coding RNA, known as BCYRN1. We further found that L389S senataxin interacts with other proteins containing regions of conserved homology with the BCYRN1 reverse complement-encoded peptide, suggesting that such aberrant protein interactions may contribute to L389S ALS4 disease pathogenesis. As the yeast two-hybrid screen also demonstrated senataxin self-association, we confirmed senataxin dimerization via its amino-terminal binding domain and determined that the L389S mutation does not abrogate senataxin self-association. Finally, based upon detection of interactions between senataxin and ubiquitin-SUMO pathway modification enzymes, we examined senataxin for the presence of ubiquitin and SUMO monomers, and observed this post-translational modification. Our senataxin protein interaction study reveals a number of features of senataxin biology that shed light on senataxin normal function and likely on senataxin molecular pathology in ALS4.	[Bennett, Craig L.] James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Bennett, Craig L.; Mason, Amanda G.; Unal, Asli; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Chen, Yingzhang] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Vignali, Marissa; Lo, Russell S.; Fields, Stanley] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA; [Saifee, Nabiha P. Huq] Univ Washington, Med Ctr, Dept Pharmacol, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [La Spada, Albert R.] Rady Childrens Hosp, La Jolla, CA USA	James Cook University; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Bennett, CL (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia.	crbennett@ucsd.edu	La Spada, Albert/AAG-8809-2020	Huq Saifee, Nabiha/0000-0003-1646-9201; Lipton, Stuart/0000-0002-3490-1259; Bennett, CRAIG/0000-0002-5847-1687; Vignali, Marissa/0000-0002-7319-3371	NHMRC [APP1045520];  [R01 GM094384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094384, T32GM007266, T32GM008666, P41GM103533] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM094384 to C. L. B. and A. R. L., and by NHMRC project grant APP1045520 to C. L. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERUCCIO F, 1991, J EXP MED, V173, P941, DOI 10.1084/jem.173.4.941; Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Avemaria F, 2011, AMYOTROPH LATERAL SC, V12, P228, DOI 10.3109/17482968.2011.566930; Banerjee A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006193; Bassuk AG, 2007, NEUROGENETICS, V8, P45, DOI 10.1007/s10048-006-0067-8; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; De Amicis A, 2011, DNA REPAIR, V10, P199, DOI 10.1016/j.dnarep.2010.10.012; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Myrianthopoulos NC, 1960, BRAIN, V83, P589; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Rabin BA, 1999, BRAIN, V122, P1539, DOI 10.1093/brain/122.8.1539; Rudnik-Schoneborn S, 2011, EUR J HUM G IN PRESS; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1995, MOL GEN GENET, V249, P571, DOI 10.1007/BF00418026; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vantaggiato C, 2011, BRAIN, V134, P1808, DOI 10.1093/brain/awr084; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang HD, 2004, NEUROSCIENTIST, V10, P456, DOI 10.1177/1073858404265866; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	56	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78837	10.1371/journal.pone.0078837	http://dx.doi.org/10.1371/journal.pone.0078837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244371	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327221600068
J	Lin, XZ; Luo, J; Zhang, LP; Wang, W; Gou, DM				Lin, Xianzi; Luo, Jun; Zhang, Liping; Wang, Wei; Gou, Deming			MiR-103 Controls Milk Fat Accumulation in Goat (Capra hircus) Mammary Gland during Lactation	PLOS ONE			English	Article							MICRORNA EXPRESSION; TRIGLYCERIDE ACCUMULATION; CONSERVED MICRORNAS; ACID-COMPOSITION; GENE NETWORKS; IDENTIFICATION; DIFFERENTIATION; CELLS; COW; TRANSCRIPTION	Milk is the primary source of nutrition for young mammals including humans. The nutritional value of milk is mainly attributable to fats and proteins fractions. In comparison to cow milk, goat milk contains greater amounts of total fat, including much higher levels of the beneficial unsaturated fatty acids. MicroRNAs (miRNAs), a well-defined group of small RNAs containing about 22 nucleotides (nt), participate in various metabolic processes across species. However, little is known regarding the role of miRNAs in regulating goat milk composition. In the present study, we performed high-throughput sequencing to identify mammary gland-enriched miRNAs in lactating goats. We identified 30 highly expressed miRNAs in the mammary gland, including miR-103. Further studies revealed that miR-103 expression correlates with the lactation. Further functional analysis showed that over-expression of miR-103 in mammary gland epithelial cells increases transcription of genes associated with milk fat synthesis, resulting in an up-regulation of fat droplet formation, triglyceride accumulation, and the proportion of unsaturated fatty acids. This study provides new insight into the functions of miR-103, as well as the molecular mechanisms that regulate milk fat synthesis.	[Lin, Xianzi; Luo, Jun; Zhang, Liping] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Wang, Wei] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Gou, Deming] Shenzhen Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Northwest A&F University - China; University of Alabama System; University of Alabama Tuscaloosa; Shenzhen University	Luo, J (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	luojun@nwsuaf.edu.cn		Wang, Wei/0000-0001-9511-3611	Special Fund for Agro-scientific Research in the Public Interest [201103038]; National Natural Science Foundation of China [31072013]; Transgenic New Species Breeding Program of China [2009ZX08009-162B]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transgenic New Species Breeding Program of China	Solexa sequencing was funded by the Special Fund for Agro-scientific Research in the Public Interest (201103038); qRT-PCR was funded by the National Natural Science Foundation of China (31072013); fatty acid analysis was funded by the Transgenic New Species Breeding Program of China (2009ZX08009-162B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuGhazaleh AA, 2009, J DAIRY SCI, V92, P6156, DOI 10.3168/jds.2009-2400; Alferez MJM, 2001, J DAIRY RES, V68, P451, DOI 10.1017/S0022029901004903; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; BABAYAN VK, 1981, J AM OIL CHEM SOC, V58, pA49, DOI 10.1007/BF02666072; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Cheng YX, 2011, INFLAMMATION, V34, P698, DOI 10.1007/s10753-010-9281-5; Chilliard Y, 2004, REPROD NUTR DEV, V44, P467, DOI 10.1051/rnd:2004052; Chilliard Y, 2000, ANN ZOOTECH, V49, P181, DOI 10.1051/animres:2000117; Clegg RA, 2001, LIVEST PROD SCI, V70, P3, DOI 10.1016/S0301-6226(01)00194-4; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Cortes C, 2010, J DAIRY SCI, V93, P3146, DOI 10.3168/jds.2009-2905; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; Doreau M, 2011, ANIM PROD SCI, V51, P19, DOI 10.1071/AN10043; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Ecker J, 2007, BIOCHEM BIOPH RES CO, V352, P805, DOI 10.1016/j.bbrc.2006.11.087; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fielding BA, 1998, BRIT J NUTR, V80, P495, DOI 10.1017/S0007114598001585; Fontanesi L, 2007, ITAL J ANIM SCI, V6, P133, DOI 10.4081/ijas.2007.1s.133; Frost RJA, 2010, J CARDIOVASC TRANSL, V3, P280, DOI 10.1007/s12265-010-9173-y; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; German T, 2002, IN VITRO CELL DEV-AN, V38, P282; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Haenlein GFW, 2001, J DAIRY SCI, V84, P2097, DOI 10.3168/jds.S0022-0302(01)74655-3; HANSEN HO, 1984, BIOCHEM J, V220, P513, DOI 10.1042/bj2200513; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Jeppesen J, 2012, J PHYSIOL-LONDON, V590, P1059, DOI 10.1113/jphysiol.2011.225011; Ji ZB, 2012, MOL BIOL RE IN PRESS; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Juarez M., 1987, INT DAIRY FED, V202, P54; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KNIGHT CH, 1982, J REPROD FERTIL, V65, P521, DOI 10.1530/jrf.0.0650521; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson L., 2013, LACT COMPR TREATISE, V2, P31, DOI [10.1016/B978-0-12-436702-9.50008-8, DOI 10.1016/B978-0-12-436702-9.50008-8]; Lee S, 2011, J CLIN VIROL, V52, P272, DOI 10.1016/j.jcv.2011.08.012; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morand-Fehr P, 2007, SMALL RUMINANT RES, V68, P20, DOI 10.1016/j.smallrumres.2006.09.019; Mosley EE, 2002, J LIPID RES, V43, P290; Moura RR, 2011, BRAZ ARCH BIOL TECHN, V54, P927, DOI 10.1590/S1516-89132011000500010; NICKERSON TA, 1960, J DAIRY SCI, V43, P598, DOI 10.3168/jds.S0022-0302(60)90210-1; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; PATTON S, 1973, J AM OIL CHEM SOC, V50, P178, DOI 10.1007/BF02640487; Ramsay TG, 2003, J ANIM SCI, V81, P3008; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; REBUFFESCRIVE M, 1985, J CLIN INVEST, V75, P1973, DOI 10.1172/JCI111914; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sahlu T, 1999, SMALL RUMINANT RES, V33, P25, DOI 10.1016/S0921-4488(99)00003-6; Sahlu T, 2005, SMALL RUMINANT RES, V60, P7, DOI 10.1016/j.smallrumres.2005.06.002; Samkova E, 2012, S AFR J ANIM SCI, V42, P83, DOI 10.4314/sajas.v42i2.1; Sanchez-Hidalgo M, 2007, AM J PHYSIOL-REG I, V292, pR2208, DOI 10.1152/ajpregu.00013.2007; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Serment A, 2011, J DAIRY SCI, V94, P3960, DOI 10.3168/jds.2010-4041; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; SONNENBERG A, 1986, J HISTOCHEM CYTOCHEM, V34, P1037, DOI 10.1177/34.8.2426332; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Teleman AA, 2010, CELL METAB, V11, P8, DOI 10.1016/j.cmet.2009.12.004; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Binsbergen R, 2012, J DAIRY SCI, V95, P2132, DOI 10.3168/jds.2011-4725; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/G11-069, 10.1139/g11-069]; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Zhang Y, 2011, J AGR FOOD CHEM, V59, P11526, DOI 10.1021/jf2028494; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P	97	67	75	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79258	10.1371/journal.pone.0079258	http://dx.doi.org/10.1371/journal.pone.0079258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244462	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600120
J	Ran, JH; Shen, TT; Liu, WJ; Wang, XQ				Ran, Jin-Hua; Shen, Ting-Ting; Liu, Wen-Juan; Wang, Xiao-Quan			Evolution of the bHLH Genes Involved in Stomatal Development: Implications for the Expansion of Developmental Complexity of Stomata in Land Plants	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; ADIANTUM-CAPILLUS-VENERIS; WATER-USE EFFICIENCY; GENOME-WIDE; ARABIDOPSIS; FERN; SELECTION; SEQUENCE; CO2; MECHANISMS	Stomata play significant roles in plant evolution. A trio of closely related basic Helix-Loop-Helix (bHLH) subgroup Ia genes, SPCH, MUTE and FAMA, mediate sequential steps of stomatal development, and their functions may be conserved in land plants. However, the evolutionary history of the putative SPCH/MUTE/FAMA genes is still greatly controversial, especially the phylogenetic positions of the bHLH Ia members from basal land plants. To better understand the evolutionary pattern and functional diversity of the bHLH genes involved in stomatal development, we made a comprehensive evolutionary analysis of the homologous genes from 54 species representing the major lineages of green plants. The phylogenetic analysis indicated: (1) All bHLH Ia genes from the two basal land plants Physcomitrella and Selaginella were closely related to the FAMA genes of seed plants; and (2) the gymnosperm 'SPCH' genes were sister to a clade comprising the angiosperm SPCH and MUTE genes, while the FAMA genes of gymnosperms and angiosperms had a sister relationship. The revealed phylogenetic relationships are also supported by the distribution of gene structures and previous functional studies. Therefore, we deduce that the function of FAMA might be ancestral in the bHLH Ia subgroup. In addition, the gymnosperm "SPCH'' genes may represent an ancestral state and have a dual function of SPCH and MUTE, two genes that could have originated from a duplication event in the common ancestor of angiosperms. Moreover, in angiosperms, SPCHs have experienced more duplications and harbor more copies than MUTEs and FAMAs, which, together with variation of the stomatal development in the entry division, implies that SPCH might have contributed greatly to the diversity of stomatal development. Based on the above, we proposed a model for the correlation between the evolution of stomatal development and the genes involved in this developmental process in land plants.	[Ran, Jin-Hua; Shen, Ting-Ting; Liu, Wen-Juan; Wang, Xiao-Quan] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Ran, JH (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	jinhua_ran@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [30870166, 30990240, 30425028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant numbers 30870166, 30990240 and 30425028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakos P, 1997, PROTOPLASMA, V198, P93, DOI 10.1007/BF01282135; Bateman RM, 1998, ANNU REV ECOL SYST, V29, P263, DOI 10.1146/annurev.ecolsys.29.1.263; Beerling DJ, 2009, NEW PHYTOL, V183, P921, DOI 10.1111/j.1469-8137.2009.02973.x; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; Chater C, 2011, CURR BIOL, V21, P1025, DOI 10.1016/j.cub.2011.04.032; Croxdale JL, 2000, AM J BOT, V87, P1069, DOI 10.2307/2656643; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Darwin F, 1898, PHILOS T R S LONDON, V190, P531, DOI DOI 10.1098/RSTB.1898.0009; de Boer HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2217; Delaux PM, 2012, PERSPECT PLANT ECOL, V14, P49, DOI 10.1016/j.ppees.2011.09.001; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Doi M, 2006, PLANT CELL PHYSIOL, V47, P748, DOI 10.1093/pcp/pcj048; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOHNSON RW, 1981, AM J BOT, V68, P260, DOI 10.2307/2442858; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; MacAlister CA, 2011, EVOL DEV, V13, P182, DOI 10.1111/j.1525-142X.2011.00468.x; Maddison W, MESQUITE MODULAR SYS; McAdam SAM, 2013, NEW PHYTOL, V198, P429, DOI 10.1111/nph.12190; McAdam SAM, 2012, ECOL LETT, V15, P1, DOI 10.1111/j.1461-0248.2011.01700.x; McAdam SAM, 2011, J EXP BOT, V62, P195, DOI 10.1093/jxb/erq260; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; PAYNE WW, 1979, TAXON, V28, P117, DOI 10.2307/1219566; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Ran JH, 2010, MOL PHYLOGENET EVOL, V54, P136, DOI 10.1016/j.ympev.2009.09.011; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; ROBINSON JM, 1994, PLANT CELL ENVIRON, V17, P345, DOI 10.1111/j.1365-3040.1994.tb00303.x; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rudall PJ, 2013, NEW PHYTOL, V200, P598, DOI 10.1111/nph.12406; Rudall PJ, 2012, INT J PLANT SCI, V173, P849, DOI 10.1086/667230; Ruszala EM, 2011, CURR BIOL, V21, P1030, DOI 10.1016/j.cub.2011.04.044; SACK FD, 1985, AM J BOT, V72, P1325, DOI 10.2307/2443504; SACK FD, 1994, AM J BOT, V81, P339, DOI 10.2307/2445461; STEBBINS GL, 1960, DEV BIOL, V2, P409, DOI 10.1016/0012-1606(60)90025-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Torii Keiko U., 2008, V9, P343, DOI 10.1007/7089_2007_135; Vaten A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-11; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	61	28	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78997	10.1371/journal.pone.0078997	http://dx.doi.org/10.1371/journal.pone.0078997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244399	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600091
J	Srinivasan, P; Subramanian, VS; Said, HM				Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.			Effect of the Cigarette Smoke Component, 4(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK), on Physiological and Molecular Parameters of Thiamin Uptake by Pancreatic Acinar Cells	PLOS ONE			English	Article							DEFICIENCY; EXPRESSION; NICOTINE; SLC19A2; INFLAMMATION; CARCINOGEN; SECRETION; INSULIN; GLUCOSE; ANEMIA	Thiamin is indispensable for the normal function of pancreatic acinar cells. These cells take up thiamin via specific carrier-mediated process that involves thiamin transporter-1 and -2 (THTR-1 and THTR-2; products of SLC19A2 and SLC19A3 genes, respectively). In this study we examined the effect of chronic exposure of pancreatic acinar cells in vitro (pancreatic acinar 266-6 cells) and in vivo (wild-type and transgenic mice carrying the SLC19A2 and SLC19A3 promoters) to the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on physiological and molecular parameters of the thiamin uptake process. The results show that chronic exposure of 266-6 cells to NNK (3 mu M, 24 h) leads to a significant inhibition in thiamin uptake. The inhibition was associated with a significant decrease in the level of expression of THTR-1 and -2 at the protein and mRNA levels as well as in the activity of SLC19A2 and SLC19A3 promoters. Similarly chronic exposure of mice to NNK (IP 10 mg/100 g body weight, three times/week for 2 weeks) leads to a significant inhibition in thiamin uptake by freshly isolated pancreatic acinar cells, as well as in the level of expression of THTR-1 and -2 protein and mRNA. Furthermore, activity of the SLC19A2 and SLC19A3 promoters expressed in transgenic mice were significantly suppressed by chronic exposure to NNK. The effect of NNK on the activity of the SLC19A2 and SLC19A3 promoters was not mediated via changes in their methylation profile, rather it appears to be exerted via an SP1/GG and SP1/GC cis-regulatory elements in these promoters, respectively. These results demonstrate, for the first time, that chronic exposure of pancreatic acinar cells to NNK negatively impacts the physiological and molecular parameters of thiamin uptake by pancreatic acinar cells and that this effect is exerted, at least in part, at the level of transcription of the SLC19A2 and SLC19A3 genes.	[Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Vet Adm Med Ctr, Dept Med Res, Long Beach, CA 90822 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Said, HM (corresponding author), Vet Adm Med Ctr, Dept Med Res, Long Beach, CA 90822 USA.	hmsaid@uci.edu	Srinivasan, Padmanabhan/A-9227-2016	Srinivasan, Padmanabhan/0000-0003-2067-7273	National Institutes of Health [AA018071, DK56061]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056061, R37DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institutes of Health (AA018071 and DK56061) and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre M, 2012, AM J PHYSIOL-GASTR L, V303, pG696, DOI 10.1152/ajpgi.00138.2012; Alexandre M, 2011, PANCREATOLOGY, V11, P469, DOI 10.1159/000332196; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Berdanier C.D., 2018, ADV NUTR MACRONUTRIE; BETTENDORFF L, 1995, J NEUROCHEM, V64, P2013; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; HECHT SS, 1978, J NATL CANCER I, V60, P819, DOI 10.1093/jnci/60.4.819; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li YY, 2011, METHODS MOL BIOL, V791, P11, DOI 10.1007/978-1-61779-316-5_2; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Mee L, 2009, AM J PHYSIOL-GASTR L, V297, pG197, DOI 10.1152/ajpgi.00092.2009; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; PRASANNAN KG, 1977, EXPERIENTIA, V33, P169, DOI 10.1007/BF02124046; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; RATHANASWAMI P, 1991, BIOCHEM INT, V24, P1057; RATHANASWAMI P, 1991, BIOCHEM INT, V25, P577; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; Said HM, 2010, AM J PHYSIOL-GASTR L, V298, pG985, DOI 10.1152/ajpgi.00068.2010; SINGH M, 1982, AM J CLIN NUTR, V36, P500, DOI 10.1093/ajcn/36.3.500; Subramanian VS, 2012, AM J PHYSIOL-GASTR L, V302, pG572, DOI 10.1152/ajpgi.00484.2011; Subramanya SB, 2011, AM J PHYSIOL-GASTR L, V301, pG896, DOI 10.1152/ajpgi.00308.2011; Tanphaichitr V., 1994, MODERN NUTR HLTH DIS, P359; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Word B, 2013, INT J TOXICOL, V32, P23, DOI 10.1177/1091581812465902; Xu H, 2007, EUR RESPIR J, V30, P633, DOI 10.1183/09031936.00014107	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78853	10.1371/journal.pone.0078853	http://dx.doi.org/10.1371/journal.pone.0078853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244374	Green Published, gold			2022-12-25	WOS:000327162900025
J	Chan, SW; Lim, CJ; Guo, FS; Tan, I; Leung, T; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Guo, Fusheng; Tan, Ivan; Leung, Thomas; Hong, Wanjin			Actin-binding and Cell Proliferation Activities of Angiomotin Family Members Are Regulated by Hippo Pathway-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Proliferation; Phosphorylation; Protein Kinases; Signal Transduction; Angiomotin; Hippo Pathway; LATS Kinase	TUMOR-SUPPRESSOR; BREAST-CANCER; MIGRATION; PROTEINS; TAZ; P130-ANGIOMOTIN; ANGIOGENESIS; EXPRESSION; INVASION; KINASES	Whether the Hippo pathway has downstream targets other than YAP and TAZ is unknown. In this report, we have identified angiomotin (Amot) family members as novel substrates of Hippo core kinases. The N-terminal regions of Amot proteins contain a conserved HXRXXS consensus site for LATS1/2-mediated phosphorylation. Phospho-specific antibodies showed that Hippo core kinases could mediate phosphorylation of endogenous as well as exogenous Amot family members. Knockdown of LATS1 and LATS2 endogenously reduced the phosphorylation of Amots detected by the phospho-specific antibodies. Mutation of the serine to alanine within this HXRXXS site in Amot and AmotL2 established that this site was essential for Hippo core kinase-mediated phosphorylation. Wild-type and non-phosphorylated Amot (Amot-S175A) were targeted to actin filaments, whereas phospho-mimic Amot (Amot-S175D) failed to be localized with actin. Overexpression of LATS2 caused dissociation of Amot from actin but not Amot-S175A. Mapping of the actin-binding site of Amot showed that serine 175 of Amot was important for the actin-binding activity. Amot-S175A promoted, whereas Amot and Amot-S175D inhibited, cell proliferation. These results collectively suggest that the Hippo pathway negatively regulates the actin-binding activity of Amot family members through direct phosphorylation.	[Chan, Siew Wee; Lim, Chun Jye; Guo, Fusheng; Tan, Ivan; Leung, Thomas; Hong, Wanjin] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Hong, Wanjin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chan, SW (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbcsw@imcb.a-star.edu.sg; mcbhwj@imcb.a-star.edu.sg			Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Bossuyt W., 2013, ONCOGENE, DOI 10.1038/onc.2013.82; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	24	69	70	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37296	37307		10.1074/jbc.M113.527598	http://dx.doi.org/10.1074/jbc.M113.527598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225952	Green Published, hybrid			2022-12-25	WOS:000329189700046
J	Bagag, A; Jault, JM; Sidahmed-Adrar, N; Refregiers, M; Giuliani, A; Le Naour, F				Bagag, Aicha; Jault, Jean-Michel; Sidahmed-Adrar, Nazha; Refregiers, Matthieu; Giuliani, Alexandre; Le Naour, Francois			Characterization of Hydrophobic Peptides in the Presence of Detergent by Photoionization Mass Spectrometry	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PHOTOIONIZATION; BINDING CASSETTE TRANSPORTER; INTEGRAL MEMBRANE-PROTEINS; BACILLUS-SUBTILIS; TETRASPANIN WEB; ABC TRANSPORTER; PROTEOMICS; IDENTIFICATION; IONIZATION; BMRA	The characterization of membrane proteins is still challenging. The major issue is the high hydrophobicity of membrane proteins that necessitates the use of detergents for their extraction and solubilization. The very poor compatibility of mass spectrometry with detergents remains a tremendous obstacle in studies of membrane proteins. Here, we investigated the potential of atmospheric pressure photoionization (APPI) for mass spectrometry study of membrane proteins. This work was focused on the tetraspanin CD9 and the multidrug transporter BmrA. A set of peptides from CD9, exhibiting a broad range of hydropathicity, was investigated using APPI as compared to electrospray ionization (ESI). Mass spectrometry experiments revealed that the most hydrophobic peptides were hardly ionized by ESI whereas all peptides, including the highly hydrophobic one that corresponds to the full sequence of the first transmembrane domain of CD9, were easily ionized by APPI. The native protein BmrA purified in the presence of the non-ionic detergent beta-D-dodecyl maltoside (DDM) was digested in-solution using trypsin. The resulting peptides were investigated by flow injection analysis of the mixture followed by mass spectrometry. Upon ESI, only detergent ions were detected and the ionic signals from the peptides were totally suppressed. In contrast, APPI allowed many peptides distributed along the sequence of the protein to be detected. Furthermore, the parent ion corresponding to the first transmembrane domain of the protein BmrA was detected under APPI conditions. Careful examination of the APPI mass spectrum revealed a-, b-, c-and y- fragment ions generated by in-source fragmentation. Those fragment ions allowed unambiguous structural characterization of the transmembrane domain. In conclusion, APPI-MS appears as a versatile method allowing the ionization and fragmentation of hydrophobic peptides in the presence of detergent.	[Bagag, Aicha; Sidahmed-Adrar, Nazha; Le Naour, Francois] INSERM, U785, Villejuif, France; [Bagag, Aicha; Sidahmed-Adrar, Nazha; Le Naour, Francois] Univ Paris 11, Inst Andre Lwoff, Villejuif, France; [Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Jault, Jean-Michel] CNRS, UMR 5075, Grenoble, France; [Jault, Jean-Michel] CEA, Inst Biol Struct, Grenoble, France; [Refregiers, Matthieu; Giuliani, Alexandre] Synchrotron SOLEIL, Gif Sur Yvette, France; [Giuliani, Alexandre] INRA, UAR CEPIA 1008, F-44026 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron; INRAE	Le Naour, F (corresponding author), INSERM, U785, Villejuif, France.	francois.le-naour@inserm.fr	Réfrégiers, Matthieu/AAE-2075-2022; jault, jean-michel/G-2086-2012; ahmed, nazha sid/AAD-4538-2020; Giuliani, Alexandre/C-1476-2011; Réfrégiers, Matthieu/A-4249-2011	jault, jean-michel/0000-0003-1743-2777; Giuliani, Alexandre/0000-0003-1710-4933; Réfrégiers, Matthieu/0000-0002-3281-2308	PRES UniverSud Paris; Fondation pour la Recherche Medicale (FRM)	PRES UniverSud Paris; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by PRES UniverSud Paris and Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; Bagag A, 2011, INT J MASS SPECTROM, V299, P1, DOI 10.1016/j.ijms.2010.08.010; Bagag A, 2012, INT J MASS SPECTROM, V328, P23, DOI 10.1016/j.ijms.2012.07.021; Bagag A, 2011, RAPID COMMUN MASS SP, V25, P3436, DOI 10.1002/rcm.5242; Bensalem N, 2007, J PROTEOME RES, V6, P1595, DOI 10.1021/pr0606272; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Carroll J, 2007, P NATL ACAD SCI USA, V104, P14330, DOI 10.1073/pnas.0706817104; Chambrion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011219; Cristoni S, 2002, RAPID COMMUN MASS SP, V16, P1686, DOI 10.1002/rcm.772; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Debois D, 2006, J MASS SPECTROM, V41, P1554, DOI 10.1002/jms.1122; Delobel A, 2003, ANAL CHEM, V75, P5961, DOI 10.1021/ac034532k; Do Cao MA, 2009, PROTEIN SCI, V18, P1507, DOI 10.1002/pro.141; Funk J, 2005, RAPID COMMUN MASS SP, V19, P2986, DOI 10.1002/rcm.2142; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Gaudin M, 2012, J AM SOC MASS SPECTR, V23, P869, DOI 10.1007/s13361-012-0341-y; Gilmore JM, 2010, J PROTEOMICS, V73, P2078, DOI 10.1016/j.jprot.2010.08.005; Giuliani A, 2006, EUR J MASS SPECTROM, V12, P189, DOI 10.1255/ejms.803; Giuliani A, 2012, NUCL INSTRUM METH B, V279, P114, DOI 10.1016/j.nimb.2011.10.038; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; Kauppila TJ, 2002, ANAL CHEM, V74, P5470, DOI 10.1021/ac025659x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Naour F, 2004, CANCER IMMUNOL IMMUN, V53, P148, DOI 10.1007/s00262-003-0477-5; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Lin Y, 2010, ELECTROPHORESIS, V31, P2705, DOI 10.1002/elps.201000161; Linke D, 2009, METHOD ENZYMOL, V463, P603, DOI 10.1016/S0076-6879(09)63034-2; Lu BW, 2008, PROTEOMICS, V8, P3947, DOI 10.1002/pmic.200800120; Matar-Merheb R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018036; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Robb DB, 2000, ANAL CHEM, V72, P3653, DOI 10.1021/ac0001636; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Syage JA, 2004, J AM SOC MASS SPECTR, V15, P1521, DOI 10.1016/j.jasms.2004.07.006; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262	47	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79033	10.1371/journal.pone.0079033	http://dx.doi.org/10.1371/journal.pone.0079033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236085	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700083
J	Santos, LEC; da Silveira, GA; Costa, VDC; Batista, AG; Madureira, AP; Rodrigues, AM; Scorza, CA; Amorim, HA; Arida, RM; Duarte, MA; Scorza, FA; Cavalheiro, EA; de Almeida, ACG				Canton Santos, Luiz Eduardo; da Silveira, Gilcelio Amaral; Cupertino Costa, Victor Diego; Batista, Aline Gisele; Madureira, Ana Paula; Rodrigues, Antonio Marcio; Scorza, Carla Alessandra; Amorim, Henrique Alves; Arida, Ricardo Mario; Duarte, Mario Antonio; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao; de Almeida, Antonio-Carlos Guimaraes			Alcohol Abuse Promotes Changes in Non-Synaptic Epileptiform Activity with Concomitant Expression Changes in Cotransporters and Glial Cells	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; UP-REGULATION; BRAIN-DAMAGE; SEIZURES; EXPOSURE; MODEL; NEURONS; STROKE; DEATH; NMDA	Non-synaptic mechanisms are being considered the common factor of brain damage in status epilepticus and alcohol intoxication. The present work reports the influence of the chronic use of ethanol on epileptic processes sustained by non-synaptic mechanisms. Adult male Wistar rats administered with ethanol (1, 2 e 3 g/kg/d) during 28 days were compared with Control. Non-synaptic epileptiform activities (NEAs) were induced by means of the zero-calcium and high-potassium model using hippocampal slices. The observed involvement of the dentate gyrus (DG) on the neurodegeneration promoted by ethanol motivated the monitoring of the electrophysiological activity in this region. The DG regions were analyzed for the presence of NKCC1, KCC2, GFAP and CD11b immunoreactivity and cell density. The treated groups showed extracellular potential measured at the granular layer with increased DC shift and population spikes (PS), which was remarkable for the group E1. The latencies to the NEAs onset were more prominent also for the treated groups, being correlated with the neuronal loss. In line with these findings were the predispositions of the treated slices for neuronal edema after NEAs induction, suggesting that restrict inter-cell space counteracts the neuronal loss and subsists the hyper-synchronism. The significant increase of the expressions of NKCC1 and CD11b for the treated groups confirms the existence of conditions favorable to the observed edematous necrosis. The data suggest that the ethanol consumption promotes changes on the non-synaptic mechanisms modulating the NEAs. For the lower ethanol dosage the neurophysiological changes were more effective suggesting to be due to the less intense neurodegenertation.	[Canton Santos, Luiz Eduardo; da Silveira, Gilcelio Amaral; Cupertino Costa, Victor Diego; Batista, Aline Gisele; Madureira, Ana Paula; Rodrigues, Antonio Marcio; Duarte, Mario Antonio; de Almeida, Antonio-Carlos Guimaraes] Univ Fed Sao Joao del Rei, Dept Engn Biossistemas, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, MG, Brazil; [Scorza, Carla Alessandra; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Neurol Expt, Sao Paulo, Brazil; [Amorim, Henrique Alves] Univ Fed Sao Paulo, Dept Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil; [Arida, Ricardo Mario] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Fisiol, Sao Paulo, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Almeida, ACG (corresponding author), Univ Fed Sao Joao del Rei, Dept Engn Biossistemas, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, MG, Brazil.	acga@ufsj.edu.br	ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/B-8028-2008; Cavalheiro, Esper A/I-3084-2016; Scorza, Carla A/AAV-2417-2020; Rodrigues, Antônio M/D-3953-2012; Arida, Ricardo M/E-2667-2013; Arida, Ricardo Mario/P-7408-2016; Cavalheiro, Esper A/F-4325-2014; Scorza, Fulvio/C-7048-2013; Santos, Luiz Eduardo Canton/AAY-8087-2020; Scorza, Carla Alessandra/C-4199-2013; Santos, Luiz Eduardo/E-9888-2018; Cavalheiro, Esper/N-3985-2019	ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/0000-0003-4893-338X; Cavalheiro, Esper A/0000-0002-0854-3582; Scorza, Carla A/0000-0001-7810-4748; Rodrigues, Antônio M/0000-0002-2678-9180; Arida, Ricardo M/0000-0002-0908-3274; Arida, Ricardo Mario/0000-0002-7771-6133; Cavalheiro, Esper A/0000-0002-0854-3582; Scorza, Fulvio/0000-0002-0694-8674; Scorza, Carla Alessandra/0000-0001-7810-4748; Santos, Luiz Eduardo/0000-0002-5465-2333; Cavalheiro, Esper/0000-0002-0854-3582; Amorim, Henrique/0000-0003-0611-1118	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPEMIG; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), FAPEMIG, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN KV, 1994, NEUROSCI LETT, V165, P211; Almeida A.C.G., 2011, UNDERLING MECH EPILE, V1, P189; Almeida AC, 2008, EPILEPSIA, V49, P1; ANTON RF, 1987, ALCOHOL CLIN EXP RES, V11, P10, DOI 10.1111/j.1530-0277.1987.tb01251.x; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Bartolomei F, 2006, EPILEPTIC DISORD, V8, pS72; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bikson M, 1999, J NEUROPHYSIOL, V82, P2262, DOI 10.1152/jn.1999.82.5.2262; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Castilla-Guerra L, 2006, EPILEPSIA, V47, P1990, DOI 10.1111/j.1528-1167.2006.00861.x; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; COHEN SM, 1993, BRAIN RES, V601, P80, DOI 10.1016/0006-8993(93)91697-Q; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5; DIAMOND I, 1994, WESTERN J MED, V161, P279; Diamond I, 1996, CECILS TXB MED, V20, P47; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Farr SA, 2005, ALCOHOL CLIN EXP RES, V29, P971, DOI 10.1097/01.ALC.0000171038.03371.56; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Fox JE, 2004, J NEUROPHYSIOL, V92, P181, DOI 10.1152/jn.00123.2004; Freedland Eric S., 1993, Journal of Emergency Medicine, V11, P463, DOI 10.1016/0736-4679(93)90251-2; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; FULLER TA, 1981, NEUROBEH TOXICOL TER, V3, P355; GONZALES RA, 1991, TRENDS PHARMACOL SCI, V12, P1, DOI 10.1016/0165-6147(91)90478-B; HAUSER WA, 1988, EPILEPSIA, V29, pS66, DOI 10.1111/j.1528-1157.1988.tb05800.x; Hughes JR, 2009, EPILEPSY BEHAV, V15, P92, DOI 10.1016/j.yebeh.2009.02.037; Ingolfsson HI, 2011, BIOPHYS J, V101, P847, DOI 10.1016/j.bpj.2011.07.013; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Little HJ, 1999, PHARMACOL THERAPEUT, V84, P333, DOI 10.1016/S0163-7258(99)00040-6; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; Lucocq John Milton, 2007, Proceedings Microscopy Conference 2007, P166, DOI 10.1017/S143192760708083X; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Morales-Aza BM, 2004, NEUROBIOL DIS, V17, P62, DOI 10.1016/j.nbd.2004.05.010; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Obernier JA, 2001, PHARM BIOCH BEHAV, V72, P1; Okabe A, 2002, NEUROSCI RES, V44, P225, DOI 10.1016/S0168-0102(02)00093-7; OLNEY JW, 2002, ENCY HUMAN BRAIN, V1, P87; Palmer RHC, 2012, DRUG ALCOHOL DEPEN, V125, P179, DOI 10.1016/j.drugalcdep.2012.07.005; Pan EH, 1996, J NEUROPHYSIOL, V75, P124, DOI 10.1152/jn.1996.75.1.124; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; ROPER SN, 1993, J NEUROPHYSIOL, V70, P857, DOI 10.1152/jn.1993.70.2.857; SATO N, 1991, AM J PHYSIOL, V260, pE946, DOI 10.1152/ajpendo.1991.260.6.E946; Scorza FA, 2003, NEUROSCI RES, V47, P323, DOI 10.1016/S0168-0102(03)00220-7; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SIGGINS GR, 1980, PHARMACOL BIOCHEM BE, V13, P203, DOI 10.1016/S0091-3057(80)80032-3; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Stanciu SG, 2008, ICTON MEDIT WIN CONF, P132, DOI 10.1109/ICTONMW.2008.4773118; Strahlendorf JC, 1999, NEUROSCI RES, V33, P155, DOI 10.1016/S0168-0102(98)00126-6; Sunkesula SRB, 2008, NEUROCHEM RES, V33, P1117, DOI 10.1007/s11064-007-9560-1; Syapin PJ, 2005, ALCOHOL CLIN EXP RES, V29, P1080, DOI 10.1097/01.ALC.0000167961.39176.E6; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; Valles SL, 2004, BRAIN PATHOL, V14, P365; Watson RR, 1992, ALCOHOL NEUROBIOLOGY; Zador Z, 2009, ROLE AQUAPORINS NONS	57	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78854	10.1371/journal.pone.0078854	http://dx.doi.org/10.1371/journal.pone.0078854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236060	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700057
J	Liu, WB; Shi, Y; Yao, LL; Zhou, Y; Ye, BC				Liu, Wei-Bing; Shi, Yang; Yao, Li-Li; Zhou, Ying; Ye, Bang-Ce			Prediction and Characterization of Small Non-Coding RNAs Related to Secondary Metabolites in Saccharopolyspora erythraea	PLOS ONE			English	Article							GENE IDENTIFICATION; ESCHERICHIA-COLI; EXPRESSION; REGULATORS; GENOME; TRANSCRIPTOME	Saccharopolyspora erythraea produces a large number of secondary metabolites with biological activities, including erythromycin. Elucidation of the mechanisms through which the production of these secondary metabolites is regulated may help to identify new strategies for improved biosynthesis of erythromycin. In this paper, we describe the systematic prediction and analysis of small non-coding RNAs (sRNAs) in S. erythraea, with the aim to elucidate sRNA-mediated regulation of secondary metabolite biosynthesis. In silico and deep-sequencing technologies were applied to predict sRNAs in S. erythraea. Six hundred and forty-seven potential sRNA loci were identified, of which 382 cis-encoded antisense RNA are complementary to protein-coding regions and 265 predicted transcripts are located in intergenic regions. Six candidate sRNAs (sernc292, sernc293, sernc350, sernc351, sernc361, and sernc389) belong to four gene clusters (tpc3, pke, pks6, and nrps5) that are involved in secondary metabolite biosynthesis. Deep-sequencing data showed that the expression of all sRNAs in the strain HL3168 E3 (E3) was higher than that in NRRL23338 (M), except for sernc292 and sernc361 expression. The relative expression of six sRNAs in strain M and E3 were validated by qRT-PCR at three different time points (24, 48, and 72 h). The results showed that, at each time point, the transcription levels of sernc293, sernc350, sernc351, and sernc389 were higher in E3 than in M, with the largest difference observed at 72 h, whereas no signals for sernc292 and sernc361 were detected. sernc293, sernc350, sernc351, and sernc389 probably regulate iron transport, terpene metabolism, geosmin synthesis, and polyketide biosynthesis, respectively. The major significance of this study is the successful prediction and identification of sRNAs in genomic regions close to the secondary metabolism-related genes in S. erythraea. A better understanding of the sRNA-target interaction would help to elucidate the complete range of functions of sRNAs in S. erythraea, including sRNA-mediated regulation of erythromycin biosynthesis.	[Liu, Wei-Bing; Shi, Yang; Yao, Li-Li; Zhou, Ying; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn			China NSF [21276079]; SRFDP of the Chinese Ministry of Education [20120074110009]; Shanghai Postdoctoral Scientific Program; Fundamental Research Funds for the Central Universities	China NSF(National Natural Science Foundation of China (NSFC)); SRFDP of the Chinese Ministry of Education; Shanghai Postdoctoral Scientific Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research work of this paper was jointly supported by the "China NSF (21276079)", "SRFDP (no. 20120074110009) of the Chinese Ministry of Education", "Shanghai Postdoctoral Scientific Program", and "the Fundamental Research Funds for the Central Universities". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Herbig A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-40; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Kang JY, 2006, ACTA CRYSTALLOGR F, V62, P1147, DOI 10.1107/S174430910604245X; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; LABEDA DP, 1987, INT J SYST BACTERIOL, V37, P19, DOI 10.1099/00207713-37-1-19; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Marcellin E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-15; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Peano C, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-32; Peano C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-37; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Tezuka T, 2009, J BACTERIOL, V191, P4896, DOI 10.1128/JB.00087-09; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034	52	5	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80676	10.1371/journal.pone.0080676	http://dx.doi.org/10.1371/journal.pone.0080676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236194	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700197
J	San Segundo, D; Ballesteros, MA; Naranjo, S; Zurbano, F; Minambres, E; Lopez-Hoyos, M				San Segundo, David; Angeles Ballesteros, Maria; Naranjo, Sara; Zurbano, Felipe; Minambres, Eduardo; Lopez-Hoyos, Marcos			Increased Numbers of Circulating CD8 Effector Memory T Cells before Transplantation Enhance the Risk of Acute Rejection in Lung Transplant Recipients	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; RENAL-TRANSPLANT; INDUCTION; TOLERANCE; SUBSETS; IMPACT; HEART	The effector and regulatory T cell subpopulations involved in the development of acute rejection episodes in lung transplantation remain to be elucidated. Twenty-seven lung transplant candidates were prospectively monitored before transplantation and within the first year post-transplantation. Regulatory, Th17, memory and naive T cells were measured in peripheral blood of lung transplant recipients by flow cytometry. No association of acute rejection with number of peripheral regulatory T cells and Th17 cells was found. However, effector memory subsets in acute rejection patients were increased during the first two months post-transplant. Interestingly, patients waiting for lung transplant with levels of CD8(+) effector memory T cells over 185 cells/mm(3) had a significant increased risk of rejection [OR: 5.62 (95% CI: 1.08-29.37), p=0.04]. In multivariate analysis adjusted for age and gender the odds ratio for rejection was: OR: 5.89 (95% CI: 1.08-32.24), p=0.04. These data suggest a correlation between acute rejection and effector memory T cells in lung transplant recipients. The measurement of peripheral blood CD8(+) effector memory T cells prior to lung transplant may define patients at high risk of acute lung rejection.	[San Segundo, David; Lopez-Hoyos, Marcos] Marques Valdecilla Hosp, Serv Immunol, Santander, Spain; [Angeles Ballesteros, Maria; Minambres, Eduardo] Marques Valdecilla Hosp, Intens Care Unit, Santander, Spain; [Naranjo, Sara] Marques Valdecilla Hosp, Thorac Surg Unit, Santander, Spain; [Zurbano, Felipe] Marques Valdecilla Hosp, Serv Pneumol, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Lopez-Hoyos, M (corresponding author), Marques Valdecilla Hosp, Serv Immunol, Santander, Spain.	inmlhm@humv.es	San Segundo, David/O-9499-2016; López-Hoyos, Marcos/ABC-1024-2020; Miñambres, Eduardo/H-7761-2019	San Segundo, David/0000-0001-5745-9072; López-Hoyos, Marcos/0000-0003-0562-427X; Ballesteros, Maria A/0000-0002-4032-9973	Fundacion Marques de Valdecilla-IFIMAV [API-11/24, API-10/02]; Fondo de Investigaciones Sanitarias-ISCIII [PI080157, PI1100990]; RENDIREN [06/16]; Fundacion Mutua Madrilena	Fundacion Marques de Valdecilla-IFIMAV; Fondo de Investigaciones Sanitarias-ISCIII(Instituto de Salud Carlos III); RENDIREN; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	DSS received a grant from the Fundacion Marques de Valdecilla-IFIMAV (API-11/24). MAB received a grant from the Fundacion Marques de Valdecilla-IFIMAV (API-10/02.) MLH received grants from the Fondo de Investigaciones Sanitarias-ISCIII (PI080157, PI1100990), RENDIREN 06/16 and Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1990, CLIN EXP IMMUNOL, V81, P225; Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Burton CM, 2009, J HEART LUNG TRANSPL, V28, P888, DOI 10.1016/j.healun.2009.04.022; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Furness PN, 2003, TRANSPLANTATION, V76, P969, DOI 10.1097/01.TP.0000082542.99416.11; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Gregson AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011354; Heidt S, 2010, CURR OPIN ORGAN TRAN, V15, P456, DOI 10.1097/MOT.0b013e32833b9bfb; Heng D, 1998, J HEART LUNG TRANSPL, V17, P1255; IBRAHIM S, 1993, AM J PATHOL, V142, P1794; Lakkis FG, 2003, J AM SOC NEPHROL, V14, P2402, DOI 10.1097/01.ASN.0000085020.78117.70; Lange CM, 2010, TRANSPL INT, V23, P266, DOI 10.1111/j.1432-2277.2009.00973.x; Lopez-Hoyos M, 2009, TRANSPLANTATION, V88, pS31, DOI 10.1097/TP.0b013e3181af7b99; Macedo C, 2012, TRANSPLANTATION, V93, P813, DOI 10.1097/TP.0b013e318247a717; Madsen CB, 2010, TRANSPL IMMUNOL, V24, P26, DOI 10.1016/j.trim.2010.06.011; Neujahr DC, 2009, TRANSPLANTATION, V88, P521, DOI 10.1097/TP.0b013e3181b0e719; Richards DM, 2003, J IMMUNOL, V171, P6919, DOI 10.4049/jimmunol.171.12.6919; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; Steger U, 2008, TRANSPLANTATION, V85, P1339, DOI 10.1097/TP.0b013e31816dd64a; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Sun YL, 2009, SCAND J CLIN LAB INV, V69, P789, DOI 10.3109/00365510903268818; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Trzonkowski P, 2006, TRANSPLANTATION, V82, P1342, DOI 10.1097/01.tp.0000239268.64408.84; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yang J, 2007, P NATL ACAD SCI USA, V104, P19954, DOI 10.1073/pnas.0704397104; Yoshizawa A, 2005, TRANSPLANT P, V37, P37, DOI 10.1016/j.transproceed.2004.12.259	30	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80601	10.1371/journal.pone.0080601	http://dx.doi.org/10.1371/journal.pone.0080601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236187	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700189
J	Shwetank; Date, OS; Kim, KS; Manjunath, R				Shwetank; Date, Onkar S.; Kim, Kwang S.; Manjunath, Ramanathapuram			Infection of Human Endothelial Cells by Japanese Encephalitis Virus: Increased Expression and Release of Soluble HLA-E	PLOS ONE			English	Article							WEST-NILE-VIRUS; TUMOR-NECROSIS-FACTOR; BLOOD-BRAIN-BARRIER; CLASS-I MOLECULES; NF-KAPPA-B; SIGNALING PATHWAYS; FLAVIVIRUS; INDUCTION; MATRIX-METALLOPROTEINASE-9; RESPONSES	Japanese encephalitis virus (JEV) is a single stranded RNA virus that infects the central nervous system leading to acute encephalitis in children. Alterations in brain endothelial cells have been shown to precede the entry of this flavivirus into the brain, but infection of endothelial cells by JEV and their consequences are still unclear. Productive JEV infection was established in human endothelial cells leading to IFN-beta and TNF-alpha production. The MHC genes for HLA-A, -B, -C and HLA-E antigens were upregulated in human brain microvascular endothelial cells, the endothelial-like cell line, ECV 304 and human foreskin fibroblasts upon JEV infection. We also report the release/shedding of soluble HLA-E (sHLA-E) from JEV infected human endothelial cells for the first time. This shedding of sHLA-E was blocked by an inhibitor of matrix metalloproteinases (MMP). In addition, MMP-9, a known mediator of HLA solubilisation was upregulated by JEV. In contrast, human fibroblasts showed only upregulation of cell-surface HLA-E. Addition of UV inactivated JEV-infected cell culture supernatants stimulated shedding of sHLA-E from uninfected ECV cells indicating a role for soluble factors/cytokines in the shedding process. Antibody mediated neutralization of TNF-alpha as well as IFNAR receptor together not only resulted in inhibition of sHLA-E shedding from uninfected cells, it also inhibited HLA-E and MMP-9 gene expression in JEV-infected cells. Shedding of sHLA-E was also observed with purified TNF-alpha and IFN-beta as well as the dsRNA analog, poly (I:C). Both IFN-beta and TNF-alpha further potentiated the shedding when added together. The role of soluble MHC antigens in JEV infection is hitherto unknown and therefore needs further investigation.	[Shwetank; Date, Onkar S.; Manjunath, Ramanathapuram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kim, Kwang S.] Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD USA	Indian Institute of Science (IISC) - Bangalore; Johns Hopkins University	Manjunath, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	mjnhm@biochem.iisc.ernet.in	, Shwetank/I-6440-2019	, Shwetank/0000-0002-5069-603X	Council for Scientific and Industrial Research, Government of India (CSIR) [CSIR 37(1436)/10/EMR-II]; Department of Atomic Energy, Government of India (DAE) [2008/37/18/BRNS/1476]; Department of Biotechnology, Government of India (DBT), Government of India; CSIR, Government of India	Council for Scientific and Industrial Research, Government of India (CSIR); Department of Atomic Energy, Government of India (DAE); Department of Biotechnology, Government of India (DBT), Government of India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Work done in the author's laboratory was funded by a grant from Council for Scientific and Industrial Research, Government of India (CSIR), grant number CSIR 37(1436)/10/EMR-II dtd 15-12-2010. Partial funding was received from Department of Atomic Energy, Government of India (DAE), grant number 2008/37/18/BRNS/1476 dtd 08-09-2008. Partial support was received from Department of Biotechnology, Government of India (DBT), Government of India as a part of the "Pathogen Biology Program". Shwetank was the recipient of a JRF and SRF fellowship from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, J VIROL, V84, P5485, DOI 10.1128/JVI.02250-09; Allard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021118; Arnold SJ, 2004, VIROLOGY, V324, P286, DOI 10.1016/j.virol.2004.03.036; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Cheng Y, 2004, VIROLOGY, V329, P361, DOI 10.1016/j.virol.2004.06.050; Contini P, 2005, J IMMUNOL, V175, P7244, DOI 10.4049/jimmunol.175.11.7244; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11; Datema G, 1999, HUM IMMUNOL, V60, P435, DOI 10.1016/S0198-8859(99)00013-0; Demaria S, 1999, HUM IMMUNOL, V60, P1216, DOI 10.1016/S0198-8859(99)00113-5; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Griffin DE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002004; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Huang CC, 2006, PHYSIOL GENOMICS, V26, P125, DOI 10.1152/physiolgenomics.00002.2006; Kabilan Lalitha, 2004, Indian Journal of Pediatrics, V71, P609, DOI 10.1007/BF02724120; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; Kurane I, 2002, CURR TOP MICROBIOL, V267, P91; Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x; Larena M, 2011, FLAVIVIRUS ENCEPHALI, P317; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130; Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; McMinn PC, 1996, VIROLOGY, V220, P414, DOI 10.1006/viro.1996.0329; Megret F, 2007, HUM IMMUNOL, V68, P294, DOI 10.1016/j.humimm.2006.12.003; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Pejawar SS, 2005, J VIROL, V79, P7544, DOI 10.1128/JVI.79.12.7544-7557.2005; Ravi V, 1997, J MED VIROL, V51, P132, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;132::AID-JMV8&gt;3.0.CO;2-8; Sehgal A, 2003, INT J PARASITOL, V33, P1589, DOI 10.1016/S0020-7519(03)00267-4; SHEN J, 1995, VIROLOGY, V208, P437, DOI 10.1006/viro.1995.1174; Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997; Shwetank Abraham S, 2011, FLAVIVIRUS ENCEPHALI, P339; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Tabayoyong WB, 2007, LEUKEMIA RES, V31, P121, DOI 10.1016/j.leukres.2006.06.008; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vashistha S, 2007, CYTOKINE, V37, P108, DOI 10.1016/j.cyto.2007.02.013; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; YAMADA A, 1984, J GEN VIROL, V65, P973, DOI 10.1099/0022-1317-65-5-973; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Zhou JH, 2002, J VIROL, V76, P7374, DOI 10.1128/JVI.76.15.7374-7384.2002	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79197	10.1371/journal.pone.0079197	http://dx.doi.org/10.1371/journal.pone.0079197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236107	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700106
J	Singh, JA; Lewallen, DG				Singh, Jasvinder A.; Lewallen, David G.			Diabetes: A Risk Factor for Poor Functional Outcome after Total Knee Arthroplasty	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; OLDER MEXICAN-AMERICANS; TOTAL HIP; SURVIVORSHIP ANALYSIS; MELLITUS; REPLACEMENT; PAIN; ASSOCIATION; POPULATION; PREDICTORS	Background: To assess the association of diabetes with postoperative limitation of activities of daily living (ADLs) after primary total knee arthroplasty (TKA). Methodology/Principal Findings: We used the prospectively collected data from the Mayo Clinic Total Joint Registry to assess the association of diabetes and diabetes with complications with moderate-severe ADL limitation 2- and 5-years after primary TKA. Multivariable logistic regression with general estimating equations adjusted for preoperative ADL limitation, comorbidity and demographic and clinical covariates. Odds ratio (OR) and 95% confidence interval (CI) are presented. 7,139 primary TKAs at 2-years and 4,234 at 5-years constituted the cohorts. In multivariable-adjusted analyses, diabetes was associated with higher odds of moderate-severe limitation at 2- and 5-years, 1.71 (95% CI: 1.26, 2.32; P = 0.001) and 1.66 (95% CI: 1.13, 2.46; P = 0.01). Respective ORs for patients with diabetes with complications were 2.73 (95% CI: 1.47, 5.07; P = 0.001) and 2.73 (95% CI: 1.21, 6.15; P = 0.016). Sensitivity analyses that adjusted for anxiety and depression or anxiety, depression and ipsilateral hip involvement showed minimal attenuation of magnitude of the association. Conclusions/Significance: In this large study of patients who underwent primary TKA, diabetes as well as its severity were independently associated with poorer functional outcome. Given the increasing rates of both diabetes as well as arthroplasty, more insight is needed into disease-related and treatment-related factors that underlie this higher risk of ADL limitation in patients with diabetes. Poor functional outcomes may be preventable by modifying the control of diabetes and associated comorbidity in pre- and post-arthroplasty periods.	[Singh, Jasvinder A.] VA Med Ctr, Med Serv, Birmingham, AL USA; [Singh, Jasvinder A.] VA Med Ctr, Ctr Surg Med Acute Care Res & Transit, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Publ Hlth, Div Epidemiol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.; Lewallen, David G.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic	Singh, JA (corresponding author), VA Med Ctr, Med Serv, Birmingham, AL USA.	Jasvinder.md@gmail.com	Singh, Jasvinder/R-6172-2019; R, Manimegalai/D-7835-2016	Singh, Jasvinder/0000-0003-3485-0006; R, Manimegalai/0000-0001-6187-2652	National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis and Musculoskeletal and Skin Disease; Department of Veterans Affairs; DePuy; Stryker; Biomet; Zimmer	National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs(US Department of Veterans Affairs); DePuy; Stryker; Biomet; Zimmer	JAS is supported by research grants from National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs), National Institute of Arthritis and Musculoskeletal and Skin Disease and the Department of Veterans Affairs (resources and the use of facilities at the Birmingham VA Medical Center, Alabama, USA). JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. DGL has received royalties/speaker fees from Zimmer, Orthosonic and Osteotech, has been a paid consultant and owns stock in Pipeline Biomedical and his institution has received research funds from DePuy, Stryker, Biomet and Zimmer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Al Snih S, 2005, J GERONTOL A-BIOL, V60, P1152, DOI 10.1093/gerona/60.9.1152; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Chiu FY, 2001, J BONE JOINT SURG BR, V83B, P691, DOI 10.1302/0301-620X.83B5.11737; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; ENGLAND SP, 1990, CLIN ORTHOP RELAT R, P130; Fisher DA, 2007, J ARTHROPLASTY, V22, P39, DOI 10.1016/j.arth.2007.04.011; GORDON SM, 1990, AM J EPIDEMIOL, V131, P905, DOI 10.1093/oxfordjournals.aje.a115580; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iorio R, 2012, J ARTHROPLASTY, V27, P726, DOI 10.1016/j.arth.2011.09.013; Jones CA, 2001, ARCH INTERN MED, V161, P454, DOI 10.1001/archinte.161.3.454; Jones CA, 2003, PHYS THER, V83, P696, DOI 10.1093/ptj/83.8.696; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Lingard EA, 2001, J BONE JOINT SURG AM, V83A, P1856, DOI 10.2106/00004623-200112000-00014; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; McGrory BJ, 1996, J ARTHROPLASTY, V11, P47, DOI 10.1016/S0883-5403(96)80160-4; Meding JB, 2003, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000093002.90435.56; Moon HK, 2008, YONSEI MED J, V49, P129, DOI 10.3349/ymj.2008.49.1.129; Nieves-Plaza M, 2013, JCR-J CLIN RHEUMATOL, V19, P1, DOI 10.1097/RHU.0b013e31827cd578; OrthoInfo, 2011, TOT KNEE REPL; Papagelopoulos PJ, 1996, CLIN ORTHOP RELAT R, P124; Rajgopal V, 2008, J ARTHROPLASTY, V23, P795, DOI 10.1016/j.arth.2007.08.005; RAND JA, 1991, J BONE JOINT SURG AM, V73A, P397, DOI 10.2106/00004623-199173030-00011; Rand JA, 2003, J BONE JOINT SURG AM, V85A, P259, DOI 10.2106/00004623-200302000-00012; Santaguida PL, 2008, CAN J SURG, V51, P428; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Singh JA, 2010, J BONE JOINT SURG BR, V92B, P799, DOI 10.1302/0301-620X.92B6.23114; Singh JA, 2010, OSTEOARTHR CARTILAGE, V18, P515, DOI 10.1016/j.joca.2009.12.001; Singh JA, 2008, CLIN ORTHOP RELAT R, V466, P2717, DOI 10.1007/s11999-008-0399-9; Singh JA, 2011, J ARTHROPLASTY, V26, P366, DOI 10.1016/j.arth.2010.02.006; Singh JA, 2010, J ARTHROPLASTY, V25, P1091, DOI 10.1016/j.arth.2009.07.020; *STROBE STAT, 2007, STRENGTH REP OBS STU; Tian WQ, 2010, AM J PHYS MED REHAB, V89, P905, DOI 10.1097/PHM.0b013e3181f1c6d8; Wasielewski RC, 1998, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-199811000-00014; Wright RJ, 2004, J BONE JOINT SURG AM, V86A, P2464, DOI 10.2106/00004623-200411000-00016; Wu JH, 2003, DIABETES CARE, V26, P314, DOI 10.2337/diacare.26.2.314; Yang K, 2001, J ARTHROPLASTY, V16, P102, DOI 10.1054/arth.2001.19159; Zeni JA, 2010, OSTEOARTHR CARTILAGE, V18, P510, DOI 10.1016/j.joca.2009.12.005	40	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78991	10.1371/journal.pone.0078991	http://dx.doi.org/10.1371/journal.pone.0078991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236080	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700078
J	Chen, H; Bai, M; Qi, XS; Liu, L; He, CY; Yin, ZX; Fan, DM; Han, GH				Chen, Hui; Bai, Ming; Qi, Xingshun; Liu, Lei; He, Chuangye; Yin, Zhanxin; Fan, Daiming; Han, Guohong			Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; POLYTETRAFLUOROETHYLENE-COVERED STENT; VASOPRESSIN RECEPTOR ANTAGONIST; SERUM SODIUM CONCENTRATION; MELD SCORE; MULTICENTER TRIAL; VEIN THROMBOSIS; LIVER-CIRRHOSIS; EARLY MORTALITY; WAITING-LIST	Background and Aim: Several models have been developed to predict survival in patients with cirrhosis undergoing TIPS; however, few of these models have gained widespread acceptance, especially in the era of covered stents. The aim of this study was to establish an evidence-based model for predicting survival after TIPS procedures. Methods: A total of 210 patients with cirrhosis treated with TIPS were considered in the study. We comprehensively investigated factors associated with one-year survival and developed a new predictive model using the Cox regression model. Results: In the multivariate analysis, the Child-Pugh score and serum sodium levels were independent predictors of one-year survival. A new score incorporating serum sodium into the Child-Pugh score was developed: Child-Na score. We compared the predictive accuracy of Child-Na score with that of other scores; only the Child-Na and MELD-Na scores had adequate predictive ability in patients with serum Na levels,138 mmol/L. The best Child-Na cut-off score (15.5) differentiated two groups of patients with distinct prognoses (one-year cumulative survival rates of 80.6% and 45.5%); this finding was confirmed in a validation cohort (n = 86). In a subgroup analysis stratifying patients by indication for TIPS, the Child-Na score distinguished patients with different prognoses. Conclusions: Patients with variceal bleeding and a Child-Na score <= 15 had a better prognosis than patients with a score >= 16. Patients with refractory ascites and a Child-Na score >= 16 had a high risk of death after the TIPS procedures; caution should be used when treating these patients with TIPS.	[Chen, Hui; Bai, Ming; Qi, Xingshun; Liu, Lei; He, Chuangye; Yin, Zhanxin; Han, Guohong] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Han, GH (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China.	guohhan@126.com	Qi, Xingshun/M-7063-2013	Qi, Xingshun/0000-0002-9448-6739; Liu, Lei/0000-0002-3570-2219				Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; Angermayr B, 2003, HEPATOLOGY, V38, P1043, DOI 10.1053/jhep.2003.50423; Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; Barrio J, 2005, EUR J RADIOL, V55, P120, DOI 10.1016/j.ejrad.2004.10.007; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Brensing KA, 2002, EUR J GASTROEN HEPAT, V14, P723, DOI 10.1097/00042737-200207000-00003; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Bureau C, 2007, LIVER INT, V27, P742, DOI 10.1111/j.1478-3231.2007.01522.x; Bureau C, 2011, J HEPATOL, V54, P901, DOI 10.1016/j.jhep.2010.08.025; Chalasani N, 2000, GASTROENTEROLOGY, V118, P138, DOI 10.1016/S0016-5085(00)70422-7; Charon JPM, 2004, J VASC INTERV RADIOL, V15, P1219, DOI 10.1097/01.RVI.0000137434.19522.E5; Chen H, 2013, THROMB RES, V131, P173, DOI 10.1016/j.thromres.2012.11.003; Gaba RC, 2013, J VASC INTERV RADIOL, V24, P411, DOI 10.1016/j.jvir.2012.10.026; Gerbes AL, 2003, GASTROENTEROLOGY, V124, P933, DOI 10.1053/gast.2003.50143; Giannini E, 2004, LIVER INT, V24, P465, DOI 10.1111/j.1478-3231.2004.0949.x; Han GH, 2011, J HEPATOL, V54, P78, DOI 10.1016/j.jhep.2010.06.029; Hausegger KA, 2004, J VASC INTERV RADIOL, V15, P239, DOI 10.1097/01.RVI.0000116194.44877.C1; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Maleux G, 2004, EUR RADIOL, V14, P1842, DOI 10.1007/s00330-004-2359-4; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Montgomery A, 2005, CARDIOVASC INTER RAD, V28, P307, DOI 10.1007/s00270-004-0145-y; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Qi XS, 2012, DIGEST DIS SCI, V57, P1072, DOI 10.1007/s10620-011-1975-5; Reuben A, 2002, HEPATOLOGY, V35, P244, DOI 10.1053/jhep.2002.0350244; RUBIN RA, 1995, AM J GASTROENTEROL, V90, P556; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Schepke M, 2003, AM J GASTROENTEROL, V98, P1167, DOI 10.1016/S0002-9270(03)00295-8; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Thompson C, 2012, BEST PRACT RES CL EN, V26, pS1, DOI 10.1016/S1521-690X(12)00019-X; Vignali C, 2005, AM J ROENTGENOL, V185, P472, DOI 10.2214/ajr.185.2.01850472; Wong F, 2003, HEPATOLOGY, V37, P182, DOI 10.1053/jhep.2003.50021	33	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79637	10.1371/journal.pone.0079637	http://dx.doi.org/10.1371/journal.pone.0079637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244533	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600141
J	Haack, KKV; Mitra, AK; Zucker, IH				Haack, Karla K. V.; Mitra, Amit K.; Zucker, Irving H.			NF-kappa B and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; SMOOTH-MUSCLE-CELLS; HEART-FAILURE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CAMP-RESPONSE; HYDROXYLASE GENE; OXIDATIVE STRESS; ACTIVATION; KINASE	Nuclear factor kappa B (NF-kappa B) and the Ets like gene-1 (Elk-1) are two transcription factors that have been previously established to contribute to the Angiotensin II mediated upregulation of Angiotensin II type 1 receptor (AT1R) in neurons. The cAMP response element binding protein (CREB) is another transcription factor that has also been implicated in AT1R gene transcription. The goal of the current study was to determine if NF-kappa B and CREB association was required for AT1R upregulation. We hypothesized that the transcription of the AT1R gene occurs via an orchestration of transcription factor interactions including NF-kappa B, CREB, and Elk-1. The synergistic role of CREB and NF-kappa B in promoting AT1R gene expression was determined using siRNA-mediated silencing of CREB. Electrophorectic Mobility Shift Assay studies employing CREB and NF-kappa B demonstrated increased protein - DNA binding as a result of Ang II stimulation which was blunted by siRNA silencing of CREB. Upstream inhibition of p38 mitogen activated protein kinase (p38 MAPK) with SB203580 or inhibition of the calmodulin kinase (CAMK) pathway using KN-62 blunted changes in CREB and NF-kappa B expression. These findings suggest that Ang II may activate multiple signaling pathways involving p38 MAPK leading to the activation of NF-kappa B and CREB, which feed back to upregulate the AT1R gene. This study provides insight into the molecular mechanisms involving multiple transcription factor activation in a coordinated fashion which may be partially responsible for sympathoexcitation in clinical conditions associated with increased activation of the renin angiotensin system.	[Haack, Karla K. V.; Mitra, Amit K.; Zucker, Irving H.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Zucker, IH (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.	izucker@unmc.edu			National Heart, Lung and Blood Institute [PO-1 62222]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062222] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Heart, Lung and Blood Institute Grant PO-1 62222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Blume A, 1999, J MOL MED, V77, P339, DOI 10.1007/s001090050360; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Coven E, 1998, J NEUROCHEM, V71, P1865; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Ganea D, 2003, CURR PHARM DESIGN, V9, P997, DOI 10.2174/1381612033455116; Gao L, 2008, HYPERTENSION, V52, P708, DOI 10.1161/HYPERTENSIONAHA.108.116228; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Haack KKV, 2012, HYPERTENSION, V60, P354, DOI 10.1161/HYPERTENSIONAHA.112.195693; Ju HS, 2003, J PHARMACOL EXP THER, V307, P932, DOI 10.1124/jpet.103.057422; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; La Porta CAM, 1998, ANTICANCER RES, V18, P2591; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Li JY, 1996, MOL ENDOCRINOL, V10, P252, DOI 10.1210/me.10.3.252; Liu DM, 2008, CIRC RES, V103, P186, DOI 10.1161/CIRCRESAHA.108.179408; Liu DM, 2006, CIRC RES, V99, P1004, DOI 10.1161/01.RES.0000247066.19878.93; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Schmeisser A, 2004, BIOCHEM BIOPH RES CO, V325, P532, DOI 10.1016/j.bbrc.2004.10.059; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; STECKELINGS U, 1992, J CARDIOVASC PHARM, V19, pS72, DOI 10.1097/00005344-199219006-00012; Stefano L, 2006, J NEUROCHEM, V97, P92, DOI 10.1111/j.1471-4159.2006.03749.x; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Swanson DJ, 1998, J BIOL CHEM, V273, P24065, DOI 10.1074/jbc.273.37.24065; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; WALKER WH, 1995, ENDOCRINOLOGY, V136, P3534, DOI 10.1210/en.136.8.3534; Widnell KL, 1996, J NEUROCHEM, V66, P1770; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Yoshimoto T, 2005, HYPERTENS RES, V28, P165, DOI 10.1291/hypres.28.165; Zucker IH, 2009, AM J PHYSIOL-HEART C, V297, pH1557, DOI 10.1152/ajpheart.00073.2009	43	33	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78695	10.1371/journal.pone.0078695	http://dx.doi.org/10.1371/journal.pone.0078695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244341	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600050
J	Lesser, MP; Slattery, M				Lesser, Michael P.; Slattery, Marc			Ecology of Caribbean Sponges: Are Top-Down or Bottom-Up Processes More Important?	PLOS ONE			English	Article							PREDATORY REEF FISH; CORAL-REEF; CALLYSPONGIA-VAGINALIS; COMMUNITY REGULATION; CHEMICAL DEFENSES; PHASE-SHIFTS; DIVERSITY; ABUNDANCE; GROWTH; WATER	Benthic-pelagic coupling and the role of bottom-up versus top-down processes are recognized as having a major impact on the structure of marine communities. While the roles of bottom-up processes are better appreciated they are still viewed as principally affecting the outcome of top-down processes. Sponges on coral reefs are important members of the benthic community and provide a critically important functional linkage between water-column productivity and the benthos. As active suspension feeders sponges utilize the abundant autotrophic and heterotrophic picoplankton in the water column. As a result sponges across the Caribbean basin exhibit a consistent and significant pattern of greater biomass, tube extension rate, and species numbers with increasing depth. Likewise, the abundance of their food supply also increases along a depth gradient. Using experimental manipulations it has recently been reported that predation is the primary determinant of sponge community structure. Here we provide data showing that the size and growth of the sponge Callyspongia vaginalis are significantly affected by food availability. Sponges increased in size and tube extension rate with increasing depth down to 46 m, while simultaneously exposed to the full range of potential spongivores at all depths. Additionally, we point out important flaws in the experimental design used to demonstrate the role of predation and suggest that a resolution of this important question will require well-controlled, multi-factorial experiments to examine the independent and interactive effects of predation and food abundance on the ecology of sponges.	[Lesser, Michael P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Slattery, Marc] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA	University System Of New Hampshire; University of New Hampshire; University of Mississippi	Lesser, MP (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	mpl@unh.edu			Caribbean Coral Reef Ecosystems program at the Smithsonian Institute; NOAAs National Institute of Undersea Science and Technology; National Science Foundation	Caribbean Coral Reef Ecosystems program at the Smithsonian Institute; NOAAs National Institute of Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF))	This project was funded by grants from the Caribbean Coral Reef Ecosystems program at the Smithsonian Institute, NOAAs National Institute of Undersea Science and Technology and the National Science Foundation. The funders had no role in the design of study, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the views of the Smithsonian Institute, National Oceanic and Atmospheric Administration, their sub agencies or the National Science Foundation.	Alcolado P.M., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P297; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Cardoso Sonia C., 2009, Marine Biodiversity Records, V2, pe148, DOI 10.1017/S1755267209990662; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Connell SD, 1997, J EXP MAR BIOL ECOL, V213, P181, DOI 10.1016/S0022-0981(96)02773-6; Diamond J., 1986, COMMUNITY ECOL, P3; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; DUFFY JE, 1992, OECOLOGIA, V90, P333, DOI 10.1007/BF00317689; Erwin PM, 2007, J MAR BIOL ASSOC UK, V87, P1683, DOI 10.1017/S0025315407058213; Fiore CL, 2010, INVERTEBR BIOL, V129, P105, DOI 10.1111/j.1744-7410.2010.00184.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V24, P105, DOI 10.1007/BF00001281; Hughes T, 1999, LIMNOL OCEANOGR, V44, P1583; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Lehnert Helmut, 1999, Memoirs of the Queensland Museum, V44, P307; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Liddell W.D., 1997, P 8 INT COR REEF S P, V1, P437; Lopez-Legentil S, 2010, SCI MAR, V74, P445, DOI 10.3989/scimar.2010.74n3445; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; PALUMBI SR, 1986, ECOLOGY, V67, P208, DOI 10.2307/1938520; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pawlik J.R., 1997, P1255; Pawlik JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062573; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Perea-Blazquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029569; Pile A.J., 1997, P1403; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Reed John K., 1997, P1387; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; Rutzler K, 1982, SMITHSON CONTRIB MAR, V12, P9; Schmahl G. P., 1990, NEW PERSPECTIVES SPO, P384; Slattery M, 2001, MAR BIOL, V138, P1183; Slattery M, 2012, P 12 INT COR REEF S; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Steele MA, 1996, J EXP MAR BIOL ECOL, V198, P249, DOI 10.1016/0022-0981(96)00011-1; Suchanek TH, 1984, S SERIES UNDERSEA RE, P55; Thoms Carsten, 2007, V28, P627; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WILKINSON CR, 1979, J EXP MAR BIOL ECOL, V37, P91, DOI 10.1016/0022-0981(79)90028-5; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1990, MAR ECOL PROG SER, V67, P285, DOI 10.3354/meps067285; WILKINSON CR, 1987, SCIENCE, V236, P1654, DOI 10.1126/science.236.4809.1654; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Wulff JL, 2005, J ANIM ECOL, V74, P313, DOI 10.1111/j.1365-2656.2005.00925.x; Wulff JL, 1997, MAR BIOL, V129, P41, DOI 10.1007/s002270050144	87	48	48	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79799	10.1371/journal.pone.0079799	http://dx.doi.org/10.1371/journal.pone.0079799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244563	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600152
J	Martinez-Garcia, PJ; Parfitt, DE; Bostock, RM; Fresnedo-Ramirez, J; Vazquez-Lobo, A; Ogundiwin, EA; Gradziel, TM; Crisosto, CH				Martinez-Garcia, Pedro J.; Parfitt, Dan E.; Bostock, Richard M.; Fresnedo-Ramirez, Jonathan; Vazquez-Lobo, Alejandra; Ogundiwin, Ebenezer A.; Gradziel, Thomas M.; Crisosto, Carlos H.			Application of Genomic and Quantitative Genetic Tools to Identify Candidate Resistance Genes for Brown Rot Resistance in Peach	PLOS ONE			English	Article							PRUNUS-PERSICA L.; MONILINIA-FRUCTICOLA; PECTIN METHYLESTERASE; IDENTIFICATION; INFECTIONS; PATHOGENS; PROTEINS; QUALITY; SNPS	The availability of a complete peach genome assembly and three different peach genome sequences created by our group provide new opportunities for application of genomic data and can improve the power of the classical Quantitative Trait Loci (QTL) approaches to identify candidate genes for peach disease resistance. Brown rot caused by Monilinia spp., is the most important fungal disease of stone fruits worldwide. Improved levels of peach fruit rot resistance have been identified in some cultivars and advanced selections developed in the UC Davis and USDA breeding programs. Whole genome sequencing of the Pop-DF parents lead to discovery of high-quality SNP markers for QTL genome scanning in this experimental population. Pop-DF created by crossing a brown rot moderately resistant cultivar 'Dr. Davis' and a brown rot resistant introgression line, 'F8,1-42', derived from an initial almond x peach interspecific hybrid, was evaluated for brown rot resistance in fruit of harvest maturity over three seasons. Using the SNP linkage map of Pop-DF and phenotypic data collected with inoculated fruit, a genome scan for QTL identified several SNP markers associated with brown rot resistance. Two of these QTLs were placed on linkage group 1, covering a large (physical) region on chromosome 1. The genome scan for QTL and SNP effects predicted several candidate genes associated with disease resistance responses in other host-pathogen systems. Two potential candidate genes, ppa011763m and ppa026453m, may be the genes primarily responsible for M. fructicola recognition in peach, activating both PAMP-triggered immunity (PTI) and effector-triggered immunity (ETI) responses. Our results provide a foundation for further genetic dissection, marker assisted breeding for brown rot resistance, and development of peach cultivars resistant to brown rot.	[Martinez-Garcia, Pedro J.; Parfitt, Dan E.; Fresnedo-Ramirez, Jonathan; Ogundiwin, Ebenezer A.; Gradziel, Thomas M.; Crisosto, Carlos H.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Bostock, Richard M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Vazquez-Lobo, Alejandra] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	University of California System; University of California Davis; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Martinez-Garcia, PJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	pjmartinezgarcia@ucdavis.edu	Fresnedo-Ramírez, Jonathan/C-2811-2011; Martinez-Garcia, Pedro Jose/AAK-1814-2020; Vazquez-Lobo, Alejandra/HDO-0323-2022	Fresnedo-Ramírez, Jonathan/0000-0003-1985-2513; Martinez-Garcia, Pedro Jose/0000-0002-7647-5235; Gradziel, Thomas/0000-0002-2206-3438; Vazquez-Lobo, Alejandra/0000-0002-7828-1653	California Cling Peach Board; University of California ANR Core Issues program; National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2008-35300-04432]; University of California Agricultural Experiment Station; USDA-Cooperative State Research, Education, and Extension Service	California Cling Peach Board; University of California ANR Core Issues program(French National Research Agency (ANR)); National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA); University of California Agricultural Experiment Station(University of California System); USDA-Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research supported by grants from the California Cling Peach Board, the University of California ANR Core Issues program, the National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) grant #2008-35300-04432, and funds from the University of California Agricultural Experiment Station and USDA-Cooperative State Research, Education, and Extension Service.	Adaskaveg JE, 2005, PHYTOPATHOLOGY, V95, pS140; Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; [Anonymous], 1989, JMP VERS 7; Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189; Bostock RM, 1994, CENTRAL VALLER POSTH, V3, P16; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Cantoni L., 1996, Rivista di Frutticoltura e di Ortofloricoltura, V58, P59; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; FELICIANO A, 1987, PHYTOPATHOLOGY, V77, P776, DOI 10.1094/Phyto-77-776; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; GRADZIEL TM, 1994, HORTSCIENCE, V29, P33, DOI 10.21273/HORTSCI.29.1.33; Gradziel TM, 2003, ACTA HORTIC, P249, DOI 10.17660/ActaHortic.2003.622.22; GRADZIEL TM, 1993, J AM SOC HORTIC SCI, V118, P675, DOI 10.21273/JASHS.118.5.675; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; He CZ, 1999, MOL PLANT MICROBE IN, V12, P1064, DOI 10.1094/MPMI.1999.12.12.1064; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Lee MH, 2010, MOL PLANT MICROBE IN, V23, P176, DOI 10.1094/MPMI-23-2-0176; Lytle BL, 2009, PROTEINS, V76, P237, DOI 10.1002/prot.22396; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P19, DOI 10.1007/s11295-012-0522-7; Martinez-Garcia PJ, 2013, PLANT MOL BIOL, V81, P161, DOI 10.1007/s11103-012-9989-8; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; NESSLER CL, 1985, PLANT PHYSIOL, V79, P499, DOI 10.1104/pp.79.2.499; Ogawa J., 1991, U CALIFORNIA DIV AGR, V3345, P461; Ogawa JM, 1985, MANAGEMENT BROWN ROT, P5; Ogundiwin EA, 2008, P 4 INT ROS GEN C PU; Padmanabhan MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003235; Prusky D, 2007, FEMS MICROBIOL LETT, V268, P1, DOI 10.1111/j.1574-6968.2006.00603.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Ooijen JW, 1997, ADV BIOM GEN P 10 M; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wietholter N, 2003, MOL PLANT MICROBE IN, V16, P945, DOI 10.1094/MPMI.2003.16.10.945; Zimaro T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/354801; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; ZUCKERKANDL EMILE, 1965, P97	47	47	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78634	10.1371/journal.pone.0078634	http://dx.doi.org/10.1371/journal.pone.0078634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244329	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600039
J	Meyer, MR; Fredette, NC; Barton, M; Prossnitz, ER				Meyer, Matthias R.; Fredette, Natalie C.; Barton, Matthias; Prossnitz, Eric R.			Regulation of Vascular Smooth Muscle Tone by Adipose-Derived Contracting Factor	PLOS ONE			English	Article							SLOW-REACTING SUBSTANCE; ANTI-INFLAMMATORY DRUGS; HIGH-FAT DIET; GENE-EXPRESSION; DEPENDENT VASOCONSTRICTION; ENDOTHELIAL DYSFUNCTION; ARACHIDONIC-ACID; PERIVASCULAR FAT; RELAXING FACTOR; KNOCKOUT MICE	Obesity and arterial hypertension, important risk factors for atherosclerosis and coronary artery disease, are characterized by an increase in vascular tone. While obesity is known to augment vasoconstrictor prostanoid activity in endothelial cells, less is known about factors released from fat tissue surrounding arteries (perivascular adipose). Using lean controls and mice with either monogenic or diet-induced obesity, we set out to determine whether and through which pathways perivascular adipose affects vascular tone. We unexpectedly found that in the aorta of obese mice, perivascular adipose potentiates vascular contractility to serotonin and phenylephrine, indicating activity of a factor generated by perivascular adipose, which we designated "adipose-derived contracting factor" (ADCF). Inhibition of cyclooxygenase (COX) fully prevented ADCF-mediated contractions, whereas COX-1 or COX-2-selective inhibition was only partially effective. By contrast, inhibition of superoxide anions, NO synthase, or endothelin receptors had no effect on ADCF activity. Perivascular adipose as a source of COX-derived ADCF was further confirmed by detecting increased thromboxane A(2) formation from perivascular adipose-replete aortae from obese mice. Taken together, this study identifies perivascular adipose as a novel regulator of arterial vasoconstriction through the release of COX-derived ADCF. Excessive ADCF activity in perivascular fat under obese conditions likely contributes to increased vascular tone by antagonizing vasodilation. ADCF may thus propagate obesity-dependent hypertension and the associated increased risk in coronary artery disease, potentially representing a novel therapeutic target.	[Meyer, Matthias R.; Fredette, Natalie C.; Prossnitz, Eric R.] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Barton, Matthias] Univ Zurich, Zurich, Switzerland	University of New Mexico; University of New Mexico's Health Sciences Center; University of Zurich	Barton, M (corresponding author), Univ Zurich, Zurich, Switzerland.	barton@access.uzh.ch; eprossnitz@salud.unm.edu	Prossnitz, Eric R./B-4543-2008; Prossnitz, Eric/I-4599-2019	Prossnitz, Eric/0000-0001-9190-8302; Meyer, Matthias/0000-0003-3206-3244	NIH [R01 CA127731, CA163890, T32 HL07736]; Dedicated Health Research Funds of the University of New Mexico School of Medicine; Swiss National Science Foundation [135874, 141501, 108258, 122504]; NATIONAL CANCER INSTITUTE [R01CA163890, R01CA127731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007736] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dedicated Health Research Funds of the University of New Mexico School of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH (R01 CA127731 and CA163890 to ERP), Dedicated Health Research Funds of the University of New Mexico School of Medicine allocated to the Signature Program in Cardiovascular and Metabolic Disease (to ERP), and the Swiss National Science Foundation (grants 135874 & 141501 to MRM and 108258 & 122504 to MB). NCF was supported by an NIH training grant T32 HL07736. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh R, 2012, ANN MED, V44, pS74, DOI 10.3109/07853890.2012.663928; BAILEY JM, 1979, ATHEROSCLEROSIS, V32, P195; Baretella O, 2013, PFLUGERS ARCH, DOI [10.1007/s00424-00013-01323-z, DOI 10.1007/S00424-00013-01323-Z]; Barton M, 2000, HYPERTENSION, V35, P329, DOI 10.1161/01.HYP.35.1.329; Barton M, 2013, CURR OPIN PHARMACOL, V13, P226, DOI 10.1016/j.coph.2013.05.005; Barton M, 2012, BRIT J PHARMACOL, V165, P591, DOI 10.1111/j.1476-5381.2011.01472.x; BERRY PA, 1964, BRIT J PHARM CHEMOTH, V23, P201, DOI 10.1111/j.1476-5381.1964.tb01579.x; Campbell DH, 1940, J IMMUNOL, V39, P103; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; Cardillo C, 2004, HYPERTENSION, V43, P36, DOI 10.1161/01.HYP.0000103868.45064.81; Chang L, 2013, CIRC J, V77, P11, DOI 10.1253/circj.CJ-12-1393; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; CHIOU WL, 1978, J PHARMACOKINET BIOP, V6, P539, DOI 10.1007/BF01062108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEMEY JG, 1982, CIRC RES, V51, P439, DOI 10.1161/01.RES.51.4.439; Eringa EC, 2012, VASC PHARMACOL, V56, P204, DOI 10.1016/j.vph.2012.02.003; Farb MG, 2013, OBESITY SIL IN PRESS, DOI [10.1002/oby.20505, DOI 10.1002/0BY.20505]; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; FERREIRA SH, 1974, BRIT J PHARMACOL, V50, P543, DOI 10.1111/j.1476-5381.1974.tb08587.x; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Ghiadoni L, 2008, HYPERTENSION, V51, P440, DOI 10.1161/HYPERTENSIONAHA.107.103093; Gollasch M, 2012, BRIT J PHARMACOL, V165, P633, DOI 10.1111/j.1476-5381.2011.01430.x; Goodwill AG, 2008, AM J PHYSIOL-HEART C, V295, pH1522, DOI 10.1152/ajpheart.00596.2008; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; GRYGLEWSKI R, 1972, BRIT J PHARMACOL, V46, P449, DOI 10.1111/j.1476-5381.1972.tb08142.x; GRYGLEWSKI R, 1972, BRIT J PHARMACOL, V45, P37, DOI 10.1111/j.1476-5381.1972.tb09574.x; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005; Kellaway CH, 1940, Q J EXP PHYSIOL CMS, V30, P121; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Ma LQ, 2010, HYPERTENS RES, V33, P446, DOI 10.1038/hr.2010.11; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Meyer MR, 2012, LIFE SCI, V91, P623, DOI 10.1016/j.lfs.2012.01.007; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; NIJKAMP FP, 1976, NATURE, V263, P479, DOI 10.1038/263479a0; Ohman MK, 2011, ATHEROSCLEROSIS, V219, P33, DOI 10.1016/j.atherosclerosis.2011.07.012; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; PIPER PJ, 1969, NATURE, V223, P29, DOI 10.1038/223029a0; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Sharma G, 2013, ENDOCRINOLOGY, V154, P4136, DOI 10.1210/en.2013-1357; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith AD, 2006, PROSTAG LEUKOTR ESS, V75, P43, DOI 10.1016/j.plefa.2006.03.008; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Traupe T, 2002, CLIN SCI, V103, p13S, DOI 10.1042/CS103S013S; Traupe T, 2002, J HYPERTENS, V20, P2239, DOI 10.1097/00004872-200211000-00024; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Xu JW, 2012, MOL BIOL REP, V39, P8177, DOI 10.1007/s11033-012-1665-1; Xu L, 2007, PROSTAG OTH LIPID M, V83, P213, DOI 10.1016/j.prostaglandins.2007.01.009; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	69	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79245	10.1371/journal.pone.0079245	http://dx.doi.org/10.1371/journal.pone.0079245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244459	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600119
J	Sempo, G; Canonge, S; Deneubourg, JL				Sempo, Gregory; Canonge, Stephane; Deneubourg, Jean-Louis			From Aggregation to Dispersion: How Habitat Fragmentation Prevents the Emergence of Consensual Decision Making in a Group	PLOS ONE			English	Article							PUBLIC INFORMATION; SHELTER SELECTION; SOCIAL-BEHAVIOR; COCKROACH; DYNAMICS; INTEGRATION; SETTLEMENT; DENSITY; PATTERN	In fragmented landscape, individuals have to cope with the fragmentation level in order to aggregate in the same patch and take advantage of group-living. Aggregation results from responses to environmental heterogeneities and/or positive influence of the presence of congeners. In this context, the fragmentation of resting sites highlights how individuals make a compromise between two individual preferences: (1) being aggregated with conspecifics and (2) having access to these resting sites. As in previous studies, when the carrying capacity of available resting sites is large enough to contain the entire group, a single aggregation site is collectively selected. In this study, we have uncoupled fragmentation and habitat loss: the population size and total surface of the resting sites are maintained at a constant value, an increase in fragmentation implies a decrease in the carrying capacity of each shelter. For our model organism, Blattella germanica, our experimental and theoretical approach shows that, for low fragmentation level, a single resting site is collectively selected. However, for higher level of fragmentation, individuals are randomly distributed between fragments and the total sheltered population decreases. In the latter case, social amplification process is not activated and consequently, consensual decision making cannot emerge and the distribution of individuals among sites is only driven by their individual propensity to find a site. This intimate relation between aggregation pattern and landscape patchiness described in our theoretical model is generic for several gregarious species. We expect that any group-living species showing the same structure of interactions should present the same type of dispersion-aggregation response to fragmentation regardless of their level of social complexity.	[Sempo, Gregory; Canonge, Stephane; Deneubourg, Jean-Louis] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Sempo, G (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	gsempo@ulb.ac.be			ARC; FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture)	ARC(Australian Research Council); FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	GS is supported by the project ARC: Individual and collective issues in dispersal and aggregation: from proximal causes to ultimate consequences at contrasting scales. SC was funded by a PhD grant from FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Ame JM, 2006, LECT NOTES COMPUT SC, V4095, P713; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; Bell W. J., 2007, COCKROACHES ECOLOGY; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Breithaupt T, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P1, DOI 10.1007/978-0-387-77101-4; Brown C. R., 1996, COLONIALITY CLIFF SW; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Canonge S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019748; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Childress MJ, 2001, ANIM BEHAV, V62, P465, DOI 10.1006/anbe.2001.1760; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Danchin E, 1998, ECOLOGY; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; EGGLESTON DB, 1992, ECOLOGY, V73, P992, DOI 10.2307/1940175; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; Fraenkel GS, 1961, ORIENTATION ANIMALS; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Giraldeau L.A., 2000, MG BEH ECOL; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Heinrich B., 1981, INSECT THERMOREGULAT, P159; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2007, AM NAT, V170, P47, DOI 10.1086/518570; Krause J, 2002, LIVING GROUPS; Lihoreau M, 2012, INSECT SOC, V59, P1; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; MEYER DJ, 1981, J NEUROBIOL, V12, P93, DOI 10.1002/neu.480120109; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; MOTE MI, 1970, J EXP ZOOL, V173, P137, DOI 10.1002/jez.1401730203; Muller KL, 1998, ANIM BEHAV, V56, P479, DOI 10.1006/anbe.1998.0806; Nichols J., 2001, DISPERSAL; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; RIVAULT C, 1990, J ETHOL, V8, P53, DOI 10.1007/BF02350274; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sempo G, 2006, LECT NOTES COMPUT SC, V4095, P703; Sempo G, 2013, J APPL ECOL, V50, P1081, DOI 10.1111/1365-2664.12140; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stamps J, 2005, ECOLOGY, V86, P2860, DOI 10.1890/05-0290; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; VanVuren D, 1996, ETHOLOGY, V102, P686; Vasquez RA, 2000, P ROY SOC B-BIOL SCI, V267, P157, DOI 10.1098/rspb.2000.0981; Wang Z, 2012, SCI REPORTS, V2; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Zar J. H., 2009, BIOSTATISTICAL ANAL	62	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78951	10.1371/journal.pone.0078951	http://dx.doi.org/10.1371/journal.pone.0078951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244392	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600085
J	Aquilano, K; Baldelli, S; Ciriolo, MR				Aquilano, Katia; Baldelli, Sara; Ciriolo, Maria R.			Nuclear Recruitment of Neuronal Nitric-oxide Synthase by alpha-Syntrophin Is Crucial for the Induction of Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Myogenesis; Nitric-oxide Synthase; S-Nitrosylation; Scaffold Proteins	CU,ZN SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; NEUROBLASTOMA-CELLS; MUSCULAR-DYSTROPHY; SIGNALING PATHWAYS; LOCALIZATION; PGC-1-ALPHA; EXPRESSION; PROTEINS; ARGININE	Neuronal nitric-oxide synthase (nNOS) has various splicing variants and different subcellular localizations. nNOS can be found also in the nucleus; however, its exact role in this compartment is still not completely defined. In this report, we demonstrate that the PDZ domain allows the recruitment of nNOS to nuclei, thus favoring local NO production, nuclear protein S-nitrosylation, and induction of mitochondrial biogenesis. In particular, overexpression of PDZ-containing nNOS (nNOS) increases S-nitrosylated CREB with consequent augmented binding on cAMP response element consensus sequence on peroxisome proliferator-activated receptor co-activator (PGC)-1 promoter. The resulting PGC-1 induction is accompanied by the expression of mitochondrial genes (e.g., TFAM, MtCO1) and increased mitochondrial mass. Importantly, full active nNOS lacking PDZ domain (nNOS) does not localize in nuclei and fails in inducing the expression of PGC-1. Moreover, we substantiate that the mitochondrial biogenesis normally accompanying myogenesis is associated with nuclear translocation of nNOS. We demonstrate that -Syntrophin, which resides in nuclei of myocytes, functions as the upstream mediator of nuclear nNOS translocation and nNOS-dependent mitochondrial biogenesis. Overall, our results indicate that altered nNOS splicing and nuclear localization could be contributing factors in human muscular diseases associated with mitochondrial impairment.	[Aquilano, Katia; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Baldelli, Sara] Univ Telemat Roma San Raffaele, I-00166 Rome, Italy; [Ciriolo, Maria R.] IRCCS San Raffaele La Pisana, I-00166 Rome, Italy	University of Rome Tor Vergata; Universita Telematica San Raffaele; IRCCS San Raffaele Pisana	Aquilano, K (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.	katia.aquilano@uniroma2.it; ciriolo@bio.uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016; AQUILANO, KATIA/K-8888-2016; BALDELLI, SARA/G-4318-2015	AQUILANO, KATIA/0000-0002-5905-9870; BALDELLI, SARA/0000-0001-7003-3172	MIUR PRIN	MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was partially supported by grants from MIUR PRIN 2009.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241; Aquilano K, 2003, J NEUROCHEM, V85, P1324, DOI 10.1046/j.1471-4159.2003.01783.x; Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; Aquilano K, 2011, J CELL SCI, V124, P1043, DOI 10.1242/jcs.077149; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; BACHS O, 1992, BIOCHIM BIOPHYS ACTA, V1113, P259, DOI 10.1016/0304-4157(92)90041-8; Baldelli S, 2008, INT J BIOCHEM CELL B, V40, P2660, DOI 10.1016/j.biocel.2008.05.013; Baldelli S, 2013, BBA-GEN SUBJECTS, V1830, P4137, DOI 10.1016/j.bbagen.2013.04.006; Baldelli S, 2011, INT J BIOCHEM CELL B, V43, P163, DOI 10.1016/j.biocel.2010.10.016; Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Bhat HF, 2013, CELL MOL LIFE SCI, V70, P2533, DOI 10.1007/s00018-012-1233-9; Bossy-Wetzel E, 2003, CELL DEATH DIFFER, V10, P757, DOI 10.1038/sj.cdd.4401244; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Buono R, 2012, STEM CELLS, V30, P197, DOI 10.1002/stem.783; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Ciani E, 2002, J NEUROCHEM, V81, P218, DOI 10.1046/j.1471-4159.2002.00857.x; Constantin B., 2013, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbamem.2013.08.023; Corso-Diaz X, 2010, J NEUROCHEM, V114, P864, DOI 10.1111/j.1471-4159.2010.06813.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018; El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Elzaouk L, 2004, BBA-GEN SUBJECTS, V1670, P56, DOI 10.1016/j.bbagen.2003.10.015; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hedderick ELF, 2011, NEUROLOGY, V76, P960, DOI 10.1212/WNL.0b013e31821043c8; Hernandez-Aguilera A., 2013, MEDIATORS INFLAMM, V2013; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Larsson B, 1998, BIOCHEM BIOPH RES CO, V251, P898, DOI 10.1006/bbrc.1998.9578; Lee MA, 1997, J CLIN INVEST, V100, P1507, DOI 10.1172/JCI119673; Lettieri Barbato D, 2012, INT J CELL BIOL, V2012; Lettieri Barbato D., 2013, CELL DEATH DIFFER, DOI 10.1038/cdd.2013137; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024; Meinen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044148; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Pagliei B, 2013, BIOCHEM PHARMACOL, V85, P335, DOI 10.1016/j.bcp.2012.11.007; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Qu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052788; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Rotilio G, 2003, IUBMB LIFE, V55, P629, DOI 10.1080/15216540310001628717; Saur D, 2000, GASTROENTEROLOGY, V118, P849, DOI 10.1016/S0016-5085(00)70171-5; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Sullivan JC, 2003, ACTA PHYSIOL SCAND, V179, P115, DOI 10.1046/j.1365-201X.2003.01181.x; Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06; Tengan CH, 2007, BIOCHEM BIOPH RES CO, V359, P771, DOI 10.1016/j.bbrc.2007.05.184; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	72	40	41	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					365	378		10.1074/jbc.M113.506733	http://dx.doi.org/10.1074/jbc.M113.506733			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235139	Green Published, hybrid			2022-12-25	WOS:000329370900032
J	Rudell, JC; Borges, LS; Rudell, JB; Beck, KA; Ferns, MJ				Rudell, Jolene Chang; Borges, Lucia S.; Rudell, John B.; Beck, Kenneth A.; Ferns, Michael J.			Determinants in the beta and delta Subunit Cytoplasmic Loop Regulate Golgi Trafficking and Surface Expression of the Muscle Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Golgi; Nicotinic Acetylcholine Receptors; Protein Motifs; Skeletal Muscle; Trafficking; Neuromuscular Junction	ALPHA-SUBUNIT; PROTEIN; RAPSYN; MEMBRANE; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; DEGRADATION; UBIQUITIN	The molecular determinants that govern nicotinic acetylcholine receptor (AChR) assembly and trafficking are poorly defined, and those identified operate largely during initial receptor biogenesis in the endoplasmic reticulum. To identify determinants that regulate later trafficking steps, we performed an unbiased screen using chimeric proteins consisting of CD4 fused to the muscle AChR subunit cytoplasmic loops. In C2 mouse muscle cells, we found that CD4- and subunit loops were expressed at very low levels on the cell surface, whereas the other subunit loops were robustly expressed on the plasma membrane. The low surface expression of CD4- and loops was due to their pronounced retention in the Golgi apparatus and also to their rapid internalization from the plasma membrane. Both retention and recovery were mediated by the proximal 25-28 amino acids in each loop and were dependent on an ordered sequence of charged and hydrophobic residues. Indeed, K353L and K351L mutations increased surface trafficking of the CD4-subunit loops by >6-fold and also decreased their internalization from the plasma membrane. Similarly, combined K353L and K351L mutations increased the surface levels of assembled AChR expressed in HEK cells to 138% of wild-type levels. This was due to increased trafficking to the plasma membrane and not decreased AChR turnover. These findings identify novel Golgi retention signals in the and subunit loops that regulate surface trafficking of assembled AChR and may help prevent surface expression of unassembled subunits. Together, these results define molecular determinants that govern a Golgi-based regulatory step in nicotinic AChR trafficking.	[Rudell, Jolene Chang; Borges, Lucia S.; Rudell, John B.; Ferns, Michael J.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Beck, Kenneth A.] Univ Calif Davis, Dept Cell Biol & Anat, Davis, CA 95616 USA; [Ferns, Michael J.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ferns, MJ (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, 1 Shields Ave, Davis, CA 95616 USA.	mjferns@ucdavis.edu		Ferns, Michael/0000-0002-1545-3024; Rudell, Jolene/0000-0003-3022-4649	Muscular Dystrophy Association [134412]; University of California Davis Physician Scientist Training Program award	Muscular Dystrophy Association(Muscular Dystrophy Association); University of California Davis Physician Scientist Training Program award	This work was supported by Muscular Dystrophy Association Grant 134412 (to M. J. F.) and a University of California Davis Physician Scientist Training Program award (to J. C. R.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Marchand S, 2000, J NEUROSCI, V20, P521, DOI 10.1523/JNEUROSCI.20-02-00521.2000; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Park JY, 2012, J NEUROSCI, V32, P7356, DOI 10.1523/JNEUROSCI.0397-12.2012; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; Ramanathan VK, 1999, J BIOL CHEM, V274, P20513, DOI 10.1074/jbc.274.29.20513; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; SALPETER MM, 1993, ANN NY ACAD SCI, V681, P155, DOI 10.1111/j.1749-6632.1993.tb22881.x; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; ZHOU J, 1995, J NEUROCHEM, V65, P1146	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					203	214		10.1074/jbc.M113.502328	http://dx.doi.org/10.1074/jbc.M113.502328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24240098	Green Published, hybrid			2022-12-25	WOS:000329370900018
J	Bretz, NP; Ridinger, J; Rupp, AK; Rimbach, K; Keller, S; Rupp, C; Marme, F; Umansky, L; Umansky, V; Eigenbrod, T; Sammar, M; Altevogt, P				Bretz, Niko P.; Ridinger, Johannes; Rupp, Anne-Kathleen; Rimbach, Katharina; Keller, Sascha; Rupp, Christian; Marme, Frederik; Umansky, Ludmila; Umansky, Viktor; Eigenbrod, Tatjana; Sammar, Marei; Altevogt, Peter			Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Induction; Exosomes; NFB Transcription Factor; STAT3; Toll-like receptor (TLR); Amniotic Fluid; Malignant Ascites	TUMOR-DERIVED EXOSOMES; RELEASED MICROVESICLES; GROWTH; BIOGENESIS; MECHANISM; DIFFERENTIATION; EXPRESSION; MICRORNAS; VESICLES; IMMUNITY	Background: Exosomes, secreted from cells, have immunomodulatory capacities. Results: NFB- and STAT3-mediated cytokine release is triggered by various types of ex vivo exosomes in a TLR-dependent fashion. Conclusion: Exosomes have inherent signaling capacities important for global inflammatory responses. Significance: Detailed knowledge about intercellular communication in cancer and inflammatory diseases is crucial for development of new therapeutic approaches. Tumor-derived exosomes have been shown to induce various immunomodulatory effects. However, the underlying signaling pathways are poorly understood. Here, we analyzed the effects of ex vivo-derived exosomes on monocytic cell differentiation/activation using THP-1 cells as model. We isolated exosomes from various body fluids such as amniotic fluid, liver cirrhosis ascites, and malignant ascites of ovarian cancer patients. We observed that exosomes were internalized by THP-1 cells and induced the production of IL-1, TNF-, and IL-6. Analysis of the signaling pathways revealed a fast triggering of NFB and a delayed activation of STAT3. Pharmacologic and antibody-blocking experiments showed that the initial production of IL-6 was instrumental for subsequent activation of STAT3. Importantly, triggering of cell signaling was not a unique property of tumor exosomes but was also observed with exosomes of noncancerous origin. Exosomal signaling was TLR-dependent as the knockdown of Toll-like receptor 2 (TLR2) and TLR4 blocked NFB and STAT3 activation. Similar results were obtained with TLR-neutralizing antibodies. Exosomes also triggered the release of cytokines from mouse bone marrow-derived dendritic cells or macrophages. This process was MyD88-dependent, further supporting a role of TLR signaling. Our results suggest that exosomes trigger TLR-dependent signaling pathways in monocytic precursor cells but possibly also in other immune cells. This process could be important for the induction of immunosuppressive mechanisms during cancer progression and inflammatory diseases.	[Bretz, Niko P.; Ridinger, Johannes; Rupp, Anne-Kathleen; Keller, Sascha; Umansky, Ludmila; Altevogt, Peter] German Canc Res Ctr, Tumor Immunol Programme, D-69120 Heidelberg, Germany; [Rimbach, Katharina; Eigenbrod, Tatjana] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Rupp, Christian] Heidelberg Univ, Dept Internal Med Gastroenterol Infect Dis & Into, D-69120 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Clin Gynecol, D-69120 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Clin Obstet, D-69120 Heidelberg, Germany; [Umansky, Viktor] German Canc Res Ctr, Skin Canc Unit, D-69120 Heidelberg, Germany; [Umansky, Viktor] Heidelberg Univ, Dept Dermatol Venereol & Allergol, Univ Med Ctr Mannheim, D-68135 Mannheim, Germany; [Sammar, Marei] ORT Braude Coll, Dept Biotechnol Engn, IL-21661 Kamiel, Israel	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Altevogt, P (corresponding author), German Canc Res Ctr, Tumor Immunol Programme, D015,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.altevogt@dkfz.de	Sammar, Marei/Q-1410-2019; Rupp, Christian/E-7652-2019	Rupp, Christian/0000-0003-2808-9230	Deutsche Krebshilfe Project [109745]; Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program	Deutsche Krebshilfe Project; Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program	This work was supported by Deutsche Krebshilfe Project 109745 and by the Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program (to P. A. and F. M.).	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Clayton A, 2012, ONCOIMMUNOLOGY, V1, P78, DOI 10.4161/onci.1.1.17826; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marton A, 2012, IMMUNOL LETT, V148, P34, DOI 10.1016/j.imlet.2012.07.006; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Rupp AK, 2011, GYNECOL ONCOL, V122, P437, DOI 10.1016/j.ygyno.2011.04.035; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Whiteside TL, 2005, BRIT J CANCER, V92, P209, DOI 10.1038/sj.bjc.6602360; Xiang XY, 2010, AM J PATHOL, V177, P1606, DOI 10.2353/ajpath.2010.100245; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867	47	173	177	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36691	36702		10.1074/jbc.M113.512806	http://dx.doi.org/10.1074/jbc.M113.512806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225954	Green Published, hybrid			2022-12-25	WOS:000328883400047
J	Carpenter, K; DiCroce, T; Kinneer, B; Simon, R				Carpenter, Kenneth; DiCroce, Tony; Kinneer, Billy; Simon, Robert			Pelvis of Gargoyleosaurus (Dinosauria: Ankylosauria) and the Origin and Evolution of the Ankylosaur Pelvis	PLOS ONE			English	Article							ORNITHISCHIA; PHYLOGENY; REDESCRIPTION; OSTEOLOGY	Discovery of a pelvis attributed to the Late Jurassic armor-plated dinosaur Gargoyleosaurus sheds new light on the origin of the peculiar non-vertical, broad, flaring pelvis of ankylosaurs. It further substantiates separation of the two ankylosaurs from the Morrison Formation of the western United States, Gargoyleosaurus and Mymoorapelta. Although horizontally oriented and lacking the medial curve of the preacetabular process seen in Mymoorapelta, the new ilium shows little of the lateral flaring seen in the pelvis of Cretaceous ankylosaurs. Comparison with the basal thyreophoran Scelidosaurus demonstrates that the ilium in ankylosaurs did not develop entirely by lateral rotation as is commonly believed. Rather, the preacetabular process rotated medially and ventrally and the postacetabular process rotated in opposition, i.e., lateral and ventrally. Thus, the dorsal surfaces of the preacetabular and postacetabular processes are not homologous. In contrast, a series of juvenile Stegosaurus ilia show that the postacetabular process rotated dorsally ontogenetically. Thus, the pelvis of the two major types of Thyreophora most likely developed independently. Examination of other ornithischians show that a non-vertical ilium had developed independently in several different lineages, including ceratopsids, pachycephalosaurs, and iguanodonts. Therefore, a separate origin for the non-vertical ilium in stegosaurs and ankylosaurs does have precedent.	[Carpenter, Kenneth] Utah State Univ Eastern, Prehist Museum, Price, UT 84501 USA; [Carpenter, Kenneth] Univ Colorado Museum, Geol Sect, Boulder, CO 80309 USA; [DiCroce, Tony; Kinneer, Billy] Denver Museum Nat & Sci, Denver, CO USA; [Simon, Robert] Dinosaur Safaris Inc, Ashland, VA USA	Utah System of Higher Education; Utah State University; Utah State University College of Eastern Utah; University of Colorado System; University of Colorado Boulder	Carpenter, K (corresponding author), Utah State Univ Eastern, Prehist Museum, Price, UT 84501 USA.	Ken.Carpenter@ceu.edu						Arbour VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062421; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2011, PALAEONTOGR ABT A, V294, P1; Carpenter K, 2010, J IBER GEOL, V36, P145, DOI 10.5209/rev_JIGE.2010.v36.n2.3; Carpenter K, 2001, LIFE O PAST, P455; Carpenter K, 1998, NATURE, V393, P782, DOI 10.1038/31684; Carpenter K., 1990, DINOSAUR SYSTEMATICS, P282; Carpenter K, 1999, UTAH GEOL SURV MISC, V99-1, P244; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; COOMBS WP, 1979, J PALEONTOL, V53, P666; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; GALTON PM, 1974, J PALEONTOL, V48, P1048; Gilmore C. W., 1930, Proceedings of the United States National Museum, V77, P1; Godefroit P, 2009, GEODIVERSITAS, V31, P525, DOI 10.5252/g2009n3a3; Hatcher JB, 1907, MONOGRAPHS US GEOLOG, V49; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hulke J. W., 1887, PHILOS T ROY SOC LON, V178, DOI [10.1098/rstb.1887.0007, DOI 10.1098/RSTB.1887.0007]; Kilbourne B, 2005, NEUES JAHRB GEOL P-A, V237, P111, DOI 10.1127/njgpa/237/2005/111; Kirkland James I., 1994, Brigham Young University Geology Studies, V40, P25; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Lull RS, 1921, AM J SCI, V1, P97; Maidment SCR, 2006, GEOL MAG, V143, P621, DOI 10.1017/S0016756806002500; Maidment SCR, 2012, P ROY SOC B-BIOL SCI, V279, P3765, DOI 10.1098/rspb.2012.1040; Maleev E. A., 1954, Travaux de l'Institut Paleozoologique Acad Sci URSS, V48, P142; Maleev E.A., 1956, T PALEONTOL I AKAD N, V62, P51; Maryanska T, 1968, PALAEONT POL, V19, P1; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Norman David B., 2001, Journal of Vertebrate Paleontology, V21, p84A; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; Norman DB, 1984, 3 S MES TERR EC; Osborn H. F., 1899, tt cc, P191; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Owen R., 1866, ANATOMY VERTEBRATES, V1; Owen Richard, 1847, ARCHETYPE HOMOLOGIES; PARISH JC, 2005, THESIS U OXFORD; ROMER ALFRED S., 1927, ACTA ZOOL [STOCKHOLM], V8, P225; Rosenbaum Jason N., 2000, Paleobios, V20, P13; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Zhou S.W, 1984, MIDDLE JURASSIC DINO	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79887	10.1371/journal.pone.0079887	http://dx.doi.org/10.1371/journal.pone.0079887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244573	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800103
J	Delle Monache, S; Angelucci, A; Sanita, P; Iorio, R; Bennato, F; Mancini, F; Gualtieri, G; Colonna, RC				Delle Monache, Simona; Angelucci, Adriano; Sanita, Patrizia; Iorio, Roberto; Bennato, Francesca; Mancini, Fabrizio; Gualtieri, Giancaterino; Colonna, Rosella Cardigno			Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNAL-REGULATED KINASE; HEAT-SHOCK PROTEINS; ELECTROMAGNETIC-FIELDS; CELLS; HSP70; EXPOSURE; CANCER; ACTIVATION; EXPRESSION	The formation of new blood vessels is an essential therapeutic target in many diseases such as cancer, ischemic diseases, and chronic inflammation. In this regard, extremely low-frequency (ELF) electromagnetic fields (EMFs) seem able to inhibit vessel growth when used in a specific window of amplitude. To investigate the mechanism of anti-angiogenic action of ELF-EMFs we tested the effect of a sinusoidal magnetic field (MF) of 2 mT intensity and frequency of 50 Hz on endothelial cell models HUVEC and MS-1 measuring cell status and proliferation, motility and tubule formation ability. MS-1 cells when injected in mice determined a rapid tumor-like growth that was significantly reduced in mice inoculated with MF-exposed cells. In particular, histological analysis of tumors derived from mice inoculated with MF-exposed MS-1 cells indicated a reduction of hemangioma size, of blood-filled spaces, and in hemorrhage. In parallel, in vitro proliferation of MS-1 treated with MF was significantly inhibited. We also found that the MF-exposure down-regulated the process of proliferation, migration and formation of tubule-like structures in HUVECs. Using western blotting and immunofluorescence analysis, we collected data about the possible influence of MF on the signalling pathway activated by the vascular endothelial growth factor (VEGF). In particular, MF exposure significantly reduced the expression and activation levels of VEGFR2, suggesting a direct or indirect influence of MF on VEGF receptors placed on cellular membrane. In conclusion MF reduced, in vitro and in vivo, the ability of endothelial cells to form new vessels, most probably affecting VEGF signal transduction pathway that was less responsive to activation. These findings could not only explain the mechanism of anti-angiogenic action exerted by MFs, but also promote the possible development of new therapeutic applications for treatment of those diseases where excessive angiogenesis is involved.	[Delle Monache, Simona; Angelucci, Adriano; Sanita, Patrizia; Iorio, Roberto; Bennato, Francesca; Gualtieri, Giancaterino; Colonna, Rosella Cardigno] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Mancini, Fabrizio] Univ Aquila, Dept Ind & Informat Engn & Econ, I-67100 Laquila, Italy	University of L'Aquila; University of L'Aquila	Delle Monache, S (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	simona.dellemonache@univaq.it	Delle Monache, Simona/M-5618-2014; Angelucci, Adriano/B-7134-2013	Delle Monache, Simona/0000-0002-8153-915X; Angelucci, Adriano/0000-0002-8755-1889; Iorio, Roberto/0000-0003-1863-5752; Bennato, Francesca/0000-0001-9030-4881	MURST ex-60% Grant from Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica	MURST ex-60% Grant from Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by MURST ex-60% Grant from "Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2000, AM J PATHOL, V156, P1469, DOI 10.1016/S0002-9440(10)65015-8; Bekhite MM, 2010, STEM CELLS DEV, V19, P731, DOI 10.1089/scd.2008.0266; Bernardini C, 2007, BIOELECTROMAGNETICS, V28, P231, DOI 10.1002/bem.20299; Blank Martin, 2009, Pathophysiology, V16, P71, DOI 10.1016/j.pathophys.2009.01.006; Blei F, 2005, CURR OPIN PEDIATR, V17, P501, DOI 10.1097/01.mop.0000171322.76429.80; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Bruns AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048539; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Carmody S, 2000, J CELL BIOCHEM, V79, P453, DOI 10.1002/1097-4644(20001201)79:3<453::AID-JCB100>3.0.CO;2-M; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Delle Monache S, 2008, BIOELECTROMAGNETICS, V29, P640, DOI 10.1002/bem.20430; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Goodman R, 2009, INT J RADIAT BIOL, V85, P851, DOI [10.3109/09553000903072488, 10.1080/09553000903072488]; Grothey A, 2008, CANCER J, V14, P170, DOI 10.1097/PPO.0b013e318178d9de; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; HANNAN CJ, 1994, ANTICANCER RES, V14, P1517; Iorio R, 2007, BIOELECTROMAGNETICS, V28, P72, DOI 10.1002/bem.20278; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lee JS, 2005, J BIOL CHEM, V280, P6634, DOI 10.1074/jbc.M412393200; Liang YY, 1997, ANTICANCER RES, V17, P2083; Lin H, 2001, J CELL BIOCHEM, V81, P143, DOI 10.1002/1097-4644(20010401)81:1<143::AID-JCB1030>3.0.CO;2-4; Lin H, 1998, J CELL BIOCHEM, V69, P181, DOI 10.1002/(SICI)1097-4644(19980501)69:2<181::AID-JCB8>3.0.CO;2-O; Markov M., 2006, BIOELECTROMAGNETICS, P1, DOI [10.1007/1-4020- 4278-7_1, DOI 10.1007/1-4020-4278-7_1]; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Markov MS, 2010, CARDIOLOGY, V117, P54, DOI 10.1159/000315433; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Nie K, 2003, J CELL BIOCHEM, V90, P1197, DOI 10.1002/jcb.10704; Okano H, 2008, BIOELECTROMAGNETICS, V29, P233, DOI 10.1002/bem.20376; Okano H, 2007, BIOELECTROMAGNETICS, V28, P497, DOI 10.1002/bem.20330; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARADISI S, 1993, BIOELECTROMAGNETICS, V14, P247, DOI 10.1002/bem.2250140308; PASSANITI A, 1992, LAB INVEST, V67, P519; Pilla Arthur A., 1994, Reviews on Environmental Health, V10, P155; Robertson JA, 2007, BIOELECTROMAGNETICS, V28, P16, DOI 10.1002/bem.20258; Ruggiero M, 2004, BIOELECTROMAGNETICS, V25, P390, DOI 10.1002/bem.20008; Salvatore J. R., 1994, Reviews on Environmental Health, V10, P197; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Sun WJ, 2008, CELL PHYSIOL BIOCHEM, V22, P507, DOI 10.1159/000185524; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Tanaka K, 1999, JPN J CANCER RES, V90, P647, DOI 10.1111/j.1349-7006.1999.tb00796.x; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; Wei M, 2000, TOXICOL APPL PHARM, V162, P166, DOI 10.1006/taap.1999.8825; Williams CD, 2001, ANTICANCER RES, V21, P3887; Yang XS, 2012, BRAIN RES BULL, V88, P371, DOI 10.1016/j.brainresbull.2012.04.002; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	54	33	33	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79309	10.1371/journal.pone.0079309	http://dx.doi.org/10.1371/journal.pone.0079309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244477	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800060
J	Gerlach, RL; Camp, JV; Chu, YK; Jonsson, CB				Gerlach, Rachael L.; Camp, Jeremy V.; Chu, Yong-Kyu; Jonsson, Colleen B.			Early Host Responses of Seasonal and Pandemic Influenza A Viruses in Primary Well-Differentiated Human Lung Epithelial Cells	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; H1N1 VIRUS; INNATE IMMUNITY; RNA VIRUSES; RIG-I; HUMAN ALVEOLAR; INFECTION; INDUCTION; APOPTOSIS; H5N1	Replication, cell tropism and the magnitude of the host's antiviral immune response each contribute to the resulting pathogenicity of influenza A viruses (IAV) in humans. In contrast to seasonal IAV in human cases, the 2009 H1N1 pandemic IAV (H1N1pdm) shows a greater tropism for infection of the lung similar to H5N1. We hypothesized that host responses during infection of well-differentiated, primary human bronchial epithelial cells (wd-NHBE) may differ between seasonal (H1N1 A/BN/59/07) and H1N1pdm isolates from a fatal (A/KY/180/10) and nonfatal (A/KY/136/09) case. For each virus, the level of infectious virus and host response to infection (gene expression and apical/basal cytokine/chemokine profiles) were measured in wd-NHBE at 8, 24, 36, 48 and 72 hours post-infection (hpi). At 24 and 36 hpi, KY/180 showed a significant, tenfold higher titer as compared to the other two isolates. Apical cytokine/chemokine levels of IL-6, IL-8 and GRO were similar in wd-NHBE cells infected by each of these viruses. At 24 and 36 hpi, NHBE cells had greater levels of pro-inflammatory cytokines including IFN-alpha, CCL2, TNF-alpha, and CCL5, when infected by pandemic viruses as compared with seasonal. Polarization of IL-6 in wd-NHBE cells was greatest at 36 hpi for all isolates. Differential polarized secretion was suggested for CCL5 across isolates. Despite differences in viral titer across isolates, no significant differences were observed in KY/180 and KY/136 gene expression intensity profiles. Microarray profiles of wd-NHBE cells diverged at 36 hpi with 1647 genes commonly shared by wd-NHBE cells infected by pandemic, but not seasonal isolates. Significant differences were observed in cytokine signaling, apoptosis, and cytoskeletal arrangement pathways. Our studies revealed differences in temporal dynamics and basal levels of cytokine/chemokine responses of wd-NHBE cells infected with each isolate; however, wd-NHBE cell gene intensity profiles were not significantly different between the two pandemic isolates suggesting post-transcriptional or later differences in viral-host interactions.	[Gerlach, Rachael L.; Camp, Jeremy V.; Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chu, Yong-Kyu; Jonsson, Colleen B.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; 	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Funding support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to CBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Camp JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056602; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; EBISAWA IT, 1969, AM REV RESPIR DIS, V99, P507; Fowlkes AL, 2011, CLIN INFECT DIS   S1, V52, pS60; Frank JA, 2007, AM J PHYSIOL-LUNG C, V293, pL52, DOI 10.1152/ajplung.00256.2006; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ioannidis I, 2012, J VIROL, V86, P5422, DOI 10.1128/JVI.06757-11; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Jeffery PK, 1997, EUR RESPIR J, V10, P1655, DOI 10.1183/09031936.97.10071655; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Patel JR, 2011, VIRAL IMMUNOL, V24, P89, DOI 10.1089/vim.2010.0122; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Price GE, 1997, J GEN VIROL, V78, P2821, DOI 10.1099/0022-1317-78-11-2821; Proudfoot AG, 2011, DIS MODEL MECH, V4, P145, DOI 10.1242/dmm.006213; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Song BM, 2011, VIRAL IMMUNOL, V24, P179, DOI 10.1089/vim.2010.0125; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; van den Brand JMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042343; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang Q, 2012, INFLAMM RES, V61, P977, DOI 10.1007/s00011-012-0490-2; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3; Yang XX, 2010, BIOMED ENVIRON SCI, V23, P259, DOI 10.1016/S0895-3988(10)60061-X; Zeng H, 2011, J VIROL, V85, P686, DOI 10.1128/JVI.01568-10	58	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78912	10.1371/journal.pone.0078912	http://dx.doi.org/10.1371/journal.pone.0078912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244384	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800020
J	Kalle, R; Ramesh, T; Qureshi, Q; Sankar, K				Kalle, Riddhika; Ramesh, Tharmalingam; Qureshi, Qamar; Sankar, Kalyanasundaram			Predicting the Distribution Pattern of Small Carnivores in Response to Environmental Factors in the Western Ghats	PLOS ONE			English	Article							SPECIES DISTRIBUTION; CONSERVATION; RARE; PERFORMANCE; MODELS; AUC	Due to their secretive habits, predicting the pattern of spatial distribution of small carnivores has been typically challenging, yet for conservation management it is essential to understand the association between this group of animals and environmental factors. We applied maximum entropy modeling (MaxEnt) to build distribution models and identify environmental predictors including bioclimatic variables, forest and land cover type, topography, vegetation index and anthropogenic variables for six small carnivore species in Mudumalai Tiger Reserve. Species occurrence records were collated from camera-traps and vehicle transects during the years 2010 and 2011. We used the average training gain from forty model runs for each species to select the best set of predictors. The area under the curve (AUC) of the receiver operating characteristic plot (ROC) ranged from 0.81 to 0.93 for the training data and 0.72 to 0.87 for the test data. In habitat models for F. chaus, P. hermaphroditus, and H. smithii "distance to village'' and precipitation of the warmest quarter emerged as some of the most important variables. "Distance to village'' and aspect were important for V. indica while "distance to village'' and precipitation of the coldest quarter were significant for H. vitticollis. "Distance to village'', precipitation of the warmest quarter and land cover were influential variables in the distribution of H. edwardsii. The map of predicted probabilities of occurrence showed potentially suitable habitats accounting for 46 km(2) of the reserve for F. chaus, 62 km(2) for V. indica, 30 km(2) for P. hermaphroditus, 63 km(2) for H. vitticollis, 45 km(2) for H. smithii and 28 km(2) for H. edwardsii. Habitat heterogeneity driven by the east-west climatic gradient was correlated with the spatial distribution of small carnivores. This study exemplifies the usefulness of modeling small carnivore distribution to prioritize and direct conservation planning for habitat specialists in southern India.	[Kalle, Riddhika; Ramesh, Tharmalingam] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Qureshi, Qamar] Wildlife Inst India, Dept Landscape Ecol, Dehra Dun, Uttarakhand, India; [Sankar, Kalyanasundaram] Wildlife Inst India, Dept Habitat Ecol, Dehra Dun, Uttarakhand, India	Wildlife Institute of India; Wildlife Institute of India; Wildlife Institute of India	Kalle, R (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	riddhikalle@gmail.com			Wildlife Institute of India	Wildlife Institute of India	The research project was supported by the Wildlife Institute of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan M., 2007, SMALL CARNIVORE CONS, V36, P9; BEERS TW, 1966, J FOREST, V64, P691; Burneo Santiago F., 2009, Small Carnivore Conservation, V41, P41; Champion H. G., 1968, REVISED SURVEY FORES, P404; Choudhury A, 2011, IUCN 2012 IUCN RED L; Choudhury A, 2008, IUCN 2011 IUCN RED L; Duckworth J.W., 2008, NAEMORHEDUS GRISEUS, DOI [10.2305/IUCN.UK.2008.RLTS.T14303A4430834.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14303A4430834.EN]; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gerber B, 2010, ORYX, V44, P219, DOI 10.1017/S0030605309991037; Gupta S., 2011, THESIS SAURASHTRA U; Hanfee F, 1999, ENVIS B WILDLIFE PRO, P113; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Jackson P., 1996, BIOL CONSERVATION; Jennings AP, 2011, J MAMMAL, V92, P316, DOI 10.1644/10-MAMM-A-155.1; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; JOSHI AR, 1995, J MAMMAL, V76, P1205, DOI 10.2307/1382613; Kalle R., 2012, J SCI T ENV TECHNOVA, V6, P44; Krishnakumar Hema, 2003, Small Carnivore Conservation, V28, P10; Kumar A., 1999, ENVIS B, V2, P74; Kumar A, 1999, ENVIS B WILDLIFE PRO, P87; Kumara H. N., 2007, Journal of the Bombay Natural History Society, V104, P153; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Monk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034558; Monterroso P, 2009, J ZOOL, V279, P27, DOI 10.1111/j.1469-7998.2009.00585.x; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Mudappa D, 1999, ENVIS B WILDLIFE PRO, P65; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; Mudappa D, 2001, THESIS S ALI CTR ORN; Mukherjee S, 2004, J ZOOL, V262, P405, DOI 10.1017/S0952836903004783; Mukherjee S, 1998, THESIS U SAURASHTRA; Mukherjee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013724; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon AMA, 2010, CIVET CHRONICLES SEA; Patel Kunal, 2006, Cat News, V45, P27; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pillay Rajeev, 2009, Small Carnivore Conservation, V40, P36; Prakash N, 2012, TROP CONSERV SCI, V5, P67, DOI 10.1177/194008291200500107; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Ramesh T., 2010, THESIS SAURASHTRA U; Ramesh T, 2013, EUR J WILDLIFE RES, V59, P271, DOI 10.1007/s10344-012-0676-5; Trabucco A., 2010, GLOBAL HIGH RESOLUTI; Van Rompaey Harry, 2003, Small Carnivore Conservation, V28, P14; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Yoganand T.R.K., 1995, Small Carnivore Conservation, V13, P1	55	39	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79295	10.1371/journal.pone.0079295	http://dx.doi.org/10.1371/journal.pone.0079295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244470	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800056
J	Harcus, D; Dignard, D; Lepine, G; Askew, C; Raymond, M; Whiteway, M; Wu, CL				Harcus, Doreen; Dignard, Daniel; Lepine, Guylaine; Askew, Chris; Raymond, Martine; Whiteway, Malcolm; Wu, Cunle			Comparative Xylose Metabolism among the Ascomycetes C. albicans, S. stipitis and S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; PICHIA-STIPITIS; GENE DISRUPTION; PENTOSE UTILIZATION; GLUCOSE REPRESSION; ETHANOL-PRODUCTION; FERMENTATION; REDUCTASE; STRAINS	The ascomycetes Candida albicans, Saccharomyces cerevisiae and Scheffersomyces stipitis metabolize the pentose sugar xylose very differently. S. cerevisiae fails to grow on xylose, while C. albicans can grow, and S. stipitis can both grow and ferment xylose to ethanol. However, all three species contain highly similar genes that encode potential xylose reductases and xylitol dehydrogenases required to convert xylose to xylulose, and xylulose supports the growth of all three fungi. We have created C. albicans strains deleted for the xylose reductase gene GRE3, the xylitol dehydrogenase gene XYL2, as well as the gre3 xyl2 double mutant. As expected, all the mutant strains cannot grow on xylose, while the single gre3 mutant can grow on xylitol. The gre3 and xyl2 mutants are efficiently complemented by the XYL1 and XYL2 from S. stipitis. Intriguingly, the S. cerevisiae GRE3 gene can complement the Cagre3 mutant, while the ScSOR1 gene can complement the Caxyl2 mutant, showing that S. cerevisiae contains the enzymatic capacity for converting xylose to xylulose. In addition, the gre3 xyl2 double mutant of C. albicans is effectively rescued by the xylose isomerase (XI) gene of either Piromyces or Orpinomyces, suggesting that the XI provides an alternative to the missing oxido-reductase functions in the mutant required for the xylose-xylulose conversion. Overall this work suggests that C. albicans strains engineered to lack essential steps for xylose metabolism can provide a platform for the analysis of xylose metabolism enzymes from a variety of species, and confirms that S. cerevisiae has the genetic potential to convert xylose to xylulose, although non-engineered strains cannot proliferate on xylose as the sole carbon source.	[Harcus, Doreen; Dignard, Daniel; Whiteway, Malcolm; Wu, Cunle] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Lepine, Guylaine] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Askew, Chris; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Raymond, Martine] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Whiteway, Malcolm] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Wu, Cunle] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	National Research Council Canada; Universite de Montreal; McGill University; Universite de Montreal; Concordia University - Canada; McGill University	Whiteway, M (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	Malcolm.whiteway@concordia.ca; cunle.wu@cnrc-nrc.gc.ca			Canadian Institutes of Health Research (CIHR) [MOP42516, CTP79843]; Agricultural Bioproducts Innovation Program (ABIP)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Agricultural Bioproducts Innovation Program (ABIP)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) to MW (MOP42516) and MW and MR (CTP79843), and from the Agricultural Bioproducts Innovation Program (ABIP). This is NRC publication 49551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Bera AK, 2011, J IND MICROBIOL BIOT, V38, P617, DOI 10.1007/s10295-010-0806-6; Bettiga M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-40; Brachmann CB, 1998, YEAST, V14, P115; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; DENG X X, 1990, Applied Biochemistry and Biotechnology, V24-25, P193, DOI 10.1007/BF02920245; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; Kay J, 1987, KREBS CITRIC ACID CY; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; Liang L, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-36; Nantel A, 2006, MICROARRAYS STUDYING; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Saitoh S, 2011, APPL MICROBIOL BIOT, V91, P1553, DOI 10.1007/s00253-011-3357-5; Schwartz K, 2012, GENETICS, V191, P621, DOI 10.1534/genetics.112.140053; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Walfridsson M, 1996, APPL ENVIRON MICROB, V62, P4648, DOI 10.1128/AEM.62.12.4648-4651.1996; Watanabe S, 2007, MICROBIOL-SGM, V153, P3044, DOI 10.1099/mic.0.2007/007856-0; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P1365, DOI 10.1271/bbb.70104; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108	38	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80733	10.1371/journal.pone.0080733	http://dx.doi.org/10.1371/journal.pone.0080733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236198	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700201
J	Li, L; Yan, HF				Li, Lin; Yan, Haifei			A Remarkable New Species of Liparis (Orchidaceae) from China and Its Phylogenetic Implications	PLOS ONE			English	Article							EPIDENDROIDEAE; MALAXIDINAE; MORPHOLOGY; GENUS	In the present study, we formally describe Liparis pingxiangensis as a new species from Guangxi, China on the basis of morphological and molecular phylogenetic analyses. It is easily distinguished from closely related species by strongly curved column without column wings, and broadly rhombic-elliptic lip with 2 uncinate calli at the base. In particular, it differs most markedly from its congeners in possessing two pollinia attached by long and prominent caudicles (not stipes), to a distinct sticky disc. This type of pollinarium, as far as we know, is not found in any other species of Liparis, and is also unique among the orchids with waxy pollinia. We then proceeded to a phylogenetic analysis to ascertain the systematic position of this enigmatic species. Molecular study based on nuclear ribosomal ITS and plastid matK DNA sequence data supports L. pingxiangensis as a distinct species, which forms an independent lineage sister to L. nervosa and its allies (93% BS, 1.00 BPP). In the light of previous work, the findings have important implications for a better understanding of the well-supported pattern mainly based on vegetative features in Malaxideae.	[Li, Lin; Yan, Haifei] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS	Yan, HF (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	yanhaifei@scbg.ac.cn	Li, Lin/J-6925-2019	Li, Lin/0000-0001-7091-9686	National Natural Science Foundation of China [31100149]; Doctoral Fund for Scientific Research of South China Botanical Garden, CAS [201007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund for Scientific Research of South China Botanical Garden, CAS	This study was financially supported by the National Natural Science Foundation of China (31100149) and Doctoral Fund for Scientific Research of South China Botanical Garden, CAS (201007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ORCHIDEE; [Anonymous], 1992, ORCHIDS PENINSULAR M; Cameron KM, 2005, AM J BOT, V92, P1025, DOI 10.3732/ajb.92.6.1025; Chen S.C., 2009, FLORA CHINA, V25, P211; Comber J. B., 1990, ORCHIDS JAVA; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Jones DL, 2004, ORCHADIAN, V15, P33; Jones DL, 2004, ORCHADIAN SCI S, V14, P1; Liu ZJ, 2008, J SYST EVOL, V46, P622, DOI 10.3724/SP.J.1002.2008.08082; Margonska HB, 2001, ANN BOT FENN, V38, P77; Ohi-Toma Tetsuo, 2007, APG Acta Phytotaxonomica et Geobotanica, V58, P105; Pearce N R, 2002, FLORA BHUTAN 3, V3, P195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pridgeon A.M., 2005, GENERA ORCHIDACEARUM, V4, P453; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Pridgeon AM, 2001, AM J BOT, V88, P2286, DOI 10.2307/3558390; Rambaut A, 2007, SE AL SEQUENCE ALIGN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SEIDENFADEN G, 1976, DAN BOT ARK, V31, P5; Singer Rodrigo B., 2008, Selbyana, V29, P6; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szlachetko DL, 2008, ACTA SOC BOT POL, V77, P35; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsumi C, 2007, J PLANT RES, V120, P405, DOI 10.1007/s10265-007-0077-0; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837	34	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78112	10.1371/journal.pone.0078112	http://dx.doi.org/10.1371/journal.pone.0078112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236013	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700010
J	Schoborg, T; Kuruganti, S; Rickels, R; Labrador, M				Schoborg, Todd; Kuruganti, Srilalitha; Rickels, Ryan; Labrador, Mariano			The Drosophila gypsy Insulator Supports Transvection in the Presence of the vestigial Enhancer	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; LONG-RANGE INTERACTION; PROMOTER INTERACTIONS; TRANSCRIPTIONAL ENHANCERS; TRANSPOSABLE ELEMENT; REGULATORY REGIONS; TRANS-INACTIVATION; BROWN GENE; MELANOGASTER; GENOME	Though operationally defined as cis-regulatory elements, enhancers can also communicate with promoters on a separate homolog in trans, a mechanism that has been suggested to account for the ability of certain alleles of the same gene to complement one another in a process otherwise known as transvection. This homolog-pairing dependent process is facilitated in Drosophila by chromatin-associated pairing proteins, many of which remain unknown and their mechanism of action uncharacterized. Here we have tested the role of the gypsy chromatin insulator in facilitating pairing and communication between enhancers and promoters in trans using a transgenic eGFP reporter system engineered to allow for targeted deletions in the vestigial Boundary Enhancer (vgBE) and the hsp70 minimal promoter, along with one or two flanking gypsy elements. We found a modest 2.5-3x increase in eGFP reporter levels from homozygotes carrying an intact copy of the reporter on each homolog compared to unpaired hemizygotes, although this behavior was independent of gypsy. However, detectable levels of GFP protein along the DV wing boundary in trans-heterozygotes lacking a single enhancer and promoter was only observed in the presence of two flanking gypsy elements. Our results demonstrate that gypsy can stimulate enhancer-promoter communication in trans throughout the genome in a context-dependent manner, likely through modulation of local chromatin dynamics once pairing has been established by other elements and highlights chromatin structure as the master regulator of this phenomenon.	[Schoborg, Todd; Kuruganti, Srilalitha; Rickels, Ryan; Labrador, Mariano] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Labrador, M (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	labrador@utk.edu		Labrador-San Jose, Mariano/0000-0002-8075-2717; Schoborg, Todd/0000-0003-0017-0942	BCMB Department, the College of Arts and Sciences at the University of Tennessee; Office of Research at the University of Tennessee; NIH [GM78132-2]; NSF [MCB-0616081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078132] Funding Source: NIH RePORTER	BCMB Department, the College of Arts and Sciences at the University of Tennessee; Office of Research at the University of Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the BCMB Department, the College of Arts and Sciences and Office of Research at the University of Tennessee for support in addition to US Public Health Service Award GM78132-2 from the NIH and MCB-0616081 from NSF to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Babu P, 1980, Basic Life Sci, V16, P35; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bateman JR, 2012, GENETICS, V191, P1143, DOI 10.1534/genetics.112.140954; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Buratovich MA, 1997, DEV BIOL, V185, P244, DOI 10.1006/dbio.1997.8562; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Casares F, 1997, GENETICS, V145, P123; Chen JL, 2002, P NATL ACAD SCI USA, V99, P3723, DOI 10.1073/pnas.062447999; CONDIE JM, 1989, DEV BIOL, V135, P31, DOI 10.1016/0012-1606(89)90155-3; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; DREESEN TD, 1991, GENE DEV, V5, P331, DOI 10.1101/gad.5.3.331; DUNAWAY M, 1989, NATURE, V341, P657, DOI 10.1038/341657a0; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fritsch C, 2006, CHROMOSOME RES, V14, P451, DOI 10.1007/s10577-006-1068-z; GELBART WM, 1982, P NATL ACAD SCI-BIOL, V79, P2636, DOI 10.1073/pnas.79.8.2636; GEORGIEV PG, 1995, P NATL ACAD SCI USA, V92, P5184, DOI 10.1073/pnas.92.11.5184; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gibson JB, 1999, BIOCHEM GENET, V37, P301, DOI 10.1023/A:1018707226595; Gohl D, 2008, GENETICS, V178, P127, DOI 10.1534/genetics.107.077768; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; HENIKOFF S, 1989, P NATL ACAD SCI USA, V86, P6704, DOI 10.1073/pnas.86.17.6704; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; JACK JW, 1979, P NATL ACAD SCI USA, V76, P1368, DOI 10.1073/pnas.76.3.1368; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kennison JA, 2002, ADV GENET, V46, P399; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LEISERSON WM, 1994, GENETICS, V138, P1171; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Liu H, 2008, J EXP MED, V205, P1843, DOI 10.1084/jem.20072102; LOCKE J, 1994, MOL GEN GENET, V243, P234, DOI 10.1007/BF00280321; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; MARTINEZLABORDA A, 1992, EMBO J, V11, P3645, DOI 10.1002/j.1460-2075.1992.tb05449.x; Matzke M, 2001, GENETICS, V158, P451; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Mellert DJ, 2012, GENETICS, V191, P1129, DOI 10.1534/genetics.112.140475; MODOLELL J, 1983, P NATL ACAD SCI-BIOL, V80, P1678, DOI 10.1073/pnas.80.6.1678; Morris JR, 1999, GENETICS, V151, P633; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Oh SW, 2003, GENETICS, V163, P195; PARKHURST SM, 1988, GENE DEV, V2, P1205, DOI 10.1101/gad.2.10.1205; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; PATTATUCCI AM, 1991, GENETICS, V129, P443; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Saint Phalle B, 2003, DROSOPHILA CYTOGENET, P373; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoborg TA, 2010, J MOL EVOL, V70, P74, DOI 10.1007/s00239-009-9310-x; SCHOLZ H, 1993, GENETICS, V135, P455; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sipos L, 1998, GENETICS, V149, P1031; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Spradling AC, 1999, GENETICS, V153, P135; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; Williams BR, 2007, GENETICS, V177, P31, DOI 10.1534/genetics.107.076356; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; WU CT, 1989, MOL GEN GENET, V218, P559, DOI 10.1007/BF00332424; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Zimmerman JE, 2000, GENETICS, V154, P237	83	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81331	10.1371/journal.pone.0081331	http://dx.doi.org/10.1371/journal.pone.0081331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236213	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700216
J	Suzuki, H; Takaku, Y; Ohta, I; Ishii, D; Muranaka, Y; Shimomura, M; Hariyama, T				Suzuki, Hiroshi; Takaku, Yasuharu; Ohta, Isao; Ishii, Daisuke; Muranaka, Yoshinori; Shimomura, Masatsugu; Hariyama, Takahiko			In Situ Preparation of Biomimetic Thin Films and Their Surface-Shielding Effect for Organisms in High Vacuum	PLOS ONE			English	Article								Self-standing biocompatible films have yet to be prepared by physical or chemical vapor deposition assisted by plasma polymerization because gaseous monomers have thus far been used to create only polymer membranes. Using a nongaseous monomer, we previously found a simple fabrication method for a free-standing thin film prepared from solution by plasma polymerization, and a nano-suit made by polyoxyethylene (20) sorbitan monolaurate can render multicellular organisms highly tolerant to high vacuum. Here we report thin films prepared by plasma polymerization from various monomer solutions. The films had a flat surface at the irradiated site and were similar to films produced by vapor deposition of gaseous monomers. However, they also exhibited unique characteristics, such as a pinhole-free surface, transparency, solvent stability, flexibility, and a unique out-of-plane molecular density gradient from the irradiated to the unirradiated surface of the film. Additionally, covering mosquito larvae with the films protected the shape of the organism and kept them alive under the high vacuum conditions in a field emission-scanning electron microscope. Our method will be useful for numerous applications, particularly in the biological sciences.	[Suzuki, Hiroshi] Hamamatsu Univ, Sch Med, Dept Chem, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Takaku, Yasuharu; Hariyama, Takahiko] Hamamatsu Univ, Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Ohta, Isao; Muranaka, Yoshinori] Hamamatsu Univ, Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Ishii, Daisuke] Nagoya Inst Technol, Ctr Fostering Young & Innovat Res, Showa Ku, Nagoya, Aichi, Japan; [Shimomura, Masatsugu] Tohoku Univ, World Premier Int Inst Mat Res, Aoba Ku, Sendai, Miyagi 980, Japan; [Shimomura, Masatsugu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan; [Takaku, Yasuharu; Ishii, Daisuke; Shimomura, Masatsugu; Hariyama, Takahiko] CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Nagoya Institute of Technology; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Hariyama, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan.	hariyama@hama-med.ac.jp			Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	The authors gratefully acknowledge funding from the Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Decher G, 2011, MULTILAYER THIN FILM; Frank-Finney RJ, 2012, MACROMOLECULES, V45, P165, DOI 10.1021/ma202268J; FRIDMAN A, 2008, PLASMA CHEM; Friedrich J, 2011, PLASMA PROCESS POLYM, V8, P783, DOI 10.1002/ppap.201100038; Jiang CY, 2004, ADV MATER, V16, P157, DOI 10.1002/adma.200306010; Kumar C, 2010, FREE STANDING NANOFI; Kumar DS, 2003, J APPL POLYM SCI, V90, P1102, DOI 10.1002/app.12803; Kumar SA, 2010, BIOCOMPATIBLE NANOMA; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Orosco MM, 2009, NAT NANOTECHNOL, V4, P255, DOI [10.1038/nnano.2009.11, 10.1038/NNANO.2009.11]; Pierson H.O., 1999, HDB CHEM VAPOR DEPOS, Vsecond; Quinn JF, 2012, J AM CHEM SOC, V134, P19808, DOI 10.1021/ja308716v; Smith DL., 1995, THIN FILM DEPOSITION; Takaku Y, 2013, P NATL ACAD SCI USA, V110, P7631, DOI 10.1073/pnas.1221341110; YASUDA H, 1981, MACROMOL REV, V16, P199	16	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78563	10.1371/journal.pone.0078563	http://dx.doi.org/10.1371/journal.pone.0078563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236023	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700020
J	Zhang, WH; Mi, ZQ; Yin, XY; Fan, H; An, XP; Zhang, ZY; Chen, JK; Tong, YG				Zhang, Wenhui; Mi, Zhiqiang; Yin, Xiuyun; Fan, Hang; An, Xiaoping; Zhang, Zhiyi; Chen, Jiankui; Tong, Yigang			Characterization of Enterococcus faecalis Phage IME-EF1 and Its Endolysin	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOCOCCUS-PNEUMONIAE; BACTERIOPHAGE PHI-EF24C; DIABETIC FOOT; LYTIC ENZYMES; TRNASCAN-SE; CELL-WALL; INFECTIONS; VIRULENCE; RESISTANCE	Enterococcus faecalis is increasingly becoming an important nosocomial infection opportunistic pathogen. E. faecalis can easily obtain drug resistance, making it difficult to be controlled in clinical settings. Using bacteriophage as an alternative treatment to drug-resistant bacteria has been revitalized recently, especially for fighting drug-resistant bacteria. In this research, an E. faecalis bacteriophage named IME-EF1 was isolated from hospital sewage. Whole genomic sequence analysis demonstrated that the isolated IME-EF1 belong to the Siphoviridae family, and has a linear double-stranded DNA genome consisting of 57,081 nucleotides. The IME-EF1 genome has a 40.04% G+C content and contains 98 putative coding sequences. In addition, IME-EF1 has an isometric head with a width of 35 nm to 60 nm and length of 75 nm to 90 nm, as well as morphology resembling a tadpole. IME-EF1 can adsorb to its host cells within 9 min, with an absorbance rate more than 99% and a latent period time of 25 min. The endolysin of IME-EF1 contains a CHAP domain in its N-terminal and has a wider bactericidal spectrum than its parental bacteriophage, including 2 strains of vancomycin-resistant E. faecalis. When administrated intraperitoneally, one dose of IME-EF1 or its endolysin can reduce bacterial count in the blood and protected the mice from a lethal challenge of E. faecalis, with a survival rate of 60% or 80%, respectively. Although bacteriophage could rescue mice from bacterial challenge, to the best of our knowledge, this study further supports the potential function of bacteriophage in dealing with E. faecalis infection in vivo. The results also indicated that the newly isolated bacteriophage IME-EF1 enriched the arsenal library of lytic E. faecalis bacteriophages and presented another choice for phage therapy in the future.	[Zhang, Wenhui; Mi, Zhiqiang; Fan, Hang; An, Xiaoping; Zhang, Zhiyi; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yin, Xiuyun; Chen, Jiankui] Affiliated Hosp, Acad Mil Med Sci, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Chen, JK (corresponding author), Affiliated Hosp, Acad Mil Med Sci, Beijing, Peoples R China.	chenjiankui@hotmail.com; tong62035@gmail.com	Fan, Hang/AAA-8489-2022	Tong, Yigang/0000-0002-8503-8045; Fan, Hang/0000-0002-7927-1684	National Natural Science Foundation of China [81072350, 81072250]; China Mega-Project on Major Drug Development [2011ZX09401-023]; China Mega-Project on Infectious Disease Prevention [2011ZX10004-001]; State Key Laboratory of Pathogen and BioSecurity Program [SKLPBS1113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Mega-Project on Major Drug Development; China Mega-Project on Infectious Disease Prevention; State Key Laboratory of Pathogen and BioSecurity Program	This research was supported by grants from the National Natural Science Foundation of China (No. 81072350, 81072250), the China Mega-Project on Major Drug Development (No. 2011ZX09401-023), the China Mega-Project on Infectious Disease Prevention (No. 2011ZX10004-001), and the State Key Laboratory of Pathogen and BioSecurity Program (No. SKLPBS1113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1950, METHODS STUDY BACTER; Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Brede DA, 2011, J BACTERIOL, V193, P2377, DOI 10.1128/JB.00183-11; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fard RMN, 2010, ARCH VIROL, V155, P1887, DOI 10.1007/s00705-010-0800-3; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; GERMIDA JJ, 1983, APPL ENVIRON MICROB, V45, P1380, DOI 10.1128/AEM.45.4.1380-1388.1983; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Harper DR, 2011, THER DELIV, V2, P935, DOI 10.4155/TDE.11.64; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horiuchi T, 2012, J VIROL, V86, P9538, DOI 10.1128/JVI.01424-12; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; JOHNSON AP, 1994, J ANTIMICROB CHEMOTH, V33, P1083, DOI 10.1093/jac/33.6.1083; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee YD, 2012, J VIROL, V86, P5402, DOI 10.1128/JVI.00321-12; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Rao N, 2007, DRUGS, V67, P195, DOI 10.2165/00003495-200767020-00003; Sambrook J., 2002, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Son JS, 2010, J APPL MICROBIOL, V108, P1769, DOI 10.1111/j.1365-2672.2009.04576.x; Stevens RH, 2011, FEMS MICROBIOL LETT, V317, P9, DOI 10.1111/j.1574-6968.2010.02203.x; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Uchiyama J, 2008, FEMS MICROBIOL LETT, V278, P200, DOI 10.1111/j.1574-6968.2007.00996.x; Uchiyama J, 2011, APPL ENVIRON MICROB, V77, P580, DOI 10.1128/AEM.01540-10; Vinodkumar CS, 2011, INDIAN J PATHOL MICR, V54, P90, DOI 10.4103/0377-4929.77333; Wilkins MR, 1999, METH MOL B, V112, P531; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	32	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80435	10.1371/journal.pone.0080435	http://dx.doi.org/10.1371/journal.pone.0080435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236180	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700181
J	Chaudhuri, AD; Yelamanchili, SV; Fox, HS				Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Fox, Howard S.			MicroRNA-142 Reduces Monoamine Oxidase A Expression and Activity in Neuronal Cells by Downregulating SIRT1	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; A GENE PROMOTER; DOPAMINERGIC SYNAPSES; HIV-ENCEPHALITIS; DRUG-ABUSE; BRAIN; NEURODEGENERATION; DIFFERENTIATION; POLYMORPHISM; ASSOCIATION	Aberrant expression of microRNAs (miRs) has been implicated in the pathogenesis of several neurodegenerative disorders. In HIV-associated neurocognitive disorders (HAND), miR-142 was found to be upregulated in neurons and myeloid cells in the brain. We investigated the downstream effects of chronic miR-142 upregulation in neuronal cells by comparing gene expression in stable clones of the human neuroblastoma cell line BE(2) M17 expressing miR-142 to controls. Microarray analysis revealed that miR-142 expression led to a reduction in monoamine oxidase (MAO) A mRNA, which was validated by qRT-PCR. In addition to the mRNA, the MAOA protein level and enzyme activity were also reduced. Examination of primary human neurons revealed that miR-142 expression indeed resulted in a downregulation of MAOA protein level. Although MAOA is not a direct target of miR-142, SIRT1, a key transcriptional upregulator of MAOA is, thus miR-142 downregulation of MAOA expression is indirect. MiR-142 induced decrease in MAOA expression and activity may contribute to the changes in dopaminergic neurotransmission reported in HAND.	[Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Fox, HS (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hfox@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH [R01 MH073490, P30 MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, R01MH073490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by NIH grants R01 MH073490 and P30 MH062261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chaudhuri AD, 2013, FASEB J; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Gaskill PJ, 2013, J NEUROIMMUNE PHARM, V8, P621, DOI 10.1007/s11481-013-9443-y; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; Gersten M, 2009, J NEUROSCI, V29, P12467, DOI 10.1523/JNEUROSCI.3180-09.2009; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Jin HL, 2012, MOL CELLS, V34, P177, DOI 10.1007/s10059-012-0090-6; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kumar AM, 2009, J NEUROVIROL, V15, P257, DOI 10.1080/13550280902973952; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Naoi M, 2011, INT REV NEUROBIOL, V100, P85, DOI 10.1016/B978-0-12-386467-3.00005-4; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Pacifici M, 2013, J CELL PHYSIOL, V228, P1070, DOI 10.1002/jcp.24254; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Scheller C, 2010, J NEURAL TRANSM, V117, P699, DOI 10.1007/s00702-010-0415-6; Schulze TG, 2000, AM J MED GENET, V96, P801, DOI 10.1002/1096-8628(20001204)96:6<801::AID-AJMG21>3.3.CO;2-W; Shende VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065300; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tobon KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049288; Wang X., 2009, J VIS EXP; Winkler JM, 2012, J NEUROIMMUNE PHARM, V7, P372, DOI 10.1007/s11481-012-9344-5; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Yelamanchili SV, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.56; Yu YWY, 2005, NEUROPSYCHOPHARMACOL, V30, P1719, DOI 10.1038/sj.npp.1300785; Zhou L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677	39	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79579	10.1371/journal.pone.0079579	http://dx.doi.org/10.1371/journal.pone.0079579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244526	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600136
J	Gorska, A; Swiatkowska, A; Dutkiewicz, M; Ciesiolka, J				Gorska, Agnieszka; Swiatkowska, Agata; Dutkiewicz, Mariola; Ciesiolka, Jerzy			Modulation of p53 Expression Using Antisense Oligonucleotides Complementary to the 5 '-Terminal Region of p53 mRNA In Vitro and in the Living Cells	PLOS ONE			English	Article							SECONDARY STRUCTURE; NUCLEIC-ACIDS; TRANSLATION; ISOFORMS; OLIGODEOXYNUCLEOTIDES; PROTEIN; STRESS; TARGET; MUTATIONS; SOFTWARE	The p53 protein is a key player in cell response to stress events and cancer prevention. However, up-regulation of p53 that occurs during radiotherapy of some tumours results in radio-resistance of targeted cells. Recently, antisense oligonucleotides have been used to reduce the p53 level in tumour cells which facilitates their radiation-induced apoptosis. Here we describe the rational design of antisense oligomers directed against the 5'-terminal region of p53 mRNA aimed to inhibit the synthesis of p53 protein and its Delta Np53 isoform. A comprehensive analysis of the sites accessible to oligomer hybridization in this mRNA region was performed. Subsequently, translation efficiency from the initiation codons for both proteins in the presence of selected oligomers was determined in rabbit reticulocyte lysate and in MCF-7 cells. The antisense oligomers with 2'-OMe and LNA modifications were used to study the mechanism of their impact on translation. It turned out that the remaining RNase H activity of the lysate contributed to modulation of protein synthesis efficiency which was observed in the presence of antisense oligomers. A possibility of changing the ratio of the newly synthetized p53 and DNp53 in a controlled manner was revealed which is potentially very attractive considering the relationship between the functioning of these two proteins. Selected antisense oligonucleotides which were designed based on accessibility mapping of the 5'-terminal region of p53 mRNA were able to significantly reduce the level of p53 protein in MCF-7 cells. One of these oligomers might be used in the future as a support treatment in anticancer therapy.	[Gorska, Agnieszka; Swiatkowska, Agata; Dutkiewicz, Mariola; Ciesiolka, Jerzy] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Ciesiolka, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	jerzy.ciesiolka@ibch.poznan.pl	Swiatkowska, Agata/W-4117-2018; Dutkiewicz, Mariola/AAG-5242-2021; Dutkiewicz, Mariola/M-5588-2016	Swiatkowska, Agata/0000-0002-3100-2952; Dutkiewicz, Mariola/0000-0003-1098-0308; Dutkiewicz, Mariola/0000-0003-1098-0308	Polish Ministry of Science and Higher Education [NN301272037]; Foundation for Polish Science [HOMING PLUS/2012-6/15]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the Polish Ministry of Science and Higher Education (Grant no. NN301272037) to JC and by a grant from the Foundation for Polish Science (HOMING PLUS/2012-6/15) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Alvarez-Salas LM, 2008, CURR TOP MED CHEM, V8, P1379, DOI 10.2174/156802608786141133; Blaszczyk L, 2011, BIOCHEMISTRY-US, V50, P7080, DOI 10.1021/bi200659b; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; CAZENAVE C, 1993, BIOCHIMIE, V75, P113, DOI 10.1016/0300-9084(93)90032-N; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dias N, 2002, MOL CANCER THER, V1, P347; Evers MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024308; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; HAEUPTLE MT, 1986, NUCLEIC ACIDS RES, V14, P1427, DOI 10.1093/nar/14.3.1427; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kirsebom LA, 2013, HDB RNA BIOCH; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liao FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059112; Liu XF, 2006, CELL BIOL INT, V30, P283, DOI 10.1016/j.cellbi.2005.11.010; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Mescalchin A, 2011, MOLECULES, V16, P1271, DOI 10.3390/molecules16021271; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Mitrpant C, 2009, MOL THER, V17, P1418, DOI 10.1038/mt.2009.49; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Ravichandran LV, 2004, OLIGONUCLEOTIDES, V14, P49, DOI 10.1089/154545704322988058; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Sak A, 2003, CANCER GENE THER, V10, P926, DOI 10.1038/sj.cgt.7700649; Swiatkowska A, 2007, BIOCHEMISTRY-US, V46, P5523, DOI 10.1021/bi6024287; Tian H, 2000, CANCER RES, V60, P679; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Wrzesinski J, 2000, NUCLEIC ACIDS RES, V28, P1785, DOI 10.1093/nar/28.8.1785; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78863	10.1371/journal.pone.0078863	http://dx.doi.org/10.1371/journal.pone.0078863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244378	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600074
J	Harriff, MJ; Burgdorf, S; Kurts, C; Wiertz, EJHJ; Lewinsohn, DA; Lewinsohn, DM				Harriff, Melanie J.; Burgdorf, Sven; Kurts, Christian; Wiertz, Emmanuel J. H. J.; Lewinsohn, Deborah A.; Lewinsohn, David M.			TAP Mediates Import of Mycobacterium tuberculosis-Derived Peptides into Phagosomes and Facilitates Loading onto HLA-I	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGENS; MACROPHAGES; CELLS; TRAFFICKING; COMPARTMENT; ORGANELLES; INFECTION; ACCESS	Processing and presentation of antigen on MHC-I class I molecules serves to present peptides derived from cytosolic proteins to CD8(+) T cells. Infection with bacteria that remain in phagosomal compartments, such as Mycobacterium tuberculosis (Mtb), provides a challenge to this immune recognition as bacterial proteins are segregated from the cytosol. Previously we identified the Mtb phagosome itself as an organelle capable of loading MHC Class I molecules with Mtb antigens. Here, we find that the TAP transporter, responsible for importing peptides into the ER for loading in Class I molecules, is both present and functional in Mtb phagosomes. Furthermore, we describe a novel peptide reagent, representing the N-terminal domain of the bovine herpes virus UL49.5 protein, which is capable of specifically inhibiting the lumenal face of TAP. Together, these results provide insight into the mechanism by which peptides from intra-phagosomal pathogens are loaded onto Class I molecules.	[Harriff, Melanie J.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR 97239 USA; [Harriff, Melanie J.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Burgdorf, Sven] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Burgdorf, Sven; Kurts, Christian] Univ Bonn, IMMEI, Bonn, Germany; [Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Lewinsohn, Deborah A.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; University of Bonn; University of Bonn; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Oregon Health & Science University; Oregon Health & Science University	Harriff, MJ (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	harriffm@ohsu.edu; lewinsod@ohsu.edu; lewinsod@ohsu.edu	Lewinsohn, David/I-4936-2013	Lewinsohn, David/0000-0001-9906-9494	National Institutes of Health [R01AI048090, T32HL083808]; Veterans Affairs Hospitals Merit Review Grant; Portland Veterans Affairs Medical Center; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [S10-RR023432]; Oregon Health & Sciences University MMI Imaging Core; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Hospitals Merit Review Grant; Portland Veterans Affairs Medical Center; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oregon Health & Sciences University MMI Imaging Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health Grants R01AI048090 and T32HL083808, a Veterans Affairs Hospitals Merit Review Grant, and the Portland Veterans Affairs Medical Center. The microscopy in this publication was made possible in part by Grant Number S10-RR023432 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and the Oregon Health & Sciences University MMI Imaging Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Grotzke JE, 2010, J IMMUNOL, V185, P4336, DOI 10.4049/jimmunol.1000801; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Horst D, 2011, IMMUNOL CELL BIOL; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437; Loch S, 2008, J BIOL CHEM, V283, P13428, DOI 10.1074/jbc.M800226200; Mazzaccaro RJ, 1996, P NATL ACAD SCI USA, V93, P11786, DOI 10.1073/pnas.93.21.11786; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Ramachandra L, 1999, J IMMUNOL, V162, P3263; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verweij MC, 2008, J IMMUNOL, V181, P4894, DOI 10.4049/jimmunol.181.7.4894; XU SM, 1994, J IMMUNOL, V153, P2568	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79571	10.1371/journal.pone.0079571	http://dx.doi.org/10.1371/journal.pone.0079571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244525	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600135
J	Chen, HH; Zha, JM; Liang, XF; Bu, JH; Wang, M; Wang, ZJ				Chen, Huihui; Zha, Jinmiao; Liang, Xuefang; Bu, Jihong; Wang, Miao; Wang, Zijian			Sequencing and De Novo Assembly of the Asian Clam (Corbicula fluminea) Transcriptome Using the Illumina GAIIx Method	PLOS ONE			English	Article							FRESH-WATER CLAM; MOLECULAR-CLONING; EXPRESSION; PROTEIN; BIVALVIA; GENE; EVOLUTIONARY; GENERATION; EXPOSURE; STRESS	Background: The Asian clam (Corbicula fluminea) is currently one of the most economically important aquatic species in China and has been used as a test organism in many environmental studies. However, the lack of genomic resources, such as sequenced genome, expressed sequence tags (ESTs) and transcriptome sequences has hindered the research on C. fluminea. Recent advances in large-scale RNA-Seq enable generation of genomic resources in a short time, and provide large expression datasets for functional genomic analysis. Methodology/Principal Findings: We used a next-generation high-throughput DNA sequencing technique with an Illumina GAIIx method to analyze the transcriptome from the whole bodies of C. fluminea. More than 62,250,336 high-quality reads were generated based on the raw data, and 134,684 unigenes with a mean length of 791 bp were assembled using the Velvet and Oases software. All of the assembly unigenes were annotated by running BLASTx and BLASTn similarity searches on the Nt, Nr, Swiss-Prot, COG and KEGG databases. In addition, the Clusters of Orthologous Groups (COGs), Gene Ontology (GO) terms and Kyoto Encyclopedia of Gene and Genome (KEGG) annotations were also assigned to each unigene transcript. To provide a preliminary verification of the assembly and annotation results, and search for potential environmental pollution biomarkers, 15 functional genes (five antioxidase genes, two cytochrome P450 genes, three GABA receptor-related genes and five heat shock protein genes) were cloned and identified. Expressions of the 15 selected genes following fluoxetine exposure confirmed that the genes are indeed linked to environmental stress. Conclusions/Significance: The C. fluminea transcriptome advances the underlying molecular understanding of this freshwater clam, provides a basis for further exploration of C. fluminea as an environmental test organism and promotes further studies on other bivalve organisms.	[Chen, Huihui; Zha, Jinmiao; Liang, Xuefang; Bu, Jihong; Wang, Miao; Wang, Zijian] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Zha, JM (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing, Peoples R China.	jmzha@rcees.ac.cn; wangzj@rcees.ac.cn	Chen, Huihui/L-8521-2019; Wang, Zijian/A-1538-2009; Wang, Zhiquan/HHS-6768-2022; Liang, Xuefang/GSJ-2769-2022; liang, xuefang/R-6169-2017	Wang, Zijian/0000-0002-9847-9691; cha, jin miao/0000-0003-4928-8992	National Basic Research Program of China [2009CB421605]; National Natural Science Foundation of China [21007086]; National High-tech RD Program [2012AA06A302]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD Program(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2009CB421605); the National Natural Science Foundation of China (21007086); the National High-tech R&D Program (2012AA06A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard-Joris M, 2006, ENVIRON TOXICOL CHEM, V25, P527, DOI 10.1897/05-211R.1; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAUJO R, 1993, AM MALACOL BULL, V10, P39; Bai RY, 2012, FISH SHELLFISH IMMUN, V33, P675, DOI 10.1016/j.fsi.2012.05.003; Beran L, 2006, HELDIA, V6, P6; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bigot A, 2009, ECOTOX ENVIRON SAFE, V72, P382, DOI 10.1016/j.ecoenv.2008.04.014; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3; Cara JB, 2005, COMP BIOCHEM PHYS B, V142, P426, DOI 10.1016/j.cbpb.2005.09.005; Chijimatsu T, 2013, FOOD CHEM, V136, P328, DOI 10.1016/j.foodchem.2012.08.070; Cooper NL, 2006, AQUAT TOXICOL, V76, P258, DOI 10.1016/j.aquatox.2005.09.012; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Doyen P, 2005, COMP BIOCHEM PHYS C, V140, P300, DOI 10.1016/j.cca.2005.02.013; Farcy E, 2007, SCI TOTAL ENVIRON, V374, P328, DOI 10.1016/j.scitotenv.2006.11.014; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frenzel M, 2012, J STRUCT BIOL, V178, P8, DOI 10.1016/j.jsb.2012.02.005; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gao XG, 2013, COMP BIOCHEM PHYS D, V8, P103, DOI 10.1016/j.cbd.2012.12.005; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gonzalez-Rey M, 2013, ENVIRON POLLUT, V173, P200, DOI 10.1016/j.envpol.2012.10.018; Graczyk TK, 1997, APPL ENVIRON MICROB, V63, P2910, DOI 10.1128/AEM.63.7.2910-2912.1997; Hazelton PD, 2013, SCI TOTAL ENVIRON, V445, P94, DOI 10.1016/j.scitotenv.2012.12.026; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Korniushin AV, 2004, HYDROBIOLOGIA, V529, P251; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lazzara R, 2012, AQUAT TOXICOL, V106, P123, DOI 10.1016/j.aquatox.2011.11.003; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liao NB, 2013, FOOD FUNCT, V4, P539, DOI 10.1039/c2fo30178d; Liu HC, 2012, FISH PHYSIOL BIOCHEM, V38, P745, DOI 10.1007/s10695-011-9556-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunt G.G., 1991, Seminars in the Neurosciences, V3, P251, DOI 10.1016/1044-5765(91)90022-G; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martins JC, 2009, TOXICON, V53, P409, DOI 10.1016/j.toxicon.2008.12.022; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Mcleod PB, 2008, ENVIRON SCI TECHNOL, V42, P484, DOI 10.1021/es070139a; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Morton B., 1986, American Malacological Bulletin Special Edition, P113; Mouthon J, 2001, ARCH HYDROBIOL, V151, P571; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Pfenninger M, 2002, J EVOLUTION BIOL, V15, P818, DOI 10.1046/j.1420-9101.2002.00440.x; Renard E, 2000, MOL ECOL, V9, P2009, DOI 10.1046/j.1365-294X.2000.01104.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosa IC, 2011, ECOL ECON, V70, P1805, DOI 10.1016/j.ecolecon.2011.05.006; Saavedra C, 2006, AQUACULTURE, V256, P1, DOI 10.1016/j.aquaculture.2006.02.023; Santos HM, 2007, ENVIRON TOXICOL, V22, P502, DOI 10.1002/tox.20303; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spann N, 2011, AQUAT TOXICOL, V105, P589, DOI 10.1016/j.aquatox.2011.08.010; Syvaranta J, 2011, HYDROBIOLOGIA, V658, P383, DOI 10.1007/s10750-010-0512-4; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tran D, 2003, ENVIRON TOXICOL CHEM, V22, P914, DOI [10.1897/1551-5028(2003)022&lt;0914:EOPALO&gt;2.0.CO;2, 10.1002/etc.5620220432]; Vrankovic J, 2011, ARCH BIOL SCI, V63, P37, DOI 10.2298/ABS1101037V; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; ZAMAN SH, 1992, FEBS LETT, V307, P351, DOI 10.1016/0014-5793(92)80711-O; Zanette J, 2013, AQUAT TOXICOL, V128, P101, DOI 10.1016/j.aquatox.2012.11.017; Zanette J, 2010, MAR ENVIRON RES, V69, pS1, DOI 10.1016/j.marenvres.2009.10.013; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058	70	47	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79516	10.1371/journal.pone.0079516	http://dx.doi.org/10.1371/journal.pone.0079516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244519	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900041
J	Husen, P; Tarasov, K; Katafiasz, M; Sokol, E; Vogt, J; Baumgart, J; Nitsch, R; Ekroos, K; Ejsing, CS				Husen, Peter; Tarasov, Kirill; Katafiasz, Maciej; Sokol, Elena; Vogt, Johannes; Baumgart, Jan; Nitsch, Robert; Ekroos, Kim; Ejsing, Christer S.			Analysis of Lipid Experiments (ALEX): A Software Framework for Analysis of High-Resolution Shotgun Lipidomics Data	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MULTIPLE PRECURSOR; HUMAN BRAIN; MOUSE; TOOL; QUANTIFICATION; FRAGMENTATION; INFORMATICS; CHOLESTEROL; ACQUISITION	Global lipidomics analysis across large sample sizes produces high-content datasets that require dedicated software tools supporting lipid identification and quantification, efficient data management and lipidome visualization. Here we present a novel software-based platform for streamlined data processing, management and visualization of shotgun lipidomics data acquired using high-resolution Orbitrap mass spectrometry. The platform features the ALEX framework designed for automated identification and export of lipid species intensity directly from proprietary mass spectral data files, and an auxiliary workflow using database exploration tools for integration of sample information, computation of lipid abundance and lipidome visualization. A key feature of the platform is the organization of lipidomics data in "database table format" which provides the user with an unsurpassed flexibility for rapid lipidome navigation using selected features within the dataset. To demonstrate the efficacy of the platform, we present a comparative neurolipidomics study of cerebellum, hippocampus and somatosensory barrel cortex (S1BF) from wild-type and knockout mice devoid of the putative lipid phosphate phosphatase PRG-1 (plasticity related gene-1). The presented framework is generic, extendable to processing and integration of other lipidomic data structures, can be interfaced with post-processing protocols supporting statistical testing and multivariate analysis, and can serve as an avenue for disseminating lipidomics data within the scientific community. The ALEX software is available at www.msLipidomics.info.	[Tarasov, Kirill; Ekroos, Kim] Zora Biosci Oy, Espoo, Finland; [Husen, Peter; Katafiasz, Maciej; Sokol, Elena; Ejsing, Christer S.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Vogt, Johannes; Baumgart, Jan; Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany	University of Southern Denmark; Johannes Gutenberg University of Mainz	Ekroos, K (corresponding author), Zora Biosci Oy, Espoo, Finland.	kim.ekroos@zora.fi; cse@bmb.sdu.dk	Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/O-4289-2019; Husen, Peter/F-9693-2016; Ejsing, Christer S/R-5922-2016; Vogt, Johannes/K-2278-2015	Husen, Peter/0000-0001-9583-8751; Ejsing, Christer S./0000-0003-4963-0276; Vogt, Johannes/0000-0003-2439-8247; Baumgart, Jan/0000-0003-1996-4267	Lundbeckfonden [R44-A4342]; Danish Council for Independent Research \ Natural Sciences [09-072484]	Lundbeckfonden(Lundbeckfonden); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	The work was supported by Lundbeckfonden (R44-A4342) and the Danish Council for Independent Research vertical bar Natural Sciences (09-072484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2012, LIPIDOMICS, P147; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Hubner G, 2009, J MASS SPECTROM, V44, P1676, DOI 10.1002/jms.1673; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Leavell MD, 2006, ANAL CHEM, V78, P5497, DOI 10.1021/ac0604179; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; OBRIEN JS, 1965, J LIPID RES, V6, P537; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sandhoff R, 1999, J LIPID RES, V40, P126; Schuhmann K, 2012, J MASS SPECTROM, V47, P96, DOI 10.1002/jms.2031; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Song H, 2007, J AM SOC MASS SPECTR, V18, P1848, DOI 10.1016/j.jasms.2007.07.023; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	38	116	118	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79736	10.1371/journal.pone.0079736	http://dx.doi.org/10.1371/journal.pone.0079736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244551	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900047
J	Kim, C; Yun, N; Lee, YM; Jeong, JY; Baek, JY; Song, HY; Ju, C; Youdim, MBH; Jin, BK; Kim, WK; Oh, YJ				Kim, Chiho; Yun, Nuri; Lee, Young Mook; Jeong, Jae Y.; Baek, Jeong Y.; Song, Hwa Young; Ju, Chung; Youdim, Moussa B. H.; Jin, Byung K.; Kim, Won-Ki; Oh, Young J.			Gel-based Protease Proteomics for Identifying the Novel Calpain Substrates in Dopaminergic Neuronal Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Neurodegeneration; Parkinson Disease; Protein Degradation; Proteomics; Substrates	PROTEOLYTIC CLEAVAGE; PROTECTIVE ROLE; WILD-TYPE; DEATH; CASPASE; MECHANISMS; OPTINEURIN; ACTIVATION; DISEASE; GENE	Background: It is important to assess contribution of calpain activation and identify substrates affected during neurodegeneration. Results: Gel-based protease proteomics identified novel substrates that were cleaved in neurotoxin-treated culture and rat brain disease models. Conclusion: These novel calpain substrates may confer protection against neurodegeneration. Significance: Our findings contribute to better deciphering the molecular mechanism underlying the progression of protease-mediated neurodegeneration. Calpains are a family of calcium-dependent cysteine proteases that are ubiquitously expressed in mammals and play critical roles in neuronal death by catalyzing substrate proteolysis. Here, we developed two-dimensional gel electrophoresis-based protease proteomics to identify putative calpain substrates. To accomplish this, cellular lysates from neuronal cells were first separated by pI, and the immobilized sample on a gel strip was incubated with a recombinant calpain and separated by molecular weight. Among 25 altered protein spots that were differentially expressed by at least 2-fold, we confirmed that arsenical pump-driving ATPase, optineurin, and peripherin were cleaved by calpain using in vitro and in vivo cleavage assays. Furthermore, we found that all of these substrates were cleaved in MN9D cells treated with either ionomycin or 1-methyl-4-phenylpyridinium, both of which cause a calcium-mediated calpain activation. Their cleavage was blocked by calcium chelator or calpain inhibitors. In addition, calpain-mediated cleavage of these substrates and its inhibition by calpeptin were confirmed in a middle cerebral artery occlusion model of cerebral ischemia, as well as a stereotaxic brain injection model of Parkinson disease. Transient overexpression of each protein was shown to attenuate 1-methyl-4-phenylpyridinium-induced cell death, indicating that these substrates may confer protection of varying magnitudes against dopaminergic injury. Taken together, the data indicate that our protease proteomic method has the potential to be applicable for identifying proteolytic substrates affected by diverse proteases. Moreover, the results described here will help us decipher the molecular mechanisms underlying the progression of neurodegenerative disorders where protease activation is critically involved.	[Kim, Chiho; Yun, Nuri; Youdim, Moussa B. H.; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Lee, Young Mook] Univ Colorado, Div Clin Pharmacol, Dept Med, Hlth Sci Ctr, Denver, CO 80262 USA; [Jeong, Jae Y.; Baek, Jeong Y.; Jin, Byung K.] Kyung Hee Univ, Dept Biochem & Mol Biol, Dept Neurosci, Neurodegenerat Control Res Ctr,Sch Med, Seoul 130701, South Korea; [Song, Hwa Young; Ju, Chung; Kim, Won-Ki] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea	Yonsei University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine)	Kim, WK (corresponding author), Anamdong 5 Ga, Seoul 136705, South Korea.	wonki@korea.ac.kr; yjoh@yonsei.ac.kr		Yun, Nuri/0000-0003-1853-1304	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012-0000496]; World Class University Grant [R33-10014]; Bio & Medical Technology Development Program Grant through the National Research Foundation of Korea [2011-0019440]; Ministry of Science and Technology	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University Grant; Bio & Medical Technology Development Program Grant through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2012-0000496 and World Class University Grant R33-10014 (to Y. J. O.). This work was also supported by Bio & Medical Technology Development Program Grant 2011-0019440 through the National Research Foundation of Korea funded by the Ministry of Science and Technology (to W. K. K.).	Agard NJ, 2009, CURR OPIN CHEM BIOL, V13, P503, DOI 10.1016/j.cbpa.2009.07.026; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Bevers MB, 2009, J NEUROCHEM, V108, P1237, DOI 10.1111/j.1471-4159.2008.05860.x; Bozoky Z, 2009, ARCH BIOCHEM BIOPHYS, V481, P219, DOI 10.1016/j.abb.2008.11.011; Brule C, 2010, BIOCHIMIE, V92, P1923, DOI 10.1016/j.biochi.2010.09.003; Caberoy NB, 2011, MOLECULES, V16, P1739, DOI 10.3390/molecules16021739; Camins A, 2009, CURR DRUG METAB, V10, P433, DOI 10.2174/138920009788898028; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Choi WS, 2008, BIOCHEM BIOPH RES CO, V371, P127, DOI 10.1016/j.bbrc.2008.04.020; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Demon D, 2009, TRENDS BIOTECHNOL, V27, P680, DOI 10.1016/j.tibtech.2009.09.007; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Han BS, 2003, J NEUROSCI, V23, P5069; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kedzierski W, 2001, P NATL ACAD SCI USA, V98, P7718, DOI 10.1073/pnas.141124198; Kim HE, 2001, BIOCHEM BIOPH RES CO, V286, P659, DOI 10.1006/bbrc.2001.5446; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Peng S, 2011, MOL BIOL REP, V38, P905, DOI 10.1007/s11033-010-0183-2; Ray SK, 2011, NEUROTHERAPEUTICS, V8, P180, DOI 10.1007/s13311-011-0037-1; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Samantaray S, 2008, CNS NEUROL DISORD-DR, V7, P305, DOI 10.2174/187152708784936680; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; TISA LS, 1990, J BIOL CHEM, V265, P190; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	57	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36717	36732		10.1074/jbc.M113.492876	http://dx.doi.org/10.1074/jbc.M113.492876			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24235151	Green Published, hybrid			2022-12-25	WOS:000328883400049
J	Li, WD; Jia, L; Ou, Y; Huang, YX; Jiang, SM				Li, Wei-Dong; Jia, Lin; Ou, Ya; Huang, Yao-Xing; Jiang, Shu-man			Surveillance of Intra-Abdominal Pressure and Intestinal Barrier Function in a Rat Model of Acute Necrotizing Pancreatitis and Its Potential Early Therapeutic Window	PLOS ONE			English	Article							CRITICALLY-ILL; GUT; HYPERTENSION; OCTREOTIDE; INJURY; TIME	Objectives: To monitor intra-abdominal pressure (IAP) and intestinal barrier function in a rat model of acute necrotizing pancreatitis (ANP) to elucidate a potential relevant therapeutic window. Methods: Sprague-Dawley rats were randomly divided into experimental or control groups. The ANP group (n = 40) was injected with 4.5% sodium taurocholate into the pancreatic duct to induce ANP. The controls received only abdominal opening surgery (sham-operated, SO; n = 40) or no treatment or surgery (baseline; 0 h, n = 20). The SO and ANP groups were then randomly subdivided into 3, 6, 12 and 24 h groups (n = 10 each). IAP was measured at each time point and the rats were sacrificed to measure the weight of accumulated ascites fluid and the amylase, endogenous creatinine (Cr), total bilirubin (TB), tumor necrosis factor- alpha (TNF-alpha), diamine oxidase (DAO), and D-lactate. Mortality and the development of pathological changes in the pancreas and intestines were also monitored. Results: IAP showed a continuous upward trend in the ANP group, with values 2 to 3 times higher than those in the SO group at the corresponding time points and the rising rate was peaking at 6 h. The levels of plasma amylase, TNF-alpha, Cr, TB, DAO, and D-lactate also gradually increased in the ANP group over time and were significantly higher than in the SO group at 3, 6, 12 and 24 h (all P<0.05). Moreover, the rising rate of TNF-alpha, DAO, and D-lactate also peaked at 6 h. Conclusions: The ANP-induced changes in IAP, inflammatory factors and intestinal barrier that we observed in the rat model were especially obvious at 6 h post-induction, suggesting an early therapeutic window for the treatment of ANP in humans.	[Li, Wei-Dong; Jia, Lin; Ou, Ya; Huang, Yao-Xing] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Li, Wei-Dong; Jia, Lin; Jiang, Shu-man] Guangzhou Nansha Cent Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Jia, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	jialin@medmail.com.cn						AHO HJ, 1980, SCAND J GASTROENTERO, V15, P1027, DOI 10.3109/00365528009181808; Al-Bahrani AZ, 2010, PANCREAS, V39, P1064, DOI 10.1097/MPA.0b013e3181da8d51; Ammori Basil J, 2002, J Hepatobiliary Pancreat Surg, V9, P411, DOI 10.1007/s005340200050; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Huang YX, 2012, PANCREAS, V41, P849, DOI 10.1097/MPA.0b013e31823fbdc3; Jha RK, 2008, MED SCI MONITOR, V14, pBR14; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Li WD, 2013, PANCREAS, V42, P366, DOI 10.1097/MPA.0b013e31825c5273; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; McKay CJ, 2003, PANCREATOLOGY, V3, P111, DOI 10.1159/000070078; Morel DR, 2006, INTENS CARE MED, V32, P1872, DOI 10.1007/s00134-006-0264-9; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Servin-Torres E, 2009, CIR CIR, V77, P407; Song WB, 2009, WORLD J GASTROENTERO, V15, P3916, DOI 10.3748/wjg.15.3916; Takryama Y, 2005, J GASTROENTEROL, V40, P1; Wilson PG, 1998, J ANTIMICROB CHEMOTH, V41, P51, DOI 10.1093/jac/41.suppl_1.51; Zhang QH, 2001, CHINESE MED J-PEKING, V114, P738; Zhang XP, 2008, DIGEST DIS SCI, V53, P581, DOI 10.1007/s10620-007-9868-3	22	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78975	10.1371/journal.pone.0078975	http://dx.doi.org/10.1371/journal.pone.0078975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244397	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800021
J	Tsai, CH; Baranowski, C; Livny, J; McDonough, KA; Wade, JT; Contreras, LM				Tsai, Chen-Hsun; Baranowski, Catherine; Livny, Jonathan; McDonough, Kathleen A.; Wade, Joseph T.; Contreras, Lydia M.			Identification of Novel sRNAs in Mycobacterial Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; NONCODING RNA; REGULATORY RNAS; HIGH-THROUGHPUT; TUBERCULOSIS; DISCOVERY; BACTERIA; REVEALS; ANNOTATION; EXPRESSION	Bacterial small RNAs (sRNAs) are short transcripts that typically do not encode proteins and often act as regulators of gene expression through a variety of mechanisms. Regulatory sRNAs have been identified in many species, including Mycobacterium tuberculosis, the causative agent of tuberculosis. Here, we use a computational algorithm to predict sRNA candidates in the mycobacterial species M. smegmatis and M. bovis BCG and confirmed the expression of many sRNAs using Northern blotting. Thus, we have identified 17 and 23 novel sRNAs in M. smegmatis and M. bovis BCG, respectively. We have also applied a high-throughput technique (Deep-RACE) to map the 59 and 39 ends of many of these sRNAs and identified potential regulators of sRNAs by analysis of existing ChIP-seq datasets. The sRNAs identified in this work likely contribute to the unique biology of mycobacteria.	[Tsai, Chen-Hsun; Contreras, Lydia M.] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA; [Baranowski, Catherine; McDonough, Kathleen A.; Wade, Joseph T.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Livny, Jonathan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [McDonough, Kathleen A.; Wade, Joseph T.] SUNY Albany, Dept Biomed Sci, Albany, NY USA	University of Texas System; University of Texas Austin; State University of New York (SUNY) System; Wadsworth Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Contreras, LM (corresponding author), Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA.	lcontrer@che.utexas.edu	Contreras, Lydia/AAS-8845-2021	Wade, Joseph/0000-0002-9779-3160	Welch foundation; DTRA Young Investigator program; National Institutes of Health (NIH) [1DP2OD007188]; Emerging Infectious Diseases (EID) Fellowship Program; Centers for Disease Control and Prevention (CDC); NIH [GM39422, GM44844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, R01GM044844, R01GM039422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007188] Funding Source: NIH RePORTER	Welch foundation(The Welch Foundation); DTRA Young Investigator program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Infectious Diseases (EID) Fellowship Program; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Welch foundation, the DTRA Young Investigator program, National Institutes of Health (NIH) grant 1DP2OD007188 (JTW), and by an appointment (CB) to the Emerging Infectious Diseases (EID) Fellowship Program administered by the Association of Public Health Laboratories (APHL) and funded by the Centers for Disease Control and Prevention (CDC). Initial funding for preliminary studies was provided by (NIH) grants GM39422 and GM44844 to Dr. Marlene Belfort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Khoo JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S13; Lamichhane G, 2013, TUBERCULOSIS, V93, P26, DOI 10.1016/j.tube.2012.11.010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SK, 2013, RNA, V19, P74, DOI 10.1261/rna.034116.112; Livny J, 2012, BACTERIAL REGULATORY, V905, P3; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lu XJ, 2011, RNA, V17, P1635, DOI 10.1261/rna.2689811; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Pelly S, 2012, GENE, V500, P85, DOI 10.1016/j.gene.2012.03.044; Postic G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-625; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xia L, 2012, NUCLEIC ACID THER, V22, P177, DOI 10.1089/nat.2011.0339	33	25	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79411	10.1371/journal.pone.0079411	http://dx.doi.org/10.1371/journal.pone.0079411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244498	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800074
J	De Clercq, S; Boucherie, C; Vandekerckhove, J; Gettemans, J; Guillabert, A				De Clercq, Sarah; Boucherie, Ciska; Vandekerckhove, Joel; Gettemans, Jan; Guillabert, Aude			L-Plastin Nanobodies Perturb Matrix Degradation, Podosome Formation, Stability and Lifetime in THP-1 Macrophages	PLOS ONE			English	Article							LEUKEMIA-CELL LINE; ENDOTHELIAL-CELLS; ACTIN; PROTEIN; GELSOLIN; INVADOPODIA; PHOSPHORYLATION; DOMAIN; PHAGOCYTOSIS; ORGANIZATION	Podosomes are cellular structures acting as degradation 'hot-spots' in monocytic cells. They appear as dot-like structures at the ventral cell surface, enriched in F-actin and actin regulators, including gelsolin and L-plastin. Gelsolin is an ubiquitous severing and capping protein, whereas L-plastin is a leukocyte-specific actin bundling protein. The presence of the capping protein CapG in podosomes has not yet been investigated. We used an innovative approach to investigate the role of these proteins in macrophage podosomes by means of nanobodies or Camelid single domain antibodies. Nanobodies directed against distinct domains of gelsolin, L-plastin or CapG were stably expressed in macrophage-like THP-1 cells. CapG was not enriched in podosomes. Gelsolin nanobodies had no effect on podosome formation or function but proved very effective in tracing distinct gelsolin populations. One gelsolin nanobody specifically targets actin-bound gelsolin and was effectively enriched in podosomes. A gelsolin nanobody that blocks gelsolin-G-actin interaction was not enriched in podosomes demonstrating that the calcium-activated and actin-bound conformation of gelsolin is a constituent of podosomes. THP-1 cells expressing inhibitory L-plastin nanobodies were hampered in their ability to form stable podosomes. Nanobodies did not perturb Ser5 phosphorylation of L-plastin although phosphorylated L-plastin was highly enriched in podosomes. Furthermore, nanobody-induced inhibition of L-plastin function gave rise to an irregular and unstable actin turnover of podosomes, resulting in diminished degradation of the underlying matrix. Altogether these results indicate that L-plastin is indispensable for podosome formation and function in macrophages.	[De Clercq, Sarah; Boucherie, Ciska; Vandekerckhove, Joel; Gettemans, Jan; Guillabert, Aude] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium	Ghent University	Gettemans, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be			League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA); Research Foundation-Flanders (FWO-Vlaanderen); Interuniversity Attraction Poles Programme; Ghent University	League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA)(Ghent University); Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Ghent University(Ghent University)	This work was supported by grants from the League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA), the Research Foundation-Flanders (FWO-Vlaanderen), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. SDC was supported by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINK M, 1994, LEUKEMIA, V8, P1579; Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Banon-Rodriguez I, 2011, EUR J CELL BIOL, V90, P213, DOI 10.1016/j.ejcb.2010.09.001; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burger KL, 2011, CYTOSKELETON, V68, P694, DOI 10.1002/cm.20545; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; KELLY T, 1994, J CELL PHYSIOL, V158, P299, DOI 10.1002/jcp.1041580212; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Labernadie A, 2010, P NATL ACAD SCI USA, V107, P21016, DOI 10.1073/pnas.1007835107; LEAVITT J, 1994, ELECTROPHORESIS, V15, P345, DOI 10.1002/elps.1150150154; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697; MESSIER JM, 1993, CELL MOTIL CYTOSKEL, V25, P223, DOI 10.1002/cm.970250303; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ochs HD, 2001, CLIN REV ALLERG IMMU, V20, P61, DOI 10.1385/CRIAI:20:1:61; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Parikh SS, 2003, INFECT IMMUN, V71, P6582, DOI 10.1128/IAI.71.11.6582-6590.2003; PARK TS, 1994, CANCER RES, V54, P1775; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; SHINOMIYA H, 1995, J IMMUNOL, V154, P3471; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Audenhove I, 2013, CYTOSKELETON, V70, P604, DOI 10.1002/cm.21122; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wernimont SA, 2008, EUR J CELL BIOL, V87, P507, DOI 10.1016/j.ejcb.2008.01.011; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1980, J BIOL CHEM, V255, P9490; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912	79	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78108	10.1371/journal.pone.0078108	http://dx.doi.org/10.1371/journal.pone.0078108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236012	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700009
J	Eloot, S; Van Biesen, W; Glorieux, G; Neirynck, N; Dhondt, A; Vanholder, R				Eloot, Sunny; Van Biesen, Wim; Glorieux, Griet; Neirynck, Nathalie; Dhondt, Annemieke; Vanholder, Raymond			Does the Adequacy Parameter Kt/V-urea Reflect Uremic Toxin Concentrations in Hemodialysis Patients?	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; PROTEIN CATABOLIC RATE; GLYCATION END-PRODUCTS; HIGH-FLUX HEMODIALYSIS; CONVENTIONAL HEMODIALYSIS; P-CRESOL; BETA-2-MICROGLOBULIN LEVELS; METABOLIC PHENOTYPES; NUTRITIONAL-STATUS; RETENTION SOLUTES	Hemodialysis aims at removing uremic toxins thus decreasing their concentrations. The present study investigated whether Kt/V-urea, used as marker of dialysis adequacy, is correlated with these concentrations. Predialysis blood samples were taken before a midweek session in 71 chronic HD patients. Samples were analyzed by colorimetry, HPLC, or ELISA for a broad range of uremic solutes. Solute concentrations were divided into four groups according to quartiles of Kt/V-urea, and also of different other parameters with potential impact, such as age, body weight (BW), Protein equivalent of Nitrogen Appearance (PNA), Residual Renal Function (RRF), and dialysis vintage. Dichotomic concentration comparisons were performed for gender and Diabetes Mellitus (DM). Analysis of Variance in quartiles of Kt/V-urea did not show significant differences for any of the solute concentrations. For PNA, however, concentrations showed significant differences for urea (P<0.001), uric acid (UA), p-cresylsulfate (PCS), and free PCS (all P<0.01), and for creatinine (Crea) and hippuric acid (HA) (both P<0.05). For RRF, concentrations varied for beta(2)-microglobulin (P<0.001), HA, free HA, free indoxyl sulfate, and free indole acetic acid (all P<0.01), and for p-cresylglucuronide (PCG), 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), free PCS, and free PCG (all P<0.05). Gender and body weight only showed differences for Crea and UA, while age, vintage, and diabetes mellitus only showed differences for one solute concentration (UA, UA, and free PCS, respectively). Multifactor analyses indicated a predominant association of concentration with protein intake and residual renal function. In conclusion, predialysis concentrations of uremic toxins seem to be dependent on protein equivalent of nitrogen appearance and residual renal function, and not on dialysis adequacy as assessed by Kt/V-urea. Efforts to control intestinal load of uremic toxin precursors by dietary or other interventions, and preserving RRF seem important approaches to decrease uremic solute concentration and by extension their toxicity.	[Eloot, Sunny; Van Biesen, Wim; Glorieux, Griet; Neirynck, Nathalie; Dhondt, Annemieke; Vanholder, Raymond] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium	Ghent University; Ghent University Hospital	Eloot, S (corresponding author), Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium.	sunny.eloot@ugent.be			Fresenius Medical Care; Baxter Healthcare; Gambro; Bellco	Fresenius Medical Care; Baxter Healthcare; Gambro; Bellco	Raymond Vanholder receives unrestricted research grants from Fresenius Medical Care, Baxter Healthcare, Gambro, and Bellco. The funding that Raymond Vanholder received is not related to the submitted study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ACCHIARDO SR, 1983, KIDNEY INT S16, V24, P199; [Anonymous], 2002, NEPHROL DIAL TRAN S7, V17, P16; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Azar AT, 2007, AM J NEPHROL, V27, P113, DOI 10.1159/000099836; Bammens B, 2004, AM J CLIN NUTR, V80, P1536, DOI 10.1093/ajcn/80.6.1536; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Basile C, 2011, NEPHROL DIAL TRANSPL, V26, P1296, DOI 10.1093/ndt/gfq543; BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329; BOUMENDILPODEVIN EF, 1975, J CLIN INVEST, V55, P1142, DOI 10.1172/JCI108031; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Daugirdas JT, 2010, KIDNEY INT, V77, P637, DOI 10.1038/ki.2009.525; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Daugirdas JT, 1997, KIDNEY INT, V51, P1270, DOI 10.1038/ki.1997.173; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; Eloot S, 2005, KIDNEY INT, V67, P1566, DOI 10.1111/j.1523-1755.2005.00238.x; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Eloot S, 2009, NEPHROL DIAL TRANSPL, V24, P2225, DOI 10.1093/ndt/gfp059; Evenepoel P, 2006, KIDNEY INT, V70, P794, DOI 10.1038/sj.ki.5001640; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Fagugli RM, 2001, INT J ARTIF ORGANS, V24, P256, DOI 10.1177/039139880102400503; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Fujita T, 2012, J PHARMACOL EXP THER, V341, P626, DOI 10.1124/jpet.111.187732; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Herzog CA, 2002, NEPHROL DIAL TRANSPL, V17, P7, DOI 10.1093/ndt/17.1.7; Kalantar-Zadeh K, 2004, J AM SOC NEPHROL, V15, P442, DOI 10.1097/01.ASN.0000107564.60018.51; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kloppenburg WD, 1999, KIDNEY INT, V55, P1961, DOI 10.1046/j.1523-1755.1999.00412.x; Krediet RT, 2006, NEPHROL DIAL TRANSPL, V21, pii42; Kusumoto M, 2011, CLIN EXP NEPHROL, V15, P820, DOI 10.1007/s10157-011-0524-z; LAIRD NM, 1983, KIDNEY INT, pS101; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; LINDSAY RM, 1989, AM J KIDNEY DIS, V13, P382, DOI 10.1016/S0272-6386(89)80021-6; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOPOT F, 1995, ARTIF ORGANS, V19, P832, DOI 10.1111/j.1525-1594.1995.tb02436.x; Marcen R, 1997, NEPHROL DIAL TRANSPL, V12, P2324, DOI 10.1093/ndt/12.11.2324; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; McGregor DO, 2001, BLOOD PURIFICAT, V19, P293, DOI 10.1159/000046957; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2011, SEMIN DIALYSIS, V24, P471, DOI 10.1111/j.1525-139X.2011.00979.x; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; Penne EL, 2010, CLIN J AM SOC NEPHRO, V5, P80, DOI 10.2215/CJN.03340509; Port FK, 2004, AM J KIDNEY DIS, V43, P1014, DOI 10.1053/j.ajkd.2004.02.014; Port FK, 2004, BLOOD PURIFICAT, V22, P175, DOI 10.1159/000074938; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Rocco MV, 2004, KIDNEY INT, V65, P2321, DOI 10.1111/j.1523-1755.2004.00647.x; Santoro A, 2008, AM J KIDNEY DIS, V52, P507, DOI 10.1053/j.ajkd.2008.05.011; Saran Rajiv, 2004, Am J Kidney Dis, V44, P47, DOI 10.1053/j.ajkd.2004.08.011; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; Schulman G, 2004, SEMIN DIALYSIS, V17, P479, DOI 10.1111/j.0894-0959.2004.17609.x; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Sirich TL, 2012, NEPHROL DIAL TRANSPL, V27, P1574, DOI 10.1093/ndt/gfr691; Spoto B, 2007, J NEPHROL, V20, P554; STEGEMAN CA, 1995, AM J KIDNEY DIS, V25, P887, DOI 10.1016/0272-6386(95)90571-5; Suda T, 2000, NEPHROL DIAL TRANSPL, V15, P396, DOI 10.1093/ndt/15.3.396; Suliman ME, 2004, AM J KIDNEY DIS, V44, P455, DOI 10.1053/j.ajkd.2004.04.049; Suliman M, 2007, NEPHROL DIAL TRANSPL, V22, P209, DOI 10.1093/ndt/gfl510; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Tattersall JE, 1996, KIDNEY INT, V50, P2094, DOI 10.1038/ki.1996.534; VANHOLDER R, 1992, KIDNEY INT, V41, P1707, DOI 10.1038/ki.1992.244; Vanholder R, 2006, BLOOD PURIFICAT, V24, P33, DOI 10.1159/000089434; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Vanholder R, 2012, SEMIN DIALYSIS, V25, P9, DOI 10.1111/j.1525-139X.2011.01003.x; VAZIRI ND, 1995, J AM SOC NEPHROL, V6, P1313; Viaene L, 2012, NEPHROL DIAL TRANSPL, V27, P2017, DOI 10.1093/ndt/gfr596; Walsh M, 2010, HEMODIAL INT, V14, P174, DOI 10.1111/j.1542-4758.2009.00418.x; Yilmaz MI, 2008, J AM SOC NEPHROL, V19, P388, DOI 10.1681/ASN.2007040461; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	85	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e76838	10.1371/journal.pone.0076838	http://dx.doi.org/10.1371/journal.pone.0076838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236005	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700001
J	Laeyendecker, O; Kulich, M; Donnell, D; Komarek, A; Omelka, M; Mullis, CE; Szekeres, G; Piwowar-Manning, E; Fiamma, A; Gray, RH; Lutalo, T; Morrison, CS; Salata, RA; Chipato, T; Celum, C; Kahle, EM; Taha, TE; Kumwenda, NI; Karim, QA; Naranbhai, V; Lingappa, JR; Sweat, MD; Coates, T; Eshleman, SH				Laeyendecker, Oliver; Kulich, Michal; Donnell, Deborah; Komarek, Arnost; Omelka, Marek; Mullis, Caroline E.; Szekeres, Greg; Piwowar-Manning, Estelle; Fiamma, Agnes; Gray, Ronald H.; Lutalo, Tom; Morrison, Charles S.; Salata, Robert A.; Chipato, Tsungai; Celum, Connie; Kahle, Erin M.; Taha, Taha E.; Kumwenda, Newton I.; Karim, Quarraisha Abdool; Naranbhai, Vivek; Lingappa, Jairam R.; Sweat, Michael D.; Coates, Thomas; Eshleman, Susan H.			Development of Methods for Cross-Sectional HIV Incidence Estimation in a Large, Community Randomized Trial	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; PROJECT ACCEPT; RAKAI DISTRICT; UNITED-STATES; PREVENTION; TRANSMISSION; SPECIFICITY; ACYCLOVIR; INFECTION; UGANDA	Background: Accurate methods of HIV incidence determination are critically needed to monitor the epidemic and determine the population level impact of prevention trials. One such trial, Project Accept, a Phase III, community-randomized trial, evaluated the impact of enhanced, community-based voluntary counseling and testing on population-level HIV incidence. The primary endpoint of the trial was based on a single, cross-sectional, post-intervention HIV incidence assessment. Methods and Findings: Test performance of HIV incidence determination was evaluated for 403 multi-assay algorithms [MAAs] that included the BED capture immunoassay [BED-CEIA] alone, an avidity assay alone, and combinations of these assays at different cutoff values with and without CD4 and viral load testing on samples from seven African cohorts (5,325 samples from 3,436 individuals with known duration of HIV infection [1 month to >10 years]). The mean window period (average time individuals appear positive for a given algorithm) and performance in estimating an incidence estimate (in terms of bias and variance) of these MAAs were evaluated in three simulated epidemic scenarios (stable, emerging and waning). The power of different test methods to detect a 35% reduction in incidence in the matched communities of Project Accept was also assessed. A MAA was identified that included BED-CEIA, the avidity assay, CD4 cell count, and viral load that had a window period of 259 days, accurately estimated HIV incidence in all three epidemic settings and provided sufficient power to detect an intervention effect in Project Accept. Conclusions: In a Southern African setting, HIV incidence estimates and intervention effects can be accurately estimated from cross-sectional surveys using a MAA. The improved accuracy in cross-sectional incidence testing that a MAA provides is a powerful tool for HIV surveillance and program evaluation.	[Laeyendecker, Oliver] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Mullis, Caroline E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kulich, Michal; Komarek, Arnost; Omelka, Marek] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Stat, Prague, Czech Republic; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Szekeres, Greg; Fiamma, Agnes; Coates, Thomas] Univ Calif Los Angeles, UCLA Program Global Hlth, Los Angeles, CA USA; [Piwowar-Manning, Estelle; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gray, Ronald H.; Taha, Taha E.; Kumwenda, Newton I.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gray, Ronald H.; Lutalo, Tom] Rakai Hlth Sci Program, Entebbe, Uganda; [Morrison, Charles S.] Family Hlth Int, Clin Sci, Durham, NC USA; [Salata, Robert A.] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Salata, Robert A.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe; [Celum, Connie] Univ Washington, Dept Global Hlth Med & Epidemiol, Seattle, WA 98195 USA; [Kahle, Erin M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Naranbhai, Vivek] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa CAPRISA, Congella, South Africa; [Lingappa, Jairam R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Med & Pediat, Seattle, WA 98195 USA; [Sweat, Michael D.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Charles University Prague; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Zimbabwe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; University of Kwazulu Natal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Medical University of South Carolina	Laeyendecker, O (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	olaeyen1@jhmi.edu	Komarek, Arnost/A-5534-2012; Omelka, Marek/AAG-9535-2019; Kulich, Michal/B-1483-2013; Lingappa, Jairam/N-7760-2017; Omelka, Marek/I-2447-2014; Kumwenda, Newton/ADL-6890-2022; Abdool Karim, Quarraisha/GVS-1160-2022	Komarek, Arnost/0000-0001-8778-3762; Kulich, Michal/0000-0002-2812-8968; Omelka, Marek/0000-0002-0396-9373; Abdool Karim, Quarraisha/0000-0002-0985-477X; , Erin/0000-0001-6060-9852; Donnell, Deborah/0000-0002-0587-7480; Kumwenda, Newton/0000-0003-2622-4339; Laeyendecker, Oliver/0000-0002-6429-4760; Taha, Taha/0000-0001-9814-4894; Naranbhai, Vivek/0000-0003-4281-8882	U.S. National Institute of Mental Health [U01MH066687, U01MH066688, U01MH066701, U01MH066702]; HPTN Network Laboratory [U01AI068613/UM1AI068613]; SCHARP [U01AI068617/UM1AI068617]; HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068619/UM1AI068619]; Office of AIDS Research of the U.S. National Institutes of Health; Division of Intramural Research, NIAID, NIH [R01-AI095068]; PEPI [U50 PS022061-05, U50/CC0222061]; U.S. Centers for Disease Control and Prevention; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; Bill and Melinda Gates Foundation [26469]; US National Institutes of Health [P30 A127757, P01 057005, K08 AI0744248]; NIAID [R01 A134826, K22 AI092150-01, R01 A134265]; NICHD [RO1 HD 050180]; World Bank STI Project, Uganda; Henry M. Jackson Foundation; Fogarty Foundation [5D43TW00010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD003310, R01HD050180] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U50PS022061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068617, K22AI092150, R01AI095068, U01AI068613, U01AI052054, U01AI046749, ZIAAI000361, U01AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066687, U01MH066702, U01MH066688, U01MH066701] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HPTN Network Laboratory; SCHARP; HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; Office of AIDS Research of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PEPI; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); World Bank STI Project, Uganda; Henry M. Jackson Foundation; Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Primary sources of support: This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 Johns Hopkins University - David Celentano, PI); U01MH066688 Medical University of South Carolina - Michael Sweat, PI); U01MH066701 University of California, Los Angeles - Thomas J. Coates, PI); and U01MH066702 University of California, San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613/UM1AI068613 HPTN Network Laboratory - Susan Eshleman, PI); U01AI068617/UM1AI068617 SCHARP - Deborah Donnell, PI); and U01AI068619/UM1AI068619 HIV Prevention Trials Network - Sten Vermund/Wafaa El-Sadr, PIs) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; and by the Office of AIDS Research of the U. S. National Institutes of Health. Views expressed are those of the authors, and not necessarily those of sponsoring agencies. Additional support was provided by the Division of Intramural Research, NIAID, NIH and from R01-AI095068 Susan Eshleman/Ron Brookmeyer, PIs). Support for studies that provided samples and data for this work: 1) PEPI- Malawi Study: Cooperative Agreement U50 PS022061-05; Award # U50/CC0222061) from the U.S. Centers for Disease Control and Prevention and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. 2) Partners in Prevention HSV/HIV Transmission Study funded by the Bill and Melinda Gates Foundation grant 26469) with support from the US National Institutes of Health P30 A127757 to the University of Washington Center for AIDS Research, P01 057005, and K08 AI0744248). 3) Rakai Health Sciences Program was funded by NIAID grants R01 A134826, K22 AI092150-01, and R01 A134265); NICHD grant RO1 HD 050180); the World Bank STI Project, Uganda; the Henry M. Jackson Foundation; the Fogarty Foundation grant 5D43TW00010).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Brookmeyer R, 2010, JAIDS-J ACQ IMM DEF, V54, P406, DOI 10.1097/QAI.0b013e3181dc6d2c; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Conroy SA, 2010, AIDS RES HUM RETROV, V26, P1087, DOI 10.1089/aid.2010.0054; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kulich M, 2013, EVALUATION MUL UNPUB; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laeyendecker O, 2013, 043 HIV PREV TRIALS; Laeyendecker O, 2013, 20 C RETR OPP INF AT; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P1177, DOI 10.1089/aid.2011.0341; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2010, 17 C RETR OPP INF SA; Mastro TD, 2012, J INFECT DIS; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Mullis CE, 2012, 18 C RETR OPP INF SE; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Piwowar-Manning E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-251; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS Reference Group on Estimates MaP, 2006, WEEKLY EPIDEMIOLOGIC, V81, P33; Valley-Omar Z, 2012, J INFECT DIS, V206, P35, DOI 10.1093/infdis/jis305; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	36	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78818	10.1371/journal.pone.0078818	http://dx.doi.org/10.1371/journal.pone.0078818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236054	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700051
J	Maliphol, AB; Garth, DJ; Medler, KF				Maliphol, Amanda B.; Garth, Deborah J.; Medler, Kathryn F.			Diet-Induced Obesity Reduces the Responsiveness of the Peripheral Taste Receptor Cells	PLOS ONE			English	Article							CHORDA TYMPANI RESPONSES; DIABETIC DB/DB MOUSE; SWEET TASTE; BITTER TASTE; ENHANCED RESPONSES; ACESULFAME-K; BODY-WEIGHT; MICE; SENSITIVITY; LEPTIN	Introduction: Obesity is a growing epidemic that causes many serious health related complications. While the causes of obesity are complex, there is conclusive evidence that overconsumption coupled with a sedentary lifestyle is the primary cause of this medical condition. Dietary consumption is controlled by appetite which is in turn regulated by multiple neuronal systems, including the taste system. However, the relationship between taste and obesity has not been well defined. Growing evidence suggests that taste perception in the brain is altered in obese animals and humans, however no studies have determined if there are altered taste responses in the peripheral taste receptor cells, which is the initiation site for the detection and perception of taste stimuli. Methodology/Principal Findings: In this study, we used C57Bl/6 mice which readily become obese when placed on a high fat diet. After ten weeks on the high fat diet, we used calcium imaging to measure how taste-evoked calcium signals were affected in the obese mice. We found that significantly fewer taste receptor cells were responsive to some appetitive taste stimuli while the numbers of taste cells that were sensitive to aversive taste stimuli did not change. Properties of the taste-evoked calcium signals were also significantly altered in the obese mice. Behavioral analyses found that mice on the high fat diet had reduced ability to detect some taste stimuli compared to their littermate controls. Conclusions/Significance: Our findings demonstrate that diet-induced obesity significantly influences peripheral taste receptor cell signals which likely leads to changes in the central taste system and may cause altered taste perception.	[Maliphol, Amanda B.; Garth, Deborah J.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Medler, KF (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Medler, Kathryn/0000-0001-9664-3606	National Science Foundation [0917893, 1256950]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation [Grants #0917893 and #1256950] to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroff K, 2007, PHYSIOL BEHAV, V92, P468, DOI 10.1016/j.physbeh.2007.04.021; Ackroff K, 2012, PHYSIOL BEHAV, V107, P207, DOI 10.1016/j.physbeh.2012.06.022; ANDERSON GH, 1995, AM J CLIN NUTR, V62, p195S, DOI 10.1093/ajcn/62.1.195S; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Bi S, 2007, AM J PHYSIOL-REG I, V293, pR55, DOI 10.1152/ajpregu.00002.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Chevrot M., 2013, J LIPID RES; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3221, DOI 10.1152/jn.00129.2012; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3206, DOI 10.1152/jn.00916.2011; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; GRINKER J, 1978, AM J CLIN NUTR, V31, P1078, DOI 10.1093/ajcn/31.6.1078; Hacker K, 2008, J NEUROPHYSIOL, V99, P1503, DOI 10.1152/jn.00892.2007; Hajnal A, 2005, AM J PHYSIOL-REG I, V289, pR1675, DOI 10.1152/ajpregu.00412.2005; Hajnal A, 2005, PHYSIOL BEHAV, V84, P363, DOI 10.1016/j.physbeh.2004.12.014; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; Hellstrom PM, 2004, BRIT J NUTR, V92, pS47, DOI 10.1079/BJN20041142; Hill JO, 2005, PSYCHIAT CLIN N AM, V28, P1, DOI 10.1016/j.psc.2004.09.010; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Huang YJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030662; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kovacs P, 2008, J NEUROPHYSIOL, V100, P2145, DOI 10.1152/jn.01359.2007; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Martin B, 2010, DIABETES; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Medler KF, 2003, J NEUROSCI, V23, P2608; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Ninomiya Y, 1998, AM J PHYSIOL-REG I, V274, pR1324, DOI 10.1152/ajpregu.1998.274.5.R1324; NINOMIYA Y, 1995, AM J PHYSIOL-REG I, V269, pR930, DOI 10.1152/ajpregu.1995.269.4.R930; Ninomiya Y, 2002, VITAM HORM, V64, P221, DOI 10.1016/S0083-6729(02)64007-5; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Ohta R, 2003, NEUROBIOL LEARN MEM, V80, P105, DOI 10.1016/S1074-7427(03)00046-7; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Pepino MY, 2010, OBESITY, V18, P959, DOI 10.1038/oby.2009.493; Preacher KJ, 2001, CALCULATION CHI SQUA; Rebello MR, 2010, EUR J NEUROSCI, V32, P1825, DOI 10.1111/j.1460-9568.2010.07463.x; Sanematsu K, 2009, ANN NY ACAD SCI, V1170, P102, DOI 10.1111/j.1749-6632.2009.03893.x; SCHIFFMAN SS, 1979, PHYSIOL BEHAV, V23, P1, DOI 10.1016/0031-9384(79)90113-6; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shimizu Y, 2003, J NEUROPHYSIOL, V90, P128, DOI 10.1152/jn.01170.2002; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Yamada K, 1999, PHYSIOL BEHAV, V66, P863, DOI 10.1016/S0031-9384(99)00032-3; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Zukerman S, 2011, AM J PHYSIOL-REG I, V301, pR1635, DOI 10.1152/ajpregu.00425.2011; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	53	49	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79403	10.1371/journal.pone.0079403	http://dx.doi.org/10.1371/journal.pone.0079403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236129	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700128
J	Mameli, G; Madeddu, G; Mei, A; Uleri, E; Poddighe, L; Delogu, LG; Maida, I; Babudieri, S; Serra, C; Manetti, R; Mura, MS; Dolei, A				Mameli, Giuseppe; Madeddu, Giordano; Mei, Alessandra; Uleri, Elena; Poddighe, Luciana; Delogu, Lucia G.; Maida, Ivana; Babudieri, Sergio; Serra, Caterina; Manetti, Roberto; Mura, Maria S.; Dolei, Antonina			Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?	PLOS ONE			English	Article							B-CELLS; BRAIN; EXPRESSION; RISK; TRANSCRIPTION; ASSOCIATION; MODULATION; UNIVERSITY; DEATH; BLOOD	The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention.	[Mameli, Giuseppe; Mei, Alessandra; Uleri, Elena; Poddighe, Luciana; Serra, Caterina; Dolei, Antonina] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Madeddu, Giordano; Maida, Ivana; Babudieri, Sergio; Manetti, Roberto; Mura, Maria S.] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Delogu, Lucia G.] Univ Sassari, Dept Chem & Pharm, I-07100 Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Dolei, A (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	doleivir@uniss.it	MADEDDU, Giordano/AAP-4342-2020	MADEDDU, Giordano/0000-0001-6099-2273; Delogu, Lucia Gemma/0000-0002-2329-7260; mameli, giuseppe/0000-0002-0286-5433; MAIDA, Ivana/0000-0003-4895-7576; BABUDIERI, SERGIO/0000-0001-7291-8687; Uleri, Elena/0000-0003-1014-0042	Fondazione Italiana Sclerosi Multipla onlus [2010/R/16]; Regione Sardegna; Fondazione Banco di Sardegna	Fondazione Italiana Sclerosi Multipla onlus(Fondazione Italiana Sclerosi Multipla (FISM)); Regione Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported in part by Fondazione Italiana Sclerosi Multipla onlus grant 2010/R/16 (AD), by Regione Sardegna (grant 2010, AD), by Fondazione Banco di Sardegna (grant 2011, CS, and a research fellowship 2011 to support GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohmeed YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061110; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Arru Giannina, 2007, Int J Biomed Sci, V3, P292; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Borkosky SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032160; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Chung BK, 2013, BLOOD; Coppotelli G, 2013, NUCLEIC ACIDS RES, V41, P2950, DOI 10.1093/nar/gkt032; Cusick MF, 2013, CURR OPIN RHEUMATOL, V25, P496, DOI 10.1097/BOR.0b013e328362004d; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Dolei Antonina, 2006, Expert Rev Clin Immunol, V2, P149, DOI 10.1586/1744666X.2.1.149; Dolei A, 2009, J NEUROVIROL, V15, P4, DOI 10.1080/13550280802448451; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Komijani M, 2011, INT J NEUROSCI, V121, P437, DOI 10.3109/00207454.2011.569039; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Meier UC, 2012, CLIN EXP IMMUNOL, V167, P1, DOI 10.1111/j.1365-2249.2011.04446.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Nielsen TR, 2009, MULT SCLER J, V15, P431, DOI 10.1177/1352458508100037; Owens GP, 2012, MULT SCLER J, V18, P1204, DOI 10.1177/1352458512448109; Pakpoor J, 2013, EXPERT REV NEUROTHER, V13, P287, DOI [10.1586/ERN.13.6, 10.1586/ern.13.6]; Pakpoor J, 2013, MULT SCLER J, V19, P162, DOI 10.1177/1352458512449682; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Serra C, 2003, J NEUROVIROL, V9, P637, DOI 10.1080/714044485; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Sotgiu S, 2006, MULT SCLER J, V12, P357, DOI 10.1191/135248506ms1303sr; Sotgiu S, 2002, NEUROLOGY, V59, P1071, DOI 10.1212/WNL.59.7.1071; Sotgiu S, 2010, MULT SCLER, V16, P1248, DOI 10.1177/1352458510376956; Tselis A, 2012, CURR OPIN RHEUMATOL, V24, P424, DOI 10.1097/BOR.0b013e3283542cf8; Wood VHJ, 2007, ONCOGENE, V26, P4135, DOI 10.1038/sj.onc.1210496	60	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78474	10.1371/journal.pone.0078474	http://dx.doi.org/10.1371/journal.pone.0078474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236019	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700016
J	Parmigiani, A; Alcaide, ML; Freguja, R; Pallikkuth, S; Frasca, D; Fischl, MA; Pahwa, S				Parmigiani, Anita; Alcaide, Maria L.; Freguja, Ricardo; Pallikkuth, Suresh; Frasca, Daniela; Fischl, Margaret A.; Pahwa, Savita			Impaired Antibody Response to Influenza Vaccine in HIV-Infected and Uninfected Aging Women Is Associated with Immune Activation and Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA TNF-ALPHA; CD4 T-CELLS; B-CELLS; REPLICATIVE SENESCENCE; ANTIRETROVIRAL THERAPY; DISEASE; VIRUS; AIDS; PROGRESSION	Background: Aging and HIV infection are independently associated with excessive immune activation and impaired immune responses to vaccines, but their relationships have not been examined. Methods: For selecting an aging population we enrolled 28 post-menopausal women including 12 healthy volunteers and 16 HIV-infected women on antiretroviral treatment with <100 HIV RNA copies/ml. Antibody titers to trivalent influenza vaccination given during the 2011-2012 season were determined before and 4 weeks after vaccination. Results: Seroprotective influenza antibody titers (>= 1: 40) were observed in 31% HIV+ and 58% HIV-uninfected women pre-vaccination. Following vaccination, magnitude of antibody responses and frequency of seroprotection were lower in HIV+(75%) than in HIV-(91%) women. Plasma IL-21, the signature cytokine of T follicular helper cells (Tfh), and CD4 T cell IL-21R were upregulated with seroconversion (>= 4 fold increase in antibody titer). Post-vaccine antibody responses were inversely correlated with pre-vaccination plasma TNF alpha levels and with activated CD4 T cells, including activated peripheral (p) Tfh. Plasma TNFa levels were correlated with activated pTfh cells (r=0.48, p=0.02), and inversely with the post-vaccination levels of plasma IL-21 (r=-0.53, p=0.02). In vitro TNFa blockade improved the ability of CD4 T cells to produce IL-21 and of B cells to secrete immunoglobulins, and addition of exogenous IL-21 to cell cultures enhanced B cell function. Higher frequencies of activated and exhausted CD8 T and B cells were noted in HIV+ women, but these markers did not show a correlation with antibody responses. Conclusions: In aging HIV-infected and uninfected women, activated CD4 and pTfh cells may compromise influenza vaccine-induced antibody response, for which a mechanism of TNF alpha-mediated impairment of pTfh-induced IL-21 secretion is postulated. Interventions aimed at reducing chronic inflammation and immune activation in aging, HIV-infected patients may improve their response to vaccines.	[Parmigiani, Anita; Pallikkuth, Suresh; Frasca, Daniela; Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Alcaide, Maria L.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Freguja, Ricardo] Univ Padua, Unit Viral Oncol, Oncol & Immunol Sect, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Freguja, Ricardo] Univ Padua, AIDS Reference Ctr, Padua, Italy; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Div Infect Dis, UM AIDS Clin Res Unit, Miami, FL 33136 USA	University of Miami; University of Miami; University of Padua; University of Padua; University of Miami	Pahwa, S (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	Spahwa@med.miami.edu	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Alcaide, Maria/0000-0003-4648-0145	University of Miami Center for AIDS Research (CFAR) (National Institute of Health) [P30AI073961]; NIAID [R01 AI108472]; OAR (Office of AIDS Research); NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC (Fogarty International Center); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108472, P30AI073961] Funding Source: NIH RePORTER	University of Miami Center for AIDS Research (CFAR) (National Institute of Health); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OAR (Office of AIDS Research); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the University of Miami Center for AIDS Research (CFAR) via a CFAR developmental award to MLA and AP (National Institute of Health, P30AI073961) and NIAID (R01 AI108472). The CFAR program at the NIH includes the following co-funding and participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC (Fogarty International Center), and OAR (Office of AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; ALCAIDE ML, 2013, IMMUNE ACTIVATION HI; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Bender BS, 2003, IMMUNOL ALLERGY CLIN, V23, P57, DOI 10.1016/S0889-8561(02)00078-4; Bose F, 2011, CLIN IMMUNOL, V139, P164, DOI 10.1016/j.clim.2011.01.015; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V121, P255, DOI 10.1046/j.1365-2249.2000.01281.x; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Douek Daniel, 2007, Top HIV Med, V15, P114; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; FRASCA D, 2013, VACCINE; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Frasca D, 2012, J IMMUNOL, V188, P279, DOI 10.4049/jimmunol.1003964; Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; GARDNER ID, 1980, REV INFECT DIS, V2, P801; Gardner P, 2004, EMERG INFECT DIS, V10, P1990; GODFRIED MH, 1994, J INFECT DIS, V169, P739, DOI 10.1093/infdis/169.4.739; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hsiung G.D., 1994, HSIUNGS DIAGNOSTIC V, P404; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Jackson LA, 2012, J INFECT DIS, V206, P811, DOI 10.1093/infdis/jis427; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; LAHDEVIRTA J, 1988, AM J MED, V85, P289, DOI 10.1016/0002-9343(88)90576-1; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; LEVACHER M, 1992, CLIN EXP IMMUNOL, V90, P376; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; Mocroft A, 1997, J ACQ IMMUN DEF SYND, V14, P158, DOI 10.1097/00042560-199702010-00009; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; SalazarGonzalez JF, 1997, CLIN IMMUNOL IMMUNOP, V84, P36, DOI 10.1006/clin.1997.4364; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; YAO ZQ, 2013, ARCH IMMUNOL THER EX; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	70	79	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79816	10.1371/journal.pone.0079816	http://dx.doi.org/10.1371/journal.pone.0079816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236161	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700161
J	Payne, C; Bachevalier, J				Payne, Christa; Bachevalier, Jocelyne			Crossmodal Integration of Conspecific Vocalizations in Rhesus Macaques	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; PERVASIVE DEVELOPMENTAL DISORDER; CHIMPANZEE PAN-TROGLODYTES; MULTISENSORY INTEGRATION; AMYGDALA DAMAGE; EMOTION RECOGNITION; FACIAL EXPRESSIONS; MACACA-MULATTA; GAZE BEHAVIOR; EYE-MOVEMENTS	Crossmodal integration of audio/visual information is vital for recognition, interpretation and appropriate reaction to social signals. Here we examined how rhesus macaques process bimodal species-specific vocalizations by eye tracking, using an unconstrained preferential looking paradigm. Six adult rhesus monkeys (3M, 3F) were presented two side-by-side videos of unknown male conspecifics emitting different vocalizations, accompanied by the audio signal corresponding to one of the videos. The percentage of time animals looked to each video was used to assess crossmodal integration ability and the percentages of time spent looking at each of the six a priori ROIs (eyes, mouth, and rest of each video) were used to characterize scanning patterns. Animals looked more to the congruent video, confirming reports that rhesus monkeys spontaneously integrate conspecific vocalizations. Scanning patterns showed that monkeys preferentially attended to the eyes and mouth of the stimuli, with subtle differences between males and females such that females showed a tendency to differentiate the eye and mouth regions more than males. These results were similar to studies in humans indicating that when asked to assess emotion-related aspects of visual speech, people preferentially attend to the eyes. Thus, the tendency for female monkeys to show a greater differentiation between the eye and mouth regions than males may indicate that female monkeys were slightly more sensitive to the socio-emotional content of complex signals than male monkeys. The current results emphasize the importance of considering both the sex of the observer and individual variability in passive viewing behavior in nonhuman primate research.	[Payne, Christa; Bachevalier, Jocelyne] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Payne, Christa; Bachevalier, Jocelyne] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA	Emory University	Payne, C (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	christa.payne@emory.edu		Payne, Christa/0000-0002-6281-1269	National Institute of Child Health and Human Development [35471]; National Institute Mental Health [58846, T32-MH0732505]; Yerkes Base Grant [NIH RR00165]; Office of Research Infrastructure Programs/OD [P51OD11132]; Center for Behavioral Neuroscience [NSF IBN-9876754]; Robert W. Woodruff Health Sciences Center Fund, Emory University; Autism Speaks Mentor-Based Predoctoral Fellowship [1657]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058846] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute Mental Health; Yerkes Base Grant; Office of Research Infrastructure Programs/OD; Center for Behavioral Neuroscience; Robert W. Woodruff Health Sciences Center Fund, Emory University; Autism Speaks Mentor-Based Predoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by National Institute of Child Health and Human Development 35471; National Institute Mental Health 58846; Yerkes Base Grant NIH RR00165 (currently supported by the Office of Research Infrastructure Programs/OD P51OD11132); Center for Behavioral Neuroscience grant NSF IBN-9876754; The Robert W. Woodruff Health Sciences Center Fund, Emory University; National Institute of Mental Health T32-MH0732505; Autism Speaks Mentor-Based Predoctoral Fellowship Grant: 1657. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; [Anonymous], 2005, EMOTIONAL DEV RECENT; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Brothers Leslie, 1995, P1107; Buchan JN, 2007, SOC NEUROSCI-UK, V2, P1, DOI 10.1080/17470910601043644; Buchan JN, 2008, BRAIN RES, V1242, P162, DOI 10.1016/j.brainres.2008.06.083; Byrne R., 1988, MACHIAVELLIAN INTELL; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; de Gelder B, 2005, SCHIZOPHR RES, V72, P195, DOI 10.1016/j.schres.2004.02.013; de Jong JJ, 2010, SCHIZOPHR RES, V122, P136, DOI 10.1016/j.schres.2010.04.010; de Jong JJ, 2009, SCHIZOPHR RES, V107, P286, DOI 10.1016/j.schres.2008.10.001; De Waal, 1989, PEACEMAKING PRIMATES; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; Farzin F, 2009, J AUTISM DEV DISORD, V39, P946, DOI 10.1007/s10803-009-0744-1; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Goursaud APS, 2007, BEHAV BRAIN RES, V176, P75, DOI 10.1016/j.bbr.2006.09.020; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hinde R, 1962, P ROY SOC LON B, V138; HOBSON RP, 1988, PSYCHOL MED, V18, P911, DOI 10.1017/S0033291700009843; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lansing CR, 1999, J SPEECH LANG HEAR R, V42, P526, DOI 10.1044/jslhr.4203.526; Lansing IR, 2003, PERCEPT PSYCHOPHYS, V65, P536, DOI 10.3758/BF03194581; Loveland K, 1995, DEV PSYCHOPATHOL, V7; Loveland K. A., 2005, INT M AUT RES BOST M; Machado CJ, 2011, AM J PRIMATOL, V73, P562, DOI 10.1002/ajp.20928; Magnee MJCM, 2008, J CHILD PSYCHOL PSYC, V49, P995, DOI 10.1111/j.1469-7610.2008.01902.x; Magnee MJCM, 2007, J CHILD PSYCHOL PSYC, V48, P1122, DOI 10.1111/j.1469-7610.2007.01779.x; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; Parr LA, 2004, ANIM COGN, V7, P171, DOI 10.1007/s10071-004-0207-1; Partan SR, 2004, HDB MULTISENSORY PRO, P225; Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Roma PG, 2006, CHILD DEV, V77, P118, DOI 10.1111/j.1467-8624.2006.00860.x; Romanski Lizabeth M., 2010, P500; Sackett GP, 2002, AM J PRIMATOL, V56, P165, DOI 10.1002/ajp.1072; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Vatikiotis-Bateson E, 1998, PERCEPT PSYCHOPHYS, V60, P926, DOI 10.3758/BF03211929	53	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81825	10.1371/journal.pone.0081825	http://dx.doi.org/10.1371/journal.pone.0081825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236218	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700221
J	Scarpa, A; Sikora, K; Fassan, M; Rachiglio, AM; Cappellesso, R; Antonello, D; Amato, E; Mafficini, A; Lambiase, M; Esposito, C; Bria, E; Simonato, F; Scardoni, M; Turri, G; Chilosi, M; Tortora, G; Fassina, A; Normanno, N				Scarpa, Aldo; Sikora, Katarzyna; Fassan, Matteo; Rachiglio, Anna Maria; Cappellesso, Rocco; Antonello, Davide; Amato, Eliana; Mafficini, Andrea; lambiase, MatilDe; Esposito, Claudia; Bria, Emilio; Simonato, Francesca; Scardoni, Maria; Turri, Giona; Chilosi, Marco; Tortora, Giampaolo; Fassina, Ambrogio; Normanno, Nicola			Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FINE-NEEDLE-ASPIRATION; TARGETED THERAPIES; MUTATION STATUS; CANCER; EGFR; GEFITINIB; CLASSIFICATION; DIAGNOSTICS; RESISTANCE	Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be needed to assess is expected to rapidly increase. This calls for the implementation of methods probing the mutational status of multiple genes for inoperable cases, for which limited cytological or bioptic material is available. Cytology specimens from 38 lung adenocarcinomas were subjected to the simultaneous assessment of 504 mutational hotspots of 22 lung cancer-associated genes using 10 nanograms of DNA and Ion Torrent PGM next-generation sequencing. Thirty-six cases were successfully sequenced (95%). In 24/36 cases (67%) at least one mutated gene was observed, including EGFR, KRAS, PIK3CA, BRAF, TP53, PTEN, MET, SMAD4, FGFR3, STK11, MAP2K1. EGFR and KRAS mutations, respectively found in 6/36 (16%) and 10/36 (28%) cases, were mutually exclusive. Nine samples (25%) showed concurrent alterations in different genes. The next-generation sequencing test used is superior to current standard methodologies, as it interrogates multiple genes and requires limited amounts of DNA. Its applicability to routine cytology samples might allow a significant increase in the fraction of lung cancer patients eligible for personalized therapy.	[Scarpa, Aldo; Sikora, Katarzyna; Fassan, Matteo; Amato, Eliana; Mafficini, Andrea] Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy; [Scarpa, Aldo; Fassan, Matteo; Antonello, Davide; Scardoni, Maria; Turri, Giona; Chilosi, Marco] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Rachiglio, Anna Maria; lambiase, MatilDe; Esposito, Claudia] INT Fdn Pascale, Ctr Ric Oncol Mercogliano, Pharmacogen Lab, Mercogliano, Italy; [Simonato, Francesca; Fassina, Ambrogio] Univ Padua, Dept Med, Padua, Italy; [Tortora, Giampaolo] Univ Verona, Dept Med, Oncol Unit, I-37100 Verona, Italy; [Normanno, Nicola] INT Fdn Pascale, Cell Biol & Biotherapy Unit, Naples, Italy	University of Verona; University of Verona; IRCCS Fondazione Pascale; University of Padua; University of Verona; IRCCS Fondazione Pascale	Fassan, M (corresponding author), Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy.	matteo.fassan@gmail.com	Bria, Emilio/A-8574-2019; Normanno, Nicola/AAT-1107-2021; Lambiase, Matilde/AAB-8356-2022; Cappellesso, Rocco/L-5463-2016; Rachiglio, Anna Maria/AAA-5208-2019; Tortora, Giampaolo/HGB-6261-2022; CHILOSI, MARCO/ABB-8028-2021; Fassan, Matteo/F-5152-2012; Tortora, Giampaolo/AAA-1252-2019; scarpa, aldo/K-6832-2016; Mafficini, Andrea/AAK-8158-2020	Bria, Emilio/0000-0002-2333-704X; Lambiase, Matilde/0000-0002-4478-8042; Cappellesso, Rocco/0000-0002-0480-3412; Rachiglio, Anna Maria/0000-0002-4144-7066; Fassan, Matteo/0000-0001-6515-5482; scarpa, aldo/0000-0003-1678-739X; Mafficini, Andrea/0000-0002-7471-3121; Normanno, Nicola/0000-0002-7158-2605; Tortora, Giampaolo/0000-0002-1378-4962	Italian Cancer Genome Project [FIRB RBAP10AHJB]; Associazione Italiana Ricerca Cancro (AIRC) [12182]	Italian Cancer Genome Project; Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Cancer Genome Project (FIRB RBAP10AHJB) and Associazione Italiana Ricerca Cancro (AIRC 5 per mille grant n. 12182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Cheng L, 2012, MODERN PATHOL, V25, P347, DOI 10.1038/modpathol.2011.215; Chilosi M, 2010, ARCH PATHOL LAB MED, V134, P55, DOI 10.1043/1543-2165-134.1.55; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daniels M, 2012, J THORAC DIS, V4, P155, DOI 10.3978/j.issn.2072-1439.2012.02.01; De Luca A, 2010, CURR DRUG TARGETS, V11, P851, DOI 10.2174/138945010791320773; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Ellis LM, 2009, CLIN CANCER RES, V15, P7471, DOI 10.1158/1078-0432.CCR-09-1070; Fassina A, 2012, CYTOPATHOLOGY, V23, P213, DOI 10.1111/j.1365-2303.2012.01005.x; Fassina A, 2011, CYTOPATHOLOGY, V22, P306, DOI 10.1111/j.1365-2303.2010.00802.x; Fassina A, 2009, J CLIN PATHOL, V62, P1096, DOI 10.1136/jcp.2009.067587; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Gazziero A, 2009, J CLIN PATHOL, V62, P429, DOI 10.1136/jcp.2008.059808; Geurts-Giele WRR, 2013, VIRCHOWS ARCH, V462, P249, DOI 10.1007/s00428-012-1346-4; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kris MG, 2011, J CLIN ONCOL, V29, P7506; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Marcheti A, 2010, PATHOLOGICA, V102, P119; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Normanno N, 2013, J CELL BIOCHEM, V114, P514, DOI 10.1002/jcb.24401; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peled N, 2012, J THORAC ONCOL, V7, pE14, DOI 10.1097/JTO.0b013e3182614ab5; Pirker R, 2012, J THORAC ONCOL, V5, P1706; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossi A, 2013, CANCER TREAT REV, V39, P489, DOI 10.1016/j.ctrv.2012.09.001; Sanchez-Cespedes M, 2011, FAM CANCER, V10, P447, DOI 10.1007/s10689-011-9443-0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorio C, 2004, VIRCHOWS ARCH, V444, P269, DOI 10.1007/s00428-003-0936-6; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	45	70	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80478	10.1371/journal.pone.0080478	http://dx.doi.org/10.1371/journal.pone.0080478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236184	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700185
J	Stalvey, MS; Clines, KL; Havasi, V; McKibbin, CR; Dunn, LK; Chung, WJ; Clines, GA				Stalvey, Michael S.; Clines, Katrina L.; Havasi, Viktoria; McKibbin, Christopher R.; Dunn, Lauren K.; Chung, W. Joon; Clines, Gregory A.			Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PARATHYROID-HORMONE; OSTEOCLAST DIFFERENTIATION; ANIMAL-MODEL; MURINE MODEL; RECEPTOR; MICE; OSTEOPENIA; DENSITY; PROTEIN	Low bone mass and increased fracture risk are recognized complications of cystic fibrosis (CF). CF-related bone disease (CFBD) is characterized by uncoupled bone turnover-impaired osteoblastic bone formation and enhanced osteoclastic bone resorption. Intestinal malabsorption, vitamin D deficiency and inflammatory cytokines contribute to CFBD. However, epidemiological investigations and animal models also support a direct causal link between inactivation of skeletal cystic fibrosis transmembrane regulator (CFTR), the gene that when mutated causes CF, and CFBD. The objective of this study was to examine the direct actions of CFTR on bone. Expression analyses revealed that CFTR mRNA and protein were expressed in murine osteoblasts, but not in osteoclasts. Functional studies were then performed to investigate the direct actions of CFTR on osteoblasts using a CFTR knockout (Cftr-/-) mouse model. In the murine calvarial organ culture assay, Cftr-/- calvariae displayed significantly less bone formation and osteoblast numbers than calvariae harvested from wildtype (Cftr+/+) littermates. CFTR inactivation also reduced alkaline phosphatase expression in cultured murine calvarial osteoblasts. Although CFTR was not expressed in murine osteoclasts, significantly more osteoclasts formed in Cftr-/- compared to Cftr+/+ bone marrow cultures. Indirect regulation of osteoclastogenesis by the osteoblast through RANK/RANKL/OPG signaling was next examined. Although no difference in receptor activator of NF-kappa B ligand (Rankl) mRNA was detected, significantly less osteoprotegerin (Opg) was expressed in Cftr-/- compared to Cftr+/+ osteoblasts. Together, the Rankl: Opg ratio was significantly higher in Cftr-/- murine calvarial osteoblasts contributing to a higher osteoclastogenesis potential. The combined findings of reduced osteoblast differentiation and lower Opg expression suggested a possible defect in canonical Wnt signaling. In fact, Wnt3a and PTH-stimulated canonical Wnt signaling was defective in Cftr-/- murine calvarial osteoblasts. These results support that genetic inactivation of CFTR in osteoblasts contributes to low bone mass and that targeting osteoblasts may represent an effective strategy to treat CFBD.	[Stalvey, Michael S.; Havasi, Viktoria] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Clines, Katrina L.; Clines, Gregory A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [McKibbin, Christopher R.; Dunn, Lauren K.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Chung, W. Joon] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Clines, Gregory A.] Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Virginia; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Clines, GA (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	clines@uab.edu	Havasi, Viktoria/B-1309-2009	Stalvey, Michael/0000-0003-4257-5710	American Society for Bone and Mineral Research (GAC); NIH [K08DK094784, R21AR056826]; UAB CMBD Bone Histomorphometry Core [P30AR046031]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R21AR056826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094784, P30DK027651] Funding Source: NIH RePORTER	American Society for Bone and Mineral Research (GAC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB CMBD Bone Histomorphometry Core; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Enhancement Award from the American Society for Bone and Mineral Research (GAC), NIH K08DK094784 (MSS), NIH R21AR056826 (GAC) and the UAB CMBD Bone Histomorphometry Core (P30AR046031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Aris RM, 2005, J CLIN ENDOCR METAB, V90, P1888, DOI 10.1210/jc.2004-1629; Aris RM, 2002, OSTEOPOROSIS INT, V13, P151, DOI 10.1007/s001980200007; Aris RM, 1998, ANN INTERN MED, V128, P186, DOI 10.7326/0003-4819-128-3-199802010-00004; Bakker A, 2003, METH MOLEC MED, V80, P19; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Baroncelli GI, 1997, PEDIATR RES, V41, P397, DOI 10.1203/00006450-199703000-00016; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dif F, 2004, BONE, V35, P595, DOI 10.1016/j.bone.2004.05.021; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Elkin SL, 2001, OSTEOPOROSIS INT, V12, P366, DOI 10.1007/s001980170104; Foundation CF, 2011, PATIENT REGISTRY ANN; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; HAHN TJ, 1979, J PEDIATR-US, V94, P38, DOI 10.1016/S0022-3476(79)80346-7; Haston CK, 2008, AM J RESP CRIT CARE, V177, P309, DOI 10.1164/rccm.200705-659OC; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kent G, 1997, J CLIN INVEST, V100, P3060, DOI 10.1172/JCI119861; King SJ, 2005, EUR RESPIR J, V25, P54, DOI 10.1183/09031936.04.00050204; KOLLER BH, 1991, P NATL ACAD SCI USA, V88, P10730, DOI 10.1073/pnas.88.23.10730; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamhonwah AM, 2010, ANN NEUROL, V67, P802, DOI 10.1002/ana.21982; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Le Heron L, 2010, J CYST FIBROS, V9, P69, DOI 10.1016/j.jcf.2009.11.005; Liang HT, 2010, CLIN EXP PHARMACOL P, V37, P506, DOI 10.1111/j.1440-1681.2009.05319.x; MISCHLER EH, 1979, AM J DIS CHILD, V133, P632, DOI 10.1001/archpedi.1979.02130060072016; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Pashuck TD, 2009, PEDIATR RES, V65, P311, DOI 10.1203/PDR.0b013e3181961e80; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Shapiro B J, 1999, Curr Opin Pulm Med, V5, P365, DOI 10.1097/00063198-199911000-00008; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Shead EF, 2010, J CYST FIBROS, V9, P93, DOI 10.1016/j.jcf.2009.11.007; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SNOUWAERT JN, 1995, AM J RESP CRIT CARE, V151, pS59, DOI 10.1164/ajrccm/151.3_Pt_2.S59; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329	46	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80098	10.1371/journal.pone.0080098	http://dx.doi.org/10.1371/journal.pone.0080098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236172	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700173
J	Trevisi, P; Gandolfi, G; Priori, D; Messori, S; Colombo, M; Mazzoni, M; Lalles, JP; Bosi, P				Trevisi, Paolo; Gandolfi, Greta; Priori, Davide; Messori, Stefano; Colombo, Michela; Mazzoni, Maurizio; Lalles, Jean-Paul; Bosi, Paolo			Age-Related Expression of the Polymeric Immunoglobulin Receptor (pIgR) in the Gastric Mucosa of Young Pigs	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; ADAPTIVE IMMUNE-RESPONSES; GENE-EXPRESSION; IG RECEPTOR; SECRETORY COMPONENT; RNA EXPRESSION; GUT; SYSTEM; TOLERANCE; TISSUES	To date few studies have addressed the development and function of the porcine gastric mucosal immune system and this is a major limitation to understanding the immunopathogenesis of infections occurring in young pigs. The polymeric immunoglobulin receptor (pIgR) mediates the transport of secretory immunoglobulins until luminal surface of the gut mucosa and the aim of this study was to investigate the time course of pIgR expression and to determine its localization in three functionally different porcine gastric sites during the suckling period and after weaning. An additional goal was to investigate the time course expression of toll-like receptors (TLRs) in relation to pIgR expression. Gastric samples were collected from the cardiac-to-oxyntic transition (Cd), the oxyntic (Ox), and the pyloric (Py) regions in 84 pigs, slaughtered before weaning (14, 21 and 28 days of age; 23, 23 and 19 pigs, respectively) and 14 days post-weaning (42 days of age, 23 pigs). PIgR was expressed in the mucosa of all the three gastric sites, and its transcript levels were modulated during suckling and after weaning, with regional differences. PIgR expression increased linearly during suckling (P=0.019) and also increased post-weaning (P=0.001) in Cd, it increased post-weaning in Py (P=0.049) and increased linearly during suckling in Ox (P=0.036). TLRs expression was also modulated during development: in Cd, TLR2 increased linearly during suckling (P=0.003); in Ox, TLR2 decreased after weaning (P=0.038) while TLR4 increased linearly during suckling(P=0.008). The expression of TLR2, 3 and 4 in Ox was positively correlated with pIgR expression (P<0.001). Importantly, both pIgR protein and mRNA were localized, by immunohistochemistry and in situ hybridization, respectively, in the gastric glands of the lamina propria. These results indicate that pIgR is actively synthesized in the gastric mucosa and suggest that pIgR could play a crucial role in gastric mucosal immune defense of growing pigs.	[Trevisi, Paolo; Gandolfi, Greta; Priori, Davide; Messori, Stefano; Colombo, Michela; Bosi, Paolo] Univ Bologna, Dept Agr & Food Sci, Reggio Emilia, Italy; [Mazzoni, Maurizio] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy; [Lalles, Jean-Paul] INRA, Cent & Behav Adaptat Dept, Food & Digest, St Gilles, France	University of Bologna; University of Bologna; INRAE	Trevisi, P (corresponding author), Univ Bologna, Dept Agr & Food Sci, Reggio Emilia, Italy.	paolo.trevisi@unibo.it	Messori, Stefano/G-2425-2016; Mazzoni, Maurizio/J-1918-2016	Messori, Stefano/0000-0002-6988-7960; Mazzoni, Maurizio/0000-0002-7384-5990; TREVISI, PAOLO/0000-0001-7019-6828; Gandolfi, Greta/0000-0001-7498-424X; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]	European Union(European Commission)	This research was funded by the European Union Seventh Framework Program (FP7/2007-2013) under the grant agreement no. 227549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2004, SCAND J IMMUNOL, V60, P267, DOI 10.1111/j.0300-9475.2004.01456.x; Asano Masatake, 2011, J Oral Sci, V53, P147; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bjorkholm BM, 2002, J BIOL CHEM, V277, P34191, DOI 10.1074/jbc.M203613200; Bosi P, 2006, J NUTR, V136, P1229, DOI 10.1093/jn/136.5.1229; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Bruno MEC, 2010, IMMUNOL INVEST, V39, P356, DOI 10.3109/08820131003622809; Burkey TE, 2009, J ANIM SCI, V87, P1493, DOI 10.2527/jas.2008-1330; Diebel LN, 2011, J TRAUMA, V70, P691, DOI 10.1097/TA.0b013e31820c780e; Goebel M, 2011, PHYSIOL GENOMICS, V43, P237, DOI 10.1152/physiolgenomics.00193.2010; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; HULING S, 1992, P NATL ACAD SCI USA, V89, P4260, DOI 10.1073/pnas.89.10.4260; Jenkins SL, 2003, AM J PHYSIOL-GASTR L, V285, pG714, DOI 10.1152/ajpgi.00130.2003; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Karlsson MR, 2010, ALLERGY, V65, P561, DOI 10.1111/j.1398-9995.2009.02225.x; KRAJCI P, 1989, BIOCHEM BIOPH RES CO, V158, P783, DOI 10.1016/0006-291X(89)92790-3; Mazzoni M, 2011, J ANAT, V219, P611, DOI 10.1111/j.1469-7580.2011.01415.x; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Pan ZY, 2011, J ANIM VET ADV, V10, P2312, DOI 10.3923/javaa.2011.2312.2316; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Resendiz-Albor AA, 2010, IMMUNOL LETT, V128, P59, DOI 10.1016/j.imlet.2009.11.005; ROTHKOTTER HJ, 1991, PEDIATR RES, V29, P237, DOI 10.1203/00006450-199103000-00004; Sang Y, 2008, VET IMMUNOL IMMUNOP, V125, P162, DOI 10.1016/j.vetimm.2008.04.017; Schneeman TA, 2005, J IMMUNOL, V175, P376, DOI 10.4049/jimmunol.175.1.376; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Trevisi P, 2008, NUTRITION, V24, P1023, DOI 10.1016/j.nut.2008.04.008; Uddin MJ, 2013, RES VET SCI, V95, P92, DOI 10.1016/j.rvsc.2013.01.027; VALNES K, 1984, GASTROENTEROLOGY, V86, P402; VEGALOPEZ MA, 1995, VET IMMUNOL IMMUNOP, V44, P319, DOI 10.1016/0165-2427(94)05309-G	30	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81473	10.1371/journal.pone.0081473	http://dx.doi.org/10.1371/journal.pone.0081473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236214	gold, Green Submitted, Green Published			2022-12-25	WOS:000327254700217
J	Zou, MY; Li, XZ; Zhao, J; Qu, YB				Zou, Mouyong; Li, Xuezhi; Zhao, Jian; Qu, Yinbo			Characteristics of Polygalacturonate Lyase C from Bacillus subtilis 7-3-3 and Its Synergistic Action with PelA in Enzymatic Degumming	PLOS ONE			English	Article							ALKALINE	An alkaline polygalacturonate lyase (PGL) from Bacillus subtilis 7-3-3, PelC, with diverse depolymerization abilities for different pectin substrates was found. The PGL activity of PelC decreased with increasing degree of methyl esterification of the substrate. PelA and PelC displayed notable synergistic effects in the enzymatic degumming of ramie fibers. Gum loss rates increased by 62% when PelC was used to replace up to three-eighths of the PelA dose (PelC, 60 U g(-1) ramie fibers). To the best of our knowledge, this study is the first to report the synergistic action of members of polysaccharide lyase families 1 and 3, represented by PelA and PelC, respectively. The present paper provides new insights into the improvement and production of enzymes used in enzymatic degumming.	[Zou, Mouyong; Li, Xuezhi; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, J (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	zhaojian@sdu.edu.cn			National High Technology Research and Development Program of China [2012AA022203B]; National Natural Sciences Foundation of China [31170107]; Natural Sciences Foundation of Shandong Province [ZR2010CM023]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National High Technology Research and Development Program of China (No. 2012AA022203B)(http://www.863.gov.cn/), the National Natural Sciences Foundation of China (31170107)(http://www.nsfc.gov.cn/Portal0/default152.htm), and the Natural Sciences Foundation of Shandong Province (ZR2010CM023)(http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; Basu S, 2009, J IND MICROBIOL BIOT, V36, P239, DOI 10.1007/s10295-008-0490-y; Bin Z, 2008, BIOCHEM ENG J, V40, P92, DOI 10.1016/j.bej.2007.11.018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhlmann F, 2000, J BIOTECHNOL, V76, P43, DOI 10.1016/S0168-1656(99)00175-3; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Kapoor M, 2001, PROCESS BIOCHEM, V36, P803, DOI 10.1016/S0032-9592(00)00282-X; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zheng LS, 2001, BIORESOURCE TECHNOL, V78, P89, DOI 10.1016/S0960-8524(00)00154-1; Zou M, 2013, PROCESS BIOCH	16	16	16	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79357	10.1371/journal.pone.0079357	http://dx.doi.org/10.1371/journal.pone.0079357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236123	Green Submitted, gold, Green Published			2022-12-25	WOS:000327254700122
J	Shelef, O; Helman, Y; Friedman, ALL; Behar, A; Rachmilevitch, S				Shelef, Oren; Helman, Yael; Friedman, Ariel-Leib-Leonid; Behar, Adi; Rachmilevitch, Shimon			Tri-Party Underground Symbiosis between a Weevil, Bacteria and a Desert Plant	PLOS ONE			English	Article							NITROGEN-FIXATION; NATURAL-POPULATIONS; BIOLOGICAL-CONTROL; HOST-SPECIFICITY; CURCULIONIDAE; ENDOSYMBIONTS; RHIZOBIUM; COL.	Inhabitants of arid ecosystems face severe nitrogen and water limitations. Inventive adaptations by organisms occupying such habitats are essential for survival. This study describes a tri-party symbiotic interaction between a plant (Salsola inermis), a beetle (Conorhynchus pistor), and a bacterium (Klebsiella pneumonia). The weevil survives by living within a mud structure affixed to the plant roots, thus benefiting from increased carbon and water, and refuge from predators and parasites. Active nitrogen-fixing bacteria harbored within the weevil's gut mediate this interaction, by supplying nitrogen to the system, which eventually promotes seed development. We studied the correlation between the weevil's existence and (i) root carbon and nitrogen content, (ii) soil water content and (iii) seed weight. Roots hosting weevils contained more nitrogen, heavier seeds and less carbon. In addition, water content was higher around the roots than in open spaces a short distance from the plant stem. Bacterial studies and nitrogen-fixation analyses, including molecular and chemical assays, indicated atmospheric nitrogen fixation in the larval stage and identified the bacterium. The coexistence of weevil and bacterial behavior coinciding with the plant's life cycle was revealed here by a long period of field observations. Out of over 60,000 known weevils, this is the only report of a weevil living most of its life underground without harming plants. The unique tri-party interaction described herein shows the important ecological role of desert plant roots and provides an example of a sustainable consortium of living organisms coping with the challenging desert environment.	[Shelef, Oren; Rachmilevitch, Shimon] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Helman, Yael; Behar, Adi] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Friedman, Ariel-Leib-Leonid] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Ben Gurion University; Hebrew University of Jerusalem; Tel Aviv University	Rachmilevitch, S (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	rshimon@bgu.ac.il	Shelef, Oren/ABD-9396-2020; Rachmilevitch, Shimon/F-1329-2012	Rachmilevitch, Shimon/0000-0003-3600-5949; Friedman, Ariel-Leib-Leonid/0000-0003-4389-6858	Israeli Science Foundation [8554122]; French Associates Institute for Agriculture & Biotechnology of Drylands	Israeli Science Foundation(Israel Science Foundation); French Associates Institute for Agriculture & Biotechnology of Drylands	This work was partially supported by the Israeli Science Foundation grant no. 8554122 and by the French Associates Institute for Agriculture & Biotechnology of Drylands. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NITROGEN FIXATION; Begon M., 2009, ECOLOGY INDIVIDUALS; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; BENEMANN JR, 1973, SCIENCE, V181, P164, DOI 10.1126/science.181.4095.164; BOULOS L, 1994, J U KUWAIT-SCI, V21, P203; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Esser HG, 2010, J PLANT NUTR SOIL SC, V173, P757, DOI 10.1002/jpln.200900188; EVENARI M., 1966, Zeitschrift fur Pflanzenphysiologie, V54, P1; Feinbrun-Dothan N., 1998, ANAL FLORA ERETZ ISR; FRASER NHC, 1993, P ROY SOC B-BIOL SCI, V252, P135, DOI 10.1098/rspb.1993.0057; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; GUTTERMAN Y, 1994, BOT REV, V60, P373, DOI 10.1007/BF02857924; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; NARDON P, 1993, ANN SOC ENTOMOL FR, V29, P113; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Okon Y., 1988, Biological nitrogen fixation: recent developments., P175; Perrine-Walker F, 2011, CURR PROTEIN PEPT SC, V12, P156, DOI 10.2174/138920311795684896; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Rewald B, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P196, DOI 10.1079/9781845938147.0196; Shelef O, 2011, J ARID ENVIRON, V75, P960, DOI 10.1016/j.jaridenv.2011.04.016; Sobhian R, 2003, J APPL ENTOMOL, V127, P322, DOI 10.1046/j.1439-0418.2003.00761.x; Sobhian R, 1999, J APPL ENTOMOL, V123, P205, DOI 10.1046/j.1439-0418.1999.00351.x; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; TOKGAEV T., 1964, IZV AKAD NAUK TURKM SSR SER BIOL NAUK, V1, P53; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0; Vaishampayan A, 2001, BOT REV, V67, P453, DOI 10.1007/BF02857893; Wallace A., 1978, US/IBP Synthesis Series, V9, P130; Wallace A, 1974, US IBP DESERT BIOME, P36; West NE, 1978, NITROGEN DESERT ECOS	39	17	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e76588	10.1371/journal.pone.0076588	http://dx.doi.org/10.1371/journal.pone.0076588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244267	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600005
J	Chan, R; Leung, J; Woo, J				Chan, Ruth; Leung, Jason; Woo, Jean			A Prospective Cohort Study Examining the Associations of Dietary Calcium Intake with All-Cause and Cardiovascular Mortality in Older Chinese Community-Dwelling People	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; HONG-KONG; RISK; WOMEN; SUPPLEMENTATION; MAGNESIUM; STROKE; MEN	Background: Most epidemiological studies of calcium intake and mortality risk have been conducted in populations with moderate to high calcium intake, and limited studies have focused on populations with low habitual calcium intake (i.e., mean dietary calcium intake <700 mg/d). Objective: This study investigated the association between dietary calcium intake and death from all causes and cardiovascular disease in Chinese population with low habitual calcium intake. Design: Data from 3,139 Chinese men and women in a population-based prospective cohort study, aged >= 65 years and free of heart diseases or stroke at baseline, were analyzed. Primary outcome measures, identified from the death registry, were death from all causes and cardiovascular disease. Dietary calcium intake assessed using a validated food frequency questionnaire was categorized into sex-specific quartiles. Data on use of supplemental calcium (yes or no) including individual calcium supplements and other calcium containing supplement were collected. Cox regression models adjusted for demographic and lifestyle variables were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI). Results: During a median of 9.1 years of follow-up, 529 all-cause deaths (344 men, 185 women) and 114 (74 men, 40 women) deaths from cardiovascular disease were identified. An inverse trend between dietary calcium intake and mortality was observed. Compared with the lowest quartile (< 458 mg/d for men, < 417 mg/d for women), the highest quartile of dietary calcium intake (> 762 mg/d for men, > 688 mg/d for women) had a significantly reduced risk of all-cause mortality (multivariate HR=0.63, 95% CI= 0.49-0.81, P-trend<0.001) but an insignificant decreased risk of cardiovascular mortality (multivariate HR= 0.70, 95% CI= 0.41-1.21, P-trend=0.228). Similar inverse association was observed when the analyses were stratified on calcium supplemental use. Conclusions: Higher intake of dietary calcium was associated with reduced risk of all-cause mortality and possibly cardiovascular mortality in Chinese older people with low habitual calcium intake.	[Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Chan, Ruth/K-4995-2014; Woo, Jean/K-2625-2014	Woo, Jean/0000-0001-7593-3081; Chan, Ruth/0000-0002-5725-4066	Research Grants Council of Hong Kong [CUHK 4101/02M]; Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies; Chinese University of Hong Kong(Chinese University of Hong Kong)	The work was supported by grants from the Research Grants Council of Hong Kong, CUHK 4101/02M; the Hong Kong Jockey Club Charities Trust; the SH Ho Centre for Gerontology and Geriatric; and the Centre for Nutritional Studies, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2013, KIDNEY INT, V83, P160, DOI 10.1038/ki.2012.327; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; CHAN R, 2013, JAMA INTERN IN PRESS; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Larsson SC, 2013, AM J CLIN NUTR, V97, P951, DOI 10.3945/ajcn.112.052449; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Michaelsson K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f228; Paul A.A., 1978, MCCANCE WIDDOWSONS C; Reid IR, 2011, OSTEOPOROSIS INT, V22, P1649, DOI 10.1007/s00198-011-1599-9; Reid IR, 2012, HEART, V98, P895, DOI 10.1136/heartjnl-2012-301904; Sacks FM, 1998, HYPERTENSION, V31, P131, DOI 10.1161/01.HYP.31.1.131; Torres MRSG, 2012, CLINICS, V67, P839, DOI 10.6061/clinics/2012(07)22; VANDERVIJVER LPL, 1992, INT J EPIDEMIOL, V21, P36, DOI 10.1093/ije/21.1.36; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Wang L, 2012, AM J CARDIOVASC DRUG, V12, P105, DOI 10.2165/11595400-000000000-00000; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P1933, DOI 10.1007/s00198-005-1968-3; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.	24	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80895	10.1371/journal.pone.0080895	http://dx.doi.org/10.1371/journal.pone.0080895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224062	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400125
J	Hu, ZY; Crump, SM; Anand, M; Kant, R; Levi, R; Abbott, GW				Hu, Zhaoyang; Crump, Shawn M.; Anand, Marie; Kant, Ritu; Levi, Roberto; Abbott, Geoffrey W.			Kcne3 deletion initiates extracardiac arrhythmogenesis in mice	FASEB JOURNAL			English	Article						long-QT syndrome; subunit; potassium channel	NOREPINEPHRINE RELEASE; GENETIC-BASIS; HEART; ALDOSTERONE; ARRHYTHMIAS; DISRUPTION; EXPRESSION; MUTATION; RECEPTOR; SUBUNIT	Mutations in the human KCNE3 potassium channel ancillary subunit gene are associated with life-threatening ventricular arrhythmias. Most genes underlying inherited cardiac arrhythmias, including KCNE3, are not exclusively expressed in the heart, suggesting potentially complex disease etiologies. Here we investigated mechanisms of KCNE3-linked arrhythmogenesis in Kcne3(-/-) mice using real-time qPCR, echo- and electrocardiography, ventricular myocyte patch-clamp, coronary artery ligation/reperfusion, blood analysis, cardiac synaptosome exocytosis, microarray and pathway analysis, and multitissue histology. Kcne3 transcript was undetectable in adult mouse atria, ventricles, and adrenal glands, but Kcne3(-/-) mice exhibited 2.3-fold elevated serum aldosterone (P=0.003) and differentially expressed gene networks consistent with an adrenal-targeted autoimmune response. Furthermore, 8/8 Kcne3(-/-) mice vs. 0/8 Kcne3(+/+) mice exhibited an activated-lymphocyte adrenal infiltration (P=0.0002). Kcne3 deletion also caused aldosterone-dependent ventricular repolarization delay (19.6% mean QT(c) prolongation in females; P<0.05) and aldosterone-dependent predisposition to postischemia arrhythmogenesis. Thus, 5/11 Kcne3(-/-) mice vs. 0/10 Kcne3(+/+) mice exhibited sustained ventricular tachycardia during reperfusion (P<0.05). Kcne3 deletion is therefore arrhythmogenic by a novel mechanism in which secondary hyperaldosteronism, associated with an adrenal-specific lymphocyte infiltration, impairs ventricular repolarization. The findings highlight the importance of considering extracardiac pathogenesis when investigating arrhythmogenic mechanisms, even in inherited, monogenic channelopathies.Hu, Z., Crump, S. M., Anand, M., Kant, R., Levi, R., Abbott, G. W. Kcne3 deletion initiates extracardiac arrhythmogenesis in mice.	[Hu, Zhaoyang; Crump, Shawn M.; Anand, Marie; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Bioelect Lab, Irvine, CA 92697 USA; [Hu, Zhaoyang; Crump, Shawn M.; Anand, Marie; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; [Hu, Zhaoyang; Crump, Shawn M.; Anand, Marie; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Levi, Roberto] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cornell University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu			U.S. National Institutes of Health-National Heart, Lung and Blood Institute [HL079275, HL034215]; University of California-Irvine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL034215] Funding Source: NIH RePORTER	U.S. National Institutes of Health-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California-Irvine(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Vikram Kanda for expert technical assistance. The authors are grateful for financial support from the U.S. National Institutes of Health-National Heart, Lung and Blood Institute (HL079275 to G. W. A.; HL034215 to R. L.) and University of California-Irvine setup funds (to G.W.A.).	Abbott GW, 2013, EXPERT REV CLIN PHAR, V6, P49, DOI [10.1586/ECP.12.76, 10.1586/ecp.12.76]; Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Arrighi I, 2001, P NATL ACAD SCI USA, V98, P8792, DOI 10.1073/pnas.141233398; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Benitah JP, 2001, J PHYSIOL-LONDON, V537, P151, DOI 10.1111/j.1469-7793.2001.0151k.x; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; Gao XR, 2007, J CARD FAIL, V13, P170, DOI 10.1016/j.cardfail.2006.11.015; George AL, 2013, J CLIN INVEST, V123, P75, DOI 10.1172/JCI62928; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; KAUDEWITZ P, 1986, J INVEST DERMATOL, V86, P350, DOI 10.1111/1523-1747.ep12285562; Koyama M, 2003, MOL PHARMACOL, V63, P378, DOI 10.1124/mol.63.2.378; Mackins CJ, 2006, J CLIN INVEST, V116, P1063, DOI 10.1172/JCI25713; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McGee B, 1996, J RHEUMATOL, V23, P36; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Nakajima T, 2012, CIRC J, V76, P2763, DOI 10.1253/circj.CJ-12-0551; Napolitano C, 2012, PEDIATR CARDIOL, V33, P980, DOI 10.1007/s00246-012-0287-7; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Roden DM, 1996, AM J CARDIOL, V78, P12, DOI 10.1016/S0002-9149(96)00448-1; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Sole L, 2013, CHANNELS, V7, P85, DOI 10.4161/chan.23258; Wei JF, 2010, CLIN CARDIOL, V33, P572, DOI 10.1002/clc.20762	27	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					935	945		10.1096/fj.13-241828	http://dx.doi.org/10.1096/fj.13-241828			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24225147	Green Published, Green Submitted			2022-12-25	WOS:000331072200038
J	Michel, CH; Kumar, S; Pinotsi, D; Tunnacliffe, A; St George-Hyslop, P; Mandelkow, E; Mandelkow, EM; Kaminski, CF; Schierle, GSK				Michel, Claire H.; Kumar, Satish; Pinotsi, Dorothea; Tunnacliffe, Alan; St George-Hyslop, Peter; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski			Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN; TRANSMISSION; AGGREGATION; PROPAGATION; ENDOCYTOSIS; EXOCYTOSIS; TAUOPATHY; MODEL	Understanding the formation and propagation of aggregates of the Alzheimer disease-associated Tau protein in vivo is vital for the development of therapeutics for this devastating disorder. Using our recently developed live-cell aggregation sensor in neuron-like cells, we demonstrate that different variants of exogenous monomeric Tau, namely full-length Tau (hTau40) and the Tau-derived construct K18 comprising the repeat domain, initially accumulate in endosomal compartments, where they form fibrillar seeds that subsequently induce the aggregation of endogenous Tau. Using superresolution imaging, we confirm that fibrils consisting of endogenous and exogenous Tau are released from cells and demonstrate their potential to spread Tau pathology. Our data indicate a greater pathological risk and potential toxicity than hitherto suspected for extracellular soluble Tau.	[Michel, Claire H.; Pinotsi, Dorothea; Tunnacliffe, Alan; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England; [Kumar, Satish; Mandelkow, Eckhard; Mandelkow, Eva-Maria] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Kumar, Satish; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DESY, MPI Neurol Res, Hamburg Outstn, D-22607 Hamburg, Germany; [St George-Hyslop, Peter] Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 0XY, England; [St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Mandelkow, Eckhard; Mandelkow, Eva-Maria] Ctr Adv European Studies & Res, D-53175 Bonn, Germany	University of Cambridge; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Toronto; Center of Advanced European Studies & Research (CAESAR)	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Pembroke St, Cambridge CB2 3RA, England.	cfk23@cam.ac.uk; gsk20@cam.ac.uk	Kumar, Satish/AAF-3112-2019; Kaminski, Clemens/G-7488-2016	Kumar, Satish/0000-0002-2993-3694; Kaminski, Clemens/0000-0002-5194-0962; Tunnacliffe, Alan/0000-0001-8570-125X; St George-Hyslop, Peter/0000-0003-0796-7209	Wellcome Trust [089703/Z/09/Z]; Medical Research Council [089703/Z/09/Z, MR/K015850/1, G09022243]; Alzheimer's Research UK [ARUK-EG2012A-1, ARUK-ESG2012-1]; Engineering and Physical Sciences Research Council [EP/H018301/1]; European Research Council [AdG 233232]; Alzheimers Research UK [ARUK-EG2012A-1, ARUK-ESG2012-1] Funding Source: researchfish; Medical Research Council [G0902243, MR/K02292X/1, MC_G1000734] Funding Source: researchfish; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, MR/K015850/1, G0902243, MC_G1000734] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust and Medical Research Council joint funding Grant 089703/Z/09/Z, by Medical Research Council Grants MR/K015850/1 and G09022243, by Alzheimer's Research UK Grants ARUK-EG2012A-1 and ARUK-ESG2012-1, by Engineering and Physical Sciences Research Council Grant EP/H018301/1, and by European Research Council Grant AdG 233232.	Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Frank JH, 2007, J MICROSC-OXFORD, V227, P203, DOI 10.1111/j.1365-2818.2007.01803.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Karch CM, 2013, NEUROBIOL AGING, V34, P374, DOI 10.1016/j.neurobiolaging.2012.05.003; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Niles WD, 1999, J MEMBRANE BIOL, V167, P85, DOI 10.1007/s002329900474; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rees E. J., 2012, OPTICAL NANOSCOPY, V1, P1, DOI DOI 10.1186/2192-2853-1-12; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3	42	110	115	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					956	967		10.1074/jbc.M113.515445	http://dx.doi.org/10.1074/jbc.M113.515445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24235150	hybrid, Green Published			2022-12-25	WOS:000330541200030
J	Deschasaux, M; Zelek, L; Pouchieu, C; His, M; Hercberg, S; Galan, P; Latino-Martel, P; Touvier, M				Deschasaux, Melanie; Zelek, Laurent; Pouchieu, Camille; His, Mathilde; Hercberg, Serge; Galan, Pilar; Latino-Martel, Paule; Touvier, Mathilde			Prospective Association between Dietary Fiber Intake and Breast Cancer Risk	PLOS ONE			English	Article							INSULIN; FOOD; PREMENOPAUSAL; INFLAMMATION; PROTEIN; METAANALYSIS; NUTRITION; SU.VI.MAX; ESTROGEN; COHORT	Background: Mechanistic hypotheses suggest a potential effect of dietary fiber on breast carcinogenesis through the modulation of insulin-like growth factor bioactivity, estrogen metabolism and inflammation. An association between dietary fiber intake and breast cancer risk has been suggested in epidemiological studies but remains inconclusive. In particular, data is lacking regarding the different types of dietary fibers. Objective: The objective was to investigate the prospective relationship between dietary fiber intake and breast cancer risk, taking into account different types of dietary fiber (overall, insoluble, soluble and from different food sources: cereals, vegetables, fruits and legumes). Design: 4684 women from the SU.VI.MAX cohort were included in this analysis as they completed at least three 24h-dietary records within the first two years of follow-up. Among them, 167 incident invasive breast cancers were diagnosed during a median follow-up of 12.6 years (between 1994 and 2007). The associations between quartiles of dietary fiber intake and breast cancer risk were characterized using multivariate Cox proportional hazards models. Results: Total fiber intake was not associated with breast cancer risk (HRQuartile4vs.Quartile1 = 1.29 (95% CI 0.66-2.50), P-trend = 0.5), nor was fiber intake from cereals (P-trend = 0.1), fruits (P-trend = 0.9) and legumes (P-trend = 0.3). In contrast, vegetable fiber intake was related to a decreased risk of breast cancer (HRQ4vs.Q1 = 0.50 (0.29-0.88), P-trend = 0.03). Overall vegetable intake (in g/day) was not associated with breast cancer risk (P-trend = 0.2). Conclusion: This prospective study suggests that vegetable fiber intake may contribute to reduce breast cancer risk, in line with experimental mechanistic data.	[Deschasaux, Melanie; Zelek, Laurent; Pouchieu, Camille; His, Mathilde; Hercberg, Serge; Galan, Pilar; Latino-Martel, Paule; Touvier, Mathilde] Univ Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr, INSERM,INRA,Cnam,U557,U1125,SMPH Paris 13, Bobigny, France; [Zelek, Laurent] Avicenne Hosp, Dept Oncol, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Deschasaux, M (corresponding author), Univ Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr, INSERM,INRA,Cnam,U557,U1125,SMPH Paris 13, Bobigny, France.	m.deschasaux@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Touvier, Mathilde/E-8817-2017; Deschasaux, Mélanie/AAK-9116-2020; Laurent, Zelek/F-2906-2017; Latino-Martel, Paule/O-1549-2019; HERCBERG, Serge/B-4429-2008; Latino-Martel, Paule/W-1437-2017; Latino-Martel, Paule/F-2706-2017; Serge, Hercberg/F-3038-2017	Pilar, Galan/0000-0003-1706-3107; Touvier, Mathilde/0000-0002-8322-8857; Deschasaux, Mélanie/0000-0002-3359-420X; Laurent, Zelek/0000-0001-7455-2009; Latino-Martel, Paule/0000-0003-4581-852X; HERCBERG, Serge/0000-0002-3168-1350; Latino-Martel, Paule/0000-0003-4581-852X; Latino-Martel, Paule/0000-0003-4581-852X; Serge, Hercberg/0000-0002-3168-1350; His, Mathilde/0000-0003-3850-8291	Canceropole Ile-de-France; Paris region	Canceropole Ile-de-France(Region Ile-de-France); Paris region(Region Ile-de-France)	Melanie Deschasaux was supported by a grant from the "Canceropole Ile-de-France" (public funding from the Paris region). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; ANDERSON JW, 1994, AM J CLIN NUTR, V59, p1242S, DOI 10.1093/ajcn/59.5.1242S; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Aubertin-Leheudre M, 2008, J STEROID BIOCHEM, V112, P32, DOI 10.1016/j.jsbmb.2008.08.002; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Belle FN, 2011, CANCER EPIDEM BIOMAR, V20, P890, DOI 10.1158/1055-9965.EPI-10-1278; BOURQUIN LD, 1993, J NUTR, V123, P860, DOI 10.1093/jn/123.5.860; Cohen LA, 1996, J NATL CANCER I, V88, P899, DOI 10.1093/jnci/88.13.899; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Dahm CC, 2010, JNCI-J NATL CANCER I, V102, P614, DOI 10.1093/jnci/djq092; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dong JY, 2011, AM J CLIN NUTR, V94, P900, DOI 10.3945/ajcn.111.015578; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Ferrari P, 2013, AM J CLIN NUTR, V97, P344, DOI 10.3945/ajcn.112.034025; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; Gerber M, 1996, J NATL CANCER I, V88, P857, DOI 10.1093/jnci/88.13.857; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Gross A, 2013, CANC EPIDEMIOL BIOMA; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Hercberg S, 2005, TABLE COMPOSITION SU; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; James SL, 2003, INTERN MED J, V33, P291, DOI 10.1046/j.1445-5994.2003.00404.x; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kantor ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067833; Kerver JM, 2010, AM J CLIN NUTR, V91, P643, DOI 10.3945/ajcn.2009.28205; Key TJ, 2011, STEROIDS, V76, P812, DOI 10.1016/j.steroids.2011.02.029; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim J.-O., 1978, FACTOR ANAL STAT MET; King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502; Lairon D, 2003, P NUTR SOC, V62, P11, DOI 10.1079/PNS2002210; Longcope C, 2000, J CLIN ENDOCR METAB, V85, P293, DOI 10.1210/jc.85.1.293; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Moore MA, 1998, CRIT REV ONCOL HEMAT, V27, P229, DOI 10.1016/S1040-8428(98)00006-7; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Probst-Hensch NM, 2003, CANCER EPIDEM BIOMAR, V12, P739; PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Walker K, 2011, BRIT J CANCER, V105, P1451, DOI 10.1038/bjc.2011.358; WCRF/AIRC, 2010, SYST LIT REV CONT UP; Willett WC, 2001, J INTERN MED, V249, P395, DOI 10.1046/j.1365-2796.2001.00822.x; World Health Organization (WHO), 2010, ICD 10 INT CLASS DIS; Zhang CX, 2011, EUR J CLIN NUTR, V65, P929, DOI 10.1038/ejcn.2011.57	52	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79718	10.1371/journal.pone.0079718	http://dx.doi.org/10.1371/journal.pone.0079718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244548	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800097
J	Syamsunarno, MRAA; Iso, T; Hanaoka, H; Yamaguchi, A; Obokata, M; Koitabashi, N; Goto, K; Hishiki, T; Nagahata, Y; Matsui, H; Sano, M; Kobayashi, M; Kikuchi, O; Sasaki, T; Maeda, K; Murakami, M; Kitamura, T; Suematsu, M; Tsushima, Y; Endo, K; Hotamisligil, GS; Kurabayashi, M				Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Hanaoka, Hirofumi; Yamaguchi, Aiko; Obokata, Masaru; Koitabashi, Norimichi; Goto, Kosaku; Hishiki, Takako; Nagahata, Yoshiko; Matsui, Hiroki; Sano, Motoaki; Kobayashi, Masaki; Kikuchi, Osamu; Sasaki, Tsutomu; Maeda, Kazuhisa; Murakami, Masami; Kitamura, Tadahiro; Suematsu, Makoto; Tsushima, Yoshito; Endo, Keigo; Hotamisligil, Goekhan S.; Kurabayashi, Masahiko			A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting	PLOS ONE			English	Article							METABOLIC-RESPONSES; INSULIN-RESISTANCE; RAT-LIVER; MICE; RECEPTOR; OBESITY; OXIDATION; ALPHA; MOUSE	During prolonged fasting, fatty acid (FA) released from adipose tissue is a major energy source for peripheral tissues, including the heart, skeletal muscle and liver. We recently showed that FA binding protein 4 (FABP4) and FABP5, which are abundantly expressed in adipocytes and macrophages, are prominently expressed in capillary endothelial cells in the heart and skeletal muscle. In addition, mice deficient for both FABP4 and FABP5 (FABP4/5 DKO mice) exhibited defective uptake of FA with compensatory up-regulation of glucose consumption in these tissues during fasting. Here we showed that deletion of FABP4/5 resulted in a marked perturbation of metabolism in response to prolonged fasting, including hyperketotic hypoglycemia and hepatic steatosis. Blood glucose levels were reduced, whereas the levels of non-esterified FA (NEFA) and ketone bodies were markedly increased during fasting. In addition, the uptake of the I-125-BMIPP FA analogue in the DKO livers was markedly increased after fasting. Consistent with an increased influx of NEFA into the liver, DKO mice showed marked hepatic steatosis after a 48-hr fast. Although gluconeogenesis was observed shortly after fasting, the substrates for gluconeogenesis were reduced during prolonged fasting, resulting in insufficient gluconeogenesis and enhanced hypoglycemia. These metabolic responses to prolonged fasting in DKO mice were readily reversed by re-feeding. Taken together, these data strongly suggested that a maladaptive response to fasting in DKO mice occurred as a result of an increased influx of NEFA into the liver and pronounced hypoglycemia. Together with our previous study, the metabolic consequence found in the present study is likely to be attributed to an impairment of FA uptake in the heart and skeletal muscle. Thus, our data provided evidence that peripheral uptake of FA via capillary endothelial FABP4/5 is crucial for systemic metabolism and may establish FABP4/5 as potentially novel targets for the modulation of energy homeostasis.	[Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Obokata, Masaru; Koitabashi, Norimichi; Goto, Kosaku; Matsui, Hiroki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan; [Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 371, Japan; [Hanaoka, Hirofumi; Yamaguchi, Aiko] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 371, Japan; [Tsushima, Yoshito; Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan; [Murakami, Masami] Gunma Univ, Grad Sch Med, Dept Clin Lab Med, Maebashi, Gunma 371, Japan; [Matsui, Hiroki] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 371, Japan; [Kobayashi, Masaki; Kikuchi, Osamu; Sasaki, Tsutomu; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan; [Hishiki, Takako; Nagahata, Yoshiko; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Hishiki, Takako; Nagahata, Yoshiko; Suematsu, Makoto] Keio Univ, Sch Med, Suematsu Gas Biol Project, JST,ERATO,Shinjuku Ku, Tokyo, Japan; [Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Maeda, Kazuhisa; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis & Nutr, Broad Inst Harvard & MIT, Boston, MA 02115 USA	Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Keio University; Japan Science & Technology Agency (JST); Keio University; Keio University; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Iso, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan.	isot@gunma-u.ac.jp	Hanaoka, Hirofumi/T-6261-2019; Sano, Motoaki/L-3405-2013; Yamaguchi, Aiko/AAJ-1588-2021; Suematsu, Makoto/O-5762-2018; Suematsu, Makoto/I-8135-2013; Matsui, Hiroki/P-4033-2019; Koitabashi, Norimichi/AAM-8788-2020	Hanaoka, Hirofumi/0000-0003-2421-7397; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Matsui, Hiroki/0000-0003-3243-333X; Yamaguchi, Aiko/0000-0002-7631-3164; Iso, Tatsuya/0000-0001-5045-1676; Obokata, Masaru/0000-0002-5473-0688; Sasaki, Tsutomu/0000-0001-8041-1915	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Takeda Science Foundation; Therapeutic Research for Metabolic Syndrome; Astra Zeneca; Vehicle Racing Commemorative Foundation; Institute for Molecular and Cellular Regulation, Gunma University [13011]; Japan Science and Technology Agency; Exploratory Research for Advanced Technology; Suematsu Gas Biology Project; National Institutes of Health [DK064360]; Grants-in-Aid for Scientific Research [25504002] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK064360] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Therapeutic Research for Metabolic Syndrome; Astra Zeneca(AstraZeneca); Vehicle Racing Commemorative Foundation; Institute for Molecular and Cellular Regulation, Gunma University; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Exploratory Research for Advanced Technology; Suematsu Gas Biology Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MK and TI), a grant from the Japan Cardiovascular Foundation (to MK) and grants from Takeda Science Foundation, Therapeutic Research for Metabolic Syndrome, Astra Zeneca and the Vehicle Racing Commemorative Foundation (to TI). This study was carried out by the joint research program (#13011) of the Institute for Molecular and Cellular Regulation, Gunma University. MS is supported in part by the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Suematsu Gas Biology Project. GSH is supported in part by the National Institutes of Health (DK064360). The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Blaxter K, 1989, ENERGY METABOLISM AN; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Goto K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004861; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iso T, 2013, ARTERIOSCLER THROMB; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Marray R. K., 2009, HARPERS ILLUSTRATED; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Matsui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033283; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91; Salway JG, 2004, METABOLISM GLANCE; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011	34	20	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79386	10.1371/journal.pone.0079386	http://dx.doi.org/10.1371/journal.pone.0079386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244493	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800069
J	Kuribayashi, N; Uchida, D; Kinouchi, M; Takamaru, N; Tamatani, T; Nagai, H; Miyamoto, Y				Kuribayashi, Nobuyuki; Uchida, Daisuke; Kinouchi, Makoto; Takamaru, Natsumi; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji			The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; ENDOGENOUS ACTIVATION; PROGENITOR CELLS; CNS DISORDERS; EXPRESSION; CARCINOMA; CXCR4; PROLIFERATION; PROTEIN; ANTAGONISTS	We have demonstrated that blocking CXCR4 may be a potent anti-metastatic therapy for CXCR4-related oral cancer. However, as CXCR4 antagonists are currently in clinical use to induce the mobilization of hematopoietic stem cells, continuous administration as an inhibitor for the metastasis may lead to persistent leukocytosis. In this study, we investigated the novel therapeutic downstream target(s) of the SDF-1/CXCR4 system, using B88-SDF-1 cells, which have an autocrine SDF-1/CXCR4 system and exhibit distant metastatic potential in vivo. Microarray analysis revealed that 418 genes were upregulated in B88-SDF-1 cells. We identified a gene that is highly upregulated in B88-SDF-1 cells, metabotropic glutamate receptor 5 (mGluR5), which was downregulated following treatment with 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride (AMD3100), a CXCR4 antagonist. The upregulation of mGluR5 mRNA in the SDF-1/CXCR4 system was predominately regulated by the Ras-extracellular signal-regulated kinase (ERK)1/2 pathway. Additionally, the growth of B88-SDF-1 cells was not affected by the mGluR5 agonist (S)-3,5-DHPG (DHPG) or the mGluR5 antagonists 2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP). However, we observed that DHPG promoted B88-SDF-1 cell migration, whereas both MPEP and MTEP inhibited B88-SDF-1 cell migration. To assess drug toxicity, the antagonists were intraperitoneally injected into immunocompetent mice for 4 weeks. Mice injected with MPEP (5 mg/kg) and MTEP (5 mg/kg) did not exhibit any side effects, such as hematotoxicity, allergic reactions or weight loss. The administration of antagonists significantly inhibited the metastasis of B88-SDF-1 cells to the lungs of nude mice. These results suggest that blocking mGluR5 with antagonists such as MPEP and MTEP could prevent metastasis in CXCR4-related oral cancer without causing side effects.	[Kuribayashi, Nobuyuki; Uchida, Daisuke; Kinouchi, Makoto; Takamaru, Natsumi; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji] Univ Tokushima, Grad Sch, Inst Hlth Biosci,Subdiv Mol Oral Med, Div Integrated Sci Translat Res,Dept Oral Surg, Kuramoto, Tokushima, Japan	Tokushima University	Uchida, D (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci,Subdiv Mol Oral Med, Div Integrated Sci Translat Res,Dept Oral Surg, Kuramoto, Tokushima, Japan.	daisuke@tokushima-u.ac.jp			 [24792225]; Grants-in-Aid for Scientific Research [24792225] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Young Scientists (B; 24792225; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti A, 2004, INT J ONCOL, V25, P65; Bathe OF, 2011, CANCER EPIDEM BIOMAR, V20, P140, DOI 10.1158/1055-9965.EPI-10-0712; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Cappuccio I, 2005, NEUROPHARMACOLOGY, V49, P196, DOI 10.1016/j.neuropharm.2005.05.014; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Cleva RM, 2011, MOLECULES, V16, P2097, DOI 10.3390/molecules16032097; Corti C, 2003, J BIOL CHEM, V278, P33105, DOI 10.1074/jbc.M212380200; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; Genzyme, 2009, PLER INJ INV BROCH V; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Kuzmiski JB, 2010, J NEUROENDOCRINOL, V22, P785, DOI 10.1111/j.1365-2826.2010.02020.x; Lea PM, 2006, CNS DRUG REV, V12, P149, DOI 10.1111/j.1527-3458.2006.00149.x; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Luo YQ, 2005, J NEUROCHEM, V93, P452, DOI 10.1111/j.1471-4159.2005.03049.x; Luyt K, 2004, BIOCHEM BIOPH RES CO, V319, P120, DOI 10.1016/j.bbrc.2004.04.158; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Onoue T, 2006, INT J ONCOL, V29, P1133; Park SY, 2007, ONCOL REP, V17, P81; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Pilla M, 2010, BIOORG MED CHEM LETT, V20, P7521, DOI 10.1016/j.bmcl.2010.09.120; Pissimissis N, 2009, ANTICANCER RES, V29, P371; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Scotton CJ, 2002, CANCER RES, V62, P5930; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Spooren W, 2003, BEHAV PHARMACOL, V14, P257, DOI 10.1097/01.fbp.0000081783.35927.8f; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Uchida D, 2007, MOL CANCER RES, V5, P1, DOI DOI 10.1158/1541-7786.MCR-06-0208.PUBMED:17259342; Uchida D, 2013, CLIN EXP METASTAS, V30, P133, DOI 10.1007/s10585-012-9518-9; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; Vahle AK, 2012, CANCER LETT, V317, P199, DOI 10.1016/j.canlet.2011.11.027; Vanhoutte N, 2008, FEBS LETT, V582, P1847, DOI 10.1016/j.febslet.2008.04.053; Wisniewski K, 2012, DRUG RES, V8, P101; Ye ZC, 1999, CANCER RES, V59, P4383; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhao L, 2011, NEUROSCIENCE, V192, P185, DOI 10.1016/j.neuroscience.2011.06.044; Zijlstra A, 2002, CANCER RES, V62, P7083	46	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80773	10.1371/journal.pone.0080773	http://dx.doi.org/10.1371/journal.pone.0080773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236200	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700203
J	Lundmark, K; Shariatpanahi, AV; Westermark, GT				Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat; Westermark, Gunilla T.			Depletion of Spleen Macrophages Delays AA Amyloid Development: A Study Performed in the Rapid Mouse Model of AA Amyloidosis	PLOS ONE			English	Article							FIBRIL PROTEIN; MARGINAL ZONE; DEPOSITION; LIPOSOMES; PHASE; CELLS; SAA; AMYLOIDOGENESIS; MEMBRANE; MONOCYTE	AA amyloidosis is a systemic disease that develops secondary to chronic inflammatory diseases Macrophages are often found in the vicinity of amyloid deposits and considered to play a role in both formation and degradation of amyloid fibrils. In spleen reside at least three types of macrophages, red pulp macrophages (RPM), marginal zone macrophages (MZM), metallophilic marginal zone macrophages (MMZM). MMZM and MZM are located in the marginal zone and express a unique collection of scavenger receptors that are involved in the uptake of blood-born particles. The murine AA amyloid model that resembles the human form of the disease has been used to study amyloid effects on different macrophage populations. Amyloid was induced by intravenous injection of amyloid enhancing factor and subcutaneous injections of silver nitrate and macrophages were identified with specific antibodies. We show that MZMs are highly sensitive to amyloid and decrease in number progressively with increasing amyloid load. Total area of MMZMs is unaffected by amyloid but cells are activated and migrate into the white pulp. In a group of mice spleen macrophages were depleted by an intravenous injection of clodronate filled liposomes. Subsequent injections of AEF and silver nitrate showed a sustained amyloid development. RPMs that constitute the majority of macrophages in spleen, appear insensitive to amyloid and do not participate in amyloid formation.	[Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat] Linkoping Univ, Fac Hlth Sci, Div Expt Pathol, Dept Clin & Expt Med, Linkoping, Sweden; [Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat] Cty Council Ostergotland, Pathol Clin, Linkoping, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Linkoping University; City Council Ostergotland; Uppsala University	Westermark, GT (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Gunilla.westermark@mcb.uu.se			Swedish Research Council [GTW5343]; County Council of Ostergotland Magnus Bergvalls research foundation; Ingrid Svenssons research foundation; Broderna Karlssons research foundation; Hildur Pettersons research foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Ostergotland Magnus Bergvalls research foundation; Ingrid Svenssons research foundation; Broderna Karlssons research foundation; Hildur Pettersons research foundation	Funding provided by Swedish Research Council (GTW5343), County Council of Ostergotland Magnus Bergvalls research foundation, Ingrid Svenssons research foundation, Broderna Karlssons research foundation and Hildur Pettersons research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Buiting AMJ, 1996, J IMMUNOL METHODS, V192, P55, DOI 10.1016/0022-1759(96)00034-8; CHRONOPOULOS S, 1994, J PATHOL, V173, P361, DOI 10.1002/path.1711730412; EIN D, 1972, J BIOL CHEM, V247, P5653; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Giurleo JT, 2008, J MOL BIOL, V381, P1332, DOI 10.1016/j.jmb.2008.06.043; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kisilevsky Robert, 2004, V299, P237; Kluve-Beckerman B, 2002, ARTHRITIS RHEUM-US, V46, P1905, DOI 10.1002/art.10335; KRAAL G, 1986, IMMUNOLOGY, V58, P665; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Magy N, 2007, AMYLOID, V14, P51, DOI 10.1080/13506120601116575; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; Mambule C, 2000, BBA-GEN SUBJECTS, V1474, P331, DOI 10.1016/S0304-4165(00)00032-5; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; NIEWOLD TA, 1993, SCAND J IMMUNOL, V37, P29, DOI 10.1111/j.1365-3083.1993.tb01660.x; Nystrom SN, 2012, AMYLOID, V19, P138, DOI 10.3109/13506129.2012.711391; Olsen KE, 1999, AMYLOID, V6, P89, DOI 10.3109/13506129909007308; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rogers Maurice, 2011, Scottish Forestry, V65, P34; SHIRAHAMA T, 1971, AM J PATHOL, V63, P463; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sorby R, 2008, AMYLOID, V15, P20, DOI 10.1080/13506120701815332; Sponarova J, 2013, AM J PATHOL, V182, P1297, DOI 10.1016/j.ajpath.2012.12.035; STEEL DM, 1993, BIOCHEM J, V291, P701, DOI 10.1042/bj2910701; Steiniger B., 2000, ADV ANAT EMBRYOL, DOI [10.1007/978-3-642-57088-9, DOI 10.1007/978-3-642-57088-9]; TAKAHASHI M, 1989, VIRCHOWS ARCH A, V415, P411, DOI 10.1007/BF00747742; VANROOIJEN N, 1992, RES IMMUNOL, V143, P177; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WESTERMARK GT, 1987, LAB INVEST, V57, P57; Westermark P, 2012, UPSALA J MED SCI, V117, P244, DOI 10.3109/03009734.2012.654861	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79104	10.1371/journal.pone.0079104	http://dx.doi.org/10.1371/journal.pone.0079104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236094	gold, Green Published, Green Submitted			2022-12-25	WOS:000327254700092
J	Nord, KH; Nilsson, J; Arbajian, E; von Steyern, FV; Brosjo, O; Cleton-Jansen, AM; Szuhai, K; Hogendoorn, PCW				Nord, Karolin H.; Nilsson, Jenny; Arbajian, Elsa; von Steyern, Fredrik Vult; Brosjo, Otte; Cleton-Jansen, Anne-Marie; Szuhai, Karoly; Hogendoorn, Pancras C. W.			Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway	PLOS ONE			English	Article							MENINGIOMA 1; SUPPRESSOR; BONE; DIFFERENTIATION; MEMBRANE; GROWTH; GENE	Osteoblastoma is a bone forming tumor with histological features highly similar to osteoid osteoma; the discrimination between the tumor types is based on size and growth pattern. The vast majority of osteoblastomas are benign but there is a group of so-called aggressive osteoblastomas that can be diagnostically challenging at the histopathological level. The genetic aberrations required for osteoblastoma development are not known and no genetic difference between conventional and aggressive osteoblastoma has been reported. In order to identify recurrent genomic aberrations of importance for tumor development we applied cytogenetic and/or SNP array analyses on nine conventional and two aggressive osteoblastomas. The conventional osteoblastomas showed few or no acquired genetic aberrations while the aggressive tumors displayed heavily rearranged genomes. In one of the aggressive osteoblastomas, three neighboring regions in chromosome band 22q12 were homozygously deleted. Hemizygous deletions of these regions were found in two additional cases, one aggressive and one conventional. In total, 10 genes were recurrently and homozygously lost in osteoblastoma. Four of them are functionally involved in regulating osteogenesis and/or tumorigenesis. MN1 and NF2 have previously been implicated in the development of leukemia and solid tumors, and ZNRF3 and KREMEN1 are inhibitors of the Wnt/beta-catenin signaling pathway. In line with deletions of the latter two genes, high beta-catenin protein expression has previously been reported in osteoblastoma and aberrations affecting the Wnt/beta-catenin pathway have been found in other bone lesions, including osteoma and osteosarcoma.	[Nord, Karolin H.; Nilsson, Jenny; Arbajian, Elsa] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [von Steyern, Fredrik Vult] Skane Univ Hosp, Dept Orthoped, Lund, Sweden; [Brosjo, Otte] Karolinska Hosp, Dept Orthoped, S-10401 Stockholm, Sweden; [Cleton-Jansen, Anne-Marie; Hogendoorn, Pancras C. W.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nord, KH (corresponding author), Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden.	Karolin.Hansen_Nord@med.lu.se	Arbajian, Elsa/AAW-9123-2021; Hogendoorn, Pancras C.W./H-5859-2015; Hogendoorn, Pancras/O-6494-2019; Szuhai, Karoly/A-1100-2008	Arbajian, Elsa/0000-0002-1484-0073; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Hogendoorn, Pancras/0000-0002-1513-8104; Szuhai, Karoly/0000-0002-1228-4245; Hansen Nord, Karolin/0000-0002-2397-2254	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Cancer Society	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Magnus Bergvall Foundation, the Royal Physiographic Society (Lund, Sweden) and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffi MR, 2001, CANCER GENET CYTOGEN, V124, P127, DOI 10.1016/S0165-4608(00)00327-7; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; Davidson TB, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-19; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Fletcher C, 2013, IARC WHO CLASSIFICAT, V5; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hogendoorn PCW, 2013, WHO CLASSIFICATION T, V4th, P277; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MERTENS F, 1993, INT J CANCER, V55, P44, DOI 10.1002/ijc.2910550109; Mertens F., 2013, WHO CLASSIFICATION T, P282; Mitelman F, 2013, MITELMAN DATABASE CH; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nord KH, 2010, P NATL ACAD SCI USA, V107, P21122, DOI 10.1073/pnas.1013512107; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Radig K, 1998, PATHOL RES PRACT, V194, P669, DOI 10.1016/S0344-0338(98)80125-8; Schiller A., 2013, WHO CLASSIFICATION T, P279, DOI [10.1097/PAT.0000000000000050, DOI 10.1097/PAT.0000000000000050]; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Zhang XX, 2009, J BIOL CHEM, V284, P18174, DOI 10.1074/jbc.M109.001354; Zhang Y, 2012, BONE, V50, pS146, DOI 10.1016/j.bone.2012.02.453; Zhou L, 2012, FEBS LETT, V586, P1403, DOI 10.1016/j.febslet.2012.03.016	30	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80725	10.1371/journal.pone.0080725	http://dx.doi.org/10.1371/journal.pone.0080725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236197	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700200
J	Onasoga-Jarvis, AA; Leiderman, K; Fogelson, AL; Wang, M; Manco-Johnson, MJ; Di Paola, JA; Neeves, KB				Onasoga-Jarvis, Abimbola A.; Leiderman, Karin; Fogelson, Aaron L.; Wang, Michael; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.; Neeves, Keith B.			The Effect of Factor VIII Deficiencies and Replacement and Bypass Therapies on Thrombus Formation under Venous Flow Conditions in Microfluidic and Computational Models	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIIA; TISSUE FACTOR; BLOOD-COAGULATION; HEMOPHILIA-A; SHEAR RATES; ACTIVATION; DEPOSITION; PLATELETS; MOUSE; CLOTS	Clinical evidence suggests that individuals with factor VIII (FVIII) deficiency (hemophilia A) are protected against venous thrombosis, but treatment with recombinant proteins can increase their risk for thrombosis. In this study we examined the dynamics of thrombus formation in individuals with hemophilia A and their response to replacement and bypass therapies under venous flow conditions. Fibrin and platelet accumulation were measured in microfluidic flow assays on a TF-rich surface at a shear rate of 100 s(-1). Thrombin generation was calculated with a computational spatial-temporal model of thrombus formation. Mild FVIII deficiencies (5-30% normal levels) could support fibrin fiber formation, while severe (<1%) and moderate (1-5%) deficiencies could not. Based on these experimental observations, computational calculations estimate an average thrombin concentration of similar to 10 nM is necessary to support fibrin formation under flow. There was no difference in fibrin formation between severe and moderate deficiencies, but platelet aggregate size was significantly larger for moderate deficiencies. Computational calculations estimate that the local thrombin concentration in moderate deficiencies is high enough to induce platelet activation (>1 nM), but too low to support fibrin formation (, 10 nM). In the absence of platelets, fibrin formation was not supported even at normal FVIII levels, suggesting platelet adhesion is necessary for fibrin formation. Individuals treated by replacement therapy, recombinant FVIII, showed normalized fibrin formation. Individuals treated with bypass therapy, recombinant FVIIa, had a reduced lag time in fibrin formation, as well as elevated fibrin accumulation compared to healthy controls. Treatment of rFVIIa, but not rFVIII, resulted in significant changes in fibrin dynamics that could lead to a prothrombotic state.	[Onasoga-Jarvis, Abimbola A.; Neeves, Keith B.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA; [Leiderman, Karin] Univ Calif Merced, Sch Nat Sci, Appl Math Unit, Merced, CA USA; [Fogelson, Aaron L.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Fogelson, Aaron L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Wang, Michael; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.; Neeves, Keith B.] Univ Colorado Denver, Hemophilia & Thrombosis Ctr, Dept Pediat, Aurora, CO USA	Colorado School of Mines; University of California System; University of California Merced; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Neeves, KB (corresponding author), Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA.	kneeves@mines.edu	Neeves, Keith/J-9494-2019	Neeves, Keith/0000-0001-7546-4588	American Heart Association; National Heart, Lung, and Blood Institute [HL100333]; Postle Family Chair; Colorado Office of Economic Development and International Trade; Bayer Hemophilia Awards Program; Boettcher Foundation's Webb-Waring Biomedical Research Award; Direct For Mathematical & Physical Scien [1148230] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100333] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postle Family Chair; Colorado Office of Economic Development and International Trade; Bayer Hemophilia Awards Program; Boettcher Foundation's Webb-Waring Biomedical Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Scientist Development Grant (to KBN) from the American Heart Association, the National Heart, Lung, and Blood Institute (HL100333), the Postle Family Chair (to JDP), the Colorado Office of Economic Development and International Trade, the Bayer Hemophilia Awards Program and the Boettcher Foundation's Webb-Waring Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1993, CVGIP-GRAPH MODEL IM, V55, P325, DOI 10.1006/cgip.1993.1024; Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Duchemin J, 2008, THROMB HAEMOSTASIS, V99, P767, DOI 10.1160/TH07-09-0581; Flamm MH, 2012, BLOOD, V120, P190, DOI 10.1182/blood-2011-10-388140; FRESSINAUD E, 1992, BLOOD, V80, P988; GEMMELL CH, 1988, BLOOD, V72, P1404; Girolami A, 2006, J THROMB THROMBOLYS, V21, P279, DOI 10.1007/s11239-006-6556-7; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; JONES PK, 1991, ANN INTERN MED, V114, P641, DOI 10.7326/0003-4819-114-8-641; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; Lisman T, 2005, J THROMB HAEMOST, V3, P742, DOI 10.1111/j.1538-7836.2005.01227.x; Mann KG, 2012, J THROMB HAEMOST, V10, P1463, DOI 10.1111/j.1538-7836.2012.04799.x; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; Neeves KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054680; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; Ogawa S, 2012, HAEMOPHILIA, V18, P926, DOI 10.1111/j.1365-2516.2012.02867.x; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Reininger AJ, 2010, J AM COLL CARDIOL, V55, P1147, DOI 10.1016/j.jacc.2009.11.051; Smith S, 2004, J THROMB HAEMOST; Sugita C, 2009, THROMB RES, V124, P601, DOI 10.1016/j.thromres.2009.06.035; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; WEISS HJ, 1984, BLOOD, V63, P1004, DOI 10.1182/blood.V63.5.1004.1004; Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331	29	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78732	10.1371/journal.pone.0078732	http://dx.doi.org/10.1371/journal.pone.0078732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236042	Green Published, gold, Green Submitted			2022-12-25	WOS:000327254700039
J	Wilcox, CL; Terry, NA; May, CL				Wilcox, Crystal L.; Terry, Natalie A.; May, Catherine Lee			Arx Polyalanine Expansion in Mice Leads to Reduced Pancreatic alpha-Cell Specification and Increased alpha-Cell Death	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INFANTILE SPASMS; ABNORMAL GENITALIA; HOMEOBOX GENE; MUTATIONS; DISORDERS; EPILEPSY	ARX/Arx is a homeodomain-containing transcription factor necessary for the specification and early maintenance of pancreatic endocrine alpha-cells. Many transcription factors important to pancreas development, including ARX/Arx, are also crucial for proper brain development. Although null mutations of ARX in human patients result in the severe neurologic syndrome XLAG (X-linked lissencephaly associated with abnormal genitalia), the most common mutation is the expansion of the first polyalanine tract of ARX, which results primarily in the clinical syndrome ISSX (infantile spasms). Mouse models of XLAG, ISSX and other human ARX mutations demonstrate a direct genotype-phenotype correlation in ARX-related neurologic disorders. Furthermore, mouse models utilizing a polyalanine tract expansion mutation have illustrated critical developmental differences between null mutations and expansion mutations in the brain, revealing context-specific defects. Although Arx is known to be required for the specification and early maintenance of pancreatic glucagon-producing alpha-cells, the consequences of the Arx polyalanine expansion on pancreas development remain unknown. Here we report that mice with an expansion mutation in the first polyalanine tract of Arx exhibit impaired alpha-cell specification and maintenance, with gradual alpha-cell loss due to apoptosis. This is in contrast to the re-specification of alpha-cells into beta- and delta-cells that occurs in mice null for Arx. Overall, our analysis of an Arx polyalanine expansion mutation on pancreatic development suggests that impaired alpha-cell function might also occur in ISSX patients.	[Wilcox, Crystal L.; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Terry, Natalie A.] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	May, CL (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu			Center for Molecular Studies in Digestive and Liver Disease [P30-DK050306]; Penn Institute for Diabetes, Obesity, and Metabolism (DERC) [P30-DK19525]; NIH/NIDDK [T32-DK007066, NIH-5K12HD043245]; CHOP Foerderer Award;  [NIHDK078606];  [NIH-DK019525];  [JDRF2-2007-730]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066, P30DK019525, R56DK078606, P30DK050306, R01DK078606] Funding Source: NIH RePORTER	Center for Molecular Studies in Digestive and Liver Disease; Penn Institute for Diabetes, Obesity, and Metabolism (DERC); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CHOP Foerderer Award; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of these studies were supported by the Center for Molecular Studies in Digestive and Liver Disease (P30-DK050306) and Penn Institute for Diabetes, Obesity, and Metabolism (DERC: P30-DK19525). CLM is supported by NIHDK078606, NIH-DK019525 and JDRF2-2007-730. NAT is supported by NIH/NIDDK T32-DK007066 and NIH-5K12HD043245. These studies were also supported by the CHOP Foerderer Award. www2.niddk.nih.gov/. http://jdrf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Depienne C, 2012, GENES INFANTILE EPIL; Friocourt G, 2006, EUR J NEUROSCI, V23, P869, DOI 10.1111/j.1460-9568.2006.04629.x; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Nasrallah MP, 2011, HUM MOL GENET; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Uyanik G, 2003, NEUROLOGY, V61, P232, DOI 10.1212/01.WNL.0000079371.19562.BA; Wilcox CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066214	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78741	10.1371/journal.pone.0078741	http://dx.doi.org/10.1371/journal.pone.0078741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236044	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700041
J	Wongkajornsilp, A; Wamanuttajinda, V; Kasetsinsombat, K; Duangsa-ard, S; Sa-ngiamsuntorn, K; Hongeng, S; Maneechotesuwan, K				Wongkajornsilp, Adisak; Wamanuttajinda, Valla; Kasetsinsombat, Kanda; Duangsa-ard, Sunisa; Sa-ngiamsuntorn, Khanit; Hongeng, Suradej; Maneechotesuwan, Kittipong			Sunitinib Indirectly Enhanced Anti-Tumor Cytotoxicity of Cytokine-Induced Killer Cells and CD3(+) CD56(+) Subset through the Co-Culturing Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; TYROSINE KINASE INHIBITOR; CARCINOMA PATIENTS; CANCER-PATIENTS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE SUPPRESSION; LUNG-CANCER; SORAFENIB; PROLIFERATION; POPULATION	Cytokine-induced killer (CIK) cells have reached clinical trials for leukemia and solid tumors. Their anti-tumor cytotoxicity had earlier been shown to be intensified after the co-culture with dendritic cells (DCs). We observed markedly enhanced antitumor cytotoxicity activity of CIK cells after the co-culture with sunitinib-pretreated DCs over that of untreated DCs. This cytotoxicity was reliant upon DC modulation by sunitinib because the direct exposure of CIK cells to sunitinib had no significant effect. Sunitinib promoted Th1-inducing and pro-inflammatory phenotypes (IL-12, IFN-gamma and IL-6) in DCs at the expense of Th2 inducing phenotype (IL-13) and regulatory phenotype (PD-L1, IDO). Sunitinib-treated DCs subsequently induced the upregulation of Th1 phenotypic markers (IFN-gamma and T-bet) and the downregulation of the Th2 signature (GATA-3) and the Th17 marker (RORC) on the CD3(+) CD56(+) subset of CIK cells. It concluded that sunitinib-pretreated DCs drove the CD3(+) CD56(+) subset toward Th1 phenotype with increased anti-tumor cytotoxicity.	[Wongkajornsilp, Adisak; Wamanuttajinda, Valla; Kasetsinsombat, Kanda; Duangsa-ard, Sunisa; Sa-ngiamsuntorn, Khanit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pharmacol, Bangkok 10700, Thailand; [Maneechotesuwan, Kittipong] Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; [Sa-ngiamsuntorn, Khanit] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Maneechotesuwan, K (corresponding author), Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.	kittipong.man@mahidol.ac.th	Wongkajornsilp, Adisak/AAH-7668-2019	Wongkajornsilp, Adisak/0000-0002-3965-0997; Sa-ngiamsuntorn, Khanit/0000-0001-7010-345X	Thailand Research Fund; Mahidol University; Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by research grants from Thailand Research Fund and Mahidol University (to AW). AW and KM are recipients of Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, J IMMUNOTHER, V33, P991, DOI 10.1097/CJI.0b013e3181f4c208; Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Barbi J, 2013, IMMUNOL REV, V252, P52, DOI 10.1111/imr.12029; Bose A, 2011, INT J CANCER, V129, P2158, DOI 10.1002/ijc.25863; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Erhardt M, 2006, ARCH IMMUNOL THER EX, V54, P403, DOI 10.1007/s00005-006-0048-5; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Friberg M, 2002, INT J CANCER, V101, P151, DOI 10.1002/ijc.10645; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019; Heine A, 2011, LEUKEMIA, V25, P899, DOI 10.1038/leu.2011.24; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Kao J, 2011, CRIT REV ONCOL HEMAT, V77, P13, DOI 10.1016/j.critrevonc.2010.02.004; Ko JS, 2010, CANCER RES, V70, P3526, DOI 10.1158/0008-5472.CAN-09-3278; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kobayashi M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0556-1; Krusch M, 2009, J IMMUNOL, V183, P8286, DOI 10.4049/jimmunol.0902404; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Li H, 2007, J CLIN IMMUNOL, V27, P317, DOI 10.1007/s10875-007-9076-0; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; LU PH, 1994, J IMMUNOL, V153, P1687; Marten A, 2001, J IMMUNOTHER, V24, P502, DOI 10.1097/00002371-200111000-00007; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nishioka Y, 2011, IMMUNOTHERAPY-UK, V3, P107, DOI [10.2217/imt.10.79, 10.2217/IMT.10.79]; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Schmidt J, 2004, CANCER IMMUNOL IMMUN, V53, P1018, DOI 10.1007/s00262-004-0554-4; SchmidtWolf GD, 1997, ANN HEMATOL, V74, P51, DOI 10.1007/s002770050257; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; van Cruijsen H, 2008, CLIN CANCER RES, V14, P5884, DOI 10.1158/1078-0432.CCR-08-0656; Wongkajornsilp A, 2005, J ORTHOP RES, V23, P1460, DOI 10.1016/j.orthres.2005.03.009; Wongkajornsilp A, 2009, CANCER INVEST, V27, P140, DOI 10.1080/07357900802189832; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	38	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78980	10.1371/journal.pone.0078980	http://dx.doi.org/10.1371/journal.pone.0078980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232460	Green Published, Green Submitted, gold			2022-12-25	WOS:000327254700076
J	Connelly, WM; Errington, AC; Crunelli, V				Connelly, William M.; Errington, Adam C.; Crunelli, Vincenzo			gamma-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABA(A) Receptors	PLOS ONE			English	Article							MOUSE DENTATE GYRUS; RAT-BRAIN; BINDING-SITES; SUBUNIT ISOFORMS; TONIC INHIBITION; PROTEIN-KINASE; HIGH-AFFINITY; A RECEPTOR; NEURONS; ACTIVATION	gamma-Hydroxybutyric acid (GHB) is an endogenous compound and a drug used clinically to treat the symptoms of narcolepsy. GHB is known to be an agonist of GABA(B) receptors with millimolar affinity, but also binds with much higher affinity to another site, known as the GHB receptor. While a body of evidence has shown that GHB does not bind to GABA(A) receptors widely, recent evidence has suggested that the GHB receptor is in fact on extrasynaptic alpha 4 beta 1 delta GABA(A) receptors, where GHB acts as an agonist with an EC50 of 140 nM. We investigated three neuronal cell types that express a tonic GABA(A) receptor current mediated by extrasynaptic receptors: ventrobasal (VB) thalamic neurons, dentate gyrus granule cells and striatal medium spiny neurons. Using whole-cell voltage clamp in brain slices, we found no evidence that GHB (10 mu M) induced any GABAA receptor mediated current in these cell types, nor that it modulated inhibitory synaptic currents. Furthermore, a high concentration of GHB (3 mM) was able to produce a GABA(B) receptor mediated current, but did not induce any other currents. These results suggest either that GHB is not a high affinity agonist at native alpha 4 beta 1 delta receptors, or that these receptors do not exist in classical areas associated with extrasynaptic currents.	[Connelly, William M.; Errington, Adam C.; Crunelli, Vincenzo] Cardiff Univ, Div Neurosci, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Connelly, WM (corresponding author), Cardiff Univ, Div Neurosci, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	connellywm@cardiff.ac.uk; crunelli@cardiff.ac.uk	; Errington, Adam/D-1678-2011	Connelly, William/0000-0002-0986-6260; Errington, Adam/0000-0002-2171-389X; Crunelli, Vincenzo/0000-0001-7154-9752	Wellcome Trust [91882]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant 91882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalom N, 2012, P NATL ACAD SCI USA, V109, P13404, DOI 10.1073/pnas.1204376109; Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Brancucci A, 2004, NEUROPSYCHOPHARMACOL, V29, P537, DOI 10.1038/sj.npp.1300344; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Carai MAM, 2008, J PHARMACOL SCI, V106, P199, DOI 10.1254/jphs.FP0071487; Carter LP, 2005, DRUG ALCOHOL DEPEN, V78, P91, DOI 10.1016/j.drugalcdep.2004.10.002; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Connelly WM, 2013, J NEUROSCI, V33, P3780, DOI 10.1523/JNEUROSCI.4989-12.2013; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; DOHERTY JD, 1978, J PHARMACOL EXP THER, V207, P130; Emri Z, 1996, NEUROSCI LETT, V216, P121; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Felmlee MA, 2010, J PHARMACOL EXP THER, V333, P764, DOI 10.1124/jpet.109.165381; Gervasi N, 2003, J NEUROSCI, V23, P11469; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Jacobson LH, 2006, J PHARMACOL EXP THER, V319, P1317, DOI 10.1124/jpet.106.111971; Jensen K, 2001, CEREB CORTEX, V11, P424, DOI 10.1093/cercor/11.5.424; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Li Q, 2007, NEUROSCIENCE, V150, P82, DOI 10.1016/j.neuroscience.2007.08.023; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mehta AK, 2001, J PHARMACOL EXP THER, V299, P1148; Molnar T, 2009, NEUROSCIENCE, V162, P268, DOI 10.1016/j.neuroscience.2009.05.017; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHMIDT C, 1991, EUR J PHARMACOL, V203, P393, DOI 10.1016/0014-2999(91)90896-X; Schweitzer P, 2004, J PHARMACOL EXP THER, V311, P172, DOI 10.1124/jpet.104.069534; SERRA M, 1991, PSYCHOPHARMACOLOGY, V104, P351, DOI 10.1007/BF02246035; SNEAD OC, 1976, NEUROLOGY, V26, P51, DOI 10.1212/WNL.26.1.51; SNEAD OC, 1992, NEUROCHEM RES, V17, P201; SNEAD OC, 1987, NEUROPHARMACOLOGY, V26, P1519, DOI 10.1016/0028-3908(87)90173-0; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wellendorph P, 2005, J PHARMACOL EXP THER, V315, P346, DOI 10.1124/jpet.105.090472; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001	45	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79062	10.1371/journal.pone.0079062	http://dx.doi.org/10.1371/journal.pone.0079062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244421	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000327221600106
J	Freilich, RW; Woodbury, ME; Ikezu, T				Freilich, Robert W.; Woodbury, Maya E.; Ikezu, Tsuneya			Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INHIBIT INFLAMMATORY RESPONSES; NITRIC-OXIDE PRODUCTION; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; MYELOID CELLS	Neuroinflammation contributes to many neurologic disorders including Alzheimer's disease, multiple sclerosis, and stroke. Microglia is brain resident myeloid cells and have emerged as a key driver of the neuroinflammatory responses. MicroRNAs (miRNAs) provide a novel layer of gene regulation and play a critical role in regulating the inflammatory response of peripheral macrophages. However, little is known about the miRNA in inflammatory activation of microglia. To elucidate the role that miRNAs have on microglial phenotypes under classical (M1) or alternative (M2) activation under lipopolysaccharide ('M1'-skewing) and interleukin-4 ('M2a'-skewing) stimulation conditions, we performed microarray expression profiling and bioinformatics analysis of both mRNA and miRNA using primary cultured murine microglia. miR-689, miR-124, and miR-155 were the most strongly associated miRNAs predicted to mediate pro-inflammatory pathways and M1-like activation phenotype. miR-155, the most strongly up-regulated miRNA, regulates the signal transducer and activator of transcription 3 signaling pathway enabling the late phase response to M1-skewing stimulation. Reduced expression in miR-689 and miR-124 are associated with dis-inhibition of many canonical inflammatory pathways. miR-124, miR-711, miR-145 are the strongly associated miRNAs predicted to mediate anti-inflammatory pathways and M2-like activation phenotype. Reductions in miR-711 and miR-124 may regulate inflammatory signaling pathways and peroxisome proliferator-activated receptor-gamma pathway. miR-145 potentially regulate peripheral monocyte/macrophage differentiation and faciliate the M2-skewing phenotype. Overall, through combined miRNA and mRNA expression profiling and bioinformatics analysis we have identified six miRNAs and their putative roles in M1 and M2-skewing of microglial activation through different signaling pathways.	[Freilich, Robert W.; Woodbury, Maya E.; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Lab Mol NeuroTherapeut, Boston, MA 02118 USA; [Woodbury, Maya E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Lab Mol NeuroTherapeut, Boston, MA 02118 USA.	tikezu@bu.edu		Ikezu, Tsuneya/0000-0002-3979-8596	National Institutes of Health (NIH) [5T32GM008541]; PhRMA Foundation Paul Calabresi Medical Student Research Fellowship; Faculty Recruit Fund; NIH [UL1 TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation Paul Calabresi Medical Student Research Fellowship; Faculty Recruit Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is partly funded by National Institutes of Health (NIH) 5T32GM008541 (RWF, MEW), PhRMA Foundation Paul Calabresi Medical Student Research Fellowship (RWF), Faculty Recruit Fund (TI), and NIH UL1 TR000157 (BU-CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Cormier SA, 2002, AM J RESP CELL MOL, V27, P678, DOI 10.1165/rcmb.4882; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Dushkin MI, 2007, B EXP BIOL MED+, V144, P713, DOI 10.1007/s10517-007-0413-3; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; Fenn AM, 2011, BRAIN BEHAV IMMUN; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Freilich RW, 2011, J NEUROIMMUNE PHARM, V6, P41, DOI 10.1007/s11481-010-9250-7; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Jang YS, 2009, CYTOKINE, V47, P43, DOI 10.1016/j.cyto.2009.04.005; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Leah Emma, 2011, Nat Rev Rheumatol, V7, P437, DOI 10.1038/nrrheum.2011.101; Leonard BE, 2009, HUM PSYCHOPHARM CLIN, V24, P165, DOI 10.1002/hup.1011; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MATSUI M, 1990, ANN NEUROL, V27, P647, DOI 10.1002/ana.410270611; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Paludan SR, 1999, SCAND J IMMUNOL, V49, P169; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Saijo K, 2012, GLIA; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Schaier M, 2004, J MOL MED, V82, P116, DOI 10.1007/s00109-003-0510-3; Schnegg CI, 2011, PPAR RES, V2011, DOI 10.1155/2011/373560; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shahab SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022508; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Vaksman O, 2011, J CELL MOL MED, V15, P1593, DOI 10.1111/j.1582-4934.2010.01148.x; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yin R, 2011, ONCOL REP, V25, P1747, DOI 10.3892/or.2011.1252; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Zhang-Gandhi CX, 2007, J NEUROIMMUNOL, V183, P50, DOI 10.1016/j.jneuroim.2006.11.007	84	106	112	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79416	10.1371/journal.pone.0079416	http://dx.doi.org/10.1371/journal.pone.0079416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244499	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600128
J	Liu, X; Wang, YN; Wang, C; Shi, CG; Cheng, CL; Chen, JX; Ma, HJ; Lv, LS; Li, L; Lou, TQ				Liu, Xun; Wang, Yanni; Wang, Cheng; Shi, Chenggang; Cheng, Cailian; Chen, Jinxia; Ma, Huijuan; Lv, Linsheng; Li, Lin; Lou, Tanqi			A New Equation to Estimate Glomerular Filtration Rate in Chinese Elderly Population	PLOS ONE			English	Article							SERUM CREATININE; GFR	Background: We sought to develop a new equation to estimate glomerular filtration rate (GFR) in Chinese elderly population. Methods: A total of 668 Chinese elderly participants, including the development cohort (n = 433), the validation cohort (n = 235) were enrolled. The new equation using the generalized additive model, and age, gender, serum creatinine as predictor variables was developed and the performances was compared with the CKD-EPI equation. Results: In the validation data set, both bias and precision were improved with the new equation, as compared with the CKD-EPI equation (median difference, 21.5 ml/min/1.73 m 2 vs. 7.4 ml/min/1.73 m(2) for the new equation and the CKD-EPI equation, [P<0.001]; interquartile range [IQR] for the difference, 16.2 ml/min/1.73 m(2) vs. 19.0 ml/min/1.73 m(2) [P<0.001]), as were accuracies (15% accuracy, 40.4% vs. 30.6% [P = 0.02]; 30% accuracy, 71.1% vs. 47.2%, [P<0.001]; 50% accuracy, 90.2% vs. 75.7%, [P<0.001]), allowing improvement in GFR categorization (GFR category misclassification rate, 37.4% vs. 53.2% [P = <0.001]). Conclusions: A new equation was developed in Chinese elderly population. In the validation data set, the new equation performed better than the original CKD-EPI equation. The new equation needs further external validations. Calibration of the GFR referent standard to a more accurate one should be an useful way to improve the performance of GFR estimating equations.	[Liu, Xun; Wang, Yanni; Wang, Cheng; Shi, Chenggang; Cheng, Cailian; Chen, Jinxia; Ma, Huijuan; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xun] S China Univ Technol, Coll Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Li, Lin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Sun Yat Sen University; Sun Yat Sen University	Li, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China.	lilin5786@263.net; lou.tq@163.com	wang, cheng/A-4225-2017		National Natural Science Foundation of China [81370866, 81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [2011B031800084]; Fundamental Research Funds for the Central Universities [11ykpy38]; Ministry of Science & Technology of China [2011BAI10B00]; National Project of Scientific and Technical Supporting Programs	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Project of Scientific and Technical Supporting Programs	Project 81370866 and 81070612 supported by National Natural Science Foundation of China. This work was also supported by the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant No. 2011B031800084), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38) and the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (Grant No. 2011BAI10B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaufox MD, 1996, J NUCL MED, V37, P1883; DANZIGER RS, 1990, J AM GERIATR SOC, V38, P1127, DOI 10.1111/j.1532-5415.1990.tb01376.x; Dean A., OPENEPI OPEN SOURCE; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Heikkinen JO, 2001, NUCL MED COMMUN, V22, P987, DOI 10.1097/00006231-200109000-00008; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058242; Liu X, 2012, CLIN INTERV AGING, V7, P409, DOI 10.2147/CIA.S36152; Liu X, 2010, ARCH GERONTOL GERIAT, V51, P13, DOI 10.1016/j.archger.2009.06.005; Ma YC, 2011, CLIN NEPHROL, V76, P296, DOI 10.5414/CN106912; Ma YC, 2007, NEPHROL DIAL TRANSPL, V22, P417, DOI 10.1093/ndt/gfl603; Pei XH, 2012, SCAND J UROL NEPHROL, V46, P223, DOI 10.3109/00365599.2012.660985; Pei XH, 2012, INT UROL NEPHROL, V44, P1877, DOI 10.1007/s11255-012-0278-x; The State Council of the People's Republic of China, CHIN AG DEV 12 5 YEA; World Health Organization (WHO), AG LIF COURS; Xie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062328	20	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79675	10.1371/journal.pone.0079675	http://dx.doi.org/10.1371/journal.pone.0079675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244543	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600146
J	Qi, YY; Jiang, Q; Chen, C; Cao, Y; Qian, LL				Qi, Yuanyuan; Jiang, Qian; Chen, Chao; Cao, Yun; Qian, Liling			Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide	PLOS ONE			English	Article							BONE-MARROW; PRETERM INFANTS; PULMONARY-HYPERTENSION; LUNG GROWTH; ANGIOGENESIS; SYNTHASE; NO; VEGF; STEM; PATHOGENESIS	Background: Impairment of endothelial progenitor cells (EPCs) has been shown to contribute to the development of bronchopulmonary dysplasia (BPD). In the current study, the relationship between EPC changes of after birth and the development of BPD was investigated, and the effects of inhaled nitric oxide (iNO) on EPCs were evaluated. Methods: Sixty infants with a gestational age of less than 32 weeks and a birth weight of less than 1500 g were studied. NO was administered to infants who were receiving mechanical ventilation or CPAP for at least 2 days between the ages of 7 and 21 days. EPC level was determined by flow cytometry at birth, 7, 21 and 28 days of age and 36 weeks' postmenstrual age (PMA), before and after the iNO treatment. Plasma concentrations of vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 and granulocyte-macrophage colony-stimulating factor were determined via immunochemical assay. Results: Twenty-five neonates developed BPD, 35 neonates survived and did not develop BPD. EPC level was decreased on day 7 and 21 in infants who later developed BPD compared with infants that did not develop BPD. From birth to 21 days of age, BPD infants had a persistently lower VEGF concentration compared with non-BPD infants. No difference was found between the two groups at day 28 or 36 weeks PMA. In infants that later developed BPD, iNO raised the KDR(+)CD133(+) and CD34(+)KDR(+)CD133(+) EPC numbers along with increasing the level of plasma VEGF. Conclusion: EPC level was reduced at 7 days of age in infants with BPD, and iNO increased the EPC number along with increasing the level of VEGF. Further studies are needed to elucidate the mechanism leading to the decrease of EPCs in infants with BPD and to investigate the role of iNO treatment in the prevention of BPD.	[Qi, Yuanyuan; Jiang, Qian; Chen, Chao; Cao, Yun; Qian, Liling] Fudan Univ, Childrens Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University	Qian, LL (corresponding author), Fudan Univ, Childrens Hosp, Dept Pediat, Shanghai 200433, Peoples R China.	llqian@126.com			National Natural Science Foundation of China [81070517]; Program for New Century Excellent Talents in University from Ministry of Education [NCET-12-0126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Natural Science Foundation of China (No. 81070517) and the Program for New Century Excellent Talents in University from Ministry of Education (No. NCET-12-0126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Acarregui MJ, 1999, AM J RESP CELL MOL, V20, P14, DOI 10.1165/ajrcmb.20.1.3251; Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baker CD, 2012, EUR RESPIR J, V40, P1516, DOI 10.1183/09031936.00017312; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bizzarro MJ, 2007, ACTA PAEDIATR, V96, P521, DOI 10.1111/j.1651-2227.2007.00194.x; Borghesi A, 2009, AM J RESP CRIT CARE, V180, P540, DOI 10.1164/rccm.200812-1949OC; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Dani C, 2006, ACTA PAEDIATR, V95, P1116, DOI 10.1080/08035250600702594; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fujinaga H, 2009, AM J PHYSIOL-LUNG C, V297, pL1160, DOI 10.1152/ajplung.00234.2009; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Javanmard SH, 2010, INT J CARDIOL, V143, P213, DOI 10.1016/j.ijcard.2008.11.203; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kheirandish-Gozal L, 2010, AM J RESP CRIT CARE, V182, P92, DOI 10.1164/rccm.200912-1845OC; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Paviotti G, 2011, EARLY HUM DEV, V87, P461, DOI 10.1016/j.earlhumdev.2011.03.011; Qi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033859; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Safranow K, 2012, J PERINAT MED, V40, P455, DOI 10.1515/jpm-2011-0199; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Stevens TP, 2010, PEDIATR PULM, V45, P371, DOI 10.1002/ppul.21199; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Van Marter LJ, 2009, SEMIN FETAL NEONAT M, V14, P358, DOI 10.1016/j.siny.2009.08.007; Walsh MC, 2006, PEDIATRICS, V117, pS52, DOI 10.1542/peds.2005-0620I; Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058	41	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79060	10.1371/journal.pone.0079060	http://dx.doi.org/10.1371/journal.pone.0079060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244420	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600105
J	Rashid, MH; Heinzelmann, G; Huq, R; Tajhya, RB; Chang, SC; Chhabra, S; Pennington, MW; Beeton, C; Norton, RS; Kuyucak, S				Rashid, M. Harunur; Heinzelmann, Germano; Huq, Redwan; Tajhya, Rajeev B.; Chang, Shih Chieh; Chhabra, Sandeep; Pennington, Michael W.; Beeton, Christine; Norton, Raymond S.; Kuyucak, Serdar			A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation	PLOS ONE			English	Article							SEA-ANEMONE TOXIN; MEMORY T-CELLS; AUTOIMMUNE-DISEASES; SHK TOXIN; MOLECULAR-DYNAMICS; POTASSIUM CHANNELS; MULTIPLE-SCLEROSIS; K+ CHANNELS; PROTEIN; LYMPHOCYTES	The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune diseases. ShK peptide from a sea anemone is one of the most potent blockers of Kv1.3 but its application as a therapeutic agent for autoimmune diseases is limited by its lack of selectivity against other Kv channels, in particular Kv1.1. Accurate models of Kv1.x-ShK complexes suggest that specific charge mutations on ShK could considerably enhance its specificity for Kv1.3. Here we evaluate the K18A mutation on ShK, and calculate the change in binding free energy associated with this mutation using the path-independent free energy perturbation and thermodynamic integration methods, with a novel implementation that avoids convergence problems. To check the accuracy of the results, the binding free energy differences were also determined from path-dependent potential of mean force calculations. The two methods yield consistent results for the K18A mutation in ShK and predict a 2 kcal/mol gain in Kv1.3/Kv1.1 selectivity free energy relative to wild-type peptide. Functional assays confirm the predicted selectivity gain for ShK[K18A] and suggest that it will be a valuable lead in the development of therapeutics for autoimmune diseases.	[Rashid, M. Harunur; Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Huq, Redwan; Tajhya, Rajeev B.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Huq, Redwan; Tajhya, Rajeev B.] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Chang, Shih Chieh; Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Pennington, Michael W.] Peptides Int, Louisville, KY USA	University of Sydney; Baylor College of Medicine; Baylor College of Medicine; Monash University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	ray.norton@monash.edu; serdar@physics.usyd.edu.au	chhabra, sandeep/R-9942-2017; Chhabra, Sandeep/T-5468-2018; Heinzelmann, Germano/C-3460-2016; Kuyucak, Serdar/AAH-8417-2021; Tajhya, Rajeev/C-7321-2016	Chhabra, Sandeep/0000-0002-5225-1333; Heinzelmann, Germano/0000-0001-7168-6941; Norton, Raymond/0000-0001-8893-0584; Beeton, Christine/0000-0002-2500-5874; Kuyucak, Serdar/0000-0003-4315-9532; pennington, michael/0000-0001-5446-3447; Tajhya, Rajeev/0000-0002-5363-2293	National Institutes of Health [NS073712]; Australian Research Council [DP1092729]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in parts by grants from the National Institutes of Health (NS073712 to CB, MWP and RSN) and the Australian Research Council (DP1092729) to SK. RSN acknowledges the award of a fellowship by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C., 2007, JOVE-J VIS EXP, V8, P325; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Beeton Christine, 2007, J Vis Exp, P237, DOI 10.3791/237; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pennington MW, 2012, FEBS LETT, V586, P3996, DOI 10.1016/j.febslet.2012.09.038; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; ZACHARIAS M, 1994, J CHEM PHYS, V100, P9025, DOI 10.1063/1.466707	33	45	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78712	10.1371/journal.pone.0078712	http://dx.doi.org/10.1371/journal.pone.0078712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244345	gold, Green Published			2022-12-25	WOS:000327162900024
J	Scaria, J; Mao, CH; Chen, JW; McDonough, SP; Sobral, B; Chang, YF				Scaria, Joy; Mao, Chunhong; Chen, Jenn-Wei; McDonough, Sean P.; Sobral, Bruno; Chang, Yung-Fu			Differential Stress Transcriptome Landscape of Historic and Recently Emerged Hypervirulent Strains of Clostridium difficile Strains Determined Using RNA-seq	PLOS ONE			English	Article							TOXIN PRODUCTION; DEFINED MEDIUM; ETHANOLAMINE UTILIZATION; SALMONELLA-TYPHIMURIUM; SEVERE-DISEASE; GROEL HSP60; PAN-GENOME; INFECTION; EPIDEMIOLOGY; PATHOGEN	C. difficile is the most common cause of nosocomial diarrhea in North America and Europe. Genomes of individual strains of C. difficile are highly divergent. To determine how divergent strains respond to environmental changes, the transcriptomes of two historic and two recently isolated hypervirulent strains were analyzed following nutrient shift and osmotic shock. Illumina based RNA-seq was used to sequence these transcriptomes. Our results reveal that although C. difficile strains contain a large number of shared and strain specific genes, the majority of the differentially expressed genes were core genes. We also detected a number of transcriptionally active regions that were not part of the primary genome annotation. Some of these are likely to be small regulatory RNAs.	[Scaria, Joy; Chen, Jenn-Wei; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA; [Mao, Chunhong; Sobral, Bruno] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [McDonough, Sean P.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Cornell University; Virginia Polytechnic Institute & State University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA.	yc42@cornell.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Scaria, Joy/0000-0002-5299-8074	Virginia Tech [62078/A001]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900040C]; USDA Animal Health and Disease Research Program [NYCV-478820]; USDA formula fund [NYC-478499]	Virginia Tech; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA Animal Health and Disease Research Program; USDA formula fund(United States Department of Agriculture (USDA))	This work was partially supported by a subcontract (project no. 62078/A001) from the Virginia Tech, which has been funded from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900040C, a grant (NYCV-478820) from the USDA Animal Health and Disease Research Program and a grant (NYC-478499) from the USDA formula fund. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gerding DN, 2012, DISCOV MED, V13, P75; Gerding DN, 2010, INFECT CONT HOSP EP, V31, pS32, DOI 10.1086/655998; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Ikeda D, 1998, ZBL BAKT-INT J MED M, V287, P375; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Karasawa T, 1997, MICROBIOL IMMUNOL, V41, P581, DOI 10.1111/j.1348-0421.1997.tb01895.x; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karlsson S, 2000, INFECT IMMUN, V68, P5881, DOI 10.1128/IAI.68.10.5881-5888.2000; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056545; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; Maegavva T, 2002, J MED MICROBIOL, V51, P34, DOI 10.1099/0022-1317-51-1-34; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Noren T, 2010, METHODS MOL BIOL, V646, P9, DOI 10.1007/978-1-60327-365-7_2; Pacheco SM, 2013, CURR OPIN GASTROEN, V29, P42, DOI 10.1097/MOG.0b013e32835a68d4; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Peterkofsky A, 2006, ARCH BIOCHEM BIOPHYS, V453, P101, DOI 10.1016/j.abb.2006.01.004; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; Rupnik M, 2005, J MED MICROBIOL, V54, P113, DOI 10.1099/jmm.0.45810-0; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Scaria J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015147; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; STOCK JB, 1982, J BIOL CHEM, V257, P4543; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waligora AJ, 1999, APPL ENVIRON MICROB, V65, P4234; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; YAMAKAWA K, 1994, J MED MICROBIOL, V41, P319, DOI 10.1099/00222615-41-5-319; Yamakawa K, 1998, J MED MICROBIOL, V47, P767, DOI 10.1099/00222615-47-9-767	67	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78489	10.1371/journal.pone.0078489	http://dx.doi.org/10.1371/journal.pone.0078489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244315	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900020
J	Kim, HP; Cho, GA; Han, SW; Shin, JY; Jeong, EG; Song, SH; Lee, WC; Lee, KH; Bang, D; Seo, JS; Kim, JI; Kim, TY				Kim, H-P; Cho, G-A; Han, S-W; Shin, J-Y; Jeong, E-G; Song, S-H; Lee, W-C; Lee, K-H; Bang, D.; Seo, J-S; Kim, J-Il; Kim, T-Y			Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis	ONCOGENE			English	Article						gene fusion; fusion transcript; gastric cancer; transcriptome sequencing; next-generation sequencing	PROSTATE-CANCER; GENE FUSIONS; KINASE; MET; IDENTIFICATION; REARRANGEMENTS; INHIBITORS; DISCOVERY; RNAS	Gene fusion is involved in the development of various types of malignancies. Recent advances in sequencing technology have facilitated identification of gene fusions and have stimulated the research of this field in cancer. In the present study, we performed next-generation transcriptome sequencing in order to discover novel gene fusions in gastric cancer. A total of 282 fusion transcript candidates were detected from 12 gastric cancer cell lines by bioinformatic filtering. Among the candidates, we have validated 19 fusion transcripts, which are 7 inter-chromosomal and 12 intra-chromosomal fusions. A novel DUS4L-BCAP29 fusion transcript was found in 2 out of 12 cell lines and 10 out of 13 gastric cancer tissues. Knockdown of DUS4L-BCAP29 transcript using siRNA inhibited cell proliferation. Soft agar assay further confirmed that this novel fusion transcript has tumorigenic potential. We also identified that microRNA-coding gene PVT1, which is amplified in double minute chromosomes in SNU-16 cells, is recurrently involved in gene fusion. PVT1 produced six different fusion transcripts involving four different genes as fusion partners. Our findings provide better insight into transcriptional and genetic alterations of gastric cancer: namely, the tumorigenic effects of transcriptional read-through and a candidate region for genetic instability.	[Kim, H-P; Cho, G-A; Han, S-W; Jeong, E-G; Song, S-H; Lee, K-H; Kim, T-Y] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea; [Han, S-W; Lee, K-H; Kim, T-Y] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Shin, J-Y; Lee, W-C; Seo, J-S; Kim, J-Il] Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Seoul 110744, South Korea; [Shin, J-Y; Seo, J-S; Kim, J-Il] Psoma Therapeut Inc, Seoul, South Korea; [Lee, W-C; Seo, J-S; Kim, J-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 110744, South Korea; [Bang, D.] Yonsei Univ, Coll Sci, Dept Chem, Seoul 120749, South Korea; [Seo, J-S; Kim, J-Il] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110744, South Korea; [Seo, J-S] Macrogen Inc, Seoul, South Korea; [Kim, T-Y] Seoul Natl Univ, Coll Med, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Macrogen, Inc.; Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.	kimty@snu.ac.kr	KIM, JONG-IL/D-1019-2011; Lee, Won-Chul/D-5789-2012; Seo, Jeong-Sun/J-2763-2012	KIM, JONG-IL/0000-0002-7240-3744; Lee, Won-Chul/0000-0001-8052-2420; 	Korean Healthcare 21 and Technology R& D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A091081]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2009-0093820]	Korean Healthcare 21 and Technology R& D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was partially funded by the Korean Healthcare 21 and Technology R& D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Grant No. A091081), and by the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea (2009-0093820).	Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; FUSHIDA S, 1993, INT J ONCOL, V3, P1067; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Kawamata N, 2009, LEUKEMIA RES, V33, P569, DOI 10.1016/j.leukres.2008.07.030; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nagoshi H, 2012, CANCER RES, V72, P4954, DOI 10.1158/0008-5472.CAN-12-0213; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tao J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001423; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749; Zhang YM, 2012, CANCER DISCOV, V2, P598, DOI 10.1158/2159-8290.CD-12-0042	35	60	67	1	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5434	5441		10.1038/onc.2013.490	http://dx.doi.org/10.1038/onc.2013.490			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24240688				2022-12-25	WOS:000345120700005
J	Ningshen, TJ; Aparoy, P; Ventaku, VR; Dutta-Gupta, A				Ningshen, Thuirei Jacob; Aparoy, Polamarasetty; Ventaku, Venkat Rao; Dutta-Gupta, Aparna			Functional Interpretation of a Non-Gut Hemocoelic Tissue Aminopeptidase N (APN) in a Lepidopteran Insect Pest Achaea janata	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY; BORDER MEMBRANE-VESICLES; RNA-INTERFERENCE; BOMBYX-MORI; FAT-BODY; HELICOVERPA-ARMIGERA; CRYSTAL-STRUCTURES; DELTA-ENDOTOXIN; TOXIN BINDING; APPLE MOTH	Insect midgut membrane-anchored aminopeptidases N (APNs) are Zn++ dependent metalloproteases. Their primary role in dietary protein digestion and also as receptors in Cry toxin-induced pathogenesis is well documented. APN expression in few non-gut hemocoelic tissues of lepidopteran insects has also been reported but their functions are widely unknown. In the present study, we observed specific in vitro interaction of Cry1Aa toxin with a 113 kDa AjAPN1 membrane protein of larval fat body, Malpighian tubule and salivary gland of Achaea janata. Analyses of 3D molecular structure of AjAPN1, the predominantly expressed APN isoform in these non-gut hemocoelic tissues of A. janata showed high structural similarity to the Cry1Aa toxin binding midgut APN of Bombyx mori, especially in the toxin binding region. Structural similarity was further substantiated by in vitro binding of Cry1Aa toxin. RNA interference (RNAi) resulted in significant down-regulation of AjAPN1 transcript and protein expression in fat body and Malpighian tubule but not in salivary gland. Consequently, reduced AjAPN1 expression resulted in larval mortality, larval growth arrest, development of lethal larval-pupal intermediates, development of smaller pupae and emergence of viable defective adults. In vitro Cry1Aa toxin binding analysis of non-gut hemocoelic tissues of AjAPN1 knockdown larvae showed reduced interaction of Cry1Aa toxin with the 113 kDa AjAPN1 protein, correlating well with the significant silencing of AjAPN1 expression. Thus, our observations suggest AjAPN1 expression in non-gut hemocoelic tissues to play important physiological role(s) during post-embryonic development of A. janata. Though specific interaction of Cry1Aa toxin with AjAPN1 of non-gut hemocoelic tissues of A. janata was demonstrated, evidences to prove its functional role as a Cry1Aa toxin receptor will require more in-depth investigation.	[Ningshen, Thuirei Jacob; Ventaku, Venkat Rao; Dutta-Gupta, Aparna] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Aparoy, Polamarasetty] Cent Univ Himachal Pradesh, Sch Life Sci, Ctr Computat Biol & Bioinformat, Dharamshala, Himachal Prades, India	University of Hyderabad; Central University of Himachal Pradesh	Dutta-Gupta, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	apdgsl@uohyd.ernet.in		Polamarasetty, Aparoy/0000-0002-4030-5699	University Grants Commission, India [36-305/2008/SR]	University Grants Commission, India(University Grants Commission, India)	This work was supported by University Grants Commission, India (Grant No. 36-305/2008/SR). The funder had no role in study design, conduct of experiments, results analysis, decision to publish, or preparation of the manuscript.	Albiston AL, 2004, PROTEIN PEPTIDE LETT, V11, P491, DOI 10.2174/0929866043406643; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1999, PROF 3D US GUID; Aparoy P, 2008, J COMPUT AID MOL DES, V22, P611, DOI 10.1007/s10822-008-9180-0; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Atsumi S, 2005, APPL ENVIRON MICROB, V71, P3966, DOI 10.1128/AEM.71.7.3966-3977.2005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Budatha M, 2007, BIOTECHNOL LETT, V29, P1651, DOI 10.1007/s10529-007-9453-z; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Cerstiaens A, 2001, APPL ENVIRON MICROB, V67, P3923, DOI 10.1128/AEM.67.9.3923-3927.2001; Cheon Hyang Mi, 1997, Korean Journal of Biological Sciences, V1, P507; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hara H, 2003, FEBS LETT, V538, P29, DOI 10.1016/S0014-5793(03)00117-0; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MK, 1996, APPL ENVIRON MICROB, V62, P2845, DOI 10.1128/AEM.62.8.2845-2849.1996; LEE MK, 1992, J BIOL CHEM, V267, P3115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik K., 2001, J BIOL SCI, V1, P782; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Nakanishi K, 1999, BBA-PROTEIN STRUCT M, V1432, P57, DOI 10.1016/S0167-4838(99)00086-2; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; Ningshen TJ, 2013, COMP BIOC B IN PRESS; Pazos SA, 2008, REV ACAD COLOMB CIEN, V32, P139; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Shinkawa A, 1999, CURR MICROBIOL, V39, P14, DOI 10.1007/PL00006820; Simpson RM, 2008, INSECT SCI, V15, P505, DOI 10.1111/j.1744-7917.2008.00239.x; Singh A, 2009, BIOINFORMATION, V3, P321, DOI 10.6026/97320630003321; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; Wang P, 2005, INSECT BIOCHEM MOLEC, V35, P611, DOI 10.1016/j.ibmb.2005.02.002; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475, DOI 10.1007/BF01954236; Yang G, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P27; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Yaoi K, 1999, BBA-GENE STRUCT EXPR, V1444, P131, DOI 10.1016/S0167-4781(98)00250-4; Yu N., 2012, INSECT SCI, P1, DOI [10.1111/J/1744-7917.2012.01534.X., DOI 10.1111/J/1744-7917.2012.01534.X]; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	67	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79468	10.1371/journal.pone.0079468	http://dx.doi.org/10.1371/journal.pone.0079468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244508	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800079
J	Stegger, M; Liu, CM; Larsen, J; Soldanova, K; Aziz, M; Contente-Cuomo, T; Petersen, A; Vandendriessche, S; Jimenez, JN; Mammina, C; van Belkum, A; Salmenlinna, S; Laurent, F; Skov, RL; Larsen, AR; Andersen, PS; Price, LB				Stegger, Marc; Liu, Cindy M.; Larsen, Jesper; Soldanova, Katerina; Aziz, Maliha; Contente-Cuomo, Tania; Petersen, Andreas; Vandendriessche, Stien; Jimenez, Judy N.; Mammina, Caterina; van Belkum, Alex; Salmenlinna, Saara; Laurent, Frederic; Skov, Robert L.; Larsen, Anders R.; Andersen, Paal S.; Price, Lance B.			Rapid Differentiation between Livestock-Associated and Livestock-Independent Staphylococcus aureus CC398 Clades	PLOS ONE			English	Article							METHICILLIN-RESISTANT; COMPLEMENT INHIBITOR; NEW-YORK; ST398; INFECTIONS; EMERGENCE; HUMANS; PIGS	Staphylococcus aureus clonal complex 398 (CC398) isolates cluster into two distinct phylogenetic clades based on single-nucleotide polymorphisms (SNPs) revealing a basal human clade and a more derived livestock clade. The scn and tet(M) genes are strongly associated with the human and the livestock clade, respectively, due to loss and acquisition of mobile genetic elements. We present canonical single-nucleotide polymorphism (canSNP) assays that differentiate the two major host-associated S. aureus CC398 clades and a duplex PCR assay for detection of scn and tet(M). The canSNP assays correctly placed 88 S. aureus CC398 isolates from a reference collection into the human and livestock clades and the duplex PCR assay correctly identified scn and tet(M). The assays were successfully applied to a geographically diverse collection of 272 human S. aureus CC398 isolates. The simple assays described here generate signals comparable to a whole-genome phylogeny for major clade assignment and are easily integrated into S. aureus CC398 surveillance programs and epidemiological studies.	[Stegger, Marc; Larsen, Jesper; Petersen, Andreas; Skov, Robert L.; Larsen, Anders R.; Andersen, Paal S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Stegger, Marc; Liu, Cindy M.; Soldanova, Katerina; Aziz, Maliha; Contente-Cuomo, Tania; Andersen, Paal S.; Price, Lance B.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Vandendriessche, Stien] Free Univ Brussels, Hop Erasme, Lab Reference MRSA Staphylocoques, B-1070 Brussels, Belgium; [Jimenez, Judy N.] Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot GD Alessandro, Palermo, Italy; [van Belkum, Alex] Microbiol R&D, BioMerieux, La Balme Les Grottes, France; [Salmenlinna, Saara] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Laurent, Frederic] Hop Croix Rousse, Bacteriol Lab, Natl Reference Ctr Staphylococci, Inserm U851, F-69317 Lyon, France; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA	Statens Serum Institut; Translational Genomics Research Institute; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universidad de Antioquia; University of Palermo; bioMerieux; Finland National Institute for Health & Welfare; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); George Washington University	Stegger, M (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	mtg@ssi.dk	LAURENT, Frederic/AGM-0706-2022; Larsen, Jesper/AAJ-3161-2021; Andersen, Paal S/H-2087-2015; Liu, Cindy/ABF-7427-2020; Laurent, Frederic/M-4719-2014; Mammina, Caterina/M-9339-2013; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Andersen, Paal S/0000-0001-5656-0427; Mammina, Caterina/0000-0003-2881-8018; Skov, Robert/0000-0002-6079-5381; Petersen, Andreas/0000-0002-6864-0624; Jimenez, J Natalia/0000-0002-9183-1912; Papp, Katerina/0000-0001-8126-4822; Larsen, Anders Rhod/0000-0002-1713-8765; Stegger, Marc/0000-0003-0321-1180; laurent, frederic/0000-0003-0609-9091	TGen Foundation; National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI101371-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER	TGen Foundation; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the TGen Foundation and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (project number 1R01AI101371-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mammina C, 2010, SCAND J INFECT DIS, V42, P955, DOI 10.3109/00365548.2010.524662; Mammina C, 2010, EMERG INFECT DIS, V16, P730, DOI 10.3201/eid1604.091584; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Jimenez JN, 2011, EMERG INFECT DIS, V17, P1970, DOI 10.3201/eid1710.110638; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Resch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058187; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Salmenlinna S, 2010, EMERG INFECT DIS, V16, P1626, DOI 10.3201/eid1610.091571; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Warsa UC, 1996, J ANTIBIOT, V49, P1127, DOI 10.7164/antibiotics.49.1127; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x	29	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79645	10.1371/journal.pone.0079645	http://dx.doi.org/10.1371/journal.pone.0079645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244535	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800094
J	Hunter, JC; Yang, JE; Crawley, AW; Biesiadecki, L; Aragon, TJ				Hunter, Jennifer C.; Yang, Jane E.; Crawley, Adam W.; Biesiadecki, Laura; Aragon, Tomas J.			Public Health Response Systems In-Action: Learning from Local Health Departments' Experiences with Acute and Emergency Incidents	PLOS ONE			English	Article							DELIVERY-SYSTEMS; PREPAREDNESS	As part of their core mission, public health agencies attend to a wide range of disease and health threats, including those that require routine, acute, and emergency responses. While each incident is unique, the number and type of response activities are finite; therefore, through comparative analysis, we can learn about commonalities in the response patterns that could improve predictions and expectations regarding the resources and capabilities required to respond to future acute events. In this study, we interviewed representatives from more than 120 local health departments regarding their recent experiences with real-world acute public health incidents, such as infectious disease outbreaks, severe weather events, chemical spills, and bioterrorism threats. We collected highly structured data on key aspects of the incident and the public health response, particularly focusing on the public health activities initiated and community partners engaged in the response efforts. As a result, we are able to make comparisons across event types, create response profiles, and identify functional and structural response patterns that have import for future public health preparedness and response. Our study contributes to clarifying the complexity of public health response systems and our analysis reveals the ways in which these systems are adaptive to the character of the threat, resulting in differential activation of functions and partners based on the type of incident. Continued and rigorous examination of the experiences of health departments throughout the nation will refine our very understanding of what the public health response system is, will enable the identification of organizational and event inputs to performance, and will allow for the construction of rich, relevant, and practical models of response operations that can be employed to strengthen public health systems.	[Hunter, Jennifer C.; Yang, Jane E.; Aragon, Tomas J.] Univ Calif Berkeley, Sch Publ Hlth, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA; [Crawley, Adam W.] San Mateo Cty Hlth Syst, Div Publ Hlth Policy & Planning, San Mateo, CA USA; [Biesiadecki, Laura] Natl Assoc Cty & City Hlth Officials, Washington, DC USA; [Aragon, Tomas J.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California Berkeley; San Francisco Department of Public Health	Hunter, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA.	jhunter@berkeley.edu		Aragon, Tomas/0000-0002-2058-0423	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention under FOA [RFA-TP-08-001, 5P01TP000295]	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention under FOA	This study was supported by a Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention, under FOA RFA-TP-08-001, to the University of California at Berkeley (grant number 5P01TP000295). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control & Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J., 2009, NATL AGENDA PUBLIC H; Altevogt BM, 2008, RES PRIORITIES EMERG; [Anonymous], 2006, HOMELAND SECURITY AF; Asch SM, 2005, PUBLIC HEALTH REP, V120, P532, DOI 10.1177/003335490512000508; Bovaird T, 2008, PUBLIC MANAG REV, V10, P319, DOI 10.1080/14719030802002741; Burke DS, 2013, J PUBLIC HEALTH MAN, V19, pS12, DOI 10.1097/PHH.0b013e31828a842f; Centers for Disease Control and Prevention (US), 2011, PUBL HLTH PREP CAP N; Dato V, 2004, PUBLIC HEALTH REP, V119, P464, DOI 10.1016/j.phr.2004.07.003; Harris JK, 2007, PUBLIC HEALTH REP, V122, P488, DOI 10.1177/003335490712200410; Hunter JC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-680; Larson RC, 2006, INTERFACES, V36, P486, DOI 10.1287/inte.1060.0250; Lurie N, 2006, HEALTH AFFAIR, V25, P935, DOI 10.1377/hlthaff.25.4.935; March JG, 1991, ORGAN SCI, V2, P1, DOI 10.1287/orsc.2.1.1; Mays GP, 2010, MILBANK Q, V88, P81, DOI 10.1111/j.1468-0009.2010.00590.x; Mays GP, 2009, AM J PREV MED, V36, P256, DOI 10.1016/j.amepre.2008.11.008; Mays GR, 2004, AM J PUBLIC HEALTH, V94, P1019, DOI 10.2105/AJPH.94.6.1019; *NACCHO, 2012, LHD BUDG CUTS JOB LO; *NACCHO, 2010, NAT PROF LOC HLTH DE; *NAT BIOD SCIENC B, 2011, CALL ACT INCL SCI IN; *NAT WEATH SERV, 2012, US STAT TERR; NELSON C, 2007, ASSESSING PUBLIC HLT, DOI DOI 10.1146/ANNUREV.PUBLHEALTH.28.021406.144054; Nelson Christopher, 2007, Am J Public Health, V97 Suppl 1, pS9, DOI 10.2105/AJPH.2007.114496; Nelson CD, 2010, HEALTH AFFAIR, V29, P2286, DOI 10.1377/hlthaff.2010.0189; Pisati M., 2007, SPMAP STATA MODULE V; ROCHLIN GI, 1987, NAVAL WAR COLL REV; Savoia E, 2012, INT J ENV RES PUB HE, V9, P2949, DOI 10.3390/ijerph9082949; STOTO M, 2013, FRONTIERS PUBLIC HLT, V2; STOTO M, 2005, LEARNING EXPERIENCE; Stoto M, 2013, J PUBLIC HEALTH MAN, V19, pS16, DOI 10.1097/PHH.0b013e318294b0e3; Thompson J.D., 2003, ORG ACTION SOCIAL SC; *US CDCP, CDC EM PREP RESP SIT	31	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79457	10.1371/journal.pone.0079457	http://dx.doi.org/10.1371/journal.pone.0079457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236137	Green Published, gold			2022-12-25	WOS:000327254700136
J	Darkoh, C; Brown, EL; Kaplan, HB; DuPont, HL				Darkoh, Charles; Brown, Eric L.; Kaplan, Heidi B.; DuPont, Herbert L.			Bile Salt Inhibition of Host Cell Damage by Clostridium Difficile Toxins	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; A-INDUCED APOPTOSIS; HYDROLASE ACTIVITY; RHO-PROTEINS; URSODEOXYCHOLATE PROTECT; CONTROLLED TRIAL; SMALL-INTESTINE; INFECTION; DISEASE; ACID	Virulent Clostridium difficile strains produce toxin A and/or toxin B that are the etiological agents of diarrhea and pseudomembranous colitis. Treatment of C. difficile infections (CDI) has been hampered by resistance to multiple antibiotics, sporulation, emergence of strains with increased virulence, recurrence of the infection, and the lack of drugs that preserve or restore the colonic bacterial flora. As a result, there is new interest in non-antibiotic CDI treatments. The human conjugated bile salt taurocholate was previously shown in our laboratory to inhibit C. difficile toxin A and B activities in an in vitro assay. Here we demonstrate for the first time in an ex vivo assay that taurocholate can protect Caco-2 colonic epithelial cells from the damaging effects of the C. difficile toxins. Using caspase-3 and lactate dehydrogenase assays, we have demonstrated that taurocholate reduced the extent of toxin B-induced apoptosis and cell membrane damage. Confluent Caco-2 cells cultured with toxin B induced elevated caspase-3 activity. Remarkably, addition of 5 mM taurocholate reduced caspase-3 activity in cells treated with 2, 4, 6, and 12 mg/ml of toxin B by 99%, 78%, 64%, and 60%, respectively. Furthermore, spent culture medium from Caco-2 cells incubated with both toxin B and taurocholate exhibited significantly decreased lactate dehydrogenase activity compared to spent culture medium from cells incubated with toxin B only. Our results suggest that the mechanism of taurocholate-mediated inhibition functions at the level of toxin activity since taurocholate did not affect C. difficile growth and toxin production. These findings open up a new avenue for the development of non-antibiotic therapeutics for CDI treatment.	[Darkoh, Charles; Brown, Eric L.; DuPont, Herbert L.] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA; [Darkoh, Charles; Kaplan, Heidi B.; DuPont, Herbert L.] Univ Texas Grad Sch Biomed Sci, Houston, TX USA; [Kaplan, Heidi B.; DuPont, Herbert L.] Univ Texas Med Sch, Houston, TX USA; [DuPont, Herbert L.] St Lukes Episcopal Hosp, Houston, TX 77030 USA; [DuPont, Herbert L.] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Saint Lukes Episcopal Hospital; Baylor College of Medicine	Darkoh, C (corresponding author), Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA.	Charles.darkoh@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021	Darkoh, Charles/0000-0003-0063-7856	University of Texas School of Public Health; Texas Medical Center Digestive Diseases Center (Public Health Service Grant) [DK56338]; United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	University of Texas School of Public Health; Texas Medical Center Digestive Diseases Center (Public Health Service Grant)(United States Department of Health & Human ServicesUnited States Public Health Service); United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part, by discretionary funds from The University of Texas School of Public Health, Texas Medical Center Digestive Diseases Center (Public Health Service Grant DK56338), and United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Aspevall O, 2006, ANTIMICROB AGENTS CH, V50, P1890, DOI 10.1128/AAC.50.5.1890-1892.2006; BAILEY ME, 1976, BRIT J SURG, V63, P774, DOI 10.1002/bjs.1800631011; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bartlett John G, 2009, Curr Infect Dis Rep, V11, P21, DOI 10.1007/s11908-009-0004-8; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Bishara J, 2006, DIAGN MICR INFEC DIS, V54, P141, DOI 10.1016/j.diagmicrobio.2005.09.008; BORRIELLO SP, 1985, J MED MICROBIOL, V19, P339, DOI 10.1099/00222615-19-3-339; Brandes V, 2011, BIOL CHEM; Brandt Lawrence J, 2012, Gastroenterol Hepatol (N Y), V8, P191; Brito GAC, 2002, J INFECT DIS, V186, P1438, DOI 10.1086/344729; Brown EL, 2010, ANTIMICROB AGENTS CH, V54, P388, DOI 10.1128/AAC.00691-09; Carneiro BA, 2006, INFECT IMMUN, V74, P81, DOI 10.1128/IAI.74.1.81-87.2006; Darkoh C, 2011, J CLIN MICROBIOL, V49, P4219, DOI 10.1128/JCM.01033-11; Darkoh C, 2011, J CLIN MICROBIOL, V49, P2933, DOI 10.1128/JCM.00037-11; DESMET I, 1995, J APPL BACTERIOL, V79, P292; DILLON ST, 1995, INFECT IMMUN, V63, P1421, DOI 10.1128/IAI.63.4.1421-1426.1995; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Dowling R H, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P59; DuPont HL, 2011, NEW ENGL J MED, V364, P473, DOI 10.1056/NEJMe1013236; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; GOUMA DJ, 1986, AM J SURG, V151, P476, DOI 10.1016/0002-9610(86)90107-8; HEUMAN DM, 1991, GASTROENTEROLOGY, V100, P203, DOI 10.1016/0016-5085(91)90602-H; HEUMAN DM, 1991, HEPATOLOGY, V14, P920, DOI 10.1002/hep.1840140527; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck SC, 2009, CELL MOTIL CYTOSKEL, V66, P967, DOI 10.1002/cm.20390; HUIJGHEBAERT SM, 1982, APPL ENVIRON MICROB, V43, P185, DOI 10.1128/AEM.43.1.185-192.1982; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; LILLIENAU J, 1991, AM J PHYSIOL, V261, pG1065, DOI 10.1152/ajpgi.1991.261.6.G1065; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Moser SA, 2001, APPL ENVIRON MICROB, V67, P3476, DOI 10.1128/AEM.67.8.3476-3480.2001; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; QUENEAU PE, 1993, TRANSPLANTATION, V56, P530, DOI 10.1097/00007890-199309000-00008; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Shikita M, 1999, BIOCHEM J, V341, P725, DOI 10.1042/0264-6021:3410725; SHUBEITA HE, 1987, P NATL ACAD SCI USA, V84, P5645, DOI 10.1073/pnas.84.16.5645; SUNG JY, 1993, DIGEST DIS SCI, V38, P2104, DOI 10.1007/BF01297092; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; VANELDERE J, 1988, APPL ENVIRON MICROB, V54, P2112, DOI 10.1128/AEM.54.8.2112-2117.1988; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WILSON KH, 1983, J INFECT DIS, V147, P733, DOI 10.1093/infdis/147.4.733; Yuan Junying, 2004, Cell, VS116, pS53, DOI 10.1016/S0092-8674(04)00028-5	71	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79631	10.1371/journal.pone.0079631	http://dx.doi.org/10.1371/journal.pone.0079631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244530	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600138
J	Lustrek, M; Lorenz, P; Kreutzer, M; Qian, ZL; Steinbeck, F; Wu, D; Born, N; Ziems, B; Hecker, M; Blank, M; Shoenfeld, Y; Cao, ZW; Glocker, MO; Li, YX; Fuellen, G; Thiesen, HJ				Lustrek, Mitja; Lorenz, Peter; Kreutzer, Michael; Qian, Zilliang; Steinbeck, Felix; Wu, Di; Born, Nadine; Ziems, Bjoern; Hecker, Michael; Blank, Miri; Shoenfeld, Yehuda; Cao, Zhiwei; Glocker, Michael O.; Li, Yixue; Fuellen, Georg; Thiesen, Hans-Juergen			Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins	PLOS ONE			English	Article							B-CELL EPITOPES; RECEPTOR; ANTIGENICITY; INDUCTION; PEPTIDES; DISEASE; SERUM; MODEL	Epitope-antibody-reactivities (EAR) of intravenous immunoglobulins (IVIGs) determined for 75,534 peptides by microarray analysis demonstrate that roughly 9% of peptides derived from 870 different human protein sequences react with antibodies present in IVIG. Computational prediction of linear B cell epitopes was conducted using machine learning with an ensemble of classifiers in combination with position weight matrix (PWM) analysis. Machine learning slightly outperformed PWM with area under the curve (AUC) of 0.884 vs. 0.849. Two different types of epitope-antibody recognitionmodes (Type I EAR and Type II EAR) were found. Peptides of Type I EAR are high in tyrosine, tryptophan and phenylalanine, and low in asparagine, glutamine and glutamic acid residues, whereas for peptides of Type II EAR it is the other way around. Representative crystal structures present in the Protein Data Bank (PDB) of Type I EAR are PDB 1TZI and PDB 2DD8, while PDB 2FD6 and 2J4W are typical for Type II EAR. Type I EAR peptides share predicted propensities for being presented by MHC class I and class II complexes. The latter interaction possibly favors T cell-dependent antibody responses including IgG class switching. Peptides of Type II EAR are predicted not to be preferentially presented by MHC complexes, thus implying the involvement of T cell-independent IgG class switch mechanisms. The high extent of IgG immunoglobulin reactivity with human peptides implies that circulating IgG molecules are prone to bind to human protein/peptide structures under non-pathological, non-inflammatory conditions. A webserver for predicting EAR of peptide sequences is available at www.sysmed-immun.eu/EAR.	[Lustrek, Mitja; Fuellen, Georg] Univ Rostock, Univ Med Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Lustrek, Mitja] Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia; [Lorenz, Peter; Kreutzer, Michael; Qian, Zilliang; Steinbeck, Felix; Wu, Di; Born, Nadine; Thiesen, Hans-Juergen] Univ Rostock, Univ Med Rostock, Inst Immunol, D-18055 Rostock, Germany; [Qian, Zilliang; Wu, Di; Li, Yixue] Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ziems, Bjoern] Gesell Individualisierte Med GmbH, Rostock, Germany; [Hecker, Michael] Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany; [Blank, Miri; Shoenfeld, Yehuda] Sheba Med Ctr, Zabludovicz Ctr Autoimmune Dis, Ramat Gan, Israel; [Cao, Zhiwei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Glocker, Michael O.] Univ Rostock, Proteome Ctr Rostock, D-18055 Rostock, Germany	University of Rostock; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Rostock; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chaim Sheba Medical Center; Tongji University; University of Rostock	Thiesen, HJ (corresponding author), Univ Rostock, Univ Med Rostock, Inst Immunol, D-18055 Rostock, Germany.	HJ.Thiesen@gmx.de	Wu, Di/J-4483-2012	Wu, Di/0000-0001-9565-1217; Lorenz, Peter A./0000-0001-7925-1002; Hecker, Michael/0000-0001-7015-3094	Autorome [LSHM-CT-2004-005264]; E-RARE [01GM0803]; BMBF [0315450D]; State of Mecklenburg-Vorpommern MV-Excellence [UR08051, UR09012]	Autorome; E-RARE; BMBF(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern MV-Excellence	EU funded Autorome (LSHM-CT-2004-005264) and E-RARE (01GM0803); BMBF support through Med-Sys (0315450D), and funding by the State of Mecklenburg-Vorpommern MV-Excellence: (UR08051 und UR09012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2011, CELLULAR MOL IMMUNOL; Al-Majdoub M, 2013, J MASS SPECTROM, V48, P651, DOI 10.1002/jms.3208; Almqvist N, 2012, SCAND J IMMUNOL, V76, P256, DOI 10.1111/j.1365-3083.2012.02751.x; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Clark MR, 2011, MOL IMMUNOL, V48, P1281, DOI 10.1016/j.molimm.2010.10.024; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Fujita Y, 2012, THER DELIV, V3, P749, DOI 10.4155/TDE.12.52; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hecker M, 2012, AUTOIMMUN REV, V11, P180, DOI 10.1016/j.autrev.2011.05.010; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Hoffmann MH, 2011, J AUTOIMMUN, V36, P288, DOI 10.1016/j.jaut.2011.02.007; Inaba K, 2005, INT J HEMATOL, V81, P181, DOI 10.1532/IJH97.04200; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kracker S, 2011, IMMUNOL LETT, V138, P97, DOI 10.1016/j.imlet.2011.02.004; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Linnebacher M, 2012, ANAL BIOANAL CHEM, V403, P227, DOI 10.1007/s00216-012-5781-5; Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Nielsen CH, 2012, ADV EXP MED BIOL, V750, P116, DOI 10.1007/978-1-4614-3461-0_9; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pasquali JL, 2012, ADV EXP MED BIOL, V750, P145, DOI 10.1007/978-1-4614-3461-0_11; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; Pone EJ, 2012, FRONT BIOSCI-LANDMRK, V17, P2594, DOI 10.2741/4073; Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Saul F A, 1996, Methods Mol Biol, V66, P11; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Seewald A. K., 2002, 19 INT C MACH LEARN, P554, DOI DOI 10.1017/CBO9781107415324.004; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Sun J, 2011, IMMUNOME RES, V7, P1; Suri A, 2006, CURR OPIN IMMUNOL, V18, P70, DOI 10.1016/j.coi.2005.11.002; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935; Watanabe K, 2008, BIOCHEM BIOPH RES CO, V374, P274, DOI 10.1016/j.bbrc.2008.07.013; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78605	10.1371/journal.pone.0078605	http://dx.doi.org/10.1371/journal.pone.0078605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244326	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600036
J	Ng, THH; Mossey, JM; Lee, BK				Ng, Tsz Hin H.; Mossey, Jana M.; Lee, Brian K.			Total Blood Mercury Levels and Depression among Adults in the United States: National Health and Nutrition Examination Survey 2005-2008	PLOS ONE			English	Article							METHYLMERCURY EXPOSURE; FISH CONSUMPTION; SYMPTOMS; LIFE; RESIDENTS; TOXICITY; OUTCOMES; MICE	Background: Mercury is a neurotoxicant linked with psychiatric symptoms at high levels of exposure. However, it is unclear whether an association is present at the low exposure levels in the US adult population. Materials and Methods: Cross-sectional associations of total blood mercury and depression were assessed in 6,911 adults age >= 20 in the National Health and Nutrition Examination Survey (NHANES), 2005-2008. The Patient Health Questionnaire-9 was used to assess depression (high likelihood of a depressive spectrum disorder diagnosis; score 5-27). Results: Unadjusted survey weighted logistic regression suggested that higher total blood mercury was associated with lower odds of depression (Odds Ratio =0.49, 95% Confidence Interval: 0.36-0.65, comparing the highest and lowest mercury quintiles). This association largely disappeared after adjustment for sociodemographic variables (income-poverty ratio, education, marital status). However, in age-stratified analyses, this inverse relationship remained in older adults (age >= 40) even after adjustment for sociodemographic variables. Simulation analyses adjusting for expected confounding effects of fish intake suggested that the inverse relationship among older adults may be plausibly attributed to residual confounding (Odds Ratio =0.75, 95% Confidence Interval: 0.50-1.12, comparing the highest and lowest mercury quintiles). Conclusions: Higher total blood mercury was not associated with increased odds of depression. The lower odds of depression in older adults with higher total blood mercury may be due to residual confounding.	[Ng, Tsz Hin H.; Mossey, Jana M.; Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Drexel University	Lee, BK (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	bklee@drexel.edu		Lee, Brian/0000-0002-3635-8034				Akbaraly TN, 2008, BRIT J NUTR, V100, P1116, DOI 10.1017/S0007114508971312; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; Bates MN, 2004, INT J EPIDEMIOL, V33, P894, DOI 10.1093/ije/dyh164; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bourdineaud JP, 2011, ENVIRON INT, V37, P303, DOI 10.1016/j.envint.2010.09.003; Bourdineaud JP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-53; Centers for Disease Control and Prevention, 2009, 4 CDCP; Choi AL, 2008, CRIT REV TOXICOL, V38, P877, DOI [10.1080/10408440802273164, 10.1080/10408440802273164 ]; Division of Nutrition Physical Activity and Obesity Centers for Disease Control and Prevention, 2011, BOD MASS IND; Environmental Protection Agency, 2010, MERC HUM EXP; FDA, 2011, MERC LEV COMM FISH S; GOYER RA, 2003, CASARETT DOULLS ESSE, P348; Heyer NJ, 2004, TOXICOL SCI, V81, P354, DOI 10.1093/toxsci/kfh220; Kokayi K, 2006, EXPLORE-NY, V2, P400, DOI 10.1016/j.explore.2006.06.008; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Krishnan KRR, 2010, BIOL PSYCHIAT, V68, P116, DOI 10.1016/j.biopsych.2010.05.009; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Maximino C, 2011, NEUROTOXICOL TERATOL, V33, P727, DOI 10.1016/j.ntt.2011.08.006; Moreira PA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-58; National Academy of Sciences, 2000, TOX EFF METH; National Center for Health Statistics, 2010, NHANES 2007 2008 PUB; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; National Center for Health Statistics Centers for Disease Control and Prevention, 2011, NCHS RES ETH REV BOA; National Center for Health Statistics Centers for Disease Control and Prevention, 2004, LAB PROC MAN TOT MER; National Center for Health Statistics Centers for Disease Control and Prevention, 2011, SAMPL DES; National Center for Health Statistics Centers for Disease Control and Prevention, 2009, 2007 2008 DAT DOC CO; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, 2007 2008 DAT DOC CO; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, TASK 2 KEY CONC UND; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, 2007 2008 DAT DO CCO; National Center for Toxicological Research, 2009, WHIT PAP FDA UPD REV; Onishchenko N, 2007, TOXICOL SCI, V97, P428, DOI 10.1093/toxsci/kfl199; Pasco JA, 2012, COMPLEMENT THER MED, V20, P119, DOI 10.1016/j.ctim.2011.12.008; Seabrook JA, 2012, CAN REV SOCIOL, V49, P50, DOI 10.1111/j.1755-618X.2011.01280.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tran NL, 2004, RISK ANAL, V24, P19, DOI 10.1111/j.0272-4332.2004.00408.x; United Nations Environment Programme International Labour Organisation World Health Organization, 1990, ENV HLTH CRIT; United Nations Environment Programme World Health Organization, 1976, ENV HLTH CRIT; US Department of Health and Human Services, 2012, POV GUID RES MEAS; US National Center for Health Statistics, 2012, 2007 2008 NAT HLTH N; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; Yaginuma-Sakurai K, 2012, J TOXICOL SCI, V37, P123, DOI 10.2131/jts.37.123; Yorifuji T, 2011, ENVIRON INT, V37, P907, DOI 10.1016/j.envint.2011.03.008; Zachi EC, 2007, BRAZ J MED BIOL RES, V40, P425, DOI 10.1590/S0100-879X2007000300019	46	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79339	10.1371/journal.pone.0079339	http://dx.doi.org/10.1371/journal.pone.0079339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244482	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600125
J	Pepper, M; Doughty, P; Fujita, MK; Moritz, C; Keogh, JS				Pepper, Mitzy; Doughty, Paul; Fujita, Matthew K.; Moritz, Craig; Keogh, J. Scott			Speciation on the Rocks: Integrated Systematics of the Heteronotia spelea Species Complex (Gekkota; Reptilia) from Western and Central Australia	PLOS ONE			English	Article							GEKKONIDAE; EVOLUTION; DELIMITATION; SQUAMATA; GECKOS; DIVERSIFICATION; DIVERSITY; RADIATION; ENDEMISM; MODELS	The isolated uplands of the Australian arid zone are known to provide mesic refuges in an otherwise xeric landscape, and divergent lineages of largely arid zone taxa have persisted in these regions following the onset of Miocene aridification. Geckos of the genus Heteronotia are one such group, and have been the subject of many genetic studies, including H. spelea, a strongly banded form that occurs in the uplands of the Pilbara and Central Ranges regions of the Australian arid zone. Here we assess the systematics of these geckos based on detailed examination of morphological and genetic variation. The H. spelea species complex is a monophyletic lineage to the exclusion of the H. binoei and H. planiceps species complexes. Within the H. spelea complex, our previous studies based on mtDNA and nine nDNA loci found populations from the Central Ranges to be genetically divergent from Pilbara populations. Here we supplement our published molecular data with additional data gathered from central Australian samples. In the spirit of integrative species delimitation, we combine multi-locus, coalescent-based lineage delimitation with extensive morphological analyses to test species boundaries, and we describe the central populations as a new species, H. fasciolatus sp. nov. In addition, within the Pilbara there is strong genetic evidence for three lineages corresponding to northeastern (type), southern, and a large-bodied melanic population isolated in the northwest. Due to its genetic distinctiveness and extreme morphological divergence from all other Heteronotia, we describe the melanic form as a new species, H. atra sp. nov. The northeastern and southern Pilbara populations are morphologically indistinguishable with the exception of a morpho-type in the southeast that has a banding pattern resembling H. planiceps from the northern monsoonal tropics. Pending more extensive analyses, we therefore treat Pilbara H. spelea as a single species with phylogenetic structure and morphological heterogeneity.	[Pepper, Mitzy; Moritz, Craig; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Doughty, Paul] Western Australian Museum, Dept Terr Zool, Perth, WA 6000, Australia; [Fujita, Matthew K.] Harvard Univ, Cambridge, MA 02138 USA; [Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Australian National University; Western Australian Museum; Harvard University; University of Texas System; University of Texas Arlington	Pepper, M (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	mitzy.pepper@anu.edu.au	Keogh, Scott/C-8441-2009	Keogh, Scott/0000-0002-1373-6186; Pepper, Mitzy/0000-0003-4828-9977	MCZ Putnam Exploration Grant; Australian Research Council [DP0985054]	MCZ Putnam Exploration Grant; Australian Research Council(Australian Research Council)	Fieldwork was supported by the MCZ Putnam Exploration Grant to MKF (http://www.mcz.harvard.edu/grants_and_funding/putnam-expedition.html). Labwork was supported by the Australian Research Council grant DP0985054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN C, 1981, BIOL J LINN SOC, V15, P235, DOI 10.1111/j.1095-8312.1981.tb00761.x; [Anonymous], 2010, COMPLETE GUIDE REPTI; Bauer Aaron M., 1997, Proceedings of the California Academy of Sciences, V49, P447; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bittner TD, 2002, COPEIA, P477, DOI 10.1643/0045-8511(2002)002[0477:EOBSAM]2.0.CO;2; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Cogger H, 2000, REPTILES AMPHIBIANS; Cogger H. G., 1983, REPTILES AMPHIBIANS; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doughty Paul, 2011, Records of the Western Australian Museum, P315; Doughty Paul, 2012, Records of the Western Australian Museum, V27, P117; Doughty Paul, 2011, Records of the Western Australian Museum, V26, P115; Doughty Paul, 2010, Zootaxa, V2393, P33; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Galimberti DF, 2012, MOL ECOL RES; Glaw Frank, 2010, Zootaxa, V2383, P1; Gray J.E., 1845, CATALOGUE SPECIMENS; Heinicke MP, 2011, ZOOL SCR, V40, P584, DOI 10.1111/j.1463-6409.2011.00495.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; Horner Paul, 2005, Beagle, V21, P165; Jackman TR, 2008, ACTA HERPETOL, V3, P1; KING M, 1979, AUST J ZOOL, V27, P373, DOI 10.1071/ZO9790373; King M, 1983, AMPHIBIA-REPTILIA, P4147; KLUGE ARNOLD G., 1963, JOUR ROY SOC W AUSTRALIA, V46, P63; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; LEWIS TH, 1949, COPEIA, P181; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; McKenzie N.L., 2009, RECORDS W AUSTR MU S, V78, P3, DOI DOI 10.18195/ISSN.0313-122X.78(1).2009.003-089; Miller GH, 1997, NATURE, V385, P241, DOI 10.1038/385241a0; MORITZ C, 1986, SYST ZOOL, V35, P46, DOI 10.2307/2413290; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; MORITZ C, 1990, COPEIA, P333, DOI 10.2307/1446339; NORRIS KS, 1964, ECOLOGY, V45, P565; Oliver Paul, 2010, Zootaxa, V2354, P45; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; Pepper M, 2011, MOL ECOL, V20, P1529, DOI 10.1111/j.1365-294X.2011.05036.x; Pepper M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-152; R Development Core Team, 2007, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Shoo LP, 2008, MOL PHYLOGENET EVOL, V48, P528, DOI 10.1016/j.ympev.2008.03.022; Sistrom M, 2012, J EVOLUTION BIOL, V25, P647, DOI 10.1111/j.1420-9101.2012.02460.x; Sistrom MJ, 2009, ZOOTAXA, P14, DOI 10.11646/zootaxa.2277.1.2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart DA, 1996, THESIS U QUEENSLAND; STORR G M, 1989, Records of the Western Australian Museum, V14, P269; STORR G.M., 1990, LIZARDS W AUSTR; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wermuth H., 1965, Tierreich, V80, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	62	25	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78110	10.1371/journal.pone.0078110	http://dx.doi.org/10.1371/journal.pone.0078110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244289	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600016
J	Sanphui, P; Pramanik, SK; Chatterjee, N; Moorthi, P; Banerji, B; Biswas, SC				Sanphui, Priyankar; Pramanik, Sumit Kumar; Chatterjee, Nandini; Moorthi, Ponnusamy; Banerji, Biswadip; Biswas, Subhas Chandra			Efficacy of Cyclin Dependent Kinase 4 Inhibitors as Potent Neuroprotective Agents against Insults Relevant to Alzheimer's Disease	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURONAL CELL-DEATH; NF-KAPPA-B; GENE-EXPRESSION; BIM; MECHANISMS; PROTEIN; NEURODEGENERATION; MOLECULES; APOPTOSIS	Alzheimer's disease (AD) is a progressive neurodegenerative disease with no cure till today. Aberrant activation of cell cycle regulatory proteins is implicated in neurodegenerative diseases including AD. We and others have shown that Cyclin dependent kinase 4 (Cdk4) is activated in AD brain and is required for neuron death. In this study, we tested the efficiency of commercially available Cdk4 specific inhibitors as well as a small library of synthetic molecule inhibitors targeting Cdk4 as neuroprotective agents in cellular models of neuron death. We found that several of these inhibitors significantly protected neuronal cells against death induced by nerve growth factor (NGF) deprivation and oligomeric beta amyloid (Ab) that are implicated in AD. These neuroprotective agents inhibit specifically Cdk4 kinase activity, loss of mitochondrial integrity, induction of pro-apoptotic protein Bim and caspase3 activation in response to NGF deprivation. The efficacies of commercial and synthesized inhibitors are comparable. The synthesized molecules are either phenanthrene based or naphthalene based and they are synthesized by using Pschorr reaction and Buchwald coupling respectively as one of the key steps. A number of molecules of both kinds block neurodegeneration effectively. Therefore, we propose that Cdk4 inhibition would be a therapeutic choice for ameliorating neurodegeneration in AD and these synthetic Cdk4 inhibitors could lead to development of effective drugs for AD.	[Sanphui, Priyankar; Chatterjee, Nandini; Moorthi, Ponnusamy; Biswas, Subhas Chandra] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata, India; [Pramanik, Sumit Kumar; Banerji, Biswadip] Indian Inst Chem Biol, CSIR, Div Chem, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Banerji, B (corresponding author), Indian Inst Chem Biol, CSIR, Div Chem, Kolkata, India.	biswadip.banerji@gmail.com; biswassc@gmail.com		Ponnusamy, Moorthi/0000-0002-3275-6473	CSIR-EMPOWER; DST, Govt. of India	CSIR-EMPOWER; DST, Govt. of India(Department of Science & Technology (India))	This work was supported in part by grants from CSIR-EMPOWER (SCB & BB) and DST (SCB), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Calissano P, 2010, CELL DEATH DIFFER, V17, P1126, DOI 10.1038/cdd.2010.38; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Copani A, 2008, CURR MED CHEM, V15, P2420, DOI 10.2174/092986708785909030; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Fors BP, 2008, ORG LETT, V10, P3505, DOI 10.1021/ol801285g; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Karran E, 2012, J NEUROCHEM, V123, P647, DOI 10.1111/jnc.12009; Kim D, 2009, ANN NY ACAD SCI, V1170, P674, DOI 10.1111/j.1749-6632.2009.04105.x; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee HG, 2009, AM J PATHOL, V174, P891, DOI 10.2353/ajpath.2009.080583; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Massoud F, 2010, CURR NEUROPHARMACOL, V8, P69, DOI 10.2174/157015910790909520; Neve RL, 2007, BBA-MOL BASIS DIS, V1772, P430, DOI 10.1016/j.bbadis.2006.10.008; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Rao HV, 2007, J NEUROCHEM, V101, P498, DOI 10.1111/j.1471-4159.2006.04389.x; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Ruberti F, 2000, J NEUROSCI, V20, P2589; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Spires TL, 2004, REV NEUROSCIENCE, V15, P267, DOI 10.1515/REVNEURO.2004.15.4.267; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Troy CM, 2000, J NEUROSCI, V20, P1386; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Xie YL, 2008, TETRAHEDRON LETT, V49, P2320, DOI 10.1016/j.tetlet.2008.01.136; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2003, J NEUROSCI, V23, P2557; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78842	10.1371/journal.pone.0078842	http://dx.doi.org/10.1371/journal.pone.0078842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244372	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600069
J	Singh, S; Kumar, S; Kolte, AP; Kumar, S				Singh, Sachin; Kumar, Satish, Jr.; Kolte, Atul P.; Kumar, Satish			Extensive Variation and Sub-Structuring in Lineage A mtDNA in Indian Sheep: Genetic Evidence for Domestication of Sheep in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; CONTROL REGION; OVIS-ARIES; ORIGIN; DIVERSITY; SEQUENCE; PHYLOGEOGRAPHY; BREEDS; WILD	Previous studies on mitochondrial DNA analysis of sheep from different regions of the world have revealed the presence of two major-A and B, and three minor-C, D and E maternal lineages. Lineage A is more frequent in Asia and lineage B is more abundant in regions other than Asia. We have analyzed mitochondrial DNA sequences of 330 sheep from 12 different breeds of India. Neighbor-joining analysis revealed lineage A, B and C in Indian sheep. Surprisingly, multidimensional scaling plot based on F-ST values of control region of mtDNA sequences showed significant breed differentiation in contrast to poor geographical structuring reported earlier in this species. The breed differentiation in Indian sheep was essentially due to variable contribution of two major lineages to different breeds, and sub-structuring of lineage A, possibly the latter resulting from genetic drift. Nucleotide diversity of this lineage was higher in Indian sheep (0.014 +/- 0.007) as compared to that of sheep from other regions of the world (0.009 +/- 0.005 to 0.01 +/- 0.005). Reduced median network analysis of control region and cytochrome b gene sequences of Indian sheep when analyzed along with available published sequences of sheep from other regions of the world showed that several haplotypes of lineage A were exclusive to Indian sheep. Given the high nucleotide diversity in Indian sheep and the poor sharing of lineage A haplotypes between Indian and non-Indian sheep, we propose that lineage A sheep has also been domesticated in the east of Near East, possibly in Indian sub-continent. Finally, our data provide support that lineage B and additional lineage A haplotypes of sheep might have been introduced to Indian sub-continent from Near East, probably by ancient sea trade route.	[Singh, Sachin; Kumar, Satish] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Kumar, Satish, Jr.] ICAR Cent Sheep & Wool Res Inst, Avikanagar, India; [Kolte, Atul P.] ICAR Natl Inst Anim Nutr & Physiol, Bangaluru, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Indian Council of Agricultural Research (ICAR); ICAR - Central Sheep & Wool Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology	Kumar, S (corresponding author), DBT Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India.	satishk@ccmb.res.in			Centre for Cellular and Molecular Biology, Hyderabad; Central Sheep and Wool Research Institute, Avikanagar	Centre for Cellular and Molecular Biology, Hyderabad; Central Sheep and Wool Research Institute, Avikanagar	This study was supported by in-house research funds from the Centre for Cellular and Molecular Biology, Hyderabad and the Central Sheep and Wool Research Institute, Avikanagar. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R M, 1982, SHEEP GOAT BREEDS IN; Babar ME, 2012, ANIM GENET, V43, P315, DOI 10.1111/j.1365-2052.2011.02250.x; BANDELT HJ, 1995, GENETICS, V141, P743; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Fu YX, 1997, GENETICS, V147, P915; Giuffra E, 2000, GENETICS, V154, P1785; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kumar S, 2007, ANIM GENET, V38, P227, DOI 10.1111/j.1365-2052.2007.01602.x; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; McIntosh J., 2008, MCINTOSH; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Pardeshi VC, 2007, ANIM GENET, V38, P460, DOI 10.1111/j.1365-2052.2007.01636.x; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider S, 1999, GENETICS, V152, P1079; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; TEMPLETON AR, 1995, GENETICS, V140, P767; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Wang X, 2007, SMALL RUMINANT RES, V72, P232, DOI 10.1016/j.smallrumres.2006.10.016; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	46	21	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77858	10.1371/journal.pone.0077858	http://dx.doi.org/10.1371/journal.pone.0077858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244282	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600010
J	Sun, X; Zhou, W; Liu, H; Zhang, AJ; Ai, CR; Zhou, SS; Zhou, CX; Wang, MQ				Sun, Xiao; Zhou, Wen; Liu, Hao; Zhang, Aijun; Ai, Chao-Ren; Zhou, Shuang-Shuang; Zhou, Chang-Xiang; Wang, Man-Qun			Transgenic Bt Rice Does Not Challenge Host Preference of the Target Pest of Rice Leaffolder, Cnaphalocrocis medinalis (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							ELECTRONIC NOSE; INDICA RICE; STEM BORER; CRY2A RICE; VOLATILES; COTTON; LEAF; RESISTANCE; RESPONSES; BOLLWORM	Background: Transgenic Bt rice line T2A-1 expresses a synthesized cry2A gene that shows high resistance to Lepidoptera pests, including Cnaphalocrocis medinalis (Guenee) (Lepidoptera: Pyralidae). Plant volatile orientation cues and the physical characteristics of the leaf surface play key roles in host location or host-plant acceptance of phytophagous insects. These volatile compounds and physical traits may become altered in Bt rice and it is not known whether this influences the behavior of C. medinalis when searching for oviposition sites. Results: The results of electronic nose analysis showed that the Radar map of Bt rice cultivars was analogous to the non-Bt rice cultivars at each growing stage. PCA analysis was able to partly discriminate between some of the Bt vs. non-Bt rice sensors, but could not to separate Bt cultivars from non-Bt cultivars. The total ion chromatogram between Bt and non-Bt rice cultivars at the seedling, booting and tillering stages were similar and 25 main compounds were identified by GC-MS. For most compounds, there was no significant difference in compound quantities between Bt and non-Bt rice cultivars at equivalent growth stages. The densities of the tubercle papicles and the trichomes on the upper and lower surfaces were statistically equal in Bt and non-Bt rice. The target pest, C. medinalis, was attracted to host rice plants, but it could not distinguish between the transgenic and the isogenic rice lines. Conclusions: There were no significant differences between the Bt rice line, T2A-1 and the non-Bt rice for volatiles produced or in its physical characteristics and there were no negative impacts on C. medinalis oviposition behavior. These results add to the mounting evidence that Bt rice has no negative impact on the target insect oviposition behavior.	[Sun, Xiao; Zhou, Wen; Liu, Hao; Ai, Chao-Ren; Zhou, Shuang-Shuang; Zhou, Chang-Xiang; Wang, Man-Qun] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA	Huazhong Agricultural University; United States Department of Agriculture (USDA)	Wang, MQ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	mqwang@mail.hzau.edu.cn	Wang, Man-Qun/AAO-3802-2020		National Genetically Modified Organisms Breeding Major Projects of China [2011ZZX08001-001]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Ministry of Agriculture of China [200903051]	National Genetically Modified Organisms Breeding Major Projects of China; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This study was supported and funded by the National Genetically Modified Organisms Breeding Major Projects of China (No: 2011ZZX08001-001), Huazhong Agricultural University Scientific & Technological Self-innovation Foundation and The Industry Project of the Ministry of Agriculture of China (200903051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bai Yao-yu, 2005, Acta Phytophylacica Sinica, V32, P225; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Bondada BR, 2000, ANN BOT-LONDON, V86, P1143, DOI 10.1006/anbo.2000.1283; BRYSON CT, 1983, CROP SCI, V23, P369, DOI 10.2135/cropsci1983.0011183X002300020043x; Camurati E, 2006, RIV ITAL SOSTANZE GR, V83, P205; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen M, 2006, ENVIRON ENTOMOL, V35, P127, DOI 10.1603/0046-225X-35.1.127; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Dean JM, 2006, J CHEM ECOL, V32, P713, DOI 10.1007/s10886-006-9040-0; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Eifler J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021026; Fettig CJ, 2009, J APPL ENTOMOL, V133, P143, DOI 10.1111/j.1439-0418.2008.01317.x; Gallego D, 2008, J APPL ENTOMOL, V132, P654, DOI 10.1111/j.1439-0418.2008.01304.x; Han Y, 2011, AGR SCI CHINA, V10, P1739, DOI 10.1016/S1671-2927(11)60172-7; HEATH RR, 1994, J CHEM ECOL, V20, P593, DOI 10.1007/BF02059600; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Ibrahim MA, 2008, PLANT BIOLOGY, V10, P97, DOI 10.1111/j.1438-8677.2007.00013.x; Jaffe G, 2009, COMPLACENCY FARM; Jyothi KN, 2002, J APPL ENTOMOL, V126, P175, DOI 10.1046/j.1439-0418.2002.00628.x; KAMEL SA, 1965, J ECON ENTOMOL, V58, P209, DOI 10.1093/jee/58.2.209; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; de Lerma NL, 2012, FOOD CHEM, V130, P447, DOI 10.1016/j.foodchem.2011.07.058; Lou YG, 2005, J CHEM ECOL, V31, P2357, DOI 10.1007/s10886-005-7106-z; Lu BQ, 2011, ENTOMOL EXP APPL, V140, P17, DOI 10.1111/j.1570-7458.2011.01135.x; Lu K, 2010, CHINESE SCI BULL, V55, P2925; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; Obonyo D, 2008, J APPL BIOSCIENCES, V10, P424; Obonyo DN, 2009, THESIS; Perkowski J, 2008, INT J FOOD MICROBIOL, V126, P127, DOI 10.1016/j.ijfoodmicro.2008.05.028; Peterson JA, 2011, J ARACHNOL, V39, P1, DOI 10.1636/M10-98.1; RAMACHANDRAN R, 1990, J CHEM ECOL, V16, P2647, DOI 10.1007/BF00988076; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; SCARPATI ML, 1993, J CHEM ECOL, V19, P881, DOI 10.1007/BF00985017; Schuler TH, 1999, TRENDS BIOTECHNOL, V17, P210, DOI 10.1016/S0167-7799(98)01298-0; SPADONE JC, 1990, J AGR FOOD CHEM, V38, P226, DOI 10.1021/jf00091a050; Sun X, 2013, J INSECT SCI; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Turlings TCJ, 2005, TRANSGENIC RES, V14, P807, DOI 10.1007/s11248-005-0008-6; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; Van den Berg J, 2007, ENTOMOL EXP APPL, V122, P45, DOI 10.1111/j.1570-7458.2006.00492.x; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vogler U, 2010, TRANSGENIC RES, V19, P77, DOI 10.1007/s11248-009-9294-8; Wang YM, 2010, CROP PROT, V29, P128, DOI 10.1016/j.cropro.2009.10.004; Wechgama K., 2008, Biotechnology, V7, P718; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XL, 2011, SCI CHINA LIFE SCI, V54, P1019, DOI 10.1007/s11427-011-4234-2; Xue K, 2008, SCI CHINA SER C, V51, P145, DOI 10.1007/s11427-008-0028-6; Yan F, 2004, J APPL ENTOMOL, V128, P354, DOI 10.1111/j.1439-0418.2004.00857.x; Yan Feng, 2010, Chinese Bulletin of Entomology, V47, P96; Ye GY, 2000, B ENTOMOL RES, V90, P179, DOI 10.1017/S0007485300000298; Yu HC, 2007, SENSOR ACTUAT B-CHEM, V122, P134, DOI 10.1016/j.snb.2006.05.019; Zhuge PP, 2010, J APPL ENTOMOL, V134, P600, DOI 10.1111/j.1439-0418.2010.01540.x	60	24	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79032	10.1371/journal.pone.0079032	http://dx.doi.org/10.1371/journal.pone.0079032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244410	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600098
J	Tseng, JR; Ho, TY; Lin, CY; Lee, LY; Wang, HM; Liao, CT; Yen, TC				Tseng, Jing-Ren; Ho, Tsung-Ying; Lin, Chien-Yu; Lee, Li-Yu; Wang, Hung-Ming; Liao, Chun-Ta; Yen, Tzu-Chen			Clinical Outcomes of Patients with Oral Cavity Squamous Cell Carcinoma and Retropharyngeal Lymph Node Metastasis Identified by FDG PET/CT	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; NECK RECURRENCE; F-18-FDG PET; CANCER; HEAD; CT	Purpose: Retropharyngeal lymph node (RPLN) metastasis is an uncommon finding in patients with oral cavity squamous carcinoma (OSCC). We sought to investigate the clinical outcomes, clinicopathological characteristics, and the priority of treatment with curative intent in OSCC patients with RPLN involvement. Methods and Materials: Between January 2007 and January 2011, we identified 36 patients with primary RPLN metastases (n = 10) or RPLN relapse (n = 26). The follow-up continued until June 2013. Disease-specific survival (DSS), disease-free survival (DFS), and the potential benefits of salvage therapy served as the main outcome measures. Results: The 2-year DSS and DFS rates of untreated patients with RPLN involvement were 20% and 24%, respectively. Level IV/V neck lymph node involvement was an adverse prognostic factor for DSS (P = 0.048) and DFS (P = 0.018). All of the patients presenting with neck lymph node involvement at level IV/V died within 6 months. Among patients who were treated for RPLN relapse, the 2-year DSS and DFS rates from the relapse day were 12.8% and 9.6%, respectively. Concomitant contralateral neck lymph node metastases (N2c) were associated with lower 2-year DSS (P = 0.005) and DFS (P = 0.011) rates. Moreover, five (55%) of the nine patients with recurrent disease in the contralateral RPLN had distant metastases within 6 months. Salvage therapy yielded the maximum survival benefit in patients without N2c disease and ipsilateral RPLN involvement alone (P = 0.005). Conclusion: OSCC patients with RPLN involvement have poor outcomes. The risk factor for definitive treatment in OSCC patients with FDG PET/CT defined RPLN disease in primary disease was neck lymph node involvement at level IV/V and N2c and/or contralateral RPLN disease in recurrent disease. Treatment efforts with curative intent should be tailored according to individual risk factors.	[Tseng, Jing-Ren; Ho, Tsung-Ying; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Dept Nucl Med, Tao Yuan, Taiwan; [Tseng, Jing-Ren; Ho, Tsung-Ying; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Mol Imaging Ctr, Tao Yuan, Taiwan; [Liao, Chun-Ta] Chang Gung Mem Hosp Linkou, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Lin, Chien-Yu] Chang Gung Mem Hosp Linkou, Dept Radiat Oncol, Tao Yuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp Linkou, Dept Pathol, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp Linkou, Dept Med Oncol, Tao Yuan, Taiwan; [Tseng, Jing-Ren; Ho, Tsung-Ying; Lin, Chien-Yu; Lee, Li-Yu; Wang, Hung-Ming; Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Dept Head & Neck Oncol Grp, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liao, CT (corresponding author), Chang Gung Mem Hosp Linkou, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan.	liaoct@cgmh.org.tw; yen1110@adm.cgmh.org.tw	Li-yu, Lee/G-5055-2010	Ho, Tsung-Ying/0000-0002-8468-2226; Tseng, Jing-Ren/0000-0002-2232-9347				BALLANTYNE AJ, 1964, AM J SURG, V108, P500, DOI 10.1016/0002-9610(64)90143-6; Chan SC, 2010, NUCL MED COMMUN, V31, P260, DOI 10.1097/MNM.0b013e3283360133; Chu HR, 2009, OTOLARYNG HEAD NECK, V141, P633, DOI 10.1016/j.otohns.2009.08.008; Dirix P, 2006, INT J RADIAT ONCOL, V65, P739, DOI 10.1016/j.ijrobp.2006.02.027; Kimura Y, 1998, AM J NEURORADIOL, V19, P1221; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2013, ANN SURG ONCOL, V20, P257, DOI 10.1245/s10434-012-2580-3; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; Liao CT, 2009, ANN SURG ONCOL, V16, P159, DOI 10.1245/s10434-008-0196-4; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; Morrissey DD, 2000, ARCH OTOLARYNGOL, V126, P1478, DOI 10.1001/archotol.126.12.1478; Ng SH, 1997, NEURORADIOLOGY, V39, P741, DOI 10.1007/s002340050499; Nishida M, 2005, J ORAL MAXIL SURG, V63, P410, DOI 10.1016/j.joms.2004.04.035; Okumura K, 1998, Nihon Jibiinkoka Gakkai Kaiho, V101, P573; Umeda M, 2009, INT J ORAL MAX SURG, V38, P1004, DOI 10.1016/j.ijom.2009.04.015; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570	16	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79766	10.1371/journal.pone.0079766	http://dx.doi.org/10.1371/journal.pone.0079766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244559	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600151
J	Beck-Johnson, LM; Nelson, WA; Paaijmans, KP; Read, AF; Thomas, MB; Bjornstad, ON				Beck-Johnson, Lindsay M.; Nelson, William A.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.			The Effect of Temperature on Anopheles Mosquito Population Dynamics and the Potential for Malaria Transmission	PLOS ONE			English	Article							GAMBIAE GILES COMPLEX; CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; GENERATION SEPARATION; DEPENDENT DEVELOPMENT; IMMATURE STAGES; AQUATIC STAGES; BODY-SIZE; DIPTERA; MODEL	The parasites that cause malaria depend on Anopheles mosquitoes for transmission; because of this, mosquito population dynamics are a key determinant of malaria risk. Development and survival rates of both the Anopheles mosquitoes and the Plasmodium parasites that cause malaria depend on temperature, making this a potential driver of mosquito population dynamics and malaria transmission. We developed a temperature-dependent, stage-structured delayed differential equation model to better understand how climate determines risk. Including the full mosquito life cycle in the model reveals that the mosquito population abundance is more sensitive to temperature than previously thought because it is strongly influenced by the dynamics of the juvenile mosquito stages whose vital rates are also temperature-dependent. Additionally, the model predicts a peak in abundance of mosquitoes old enough to vector malaria at more accurate temperatures than previous models. Our results point to the importance of incorporating detailed vector biology into models for predicting the risk for vector borne diseases.	[Beck-Johnson, Lindsay M.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Beck-Johnson, Lindsay M.; Read, Andrew F.; Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Read, Andrew F.; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Beck-Johnson, LM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	lmb404@psu.edu	de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013; Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016	de Voogd, Nicole/0000-0002-7985-5604; Peijnenburg, Katja TCA/0000-0001-7544-1079; Erpenbeck, Dirk/0000-0003-2716-1085	United States Department of Agriculture National Research Initiative [2006-35302-17149]; National Science Foundation-EID program grant [EF-0914384]	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation-EID program grant	This research was supported by United States Department of Agriculture National Research Initiative 2006-35302-17149 to ONB, www.usda.gov, and by National Science Foundation-EID program grant EF-0914384 to MBT and AFR, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bayoh MN, 2001, THESIS U DURHAM; Beaty B.J., 1996, BIOL DIS VECTORS; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Centers for Disease Control and Prevention (CDC), 2012, MAL FACTS; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Clements AN., 1992, BIOL MOSQUITOES DEV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Mukiama TK, 1989, FIELD STUDIES LARVAL; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; NISBET RM, 1983, THEOR POPUL BIOL, V23, P114, DOI 10.1016/0040-5809(83)90008-4; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2009, ENV HLTH PERSPECT, V118; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; REISEN WK, 1975, MOSQ NEWS, V35, P473; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Ross R., 1910, PREVENTION MALARIA; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201; [No title captured]	60	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79276	10.1371/journal.pone.0079276	http://dx.doi.org/10.1371/journal.pone.0079276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24098416	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800053
J	Brewer, MS; Swafford, L; Spruill, CL; Bond, JE				Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.; Bond, Jason E.			Arthropod Phylogenetics in Light of Three Novel Millipede (Myriapoda: Diplopoda) Mitochondrial Genomes with Comments on the Appropriateness of Mitochondrial Genome Sequence Data for Inferring Deep Level Relationships	PLOS ONE			English	Article							NUCLEOTIDE COMPOSITION; GENE ORDER; MODEL; EVOLUTION; XYSTODESMIDAE; MITOGENOMICS; POLYDESMIDA; SYMPHYLA; SYNOPSIS; RESOLVE	Background: Arthropods are the most diverse group of eukaryotic organisms, but their phylogenetic relationships are poorly understood. Herein, we describe three mitochondrial genomes representing orders of millipedes for which complete genomes had not been characterized. Newly sequenced genomes are combined with existing data to characterize the protein coding regions of myriapods and to attempt to reconstruct the evolutionary relationships within the Myriapoda and Arthropoda. Results: The newly sequenced genomes are similar to previously characterized millipede sequences in terms of synteny and length. Unique translocations occurred within the newly sequenced taxa, including one half of the Appalachioria falcifera genome, which is inverted with respect to other millipede genomes. Across myriapods, amino acid conservation levels are highly dependent on the gene region. Additionally, individual loci varied in the level of amino acid conservation. Overall, most gene regions showed low levels of conservation at many sites. Attempts to reconstruct the evolutionary relationships suffered from questionable relationships and low support values. Analyses of phylogenetic informativeness show the lack of signal deep in the trees (i.e., genes evolve too quickly). As a result, the myriapod tree resembles previously published results but lacks convincing support, and, within the arthropod tree, well established groups were recovered as polyphyletic. Conclusions: The novel genome sequences described herein provide useful genomic information concerning millipede groups that had not been investigated. Taken together with existing sequences, the variety of compositions and evolution of myriapod mitochondrial genomes are shown to be more complex than previously thought. Unfortunately, the use of mitochondrial protein-coding regions in deep arthropod phylogenetics appears problematic, a result consistent with previously published studies. Lack of phylogenetic signal renders the resulting tree topologies as suspect. As such, these data are likely inappropriate for investigating such ancient relationships.	[Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Brewer, Michael S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Brewer, Michael S.] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA; [Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Bond, Jason E.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA	University of North Carolina; East Carolina University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Auburn University System; Auburn University; Auburn University System; Auburn University	Brewer, MS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	michaelsbrewer@gmail.com	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 05-29715]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation, DEB 05-29715 (nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bond JE, 2002, EVOLUTION, V56, P1123; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P285, DOI 10.1016/j.ympev.2010.05.011; Brewer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037240; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Chen WJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-246; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Delsuc F, 2003, SCIENCE, V301, P1482; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Hoffman R.L., 2002, P505; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jones M, 2007, MOL PHYLOGENET EVOL, V43, P583, DOI 10.1016/j.ympev.2006.11.017; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marek P, 2011, CURR BIOL, V21, pR680, DOI 10.1016/j.cub.2011.08.012; Marek PE, 2007, ZOOTAXA, P27; Marek PE, 2006, MOL PHYLOGENET EVOL, V41, P704, DOI 10.1016/j.ympev.2006.05.043; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Podsiadlowski L, 2007, MOL PHYLOGENET EVOL, V45, P251, DOI 10.1016/j.ympev.2007.07.017; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2001, ZOOL J LINN SOC-LOND, V132, P469, DOI 10.1006/zjls.2000.0277; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Shear William, 2011, Zootaxa, V3148, P159; SHELLEY RM, 1984, CAN J ZOOL, V62, P980, DOI 10.1139/z84-137; Shelley Rowland M., 2005, Fragmenta Faunistica (Warsaw), V48, P137; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swafford L, 2009, INVERTEBR SYST, V23, P445, DOI 10.1071/IS09036; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Team RCD, 2009, R LANG ENV STAT COMP; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Woo HJ, 2007, MOL CELLS, V23, P182; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	71	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68005	10.1371/journal.pone.0068005	http://dx.doi.org/10.1371/journal.pone.0068005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869209	gold, Green Published, Green Submitted			2022-12-25	WOS:000323110600008
J	Suarez-Rubio, M; Wilson, S; Leimgruber, P; Lookingbill, T				Suarez-Rubio, Marcela; Wilson, Scott; Leimgruber, Peter; Lookingbill, Todd			Threshold Responses of Forest Birds to Landscape Changes around Exurban Development	PLOS ONE			English	Article							POPULATION-CHANGE; UNITED-STATES; RESIDENTIAL DEVELOPMENT; HABITAT FRAGMENTATION; RELATIVE IMPORTANCE; SPECIES RICHNESS; COMMUNITIES; PATTERNS; CONSERVATION; TRENDS	Low-density residential development (i.e., exurban development) is often embedded within a matrix of protected areas and natural amenities, raising concern about its ecological consequences. Forest-dependent species are particularly susceptible to human settlement even at low housing densities typical of exurban areas. However, few studies have examined the response of forest birds to this increasingly common form of land conversion. The aim of this study was to assess whether, how, and at what scale forest birds respond to changes in habitat due to exurban growth. We evaluated changes in habitat composition (amount) and configuration (arrangement) for forest and forest-edge species around North America Breeding Bird Survey (BBS) stops between 1986 and 2009. We used Threshold Indicator Taxa Analysis to detect change points in species occurrence at two spatial extents (400-m and 1-km radius buffer). Our results show that exurban development reduced forest cover and increased habitat fragmentation around BBS stops. Forest birds responded nonlinearly to most measures of habitat loss and fragmentation at both the local and landscape extents. However, the strength and even direction of the response changed with the extent for several of the metrics. The majority of forest birds' responses could be predicted by their habitat preferences indicating that management practices in exurban areas might target the maintenance of forested habitats, for example through easements or more focused management for birds within existing or new protected areas.	[Suarez-Rubio, Marcela] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA; [Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Lookingbill, Todd] Univ Richmond, Dept Geog & Environm, Richmond, VA 23173 USA	University System of Maryland; University of Maryland Center for Environmental Science; Environment & Climate Change Canada; Canadian Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Richmond	Suarez-Rubio, M (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA.	marcela.suarezrubio@boku.ac.at	Wilson, Scott/AAC-7144-2021; Leimgruber, Peter/O-1304-2015; NUNEZ-PENA, MARIA ISABEL/B-3883-2011; Suarez Pellicioni, Macarena/H-5527-2015; colome, angels/H-2522-2015	Leimgruber, Peter/0000-0002-3682-0153; Lookingbill, Todd/0000-0003-4946-6429; NUNEZ-PENA, MARIA ISABEL/0000-0002-3677-859X; Suarez Pellicioni, Macarena/0000-0002-9056-9561; Suarez-Rubio, Marcela/0000-0002-0596-2626; colome, angels/0000-0002-2976-1853	Appalachian Laboratory, University of Maryland Center for Environmental Science	Appalachian Laboratory, University of Maryland Center for Environmental Science	This work was supported by Appalachian Laboratory, University of Maryland Center for Environmental Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], BIRDS N AM ONLINE; ASKINS RA, 1995, SCIENCE, V267, P1956, DOI 10.1126/science.267.5206.1956; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Berger J. O., 2013, STAT DECISION THEORY; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; BURNLEY IH, 1995, J PLAN EDUC RES, V14, P245, DOI 10.1177/0739456X9501400402; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chace JF, 2003, LANDSCAPE URBAN PLAN, V64, P179, DOI 10.1016/S0169-2046(02)00220-7; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Dauphine N, 2009, IMPACTS FREE RANGING, P205; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; ENGELS TM, 1994, CONSERV BIOL, V8, P286, DOI 10.1046/j.1523-1739.1994.08010286.x; Engle David M., 1999, Great Plains Research, V9, P55; Erskine AJ, 1978, CANADIAN WILDLIFE SE, V42, P1; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans M, 2011, BIRDS N AM ONLINE; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fraterrigo JM, 2005, LANDSCAPE URBAN PLAN, V71, P263, DOI 10.1016/S0169-2046(04)00080-5; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd; Graber JW, 1985, BIOL NOTES; Greenlaw JS, 1996, E TOWHEE PIPILO ERYT; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; HAGAN JM, 1993, AUK, V110, P863; Halkin SL, 1999, BIRDS N AM ONLINE; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; HILL SR, 1988, AM MIDL NAT, V120, P313, DOI 10.2307/2426003; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hunt PD, 1998, CONSERV BIOL, V12, P1377, DOI 10.1046/j.1523-1739.1998.97005.x; Jones KB, 2000, ENVIRON MONIT ASSESS, V63, P159, DOI 10.1023/A:1006415029890; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kim KK, 2005, GROWTH CHANGE, V36, P273, DOI 10.1111/j.1468-2257.2005.00277.x; Krementz DG, 2000, WILSON BULL, V112, P243, DOI 10.1676/0043-5643(2000)112[0243:BSDAMO]2.0.CO;2; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lang JD, 2002, AUK, V119, P109, DOI 10.1642/0004-8038(2002)119[0109:WTMAHU]2.0.CO;2; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mancke RG, 2000, ECOL APPL, V10, P598, DOI 10.1890/1051-0761(2000)010[0598:BBDIWE]2.0.CO;2; Marzluff John M., 2001, P19; Matlack GR, 1997, J BIOGEOGR, V24, P281, DOI 10.1046/j.1365-2699.1997.00108.x; Mazerolle DF, 2004, CAN J ZOOL, V82, P1774, DOI 10.1139/Z04-175; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McGranahan D.A., 1999, NATURAL AMENITIES DR; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merenlender AM, 2009, LANDSCAPE URBAN PLAN, V92, P255, DOI 10.1016/j.landurbplan.2009.05.004; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; PETERJOHN PG, 1994, WILDLIFE SOC B, V22, P155; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; R Core Team, 2021, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robbins C.S., 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sauer JR, 1995, MONITORING BIRD POPU, P151; Sherry TW, 1997, BIRDS N AM; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith RJ, 2011, BIRDS N AM ONLINE; Smith WB, 2004, FOREST RESOURCES US; Soille P., 2013, MORPHOLOGICAL IMAGE; Struyk RJ, 1996, HOUSING STUD, V11, P233, DOI 10.1080/02673039608720854; Suarez-Rubio M, 2012, REMOTE SENS ENVIRON, V124, P360, DOI 10.1016/j.rse.2012.03.029; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Theobald DM, 2005, ECOL SOC, V10; U.S. NABCI Committee, 2009, STAT BIRDS; US Census Bureau, 2010, STAT COUNT QUICK FAC; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; van den Berg L, 2000, LANDSCAPE URBAN PLAN, V48, P169, DOI 10.1016/S0169-2046(00)00040-2; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wakamiya SW, 2012, NATURAL RESOURCE DAT; Weeks Jr HP, 2011, E PHOEBE SAYORNIS PH; Weldon Cooper Center, 2010, FIN 2008 PROV 2009 P; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	104	39	40	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67593	10.1371/journal.pone.0067593	http://dx.doi.org/10.1371/journal.pone.0067593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826325	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400161
J	Zhang, C; Kong, LX; Liu, Q; Lei, X; Zhu, T; Yin, J; Lin, BR; Deng, ZX; You, DL				Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Lin, Birun; Deng, Zixin; You, Delin			In Vitro Characterization of Echinomycin Biosynthesis: Formation and Hydroxylation of L-Tryptophanyl-S-Enzyme and Oxidation of (2S,3S) beta- Hydroxytryptophan	PLOS ONE			English	Article							MBTH-LIKE PROTEINS; ESCHERICHIA-COLI; CROSS-TALK; ANTIBIOTICS; GENE; 2,3-DIOXYGENASE; THIOCORALINE; ACID; ADENYLATION; SEQUENCE	Quinoxaline-2-carboxylic acid (QXC) and 3-hydroxyquinaldic acid (HQA) feature in quinomycin family and confer anticancer activity. In light of the significant potency against cancer, the biosynthetic gene clusters have been reported from many different Streptomyces strains, and the biosynthetic pathway were proposed mainly based on the in vivo feeding experiment with isotope labeled putative intermediates. Herein we report another gene cluster from Streptomyces griseovariabilis subsp. bandungensis subsp. nov responsible for the biosynthesis of echinomycin (a member of quinomycin family, also named quinomycin A) and presented in vitro evidence to corroborate the previous hypothesis on QXC biosynthesis, showing that only with the assistance of a MbtH-like protein Qui5, did the didomain NRPS protein (Qui18) perform the loading of a L-tryptophan onto its own PCP domain. Particularly, it was found that Qui5 and Qui18 subunits form a functional tetramer through size exclusion chromatography. The subsequent hydroxylation on beta-carbon of the loaded L-tryptophan proved in vitro to be completed by cytochrome P450-dependent hydroxylase Qui15. Importantly, only the Qui18 loaded L-tryptophan can be hydroxylated by Qui15 and the enzyme was inactive on free L-tryptophan. Additionally, the chemically synthesized (2S,3S) b-hydroxytryptophan was detected to be converted by the tryptophan 2,3-dioxygenase Qui17 through LC-MS, which enriched our previous knowledge that tryptophan 2,3-dioxygenase nearly exclusively acted on L-tryptophan and 6-fluoro-tryptophan.	[Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lin, Birun] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangdong Academy of Agricultural Sciences	You, DL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	dlyou@sjtu.edu.cn	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	National Science Foundation of China (973 Program); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology	National Science Foundation of China (973 Program)(National Basic Research Program of ChinaNational Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 Programs), Shanghai Pujiang Program from the Shanghai Municipal Council of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESS KJ, 1994, BIOCHEMISTRY-US, V33, P12386, DOI 10.1021/bi00207a005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Furuya K, 1998, FEMS MICROBIOL LETT, V168, P243, DOI 10.1111/j.1574-6968.1998.tb13280.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HUANG CH, 1982, BIOCHEMISTRY-US, V21, P3704, DOI 10.1021/bi00258a028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koketsu K, 2006, ORG LETT, V8, P4719, DOI 10.1021/ol061738+; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Praseuth AP, 2008, BIOTECHNOL PROGR, V24, P1226, DOI 10.1002/btpr.34; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Watanabe K, 2009, CURR OPIN CHEM BIOL, V13, P189, DOI 10.1016/j.cbpa.2009.02.012; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	27	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56772	10.1371/journal.pone.0056772	http://dx.doi.org/10.1371/journal.pone.0056772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	24236209	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000044
J	Kong, J; Cooper, LAD; Wang, FS; Gao, JJ; Teodoro, G; Scarpace, L; Mikkelsen, T; Schniederjan, MJ; Moreno, CS; Saltz, JH; Brat, DJ				Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Scarpace, Lisa; Mikkelsen, Tom; Schniederjan, Matthew J.; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.			Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates	PLOS ONE			English	Article							MICROSCOPY IMAGES; NUCLEAR-STRUCTURE; CLASSIFICATION; OLIGODENDROGLIOMA; SURVIVAL; RECONSTRUCTION; SEGMENTATION; FRAMEWORK; COMPONENT; UPDATE	Pathologic review of tumor morphology in histologic sections is the traditional method for cancer classification and grading, yet human review has limitations that can result in low reproducibility and inter-observer agreement. Computerized image analysis can partially overcome these shortcomings due to its capacity to quantitatively and reproducibly measure histologic structures on a large-scale. In this paper, we present an end-to-end image analysis and data integration pipeline for large-scale morphologic analysis of pathology images and demonstrate the ability to correlate phenotypic groups with molecular data and clinical outcomes. We demonstrate our method in the context of glioblastoma (GBM), with specific focus on the degree of the oligodendroglioma component. Over 200 million nuclei in digitized pathology slides from 117 GBMs in the Cancer Genome Atlas were quantitatively analyzed, followed by multiplatform correlation of nuclear features with molecular and clinical data. For each nucleus, a Nuclear Score (NS) was calculated based on the degree of oligodendroglioma appearance, using a regression model trained from the optimal feature set. Using the frequencies of neoplastic nuclei in low and high NS intervals, we were able to cluster patients into three well-separated disease groups that contained low, medium, or high Oligodendroglioma Component (OC). We showed that machine-based classification of GBMs with high oligodendroglioma component uncovered a set of tumors with strong associations with PDGFRA amplification, proneural transcriptional class, and expression of the oligodendrocyte signature genes MBP, HOXD1, PLP1, MOBP and PDGFRA. Quantitative morphologic features within the GBMs that correlated most strongly with oligodendrocyte gene expression were high nuclear circularity and low eccentricity. These findings highlight the potential of high throughput morphologic analysis to complement and inform human-based pathologic review.	[Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Teodoro, George] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Scarpace, Lisa; Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Schniederjan, Matthew J.; Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Henry Ford Health System; Henry Ford Hospital; Emory University; Emory University	Kong, J (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	jun.kong@emory.edu	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	PHS from the Clinical and Translational Science Award Program, National Institutes of Health [UL 1RR025008]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant [P30 CA138292]	PHS from the Clinical and Translational Science Award Program, National Institutes of Health; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant	This work was supported in part by PHS Grant UL 1RR025008 from the Clinical and Translational Science Award Program, National Institutes of Health, Contract No. HHSN261200800001E from the National Cancer Institute, National Institutes of Health, the Georgia Cancer Coalition, and the Winship Cancer Institute Cancer Center Support Grant P30 CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cooper LAD, 2012, J AM MED INFORM ASSN, V19, P317, DOI 10.1136/amiajnl-2011-000700; Cooper LAD, 2011, I S BIOMED IMAGING, P1624, DOI 10.1109/ISBI.2011.5872714; Cooper LAD, 2010, IEEE T BIO-MED ENG, V57, P2617, DOI 10.1109/TBME.2010.2060338; DAVID H, 2005, LINEAR RANK TESTS SU; Deb P, 2005, NEUROL INDIA, V53, P329; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FOX J, 2002, ROBUST REGRESSION; Freedman D. A., 2005, STAT MODELS THEORY P; Gupta M, 2005, AM J CLIN PATHOL, V124, P755, DOI 10.1309/6JNX4PA60TQ5U5VG; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Hu MX, 2007, LECT NOTES COMPUT SC, V4791, P68; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kong J, 2011, I S BIOMED IMAGING, P2128, DOI 10.1109/ISBI.2011.5872833; Kong J, 2011, IEEE ENG MED BIO, P6605, DOI 10.1109/IEMBS.2011.6091629; Kong J, 2011, IEEE ENG MED BIO, P87, DOI 10.1109/IEMBS.2011.6089903; Kong J, 2011, IEEE T BIO-MED ENG, V58, P3469, DOI 10.1109/TBME.2011.2169256; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *NCI, 2001, HE CANC GEN ATL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PASTORINO S, 2012, P 103 ANN M AM ASS C, V72; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Pytel P, 2009, ARCH PATHOL LAB MED, V133, P1062, DOI 10.1043/1543-2165-133.7.1062; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang W, 2011, IEEE T MED IMAGING, V30, P621, DOI 10.1109/TMI.2010.2089693; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853	40	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81049	10.1371/journal.pone.0081049	http://dx.doi.org/10.1371/journal.pone.0081049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236209	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700212
J	Chen, H; Wu, N; Wang, YF; Zhu, D; Zhu, QA; Yang, G; Gao, YH; Fang, XQ; Wang, X; Peng, CH				Chen, Huai; Wu, Ning; Wang, Yanfen; Zhu, Dan; Zhu, Qiu'an; Yang, Gang; Gao, Yongheng; Fang, Xiuqin; Wang, Xu; Peng, Changhui			Inter-Annual Variations of Methane Emission from an Open Fen on the Qinghai-Tibetan Plateau: A Three-Year Study	PLOS ONE			English	Article							NITROUS-OXIDE; EXPERIMENTAL DROUGHT; CARBON-DIOXIDE; SOIL EMISSIONS; ALPINE WETLAND; NITRIC-OXIDE; RICE FIELDS; FLUXES; CLIMATE; CHINA	The study aimed to understand the inter-annual variations of methane (CH4) emissions from an open fen on the Qinghai-Tibetan Plateau (QTP) from 2005 to 2007. The weighted mean CH4 emission rate was 8.37 +/- 11.32 mg CH4 m(-2) h(-1) during the summers from 2005 to 2007, falling in the range of CH4 fluxes reported by other studies, with significant inter-annual and spatial variations. The CH4 emissions of the year of 2006 (2.11 +/- 3.48 mg CH4 m(-2) h(-1)) were 82% lower than the mean value of the years 2005 and 2007 (13.91 +/- 17.80 mg CH4 m(-2) h(-1) and 9.44 +/- 14.32 mg CH4 m(-2) h(-1), respectively), responding to the inter-annual changes of standing water depths during the growing season of the three years. Significant drawdown of standing water depth is believed to cause such significant reduction in CH4 emissions from wetlands in the year 2006, probably through changing the methanogen composition and decreasing its community size as well as activating methanotrophs to enhance CH4 oxidation. Our results are helpful to understand the inter-annual variations of CH4 emission and provide a more reasonable regional budget of CH4 emission from wetlands on the QTP and even for world-wide natural wetlands under climate change.	[Chen, Huai; Wu, Ning; Zhu, Dan] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Chen, Huai; Zhu, Qiu'an; Yang, Gang; Peng, Changhui] NW A&F Univ, Lab Ecol Forecasting & Global Change, Coll Forestry, Yangling, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yongheng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Fang, Xiuqin; Peng, Changhui] Univ Quebec Montreal, Inst Environm Sci, Montreal, PQ, Canada; [Wang, Xu] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University of Quebec; University of Quebec Montreal; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF	Chen, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	chenhuai81@gmail.com; wuning@cib.ac.cn	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X	National Natural Science Foundation of China [31100348]; Natural Science Foundation Project of CQ CSTC [2009BB7182]; Natural Sciences and Engineering Research Council of Canada (NSERC); China QianRen programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); China QianRen programme	This study was supported by the National Natural Science Foundation of China (No. 31100348), Natural Science Foundation Project of CQ CSTC (2009BB7182), Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant, and the China QianRen programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Chen H, 2009, SCI TOTAL ENVIRON, V407, P1097, DOI 10.1016/j.scitotenv.2008.10.038; Chen H, 2010, ENVIRON MONIT ASSESS, V164, P21, DOI 10.1007/s10661-009-0871-3; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Dowrick DJ, 2006, GEODERMA, V132, P384, DOI 10.1016/j.geoderma.2005.06.003; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Freeman C, 2002, SOIL BIOL BIOCHEM, V34, P61, DOI 10.1016/S0038-0717(01)00154-7; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2011, ATMOS ENVIRON, V45, P5632, DOI 10.1016/j.atmosenv.2011.03.010; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Knorr KH, 2009, SOIL BIOL BIOCHEM, V41, P1187, DOI 10.1016/j.soilbio.2009.02.030; Li L, 2010, ARCT ANTARCT ALP RES, V42, P449, DOI 10.1657/1938-4246-42.4.449; Middelburg JJ, 2002, BIOGEOCHEMISTRY, V59, P95, DOI 10.1023/A:1015515130419; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Ringeval B, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003354; SHANNON RD, 1994, BIOGEOCHEMISTRY, V27, P35, DOI 10.1007/BF00002570; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Tian JQ, 2012, EUROPEAN J SOIL BIOL, DOI [10.1016/j.ej-sobi.2012.1007.1003, DOI 10.1016/J.EJSOBI.2012.1007.1003]; [王德宣 Wang Dexuan], 2002, [地球科学进展, Advance in Earth Sciences], V17, P877; Wang MH, 1987, SCI GEOGRAPHICA SINI, V18, P145; Wu N, 1997, ERDE, V128, P67; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Xu BQ, 2001, SCI CHINA SER D, V44, P689, DOI 10.1007/BF02907198; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yan XY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003182; Zhang Y, 2011, ENVIRON MONIT ASSESS, V180, P189, DOI 10.1007/s10661-010-1781-0	42	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53878	10.1371/journal.pone.0053878	http://dx.doi.org/10.1371/journal.pone.0053878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342029	gold, Green Published			2022-12-25	WOS:000314759400093
J	Becking, LE; Erpenbeck, D; Peijnenburg, KTCA; de Voogd, NJ				Becking, Leontine E.; Erpenbeck, Dirk; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.			Phylogeography of the Sponge Suberites diversicolor in Indonesia: Insights into the Evolution of Marine Lake Populations	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; HALOCARIDINA-RUBRA; LIFE-HISTORY; CORAL-REEFS; PORIFERA; BIODIVERSITY; DEMOSPONGIAE; SPECIATION; DYNAMICS; PATTERNS	The existence of multiple independently derived populations in landlocked marine lakes provides an opportunity for fundamental research into the role of isolation in population divergence and speciation in marine taxa. Marine lakes are landlocked water bodies that maintain a marine character through narrow submarine connections to the sea and could be regarded as the marine equivalents of terrestrial islands. The sponge Suberites diversicolor (Porifera: Demospongiae: Suberitidae) is typical of marine lake habitats in the Indo-Australian Archipelago. Four molecular markers (two mitochondrial and two nuclear) were employed to study genetic structure of populations within and between marine lakes in Indonesia and three coastal locations in Indonesia, Singapore and Australia. Within populations of S. diversicolor two strongly divergent lineages (A & B) (COI: p = 0.4% and ITS: p = 7.3%) were found, that may constitute cryptic species. Lineage A only occurred in Kakaban lake (East Kalimantan), while lineage B was present in all sampled populations. Within lineage B, we found low levels of genetic diversity in lakes, though there was spatial genetic population structuring. The Australian population is genetically differentiated from the Indonesian populations. Within Indonesia we did not record an East-West barrier, which has frequently been reported for other marine invertebrates. Kakaban lake is the largest and most isolated marine lake in Indonesia and contains the highest genetic diversity with genetic variants not observed elsewhere. Kakaban lake may be an area where multiple putative refugia populations have come into secondary contact, resulting in high levels of genetic diversity and a high number of endemic species.	[Becking, Leontine E.; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands; [Becking, Leontine E.] Inst Marine Resources & Ecosyst Studies IMARES, Maritime Dept, Den Helder, Netherlands; [Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	Naturalis Biodiversity Center; Wageningen University & Research; University of Munich; University of Munich; University of Amsterdam	Becking, LE (corresponding author), Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands.	lisa.becking@naturalis.nl	de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013; Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016	de Voogd, Nicole/0000-0002-7985-5604; Peijnenburg, Katja TCA/0000-0001-7544-1079; Erpenbeck, Dirk/0000-0003-2716-1085	Netherlands Organisation for Scientific Research (NWO) [817.01.008, 825.12.007]; NWO-VENI grant [863.08.024]; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation; Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO-VENI grant; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	L. Becking is supported by the Netherlands Organisation for Scientific Research (NWO) (ALW# 817.01.008; Rubicon# 825.12.007). K. Peijnenburg was supported by NWO-VENI grant #863.08.024. Fieldwork in Indonesia was made possible through additional financial support of De Beukelaar- van der Hucht Stichting, World Wildlife Foundation Netherlands-INNO Fund, the Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW), Conservation International Ecosystem Based Management program (funded by The David and Lucile Packard Foundation), the Treub-Maatschappij Fund, the Leiden University Fund (LUF)/Slingelands, Singapore Airlines, the A.M. Buitendijk Fund and the J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Arp G, 1996, RES REPORTS S, V2, P1; Azzini Francesca, 2007, V28, P157; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Bauza-Ribot MM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-221; Becking L. E., 2009, Zoologische Mededelingen (Leiden), V83, P853; Becking LE, 2013, MAR ECOL PROG SER, V481, P105, DOI 10.3354/meps10155; Becking LE, 2011, HYDROBIOLOGIA, V677, P89, DOI 10.1007/s10750-011-0742-0; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Blanquer A, 2008, MAR ECOL PROG SER, V371, P109, DOI 10.3354/meps07679; Botello A, 2010, BIOL J LINN SOC, V99, P315, DOI 10.1111/j.1095-8312.2009.01355.x; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Chombard Catherine, 1999, Memoirs of the Queensland Museum, V44, P100; Colin P. L., 2009, MARINE ENV PALAU, P416; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Dawson M. N., 2009, ENCY ISLANDS, P603; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P679, DOI 10.1017/S0025315405011604; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; Dawson MN, 2006, JMBA GLOBAL MARINE E, V3, P26; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2005, J ZOOL SYST EVOL RES, V43, P93, DOI 10.1111/j.1439-0469.2005.00306.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GEYH MA, 1979, NATURE, V278, P441, DOI 10.1038/278441a0; Goto TV, 2011, ZOOL SCI, V28, P568, DOI 10.2108/zsj.28.568; Gotoh RO, 2009, GENES GENET SYST, V84, P287, DOI 10.1266/ggs.84.287; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hamner WM, 1998, PHYS GEOGR, V19, P175, DOI 10.1080/02723646.1998.10642647; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hoeksema Bert W., 2007, V29, P117; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lim SC, 2009, RAFFLES B ZOOL, P41; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; MAC ARTHUR ROBERT H., 1967; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Mariani S, 2005, J PLANKTON RES, V27, P249, DOI 10.1093/plankt/fbh173; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO, P378; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nuryanto A, 2009, CORAL REEFS, V28, P607, DOI 10.1007/s00338-009-0483-y; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRONZATO R, 1994, B ZOOL, V61, P395, DOI 10.1080/11250009409355912; Rambaut A., 2007, TRACER V1 4; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Russ A, 2010, REV BIOL TROP, V58, P159; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Santos SR, 2011, HYDROBIOLOGIA, V677, P53, DOI 10.1007/s10750-010-0588-x; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Tomascik T, 1997, ECOLOGY INDONESIA 2, P752; Tomascik Tomas, 1994, Tropical Biodiversity, V2, P385; Uriz MJ, 2012, ADV MAR BIOL, V61, P345, DOI 10.1016/B978-0-12-387787-1.00006-4; Vogler C, 2013, CORAL REEFS, V32, P515, DOI 10.1007/s00338-012-1003-z; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Whittaker RJ, 2008, ISLAND BIOGEOGRAPHY; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	94	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75996	10.1371/journal.pone.0075996	http://dx.doi.org/10.1371/journal.pone.0075996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098416	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100034
J	Cheng, HL; Furnham, A				Cheng, Helen; Furnham, Adrian			Correlates of Adult Binge Drinking: Evidence from a British Cohort	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; ALCOHOL-CONSUMPTION; PERSONALITY; INTELLIGENCE; CHILDHOOD; ANXIETY	Objective: To investigate whether parental social class and cognitive ability in childhood, as well as social and psychological factors, particularly personality traits, are independently associated with binge drinking in 50 year old adults assessed in a longitudinal birth cohort study. Method: 17,415 babies born in Great Britain in 1958 and followed up at 11, 33, and 50 years of age. Their binge drinking alcohol abuse at aged 50 was the outcome measure. Results: 6,478 participants with data on parental social class, childhood cognitive ability, educational qualifications at age 33, personality traits, psychological distress, occupational levels, and alcohol consumption (all measured at age 50) were included in the study. Using logistic regression analyses, results showed that parental social class, childhood intelligence, educational qualifications, occupational levels, personality traits (Extraversion and Disagreeableness), as well as psychological distress, were all significantly and independently associated with adult excessive alcohol use. Men tended to binge drink more than women (22% in men and 9.8% in women). Conclusion: Both social and psychological factors influence adult excessive alcohol consumption. Personality traits play a more important role than previously understood. There appears to be a distinction between the frequency and dose level of alcohol consumption.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England; [Furnham, Adrian] BI Norwegian Business Sch, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X				Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Chambless DL, 1987, J ANXIETY DIORD, V1, P29; Ciarrochi J, 2012, INTELLIGENCE, V40, P317, DOI 10.1016/j.intell.2012.03.003; Cook M, 1998, PERS INDIV DIFFER, V24, P641, DOI 10.1016/S0191-8869(97)00214-6; Davie R, 1972, BIRTH 7; Douglas James W.B, 1964, HOME SCH; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; Furnham A, 2003, BINGE DRINKING; Furnham A., 2008, PERSONALITY INTELLIG; George SM, 2010, PERS INDIV DIFFER, V49, P204, DOI 10.1016/j.paid.2010.03.036; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Gratzer D, 2004, J AFFECT DISORDERS, V79, P209, DOI 10.1016/S0165-0327(02)00355-5; Gunn RL, 2013, ADDICT BEHAV, V38, P2352, DOI 10.1016/j.addbeh.2013.02.009; Kanazawa S, 2012, INTELLIGENCE PARADOX; Kanazawa S, 2010, REV GEN PSYCHOL, V14, P382, DOI 10.1037/a0021526; Leete R, 1977, POPULATION TRENDS, V8, P1; Leino J, 2011, SCAND J PUBLIC HEALT, V39, P749, DOI 10.1177/1403494811421056; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; MARSH C, 1986, KEY VARIABLES SOCIAL; MARTIN NG, 1989, BEHAV GENET, V19, P97, DOI 10.1007/BF01065886; Plewis I, 2004, NATL CHILD DEV STUDY; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutter M., 1976, CYCLES DISADVANTAGE; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Wilkinson R., 2003, Social determinants of health: the solid facts	32	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78838	10.1371/journal.pone.0078838	http://dx.doi.org/10.1371/journal.pone.0078838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	23342029	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700054
J	Huang, LN; Liu, Y; Zhang, P; Kang, RT; Liu, Y; Li, XZ; Bo, LJ; Dong, ZM				Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming			In Vitro Dose-Dependent Inhibition of the Intracellular Spontaneous Calcium Oscillations in Developing Hippocampal Neurons by Ketamine	PLOS ONE			English	Article							REGIONAL EXPRESSION; CA2+ OSCILLATIONS; NMDA RECEPTORS; RAT; NEUROTOXICITY; INVOLVEMENT; MECHANISMS; GABA(A); CHANNEL; BRAIN	Spatial and temporal abnormalities in the frequency and amplitude of the cytosolic calcium oscillations can impact the normal physiological functions of neuronal cells. Recent studies have shown that ketamine can affect the growth and development and even induce the apoptotic death of neurons. This study used isolated developing hippocampal neurons as its study subjects to observe the effect of ketamine on the intracellular calcium oscillations in developing hippocampal neurons and to further explore its underlying mechanism using Fluo-4-loaded laser scanning confocal microscopy. Using a semi-quantitative method to analyze the spontaneous calcium oscillatory activities, a typical type of calcium oscillation was observed in developing hippocampal neurons. In addition, the administration of NMDA (N-Methyl-D-aspartate) at a concentration of 100 mu M increased the calcium oscillation amplitude. The administration of MK801 at a concentration of 40 mu M inhibited the amplitude and frequency of the calcium oscillations. Our results demonstrated that an increase in the ketamine concentration, starting from 30 mu M, gradually decreased the neuronal calcium oscillation amplitude. The inhibition of the calcium oscillation frequency by 300 mu M ketamine was statistically significant, and the neuronal calcium oscillations were completely eliminated with the administration of 3,000 mu M Ketamine. The administration of 100, 300, and 1,000 mu M NMDA to the 1 mM ketamine-pretreated hippocampal neurons restored the frequency and amplitude of the calcium oscillations in a dose-dependent manner. In fact, a concentration of 1,000 mu M NMDA completely reversed the decrease in the calcium oscillation frequency and amplitude that was induced by 1 mM ketamine. This study revealed that ketamine can inhibit the frequency and amplitude of the calcium oscillations in developing hippocampal neurons though the NMDAR (NMDA receptor) in a dose-dependent manner, which might highlight a possible underlying mechanism of ketamine toxicity on the rat hippocampal neurons during development.	[Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming] Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University	Dong, ZM (corresponding author), Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China.	dongzhenmingmzk@yahoo.com.cn		Mo, Jinhan/0000-0002-3178-6507	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society [CSA2010LB017]; Key Medicine Scientific Developing Program of Hebei Province [20110338]	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society; Key Medicine Scientific Developing Program of Hebei Province	This work was supported by Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society (CSA2010LB017) and Key Medicine Scientific Developing Program of Hebei Province (No. 20110338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Dunn RJ, 1999, J EXP BIOL, V202, P1319; Gomes LMRS, 2011, PAIN PHYSICIAN, V14, P83; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; IRIFUNE M, 1992, BRAIN RES, V596, P1, DOI 10.1016/0006-8993(92)91525-J; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; JACOBSON I, 1990, EXP BRAIN RES, V80, P409; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LIN LH, 1992, J PHARMACOL EXP THER, V263, P569; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Paupard MC, 1997, NEUROSCIENCE, V79, P399, DOI 10.1016/S0306-4522(96)00677-X; Przewlocki R, 1999, J NEUROSCI, V19, P9705; Sinner B, 2005, ANESTH ANALG, V100, P1660, DOI 10.1213/01.ANE.0000150946.18875.48; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Tang FJ, 2003, J NEUROSCI, V23, P927; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P877, DOI 10.1007/s10571-004-6927-6; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010; Zou XJ, 2009, TOXICOL SCI, V108, P149, DOI 10.1093/toxsci/kfn270	40	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59804	10.1371/journal.pone.0059804	http://dx.doi.org/10.1371/journal.pone.0059804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	24244522	gold, Green Published, Green Submitted			2022-12-25	WOS:000317262200040
J	Yu, H; Jin, HW; Sun, LD; Zhang, LR; Sun, G; Wang, ZL; Yu, YC				Yu, Hui; Jin, Hongwei; Sun, Lidan; Zhang, Liangren; Sun, Gang; Wang, Zhanli; Yu, Yongchun			Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies	PLOS ONE			English	Article							TLR7; RECOGNITION; INFECTION; PATTERNS; LIGANDS	Chemical feature based pharmacophore models were generated for Toll-like receptors 7 (TLR7) agonists using HypoGen algorithm, which is implemented in the Discovery Studio software. Several methods tools used in validation of pharmacophore model were presented. The first hypothesis Hypo1 was considered to be the best pharmacophore model, which consists of four features: one hydrogen bond acceptor, one hydrogen bond donor, and two hydrophobic features. In addition, homology modeling and molecular docking studies were employed to probe the intermolecular interactions between TLR7 and its agonists. The results further confirmed the reliability of the pharmacophore model. The obtained pharmacophore model (Hypo1) was then employed as a query to screen the Traditional Chinese Medicine Database (TCMD) for other potential lead compounds. One hit was identified as a potent TLR7 agonist, which has antiviral activity against hepatitis virus in vitro. Therefore, our current work provides confidence for the utility of the selected chemical feature based pharmacophore model to design novel TLR7 agonists with desired biological activity.	[Yu, Hui; Yu, Yongchun] Tongji Univ, Affiliated Peoples Hosp 10, Dept Lab Ctr, Shanghai 200092, Peoples R China; [Jin, Hongwei; Sun, Lidan; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Hui; Sun, Gang] Second Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China; [Wang, Zhanli] First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China	Tongji University; Peking University; Baotou Medical College; Baotou Medical College	Wang, ZL (corresponding author), First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China.	wang.zhanli@hotmail.com; yyc@tongji.edu.cn	Zhang, Liang/GWM-6088-2022; Patel, Hemal/C-7325-2019	Westenbrink, B. Daan/0000-0002-1362-7019; Patel, Hemal/0000-0001-6722-9625; van Gilst, Wiek/0000-0003-2968-8585	National Natural Science Foundation of China [20902068]; Ministry of Education of China [20090001120049]; Natural Science Foundation of Inner Mongolia Autonomous Region, China [2011BS1201]; State Key Laboratory of Natural and Biomimetic Drugs [K20110103]; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Inner Mongolia Autonomous Region, China; State Key Laboratory of Natural and Biomimetic Drugs; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	This work was supported in part by grants from the National Natural Science Foundation of China (No. 20902068), Doctoral Fund of Ministry of Education of China (No. 20090001120049), Natural Science Foundation of Inner Mongolia Autonomous Region, China (No. 2011BS1201), Project of State Key Laboratory of Natural and Biomimetic Drugs (No. K20110103), and Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2005, TRAD CHIN MED DAT TC; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHONG L, 2008, Patent No. 200805555; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; COOK A, 2008, Patent No. 2008004948; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gong J, 2010, J MOL MODEL, V16, P1283, DOI 10.1007/s00894-009-0640-9; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iavarone C, 2011, J IMMUNOL, V186, P4213, DOI 10.4049/jimmunol.1003585; JONES P, 2006, Patent No. 2006117670; JONES P, 2007, Patent No. 200709301; Jones P, 2011, BIOORG MED CHEM LETT, V21, P5939, DOI 10.1016/j.bmcl.2011.07.076; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li H, 2000, IUL BIOTECH, V2, P171; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Pryde DC, 2011, MEDCHEMCOMM, V2, P185, DOI 10.1039/c0md00197j; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TD, 2011, BIOORG MED CHEM LETT, V21, P2389, DOI 10.1016/j.bmcl.2011.02.092; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Yu H, 2012, CURR MED CHEM, V19, P1365, DOI 10.2174/092986712799462603	34	69	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56514	10.1371/journal.pone.0056514	http://dx.doi.org/10.1371/journal.pone.0056514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526932	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562600005
J	Yang, Y; Wang, Q				Yang, Yong; Wang, Qi			The Earliest Fleshy Cone of Ephedra from the Early Cretaceous Yixian Formation of Northeast China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GNETALES; AGE; CHLOROPLAST; FOSSIL; MORPHOLOGY; ANGIOSPERM; DISPERSAL; DIVERSITY; PORTUGAL	Bracts of female cones of extant gymnosperm Ephedra (Joint fir) are either colorful and fleshy (section Ephedra), or dry-winged and membranous (section Alatae), or dry and coriaceous (section Asarca), which have played a crucial role in long-distance seed dispersal that is responsible for a wide distribution of the genus in semiarid and arid areas of Eurasia, North Africa, North America, and South America. Recent molecular systematic studies on Ephedra have suggested that the fleshy bracts in character evolution may be plesiomorphic relative to the dry, membranous and coriaceous bracts. However, little is known about when the fleshy bracts of Ephedra have made their debut in the geological past. Herein, we describe a novel, fleshy bract-bearing female cone macrofossil from the Early Cretaceous (ca. 120-125 Ma) Yixian Formation in Liaoning, northeastern China. This cone bears three ellipsoid seeds subtended by only one whorl of fleshy bracts. Each seed has a thin outer envelope and an inner integument that extends upward and passes through the opening of the outer envelope, forming a thin and straight micropylar tube. Such a syndrome shows the closest similarity to an extant triovulate species Ephedra intermedia in the section Ephedra, but the latter bears a whorl of terminal fertile bracts and more than one whorl of inferior sterile bracts, and a thick outer envelope. Hence, we establish a new fossil species Ephedra carnosa. Our discovery provides the first direct macrofossil evidence for the previous molecular systematics of Ephedra, implying that the origin of fleshy bracts in Ephedra should not have been later than that of the membranous and coriaceous bracts by at least the Early Cretaceous.	[Yang, Yong; Wang, Qi] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, Q (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	happyking@ibcas.ac.cn	Yang, Yong/S-1202-2019	Kang, Hong-Yo/0000-0003-0626-5037; Fu, Hung-Chun/0000-0002-0660-9349	National Natural Science Foundation of China [30970177, 30600035, 40830209, 40972015]; State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences [56176G1044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National Natural Science Foundation of China (no. 30970177, 30600035, 40830209, 40972015), the State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences (no. 56176G1044) to WQ and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, STRELITZIA, V20, P1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Caveney S, 2001, AM J BOT, V88, P1199, DOI 10.2307/3558330; Cladera Gerardo, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P49; Duan SY, 1998, SCI CHINA SER D, V41, P14, DOI 10.1007/BF02932415; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Fu LK, 1999, FLORA CHINA, P97; Gifford E.M., 1989, COMP MORPHOLOGY VASC; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guo S.X., 2000, ACTA PALAEONTOLOGICA, V39, P81; Hollander JL, 2010, EVOL ECOL, V24, P333, DOI 10.1007/s10682-009-9309-1; Hollander JL, 2009, INT J PLANT SCI, V170, P323, DOI 10.1086/596334; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krassilov VA, 2009, PALEONTOL J+, V43, P1272, DOI 10.1134/S0031030109100098; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kubitzki K., 1990, FAMILIES GENERA VASC, V1, P378; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Liu HM, 2008, TAXON, V57, P577, DOI 10.2307/25066023; Pearson HHW, 1929, GNETALES; Price RA, 1996, INT J PLANT SCI, V157, pS40, DOI 10.1086/297402; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rydin C, 2006, PLANT SYST EVOL, V262, P239, DOI 10.1007/s00606-006-0481-2; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-183; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Stapf O., 1889, MATHEMATISCH NATURWI, V56, P1; Stevenson D.W., 1993, FLORA N AM, V2, P428; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Yang Y, 2005, BOT BULL ACAD SINICA, V46, P363; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231; Yang Y, 2004, AM J BOT, V91, P361, DOI 10.3732/ajb.91.3.361; Yang Y, 2001, ACTA BOT SIN, V43, P1011; Yang Y., 2002, CHIN ACAD SCI, P1; Yang Y, 2007, TAXON, V56, P1271, DOI 10.2307/25065920; Yang Yong, 2011, Journal of Tropical and Subtropical Botany, V19, P1; [杨永 Yang Yong], 2011, [地质论评, Geological Review], V57, P9; Yang Yong, 2010, Taiwania, V55, P346; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 王鑫, 2010, [科学通报, Chinese Science Bulletin], V55, P675	54	37	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53652	10.1371/journal.pone.0053652	http://dx.doi.org/10.1371/journal.pone.0053652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	24244503	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400058
